PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, CY; Borsuk, ME; Bugge, DM; Hollweg, T; Balcom, PH; Ward, DM; Williams, J; Mason, RP				Chen, Celia Y.; Borsuk, Mark E.; Bugge, Deenie M.; Hollweg, Terill; Balcom, Prentiss H.; Ward, Darren M.; Williams, Jason; Mason, Robert P.			Benthic and Pelagic Pathways of Methylmercury Bioaccumulation in Estuarine Food Webs of the Northeast United States	PLOS ONE			English	Article							SUBMARINE GROUNDWATER DISCHARGE; DISSOLVED ORGANIC-CARBON; SAN-FRANCISCO-BAY; INORGANIC MERCURY; GAS-CHROMATOGRAPHY; CONTINENTAL-SHELF; METHYL MERCURY; CHESAPEAKE BAY; TRACE-METALS; SEDIMENTS	Methylmercury (MeHg) is a contaminant of global concern that bioaccumulates and bioamagnifies in marine food webs. Lower trophic level fauna are important conduits of MeHg from sediment and water to estuarine and coastal fish harvested for human consumption. However, the sources and pathways of MeHg to these coastal fisheries are poorly known particularly the potential for transfer of MeHg from the sediment to biotic compartments. Across a broad gradient of human land impacts, we analyzed MeHg concentrations in food webs at ten estuarine sites in the Northeast US (from the Hackensack Meadowlands, NJ to the Gulf of Maine). MeHg concentrations in water column particulate material, but not in sediments, were predictive of MeHg concentrations in fish (killifish and Atlantic silversides). Moreover, MeHg concentrations were higher in pelagic fauna than in benthic-feeding fauna suggesting that MeHg delivery to the water column from methylation sites from within or outside of the estuary may be an important driver of MeHg bioaccumulation in estuarine pelagic food webs. In contrast, bulk sediment MeHg concentrations were only predictive of concentrations of MeHg in the infaunal worms. Our results across a broad gradient of sites demonstrate that the pathways of MeHg to lower trophic level estuarine organisms are distinctly different between benthic deposit feeders and forage fish. Thus, even in systems with contaminated sediments, transfer of MeHg into estuarine food webs maybe driven more by the efficiency of processes that determine MeHg input and bioavailability in the water column.	[Chen, Celia Y.; Bugge, Deenie M.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Borsuk, Mark E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Hollweg, Terill] Stratus Consulting, Boulder, CO USA; [Balcom, Prentiss H.; Mason, Robert P.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Ward, Darren M.] Humboldt State Univ, Dept Fisheries Biol, Arcata, CA 95521 USA; [Williams, Jason] Washington State Univ, Dept Civil & Environm Engn, Pullman, WA 99164 USA	Dartmouth College; Dartmouth College; University of Connecticut; California State University System; California State Polytechnic University, Humboldt; Washington State University	Chen, CY (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	Celia.Y.Chen@dartmouth.edu	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	NIH from the National Institute of Environmental Health Sciences [P42 ES007373]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	NIH from the National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described was supported by NIH Grant Number P42 ES007373 from the National Institute of Environmental Health Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcom PH, 2004, MAR CHEM, V90, P53, DOI 10.1016/j.marchem.2004.02.020; Balcom PH, 2008, MAR CHEM, V109, P1, DOI 10.1016/j.marchem.2007.09.005; Beck AJ, 2009, ESTUAR COAST, V32, P535, DOI 10.1007/s12237-009-9140-5; Benoit JM, 1998, BIOGEOCHEMISTRY, V40, P249, DOI 10.1023/A:1005905700864; Benoit JM, 2003, ACS SYM SER, V835, P262; BLOOM N, 1989, CAN J FISH AQUAT SCI, V46, P1131, DOI 10.1139/f89-147; BLOOM N, 1988, ANAL CHIM ACTA, V208, P151, DOI 10.1016/S0003-2670(00)80743-6; BLOOM NS, 1983, MAR CHEM, V14, P49, DOI 10.1016/0304-4203(83)90069-5; Bone SE, 2007, ENVIRON SCI TECHNOL, V41, P3090, DOI 10.1021/es0622453; Chasar LC, 2009, ENVIRON SCI TECHNOL, V43, P2733, DOI 10.1021/es8027567; Chen CY, 2009, ENVIRON SCI TECHNOL, V43, P1804, DOI 10.1021/es8017122; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Cleckner LB, 2003, J GREAT LAKES RES, V29, P134, DOI 10.1016/S0380-1330(03)70422-5; Coelho JP, 2008, MAR POLLUT BULL, V56, P1104, DOI 10.1016/j.marpolbul.2008.03.020; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; Conaway CH, 2003, MAR CHEM, V80, P199, DOI 10.1016/S0304-4203(02)00135-4; Davis JA, 2012, ENVIRON RES, V119, P3, DOI 10.1016/j.envres.2012.10.002; Deegan LA, 1997, MAR ECOL PROG SER, V147, P31, DOI 10.3354/meps147031; DRISCOLL CT, 1995, WATER AIR SOIL POLL, V80, P499, DOI 10.1007/BF01189700; FITZGERALD WF, 1979, ANAL CHEM, V51, P1714, DOI 10.1021/ac50047a030; Fitzgerald WF, 2010, SYNTHESIS ASSESSMENT; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Fry B, 2008, MAR ECOL PROG SER, V369, P193, DOI 10.3354/meps07644; Fry B, 2012, ECOL APPL, V22, P606, DOI 10.1890/11-0921.1; Gagnon C, 1997, ENVIRON SCI TECHNOL, V31, P993, DOI 10.1021/es960364k; Galvan K, 2011, J EXP MAR BIOL ECOL, V410, P1, DOI 10.1016/j.jembe.2011.08.007; Gehrke GE, 2011, ENVIRON SCI TECHNOL, V45, P1264, DOI 10.1021/es103053y; GILL GA, 1985, DEEP-SEA RES, V32, P287, DOI 10.1016/0198-0149(85)90080-9; Gorski PR, 2008, ENVIRON POLLUT, V154, P116, DOI 10.1016/j.envpol.2007.12.004; GRIEB TM, 1990, ENVIRON TOXICOL CHEM, V9, P919, DOI [10.1897/1552-8618(1990)9[919:FAMAIF]2.0.CO;2, 10.1002/etc.5620090710]; Guo LD, 2001, ENVIRON SCI TECHNOL, V35, P885, DOI 10.1021/es001758l; Haas HL, 2009, J EXP MAR BIOL ECOL, V369, P8, DOI 10.1016/j.jembe.2008.09.027; Hall BD, 1997, WATER AIR SOIL POLL, V100, P13; Hammerschmidt CR, 2008, MAR CHEM, V109, P165, DOI 10.1016/j.marchem.2008.01.007; Hammerschmidt CR, 2006, GEOCHIM COSMOCHIM AC, V70, P918, DOI 10.1016/j.gca.2005.10.020; Hammerschmidt CR, 2004, MAR CHEM, V90, P31, DOI 10.1016/j.marchem.2004.02.024; Hesterberg D, 2001, ENVIRON SCI TECHNOL, V35, P2741, DOI 10.1021/es001960o; Heyes A, 2006, MAR CHEM, V102, P134, DOI 10.1016/j.marchem.2005.09.018; Hollweg TA, 2010, LIMNOL OCEANOGR, V55, P2703, DOI 10.4319/lo.2010.55.6.2703; Hollweg TA, 2009, MAR CHEM, V114, P86, DOI 10.1016/j.marchem.2009.04.004; HORVAT M, 1993, ANAL CHIM ACTA, V282, P153, DOI 10.1016/0003-2670(93)80364-Q; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Kim EH, 2004, MAR CHEM, V86, P121, DOI 10.1016/j.marchem.2003.12.004; Kim EH, 2006, MAR CHEM, V102, P300, DOI 10.1016/j.marchem.2006.05.006; Kim E, 2008, ECOL MODEL, V218, P267, DOI 10.1016/j.ecolmodel.2008.07.008; King JK, 1999, ENVIRON TOXICOL CHEM, V18, P1362, DOI 10.1002/etc.5620180704; Kiviat E, 2002, HACKENSACK MEADOWLAN; Langer C. S., 2001, Wetlands Ecology and Management, V9, P295, DOI 10.1023/A:1011816819369; Lawrence AL, 2001, ENVIRON POLLUT, V111, P217, DOI 10.1016/S0269-7491(00)00072-5; Lawrence AL, 1999, ENVIRON SCI TECHNOL, V33, P1871, DOI 10.1021/es981328j; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Liu B, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000752; Mason RP, 2006, MAR CHEM, V102, P96, DOI 10.1016/j.marchem.2005.09.021; Mason RP, 2012, ENVIRON RES, V119, P101, DOI 10.1016/j.envres.2012.03.013; Mason RP, 1999, ENVIRON TOXICOL CHEM, V18, P2438, DOI 10.1002/etc.5620181109; Mason RP, 1999, MAR CHEM, V65, P77, DOI 10.1016/S0304-4203(99)00012-2; MASON RP, 1995, WATER AIR SOIL POLL, V80, P915, DOI 10.1007/BF01189744; Mason RP, 1996, ENVIRON SCI TECHNOL, V30, P1835, DOI 10.1021/es950373d; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; Mikac N, 1999, APPL ORGANOMET CHEM, V13, P715, DOI 10.1002/(SICI)1099-0739(199910)13:10<715::AID-AOC918>3.0.CO;2-4; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; Pan JF, 2004, MAR ECOL PROG SER, V276, P125, DOI 10.3354/meps276125; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pickhardt PC, 2007, ENVIRON SCI TECHNOL, V41, P125, DOI 10.1021/es060966w; Pickhardt PC, 2006, ENVIRON TOXICOL CHEM, V25, P2132, DOI 10.1897/05-595R.1; Point D, 2007, ANAL BIOANAL CHEM, V389, P787, DOI 10.1007/s00216-007-1516-4; Power M, 2002, J APPL ECOL, V39, P819, DOI 10.1046/j.1365-2664.2002.00758.x; Rolfhus KR, 2001, GEOCHIM COSMOCHIM AC, V65, P407, DOI 10.1016/S0016-7037(00)00519-6; Rolfhus KR, 2011, ECOTOXICOLOGY, V20, P1520, DOI 10.1007/s10646-011-0733-y; Rutkiewicz J, 2011, ECOTOXICOLOGY, V20, P1669, DOI 10.1007/s10646-011-0730-1; Schartup AT, 2013, ENVIRON SCI TECHNOL, V47, P695, DOI 10.1021/es302566w; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Shanley J.B., 2002, EOS T AM GEOPHYS UN, V83, P45; Skyllberg U, 2006, ENVIRON SCI TECHNOL, V40, P4174, DOI 10.1021/es0600577; Skyllberg U, 2010, ENVIRON SCI TECHNOL, V44, P1254, DOI 10.1021/es902091w; Stewart AR, 2008, CAN J FISH AQUAT SCI, V65, P2351, DOI 10.1139/F08-140; Sunderland EM, 2007, ENVIRON HEALTH PERSP, V115, P235, DOI 10.1289/ehp.9377; Sunderland EM, 2012, ENVIRON RES, V119, P27, DOI 10.1016/j.envres.2012.03.011; Sunderland EM, 2010, ENVIRON SCI TECHNOL, V44, P1698, DOI 10.1021/es9032524; Taylor DL, 2012, MAR POLLUT BULL, V64, P807, DOI 10.1016/j.marpolbul.2012.01.013; Taylor VF, 2008, ANAL BIOANAL CHEM, V392, P1283, DOI 10.1007/s00216-008-2403-3; Tseng CM, 2004, ANAL CHEM, V76, P7131, DOI 10.1021/ac049118e; United States :Environmental Protection Agency, 1998, 7473SW846 EPA; [USEPA] United States Environmental Protection Agency, 2001, EPA821R01020; USEPA United States Environmental Protection Agency, 2002, EPA821R02019; Watras CJ, 1998, SCI TOTAL ENVIRON, V219, P183, DOI 10.1016/S0048-9697(98)00228-9; WATRAS CJ, 1995, WATER AIR SOIL POLL, V84, P253, DOI 10.1007/BF00475343; WEIS P, 1986, ENVIRON POLLUT A, V40, P303, DOI 10.1016/0143-1471(86)90064-4; Wiener JG, 2012, ENVIRON POLLUT, V161, P350, DOI 10.1016/j.envpol.2011.09.025; Williams JJ, 2010, ENVIRON TOXICOL CHEM, V29, P1755, DOI 10.1002/etc.207; Wyn B, 2009, CAN J FISH AQUAT SCI, V66, P1532, DOI 10.1139/F09-097; Yee D, 2011, ENVIRON TOXICOL CHEM, V30, P88, DOI 10.1002/etc.366	95	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89305	10.1371/journal.pone.0089305	http://dx.doi.org/10.1371/journal.pone.0089305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	25144712	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700137
J	Chen, CJ; Wu, TL; Lu, PL; Chen, YT; Fung, CP; Chuang, YC; Lin, JC; Siu, LK				Chen, Chao-Ju; Wu, Tsu-Lan; Lu, Po-Liang; Chen, Ying-Tsong; Fung, Chang-Phone; Chuang, Yin-Ching; Lin, Jung-Chung; Siu, L. Kristopher			Closely Related NDM-1-Encoding Plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan	PLOS ONE			English	Article							BETA-LACTAMASE; 1ST IDENTIFICATION; RESISTANCE; STRAINS; PATIENT; OXYTOCA; NDM-1; INCN	Objective: Two plasmids carrying bla(NDM-1) isolated from carbapenem-resistant Klebsiella pneumoniae (CR-KP) and carbapenem-resistant Escherichia coli (CR-EC) were sequenced. CR-KP and CR-EC were isolated from two Taiwanese patients without travel histories. Methods: Complete sequencing of the plasmids (pLK75 and pLK78) was conducted using a shotgun approach. Annotation of the contigs was performed using the RAST Server, followed by manual inspection and correction. Results: These similar plasmids were obtained from two patients with overlapping stays at the same hospital. The pLK75 and pLK78 plasmids were 56,489-bp and 56,072-bp in length, respectively. Plasmid annotation revealed a common backbone similar to the IncN plasmid pR46. The regions flanking the bla(NDM-1) genes in these plasmids were very similar to plasmid pNDM-HU01 in Japan, which contains a complex class 1 integron located next to an ISCR1 element. The ISCR1 element has been suggested to provide a powerful mechanism for mobilising antibiotic resistance genes. Conclusion: Two indigenous NDM-1-producing Enterobacteriaceae cases were identified for the first time in Taiwan, highlighting the alarming introduction of NDM-1-producing Enterobacteriaceae in this region.	[Chen, Chao-Ju; Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Chao-Ju; Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Wu, Tsu-Lan] Linkou Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Fung, Chang-Phone] Taipei Vet Gen Hosp, Dept Med, Infect Dis Sect, Taipei, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med & Med Res, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Lin, Jung-Chung; Siu, L. Kristopher] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Lin, Jung-Chung] Natl Def Med Ctr, Inst Microbiol & Immunol, Taipei, Taiwan; [Siu, L. Kristopher] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Siu, L. Kristopher] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; National Chung Hsing University; National Chung Hsing University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Chi Mei Hospital; Chi Mei Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; China Medical University Taiwan; National Health Research Institutes - Taiwan	Lin, JC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan.	linjungchung1@yahoo.com.tw	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	Taiwan Centers for Diseases Control [DOH101-DC-1024, DOH102-DC-1508]; National Health Research Institutes; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	Taiwan Centers for Diseases Control; National Health Research Institutes(National Health Research Institutes, Japan); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the project grants, DOH101-DC-1024 and DOH102-DC-1508, from Taiwan Centers for Diseases Control and National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Chen YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048737; Chen YT, 2009, ANTIMICROB AGENTS CH, V53, P1235, DOI 10.1128/AAC.00970-08; CLSI, 2013, PERFORMANCE STANDARD; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HALL RM, 1987, NUCLEIC ACIDS RES, V15, P7491, DOI 10.1093/nar/15.18.7491; Huang TW, 2013, ANTIMICROB AGENTS CH, V57, P4072, DOI 10.1128/AAC.02266-12; Huang TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062774; Humphrey B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-53; Kim MN, 2012, J CLIN MICROBIOL, V50, P1433, DOI 10.1128/JCM.06855-11; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lai CC, 2011, DIAGN MICR INFEC DIS, V71, P474, DOI 10.1016/j.diagmicrobio.2011.09.004; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089893; Ma L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-599; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Siu LK, 1997, ANTIMICROB AGENTS CH, V41, P468, DOI 10.1128/AAC.41.2.468; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Wang SJ, 2013, DIAGN MICR INFEC DIS, V76, P248, DOI 10.1016/j.diagmicrobio.2013.02.003; Wu HS, 2010, J CHIN MED ASSOC, V73, P596, DOI 10.1016/S1726-4901(10)70129-5; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	22	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104899	10.1371/journal.pone.0104899	http://dx.doi.org/10.1371/journal.pone.0104899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144712	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100028
J	Chen, CB; Zhou, H; Zhang, XL; Ma, XL; Liu, ZJ; Liu, XG				Chen, Changbao; Zhou, Hua; Zhang, Xiaolin; Ma, Xinlong; Liu, Zhongjun; Liu, Xiaoguang			Elevated Levels of Dickkopf-1 Are Associated with beta-Catenin Accumulation and Poor Prognosis in Patients with Chondrosarcoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CANCER BONE METASTASES; HEPATOCELLULAR CARCINOMAS; NUCLEAR ACCUMULATION; EXPRESSION; PROTEIN; GENE; DKK1; REGULATOR; OSTEOSARCOMA	Background: Dickkopf-1 (DKK1) is an antagonist of Wnt/beta-catenin signaling implicated in tumorigenesis. However, the biological role of DKK1 and beta-catenin involved in chondrosarcoma has not been sufficiently investigated. This study was designed to investigate the expression profiles of DKK1 and beta-catenin, and to clarify their clinical values in chondrosarcoma. Methods: The mRNA and protein levels of DKK1 and beta-catenin in fresh chondrosarcoma and the corresponding non-tumor tissues were analyzed by Real-time PCR and Western blot, respectively. The protein expression patterns of DKK1 and bcatenin were investigated by immunohistochemistry. The associations among DKK1 level, beta-catenin accumulation, clinicopathological factors and the overall survival were separately evaluated. Results: Both DKK1 and beta-catenin levels were remarkably elevated in chondrosarcoma compared with the corresponding non-tumor tissues. High DKK1 level and positive beta-catenin accumulation in chondrosarcoma specimens were 58.7% and 53.9%, respectively. Elevated DKK1 level significantly correlated with positive beta-catenin accumulation, and they were remarkably associated with histological grade and Musculoskeletal Tumor Society stage. Furthermore, DKK1 level and bcatenin accumulation had significant impacts on the prognosis of chondrosarcoma patients. Multivariate analysis revealed that DKK1 level was an independent prognostic factor for overall survival. Conclusions: Elevated DKK1 levels associated with beta-catenin accumulation play a crucial role in chondrosarcoma. DKK1 can serve as a novel predictor of poor prognosis in patients with chondrosarcoma.	[Chen, Changbao; Zhang, Xiaolin; Ma, Xinlong] Tianjin Hosp, Dept Spinal Surg, Tianjin, Peoples R China; [Zhou, Hua; Liu, Zhongjun; Liu, Xiaoguang] Peking Univ, Dept Orthopaed Surg, Hosp 3, Beijing 100871, Peoples R China	Peking University	Ma, XL (corresponding author), Tianjin Hosp, Dept Spinal Surg, Tianjin, Peoples R China.	richivaldchen@gmail.com	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	National Natural Sciences Foundation of China [81102037]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Natural Sciences Foundation of China (81102037). http://www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Bertoni F., 2002, WHO CLASSIFICATION T, P247; Bovee JVMG, 2005, LANCET ONCOL, V6, P599, DOI 10.1016/S1470-2045(05)70282-5; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chen C, 2001, ANN SURG ONCOL, V18, P2364; Chen CB, 2011, J ORTHOP RES, V29, P143, DOI 10.1002/jor.21193; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Hall CL, 2006, J CELL BIOCHEM, V97, P661, DOI 10.1002/jcb.20735; Hameetman L, 2006, J PATHOL, V209, P501, DOI 10.1002/path.2008; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Lee N, 2007, BRIT J CANCER, V97, P1552, DOI 10.1038/sj.bjc.6604069; Li XQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-114; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Menezes ME, 2012, INT J CANCER, V130, P1477, DOI 10.1002/ijc.26449; Mitani T, 2012, J BIOL CHEM, V287, P33594, DOI 10.1074/jbc.M112.388298; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; O'Shea PJ, 2012, J BIOL CHEM, V287, P17812, DOI 10.1074/jbc.M111.311464; Rozeman LB, 2006, INT ORTHOP, V30, P437, DOI 10.1007/s00264-006-0212-x; Saito T, 2000, J PATHOL, V192, P342, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH705>3.0.CO;2-R; Schrage YM, 2009, AM J PATHOL, V174, P979, DOI 10.2353/ajpath.2009.080623; Suzuki R, 2007, BRIT J HAEMATOL, V138, P624, DOI 10.1111/j.1365-2141.2007.06702.x; Terris B, 1999, ONCOGENE, V18, P6583, DOI 10.1038/sj.onc.1203051; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9; Xu WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037624; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020	37	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105414	10.1371/journal.pone.0105414	http://dx.doi.org/10.1371/journal.pone.0105414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144712	gold, Green Submitted, Green Published			2022-12-25	WOS:000341106100065
J	Haas, LT; Kostylev, MA; Strittmatter, SM				Haas, Laura T.; Kostylev, Mikhail A.; Strittmatter, Stephen M.			Therapeutic Molecules and Endogenous Ligands Regulate the Interaction between Brain Cellular Prion Protein (PrPC) and Metabotropic Glutamate Receptor 5 (mGluR5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA OLIGOMERS; LONG-TERM DEPRESSION; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; ALLOSTERIC MODULATORS; ACTIVATION MECHANISM; SYNAPTIC PLASTICITY; COUPLED RECEPTORS; IMPAIRMENT	Soluble Amyloid-beta oligomers (A beta o) can trigger Alzheimer disease (AD) pathophysiology by binding to cell surface cellular prion protein (PrPC). PrPC interacts physically with metabotropic glutamate receptor 5 (mGluR5), and this interaction controls the transmission of neurotoxic signals to intracellular substrates. Because the interruption of the signal transduction from PrPC to mGluR5 has therapeutic potential for AD, we developed assays to explore the effect of endogenous ligands, agonists/antagonists, and antibodies on the interaction between PrPC and mGluR5 in cell lines and mouse brain. We show that the PrPC segment of amino acids 91-153 mediates the interaction with mGluR5. Agonists of mGluR5 increase the mGluR5-PrPC interaction, whereas mGluR5 antagonists suppress protein association. Synthetic A beta o promotes the protein interaction in mouse brain and transfected HEK-293 cell membrane preparations. The interaction of PrPC and mGluR5 is enhanced dramatically in the brains of familial AD transgenic model mice. In brain homogenates with A beta o, the interaction of PrPC and mGluR5 is reversed by mGluR5-directed antagonists or antibodies directed against the PrPC segment of amino acids 91-153. Silent allosteric modulators of mGluR5 do not alter Glu or basal mGluR5 activity, but they disrupt the A beta o-induced interaction of mGluR5 with PrPC. The assays described here have the potential to identify and develop new compounds that inhibit the interaction of PrPC and mGluR5, which plays a pivotal role in the pathogenesis of Alzheimer disease by transmitting the signal from extracellular A beta o into the cytosol.	[Haas, Laura T.; Kostylev, Mikhail A.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, Dept Neurol, New Haven, CT 06536 USA; [Haas, Laura T.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany	Yale University; Eberhard Karls University of Tubingen	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, 295 Congress Ave, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	; Strittmatter, Stephen/F-5739-2011	Kostylev, Mikhail/0000-0003-0435-8141; Strittmatter, Stephen/0000-0001-8188-3092	National Institutes of Health [R01AG034924]; BrightFocus Foundation; Alzheimer's Association; Falk Medical Research Trust; NATIONAL INSTITUTE ON AGING [R01AG034924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); Falk Medical Research Trust; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG034924 (to S. M. S.). This work was also supported by grants from the BrightFocus Foundation, Alzheimer's Association, and Falk Medical Research Trust (to S. M. S.). S. M. S. is a cofounder of Axerion Therapeutics, seeking to develop NgR- and PrP-based therapeutics.	Agostini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074244; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Benarroch EE, 2008, NEUROLOGY, V70, P964, DOI 10.1212/01.wnl.0000306315.03021.2a; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Bruno V, 2000, NEUROPHARMACOLOGY, V39, P2223, DOI 10.1016/S0028-3908(00)00079-4; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gandy S, 2010, ANN NEUROL, V68, P220, DOI 10.1002/ana.22052; Gasparini F, 2007, CURR NEUROPHARMACOL, V5, P187, DOI 10.2174/157015907781695900; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gregory KJ, 2012, MOL PHARMACOL, V82, P860, DOI 10.1124/mol.112.080531; Gregory KJ, 2011, NEUROPHARMACOLOGY, V60, P66, DOI 10.1016/j.neuropharm.2010.07.007; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leclerc Estelle, 2000, Human Antibodies, V9, P207; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Lu YM, 1997, J NEUROSCI, V17, P5196; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Molck C, 2014, NEUROCHEM RES, V39, P1862, DOI 10.1007/s11064-014-1248-8; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Rammes G, 2011, NEUROPHARMACOLOGY, V60, P982, DOI 10.1016/j.neuropharm.2011.01.051; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Rondard P, 2011, NEUROPHARMACOLOGY, V60, P82, DOI 10.1016/j.neuropharm.2010.08.009; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheffler DJ, 2011, ADV PHARMACOL, V62, P37, DOI 10.1016/B978-0-12-385952-5.00010-5; Spinner DS, 2007, J LEUKOCYTE BIOL, V81, P1374, DOI 10.1189/jlb.1106665; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wisniewski K, 2002, CNS DRUG REV, V8, P101; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Yusa S, 2012, VIRUSES-BASEL, V4, P3109, DOI 10.3390/v4113109; Zampagni M, 2010, J MOL MED, V88, P597, DOI 10.1007/s00109-010-0603-8; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	75	57	58	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28460	28477		10.1074/jbc.M114.584342	http://dx.doi.org/10.1074/jbc.M114.584342			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148681	Green Published, hybrid			2022-12-25	WOS:000343765400038
J	Takahashi, D; Dai, HE; Hiromasa, Y; Krishnamoorthi, R; Kanost, MR				Takahashi, Daisuke; Dai, Huaien; Hiromasa, Yasuaki; Krishnamoorthi, Ramaswamy; Kanost, Michael R.			Self-association of an Insect beta-1,3-Glucan Recognition Protein Upon Binding Laminarin Stimulates Prophenoloxidase Activation as an Innate Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL CROSS-LINKING; N-TERMINAL DOMAIN; MANDUCA-SEXTA; SERINE-PROTEASE; CDNA CLONING; PYRALID MOTH; I-TASSER; DROSOPHILA; PURIFICATION; BACTERIA	Insect beta-glucan recognition protein (beta GRP), a pathogen recognition receptor for innate immune responses, detects beta-1,3glucan on fungal surfaces via its N-terminal carbohydrate-binding domain (N-beta GRP) and triggers serine protease cascades for the activation of prophenoloxidase (pro-PO) or Toll pathways. Using biophysical and biochemical methods, we characterized the interaction of the N-terminal domain from Manduca sexta beta GRP2 (N-beta GRP2) with laminarin, a soluble form of beta-1,3-glucan. We found that carbohydrate binding by N-beta GRP2 induces the formation of two types of protein-carbohydrate complexes, depending on the molar ratio of carbohydrate to protein ([C]/[P]). Precipitation, analytical ultracentrifugation, and chemical cross-linking experiments have shown that an insoluble aggregate forms when the molar ratio of carbohydrate to protein is low ([C]/[P] similar to 1). In contrast, a soluble complex, containing at least five N-beta GRP2 molecules forms at a higher molar ratio of carbohydrate/protein ([C]/[P] > 5). A hypothesis that this complex is assembled partly due to protein-protein interactions was supported by chemical cross-linking experiments combined with LC-MS/MS spectrometry analysis, which permitted identification of a specific intermolecular cross-link site between N-beta GRP molecules in the soluble complex. The pro-PO activation in naive plasma was strongly stimulated by addition of the insoluble aggregates of N-beta GRP2. The soluble complex with laminarin formed in the plasma also stimulated pro-PO activation, but at a lower level. Taken together, these results provide experimental evidence for novel mechanisms in which associations of beta GRP with microbial polysaccharide promotes assembly of beta GRP oligomers, which may form a platform needed to trigger the pro-PO pathway activation cascade.	[Takahashi, Daisuke; Dai, Huaien; Hiromasa, Yasuaki; Krishnamoorthi, Ramaswamy; Kanost, Michael R.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Kansas State University	Kanost, MR (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	kanost@ksu.edu		Kanost, Michael/0000-0002-6827-0061	National Center for Research Resources [5P20 RR016464-11]; NIGMS, National Institutes of Health [8P20GM103440-11]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM041247, P20GM103440, R37GM041247, R01GM041247] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Maureen Gorman, David Quilici, and Rebekah Woolsey for helpful comments on the manuscript, and Lisa Brummett for technical assistance. The mass spectrometry experiment was performed by the Nevada Proteomics Center at the University of Nevada, which is supported by Grant 5P20 RR016464-11 from the National Center for Research Resources and Grant 8P20GM103440-11 from the NIGMS, National Institutes of Health.	An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Bacic A., 2009, CHEM BIOCH BIOL 1 3B; Bennett KL, 2000, PROTEIN SCI, V9, P1503, DOI 10.1110/ps.9.8.1503; Bergenstrahle M, 2010, CARBOHYD RES, V345, P2060, DOI 10.1016/j.carres.2010.06.017; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2010, BIOCHEMISTRY-US, V49, P5213, DOI 10.1021/bi1003734; BHATTACHARYYA L, 1990, BIOCHEMISTRY-US, V29, P7523, DOI 10.1021/bi00484a022; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; D'Ambrosio C, 2003, BIOCHEMISTRY-US, V42, P4430, DOI 10.1021/bi0206715; Dai HE, 2013, BIOCHEMISTRY-US, V52, P161, DOI 10.1021/bi301440p; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DUVIC B, 1990, J BIOL CHEM, V265, P9327; Fabrick JA, 2004, J BIOL CHEM, V279, P26605, DOI 10.1074/jbc.M403382200; Fabrick JA, 2003, INSECT BIOCHEM MOLEC, V33, P579, DOI 10.1016/S0965-1748(03)00029-8; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; GUPTA D, 1994, BIOCHEMISTRY-US, V33, P7495, DOI 10.1021/bi00190a001; Hanashima S, 2014, GLYCOCONJUGATE J, V31, P199, DOI 10.1007/s10719-013-9510-x; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; HRMOVA M, 1993, BIOCHEM J, V289, P453, DOI 10.1042/bj2890453; Ji CY, 2004, J BIOL CHEM, V279, P34101, DOI 10.1074/jbc.M404584200; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanagawa M, 2011, J BIOL CHEM, V286, P29158, DOI 10.1074/jbc.M111.256701; Keller R., 2004, THESIS SWISS FEDERAL; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; MANDAL DK, 1992, BIOCHEMISTRY-US, V31, P8465, DOI 10.1021/bi00151a012; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Petrotchenko EV, 2010, MASS SPECTROM REV, V29, P862, DOI 10.1002/mas.20293; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SODERHALL K, 1979, CAN J MICROBIOL, V25, P406, DOI 10.1139/m79-062; Takahasi K, 2009, P NATL ACAD SCI USA, V106, P11679, DOI 10.1073/pnas.0901671106; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; Ueda Y, 2009, J IMMUNOL, V183, P3810, DOI 10.4049/jimmunol.0900430; Wang Y, 2011, INSECT BIOCHEM MOLEC, V41, P322, DOI 10.1016/j.ibmb.2011.01.010; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	48	27	29	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28399	28410		10.1074/jbc.M114.583971	http://dx.doi.org/10.1074/jbc.M114.583971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25147183	Green Published, hybrid			2022-12-25	WOS:000343765400033
J	Liu, X; Obianyo, O; Chan, CB; Huang, JJ; Xue, SH; Yang, JJ; Zeng, FX; Goodman, M; Ye, KQ				Liu, Xia; Obianyo, Obiamaka; Chan, Chi Bun; Huang, Junjian; Xue, Shenghui; Yang, Jenny J.; Zeng, Fanxing; Goodman, Mark; Ye, Keqiang			Biochemical and Biophysical Investigation of the Brain-derived Neurotrophic Factor Mimetic 7,8-Dihydroxyflavone in the Binding and Activation of the TrkB Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain-Derived Neurotrophic Factor (BDNF); Cell Signaling; Cell Surface Receptor; Endocytosis; Phosphorylation; 7; 8-Dihydroxyflavone; TrkB	NERVE GROWTH-FACTOR; MOUSE MODEL; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; MEMORY DEFICITS; BDNF; AGONIST; SURVIVAL; INTERNALIZATION; IDENTIFICATION	Background: 7,8-DHF (7,8-dihydroxyflavone) is a TrkB agonist, but its receptor activation mechanism is not well understood. Results: 7,8-DHF and BDNF display differential receptor binding affinity, receptor activation kinetics, receptor phosphorylation pattern, and ligand-induced receptor degradation. Conclusion: 7,8-DHF and BDNF utilize different mechanisms to activate TrkB. Significance: This report provides mechanistic insights into how 7,8-DHF induces TrkB activation. 7,8-dihydroxyflavone (7,8-DHF), a newly identified small molecular TrkB receptor agonist, rapidly activates TrkB in both primary neurons and the rodent brain and mimics the physiological functions of the cognate ligand BDNF. Accumulating evidence supports that 7,8-DHF exerts neurotrophic effects in a TrkB-dependent manner. Nonetheless, the differences between 7,8-DHF and BDNF in activating TrkB remain incompletely understood. Here we show that 7,8-DHF and BDNF exhibit different TrkB activation kinetics in which TrkB maturation may be implicated. Employing two independent biophysical approaches, we confirm that 7,8-DHF interacts robustly with the TrkB extracellular domain, with a K-d of approximate to 10 nm. Although BDNF transiently activates TrkB, leading to receptor internalization and ubiquitination/degradation, in contrast, 7,8-DHF-triggered TrkB phosphorylation lasts for hours, and the internalized receptors are not degraded. Notably, primary neuronal maturation may be required for 7,8-DHF but not for BDNF to elicit the full spectrum of TrkB signaling cascades. Hence, 7,8-DHF interacts robustly with the TrkB receptor, and its agonistic effect may be mediated by neuronal development and maturation.	[Liu, Xia; Obianyo, Obiamaka; Chan, Chi Bun; Huang, Junjian; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Ctr Syst Imaging,Wesley Woods Hlth Ctr, Atlanta, GA 30322 USA; [Zeng, Fanxing; Goodman, Mark] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Ctr Syst Imaging,Wesley Woods Hlth Ctr, Atlanta, GA 30322 USA; [Zeng, Fanxing; Goodman, Mark] Emory Univ, Sch Med, Dept Psychiat, Ctr Syst Imaging,Wesley Woods Hlth Ctr, Atlanta, GA 30322 USA; [Zeng, Fanxing; Goodman, Mark] Emory Univ, Sch Med, Dept Hematol & Oncol, Ctr Syst Imaging,Wesley Woods Hlth Ctr, Atlanta, GA 30322 USA; [Xue, Shenghui; Yang, Jenny J.] Georgia State Univ, CDT, Dept Chem, Atlanta, GA 30303 USA; [Xue, Shenghui; Yang, Jenny J.] Georgia State Univ, CDT, Dept Biol, Atlanta, GA 30303 USA	Emory University; Emory University; Emory University; Emory University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Ctr Syst Imaging,Wesley Woods Hlth Ctr, Atlanta, GA 30322 USA.	kye@emory.edu		, Junjian/0000-0002-9943-0865	National Institutes of Health [RO1, DC010204, NS045627]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627, P30NS055077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1, DC010204 and NS045627 (to K. Y.).	Andero R, 2012, HIPPOCAMPUS, V22, P399, DOI 10.1002/hipo.20906; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Beattie EC, 2000, J NEUROSCI, V20, P7325; Bernard-Gauthier V, 2013, BIOORGAN MED CHEM, V21, P7816, DOI 10.1016/j.bmc.2013.10.012; Blugeot A, 2011, J NEUROSCI, V31, P12889, DOI 10.1523/JNEUROSCI.1309-11.2011; Briones TL, 2013, NEUROSCIENCE, V254, P324, DOI 10.1016/j.neuroscience.2013.09.031; Campenot RB, 2004, J NEUROBIOL, V58, P217, DOI 10.1002/neu.10322; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Choi DC, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.128; Choi DC, 2010, P NATL ACAD SCI USA, V107, P2675, DOI 10.1073/pnas.0909359107; Croll SD, 1998, EXP NEUROL, V152, P20, DOI 10.1006/exnr.1998.6836; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; English AW, 2013, P NATL ACAD SCI USA, V110, P16217, DOI 10.1073/pnas.1303646110; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Grimes ML, 1996, J NEUROSCI, V16, P7950; GUITON M, 1995, BIOCHEM SOC T, V23, pS176, DOI 10.1042/bst023176s; Gupta VK, 2013, INT J MOL SCI, V14, P10122, DOI 10.3390/ijms140510122; HANIU M, 1995, ARCH BIOCHEM BIOPHYS, V322, P256, DOI 10.1006/abbi.1995.1460; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Hung PL, 2013, STROKE, V44, P2275, DOI 10.1161/STROKEAHA.113.001552; Jadhav T, 2008, BIOCHEM BIOPH RES CO, V371, P521, DOI 10.1016/j.bbrc.2008.04.138; Jang SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011528; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jiang ML, 2013, HUM MOL GENET, V22, P2462, DOI 10.1093/hmg/ddt098; Johnson RA, 2012, J APPL PHYSIOL, V112, P704, DOI 10.1152/japplphysiol.01361.2011; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Liu X, 2012, J MED CHEM, V55, P8524, DOI 10.1021/jm301099x; Liu X, 2010, J MED CHEM, V53, P8274, DOI 10.1021/jm101206p; Makkerh JPS, 2005, EMBO REP, V6, P936, DOI 10.1038/sj.embor.7400503; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Mantilla CB, 2012, MUSCLE NERVE, V45, P274, DOI 10.1002/mus.22295; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Tsai T, 2013, MOL CELL NEUROSCI, V56, P18, DOI 10.1016/j.mcn.2013.02.007; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Uluc K, 2013, CNS NEUROL DISORD-DR, V12, P360, DOI 10.2174/18715273113129990061; Wang B, 2014, J MOL HISTOL, V45, P129, DOI 10.1007/s10735-013-9539-y; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; WINDISCH JM, 1995, BIOCHEMISTRY-US, V34, P11256, DOI 10.1021/bi00035a035; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yu Q, 2013, J NEUROSCI, V33, P13042, DOI 10.1523/JNEUROSCI.0854-13.2013; Zeng Y, 2012, J ALZHEIMERS DIS, V31, P765, DOI 10.3233/JAD-2012-120886; Zeng Y, 2012, J NEUROCHEM, V122, P800, DOI 10.1111/j.1471-4159.2012.07830.x; Zeng Y, 2011, J NEUROSCI, V31, P17800, DOI 10.1523/JNEUROSCI.3878-11.2011; Zhang ZT, 2014, NEUROPSYCHOPHARMACOL, V39, P638, DOI 10.1038/npp.2013.243; Zhou XJ, 2011, J NEUROCHEM, V119, P1205, DOI 10.1111/j.1471-4159.2011.07528.x	59	72	74	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27571	27584		10.1074/jbc.M114.562561	http://dx.doi.org/10.1074/jbc.M114.562561			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143381	Green Published, hybrid			2022-12-25	WOS:000342852800019
J	de Rezende, MM; D'Almeida, V				de Rezende, Marina Mastelaro; D'Almeida, Vania			Central and Systemic Responses to Methionine-Induced Hyperhomocysteinemia in Mice	PLOS ONE			English	Article							PLASMA TOTAL HOMOCYSTEINE; OXIDATIVE STRESS; BDNF; EXPLORATION; NEURONS; MODELS; RATS	Hyperhomocysteinemia has been considered a risk factor for neuropsychiatric disorders, but the mechanisms involved in this process have not been completely elucidated. The aim of this study was to analyze the influence of hyperhomocysteinemia induction by methionine supplementation considering different levels and periods of exposure in mice. For this purpose, methionine supplementation at concentrations of 0.5 and 1% were administered in water to increase homocysteinemia in male C57BL/6 mice, and was maintained for 3 time periods (2, 4 and 6 months of treatment). The results from one-carbon metabolism parameters, brain-derived neurotrophic factor (BDNF) concentrations and behavioral evaluation were compared. The 0.5% supplementation was efficient in increasing plasma homocysteine levels after 2 and 6 months. The 1% supplementation, increased plasma homocysteine after 2, 4 and 6 months. Little influence was observed in cysteine and glutathione concentrations. Frontal cortex BDNF levels showed a lack of treatment influence in all periods; only the expected decrease due to increasing age was observed. Moreover, the only behavioral alteration observed using a novel object recognition task was that which was expected with increasing age. We found that responses to hyperhomocysteinemia varied based on how it was reached, and the length of toxicity. Moreover, hyperhomocysteinemia can affect the normal pattern of one carbon metabolism during age increase in mice. These findings allow the establishment of a reliable animal model for studies in this field.	[de Rezende, Marina Mastelaro; D'Almeida, Vania] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	D'Almeida, V (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil.	vaniadalmeida@uol.com.br	D'Almeida, Vânia/AAV-3955-2020; D'Almeida, Vania/AAB-7115-2020	D'Almeida, Vânia/0000-0003-0947-5312; 	FAPESP (Fundo de Amparo a Pesquisa do Estado de Sao Paulo) [2010/00075-2, 2011/15699-4]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	FAPESP (Fundo de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP (Fundo de Amparo a Pesquisa do Estado de Sao Paulo) - Process # 2010/00075-2 and # 2011/15699-4 scholarship to MMR (http://www.fapesp.br/); and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) - fellowship to VD (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afman LA, 2005, DEV BRAIN RES, V158, P59, DOI 10.1016/j.devbrainres.2005.06.002; Calegare BFA, 2010, PSYCHONEUROENDOCRINO, V35, P775, DOI 10.1016/j.psyneuen.2009.11.004; Andersen M. L., 2004, PRINCIPIOS ETICOS PR; BERNARDIS LL, 1968, J ENDOCRINOL, V40, P527, DOI 10.1677/joe.0.0400527; Cai BZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063561; COELHO CND, 1990, TERATOLOGY, V42, P437, DOI 10.1002/tera.1420420412; Dayal S, 2008, ARTERIOSCL THROM VAS, V28, P1596, DOI 10.1161/ATVBAHA.108.166421; Elias MF, 2005, AM J EPIDEMIOL, V162, P644, DOI 10.1093/aje/kwi259; Gao L, 2012, NEUROL SCI, V33, P39, DOI 10.1007/s10072-011-0645-x; Heyser CJ, 2012, BEHAV PROCESS, V89, P232, DOI 10.1016/j.beproc.2011.12.004; Hooshmand B, 2013, BRAIN, V136, P2707, DOI 10.1093/brain/awt206; Imamura K, 2007, NEUROREPORT, V18, P1319, DOI 10.1097/WNR.0b013e3282aaa0b4; Jadavji NM, 2012, MOL GENET METAB, V106, P149, DOI 10.1016/j.ymgme.2012.03.020; Kado DM, 2002, AM J MED, V113, P537, DOI 10.1016/S0002-9343(02)01269-X; Kapczinski F, 2008, REV BRAS PSIQUIATR, V30, P243, DOI 10.1590/S1516-44462008000300011; Kinoshita M, 2013, EPIGENETICS-US, V8, P584, DOI 10.4161/epi.24621; Lalonde R, 2008, BRAIN RES, V1188, P122, DOI 10.1016/j.brainres.2007.10.068; Light KR, 2011, BEHAV BRAIN RES, V223, P297, DOI 10.1016/j.bbr.2011.04.050; Likogianni V, 2006, CLIN CHIM ACTA, V372, P140, DOI 10.1016/j.cca.2006.03.035; Loas G, 1996, J AFFECT DISORDERS, V41, P39, DOI 10.1016/0165-0327(96)00065-1; Lominadze D, 2012, MOL CELL BIOCHEM, V371, P89, DOI 10.1007/s11010-012-1425-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Makhro AV, 2008, B EXP BIOL MED+, V146, P33, DOI 10.1007/s10517-008-0233-0; Martins PJF, 2005, LIFE SCI, V76, P2621, DOI 10.1016/j.lfs.2004.12.011; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Matte C, 2009, NEUROSCIENCE, V163, P1039, DOI 10.1016/j.neuroscience.2009.07.023; Mattson MP, 2003, NEUROLOGY, V60, P690, DOI 10.1212/01.WNL.0000042785.02850.11; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P140, DOI 10.1016/j.bcp.2013.06.016; Muehlmann AM, 2012, BEHAV BRAIN RES, V235, P143, DOI 10.1016/j.bbr.2012.07.041; Nabi H, 2013, PSYCHONEUROENDOCRINO, V38, P2309, DOI 10.1016/j.psyneuen.2013.04.018; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Rhodehouse BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063951; Ryabinin AE, 2002, PHARMACOL BIOCHEM BE, V71, P307, DOI 10.1016/S0091-3057(01)00661-X; Sachdev PS, 2005, PROG NEURO-PSYCHOPH, V29, P1152, DOI 10.1016/j.pnpbp.2005.06.026; Souchet B, 2014, J MOL NEUROSCI; Swart KMA, 2013, J NUTR HEALTH AGING, V17, P578, DOI 10.1007/s12603-013-0047-2; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Topaloglu AK, 2001, PEDIATR RES, V49, P796, DOI 10.1203/00006450-200106000-00014; Vanzin CS, 2011, MOL GENET METAB, V104, P112, DOI 10.1016/j.ymgme.2011.06.013; Vuksan-Cusa B, 2013, NORD J PSYCHIAT, V67, P320, DOI 10.3109/08039488.2012.745601; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Yabuki Y, 2013, NEUROSCIENCE, V250, P394, DOI 10.1016/j.neuroscience.2013.07.017	44	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105704	10.1371/journal.pone.0105704	http://dx.doi.org/10.1371/journal.pone.0105704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153079	Green Published, gold			2022-12-25	WOS:000340952200071
J	Elizur, SE; Lebovitz, O; Derech-Haim, S; Dratviman-Storobinsky, O; Feldman, B; Dor, J; Orvieto, R; Cohen, Y				Elizur, Shai E.; Lebovitz, Oshrit; Derech-Haim, Sanaz; Dratviman-Storobinsky, Olga; Feldman, Baruch; Dor, Jehoshua; Orvieto, Raoul; Cohen, Yoram			Elevated Levels of FMR1 mRNA in Granulosa Cells Are Associated with Low Ovarian Reserve in FMR1 Premutation Carriers	PLOS ONE			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; CGG REPEAT NUMBER; FRAGILE; FAILURE; INTERMEDIATE; WOMEN	Aim: To assess the role of mRNA accumulation in granulosa cells as the cause of low ovarian response among FMR1 premutation carriers undergoing pre-implantation genetic diagnosis (PGD). Design: Case control study in an academic IVF unit. Twenty-one consecutive FMR1 premutation carriers and 15 control women were included. After oocyte retrieval the granulosa cells mRNA levels of FMR1 was measured using RT-PCR. Results: In FMR1 premutation carriers, there was a significant non-linear association between the number of CGG repeats and the number of retrieved oocytes (p<0.0001) and a trend to granulosa cells FMR1 mRNA levels (p = 0.07). The lowest number of retrieved oocytes and the highest level of mRNA were seen in women with mid-size CGG repeats (80-120). A significant negative linear correlation was observed between the granulosa cells FMR1 mRNA levels and the number of retrieved oocytes (R-2 linear = 0.231, P = 0.02). Conclusion: We suggest that there is a no-linear association between the number of CGG repeats and ovarian function, resulting from an increased granulosa cells FMR1 mRNA accumulation in FMR1 carriers in the mid-range (80-120 repeats).	[Cohen, Yoram] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Ramat Gan, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Cohen, Y (corresponding author), Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Ramat Gan, Israel.	ycohen1@gmail.com	Lebovitz, Oshrit/AAF-4482-2021	Lebovitz, Oshrit/0000-0003-1171-110X				Allen EG, 2007, HUM REPROD, V22, P2142, DOI 10.1093/humrep/dem148; Allen EG, 2004, HUM GENET, V114, P439, DOI 10.1007/s00439-004-1086-x; Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; Bardoni B, 2002, CURR OPIN GENET DEV, V12, P284, DOI 10.1016/S0959-437X(02)00300-3; Berry-Kravis E, 2007, MOVEMENT DISORD, V22, P2018, DOI 10.1002/mds.21493; Bianchi E, 2010, HUM MOL GENET, V19, P4886, DOI 10.1093/hmg/ddq422; Bibi G, 2010, FERTIL STERIL, V94, P869, DOI 10.1016/j.fertnstert.2009.04.047; Bodega B, 2006, HUM REPROD, V21, P952, DOI 10.1093/humrep/dei432; Bretherick KL, 2005, HUM GENET, V117, P376, DOI 10.1007/s00439-005-1326-8; Coffee B, 2009, CURR PROTOC HUM  APR; Conway GS, 1999, HUM REPROD, V14, P574; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Ennis S, 2006, EUR J HUM GENET, V14, P253, DOI 10.1038/sj.ejhg.5201510; Gleicher N, 2009, REPROD BIOMED ONLINE, V19, P385, DOI 10.1016/S1472-6483(10)60173-3; Gleicher N, 2009, FERTIL STERIL, V91, P1707, DOI 10.1016/j.fertnstert.2008.01.099; Hundscheid RDL, 2001, HUM REPROD, V16, P457, DOI 10.1093/humrep/16.3.457; Li YJ, 2012, BRAIN RES, V1462, P112, DOI 10.1016/j.brainres.2012.02.057; Murray A, 1999, HUM REPROD, V14, P1217, DOI 10.1093/humrep/14.5.1217; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; Platteau P, 2002, HUM REPROD, V17, P2807, DOI 10.1093/humrep/17.11.2807; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Shrim A, 2006, REPROD BIOMED ONLINE, V12, P418, DOI 10.1016/S1472-6483(10)61993-1; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Welt CK, 2004, J CLIN ENDOCR METAB, V89, P4569, DOI 10.1210/jc.2004-0347; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004	26	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105121	10.1371/journal.pone.0105121	http://dx.doi.org/10.1371/journal.pone.0105121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153074	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200039
J	Kobayashi, K; Okabe, H; Kawano, S; Hidaka, Y; Hara, K				Kobayashi, Katsuhiro; Okabe, Hirotaka; Kawano, Shinya; Hidaka, Yoshiki; Hara, Kazuhiro			Biophoton Emission Induced by Heat Shock	PLOS ONE			English	Article							STRESS; ULTRAWEAK	Ultraweak biophoton emission originates from the generation of reactive oxygen species (ROS) that are produced in mitochondria as by-products of cellular respiration. In healthy cells, the concentration of ROS is minimized by a system of biological antioxidants. However, heat shock changes the equilibrium between oxidative stress and antioxidant activity, that is, a rapid rise in temperature induces biophoton emission from ROS. Although the rate and intensity of biophoton emission was observed to increase in response to elevated temperatures, pretreatment at lower high temperatures inhibited photon emission at higher temperatures. Biophoton measurements are useful for observing and evaluating heat shock.	[Kobayashi, Katsuhiro; Okabe, Hirotaka; Hara, Kazuhiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Okabe, Hirotaka; Kawano, Shinya; Hidaka, Yoshiki; Hara, Kazuhiro] Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Fukuoka 812, Japan	Kyushu University; Kyushu University	Kobayashi, K (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	kobayashi@athena.ap.kyushu-u.ac.jp		Hara, Kazuhiro/0000-0001-8410-8550	JSPS KAKENHI Grant [14593004, 17500307]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (http://www.jsps.go.jp/) KAKENHI Grant Numbers 14593004 and 17500307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi R, 2008, LUMINESCENCE, V23, P59; Anshu R, 2011, J BIOMEDICAL OPTICS, V16; Chen WL, 2003, LUMINESCENCE, V18, P37, DOI 10.1002/bio.703; CILENTO G, 1995, FREE RADICAL BIO MED, V19, P103, DOI 10.1016/0891-5849(95)00002-F; Fedoroff N, 2006, ANN BOT-LONDON, V98, P289, DOI 10.1093/aob/mcl128; Fryer MJ, 2002, J EXP BOT, V53, P1249, DOI 10.1093/jexbot/53.372.1249; Havaux M, 2003, TRENDS PLANT SCI, V8, P409, DOI 10.1016/S1360-1385(03)00185-7; Havaux M, 2006, TRENDS PLANT SCI, V11, P480, DOI 10.1016/j.tplants.2006.08.001; HIDEG E, 1991, BIOCHIM BIOPHYS ACTA, V1098, P27; Inagaki H, 2008, WEED BIOL MANAG, V8, P78, DOI 10.1111/j.1445-6664.2008.00278.x; Jaskowska A, 2001, LUMINESCENCE, V16, P51, DOI 10.1002/bio.610; Kageyama C, 2006, PLANT PHYSIOL BIOCH, V44, P901, DOI 10.1016/j.plaphy.2006.09.010; KAI S, 1994, PHYSICA A, V210, P391, DOI 10.1016/0378-4371(94)90087-6; Kai S, 1995, JPN J APPL PHYS 1, V34, P6530, DOI 10.1143/JJAP.34.6530; Kang JH, 2008, J KOREAN PHYS SOC, V52, P132, DOI 10.3938/jkps.52.132; Kataoka Y, 2001, BIOCHEM BIOPH RES CO, V285, P1007, DOI 10.1006/bbrc.2001.5285; Katherine C, 2004, J ALTERN COMPLEM MED, V10, P23; Kawabata R, 2005, JPN J APPL PHYS 1, V44, P1115, DOI 10.1143/JJAP.44.1115; Kawabata R, 2004, JPN J APPL PHYS 1, V43, P5646, DOI 10.1143/JJAP.43.5646; Kim J, 2005, J HEALTH SCI, V51, P155, DOI 10.1248/jhs.51.155; Kim J, 2007, J HEALTH SCI, V53, P481, DOI 10.1248/jhs.53.481; Kim J, 2006, ELECTROMAGN BIOL MED, V25, P97, DOI 10.1080/15368370600719000; Kobayashi M, 1997, PHOTOCHEM PHOTOBIOL, V65, P535, DOI 10.1111/j.1751-1097.1997.tb08600.x; Kobayashi M, 1999, NEUROSCI RES, V34, P103, DOI 10.1016/S0168-0102(99)00040-1; Kobayashi M, 2007, J EXP BOT, V58, P465, DOI 10.1093/jxb/erl215; Laager FM, 2009, ELECTROMAGN BIOL MED, V28, P240, DOI [10.3109/15368370903065820, 10.1080/15368370903065820]; Makino T, 1996, PHOTOCHEM PHOTOBIOL, V64, P953, DOI 10.1111/j.1751-1097.1996.tb01860.x; Mansfield JW, 2005, TRENDS PLANT SCI, V10, P307, DOI 10.1016/j.tplants.2005.05.007; Moud A. M., 2008, World Journal of Agricultural Sciences, V4, P351; Ohya T, 2003, JPN J APPL PHYS 1, V42, P7625, DOI 10.1143/JJAP.42.7625; Ohya T, 2002, JPN J APPL PHYS 1, V41, P4766, DOI 10.1143/JJAP.41.4766; Ohya T, 2000, JPN J APPL PHYS 1, V39, P3696, DOI 10.1143/JJAP.39.3696; Popp F.-A., 1994, Modern Physics Letters B, V8, P1269, DOI 10.1142/S0217984994001266; POPP F A, 1981, Collective Phenomena (London), V3, P187; POPP FA, 1988, EXPERIENTIA, V44, P543, DOI 10.1007/BF01953300; Prasad A, 2011, J BIOPHOTONICS, V4, P840, DOI 10.1002/jbio.201100073; Rastogi A, 2010, SKIN RES TECHNOL, V16, P365, DOI 10.1111/j.1600-0846.2010.00442.x; Rastogi A, 2010, PLANT PHYSIOL BIOCH, V48, P117, DOI 10.1016/j.plaphy.2009.12.011; Sauermann G, 1999, METHOD ENZYMOL, V300, P419; Slawinski J, 2005, FORSCH KOMP KLAS NAT, V12, P90, DOI 10.1159/000083971; SLAWINSKI J, 1981, J LUMIN, V24-5, P791, DOI 10.1016/0022-2313(81)90093-4; SLAWINSKI J, 1987, J PLANT PHYSIOL, V130, P111, DOI 10.1016/S0176-1617(87)80215-8; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Takashi I, 1995, NEURO REP, V6, P658; Takeda M, 2004, CANCER SCI, V95, P656, DOI 10.1111/j.1349-7006.2004.tb03325.x; Takeda M, 1998, CANCER LETT, V127, P155, DOI 10.1016/S0304-3835(98)00064-0; URSINI F, 1989, J BIOLUM CHEMILUM, V4, P241, DOI 10.1002/bio.1170040134; Van Wijk EPA, 2010, J PHOTOCH PHOTOBIO B, V98, P199, DOI 10.1016/j.jphotobiol.2010.01.003; Van Wijk R, 2006, J PHOTOCH PHOTOBIO B, V83, P69, DOI 10.1016/j.jphotobiol.2005.12.005; VANWIJK R, 1992, EXPERIENTIA, V48, P1029; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Winkler R, 2009, PHOTOCHEM PHOTOBIOL, V85, P962, DOI 10.1111/j.1751-1097.2009.00537.x; Yoshinaga N, 2006, NATURWISSENSCHAFTEN, V93, P38, DOI 10.1007/s00114-005-0059-9	53	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105700	10.1371/journal.pone.0105700	http://dx.doi.org/10.1371/journal.pone.0105700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153902	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200070
J	Mansilla, MJ; Costa, C; Eixarch, H; Tepavcevic, V; Castillo, M; Martin, R; Lubetzki, C; Aigrot, MS; Montalban, X; Espejo, C				Mansilla, M. Jose; Costa, Carme; Eixarch, Herena; Tepavcevic, Vanja; Castillo, Mireia; Martin, Roland; Lubetzki, Catherine; Aigrot, Marie-Stephane; Montalban, Xavier; Espejo, Carmen			Hsp70 Regulates Immune Response in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; EXPRESSION; CYTOKINE; RECEPTOR; ASSOCIATION; RELEASE; PATHWAY; BINDING; STRESS	Heat shock protein (Hsp)70 is one of the most important stress-inducible proteins. Intracellular Hsp70 not only mediates chaperone-cytoprotective functions but can also block multiple steps in the apoptosis pathway. In addition, Hsp70 is actively released into the extracellular milieu, thereby promoting innate and adaptive immune responses. Thus, Hsp70 may be a critical molecule in multiple sclerosis (MS) pathogenesis and a potential target in this disease due to its immunological and cytoprotective functions. To investigate the role of Hsp70 in MS pathogenesis, we examined its immune and cytoprotective roles using both in vitro and in vivo experimental procedures. We found that Hsp70.1-deficient mice were more resistant to developing experimental autoimmune encephalomyelitis (EAE) compared with their wild-type (WT) littermates, suggesting that Hsp70.1 plays a critical role in promoting an effective myelin oligodendrocyte glycoprotein (MOG)-specific T cell response. Conversely, Hsp70.1-deficient mice that developed EAE showed an increased level of autoreactive T cells to achieve the same production of cytokines compared with the WT mice. Although a neuroprotective role of HSP70 has been suggested, Hsp70.1-deficient mice that developed EAE did not exhibit increased demyelination compared with the control mice. Accordingly, Hsp70 deficiency did not influence the vulnerability to apoptosis of oligodendrocyte precursor cells (OPCs) in culture. Thus, the immunological role of Hsp70 may be relevant in EAE, and specific therapies down-regulating Hsp70 expression may be a promising approach to reduce the early autoimmune response in MS patients.	[Mansilla, M. Jose; Costa, Carme; Eixarch, Herena; Castillo, Mireia; Montalban, Xavier; Espejo, Carmen] Hosp Univ Vall dHebron, Vall dHebron Inst Recerca VHIR, Ctr Esclerosi Multiple Catalunya Cemcat, Serv Neurol Neuroimmunol, Barcelona, Spain; [Mansilla, M. Jose; Costa, Carme; Eixarch, Herena; Castillo, Mireia; Montalban, Xavier; Espejo, Carmen] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Tepavcevic, Vanja; Lubetzki, Catherine; Aigrot, Marie-Stephane] Univ Paris 06, Sorbonne Univ, ICM GH Pitie Salpetriere, Inserm,CNRS,UMR 7225,U1127,UM 75, Paris, France; [Martin, Roland] Univ Zurich Hosp, Neurol Clin, Dept Neuroimmunol & Multiple Sclerosis Res, CH-8091 Zurich, Switzerland	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Zurich; University Zurich Hospital	Espejo, C (corresponding author), Hosp Univ Vall dHebron, Vall dHebron Inst Recerca VHIR, Ctr Esclerosi Multiple Catalunya Cemcat, Serv Neurol Neuroimmunol, Barcelona, Spain.	carmen.espejo@vhir.org	Costa, Carme/AAF-9852-2019; Montalban, Xavier/J-5938-2016; Tepavcevic, Vanja/ABI-5461-2020; Espejo, Carmen/E-5989-2018	Montalban, Xavier/0000-0002-0098-9918; Tepavcevic, Vanja/0000-0003-3230-4888; Espejo, Carmen/0000-0001-9949-5901; MANSILLA LOPEZ, MARIA JOSE/0000-0002-5044-6313; Castillo Juarez, Mireia/0000-0001-8979-3219; Eixarch, Herena/0000-0001-7525-9533; Costa, Carme/0000-0001-9577-3839	"Red Espanola de Esclerosis Multiple (REEM)" - Fondo de Investigacion Sanitaria (FIS), Ministry of Economy and Competition, Spain [RD12/0032]; "Ajuts per donar Suportals Grups de Recerca de Catalunya" - "Agencia de Gestio d'Ajuts Universitarisi de Recerca'' (AGAUR), Generalitat de Catalunya, Spain [2009 SGR 0793]; "Miguel Servet'' program from the FIS, Ministry of Economy and Competition, Spain [CP07/00146]; "Investissements d'avenir'' [ANR-10-IAIHU-06]; Sara Borrell program from the FIS, Ministry of Economy and Competition, Spain [CD09/00363]	"Red Espanola de Esclerosis Multiple (REEM)" - Fondo de Investigacion Sanitaria (FIS), Ministry of Economy and Competition, Spain; "Ajuts per donar Suportals Grups de Recerca de Catalunya" - "Agencia de Gestio d'Ajuts Universitarisi de Recerca'' (AGAUR), Generalitat de Catalunya, Spain(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); "Miguel Servet'' program from the FIS, Ministry of Economy and Competition, Spain; "Investissements d'avenir''(French National Research Agency (ANR)); Sara Borrell program from the FIS, Ministry of Economy and Competition, Spain	"Red Espanola de Esclerosis Multiple (REEM)'' (RD12/0032) sponsored by the Fondo de Investigacion Sanitaria (FIS), Ministry of Economy and Competition, Spain. "Ajuts per donar Suportals Grups de Recerca de Catalunya (2009 SGR 0793)'', sponsored by the "Agencia de Gestio d'Ajuts Universitarisi de Recerca'' (AGAUR), Generalitat de Catalunya, Spain. CE is partially supported by the "Miguel Servet'' program (CP07/00146) from the FIS, Ministry of Economy and Competition, Spain. HE is supported by the Sara Borrell program (CD09/00363) from the FIS, Ministry of Economy and Competition, Spain. VT was supported by "Investissements d'avenir'' ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino DA, 1997, J NEUROPATH EXP NEUR, V56, P664; AQUINO DA, 1993, J NEUROCHEM, V61, P1340, DOI 10.1111/j.1471-4159.1993.tb13627.x; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Baker D, 2012, J NEUROIMMUNOL, V242, P78, DOI 10.1016/j.jneuroim.2011.11.003; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; Bland JM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3166; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Cwiklinska H, 2003, INT IMMUNOL, V15, P241, DOI 10.1093/intimm/dxg022; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; DSOUZA SD, 1994, J NEUROIMMUNOL, V50, P17, DOI 10.1016/0165-5728(94)90210-0; Espejo C, 2001, EXP NEUROL, V172, P460, DOI 10.1006/exnr.2001.7815; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; GAO YL, 1995, J IMMUNOL, V154, P3548; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HUNT CR, 1993, GENOMICS, V16, P193, DOI 10.1006/geno.1993.1158; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Mansilla MJ, 2012, MOL MED, V18, P1018, DOI 10.2119/molmed.2012.00119; Kwon SB, 2002, J DERMATOL SCI, V28, P144, DOI 10.1016/S0923-1811(01)00156-6; Lehner T, 2000, EUR J IMMUNOL, V30, P594, DOI 10.1002/1521-4141(200002)30:2<594::AID-IMMU594>3.3.CO;2-T; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LUBETZKI C, 1991, J NEUROCHEM, V56, P671, DOI 10.1111/j.1471-4159.1991.tb08202.x; Lund BT, 2006, J NEUROL SCI, V249, P122, DOI 10.1016/j.jns.2006.05.066; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mansilla MJ, 2013, AUTOIMMUNIT IN PRESS; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Mycko MA, 2008, EUR J IMMUNOL, V38, P1999, DOI 10.1002/eji.200737661; Mycko MP, 2004, J IMMUNOL, V172, P202, DOI 10.4049/jimmunol.172.1.202; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; Tytell M, 2001, Expert Opin Ther Targets, V5, P267, DOI 10.1517/14728222.5.2.267; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; WELCH WJ, 1993, PHILOS T ROY SOC B, V339, P327, DOI 10.1098/rstb.1993.0031	43	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105737	10.1371/journal.pone.0105737	http://dx.doi.org/10.1371/journal.pone.0105737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153885	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000340952200077
J	Rossignol, R; Ranchon-Cole, I; Paris, A; Herzine, A; Perche, A; Laurenceau, D; Bertrand, P; Cercy, C; Pichon, J; Mortaud, S; Briault, S; Menuet, A; Perche, O				Rossignol, Rafaelle; Ranchon-Cole, Isabelle; Paris, Arnaud; Herzine, Ameziane; Perche, Astrid; Laurenceau, David; Bertrand, Pauline; Cercy, Christine; Pichon, Jacques; Mortaud, Stephane; Briault, Sylvain; Menuet, Arnaud; Perche, Olivier			Visual Sensorial Impairments in Neurodevelopmental Disorders: Evidence for a Retinal Phenotype in Fragile X Syndrome	PLOS ONE			English	Article							FMR1 KNOCKOUT MICE; MENTAL-RETARDATION PROTEIN; SYNDROME MOUSE MODEL; RECEPTOR-DEPENDENT TRANSLATION; SYNAPTIC DEVELOPMENT; SOCIAL-INTERACTION; RHODOPSIN CONTENT; DENDRITIC SPINES; AUTISM; PSD-95	Visual sensory impairments are common in Mental Deficiency (MD) and Autism Spectrum Disorder (ASD). These defects are linked to cerebral dysfunction in the visual cortical area characterized by the deregulation of axon growth/guidance and dendrite spine immaturity of neurons. However, visual perception had not been addressed, although the retina is part of the central nervous system with a common embryonic origin. Therefore, we investigated retinal perception, the first event of vision, in a murine model of MD with autistic features. We document that retinal function is altered in Fmr1 KO mice, a model of human Fragile X Syndrome. Indeed, In Fmr1 KO mice had a lower retinal function characterized by a decreased photoreceptors neuron response, due to a 40% decrease in Rhodopsin content and to Rod Outer Segment destabilization. In addition, we observed an alteration of the visual signal transmission between photoreceptors and the inner retina which could be attributed to deregulations of pre- and post-synaptic proteins resulting in retinal neurons synaptic destabilization and to retinal neurons immaturity. Thus, for the first time, we demonstrated that retinal perception is altered in a murine model of MD with autistic features and that there are strong similarities between cerebral and retinal cellular and molecular defects. Our results suggest that both visual perception and integration must be taken into account in assessing visual sensory impairments in MD and ASD.	[Rossignol, Rafaelle; Paris, Arnaud; Herzine, Ameziane; Pichon, Jacques; Mortaud, Stephane; Briault, Sylvain; Menuet, Arnaud; Perche, Olivier] CNRS, UMR7355, F-45071 Orleans, France; [Rossignol, Rafaelle; Paris, Arnaud; Herzine, Ameziane; Pichon, Jacques; Mortaud, Stephane; Briault, Sylvain; Menuet, Arnaud; Perche, Olivier] Univ Orleans, Orleans, France; [Perche, Astrid; Laurenceau, David; Briault, Sylvain; Perche, Olivier] Reg Hosp, Dept Genet, Orleans, France; [Ranchon-Cole, Isabelle; Bertrand, Pauline; Cercy, Christine] Univ Clermont 1, Lab Sensorial Biophys, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Centre Hospitalier Regional d'Orleans; Universite Clermont Auvergne (UCA)	Perche, O (corresponding author), CNRS, UMR7355, F-45071 Orleans, France.	operche@cnrs-orleans.fr		Ranchon-Cole, Isabelle/0000-0002-7092-6744; Mortaud, Stephane/0000-0003-0873-4781; Perche, Olivier/0000-0002-6513-5534	CNRS; Regional Hospital of Orleans; University of Orleans; FEDER [35106]; FRAXA Research Foundation	CNRS(Centre National de la Recherche Scientifique (CNRS)); Regional Hospital of Orleans; University of Orleans; FEDER(European Commission); FRAXA Research Foundation	Research was supported by CNRS, Regional Hospital of Orleans, University of Orleans, FEDER 35106, and FRAXA Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; BAKKER CE, 1994, CELL, V78, P23; Baranek GT, 2006, J CHILD PSYCHOL PSYC, V47, P591, DOI 10.1111/j.1469-7610.2005.01546.x; Baranek GT, 2002, AM J OCCUP THER, V56, P538, DOI 10.5014/ajot.56.5.538; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Battaglia A, 2011, ARCH ITAL BIOL, V149, P193, DOI 10.4449/aib.v149i2.1362; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berman RF, 2012, EPILEPSIA, V53, P150, DOI 10.1111/j.1528-1167.2012.03486.x; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; BIERSDORFF KK, 1994, AM J MENT RETARD, V98, P619; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Bonetti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015211; Braun K, 2000, CEREB CORTEX, V10, P1045, DOI 10.1093/cercor/10.10.1045; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Davidovic L, 2011, GENOME RES, V21, P2190, DOI 10.1101/gr.116764.110; Dolen G, 2009, J NEURODEV DISORD, V1, P133, DOI 10.1007/s11689-009-9015-x; Farzin F, 2011, BRAIN, V134, P3355, DOI 10.1093/brain/awr249; FOX DA, 1989, EXP EYE RES, V48, P237, DOI 10.1016/S0014-4835(89)80073-9; Frishman LJ, 2006, ORIGINS ELECTRORETIN, P139; Fulton AB, 1999, INVEST OPHTH VIS SCI, V40, P1878; Granit R, 1933, J PHYSIOL-LONDON, V77, P207, DOI 10.1113/jphysiol.1933.sp002964; HOFMANN KP, 1985, J BIOL CHEM, V260, P7990; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; KANEKO A, 1979, ANNU REV NEUROSCI, V2, P169, DOI 10.1146/annurev.ne.02.030179.001125; Klemmer P, 2011, J BIOL CHEM, V286, P25495, DOI 10.1074/jbc.M110.210260; Kogan CS, 2004, BRAIN, V127, P591, DOI 10.1093/brain/awh069; Krueger DD, 2011, P NATL ACAD SCI USA, V108, P2587, DOI 10.1073/pnas.1013855108; LAMB TD, 1992, TRENDS NEUROSCI, V15, P291, DOI 10.1016/0166-2236(92)90079-N; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Lane AE, 2010, J AUTISM DEV DISORD, V40, P112, DOI 10.1007/s10803-009-0840-2; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Lee ES, 2007, INVEST OPHTH VIS SCI, V48, P2868, DOI 10.1167/iovs.06-0035; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Levenga J, 2011, NEUROBIOL LEARN MEM, V95, P467, DOI 10.1016/j.nlm.2011.02.009; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044.122.2.293; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nader R, 2004, CLIN J PAIN, V20, P88, DOI 10.1097/00002508-200403000-00005; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Perche O, 2009, EXP EYE RES, V89, P989, DOI 10.1016/j.exer.2009.08.012; Perche O, 2007, INVEST OPHTH VIS SCI, V48, P2753, DOI 10.1167/iovs.06-1258; Perche O, 2013, EUR J MED GENET, V56, P635, DOI 10.1016/j.ejmg.2013.07.007; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Price BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049889; Purves D., 2001, NEUROSCIENCE; Shi D, 2012, J NEUROCHEM, V123, P971, DOI 10.1111/jnc.12048; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Westmark CJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00057; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhu ZW, 2011, NEUROPATHOLOGY, V31, P223, DOI 10.1111/j.1440-1789.2010.01165.x; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	65	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105996	10.1371/journal.pone.0105996	http://dx.doi.org/10.1371/journal.pone.0105996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153086	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200103
J	Tsui, CKM; Farfan, L; Roe, AD; Rice, AV; Cooke, JEK; El-Kassaby, YA; Hamelin, RC				Tsui, Clement Kin-Ming; Farfan, Lina; Roe, Amanda D.; Rice, Adrianne V.; Cooke, Janice E. K.; El-Kassaby, Yousry A.; Hamelin, Richard C.			Population Structure of Mountain Pine Beetle Symbiont Leptographium longiclavatum and the Implication on the Multipartite Beetle-Fungi Relationships	PLOS ONE			English	Article							BLUE-STAIN FUNGI; APPROXIMATE BAYESIAN COMPUTATION; INVASIVE BARK BEETLE; DENDROCTONUS-PONDEROSAE; OPHIOSTOMA-CLAVIGERUM; RANGE EXPANSION; COMPARATIVE PHYLOGEOGRAPHY; GENETIC DIFFERENTIATION; GROSMANNIA-CLAVIGERA; MICROSATELLITE DATA	Over 18 million ha of forests have been destroyed in the past decade in Canada by the mountain pine beetle (MPB) and its fungal symbionts. Understanding their population dynamics is critical to improving modeling of beetle epidemics and providing potential clues to predict population expansion. Leptographium longiclavatum and Grosmannia clavigera are fungal symbionts of MPB that aid the beetle to colonize and kill their pine hosts. We investigated the genetic structure and demographic expansion of L. longiclavatum in populations established within the historic distribution range and in the newly colonized regions. We identified three genetic clusters/populations that coincide with independent geographic locations. The genetic profiles of the recently established populations in northern British Columbia (BC) and Alberta suggest that they originated from central and southern BC. Approximate Bayesian Computation supports the scenario that this recent expansion represents an admixture of individuals originating from BC and the Rocky Mountains. Highly significant correlations were found among genetic distance matrices of L. longiclavatum, G. clavigera, and MPB. This highlights the concordance of demographic processes in these interacting organisms sharing a highly specialized niche and supports the hypothesis of long-term multipartite beetle-fungus co-evolutionary history and mutualistic relationships.	[Tsui, Clement Kin-Ming; Farfan, Lina; El-Kassaby, Yousry A.; Hamelin, Richard C.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada; [Roe, Amanda D.; Rice, Adrianne V.; Cooke, Janice E. K.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hamelin, Richard C.] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada	University of British Columbia; University of Alberta; Natural Resources Canada; Canadian Forest Service	Hamelin, RC (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada.	richard.hamelin@ubc.ca	El-Kassaby, Yousry A/K-9856-2016; Cooke, Janice E/G-5906-2011; Tsui, Clement/F-6416-2013; Cooke, Janice/W-8452-2019; Hamelin, Richard/F-7006-2010	El-Kassaby, Yousry A/0000-0002-4887-8977; Cooke, Janice E/0000-0002-4990-628X; Tsui, Clement/0000-0001-5129-1037; Cooke, Janice/0000-0002-4990-628X; Roe, Amanda/0000-0003-1502-7276; Hamelin, Richard/0000-0003-4006-532X	Genome Canada; Genome British Columbia; Genome Alberta; Government of Alberta [AAET/AFRI-859-G07]	Genome Canada(Genome Canada); Genome British Columbia; Genome Alberta; Government of Alberta	Funding for this research was provided by Genome Canada, Genome British Columbia, Genome Alberta and the Government of Alberta (AAET/AFRI-859-G07) in support of the Tria I and Tria II Projects (http://www.thetriaproject.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Alamouti SM, 2011, MOL ECOL, V20, P2581, DOI 10.1111/j.1365-294X.2011.05109.x; Aukema BH, 2006, ECOGRAPHY, V29, P427, DOI 10.1111/j.2006.0906-7590.04445.x; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bleiker KP, 2007, ENVIRON ENTOMOL, V36, P1384, DOI 10.1603/0046-225X(2007)36[1384:DBOFAT]2.0.CO;2; BRIDGES JR, 1983, ENVIRON ENTOMOL, V12, P858, DOI 10.1093/ee/12.3.858; Brown AMV, 2014, MOL ECOL, V23, P1516, DOI 10.1111/mec.12366; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Caldera EJ, 2012, AM NAT, V180, P604, DOI 10.1086/667886; Carroll AL, 2004, PACIF FOR C, V399, P223; Coletta HD, 2011, APPL ENVIRON MICROB, V77, P2596, DOI 10.1128/AEM.02172-10; Corander J, 2003, GENETICS, V163, P367; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cornuet JM, 1996, GENETICS, V144, P2001; Cullingham CI, 2012, ECOL EVOL, V2, P908, DOI 10.1002/ece3.102; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Da Silva FM, 2007, MOL ECOL, V16, P3361, DOI 10.1111/j.1365-294X.2007.03371.x; de la Giroday HMC, 2012, J BIOGEOGR, V39, P1112, DOI 10.1111/j.1365-2699.2011.02673.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frago E, 2012, TRENDS ECOL EVOL, V27, P705, DOI 10.1016/j.tree.2012.08.013; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; Goodsman DW, 2012, ENVIRON ENTOMOL, V41, P478, DOI 10.1603/EN11205; Hedrick PW., 2009, GENETICS POPULATIONS; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; James PMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025359; Johannesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051809; Khadempour L, 2012, MICROB ECOL, V64, P909, DOI 10.1007/s00248-012-0077-z; Klepzig KD, 2009, ENVIRON ENTOMOL, V38, P67, DOI 10.1603/022.038.0109; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lee S, 2007, PHYTOPATHOLOGY, V97, P1177, DOI 10.1094/PHYTO-97-9-1177; Lee S, 2005, MYCOL RES, V109, P1162, DOI 10.1017/S0953756205003588; Lee S, 2006, FUNGAL DIVERS, V22, P91; Legendre P, 2004, AUST NZ J STAT, V46, P615, DOI 10.1111/j.1467-842X.2004.00357.x; Lim YW, 2004, FEMS MICROBIOL LETT, V237, P89, DOI 10.1111/j.1574-6968.2004.tb09682.x; Lu M, 2011, ECOLOGY, V92, P2013, DOI 10.1890/11-0687.1; Marin M, 2009, FOREST PATHOL, V39, P249, DOI 10.1111/j.1439-0329.2009.00585.x; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Mitton JB, 2012, AM NAT, V179, pE163, DOI 10.1086/665007; Mock KE, 2007, MOL ECOL, V16, P553, DOI 10.1111/j.1365-294X.2006.03158.x; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; NEI M, 1978, GENETICS, V89, P583; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Popa V, 2012, PEST MANAG SCI, V68, P963, DOI 10.1002/ps.3307; Pritchard JK, 2000, GENETICS, V155, P945; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rice AV, 2008, FOREST PATHOL, V38, P113, DOI 10.1111/j.1439-0329.2007.00525.x; Rice AV, 2007, CAN J BOT, V85, P316, DOI 10.1139/B07-016; Rice AV, 2009, FOREST PATHOL, V39, P323, DOI 10.1111/j.1439-0329.2009.00593.x; Robertson C, 2009, J BIOGEOGR, V36, P1446, DOI 10.1111/j.1365-2699.2009.02100.x; Roe AD, 2011, MICROB ECOL, V62, P347, DOI 10.1007/s00248-011-9841-8; Roe AD, 2011, MOL ECOL, V20, P584, DOI 10.1111/j.1365-294X.2010.04953.x; Roe AD, 2010, MOL ECOL RESOUR, V10, P946, DOI 10.1111/j.1755-0998.2010.02844.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Safranyik L., 2006, The mountain pine beetle: a synthesis of biology, management and impacts on lodgepole pine; Samarasekera GDNG, 2012, MOL ECOL, V21, P2931, DOI 10.1111/j.1365-294X.2012.05587.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Six Diana L., 2012, Insects, V3, P339, DOI 10.3390/insects3010339; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Six DL, 1998, ENVIRON ENTOMOL, V27, P1393, DOI 10.1093/ee/27.6.1393; Six DL, 2003, CAN J FOREST RES, V33, P1331, DOI [10.1139/x03-047, 10.1139/X03-047]; Six DL, 2004, SYMBIOSIS, V37, P207; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Solheim H, 1998, CAN J BOT, V76, P561, DOI 10.1139/cjb-76-4-561; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Tsui CKM, 2009, MOL ECOL RESOUR, V9, P1501, DOI 10.1111/j.1755-0998.2009.02717.x; Tsui CKM, 2013, G3-GENES GENOM GENET, V3, P465, DOI 10.1534/g3.112.004986; Tsui CKM, 2012, MOL ECOL, V21, P71, DOI 10.1111/j.1365-294X.2011.05366.x; Vollmer SA, 2011, ENVIRON MICROBIOL, V13, P184, DOI 10.1111/j.1462-2920.2010.02319.x; Wang B, 2012, B ENTOMOL RES, V102, P71, DOI 10.1017/S000748531100037X; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yamaoka Y, 1995, EUR J FOREST PATHOL, V25, P401	88	12	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105455	10.1371/journal.pone.0105455	http://dx.doi.org/10.1371/journal.pone.0105455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153489	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200050
J	Mayola, A; Irazoki, O; Martinez, IA; Petrov, D; Menolascina, F; Stocker, R; Reyes-Darias, JA; Krell, T; Barbe, J; Campoy, S				Mayola, Albert; Irazoki, Oihane; Martinez, Ignacio A.; Petrov, Dmitri; Menolascina, Filippo; Stocker, Roman; Reyes-Darias, Jose A.; Krell, Tino; Barbe, Jordi; Campoy, Susana			RecA Protein Plays a Role in the Chemotactic Response and Chemoreceptor Clustering of Salmonella enterica	PLOS ONE			English	Article							RECOMBINATIONAL DNA-REPAIR; ESCHERICHIA-COLI; BACTERIAL MOTILITY; SWARMING MOTILITY; ATP HYDROLYSIS; SYSTEM; CLEAVAGE; GENES; TYPHIMURIUM; MUTAGENESIS	The RecA protein is the main bacterial recombinase and the activator of the SOS system. In Escherichia coli and Salmonella enterica sv. Typhimurium, RecA is also essential for swarming, a flagellar-driven surface translocation mechanism widespread among bacteria. In this work, the direct interaction between RecA and the CheW coupling protein was confirmed, and the motility and chemotactic phenotype of a S. Typhimurium Delta recA mutant was characterized through microfluidics, optical trapping, and quantitative capillary assays. The results demonstrate the tight association of RecA with the chemotaxis pathway and also its involvement in polar chemoreceptor cluster formation. RecA is therefore necessary for standard flagellar rotation switching, implying its essential role not only in swarming motility but also in the normal chemotactic response of S. Typhimurium.	[Mayola, Albert; Irazoki, Oihane; Barbe, Jordi; Campoy, Susana] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain; [Martinez, Ignacio A.; Petrov, Dmitri] ICFO, Castelldefels, Spain; [Menolascina, Filippo; Stocker, Roman] MIT, Dept Civil & Environm Engn, Cambridge, MA USA; [Reyes-Darias, Jose A.; Krell, Tino] CSIC, Environm Protect Dept, Estn Expt Zaidin, Granada, Spain	Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Massachusetts Institute of Technology (MIT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Campoy, S (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain.	Susana.Campoy@uab.cat	Campoy, Susana/C-7335-2008; Martinez, Ignacio A A/C-2024-2015; Krell, Tino/G-7296-2015; Stocker, Roman/T-9456-2017; Stocker, Roman/N-8987-2019; campoy, susana/E-4346-2010; Barbe, Jordi/G-5212-2015; irazoki, oihane/G-8416-2015	Campoy, Susana/0000-0003-1369-0197; Martinez, Ignacio A A/0000-0002-0208-7790; Krell, Tino/0000-0002-9040-3166; Stocker, Roman/0000-0002-3199-0508; campoy, susana/0000-0003-1369-0197; Barbe, Jordi/0000-0003-4408-013X; irazoki, oihane/0000-0002-8896-7480; Menolascina, Filippo/0000-0002-4937-7912	Spanish Ministry of Science and Innovation [BFU2011-23478, FIS200800114, FIS2011-24409]; Generalitat de Catalunya [2009SGR159, 2014SGR572]; Fundacio Privada Cellex Barcelona and the National Institute of Health [1R01GM100473]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100473] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio Privada Cellex Barcelona and the National Institute of Health(Foundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge financial support from the Spanish Ministry of Science and Innovation (grant BFU2011-23478 to JB and FIS200800114 and FIS2011-24409 to DP), Generalitat de Catalunya (grant 2009SGR159 to DP and 2014SGR572 to JB), Fundacio Privada Cellex Barcelona and the National Institute of Health (grant 1R01GM100473 to RS). The funders had no role in the design of the study, in data collection and analysis, in the decision to publish, or in the preparation of the manuscript.	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; Altindal T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018231; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; BARBE J, 1986, J BACTERIOL, V167, P1055, DOI 10.1128/jb.167.3.1055-1057.1986; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Borloo J, 2007, J PROTEOME RES, V6, P2587, DOI 10.1021/pr070037j; Brennan CA, 2013, APPL ENVIRON MICROB, V79, P1889, DOI 10.1128/AEM.03794-12; BRYANT FR, 1986, J BIOL CHEM, V261, P2988; Burkart M, 1998, P NATL ACAD SCI USA, V95, P2568, DOI 10.1073/pnas.95.5.2568; Campoy S, 2002, INFECT IMMUN, V70, P4721, DOI 10.1128/IAI.70.8.4721-4725.2002; Cardozo MJ, 2010, MOL MICROBIOL, V75, P1171, DOI 10.1111/j.1365-2958.2009.07032.x; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; DEFRANCO AL, 1979, J BACTERIOL, V139, P107, DOI 10.1128/JB.139.1.107-114.1979; EGUCHI Y, 1988, J MOL BIOL, V202, P565, DOI 10.1016/0022-2836(88)90286-0; Eisen JA, 1995, J MOL EVOL, V41, P1105; Gomez-Gomez JM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-14; Green M. R., 2012, MOL CLONING LAB MANU, V4th; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; KAWASHIMA H, 1984, MOL GEN GENET, V193, P288, DOI 10.1007/BF00330682; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Keyamura K, 2013, J BIOL CHEM, V288, P29229, DOI 10.1074/jbc.M113.485474; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; Koch M, 2012, NAT PHOTONICS, V6, P680, DOI [10.1038/nphoton.2012.232, 10.1038/NPHOTON.2012.232]; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Landry MP, 2009, BIOPHYS J, V97, P2128, DOI 10.1016/j.bpj.2009.07.048; LIU JD, 1989, P NATL ACAD SCI USA, V86, P8703, DOI 10.1073/pnas.86.22.8703; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MANSON MD, 1992, ADV MICROB PHYSIOL, V33, P277, DOI 10.1016/S0065-2911(08)60219-2; Mariconda S, 2006, MOL MICROBIOL, V60, P1590, DOI 10.1111/j.1365-2958.2006.05208.x; Martinez IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061630; Medina-Ruiz L, 2010, INFECT IMMUN, V78, P3217, DOI 10.1128/IAI.01321-09; Min TL, 2009, NAT METHODS, V6, P831, DOI [10.1038/NMETH.1380, 10.1038/nmeth.1380]; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; Partridge JD, 2013, J BACTERIOL, V195, P919, DOI 10.1128/JB.02064-12; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Raterman EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054133; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; ROBERTS JW, 1975, P NATL ACAD SCI USA, V72, P147, DOI 10.1073/pnas.72.1.147; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; SAUER RT, 1982, J BIOL CHEM, V257, P4458; SMITH RA, 1980, P NATL ACAD SCI-BIOL, V77, P5370, DOI 10.1073/pnas.77.9.5370; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; WARRICK HM, 1977, J BACTERIOL, V130, P223, DOI 10.1128/JB.130.1.223-231.1977	57	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105578	10.1371/journal.pone.0105578	http://dx.doi.org/10.1371/journal.pone.0105578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147953	Green Published, gold			2022-12-25	WOS:000341230600060
J	Totzeck, M; Hendgen-Cotta, UB; Kelm, M; Rassaf, T				Totzeck, Matthias; Hendgen-Cotta, Ulrike B.; Kelm, Malte; Rassaf, Tienush			Crosstalk between Nitrite, Myoglobin and Reactive Oxygen Species to Regulate Vasodilation under Hypoxia	PLOS ONE			English	Article							ARTERIAL SMOOTH-MUSCLE; ISCHEMIA-REPERFUSION; DIETARY NITRATE; BLOOD-PRESSURE; IN-VIVO; CIRCULATING NITRITE; CORONARY FLOW; OXIDE; MECHANISMS; REDUCTASE	The systemic response to decreasing oxygen levels is hypoxic vasodilation. While this mechanism has been known for more than a century, the underlying cellular events have remained incompletely understood. Nitrite signaling is critically involved in vessel relaxation under hypoxia. This can be attributed to the presence of myoglobin in the vessel wall together with other potential nitrite reductases, which generate nitric oxide, one of the most potent vasodilatory signaling molecules. Questions remain relating to the precise concentration of nitrite and the exact dose-response relations between nitrite and myoglobin under hypoxia. It is furthermore unclear whether regulatory mechanisms exist which balance this interaction. Nitrite tissue levels were similar across all species investigated. We then investigated the exact fractional myoglobin desaturation in an ex vivo approach when gassing with 1% oxygen. Within a short time frame myoglobin desaturated to 58 +/- 12%. Given that myoglobin significantly contributes to nitrite reduction under hypoxia, dose-response experiments using physiological to pharmacological nitrite concentrations were conducted. Along all concentrations, abrogation of myoglobin in mice impaired vasodilation. As reactive oxygen species may counteract the vasodilatory response, we used superoxide dismutase and its mimic tempol as well as catalase and ebselen to reduce the levels of reactive oxygen species during hypoxic vasodilation. Incubation of tempol in conjunction with catalase alone and catalase/ebselen increased the vasodilatory response to nitrite. Our study shows that modest hypoxia leads to a significant nitrite-dependent vessel relaxation. This requires the presence of vascular myoglobin for both physiological and pharmacological nitrite levels. Reactive oxygen species, in turn, modulate this vasodilation response.	[Totzeck, Matthias; Hendgen-Cotta, Ulrike B.; Kelm, Malte; Rassaf, Tienush] Univ Hosp Dusseldorf, Fac Med, Dept Med, Div Cardiol Pulm Dis & Vasc Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Rassaf, T (corresponding author), Univ Hosp Dusseldorf, Fac Med, Dept Med, Div Cardiol Pulm Dis & Vasc Med, Dusseldorf, Germany.	Tienush.Rassaf@med.uni-duesseldorf.de		Kelm, Malte/0000-0003-0060-1052	DFG [RA969/7-2, RA969/4-2]; Deutsche Herzstiftung; Forschungskommission of the Heinrich-Heine-University Dusseldorf	DFG(German Research Foundation (DFG)); Deutsche Herzstiftung; Forschungskommission of the Heinrich-Heine-University Dusseldorf	TR is a Heisenberg professor funded by the DFG (RA969/7-2). TR was supported by a grant from the DFG (RA969/4-2). MT was supported by a grant from the Deutsche Herzstiftung and by a grant from the Forschungskommission of the Heinrich-Heine-University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 1996, J VASC RES, V33, P347, DOI 10.1159/000159163; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; BUSSE R, 1984, PFLUG ARCH EUR J PHY, V401, P77, DOI 10.1007/BF00581536; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Curtis E, 2012, ANTIOXID REDOX SIGN, V17, P951, DOI 10.1089/ars.2011.4242; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; Deussen A, 2006, BASIC RES CARDIOL, V101, P453, DOI 10.1007/s00395-006-0621-4; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Feelisch M, 2008, J BIOL CHEM, V283, P33927, DOI 10.1074/jbc.M806654200; FREDRICKS KT, 1994, AM J PHYSIOL, V267, pH706, DOI 10.1152/ajpheart.1994.267.2.H706; FURCHGOTT RF, 1953, J PHARMACOL EXP THER, V108, P129; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao Q, 2009, AM J PHYSIOL-HEART C, V297, pH2262, DOI 10.1152/ajpheart.00817.2009; Gladwin MT, 2008, CIRCULATION, V117, P594, DOI 10.1161/CIRCULATIONAHA.107.753897; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gladwin MT, 2011, JAMA-J AM MED ASSOC, V305, P893, DOI 10.1001/jama.2011.235; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; Godecke A, 1998, CIRC RES, V82, P186; GRASER T, 1992, J CARDIOVASC PHARM, V20, pS117; Hall JE., 2011, TXB MED PHYSL; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105; Hendgen-Cotta UB, 2012, CIRCULATION, V126, P1983, DOI 10.1161/CIRCULATIONAHA.112.112912; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; Isbell TS, 2008, NAT MED, V14, P773, DOI 10.1038/nm1771; Isbell TS, 2007, AM J PHYSIOL-HEART C, V293, pH2565, DOI 10.1152/ajpheart.00759.2007; Jansson EA, 2008, NAT CHEM BIOL, V4, P411, DOI 10.1038/nchembio.92; Kapil V, 2010, HYPERTENSION, V56, P274, DOI 10.1161/HYPERTENSIONAHA.110.153536; Kim-Shapiro DB, 2014, NITRIC OXIDE-BIOL CH, V38, P58, DOI 10.1016/j.niox.2013.11.002; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Larsen FJ, 2006, NEW ENGL J MED, V355, P2792, DOI 10.1056/NEJMc062800; Liaw N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101721; Luedike P, 2012, CIRCULATION, V125, P1880, DOI 10.1161/CIRCULATIONAHA.111.069104; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Maher AR, 2008, CIRCULATION, V117, P670, DOI 10.1161/CIRCULATIONAHA.107.719591; Modin A, 2001, ACTA PHYSIOL SCAND, V171, P9, DOI 10.1046/j.1365-201x.2001.171001009.x; NAKHOSTINE N, 1994, PFLUG ARCH EUR J PHY, V428, P526, DOI 10.1007/BF00374574; NAKHOSTINE N, 1993, AM J PHYSIOL, V265, pH1289, DOI 10.1152/ajpheart.1993.265.4.H1289; OKADA T, 1991, J MOL CELL CARDIOL, V23, P939, DOI 10.1016/0022-2828(91)90136-A; Pinder AG, 2009, BRIT J PHARMACOL, V157, P1523, DOI 10.1111/j.1476-5381.2009.00340.x; Prieto D, 2010, AM J PHYSIOL-HEART C, V299, pH915, DOI 10.1152/ajpheart.00382.2010; Rammos C, 2014, J AM COLL CARDIOL, V63, P1584, DOI 10.1016/j.jacc.2013.08.691; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Rassaf T, 2014, CIRC RES, V114, P1601, DOI 10.1161/CIRCRESAHA.114.303822; Rodriguez J, 2003, P NATL ACAD SCI USA, V100, P336, DOI 10.1073/pnas.0234600100; Sandvik GK, 2012, AM J PHYSIOL-REG I, V302, pR468, DOI 10.1152/ajpregu.00538.2011; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Totzeck M, 2012, NITRIC OXIDE-BIOL CH, V27, P75, DOI 10.1016/j.niox.2012.05.003; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Totzeck M, 2012, NITRIC OXIDE-BIOL CH, V26, P211, DOI 10.1016/j.niox.2012.03.001; Totzeck M, 2011, CRIT CARE MED, V39, P1837, DOI 10.1097/CCM.0b013e31821b8180; Vanin AF, 2007, CELL MOL LIFE SCI, V64, P96, DOI 10.1007/s00018-006-6374-2; VONBECKERATH N, 1991, J PHYSIOL-LONDON, V442, P297, DOI 10.1113/jphysiol.1991.sp018794; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; WEI HM, 1989, AM J PHYSIOL, V257, pH1043, DOI 10.1152/ajpheart.1989.257.4.H1043; Wolin MS, 2009, AM J PHYSIOL-HEART C, V296, pH539, DOI 10.1152/ajpheart.01167.2008; Zuckerbraun BS, 2010, CIRCULATION, V121, P98, DOI 10.1161/CIRCULATIONAHA.109.891077	65	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105951	10.1371/journal.pone.0105951	http://dx.doi.org/10.1371/journal.pone.0105951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148388	Green Submitted, gold, Green Published			2022-12-25	WOS:000341230600100
J	Wardman, JH; Fricker, LD				Wardman, Jonathan H.; Fricker, Lloyd D.			ProSAAS-Derived Peptides Are Differentially Processed and Sorted in Mouse Brain and AtT-20 Cells	PLOS ONE			English	Article							PROPROTEIN CONVERTASES FURIN; PROHORMONE CONVERTASE-2; SECRETORY GRANULES; CARBOXYPEPTIDASE-E; BODY-WEIGHT; NEUROPEPTIDES; PRECURSOR; IDENTIFICATION; PURIFICATION; PEPTIDOMICS	ProSAAS is the precursor for some of the most abundant peptides found in mouse brain and other tissues, including peptides named SAAS, PEN, and LEN. Both SAAS and LEN are found in big and little forms due to differential processing. Initial processing of proSAAS is mediated by furin (and/or furin-like enzymes) and carboxypeptidase D, while the smaller forms are generated by secretory granule prohormone convertases and carboxypeptidase E. In mouse hypothalamus, PEN and big LEN colocalize with neuropeptide Y. In the present study, little LEN and SAAS were detected in mouse hypothalamus but not in cell bodies of neuropeptide Y-expressing neurons. PEN and big LEN show substantial colocalization in hypothalamus, but big LEN and little LEN do not. An antiserum to SAAS that detects both big and little forms of this peptide did not show substantial colocalization with PEN or big LEN. To further study this, the AtT-20 cells mouse pituitary corticotrophic cell line was transfected with rat proSAAS and the distribution of peptides examined. As found in mouse hypothalamus, only some of the proSAAS-derived peptides colocalized with each other in AtT-20 cells. The two sites within proSAAS that are known to be efficiently cleaved by furin were altered by site-directed mutagenesis to convert the P4 Arg into Lys; this change converts the sequences from furin consensus sites into prohormone convertase consensus sites. Upon expression of the mutated form of proSAAS in AtT-20 cells, there was significantly more colocalization of proSAAS-derived peptides PEN and SAAS. Taken together, these results indicate that proSAAS is initially cleaved in the Golgi or trans-Golgi network by furin and/or furin-like enzymes and the resulting fragments are sorted into distinct vesicles and further processed by additional enzymes into the mature peptides.	[Wardman, Jonathan H.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Fricker, Lloyd D.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	lloyd.fricker@einstein.yu.edu			National Institutes of Health [DA-004494]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by National Institutes of Health grant DA-004494 (LDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072529; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Bicknell AB, 2008, J NEUROENDOCRINOL, V20, P692, DOI 10.1111/j.1365-2826.2008.01709.x; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; Brakch N, 1997, BIOCHEMISTRY-US, V36, P16309, DOI 10.1021/bi9714767; BRESLIN MB, 1993, J BIOL CHEM, V268, P27084; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Feng Y, 2001, NEUROSCIENCE, V105, P469, DOI 10.1016/S0306-4522(01)00200-7; Feng Yun, 2002, Brain Res Gene Expr Patterns, V1, P135; FISHER JM, 1988, CELL, V54, P813, DOI 10.1016/S0092-8674(88)91131-2; Fricker L.D., 2012, NEUROPEPTIDES OTHER; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; GREENE D, 1992, BIOCHEM J, V285, P613, DOI 10.1042/bj2850613; Hatcher NG, 2008, P NATL ACAD SCI USA, V105, P12527, DOI 10.1073/pnas.0804340105; Hoshino A., 2012, C SERIES NEUROPEPTID, V1, P1; MATSUUCHI L, 1988, J CELL BIOL, V106, P239, DOI 10.1083/jcb.106.2.239; Merighi A, 2002, PROG NEUROBIOL, V66, P161, DOI 10.1016/S0301-0082(01)00031-4; Morgan DJ, 2010, J NEUROCHEM, V113, P1275, DOI 10.1111/j.1471-4159.2010.06706.x; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mzhavia N, 2002, BIOCHEM J, V361, P67, DOI 10.1042/0264-6021:3610067; Mzhavia N, 2001, J BIOL CHEM, V276, P6207, DOI 10.1074/jbc.M009067200; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Perello M, 2008, J BIOL CHEM, V283, P19936, DOI 10.1074/jbc.M800732200; Sayah M, 2001, J NEUROCHEM, V76, P1833, DOI 10.1046/j.1471-4159.2001.00165.x; SEIDAH NG, 2004, HDB PROTEOLYTIC ENZY, P1861; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; SOSSIN WS, 1989, NEURON, V2, P1407, DOI 10.1016/0896-6273(89)90186-4; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Wardman JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028152; Wardman JH, 2010, J NEUROCHEM, V114, P215, DOI 10.1111/j.1471-4159.2010.06760.x; Wei SW, 2004, J ENDOCRINOL, V180, P357, DOI 10.1677/joe.0.1800357; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630; Zhang X, 2010, J NEUROCHEM, V112, P1168, DOI 10.1111/j.1471-4159.2009.06530.x; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	41	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104232	10.1371/journal.pone.0104232	http://dx.doi.org/10.1371/journal.pone.0104232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148519	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600011
J	Elkins, CM; Qi, QM; Fuller, GG				Elkins, Claire M.; Qi, Qin M.; Fuller, Gerald G.			Corneal Cell Adhesion to Contact Lens Hydrogel Materials Enhanced via Tear Film Protein Deposition	PLOS ONE			English	Article							SILICONE-HYDROGEL; INTEGRIN BINDING; LYSOZYME DEPOSITION; SURFACE; SPECIFICITY; WEAR; DIFFERENTIATION; PRESSURE; IMPACT	Tear film protein deposition on contact lens hydrogels has been well characterized from the perspective of bacterial adhesion and viability. However, the effect of protein deposition on lens interactions with the corneal epithelium remains largely unexplored. The current study employs a live cell rheometer to quantify human corneal epithelial cell adhesion to soft contact lenses fouled with the tear film protein lysozyme. PureVision balafilcon A and AirOptix lotrafilcon B lenses were soaked for five days in either phosphate buffered saline (PBS), borate buffered saline (BBS), or Sensitive Eyes Plus Saline Solution (Sensitive Eyes), either pure or in the presence of lysozyme. Treated contact lenses were then contacted to a live monolayer of corneal epithelial cells for two hours, after which the contact lens was sheared laterally. The apparent cell monolayer relaxation modulus was then used to quantify the extent of cell adhesion to the contact lens surface. For both lens types, lysozyme increased corneal cell adhesion to the contact lens, with the apparent cell monolayer relaxation modulus increasing up to an order of magnitude in the presence of protein. The magnitude of this increase depended on the identity of the soaking solution: lenses soaked in borate-buffered solutions (BBS, Sensitive Eyes) exhibited a much greater increase in cell attachment upon protein addition than those soaked in PBS. Significantly, all measurements were conducted while subjecting the cells to moderate surface pressures and shear rates, similar to those experienced by corneal cells in vivo.	[Elkins, Claire M.; Qi, Qin M.; Fuller, Gerald G.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University	Elkins, CM (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	cma9@stanford.edu		Fuller, Gerald/0000-0002-2924-053X	Bausch Lomb	Bausch Lomb	This work was supported in part by funding from Bausch & Lomb. All other funding was provided from completely unrestricted, non-commercial funds internal to the authors' laboratory at Stanford University. This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andrade JD, 1986, ABSTR PRORGR 11 REUN, P3; Andrasko Gary, 2008, Optometry, V79, P444, DOI 10.1016/j.optm.2008.04.097; CONWAY HD, 1983, J BIOMECH ENG-T ASME, V105, P47, DOI 10.1115/1.3138383; Duench S, 2013, OPTOMETRY VISION SCI, V90, P546, DOI 10.1097/OPX.0b013e318294c2a6; Dunn AC, 2008, TRIBOL LETT, V30, P13, DOI 10.1007/s11249-008-9306-5; Flanagan JL, 2009, BIOCHIMIE, V91, P35, DOI 10.1016/j.biochi.2008.07.007; Garrett Q, 1999, INVEST OPHTH VIS SCI, V40, P897; Jones L, 2002, OPTOMETRY VISION SCI, V79, P753, DOI 10.1097/00006324-200212000-00007; Jones L, 2003, EYE CONTACT LENS, V29, P75; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537; Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062; KLOTZ SA, 1987, ARCH OPHTHALMOL-CHIC, V105, P974; LEAHY CD, 1990, OPTOMETRY VISION SCI, V67, P504, DOI 10.1097/00006324-199007000-00008; Leiske DL, 2010, EXP EYE RES, V90, P598, DOI 10.1016/j.exer.2010.02.004; Lin Meng C, 2003, Cont Lens Anterior Eye, V26, P11, DOI 10.1016/S1367-0484(02)00088-7; LIN S T, 1991, CLAO Journal, V17, P44; MARTIN DK, 1986, PHYS MED BIOL, V31, P635, DOI 10.1088/0031-9155/31/6/005; McNamara NA, 1998, OPHTHALMOLOGY, V105, P2330, DOI 10.1016/S0161-6420(98)91237-4; Nairn J. A., 1995, P ANTEC ANN TECH C, V6, P1; Ng A, 2013, J BIOMED MATER RES B, P1; Ng A, 2012, OPTOMETRY VISION SCI, V89, P392, DOI 10.1097/OPX.0b013e31824c0c4a; Pucker AD, 2010, INVEST OPHTH VIS SCI, V51, P6334, DOI 10.1167/iovs.10-5836; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rosenfeld L, 2013, INVEST OPHTH VIS SCI, V54, P2720, DOI 10.1167/iovs.12-10987; SACK RA, 1987, INVEST OPHTH VIS SCI, V28, P842; SACK RA, 1992, INVEST OPHTH VIS SCI, V33, P626; Soltys-Robitaille CE, 2001, BIOMATERIALS, V22, P3257, DOI 10.1016/S0142-9612(01)00163-6; Subbaraman LN, 2006, CURR EYE RES, V31, P787, DOI 10.1080/02713680600888799; Subbaraman LN, 2011, OPTOMETRY VISION SCI, V88, P959, DOI 10.1097/OPX.0b013e31821ffccb; Suwala Maciej, 2007, Eye Contact Lens, V33, P138, DOI 10.1097/01.icl.0000244155.87409.f6; TRIPATHI PC, 1992, INVEST OPHTH VIS SCI, V33, P121; White P, 2012, CONTACT LENS SPECTR, P1; Willcox MDP, 2001, BIOMATERIALS, V22, P3235, DOI 10.1016/S0142-9612(01)00161-2; Williams TJ, 2003, CURR EYE RES, V27, P227, DOI 10.1076/ceyr.27.4.227.16602	36	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105512	10.1371/journal.pone.0105512	http://dx.doi.org/10.1371/journal.pone.0105512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144576	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100076
J	Greiner, ER; Kelly, JW; Palhano, FL				Greiner, Erin R.; Kelly, Jeffery W.; Palhano, Fernando L.			Immunoprecipitation of Amyloid Fibrils by the Use of an Antibody that Recognizes a Generic Epitope Common to Amyloid Fibrils	PLOS ONE			English	Article							NUCLEATED CONFORMATIONAL CONVERSION; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PROTEIN AGGREGATION; YEAST PRION; DOMAIN; FORMS; IDENTIFICATION; OLIGOMERS	Amyloid fibrils are associated with many maladies, including Alzheimer's disease (AD). The isolation of amyloids from natural materials is very challenging because the extreme structural stability of amyloid fibrils makes it difficult to apply conventional protein science protocols to their purification. A protocol to isolate and detect amyloids is desired for the diagnosis of amyloid diseases and for the identification of new functional amyloids. Our aim was to develop a protocol to purify amyloid from organisms, based on the particular characteristics of the amyloid fold, such as its resistance to proteolysis and its capacity to be recognized by specific conformational antibodies. We used a two-step strategy with proteolytic digestion as the first step followed by immunoprecipitation using the amyloid conformational antibody LOC. We tested the efficacy of this method using as models amyloid fibrils produced in vitro, tissue extracts from C. elegans that overexpress A beta peptide, and cerebrospinal fluid (CSF) from patients diagnosed with AD. We were able to immunoprecipitate A beta(1-40) amyloid fibrils, produced in vitro and then added to complex biological extracts, but not alpha-synuclein and gelsolin fibrils. This method was useful for isolating amyloid fibrils from tissue homogenates from a C. elegans AD model, especially from aged worms. Although we were able to capture picogram quantities of A beta(1-40) amyloid fibrils produced in vitro when added to complex biological solutions, we could not detect any A beta amyloid aggregates in CSF from AD patients. Our results show that although immunoprecipitation using the LOC antibody is useful for isolating A beta(1-40) amyloid fibrils, it fails to capture fibrils of other amyloidogenic proteins, such as alpha-synuclein and gelsolin. Additional research might be needed to improve the affinity of these amyloid conformational antibodies for an array of amyloid fibrils without compromising their selectivity before application of this protocol to the isolation of amyloids.	[Greiner, Erin R.; Kelly, Jeffery W.; Palhano, Fernando L.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Greiner, Erin R.; Kelly, Jeffery W.; Palhano, Fernando L.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Greiner, Erin R.; Kelly, Jeffery W.; Palhano, Fernando L.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Palhano, Fernando L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, Rio De Janeiro, Brazil	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Universidade Federal do Rio de Janeiro	Palhano, FL (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	palhano@bioqmed.ufrj.br	Palhano, Fernando/AAB-3144-2021	Palhano, Fernando/0000-0001-5336-632X	NIA NIH HHS [AG031097, P01 AG031097] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG031097] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Berkelman Tom, 2008, V424, P51, DOI 10.1007/978-1-60327-064-9_5; Bieschke J, 2009, PROTEIN SCI, V18, P2231, DOI 10.1002/pro.234; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COOPER AF, 1970, J NEMATOL, V2, P305; De Genst Erwin, 2012, Methods Mol Biol, V911, P533, DOI 10.1007/978-1-61779-968-6_34; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Angarica VE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-102; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Gao CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015725; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Glenner GG, 2012, BIOCHEM BIOPH RES CO, V425, P534, DOI 10.1016/j.bbrc.2012.08.020; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; HALTIA M, 1990, BIOCHEM BIOPH RES CO, V167, P927, DOI 10.1016/0006-291X(90)90612-Q; Haupt C, 2011, J MOL BIOL, V408, P529, DOI 10.1016/j.jmb.2011.02.032; Hazenberg BPC, 2007, AMYLOID, V14, P133, DOI 10.1080/13506120701260224; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Kryndushkin D, 2013, J BIOL CHEM, V288, P27100, DOI 10.1074/jbc.M113.485359; Ladiwala ARA, 2012, P NATL ACAD SCI USA, V109, P19965, DOI 10.1073/pnas.1208797109; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Leonhardt RM, 2013, MOL BIOL CELL, V24, P964, DOI 10.1091/mbc.E12-10-0742; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; MAURY CPJ, 1990, FEBS LETT, V260, P85, DOI 10.1016/0014-5793(90)80072-Q; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Murray AN, 2010, PROTEIN SCI, V19, P836, DOI 10.1002/pro.363; Santos AN, 2007, J ALZHEIMERS DIS, V11, P117; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Page LJ, 2009, P NATL ACAD SCI USA, V106, P11125, DOI 10.1073/pnas.0811753106; Palgunow D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046198; Palhano FL, 2009, BIOCHEMISTRY-US, V48, P6811, DOI 10.1021/bi9000276; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Solis GM, 2011, JOVE-J VIS EXP, DOI 10.3791/2496; Solomon JP, 2009, BIOCHEMISTRY-US, V48, P11370, DOI 10.1021/bi901368e; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; van Ham TJ, 2010, CELL, V142, P601, DOI 10.1016/j.cell.2010.07.020; Villar-Pique A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013625; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Yam AY, 2011, BIOCHEMISTRY-US, V50, P4322, DOI 10.1021/bi200215j; Zougman A, 2008, J PROTEOME RES, V7, P386, DOI 10.1021/pr070501k	72	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105433	10.1371/journal.pone.0105433	http://dx.doi.org/10.1371/journal.pone.0105433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144803	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100070
J	Molelekwa, GF; Mukhola, MS; Van der Bruggen, B; Luis, P				Molelekwa, Gomotsegang F.; Mukhola, Murembiwa S.; Van der Bruggen, Bart; Luis, Patricia			Preliminary Studies on Membrane Filtration for the Production of Potable Water: A Case of Tshaanda Rural Village in South Africa	PLOS ONE			English	Article							POINT-OF-USE; HOUSEHOLD DRINKING-WATER; MICROBIOLOGICAL QUALITY; ESCHERICHIA-COLI; SURFACE-WATER; VENDA COMMUNITIES; DIARRHEAL DISEASE; PUBLIC-HEALTH; TECHNOLOGY; ULTRAFILTRATION	Ultrafiltration (UF) systems have been used globally for treating water from resources including rivers, reservoirs, and lakes for the production of potable water in the past decade. UF membranes with a pore size of between 0.1 and 0.01 micrometres provide an effective barrier for bacteria, viruses, suspended particles, and colloids. The use of UF membrane technology in treating groundwater for the supply of potable water in the impoverished and rural village, Tshaanda (i.e., the study area) is demonstrated. The technical and administrative processes that are critical for the successful installation of the pilot plant were developed. Given the rural nature of Tshaanda, the cultural and traditional protocols were observed. Preliminary results of the water quality of untreated water and the permeate are presented. Escherichia coli in the untreated water during the dry season (i.e., June and July) was 2 cfu/100 ml and was <1 cfu/100 ml (undetected) following UF, which complied with the WHO and South African National Standards and Guidelines of,1 cfu/100 ml. During the wet/rainy season (February) total coliform was unacceptably high (>2419.2 cfu/100 ml) before UF. Following UF, it dramatically reduced to acceptable level (7 cfu/100 ml) which is within the WHO recommended level of,10 cfu/100 ml. Additionally, during the wet/rainy season E. coli and enterococci were unacceptably high (40.4 cfu/100 ml and 73.3 cfu/100 ml, respectively) before UF but were completely removed following UF, which are within the WHO and SANS recommended limit. The values for electrical conductivity (EC) and turbidity were constantly within the WHO recommended limits of 300 mu S/cm corrected at 25 degrees C and <5 NTU, respectively, before and after UF, during dry season and wet season. This suggests that there is no need for pre-treatment of the water for suspended particles and colloids. Considering these data, it can be concluded that the water is suitable for human consumption, following UF.	[Molelekwa, Gomotsegang F.; Van der Bruggen, Bart] Katholieke Univ Leuven, Dept Chem Engn, ProcESS, Leuven, Belgium; [Molelekwa, Gomotsegang F.; Mukhola, Murembiwa S.] Tshwane Univ Technol, Dept Environm Hlth, Pretoria, South Africa; [Luis, Patricia] Catholic Univ Louvain, Mat & Proc Engn iMMC IMAP, Louvain, Belgium	KU Leuven; Tshwane University of Technology; Universite Catholique Louvain	Molelekwa, GF (corresponding author), Katholieke Univ Leuven, Dept Chem Engn, ProcESS, Leuven, Belgium.	gomotsegangfred.molelekwa@cit.kuleuven.be	Van der Bruggen, Bart/AAR-3676-2020	Luis, Patricia/0000-0002-7449-3309	VLIR-UOS, Belgium [ZEIN2011PR386]	VLIR-UOS, Belgium	The funding was received from VLIR-UOS, Belgium (Project No.: ZEIN2011PR386, URL: http://www.vliruos.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MANAGING WATER HOME; Arnal JMA, 2002, DESALINATION, V145, P305, DOI 10.1016/S0011-9164(02)00427-7; Bhausaheb M.G.S., 2011, INT SCH RES NOTICES, V2011; Boulestreau M, 2012, DESALIN WATER TREAT, V42, P125, DOI 10.1080/19443994.2012.683073; Brown JM, 2008, WATER SCI TECHNOL, V58, P757, DOI 10.2166/wst.2008.439; Cameron J., 2011, VALUING WATER VALUIN; Cameron J, 2011, SCI TOTAL ENVIRON, V410, P8, DOI 10.1016/j.scitotenv.2011.09.054; CARTWRIGHT PS, 1991, DESALINATION, V83, P225, DOI 10.1016/0011-9164(91)85097-E; Clasen T, 2009, AM J TROP MED HYG, V80, P819, DOI 10.4269/ajtmh.2009.80.819; Clasen Thomas F., 2003, Journal of Water and Health, V1, P109; de la Harpe J, 2011, S AFRICA LESSONS RUR; Department of Water Affairs (DWA), 2012, BRIEF PORTF COMM WAT; Dobrowsky PH, 2014, APPL ENVIRON MICROB, V80, P1633, DOI 10.1128/AEM.03061-13; du Preez M, 2008, WATER SA, V34, P107; du Preez M, 2008, AM J TROP MED HYG, V79, P696, DOI 10.4269/ajtmh.2008.79.696; DWAF (Department of Water Affairs and Forestry), 1996, DOMESTIC WATER USE, V1; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; Esrey SA, 1985, CORNELL INT NUTR MON, V15, P1; Fane AG, 2011, TREATISE ON WATER SCIENCE, VOL 4: WATER-QUALITY ENGINEERING, P301; Ferella F, 2013, DESALINATION, V313, P1, DOI 10.1016/j.desal.2012.11.039; Fernandez G, 2012, DESALIN WATER TREAT, V42, P73, DOI 10.5004/dwt.2012.2460; Gundry S, 2013, WATER PRACTICE TECHN, V1, P1; Gundry SW, 2009, J WATER HEALTH, V7, P259, DOI 10.2166/wh.2009.032; Hofman JAMH, 1998, DESALINATION, V119, P113, DOI 10.1016/S0011-9164(98)00129-5; KUNIKANE S, 1995, J MEMBRANE SCI, V102, P149, DOI 10.1016/0376-7388(94)00292-7; Laine JM, 2000, DESALINATION, V131, P17, DOI 10.1016/S0011-9164(00)90002-X; Landre JPB, 1998, LETT APPL MICROBIOL, V26, P352, DOI 10.1046/j.1472-765X.1998.00347.x; Manjunath D, 2013, DESALIN WATER TREAT, V51, P5873, DOI 10.1080/19443994.2013.770436; Momba MNB, 2009, WATER SA, V35, P485; Momba MNB, 2003, J WATER SUPPLY RES T, V52, P67, DOI 10.2166/aqua.2003.0007; Mpenyana-Monyatsi L, 2012, POL J ENVIRON STUD, V21, P1349; Muhammad N, 2009, J ENVIRON ENG-ASCE, V135, P1181, DOI 10.1061/(ASCE)EE.1943-7870.0000084; Murthy ZVP, 2009, GLOBAL NEST J, V11, P235; Obi CL, 2003, WATER SCI TECHNOL, V47, P59, DOI 10.2166/wst.2003.0161; Obi CL, 2002, WATER SA, V28, P287; Pearce GK, 2007, DESALINATION, V203, P286, DOI 10.1016/j.desal.2006.04.011; Peter-Varbanets M., 2011, P 35 WEDC INT C FUTU; Peter-Varbanets M, 2009, WATER RES, V43, P245, DOI 10.1016/j.watres.2008.10.030; Potgieter N, 2006, WATER SCI TECHNOL, V54, P371, DOI 10.2166/wst.2006.890; Potgieter N, 2005, J HEALTH POPUL NUTR, V23, P150; Potgieter N, 2009, WATER SA, V35, P505; RACHWAL AJ, 1994, DESALINATION, V97, P427, DOI 10.1016/0011-9164(94)00105-7; Rosa G, 2010, AM J TROP MED HYG, V82, P289, DOI 10.4269/ajtmh.2010.09-0382; South African Bureau of Standards, 2011, DRINK WAT SANS 241 1; Statistics South Africa, 2012, CENS 2011 STAT REL P; Trevett Andrew Francis, 2005, Journal of Water and Health, V3, P259; Van der Bruggen B, 2003, ENVIRON POLLUT, V122, P435, DOI 10.1016/S0269-7491(02)00308-1; Varkey AJ, 2012, WATER SA, V38, P721, DOI 10.4314/wsa.v38i5.10; Ventresque C, 1997, DESALINATION, V113, P263, DOI 10.1016/S0011-9164(97)00138-0; Wall K, 2011, SAICE INFRASTRUCTURE; WATSON BM, 1989, DESALINATION, V72, P11, DOI 10.1016/0011-9164(89)80024-4; WHO, 2008, GUID DRINK WAT QUAL; WHO, 2011, GUID DRINK WAT QUAL; WHO and UNICEF, 2013, PROGR DRINK WAT SAN; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2012, PROGR DRINK WAT SAN; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Yu ZX, 2012, DESALINATION, V285, P73, DOI 10.1016/j.desal.2011.09.036; Zamxaka M, 2004, WATER SA, V30, P333; Zheng X, 2012, DESALIN WATER TREAT, V49, P281, DOI 10.1080/19443994.2012.719337	61	11	11	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105057	10.1371/journal.pone.0105057	http://dx.doi.org/10.1371/journal.pone.0105057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144640	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100037
J	Akaike, Y; Kuwano, Y; Nishida, K; Kurokawa, K; Kajita, K; Kano, S; Masuda, K; Rokutan, K				Akaike, Y.; Kuwano, Y.; Nishida, K.; Kurokawa, K.; Kajita, K.; Kano, S.; Masuda, K.; Rokutan, K.			Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1 gamma	ONCOGENE			English	Article							DOUBLE-STRAND BREAKS; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; P53 ACTIVITY; HIPK2; REPAIR; PHOSPHORYLATION; CELLS; HP1; RECRUITMENT	Homeodomain-interacting protein kinase 2 (HIPK2) is a potential tumor suppressor that has a crucial role in the DNA damage response (DDR) by regulating cell-cycle checkpoint activation and apoptosis. However, it is unclear whether HIPK2 exerts distinct roles in DNA damage repair. The aim of this study was to identify novel target molecule(s) of HIPK2, which mediates HIPK2-dependent DNA damage repair. HIPK2-knockdown human colon cancer cells (HCT116) or hipk1/hipk2 double-deficient mouse embryonic fibroblasts could not remove histone H2A.X phosphorylated at Ser139 (gamma H2A.X) after irradiation with a sublethal dose (10 J/m(2)) of ultraviolet (UV)-C, resulting in apoptosis. Knockdown of HIPK2 in p53-null HCT116 cells similarly promoted the UV-C-induced gamma H2A.X accumulation and apoptosis. Proteomic analysis of HIPK2-associated proteins using liquid chromatography-tandem mass spectrometry identified heterochromatin protein 1 gamma (HP1 gamma) as a novel target for HIPK2. Immunoprecipitation experiments with HCT116 cells expressing FLAG-tagged HIPK2 and one of the HA-tagged HP1 family members demonstrated that HIPK2 specifically associated with HP1 gamma, but not with HP1 alpha or HP1 beta, through its chromo-shadow domain. Mutation of the HP1box motif (883-PTVSV-887) within HIPK2 abolished the association. HP1 gamma knockdown also enhanced accumulation of gamma H2A.X and apoptosis after sublethal UV-C irradiation. In vitro kinase assay demonstrated an HP1 gamma-phosphorylating activity of HIPK2. Sublethal UV-C irradiation phosphorylated HP1 gamma. This phosphorylation was absent in endogenous HIPK2-silenced cells with HIPK2 3'UTR siRNA. Overexpression of FLAG-HIPK2, but not the HP1box-mutated or kinase-dead HIPK2 mutant, in the HIPK2-silenced cells increased HP1 gamma binding to trimethylated (Lys9) histone H3 (H3K9me3), rescued the UV-C-induced phosphorylation of HP1 gamma, triggered release of HP1 gamma from histone H3K9me3 and suppressed gamma H2A.X accumulation. Our results suggest that HIPK2-dependent phosphorylation of HP1 gamma may participate in the regulation of dynamic interaction between HP1 gamma and histone H3K9me3 to promote DNA damage repair. This HIPK2/HP1 gamma pathway may uncover a new functional aspect of HIPK2 as a tumor suppressor.	[Akaike, Y.; Kuwano, Y.; Nishida, K.; Kurokawa, K.; Kajita, K.; Kano, S.; Masuda, K.; Rokutan, K.] Univ Tokushima, Grad Sch, Dept Stress Sci, Inst Hlth Biosci, Tokushima 7708503, Japan	Tokushima University	Rokutan, K (corresponding author), Univ Tokushima, Grad Sch, Dept Stress Sci, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	rokutan@tokushima-u.ac.jp	Nishida, Kensei/AAF-2829-2020	Nishida, Kensei/0000-0003-2314-785X	JSPS [24-8354]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI Grant Number 24-8354 (to YA).	[Anonymous], ONCOGENE; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Choi DW, 2013, MOL CELL, V51, P374, DOI 10.1016/j.molcel.2013.06.010; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Di Stefano V, 2005, ONCOGENE, V24, P5431, DOI 10.1038/sj.onc.1208717; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Grzenda A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-21; Hiragami-Hamada K, 2011, MOL CELL BIOL, V31, P1186, DOI 10.1128/MCB.01012-10; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hofmann TG, 2013, BIOESSAYS, V35, P55, DOI 10.1002/bies.201200060; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Kwon SH, 2008, MOL CELLS, V26, P217; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Lee DH, 2011, TRENDS BIOCHEM SCI, V36, P569, DOI 10.1016/j.tibs.2011.08.007; Lee YH, 2013, NUCLEIC ACIDS RES, V41, P5784, DOI 10.1093/nar/gkt231; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Mund A, 2012, NUCLEIC ACIDS RES, V40, P11363, DOI 10.1093/nar/gks868; Nardinocchi L, 2007, BIOCHEM BIOPH RES CO, V361, P249, DOI 10.1016/j.bbrc.2007.07.031; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rinaldo C, 2012, MOL CELL, V47, P87, DOI 10.1016/j.molcel.2012.04.029; Saul VV, 2013, J MOL CELL BIOL, V5, P27, DOI 10.1093/jmcb/mjs053; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Sombroek D, 2009, CELL DEATH DIFFER, V16, P187, DOI 10.1038/cdd.2008.154; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Yamada D, 2009, ONCOGENE, V28, P2535, DOI 10.1038/onc.2009.109; Yamaguchi T, 2001, CANCER RES, V61, P8256; Zarebski M, 2009, CYTOM PART A, V75A, P619, DOI 10.1002/cyto.a.20734; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X	51	23	25	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	26					3463	3473		10.1038/onc.2014.278	http://dx.doi.org/10.1038/onc.2014.278			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CL3SU	25151962				2022-12-25	WOS:000356871700011
J	Baureder, M; Barane, E; Hederstedt, L				Baureder, Michael; Barane, Elisabeth; Hederstedt, Lars			In Vitro Assembly of Catalase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACID BACTERIA; ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-FAECALIS; MOLECULAR EVOLUTION; VECTOR; SYSTEM	Most aerobic organisms contain catalase, which functions to decompose hydrogen peroxide. Typical catalases are structurally complex homo-tetrameric enzymes with one heme prosthetic group buried in each subunit. It is not known how catalase in the cell is assembled from its constituents. The bacterium Enterococcus faecalis cannot synthesize heme but can acquire it from the environment to form a cytoplasmic catalase. We have in E. faecalis monitored production of the enzyme polypeptide (KatA) depending on the availability of heme and used our findings to devise a procedure for the purification of preparative amounts of in vivo-synthesized apocatalase. We show that fully active catalase can be obtained in vitro by incubating isolated apoprotein with hemin. We have characterized features of the assembly process and describe a temperature-trapped hemylated intermediate of the enzyme maturation process. Hemylation of apocatalase does not require auxiliary cell components, but rapid assembly of active enzyme seemingly is assisted in the cell. Our findings provide insight about catalase assembly and offer new experimental possibilities for detailed studies of this process.	[Baureder, Michael; Barane, Elisabeth; Hederstedt, Lars] Lund Univ, Dept Biol, Microbiol Grp, SE-22362 Lund, Sweden	Lund University	Hederstedt, L (corresponding author), Lund Univ, Dept Biol, Microbiol Grp, Solvegatan 35, SE-22362 Lund, Sweden.	lars.hederstedt@biol.lu.se		Baureder, Michael/0000-0003-0810-4341; Hederstedt, Lars/0000-0002-6650-6296	Swedish Research Council [621-2010-5672]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was supported by Swedish Research Council Grant 621-2010-5672.	Ascoli F, 1981, Methods Enzymol, V76, P72; Baureder M, 2013, ADV MICROB PHYSIOL, V62, P1, DOI 10.1016/B978-0-12-410515-7.00001-9; Baureder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036725; Brugna M, 2010, FEBS J, V277, P2663, DOI [10.1111/j.1742-464X.2010.07677.x, 10.1111/j.1742-4658.2010.07677.x]; Diaz A, 2012, ARCH BIOCHEM BIOPHYS, V525, P102, DOI 10.1016/j.abb.2011.12.011; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Frankenberg L, 2002, J BACTERIOL, V184, P6351, DOI 10.1128/JB.184.22.6351-6356.2002; Frankenberg L., 2003, THESIS LUND U LUND; Hakansson KO, 2004, ACTA CRYSTALLOGR D, V60, P1374, DOI 10.1107/S0907444904012004; HANKER JS, 1975, J CLIN MICROBIOL, V2, P463; JENSEN J, 1963, SCIENCE, V141, P45, DOI 10.1126/science.141.3575.45; Loew O, 1900, SCIENCE, V11, P701, DOI 10.1126/science.11.279.701; Nicholls P, 2001, ADV INORG CHEM, V51, P51; Nicholls P, 2012, ARCH BIOCHEM BIOPHYS, V525, P95, DOI 10.1016/j.abb.2012.01.015; PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284; PUGH SYR, 1983, ARCH MICROBIOL, V136, P60, DOI 10.1007/BF00415611; RUIS H, 1979, CAN J BIOCHEM CELL B, V57, P1122, DOI 10.1139/o79-144; Vatsyayan P, 2011, BIOTECHNOL LETT, V33, P347, DOI 10.1007/s10529-010-0442-2; WHITTENBURY R, 1960, NATURE, V187, P433, DOI 10.1038/187433a0; Winstedt L, 2000, J BACTERIOL, V182, P3863, DOI 10.1128/JB.182.13.3863-3866.2000; WIRTH R, 1986, J BACTERIOL, V165, P831, DOI 10.1128/jb.165.3.831-836.1986; Zamocky M, 1999, PROG BIOPHYS MOL BIO, V72, P19, DOI 10.1016/S0079-6107(98)00058-3; Zamocky M, 2012, ARCH BIOCHEM BIOPHYS, V525, P131, DOI 10.1016/j.abb.2012.01.017	23	13	13	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28411	28420		10.1074/jbc.M114.596148	http://dx.doi.org/10.1074/jbc.M114.596148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148685	Green Published, hybrid			2022-12-25	WOS:000343765400034
J	Eigsti, RL; Sudan, B; Wilson, ME; Graff, JW				Eigsti, Renee L.; Sudan, Bayan; Wilson, Mary E.; Graff, Joel W.			Regulation of Activation-associated MicroRNA Accumulation Rates during Monocyte-to-macrophage Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSCRIPTIONAL REGULATION; TISSUE MACROPHAGES; ACUTE-INFLAMMATION; INTERFERON-GAMMA; IMMUNE-RESPONSES; CELLS; EXPRESSION; INFECTION; POLARIZATION; HOMEOSTASIS	Circulating monocytes recruited to tissues can differentiate into macrophages and adopt unique gene expression programs in response to environmental cues. We recently described the regulated expression of several microRNAs (miRNAs) in polarized human monocyte-derived macrophages (MDMs). Basal expression of these activation-associated miRNAs was low in monocytes relative to MDMs. As development occurs in the context of specific cellular environments, we hypothesized that the rate of miRNA accumulation would be modified in the presence of microbial or cellular products during monocyte-to-macrophage differentiation. Indeed, LPS treatment augmented the accumulation of miR-146a and miR-155, whereas IL-4 treatment augmented the accumulation of miR-193b and miR-222 during development. In contrast, some stimuli repressed accumulation of specific miRNAs including interferons (IFNs) (miR-27a, miR-125a-5p, and miR-222), IL-4 (miR-125a-5p), and LPS (miR-27a). RT-PCR-based expression profiling of monocytes differentiated with distinct methods showed that activation-associated miRNAs and markers of macrophage polarization were substantially altered in MDMs differentiated in the presence of non-monocytic peripheral blood mononuclear cells due in part to NF-kappa B and STAT1 pathway activation. Expression of several of these miRNAs was regulated at a preprocessing step because the expression of the primary miRNAs, but not Dicer, correlated with mature miRNA expression. We conclude that a set of miRNAs is regulated during MDM differentiation, and the rate is uniquely modified for each miRNA by environmental factors. The low basal expression of activation-associated miRNAs in monocytes and their dynamic rates of accumulation during MDM differentiation permit monocytes to tailor miRNA profiles in peripheral tissues during differentiation to macrophages.	[Eigsti, Renee L.; Sudan, Bayan; Wilson, Mary E.; Graff, Joel W.] Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA; [Wilson, Mary E.; Graff, Joel W.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Wilson, Mary E.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA; [Wilson, Mary E.; Graff, Joel W.] Vet Affairs Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Graff, JW (corresponding author), Univ Iowa, Dept Internal Med, 400 EMRB, Iowa City, IA 52242 USA.	joel-graff@uiowa.edu		Wilson, Mary/0000-0001-8680-7275	National Institutes of Health [AI080801, AI045540, AI07511, T35HL007485]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [1IK2BX001627, 1I01BX001983, 5I01BX000536]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080801, T32AI007511, R01AI045540] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001627, I01BX000536, I01BX001983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants AI080801, AI045540, and AI07511 (to M. E. W.) and T35HL007485 (a training grant to R. L. E.). This work was also supported by Grants 1IK2BX001627 (to J. W. G.), 1I01BX001983 (to M. E. W.), and 5I01BX000536 (to M. E. W.) from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Liddiard K, 2011, EUR J IMMUNOL, V41, P2503, DOI 10.1002/eji.201141743; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002510; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Nahid MA, 2013, J IMMUNOL, V190, P1250, DOI 10.4049/jimmunol.1103060; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shirasaki T, 2013, J VIROL, V87, P5270, DOI 10.1128/JVI.03022-12; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Wang Z, 2014, J IMMUNOL, V192, P2349, DOI 10.4049/jimmunol.1302982; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	36	27	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28433	28447		10.1074/jbc.M114.599316	http://dx.doi.org/10.1074/jbc.M114.599316			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148686	Green Published, hybrid			2022-12-25	WOS:000343765400036
J	Chen, Y; Liu, Y; Wang, X; Li, K; Chen, P				Chen, Yuan; Liu, Yang; Wang, Xin; Li, Kai; Chen, Pu			Preparation of High Purity Crystalline Silicon by Electro-Catalytic Reduction of Sodium Hexafluorosilicate with Sodium below 180 degrees C	PLOS ONE			English	Article							ELECTROCHEMICAL REDUCTION; DIOXIDE	The growing field of silicon solar cells requires a substantial reduction in the cost of semiconductor grade silicon, which has been mainly produced by the rod-based Siemens method. Because silicon can react with almost all of the elements and form a number of alloys at high temperatures, it is highly desired to obtain high purity crystalline silicon at relatively low temperatures through low cost process. Here we report a fast, complete and inexpensive reduction method for converting sodium hexafluorosilicate into silicon at a relatively low reaction temperature (similar to 200 degrees C). This temperature could be further decreased to less than 180 degrees C in combination with an electrochemical approach. The residue sodium fluoride is dissolved away by pure water and hydrochloric acid solution in later purifying processes below 15 degrees C. High purity silicon in particle form can be obtained. The relative simplicity of this method might lead to a low cost process in producing high purity silicon.	[Chen, Yuan; Liu, Yang; Wang, Xin; Li, Kai; Chen, Pu] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Chen, P (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca	王, 新/O-4150-2016; 王, 新/GQY-6333-2022	王, 新/0000-0002-4771-8453; 	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI); Canada Research Chairs (CRC) program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs (CRC) program(Canada Research Chairs)	This research was financially supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Foundation for Innovation (CFI) and the Canada Research Chairs (CRC) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZH, 2007, NATURE, V446, P172, DOI 10.1038/nature05570; Chen GZ, 2000, NATURE, V407, P361, DOI 10.1038/35030069; Cho SK, 2012, ANGEW CHEM INT EDIT, V51, P12740, DOI 10.1002/anie.201206789; Haynes WM, 2014, CRC HDB CHEM PHYS, V95th, DOI DOI 10.1201/B17118; HEATH JR, 1992, SCIENCE, V258, P1131, DOI 10.1126/science.258.5085.1131; Jin X., 2004, ANGEW CHEM, V116, P751; Nohira T, 2003, NAT MATER, V2, P397, DOI 10.1038/nmat900; Zulehner W., 1995, ULLMANNS ENCY IND A, VA23, P721	8	1	1	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105537	10.1371/journal.pone.0105537	http://dx.doi.org/10.1371/journal.pone.0105537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153509	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200058
J	Kabisch, R; Mejias-Luque, R; Gerhard, M; Prinz, C				Kaebisch, Romy; Mejias-Luque, Raquel; Gerhard, Markus; Prinz, Christian			Involvement of Toll-Like Receptors on Helicobacter pylori-Induced Immunity	PLOS ONE			English	Article							DENDRITIC CELL MATURATION; REGULATORY T-CELLS; GASTRIC-CANCER; RECOGNITION; INFECTION; INTERFERON; ACTIVATION; EXPRESSION; CYTOKINES; RESPONSES	Dendritic cells (DCs) play a major role in the innate immune response since they recognize a broad repertoire of PAMPs mainly via Toll-like receptors (TLRs). During Helicobacter pylori (H. pylori) infection, TLRs have been shown to be important to control cytokine response particularly in murine DCs. In the present study we analyzed the effect of blocking TLRs on human DCs. Co-incubation of human DCs with H. pylori resulted in the release of the pro-inflammatory cytokines IL-12p70, IL-6 and IL-10. Release of IL-12p70 and IL-10 was predominantly influenced when TLR4 signaling was blocked by adding specific antibodies, suggesting a strong influence on subsequent T cell responses through TLR4 activation on DCs. Co-incubation of H. pylori-primed DC with allogeneic CD4(+) T cells resulted in the production of IFN-gamma and IL-17A as well as the expression of Foxp3, validating a mixed Th1/Th17 and T-reg response in vitro. Neutralization of TLR4 during H. pylori infection resulted in significantly decreased amounts of IL-17A and IFN-gamma and reduced levels of Foxp3-expressing and IL-10-secreting T cells. Our findings suggest that DC cytokine secretion induced upon TLR4-mediated recognition of H. pylori influences inflammatory and regulatory T cell responses, which might facilitate the chronic bacterial persistence.	[Kaebisch, Romy; Mejias-Luque, Raquel; Gerhard, Markus] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-80290 Munich, Germany; [Prinz, Christian] Univ Witten Herdecke, Lehrstuhl Innere Med 1, Wuppertal, Germany	Technical University of Munich; Witten Herdecke University	Prinz, C (corresponding author), Univ Witten Herdecke, Lehrstuhl Innere Med 1, Wuppertal, Germany.	christian.prinz@helios-kliniken.de	Gerhard, Markus/P-8996-2019; Gerhard, Markus/N-3387-2014	Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Mejias-Luque, Raquel/0000-0002-4602-4927	Deutsche Forschungsgemeinschaft (German Research Scoiety = DFG) [PR 411/12-1]	Deutsche Forschungsgemeinschaft (German Research Scoiety = DFG)	Supported by the Deutsche Forschungsgemeinschaft (German Research Scoiety = DFG), Project Number Prinz = PR 411/12-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; BUELENS C, 1995, EUR J IMMUNOL, V25, P2668, DOI 10.1002/eji.1830250940; CARUSO ML, 1990, J CLIN GASTROENTEROL, V12, P601, DOI 10.1097/00004836-199010000-00025; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Chang LL, 2012, APPL MICROBIOL BIOT, V96, P211, DOI 10.1007/s00253-012-4034-z; DElios MM, 1997, EUR J IMMUNOL, V27, P1751, DOI 10.1002/eji.1830270723; DIXON MF, 1994, SCAND J GASTROENTERO, V29, P7, DOI 10.3109/00365529409105353; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Enarsson K, 2006, CLIN IMMUNOL, V121, P358, DOI 10.1016/j.clim.2006.07.002; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kaebisch R, 2014, J IMMUNOL, V192, P316, DOI 10.4049/jimmunol.1302476; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; Lagunes-Servin H, 2013, HELICOBACTER, V18, P423, DOI 10.1111/hel.12067; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Oertli M, 2013, P NATL ACAD SCI USA, V110, P3047, DOI 10.1073/pnas.1211248110; Oertli M, 2012, GUT MICROBES, V3, P566, DOI 10.4161/gmic.21750; Pachathundikandi SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019614; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Straubinger RK, 2003, INFECT IMMUN, V71, P2693, DOI 10.1128/IAI.71.5.2693-2703.2003; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003	36	14	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104804	10.1371/journal.pone.0104804	http://dx.doi.org/10.1371/journal.pone.0104804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153703	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200028
J	Kelhala, HL; Palatsi, R; Fyhrquist, N; Lehtimaki, S; Vayrynen, JP; Kallioinen, M; Kubin, ME; Greco, D; Tasanen, K; Alenius, H; Bertino, B; Carlavan, I; Mehul, B; Deret, S; Reiniche, P; Martel, P; Marty, C; Blume-Peytavi, U; Voegel, JJ; Lauerma, A				Kelhala, Hanna-Leena; Palatsi, Riitta; Fyhrquist, Nanna; Lehtimaki, Sari; Vayrynen, Juha P.; Kallioinen, Matti; Kubin, Minna E.; Greco, Dario; Tasanen, Kaisa; Alenius, Harri; Bertino, Beatrice; Carlavan, Isabelle; Mehul, Bruno; Deret, Sophie; Reiniche, Pascale; Martel, Philippe; Marty, Carine; Blume-Peytavi, Ulrike; Voegel, Johannes J.; Lauerma, Antti			IL-17/Th17 Pathway Is Activated in Acne Lesions	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INFLAMMATORY CYTOKINE RESPONSES; GELATINASE-ASSOCIATED LIPOCALIN; INNATE IMMUNE-RESPONSE; REGULATORY T-CELLS; PROPIONIBACTERIUM-ACNES; TH17 CELLS; ANTIMICROBIAL PEPTIDES; HUMAN KERATINOCYTES; UP-REGULATION	The mechanisms of inflammation in acne are currently subject of intense investigation. This study focused on the activation of adaptive and innate immunity in clinically early visible inflamed acne lesions and was performed in two independent patient populations. Biopsies were collected from lesional and non-lesional skin of acne patients. Using Affymetrix Genechips, we observed significant elevation of the signature cytokines of the Th17 lineage in acne lesions compared to non-lesional skin. The increased expression of IL-17 was confirmed at the RNA and also protein level with real-time PCR (RTPCR) and Luminex technology. Cytokines involved in Th17 lineage differentiation (IL-1 beta, IL-6, TGF-beta, IL23p19) were remarkably induced at the RNA level. In addition, proinflammatory cytokines and chemokines (TNF-alpha, IL-8, CSF2 and CCL20), Th1 markers (IL12p40, CXCR3, T-bet, IFN-gamma), T regulatory cell markers (Foxp3, IL-10, TGF-beta) and IL-17 related antimicrobial peptides (S100A7, S100A9, lipocalin, hBD2, hBD3, hCAP18) were induced. Importantly, immunohistochemistry revealed significantly increased numbers of IL-17A positive T cells and CD83 dendritic cells in the acne lesions. In summary our results demonstrate the presence of IL-17A positive T cells and the activation of Th17-related cytokines in acne lesions, indicating that the Th17 pathway is activated and may play a pivotal role in the disease process, possibly offering new targets of therapy.	[Kelhala, Hanna-Leena; Palatsi, Riitta; Kubin, Minna E.; Tasanen, Kaisa] Univ Oulu, Dept Dermatol, SF-90220 Oulu, Finland; [Kelhala, Hanna-Leena; Palatsi, Riitta; Kubin, Minna E.; Tasanen, Kaisa] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland; [Fyhrquist, Nanna; Lehtimaki, Sari; Greco, Dario; Alenius, Harri] Finnish Inst Occupat Hlth, Unit Syst Toxicol, Helsinki, Finland; [Vayrynen, Juha P.; Kallioinen, Matti] Univ Oulu, Dept Pathol, Oulu, Finland; [Vayrynen, Juha P.; Kallioinen, Matti] Oulu Univ Hosp, Oulu, Finland; [Bertino, Beatrice; Carlavan, Isabelle; Mehul, Bruno; Deret, Sophie; Reiniche, Pascale; Voegel, Johannes J.] Galderma R&D, Res, Sophia Antipolis, France; [Martel, Philippe; Marty, Carine] Galderma R&D, Early Dev, Sophia Antipolis, France; [Blume-Peytavi, Ulrike] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Lauerma, Antti] Univ Helsinki, Dept Dermatol, Helsinki, Finland; [Lauerma, Antti] Univ Helsinki, Cent Hosp, Helsinki, Finland	University of Oulu; University of Oulu; Finnish Institute of Occupational Health; University of Oulu; University of Oulu; Galderma R&D SNC; Galderma R&D SNC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Voegel, JJ (corresponding author), Galderma R&D, Res, Sophia Antipolis, France.	johannes.voegel@galderma.com; antti.lauerma@hus.fi	Väyrynen, Juha P/B-5023-2018; Lauerma, Antti/J-8180-2016; Greco, Dario/T-7113-2019	Väyrynen, Juha P/0000-0002-8683-2996; Greco, Dario/0000-0001-9195-9003; Fyhrquist, Nanna Theresia/0000-0002-5408-0005; Tasanen, Kaisa/0000-0001-8056-5949; Blume-Peytavi, Ulrike/0000-0003-3528-3752; Alenius, Harri/0000-0003-0106-8923	Oulu University Hospital Medical Research Center; Finnish Society of Dermatology; Helsinki-Uusimaa Hospital District Research Funds; Galderma R D; Galderma RD	Oulu University Hospital Medical Research Center; Finnish Society of Dermatology; Helsinki-Uusimaa Hospital District Research Funds; Galderma R D; Galderma RD	Funded by Oulu University Hospital Medical Research Center, by Finnish Society of Dermatology, by Helsinki-Uusimaa Hospital District Research Funds and by Galderma R & D internal funding. The funder Galderma R&D provided support in the form of salaries for authors (BB, IC, BM, SD, PR, PM, CM, JJV), but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agak GW, 2014, J INVEST DERMATOL, V134, P366, DOI 10.1038/jid.2013.334; Alestas T, 2006, J MOL MED, V84, P75, DOI 10.1007/s00109-005-0715-8; Bangert C, 2011, CLIN DERMATOL, V29, P360, DOI 10.1016/j.clindermatol.2011.01.006; Begon E, 2007, EUR J DERMATOL, V17, P497; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Chronnell CMT, 2001, J INVEST DERMATOL, V117, P1120, DOI 10.1046/j.0022-202x.2001.01569.x; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dispenza MC, 2012, J INVEST DERMATOL, V132, P2198, DOI 10.1038/jid.2012.111; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fogel P, 2007, BIOINFORMATICS, V23, P44, DOI 10.1093/bioinformatics/btl550; Furusawa H, 2012, RESPIR INVESTIG, V50, P104, DOI 10.1016/j.resinv.2012.07.001; Ganceviciene R, 2006, DERMATOLOGY, V213, P270, DOI 10.1159/000095058; Georgel P, 2005, INFECT IMMUN, V73, P4512, DOI 10.1128/IAI.73.8.4512-4521.2005; Guy R, 1998, J INVEST DERMATOL, V110, P410, DOI 10.1046/j.1523-1747.1998.00143.x; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; INGHAM E, 1992, J INVEST DERMATOL, V98, P895, DOI 10.1111/1523-1747.ep12460324; Jeremy AHT, 2003, J INVEST DERMATOL, V121, P20, DOI 10.1046/j.1523-1747.2003.12321.x; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; Kim J, 2005, DERMATOLOGY, V211, P193, DOI 10.1159/000087011; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Kistowska M, 2014, J INVEST DERMATOL, V134, P677, DOI 10.1038/jid.2013.438; KNUTSON DD, 1974, J INVEST DERMATOL, V62, P288, DOI 10.1111/1523-1747.ep12676804; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Layton AM, 1998, EXP DERMATOL, V7, P191, DOI 10.1111/j.1600-0625.1998.tb00323.x; Lee DY, 2008, J INVEST DERMATOL, V128, P1863, DOI 10.1038/sj.jid.5701235; Lehtimaki S, 2012, J INVEST DERMATOL, V132, P2744, DOI 10.1038/jid.2012.212; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Loser K, 2012, J INVEST DERMATOL, V132, P864, DOI 10.1038/jid.2011.375; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Lumsden KR, 2011, BRIT J DERMATOL, V165, P302, DOI 10.1111/j.1365-2133.2011.10362.x; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; Mouser PE, 2003, J INVEST DERMATOL, V121, P1226, DOI 10.1046/j.1523-1747.2003.12550_6.x; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nelson AM, 2008, J CLIN INVEST, V118, P1468, DOI 10.1172/JCI33869; NORRIS JFB, 1988, BRIT J DERMATOL, V118, P651, DOI 10.1111/j.1365-2133.1988.tb02566.x; Oeff MK, 2006, DERMATOLOGY, V213, P266, DOI 10.1159/000095056; Qin M, 2014, J INVEST DERMATOL, V134, P381, DOI 10.1038/jid.2013.309; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Sabat R, 2011, J DTSCH DERMATOL GES, V9, P518, DOI 10.1111/j.1610-0387.2011.07611.x; Shaheen B, 2011, BRIT J DERMATOL, V165, P474, DOI 10.1111/j.1365-2133.2011.10375.x; Sugisaki H, 2009, J DERMATOL SCI, V55, P47, DOI 10.1016/j.jdermsci.2009.02.015; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Thiboutot DM, 2014, J INVEST DERMATOL, V134, P307, DOI 10.1038/jid.2013.400; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Vayrynen JP, 2012, VIRCHOWS ARCH, V460, P455, DOI 10.1007/s00428-012-1232-0; Wolk K, 2011, J IMMUNOL, V186, P1228, DOI 10.4049/jimmunol.0903907; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Zouboulis CC, 2014, J EUR ACAD DERMATOL, V28, P527, DOI 10.1111/jdv.12298	56	92	102	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105238	10.1371/journal.pone.0105238	http://dx.doi.org/10.1371/journal.pone.0105238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153527	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200043
J	Varga, Z; Tubbs, RR; Moch, H				Varga, Zsuzsanna; Tubbs, Raymond R.; Moch, Holger			Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification	PLOS ONE			English	Article							CORE-NEEDLE BIOPSIES; SINGLE INSTITUTION; FISH; CARCINOMA; RECOMMENDATIONS; TECHNOLOGIES; TRASTUZUMAB; RELIABILITY; EXPRESSION; EXPERIENCE	Introduction: HER2 status assessment became a mandatory test assay in breast cancer, giving prognostic and predictive information including eligibility for adjuvant anti-HER2 therapy. Precise and reliable assessment of HER2 status is therefore of utmost importance. In this study we analyzed breast cancer samples by a novel technology for concomitant detection of the HER2 protein and gene copy number. Methods: Tissue microarrays containing 589 invasive breast cancer samples were analyzed with a double immunohistochemistry (IHC) and silver labeled in situ hybridization (SISH) assay simultaneously detecting HER2 protein and gene copy number in the same tumor cells. This bright-field assay was analyzed using scores according to the modified ASCO guidelines and the results were correlated with patient prognosis. Results: Overall concordance rate between protein expression and the presence of gene amplification was 98%. Fifty-seven of 60 tumors (95%) with IHC score 3+, 6 of 10 tumors with IHC score 2+ (60%) and only 3 of 519 tumors (0.6%) with IHC score 0/1+ were amplified by SISH. Patients with gene amplification despite IHC score 0/1+ had a tendency for worse overall survival (p = 0.088, reaching nearly statistical significance) compared to IHC score 0/1+ without amplification. In contrast, there was no difference in overall survival in IHC score 3+/2+ tumors with and without gene amplification. Conclusions: The novel double IHC and SISH assay for HER2 is efficient in the identification of breast cancer with discordant HER2 protein and HER2 gene status, especially for the prognostically relevant groups of HER2 protein negative tumors with HER2 amplification and HER2 protein positive tumors without HER2 amplification. Breast cancer without HER2 amplification among IHC score 2+/3+ tumors (10% in our cohort) suggests that other mechanisms than gene amplification contribute to protein overexpression in these cells.	[Varga, Zsuzsanna; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Tubbs, Raymond R.] Cleveland Clin, Sect Mol Pathol, Cleveland, OH 44106 USA	University of Zurich; University Zurich Hospital; Cleveland Clinic Foundation	Varga, Z (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	zsuzsanna.varga@usz.ch			NCATS NIH HHS [UL1 TR000439] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Arnouldi L, 2012, MODERN PATHOL, V25, P675, DOI 10.1038/modpathol.2011.201; Downs-Kelly E, 2005, AM J SURG PATHOL, V29, P1505, DOI 10.1097/01.pas.0000172294.67409.4f; Dowsett M, 2007, MODERN PATHOL, V20, P584, DOI 10.1038/modpathol.3800774; Dowsett M, 2009, J CLIN ONCOL, V27, P2962, DOI 10.1200/JCO.2008.19.7939; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Francis GD, 2009, DIAGN MOL PATHOL, V18, P88, DOI 10.1097/PDM.0b013e31816f6374; Fritzsche FR, 2010, AM J SURG PATHOL, V34, P1180, DOI 10.1097/PAS.0b013e3181e70e15; Gown AM, 2008, MODERN PATHOL, V21, P1271, DOI 10.1038/modpathol.2008.83; Hanna W.M., 2013, MOD PATHOL; Hicks DG, 2005, HUM PATHOL, V36, P250, DOI 10.1016/j.humpath.2004.11.010; Hirschmann A, 2012, AM J CLIN PATHOL, V138, P837, DOI 10.1309/AJCPL5IV0LAWSERG; Jacquemier J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-351; Lebeau A, 2010, J CLIN ONCOL, V28, P3264, DOI 10.1200/JCO.2009.25.9366; Lee Y, 2012, ARCH MED RES, V43, P139, DOI 10.1016/j.arcmed.2012.03.010; Martin Vittoria, 2012, Patholog Res Int, V2012, P261857, DOI 10.1155/2012/261857; Mass Robert D, 2005, Clin Breast Cancer, V6, P240, DOI 10.3816/CBC.2005.n.026; Moelans CB, 2011, CRIT REV ONCOL HEMAT, V80, P380, DOI 10.1016/j.critrevonc.2010.12.005; Moelans CB, 2010, CLIN CANCER RES, V16, P6177, DOI 10.1158/1078-0432.CCR-10-0773; Papouchado BG, 2010, AM J SURG PATHOL, V34, P767, DOI 10.1097/PAS.0b013e3181d96231; Park K, 2011, J BREAST CANCER, V14, P276, DOI 10.4048/jbc.2011.14.4.276; Penault-Llorca F, 2013, BREAST, V22, P200, DOI 10.1016/j.breast.2012.12.004; Penault-Llorca F, 2009, AM J CLIN PATHOL, V132, P539, DOI 10.1309/AJCPV2I0HGPMGBSQ; Perez EA, 2010, J CLIN ONCOL, V28, P4307, DOI 10.1200/JCO.2009.26.2154; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Schiavon BN, 2012, AM J SURG PATHOL, V36, P1489, DOI 10.1097/PAS.0b013e3182635987; Schnitt SJ, 2001, AM J CLIN PATHOL, V116, P806; Theurillat JP, 2007, CANCER IMMUNOL IMMUN, V56, P1723, DOI 10.1007/s00262-007-0316-1; Tubbs R, 2004, J MOL HISTOL, V35, P589; Tubbs RR, 2007, DIAGN MOL PATHOL, V16, P207, DOI 10.1097/PDM.0b013e318064c72a; Varga Z, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-615; Wolff A.C., 2013, J CLIN ONCOL; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wulf MA, 2012, AM J SURG PATHOL, V36, P1801, DOI 10.1097/PAS.0b013e31826ff153; Zabaglo L, 2013, ANN ONCOL	34	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105961	10.1371/journal.pone.0105961	http://dx.doi.org/10.1371/journal.pone.0105961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153153	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000340952200097
J	Fernandez-Fuente, M; Terracciano, CM; Martin-Duque, P; Brown, SC; Vassaux, G; Piercy, RJ				Fernandez-Fuente, Marta; Terracciano, Cesare M.; Martin-Duque, Pilar; Brown, Susan C.; Vassaux, Georges; Piercy, Richard J.			Calcium Homeostasis in Myogenic Differentiation Factor 1 (MyoD)-Transformed, Virally-Transduced, Skin-Derived Equine Myotubes	PLOS ONE			English	Article							CENTRAL CORE DISEASE; RYANODINE RECEPTOR MUTATIONS; RECESSIVE RYR1 MUTATIONS; CA2+ RELEASE CHANNEL; MALIGNANT HYPERTHERMIA; SKELETAL-MUSCLE; EXERTIONAL RHABDOMYOLYSIS; DERMAL FIBROBLASTS; DANTROLENE SODIUM; GENE	Dysfunctional skeletal muscle calcium homeostasis plays a central role in the pathophysiology of several human and animal skeletal muscle disorders, in particular, genetic disorders associated with ryanodine receptor 1 (RYR1) mutations, such as malignant hyperthermia, central core disease, multiminicore disease and certain centronuclear myopathies. In addition, aberrant skeletal muscle calcium handling is believed to play a pivotal role in the highly prevalent disorder of Thoroughbred racehorses, known as Recurrent Exertional Rhabdomyolysis. Traditionally, such defects were studied in human and equine subjects by examining the contractile responses of biopsied muscle strips exposed to caffeine, a potent RYR1 agonist. However, this test is not widely available and, due to its invasive nature, is potentially less suitable for valuable animals in training or in the human paediatric setting. Furthermore, increasingly, RYR1 gene polymorphisms (of unknown pathogenicity and significance) are being identified through next generation sequencing projects. Consequently, we have investigated a less invasive test that can be used to study calcium homeostasis in cultured, skin-derived fibroblasts that are converted to the muscle lineage by viral transduction with a MyoD (myogenic differentiation 1) transgene. Similar models have been utilised to examine calcium homeostasis in human patient cells, however, to date, there has been no detailed assessment of the cells' calcium homeostasis, and in particular, the responses to agonists and antagonists of RYR1. Here we describe experiments conducted to assess calcium handling of the cells and examine responses to treatment with dantrolene, a drug commonly used for prophylaxis of recurrent exertional rhabdomyolysis in horses and malignant hyperthermia in humans.	[Fernandez-Fuente, Marta; Piercy, Richard J.] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Comparat Neuromuscular Dis Lab, London, England; [Terracciano, Cesare M.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, Lab Cell Electrophysiol, London, England; [Martin-Duque, Pilar] Univ Francisco Vitoria, Fac Ciencias Biosanitarias, Madrid, Spain; [Brown, Susan C.] Univ London Royal Vet Coll, London, England; [Vassaux, Georges] Commissariat Energie Atom, DSV, iBEB, Lab TIRO,UMRE 4320, Nice, France	University of London; University of London Royal Veterinary College; Imperial College London; Universidad Francisco de Vitoria; University of London; University of London Royal Veterinary College; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Cote d'Azur	Piercy, RJ (corresponding author), Univ London Royal Vet Coll, Dept Clin Sci & Serv, Comparat Neuromuscular Dis Lab, 32 Belgrave Sq, London, England.	rpiercy@rvc.ac.uk	Martin-Duque, Pilar/AAF-2581-2020; Vassaux, Georges/N-9724-2016	Vassaux, Georges/0000-0002-1149-7716; Brown, Sue/0000-0001-8112-933X	Horserace Betting Levy Board	Horserace Betting Levy Board	This work has been funded by Horserace Betting Levy Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, J CELL SCI, V117, P6523, DOI 10.1242/jcs.01574; Aleman M, 2004, MUSCLE NERVE, V30, P356, DOI 10.1002/mus.20084; ANDERSON K, 1995, J GEN PHYSIOL, V105, P363, DOI 10.1085/jgp.105.3.363; Avila G, 2001, P NATL ACAD SCI USA, V98, P4215, DOI 10.1073/pnas.071048198; Bannister RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/390493; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Burton N M, 2000, Methods Cell Sci, V22, P51, DOI 10.1023/A:1009830114804; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cole FL, 2004, VET REC, V155, P625, DOI 10.1136/vr.155.20.625; COURT MH, 1987, J VET PHARMACOL THER, V10, P218, DOI 10.1111/j.1365-2885.1987.tb00532.x; Csernoch L, 1999, J PHYSIOL-LONDON, V515, P843, DOI 10.1111/j.1469-7793.1999.843ab.x; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; Dlamini N, 2013, NEUROMUSCULAR DISORD, V23, P540, DOI 10.1016/j.nmd.2013.03.008; Dranchak PK, 2006, AM J VET RES, V67, P1395, DOI 10.2460/ajvr.67.8.1395; Drogemuller C, 2008, GENOMICS, V92, P474, DOI 10.1016/j.ygeno.2008.07.014; Ducreux S, 2004, J BIOL CHEM, V279, P43838, DOI 10.1074/jbc.M403612200; Eltit JM, 2010, J BIOL CHEM, V285, P13781, DOI 10.1074/jbc.M110.107300; Eltit JM, 2011, P NATL ACAD SCI USA, V108, P7046, DOI 10.1073/pnas.1018380108; Fernandez-Fuente M, 2008, AM J VET RES, V69, P1637, DOI 10.2460/ajvr.69.12.1637; Fernandez-Fuente M, 2014, NEUROMUSCULAR DISORD, V24, P250, DOI 10.1016/j.nmd.2013.11.009; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GARCIA J, 1991, J PHYSIOL-LONDON, V440, P403, DOI 10.1113/jphysiol.1991.sp018715; Ghassemi F, 2009, CELL CALCIUM, V45, P192, DOI 10.1016/j.ceca.2008.10.001; Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013; Glahn KPE, 2010, BRIT J ANAESTH, V105, P417, DOI 10.1093/bja/aeq243; Gyorke S, 1997, J PHYSIOL-LONDON, V500, P297; HARRISON G G, 1972, Journal of the South African Veterinary Association, V43, P57; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HEALY JMS, 1990, BIOCHEM SOC T, V18, P326, DOI 10.1042/bst0180326; Hollingworth S, 2006, J GEN PHYSIOL, V127, P291, DOI 10.1085/jgp.200509477; Hovnanian A., 2007, V45, P337; Huang JB, 2006, AM J PHYSIOL-CELL PH, V290, pC1572, DOI 10.1152/ajpcell.00226.2005; HULL MJ, 1971, J ORAL SURG, V29, P640; Isgren CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011594; Jungbluth H, 2011, SEMIN PEDIATR NEUROL, V18, P239, DOI 10.1016/j.spen.2011.10.005; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; Klein A, 2012, HUM MUTAT, V33, P981, DOI 10.1002/humu.22056; Knych HKD, 2011, J VET PHARMACOL THER, V34, P238, DOI 10.1111/j.1365-2885.2010.01214.x; LARACH MG, 1989, ANESTH ANALG, V69, P511; Larsen Jan, 2011, BMC Res Notes, V4, P490, DOI 10.1186/1756-0500-4-490; Lattanzi L, 1998, J CLIN INVEST, V101, P2119, DOI 10.1172/JCI1505; Laver DR, 2011, J MOL CELL CARDIOL, V51, P357, DOI 10.1016/j.yjmcc.2011.05.009; Lentz LR, 1999, AM J VET RES, V60, P684; LOPEZ JR, 1986, MUSCLE NERVE, V9, P85; LOPEZ JR, 1985, MUSCLE NERVE, V8, P355, DOI 10.1002/mus.880080502; Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164; MA J, 1993, J GEN PHYSIOL, V102, P423, DOI 10.1085/jgp.102.3.423; MacLeay JM, 1999, AM J VET RES, V60, P1562; MARGRETH A, 1993, BIOCHEM BIOPH RES CO, V197, P1303, DOI 10.1006/bbrc.1993.2619; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; McKenzie EC, 2010, EQUINE VET J, V42, P613, DOI 10.1111/j.2042-3306.2010.00262.x; McKenzie EC, 2004, AM J VET RES, V65, P74, DOI 10.2460/ajvr.2004.65.74; Mickelson JR, 1996, PHYSIOL REV, V76, P537, DOI 10.1152/physrev.1996.76.2.537; Roberts MC, 2001, ANESTHESIOLOGY, V95, P716, DOI 10.1097/00000542-200109000-00026; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879; Tong JF, 1999, J BIOL CHEM, V274, P693, DOI 10.1074/jbc.274.2.693; Upjohn MM, 2005, VET REC, V156, P763, DOI 10.1136/vr.156.24.763; Voermans NC, 2012, NEUROMUSCULAR DISORD, V22, P944, DOI 10.1016/j.nmd.2012.03.012; Walmsley GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008647; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; YASIN R, 1977, J NEUROL SCI, V32, P347, DOI 10.1016/0022-510X(77)90018-1; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005; Zhou HY, 2006, AM J HUM GENET, V79, P859, DOI 10.1086/508500; Zhou HY, 2006, HUM MOL GENET, V15, P2791, DOI 10.1093/hmg/ddl221; Zhou HY, 2013, HUM MUTAT, V34, P986, DOI 10.1002/humu.22326; Zvaritch E, 2009, P NATL ACAD SCI USA, V106, P21813, DOI 10.1073/pnas.0912126106	69	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105971	10.1371/journal.pone.0105971	http://dx.doi.org/10.1371/journal.pone.0105971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148524	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000341230600101
J	Ferreira, AR; Singh, B; Cabrera-Mora, M; De Souza, ACM; Marques, MTQ; Porto, LCS; Santos, F; Banic, DM; Calvo-Calle, JM; Oliveira-Ferreira, J; Moreno, A; Lima, JDC				Ferreira, Amanda Ribeiro; Singh, Balwan; Cabrera-Mora, Monica; Magri De Souza, Alana Cristina; Queiroz Marques, Maria Teresa; Sobrino Porto, Luis Cristovao; Santos, Fatima; Banic, Dalma Maria; Calvo-Calle, J. Mauricio; Oliveira-Ferreira, Joseli; Moreno, Alberto; Lima-Junior, Josue Da Costa			Evaluation of Naturally Acquired IgG Antibodies to a Chimeric and Non-Chimeric Recombinant Species of Plasmodium vivax Reticulocyte Binding Protein-1: Lack of Association with HLA-DRB1*/DQB1*in Malaria Exposed Individuals from the Brazilian Amazon	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; CELLULAR IMMUNE-RESPONSES; PROTECTIVE IMMUNITY; NAIVE VOLUNTEERS; CLINICAL MALARIA; FALCIPARUM; VACCINE; IMMUNOGENICITY; ANTIGENS; SAFETY	The development of modular constructs that include antigenic regions targeted by protective immune responses is an attractive approach for subunit vaccine development. However, a main concern of using these vaccine platforms is how to preserve the antigenic identity of conformational B cell epitopes. In the present study we evaluated naturally acquired antibody responses to a chimeric protein engineered to contain a previously defined immunodominant domain of the Plasmodium vivax reticulocyte binding protein-1 located between amino acid positions K-435-I-777. The construct also includes three regions of the cognate protein (F-571-D-587, I-1745-S-1786 and L-2235-E-2263) predicted to contain MHC class II promiscuous T cell epitopes. Plasma samples from 253 naturally exposed individuals were tested against this chimeric protein named PvRMC-RBP1 and a control protein that includes the native sequence PvRBP1(23-751) in comparative experiments to study the frequency of total IgG and IgG subclass reactivity. HLA-DRB1 and HLA-DQB1 allelic groups were typed by PCR-SSO to evaluate the association between major HLA class II alleles and antibody responses. We found IgG antibodies that recognized the chimeric PvRMC-RBP1 and the PvRBP1(23-751) in 47.1% and 60% of the studied population, respectively. Moreover, the reactivity index against both proteins were comparable and associated with time of exposure (p<0.0001) and number of previous malaria episodes (p<0.005). IgG subclass profile showed a predominance of cytophilic IgG1 over other subclasses against both proteins tested. Collectively these studies suggest that the chimeric PvRMC-RBP1 protein retained antigenic determinants in the PvRBP1(435-777) native sequence. Although 52.9% of the population did not present detectable titers of antibodies to PvRMC-RBP1, genetic restriction to this chimeric protein does not seem to occur, since no association was observed between the HLA-DRB1* or HLA-DQB1* alleles and the antibody responses. This experimental evidence strongly suggests that the identity of the conformational B cell epitopes is preserved in the chimeric protein.	[Ferreira, Amanda Ribeiro; Magri De Souza, Alana Cristina; Oliveira-Ferreira, Joseli; Lima-Junior, Josue Da Costa] Fiocruz MS, Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, Brazil; [Singh, Balwan; Cabrera-Mora, Monica; Moreno, Alberto] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Queiroz Marques, Maria Teresa; Sobrino Porto, Luis Cristovao] Univ Estado Rio De Janeiro, Histocompatibil & Cryopreservat Lab, Rio De Janeiro, Brazil; [Santos, Fatima] Natl Hlth Fdn, Dept Entomol, Cent Lab, Porto Velho, RO, Portugal; [Banic, Dalma Maria] Fiocruz MS, Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Lab Simuliidae & Onchocerciasis, Rio De Janeiro, Brazil; [Calvo-Calle, J. Mauricio] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Moreno, Alberto] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA	Fundacao Oswaldo Cruz; Emory University; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; University of Massachusetts System; University of Massachusetts Worcester; Emory University	Moreno, A (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	alberto.moreno@emory.edu; josue@ioc.fiocruz.br	Porto, Luis Cristovao M S/I-2984-2013; Porto, Luis Cristovao/U-6499-2019; da Costa Lima-Junior, Josue/AAI-4746-2021; Lima-Junior, Josué C/B-1361-2014; Oliveira-Ferreira, Joseli/E-7942-2014	Porto, Luis Cristovao M S/0000-0003-1499-1821; Porto, Luis Cristovao/0000-0003-1499-1821; da Costa Lima-Junior, Josue/0000-0002-5848-404X; Lima-Junior, Josué C/0000-0002-5848-404X; Moreno, Alberto/0000-0002-3031-7194; Oliveira-Ferreira, Joseli/0000-0002-6063-465X	Brazilian National Research Council - CNPq; Fiocruz; US National Institutes of Health, NIAID [R01-AI064766, R21AI094402-01, R21AI095718-01]; Yerkes National Primate Research Center Base [RR00165]; National Center for Research Resources of the National Institutes of Health; CNPq Fellowship;  [NIH-U19-57319]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094402, R01AI064766, R21AI095718] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Brazilian National Research Council - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fiocruz; US National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Yerkes National Primate Research Center Base; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CNPq Fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Brazilian National Research Council - CNPq, Fiocruz, US National Institutes of Health, NIAID grant R01-AI064766, R21AI094402-01 and R21AI095718-01 and the Yerkes National Primate Research Center Base Grant No RR00165 awarded by the National Center for Research Resources of the National Institutes of Health. JMCC's involvement was supported by NIH-U19-57319. ARF was the recipient of a CNPq Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Herrera M, 2011, AM J TROP MED HYG, V84, P35, DOI 10.4269/ajtmh.2011.09-0507; Baird JK, 1998, ANN TROP MED PARASIT, V92, P367, DOI 10.1080/00034989859366; Bastos MS, 2007, CLIN VACCINE IMMUNOL, V14, P1249, DOI 10.1128/CVI.00243-07; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Caro-Aguilar I, 2005, MICROBES INFECT, V7, P1324, DOI 10.1016/j.micinf.2005.04.020; CHIZZOLINI C, 1991, AM J TROP MED HYG, V45, P57, DOI 10.4269/ajtmh.1991.45.57; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; GOOD MF, 1988, SCIENCE, V242, P574, DOI 10.1126/science.2902690; GORDON DM, 1990, AM J TROP MED HYG, V42, P527, DOI 10.4269/ajtmh.1990.42.527; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Herrera S, 2005, AM J TROP MED HYG, V73, P3, DOI 10.4269/ajtmh.2005.73.3; HERRINGTON DA, 1991, AM J TROP MED HYG, V45, P695, DOI 10.4269/ajtmh.1991.45.695; Jepsen MPG, 2013, J INFECT DIS, V208, P479, DOI 10.1093/infdis/jit185; Jiang JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063888; John CC, 2004, INFECT IMMUN, V72, P5135, DOI 10.1128/IAI.72.9.5135-5142.2004; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Lima JC, 2011, VACCINE, V29, P1801, DOI 10.1016/j.vaccine.2010.12.099; Lima-Junior JC, 2008, VACCINE, V26, P6645, DOI 10.1016/j.vaccine.2008.09.029; Lima JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036419; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Mourao LC, 2012, MICROBES INFECT, V14, P730, DOI 10.1016/j.micinf.2012.02.011; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; Nishioka M, 2001, J BIOTECHNOL, V88, P141, DOI 10.1016/S0168-1656(01)00275-9; Oliveira-Ferreira J, 2004, ACTA TROP, V92, P63, DOI 10.1016/j.actatropica.2004.02.011; Oliveira-Ferreira J, 2004, VACCINE, V22, P2023, DOI 10.1016/j.vaccine.2003.07.021; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073; Rayner JC, 2005, AM J TROP MED HYG, V72, P666, DOI 10.4269/ajtmh.2005.72.666; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Silva-Flannery LM, 2009, MICROBES INFECT, V11, P83, DOI 10.1016/j.micinf.2008.10.009; Singh AP, 2005, MOL MICROBIOL, V55, P1925, DOI 10.1111/j.1365-2958.2005.04523.x; Singh B, 2012, INFECT IMMUN, V80, P1491, DOI 10.1128/IAI.05980-11; Singh B, 2010, VACCINE, V28, P2580, DOI 10.1016/j.vaccine.2010.01.019; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Stanisic DI, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002498; Stanisic DI, 2003, INFECT IMMUN, V71, P5700, DOI 10.1128/IAI.71.10.5700-5713.2003; Storti-Melo LM, 2012, ACTA TROP, V121, P152, DOI 10.1016/j.actatropica.2011.10.009; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; Tran TM, 2005, AM J TROP MED HYG, V73, P244, DOI 10.4269/ajtmh.2005.73.244; Vargas-Serrato E, 2002, MOL BIOCHEM PARASIT, V120, P41, DOI 10.1016/S0166-6851(01)00433-9; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wu Yu-Huan, 2008, P3; Yone CLRP, 2005, INFECT IMMUN, V73, P2281, DOI 10.1128/IAI.73.4.2281-2287.2005; Zakeri S, 2011, AM J TROP MED HYG, V84, P944, DOI 10.4269/ajtmh.2011.11-0001	53	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105828	10.1371/journal.pone.0105828	http://dx.doi.org/10.1371/journal.pone.0105828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148251	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600087
J	Tanabe, T; Kato, A; Shiuchi, K; Miyamoto, K; Tsujibo, H; Maki, J; Yamamoto, S; Funahashi, T				Tanabe, Tomotaka; Kato, Ayaka; Shiuchi, Keiichi; Miyamoto, Katsushiro; Tsujibo, Hiroshi; Maki, Jun; Yamamoto, Shigeo; Funahashi, Tatsuya			Regulation of the Expression of the Vibrio parahaemolyticus peuA Gene Encoding an Alternative Ferric Enterobactin Receptor	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; IRON TRANSPORT; PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; IDENTIFICATION; PROTEIN; SIDEROPHORE; SYSTEM; TRANSDUCTION	A pvsB-vctA-irgA triple deletion mutant of Vibrio parahaemolyticus can utilize enterobactin under iron-limiting conditions by inducing a previously undescribed receptor, PeuA (VPA0150), in response to extracellular alkaline pH and enterobactin. In silico analyses revealed the existence of a two-component regulatory system operon, peuRS, immediately upstream of peuA, which constitutes an operon with the TonB2 system genes. Both the peuRS and peuA-tonB2 operons were found to be upregulated under iron-limiting conditions in a ferric uptake regulator (Fur)-dependent manner. The involvement of peuA and peuRS in enterobactin utilization was analyzed by complementation experiments using deletion mutants. Primer extension analysis indicated that, under iron-limiting conditions, the transcription of peuA was initiated from the +1 site at pH 7.0 and from both the +1 and +39 sites at pH 8.0 in the presence of enterobactin. The +39 transcript was absent from the peuRS deletion mutant. Secondary structure prediction of their 5'-untranslated regions suggested that translation initiation is blocked in the +1 transcript, but not in the +39 transcript. Consistent with this, in vitro translation analysis demonstrated that production of PeuA was determined only by the +39 transcript. These studies establish a novel gene regulation mechanism in which the two-component regulatory system PeuRS enhances expression of the alternative +39 transcript that possesses non-inhibitory structure, allowing the peuA expression to be regulated at the translation stage.	[Tanabe, Tomotaka; Kato, Ayaka; Yamamoto, Shigeo; Funahashi, Tatsuya] Matsuyama Univ, Coll Pharmaceut Sci, Lab Hyg Chem, Matsuyama, Ehime, Japan; [Shiuchi, Keiichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Miyamoto, Katsushiro; Tsujibo, Hiroshi] Osaka Univ Pharmaceut Sci, Dept Microbiol, Takatsuki, Osaka, Japan; [Maki, Jun] Matsuyama Univ, Coll Pharmaceut Sci, Infect Dis Lab, Matsuyama, Ehime, Japan	Okayama University; Osaka University of Pharmaceutical Sciences	Tanabe, T (corresponding author), Matsuyama Univ, Coll Pharmaceut Sci, Lab Hyg Chem, Matsuyama, Ehime, Japan.	ttanabe@cc.matsuyama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25870987]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Young Scientists (B) (25870987) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT LM, 1989, ANNU REV GENET, V23, P311, DOI 10.1146/annurev.ge.23.120189.001523; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson MT, 2004, J BACTERIOL, V186, P7302, DOI 10.1128/JB.186.21.7302-7311.2004; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Braun V., 1991, HDB MICROBIAL IRON C, P107; Brickman T, 2009, BIOMETALS, V22, P33, DOI 10.1007/s10534-008-9189-9; Broberg CA, 2011, MICROBES INFECT, V13, P992, DOI 10.1016/j.micinf.2011.06.013; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DEAN CR, 1993, MOL MICROBIOL, V8, P1095, DOI 10.1111/j.1365-2958.1993.tb01654.x; DEAN CR, 1993, J BACTERIOL, V175, P317, DOI 10.1128/JB.175.2.317-324.1993; Dean CR, 1996, J BACTERIOL, V178, P5361, DOI 10.1128/jb.178.18.5361-5369.1996; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Earhart CF, 2004, IRON TRANSPORT IN BACTERIA, P133; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fiedler HP, 2001, FEMS MICROBIOL LETT, V196, P147, DOI 10.1016/S0378-1097(01)00053-2; Funahashi T, 2003, MICROBIOL-SGM, V149, P1217, DOI 10.1099/mic.0.26066-0; Funahashi T, 2002, J BACTERIOL, V184, P936, DOI 10.1128/jb.184.4.936-946.2002; Funahashi T, 2009, BIOL PHARM BULL, V32, P359, DOI 10.1248/bpb.32.359; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; HANTKE K, 1983, MOL GEN GENET, V191, P301, DOI 10.1007/BF00334830; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hollander A, 2011, INFECT IMMUN, V79, P4764, DOI 10.1128/IAI.05806-11; Igbinosa EO, 2008, RES MICROBIOL, V159, P495, DOI 10.1016/j.resmic.2008.07.001; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Kuroda T, 2005, MICROBIOL IMMUNOL, V49, P711, DOI 10.1111/j.1348-0421.2005.tb03662.x; LUNDRIGAN MD, 1986, J BIOL CHEM, V261, P797; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Mey AR, 2002, INFECT IMMUN, V70, P3419, DOI 10.1128/IAI.70.7.3419-3426.2002; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Naka H, 2012, BIOMETALS, V25, P125, DOI 10.1007/s10534-011-9488-4; NAKAYAMA S, 1995, J BACTERIOL, V177, P5062, DOI 10.1128/jb.177.17.5062-5069.1995; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Sambrook J., 2001, MOL CLONING LAB MANU; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Schmitt MP, 1999, J BACTERIOL, V181, P5330, DOI 10.1128/JB.181.17.5330-5340.1999; Schubert S, 1999, J BACTERIOL, V181, P6387, DOI 10.1128/JB.181.20.6387-6395.1999; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; Tanabe T, 2003, J BACTERIOL, V185, P6938, DOI 10.1128/JB.185.23.6938-6949.2003; Tanabe T, 2012, MICROBIOL-SGM, V158, P2039, DOI 10.1099/mic.0.059568-0; Tanabe T, 2011, FEMS MICROBIOL LETT, V324, P73, DOI 10.1111/j.1574-6968.2011.02389.x; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; Vogt SL, 2012, FEMS MICROBIOL LETT, V326, P2, DOI 10.1111/j.1574-6968.2011.02406.x; WEBER RF, 1988, J MOL BIOL, V203, P467, DOI 10.1016/0022-2836(88)90013-7; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024; YAMAMOTO S, 1995, MICROBIOL IMMUNOL, V39, P759, DOI 10.1111/j.1348-0421.1995.tb03268.x; YAMAMOTO S, 1994, J BIOCHEM-TOKYO, V115, P868, DOI 10.1093/oxfordjournals.jbchem.a124432	57	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105749	10.1371/journal.pone.0105749	http://dx.doi.org/10.1371/journal.pone.0105749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148374	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600076
J	Haslik, W; Pluschnig, U; Steger, GG; Zielinski, CC; Schrogendorfer, KF; Nedomansky, J; Bartsch, R; Mader, RM				Haslik, Werner; Pluschnig, Ursula; Steger, Guenther G.; Zielinski, Christoph C.; Schroegendorfer, K. F.; Nedomansky, Jakob; Bartsch, Rupert; Mader, Robert M.			Indocyanine Green Video Angiography Predicts Outcome of Extravasation Injuries	PLOS ONE			English	Article							ADRIAMYCIN EXTRAVASATION; MANAGEMENT; NECROSIS; SURGERY; ULCERS; BURNS	Background: Extravasation of cytotoxic drugs is a serious complication of systemic cancer treatment. Still, a reliable method for early assessment of tissue damage and outcome prediction is missing. Here, we demonstrate that the evaluation of blood flow by indocyanine green (ICG) angiography in the extravasation area predicts for the need of surgical intervention. Methods: Twenty-nine patients were evaluated by ICG angiography after extravasation of vesicant or highly irritant cytotoxic drugs administered by peripheral i.v. infusion. Tissue perfusion as assessed by this standardized method was correlated with clinical outcome. Results: The perfusion index at the site of extravasation differed significantly between patients with reversible tissue damage and thus healing under conservative management (N = 22) versus those who needed surgical intervention due to the development of necrosis (N = 7; P = 0.0001). Furthermore, in patients benefiting from conservative management, the perfusion index was significantly higher in the central extravasation area denoting hyperemia, when compared with the peripheral area (P = 0.0001). Conclusions: In this patient cohort, ICG angiography as indicator of local perfusion within the extravasation area was of prognostic value for tissue damage. ICG angiography could thus be used for the early identification of patients at risk for irreversible tissue damage after extravasation of cytotoxic drugs.	[Haslik, Werner; Schroegendorfer, K. F.; Nedomansky, Jakob] Med Univ Vienna, Ctr Comprehens Canc, Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria; [Pluschnig, Ursula; Steger, Guenther G.; Zielinski, Christoph C.; Bartsch, Rupert; Mader, Robert M.] Med Univ Vienna, Ctr Comprehens Canc, Dept Med 1, Div Clin Oncol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Mader, RM (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Dept Med 1, Div Clin Oncol, Vienna, Austria.	robert.mader@meduniwien.ac.at		Mader, Robert/0000-0003-3017-8240; Schrogendorfer, Klaus F./0000-0003-0071-2334; Haslik, Werner/0000-0002-2731-2720; Nedomansky, Jakob/0000-0002-5090-1144				Askar I, 2002, ANN PLAS SURG, V49, P297, DOI 10.1097/00000637-200209000-00010; BARLOCK AL, 1979, AM J NURS, V79, P94, DOI 10.2307/3462426; Brown RFR, 1998, BURNS, V24, P692, DOI 10.1016/S0305-4179(98)00105-3; Giunta RE, 2005, BRIT J PLAST SURG, V58, P695, DOI 10.1016/j.bjps.2005.02.018; Haslik W, 2004, BURNS, V30, P232, DOI 10.1016/j.burns.2003.10.016; Kamolz LP, 2006, J TRAUMA, V61, P635, DOI 10.1097/01.ta.0000233910.47550.9c; Kamolz LP, 2003, BURNS, V29, P785, DOI 10.1016/S0305-4179(03)00200-6; LAUGHLIN RA, 1979, AM J SURG, V137, P408, DOI 10.1016/0002-9610(79)90077-1; Mader I, 2010, EXTRAVASATION OF CYTOTOXIC AGENTS: COMPENDIUM FOR PREVENTION AND MANAGEMENT, SECOND EDITION, P1, DOI 10.1007/978-3-211-88893-3; PETRO JA, 1979, SURG FORUM, V30, P535; Polom K, 2011, CANCER-AM CANCER SOC, V117, P4812, DOI 10.1002/cncr.26087; RUDOLPH R, 1976, CANCER, V38, P1087, DOI 10.1002/1097-0142(197609)38:3<1087::AID-CNCR2820380308>3.0.CO;2-X; Yannuzzi LA, 2011, AM J OPHTHALMOL, V151, P745, DOI 10.1016/j.ajo.2011.01.043	13	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103649	10.1371/journal.pone.0103649	http://dx.doi.org/10.1371/journal.pone.0103649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144707	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100008
J	Hsiao, PC; Chou, YE; Tan, P; Lee, WJ; Yang, SF; Chow, JM; Chen, HY; Lin, CH; Lee, LM; Chien, MH				Hsiao, Pei-Ching; Chou, Ying-Erh; Tan, Peng; Lee, Wei-Jiunn; Yang, Shun-Fa; Chow, Jyh-Ming; Chen, Hui-Yu; Lin, Chien-Huang; Lee, Liang-Ming; Chien, Ming-Hsien			Pterostilbene Simultaneously Induced G0/G1-Phase Arrest and MAPK-Mediated Mitochondrial-Derived Apoptosis in Human Acute Myeloid Leukemia Cell Lines	PLOS ONE			English	Article							CANCER-CELLS; CYCLE ARREST; IN-VITRO; CARCINOMA-CELLS; DEATH PROGRAM; LUNG-CANCER; RESVERATROL; INDUCTION; THERAPY; GROWTH	Background: Pterostilbene (PTER) is a dimethylated analog of the phenolic phytoalexin, resveratrol, with higher anticancer activity in various tumors. Herein, the molecular mechanisms by which PTER exerts its anticancer effects against acute myeloid leukemia (AML) cells were investigated. Methodology and Principal Findings: Results showed that PTER suppressed cell proliferation in various AML cell lines. PTER-induced G0/G1-phase arrest occurred when expressions of cyclin D3 and cyclin-dependent kinase (CDK)2/6 were inhibited. PTER-induced cell apoptosis occurred through activation of caspases-8-9/-3, and a mitochondrial membrane permeabilization (MMP)-dependent pathway. Moreover, treatment of HL-60 cells with PTER induced sustained activation of extracellular signal-regulated kinase (ERK)1/2 and c-Jun N-terminal kinase (JNK)1/2, and inhibition of both MAPKs by their specific inhibitors significantly abolished the PTER-induced activation of caspases-8/-9/-3. Of note, PTER-induced cell growth inhibition was only partially reversed by the caspase-3-specific inhibitor, Z-DEVE-FMK, suggesting that this compound may also act through a caspase-independent pathway. Interestingly, we also found that PTER promoted disruption of lysosomal membrane permeabilization (LMP) and release of activated cathepsin B. Conclusion: Taken together, our results suggest that PTER induced HL-60 cell death via MAPKs-mediated mitochondria apoptosis pathway and loss of LMP might be another cause for cell apoptosis induced by PTER.	[Hsiao, Pei-Ching] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsiao, Pei-Ching] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Chou, Ying-Erh; Yang, Shun-Fa; Chen, Hui-Yu] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tan, Peng; Chien, Ming-Hsien] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Lee, Wei-Jiunn; Lee, Liang-Ming] Taipei Med Univ, Wan Fang Hosp, Dept Urol, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chow, Jyh-Ming] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Taipei, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Lee, LM (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Urol, Taipei, Taiwan.	lm@tmu.edu.tw; mhchien1976@gmail.com	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Lin, Chien-Huang/0000-0002-0916-8737	Wan Fang Hospital-Taipei Medical University [103 swf03, 103 TMU-WFH-04]; Chung Shan Medical University Hospital, Taiwan [CSH-2014-C-020]	Wan Fang Hospital-Taipei Medical University; Chung Shan Medical University Hospital, Taiwan	This study was supported by no. 103 swf03 and 103 TMU-WFH-04 from Wan Fang Hospital-Taipei Medical University. This study was also supported by a grant (CSH-2014-C-020) from Chung Shan Medical University Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Alosi JA, 2010, J SURG RES, V161, P195, DOI 10.1016/j.jss.2009.07.027; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Bishop JF, 1997, SEMIN ONCOL, V24, P57; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Burns J, 2002, J AGR FOOD CHEM, V50, P3337, DOI 10.1021/jf0112973; Carter BZ, 2012, LEUKEMIA, V26, P443, DOI 10.1038/leu.2011.246; Chen TF, 2008, J AGR FOOD CHEM, V56, P10574, DOI 10.1021/jf802125t; Chien MH, 2009, CARCINOGENESIS, V30, P2005, DOI 10.1093/carcin/bgp244; Chinkwo KA, 2005, J ETHNOPHARMACOL, V98, P163, DOI 10.1016/j.jep.2005.01.016; Cichocki M, 2008, MOL NUTR FOOD RES, V52, pS62, DOI 10.1002/mnfr.200700466; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Garcia-Zepeda SP, 2013, EUR J CANC PREV; Gautam SC, 2000, BONE MARROW TRANSPL, V25, P639, DOI 10.1038/sj.bmt.1702189; Groth-Pedersen L, 2007, CANCER RES, V67, P2217, DOI 10.1158/0008-5472.CAN-06-3520; Hwang JM, 2009, MOL CELL BIOCHEM, V327, P135, DOI 10.1007/s11010-009-0051-3; Jacks T, 1996, NATURE, V381, P643, DOI 10.1038/381643a0; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; Liu P, 2013, CLIN TRANSL ONCOL; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Mena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044524; Mgbonyebi OP, 1998, INT J ONCOL, V12, P865; Nutakul W, 2011, J AGR FOOD CHEM, V59, P10964, DOI 10.1021/jf202846b; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pan MH, 2007, J AGR FOOD CHEM, V55, P7777, DOI 10.1021/jf071520h; Pan ZQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-7; Ralph SJ, 2009, MOL NUTR FOOD RES, V53, P9, DOI 10.1002/mnfr.200800044; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; Roslie H, 2012, J TOXICOL SCI, V37, P13, DOI 10.2131/jts.37.13; Schneider JG, 2010, J SURG RES, V161, P18, DOI 10.1016/j.jss.2009.06.027; Schneider Y, 2000, CANCER LETT, V158, P85, DOI 10.1016/S0304-3835(00)00511-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sheth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051655; Siedlecka-Kroplewska K, 2012, FOLIA HISTOCHEM CYTO, V50, P574, DOI [10.5603/FHC.2012.0080, 10.5603/20257]; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tsan MF, 2000, BRIT J HAEMATOL, V109, P405, DOI 10.1046/j.1365-2141.2000.01980.x; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang TTY, 2010, MOL NUTR FOOD RES, V54, P335, DOI 10.1002/mnfr.200900143; Wang YS, 2012, AM J TRANSL RES, V4, P44; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Zhang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046853	49	41	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105342	10.1371/journal.pone.0105342	http://dx.doi.org/10.1371/journal.pone.0105342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144448	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100055
J	Okulicz, JF; Mesner, O; Ganesan, A; O'Bryan, TA; Deiss, RG; Agan, BK				Okulicz, Jason F.; Mesner, Octavio; Ganesan, Anuradha; O'Bryan, Thomas A.; Deiss, Robert G.; Agan, Brian K.			Hepatitis B Vaccine Responsiveness and Clinical Outcomes in HIV Controllers	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; T-CELL COUNT; INFECTED INDIVIDUALS; VIRUS VACCINE; ELITE CONTROLLERS; NATURAL-HISTORY; LONG-TERM; LOW-LEVEL; ANTIGEN; ADULTS	Background: Hepatitis B virus (HBV) vaccine responsiveness is associated with reduced risk of AIDS or death in HIV-infected individuals. Although HIV controllers (HIC) typically have favorable immunologic and clinical characteristics compared to non-controllers, vaccine responsiveness has not been studied. Methods and Findings: In the U.S. Military HIV Natural History Study, HBV vaccine response was defined as antibody to hepatitis B surface antigen (anti-HBs) >= 10 IU/L after last vaccination. For determination of vaccine responsiveness, HIC (n = 44) and treatment-naive non-controllers (n = 476) were not on highly active antiretroviral therapy (HAART) when vaccinated while treated non-controllers (n = 284) received all HBV vaccine doses during viral load (VL)-suppressive HAART. Progression to AIDS or death was also compared for all HIC (n = 143) and non-controllers (n = 1566) with documented anti-HBs regardless of the timing of HBV vaccination. Positive vaccine responses were more common in HIC (65.9%) compared to HAART-naive non-controllers (36.6%; P<0.001), but similar to non-controllers on HAART (59.9%; P = 0.549). Factors associated with vaccine response for HIC compared to HAART-naive non-controllers include HIC status (OR 2.65, 95% CI 1.23-5.89; P - 0.014), CD4 count at last vaccination (OR 1.28, 1.15-1.45 for every 100 cells/uL; P<0.001), and number of vaccine doses administered (OR 0.56, 0.35-0.88; P = 0.011). When HIC were compared to non-controllers on HAART, only CD4 count at last vaccination was significant (OR 1.23, 1.1-1.38 for every 100 cells/uL; P<0.001). The rate of AIDS or death per 100 person/years for HIC compared to non-controllers was 0.14 (95% CI 0-0.76) versus 0.98 (95% CI 0.74-1.28) for vaccine responders and 0 (95% CI 0-2.22) versus 4.11 (95% CI 3.38-4.96) for non-responders, respectively. Conclusions: HIC have improved HBV vaccine responsiveness compared to treatment-naive non-controllers, but similar to those on VL-suppressive HAART. Progression to AIDS or death can be predicted by HBV vaccine responder status for non-controllers, however these events are rarely observed in HIC.	[Okulicz, Jason F.; Mesner, Octavio; Ganesan, Anuradha; O'Bryan, Thomas A.; Deiss, Robert G.; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Okulicz, Jason F.; O'Bryan, Thomas A.] San Antonio Mil Med Ctr, Infect Dis Serv, San Antonio, TX USA; [Ganesan, Anuradha] Walter Reed Natl Mil Med Ctr, Infect Dis Serv, Bethesda, MD USA; [Deiss, Robert G.] Naval Med Ctr San Diego, Infect Dis Clin, San Diego, CA USA	Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy; Naval Medical Center San Diego	Okulicz, JF (corresponding author), Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.	jason.f.okulicz.mil@mail.mil		Agan, Brian/0000-0002-5114-1669; Mesner, Octavio/0000-0002-6024-9508	Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) through the Uniformed Services University of the Health Sciences [IDCRP-000-05]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement [Y1-AI-5072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work (IDCRP-000-05) was provided by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2013, CLIN INFECT DIS; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bauer T, 2006, VACCINE, V24, P572, DOI 10.1016/j.vaccine.2005.08.058; Brandt L, 2011, JAIDS-J ACQ IMM DEF, V57, P101, DOI 10.1097/QAI.0b013e318215a991; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; COLLIER AC, 1988, ANN INTERN MED, V109, P101, DOI 10.7326/0003-4819-109-2-101; Cooper CL, 2005, AIDS, V19, P1473, DOI 10.1097/01.aids.0000183514.37513.d2; Balado MDD, 2010, J INFECT DIS, V202, P362, DOI 10.1086/653707; Fonseca MO, 2005, VACCINE, V23, P2902, DOI 10.1016/j.vaccine.2004.11.057; Gaardbo JC, 2013, J ACQUIR IMMUNE DEFI; Goncalves L, 2004, VIROLOGY, V326, P20, DOI 10.1016/j.virol.2004.04.042; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Landrum ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033488; Landrum ML, 2009, VACCINE, V27, P4731, DOI 10.1016/j.vaccine.2009.04.016; Lao-Araya M, 2007, VACCINE, V25, P5324, DOI 10.1016/j.vaccine.2007.05.006; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Moir S, 2003, P NATL ACAD SCI USA, V100, P6057, DOI 10.1073/pnas.0730819100; Okulicz JF, 2010, CLIN INFECT DIS, V50, P1187, DOI 10.1086/651421; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Overton ET, 2005, CLIN INFECT DIS, V41, P1045, DOI 10.1086/433180; Pasricha N, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-65; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Potsch DV, 2012, VACCINE, V30, P5973, DOI 10.1016/j.vaccine.2012.07.028; Sajadi MM, 2009, JAIDS-J ACQ IMM DEF, V50, P403, DOI 10.1097/QAI.0b013e3181945f1e; Shafran SD, 2007, HIV MED, V8, P295, DOI 10.1111/j.1468-1293.2007.00473.x; Tsai IJ, 2000, VACCINE, V19, P437, DOI 10.1016/S0264-410X(00)00205-X; van den Berg R, 2009, AIDS REV, V11, P157; Vingert B, 2012, J VIROL, V86, P10661, DOI 10.1128/JVI.00056-12; Whittall T, 2011, CLIN EXP IMMUNOL, V166, P208, DOI 10.1111/j.1365-2249.2011.04463.x; Yao ZQ, 2013, ARCH IMMUNOL THER EX, V61, P193, DOI 10.1007/s00005-013-0219-0	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105591	10.1371/journal.pone.0105591	http://dx.doi.org/10.1371/journal.pone.0105591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144773	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100090
J	Zhao, L; Luo, L; Jia, WK; Xiao, J; Huang, G; Tian, G; Li, JW; Xiao, YB				Zhao, Liang; Luo, Lin; Jia, Weikun; Xiao, Juan; Huang, Gang; Tian, Geng; Li, Jingwei; Xiao, Yingbin			Serum Diamine Oxidase as a Hemorrhagic Shock Biomarker in a Rabbit Model	PLOS ONE			English	Article							MULTIPLE-ORGAN FAILURE; GUT BARRIER FAILURE; TRAUMA-HEMORRHAGE; MESENTERIC LYMPH; ISCHAEMIA/REPERFUSION INJURY; MYELOPEROXIDASE ACTIVITY; BACTERIAL TRANSLOCATION; NEUTROPHIL INFILTRATION; CYTOKINE RESPONSE; MUCUS LAYER	Background: In prolonged hemorrhagic shock, reductions in intestinal mucosal blood perfusion lead to mucosal barrier damage and systemic inflammation. Gastrointestinal failure in critically ill patients has a poor prognosis, so early assessment of mucosal barrier injury in shock patients is clinically relevant. Unfortunately, there is no serum marker that can accurately assess intestinal ischemia-reperfusion injury. Objective: The aim of this study was to assess if serum diamine oxidase levels can reflect intestinal mucosal injury subsequent to prolonged hemorrhagic shock. Methods: Thirty New Zealand white rabbits were divided into three groups: a control group, a medium blood pressure (BP) group (exsanguinated to a shock BP of 50 to 41 mm Hg), and a low BP group (exsanguinated to a shock blood pressure of 40 to 31 mm Hg), in which the shock BP was sustained for 180 min prior to fluid resuscitation. Results: The severity of hemorrhagic shock in the low BP group was significantly greater than that of the medium BP group according to the post-resuscitation BP, serum tumor necrosis factor (TNF)-alpha, and arterial lactate. Intestinal damage was significantly more severe in the low BP group according to Chiu's scoring, claudin-1, intercellular adhesion molecule (ICAM)-1, and myeloperoxidase expression. Serum diamine oxidase was significantly increased in the low BP group compared to the medium BP and control groups and was negatively correlated with shock BP. Conclusion: Serum diamine oxidase can be used as a serological marker in evaluating intestinal injury and shows promise as an indicator of hemorrhagic shock severity.	[Zhao, Liang; Luo, Lin; Jia, Weikun; Xiao, Juan; Huang, Gang; Tian, Geng; Li, Jingwei; Xiao, Yingbin] Third Mil Med Univ, Xinqiao Hosp, Dept Cardiovasc Surg, Chongqing, Peoples R China	Army Medical University	Xiao, YB (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Cardiovasc Surg, Chongqing, Peoples R China.	xyb023@126.com		Li, Jing-Wei/0000-0003-1638-2317	Military Clinical High Technology Major Project of China [2010gxjs069]	Military Clinical High Technology Major Project of China	This study was supported by the Military Clinical High Technology Major Project of China (grant number: 2010gxjs069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaser AR, 2013, INTENS CARE MED, V39, P899, DOI 10.1007/s00134-013-2831-1; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; BOUNOUS G, 1984, DIGEST DIS SCI, V29, P872, DOI 10.1007/BF01318436; BRAGG LE, 1991, J SURG RES, V50, P228, DOI 10.1016/0022-4804(91)90183-M; Cai CM, 2012, HEPATO-GASTROENTEROL, V59, P155, DOI 10.5754/hge11226; Cakmaz R, 2013, LIBYAN J MED, V8, DOI 10.3402/ljm.v8i0.20596; Caputo FJ, 2007, SHOCK, V28, P441, DOI 10.1097/shk.0b013e31804858f2; Childs EW, 1999, SHOCK, V11, P248, DOI 10.1097/00024382-199904000-00004; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Ciesla DJ, 2005, ARCH SURG-CHICAGO, V140, P432, DOI 10.1001/archsurg.140.5.432; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; DAGOSTINO L, 1984, ENZYME, V31, P217, DOI 10.1159/000469529; Dayal SD, 2002, SHOCK, V17, P491, DOI 10.1097/00024382-200206000-00009; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Fazal N, 2000, CRIT CARE MED, V28, P1550, DOI 10.1097/00003246-200005000-00048; Fishman JE, 2013, AM J PHYSIOL-GASTR L, V304, pG57, DOI 10.1152/ajpgi.00170.2012; Frink M, 2007, MOL IMMUNOL, V44, P2625, DOI 10.1016/j.molimm.2006.12.009; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Hierholzer C, 2004, AM J PHYSIOL-GASTR L, V286, pG225, DOI 10.1152/ajpgi.00447.2002; Homma H, 2005, AM J PHYSIOL-GASTR L, V288, pG466, DOI 10.1152/ajpgi.00036.2004; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; James JH, 1999, LANCET, V354, P505, DOI 10.1016/S0140-6736(98)91132-1; Jastrow KM, 2009, J AM COLL SURGEONS, V209, P320, DOI 10.1016/j.jamcollsurg.2009.05.002; KUROSE I, 1994, CIRC RES, V74, P336, DOI 10.1161/01.RES.74.2.336; Lee CC, 2007, ANN EMERG MED, V49, P37, DOI 10.1016/j.annemergmed.2006.05.031; Lu Q, 2004, CRIT CARE MED, V32, P2464, DOI 10.1097/01.CCM.0000147833.51214.03; Lu Q, 2011, J TRAUMA, V70, P630, DOI 10.1097/TA.0b013e3181e1221b; Mondello S, 2010, EUR J PHARMACOL, V643, P304, DOI 10.1016/j.ejphar.2010.06.044; Moomey CB, 1999, CRIT CARE MED, V27, P154, DOI 10.1097/00003246-199901000-00044; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Puleo F, 2011, SEMIN RESP CRIT CARE, V32, P626, DOI 10.1055/s-0031-1287871; Reintam A, 2008, CRIT CARE, V12, DOI 10.1186/cc6958; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008; Sambol JT, 2009, J APPL PHYSIOL, V106, P57, DOI 10.1152/japplphysiol.90937.2008; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sheng WH, 2005, J FORMOS MED ASSOC, V104, P715; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Tamion F, 1997, AM J PHYSIOL-GASTR L, V273, pG314, DOI 10.1152/ajpgi.1997.273.2.G314; Wanner GA, 1999, SHOCK, V11, P391; WOLVEKAMP MCJ, 1994, DIGEST DIS, V12, P2; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P277, DOI 10.1189/jlb.0705363	47	29	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e102285	10.1371/journal.pone.0102285	http://dx.doi.org/10.1371/journal.pone.0102285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144315	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100003
J	Hirsch, O; Kluckner, VJ; Brandt, S; Moss, A; Weck, M; Florath, I; Wabitsch, M; Hebebrand, J; Schimmelmann, BG; Christiansen, H				Hirsch, Oliver; Kluckner, Viktoria J.; Brandt, Stephanie; Moss, Anja; Weck, Melanie; Florath, Ines; Wabitsch, Martin; Hebebrand, Johannes; Schimmelmann, Benno G.; Christiansen, Hanna			Restrained and External-Emotional Eating Patterns in Young Overweight Children-Results of the Ulm Birth Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; RISK-FACTORS; WEIGHT; BEHAVIORS; PSYCHOPATHOLOGY; QUESTIONNAIRE; ASSOCIATION; PREVALENCE; ADULTHOOD	Childhood obesity is one of the greatest public health challenges in Western countries. Abnormal eating behavior is thought to be a developmental trajectory to obesity. The Eating Pattern Inventory for Children (EPI-C) has not been used for children as young as eight years, and possible associations with body weight have not yet been established. Five hundred and twenty-one children of the Ulm Birth Cohort Study (UBCS; age eight) filled out the EPI-C and BMI was assessed. Adequacy of the scales was tested with confirmatory factor analysis and a MANOVA and cluster analysis established associations between eating patterns and BMI. The factor structure of the EPI-C was confirmed (GFI =.968) and abnormal eating behavior was associated with overweight (chi(2) (8) = 79.29, p<.001). The EPI-C is a valid assessment tool in this young age group. Overweight children consciously restrain their eating.	[Hirsch, Oliver; Christiansen, Hanna] Univ Marburg, Dept Child & Adolescent Psychol, Marburg, Germany; [Kluckner, Viktoria J.; Schimmelmann, Benno G.] Univ Bern, Univ Hosp Child & Adolescent Psychiat, Bern, Switzerland; [Brandt, Stephanie; Moss, Anja; Wabitsch, Martin] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, Ulm, Germany; [Weck, Melanie; Florath, Ines] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Hebebrand, Johannes] Univ Duisburg Essen, Dept Child & Adolescent Psychiat & Psychotherapy, Essen, Germany	Philipps University Marburg; University of Bern; University Hospital of Bern; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen	Hirsch, O (corresponding author), Univ Marburg, Dept Child & Adolescent Psychol, Marburg, Germany.	oliver.hirsch@staff.uni-marburg.de	Hirsch, Oliver/H-2876-2019		"Kompetenznetz Adipositas" (Competence Network for Adipositas) - Federals Ministry of Education and Research [FKZ 01GI0840]	"Kompetenznetz Adipositas" (Competence Network for Adipositas) - Federals Ministry of Education and Research	This work was supported by the "Kompetenznetz Adipositas" (Competence Network for Adipositas) funded by the Federals Ministry of Education and Research (FKZ 01GI0840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0043503; Anschutz DJ, 2009, AM J CLIN NUTR, V89, P1328, DOI 10.3945/ajcn.2008.27075; Arbuckle J., 2008, AMOS 17 0 USERS GUID; Blunch N. J., 2008, INTRO STRUCTURAL EQU; Braet C, 1997, BEHAV RES THER, V35, P863, DOI 10.1016/S0005-7967(97)00045-4; Braet C, 2008, J HEALTH PSYCHOL, V13, P733, DOI 10.1177/1359105308093850; Brophy S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-467; Butryn ML, 2005, INT J EAT DISORDER, V37, P285, DOI 10.1002/eat.20098; Campbell KJ, 2006, INT J OBESITY, V30, P1272, DOI 10.1038/sj.ijo.0803266; Carnell S, 2013, PHYSL BEHAV; Casey PH, 2012, J PERINATOL, V32, P91, DOI 10.1038/jp.2011.75; Christiansen H, 2013, WENN KINDER JUGENDLI, P135; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Field AE, 2003, PEDIATRICS, V112, P900, DOI 10.1542/peds.112.4.900; Florath I, 2014, PEDIATR OBES, V9, P121, DOI 10.1111/j.2047-6310.2012.00146.x; Flores G, 2013, INT J OBESITY, V37, P31, DOI 10.1038/ijo.2012.168; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Grissom R.J., 2012, EFFECT SIZES RES; Halvarsson K, 1998, EUR EAT DISORD REV, V6, P115, DOI 10.1002/(SICI)1099-0968(199806)6:2<115::AID-ERV222>3.3.CO;2-D; Huber PJ, 2009, WILEY SERIES PROBABI; Jennings A, 2012, OBESITY, V20, P1462, DOI 10.1038/oby.2012.72; Knussmann R., 1996, VERGLEICHENDE BIOL M; LANDMAN GB, 1989, PEDIATR ANN, V18, P373, DOI 10.3928/0090-4481-19890601-08; LATHROP RG, 1990, EDUC PSYCHOL MEAS, V50, P325, DOI 10.1177/0013164490502010; Lee Sarah M., 2011, Morbidity and Mortality Weekly Report, V60, P1; Long JM, 2012, J SPEC PEDIATR NURS, V17, P41, DOI 10.1111/j.1744-6155.2011.00309.x; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Martin R., 1957, LEHRBUCH ANTHR, V3rd; McVey G, 2004, CAN MED ASSOC J, V170, P1559, DOI 10.1503/cmaj.1031247; Micali N, 2011, J DEV BEHAV PEDIATR, V32, P572, DOI 10.1097/DBP.0b013e31822bc7b7; Moreno G, 2013, J SCHOOL HEALTH, V83, P157, DOI 10.1111/josh.12011; Olstad DL, 2009, APPL PHYSIOL NUTR ME, V34, P551, DOI 10.1139/H09-016; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Raykov T., 2006, 1 COURSE STRUCTURAL, V2nd; Rifas-Shiman SL, 2012, OBESITY, V20, P1261, DOI 10.1038/oby.2011.350; Rooney BL, 2011, MATERN CHILD HLTH J, V15, P1166, DOI 10.1007/s10995-010-0689-1; Schacht M, 2006, J CLIN PSYCHOL, V62, P1259, DOI 10.1002/jclp.20300; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Sinha A, 2009, OBES SURG, V19, P113, DOI 10.1007/s11695-008-9650-4; Snoek HM, 2013, APPETITE, V67, P81, DOI 10.1016/j.appet.2013.03.014; Stice E, 2005, J CONSULT CLIN PSYCH, V73, P195, DOI 10.1037/0022-006X.73.2.195; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub2, 10.1002/14651858.CD001871.pub4]; Tanofsky-Kraff M, 2005, INT J EAT DISORDER, V38, P112, DOI 10.1002/eat.20158; Tanofsky-Kraff M, 2004, J CONSULT CLIN PSYCH, V72, P53, DOI 10.1037/0022-006X.72.1.53; Truby H, 2002, BRIT J CLIN PSYCHOL, V41, P185, DOI 10.1348/014466502163967; van Strien T, 2008, INT J EAT DISORDER, V41, P72, DOI 10.1002/eat.20424; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Volker MA, 2006, PSYCHOL SCHOOLS, V43, P653, DOI 10.1002/pits.20176; Weiber R., 2010, STRUCTURAL EQUATION; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wijnhoven TMA, 2013, PEDIATR OBES, V8, P79, DOI 10.1111/j.2047-6310.2012.00090.x	51	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105303	10.1371/journal.pone.0105303	http://dx.doi.org/10.1371/journal.pone.0105303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25141134	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200069
J	Maslunka, C; Gifford, B; Tucci, J; Gurtler, V; Seviour, RJ				Maslunka, Christopher; Gifford, Bianca; Tucci, Joseph; Guertler, Volker; Seviour, Robert J.			Insertions or Deletions (Indels) in the rrn 16S-23S rRNA Gene Internal Transcribed Spacer Region (ITS) Compromise the Typing and Identification of Strains within the Acinetobacter calcoaceticus-baumannii (Acb) Complex and Closely Related Members	PLOS ONE			English	Article							GENOMIC SPECIES 13TU; INTERGENIC SPACER; SEQUENCE-ANALYSIS; RAPID IDENTIFICATION; BACTERIA; OPERON; PATHOGENESIS; PROBES; ARRAY; SPP.	To determine whether ITS sequences in the rrn operon are suitable for identifying individual Acinetobacter Acb complex members, we analysed length and sequence differences between multiple ITS copies within the genomes of individual strains. Length differences in ITS reported previously between A. nosocomialis BCRC15417(T) (615 bp) and other strains (607 bp) can be explained by presence of an insertion (indel 13i/1) in the longer ITS variant. The same Indel 13i/1 was also found in ITS sequences of ten strains of A. calcoaceticus, all 639 bp long, and the 628 bp ITS of Acinetobacter strain BENAB127. Four additional indels (13i/2-13i/5) were detected in Acinetobacter strain c/t13TU 10090 ITS length variants (608, 609, 620, 621 and 630 bp). These ITS variants appear to have resulted from horizontal gene transfer involving other Acinetobacter species or in some cases unrelated bacteria. Although some ITS copies in strain c/t13TU 10090 are of the same length (620 bp) as those in Acinetobacter strains b/n1&3, A. pittii (10 strains), A. calcoaceticus and A. oleivorans (not currently acknowledged as an Acb member), their individual ITS sequences differ. Thus ITS length by itself can not by itself be used to identify Acb complex strains. A shared indel in ITS copies in two separate Acinetobacter species compromises the specificity of ITS targeted probes, as shown with the Aun-3 probe designed to target the ITS in A. pitti. The presence of indel 13i/5 in the ITS of Acinetobacter strain c/t13TU means it too responded positively to this probe. Thus, neither ITS sequencing nor the currently available ITS targeted probes can distinguish reliably between Acb member species.	[Maslunka, Christopher; Gifford, Bianca; Tucci, Joseph; Seviour, Robert J.] La Trobe Univ, Biotechnol Res Ctr, Bendigo, Vic, Australia; [Guertler, Volker] Bundoora Campus RMIT Univ, Sch Appl Sci, Bundoora, Vic, Australia	La Trobe University; Royal Melbourne Institute of Technology (RMIT)	Seviour, RJ (corresponding author), La Trobe Univ, Dept Microbiol, Bundoora, Vic 3083, Australia.	r.seviour@latrobe.edu.au		seviour, robert/0000-0002-1366-0484	La Trobe University Postgraduate Scholarship; Australian Research Council	La Trobe University Postgraduate Scholarship; Australian Research Council(Australian Research Council)	CM was supported by a La Trobe University Postgraduate Scholarship. BG was supported by an Australian Post Graduate Award from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Barry T, 1991, PCR Methods Appl, V1, P51; BEACHAM AM, 1990, WATER RES, V24, P23, DOI 10.1016/0043-1354(90)90060-J; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Carr EL, 2004, SYST APPL MICROBIOL, V27, P478, DOI 10.1078/0723202041438491; Chan JZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-302; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chen TL, 2007, CLIN MICROBIOL INFEC, V13, P801, DOI 10.1111/j.1469-0691.2007.01744.x; Chen Y, 2012, J BACTERIOL, V194, P204, DOI 10.1128/JB.06202-11; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dijkshoorn Lenie, 2008, P1; GERISCHER U., 2008, ACINETOBACTER MOL BI; GERNERSMIDT P, 1993, APMIS, V101, P826, DOI 10.1111/j.1699-0463.1993.tb00187.x; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Golanbar GD, 2011, J CLIN MICROBIOL, V49, P2121, DOI 10.1128/JCM.02373-10; Goncalves ER, 2002, INT J SYST EVOL MICR, V52, P355, DOI 10.1099/00207713-52-2-355; Gurtler V, 2013, J MICROBIOL METH, V93, P257, DOI 10.1016/j.mimet.2013.02.013; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Gurtler V, 1999, GENE, V238, P241, DOI 10.1016/S0378-1119(99)00224-3; Gurtler V, 2014, METHODS MIC IN PRESS, V41; Gurtler V, 2012, J MICROBIOL METH, V90, P167, DOI 10.1016/j.mimet.2012.05.002; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; JENSEN MA, 1993, APPL ENVIRON MICROB, V59, P945, DOI 10.1128/AEM.59.4.945-952.1993; Jung J, 2011, APPL ENVIRON MICROB, V77, P7418, DOI 10.1128/AEM.05231-11; Jung J, 2010, J BACTERIOL, V192, P4794, DOI 10.1128/JB.00722-10; Ko WC, 2008, J CLIN MICROBIOL, V46, P2052, DOI 10.1128/JCM.00014-08; Lagatolla C, 1998, RES MICROBIOL, V149, P557, DOI 10.1016/S0923-2508(99)80003-5; Lai CC, 2012, J CLIN MICROBIOL, V50, P2982, DOI 10.1128/JCM.01194-12; Lebuhn M, 2006, SYST APPL MICROBIOL, V29, P265, DOI 10.1016/j.syapm.2005.11.003; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Lin YC, 2008, J CLIN MICROBIOL, V46, P612, DOI 10.1128/JCM.01798-07; Luz SP, 1998, J BACTERIOL, V180, P2144, DOI 10.1128/JB.180.8.2144-2151.1998; Maslunka C, 2006, SYST APPL MICROBIOL, V29, P216, DOI 10.1016/j.syapm.2005.07.015; Maslunka C, 2008, J MICROBIOL METH, V73, P227, DOI 10.1016/j.mimet.2008.03.003; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Peix A, 2009, SYST APPL MICROBIOL, V32, P334, DOI 10.1016/j.syapm.2009.03.004; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046984; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Ramirez MS, 2010, J CLIN MICROBIOL, V48, P1488, DOI 10.1128/JCM.01264-09; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; Su SC, 2009, J MED MICROBIOL, V58, P596, DOI 10.1099/jmm.0.004606-0; TJERNBERG I, 1989, APMIS, V97, P595, DOI 10.1111/j.1699-0463.1989.tb00449.x; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Vaneechoutte M, 2009, J CLIN MICROBIOL, V47, P1281; Zarrilli R, 2009, J CLIN MICROBIOL, V47, P1281, DOI 10.1128/JCM.02022-08; Zhan YH, 2011, J BACTERIOL, V193, P2672, DOI 10.1128/JB.00261-11	50	10	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105390	10.1371/journal.pone.0105390	http://dx.doi.org/10.1371/journal.pone.0105390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141005	gold, Green Submitted, Green Published			2022-12-25	WOS:000342687200085
J	Yahi, N; Fantini, J				Yahi, Nouara; Fantini, Jacques			Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding Peptide	PLOS ONE			English	Article							BETA-PROTEIN; MEMBRANE MICRODOMAINS; PLASMA-MEMBRANE; ALPHA-SYNUCLEIN; CHOLESTEROL; DISEASE; DOMAIN; HIV-1; GM1; RAFTS	A broad range of microbial and amyloid proteins interact with cell surface glycolipids which behave as infectivity and/or toxicity cofactors in human pathologies. Here we have deciphered the biochemical code that determines the glycolipid-binding specificity of two major amyloid proteins, Alzheimer's beta-amyloid peptide (Ab) and Parkinson's disease associated protein alpha-synuclein. We showed that both proteins interact with selected glycolipids through a common loop-shaped motif exhibiting little sequence homology. This 12-residue domain corresponded to fragments 34-45 of alpha-synuclein and 5-16 of Ab. By modulating the amino acid sequence of alpha-synuclein at only two positions in which we introduced a pair of histidine residues found in Ab, we created a chimeric alpha-synuclein/A beta peptide with extended ganglioside-binding properties. This chimeric peptide retained the property of alpha-synuclein to recognize GM3, and acquired the capacity to recognize GM1 (an Ab-inherited characteristic). Free histidine (but not tryptophan or asparagine) and Zn2+ (but not Na+) prevented this interaction, confirming the key role of His-13 and His-14 in ganglioside binding. Molecular dynamics studies suggested that the chimeric peptide recognized cholesterol-constrained conformers of GM1, including typical chalice-shaped dimers, that are representative of the condensed cholesterol-ganglioside complexes found in lipid raft domains of the plasma membrane of neural cells. Correspondingly, the peptide had a particular affinity for raft-like membranes containing both GM1 and cholesterol. The chimeric peptide also interacted with several other gangliosides, including major brain gangliosides (GM4, GD1a, GD1b, and GT1b) but not with neutral glycolipids such as GlcCer, LacCer or asialo-GM1. It could inhibit the binding of A beta 1-42 onto neural SH-SY5Y cells and did not induce toxicity in these cells. In conclusion, deciphering the glycolipid code of amyloid proteins allowed us to create a universal ganglioside-binding peptide of only 12-residues with potential therapeutic applications in infectious and neurodegenerative diseases that involve cell surface gangliosides as receptors.	[Yahi, Nouara; Fantini, Jacques] Aix Marseille Univ, Fac Sci, PPSN EA4674, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Fantini, J (corresponding author), Aix Marseille Univ, Fac Sci, PPSN EA4674, Marseille, France.	jacques.fantini@univ-amu.fr		Fantini, Jacques/0000-0001-8653-5521				Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; ASOU H, 1989, CELL STRUCT FUNCT, V14, P561, DOI 10.1247/csf.14.561; Aubert-Jousset E, 2004, STRUCTURE, V12, P1437, DOI 10.1016/j.str.2004.05.016; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chakrabandhu K, 2008, CELL DEATH DIFFER, V15, P1824, DOI 10.1038/cdd.2008.115; Di Scala C, 2014, BIOCHEMISTRY-US, V53, P4489, DOI 10.1021/bi500373k; Diaz JC, 2006, BIOL RES, V39, P447, DOI 10.4067/S0716-97602006000300007; Fantini J, 2003, CELL MOL LIFE SCI, V60, P1027, DOI 10.1007/s00018-003-3003-1; Fantini J, 2007, CURR MED CHEM, V14, P2911, DOI 10.2174/092986707782360033; Fantini J, 2006, BIOCHEMISTRY-US, V45, P10957, DOI 10.1021/bi060762s; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Fantini J, 2013, ADV EXP MED BIOL, V991, P15, DOI 10.1007/978-94-007-6331-9_2; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00120; Fantini J, 2011, BBA-BIOMEMBRANES, V1808, P2343, DOI 10.1016/j.bbamem.2011.06.017; Fantini J, 2011, J MOL BIOL, V408, P654, DOI 10.1016/j.jmb.2011.03.009; Fantini J, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001602; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamel S, 2010, J CELL BIOL, V188, P581, DOI 10.1083/jcb.200907116; Hammache D, 1999, J VIROL, V73, P5244, DOI 10.1128/JVI.73.6.5244-5248.1999; Hammache D, 1998, J BIOL CHEM, V273, P7967, DOI 10.1074/jbc.273.14.7967; Hammache D, 2000, METHOD ENZYMOL, V312, P495; Hannson HA, 1977, P NATL ACAD SCI USA, V74, P3782; Heuss SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074392; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001448; Jang H, 2013, PHYS CHEM CHEM PHYS, V15, P8868, DOI 10.1039/c3cp00017f; Kakio A, 2003, BIOCHEM BIOPH RES CO, V303, P514, DOI 10.1016/S0006-291X(03)00386-3; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Levy M, 2006, FEBS J, V273, P5724, DOI 10.1111/j.1742-4658.2006.05562.x; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Mahfoud R, 2002, J LIPID RES, V43, P1670, DOI 10.1194/jlr.M200165-JLR200; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; Matsubara T, 1999, FEBS LETT, V456, P253, DOI 10.1016/S0014-5793(99)00962-X; Matsubara T, 2008, BIOCHEMISTRY-US, V47, P6745, DOI 10.1021/bi8000837; Matsubara T, 2013, LANGMUIR, V29, P2258, DOI 10.1021/la3038999; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Mattei V, 2004, FEBS LETT, V560, P14, DOI 10.1016/S0014-5793(04)00029-8; Nelson TJ, 2007, J BIOL CHEM, V282, P31238, DOI 10.1074/jbc.M705558200; Oikawa N, 2009, NEUROREPORT, V20, P1043, DOI 10.1097/WNR.0b013e32832e4b9d; Puryear WB, 2012, P NATL ACAD SCI USA, V109, P7475, DOI 10.1073/pnas.1201104109; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Rasool S, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-37; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; Taieb N, 2004, ADV DRUG DELIVER REV, V56, P779, DOI 10.1016/j.addr.2003.09.007; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Wu GS, 2012, J NEUROSCI RES, V90, P1997, DOI 10.1002/jnr.23090; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079; Yamamoto N, 2007, BBA-BIOMEMBRANES, V1768, P1128, DOI 10.1016/j.bbamem.2007.01.009; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062	50	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104751	10.1371/journal.pone.0104751	http://dx.doi.org/10.1371/journal.pone.0104751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140899	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200031
J	Zhao, D; Pan, C; Sun, J; Gilbert, C; Drews-Elger, K; Azzam, DJ; Picon-Ruiz, M; Kim, M; Ullmer, W; El-Ashry, D; Creighton, CJ; Slingerland, JM				Zhao, D.; Pan, C.; Sun, J.; Gilbert, C.; Drews-Elger, K.; Azzam, D. J.; Picon-Ruiz, M.; Kim, M.; Ullmer, W.; El-Ashry, D.; Creighton, C. J.; Slingerland, J. M.			VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2	ONCOGENE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; BREAST-CANCER; TUMOR-GROWTH; LUNG; SURVIVAL; PATHWAY; ANGIOGENESIS; METASTASIS; EXPRESSION; CAPACITY	Vascular endothelial growth factor-A (VEGF), a potent angiogenic factor, is also implicated in self-renewal in several normal tissue types. VEGF has been shown to drive malignant stem cells but mechanisms thereof and tumor types affected are not fully characterized. Here, we show VEGF promotes breast and lung cancer stem cell (CSC) self-renewal via VEGF receptor-2 (VEGFR-2)/STAT3-mediated upregulation of Myc and Sox2. VEGF increased tumor spheres and aldehyde dehydrogenase activity, both proxies for stem cell function in vitro, in triple-negative breast cancer (TNBC) lines and dissociated primary cancers, and in lung cancer lines. VEGF exposure before injection increased breast cancer-initiating cell abundance in vivo yielding increased orthotopic tumors, and increased metastasis from orthotopic primaries and following tail vein injection without further VEGF treatment. VEGF rapidly stimulated VEGFR-2/JAK2/STAT3 binding and activated STAT3 to bind MYC and SOX2 promoters and induce their expression. VEGFR-2 knockdown or inhibition abrogated VEGF-mediated STAT3 activation, MYC and SOX2 induction and sphere formation. Notably, knockdown of either STAT3, MYC or SOX2 impaired VEGF-upregulation of pSTAT3, MYC and SOX2 expression and sphere formation. Each transcription factor, once upregulated, appears to promote sustained activation of the others, creating a feed-forward loop to drive self-renewal. Thus, in addition to angiogenic effects, VEGF promotes tumor-initiating cell self-renewal through VEGFR-2/STAT3 signaling. Analysis of primary breast and lung cancers (>1300 each) showed high VEGF expression, was prognostic of poor outcome and strongly associated with STAT3 and MYC expression, supporting the link between VEGF and CSC self-renewal. High-VEGF tumors may be most likely to escape anti-angiogenics by upregulating VEGF, driving CSC self-renewal to re-populate post-treatment. Our work highlights the need to better define VEGF-driven cancer subsets and supports further investigation of combined therapeutic blockade of VEGF or VEGFR-2 and JAK2/STAT3.	[Zhao, D.; Pan, C.; Sun, J.; Gilbert, C.; Drews-Elger, K.; Azzam, D. J.; Picon-Ruiz, M.; Kim, M.; Ullmer, W.; El-Ashry, D.; Slingerland, J. M.] Univ Miami, Miller Sch Med, Braman Family Breast Canc Inst, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Zhao, D.; El-Ashry, D.; Slingerland, J. M.] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL 33136 USA; [Azzam, D. J.; Kim, M.; Slingerland, J. M.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [El-Ashry, D.; Slingerland, J. M.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Creighton, C. J.] Baylor Coll Med, Div Biostat, Duncan Canc Ctr, Houston, TX 77030 USA	University of Miami; University of Miami; University of Miami; University of Miami; Baylor College of Medicine	Slingerland, JM (corresponding author), Univ Miami, Miller Sch Med, Braman Family Breast Canc Inst, Sylvester Comprehens Canc Ctr, 1501 NW 10th Ave,BRB708, Miami, FL 33136 USA.	jslingerland@med.miami.edu	Ruiz, Manuel Picón/I-3624-2015; Zhao, Dekuang/H-5671-2015; Azzam, Diana/ABB-8342-2021	Ruiz, Manuel Picón/0000-0002-9427-0946; Zhao, Dekuang/0000-0002-7251-2481; Azzam, Diana/0000-0002-2605-8855; Drews-Elger, Katherine/0000-0001-9540-0610	Breast Cancer Research Foundation;  [P30 CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Breast Cancer Research Foundation (JMS) and P30 CA125123 (CJC). We thank Fengju Chen for technical assistance. We also thank Dr Brekken (UT southwestern Medical Center) for providing VEGFR-2 blocking antibody 2C3.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Annovazzi L, 2011, CANCER GENOM PROTEOM, V8, P139; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Boere IA, 2010, CANCER SCI, V101, P7, DOI 10.1111/j.1349-7006.2009.01369.x; Brekken RA, 2000, CANCER RES, V60, P5117; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Calvo CF, 2011, GENE DEV, V25, P831, DOI 10.1101/gad.615311; Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Drews-Elger K, 2014, BREAST CANCER RES TR, V144, P503, DOI 10.1007/s10549-014-2887-9; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Feng XH, 2010, NAT REV MOL CELL BIO, V11, P466, DOI 10.1038/nrm2923; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Foshay KM, 2008, STEM CELLS DEV, V17, P269, DOI 10.1089/scd.2007.0098; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Goel HL, 2013, EMBO MOL MED, V5, P488, DOI 10.1002/emmm.201202078; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Han H, 2001, ANN SURG ONCOL, V8, P72, DOI 10.1245/aso.2001.8.1.72; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Kane NM, 2011, PHARMACOL THERAPEUT, V129, P29, DOI 10.1016/j.pharmthera.2010.10.004; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miller Kathy D, 2003, Clin Breast Cancer, V3, P421, DOI 10.3816/CBC.2003.n.007; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mishra DK, 2014, INT J CANCER, V134, P789, DOI 10.1002/ijc.28428; Montero AJ, 2012, CURR ONCOL REP, V14, P1, DOI 10.1007/s11912-011-0202-z; Montero AJ, 2012, NEW ENGL J MED, V366, P374, DOI 10.1056/NEJMe1113368; Nair R, 2014, ONCOGENE, V33, P3992, DOI 10.1038/onc.2013.368; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nourse MB, 2010, ARTERIOSCL THROM VAS, V30, P80, DOI 10.1161/ATVBAHA.109.194233; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Ryden L, 2005, BREAST CANCER RES TR, V89, P135, DOI 10.1007/s10549-004-1655-7; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tanno S, 2004, LUNG CANCER, V46, P11, DOI 10.1016/j.lungcan.2004.03.006; Verseijden F, 2009, TISSUE ENG PT A, V15, P445, DOI 10.1089/ten.tea.2007.0429; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yang F, 2011, CANCER RES, V71, P5512, DOI 10.1158/0008-5472.CAN-10-2614; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591	73	165	179	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2015	34	24					3107	3119		10.1038/onc.2014.257	http://dx.doi.org/10.1038/onc.2014.257			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3FD	25151964				2022-12-25	WOS:000356101100003
J	Ito, K; Yamazaki, S; Yamamoto, R; Tajima, Y; Yanagida, A; Kobayashi, T; Kato-Itoh, M; Kakuta, S; Iwakura, Y; Nakauchi, H; Kamiya, A				Ito, Keiichi; Yamazaki, Satoshi; Yamamoto, Ryo; Tajima, Yoko; Yanagida, Ayaka; Kobayashi, Toshihiro; Kato-Itoh, Megumi; Kakuta, Shigeru; Iwakura, Yoichiro; Nakauchi, Hiromitsu; Kamiya, Akihide			Gene Targeting Study Reveals Unexpected Expression of Brain-expressed X-linked 2 in Endocrine and Tissue Stem/Progenitor Cells in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Gene Expression; Gene Knock-out; Hematopoietic Stem Cells; Liver; Stem Cells; Brain-expressed X-linked Gene; X-linked Gene; Endocrine Cells	HEMATOPOIETIC STEM-CELL; RNA-POLYMERASE-II; SELF-RENEWAL; NEUROTROPHIN RECEPTOR; TRANSCRIPTION FACTORS; DEFINITIVE ENDODERM; MENTAL-RETARDATION; LIVER DEVELOPMENT; PROGENITOR CELLS; MOUSE	Background: The role and precise expression pattern of individual brain-expressed X-linked genes in vivo were unknown. Results: Bex2-EGFP knock-in-knock-out mice were viable and fertile. Outside the brain, EGFP was expressed in specific cell populations. Conclusion: Bex2 plays redundant roles in vivo but is specifically expressed in endocrine and stem/progenitor cells. Significance: Bex2 is a novel marker for endocrine and stem/progenitor cells. Identification of genes specifically expressed in stem/progenitor cells is an important issue in developmental and stem cell biology. Genome-wide gene expression analyses in liver cells performed in this study have revealed a strong expression of X-linked genes that include members of the brain-expressed X-linked (Bex) gene family in stem/progenitor cells. Bex family genes are expressed abundantly in the neural cells and have been suggested to play important roles in the development of nervous tissues. However, the physiological role of its individual members and the precise expression pattern outside the nervous system remain largely unknown. Here, we focused on Bex2 and examined its role and expression pattern by generating knock-in mice; the enhanced green fluorescence protein (EGFP) was inserted into the Bex2 locus. Bex2-deficient mice were viable and fertile under laboratory growth conditions showing no obvious phenotypic abnormalities. Through an immunohistochemical analysis and flow cytometry-based approach, we observed unique EGFP reporter expression patterns in endocrine and stem/progenitor cells of the liver, pyloric stomach, and hematopoietic system. Although Bex2 seems to play redundant roles in vivo, these results suggest the significance and potential applications of Bex2 in studies of endocrine and stem/progenitor cells.	[Ito, Keiichi; Yamazaki, Satoshi; Yamamoto, Ryo; Tajima, Yoko; Yanagida, Ayaka; Kato-Itoh, Megumi; Nakauchi, Hiromitsu; Kamiya, Akihide] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell & Regenerat Med,Minato Ku, Tokyo 1088639, Japan; [Kobayashi, Toshihiro; Kato-Itoh, Megumi; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, NAKAUCHI Stem Cell & Organ Regenerat Project, Chiyoda Ku, Tokyo 1028666, Japan; [Kobayashi, Toshihiro] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Kakuta, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Ctr Anim Dis Models, Noda, Chiba 2780022, Japan; [Yamamoto, Ryo; Nakauchi, Hiromitsu] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Kamiya, Akihide] Tokai Univ, Inst Innovat Sci & Technol, Lab Stem Cell Therapy, Isehara, Kanagawa 2591143, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Cambridge; University of Tokyo; Tokyo University of Science; Stanford University; Tokai University	Kamiya, A (corresponding author), Tokai Univ, Inst Innovat Sci & Technol, Lab Stem Cell Therapy, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	kamiyaa@tokai-u.jp	Iwakura, Yoichiro/E-5457-2011; Kakuta, Shigeru/L-2241-2018; Yamamoto, Ryo/Y-9464-2018; Yamamoto, Ryo/V-9312-2019	Iwakura, Yoichiro/0000-0002-9934-5775; Kakuta, Shigeru/0000-0002-5900-1425; Yamamoto, Ryo/0000-0001-5504-6004; Kobayashi, Toshihiro/0000-0001-8019-0008	Ministry of Education, Culture, Sports, and Technology, Japan	Ministry of Education, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research on innovative areas from the Ministry of Education, Culture, Sports, and Technology, Japan.	ALTABA ARI, 1993, MECH DEVELOP, V44, P91, DOI 10.1016/0925-4773(93)90060-B; Alvarez E, 2005, GENE, V357, P18, DOI 10.1016/j.gene.2005.05.012; Andrew A, 1998, J PATHOL, V186, P117, DOI 10.1002/(SICI)1096-9896(1998100)186:2<117::AID-PATH152>3.0.CO;2-J; ANDREW A, 1983, GASTROENTEROLOGY, V84, P429; ANG SL, 1993, DEVELOPMENT, V119, P1301; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Behrens M, 2003, J NEUROCHEM, V86, P1289, DOI 10.1046/j.1471-4159.2003.01940.x; Besson V, 2011, P NATL ACAD SCI USA, V108, P11470, DOI 10.1073/pnas.1103873108; Brown AL, 1999, HUM MOL GENET, V8, P611, DOI 10.1093/hmg/8.4.611; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Fischer C, 2007, LEUKEMIA, V21, P374, DOI 10.1038/sj.leu.2404493; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Hagens O, 2006, HUM GENET, V118, P578, DOI 10.1007/s00439-005-0072-2; Hiemisch H, 1997, EMBO J, V16, P3995, DOI 10.1093/emboj/16.13.3995; Hocker M, 1998, ANN NY ACAD SCI, V859, P160, DOI 10.1111/j.1749-6632.1998.tb11120.x; Hofsli E, 2008, BRIT J CANCER, V99, P1330, DOI 10.1038/sj.bjc.6604565; Ito K, 2014, LIVER INT, V34, P1378, DOI 10.1111/liv.12387; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Kakinuma S, 2009, J HEPATOL, V51, P127, DOI 10.1016/j.jhep.2009.02.033; Khazaei MR, 2010, J NEUROCHEM, V115, P910, DOI 10.1111/j.1471-4159.2010.06960.x; Koo JH, 2007, BIOCHEM BIOPH RES CO, V363, P405, DOI 10.1016/j.bbrc.2007.08.186; Koo JH, 2005, J COMP NEUROL, V487, P1, DOI 10.1002/cne.20486; Koo JH, 2004, J NEUROCHEM, V90, P102, DOI 10.1111/j.1471-4159.2004.02463.x; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Li HJ, 2011, DIABETES OBES METAB, V13, P5, DOI 10.1111/j.1463-1326.2011.01438.x; McDonald E, 2009, STEM CELLS DEV, V18, P1379, DOI 10.1089/scd.2009.0240; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Mukai J, 2002, J BIOL CHEM, V277, P13973, DOI 10.1074/jbc.M106342200; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Okada K, 2012, STEM CELLS DEV, V21, P1124, DOI 10.1089/scd.2011.0229; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Osawa M, 1996, J IMMUNOL, V156, P3207; PEARSE AGE, 1969, J HISTOCHEM CYTOCHEM, V17, P303, DOI 10.1177/17.5.303; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; Sharpe RM, 2006, BEST PRACT RES CL EN, V20, P91, DOI 10.1016/j.beem.2005.09.005; Sharpe RM, 2003, PURE APPL CHEM, V75, P2023, DOI 10.1351/pac200375112023; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Yamaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041007; Yamaoka T, 1999, INT J MOL MED, V3, P247; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zhou XP, 2012, BIOCHEM BIOPH RES CO, V427, P574, DOI 10.1016/j.bbrc.2012.09.100	50	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29892	29911		10.1074/jbc.M114.580084	http://dx.doi.org/10.1074/jbc.M114.580084			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25143383	Green Published, hybrid			2022-12-25	WOS:000344370800033
J	Bonardi, D; Ravasio, V; Borsani, G; d'Azzo, A; Bresciani, R; Monti, E; Giacopuzzi, E				Bonardi, Dario; Ravasio, Viola; Borsani, Giuseppe; d'Azzo, Alessandra; Bresciani, Roberto; Monti, Eugenio; Giacopuzzi, Edoardo			In Silico Identification of New Putative Pathogenic Variants in the Neu1 Sialidase Gene Affecting Enzyme Function and Subcellular Localization	PLOS ONE			English	Article							HUMAN LYSOSOMAL NEURAMINIDASE; ELASTIN-DERIVED PEPTIDES; SIALIDOSIS; MUTATIONS; PREVALENCE; DEFICIENCY; INSIGHTS; DISEASE; GENOMES; IMPACT	The NEU1 gene is the first identified member of the human sialidases, glycohydrolitic enzymes that remove the terminal sialic acid from oligosaccharide chains. Mutations in NEU1 gene are causative of sialidosis (MIM 256550), a severe lysosomal storage disorder showing autosomal recessive mode of inheritance. Sialidosis has been classified into two subtypes: sialidosis type I, a normomorphic, late-onset form, and sialidosis type II, a more severe neonatal or early-onset form. A total of 50 causative mutations are reported in HGMD database, most of which are missense variants. To further characterize the NEU1 gene and identify new functionally relevant protein isoforms, we decided to study its genetic variability in the human population using the data generated by two large sequencing projects: the 1000 Genomes Project (1000G) and the NHLBI GO Exome Sequencing Project (ESP). Together these two datasets comprise a cohort of 7595 sequenced individuals, making it possible to identify rare variants and dissect population specific ones. By integrating this approach with biochemical and cellular studies, we were able to identify new rare missense and frameshift alleles in NEU1 gene. Among the 9 candidate variants tested, only two resulted in significantly lower levels of sialidase activity (p<0.05), namely c.650T>C and c.700G>A. These two mutations give rise to the amino acid substitutions p.V217A and p.D234N, respectively. NEU1 variants including either of these two amino acid changes have 44% and 25% residual sialidase activity when compared to the wild-type enzyme, reduced protein levels and altered subcellular localization. Thus they may represent new, putative pathological mutations resulting in sialidosis type I. The in silico approach used in this study has enabled the identification of previously unknown NEU1 functional alleles that are widespread in the population and could be tested in future functional studies.	[Bonardi, Dario; Bresciani, Roberto; Monti, Eugenio] Univ Brescia, Unit Biotechnol, Dept Mol & Translat Med, Brescia, Lombardy, Italy; [Ravasio, Viola; Borsani, Giuseppe; Giacopuzzi, Edoardo] Univ Brescia, Unit Biol & Genet, Dept Mol & Translat Med, Brescia, Lombardy, Italy; [d'Azzo, Alessandra] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	University of Brescia; University of Brescia; St Jude Children's Research Hospital	Giacopuzzi, E (corresponding author), Univ Brescia, Unit Biol & Genet, Dept Mol & Translat Med, Brescia, Lombardy, Italy.	edoardo.giacopuzzi@unibs.it	Bresciani, Roberto/AAA-9728-2020; Borsani, Giuseppe/B-1709-2010	Bresciani, Roberto/0000-0002-7881-7550; Giacopuzzi, Edoardo/0000-0002-5692-366X; MONTI, Eugenio/0000-0002-4742-7445; Borsani, Giuseppe/0000-0003-0110-1148	"Ministero dell'Istruzione, dell'Universita e della Ricerca'' (MIUR); Regione Lombardia; Network Enable Drug Discovery (NEDD)	"Ministero dell'Istruzione, dell'Universita e della Ricerca'' (MIUR)(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia); Network Enable Drug Discovery (NEDD)	This work was supported by "Ministero dell'Istruzione, dell'Universita e della Ricerca'' (MIUR) funds to GB and EM, and was partly supported by Regione Lombardia (http://www.regione.lombardia.it), and Network Enable Drug Discovery (NEDD) grant to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Annunziata I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3734; Blaise S, 2013, DIABETES, V62, P3807, DOI 10.2337/db13-0508; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2000, HUM MOL GENET, V9, P2715, DOI 10.1093/hmg/9.18.2715; Bonten EJ, 2009, J BIOL CHEM, V284, P28430, DOI 10.1074/jbc.M109.031419; Buschiazzo A, 2008, CURR OPIN CHEM BIOL, V12, P565, DOI 10.1016/j.cbpa.2008.06.017; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; d'Azzo A, 2010, BIOCHEM SOC T, V38, P1453, DOI 10.1042/BST0381453; Dridi L, 2013, DIABETES, V62, P2338, DOI 10.2337/db12-1825; Gayral S, 2014, CARDIOVASC RES, V102, P118, DOI 10.1093/cvr/cvt336; Giacopuzzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044193; Giacopuzzi E, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-45; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LOWDEN JA, 1979, AM J HUM GENET, V31, P1; Lukong KE, 2001, J BIOL CHEM, V276, P17286, DOI 10.1074/jbc.M100460200; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Naganawa Y, 2000, J HUM GENET, V45, P241, DOI 10.1007/s100380070034; Natori Y, 2013, BIOL PHARM BULL, V36, P1027, DOI 10.1248/bpb.b12-00995; Pattison S, 2004, HUM MUTAT, V23, P32, DOI 10.1002/humu.10278; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seyrantepe V, 2003, HUM MUTAT, V22, P343, DOI 10.1002/humu.10268; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; van der Spoel A, 1998, EMBO J, V17, P1588, DOI 10.1093/emboj/17.6.1588; Wang D, 2009, BBA-GEN SUBJECTS, V1790, P275, DOI 10.1016/j.bbagen.2009.01.006; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	33	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104229	10.1371/journal.pone.0104229	http://dx.doi.org/10.1371/journal.pone.0104229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153125	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200016
J	Nilsen, A; Fusser, M; Greggains, G; Fedorcsak, P; Klungland, A				Nilsen, Anja; Fusser, Markus; Greggains, Gareth; Fedorcsak, Peter; Klungland, Arne			ALKBH4 Depletion in Mice Leads to Spermatogenic Defects	PLOS ONE			English	Article							MEIOTIC PROPHASE; SYNAPTONEMAL COMPLEX; ACTIN; MOUSE; RNA; DYNAMICS; DIFFERENTIATION; RECOMBINATION; DEMETHYLATION; TRANSCRIPTION	ALKBH4, an AlkB homologue in the 2-oxoglutarate and Fe2+ dependent hydroxylase family, has previously been shown to regulate the level of monomethylated lysine-84 in actin and thereby indirectly influences the ability of non-muscular myosin II to bind actin filaments. ALKBH4 modulates fundamental processes including cytokinesis and cell motility, and its depletion is lethal during early preimplantation embryo stage. The aim of this study was to investigate the effect of ALKBH4 deficiency in a physiological context, using inducible Alkbh4 knockout mice. Here, we report that ALKBH4 is essential for the development of spermatocytes during the prophase of meiosis, and that ALKBH4 depletion leads to insufficient establishment of the synaptonemal complex. We also show that ALKBH4 is localized in nucleolar structures of Sertoli cells, spermatogonia and primary spermatocytes.	[Nilsen, Anja; Fusser, Markus; Klungland, Arne] Univ Oslo, Oslo Univ Hosp, Inst Med Microbiol, Rikshosp, Oslo, Norway; [Greggains, Gareth; Fedorcsak, Peter] Oslo Univ Hosp, Rikshosp, Sect Reprod Med, Dept Gynecol, Oslo, Norway; [Klungland, Arne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Fedorcsak, P (corresponding author), Oslo Univ Hosp, Rikshosp, Sect Reprod Med, Dept Gynecol, Oslo, Norway.	peter.fedorcsak@medisin.uio.no; arne.klungland@rr-research.no	Klungland, Arne/X-1233-2019	Klungland, Arne/0000-0001-7274-3661; Greggains, Gareth/0000-0003-2424-4694	Norwegian Research Council; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the Norwegian Research Council and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAVIND L, 2001, GENOME BIOL, V2; Bass HW, 2003, CELL MOL LIFE SCI, V60, P2319, DOI 10.1007/s00018-003-3312-4; Bjornstad LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049045; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Farrants AKO, 2008, FEBS LETT, V582, P2041, DOI 10.1016/j.febslet.2008.04.032; FAWCETT DW, 1959, J BIOPHYS BIOCHEM CY, V5, P453, DOI 10.1083/jcb.5.3.453; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Kerr JB, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P827; KIERSZENBAUM AL, 1974, J CELL BIOL, V60, P39, DOI 10.1083/jcb.60.1.39; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Lui DY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003197; MacQueen AJ, 2011, TRENDS CELL BIOL, V21, P393, DOI 10.1016/j.tcb.2011.03.004; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Percipalle P, 2009, CELL MOL LIFE SCI, V66, P2151, DOI 10.1007/s00018-009-0012-8; Qi TY, 2011, J BIOL CHEM, V286, P15171, DOI 10.1074/jbc.M110.184374; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; SCHWARZACHER HG, 1993, ANAT EMBRYOL, V188, P515; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Tres LL, 2005, MOL REPROD DEV, V72, P1, DOI 10.1002/mrd.20334; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Vogl AW, 2009, SERTOLI CELL CYTOSKE, P186; Xiao Xiang, 2007, Journal of Zhejiang University-Science B, V8, P498, DOI 10.1631/jzus.2007.B0498; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	40	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105113	10.1371/journal.pone.0105113	http://dx.doi.org/10.1371/journal.pone.0105113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153837	Green Submitted, gold, Green Published			2022-12-25	WOS:000340952200037
J	Ojha, D; Mukherjee, H; Mondal, S; Jena, A; Dwivedi, VP; Mondal, KC; Malhotra, B; Samanta, A; Chattopadhyay, D				Ojha, Durbadal; Mukherjee, Hemanta; Mondal, Supriya; Jena, Aditya; Dwivedi, Ved Prakash; Mondal, Keshab C.; Malhotra, Bharti; Samanta, Amalesh; Chattopadhyay, Debprasad			Anti-Inflammatory Activity of Odina wodier Roxb, an Indian Folk Remedy, through Inhibition of Toll-Like Receptor 4 Signaling Pathway	PLOS ONE			English	Article							NITRIC-OXIDE; PERMEABILITY; INFLAMMATION; INNATE; FAMILY; TLR4; MICE; LPS	Inflammation is part of self-limiting non-specific immune response, which occurs during bodily injury. In some disorders the inflammatory process becomes continuous, leading to the development of chronic inflammatory diseases including cardiovascular diseases, diabetes, cancer etc. Several Indian tribes used the bark of Odina wodier (OWB) for treating inflammatory disorders. Thus, we have evaluated the immunotherapeutic potential of OWB methanol extract and its major constituent chlorogenic acid (CA), using three popular in vivo antiinflammatory models: Carrageenan-and Dextran-induced paw edema, Cotton pellet granuloma, and Acetic acid-induced vascular permeability. To elucidate the possible antiinflammatory mechanism of action we determine the level of major inflammatory mediators (NO, iNOS, COX-2-dependent prostaglandin E2 or PGE2), and pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6, and IL-12). Further, we determine the toll-like receptor 4 (TLR4), Myeloid differentiation primary response gene 88 (MyD88), c-Jun N-terminal kinases (JNK), nuclear factor kappa-B cells (NF-kappa B), and NF-kappa B inhibitor alpha (IK-B alpha) by protein and mRNA expression, and Western blot analysis in drug treated LPS-induced murine macrophage model. Moreover, we determined the acute and sub-acute toxicity of OWB extract in BALB/c mice. Our study demonstrated a significant anti-inflammatory activity of OWB extract and CA along with the inhibition of TNF-alpha, IL-1 beta, IL-6 and IL-12 expressions. Further, the expression of TLR4, NF-kappa Bp65, MyD88, iNOS and COX-2 molecules were reduced in drug-treated groups, but not in the LPS-stimulated untreated or control groups, Thus, our results collectively indicated that the OWB extract and CA can efficiently inhibit inflammation through the down regulation of TLR4/MyD88/NF-kappa B signaling pathway.	[Ojha, Durbadal; Mukherjee, Hemanta; Mondal, Supriya; Jena, Aditya; Dwivedi, Ved Prakash; Chattopadhyay, Debprasad] ID & BG Hosp, ICMR Virus Unit, Kolkata, India; [Ojha, Durbadal; Samanta, Amalesh] Jadavpur Univ, Dept Pharmaceut Technol, Div Microbiol, Kolkata, India; [Mondal, Keshab C.] Vidyasagar Univ, Dept Microbiol, Midnapore, W Bengal, India; [Malhotra, Bharti] SMS Med Coll & Hosp, Dept Microbiol, Jaipur, Rajasthan, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; Jadavpur University; Vidyasagar University; SMS Medical College & Hospital	Samanta, A (corresponding author), Jadavpur Univ, Dept Pharmaceut Technol, Div Microbiol, Kolkata, India.	asamanta61@yahoo.co.in; debprasadc@yahoo.co.in	; Mondal, Keshab Chandra/B-3538-2019	CHATTOPADHYAY, Dr DEBPRASAD/0000-0002-7999-329X; Mondal, Keshab Chandra/0000-0003-3180-1567; Dwivedi, Ved Prakash/0000-0003-4321-2567				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arunachalam G, 2002, PHYTOMEDICINE, V9, P632, DOI 10.1078/094471102321616445; Bag P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077937; BETZ M, 1991, J IMMUNOL, V146, P108; Biswajit Mukherjee, 2006, Trends in Applied Sciences Research, V1, P309; Brown JN., 2006, GOODMAN GILMANS PHAR, V11, P645; Calixto JB, 2003, PLANTA MED, V69, P973, DOI [10.1055/s-2003-45141, 10.1055/s-2004-815483]; Chagas-Paula DA, 2011, J ETHNOPHARMACOL, V136, P355, DOI 10.1016/j.jep.2011.04.067; Chattopadhyay D, 2002, J ETHNOPHARMACOL, V82, P229, DOI 10.1016/S0378-8741(02)00165-4; Chattopadhyay D., 2012, EVIDENCED BASED COMP, V2012, DOI [10.1155/2012/254849, DOI 10.1155/2012/254849]; Chattopadhyay D, 2008, BIOTECHNOL ANN REV, V14, P297, DOI 10.1016/S1387-2656(08)00012-4; COLDITZ IG, 1985, SURV SYN PATHOL RES, V4, P44; dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Gaddi A, 2004, ARCH GERONTOL GERIAT, V38, P201, DOI 10.1016/j.archger.2003.10.001; Ghosh S, 2013, MED CHEM RES, V22, P4347, DOI 10.1007/s00044-012-0449-4; Griffon B, 1998, HEPATOLOGY, V28, P1300, DOI 10.1002/hep.510280519; Harbrecht BG, 1997, J LEUKOCYTE BIOL, V61, P712, DOI 10.1002/jlb.61.6.712; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Heller A, 1998, DRUGS, V55, P487, DOI 10.2165/00003495-199855040-00001; Imler JL, 2003, NAT IMMUNOL, V4, P105, DOI 10.1038/ni0203-105; Jagavelu K, 2010, HEPATOLOGY, V52, P590, DOI 10.1002/hep.23739; KASAMA T, 1993, J EXP MED, V178, P63, DOI 10.1084/jem.178.1.63; Kirtikar KR, 1999, INDIAN MED PLANTS; KLINGEMANN HG, 1986, BLOOD, V68, P102; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MAROTTA P, 1992, BRIT J PHARMACOL, V107, P640, DOI 10.1111/j.1476-5381.1992.tb14499.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MIZUSHIM.Y, 1965, LANCET, V1, P169; MOTA MLR, 1985, J ETHNOPHARMACOL, V13, P289, DOI 10.1016/0378-8741(85)90074-1; Mukherjee H, 2013, MICROBIOL RES, V168, P238, DOI 10.1016/j.micres.2012.11.002; Muthu C, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-43; Nagy LE, 2003, EXP BIOL MED, V228, P882, DOI 10.1177/153537020322800803; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ojha D, 2013, J APPL MICROBIOL, V115, P1317, DOI 10.1111/jam.12330; REED L. J., 1938, AMER JOUR HYG, V27, P493; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sur TK, 2002, PHYTOTHER RES, V16, P669, DOI 10.1002/ptr.942; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; WHITTLE BA, 1964, BRIT J PHARM CHEMOTH, V22, P246, DOI 10.1111/j.1476-5381.1964.tb02030.x; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; WILLIAMS TJ, 1973, NATURE, V246, P215, DOI 10.1038/246215a0	47	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104939	10.1371/journal.pone.0104939	http://dx.doi.org/10.1371/journal.pone.0104939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153081	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200031
J	Li, WH; Chang, CH; Huang, CW; Wei, CC; Liao, VHC				Li, Wen-Hsuan; Chang, Chun-Han; Huang, Chi-Wei; Wei, Chia-Cheng; Liao, Vivian Hsiu-Chuan			Selenite Enhances Immune Response against Pseudomonas aeruginosa PA14 via SKN-1 in Caenorhabditis elegans	PLOS ONE			English	Article							OXIDATIVE-STRESS-RESPONSE; TRANSCRIPTION FACTOR SKN-1; BIOFILM FORMATION; INNATE IMMUNITY; HUMAN-DISEASE; C. ELEGANS; VIRULENCE; SELENOPROTEINS; INFECTION; TRXR-1	Background: Selenium (Se) is an important nutrient that carries out many biological processes including maintaining optimal immune function. Here, inorganic selenite (Se(IV)) was evaluated for its pathogen resistance and potential-associated factors in Caenorhabditis elegans. The immune effects of Se(IV) were investigated by examining the responses of C. elegans to Pseudomonas aerugonisa PA14 strain. Principal Findings: Se(IV)-treated C. elegans showed increased survival under PA14 infection compared with untreated controls. The significant pathogen resistance of Se(IV) on C. elegans might not be attributed to the effects of Se(IV) on PA14 as Se(IV) showed no effect on bacterial quorum-sensing and virulence factors of PA14. This study showed that Se(IV) enhanced the expression of a gene pivotal for the innate immunity in C. elegans. The study found that the pathogen-resistant phenotypes contributed by Se(IV) was absent from the skn-1 mutant worms. Moreover, Se(IV) influenced the subcellular distribution of SKN-1/Nrf in C. elegans upon PA14 infection. Furthermore, Se(IV) increased mRNA levels of SKN-1 target genes (gst-4 and gcs-1). Conclusions: This study found evidence of Se(IV) protecting C. elegans against P. aeruginosa PA14 infection by exerting effects on the innate immunity of C. elegans that is likely mediated via regulation of a SKN-1-dependent signaling pathway.	[Li, Wen-Hsuan; Chang, Chun-Han; Huang, Chi-Wei; Wei, Chia-Cheng; Liao, Vivian Hsiu-Chuan] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan	National Taiwan University	Liao, VHC (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	vivianliao@ntu.edu.tw		Chang, Chun-Han/0000-0002-1920-1262; Huang, Chi-Wei/0000-0001-9830-144X; Wei, Chia-Cheng/0000-0002-0694-7284; Liao, Vivian/0000-0002-4676-9953	Ministry of Science and Technology of Taiwan [NSC 101-2313-B-002-041-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was financially supported by grant (NSC 101-2313-B-002-041-MY3) from the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw/) to VHCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Arthur JR, 2003, J NUTR, V133, p1457S, DOI 10.1093/jn/133.5.1457S; BAINBRIDGE DR, 1976, IMMUNOLOGY, V30, P135; Beck MA, 2003, J NUTR, V133, p1463S, DOI 10.1093/jn/133.5.1463S; BEHNE D, 1983, J NUTR, V113, P456, DOI 10.1093/jn/113.2.456; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Brown K M, 2001, Public Health Nutr, V4, P593; Campa A, 1999, J ACQ IMMUN DEF SYND, V20, P508, DOI 10.1097/00042560-199904150-00015; Dharmalingam K, 2012, J ETHNOPHARMACOL, V139, P657, DOI 10.1016/j.jep.2011.12.016; DOW JM, 1990, APPL ENVIRON MICROB, V56, P2994, DOI 10.1128/AEM.56.10.2994-2998.1990; Durai S, 2013, J APPL MICROBIOL, V115, P1329, DOI 10.1111/jam.12335; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Ewbank JJ, 2006, SIGNALING IMMUNE RES, P1; Gander S, 1996, J ANTIMICROB CHEMOTH, V37, P1047, DOI 10.1093/jac/37.6.1047; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Hoffmann PR, 2008, MOL NUTR FOOD RES, V52, P1273, DOI 10.1002/mnfr.200700330; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Husain FM, 2013, J BIOSCIENCES, V38, P835, DOI 10.1007/s12038-013-9385-9; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kandasamy S, 2012, MAR DRUGS, V10, P84, DOI 10.3390/md10010084; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; KING EO, 1954, J LAB CLIN MED, V44, P301; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Li W, 2012, MOL CELLS, V34, P209, DOI 10.1007/s10059-012-0155-6; Li WH, 2014, MOL NUTR FOOD RES, V58, P863, DOI 10.1002/mnfr.201300404; Li WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062387; Li WH, 2011, FOOD CHEM TOXICOL, V49, P812, DOI 10.1016/j.fct.2010.12.002; Liu JH, 2013, APPL ENVIRON MICROB, V79, P7343, DOI 10.1128/AEM.01927-13; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Papp D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002673; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Rudrappa T, 2008, J AGR FOOD CHEM, V56, P1955, DOI 10.1021/jf072591j; Sarabhai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053441; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; SPALLHOLZ JE, 1990, ANN NY ACAD SCI, V587, P123, DOI 10.1111/j.1749-6632.1990.tb00140.x; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tan MW, 2011, CELL MICROBIOL, V13, P497, DOI 10.1111/j.1462-5822.2011.01570.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Vunta H, 2008, MOL NUTR FOOD RES, V52, P1316, DOI 10.1002/mnfr.200700346; Wagner Victoria E., 2008, P129; Yu MW, 1999, AM J EPIDEMIOL, V150, P367, DOI 10.1093/oxfordjournals.aje.a010016; Yu SY, 1997, BIOL TRACE ELEM RES, V56, P117, DOI 10.1007/BF02778987	61	5	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105810	10.1371/journal.pone.0105810	http://dx.doi.org/10.1371/journal.pone.0105810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147937	gold, Green Submitted, Green Published			2022-12-25	WOS:000341230600084
J	Lungu, O; Monchi, O; Albouy, G; Jubault, T; Ballarin, E; Burnod, Y; Doyon, J				Lungu, Ovidiu; Monchi, Oury; Albouy, Genevieve; Jubault, Thomas; Ballarin, Emanuelle; Burnod, Yves; Doyon, Julien			Striatal and Hippocampal Involvement in Motor Sequence Chunking Depends on the Learning Strategy	PLOS ONE			English	Article							BASAL GANGLIA; SKILLED PERFORMANCE; MOVEMENT CHUNKING; TIME-COURSE; MEMORY; CONSOLIDATION; ACQUISITION; PLASTICITY; BRAIN; TASK	Motor sequences can be learned using an incremental approach by starting with a few elements and then adding more as training evolves (e.g., learning a piano piece); conversely, one can use a global approach and practice the whole sequence in every training session (e.g., shifting gears in an automobile). Yet, the neural correlates associated with such learning strategies in motor sequence learning remain largely unexplored to date. Here we used functional magnetic resonance imaging to measure the cerebral activity of individuals executing the same 8-element sequence after they completed a 4-days training regimen (2 sessions each day) following either a global or incremental strategy. A network comprised of striatal and fronto-parietal regions was engaged significantly regardless of the learning strategy, whereas the global training regimen led to additional cerebellar and temporal lobe recruitment. Analysis of chunking/grouping of sequence elements revealed a common prefrontal network in both conditions during the chunk initiation phase, whereas execution of chunk cores led to higher mediotemporal activity (involving the hippocampus) after global than incremental training. The novelty of our results relate to the recruitment of mediotemporal regions conditional of the learning strategy. Thus, the present findings may have clinical implications suggesting that the ability of patients with lesions to the medial temporal lobe to learn and consolidate new motor sequences may benefit from using an incremental strategy.	[Lungu, Ovidiu; Monchi, Oury; Albouy, Genevieve; Jubault, Thomas; Doyon, Julien] UNF, Montreal, PQ, Canada; [Lungu, Ovidiu; Monchi, Oury; Albouy, Genevieve; Jubault, Thomas; Doyon, Julien] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Lungu, Ovidiu] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Lungu, Ovidiu] Donald Berman Maimonides Geriatr Ctr, Ctr Res Aging, Montreal, PQ, Canada; [Albouy, Genevieve; Doyon, Julien] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Ballarin, Emanuelle] Univ Lyon 2, Grad Program Neuropsychol, Lyon, France; [Burnod, Yves] Univ Paris 06, INSERM, U678, Paris, France; [Monchi, Oury] Univ Montreal, Dept Radiol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite Lyon 2; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Montreal	Lungu, O (corresponding author), UNF, Montreal, PQ, Canada.	o.lungu@umontreal.ca	Monchi, Oury/N-8417-2019; ALBOUY, Genevieve/K-5350-2015; ALBOUY, Genevieve/P-4723-2019	ALBOUY, Genevieve/0000-0002-5437-023X; ALBOUY, Genevieve/0000-0002-5437-023X; Lungu, Ovidiu/0000-0001-6608-5818	Canadian Institutes of Health Research [MOP86463]; Natural Sciences and Engineering Research Council of Canada [42909-2009, 327518]; Ministere du Developpement economique, de l'Innovation et de l'Exportation (MDEIE) du Quebec, Quebec, QC, Canada; Fondation FYSSEN, France; C.I.H.R. postdoctoral grant	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministere du Developpement economique, de l'Innovation et de l'Exportation (MDEIE) du Quebec, Quebec, QC, Canada; Fondation FYSSEN, France; C.I.H.R. postdoctoral grant(Canadian Institutes of Health Research (CIHR))	The work received the following support: Julien Doyon: Canadian Institutes of Health Research (MOP86463), Natural Sciences and Engineering Research Council of Canada (42909-2009); Ovidiu Lungu: Postdoctoral fellowship from the Ministere du Developpement economique, de l'Innovation et de l'Exportation (MDEIE) du Quebec, Quebec, QC, Canada; Genevieve Albouy: Supported by a Postdoctoral fellowship from the Fondation FYSSEN, France and a C.I.H.R. postdoctoral grant; and Oury Monchi: Natural Sciences and Engineering Research Council of Canada (No 327518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi-Japha E, 2008, J EXP PSYCHOL LEARN, V34, P1544, DOI 10.1037/a0013217; Albouy G., 2012, J SLEEP RES; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052805; Albouy G, 2012, NEUROIMAGE, V60, P324, DOI 10.1016/j.neuroimage.2011.12.049; Bapi RS, 2000, EXP BRAIN RES, V132, P149, DOI 10.1007/s002219900332; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; Barakat M, 2012, SLEEP SPINDLES PREDI; Beldarrain MG, 2008, CLIN NEUROL NEUROSUR, V110, P245, DOI 10.1016/j.clineuro.2007.11.004; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Cameron IGM, 2009, EUR J NEUROSCI, V29, P2413, DOI 10.1111/j.1460-9568.2009.06776.x; Cavaco S, 2004, BRAIN, V127, P1853, DOI 10.1093/brain/awh208; Curran T, 1997, J COGNITIVE NEUROSCI, V9, P522, DOI 10.1162/jocn.1997.9.4.522; Daniel R, 2011, J COGNITIVE NEUROSCI, V23, P1781, DOI 10.1162/jocn.2010.21541; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; DeCoteau WE, 2000, BEHAV NEUROSCI, V114, P1096, DOI 10.1037//0735-7044.114.6.1096; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Donohue SE, 2005, NEUROIMAGE, V26, P1140, DOI 10.1016/j.neuroimage.2005.03.019; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Ergorul C, 2006, J NEUROSCI, V26, P4111, DOI 10.1523/JNEUROSCI.0441-06.2006; Fernandez-Seara MA, 2009, NEUROIMAGE, V47, P1797, DOI 10.1016/j.neuroimage.2009.05.061; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Francois-Brosseau FE, 2009, EUR J NEUROSCI, V29, P1277, DOI 10.1111/j.1460-9568.2009.06671.x; Ganor-Stern D, 2013, ACTA PSYCHOL, V144, P180, DOI 10.1016/j.actpsy.2013.06.001; Gheysen F, 2010, EXP BRAIN RES, V202, P795, DOI 10.1007/s00221-010-2186-6; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Hansen S, 2005, RES Q EXERCISE SPORT, V76, P60; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P1877, DOI 10.1016/j.neuropsychologia.2004.05.008; Jamadar S, 2010, NEUROIMAGE, V51, P432, DOI 10.1016/j.neuroimage.2010.01.090; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Levesque M, 2007, EXP BRAIN RES, V182, P499, DOI 10.1007/s00221-007-1010-4; Ma LS, 2010, BRAIN RES, V1318, P64, DOI 10.1016/j.brainres.2009.12.073; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326; Nee DE, 2009, NEUROIMAGE, V45, P963, DOI 10.1016/j.neuroimage.2009.01.005; Penny W., 2003, HUMAN BRAIN FUNCTION; ROSENBAUM DA, 1983, J EXP PSYCHOL HUMAN, V9, P86, DOI 10.1037/0096-1523.9.1.86; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Souza MJ, 2009, NEUROIMAGE, V46, P299, DOI 10.1016/j.neuroimage.2009.01.046; Spiers HJ, 2001, NEUROCASE, V7, P357, DOI 10.1076/neur.7.5.357.16245; Steele CJ, 2010, J NEUROSCI, V30, P8332, DOI 10.1523/JNEUROSCI.5569-09.2010; Touron DR, 2006, PSYCHON B REV, V13, P781, DOI 10.3758/BF03193997; Tremblay PL, 2010, EXP BRAIN RES, V205, P375, DOI 10.1007/s00221-010-2372-6; Tremblay PL, 2009, BEHAV BRAIN RES, V198, P231, DOI 10.1016/j.bbr.2008.11.002; Tubau E, 2004, PSYCHOL RES-PSYCH FO, V68, P55, DOI 10.1007/s00426-003-0139-4; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038	59	25	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e103885	10.1371/journal.pone.0103885	http://dx.doi.org/10.1371/journal.pone.0103885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LL	25148078	Green Published, gold			2022-12-25	WOS:000341230600008
J	Overeem, KR; Gabriel, PO; Zirpoli, JA; Black, JM				Overeem, Katlin R.; Gabriel, Pia O.; Zirpoli, Jeff A.; Black, Jeffrey M.			Steller Sex: Infidelity and Sexual Selection in a Social Corvid (Cyanocitta stelleri)	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; PLUMAGE COLOR; GENETIC MONOGAMY; PARENTAL CARE; MEXICAN JAY; BODY-SIZE; BLUE TITS; BIRDS; FERTILIZATION; EVOLUTION	Genetic analysis of avian mating systems has revealed that more than 70% of monogamous species show incidence of offspring parentage that does not match the social partner. Extra-pair parentage (EPP) has been linked to a variety of factors, including size and symmetry of ornamental traits, coloration, resource availability, and local conspecific density. We examined how ornamental plumage traits of individual Steller's jays (Cyanocitta stelleri) and territory characteristics influence genetic fidelity of socially monogamous pairs. We used seven highly polymorphic microsatellite markers to assign paternity to 79 offspring, and identified 12 (15.2%) as extra-pair young (EPY). Steller's jays with extra-pair young had significantly lower values of feather brightness and hue, indicating more ultraviolet-blue shifted coloration, and nested in closer proximity to the forest edge than Steller's jays with no detected EPY. Body size, crest height, asymmetry of ornamental crest stripes, as well as vegetative composition of territories and their proximity to supplemental feeders appeared to have little relationship to EPP. These results indicate that extra-pair parentage plays a role in the evolution of secondary sexual characteristics in both sexes, and suggest local density and availability of resources may influence Steller's jay mating dynamics.	[Overeem, Katlin R.; Gabriel, Pia O.; Zirpoli, Jeff A.; Black, Jeffrey M.] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt	Overeem, KR (corresponding author), Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA.	Katlinovereem@yahoo.com			Humboldt State University's [5741]	Humboldt State University's	This work was supported by Humboldt State University's Small Grant (No. 5741), obtained by POG and JAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Anderson D.R., 2008, MODEL BASED INFERENC; Andersson Staffan, 2006, P41; Armenta JK, 2008, J EXP BIOL, V211, P2423, DOI 10.1242/jeb.013094; Arnold KE, 2002, P ROY SOC B-BIOL SCI, V269, P1263, DOI 10.1098/rspb.2002.2013; Balenger S, 2009, BEHAV ECOL SOCIOBIOL, V63, P403, DOI 10.1007/s00265-008-0674-5; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Birkhead T.R., 1996, Oxford Ornithology Series, V6, P323; BIRKHEAD TR, 1995, ANIM BEHAV, V49, P843, DOI 10.1016/0003-3472(95)80217-7; Birkhead TR, 1992, SPERM COMPETITION BI; Bitton PP, 2007, ANIM BEHAV, V74, P1777, DOI 10.1016/j.anbehav.2007.03.018; Black Jeffrey M., 1996, Oxford Ornithology Series, V6, P3; Bouwman KM, 2005, BEHAV ECOL, V16, P499, DOI 10.1093/beheco/ari021; Brand LA, 2001, AUK, V118, P678, DOI 10.1642/0004-8038(2001)118[0678:ROPBTF]2.0.CO;2; BROWN J.L., 1964, INTEGRATION AGONISTI; Burg TM, 2005, MOL ECOL, V14, P3745, DOI 10.1111/j.1365-294X.2005.02710.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Charmantier A, 2004, BEHAV ECOL SOCIOBIOL, V56, P360, DOI 10.1007/s00265-004-0794-5; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Darwin G., 1871, P423; Doucet SM, 2002, CONDOR, V104, P30, DOI 10.1650/0010-5422(2002)104[0030:SPCMBS]2.0.CO;2; Doucet SM, 2004, P ROY SOC B-BIOL SCI, V271, P1663, DOI 10.1098/rspb.2004.2779; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Evans KL, 2010, BIOL REV, V85, P643, DOI 10.1111/j.1469-185X.2010.00121.x; Ferns PN, 2004, ANIM BEHAV, V67, P261, DOI 10.1016/j.anbehav.2003.05.006; Fishman MA, 2002, B MATH BIOL, V64, P809, DOI 10.1006/bulm.2002.0301; Gabriel PO, 2012, AUK, V129, P377, DOI 10.1525/auk.2012.11234; Gabriel PO, 2012, ETHOLOGY, V118, P76, DOI 10.1111/j.1439-0310.2011.01990.x; Gabriel PO, 2010, ANIM BEHAV, V80, P689, DOI 10.1016/j.anbehav.2010.07.004; Gienapp P, 2010, PLOS ONE, V5, P1; Gomez D, 2004, ECOL LETT, V7, P279, DOI 10.1111/j.1461-0248.2004.00584.x; Gowaty Patricia Adair, 1996, Oxford Ornithology Series, V6, P21; Greene E., 1998, BIRDS N AM; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griggio M, 2010, ECOL RES, V25, P77, DOI 10.1007/s11284-009-0632-3; Hausmann F, 2003, P ROY SOC B-BIOL SCI, V270, P61, DOI 10.1098/rspb.2002.2200; Henderson IG, 2000, J AVIAN BIOL, V31, P177, DOI 10.1034/j.1600-048X.2000.310209.x; HOPE S, 1980, AM NAT, V116, P788, DOI 10.1086/283670; Hunt S, 1999, ANIM BEHAV, V58, P809, DOI 10.1006/anbe.1999.1214; Jawor JM, 2004, ANIM BEHAV, V67, P875, DOI 10.1016/j.anbehav.2003.05.015; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Jones IL, 1999, ANIM BEHAV, V57, P521, DOI 10.1006/anbe.1998.1012; Kalinowski RS, 2010, CONDOR, V112, P274, DOI 10.1525/cond.2010.090037; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Keyser AJ, 1999, P ROY SOC B-BIOL SCI, V266, P771, DOI 10.1098/rspb.1999.0704; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Lack D., 1968, pvii; Li SH, 2000, ANIM BEHAV, V60, P867, DOI 10.1006/anbe.2000.1554; Li SH, 1997, MOL ECOL, V6, P499, DOI 10.1046/j.1365-294X.1997.00215.x; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; Moller A.P., 1997, ASYMMETRY DEV STABIL; Moller AP, 1998, AM NAT, V151, P236, DOI 10.1086/286114; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; MOLLER AP, 1992, NATURE, V357, P238, DOI 10.1038/357238a0; Montgomerie, 2008, CLR VERSION 1 05; Montgomerie Robert, 2006, P90; Newton I., 1998, POPULATION LIMITATIO; O'Brien EL, 2011, BEHAV ECOL, V22, P66, DOI 10.1093/beheco/arq167; Ornborg J, 2002, BIOL J LINN SOC, V76, P237, DOI 10.1046/j.1095-8312.2002.00061.x; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; Prum RO, 2006, BIRD COLORATION, V1, P295; Quinn JS, 1999, BEHAV ECOL SOCIOBIOL, V45, P1, DOI 10.1007/s002650050534; Rockwell C, 2012, BEHAV ECOL, V23, P676, DOI 10.1093/beheco/ars015; Saino N, 1997, EVOLUTION, V51, P562, DOI 10.1111/j.1558-5646.1997.tb02443.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shawkey MD, 2006, J EXP BIOL, V209, P1245, DOI 10.1242/jeb.02115; Siefferman L, 2005, J AVIAN BIOL, V36, P428, DOI 10.1111/j.0908-8857.2005.03401.x; Siefferman L, 2008, J ORNITHOL, V149, P357, DOI 10.1007/s10336-008-0289-7; Stenzler LM, 2002, MOL ECOL NOTES, V2, P547, DOI 10.1046/j.1471-8286.2002.00312.x; Thery Marc, 2006, P148; Townsend AK, 2011, BEHAV ECOL, V22, P464, DOI 10.1093/beheco/arq227; Townsend AK, 2009, ANIM BEHAV, V77, P503, DOI 10.1016/j.anbehav.2008.10.030; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; Whittingham LA, 2001, CURR ORNITHOL, V16, P257; Zirpoli JA, 2013, ETHOL ECOL EVOL, V25, P103, DOI 10.1080/03949370.2012.742462	80	3	3	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105257	10.1371/journal.pone.0105257	http://dx.doi.org/10.1371/journal.pone.0105257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148039	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600037
J	Wang, YL; Yan, GQ				Wang, Yiling; Yan, Guiqin			Molecular Phylogeography and Population Genetic Structure of O-longilobus and O-taihangensis (Opisthopappus) on the Taihang Mountains	PLOS ONE			English	Article							2 REFUGE AREAS; CHLOROPLAST DNA PHYLOGEOGRAPHY; EAST-ASIA; TEMPERATE PLANTS; CLIMATIC OSCILLATIONS; SEQUENCE VARIATION; ADJACENT REGIONS; NUCLEAR-DNA; CHINA; DIVERSITY	Historic events such as the uplift of mountains and climatic oscillations in the Quaternary periods greatly affected the evolution and modern distribution of the flora. We sequenced the trnL-trnF, ndhJ-trnL and ITS from populations throughout the known distributions of O. longilobus and O. taihangensis to understand the evolutionary history and the divergence related to the past shifts of habitats in the Taihang Mountains regions. The results showed high genetic diversity and pronounced genetic differentiation among the populations of the two species with a significant phylogeographical pattern (N-ST>G(ST), P<0.05), which imply restricted gene flow among the populations and significant geographical or environmental isolation. Ten chloroplast DNA (cpDNA) and eighteen nucleus ribosome DNA (nrDNA) haplotypes were identified and clustered into two lineages. Two corresponding refuge areas were revealed across the entire distribution ranges of O. longilobus and at least three refuge areas for O. taihangensis. O. longilobus underwent an evolutionary historical process of long-distance dispersal and colonization, whereas O. taihangensis underwent a population expansion before the main uplift of Taihang Mountains. The differentiation time between O. longilobus and O. taihangensis is estimated to have occurred at the early Pleistocene. Physiographic complexity and paleovegetation transition of Taihang Mountains mainly shaped the specific formation and effected the present distribution of these two species. The results therefore support the inference that Quaternary refugial isolation promoted allopatric speciation in Taihang Mountains. This may help to explain the existence of high diversity and endemism of plant species in central/northern China.	[Wang, Yiling; Yan, Guiqin] Shanxi Normal Univ, Coll Life Sci, Linfen, Peoples R China	Shanxi Normal University	Yan, GQ (corresponding author), Shanxi Normal Univ, Coll Life Sci, Linfen, Peoples R China.	guiqiny@dns.sxnu.edu.cn			Natural Science Foundation of Shanxi Normal University [ZR1106]; Natural Science Foundation of Shanxi Province, China [2011011031-2]; High-tech Industrialization project of Shanxi Province, China [20110014]	Natural Science Foundation of Shanxi Normal University; Natural Science Foundation of Shanxi Province, China(Natural Science Foundation of Shanxi Province); High-tech Industrialization project of Shanxi Province, China	The study was financially supported by Natural Science Foundation of Shanxi Normal University (ZR1106), Natural Science Foundation of Shanxi Province, China (2011011031-2) and High-tech Industrialization project of Shanxi Province, China (20110014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Cao MM, 2012, MOL PHYLOGENET EVOL, V65, P823, DOI 10.1016/j.ympev.2012.08.004; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; Chou YW, 2011, J BIOGEOGR, V38, P1992, DOI 10.1111/j.1365-2699.2011.02537.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; Ding B. Z., 1998, FLORA HENANICA; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gong M., 2010, THESIS CHINESE ACAD; Gong W, 2008, MOL PHYLOGENET EVOL, V48, P1094, DOI 10.1016/j.ympev.2008.05.003; GRAUR D, FUNDAMENTALS MOL EVO; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hu X, 2008, THESIS BEIJING FORES; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jia DR, 2011, BIOL J LINN SOC, V102, P37, DOI 10.1111/j.1095-8312.2010.01553.x; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; LIU KB, 1988, QUATERNARY SCI REV, V7, P1, DOI 10.1016/0277-3791(88)90089-3; Liu L, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085920, 10.1371/journal.pone.0088791]; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Meng HH, 2013, MOL PHYLOGENET EVOL, V68, P398, DOI 10.1016/j.ympev.2013.04.012; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qian H, 2001, NATURE, V413, P130, DOI 10.1038/35093169; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; Rambaut A, 2009, TRACER V1 5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian B, 2009, J BIOGEOGR, V36, P2148, DOI 10.1111/j.1365-2699.2009.02157.x; Till-Bottraud I, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P23; Turchetto-Zolet AC, 2012, MOL PHYLOGENET EVOL, V65, P174, DOI 10.1016/j.ympev.2012.06.012; Vijverberg K, 1999, MOL BIOL EVOL, V16, P1329, DOI 10.1093/oxfordjournals.molbev.a026043; Wang F.Z., 1978, FLORA CHINA, P73; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wang YL, 2010, MOL PHYLOGENET EVOL, V55, P721, DOI 10.1016/j.ympev.2010.02.010; Wang YL, 2013, PLANT SYST EVOL, V299, P1849, DOI 10.1007/s00606-013-0840-8; Wang YL, 2013, BIOCHEM SYST ECOL, V49, P115, DOI 10.1016/j.bse.2013.03.014; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu C, 1999, N CHINA EARTHQUAKE S, V17, P1, DOI DOI 10.1007/S11430-012-4516-Y; Wu C.Y., 1995, VEGETATION CHINA; Xie KQ, 2013, BIOCHEM SYST ECOL, V50, P39, DOI 10.1016/j.bse.2013.03.031; Xu JW, 2012, MOL PHYLOGENET EVOL, V64, P118, DOI 10.1016/j.ympev.2012.03.009; YANG XL, 1999, GEOGRAPHY TERRITORIA, V15, P81; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang RY, 2012, MOL PHYLOGENET EVOL, V65, P562, DOI 10.1016/j.ympev.2012.07.011; Zhang YH, 2010, MOL PHYLOGENET EVOL, V57, P1162, DOI 10.1016/j.ympev.2010.08.033; Zhao C, 2013, MOL PHYLOGENET EVOL, V68, P628, DOI 10.1016/j.ympev.2013.04.007; ZHAO SL, 1990, OCEANOL LIMNOL SIN, V8, P289; Zhao YP, 2013, MOL PHYLOGENET EVOL, V68, P300, DOI 10.1016/j.ympev.2013.03.025; Zhou TH, 2010, MOL PHYLOGENET EVOL, V57, P176, DOI 10.1016/j.ympev.2010.07.001; Zhu LM, 2008, THESIS HEBEI U	73	15	15	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104773	10.1371/journal.pone.0104773	http://dx.doi.org/10.1371/journal.pone.0104773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148249	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600021
J	Wei, W; Fan, ZS; Wang, LH; Li, ZW; Jiao, WZ; Li, Y				Wei, Wen; Fan, Zhaoshan; Wang, Lihua; Li, Zhiwei; Jiao, Wanzhen; Li, Yun			Correlation Analysis between Central Corneal Thickness and Intraocular Pressure in Juveniles in Northern China: The Jinan City Eye Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; APPLANATION TONOMETRY; REFRACTIVE ERROR; CHILDREN; SCHOOLCHILDREN; POPULATION; MYOPIA; AGE; PACHYMETRY; CURVATURE	Purpose: To determine the distributions and relation of central corneal thickness (CCT) and intraocular pressure (IOP) by NT-530P in Chinese juveniles, and the effect of gender, age, height, weight and refractive errors on the CTT and IOP. Methods: CCT and IOP of 982 eyes in 514 juveniles aged from 7 to 18 years were measured with NT-530P. Multi-linear regression and ANOVA analysis were used to analyze the relation of CCT and IOP, and the effect of gender, age, height, weight, refractive condition on CCT and IOP respectively. Results: The mean CCT and IOP were 554.19 +/- 35.46 mu m and 15.31 +/- 2.57 mmHg. There were significant correlations between the CCT and IOP values. Linear regression analysis revealed a positive correlation between CCT and IOP (r = 0.44, P<0.05). Linear regression equation: IOP = -2.35+0.032CCT, which means the IOP will increase 0.32 mm Hg for every 10-mu m increase in CCT. The mean of Corrected IOP (CIOP) was 15.32 +/- 2.38 mmHg and had no relation with CCT. There was a negative correlation between refraction degree and CCT (P<0.05), but no correlation between refraction degree and IOP. Multi-linear regression model revealed that the height, weight, age and gender have no effect on the distribution of CCT and IOP respectively. Conclusions: There is a 0.32 mmHg increase in IOP for every 10-mu m increase in CCT. The height, weight, age and gender has no effect on the distribution of CCT and IOP. CCT will become thinner with myopia diopters increases in juveniles. The measurement of CCT is helpful in evaluating the actual IOP correctly.	[Wei, Wen; Fan, Zhaoshan; Wang, Lihua; Li, Zhiwei; Jiao, Wanzhen; Li, Yun] Shandong Univ, Shandong Prov Hosp, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, Y (corresponding author), Shandong Univ, Shandong Prov Hosp, Jinan 250100, Peoples R China.	liyun32008@163.com			shandong provincial technical development project [2012GSP11822]; shandong medical technical development project [2011HZ076]	shandong provincial technical development project; shandong medical technical development project	This research was supported by shandong provincial technical development project (2012GSP11822) and shandong medical technical development project (2011HZ076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mohtaseb ZN, 2013, GRAEF ARCH CLIN EXP, V251, P1855, DOI 10.1007/s00417-013-2280-0; Bradfield YS, 2011, ARCH OPHTHALMOL-CHIC, V129, P1132, DOI 10.1001/archophthalmol.2011.225; Bresson-Dumont H, 2009, J FR OPHTALMOL, V32, P176, DOI 10.1016/j.jfo.2009.03.008; Bron AM, 1999, GRAEF ARCH CLIN EXP, V237, P220, DOI 10.1007/s004170050222; Chang SW, 2001, BRIT J OPHTHALMOL, V85, P916, DOI 10.1136/bjo.85.8.916; Chatterjee A, 1997, OPHTHALMOLOGY, V104, P355, DOI 10.1016/S0161-6420(97)30308-X; Dai E, 2006, J AAPOS, V10, P22, DOI 10.1016/j.jaapos.2005.12.007; DAVID R, 1985, ARCH OPHTHALMOL-CHIC, V103, P1812; Detry-Morel M, 2011, J FR OPHTALMOL, V34, P392, DOI 10.1016/j.jfo.2011.03.009; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Doughty MJ, 2002, OPHTHAL PHYSL OPT, V22, P491, DOI 10.1046/j.1475-1313.2002.00053.x; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P34; Garcia-Resua C, 2013, CLIN EXP OPTOM, V96, P286, DOI 10.1111/j.1444-0938.2012.00818.x; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Haider KM, 2008, J PEDIAT OPHTH STRAB, V45, P227, DOI 10.3928/01913913-20080701-07; Heidary F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025208; Herndon LW, 1997, ARCH OPHTHALMOL-CHIC, V115, P1137, DOI 10.1001/archopht.1997.01100160307007; Hussein MAW, 2004, AM J OPHTHALMOL, V138, P744, DOI 10.1016/j.ajo.2004.06.030; Jorge J, 2013, CLIN OPHTHALMOL, V7, P417, DOI 10.2147/OPTH.S35121; Kniestedt C, 2005, ARCH OPHTHALMOL-CHIC, V123, P1532, DOI 10.1001/archopht.123.11.1532; Krzyzanowska-Berkowska P, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-61; La Rosa FA, 2001, ARCH OPHTHALMOL-CHIC, V119, P23; Lee AJ, 2004, BRIT J OPHTHALMOL, V88, P5, DOI 10.1136/bjo.88.1.5; Lee YG, 2011, OPTOMETRY VISION SCI, V88, P843, DOI 10.1097/OPX.0b013e31821896f1; Lei G, 2008, CHINESE J PRACTICAL, V26, P907; Li J H, 1994, Zhonghua Yan Ke Za Zhi, V30, P445; Liu ZG, 2000, OPHTHALMOLOGY, V107, P105, DOI 10.1016/S0161-6420(99)00027-5; Manny RE, 2011, OPTOMETRY VISION SCI, V88, P1445, DOI 10.1097/OPX.0b013e318230f559; Mastropasqua L, 1992, Eur J Ophthalmol, V2, P33; Muir KW, 2004, OPHTHALMOLOGY, V111, P2220, DOI 10.1016/j.ophtha.2004.06.020; Muller A, 2000, BRIT J OPHTHALMOL, V84, P692, DOI 10.1136/bjo.84.7.692; Nomura H, 2004, OPHTHAL PHYSL OPT, V24, P41, DOI 10.1046/j.1475-1313.2003.00158.x; Osmera J, 2009, Cesk Slov Oftalmol, V65, P19; QUINN GE, 1995, OPHTHALMOLOGY, V102, P180; Sakalar YB, 2012, OPHTHAL EPIDEMIOL, V19, P83, DOI 10.3109/09286586.2011.649227; Sauer A, 2011, J FR OPHTALMOL, V34, P238, DOI 10.1016/j.jfo.2011.01.010; Shisheng Z, 2002, CHINESE J OPTOMETRY, V4, P43; Sihota R, 2006, J PEDIAT OPHTH STRAB, V43, P14, DOI 10.3928/01913913-20060101-01; Tong L, 2004, INVEST OPHTH VIS SCI, V45, P4004, DOI 10.1167/iovs.04-0121; Tuulonen A, 2003, ACTA OPHTHALMOL SCAN, V81, P3, DOI 10.1034/j.1600-0420.2003.00021.x; Wang W-Q, 2005, INT EYE SCI, V5, P93; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592, DOI 10.1016/S0002-9394(14)71455-2; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Yildirim N, 2007, J PEDIAT OPHTH STRAB, V44, P216, DOI 10.3928/01913913-20070701-02; Zheng YF, 2008, CORNEA, V27, P776, DOI 10.1097/ICO.0b013e31816f62d3	45	24	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104842	10.1371/journal.pone.0104842	http://dx.doi.org/10.1371/journal.pone.0104842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148520	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600023
J	Benjamin, R; Banerjee, A; Balakrishnan, K; Sivangala, R; Gaddam, S; Banerjee, S				Benjamin, Ronald; Banerjee, Atoshi; Balakrishnan, Kannan; Sivangala, Ramya; Gaddam, Sumanlatha; Banerjee, Sharmistha			Mycobacterial and HIV Infections Up-Regulated Human Zinc Finger Protein 134, a Novel Positive Regulator of HIV-1 LTR Activity and Viral Propagation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; TRANSCRIPTION FACTORS; DNA-BINDING; IN-VITRO; T-CELLS; PULMONARY TUBERCULOSIS; ALVEOLAR MACROPHAGES; TYPE-1 TRANSCRIPTION; KINASE-C	Background: Concurrent occurrence of HIV and Tuberculosis (TB) infections influence the cellular environment of the host for synergistic existence. An elementary approach to understand such coalition at the molecular level is to understand the interactions of the host and the viral factors that subsequently effect viral replication. Long terminal repeats (LTR) of HIV genome serve as a template for binding trans-acting viral and cellular factors that regulate its transcriptional activity, thereby, deciding the fate of HIV pathogenesis, making it an ideal system to explore the interplay between HIV and the host. Methodology/Principal Findings: In this study, using biotinylated full length HIV-1 LTR sequence as bait followed by MALDI analyses, we identified and further characterized human-Zinc-finger-protein-134 (hZNF-134) as a novel positive regulator of HIV-1 that promoted LTR-driven transcription and viral production. Over-expression of hZNF-134 promoted LTR driven luciferase activity and viral transcripts, resulting in increased virus production while siRNA mediated knockdown reduced both the viral transcripts and the viral titers, establishing hZNF-134 as a positive effector of HIV-1. HIV, Mycobacteria and HIV-TB co-infections increased hZNF-134 expressions in PBMCs, the impact being highest by mycobacteria. Corroborating these observations, primary TB patients (n = 22) recorded extraordinarily high transcript levels of hZNF-134 as compared to healthy controls (n = 16). Conclusions/Significance: With these observations, it was concluded that hZNF-134, which promoted HIV-1 LTR activity acted as a positive regulator of HIV propagation in human host. High titers of hZNF-134 transcripts in TB patients suggest that up-regulation of such positive effectors of HIV-1 upon mycobacterial infection can be yet another mechanism by which mycobacteria assists HIV-1 propagation during HIV-TB co-infections. hZNF-134, an uncharacterized host protein, thus assumes a novel regulatory role during HIV-host interactions. Our study provides new insights into the emerging role of zinc finger proteins in HIV-1 pathogenesis.	[Benjamin, Ronald; Banerjee, Atoshi; Balakrishnan, Kannan; Banerjee, Sharmistha] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Telangana, India; [Sivangala, Ramya; Gaddam, Sumanlatha] AC Guards, Bhagwan Mahavir Med Res Ctr, Dept Immunol, Hyderabad, Telangana, India; [Gaddam, Sumanlatha] Osmania Univ, Dept Genet, Hyderabad 500007, Telangana, India	University of Hyderabad; Osmania University	Banerjee, S (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Telangana, India.	sbsl@uohyd.ernet.in	Babu, Ronald/AAT-6101-2020; Banerjee, Atoshi/AAU-9256-2020; Banerjee, Atoshi/M-6404-2018	Babu, Ronald/0000-0003-2622-9359; Banerjee, Atoshi/0000-0002-3134-1268; Banerjee, Atoshi/0000-0002-3134-1268	Department of Biotechnology (CoE) [BT/PR3260/BRB/10/967/2011]; Department of Science and Technology [DST/INT/Spain/P-26/2011]; CSIR; UGC; DST-FIST; DST-PURSE; DBT-CREBB; XIIth Plan; Department of Biotechnology (IYBA) [BT/PR3260/BRB/10/967/2011]	Department of Biotechnology (CoE); Department of Science and Technology(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India); DST-FIST(Department of Science & Technology (India)); DST-PURSE; DBT-CREBB(Department of Biotechnology (DBT) India); XIIth Plan; Department of Biotechnology (IYBA)	This work was supported by grants from Department of Biotechnology (BT/PR3260/BRB/10/967/2011, CoE and IYBA) and Department of Science and Technology (DST/INT/Spain/P-26/2011) to SB. Funding from CSIR to AB and UGC to RB are acknowledged. The core financial support to the Department and University by DST-FIST, DST-PURSE, DBT-CREBB and XIIth Plan grants are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Anderson EC, 2006, J VIROL, V80, P10478, DOI 10.1128/JVI.02596-05; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Banerjee A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-18; Banerjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072905; Bargonetti J, 1997, CELL MOL BIOL, V43, P935; Benjamin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070250; Bernier R, 1998, J GEN VIROL, V79, P1353, DOI 10.1099/0022-1317-79-6-1353; Bhat KH, 2012, J BIOL CHEM, V287, P16930, DOI 10.1074/jbc.M111.327825; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chen KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034240; Dandekar DH, 2005, ANAL BIOCHEM, V342, P341, DOI 10.1016/j.ab.2005.02.006; Dash PK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-25; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; Dube M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-114; Haedicke J, 2009, P NATL ACAD SCI USA, V106, P14040, DOI 10.1073/pnas.0900502106; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Herchenroder O, 1999, BBA-GENE STRUCT EXPR, V1445, P216, DOI 10.1016/S0167-4781(99)00046-9; HO WZ, 1991, J ACQ IMMUN DEF SYND, V4, P1098; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; Horiba M, 2007, J GEN VIROL, V88, P236, DOI 10.1099/vir.0.82066-0; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Hoshino Y, 2007, J INFECT DIS, V195, P1303, DOI 10.1086/513438; JAKOBOVITS A, 1990, EMBO J, V9, P1165, DOI 10.1002/j.1460-2075.1990.tb08223.x; Jeanson L, 2002, J BIOL CHEM, V277, P4918, DOI 10.1074/jbc.M110830200; Kitaura H, 2001, FEMS IMMUNOL MED MIC, V31, P97, DOI 10.1016/S0928-8244(01)00249-8; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kumar S, 1996, J BIOL CHEM, V271, P30864, DOI 10.1074/jbc.271.48.30451; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lazdins JK, 1997, J EXP MED, V185, P81, DOI 10.1084/jem.185.1.81; LEGRANDPOELS S, 1993, J PHOTOCH PHOTOBIO B, V17, P229, DOI 10.1016/1011-1344(93)80020-A; MAJELLO B, 1994, NUCLEIC ACIDS RES, V22, P4914, DOI 10.1093/nar/22.23.4914; Manavathi B, 2012, J BIOL CHEM, V287, P5600, DOI 10.1074/jbc.M111.289843; MARGOLIS DM, 1994, J VIROL, V68, P905, DOI 10.1128/JVI.68.2.905-910.1994; Millhouse S, 1998, J NEUROVIROL, V4, P312, DOI 10.3109/13550289809114532; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Rabbi MF, 1998, VIROLOGY, V245, P257, DOI 10.1006/viro.1998.9158; Reed-Inderbitzin E, 2003, VIROLOGY, V314, P680, DOI 10.1016/S0042-6822(03)00508-7; Reynolds L, 2003, P NATL ACAD SCI USA, V100, P1615, DOI 10.1073/pnas.252770699; Roesch F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002792; Romanchikova N, 2003, IMMUNOBIOLOGY, V208, P361, DOI 10.1078/0171-2985-00283; Sakkhachornphop S, 2012, HUM GENE THER, V23, P932, DOI 10.1089/hum.2011.124; Santos S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-65; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; STEWART DJ, 1994, INT J RADIAT ONCOL, V28, P531, DOI 10.1016/0360-3016(94)90082-5; Stroud JC, 2009, J MOL BIOL, V393, P98, DOI 10.1016/j.jmb.2009.08.023; Toossi Z, 1997, J ACQ IMMUN DEF SYND, V15, P325, DOI 10.1097/00042560-199708150-00001; Toossi Z, 2004, J LAB CLIN MED, V144, P108, DOI 10.1016/j.lab.2004.05.012; Towatari M, 1998, AIDS, V12, P253, DOI 10.1097/00002030-199803000-00002; Turk G, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-14; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Xiong XF, 2007, BIOCHEM BIOPH RES CO, V358, P29, DOI 10.1016/j.bbrc.2007.04.048; YANG ZY, 1993, NUCLEIC ACIDS RES, V21, P2831, DOI 10.1093/nar/21.12.2831; YOON JB, 1994, MOL CELL BIOL, V14, P1776, DOI 10.1128/MCB.14.3.1776	61	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104908	10.1371/journal.pone.0104908	http://dx.doi.org/10.1371/journal.pone.0104908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144775	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100030
J	Du, ZJ; Wang, L; Zhao, YH; Cao, J; Wang, T; Liu, P; Zhang, YB; Yang, XJ; Cheng, XB; Liu, BL; Lei, DL				Du, Zhaojie; Wang, Lei; Zhao, Yinghua; Cao, Jian; Wang, Tao; Liu, Peng; Zhang, Yabo; Yang, Xinjie; Cheng, Xiaobing; Liu, Baolin; Lei, Delin			Sympathetic Denervation-Induced MSC Mobilization in Distraction Osteogenesis Associates with Inhibition of MSC Migration and Osteogenesis by Norepinephrine/adrb3	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; NERVOUS-SYSTEM; HUMAN OSTEOBLASTS; TENSION-STRESS; RABBIT MODEL; PROLIFERATION; INNERVATION; DIFFERENTIATION; REGENERATION	The sympathetic nervous system regulates bone formation and resorption under physiological conditions. However, it is still unclear how the sympathetic nerves affect stem cell migration and differentiation in bone regeneration. Distraction osteogenesis is an ideal model of bone regeneration due to its special nature as a self-engineering tissue. In this study, a rat model of mandibular distraction osteogenesis with transection of cervical sympathetic trunk was used to demonstrate that sympathetic denervation can deplete norepinephrine (NE) in distraction-induced bone callus, down-regulate beta 3-adrenergic receptor (adrb3) in bone marrow mesenchymal stem cells (MSCs), and promote MSC migration from perivascular regions to bone-forming units. An in vitro Transwell assay was here used to demonstrate that NE can inhibit stroma-derived factor-1 (SDF-1)-induced MSC migration and expression of the migration-related gene matrix metalloproteinase-2 (MMP-2) and downregulate that of the anti-migration gene tissue inhibitor of metalloproteinase-3 (TIMP-3). Knockdown of adrb3 using siRNA abolishes inhibition of MSC migration. An in vitro osteogenic assay was used to show that NE can inhibit the formation of MSC bone nodules and expression of the osteogenic marker genes alkaline phosphatase (ALP), osteocalcin (OCN), and runt-related transcription factor-2 (RUNX2), but knockdown of adrb3 by siRNA can abolish such inhibition of the osteogenic differentiation of MSCs. It is here concluded that sympathetic denervation-induced MSC mobilization in rat mandibular distraction osteogenesis is associated with inhibition of MSC migration and osteogenic differentiation by NE/adrb3 in vitro. These findings may facilitate understanding of the relationship of MSC mobilization and sympathetic nervous system across a wide spectrum of tissue regeneration processes.	[Du, Zhaojie; Wang, Lei; Cao, Jian; Wang, Tao; Liu, Peng; Zhang, Yabo; Yang, Xinjie; Cheng, Xiaobing; Liu, Baolin; Lei, Delin] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Du, Zhaojie] 425 Hosp PLA, Dept Oral & Maxillofacial Surg, Sanya, Peoples R China; [Zhao, Yinghua] Xi An Jiao Tong Univ, Stomatol Hosp, Dept Prosthodont, Xian 710049, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University	Wang, L (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.	wanglzyh@fmmu.edu.cn; leidelin@fmmu.edu.cn			National Natural Science Foundation of China [81270015, 30901685, 81070811]; State Key Laboratory of Military Stomatology, School of Stomatology, the Fourth Military Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Military Stomatology, School of Stomatology, the Fourth Military Medical University	This work was supported by the National Natural Science Foundation of China (No. 81270015 and No. 30901685 to Lei Wang, No. 81070811 to Delin Lei) and an independent grant from State Key Laboratory of Military Stomatology, School of Stomatology, the Fourth Military Medical University (to Delin Lei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet N, 2005, MED SCI SPORT EXER, V37, P1493, DOI 10.1249/01.mss.0000177592.82507.95; Brodal P., 2004, CENTRAL NERVOUS SYST, P369; Castro-Govea Y, 2012, J CRANIOFAC SURG, V23, P392, DOI 10.1097/SCS.0b013e318240fe9b; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; Du ZJ, 2011, BRIT J ORAL MAX SURG, V49, P557, DOI 10.1016/j.bjoms.2011.07.002; DUNCAN CP, 1977, J BONE JOINT SURG BR, V59, P323, DOI 10.1302/0301-620X.59B3.19482; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; Feng X, 2008, BRIT J ORAL MAX SURG, V46, P527, DOI 10.1016/j.bjoms.2008.03.005; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Garcia-Castellano J M, 2000, Iowa Orthop J, V20, P49; Haasper C, 2008, EXP TOXICOL PATHOL, V59, P355, DOI [10.1016/j.etp.2007.11.013, 10.1016/j.etp.2007.11.008]; Han J, 2009, ARCH BIOCHEM BIOPHYS, V490, P96, DOI 10.1016/j.abb.2009.08.009; ILIZAROV GA, 1990, CLIN ORTHOP RELAT R, P8; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kemp KC, 2005, LEUKEMIA LYMPHOMA, V46, P1531, DOI 10.1080/10428190500215076; Kodama D, 2013, BRIT J PHARMACOL, V168, P1230, DOI 10.1111/bph.12000; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; MCCARTHY JG, 1992, PLAST RECONSTR SURG, V89, P1, DOI 10.1097/00006534-199289010-00001; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; MOORE RE, 1993, BONE MINER, V23, P301, DOI 10.1016/S0169-6009(08)80105-5; NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109; Ortakoglu Kerim, 2007, Head Face Med, V3, P7, DOI 10.1186/1746-160X-3-7; Patel NJ, 2010, EUR J PHARMACOL, V633, P1, DOI 10.1016/j.ejphar.2010.01.012; Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200; Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008; Rosa-Ranal M, 2001, REV INVEST CLIN, V53, P362; Sato K, 2010, ORAL SURG ORAL MED O, V110, P32, DOI 10.1016/j.tripleo.2009.11.005; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Smith P, 1998, UROLOGY, V51, P663, DOI 10.1016/S0090-4295(97)00695-X; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Suzuki A, 1998, BONE, V23, P197, DOI 10.1016/S8756-3282(98)00099-4; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tang Y, 1999, J NEUROIMMUNOL, V96, P182, DOI 10.1016/S0165-5728(99)00032-6; Torres KCL, 2005, J NEUROIMMUNOL, V166, P144, DOI 10.1016/j.jneuroim.2005.06.006; Wang L, 2012, J DENT RES, V91, P1003, DOI 10.1177/0022034512460404; Wang L, 2010, BRIT J ORAL MAX SURG, V48, P515, DOI 10.1016/j.bjoms.2009.08.042; Wang L, 2006, J ORTHOP RES, V24, P2238, DOI 10.1002/jor.20269; Wang T, 2012, J CRANIOFAC SURG, V23, P1524, DOI 10.1097/SCS.0b013e31825daab2; Wiley LA, 2005, INVEST OPHTH VIS SCI, V46, P744, DOI 10.1167/iovs.04-1023; Wu YJ, 2012, STEM CELL REV REP, V8, P243, DOI 10.1007/s12015-011-9293-z; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318	46	18	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105976	10.1371/journal.pone.0105976	http://dx.doi.org/10.1371/journal.pone.0105976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144690	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100128
J	Monori-Kiss, A; Monos, E; Nadasy, GL				Monori-Kiss, Anna; Monos, Emil; Nadasy, Gyoergy L.			Quantitative Analysis of Vasodilatory Action of Quercetin on Intramural Coronary Resistance Arteries of the Rat In Vitro	PLOS ONE			English	Article							RED WINE POLYPHENOLS; VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE; FLAVONOID ANTIOXIDANT; BLOOD-PRESSURE; METABOLITES; CONDUCTANCE; RELAXATION; PLASMA; RUTIN	Background: Dietary quercetin improves cardiovascular health, relaxes some vascular smooth muscle and has been demonstrated to serve as a substrate for the cyclooxygenase enzyme. Aims: 1. To test quantitatively a potential direct vasodilatory effect on intramural coronary resistance artery segments, in different concentrations. 2. To scale vasorelaxation at different intraluminal pressure loads on such vessels of different size. 3. To test the potential role of prostanoids in vasodilatation induced by quercetin. Methods: Coronary arterioles (70-240 mu m) were prepared from 24 rats and pressurized in PSS, using a pressure microangiometer. Results: The spontaneous tone that developed at 50 mmHg was relaxed by quercetin in the 10(-9) moles/lit concentration (p<0.05), while 10(-5) moles/lit caused full relaxation. Significant relaxation was observed at all pressure levels (10-100 mmHg) at 10(-7) moles/lit concentration of quercetin. The cyclooxygenase blocker indomethacin (10(-5) moles/lit) induced no relaxation but contraction when physiological concentrations of quercetin were present in the tissue bath (p<0.02 with Anova), this contraction being more prominent in smaller vessels and in the higher pressure range (p<0.05, Pearson correlation). A further 2-8% contraction could be elicited by the NO blocker L-NAME (10(-4) moles/lit). Conclusion: These results demonstrate that circulating levels of quercetin (10(-7) moles/lit) exhibit a substantial coronary vasodilatory effect. The extent of it is commeasurable with that of several other physiological mechanisms of coronary blood flow control. At least part of this relaxation is the result of an altered balance toward the production of endogenous vasodilatory prostanoids in the coronary arteriole wall.	[Monori-Kiss, Anna; Monos, Emil; Nadasy, Gyoergy L.] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary	Semmelweis University	Monori-Kiss, A (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary.	monorikiss.anna@med.semmelweis-univ.hu			Hungarian National grant [OTKA TO 32019]; Hungarian Hypertension Society; Hungarian Kidney Foundation	Hungarian National grant; Hungarian Hypertension Society; Hungarian Kidney Foundation	The study was supported by Hungarian National grant OTKA TO 32019, by the Hungarian Hypertension Society and the Hungarian Kidney Foundation. The Hungarian Ministry of Human Resources assured a PhD stipend for the first author (AM-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fayez M, 2006, CANCER CHEMOTH PHARM, V58, P816, DOI 10.1007/s00280-006-0228-3; Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405; Fusi F, 2003, EUR J NUTR, V42, P10, DOI 10.1007/s00394-003-0395-5; Ibarra M, 2002, PLANTA MED, V68, P307, DOI 10.1055/s-2002-26752; Kim DH, 1998, ARCH PHARM RES, V21, P17, DOI 10.1007/BF03216747; Kurin E, 2012, PLANTA MED, V78, P772, DOI 10.1055/s-0031-1298440; Machha A, 2007, NITRIC OXIDE-BIOL CH, V16, P442, DOI 10.1016/j.niox.2007.04.001; Maciel RM, 2013, RES VET SCI, V95, P389, DOI 10.1016/j.rvsc.2013.04.028; MANACH C, 1995, J NUTR, V125, P1911, DOI 10.1093/jn/125.7.1911; Medina-Remon A, 2011, NUTR METAB CARDIOVAS, V21, P323, DOI 10.1016/j.numecd.2009.10.019; Molina MF, 2003, BIOL PHARM BULL, V26, P1398, DOI 10.1248/bpb.26.1398; Mullen W, 2004, J CHROMATOGR A, V1058, P163, DOI 10.1016/j.chroma.2004.08.117; Nadasy GL, 2001, MICROVASC RES, V61, P282, DOI 10.1006/mvre.2000.2297; Pechanova O, 2004, J HYPERTENS, V22, P1551, DOI 10.1097/01.hjh.0000133734.32125.c7; Perez-Vizcaino F, 2002, J PHARMACOL EXP THER, V302, P66, DOI 10.1124/jpet.302.1.66; Perez-Vizcaino F, 2012, J SCI FOOD AGR, V92, P1822, DOI 10.1002/jsfa.5697; Rendig SV, 1998, FASEB J, V12, pA405; Rendig SV, 2001, J CARDIOVASC PHARM, V38, P219, DOI 10.1097/00005344-200108000-00007; Rezaei-Sadabady R, 2016, ARTIF CELL NANOMED B, V44, P128, DOI 10.3109/21691401.2014.926456; Rusznyak S, 1936, NATURE, V138, P27, DOI 10.1038/138027a0; Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022; Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003; Suri S, 2010, BRIT J PHARMACOL, V159, P566, DOI 10.1111/j.1476-5381.2009.00556.x; Szekacs B, 1996, PROSTAG OTH LIPID M, V52, P221, DOI 10.1016/S0090-6980(96)00099-8; Szekeres M, 2004, J CARDIOVASC PHARM, V43, P242, DOI 10.1097/00005344-200402000-00012; Szekeres M, 2001, J CARDIOVASC PHARM, V38, P584, DOI 10.1097/00005344-200110000-00011; Szekeres M., 2006, ACTA PHYSIOLOGICA HUNGARICA, V93, P1, DOI 10.1556/APhysiol.93.2006.1.1; Taubert D, 2002, J CARDIOVASC PHARM, V40, P701, DOI 10.1097/00005344-200211000-00008; VICKERY HB, 1950, SCIENCE, V112, P628; Wang P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012316; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Xu YC, 2007, PHYTOCHEMISTRY, V68, P1179, DOI 10.1016/j.phytochem.2007.02.013; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7	33	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105587	10.1371/journal.pone.0105587	http://dx.doi.org/10.1371/journal.pone.0105587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144688	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100088
J	Faye, E; Herrera, M; Bellomo, L; Silvain, JF; Dangles, O				Faye, Emile; Herrera, Mario; Bellomo, Lucio; Silvain, Jean-Francois; Dangles, Olivier			Strong Discrepancies between Local Temperature Mapping and Interpolated Climatic Grids in Tropical Mountainous Agricultural Landscapes	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; POTATO TUBERWORM; MICROCLIMATES; PROJECTIONS; CHALLENGES; ECTOTHERMS; MOVEMENT; MINIMUM; TERRAIN; BIOLOGY	Bridging the gap between the predictions of coarse-scale climate models and the fine-scale climatic reality of species is a key issue of climate change biology research. While it is now well known that most organisms do not experience the climatic conditions recorded at weather stations, there is little information on the discrepancies between microclimates and global interpolated temperatures used in species distribution models, and their consequences for organisms' performance. To address this issue, we examined the fine-scale spatiotemporal heterogeneity in air, crop canopy and soil temperatures of agricultural landscapes in the Ecuadorian Andes and compared them to predictions of global interpolated climatic grids. Temperature time-series were measured in air, canopy and soil for 108 localities at three altitudes and analysed using Fourier transform. Discrepancies between local temperatures vs. global interpolated grids and their implications for pest performance were then mapped and analysed using GIS statistical toolbox. Our results showed that global interpolated predictions over-estimate by 77.5 +/- 10% and under-estimate by 82.1 +/- 12% local minimum and maximum air temperatures recorded in the studied grid. Additional modifications of local air temperatures were due to the thermal buffering of plant canopies (from -2.7 degrees K during daytime to 1.3 degrees K during night-time) and soils (from -4.9 degrees K during daytime to 6.7 degrees K during night-time) with a significant effect of crop phenology on the buffer effect. This discrepancies between interpolated and local temperatures strongly affected predictions of the performance of an ectothermic crop pest as interpolated temperatures predicted pest growth rates 2.3-4.3 times lower than those predicted by local temperatures. This study provides quantitative information on the limitation of coarse-scale climate data to capture the reality of the climatic environment experienced by living organisms. In highly heterogeneous region such as tropical mountains, caution should therefore be taken when using global models to infer local-scale biological processes.	[Faye, Emile; Silvain, Jean-Francois; Dangles, Olivier] CNRS, UPR 9034, UR 072, Lab Evolut Genomes & Speciat,IRD, Gif Sur Yvette, France; [Faye, Emile; Silvain, Jean-Francois; Dangles, Olivier] Univ Paris 11, Orsay, France; [Faye, Emile] Univ Paris 04, UPMC Univ Paris06, Paris, France; [Faye, Emile; Herrera, Mario; Dangles, Olivier] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Quito, Ecuador; [Bellomo, Lucio] Univ Toulon & Var, MIO, CNRS INSU, IRD,UM 110, La Garde, France; [Dangles, Olivier] Univ Mayor San Andres, Inst Ecol, La Paz, Bolivia	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Pontificia Universidad Catolica del Ecuador; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon; Universidad Mayor de San Andres	Faye, E (corresponding author), CNRS, UPR 9034, UR 072, Lab Evolut Genomes & Speciat,IRD, Gif Sur Yvette, France.	ehfaye@gmail.com; olivier.dangles@ird.fr	Dangles, Olivier/C-4924-2009	Dangles, Olivier/0000-0002-1987-8433; Herrera Defaz, Mario/0000-0002-4444-2279; Faye, Emile/0000-0001-7764-3256	Agence Nationale pour la Recherche (ANR) [ANR-12-JSV7-0013-01]; McKnight Foundation	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); McKnight Foundation	This work was partly conducted within the project "Adaptive management in insect pest control in thermally heterogeneous agricultural landscapes" (ANR-12-JSV7-0013-01) funded by the Agence Nationale pour la Recherche (ANR, http://www.agence-nationale-recherche.fr/). A financial support of the McKnight Foundation (http://www.mcknight.org/) to EF during the fieldwork of this study is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken GS, 2014, FUNCT ECOL, V28, P96, DOI 10.1111/1365-2435.12149; BALDOCCHI DD, 1983, AGR METEOROL, V28, P321, DOI 10.1016/0002-1571(83)90009-2; Beaumont LJ, 2007, GLOBAL CHANGE BIOL, V13, P1368, DOI 10.1111/j.1365-2486.2007.01357.x; Bennie J, 2013, ECOL LETT, V117, P285; Bloomfield P., 2004, FOURIER ANAL TIME SE; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Cameron PJ, 2002, ENVIRON ENTOMOL, V31, P65, DOI 10.1603/0046-225X-31.1.65; CLOUDSLEYTHOMPS.JL, 1962, ANNU REV ENTOMOL, V7, P199, DOI 10.1146/annurev.en.07.010162.001215; Crespo-Perez V, 2013, B ENTOMOL RES, V103, P336, DOI 10.1017/S0007485312000776; Crespo-Perez V, 2011, LANDSCAPE ECOL, V26, P1447, DOI 10.1007/s10980-011-9649-4; Dangles O, 2008, ECOL APPL, V18, P1795, DOI 10.1890/07-1638.1; Dangles O, 2010, AMBIO, V39, P325, DOI 10.1007/s13280-010-0041-4; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dillon ME, 2012, J THERM BIOL, V37, P631, DOI 10.1016/j.jtherbio.2012.07.004; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fitzpatrick EA, 1964, ARCH METEOR GEOPHY B, V13, P270; Fridley JD, 2009, J APPL METEOROL CLIM, V48, P1033, DOI 10.1175/2008JAMC2084.1; Geiger R., 1965, CLIMATE NEAR GROUND; Gilbert E, 2004, B MATH BIOL, V66, P1821, DOI 10.1016/j.bulm.2004.04.003; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanafi A, 1999, POTATO RES, V42, P373, DOI 10.1007/BF02357863; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jones, 1992, PLANTS MICROCLIMATES; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney MR, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.6; Kearney MR, 2014, METHODS ECOL EVOL, V5, P273, DOI 10.1111/2041-210X.12148; Kinahan AA, 2007, J THERM BIOL, V32, P47, DOI 10.1016/j.jtherbio.2006.09.002; Logan ML, 2013, GLOBAL CHANGE BIOL, V19, P3093, DOI 10.1111/gcb.12253; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; Rondon SI, 2010, AM J POTATO RES, V87, P149, DOI 10.1007/s12230-009-9123-x; Scheffers BR, 2014, GLOBAL CHANGE BIOL, V20, P495, DOI 10.1111/gcb.12439; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Scherrer D, 2010, GLOBAL CHANGE BIOL, V16, P2602, DOI 10.1111/j.1365-2486.2009.02122.x; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; Sears MW, 2011, INTEGR COMP BIOL, V51, P666, DOI 10.1093/icb/icr111; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; TRACY CR, 1977, SCIENCE, V198, P1034, DOI 10.1126/science.929184; Unwin D.M., 1991, INSECTS PLANTS MICRO; Warren RJ, 2013, GLOBAL CHANGE BIOL, V19, P2082, DOI 10.1111/gcb.12169; Wilhelm WW, 2000, CROP SCI, V40, P1179, DOI 10.2135/cropsci2000.4041179x; WILLMER PG, 1982, ADV INSECT PHYSIOL, V16, P1, DOI 10.1016/S0065-2806(08)60151-4	44	25	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105541	10.1371/journal.pone.0105541	http://dx.doi.org/10.1371/journal.pone.0105541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141212	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200096
J	Jahn, K; Hille, C				Jahn, Karolina; Hille, Carsten			Asante Calcium Green and Asante Calcium Red-Novel Calcium Indicators for Two-Photon Fluorescence Lifetime Imaging	PLOS ONE			English	Article							INTRACELLULAR CA2+; SALIVARY-GLANDS; DUCT CELLS; COCKROACH; EXCITATION; MICROSCOPY; DYNAMICS; BINDING; NA+; PH	For a comprehensive understanding of cellular processes and potential dysfunctions therein, an analysis of the ubiquitous intracellular second messenger calcium is of particular interest. This study examined the suitability of the novel Ca2+-sensitive fluorescent dyes Asante Calcium Red (ACR) and Asante Calcium Green (ACG) for two-photon (2P)-excited time-resolved fluorescence measurements. Both dyes displayed sufficient 2P fluorescence excitation in a range of 720-900 nm. In vitro, ACR and ACG exhibited a biexponential fluorescence decay behavior and the two decay time components in the ns-range could be attributed to the Ca2+-free and Ca2+-bound dye species. The amplitude-weighted average fluorescence decay time changed in a Ca2+-dependent way, unraveling in vitro dissociation constants K-D of 114 nM and 15 nM for ACR and ACG, respectively. In the presence of bovine serum albumin, the absorption and steady-state fluorescence behavior of ACR was altered and its biexponential fluorescence decay showed about 5-times longer decay time components indicating dye-protein interactions. Since no ester derivative of ACG was commercially available, only ACR was evaluated for 2P-excited fluorescence lifetime imaging microscopy (2P-FLIM) in living cells of American cockroach salivary glands. In living cells, ACR also exhibited a biexponential fluorescence decay with clearly resolvable short (0.56 ns) and long (2.44 ns) decay time components attributable to the Ca2+-free and Ca2+-bound ACR species. From the amplitude-weighted average fluorescence decay times, an in situ K-D of 180 nM was determined. Thus, quantitative [Ca2+](i) recordings were realized, unraveling a reversible dopamine-induced [Ca2+](i) elevation from 21 nM to 590 nM in salivary duct cells. It was concluded that ACR is a promising new Ca2+ indicator dye for 2P-FLIM recordings applicable in diverse biological systems.	[Jahn, Karolina; Hille, Carsten] Univ Potsdam, Dept Phys Chem ALS ComBi, Potsdam, Germany	University of Potsdam	Hille, C (corresponding author), Univ Potsdam, Dept Phys Chem ALS ComBi, Potsdam, Germany.	hille@uni-potsdam.de		Hille, Carsten/0000-0003-3454-8077	German Research Foundation [1850/30001355]; Federal Ministry of Education and Research [03IPT517Y]; University of Potsdam	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); University of Potsdam	This work was funded by the German Research Foundation (1850/30001355, www.dfg.de), the Federal Ministry of Education and Research (03IPT517Y, www.bmbf.de), and the University of Potsdam (to KJ, www.uni-potsdam.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, TEFL FLUOR ION IND H; BANCEL F, 1992, ANAL BIOCHEM, V204, P231, DOI 10.1016/0003-2697(92)90232-V; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Borst JW, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/10/102002; Chen F, 2003, INT J PHOTOENERGY, V5, P209, DOI 10.1155/S1110662X03000345; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Diaspro A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-36; Dietrich S, 2010, PROC SPIE, V7569, DOI 10.1117/12.849742; Escamilla P. R., 2012, patent, Patent No. [WO 2012040204 A2, 2012040204]; Fery-Forgues S, 1999, J CHEM EDUC, V76, P1260, DOI 10.1021/ed076p1260; Gersbach M, 2009, OPT LETT, V34, P362, DOI 10.1364/OL.34.000362; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARRISON SM, 1989, AM J PHYSIOL, V256, pC1250, DOI 10.1152/ajpcell.1989.256.6.C1250; Haugland R.P., 2005, HDB GUIDE FLUORESCEN; Hegyi P, 2004, PANCREAS, V28, P427, DOI 10.1097/00006676-200405000-00012; Hille C, 2006, CELL CALCIUM, V39, P305, DOI 10.1016/j.ceca.2005.11.006; Hille C, 2008, PHOTOCHEM PHOTOBIOL, V8, P319; Hille C, 2008, J EXP BIOL, V211, P568, DOI 10.1242/jeb.010207; Hirshfield KM, 1996, BIOPHYS CHEM, V62, P25, DOI 10.1016/S0301-4622(96)00027-0; HOVEMADSEN L, 1992, BIOPHYS J, V63, P89, DOI 10.1016/S0006-3495(92)81597-7; Hyrc KL, 2013, CELL CALCIUM, V54, P320, DOI 10.1016/j.ceca.2013.08.001; JUST F, 1994, J MORPHOL, V220, P35, DOI 10.1002/jmor.1052200105; Lahn M, 2011, AM J PHYSIOL-CELL PH, V300, pC1323, DOI 10.1152/ajpcell.00320.2010; Lakowicz J R, 1992, J Fluoresc, V2, P47, DOI 10.1007/BF00866388; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4]; LAKOWICZ JR, 1992, CELL CALCIUM, V13, P131, DOI 10.1016/0143-4160(92)90041-P; LAKOWICZ JR, 1994, CELL CALCIUM, V15, P7, DOI 10.1016/0143-4160(94)90100-7; Lang I, 1999, J EXP BIOL, V202, P729; Ljubojevic S, 2011, BIOPHYS J, V100, P2356, DOI 10.1016/j.bpj.2011.03.060; Makarov NS, 2008, OPT EXPRESS, V16, P4029, DOI 10.1364/OE.16.004029; Makarov NS, 2010, THESIS MONTANA STATE; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Sagolla K, 2013, ANAL BIOANAL CHEM, V405, P8525, DOI 10.1007/s00216-013-7290-6; SNARE MJ, 1982, J PHOTOCHEM, V18, P335, DOI 10.1016/0047-2670(82)87023-8; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; SZMACINSKI H, 1994, TOPICS FLUORESCENCE, V4, P295; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tsien RY, 1999, CALCIUM AS A CELLULAR REGULATOR, P28; Walz B, 2006, ARCH INSECT BIOCHEM, V62, P141, DOI 10.1002/arch.20128; Wilms CD, 2006, CELL CALCIUM, V40, P73, DOI 10.1016/j.ceca.2006.03.006; Wilms CD, 2007, J MICROSC-OXFORD, V225, P209, DOI 10.1111/j.1365-2818.2007.01746.x; Wurth C, 2011, ANAL CHEM, V83, P3431, DOI 10.1021/ac2000303; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Xu T, 2004, J BIOCHEM BIOPH METH, V58, P219, DOI 10.1016/j.jbbm.2003.11.001; Yoshiki K, 2005, OPT REV, V12, P415, DOI 10.1007/s10043-005-0415-1	48	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105334	10.1371/journal.pone.0105334	http://dx.doi.org/10.1371/journal.pone.0105334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140519	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200072
J	Lowe, EC; Wilder, SM; Hochuli, DF				Lowe, Elizabeth C.; Wilder, Shawn M.; Hochuli, Dieter F.			Urbanisation at Multiple Scales Is Associated with Larger Size and Higher Fecundity of an Orb-Weaving Spider	PLOS ONE			English	Article							NEPHILA-PLUMIPES ARANEAE; CARABID BEETLE ASSEMBLAGES; HABITAT FRAGMENTATION; GLOBAL CHANGE; WEB SPIDERS; LAND-USE; URBAN; DIVERSITY; ECOLOGY; BIRD	Urbanisation modifies landscapes at multiple scales, impacting the local climate and changing the extent and quality of natural habitats. These habitat modifications significantly alter species distributions and can result in increased abundance of select species which are able to exploit novel ecosystems. We examined the effect of urbanisation at local and landscape scales on the body size, lipid reserves and ovary weight of Nephila plumipes, an orb weaving spider commonly found in both urban and natural landscapes. Habitat variables at landscape, local and microhabitat scales were integrated to create a series of indexes that quantified the degree of urbanisation at each site. Spider size was negatively associated with vegetation cover at a landscape scale, and positively associated with hard surfaces and anthropogenic disturbance on a local and microhabitat scale. Ovary weight increased in higher socioeconomic areas and was positively associated with hard surfaces and leaf litter at a local scale. The larger size and increased reproductive capacity of N. plumipes in urban areas show that some species benefit from the habitat changes associated with urbanisation. Our results also highlight the importance of incorporating environmental variables from multiple scales when quantifying species responses to landscape modification.	[Lowe, Elizabeth C.; Wilder, Shawn M.; Hochuli, Dieter F.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Lowe, EC (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	Elizabeth.lowe@sydney.edu.au	Hochuli, Dieter/E-5023-2010	Hochuli, Dieter/0000-0002-6673-4475; Lowe, Elizabeth/0000-0003-3792-3178; Wilder, Shawn/0000-0003-0359-7220				ABS (Australian Bureal Statistics), 2011, CENS COMM PROF; Agnarsson I, 2011, NATURWISSENSCHAFTEN, V98, P163, DOI 10.1007/s00114-010-0750-3; Alaruikka D, 2002, J INSECT CONSERV, V6, P195, DOI 10.1023/A:1024432830064; Alvey Alexis A., 2006, Urban Forestry & Urban Greening, V5, P195, DOI 10.1016/j.ufug.2006.09.003; Antonov A, 2003, ORNIS FENNICA, V80, P21; Barbaro L, 2005, ECOSCIENCE, V12, P110, DOI 10.2980/i1195-6860-12-1-110.1; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bolger DT, 2008, DIVERS DISTRIB, V14, P655, DOI 10.1111/j.1472-4642.2008.00470.x; Bolger DT, 2000, ECOL APPL, V10, P1230, DOI 10.1890/1051-0761(2000)010[1230:AIUHFI]2.0.CO;2; Cadenasso ML, 2007, FRONT ECOL ENVIRON, V5, P80, DOI 10.1890/1540-9295(2007)5[80:SHIUER]2.0.CO;2; Christie Fiona J., 2010, Urban Ecosystems, V13, P169, DOI 10.1007/s11252-009-0115-x; Churchill TB, 1999, J INSECT CONSERV, V3, P287, DOI 10.1023/A:1009638706789; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dominoni DM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0593; Dousset B, 2003, ISPRS J PHOTOGRAMM, V58, P43, DOI 10.1016/S0924-2716(03)00016-9; Dugdale JS, 1996, J ROY SOC NEW ZEAL, V26, P251, DOI 10.1080/03014223.1996.9517513; Eisenbeis G, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P243, DOI 10.1017/CBO9780511609763.016; Emery Timothy J., 2004, P124; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Gaublomme E, 2008, BIOL CONSERV, V141, P2585, DOI 10.1016/j.biocon.2008.07.022; Gehrt SD, 2003, ECOL APPL, V13, P939, DOI 10.1890/02-5188; Gering JC, 1999, ECOGRAPHY, V22, P532, DOI 10.1111/j.1600-0587.1999.tb00542.x; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Griffiths BV, 2003, AUST J ZOOL, V51, P119, DOI 10.1071/ZO02048; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grostal P, 1997, OECOLOGIA, V111, P570, DOI 10.1007/s004420050273; Harvey MS, 2007, INVERTEBR SYST, V21, P407, DOI 10.1071/IS05016; Heiling AM, 1999, BEHAV ECOL SOCIOBIOL, V46, P43, DOI 10.1007/s002650050590; HERBERSTEIN ME, 1994, AUST J ECOL, V19, P451, DOI 10.1111/j.1442-9993.1994.tb00511.x; Higgins L, 2011, J ARACHNOL, V39, P399, DOI 10.1636/B11-18.1; Hu Y, 2009, BEHAV ECOL, V20, P1268, DOI 10.1093/beheco/arp131; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Johnson JC, 2012, AM MIDL NAT, V168, P333, DOI 10.1674/0003-0031-168.2.333; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Karlsson B, 2005, P ROY SOC B-BIOL SCI, V272, P1257, DOI 10.1098/rspb.2005.3074; Kasumovic MM, 2009, ECOLOGY, V90, P2287, DOI 10.1890/08-1540.1; Kinzig AP, 2005, ECOL SOC, V10; Koivula M, 1999, ECOGRAPHY, V22, P424, DOI 10.1111/j.1600-0587.1999.tb00579.x; Lassau SA, 2005, DIVERS DISTRIB, V11, P73, DOI 10.1111/j.1366-9516.2005.00124.x; Li DQ, 1996, J THERM BIOL, V21, P245, DOI 10.1016/0306-4565(96)00009-5; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Lo CP, 1997, INT J REMOTE SENS, V18, P287, DOI 10.1080/014311697219079; Magura T, 2010, LANDSCAPE ECOL, V25, P621, DOI 10.1007/s10980-009-9445-6; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; Meineke EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059687; Miyashita T, 1998, BIOL CONSERV, V86, P357, DOI 10.1016/S0006-3207(98)00025-1; MIYASHITA T, 1992, RES POPUL ECOL, V34, P143, DOI 10.1007/BF02513527; Niemela J, 2002, LANDSCAPE ECOL, V17, P387, DOI 10.1023/A:1021270121630; Parris KM, 2005, BIOL CONSERV, V124, P267, DOI 10.1016/j.biocon.2005.01.035; Partecke J, 2004, P ROY SOC B-BIOL SCI, V271, P1995, DOI 10.1098/rspb.2004.2821; Puzin C, 2011, ANIM BIOL, V61, P127, DOI 10.1163/157075511X566461; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schneider JM, 2002, J EVOLUTION BIOL, V15, P84, DOI 10.1046/j.1420-9101.2002.00363.x; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2004, ECOL APPL, V14, P268, DOI 10.1890/02-5341; Sorace A, 2009, LANDSCAPE URBAN PLAN, V90, P111, DOI 10.1016/j.landurbplan.2008.10.019; Trubl P, 2012, URBAN ECOSYST, V15, P599, DOI 10.1007/s11252-011-0223-2; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; UETZ GW, 1979, OECOLOGIA, V40, P29, DOI 10.1007/BF00388808; Wilder SM, 2010, OECOLOGIA, V162, P617, DOI 10.1007/s00442-009-1518-3; Yuan F, 2007, REMOTE SENS ENVIRON, V106, P375, DOI 10.1016/j.rse.2006.09.003	64	43	48	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105480	10.1371/journal.pone.0105480	http://dx.doi.org/10.1371/journal.pone.0105480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140809	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200092
J	Yang, CS; Matsuura, K; Huang, NJ; Robeson, AC; Huang, B; Zhang, L; Kornbluth, S				Yang, C-S; Matsuura, K.; Huang, N-J; Robeson, A. C.; Huang, B.; Zhang, L.; Kornbluth, S.			Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death	ONCOGENE			English	Article							METABOLIC-REGULATION; LIPID-METABOLISM; THERAPEUTIC TARGET; APOPTOSIS; ACTIVATION; MTOR; SUPPRESSOR; HYPOXIA; STRESS; RTP801	Blockade of fatty acid synthase (FASN), a key enzyme involved in de novo lipogenesis, results in robust death of ovarian cancer cells. However, known FASN inhibitors have proven to be poor therapeutic agents due to their ability to induce cachexia. Therefore, we sought to identify additional targets in the pathway linking FASN inhibition and cell death whose modulation might kill ovarian cancer cells without the attendant side effects. Here, we show that the initiator caspase-2 is required for robust death of ovarian cancer cells induced by FASN inhibitors. REDD1 (also known as Rtp801 or DDIT4), a known mTOR inhibitor previously implicated in the response to FASN inhibition, is a novel caspase-2 regulator in this pathway. REDD1 induction is compromised in ovarian cancer cells that do not respond to FASN inhibition. Inhibition of FASN induced an ATF4-dependent transcriptional induction of REDD1; downregulation of REDD1 prevented orlistat-induced activation of caspase-2, as monitored by its cleavage, proteolytic activity and dimerization. Abrogation of REDD1-mediated suppression of mTOR by TSC2 RNAi protected FASN inhibitor-sensitive ovarian cancer cells (OVCA420 cells) from orlistat-induced death. Conversely, suppression of mTOR with the chemical inhibitors PP242 or rapamycin-sensitized DOV13, an ovarian cancer cell line incapable of inducing REDD1, to orlistat-induced cell death through caspase-2. These findings indicate that REDD1 positively controls caspase-2-dependent cell death of ovarian cancer cells by inhibiting mTOR, placing mTOR as a novel upstream regulator of caspase-2 and supporting the possibility of manipulating mTOR to enhance caspase-2 activation in ovarian cancer.	[Yang, C-S; Matsuura, K.; Huang, N-J; Robeson, A. C.; Huang, B.; Zhang, L.; Kornbluth, S.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Kornbluth, S (corresponding author), Duke Univ, Box 90005, Durham, NC 27710 USA.	sally.kornbluth@duke.edu		Matsuura, Kenkyo/0000-0003-4612-6031	 [R01 GM080333]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080333, T32GM007184] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs Susan Murphy and Andrew Berchuck for de-identified human ovarian cancer biopsy samples, and the members of the Kornbluth laboratory for sharing reagents and discussion. This work was supported by R01 GM080333 to SK.	Alo PL, 2000, ONCOL REP, V7, P1383; Andersen JL, 2011, MOL CELL, V43, P834, DOI 10.1016/j.molcel.2011.07.028; Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bouchier-Hayes L, 2010, J CELL MOL MED, V14, P1212, DOI 10.1111/j.1582-4934.2010.01037.x; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Ho TS, 2007, BIOMED PHARMACOTHER, V61, P578, DOI 10.1016/j.biopha.2007.08.020; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang NJ, 2012, J CELL BIOL, V197, P361, DOI [10.1083/jcb.201111141, 10.1083/jcb.201108062]; Jin HO, 2011, ONCOGENE, V30, P3792, DOI 10.1038/onc.2011.102; Knowles LM, 2008, J BIOL CHEM, V283, P31378, DOI 10.1074/jbc.M803384200; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Malagelada C, 2006, J NEUROSCI, V26, P9996, DOI 10.1523/JNEUROSCI.3292-06.2006; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Parsons MJ, 2013, CELL DEATH DIFFER, V20, P1174, DOI 10.1038/cdd.2013.38; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Puccini J, 2013, P NATL ACAD SCI USA, V110, P19920, DOI 10.1073/pnas.1311947110; Pyragius CE, 2013, INT J MOL SCI, V14, P7742, DOI 10.3390/ijms14047742; Rahman MT, 2012, BRIT J CANCER, V107, P300, DOI 10.1038/bjc.2012.246; Ribe EM, 2012, BIOCHEM J, V444, P591, DOI 10.1042/BJ20111588; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Tania M, 2010, CURR ONCOL, V17, P6; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tomek K, 2011, MOL CANCER RES, V9, P1767, DOI 10.1158/1541-7786.MCR-10-0467; Upreti M, 2008, MOL CANCER THER, V7, P2224, DOI 10.1158/1535-7163.MCT-07-2299; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P555, DOI 10.1038/sj.cdd.4402286; Yang CS, 2010, EMBO J, V29, P3196, DOI 10.1038/emboj.2010.191; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439	50	33	36	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3264	3272		10.1038/onc.2014.271	http://dx.doi.org/10.1038/onc.2014.271			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25151963	Green Accepted			2022-12-25	WOS:000356592300005
J	Mori, T; Koyama, N; Segawa, T; Maeda, M; Maruyama, N; Kinoshita, N; Hou, HY; Tan, J; Town, T				Mori, Takashi; Koyama, Naoki; Segawa, Tatsuya; Maeda, Masahiro; Maruyama, Nobuhiro; Kinoshita, Noriaki; Hou, Huayan; Tan, Jun; Town, Terrence			Methylene Blue Modulates beta-Secretase, Reverses Cerebral Amyloidosis, and Improves Cognition in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; A-BETA; MOUSE MODEL; MEMORY DEFICITS; ASPARTYL PROTEASE; TAU-AGGREGATION; BACE1; BRAIN; PRESENILIN-1	Amyloid precursor protein (APP) proteolysis is required for production of amyloid-beta (A beta) peptides that comprise beta-amyloid plaques in the brains of patients with Alzheimer disease (AD). Here, we tested whether the experimental agent methylene blue (MB), used for treatment of methemoglobinemia, might improve AD-like pathology and behavioral deficits. We orally administered MB to the aged transgenic PSAPP mouse model of cerebral amyloidosis and evaluated cognitive function and cerebral amyloid pathology. Beginning at 15 months of age, animals were gavaged with MB (3 mg/kg) or vehicle once daily for 3 months. MB treatment significantly prevented transgene-associated behavioral impairment, including hyperactivity, decreased object recognition, and defective spatial working and reference memory, but it did not alter nontransgenic mouse behavior. Moreover, brain parenchymal and cerebral vascular beta-amyloid deposits as well as levels of various A beta species, including oligomers, were mitigated in MB-treated PSAPP mice. These effects occurred with inhibition of amyloidogenic APP proteolysis. Specifically, beta-carboxyl-terminal APP fragment and beta-site APP cleaving enzyme 1 protein expression and activity were attenuated. Additionally, treatment of Chinese hamster ovary cells overexpressing human wild-type APP with MB significantly decreased A beta production and amyloidogenic APP proteolysis. These results underscore the potential for oral MB treatment against AD-related cerebral amyloidosis by modulating the amyloidogenic pathway.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr, Dept Biomed Sci, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi] Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama 3508550, Japan; Univ Kawagoe, Kawagoe, Saitama 3508550, Japan; [Segawa, Tatsuya; Maeda, Masahiro; Maruyama, Nobuhiro; Kinoshita, Noriaki] Immunobiol Labs Co Ltd, Gunma 3750005, Japan; [Hou, Huayan; Tan, Jun] Univ S Florida, Morsoni Coll Med, Silver Child Dev Ctr, Rashid Lab Dev Neurobiol, Tampa, FL 33613 USA; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Dept Psychiat & Behav Neurosci, Neuroimmunol Lab, Tampa, FL 33613 USA; [Town, Terrence] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA	Saitama Medical University; Saitama Medical University; Immuno-Biological Laboratories Co. Ltd.; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Southern California	Mori, T (corresponding author), Saitama Med Ctr, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	t_mori@saitama-med.ac.jp; ttown@usc.edu			National Institutes of Health from NINDS [1R01NS076794-01]; Japan Society for the Promotion of Science [22500320]; Alzheimer's Association Zenith Fellows Award [ZEN-10-174633]; American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research Grant [M11472]; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alzheimer's Association Zenith Fellows Award(Alzheimer's Association); American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research Grant; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01NS076794-01 from NINDS (to T. T.). This work was also supported by Grant-in-aid for Scientific Research (C) from the Japan Society for the Promotion of Science 22500320 (to T. M.), Alzheimer's Association Zenith Fellows Award ZEN-10-174633 (to T. T.), American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research Grant M11472 (to T. T.), and generous start-up funds from the Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California (to T. T.).	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Alzheimer's Disease International, 2012, OV STIGM DEM WORLD A; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Brookmeyer R, 2000, STAT MED, V19, P1481, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1481::AID-SIM440>3.0.CO;2-U; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Clifton Jack 2nd, 2003, Am J Ther, V10, P289; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deiana S, 2009, PSYCHOPHARMACOLOGY, V202, P53, DOI 10.1007/s00213-008-1394-2; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; DISANTO AR, 1972, J PHARM SCI, V61, P1086, DOI 10.1002/jps.2600610710; Dourson ML, 1996, REGUL TOXICOL PHARM, V24, P108, DOI 10.1006/rtph.1996.0116; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gandhi S, 2004, J MOL NEUROSCI, V24, P137, DOI 10.1385/JMN:24:1:137; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Gura T, 2008, NAT MED, V14, P894, DOI 10.1038/nm0908-894; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harvey BH, 2010, BIOCHEM PHARMACOL, V80, P1580, DOI 10.1016/j.bcp.2010.07.037; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Hosokawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052389; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Klamer D, 2004, BASIC CLIN PHARMACOL, V94, P65, DOI 10.1111/j.1742-7843.2004.pto940203.x; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Laghmouch A, 1997, BEHAV GENET, V27, P67, DOI 10.1023/A:1025667426222; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Mori T, 2006, J PHARMACOL EXP THER, V318, P571, DOI 10.1124/jpet.106.105171; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Muller T, 1998, HISTOL HISTOPATHOL, V13, P1019, DOI 10.14670/HH-13.1019; NARSAPUR SL, 1983, J AFFECT DISORDERS, V5, P155, DOI 10.1016/0165-0327(83)90008-3; NAYLOR GJ, 1986, BIOL PSYCHIAT, V21, P915, DOI 10.1016/0006-3223(86)90265-9; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Nordberg A, 2006, ALZ DIS ASSOC DIS, V20, pS12, DOI 10.1097/01.wad.0000213804.59187.2d; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Paban V, 2014, NEUROPHARMACOLOGY, V76, P68, DOI 10.1016/j.neuropharm.2013.06.033; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Riha PD, 2005, EUR J PHARMACOL, V511, P151, DOI 10.1016/j.ejphar.2005.02.001; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; van Bebber F, 2010, NEUROBIOL DIS, V39, P265, DOI 10.1016/j.nbd.2010.03.023; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walter-Sack I, 2009, EUR J CLIN PHARMACOL, V65, P179, DOI 10.1007/s00228-008-0563-x; Wang H, 2010, J NEUROSCI, V30, P13808, DOI 10.1523/JNEUROSCI.1070-10.2010; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wischik C, 2009, J NUTR HEALTH AGING, V13, P367, DOI 10.1007/s12603-009-0046-5; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	85	34	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30303	30317		10.1074/jbc.M114.568212	http://dx.doi.org/10.1074/jbc.M114.568212			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25157105	hybrid, Green Published			2022-12-25	WOS:000344549700014
J	Ahlgren, KM; Fall, T; Landegren, N; Grimelius, L; von Euler, H; Sundberg, K; Lindblad-Toh, K; Lobell, A; Hedhammar, A; Andersson, G; Hansson-Hamlin, H; Lernmark, A; Kampe, O				Ahlgren, Kerstin M.; Fall, Tove; Landegren, Nils; Grimelius, Lars; von Euler, Henrik; Sundberg, Katarina; Lindblad-Toh, Kerstin; Lobell, Anna; Hedhammar, Ake; Andersson, Goran; Hansson-Hamlin, Helene; Lernmark, Ake; Kampe, Olle			Lack of Evidence for a Role of Islet Autoimmunity in the Aetiology of Canine Diabetes Mellitus	PLOS ONE			English	Article							DOGS; AUTOANTIBODIES	Aims/Hypothesis: Diabetes mellitus is one of the most common endocrine disorders in dogs and is commonly proposed to be of autoimmune origin. Although the clinical presentation of human type 1 diabetes (T1D) and canine diabetes are similar, the aetiologies may differ. The aim of this study was to investigate if autoimmune aetiology resembling human T1D is as prevalent in dogs as previously reported. Methods: Sera from 121 diabetic dogs representing 40 different breeds were tested for islet cell antibodies (ICA) and GAD65 autoantibodies (GADA) and compared with sera from 133 healthy dogs. ICA was detected by indirect immunofluorescence using both canine and human frozen sections. GADA was detected by in vitro transcription and translation (ITT) of human and canine GAD65, followed by immune precipitation. Sections of pancreata from five diabetic dogs and two control dogs were examined histopathologically including immunostaining for insulin, glucagon, somatostatin and pancreas polypeptide. Results: None of the canine sera analysed tested positive for ICA on sections of frozen canine or human ICA pancreas. However, serum from one diabetic dog was weakly positive in the canine GADA assay and serum from one healthy dog was weakly positive in the human GADA assay. Histopathology showed marked degenerative changes in endocrine islets, including vacuolisation and variable loss of immune-staining for insulin. No sign of inflammation was noted. Conclusions/Interpretations: Contrary to previous observations, based on results from tests for humoral autoreactivity towards islet proteins using four different assays, and histopathological examinations, we do not find any support for an islet autoimmune aetiology in canine diabetes mellitus.	[Ahlgren, Kerstin M.; Landegren, Nils; Lobell, Anna; Kampe, Olle] Uppsala Univ, Dept Med Sci, Sci Life Lab, Uppsala, Sweden; [Fall, Tove] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Grimelius, Lars] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [von Euler, Henrik; Hedhammar, Ake; Hansson-Hamlin, Helene] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Sundberg, Katarina; Andersson, Goran] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Broad Inst Harvard & MIT, Cambridge, MA USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Lernmark, Ake] Lund Univ, Dept Clin Sci, Diabet & Celiac Dis Unit, Malmo, Sweden	Uppsala University; Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University; Lund University	Fall, T (corresponding author), Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden.	tove.fall@medsci.uu.se	Andersson, Goran/AAK-6564-2020; Lernmark, Åke/F-8140-2015; Fall, Tove/O-7226-2014; Ronnberg, HENRIK Paul Olof/AAP-9678-2021	Andersson, Goran/0000-0001-5131-3144; Lernmark, Åke/0000-0003-1735-0499; Ronnberg, HENRIK Paul Olof/0000-0001-6098-5364; Hedhammar, Ake/0000-0001-7048-3851; Kampe, Olle/0000-0001-6091-9914; Hamlin, Helene/0000-0002-8015-4688	European Commission (FP7-LUPA) [GA-201370]; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; NovoNordisk Foundation; Agria Djurforsakringar Research Foundation; ESF; Novo Nordisk Fonden [NNF13OC0005975, NNF14OC0011003] Funding Source: researchfish	European Commission (FP7-LUPA)(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; NovoNordisk Foundation(Novo Nordisk Foundation); Agria Djurforsakringar Research Foundation; ESF(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the European Commission (FP7-LUPA, GA-201370), the Swedish Research Council, the Torsten and Ragnar Soderberg Foundation, The NovoNordisk Foundation and Agria Djurforsakringar Research Foundation. KLT is the recipient of EURYI award from the ESF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEJANDRO R, 1988, J AM VET MED ASSOC, V193, P1050; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Catchpole B, 2005, DIABETOLOGIA, V48, P1948, DOI 10.1007/s00125-005-1921-1; Davison LJ, 2008, VET IMMUNOL IMMUNOP, V126, P83, DOI 10.1016/j.vetimm.2008.06.016; Davison LJ, 2011, RES VET SCI, V91, P58, DOI 10.1016/j.rvsc.2010.08.007; EIGENMANN JE, 1983, ACTA ENDOCRINOL-COP, V104, P167, DOI 10.1530/acta.0.1040167; Fall T, 2008, VET REC, V163, P266, DOI 10.1136/vr.163.9.266; Fall T, 2010, J VET INTERN MED, V24, P1322, DOI 10.1111/j.1939-1676.2010.0630.x; Fall T, 2007, J VET INTERN MED, V21, P1209, DOI 10.1892/07-021.1; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gepts W, 1967, Diabetologia, V3, P249, DOI 10.1007/BF01222202; HOENIG M, 1992, VET IMMUNOL IMMUNOP, V32, P195, DOI 10.1016/0165-2427(92)90046-S; IMAMURA T, 1988, DIABETES, V37, P600, DOI 10.2337/diabetes.37.5.600; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; LING GV, 1977, J AM VET MED ASSOC, V170, P521; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Rand JS, 2004, J NUTR, V134, p2072S, DOI 10.1093/jn/134.8.2072S	19	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105473	10.1371/journal.pone.0105473	http://dx.doi.org/10.1371/journal.pone.0105473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153886	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200053
J	de Costa, F; Yendo, ACA; Cibulski, SP; Fleck, JD; Roehe, PM; Spilki, FR; Gosmann, G; Fett-Neto, AG				de Costa, Fernanda; Yendo, Anna Carolina A.; Cibulski, Samuel P.; Fleck, Juliane D.; Roehe, Paulo M.; Spilki, Fernando R.; Gosmann, Grace; Fett-Neto, Arthur G.			Alternative Inactivated Poliovirus Vaccines Adjuvanted with Quillaja brasiliensis or Quil-A Saponins Are Equally Effective in Inducing Specific Immune Responses	PLOS ONE			English	Article							MUCOSAL ADJUVANT; IMMUNOADJUVANT; INDUCTION; TYPE-1; LEAVES; MICE	Inactivated polio vaccines (IPV) have an important role at the final stages of poliomyelitis eradication programs, reducing the risks associated with the use of attenuated polio vaccine (OPV). An affordable option to enhance vaccine immunogenicity and reduce costs of IPV may be the use of an effective and renewable adjuvant. In the present study, the adjuvant activity of aqueous extract (AE) and saponin fraction QB-90 from Quillaja brasiliensis using poliovirus antigen as model were analyzed and compared to a preparation adjuvanted with Quil-A, a well-known saponin-based commercial adjuvant. Experimental vaccines were prepared with viral antigen plus saline (control), Quil-A (50 mu g), AE (400 mu g) or QB-90 (50 mu g). Sera from inoculated mice were collected at days 0, 28, 42 and 56 post-inoculation of the first dose of vaccine. Serum levels of specific IgG, IgG1 and IgG2a were significantly enhanced by AE, QB-90 and Quil-A compared to control group on day 56. The magnitude of enhancement was statistically equivalent for QB-90 and Quil-A. The cellular response was evaluated through DTH and analysis of IFN-gamma and IL-2 mRNA levels using in vitro reestimulated splenocytes. Results indicated that AE and QB-90 were capable of stimulating the generation of Th1 cells against the administered antigen to the same extent as Quil-A. Mucosal immune response was enhanced by the vaccine adjuvanted with QB-90 as demonstrated by increases of specific IgA titers in bile, feces and vaginal washings, yielding comparable or higher titers than Quil-A. The results obtained indicate that saponins from Q. brasiliensis are potent adjuvants of specific cellular and humoral immune responses and represent a viable option to Quil-A.	[de Costa, Fernanda; Yendo, Anna Carolina A.; Fett-Neto, Arthur G.] Fed Univ Rio Grande UFRGS, Ctr Biotechnol, Plant Physiol Lab, Porto Alegre, RS, Brazil; [de Costa, Fernanda; Yendo, Anna Carolina A.; Fett-Neto, Arthur G.] Univ Fed Rio Grande Sul UFRGS, Dept Bot, Porto Alegre, RS, Brazil; [de Costa, Fernanda; Yendo, Anna Carolina A.; Gosmann, Grace] Univ Fed Rio Grande do Sul, Fac Pharm, Porto Alegre, RS, Brazil; [Cibulski, Samuel P.; Roehe, Paulo M.] Inst Vet Res Desiderio Finamor IPVDF, Fepagro Anim Hlth, Eldorado Do Sul, Brazil; [Cibulski, Samuel P.; Roehe, Paulo M.] Univ Fed Rio Grande do Sul, Dept Microbiol, Virol Lab, Porto Alegre, RS, Brazil; [Fleck, Juliane D.; Spilki, Fernando R.] Feevale Univ, Mol Microbiol Lab, Novo Hamburgo, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Feevale	Fett-Neto, AG (corresponding author), Fed Univ Rio Grande UFRGS, Ctr Biotechnol, Plant Physiol Lab, Porto Alegre, RS, Brazil.	fettneto@cbiot.ufrgs.br	Spilki, Fernando/E-3736-2010; Fett-Neto, Arthur G/B-6944-2013; Gosmann, Grace/G-3331-2012; Fleck, Juliane Deise/AAX-3826-2020; ROEHE, PAULO MICHEL/K-1208-2012; Cibulski, Samuel P/G-5190-2017; de Costa, Fernanda/Q-1771-2015; Gosmann, Grace/AAJ-9760-2020	Spilki, Fernando/0000-0001-5804-7045; Fett-Neto, Arthur G/0000-0001-5477-2610; Gosmann, Grace/0000-0001-6823-8312; Fleck, Juliane Deise/0000-0002-3523-3192; ROEHE, PAULO MICHEL/0000-0002-2370-7661; Gosmann, Grace/0000-0001-6823-8312; de Costa, Fernanda/0000-0002-3321-3921; Cibulski, Samuel/0000-0003-0503-8692	Brazilian Agencies National Comission for Improvement of Higher Education Personnel [CGCI 040/2011]; National Council for Scientific and Technological Development [306079/2013-5]	Brazilian Agencies National Comission for Improvement of Higher Education Personnel; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by the Brazilian Agencies National Comission for Improvement of Higher Education Personnel (www.capes.gov.br, Capes-Udelar number CGCI 040/2011) to GG and National Council for Scientific and Technological Development (www.cnpq.br, CNPq number 306079/2013-5) to AGFN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhate G, 2013, INT J PHARMACEUT, V441, P636, DOI 10.1016/j.ijpharm.2012.10.033; Bhutta ZA, 2013, JAMA-J AM MED ASSOC, V310, P905, DOI 10.1001/jama.2013.276583; Boyaka PN, 2001, J IMMUNOL, V166, P2283, DOI 10.4049/jimmunol.166.4.2283; Broere F, 2011, PRINCIPLES IMMUNOPHA, P15, DOI [DOI 10.1007/978-3-0346-0136-8_2, 10.1007/978-3-0346-0136-8_2]; Buisman AM, 2000, J INFECT DIS, V181, P815, DOI 10.1086/315326; de Costa F, 2011, MINI-REV MED CHEM, V11, P857, DOI 10.2174/138955711796575470; de Costa F, 2013, PLANT PHYSIOL BIOCH, V66, P56, DOI 10.1016/j.plaphy.2013.02.003; ELSON CO, 1984, J IMMUNOL, V132, P2736; Fleck JD, 2006, VACCINE, V24, P7129, DOI 10.1016/j.vaccine.2006.06.059; Fleck JD, 2009, IN VITRO CELL DEV-PL, V45, P715, DOI 10.1007/s11627-009-9222-x; Freshney RI, 2010, SUBCULTURE CELL LINE, P187; Grassly NC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0140; Hawken J, 2012, VACCINE, V30, P6971, DOI 10.1016/j.vaccine.2012.09.059; Heinsbroek E, 2010, VACCINE, V28, P3778, DOI 10.1016/j.vaccine.2010.02.095; Hernandez A, 2005, VET IMMUNOL IMMUNOP, V104, P45, DOI 10.1016/j.vetimm.2004.10.006; Kauffmann C, 2004, NAT PROD RES, V18, P153, DOI 10.1080/14786410310001608055; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangal TD, 2013, AM J EPIDEMIOL, V178, P1579, DOI 10.1093/aje/kwt203; Mastelic Beatris, 2010, Biologicals, V38, P594, DOI 10.1016/j.biologicals.2010.06.002; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Reitz R., 1996, FLORA ILUSTRADA CATA; SALK JE, 1960, ANN NY ACAD SCI, V83, P609, DOI 10.1111/j.1749-6632.1960.tb40933.x; San Martin R, 1999, ECON BOT, V53, P302, DOI 10.1007/BF02866642; Sasaki S, 1998, J VIROL, V72, P4931, DOI 10.1128/JVI.72.6.4931-4939.1998; Silveira F, 2011, VACCINE, V29, P9177, DOI 10.1016/j.vaccine.2011.09.137; Spilki FR, 2005, J VIROL METHODS, V129, P191, DOI 10.1016/j.jviromet.2005.06.008; Steil BP, 2014, VACCINE, V32, P558, DOI 10.1016/j.vaccine.2013.11.101; Sun HX, 2009, VACCINE, V27, P1787, DOI 10.1016/j.vaccine.2009.01.091; Yoshino N, 2009, VACCINE, V27, P4808, DOI 10.1016/j.vaccine.2009.05.081	29	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105374	10.1371/journal.pone.0105374	http://dx.doi.org/10.1371/journal.pone.0105374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148077	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600044
J	Ulrich, D; Edwards, SL; Letouzey, V; Su, K; White, JF; Rosamilia, A; Gargett, CE; Werkmeister, JA				Ulrich, Daniela; Edwards, Sharon L.; Letouzey, Vincent; Su, Kai; White, Jacinta F.; Rosamilia, Anna; Gargett, Caroline E.; Werkmeister, Jerome A.			Regional Variation in Tissue Composition and Biomechanical Properties of Postmenopausal Ovine and Human Vagina	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; COLLAGENS; WOMEN; PREVALENCE; ELASTIN	Objective: There are increasing numbers of reports describing human vaginal tissue composition in women with and without pelvic organ prolapse with conflicting results. The aim of this study was to compare ovine and human posterior vaginal tissue in terms of histological and biochemical tissue composition and to assess passive biomechanical properties of ovine vagina to further characterise this animal model for pelvic organ prolapse research. Study Design: Vaginal tissue was collected from ovariectomised sheep (n = 6) and from postmenopausal women (n = 7) from the proximal, middle and distal thirds. Tissue histology was analyzed using Masson's Trichrome staining; total collagen was quantified by hydroxyproline assays, collagen III/I+III ratios by delayed reduction SDS PAGE, glycosaminoglycans by dimethylmethylene blue assay, and elastic tissue associated proteins (ETAP) by amino acid analysis. Young's modulus, maximum stress/strain, and permanent strain following cyclic loading were determined in ovine vagina. Results: Both sheep and human vaginal tissue showed comparable tissue composition. Ovine vaginal tissue showed significantly higher total collagen and glycosaminoglycan values (p<0.05) nearest the cervix. No significant differences were found along the length of the human vagina for collagen, GAG or ETAP content. The proximal region was the stiffest (Young's modulus, p<0.05), strongest (maximum stress, p<0.05) compared to distal region, and most elastic (permanent strain). Conclusion: Sheep tissue composition and mechanical properties showed regional differences along the postmenopausal vaginal wall not apparent in human vagina, although the absolute content of proteins were similar. Knowledge of this baseline variation in the composition and mechanical properties of the vaginal wall will assist future studies using sheep as a model for vaginal surgery.	[Ulrich, Daniela; Letouzey, Vincent; Gargett, Caroline E.] MIMR PHI Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Edwards, Sharon L.; Su, Kai; White, Jacinta F.; Werkmeister, Jerome A.] CSIRO, Mfg Flagship, Clayton, Vic, Australia; [Letouzey, Vincent] Caremeau Univ Hosp, Dept Gynecol & Obstet, Nimes, France; [Ulrich, Daniela; Rosamilia, Anna; Gargett, Caroline E.] Monash Univ, Monash Med Ctr, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia	Prince Henry's Institute of Medical Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universite de Montpellier; CHU de Nimes; Monash University	Werkmeister, JA (corresponding author), CSIRO, Mfg Flagship, Clayton, Vic, Australia.	Jerome.Werkmeister@csiro.au	Gargett, Caroline Eve/I-4895-2019; White, Jacinta F/D-6961-2013; Gold, Daniela/ABE-4818-2020; Gargett, Caroline E/Q-7911-2019	White, Jacinta F/0000-0002-4855-0170; Gold, Daniela/0000-0002-7196-454X; Gargett, Caroline E/0000-0002-3590-2077	National Health and Medical Research Council (NHMRC) of Australia [1021126]; South East Melbourne Alliance for Regenerative Therapies; Australian Gynaecological Endoscopic Society grant; Victorian Government's Operational Infrastructure Support Program;  [1042298]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); South East Melbourne Alliance for Regenerative Therapies; Australian Gynaecological Endoscopic Society grant; Victorian Government's Operational Infrastructure Support Program; 	This study was supported by the National Health and Medical Research Council (NHMRC) of Australia grant (1021126) (CEG, JAW, AR) and Senior Research Fellowship (1042298) (CEG), South East Melbourne Alliance for Regenerative Therapies (CEG, JAW, AR, SE), Australian Gynaecological Endoscopic Society grant (AR) and Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitch SD, 2009, EUR J OBSTET GYN R B, V144, pS146, DOI 10.1016/j.ejogrb.2009.02.022; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; CHAN D, 1984, ANAL BIOCHEM, V139, P322, DOI 10.1016/0003-2697(84)90012-5; CHANDRASEKHAR S, 1987, ANAL BIOCHEM, V161, P103, DOI 10.1016/0003-2697(87)90658-0; Couri Bruna M, 2012, Expert Rev Obstet Gynecol, V7, P249; De Landsheere L, 2013, INT UROGYNECOL J, V24, P2011, DOI 10.1007/s00192-013-2111-1; DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717, DOI 10.1016/0002-9378(92)91562-O; Ennen S, 2011, THERIOGENOLOGY, V75, P212, DOI 10.1016/j.theriogenology.2010.08.007; Gabriel B, 2011, INT UROGYNECOL J, V22, P23, DOI 10.1007/s00192-010-1237-7; Gerhard Meisenberg WHSPD, 2006, PRINCIPLES MED BIOCH; Gyhagen M, 2013, BJOG-INT J OBSTET GY, V120, P152, DOI 10.1111/1471-0528.12020; Jean-Charles C, 2010, INT UROGYNECOL J, V21, P1535, DOI 10.1007/s00192-010-1208-z; Kannan K, 2011, J OBSTET GYNAECOL, V31, P250, DOI 10.3109/01443615.2011.553690; Moalli PA, 2005, OBSTET GYNECOL, V106, P953, DOI 10.1097/01.AOG.0000182584.15087.dd; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4; Rubod C, 2012, J UROLOGY, V79; Rubod C, 2008, INT UROGYNECOL J, V19, P811, DOI 10.1007/s00192-007-0533-3; Rubod C, 2007, J UROLOGY, V178, P320, DOI 10.1016/j.juro.2007.03.040; Skoczylas LC, 2013, REPROD SCI, V20, P382, DOI 10.1177/1933719112472733; SYKES B, 1976, BIOCHEM BIOPH RES CO, V72, P1472, DOI 10.1016/S0006-291X(76)80180-5; Ulrich D, TISSUE ENG, V20, P785; Ulrich D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093172; Ulrich D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050044; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; WOESSNER JF, 1963, BIOCHEM J, V89, P75, DOI 10.1042/bj0890075; Zong WJ, 2010, OBSTET GYNECOL, V115, P953, DOI 10.1097/AOG.0b013e3181da7946	27	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104972	10.1371/journal.pone.0104972	http://dx.doi.org/10.1371/journal.pone.0104972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148261	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600027
J	Wang, HL; Wang, MJ; Tan, H; Li, Y; Zhang, ZD; Song, JN				Wang, Huilin; Wang, Mingjun; Tan, Hao; Li, Yuan; Zhang, Ziding; Song, Jiangning			PredPPCrys: Accurate Prediction of Sequence Cloning, Protein Production, Purification and Crystallization Propensity from Protein Sequences Using Multi-Step Heterogeneous Feature Fusion and Selection	PLOS ONE			English	Article							WEB SERVER; DATABASE; PEPTIDES; FOREST; SITES; SCALE	X-ray crystallography is the primary approach to solve the three-dimensional structure of a protein. However, a major bottleneck of this method is the failure of multi-step experimental procedures to yield diffraction-quality crystals, including sequence cloning, protein material production, purification, crystallization and ultimately, structural determination. Accordingly, prediction of the propensity of a protein to successfully undergo these experimental procedures based on the protein sequence may help narrow down laborious experimental efforts and facilitate target selection. A number of bioinformatics methods based on protein sequence information have been developed for this purpose. However, our knowledge on the important determinants of propensity for a protein sequence to produce high diffraction-quality crystals remains largely incomplete. In practice, most of the existing methods display poorer performance when evaluated on larger and updated datasets. To address this problem, we constructed an up-to-date dataset as the benchmark, and subsequently developed a new approach termed 'PredPPCrys' using the support vector machine (SVM). Using a comprehensive set of multifaceted sequence-derived features in combination with a novel multi-step feature selection strategy, we identified and characterized the relative importance and contribution of each feature type to the prediction performance of five individual experimental steps required for successful crystallization. The resulting optimal candidate features were used as inputs to build the first-level SVM predictor (PredPPCrys I). Next, prediction outputs of PredPPCrys I were used as the input to build second-level SVM classifiers (PredPPCrys II), which led to significantly enhanced prediction performance. Benchmarking experiments indicated that our PredPPCrys method outperforms most existing procedures on both up-to-date and previous datasets. In addition, the predicted crystallization targets of currently non-crystallizable proteins were provided as compendium data, which are anticipated to facilitate target selection and design for the worldwide structural genomics consortium.	[Wang, Huilin; Wang, Mingjun; Li, Yuan; Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China; [Wang, Huilin; Wang, Mingjun; Li, Yuan; Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Tan, Hao; Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Zhang, Ziding] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Song, Jiangning] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3004, Australia	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Monash University; China Agricultural University; Monash University	Zhang, ZD (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	Jiangning.Song@monash.edu; zidingzhang@cau.edu.cn	, zidingzhang/E-9320-2011; Song, Jiangning/F-9787-2010	, zidingzhang/0000-0002-9296-571X; Song, Jiangning/0000-0001-8031-9086	National Natural Science Foundation of China [61202167, 61303169, 31350110507, 11250110508]; National Health and Medical Research Council of Australia (NHMRC) [490989]; Hundred Talents Program of the Chinese Academy of Sciences (CAS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hundred Talents Program of the Chinese Academy of Sciences (CAS)	This work was financially supported by the National Natural Science Foundation of China (61202167, 61303169, 31350110507, 11250110508) and the National Health and Medical Research Council of Australia (NHMRC) (490989). JS is an NHMRC Peter Doherty Fellow and a recipient of the Hundred Talents Program of the Chinese Academy of Sciences (CAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babnigg Gyoergy, 2010, Journal of Structural and Functional Genomics, V11, P71, DOI 10.1007/s10969-010-9080-0; Berman HM, 2009, NUCLEIC ACIDS RES, V37, pD365, DOI 10.1093/nar/gkn790; Bertone P, 2001, NUCLEIC ACIDS RES, V29, P2884, DOI 10.1093/nar/29.13.2884; Burley SK, 2000, NAT STRUCT BIOL, V7, P932, DOI 10.1038/80697; Cai YD, 2008, BIOCHEM BIOPH RES CO, V372, P862, DOI 10.1016/j.bbrc.2008.05.143; Cai YD, 2012, AMINO ACIDS, V42, P1387, DOI 10.1007/s00726-011-0835-0; Chang CCH, 2013, BRIEF BIOINFOR; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Charoenkwan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072368; Chayen NE, 2004, CURR OPIN STRUC BIOL, V14, P577, DOI 10.1016/j.sbi.2004.08.002; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Chen L, 2004, BIOINFORMATICS, V20, P2860, DOI 10.1093/bioinformatics/bth300; Chen Z, 2013, BBA-PROTEINS PROTEOM, V1834, P1461, DOI 10.1016/j.bbapap.2013.04.006; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Creamer TP, 2000, PROTEINS, V40, P443, DOI 10.1002/1097-0134(20000815)40:3<443::AID-PROT100>3.3.CO;2-C; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Ellrott K, 2011, NUCLEIC ACIDS RES, V39, pD494, DOI 10.1093/nar/gkq902; Goh CS, 2004, J MOL BIOL, V336, P115, DOI 10.1016/j.jmb.2003.11.053; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Jahandideh S, 2014, ACTA CRYSTALLOGR D, V70, P627, DOI 10.1107/S1399004713032070; Jahandideh S, 2012, J THEOR BIOL, V306, P115, DOI 10.1016/j.jtbi.2012.04.028; Joachimiak A, 2009, CURR OPIN STRUC BIOL, V19, P573, DOI 10.1016/j.sbi.2009.08.002; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P423, DOI 10.2174/092986610790963726; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Kurgan L, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-50; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu BH, 2007, BIOCHEM BIOPH RES CO, V358, P136, DOI 10.1016/j.bbrc.2007.04.097; Mizianty MJ, 2012, PROTEIN PEPTIDE LETT, V19, P40; Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229; Niu S, 2010, J PROTEOME RES, V9, P6490, DOI 10.1021/pr1007152; Overton IM, 2008, BIOINFORMATICS, V24, P901, DOI 10.1093/bioinformatics/btn055; Overton IM, 2006, FEBS LETT, V580, P4005, DOI 10.1016/j.febslet.2006.06.015; Overton IM, 2011, PROTEINS, V79, P1027, DOI 10.1002/prot.22914; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rucker AL, 2002, PROTEIN SCI, V11, P980, DOI 10.1110/ps.4550102; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Smialowski P, 2006, PROTEINS, V62, P343, DOI 10.1002/prot.20789; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Terwilliger Thomas C., 2011, Journal of Structural and Functional Genomics, V12, P43, DOI 10.1007/s10969-011-9114-2; Wang MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043847; Wang XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026767; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Xia JF, 2010, PROTEIN PEPTIDE LETT, V17, P137, DOI 10.2174/092986610789909403; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203; Zheng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049716; Zheng LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028221; Zhu L, 2010, J COMPUT CHEM, V31, P1478, DOI 10.1002/jcc.21433	56	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105902	10.1371/journal.pone.0105902	http://dx.doi.org/10.1371/journal.pone.0105902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148528	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600095
J	Baron, M; Belo, R; Cathelin, D; Moreira-Teixeira, L; Cartery, C; Rondeau, E; Mesnard, L; Leite-de-Moraes, M				Baron, Marine; Belo, Renata; Cathelin, Dominique; Moreira-Teixeira, Lucia; Cartery, Claire; Rondeau, Eric; Mesnard, Laurent; Leite-de-Moraes, Maria			Innate-Like and Conventional T Cell Populations from Hemodialyzed and Kidney Transplanted Patients Are Equally Compromised	PLOS ONE			English	Article							STAGE RENAL-DISEASE; INVARIANT NKT CELLS; IMMUNITY; DIALYSIS; SUBSETS; DEFECTS; BIOLOGY; MICE	Clinicians are well aware of existing pharmacologically-induced immune deficient status in kidney-transplanted patients that will favor their susceptibility to bacterial or viral infections. Previous studies indicated that advanced Stage 4-5 Chronic Kidney Disease might also be regarded as an immune deficiency-like status as well, even though the mechanisms are not fully understood. Here, we analyzed the ex vivo frequency and the functional properties of both conventional and innate-like T (ILT) lymphocyte subsets in the peripheral blood of 35 patients on hemodialysis, 29 kidney transplanted patients and 38 healthy donors. We found that peripheral blood cell count of ILT cells, as iNKT (invariant Natural Killer T) and MAIT (mucosal-associated invariant T), were significantly decreased in hemodialyzed patients compared to healthy controls. This deficiency was also observed regarding conventional T cells, including the IL-17-producing CD4(+) Th17 cells. Pertaining to regulatory T cells, we also noticed major modifications in the global frequency of CD4(+)CD25(+)Foxp3(+) T lymphocytes, including the resting suppressive CD45RA(+)Foxp3(lo) and activated suppressive CD45RA(-)Foxp3(hi) T cell subpopulations. We found no significant differences between the immune status of hemodialyzed and kidney-transplanted subjects. In conclusion, we demonstrated that both ILT and conventional T cell numbers are equally impaired in hemodialyzed and kidney-transplanted patients.	[Baron, Marine; Belo, Renata; Moreira-Teixeira, Lucia; Leite-de-Moraes, Maria] Univ Paris 05, Hop Necker Enfants Malad, Sorbonne Paris Cite, INEM,CNRS UMR 8253,INSERM UMR 1151, Paris, France; [Cathelin, Dominique; Rondeau, Eric; Mesnard, Laurent] Univ Paris 06, Hop Tenon, AP HP, INSERM UMR S 702, Paris, France; [Cathelin, Dominique; Rondeau, Eric; Mesnard, Laurent] Univ Paris 06, Hop Tenon, AP HP, Paris, France; [Cartery, Claire] Hop Tenon, AP HP, F-75970 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Mesnard, L (corresponding author), Univ Paris 06, Hop Tenon, AP HP, INSERM UMR S 702, Paris, France.	laurent.mesnard@tnn.aphp.fr; maria.leite-de-moraes@parisdescartes.fr	de Moraes, Maria Leite/AAV-9159-2020; Moreira-Teixeira, Lúcia/AAH-4216-2020	de Moraes, Maria Leite/0000-0002-2891-2269; Moreira-Teixeira, Lúcia/0000-0002-4817-8196; baron, marine/0000-0003-0212-8684	CNRS (Centre National de la Recherche Scientifique); Rene Descartes University; INSERM (Institut National de la Sante et de la Recherche Medicale); FRM (Fondation pour la Recherche Medicale); Day Solvay Foundation; FCT (Fundacao para a Ciencia e a Tecnologia)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Rene Descartes University; INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); Day Solvay Foundation(Solvay SA); FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology)	This work was supported by research grants from CNRS (Centre National de la Recherche Scientifique), Rene Descartes University, INSERM (Institut National de la Sante et de la Recherche Medicale), FRM (Fondation pour la Recherche Medicale), Day Solvay Foundation and FCT (Fundacao para a Ciencia e a Tecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Cypowyj S, 2012, EUR J IMMUNOL, V42, P2246, DOI 10.1002/eji.201242605; DEENITCHINA SS, 1995, AM J NEPHROL, V15, P57, DOI 10.1159/000168802; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Jaber BL, 2005, KIDNEY INT, V67, P2508, DOI 10.1111/j.1523-1755.2005.00364.x; Jaber BL, 2001, KIDNEY INT, V59, pS197, DOI 10.1046/j.1523-1755.2001.59780197.x; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim YG, 2012, AM J NEPHROL, V36, P472, DOI 10.1159/000343571; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; LEWIS SL, 1987, AM J KIDNEY DIS, V9, P381, DOI 10.1016/S0272-6386(87)80141-5; Mesnard L, 2009, J AM SOC NEPHROL, V20, P1282, DOI 10.1681/ASN.2008040433; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moreira-Teixeira L, 2012, J IMMUNOL, V188, P624, DOI 10.4049/jimmunol.1102281; Moreira-Teixeira L, 2011, J IMMUNOL, V186, P5758, DOI 10.4049/jimmunol.1003043; Paget C, 2013, MUCOSAL IMMUNOL, V6, P1054, DOI 10.1038/mi.2013.59; Peraldi MN, 2013, BLOOD PURIFICAT, V35, P14, DOI 10.1159/000350839; RASKA K, 1983, AM J MED, V75, P734, DOI 10.1016/0002-9343(83)90401-1; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; VANHOLDER R, 1993, J AM SOC NEPHROL, V3, P1541; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	23	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105422	10.1371/journal.pone.0105422	http://dx.doi.org/10.1371/journal.pone.0105422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144742	gold, Green Submitted, Green Published			2022-12-25	WOS:000341106100068
J	Guo, MZ; Pan, YL; Zhang, R; Cao, Y; Chen, JZ; Pan, YJ				Guo, Mengzhe; Pan, Youlu; Zhang, Rong; Cao, Yang; Chen, Jianzhong; Pan, Yuanjiang			The Specific Cleavage of Lactone Linkage to Open-Loop in Cyclic Lipopeptide during Negative ESI Tandem Mass Spectrometry: The Hydrogen Bond Interaction Effect of 4-Ethyl Guaiacol	PLOS ONE			English	Article							COLLISION-INDUCED DISSOCIATION; ASPARTIC-ACID; POSTTRANSLATIONAL MODIFICATIONS; DEPROTONATED PEPTIDES; GLUTAMIC-ACID; FRAGMENTATION; SURFACTIN; DISULFIDES; LICHENYSIN; IONS	Mass spectrometry is a valuable tool for the analysis and identification of chemical compounds, particularly proteins and peptides. Lichenysins G, the major cyclic lipopeptide of lichenysin, and the non-covalent complex of lichenysins G and 4-ethylguaiacol were investigated with negative ion ESI tandem mass spectrometry. The different fragmentation mechanisms for these compounds were investigated. Our study shows the 4-ethylguaiacol hydrogen bond with the carbonyl oxygen of the ester group in the loop of lichenysins G. With the help of this hydrogen bond interaction, the ring structure preferentially opens in lactone linkage rather than O-C bond of the ester-group to produce alcohol and ketene. Isothermal titration H-1-NMR analysis verified the hydrogen bond and determined the proportion of subject and ligand in the non-covalent complex to be 1:1. Theoretical calculations also suggest that the addition of the ligand can affect the energy of the transition structures (TS) during loop opening.	[Guo, Mengzhe; Pan, Yuanjiang] Zhejiang Univ, Dept Chem, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Youlu; Cao, Yang; Chen, Jianzhong] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Rong] Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China	Zhejiang University; Zhejiang University; Jiangnan University	Pan, YJ (corresponding author), Zhejiang Univ, Dept Chem, Hangzhou 310003, Zhejiang, Peoples R China.	panyuanjiang@zju.edu.cn			Natural Science Foundation of China [21025207]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by contact/grant sponsor: Natural Science Foundation of China Contact/grant number: 21025207, the URL: http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreazza HJ, 2009, RAPID COMMUN MASS SP, V23, P1825, DOI 10.1002/rcm.4081; Benjamin M, 2012, J AM SOC MASS SPECTR, V23, P460; Bilusich D, 2009, MASS SPECTROM REV, V28, P20, DOI 10.1002/mas.20206; Boernsen KO, 2007, J MASS SPECTROM, V42, P793, DOI 10.1002/jms.1215; Chai YF, 2012, ORG BIOMOL CHEM, V10, P791, DOI 10.1039/c1ob06020a; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Graeme C, 2012, ANAL CHEM, V84, P2875; Grangemard I, 1999, J ANTIBIOT, V52, P363, DOI 10.7164/antibiotics.52.363; Grangemard I, 2001, APPL BIOCHEM BIOTECH, V90, P199, DOI 10.1385/ABAB:90:3:199; Grau A, 1999, BBA-BIOMEMBRANES, V1418, P307, DOI 10.1016/S0005-2736(99)00039-5; Guo C, 2013, J AM SOC MASS SPECTR, V24, P381, DOI 10.1007/s13361-012-0561-1; Guo C, 2012, ORG BIOMOL CHEM, V10, P7070, DOI 10.1039/c2ob26011e; Harrison AG, 2004, J AM SOC MASS SPECTR, V15, P446, DOI 10.1016/j.jasms.2003.11.018; Harrison AG, 2004, J MASS SPECTROM, V39, P136, DOI 10.1002/jms.515; Harrison AG, 2006, INT J MASS SPECTROM, V255, P111, DOI 10.1016/j.ijms.2005.12.037; LEECK DT, 1994, J AM CHEM SOC, V116, P3028, DOI 10.1021/ja00086a036; Li Z, 2006, J MASS SPECTROM, V41, P939, DOI 10.1002/jms.1053; Madslien EH, 2013, J APPL MICROBIOL, V115, P1068, DOI 10.1111/jam.12299; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P599, DOI 10.1016/1044-0305(92)85001-Z; Men LJ, 2006, RAPID COMMUN MASS SP, V20, P777, DOI 10.1002/rcm.2374; Mor A, 2000, DRUG DEVELOP RES, V50, P440, DOI 10.1002/1098-2299(200007/08)50:3/4<440::AID-DDR27>3.3.CO;2-W; Niessen WMA, 2012, MASS SPECTROM REV, V31, P626, DOI 10.1002/mas.20359; Pathak KV, 2012, J AM SOC MASS SPECTR, V23, P1716, DOI 10.1007/s13361-012-0437-4; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; Pu D, 2008, RAPID COMMUN MASS SP, V22, P91, DOI 10.1002/rcm.3337; Rumachik NG, 2012, J AM SOC MASS SPECTR, V23, P718, DOI 10.1007/s13361-011-0331-5; Samantha S, 2012, J AM SOC MASS SPECTR, V23, P1544; Samgina TY, 2013, J AM SOC MASS SPECTR, V24, P1037, DOI 10.1007/s13361-013-0632-y; Thakur SS, 2009, J AM SOC MASS SPECTR, V20, P2221, DOI 10.1016/j.jasms.2009.08.010; Thakur SS, 2009, J AM SOC MASS SPECTR, V20, P783, DOI 10.1016/j.jasms.2008.12.019; Tilvi S, 2007, J MASS SPECTROM, V42, P70, DOI 10.1002/jms.1140; Vrkic AK, 2004, J AM SOC MASS SPECTR, V15, P715, DOI 10.1016/j.jasms.2004.01.008; Xie TZ, 2012, ANGEW CHEM INT EDIT, V51, P1177, DOI 10.1002/anie.201106504; Zhang MX, 2006, ANAL CHEM, V78, P4820, DOI 10.1021/ac060132w	34	5	5	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104835	10.1371/journal.pone.0104835	http://dx.doi.org/10.1371/journal.pone.0104835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144459	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100025
J	Lee, CY; Liu, YL; Lin, CL; Liu, GY; Hung, HC				Lee, Chien-Yun; Liu, Yi-Liang; Lin, Chih-Li; Liu, Guang-Yaw; Hung, Hui-Chih			Functional Roles of the Dimer-Interface Residues in Human Ornithine Decarboxylase	PLOS ONE			English	Article							METHOTREXATE-INDUCED APOPTOSIS; SIZE-DISTRIBUTION ANALYSIS; ANALYTICAL ULTRACENTRIFUGATION; ANTIZYME INHIBITOR; ACTIVE-SITE; POLYAMINE METABOLISM; ANGSTROM RESOLUTION; SUBSTRATE-BINDING; PROTEIN; DEGRADATION	Ornithine decarboxylase (ODC) catalyzes the decarboxylation of ornithine to putrescine and is the rate-limiting enzyme in the polyamine biosynthesis pathway. ODC is a dimeric enzyme, and the active sites of this enzyme reside at the dimer interface. Once the enzyme dissociates, the enzyme activity is lost. In this paper, we investigated the roles of amino acid residues at the dimer interface regarding the dimerization, protein stability and/or enzyme activity of ODC. A multiple sequence alignment of ODC and its homologous protein antizyme inhibitor revealed that 5 of 9 residues (residues 165, 277, 331, 332 and 389) are divergent, whereas 4 (134, 169, 294 and 322) are conserved. Analytical ultracentrifugation analysis suggested that some dimer-interface amino acid residues contribute to formation of the dimer of ODC and that this dimerization results from the cooperativity of these interface residues. The quaternary structure of the sextuple mutant Y331S/Y389D/R277S/D332E/V322D/D134A was changed to a monomer rather than a dimer, and the K-d value of the mutant was 52.8 mu M, which is over 500-fold greater than that of the wild-type ODC (ODC_WT). In addition, most interface mutants showed low but detectable or negligible enzyme activity. Therefore, the protein stability of these interface mutants was measured by differential scanning calorimetry. These results indicate that these dimer-interface residues are important for dimer formation and, as a consequence, are critical for enzyme catalysis.	[Lee, Chien-Yun; Liu, Yi-Liang; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lee, Chien-Yun] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lee, Chien-Yun] Acad Sinica, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei 115, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ & Hosp, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ & Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lin, Chih-Li] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Hung, Hui-Chih] NCHU, ABC, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; National Chung Hsing University; National Chung Hsing University	Liu, GY (corresponding author), Chung Shan Med Univ & Hosp, Inst Microbiol & Immunol, Taichung, Taiwan.	liugy@csmu.edu.tw; hchung@dragon.nchu.edu.tw	Lin, Chih-Li/H-9515-2019; Lin, Chih-Li/GQZ-6480-2022; Hung, Hui-Chih/L-8061-2019; Hung, Hui-Chih/G-4485-2013	Lin, Chih-Li/0000-0003-4553-3727; Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	Ministry of Science and Technology, ROC [NSC 102-2321-B-005-008]; Ministry of Education, Taiwan, R.O.C. under the ATU plan	Ministry of Science and Technology, ROC; Ministry of Education, Taiwan, R.O.C. under the ATU plan(Ministry of Education, Taiwan)	This work was supported by the Ministry of Science and Technology (http://web1.most.gov.tw/), ROC (NSC 102-2321-B-005-008 to HCH) and in part by the Ministry of Education, Taiwan, R.O.C. under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; COLEMAN CS, 1994, J BIOL CHEM, V269, P3155; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Furumitsu Y, 2000, J RHEUMATOL, V27, P1352; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; HAYASHI S, 1984, ADV ENZYME REGUL, V23, P311, DOI 10.1016/0065-2571(85)90054-8; Hsieh JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024366; Hsu HC, 1999, AUTOIMMUNITY, V29, P299, DOI 10.3109/08916939908994750; Hsu PC, 2006, APOPTOSIS, V11, P389, DOI 10.1007/s10495-006-4002-0; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Liu GY, 2005, APOPTOSIS, V10, P569, DOI 10.1007/s10495-005-1891-2; Liu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026835; Liu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019253; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Medina MA, 1999, BIOCHEM PHARMACOL, V57, P1341, DOI 10.1016/S0006-2952(99)00005-2; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; Morrison LD, 1998, J NEUROCHEM, V71, P288; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Myers DP, 2001, BIOCHEMISTRY-US, V40, P13230, DOI 10.1021/bi0155908; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; OBrien TG, 1997, CANCER RES, V57, P2630; Osterman AL, 1997, BIOCHEMISTRY-US, V36, P4558, DOI 10.1021/bi962916h; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Park JK, 2002, MOL PHARMACOL, V62, P1400, DOI 10.1124/mol.62.6.1400; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Schluter KD, 2000, CARDIOVASC RES, V45, P410, DOI 10.1016/S0008-6363(99)00351-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seiler N, 1998, INT J ONCOL, V13, P993; Smith MK, 1997, CANCER RES, V57, P2104; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; Su KL, 2009, J BIOL CHEM, V284, P26768, DOI 10.1074/jbc.M109.007807; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Thomson SC, 2001, J CLIN INVEST, V107, P217, DOI 10.1172/JCI10963; TOBIAS KE, 1993, BIOCHEMISTRY-US, V32, P5842, DOI 10.1021/bi00073a017; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200	56	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104865	10.1371/journal.pone.0104865	http://dx.doi.org/10.1371/journal.pone.0104865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140796	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200038
J	Loffing, F; Solter, F; Hagemann, N				Loffing, Florian; Soelter, Florian; Hagemann, Norbert			Left Preference for Sport Tasks Does Not Necessarily Indicate Left-Handedness: Sport-Specific Lateral Preferences, Relationship with Handedness and Implications for Laterality Research in Behavioural Sciences	PLOS ONE			English	Article							HAND PREFERENCE; FIGHTING HYPOTHESIS; TAKEOFF LEG; FREQUENCY; ADVANTAGE; INVENTORY; DOMINANCE; EXPLAIN; WORLD; AGE	In the elite domain of interactive sports, athletes who demonstrate a left preference (e.g., holding a weapon with the left hand in fencing or boxing in a 'southpaw' stance) seem overrepresented. Such excess indicates a performance advantage and was also interpreted as evidence in favour of frequency-dependent selection mechanisms to explain the maintenance of left-handedness in humans. To test for an overrepresentation, the incidence of athletes' lateral preferences is typically compared with an expected ratio of left- to right-handedness in the normal population. However, the normal population reference values did not always relate to the sport-specific tasks of interest, which may limit the validity of reports of an excess of 'left-oriented' athletes. Here we sought to determine lateral preferences for various sport-specific tasks (e.g., baseball batting, boxing) in the normal population and to examine the relationship between these preferences and handedness. To this end, we asked 903 participants to indicate their lateral preferences for sport-specific and common tasks using a paper-based questionnaire. Lateral preferences varied considerably across the different sport tasks and we found high variation in the relationship between those preferences and handedness. In contrast to unimanual tasks (e.g., fencing or throwing), for bimanually controlled actions such as baseball batting, shooting in ice hockey or boxing the incidence of left preferences was considerably higher than expected from the proportion of left-handedness in the normal population and the relationship with handedness was relatively low. We conclude that (i) task-specific reference values are mandatory for reliably testing for an excess of athletes with a left preference, (ii) the term 'handedness' should be more cautiously used within the context of sport-related laterality research and (iii) observation of lateral preferences in sports may be of limited suitability for the verification of evolutionary theories of handedness.	[Loffing, Florian; Soelter, Florian; Hagemann, Norbert] Univ Kassel, Inst Sports & Sports Sci, D-34125 Kassel, Germany; [Soelter, Florian] Univ Munster, Inst Sport & Exercise Sci, D-48149 Munster, Germany	Universitat Kassel; University of Munster	Loffing, F (corresponding author), Univ Kassel, Inst Sports & Sports Sci, D-34125 Kassel, Germany.	f.loffing@uni-kassel.de	Loffing, Florian/I-3582-2015; Loffing, Florian/AGJ-4713-2022	Loffing, Florian/0000-0002-5496-9146; Loffing, Florian/0000-0002-5496-9146; Hagemann, Norbert/0000-0002-7721-7916	German Research Foundation (DFG) [HA 4361/5-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG, http://www.dfg.de/en/index.jsp) [HA 4361/5-2]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DM, 2012, J R SOC INTERFACE, V9, P2718, DOI 10.1098/rsif.2012.0211; AGGLETON JP, 1990, INT J SPORT PSYCHOL, V21, P46; Baker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079793; Brooks R, 2004, P ROY SOC B-BIOL SCI, V271, pS64, DOI 10.1098/rsbl.2003.0100; Brown S, 2006, MAMM GENOME, V17, P1, DOI 10.1007/s00335-005-0900-7; Busch D, 2010, LATERALITY, V15, P610, DOI 10.1080/13576500903081806; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; COREN S, 1993, B PSYCHONOMIC SOC, V31, P1, DOI 10.3758/bf03334122; Corey DM, 2001, NEUROPSY NEUROPSY BE, V14, P144; Dane S, 2005, PERCEPT MOTOR SKILL, V100, P743, DOI 10.2466/PMS.100.3.743-746; Faurie C, 2005, CURR ANTHROPOL, V46, P142, DOI 10.1086/427101; Faurie C, 2004, P ROY SOC B-BIOL SCI, V271, pS43, DOI 10.1098/rsbl.2003.0092; Faurie C, 2013, ANN NY ACAD SCI, V1288, P110, DOI 10.1111/nyas.12159; Fazio R, 2012, LATERALITY, V17, P70, DOI 10.1080/1357650X.2010.532801; Frayer DW, 2012, LATERALITY, V17, P51, DOI 10.1080/1357650X.2010.529451; FRIBERG O, 1988, INT J SPORTS MED, V9, P349, DOI 10.1055/s-2007-1025039; GILBERT AN, 1992, NEUROPSYCHOLOGIA, V30, P601, DOI 10.1016/0028-3932(92)90065-T; Gorney C, 2009, NY TIMES; Gorynia I, 2000, CORTEX, V36, P1, DOI 10.1016/S0010-9452(08)70832-3; Groothuis TGG, 2013, ANN NY ACAD SCI, V1288, P100, DOI 10.1111/nyas.12164; Grouios G, 2004, PERCEPT MOTOR SKILL, V98, P53; Gursoy R, 2009, BRIT J SPORT MED, V43, P142, DOI 10.1136/bjsm.2007.043547; Hagemann N, 2009, ATTEN PERCEPT PSYCHO, V71, P1641, DOI 10.3758/APP.71.7.1641; Holtzen DW, 2000, INT J NEUROSCI, V105, P101, DOI 10.3109/00207450009003270; Llaurens V, 2009, PHILOS T R SOC B, V364, P881, DOI 10.1098/rstb.2008.0235; Loffing F., 2012, BIAS HUMAN BEHAV, P163; Loffing F, 2014, Z SPORTPSYCHOL, V21, P63, DOI 10.1026/1612-5010/a000117; Loffing F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049325; Loffing F, 2012, ATTEN PERCEPT PSYCHO, V74, P446, DOI 10.3758/s13414-011-0252-1; Loffing F, 2010, HIGH ABIL STUD, V21, P19, DOI 10.1080/13598139.2010.488084; Loffing F, 2010, J SPORT SCI, V28, P435, DOI 10.1080/02640410903536459; MCLEAN JM, 1982, NEW ENGL J MED, V307, P1278; McManus I.C., 2002, RIGHT HAND LEFT HAND; Mikheev M, 2002, NEUROPSYCHOLOGIA, V40, P1209, DOI 10.1016/S0028-3932(01)00227-5; Miyaguchi K, 2010, J STRENGTH COND RES, V24, P2516, DOI 10.1519/JSC.0b013e3181e380b5; Oberbeck H, 1989, SEITIGKEITSPHANOMENE; Oberbeck H, 1992, LEISTUNGSSPORT, V22, P35; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PETERS M, 1992, NEUROPSYCHOLOGIA, V30, P373, DOI 10.1016/0028-3932(92)90110-8; Peters M, 2006, BRAIN COGNITION, V62, P177, DOI 10.1016/j.bandc.2006.04.005; Pollet TV, 2013, ANIM BEHAV, V86, P839, DOI 10.1016/j.anbehav.2013.07.026; Puterman J, 2010, J SPORT SCI, V28, P1581, DOI 10.1080/02640414.2010.514281; Raymond M, 2004, LATERALITY, V9, P35, DOI 10.1080/13576500244000274; Raymond M, 1996, P ROY SOC B-BIOL SCI, V263, P1627, DOI 10.1098/rspb.1996.0238; Schachter SC, 2000, SIDE BIAS: A NEUROPSYCHOLOGICAL PERSPECTIVE, P155; Schorer J, 2012, J SPORT SCI, V30, P507, DOI 10.1080/02640414.2012.654811; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; WOOD CJ, 1989, BRIT J PSYCHOL, V80, P227, DOI 10.1111/j.2044-8295.1989.tb02316.x; Ziyagil MA, 2010, PERCEPT MOTOR SKILL, V111, P65, DOI 10.2466/04.05.19.25.PMS.111.4.65-70	49	41	41	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105800	10.1371/journal.pone.0105800	http://dx.doi.org/10.1371/journal.pone.0105800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141020	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200122
J	Margeridon-Thermet, S; Le Pogam, S; Li, L; Liu, TF; Shulman, N; Shafer, RW; Najera, I				Margeridon-Thermet, Severine; Le Pogam, Sophie; Li, Lewyn; Liu, Tommy F.; Shulman, Nancy; Shafer, Robert W.; Najera, Isabel			Similar Prevalence of Low-Abundance Drug-Resistant Variants in Treatment-Naive Patients with Genotype 1a and 1b Hepatitis C Virus Infections as Determined by Ultradeep Pyrosequencing	PLOS ONE			English	Article							PLUS PEGINTERFERON ALPHA-2A; DIRECT-ACTING ANTIVIRALS; IN-VITRO RESISTANCE; INHIBITOR; POLYMERASE; NS5B; RIBAVIRIN; NONNUCLEOSIDE; COMBINATION; THERAPY	Background and Objectives: Hepatitis C virus (HCV) variants that confer resistance to direct-acting-antiviral agents (DAA) have been detected by standard sequencing technology in genotype (G) 1 viruses from DAA-naive patients. It has recently been shown that virological response rates are higher and breakthrough rates are lower in G1b infected patients than in G1a infected patients treated with certain classes of HCV DAAs. It is not known whether this corresponds to a difference in the composition of G1a and G1b HCV quasispecies in regards to the proportion of naturally occurring DAA-resistant variants before treatment. Methods: We used ultradeep pyrosequencing to determine the prevalence of low-abundance (<25% of the sequence reads) DAA-resistant variants in 191 NS3 and 116 NS5B isolates from 208 DAA-naive G1-infected patients. Results: A total of 3.5 million high-quality reads of >= 200 nucleotides were generated. The median coverage depth was 4150x and 4470x per NS3 and NS5B amplicon, respectively. Both G1a and G1b populations showed Shannon entropy distributions, with no difference between G1a and G1b in NS3 or NS5B region at the nucleotide level. A higher number of substitutions that confer resistance to protease inhibitors were observed in G1a isolates (mainly at amino acid 80 of the NS3 region). The prevalence of amino acid substitutions that confer resistance to NS5B non-nucleoside inhibitors was similar in G1a and G1b isolates. The NS5B S282T variant, which confers resistance to the polymerase inhibitors mericitabine and sofosbuvir, was not detected in any sample. Conclusion: The quasispecies genetic diversity and prevalence of DAA-resistant variants was similar in G1a and G1b isolates and in both NS3 and NS5B regions, suggesting that this is not a determinant for the higher level of DAA resistance observed across G1a HCV infected patients upon treatment.	[Margeridon-Thermet, Severine; Liu, Tommy F.; Shafer, Robert W.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Le Pogam, Sophie; Li, Lewyn; Najera, Isabel] Roche, Infect Dis Discovery, Pharma Res Early Dev, Nutley, NJ 07110 USA; [Le Pogam, Sophie; Shulman, Nancy] Genentech Inc, Pharma Dev, San Francisco, CA 94080 USA; [Najera, Isabel] Roche, Pharma Res Early Dev, Infect Dis Discovery, Shanghai, Peoples R China	Stanford University; Roche Holding; Roche Holding; Genentech	Najera, I (corresponding author), Roche, Infect Dis Discovery, Pharma Res Early Dev, Nutley, NJ 07110 USA.	isabel.najera@roche.com			F. Hoffmann-La Roche Ltd.	F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	This work was supported by F. Hoffmann-La Roche Ltd. The funder provided support in the form of salaries for authors SLP, LL, NS & IN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali S, 2008, ANTIMICROB AGENTS CH, V52, P4356, DOI 10.1128/AAC.00444-08; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; De Meyer S, 2012, HEPATOLOGY, V56, P2106, DOI 10.1002/hep.25962; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Gane EJ, 2014, ANTIMICROB AGENTS CH, V58, P1136, DOI 10.1128/AAC.01515-13; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; INA Y, 1994, J MOL EVOL, V38, P50; Jacobson I, 2013, J HEPATOL, V58, pS574, DOI 10.1016/S0168-8278(13)61424-5; Jensen DM, 2014, HEPATOL INT, V8, pS201; Jesudian AB, 2013, CLIN GASTROENTEROL H, V11, P612, DOI 10.1016/j.cgh.2013.04.003; Kukolj G, 2005, J BIOL CHEM, V280, P39260, DOI 10.1074/jbc.M506407200; Lagace L, 2010, HEPATOLOGY, V52, p1205A; Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12; Lam AM, 2011, J VIROL, V85, P12334, DOI 10.1128/JVI.05639-11; Lauck M, 2012, J VIROL, V86, P3952, DOI 10.1128/JVI.06627-11; Lawitz E, 2013, J HEPATOL, V59, P18, DOI 10.1016/j.jhep.2013.02.009; Le Pogam S, 2012, ANTIMICROB AGENTS CH, V56, P5494, DOI 10.1128/AAC.01035-12; Le Pogam S, 2008, J ANTIMICROB CHEMOTH, V61, P1205, DOI 10.1093/jac/dkn085; Le Pogam S, 2012, HEPATOLOGY, V56, p571A; Le Pogam S, 2010, J INFECT DIS, V202, P1510, DOI 10.1086/656774; Lenz O, 2012, GASTROENTEROLOGY, V143, P1176, DOI 10.1053/j.gastro.2012.07.117; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Marcellin P, 2013, GASTROENTEROLOGY, V145, P790, DOI 10.1053/j.gastro.2013.06.051; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Moreau I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-78; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Nelson DR, 2012, ANN HEPATOL, V11, P15, DOI 10.1016/S1665-2681(19)31482-6; Ogert RA, 2013, ANTIVIR THER, V18, P387, DOI 10.3851/IMP2549; Pawlotsky JM, 2006, CURR TOP MICROBIOL, V299, P261; Pelosi LA, 2012, ANTIMICROB AGENTS CH, V56, P5230, DOI 10.1128/AAC.01209-12; Pockros PJ, 2008, HEPATOLOGY, V48, P385, DOI 10.1002/hep.22357; Pockros PJ, 2013, HEPATOLOGY, V58, P514, DOI 10.1002/hep.26275; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Randolph JT, 2009, J MED CHEM, V52, P3174, DOI 10.1021/jm801485z; Seiwert SD, 2007, J HEPATOL, V46, pS244, DOI 10.1016/S0168-8278(07)62245-4; Shih IH, 2011, ANTIMICROB AGENTS CH, V55, P4196, DOI 10.1128/AAC.00307-11; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Svarovskaia E, 2013, J HEPATOL, V58, pS496, DOI 10.1016/S0168-8278(13)61222-2; Thomas XV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041191; Thompson PA, 2008, HEPATOLOGY, V48, p1164A; Tong X, 2014, ANTIMICROB AGENTS CH; Tong X, 2013, J INFECT DIS; Tong X, 2006, ANTIVIR RES, V70, P28, DOI 10.1016/j.antiviral.2005.12.003; Trimoulet P, 2013, ANTIVIR THER, V18, P723, DOI 10.3851/IMP2632; Troke PJF, 2012, ANTIMICROB AGENTS CH, V56, P1331, DOI 10.1128/AAC.05611-11; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Wilke CO, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-44; Yi GH, 2012, ANTIMICROB AGENTS CH, V56, P830, DOI 10.1128/AAC.05438-11; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zeuzem S, 2013, HEPATOLOGY, V58, p733A; Zheng XF, 2011, BIOORG MED CHEM LETT, V21, P2925, DOI 10.1016/j.bmcl.2011.03.067	55	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105569	10.1371/journal.pone.0105569	http://dx.doi.org/10.1371/journal.pone.0105569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140696	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200100
J	Pandey, MK; Upadhyaya, HD; Rathore, A; Vadez, V; Sheshshayee, MS; Sriswathi, M; Govil, M; Kumar, A; Gowda, MVC; Sharma, S; Hamidou, F; Kumar, VA; Khera, P; Bhat, RS; Khan, AW; Singh, S; Li, HJ; Monyo, E; Nadaf, HL; Mukri, G; Jackson, SA; Guo, BZ; Liang, XQ; Varshney, RK				Pandey, Manish K.; Upadhyaya, Hari D.; Rathore, Abhishek; Vadez, Vincent; Sheshshayee, M. S.; Sriswathi, Manda; Govil, Mansee; Kumar, Ashish; Gowda, M. V. C.; Sharma, Shivali; Hamidou, Falalou; Kumar, V. Anil; Khera, Pawan; Bhat, Ramesh S.; Khan, Aamir W.; Singh, Sube; Li, Hongjie; Monyo, Emmanuel; Nadaf, H. L.; Mukri, Ganapati; Jackson, Scott A.; Guo, Baozhu; Liang, Xuanqiang; Varshney, Rajeev K.			Genomewide Association Studies for 50 Agronomic Traits in Peanut Using the 'Reference Set' Comprising 300 Genotypes from 48 Countries of the Semi-Arid Tropics of the World	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; ARACHIS-HYPOGAEA L.; MINI CORE COLLECTION; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; RUST RESISTANCE; MARKERS; IDENTIFICATION; DIVERSITY; GENOMICS	Peanut is an important and nutritious agricultural commodity and a livelihood of many small-holder farmers in the semi-arid tropics (SAT) of world which are facing serious production threats. Integration of genomics tools with on-going genetic improvement approaches is expected to facilitate accelerated development of improved cultivars. Therefore, high-resolution genotyping and multiple season phenotyping data for 50 important agronomic, disease and quality traits were generated on the 'reference set' of peanut. This study reports comprehensive analyses of allelic diversity, population structure, linkage disequilibrium (LD) decay and marker-trait association (MTA) in peanut. Distinctness of all the genotypes can be established by using either an unique allele detected by a single SSR or a combination of unique alleles by two or more than two SSR markers. As expected, DArT features (2.0 alleles/locus, 0.125 PIC) showed lower allele frequency and polymorphic information content (PIC) than SSRs (22.21 alleles /locus, 0.715 PIC). Both marker types clearly differentiated the genotypes of diploids from tetraploids. Multi-allelic SSRs identified three sub-groups (K = 3) while the LD simulation trend line based on squared-allele frequency correlations (r(2)) predicted LD decay of 15-20 cM in peanut genome. Detailed analysis identified a total of 524 highly significant MTAs (pvalue.2.1610-6) with wide phenotypic variance (PV) range (5.81-90.09%) for 36 traits. These MTAs after validation may be deployed in improving biotic resistance, oil/seed/nutritional quality, drought tolerance related traits, and yield/yield components.	[Pandey, Manish K.; Upadhyaya, Hari D.; Rathore, Abhishek; Vadez, Vincent; Sriswathi, Manda; Govil, Mansee; Kumar, Ashish; Sharma, Shivali; Kumar, V. Anil; Khera, Pawan; Khan, Aamir W.; Singh, Sube; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India; [Sheshshayee, M. S.] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India; [Kumar, Ashish] Jawahar Lal Nehru Krishi Vishwa Vidyalaya JNKVV, Plant Pathol, Jabalpur, Madhya Pradesh, India; [Gowda, M. V. C.; Nadaf, H. L.; Mukri, Ganapati] Univ Agr Sci, Dept Genet & Plant Breeding, Dharwad, Karnataka, India; [Hamidou, Falalou] Int Crops Res Inst Semi Arid Trop, Sahelian Ctr, Niamey, Niger; [Bhat, Ramesh S.] Univ Agr Sci, Dept Biotechnol, Dharwad, Karnataka, India; [Li, Hongjie] ShanDong Shofine Seed Technol Co Ltd, Jining, Shandong, Peoples R China; [Monyo, Emmanuel] Int Crops Res Inst Semi Arid Trop, Nairobi, Kenya; [Jackson, Scott A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA; [Liang, Xuanqiang] GAAS, Crop Res Inst, Guangzhou, Guangdong, Peoples R China	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Agricultural Sciences Bangalore; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Guangdong Academy of Agricultural Sciences	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India.	r.k.varshney@cgiar.org	Khan, Mohammad Aamir Waseem/AAP-1262-2021; Vadez, Vincent/GLU-8981-2022; Varshney, Rajeev K/C-5295-2014; Bhat, Ramesh S/C-8080-2014; Sreeman, Sheshshayee/ABI-2719-2020; Updhayaya, Hari/C-4858-2014; Vadez, Vincent/C-5310-2014	Khan, Mohammad Aamir Waseem/0000-0001-9734-8123; Varshney, Rajeev K/0000-0002-4562-9131; Updhayaya, Hari/0000-0002-5166-6844; Sreeman, Sheshshayee/0000-0002-2634-8596; jackson, scott/0000-0002-3172-1607; Pandey, Manish/0000-0002-4101-6530	Bill & Melinda Gates Foundation (BMGF) through CGIAR Generation Challenge Programme; Peanut Foundation, USA; ShanDong Shofine Seed Technology Co Ltd, Jining, Shandong, China; ARS [ARS-0425281] Funding Source: Federal RePORTER	Bill & Melinda Gates Foundation (BMGF) through CGIAR Generation Challenge Programme; Peanut Foundation, USA; ShanDong Shofine Seed Technology Co Ltd, Jining, Shandong, China; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was undertaken as a part of Tropical Legumes I (TLI-Objective 1: Groundnut) funded by Bill & Melinda Gates Foundation (BMGF) through CGIAR Generation Challenge Programme (http://www.generationcp.org/) and The Peanut Foundation, USA (http://www.peanutfoundation.org/). This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. ShanDong Shofine Seed Technology Co Ltd, Jining, Shandong, China provided support in the form of a salary for author HL who participated in data analysis using analytical tools, but did not have any additional role in the study design and data collection, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Bertioli DJ, 2011, PLANT GENET RESOUR-C, V9, P134, DOI 10.1017/S1479262110000444; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hamidou F, 2012, FIELD CROP RES, V126, P189, DOI 10.1016/j.fcr.2011.10.009; Heckenberger M, 2004, MOL BREEDING, V10, P181; Herselman L, 2004, THEOR APPL GENET, V109, P1426, DOI 10.1007/s00122-004-1756-z; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; Kilian A., 2008, P 3 INT C AR GEN BIO; Kulwal P, 2012, THEOR APPL GENET, V125, P793, DOI 10.1007/s00122-012-1872-0; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Nandakumar N, 2004, EUPHYTICA, V136, P257, DOI 10.1023/B:EUPH.0000032706.92360.c6; Nigam SN, 2005, ANN APPL BIOL, V146, P433, DOI 10.1111/j.1744-7348.2005.040076.x; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Perrier X., 2006, DARWIN SOFTWARE; Pritchard JK, 2000, GENETICS, V155, P945; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Selvaraj MG, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue2-fulltext-13; Sharma S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00309; Shirasawa K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-80; Song QJ, 1999, PLANT VAR SEEDS, V12, P207; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Tommasini L, 2003, THEOR APPL GENET, V106, P1091, DOI 10.1007/s00122-002-1125-8; Upadhyaya H. D., 2010, Electronic Journal of Plant Breeding, V1, P1294; Upadhyaya HD, 2012, CROP SCI, V52, P2628, DOI 10.2135/cropsci2012.05.0306; Upadhyaya HD, 2011, EUPHYTICA, V182, P103, DOI 10.1007/s10681-011-0518-7; Upadhyaya HD, 2005, CROP SCI, V45, P1432, DOI 10.2135/cropsci2004.0389; Upadhyaya HD, 2003, GENET RESOUR CROP EV, V50, P139, DOI 10.1023/A:1022945715628; Upadhyaya HD, 2002, CROP SCI, V42, P2150, DOI 10.2135/cropsci2002.2150; Varshney RK, 2009, THEOR APPL GENET, V118, P729, DOI 10.1007/s00122-008-0933-x; Varshney R.K., 2007, GENOMICS ASSISTED CR, P1; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Varshney RK, 2013, BIOTECHNOL ADV, V31, P1120, DOI 10.1016/j.biotechadv.2013.01.001; Varshney RK, 2012, NAT BIOTECHNOL, V30, P1172, DOI 10.1038/nbt.2440; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Wang ML, 2011, THEOR APPL GENET, V123, P1307, DOI 10.1007/s00122-011-1668-7; Weir BS, 1996, METHODS DISCRETE POP, VII; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Zhou H, 2012, J ZHEJIANG UNIV-SC B, V13, P438, DOI 10.1631/jzus.B1200003	48	61	66	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105228	10.1371/journal.pone.0105228	http://dx.doi.org/10.1371/journal.pone.0105228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140620	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000342687200064
J	Choi, MJ; Cho, KH; Lee, S; Bae, YJ; Jeong, KJ; Rha, SY; Choi, EJ; Park, JH; Kim, JM; Lee, JS; Mills, GB; Lee, HY				Choi, M. J.; Cho, K. H.; Lee, S.; Bae, Y. J.; Jeong, K. J.; Rha, S. Y.; Choi, E. J.; Park, J. H.; Kim, J. M.; Lee, J-S; Mills, G. B.; Lee, H. Y.			hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; TELOMERASE ACTIVITY; CHRONIC STRESS; CELLS; SRC; ACTIVATION; PROMOTES; KINASE; TARGET	Stress hormones have been implicated in both tumor initiation and progression. Human telomerase reverse transcriptase (hTERT) is overexpressed in cancer cells and associated with malignant tumor progression and poor outcome. We thus sought to determine whether the stress hormone norepinephrine (NE) could induce hTERT expression and subsequently ovarian cancer progression. Unexpectedly, NE induced hTERT transcript and protein expression, and subsequently ovarian cancer cell invasion. Pharmacologic inhibition of beta 2-adrenergic receptor 2 and protein kinase A, as well as silencing of hypoxia-inducible factor-1 alpha and c-Myc expression, profoundly attenuated NE-induced hTERT expression. Strikingly, stimulation of the cells with NE or ectopic expression of hTERT induced expression of Slug, ovarian cancer cell epithelial-mesenchymal transition (EMT) and invasion. Silencing of hTERT expression abrogated NE-induced ovarian cancer cell invasion, EMT and Slug expression. In addition, silencing of Slug expression significantly inhibited NE-and hTERT-induced ovarian cancer cell EMT and invasion. Moreover, continuous exposure to NE was sufficient to enhance in vivo hTERT expression and metastasis of ovarian cancer cells to the lung. Finally, we provide evidence that hTERT links Src to Slug expression in NE-induced ovarian cancer EMT and metastasis. We thus demonstrate a novel role of hTERT in stress hormone-induced ovarian cancer aggressiveness through inducing Slug, providing novel biomarkers and potential therapeutic targets for ovarian cancer.	[Choi, M. J.; Cho, K. H.; Bae, Y. J.; Lee, H. Y.] Konyang Univ, Dept Pharmacol, Myunggok Med Res Inst, Coll Med, Taejon 302718, South Korea; [Lee, S.; Park, J. H.] Konyang Univ, Dept Biochem, Coll Med, Myunggok Med Res Inst, Taejon 302718, South Korea; [Jeong, K. J.; Lee, J-S; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Rha, S. Y.; Lee, H. Y.] Yonsei Univ, Coll Med, Yonsei Canc Res Inst, Seoul, South Korea; [Choi, E. J.] Konyang Univ, Dept Optometry, Coll Med Sci, Taejon 302718, South Korea; [Kim, J. M.] Chungnam Natl Univ, Sch Med, Canc Res Inst, Reg Canc Ctr, Taejon, South Korea; [Kim, J. M.] Chungnam Natl Univ, Sch Med, Infect Signaling Network Res Ctr, Taejon, South Korea	Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; University of Texas System; UTMD Anderson Cancer Center; Yonsei University; Yonsei University Health System; Konyang University; Chungnam National University; Chungnam National University	Lee, HY (corresponding author), Konyang Univ, Dept Pharmacol, Coll Med, 821 Med Sci Bldg,681 Gasuwon Dong, Taejon 302718, South Korea.	hoi@konyang.ac.kr	Jeong, Kangjin/HGT-9268-2022	KIM, JIN MAN/0000-0003-0905-9730; Rha, Sun Young/0000-0002-2512-4531; Choi, Moonjung/0000-0002-7218-4924; Choi, Eun Jung/0000-0002-5020-3055	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [121182]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0015761, 2013R1A1A2A10059565]; NATIONAL CANCER INSTITUTE [P50CA083639] Funding Source: NIH RePORTER	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Professor Bong-Kyeong Oh (KonKuk University, Seoul, South Korea) for a plasmid-containing hTERT, Sun Hee Leem (Dong-A University, Pusan, Korea) for hTERT promoter and Seong-Lan Yu for experimental support. This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (121182) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0015761, 2013R1A1A2A10059565).	Armaiz-Pena GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2413; BARONE MV, 1995, NATURE, V378, P509, DOI 10.1038/378509a0; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Chakroborty D, 2009, CANCER RES, V69, P3727, DOI 10.1158/0008-5472.CAN-08-4289; Chao C, 2007, ONCOGENE, V26, P1013, DOI 10.1038/sj.onc.1209862; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Ghosh JS, 2012, APPL MICROBIOL BIOT, V93, P753, DOI 10.1007/s00253-011-3471-4; Goldstein DS, 2010, CLIN AUTON RES, V20, P331, DOI 10.1007/s10286-010-0065-7; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Jeong KJ, 2012, ONCOGENE, V31, P4279, DOI 10.1038/onc.2011.595; KEMP VH, 1989, RES NURS HEALTH, V12, P331, DOI 10.1002/nur.4770120509; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kyo S, 1999, INT J CANCER, V80, P804; Lambertini E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-13; Lara HE, 2001, ENDOCRINE, V15, P187, DOI 10.1385/ENDO:15:2:187; Lee J, 2006, CLIN CANCER RES, V12, P6351, DOI 10.1158/1078-0432.CCR-06-1252; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Low KC, 2013, TRENDS BIOCHEM SCI, V38, P426, DOI 10.1016/j.tibs.2013.07.001; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; Meng E, 2012, GYNECOL ONCOL, V124, P598, DOI 10.1016/j.ygyno.2011.11.018; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Nilsson MB, 2007, J BIOL CHEM, V282, P29919, DOI 10.1074/jbc.M611539200; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Park SY, 2011, ONCOGENE, V30, P1351, DOI 10.1038/onc.2010.517; Park SY, 2011, INT J CANCER, V128, P2306, DOI 10.1002/ijc.25589; RILEY V, 1975, SCIENCE, V189, P465, DOI 10.1126/science.168638; Sakai D, 2005, DEV GROWTH DIFFER, V47, P471, DOI 10.1111/j.1440-169X.2005.00821.x; Saul AN, 2005, JNCI-J NATL CANCER I, V97, P1760, DOI 10.1093/jnci/dji401; Schmidt C, 1996, Eur J Med Res, V1, P528; Seo JH, 2010, CANCER LETT, V288, P50, DOI 10.1016/j.canlet.2009.06.023; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Wang YP, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-12; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Yatabe N, 2004, ONCOGENE, V23, P3708, DOI 10.1038/sj.onc.1207460; Yu ST, 2009, INT J ONCOL, V35, P329, DOI 10.3892/ijo_00000344; Zhang C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000106	51	48	50	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	26					3402	3412		10.1038/onc.2014.270	http://dx.doi.org/10.1038/onc.2014.270			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CL3SU	25151968				2022-12-25	WOS:000356871700006
J	Bernardo, BC; Nguyen, SS; Winbanks, CE; Gao, XM; Boey, EJH; Tham, YK; Kiriazis, H; Ooi, JYY; Porrello, ER; Igoor, S; Thomas, CJ; Gregorevic, P; Lin, RCY; Du, XJ; McMullen, JR				Bernardo, Bianca C.; Nguyen, Sally S.; Winbanks, Catherine E.; Gao, Xiao-Ming; Boey, Esther J. H.; Tham, Yow Keat; Kiriazis, Helen; Ooi, Jenny Y. Y.; Porrello, Enzo R.; Igoor, Sindhu; Thomas, Colleen J.; Gregorevic, Paul; Lin, Ruby C. Y.; Du, Xiao-Jun; McMullen, Julie R.			Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy	FASEB JOURNAL			English	Article						microRNAs; pressure overload; heart failure; LNA-therapeutics	CARDIAC-HYPERTROPHY; MICRORNA THERAPEUTICS; HUMAN JAGGED1; TASK-FORCE; EXPRESSION; PROTECTS; INHIBITION; ANGIOGENESIS; ASSOCIATION; ACTIVATION	Expression of microRNA-652 (miR-652) increases in the diseased heart, decreases in a setting of cardioprotection, and is inversely correlated with heart function. The aim of this study was to assess the therapeutic potential of inhibiting miR-652 in a mouse model with established pathological hypertrophy and cardiac dysfunction due to pressure overload. Mice were subjected to a sham operation or transverse aortic constriction (TAC) for 4 wk to induce hypertrophy and cardiac dysfunction, followed by administration of a locked nucleic acid (LNA)-antimiR-652 (miR-652 inhibitor) or LNA control. Cardiac function was assessed before and 8 wk post-treatment. Expression of miR-652 increased in hearts subjected to TAC compared to sham surgery (2.9-fold), and this was suppressed by similar to 95% in LNA-antimiR-652-treated TAC mice. Inhibition of miR-652 improved cardiac function in TAC mice (fractional shortening: 29 +/- 1% at 4 wk post-TAC compared to 35 +/- 1% post-treatment) and attenuated cardiac hypertrophy. Improvement in heart function was associated with reduced cardiac fibrosis, less apo-ptosis and B-type natriuretic peptide gene expression, and preserved angiogenesis. Mechanistically, we identified Jagged1 (a Notch1 ligand) as a novel direct target of miR-652. In summary, these studies provide the first evidence that silencing of miR-652 protects the heart against pathological remodeling and improves heart function.	[Bernardo, Bianca C.; Nguyen, Sally S.; Winbanks, Catherine E.; Gao, Xiao-Ming; Boey, Esther J. H.; Tham, Yow Keat; Kiriazis, Helen; Ooi, Jenny Y. Y.; Gregorevic, Paul; Du, Xiao-Jun; McMullen, Julie R.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Nguyen, Sally S.; Thomas, Colleen J.] La Trobe Univ, Dept Human Biosci, Bundoora, Vic, Australia; [Porrello, Enzo R.; Igoor, Sindhu] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Ramaciotti Ctr Genom, Sydney, NSW, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Baker Heart and Diabetes Institute; La Trobe University; University of Queensland; University of New South Wales Sydney; University of New South Wales Sydney	Bernardo, BC (corresponding author), Baker IDI Heart & Diabet Inst, POB 6492, Melbourne, Vic 3004, Australia.	bianca.bernardo@bakeridi.edu.au; julie.mcmullen@bakeridi.edu.au	Gregorevic, Paul/AAH-6040-2021; Lin, Ruby CY/A-1636-2009; Tham, Yow Keat/ABC-8856-2021	Gregorevic, Paul/0000-0002-7418-8945; Lin, Ruby CY/0000-0003-4163-511X; Tham, Yow Keat/0000-0002-9790-1926; Ooi, Jenny/0000-0002-4800-6124; Porrello, Enzo/0000-0001-6105-7463; Bernardo, Bianca Christine/0000-0002-4534-0549	National Health and Medical Research Council of Australia [586603]; Victorian Government's Operational Infrastructure Support Program; Australian Research Council Future Fellowship [FT0001657]; University of New South Wales Vice Chancellor Research Fellowship; National Health and Medical Research Council [1046782]; National Health and Medical Research Council; National Heart Foundation [APP1033815, 635530]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Australian Research Council Future Fellowship(Australian Research Council); University of New South Wales Vice Chancellor Research Fellowship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia)	This study was funded by National Health and Medical Research Council of Australia project grant 586603 (to J.R.M and R.C.Y.L), and also supported in part by the Victorian Government's Operational Infrastructure Support Program. X.J.D. and J.R.M. are National Health and Medical Research Council Senior Research Fellows (APP1043026 and 586604). J.R.M., R.C.Y.L., and P.G. are supported by an Australian Research Council Future Fellowship (FT0001657), a University of New South Wales Vice Chancellor Research Fellowship, and a R.D. Wright Biomedical Research Fellowship from the National Health and Medical Research Council (1046782), respectively. E.R.P. is supported by grants and fellowships from the National Health and Medical Research Council and the National Heart Foundation (APP1033815 and 635530). The authors declare no conflicts of interest.	Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bernardo BC, 2012, DRUG DISCOV TODAY TH, V9, pe163, DOI [10.1016/j.ddstr.2013.10.001, DOI 10.1016/J.DDSTR.2013.10.001]; Bernardo BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090337; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bernardo BC, 2012, HEART LUNG CIRC, V21, P131, DOI 10.1016/j.hlc.2011.11.002; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Cooley N, 2012, PHYSIOL GENOMICS, V44, P211, DOI 10.1152/physiolgenomics.00111.2011; Croquelois A, 2008, J EXP MED, V205, P3173, DOI 10.1084/jem.20081427; Dangwal S, 2014, ANNU REV PHARMACOL, V54, P185, DOI 10.1146/annurev-pharmtox-011613-135957; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gude N, 2012, J MOL CELL CARDIOL, V52, P1226, DOI 10.1016/j.yjmcc.2012.03.007; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; Hata A, 2013, ANNU REV PHYSIOL, V75, P69, DOI 10.1146/annurev-physiol-030212-183737; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hullinger TG, 2012, CIRC RES, V110, P71, DOI 10.1161/CIRCRESAHA.111.244442; Huynh K, 2014, PHARMACOL THERAPEUT, V142, P375, DOI 10.1016/j.pharmthera.2014.01.003; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ikeda S, 2010, CURR DRUG TARGETS, V11, P913, DOI 10.2174/138945010791591304; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lei B, 2008, J MOL CELL CARDIOL, V45, P404, DOI 10.1016/j.yjmcc.2008.06.008; Leptidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057800; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Li XM, 2009, CLIN EXP PHARMACOL P, V36, P1054, DOI 10.1111/j.1440-1681.2009.05243.x; Lin RCY, 2010, ARTERIOSCL THROM VAS, V30, P724, DOI 10.1161/ATVBAHA.109.201988; Matkovich SJ, 2013, CIRC RES, V113, P62, DOI 10.1161/CIRCRESAHA.113.300975; Meloni M, 2013, MOL THER, V21, P1390, DOI 10.1038/mt.2013.89; Nemir M, 2014, EUR HEART J, V35, P2174, DOI 10.1093/eurheartj/ehs269; Ng DCH, 2011, J BIOL CHEM, V286, P1576, DOI 10.1074/jbc.M110.128157; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Ooi JYY, 2014, FUTURE MED CHEM, V6, P205, DOI 10.4155/fmc.13.196; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; Taimeh Z, 2013, NAT REV CARDIOL, V10, P519, DOI 10.1038/nrcardio.2013.94; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Weeks KL, 2012, CIRC-HEART FAIL, V5, P523, DOI 10.1161/CIRCHEARTFAILURE.112.966622; Winbanks CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073589; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	57	61	62	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5097	5110		10.1096/fj.14-253856	http://dx.doi.org/10.1096/fj.14-253856			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25145628				2022-12-25	WOS:000345894500007
J	Taberner, FJ; Lopez-Cordoba, A; Fernandez-Ballester, G; Korchev, Y; Ferrer-Montiel, A				Jose Taberner, Francisco; Lopez-Cordoba, Ainara; Fernandez-Ballester, Gregorio; Korchev, Yuri; Ferrer-Montiel, Antonio			The Region Adjacent to the C-end of the Inner Gate in Transient Receptor Potential Melastatin 8 (TRPM8) Channels Plays a Central Role in Allosteric Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD SENSOR TRPM8; DOMAIN; IDENTIFICATION; DESENSITIZATION; MECHANISM; SENSATION; REVEALS; VOLTAGE; QUALITY; BOX	The ability of transient receptor potential (TRP) channels to sense and respond to environmental and endogenous cues is crucial in animal sensory physiology. The molecular mechanism of channel gating is yet elusive. The TRP box, a conserved region in the N-end of the C terminus domain, has been signaled as pivotal for allosteric activation in TRP channels. Here, we have examined the role of the linker region between the TRPM8 inner gate and the TRP box (referred to as the S6-TRP box linker) to identify structural determinants of channel gating. Stepwise substitutions of segments in the S6-TRP box linker of TRPM8 channel with the cognate TRPV1 channel sequences produced functional chimeric channels, and identified Tyr(981) as a central molecular determinant of channel function. Additionally, mutations in the 986-990 region had a profound impact on channel gating by voltage and menthol, as evidenced by the modulation of the conductance-to-voltage (G-V) relationships. Simulation of G-V curves using an allosteric model for channel activation revealed that these mutations altered the allosteric constants that couple stimuli sensing to pore opening. A molecular model of TRPM8, based on the recently reported TRPV1 structural model, showed that Tyr(981) may lie in a hydrophobic pocket at the end of the S6 transmembrane segment and is involved in inter-subunit interactions with residues from neighbor subunits. The 986-990 region holds intrasubunit interactions between the TRP domain and the S4-S5 linker. These findings substantiate a gating mechanism whereby the TRP domain acts as a coupling domain for efficient channel opening. Furthermore, they imply that protein-protein interactions of the TRP domain may be targets for channel modulation and drug intervention.	[Jose Taberner, Francisco; Lopez-Cordoba, Ainara; Fernandez-Ballester, Gregorio; Ferrer-Montiel, Antonio] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche 03202, Spain; [Korchev, Yuri] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England; [Ferrer-Montiel, Antonio] Univ Basque Country, CSIC, Unidad Biofis, Leioa 48940, Spain	Universidad Miguel Hernandez de Elche; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Ferrer-Montiel, A (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Av Univ S-N, Elche 03202, Spain.	aferrer@umh.es	Ferrer-Montiel, Antonio/C-3072-2015; TABERNER, FRANCISCO J/AAA-9402-2019	Ferrer-Montiel, Antonio/0000-0002-2973-6607; TABERNER, FRANCISCO J/0000-0001-5725-6267	Ministerio de Economia y Competitividad [BFU2012-39092-C02-01, CSD2008-00005]; Generalitat Valenciana Grant [PROMETEO/2014/011]; FPU (Formacion Profesorado Universitario) fellowship form the Ministerio de Educacion; Biotechnology and Biological Sciences Research Council [C19021] Funding Source: researchfish	Ministerio de Economia y Competitividad(Spanish Government); Generalitat Valenciana Grant(Center for Forestry Research & Experimentation (CIEF)); FPU (Formacion Profesorado Universitario) fellowship form the Ministerio de Educacion(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by el Ministerio de Economia y Competitividad Grants BFU2012-39092-C02-01, CONSOLIDER-INGENIO 2010, CSD2008-00005 and la Generalitat Valenciana Grant PROMETEO/2014/011.; Recipient of a FPU (Formacion Profesorado Universitario) fellowship form the Ministerio de Educacion.	Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gregorio-Teruel L, 2014, J GEN PHYSIOL, V143, P361, DOI 10.1085/jgp.201311070; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hirschler-Laszkiewicz I, 2011, J BIOL CHEM, V286, P30636, DOI 10.1074/jbc.M111.238360; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Jun JH, 2012, INT NEUROUROL J, V16, P69, DOI 10.5213/inj.2012.16.2.69; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Pedretti A, 2011, BIOCHEM BIOPH RES CO, V414, P14, DOI 10.1016/j.bbrc.2011.08.134; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tsavaler L, 2001, CANCER RES, V61, P3760; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Valente P, 2011, FASEB J, V25, P1628, DOI 10.1096/fj.10-174433; Valero M, 2011, PFLUG ARCH EUR J PHY, V461, P99, DOI 10.1007/s00424-010-0895-0; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Voets T, 2012, REV PHYSIOL BIOCH P, V162, P91, DOI 10.1007/112_2011_5; Xie J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00146; Yudin Y, 2011, J PHYSIOL-LONDON, V589, P6007, DOI 10.1113/jphysiol.2011.220228	39	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28579	28594		10.1074/jbc.M114.577478	http://dx.doi.org/10.1074/jbc.M114.577478			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25157108	hybrid, Green Published			2022-12-25	WOS:000343765400047
J	Kliper, E; Ben Assayag, E; Tarrasch, R; Artzi, M; Korczyn, AD; Shenhar-Tsarfaty, S; Aizenstein, O; Hallevi, H; Mike, A; Shopin, L; Bornstein, NM; Ben Bashat, D				Kliper, Efrat; Ben Assayag, Einor; Tarrasch, Ricardo; Artzi, Moran; Korczyn, Amos D.; Shenhar-Tsarfaty, Shani; Aizenstein, Orna; Hallevi, Hen; Mike, Anat; Shopin, Ludmila; Bornstein, Natan M.; Ben Bashat, Dafna			Cognitive State following Stroke: The Predominant Role of Preexisting White Matter Lesions	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; 1ST-EVER STROKE; ISCHEMIC-STROKE; DEMENTIA; BRAIN; IMPAIRMENT; LOCATION; HYPERINTENSITIES; INTEGRITY; ABNORMALITIES	Background and purpose: Stroke is a major cause of cognitive impairment and dementia in adults, however the role of the ischemic lesions themselves, on top of other risk factors known in the elderly, remains controversial. This study used structural equation modeling to determine the respective impact of the new ischemic lesions' volume, preexisting white matter lesions and white matter integrity on post stroke cognitive state. Methods: Consecutive first ever mild to moderate stroke or transient ischemic attack patients recruited into the ongoing prospective TABASCO study underwent magnetic resonance imaging scans within seven days of stroke onset and were cognitively assessed one year after the event using a computerized neuropsychological battery. The volumes of both ischemic lesions and preexisting white matter lesions and the integrity of the normal appearing white matter tissue were measured and their contribution to cognitive state was assessed using structural equation modeling path analysis taking into account demographic parameters. Two models were hypothesized, differing by the role of ischemic lesions' volume. Results: Structural equation modeling analysis of 142 patients confirmed the predominant role of white matter lesion volume (standardized path coefficient beta = -0.231) and normal appearing white matter integrity (beta = -0.176) on the global cognitive score, while ischemic lesions' volume showed no such effect (beta = 0.038). The model excluding the ischemic lesion presented better fit to the data (comparative fit index 0.9 versus 0.092). Conclusions: Mild to moderate stroke patients with preexisting white matter lesions are more vulnerable to cognitive impairment regardless of their new ischemic lesions. Thus, these patients can serve as a target group for studies on cognitive rehabilitation and neuro-protective therapies which may, in turn, slow their cognitive deterioration.	[Kliper, Efrat; Artzi, Moran; Aizenstein, Orna; Ben Bashat, Dafna] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, IL-69978 Tel Aviv, Israel; [Kliper, Efrat; Artzi, Moran; Korczyn, Amos D.; Bornstein, Natan M.; Ben Bashat, Dafna] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Kliper, Efrat; Ben Assayag, Einor; Shenhar-Tsarfaty, Shani; Hallevi, Hen; Mike, Anat; Shopin, Ludmila; Bornstein, Natan M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Tarrasch, Ricardo] Tel Aviv Univ, Jaime & Joan Constantiner Sch Educ, IL-69978 Tel Aviv, Israel; [Tarrasch, Ricardo; Ben Bashat, Dafna] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv University	Ben Bashat, D (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, IL-69978 Tel Aviv, Israel.	dafnab@tlvmc.gov.il	Korczyn, Amos D/C-3461-2017; Artzi, Moran/AAF-5167-2020; Tarrasch, Ricardo/H-9197-2013	Korczyn, Amos D/0000-0003-0125-2579; Tarrasch, Ricardo/0000-0003-1677-6615; Ben Bashat, Dafna/0000-0001-8396-1031; Shenhar-Tsarfaty, Shani/0000-0002-8268-1799	Chief Scientist Office, Ministry of Health, Israel [3000000-5062]; American Federation for Aging Research [RAG11482]	Chief Scientist Office, Ministry of Health, Israel; American Federation for Aging Research	This study is supported by grant 3000000-5062 from the Chief Scientist Office, Ministry of Health, Israel and grant RAG11482 from the American Federation for Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artzi M, 2013, EUR J RADIOL, V82, P1512, DOI 10.1016/j.ejrad.2013.05.029; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; Baune BT, 2009, STROKE, V40, P667, DOI 10.1161/STROKEAHA.108.534230; BELOOSESKY Y, 1995, AGE AGEING, V24, P515, DOI 10.1093/ageing/24.6.515; Ben Assayag E, 2012, INT J STROKE, V7, P341, DOI 10.1111/j.1747-4949.2011.00652.x; Bolandzadeh N, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-126; Bornstein NM, 1996, STROKE, V27, P904, DOI 10.1161/01.STR.27.5.904; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; de Groot JC, 2000, ANN NEUROL, V47, P145; de Groot M, 2013, STROKE, V44, P1037, DOI 10.1161/STROKEAHA.112.680223; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Dufouil C, 2009, STROKE, V40, P2219, DOI 10.1161/STROKEAHA.108.540633; ENGLUND E, 1988, BRAIN, V111, P1425, DOI 10.1093/brain/111.6.1425; Fillit HM, 2008, ALZHEIMERS DEMENT, V4, P14, DOI 10.1016/j.jalz.2007.09.008; Frisoni GB, 2007, NAT CLIN PRACT NEURO, V3, P620, DOI 10.1038/ncpneuro0638; Ganesan V, 1999, ARCH DIS CHILD, V81, P295, DOI 10.1136/adc.81.4.295; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hoffmann M, 2006, COGN BEHAV NEUROL, V19, P85, DOI 10.1097/01.wnn.0000213903.59827.50; Ihle-Hansen H, 2012, DEMENT GER COGN D EX, V2, P38, DOI 10.1159/000336817; Ivan CS, 2004, STROKE, V35, P1264, DOI 10.1161/01.STR.0000127810.92616.78; Jacobs HIL, 2013, HUM BRAIN MAPP, V34, P77, DOI 10.1002/hbm.21412; Kim SH, 2011, J NEUROIMAGING, V21, P317, DOI 10.1111/j.1552-6569.2010.00527.x; Leritz EC, 2014, HUM BRAIN MAPP, V35, P1085, DOI 10.1002/hbm.22236; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Leys D, 1999, EUR NEUROL, V42, P67, DOI 10.1159/000069414; Mailhard P, 2013, AM J NEURORADIOL, V34, P54, DOI 10.3174/ajnr.A3146; Maillard P, 2011, STROKE, V42, P1917, DOI 10.1161/STROKEAHA.110.609768; Makin SDJ, 2013, J NEUROL NEUROSUR PS, V84, P893, DOI 10.1136/jnnp-2012-303645; Mukherjee P, 2005, NEUROIMAG CLIN N AM, V15, P655, DOI 10.1016/j.nic.2005.08.010; Norman GR, 2003, PDQ STAT, P156; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; O'Sullivan M, 2010, STROKE, V41, pS154, DOI 10.1161/STROKEAHA.110.595314; Peek MK, 2000, AM J PHYS MED REHAB, V79, P301, DOI 10.1097/00002060-200005000-00014; Pendlebury ST, 2009, MATURITAS, V64, P165, DOI 10.1016/j.maturitas.2009.09.010; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Penke L, 2010, NEUROBIOL AGING, V31, P1656, DOI 10.1016/j.neurobiolaging.2009.10.019; Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717; Radanovic M, 2013, EXPERT REV NEUROTHER, V13, P483, DOI [10.1586/ERN.13.45, 10.1586/ern.13.45]; Richard E, 2010, STROKE, V41, P554, DOI 10.1161/STROKEAHA.109.571281; Ropele S, 2009, J MAGN RESON IMAGING, V29, P268, DOI 10.1002/jmri.21580; Rosenberg GA, 2009, STROKE, V40, pS20, DOI 10.1161/STROKEAHA.108.533133; Sachdev PS, 2006, DEMENT GERIATR COGN, V21, P275, DOI 10.1159/000091434; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P670, DOI 10.1111/j.1365-2990.2007.00890.x; Srikanth VK, 2006, STROKE, V37, P2479, DOI 10.1161/01.STR.0000239666.46828.d7; Srikanth VK, 2004, NEUROLOGY, V63, P785, DOI 10.1212/01.WNL.0000137042.01774.33; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165	54	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105461	10.1371/journal.pone.0105461	http://dx.doi.org/10.1371/journal.pone.0105461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153800	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200052
J	Meyer, KS; Soltwedel, T; Bergmann, M				Meyer, Kirstin S.; Soltwedel, Thomas; Bergmann, Melanie			High Biodiversity on a Deep-Water Reef in the Eastern Fram Strait	PLOS ONE			English	Article							ROCKY-REEF; COMMUNITY STRUCTURE; HERBIVOROUS INVERTEBRATES; MEGAFAUNAL ASSEMBLAGES; HABITAT STRUCTURE; SELF-RECRUITMENT; FISH; ABUNDANCE; GULF; CORALS	We report on the distribution and abundance of megafauna on a deep- water rocky reef (1796- 2373 m) in the Fram Strait, west of Svalbard. Biodiversity and population density are high, with a maximum average of 26.7 +/- 0.9 species m(-2) and 418.1 +/- 49.6 individuals m(-2) on the east side of the reef summit. These figures contrast with the surrounding abyssal plain fauna, with an average of only 18.1 +/- 1.4 species and 29.4 +/- 4.3 individuals m(-2) (mean +/- standard error). The east side of the reef summit, where the highest richness and density of fauna are found, faces into the predominant bottom current, which likely increases in speed to the summit and serves as a source of particulate food for the numerous suspension feeders present there. We conclude that the observed faunal distribution patterns could be the result of hydrodynamic patterns and food availability above and around the reef. To our knowledge, this study is the first to describe the distribution and diversity of benthic fauna on a rocky reef in deep water.	[Meyer, Kirstin S.] Oregon Inst Marine Biol, Charleston, OR USA; [Soltwedel, Thomas; Bergmann, Melanie] Alfred Wegener Inst, Helmholtz Zentrum Polar & Meeresforsch, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Meyer, KS (corresponding author), Oregon Inst Marine Biol, Charleston, OR USA.	kimeyer@alumni.nmu.edu	Soltwedel, Thomas/P-1852-2016; Bergmann, Melanie/H-3347-2015	Soltwedel, Thomas/0000-0002-8214-5937; Bergmann, Melanie/0000-0001-5212-9808; Meyer-Kaiser, Kirstin/0000-0003-2219-6086	Fulbright Study-Research grant	Fulbright Study-Research grant	K. Meyer was funded by a Fulbright Study-Research grant during the duration (July 2011-May 2012) of her tenure at the AWI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2001, MAR ECOL-P S Z N I, V22, P283, DOI 10.1046/j.1439-0485.2001.t01-1-01747.x; Bergmann M, 2011, DEEP-SEA RES PT I, V58, P711, DOI 10.1016/j.dsr.2011.03.007; Bergmann M, 2011, MAR BIOL RES, V7, P525, DOI 10.1080/17451000.2010.535834; Bergmann M, 2009, DEEP-SEA RES PT I, V56, P408, DOI 10.1016/j.dsr.2008.10.004; Brind'Amour A, 2014, CONT SHELF RES, V72, P1, DOI 10.1016/j.csr.2013.10.015; BURCHMORE JJ, 1985, B MAR SCI, V37, P70; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; COLIN PL, 1976, B MAR SCI, V26, P603; Connell SD, 2001, MAR ENVIRON RES, V52, P115, DOI 10.1016/S0141-1136(00)00266-X; FARROW GE, 1983, CAN J FISH AQUAT SCI, V40, P273, DOI 10.1139/f83-289; Feitoza BM, 2005, B MAR SCI, V76, P725; Garcia-Charton JA, 1998, MAR ECOL-P S Z N I, V19, P111; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Heterier V, 2008, MAR ECOL PROG SER, V364, P67, DOI 10.3354/meps07487; HOLM S, 1979, SCAND J STAT, V6, P65; JONES GP, 1988, NEW ZEAL J MAR FRESH, V22, P445, DOI 10.1080/00288330.1988.9516315; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Leys SP, 2004, MAR ECOL PROG SER, V283, P133, DOI 10.3354/meps283133; Margalef R., 1968, PERSPECTIVES ECOLOGI; Meyer KS, 2013, BIOGEOSCIENCES, V10, P3479, DOI 10.5194/bg-10-3479-2013; Miller RJ, 2008, ECOLOGY, V89, P452, DOI 10.1890/06-1099.1; Mortensen PB, 2005, ERLANGEN EARTH C SER, P247, DOI 10.1007/3-540-27673-4_12; Mortensen PB, 2001, J MAR BIOL ASSOC UK, V81, P581, DOI 10.1017/S002531540100426X; MULLINEAUX LS, 1987, DEEP-SEA RES, V34, P165, DOI 10.1016/0198-0149(87)90080-X; Oigman-Pszczol SS, 2004, MAR ECOL-P S Z N I, V25, P173, DOI 10.1111/j.1439-0485.2004.00018.x; OJEDA FP, 1989, MAR ECOL PROG SER, V57, P147, DOI 10.3354/meps057147; Ontrup J., 2009, OCEANS 2009 EUROPE, V17, DOI [10.1109/OCEANSE.2009.5278332, DOI 10.1109/OCEANSE.2009.5278332]; Oschmann W., 1990, Senckenbergiana Maritima, V21, P55; PIELOU E C, 1969, P286; Quattrini AM, 2012, MAR BIOL, V159, P1079, DOI 10.1007/s00227-012-1888-7; Queric NV, 2007, MAR ECOL-EVOL PERSP, V28, P66, DOI 10.1111/j.1439-0485.2007.00177.x; Roberts DE, 2006, MAR ECOL PROG SER, V307, P143, DOI 10.3354/meps307143; Robillard MMR, 2010, J SHELLFISH RES, V29, P291, DOI 10.2983/035.029.0203; Rogers AD, 2008, SEAMOUNTS ECOLOGY FI; Ross SW, 2007, DEEP-SEA RES PT I, V54, P975, DOI 10.1016/j.dsr.2007.03.010; Ruitton S, 2000, ESTUAR COAST SHELF S, V50, P217, DOI 10.1006/ecss.1999.0546; Schoening T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038179; Schulz M, 2010, POLAR BIOL, V33, P1359, DOI 10.1007/s00300-010-0825-9; Shannon C.E., 1963, MATH THEORY COMMUNIC; Smith F, 1999, ECOLOGY, V80, P51, DOI 10.2307/176979; Soltwedel T., 2005, OCEANOGRAPHY, V18, P46, DOI [10.5670/oceanog.2005.24, DOI 10.5670/0CEAN0G.2005.24]; Swearer SE, 2002, B MAR SCI, V70, P251; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; THRESHER RE, 1986, B MAR SCI, V38, P253; Tissot BN, 2005, FISH B, V104, P167; Tuya F, 2004, MAR ECOL PROG SER, V278, P157, DOI 10.3354/meps278157; Vacelet J, 2002, CAH BIOL MAR, V43, P141; Vanderklift MA, 2004, MAR FRESHWATER RES, V55, P93, DOI 10.1071/MF03057; Wahl M, 2009, ECOL STUD-ANAL SYNTH, V206, P1, DOI 10.1007/b76710; WELLINGTON GM, 1982, ECOL MONOGR, V52, P223, DOI 10.2307/2937329	53	17	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105424	10.1371/journal.pone.0105424	http://dx.doi.org/10.1371/journal.pone.0105424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153985	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200046
J	Wu, JY; Zong, Y; Fei, XC; Chen, XS; Huang, O; He, JR; Chen, WG; Li, YF; Shen, KW; Zhu, L				Wu, Jiayi; Zong, Yu; Fei, Xiaochun; Chen, Xiaosong; Huang, Ou; He, Jianrong; Chen, Weiguo; Li, Yafen; Shen, Kunwei; Zhu, Li			Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; HEPATOCELLULAR-CARCINOMA; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; SUBTYPES; PROTEIN; ABERRATIONS; METASTASIS; INHIBITOR; GROWTH	Background: The chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like gene (CHD1L) is a recently identified oncogene localized at 1q21. CHD1L protein over-expression in primary hepatocellular carcinoma is correlated with enhanced apoptosis inhibition, reduced chemosensitivity and shortened patient survival. However, CHD1L protein status or mRNA expression in breast cancer and its clinical significance remain obscure. Material and Methods: In this study, immunohistochemical staining for CHD1L expression was performed on tissue microarrays containing 179 primary invasive breast cancers and 65 matched normal breast tissue specimens. Clinicopathological features were collected and compared between different CHD1L statuses. Kaplan-Meier curves were applied to estimate disease-free survival (DFS) and overall survival (OS). Cox regression was used to identify independent prognostic factors. Also, quantitative real-time polymerase chain reaction (QRT-PCR) was employed to evaluate the mRNA level expression of CHD1L in six breast cancer cell lines. Results: Presence of CHD1L over-expression was observed in 87 of the 179 patients (48.6%), which associated with a younger age (P = 0.011), higher grade (P = 0.004), higher Ki-67 index (P = 0.018) and HER2 over-expression/amplification (P = 0.037). After a median follow-up of 55 months, patients with presence of CHD1L over-expression had significantly poorer DFS (82.6% Vs 76.3%, P = 0.035), but not OS (87.0% Vs 94.9%, P = 0.439). In multivariate analysis, CHD1L status (HR = 2.169, [95% CI, 1.029-4.573], P = 0.042), triple negative subtype (HR = 2.809, [95% CI 1.086-7.264], P = 0.033) and HER2 positive subtype (HR = 5.221, [95% CI 1.788-15.240], P = 0.002) were identified as independent prognostic factors for DFS. In vitro study indicated that relative mRNA expression level of CHD1L was higher in breast cancer cell lines, especially in MDA-MB-231 and LM2-4175, when compared to normal breast epithelial cell line. Conclusions: Presence of CHD1L over-expression is probably associated with aggressive tumor biology in breast cancer. CHD1L status might be a novel prognostic biomarker for patients with breast cancer.	[Wu, Jiayi; Zong, Yu; Chen, Xiaosong; Huang, Ou; He, Jianrong; Chen, Weiguo; Li, Yafen; Shen, Kunwei; Zhu, Li] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Comprehens Breast Hlth Ctr, Shanghai 200030, Peoples R China; [Fei, Xiaochun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Dept Pathol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhu, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Comprehens Breast Hlth Ctr, Shanghai 200030, Peoples R China.	zhuli8@hotmail.com	吴, 家怡/GSI-7419-2022	Zhu, Li/0000-0002-9294-5727; Zong, Yu/0000-0001-9352-5997	Shanghai Natural Science Foundation [11ZR1422900]; National Natural Science Foundation of China [81102017]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Shanghai Natural Science Foundation 11ZR1422900 and National Natural Science Foundation of China (Young Investigators) 81102017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Bisaro B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3342; Chang J, 2002, CANCER LETT, V182, P193, DOI 10.1016/S0304-3835(02)00083-6; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen LL, 2011, GUT, V60, P534, DOI 10.1136/gut.2010.224071; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen LL, 2009, HEPATOLOGY, V50, P122, DOI 10.1002/hep.22933; Chen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006727; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Deng WB, 2009, CELL STEM CELL, V5, P349, DOI 10.1016/j.stem.2009.09.002; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Guan XY, 2000, GENE CHROMOSOME CANC, V29, P110; Gunther K, 2001, J PATHOL, V193, P40, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH745>3.0.CO;2-N; He WP, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-437; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Hyeon J, 2013, KOREAN J PATHOL, V47, P9, DOI [10.4132/KoreanJPathol.2013.47.1.9, 10.4132/KoreanJPathol.2014.48.2.91]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kusano N, 1999, HEPATOLOGY, V29, P1858, DOI 10.1002/hep.510290636; Laakso M, 2006, CLIN CANCER RES, V12, P4185, DOI 10.1158/1078-0432.CCR-06-0353; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Marchio A, 1997, GENE CHROMOSOME CANC, V18, P59, DOI 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Sakakura C, 1999, BRIT J CANCER, V80, P2034, DOI 10.1038/sj.bjc.6690638; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Thomas PA, 1999, CLIN CANCER RES, V5, P2698; Tsuji Katumi, 2010, BMC Cancer, V10, P15, DOI 10.1186/1471-2407-10-15; Wong N, 1999, AM J PATHOL, V154, P37, DOI 10.1016/S0002-9440(10)65248-0; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472	36	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e98673	10.1371/journal.pone.0098673	http://dx.doi.org/10.1371/journal.pone.0098673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153161	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200001
J	Blazquez-Medela, AM; Garcia-Sanchez, O; Blanco-Gozalo, V; Quiros, Y; Montero, MJ; Martinez-Salgado, C; Lopez-Novoa, JM; Lopez-Hernandez, FJ				Blazquez-Medela, Ana M.; Garcia-Sanchez, Omar; Blanco-Gozalo, Victor; Quiros, Yaremi; Montero, Maria J.; Martinez-Salgado, Carlos; Lopez-Novoa, Jose M.; Lopez-Hernandez, Francisco J.			Hypertension and Hyperglycemia Synergize to Cause Incipient Renal Tubular Alterations Resulting in Increased NGAL Urinary Excretion in Rats	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; CHRONIC KIDNEY-DISEASE; TNF RECEPTORS 1; PROXIMAL TUBULE; CARDIOVASCULAR RISK; MARKER; BIOMARKER; PROGRESSION; CKD; NEPHROPATHIES	Background: Hypertension and diabetes are the two leading causes of chronic kidney disease (CKD) eventually leading to end stage renal disease (ESRD) and the need of renal replacement therapy. Mortality among CKD and ESRD patients is high, mostly due to cardiovascular events. New early markers of risk are necessary to better anticipate the course of the disease, to detect the renal affection of additive risk factors, and to appropriately handle patients in a pre-emptive and personalized manner. Methods: Renal function and NGAL urinary excretion was monitored in rats with spontaneous (SHR) or L-NAME induced hypertension rendered hyperglycemic (or not as controls). Results: Combination of hypertension and hyperglycemia (but not each of these factors independently) causes an increased urinary excretion of neutrophil gelatinase-associated lipocalin (NGAL) in the rat, in the absence of signs of renal damage. Increased NGAL excretion is observed in diabetic animals with two independent models of hypertension. Elevated urinary NGAL results from a specific alteration in its tubular handling, rather than from an increase in its renal expression. In fact, when kidneys of hyperglycaemic-hypertensive rats are perfused in situ with Krebs-dextran solution containing exogenous NGAL, they excrete more NGAL in the urine than hypertensive rats. We also show that albuminuria is not capable of detecting the additive effect posed by the coexistence of these two risk factors. Conclusions: Our results suggest that accumulation of hypertension nd hyperglycemia induces an incipient and quite specific alteration in the tubular handling of NGAL resulting in its increased urinary excretion.	[Blanco-Gozalo, Victor; Martinez-Salgado, Carlos; Lopez-Hernandez, Francisco J.] Hosp Univ Salamanca, IECSCYL, Inst Invest Biomed Salamanca IBSAL, Unidad Invest, Salamanca, Spain; [Blazquez-Medela, Ana M.; Garcia-Sanchez, Omar; Blanco-Gozalo, Victor; Quiros, Yaremi; Montero, Maria J.; Martinez-Salgado, Carlos; Lopez-Novoa, Jose M.; Lopez-Hernandez, Francisco J.] Univ Salamanca, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain; [Blazquez-Medela, Ana M.; Garcia-Sanchez, Omar; Martinez-Salgado, Carlos; Lopez-Novoa, Jose M.; Lopez-Hernandez, Francisco J.] Fdn Inigo Alvarez Toledo, Inst Reina Sofia Invest Nefrol, Madrid, Spain; [Blanco-Gozalo, Victor; Quiros, Yaremi] BioinRen SL, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Lopez-Hernandez, FJ (corresponding author), Hosp Univ Salamanca, IECSCYL, Inst Invest Biomed Salamanca IBSAL, Unidad Invest, Salamanca, Spain.	flopezher@usal.es	Blázquez-Medela, Ana/K-3142-2014; Blázquez-Medela, Ana/ABC-1517-2021; Montero, María José MJ/C-3084-2018; Lopez-Novoa, Jose M/A-3672-2008; Lopez-Hernandez, Francisco J/A-5422-2016	Blázquez-Medela, Ana/0000-0003-3829-6997; Montero, María José MJ/0000-0003-2125-0378; Martinez-Salgado, Carlos/0000-0003-4641-6717; Garcia-Sanchez, Omar/0000-0002-5145-8455; Lopez-Hernandez, Francisco J/0000-0001-7778-7495	Junta de Castilla y Leon, Spain [HUS02B06, GRS80/A/06, GR-100]; Instituto de Salud Carlos III, Madrid, Spain [PI081900, PI11/02278, PS0901067, 06/0016]; Fundacion Renal Inigo Alvarez de Toledo, Madrid, Spain	Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Fundacion Renal Inigo Alvarez de Toledo, Madrid, Spain	This work was supported by grants from the Junta de Castilla y Leon (Consejeria de Educacion, HUS02B06; Consejeria de Sanidad, GRS80/A/06; and Excellence Group, GR-100), Spain; Instituto de Salud Carlos III (FIS, PI081900, PI11/02278, PS0901067; and RETIC 06/0016, RedinRen), Madrid, Spain; and Fundacion Renal Inigo Alvarez de Toledo, Madrid, Spain. AMB-M and OG-S were recipients of a fellowship from the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins RC, 2005, KIDNEY INT, V67, pS14, DOI 10.1111/j.1523-1755.2005.09403.x; Basi S, 2008, DIABETES CARE, V31, pS194, DOI 10.2337/dc08-s249; Bergeron M, 1996, AM J PHYSIOL-RENAL, V271, pF908, DOI 10.1152/ajprenal.1996.271.4.F908; Bolignano D, 2010, EUR J CLIN INVEST, V40, P273, DOI 10.1111/j.1365-2362.2010.02258.x; Bolignano D, 2009, KIDNEY BLOOD PRESS R, V32, P91, DOI 10.1159/000209379; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlson M, 2002, GUT, V50, P501, DOI 10.1136/gut.50.4.501; Carrero JJ, 2011, NAT REV NEPHROL, V7, P65, DOI 10.1038/nrneph.2010.177; Chaudhary K, 2010, CURR DIABETES REP, V10, P37, DOI 10.1007/s11892-009-0080-z; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; De Zeeuw D, 2005, KIDNEY INT, V68, pS25, DOI 10.1111/j.1523-1755.2005.09805.x; Devarajan P, 2008, SCAND J CLIN LAB INV, V68, P89, DOI 10.1080/00365510802150158; Devarajan P, 2010, BIOMARK MED, V4, P265, DOI [10.2217/bmm.10.12, 10.2217/BMM.10.12]; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gaspari F, 2010, NEPHRON CLIN PRACT, V115, pC154, DOI 10.1159/000312879; Gohda T, 2013, CURR DIABETES REP, V13, P560, DOI 10.1007/s11892-013-0385-9; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Grossman E, 2008, ADV CARDIOL, V45, P82, DOI 10.1159/000115189; Hryciw DH, 2004, CLIN EXP PHARMACOL P, V31, P372, DOI 10.1111/j.1440-1681.2004.04001.x; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Izumi Y, 2013, DIABETES RES CLIN PR, V99, P145, DOI 10.1016/j.diabres.2012.11.002; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Lebkowska U, 2009, TRANSPL P, V41, P154, DOI 10.1016/j.transproceed.2008.10.092; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; LOPEZNOVOA JM, 1986, AM J PHYSIOL, V250, pE545, DOI 10.1152/ajpendo.1986.250.5.E545; Malyszko J, 2008, RENAL FAILURE, V30, P625, DOI 10.1080/08860220802134607; Malyszko J, 2008, NEPHROLOGY, V13, P153, DOI 10.1111/j.1440-1797.2007.00899.x; Mancia G, 2005, ACTA DIABETOL, V42, pS17, DOI 10.1007/s00592-005-0177-z; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nagai J, 2001, AM J PHYSIOL-RENAL, V281, pF337, DOI 10.1152/ajprenal.2001.281.2.F337; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Quiros Y, 2010, KIDNEY INT, V78, P1006, DOI 10.1038/ki.2010.267; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Sahakyan K, 2010, AM HEART J, V159, P1074, DOI 10.1016/j.ahj.2010.03.023; SEEBER AM, 1982, CLIN SCI, V63, P217, DOI 10.1042/cs0630217; Soni SS, 2010, INT UROL NEPHROL, V42, P141, DOI 10.1007/s11255-009-9608-z; Szczech LA, 2004, KIDNEY INT, V66, pS3, DOI 10.1111/j.1523-1755.2004.09002.x; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; United States Renal Data Systems, USRDS 2007 ANN DAT R; *USRDS, 2009, 2009 ANN DAT REP ATL; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Wasilewska A, 2010, PEDIATR NEPHROL, V25, P889, DOI 10.1007/s00467-009-1397-1; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753	51	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105988	10.1371/journal.pone.0105988	http://dx.doi.org/10.1371/journal.pone.0105988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148248	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600105
J	Kovacevic, L; Tambets, K; Ilumae, AM; Kushniarevich, A; Yunusbayev, B; Solnik, A; Bego, T; Primorac, D; Skaro, V; Leskovac, A; Jakovski, Z; Drobnic, K; Tolk, HV; Kovacevic, S; Rudan, P; Metspalu, E; Marjanovic, D				Kovacevic, Lejla; Tambets, Kristiina; Ilumaee, Anne-Mai; Kushniarevich, Alena; Yunusbayev, Bayazit; Solnik, Anu; Bego, Tamer; Primorac, Dragan; Skaro, Vedrana; Leskovac, Andreja; Jakovski, Zlatko; Drobnic, Katja; Tolk, Helle-Viivi; Kovacevic, Sandra; Rudan, Pavao; Metspalu, Ene; Marjanovic, Damir			Standing at the Gateway to Europe - The Genetic Structure of Western Balkan Populations Based on Autosomal and Haploid Markers	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; Y-CHROMOSOME; MODERN HUMANS; SOUTHEASTERN EUROPE; MTDNA HAPLOGROUPS; HERITAGE; NEANDERTHALS; COLONIZATION; LINEAGES; BOSNIANS	Contemporary inhabitants of the Balkan Peninsula belong to several ethnic groups of diverse cultural background. In this study, three ethnic groups from Bosnia and Herzegovina - Bosniacs, Bosnian Croats and Bosnian Serbs - as well as the populations of Serbians, Croatians, Macedonians from the former Yugoslav Republic of Macedonia, Montenegrins and Kosovars have been characterized for the genetic variation of 660 000 genome-wide autosomal single nucleotide polymorphisms and for haploid markers. New autosomal data of the 70 individuals together with previously published data of 20 individuals from the populations of the Western Balkan region in a context of 695 samples of global range have been analysed. Comparison of the variation data of autosomal and haploid lineages of the studied Western Balkan populations reveals a concordance of the data in both sets and the genetic uniformity of the studied populations, especially of Western South-Slavic speakers. The genetic variation of Western Balkan populations reveals the continuity between the Middle East and Europe via the Balkan region and supports the scenario that one of the major routes of ancient gene flows and admixture went through the Balkan Peninsula.	[Kovacevic, Lejla; Tambets, Kristiina; Ilumaee, Anne-Mai; Kushniarevich, Alena; Yunusbayev, Bayazit; Solnik, Anu; Tolk, Helle-Viivi; Metspalu, Ene] Univ Tartu, Estonian Bioctr, Tartu, Estonia; [Kovacevic, Lejla; Tambets, Kristiina; Ilumaee, Anne-Mai; Kushniarevich, Alena; Yunusbayev, Bayazit; Solnik, Anu; Tolk, Helle-Viivi; Metspalu, Ene] Univ Tartu, Dept Evolutionary Biol, Tartu, Estonia; [Kovacevic, Lejla; Marjanovic, Damir] Inst Genet Engn & Biotechnol, Sarajevo, Bosnia & Herceg; [Kovacevic, Lejla; Yunusbayev, Bayazit] RAS, Ufa Res Ctr, Inst Biochem & Genet, Ufa, Bashkortostan, Russia; [Bego, Tamer] Univ Sarajevo, Fac Pharm, Sarajevo, Bosnia & Herceg; [Primorac, Dragan; Marjanovic, Damir] Univ Ctr Forens Sci, Split, Croatia; [Skaro, Vedrana] Genos Doo, Zagreb, Croatia; [Leskovac, Andreja] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade, Serbia; [Jakovski, Zlatko] Univ St Cyril & Methodius, Fac Med, Inst Forens Med Criminol & Med Deontol, Skopje, Macedonia; [Drobnic, Katja] Natl Forens Lab, Minist Interior, Ljubljana, Slovenia; [Kovacevic, Sandra] Forens Ctr, Police Directorate, Danilovgrad, Montenegro; [Rudan, Pavao] Croatian Acad Sci & Art, Zagreb, Croatia	Estonian Biocentre; University of Tartu; University of Tartu; University of Sarajevo; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; University of Sarajevo; University of Split; University of Belgrade; Saints Cyril & Methodius University of Skopje; Croatian Academy of Sciences & Arts	Kovacevic, L (corresponding author), Univ Tartu, Estonian Bioctr, Tartu, Estonia.	lejla_kova@yahoo.com	Leskovac, Andreja/H-4969-2016; Primorac, Dragan/I-6941-2017; Primorac, Dragan/GYJ-1505-2022; Primorac, Dragan/ABF-6238-2020; Tambets, Kristiina/M-2568-2019; Yunusbaev, Bayazit/T-5444-2019	Leskovac, Andreja/0000-0002-6293-5237; Tambets, Kristiina/0000-0002-8173-6380; Yunusbayev, Bayazit/0000-0002-6035-8763; Marjanovic, Damir/0000-0002-7472-4525; Ilumae, Anne-Mai/0000-0001-6920-1335; Skaro, Vedrana/0000-0002-8275-867X	European Union European Regional Development Fund through the Centre of Excellence in Genomics; Estonian Biocentre (EBC); University of Tartu; European Commission ECOGENE [205419]; Estonian Basic Research [SF 0270177s08]	European Union European Regional Development Fund through the Centre of Excellence in Genomics; Estonian Biocentre (EBC); University of Tartu; European Commission ECOGENE; Estonian Basic Research	This work was supported by the European Union European Regional Development Fund through the Centre of Excellence in Genomics, by the Estonian Biocentre (EBC) and the University of Tartu, by the European Commission grant 205419 ECOGENE to the EBC, and by the Estonian Basic Research Grant SF 0270177s08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Barac L, 2003, EUR J HUM GENET, V11, P535, DOI 10.1038/sj.ejhg.5200992; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Berg K, 2005, AM J HUM GENET, V77, P519; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Curta F, 2006, CAMB MEDIEV TEXTB, P1; Cvjetan S, 2004, COLLEGIUM ANTROPOL, V28, P193; Dolukhanov P. M., 2000, ROOTS PEOPLES LANGUA, P71; Durham ME, 1909, HIGH ALBANIA, P95; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foley R., 2001, ARCHAEOGENETICS DNA, P45; GEORGIEV V, 1966, SLAVON E EUR REV, V44, P285; Gnammankou D, 1988, AFRICAN SLAVE TRACE; Gray RD, 2011, PHILOS T R SOC B, V366, P1090, DOI 10.1098/rstb.2010.0378; Hoffecker JF, 2009, P NATL ACAD SCI USA, V106, P16040, DOI 10.1073/pnas.0903446106; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; IMAMOVIC E, 1998, BOSNIA HERZEGOVINA O; JANKOVIC I, 2012, PALEOANTHROPOLOGY, P87, DOI DOI 10.4207/PA.2012.ART72; Jeran N, 2009, COLLEGIUM ANTROPOL, V33, P1323; Karavanic I, 1998, J HUM EVOL, V34, P223, DOI 10.1006/jhev.1997.0192; KARAVANIC I, 1995, J ANTHROPOL RES, V51, P9, DOI 10.1086/jar.51.1.3630370; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Malcolm N, 1998, KOSOVO SHORT HIST, P14; Malyarchuk BA, 2003, ANN HUM GENET, V67, P412, DOI 10.1046/j.1469-1809.2003.00042.x; Marjanovic D, 2005, ANN HUM GENET, V69, P757, DOI 10.1111/j.1529-8817.2005.00190.x; Markotic V, 1964, ARCHEOLOGY, P20; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; Mellars P, 2006, EVOL ANTHROPOL, V15, P167, DOI 10.1002/evan.20103; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morley MW, 2011, QUATERNARY RES, V75, P683, DOI 10.1016/j.yqres.2011.02.005; Murphey R, 1999, OTTOMAN WARFARE 1500, P1; Paschou P, 2014, P NATL ACAD SCI USA, V111, P9211, DOI 10.1073/pnas.1320811111; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pereira L, 2004, INT CONGR SER, V1261, P416, DOI 10.1016/S0531-5131(03)01651-0; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Perle C., 2000, HUNTERS GOLDEN AGE M, P375; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Primorac D, 2011, CROAT MED J, V52, P225, DOI 10.3325/cmj.2011.52.225; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Saric J, 2009, PALEOLITHIC MESOLITH, VLVIII, P9; SAVLI J, 1996, VENETI 1 BUILDERS EU; Schevill F, 1922, HIST BALKAN PENINSUL, P59; SEDOV VV, 1979, ORIGIN EARLY HIST SL; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Stavros L, 2000, BALKANS 1453, P5; Stipicevic A, 1999, QUESTION ILLYRIAN AL; Tolk HV, 2000, COLLEGIUM ANTROPOL, V24, P267; Tolk HV, 2001, EUR J HUM GENET, V9, P717, DOI 10.1038/sj.ejhg.5200709; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Varzari A, 2012, AM J HUM BIOL, V21, P326; Wachtel A.B., 2008, BALKANS WORLD HIST, P51; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilkes John, 1992, THE ILLYRIANS; Yunusbayev B, 2014, COLD SPRING HARBOR L	68	37	37	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105090	10.1371/journal.pone.0105090	http://dx.doi.org/10.1371/journal.pone.0105090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148043	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600031
J	Sutliff, RL; Walp, ER; Kim, YH; Walker, LA; El-Ali, AM; Ma, J; Bonsall, R; Ramosevac, S; Eaton, DC; Verlander, JW; Hansen, L; Gleason, RL; Pham, TD; Hong, S; Pech, V; Wall, SM				Sutliff, Roy L.; Walp, Erik R.; Kim, Young Hee; Walker, Lori A.; El-Ali, Alexander M.; Ma, Jing; Bonsall, Robert; Ramosevac, Semra; Eaton, Douglas C.; Verlander, Jill W.; Hansen, Laura; Gleason, Rudolph L., Jr.; Pham, Truyen D.; Hong, Seongun; Pech, Vladimir; Wall, Susan M.			Contractile Force Is Enhanced in Aortas from Pendrin Null Mice Due to Stimulation of Angiotensin II-Dependent Signaling	PLOS ONE			English	Article							SMOOTH-MUSCLE; BLOOD-PRESSURE; PSYCHOPHYSIOLOGICAL INVESTIGATIONS; VASCULAR REACTIVITY; MYOCARDIAL-ISCHEMIA; ISOMETRIC FORCE; HEAVY-CHAIN; MOUSE; PROTEIN; MYOSIN	Pendrin is a Cl-/HCO3- exchanger expressed in the apical regions of renal intercalated cells. Following pendrin gene ablation, blood pressure falls, in part, from reduced renal NaCl absorption. We asked if pendrin is expressed in vascular tissue and if the lower blood pressure observed in pendrin null mice is accompanied by reduced vascular reactivity. Thus, the contractile responses to KCl and phenylephrine (PE) were examined in isometrically mounted thoracic aortas from wild-type and pendrin null mice. Although pendrin expression was not detected in the aorta, pendrin gene ablation changed contractile protein abundance and increased the maximal contractile response to PE when normalized to cross sectional area (CSA). However, the contractile sensitivity to this agent was unchanged. The increase in contractile force/cross sectional area observed in pendrin null mice was due to reduced cross sectional area of the aorta and not from increased contractile force per vessel. The pendrin-dependent increase in maximal contractile response was endothelium- and nitric oxide-independent and did not occur from changes in Ca2+ sensitivity or chronic changes in catecholamine production. However, application of 100 nM angiotensin II increased force/CSA more in aortas from pendrin null than from wild type mice. Moreover, angiotensin type 1 receptor inhibitor (candesartan) treatment in vivo eliminated the pendrin-dependent changes contractile protein abundance and changes in the contractile force/cross sectional area in response to PE. In conclusion, pendrin gene ablation increases aorta contractile force per cross sectional area in response to angiotensin II and PE due to stimulation of angiotensin type 1 receptor-dependent signaling. The angiotensin type 1 receptor-dependent increase in vascular reactivity may mitigate the fall in blood pressure observed with pendrin gene ablation.	[Sutliff, Roy L.; Walp, Erik R.; El-Ali, Alexander M.; Ma, Jing] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; [Sutliff, Roy L.; Walp, Erik R.; Kim, Young Hee; El-Ali, Alexander M.; Ma, Jing; Pham, Truyen D.; Hong, Seongun; Pech, Vladimir; Wall, Susan M.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Walker, Lori A.] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO USA; [Walker, Lori A.] Univ Colorado, Hlth Sci Ctr, Dept Cardiol, Aurora, CO USA; [Bonsall, Robert] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Ramosevac, Semra; Wall, Susan M.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Verlander, Jill W.] Univ Florida, Dept Med, Gainesville, FL USA; [Hansen, Laura; Gleason, Rudolph L., Jr.] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Emory University; Emory University; State University System of Florida; University of Florida; University System of Georgia; Georgia Institute of Technology	Wall, SM (corresponding author), Emory Univ, Dept Med, Atlanta, GA 30322 USA.	smwall@emory.edu	Walker, Lori/J-7098-2013; Verlander, Jill/I-5991-2015	Walker, Lori/0000-0003-2556-8076; Pech, Vladimir/0000-0002-1994-4277; Hansen, Laura/0000-0002-3936-9476	National Institute of Diabetes, Digestive and Kidney Diseases [46493, 37963]; National Heart, Lung and Blood Institute [070892]	National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Institute of Diabetes, Digestive and Kidney Diseases grants 46493 (to S. M. Wall); 37963 (to D. C. Eaton); and National Heart, Lung and Blood Institute grant 070892 (to R. L. Sutliff). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BRUNER CA, 1992, HYPERTENSION, V20, P59, DOI 10.1161/01.HYP.20.1.59; Chamiot-Clerc P, 2001, HYPERTENSION, V37, P313, DOI 10.1161/01.HYP.37.2.313; Chipperfield AR, 2000, PROG BIOPHYS MOL BIO, V74, P175, DOI 10.1016/S0079-6107(00)00024-9; Eddinger TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC493, DOI 10.1152/ajpcell.00131.2007; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Goldberg AD, 1996, CIRCULATION, V94, P2402, DOI 10.1161/01.CIR.94.10.2402; GRIFFIN SA, 1991, HYPERTENSION, V17, P626, DOI 10.1161/01.HYP.17.5.626; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; IKEBE M, 1991, J BIOL CHEM, V266, P7030; Kaufmann PG, 1998, PSYCHOSOM MED, V60, P56, DOI 10.1097/00006842-199801000-00014; KILTS CD, 1984, J NEUROSCI METH, V11, P257, DOI 10.1016/0165-0270(84)90088-8; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Kim YH, 2007, AM J PHYSIOL-RENAL, V293, pF1314, DOI 10.1152/ajprenal.00155.2007; Kim YH, 2009, AM J PHYSIOL-RENAL, V297, pF1069, DOI 10.1152/ajprenal.90581.2008; Knauf F, 2001, P NATL ACAD SCI USA, V98, P9425, DOI 10.1073/pnas.141241098; Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0; Lalli J, 1997, CIRC RES, V80, P506, DOI 10.1161/01.RES.80.4.506; LONGHURST PA, 1988, HYPERTENSION, V12, P133, DOI 10.1161/01.HYP.12.2.133; Martin AF, 2007, AM J PHYSIOL-CELL PH, V293, pC238, DOI 10.1152/ajpcell.00567.2006; MAZE M, 1985, LIFE SCI, V37, P1571, DOI 10.1016/0024-3205(85)90475-8; MCMAHON EG, 1986, AM J PHYSIOL, V250, pC468, DOI 10.1152/ajpcell.1986.250.3.C468; MCMAHON EG, 1985, CIRC RES, V56, P427, DOI 10.1161/01.RES.56.3.427; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Pech V, 2010, J AM SOC NEPHROL, V21, P1928, DOI 10.1681/ASN.2009121257; Rajagopalan S, 1997, HYPERTENSION, V30, P29, DOI 10.1161/01.HYP.30.1.29; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Russell A, 2000, J PHARMACOL EXP THER, V294, P598; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Simon G, 2001, HYPERTENSION, V37, P255, DOI 10.1161/01.HYP.37.2.255; Stapleton Phoebe A, 2008, Pathophysiology, V15, P79, DOI 10.1016/j.pathophys.2008.04.007; Sutliff RL, 1999, ENDOCRINOLOGY, V140, P2077, DOI 10.1210/en.140.5.2077; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Tanaka M, 1999, BIOCHEM BIOPH RES CO, V258, P194, DOI 10.1006/bbrc.1999.0500; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; TURLA MB, 1991, CIRC RES, V68, P288, DOI 10.1161/01.RES.68.1.288; Verlander JW, 2006, AM J PHYSIOL-RENAL, V291, pF833, DOI 10.1152/ajprenal.00474.2005; Verlander JW, 2011, AM J PHYSIOL-RENAL, V301, pF1314, DOI 10.1152/ajprenal.00114.2011; Verlander JW, 2003, HYPERTENSION, V42, P356, DOI 10.1161/01.HYP.0000088321.67254.B7; Walker LA, 2001, J BIOL CHEM, V276, P24519, DOI 10.1074/jbc.M103560200; Wall SM, 2004, HYPERTENSION, V44, P982, DOI 10.1161/01.HYP.0000145863.96091.89; Wall SM, 2006, AM J PHYSIOL-RENAL, V290, pF409, DOI 10.1152/ajprenal.00309.2005; Wall SM, 2003, AM J PHYSIOL-RENAL, V284, pF229, DOI 10.1152/ajprenal.00147.2002; Wang D, 2006, J VASC RES, V43, P109, DOI 10.1159/000089969; Zhao GS, 2001, ENDOCRINOLOGY, V142, P623, DOI 10.1210/en.142.2.623; Zhou YB, 2003, AM J PHYSIOL-HEART C, V285, pH2797, DOI 10.1152/ajpheart.00466.2003	46	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105101	10.1371/journal.pone.0105101	http://dx.doi.org/10.1371/journal.pone.0105101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148130	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600032
J	Airola, MV; Tumolo, JM; Snider, J; Hannun, YA				Airola, Michael V.; Tumolo, Jessica M.; Snider, Justin; Hannun, Yusuf A.			Identification and Biochemical Characterization of an Acid Sphingomyelinase-Like Protein from the Bacterial Plant Pathogen Ralstonia solanacearum that Hydrolyzes ATP to AMP but Not Sphingomyelin to Ceramide	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ALKALINE SPHINGOMYELINASE; NEUTRAL SPHINGOMYELINASE; STRUCTURAL BASIS; MUTATIONS; ENZYME; GENE; EXPRESSION; DISEASE; TOXIN	Acid sphingomyelinase (aSMase) is a human enzyme that catalyzes the hydrolysis of sphingomyelin to generate the bioactive lipid ceramide and phosphocholine. ASMase deficiency is the underlying cause of the genetic diseases Niemann-Pick Type A and B and has been implicated in the onset and progression of a number of other human diseases including cancer, depression, liver, and cardiovascular disease. ASMase is the founding member of the aSMase protein superfamily, which is a subset of the metallophosphatase (MPP) superfamily. To date, MPPs that share sequence homology with aSMase, termed aSMase-like proteins, have been annotated and presumed to function as aSMases. However, none of these aSMase-like proteins have been biochemically characterized to verify this. Here we identify RsASML, previously annotated as RSp1609: acid sphingomyelinase-like phosphodiesterase, as the first bacterial aSMase-like protein from the deadly plant pathogen Ralstonia solanacearum based on sequence homology with the catalytic and C-terminal domains of human aSMase. A biochemical characterization of RsASML does not support a role in sphingomyelin hydrolysis but rather finds RsASML capable of acting as an ATP diphosphohydrolase, catalyzing the hydrolysis of ATP and ADP to AMP. In addition, RsASML displays a neutral, not acidic, pH optimum and prefers Ni2+ or Mn2+, not Zn2+, for catalysis. This alters the expectation that all aSMase-like proteins function as acid SMases and expands the substrate possibilities of this protein superfamily to include nucleotides. Overall, we conclude that sequence homology with human aSMase is not sufficient to predict substrate specificity, pH optimum for catalysis, or metal dependence. This may have implications to the biochemically uncharacterized human aSMase paralogs, aSMase-like 3a (aSML3a) and aSML3b, which have been implicated in cancer and kidney disease, respectively, and assumed to function as aSMases.	[Airola, Michael V.; Snider, Justin; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Airola, Michael V.; Snider, Justin; Hannun, Yusuf A.] SUNY Stony Brook, Ctr Canc, Stony Brook, NY 11794 USA; [Tumolo, Jessica M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Medical University of South Carolina	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	yusuf.hannun@sbumed.org		Airola, Michael/0000-0003-4981-1253; Tumolo, Jessica/0000-0002-1999-5672	National Institutes of Health [NIGMS R37 GM043825, NIGMS F32 GM100679]; MUSC Summer Undergraduate Research Program (SURP); NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, F32GM100679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MUSC Summer Undergraduate Research Program (SURP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health NIGMS R37 GM043825 (to Y.A.H.) and NIGMS F32 GM100679 (to M. V. A.). The MUSC Summer Undergraduate Research Program (SURP) provided additional support (to J.M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago H, 2006, J BIOL CHEM, V281, P16157, DOI 10.1074/jbc.M601089200; Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Aldon D, 2000, EMBO J, V19, P2304, DOI 10.1093/emboj/19.10.2304; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atilla-Gokcumen GE, 2014, CELL; Bartelsen O, 1998, J BIOTECHNOL, V63, P29, DOI 10.1016/S0168-1656(98)00070-4; Buckhaults P, 2001, CANCER RES, V61, P6996; Choi J, 2014, SCIENCE, V343, P290, DOI 10.1126/science.343.6168.290; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Dardis Andrea, 2005, Hum Mutat, V26, P164, DOI 10.1002/humu.9353; Desnick JP, 2010, MOL MED, V16, P316, DOI 10.2119/molmed.2010.00017; Devlin CM, 2008, ARTERIOSCL THROM VAS, V28, P1723, DOI 10.1161/ATVBAHA.108.173344; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Duan RD, 2006, BBA-MOL CELL BIOL L, V1761, P281, DOI 10.1016/j.bbalip.2006.03.007; Ferlinz K, 1997, EUR J BIOCHEM, V243, P511, DOI 10.1111/j.1432-1033.1997.511_1a.x; Fornoni A, 2014, NATURE REV NEPHROLOG; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Genin S, 2012, ANNU REV PHYTOPATHOL, V50, P67, DOI 10.1146/annurev-phyto-081211-173000; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Huseby M, 2007, J BACTERIOL, V189, P8719, DOI 10.1128/JB.00741-07; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Lang PA, 2007, NAT MED, V13, P164, DOI 10.1038/nm1539; Lansmann S, 2003, EUR J BIOCHEM, V270, P1076, DOI 10.1046/j.1432-1033.2003.03435.x; Nambiar PR, 2004, CANCER RES, V64, P6394, DOI 10.1158/0008-5472.CAN-04-0933; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Noto PB, 2012, MOL PHARMACOL, V82, P719, DOI 10.1124/mol.112.078865; Oda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038054; Openshaw AEA, 2005, J BIOL CHEM, V280, P35011, DOI 10.1074/jbc.M506800200; Pavlu H, 1997, J INHERIT METAB DIS, V20, P615, DOI 10.1023/A:1005387932546; Pavlu-Pereira H, 2005, J INHERIT METAB DIS, V28, P203, DOI 10.1007/s10545-005-5671-5; Peeters N, 2013, MOL PLANT PATHOL, V14, P651, DOI 10.1111/mpp.12038; Pittis M G, 2004, Hum Mutat, V24, P186, DOI 10.1002/humu.9263; Poueymiro M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/j.mib.2008.11.008; Ricci V, 2004, Hum Mutat, V24, P105, DOI 10.1002/humu.9258; Rodriguez-Pascau L, 2009, HUM MUTAT, V30, P1117, DOI 10.1002/humu.21018; Sabourdy F, 2011, BLOOD, V117, P3695, DOI 10.1182/blood-2010-11-318493; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schissel SL, 1998, J BIOL CHEM, V273, P2738, DOI 10.1074/jbc.273.5.2738; Sikora J, 2003, ANN HUM GENET, V67, P63, DOI 10.1046/j.1469-1809.2003.00009.x; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; Sinha A, 2013, NATURE REV NEPHROLOG; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; SPENCE MW, 1989, J BIOL CHEM, V264, P5358; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Takahashi T, 1997, HUM PATHOL, V28, P385, DOI 10.1016/S0046-8177(97)90141-6; TITBALL RW, 1991, INFECT IMMUN, V59, P1872, DOI 10.1128/IAI.59.5.1872-1874.1991; Wright KO, 2002, J UROLOGY, V168, P2645, DOI 10.1016/S0022-5347(05)64236-X; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z; Yoo T-H, 2014, J AM SOC NEPHROLOGY; Yu H, 2009, AM J RESP CELL MOL, V41, P367, DOI 10.1165/rcmb.2008-0295OC	53	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105830	10.1371/journal.pone.0105830	http://dx.doi.org/10.1371/journal.pone.0105830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144372	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100124
J	Jayaweera, T; Siriwardana, C; Dharmasiri, S; Quint, M; Gray, WM; Dharmasiri, N				Jayaweera, Thilanka; Siriwardana, Chamindika; Dharmasiri, Sunethra; Quint, Marcel; Gray, William M.; Dharmasiri, Nihal			Alternative Splicing of Arabidopsis IBR5 Pre-mRNA Generates Two IBR5 Isoforms with Distinct and Overlapping Functions	PLOS ONE			English	Article							DROUGHT STRESS TOLERANCE; MAPK PHOSPHATASE IBR5; AUXIN RESPONSES; SIGNAL-TRANSDUCTION; FAMILY; MPK12; EXPRESSION; MECHANISM; MUTANTS; REVEALS	The INDOLE-3-BUTYRIC ACID RESPONSE5 (IBR5) gene encodes a dual specificity phosphatase that regulates plant auxin responses. IBR5 has been predicted to generate two transcripts through alternative splicing, but alternative splicing of IBR5 has not been confirmed experimentally. The previously characterized ibr5-1 null mutant exhibits many auxin related defects such as auxin insensitive primary root growth, defective vascular development, short stature and reduced lateral root development. However, whether all these defects are caused by the lack of phosphatase activity is not clear. Here we describe two new auxin insensitive IBR5 alleles, ibr5-4, a catalytic site mutant, and ibr5-5, a splice site mutant. Characterization of these new mutants indicates that IBR5 is post-transcriptionally regulated to generate two transcripts, AT2G04550.1 and AT2G04550.3, and consequently two IBR5 isoforms, IBR5.1 and IBR5.3. The IBR5.1 isoform exhibits phosphatase catalytic activity that is required for both proper degradation of Aux/IAA proteins and auxin-induced gene expression. These two processes are independently regulated by IBR5.1. Comparison of new mutant alleles with ibr5-1 indicates that all three mutant alleles share many phenotypes. However, each allele also confers distinct defects implicating IBR5 isoform specific functions. Some of these functions are independent of IBR5.1 catalytic activity. Additionally, analysis of these new mutant alleles suggests that IBR5 may link ABP1 and SCFTIR1/AFBs auxin signaling pathways.	[Jayaweera, Thilanka; Siriwardana, Chamindika; Dharmasiri, Sunethra; Dharmasiri, Nihal] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Siriwardana, Chamindika] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA; [Quint, Marcel; Gray, William M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Quint, Marcel] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Halle, Saale, Germany	Texas State University System; Texas State University San Marcos; University of Oklahoma System; University of Oklahoma - Norman; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzenbiochemie	Dharmasiri, N (corresponding author), Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	nihal@txstate.edu	Gray, William M/F-9402-2010	Gray, William M/0000-0002-1320-290X; Siriwardana, Chamindika/0000-0002-7746-9427; Quint, Marcel/0000-0003-2935-4083	National Science Foundation [IOB-0845305, DBI-0821252]; Texas State University [9000000525]; National Institute of Health [GM067203]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067203] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Texas State University; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (IOB-0845305 to ND), (DBI-0821252 to JRK DG), Texas State University (9000000525 to ND), and the National Institute of Health (GM067203 to WG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Villalobos LIAC, 2012, NAT CHEM BIOL, V8, P477, DOI [10.1038/NCHEMBIO.926, 10.1038/nchembio.926]; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; Chuang HW, 2004, PLANT CELL, V16, P1883, DOI 10.1105/tpc.021923; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Filichkin SA, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-20; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Freeman J, 2003, CANCER CELL, V02; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jammes F, 2011, PLANT SIGNAL BEHAV, V6, P1875, DOI 10.4161/psb.6.11.17933; Jammes F, 2009, P NATL ACAD SCI USA, V106, P20520, DOI 10.1073/pnas.0907205106; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kriechbaumer V, 2012, PLANT J, V70, P292, DOI 10.1111/j.1365-313X.2011.04866.x; Lee JS, 2007, J BIOL CHEM, V282, P25020, DOI 10.1074/jbc.M701888200; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li WF, 2013, PLANT PHYSIOL, V162, P1750, DOI 10.1104/pp.113.217778; Li YG, 2012, PLANT SCI, V188, P10, DOI 10.1016/j.plantsci.2012.02.005; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Monroe-Augustus M, 2003, PLANT CELL, V15, P2979, DOI 10.1105/tpc.017046; Oono Y, 1998, PLANT CELL, V10, P1649, DOI 10.1105/tpc.10.10.1649; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Quint M, 2005, PLANT J, V43, P371, DOI 10.1111/j.1365-313X.2005.02449.x; Rasband W., 2006, IMAGEJ; Remy E, 2013, PLANT CELL, V25, P901, DOI 10.1105/tpc.113.110353; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Strader LC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-41; Strader LC, 2008, GENETICS, V180, P2019, DOI 10.1534/genetics.108.091512; Streitner C, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24638; Tang F, 2013, PLANT MOL BIOL, V1, P8; Tromas A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3496; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Ulm R, 2002, EMBO J, V21, P6483, DOI 10.1093/emboj/cdf646; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Yan K, 2012, MOL CELL, V48, P521, DOI 10.1016/j.molcel.2012.08.032	45	13	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e102301	10.1371/journal.pone.0102301	http://dx.doi.org/10.1371/journal.pone.0102301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144378	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100004
J	Luo, YH; Ouyang, PB; Tian, J; Guo, XJ; Duan, XC				Luo, Yong-Heng; Ouyang, Ping-Bo; Tian, Jiao; Guo, Xiao-Jian; Duan, Xuan-Chu			Rosiglitazone Inhibits TGF-beta 1 Induced Activation of Human Tenon Fibroblasts via p38 Signal Pathway	PLOS ONE			English	Article							INDUCED MYOFIBROBLAST TRANSDIFFERENTIATION; POLYCYSTIC KIDNEY-DISEASE; HEPATIC STELLATE CELLS; TGF-BETA; KINASE INHIBITORS; GROWTH-FACTOR; FIBROSIS; RATS; MICE	Purpose: Transdifferentiation of human Tenon fibroblasts to myofibroblasts and subsequent deposition of extracellular matrix is a key step in the scarring after glaucoma filtration surgery. The p38 signaling pathway plays an important role in cell proliferation and differentiation, and its upstream regulators and downstream molecules are widely distributed in the eye. We aimed to investigate the role of p38 in the activation of Tenon fibroblasts and that of the anti-fibrotic mechanism of rosiglitazone in the modulation of the p38 signaling pathway. Methods: Cultured Tenon fibroblasts were stimulated with transforming growth factor (TGF)-beta 1. Activation of p38 was examined by western blot analysis. Rosiglitazone and blocking of the p38 signaling pathway by SB203580 were used to antagonize stimulation by TGF-beta 1. Fibroblast motility was examined by wound closure assay; alpha-smooth muscle actin, connective tissue growth factor, and collagen type I were determined by qPCR and western blot. Expression and localization of alpha-smooth muscle actin were determined by immunofluorescence staining. Results: Phosphorylated p38 was upregulated in fibroblasts stimulated with TGF-beta 1, and this effect was substantially inhibited by rosiglitazone. Proliferation and migration of fibroblasts were suppressed by rosiglitazone and SB203580. Expression of alpha-smooth muscle actin, connective tissue growth factor, and collagen type I were decreased at the mRNA and protein levels by rosiglitazone and SB203580. However, the inhibitory effect of SB203580 on transcription and protein expression was weaker than that of rosiglitazone. Similar phenomena were found on immunofluorescence microscopy of alpha-smooth muscle actin. Conclusions: The p38 signaling pathway mediates the TGF-beta 1-induced transdifferentiation of human Tenon fibroblasts to myofibroblasts. Rosiglitazone can exert anti-fibrotic activity by interfering with the TGF-beta/p38 signaling pathway and might be useful for modulating scar formation after glaucoma filtration surgery.	[Luo, Yong-Heng; Ouyang, Ping-Bo; Tian, Jiao; Guo, Xiao-Jian; Duan, Xuan-Chu] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China	Central South University	Duan, XC (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China.	duanxchu@126.com			National Natural Science Foundation of China [81170843, 81370913]; Science and Technology Program of Hunan Province [2011WK3044]; Postdoctoral Fund of central south university [140204]; Doctoral Site Fund of Ministry of Education of China [20120162110062]; Hunan Provincial Development and Reform Project Infrastructure Investment Plan (Hunan Province) [High-Tech 1060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Hunan Province; Postdoctoral Fund of central south university; Doctoral Site Fund of Ministry of Education of China(Ministry of Education, China); Hunan Provincial Development and Reform Project Infrastructure Investment Plan (Hunan Province)	Supported by National Natural Science Foundation of China Grant 81170843, 81370913, Hunan Provincial Development and Reform Project 2010 Infrastructure Investment Plan (Hunan Province, High-Tech 1060, 2010), 2011 Science and Technology Program of Hunan Province Grant 2011WK3044, Postdoctoral Fund of central south university 140204, Doctoral Site Fund of Ministry of Education of China 20120162110062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angell R, 2008, BIOORG MED CHEM LETT, V18, P4428, DOI 10.1016/j.bmcl.2008.06.048; Asano T, 2012, J MED CHEM, V55, P7772, DOI 10.1021/jm3008008; Borkham-Kamphorst E, 2007, J HEPATOL, V46, P1064, DOI 10.1016/j.jhep.2007.01.029; Chang Y, 2009, J INT MED RES, V37, P727, DOI 10.1177/147323000903700316; Dai B, 2010, CLIN SCI, V119, P323, DOI 10.1042/CS20100113; Fan F, 2012, GRAEF ARCH CLIN EXP, V250, P1213, DOI 10.1007/s00417-011-1903-6; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kiyono T, 2007, EXPERT OPIN THER TAR, V11, P1623, DOI 10.1517/14728222.11.12.1623; Lama PJ, 2003, SURV OPHTHALMOL, V48, P314, DOI 10.1016/S0039-6257(03)00038-9; Laufer SA, 2008, J MED CHEM, V51, P2580, DOI 10.1021/jm701343f; Mac Ivan, 2003, Curr Opin Ophthalmol, V14, P91, DOI 10.1097/00055735-200304000-00007; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Nakamoto M, 2008, HYPERTENS RES, V31, P353, DOI 10.1291/hypres.31.353; Robertson JV, 2010, INVEST OPHTH VIS SCI, V51, P308, DOI 10.1167/iovs.09-3380; Saika Shizuya, 2009, Front Biosci (Schol Ed), V1, P376, DOI 10.2741/s32; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wrobleski ST, 2008, BIOORG MED CHEM LETT, V18, P2739, DOI 10.1016/j.bmcl.2008.02.067; Yamanaka O, 2007, MOL VIS, V13, P1730; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoshihara D, 2011, AM J PHYSIOL-RENAL, V300, pF465, DOI 10.1152/ajprenal.00460.2010; Yu J, 2010, INT J BIOCHEM CELL B, V42, P948, DOI 10.1016/j.biocel.2010.02.006; Zhao CY, 2006, BIOCHEM BIOPH RES CO, V350, P385, DOI 10.1016/j.bbrc.2006.09.069; Zhuo WL, 2008, BIOCHEM BIOPH RES CO, V369, P1098, DOI 10.1016/j.bbrc.2008.02.143	26	8	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105796	10.1371/journal.pone.0105796	http://dx.doi.org/10.1371/journal.pone.0105796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144187	Green Submitted, gold, Green Published			2022-12-25	WOS:000341106100121
J	Ma, N; Xu, ZQ; Mo, DP; Gao, F; Gao, K; Sun, X; Xu, XT; Liu, L; Song, LG; Wang, TJ; Zhao, XQ; Wang, YL; Wang, YJ; Miao, ZR				Ma, Ning; Xu, Ziqi; Mo, Dapeng; Gao, Feng; Gao, Kun; Sun, Xuan; Xu, Xiaotong; Liu, Lian; Song, Ligang; Wang, Tiejun; Zhao, Xingquan; Wang, Yilong; Wang, Yongjun; Miao, Zhongrong			Safety of Low-Dose Aspirin in Endovascular Treatment for Intracranial Atherosclerotic Stenosis	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ANGIOPLASTY; STROKE; CLOPIDOGREL; MANAGEMENT; SAMMPRIS; STANDARD; EVENTS	Objectives: To evaluate the safety of low-dose aspirin plus clopidogrel versus high-dose aspirin plus clopidogrel in prevention of vascular risk within 90 days of duration of dual antiplatelet therapy in patients treated with intracranial endovascular treatment. Methods: From January 2012 to December 2013, this prospective and observational study enrolled 370 patients with symptomatic intracranial atherosclerotic stenosis of >= 70% with poor collateral undergoing intracranial endovascular treatment. Antiplatelet therapy consists of aspirin, at a low-dose of 100 mg or high-dose of 300 mg daily; clopidogrel, at a dose of 75 mg daily for 5 days before endovascular treatment. The dual antiplatelet therapy continued for 90 days after intervention. The study endpoints include acute thrombosis, subacute thrombosis, stroke or death within 90 days after intervention. Results: Two hundred and seventy three patients received low-dose aspirin plus clopidogrel and 97 patients received high-dose aspirin plus clopidogrel before intracranial endovascular treatment. Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose aspirin group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups. Conclusion: Low-dose aspirin plus clopidogrel is comparative in safety with high-dose aspirin plus clopidogrel within 90 days of duration of dual antiplatelet therapy in patients treated with intracranial endovascular treatment.	[Ma, Ning; Mo, Dapeng; Gao, Feng; Gao, Kun; Sun, Xuan; Xu, Xiaotong; Liu, Lian; Song, Ligang; Miao, Zhongrong] Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Beijing, Peoples R China; [Zhao, Xingquan; Wang, Yilong; Wang, Yongjun] Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing, Peoples R China; [Xu, Ziqi] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Tiejun] Daxing Dist Hosp Beijing, Dept Neurol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Zhejiang University	Miao, ZR (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Beijing, Peoples R China.	zhongrongm@163.com			National Natural Science Foundation of China [81371290]; Beijing High-level Personnel Funds [2013-2-19]; Capital Medical University [13JL40]; Beijing Municipal Science and Technology Commission [D111107003111007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing High-level Personnel Funds; Capital Medical University; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	The following investigators have financial disclosure: Prof Z-R Miao - Contract grant sponsor from the National Natural Science Foundation of China (Contract grant number: 81371290) and from the Beijing High-level Personnel Funds (Contract grant number: 2013-2-19). Prof Ning Ma - Contract grant sponsor from the Clinical and Basic Medical Cooperation Project of Capital Medical University (Contract grant number: 13JL40). Prof X-Q Zhao - Contract grant sponsor from the Beijing Municipal Science and Technology Commission (Contract grant number: D111107003111007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chimowitz MI, 2013, STROKE, V44, P2664, DOI 10.1161/STROKEAHA.113.001290; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Derdeyn CP, 2013, NEUROSURGERY, V72, P777, DOI 10.1227/NEU.0b013e318286fdc8; Fiorella D, 2012, STROKE, V43, P2682, DOI 10.1161/STROKEAHA.112.661173; [高培毅 Gao Peiyi], 2003, [中华放射学杂志, Chinese Journal of Radiology], V37, P882; Higashida Randall, 2003, J Vasc Interv Radiol, V14, pS493; Hussain MS, 2012, J NEUROINTERV SURG, V4, P397, DOI 10.1136/neurintsurg-2012-010405; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Lutsep HL, 2004, STROKE, V35, P1388, DOI 10.1161/01.STR.0000128708.86762.d6; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Miao ZR, 2015, J NEUROINTERV SURG, V7, P331, DOI 10.1136/neurintsurg-2014-011109; Mori T, 1998, AM J NEURORADIOL, V19, P1525; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Riedel CH, 2009, STROKE, V40, P1310, DOI 10.1161/STROKEAHA.108.531400; Sanchez-Arjona MB, 2007, AM J NEURORADIOL, V28, P640; Schumacher HC, 2009, STROKE, V40, pE348, DOI 10.1161/STROKEAHA.108.527580; Topol EJ, 2003, CIRCULATION, V108, P399, DOI 10.1161/01.CIR.0000084501.48570.F6; Wada Tadashi, 2013, ISRN Cardiol, V2013, P518968, DOI 10.1155/2013/518968; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Yu SCH, 2013, HONG KONG MED J, V19, P69; Yu SCH, 2014, J NEUROINTERV SURG, V6, P212, DOI 10.1136/neurintsurg-2012-010593; Zaidat OO, 2014, J NEUROINTERV SURG, V6, P225, DOI 10.1136/neurintsurg-2013-010667	24	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105252	10.1371/journal.pone.0105252	http://dx.doi.org/10.1371/journal.pone.0105252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144449	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100045
J	Ye, FP; Zheng, Y; Wang, X; Tan, XL; Zhang, T; Xin, WW; Wang, J; Huang, Y; Fan, QS; Wang, JL				Ye, Fengping; Zheng, Ying; Wang, Xi; Tan, Xiaolong; Zhang, Tao; Xin, Wenwen; Wang, Jie; Huang, Yong; Fan, Quanshui; Wang, Jinglin			Recognition of Bungarus multicinctus Venom by a DNA Aptamer against beta-Bungarotoxin	PLOS ONE			English	Article							IN-VITRO SELECTION; RNA MOLECULES; SNAKE-VENOMS; IDENTIFICATION; BINDING; NEUROTOXIN; EVOLUTION; LIGANDS; KRAIT; NEED	Antibody-based technology is the main method for diagnosis and treatment of snake bite envenoming currently. However, the development of an antibody, polyclonal or monoclonal, is a complicated and costly procedure. Aptamers are single stranded oligonucleotides that recognize specific targets such as proteins and have shown great potential over the years as diagnostic and therapeutic agents. In contrast to antibodies, aptamers can be selected in vitro without immunization of animals, and synthesized chemically with extreme accuracy, low cost and high degree of purity. In this study we firstly report on the identification of DNA aptamers that bind to beta-bungarotoxin (beta-BuTx), a neurotoxin from the venom of Bungarus multicinctus. A plate-SELEX method was used for the selection of beta-BuTx specific aptamers. After 10 rounds of selection, four aptamer candidates were obtained, with the dissociation constant ranged from 65.9 nM to 995 nM measured by fluorescence spectroscopy. Competitive binding assays using both the fluorescently labeled and unlabeled aptamers revealed that the four aptamers bound to the same binding site of beta-BuTx. The best binder, beta B-1, bound specifically to beta-BuTx, but not to BSA, casein or alpha-Bungarotoxin. Moreover, electrophoretic mobility shift assay and enzyme-linked aptamer assay demonstrated that beta B-1 could discriminate B. multicinctus venom from other snake venoms tested. The results suggest that aptamer beta B-1 can serve as a useful tool for the design and development of drugs and diagnostic tests for beta-BuTx poisoning and B. multicinctus bites.	[Ye, Fengping; Zhang, Tao; Xin, Wenwen; Wang, Jinglin] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Ye, Fengping; Zheng, Ying; Wang, Xi; Tan, Xiaolong; Wang, Jie; Huang, Yong; Fan, Quanshui] Chengdu Mil Reg Ctr Dis Control & Prevent, Inst Mil Med, Kunming, Peoples R China		Fan, QS (corresponding author), Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	fqs168@126.com; wangjl6481@hotmail.com			Medical Science Foundation of Chengdu Military Region [C14048]	Medical Science Foundation of Chengdu Military Region	This work was supported by the Medical Science Foundation of Chengdu Military Region (C14048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Chan JCN, 1995, J TROP MED HYG, V98, P457; Chang CC, 1999, J BIOMED SCI, V6, P368, DOI 10.1159/000025412; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Chu Nai-Shin, 2005, J Hist Neurosci, V14, P138, DOI 10.1080/096470490881770; CHUANG LY, 1989, TOXICON, V27, P211, DOI 10.1016/0041-0101(89)90134-7; Cruz-Aguado JA, 2008, J AGR FOOD CHEM, V56, P10456, DOI 10.1021/jf801957h; de Roodt AR, 2003, COMP BIOCHEM PHYS C, V135, P469, DOI 10.1016/S1532-0456(03)00169-8; Dong LV, 2003, J IMMUNOL METHODS, V282, P13, DOI 10.1016/S0022-1759(03)00277-1; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gao JF, 2013, J IMMUNOL METHODS, V387, P211, DOI 10.1016/j.jim.2012.10.016; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; Ha TH, 2009, SE ASIAN J TROP MED, V40, P518; Hesselberth JR, 2000, J BIOL CHEM, V275, P4937, DOI 10.1074/jbc.275.7.4937; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Hong P, 2012, SENSORS-BASEL, V12, P1181, DOI 10.3390/s120201181; Hu P, 2013, J AGR FOOD CHEM, V61, P3533, DOI 10.1021/jf400880r; Isbister GK, 2010, VACCINE, V28, P798, DOI 10.1016/j.vaccine.2009.10.055; Joeng CB, 2009, BIOORGAN MED CHEM, V17, P5380, DOI 10.1016/j.bmc.2009.06.044; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; KELLY RB, 1974, J NEUROBIOL, V5, P135, DOI 10.1002/neu.480050205; KONDO K, 1982, J BIOCHEM, V91, P1531, DOI 10.1093/oxfordjournals.jbchem.a133844; KWONG PD, 1995, STRUCTURE, V3, P1109, DOI 10.1016/S0969-2126(01)00246-5; Lalloo DG, 2003, J TOXICOL-CLIN TOXIC, V41, P277, DOI 10.1081/CLT-120021113; Lauridsen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041702; Lauridsen LH, 2012, NUCLEIC ACID THER, V22, P371, DOI 10.1089/nat.2012.0377; Levesque D, 2007, BIOCHEM J, V403, P129, DOI 10.1042/BJ20061216; Li W, 2007, ANALYST, V132, P107, DOI 10.1039/b614138b; Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; McKeague M, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/748913; Mendonsa SD, 2004, J AM CHEM SOC, V126, P20, DOI 10.1021/ja037832s; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Pe T, 1997, T ROY SOC TROP MED H, V91, P686, DOI 10.1016/S0035-9203(97)90524-1; Qin G., 1998, CHINA POISONOUS SNAK, P708; RYAN PC, 1991, J MOL BIOL, V221, P1257, DOI 10.1016/0022-2836(91)80125-E; Selvanayagam ZE, 1999, TOXICON, V37, P565, DOI 10.1016/S0041-0101(98)00203-7; SITTENFELD A, 1991, TOXICON, V29, P1213, DOI 10.1016/0041-0101(91)90194-V; STRONG PN, 1976, P NATL ACAD SCI USA, V73, P178, DOI 10.1073/pnas.73.1.178; Svobodova M, 2012, ANAL BIOANAL CHEM, V404, P835, DOI 10.1007/s00216-012-6183-4; Tan WH, 2013, CHEM REV, V113, P2842, DOI 10.1021/cr300468w; Tok JBH, 2008, CHEM COMMUN, P1883, DOI 10.1039/b717936g; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ueno E, 1996, TOXICON, V34, P1219, DOI 10.1016/S0041-0101(96)00113-4; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; WHO, 2010, WHO GUIDELINES PRODU; Yan H, 2007, MOL CELL BIOCHEM, V306, P71, DOI 10.1007/s11010-007-9555-x	49	18	19	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105404	10.1371/journal.pone.0105404	http://dx.doi.org/10.1371/journal.pone.0105404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144237	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100062
J	Doyle, OM; Westman, E; Marquand, AF; Mecocci, P; Vellas, B; Tsolaki, M; Kloszewska, I; Soininen, H; Lovestone, S; Williams, SCR; Simmons, A				Doyle, Orla M.; Westman, Eric; Marquand, Andre F.; Mecocci, Patrizia; Vellas, Bruno; Tsolaki, Magda; Kloszewska, Iwona; Soininen, Hilkka; Lovestone, Simon; Williams, Steve C. R.; Simmons, Andrew		AddNeuroMed Consortium Alzheimer	Predicting Progression of Alzheimer's Disease Using Ordinal Regression	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; GAUSSIAN-PROCESSES; CEREBRAL ATROPHY; BRAIN ATROPHY; MRI; CLASSIFICATION; PATTERNS	We propose a novel approach to predicting disease progression in Alzheimer's disease (AD) - multivariate ordinal regression - which inherently models the ordered nature of brain atrophy spanning normal aging (CTL) to mild cognitive impairment (MCI) to AD. Ordinal regression provides probabilistic class predictions as well as a continuous index of disease progression - the ORCHID (Ordinal Regression Characteristic Index of Dementia) score. We applied ordinal regression to 1023 baseline structural MRI scans from two studies: the US-based Alzheimer's Disease Neuroimaging Initiative (ADNI) and the European based AddNeuroMed program. Here, the acquired AddNeuroMed dataset was used as a completely independent test set for the ordinal regression model trained on the ADNI cohort providing an optimal assessment of model generalizability. Distinguishing CTL-like (CTL and stable MCI) from AD-like (MCI converters and AD) resulted in balanced accuracies of 82% (cross-validation) for ADNI and 79% (independent test set) for AddNeuroMed. For prediction of conversion from MCI to AD, balanced accuracies of 70% (AUC of 0.75) and 75% (AUC of 0.81) were achieved. The ORCHID score was computed for all subjects. We showed that this measure significantly correlated with MMSE at 12 months (rho = -0.64, ADNI and rho = -0.59, AddNeuroMed). Additionally, the ORCHID score can help fractionate subjects with unstable diagnoses (e.g. reverters and healthy controls who later progressed to MCI), moderately late converters (12-24 months) and late converters (24-36 months). A comparison with results in the literature and direct comparison with a binary classifier suggests that the performance of this framework is highly competitive.	[Doyle, Orla M.; Westman, Eric; Marquand, Andre F.; Williams, Steve C. R.; Simmons, Andrew] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England; [Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Lovestone, Simon; Williams, Steve C. R.; Simmons, Andrew] NIHR Biomed Res Ctr Mental Hlth South London, London, England; [Simmons, Andrew] NIHR Biomed Res Unit Dementia South London, London, England; [Mecocci, Patrizia] Univ Perugia, Inst Gerontol & Geriatr, I-06100 Perugia, Italy; [Vellas, Bruno] Univ Toulouse, INSERM, U558, Toulouse, France; [Tsolaki, Magda] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece; [Kloszewska, Iwona] Med Univ Lodz, Lodz, Poland; [Soininen, Hilkka] Univ Eastern Finland, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Williams, Steve C. R.; Simmons, Andrew] Maudsley NHS Fdn Trust, London, England; [Williams, Steve C. R.; Simmons, Andrew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; King's College London; Karolinska Institutet; University of Perugia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Aristotle University of Thessaloniki; Medical University Lodz; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; South London & Maudsley NHS Trust; University of London; King's College London	Doyle, OM (corresponding author), Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England.	orla.doyle@kcl.ac.uk	Marquand, Andre F/B-6050-2012; Simmons, Andrew/B-8848-2008; Mecocci, Patrizia/W-2116-2019; Williams, Steve C/D-6979-2011; Westman, Eric/H-5771-2011	Marquand, Andre F/0000-0001-5903-203X; Simmons, Andrew/0000-0003-2306-5811; Mecocci, Patrizia/0000-0003-0729-5246; Williams, Steve C/0000-0003-4299-1941; Westman, Eric/0000-0002-3115-2977; Tsolaki, Magda/0000-0002-2072-8010; Doyle, Orla/0000-0002-6964-0140; opoku, anita/0000-0001-7243-8157; Lovestone, Simon/0000-0003-0473-4565	Innovative Medicines Initiative [115008]; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust; EPSRC [WT088641/Z/09/Z]; Kuopio University Hospital; NIHR Biomedical Research Centre for Mental Health; NIHR Biomedical Research Unit for Dementia at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Alzheimer's Research UK; Innovative Medicines Initiative; InnoMed, (Innovative Medicines in Europe) an Integrated Project - European Union [FP6-2004-LIFESCIHEALTH-5]; Life Sciences, Genomics and Biotechnology for Health; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; Alzheimers Research UK [ARUK-EXT2013-4, ART-PG2010-4] Funding Source: researchfish; Medical Research Council [G0801464] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10053] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [U01AG024904, K01AG030514, P30AG010129] Funding Source: NIH RePORTER; MRC [G0801464] Funding Source: UKRI	Innovative Medicines Initiative; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Kuopio University Hospital; NIHR Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit for Dementia at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Innovative Medicines Initiative; InnoMed, (Innovative Medicines in Europe) an Integrated Project - European Union; Life Sciences, Genomics and Biotechnology for Health(European Commission); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	OMD is supported by the Innovative Medicines Initiative Joint Undertaking under Grant Agreement No 115008 (NEWMEDS). The Innovative Medicines Initiative Joint Undertaking is a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations. AFM gratefully acknowledges support from King's College London Centre of Excellence in Medical Engineering, funded by the Wellcome Trust and EPSRC under grant no. WT088641/Z/09/Z. EW wishes to thank Swedish Brain Power, the Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro), the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet, Health Research Council of Academy of Finland, University of Eastern Finland UEFBRAIN and EVO funding from Kuopio University Hospital. AS is supported by funds from NIHR Biomedical Research Centre for Mental Health, the NIHR Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, Alzheimer's Research UK and the Innovative Medicines Initiative funded European Medical Information Framework. The AddNeuroMed study was supported by InnoMed, (Innovative Medicines in Europe) an Integrated Project funded by the European Union of the Sixth Framework program priority FP6-2004-LIFESCIHEALTH-5, Life Sciences, Genomics and Biotechnology for Health. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE HealtCTLare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaszewski S, 2013, NEUROBIOL AGING, V34, P2815, DOI 10.1016/j.neurobiolaging.2013.06.015; Bishop CM, 2006, PATTERN RECOGN, Vxx; Chu W, 2005, J MACH LEARN RES, V6, P1019; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Doyle OM, 2013, NEUROIMAGE, V81, P347, DOI 10.1016/j.neuroimage.2013.05.036; Doyle OM, 2013, J PHARMACOL EXP THER, V345, P151, DOI 10.1124/jpet.112.201665; Eskildsen SF, 2013, NEUROIMAGE, V65, P511, DOI 10.1016/j.neuroimage.2012.09.058; Fan Y, 2011, LECT NOTES COMPUT SC, V7012, P44, DOI 10.1007/978-3-642-24446-9_6; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Hastie T., 2009, ELEMENTS STAT LEARNI, Vsecond, pXXII, DOI DOI 10.1007/978-0-387-84858-7; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Leung KK, 2013, NEUROLOGY, V80, P648, DOI 10.1212/WNL.0b013e318281ccd3; Liu X, 2013, NEUROIMAGE, V83, P148, DOI 10.1016/j.neuroimage.2013.06.033; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; POWELL MJD, 1964, COMPUT J, V7, P155, DOI 10.1093/comjnl/7.2.155; Rasmussen CE, 2010, J MACH LEARN RES, V11, P3011; Schuff N, 2012, NEUROBIOL AGING, V33, P845, DOI 10.1016/j.neurobiolaging.2010.07.012; Sluimer JD, 2008, NEUROLOGY, V70, P1836, DOI 10.1212/01.wnl.0000311446.61861.e3; Spulber G, 2013, J INTERN MED, V273, P396, DOI 10.1111/joim.12028; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Westman E, 2013, BRAIN TOPOGR, V26, P9, DOI 10.1007/s10548-012-0246-x; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Westman E, 2011, NEUROIMAGE, V58, P818, DOI 10.1016/j.neuroimage.2011.06.065; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Young J, 2013, NEUROIMAGE-CLIN, V2, P735, DOI 10.1016/j.nicl.2013.05.004	32	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105542	10.1371/journal.pone.0105542	http://dx.doi.org/10.1371/journal.pone.0105542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141298	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200097
J	Schweigmann, U; Biliczki, P; Ramirez, RJ; Marschall, C; Takac, I; Brandes, RP; Kotzot, D; Girmatsion, Z; Hohnloser, SH; Ehrlich, JR				Schweigmann, Ulrich; Biliczki, Peter; Ramirez, Rafael J.; Marschall, Christoph; Takac, Ina; Brandes, Ralf P.; Kotzot, Dieter; Girmatsion, Zenawit; Hohnloser, Stefan H.; Ehrlich, Joachim R.			Elevated Heart Rate Triggers Action Potential Alternans and Sudden Death. Translational Study of a Homozygous KCNH2 Mutation	PLOS ONE			English	Article							LONG-QT-SYNDROME; HUMAN VENTRICULAR TISSUE; POTASSIUM CHANNEL; TRANSMURAL DISPERSION; HERG; REPOLARIZATION; ARRHYTHMIAS; DEFECTS; MODEL	Background: Long QT syndrome (LQTS) leads to arrhythmic events and increased risk for sudden cardiac death (SCD). Homozygous KCNH2 mutations underlying LQTS-2 have previously been termed "human HERG knockout'' and typically express severe phenotypes. We studied genotype-phenotype correlations of an LQTS type 2 mutation identified in the homozygous index patient from a consanguineous Turkish family after his brother died suddenly during febrile illness. Methods and Results: Clinical work-up, DNA sequencing, mutagenesis, cell culture, patch-clamp, in silico mathematical modelling, protein biochemistry, confocal microscopy were performed. Genetic analysis revealed a homozygous C-terminal KCNH2 mutation (p.R835Q) in the index patient (QTc similar to 506 ms with notched T waves). Parents were I-D cousins - both heterozygous for the mutation and clinically unremarkable (QTc similar to 447 ms, father and similar to 396 ms, mother). Heterologous expression of KCNH2-R835Q showed mildly reduced current amplitudes. Biophysical properties of ionic currents were also only nominally changed with slight acceleration of deactivation and more negative V-50 in R835Q-currents. Protein biochemistry and confocal microscopy revealed similar expression patterns and trafficking of WT and R835Q, even at elevated temperature. In silico analysis demonstrated mildly prolonged ventricular action potential duration (APD) compared to WT at a cycle length of 1000 ms. At a cycle length of 350 ms M-cell APD remained stable in WT, but displayed APD alternans in R835Q. Conclusion: Kv11.1 channels affected by the C-terminal R835Q mutation display mildly modified biophysical properties, but leads to M-cell APD alternans with elevated heart rate and could precipitate SCD under specific clinical circumstances associated with high heart rates.	[Schweigmann, Ulrich] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Biliczki, Peter; Girmatsion, Zenawit; Hohnloser, Stefan H.; Ehrlich, Joachim R.] Goethe Univ Frankfurt, Div Clin Electrophysiol, D-60054 Frankfurt, Germany; [Ramirez, Rafael J.] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [Marschall, Christoph] Lab Human Genet, Martinsried, Germany; [Takac, Ina; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, D-60054 Frankfurt, Germany; [Kotzot, Dieter] Med Univ Innsbruck, Sect Human Genet, A-6020 Innsbruck, Austria; [Biliczki, Peter; Ehrlich, Joachim R.] Deutsch Klin Diagnost, Div Cardiol, Wiesbaden, Germany	Medical University of Innsbruck; Goethe University Frankfurt; University of Michigan System; University of Michigan; Goethe University Frankfurt; Medical University of Innsbruck	Ehrlich, JR (corresponding author), Goethe Univ Frankfurt, Div Clin Electrophysiol, D-60054 Frankfurt, Germany.	joachimehrlich@t-online.de	Brandes, Ralf P/L-3058-2017; Ramirez, Rafael J./AAI-7712-2020	Brandes, Ralf P/0000-0002-8035-0048; 	Else Kroner-Fresenius-Stiftung; Deutsche Stiftung fur Herzforschung; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081080] Funding Source: NIH RePORTER	Else Kroner-Fresenius-Stiftung; Deutsche Stiftung fur Herzforschung; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Joachim R. Ehrlich received funding from Else Kroner-Fresenius-Stiftung and Deutsche Stiftung fur Herzforschung. Administrative help from Gesellschaft zur Forderung der Forschung an der DKD is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2008, J CLIN INVEST, V118, P2552, DOI 10.1172/JCI35337; Antzelevitch C, 2001, BASIC RES CARDIOL, V96, P517, DOI 10.1007/s003950170002; Antzelevitch C, 1999, J CARDIOVASC ELECTR, V10, P1124, DOI 10.1111/j.1540-8167.1999.tb00287.x; Biliczki P, 2008, HEART RHYTHM, V5, P1159, DOI 10.1016/j.hrthm.2008.04.016; Biliczki P, 2009, HEART RHYTHM, V6, P1792, DOI 10.1016/j.hrthm.2009.08.009; Burashnikov A, 2008, CIRC-ARRHYTHMIA ELEC, V1, P202, DOI 10.1161/CIRCEP.107.691931; Crotti L, 2005, CIRCULATION, V112, P1251, DOI 10.1161/CIRCULATIONAHA.105.549071; Crotti L, 2009, CIRCULATION, V120, P1657, DOI 10.1161/CIRCULATIONAHA.109.879643; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Hayashi K, 2010, HEART RHYTHM, V7, P973, DOI 10.1016/j.hrthm.2010.03.038; Hoorntje T, 1999, CIRCULATION, V100, P1264, DOI 10.1161/01.CIR.100.12.1264; Hua F, 2004, AM J PHYSIOL-HEART C, V286, pH2342, DOI 10.1152/ajpheart.00793.2003; Johnson WH, 2003, PEDIATR RES, V53, P744, DOI 10.1203/01.PDR.0000059750.17002.B6; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Lupoglazoff JM, 2004, J AM COLL CARDIOL, V43, P826, DOI 10.1016/j.jacc.2003.09.049; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Piippo K, 2000, J AM COLL CARDIOL, V35, P1919, DOI 10.1016/S0735-1097(00)00636-7; Schwartz PJ, 2001, CIRCULATION, V103, P89; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Teng GQ, 2008, CIRC RES, V103, P1483, DOI 10.1161/CIRCRESAHA.108.177055; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Westenskow P, 2004, CIRCULATION, V109, P1834, DOI 10.1161/01.CIR.0000125524.34234.13; ZAREBA W, 1994, J AM COLL CARDIOL, V23, P1541, DOI 10.1016/0735-1097(94)90653-X; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	25	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103150	10.1371/journal.pone.0103150	http://dx.doi.org/10.1371/journal.pone.0103150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140878	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200004
J	Xiao, X; Lucas, HD; Paller, KA; Ding, JH; Guo, CY				Xiao, Xin; Lucas, Heather D.; Paller, Ken A.; Ding, Jin-hong; Guo, Chun-yan			Retrieval Intention Modulates the Effects of Directed Forgetting Instructions on Recollection	PLOS ONE			English	Article							IMPLICIT MEMORY; EXPLICIT; ERP	The neurocognitive basis of memory retrieval is often examined by investigating brain potential old/new effects, which are differences in brain activity between successfully remembered repeated stimuli and correctly rejected new stimuli in a recognition test. In this study, we combined analyses of old/new effects for words with an item-method directed-forgetting manipulation in order to isolate differences between the retrieval processes elicited by words that participants were initially instructed to commit to memory and those that participants were initially instructed to forget. We compared old/new effects elicited by to-be-forgotten (TBF) words with those elicited by to-be-remembered (TBR) words in both an explicit-memory test (a recognition test) and an implicit-memory test (a lexical-decision test). Behavioral results showed clear directed forgetting effects in the recognition test, but not in the lexical decision test. Mirroring the behavioral findings, analyses of brain potentials showed evidence of directed forgetting only in the recognition test. In this test, potentials from 450-650 ms (P600 old/new effects) were more positive for TBR relative to TBF words. By contrast, P600 effects evident during the lexical-decision test did not differ in magnitude between TBR and TBF items. When taken in the context of prior studies that have linked similar parietal old/new effects to the recollection of episodic information, these data suggest that directed-forgetting effects manifest primarily in greater episodic retrieval by TBR than TBF items, and that retrieval intention may be important for these directed-forgetting effects to occur.	[Xiao, Xin; Ding, Jin-hong; Guo, Chun-yan] Capital Normal Univ, Beijing Key Lab Learning & Cognit, Dept Psychol, Beijing, Peoples R China; [Lucas, Heather D.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Paller, Ken A.] Northwestern Univ, Dept Psychol, Evanston, IL USA	Capital Normal University; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University	Guo, CY (corresponding author), Capital Normal Univ, Beijing Key Lab Learning & Cognit, Dept Psychol, Beijing, Peoples R China.	guocy@hotmail.com	Paller, Ken/M-2676-2019; Lucas, Heather D/H-2736-2019	Paller, Ken/0000-0003-4415-4143	National Natural Science Foundation of China [31271078]; Beijing Municipal Commission of Education Key program of science and technology [KZ201410028034]; Scientific Research Base Development Program of the Beijing Municipal Commission of Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education Key program of science and technology; Scientific Research Base Development Program of the Beijing Municipal Commission of Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The present study was supported by the National Natural Science Foundation of China (31271078), the Beijing Municipal Commission of Education Key program of science and technology (KZ201410028034), and Scientific Research Base Development Program of the Beijing Municipal Commission of Education. The funders of this project had no role in the study design, data collection and analysis, or preparation of the manuscript.	AARTS JHP, 1984, BRAIN, V107, P293, DOI 10.1093/brain/107.1.293; Berntsen D, 2010, CURR DIR PSYCHOL SCI, V19, P138, DOI 10.1177/0963721410370301; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; Brinegar KA, 2013, PSYCHON B REV, V20, P528, DOI 10.3758/s13423-013-0383-6; Cheng SK, 2012, BIOL PSYCHOL, V89, P283, DOI 10.1016/j.biopsycho.2011.10.019; Coles ME, 2002, CLIN PSYCHOL REV, V22, P587, DOI 10.1016/S0272-7358(01)00113-1; Curran T, 1999, NEUROPSYCHOLOGIA, V37, P771, DOI 10.1016/S0028-3932(98)00133-X; Curran T., 2006, BINDING HUMAN MEMORY, P467, DOI DOI 10.1093/ACPROF:OSO/9780198529675.003.0018; Dew ITZ, 2011, ANN NY ACAD SCI, V1224, P174, DOI 10.1111/j.1749-6632.2010.05946.x; Falsetti S.A., 2002, J COGN PSYCHOTHER, V16, P127, DOI DOI 10.1891/JCOP.16.2.127.63993; Fleck DE, 2001, PSYCHOL REC, V51, P207, DOI 10.1007/BF03395395; GRAF P, 1982, SCIENCE, V218, P1243, DOI 10.1126/science.7146909; Hsieh LT, 2009, BRAIN RES, V1250, P190, DOI 10.1016/j.brainres.2008.11.016; Jacoby L.L., 1984, NEUROPSYCHOLOGY MEMO, P145; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lehman M, 2009, J EXP PSYCHOL LEARN, V35, P970, DOI 10.1037/a0015728; Lucas HD, 2012, NEUROPSYCHOLOGIA, V50, P3041, DOI 10.1016/j.neuropsychologia.2012.07.036; Mace J.H., 2010, ACT REMEMBERING UNDE, P71, DOI DOI 10.1002/9781444328202.CH5; MacKenzie G, 2009, NEUROPSYCHOLOGIA, V47, P2756, DOI 10.1016/j.neuropsychologia.2009.05.025; MACLEOD CM, 1989, J EXP PSYCHOL LEARN, V15, P13, DOI 10.1037/0278-7393.15.1.13; Malmberg KJ, 2005, J EXP PSYCHOL LEARN, V31, P322, DOI 10.1037/0278-7393.31.2.322; PALLER KA, 1995, PSYCHOL SCI, V6, P107, DOI 10.1111/j.1467-9280.1995.tb00315.x; PALLER KA, 1990, J EXP PSYCHOL LEARN, V16, P1021, DOI 10.1037/0278-7393.16.6.1021; Paller KA, 1999, COGNITIVE BRAIN RES, V7, P519, DOI 10.1016/S0926-6410(98)00050-0; Paller KA, 2000, BEHAV NEUROL, V12, P127, DOI 10.1155/2000/865250; Paller KA, 2007, TRENDS COGN SCI, V11, P243, DOI 10.1016/j.tics.2007.04.002; Paz-Caballero MD, 1999, EUR J COGN PSYCHOL, V11, P239, DOI 10.1080/713752308; Reynolds M, 1999, BEHAV RES THER, V37, P201, DOI 10.1016/S0005-7967(98)00132-6; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Rugg MD, 2000, OXFORD HDB MEMORY, P521; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sahakyan L, 2002, J EXP PSYCHOL LEARN, V28, P1064, DOI 10.1037//0278-7393.28.6.1064; Sahakyan L, 2005, J EXP PSYCHOL LEARN, V31, P789, DOI 10.1037/0278-7393.31.4.789; Sahakyan L, 2009, J MEM LANG, V61, P134, DOI 10.1016/j.jml.2009.02.006; Schooler LJ, 2001, PSYCHOL REV, V108, P257, DOI 10.1037/0033-295X.108.1.257; Schott BH, 2005, P NATL ACAD SCI USA, V102, P1257, DOI 10.1073/pnas.0409070102; SMITH ME, 1990, J EXP PSYCHOL LEARN, V16, P1033, DOI 10.1037/0278-7393.16.6.1033; SMITH SM, 1984, MEM COGNITION, V12, P477, DOI 10.3758/BF03198309; Smith SM, 2001, PSYCHON B REV, V8, P203, DOI 10.3758/BF03196157; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Ullsperger M, 2000, J COGNITIVE NEUROSCI, V12, P924, DOI 10.1162/08989290051137477; Van Hooff JC, 2009, BRAIN COGNITION, V71, P153, DOI 10.1016/j.bandc.2009.05.001; Vonk J, 2006, MEM COGNITION, V34, P505, DOI 10.3758/BF03193574; Voss JL, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00227; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143	45	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104701	10.1371/journal.pone.0104701	http://dx.doi.org/10.1371/journal.pone.0104701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25140658	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200028
J	Zhang, J; Qin, X; Sun, Q; Guo, H; Wu, X; Xie, F; Xu, Q; Yan, M; Liu, J; Han, Z; Chen, W				Zhang, J.; Qin, X.; Sun, Q.; Guo, H.; Wu, X.; Xie, F.; Xu, Q.; Yan, M.; Liu, J.; Han, Z.; Chen, W.			Transcriptional control of PAX4-regulated miR-144/451 modulates metastasis by suppressing ADAMs expression	ONCOGENE			English	Article							B-CELL LYMPHOMAS; BREAST-CANCER; DIABETES-MELLITUS; DOWN-REGULATION; PAX4 GENE; INVASION; DISINTEGRIN; CARCINOMA; MIGRATION; MICRORNA	Paired box gene 4 (PAX4) is a transcriptional modulator located on chromosome 7q32, and its expression is dysregulated in a variety of human cancers, suggesting that PAX4 may be important in multiple tumors as a driver gene. Here, we show that PAX4 promoted migration and invasion in human epithelial cancers by decreasing miR-144 and miR-451 (miR-144/451) expression levels. Accordingly, miR-144/451 suppressed the migratory and invasive phenotypes, even in PAX4-expressing cells. Mechanistically, miR-144/451 inhibits cancer metastasis by targeting the A disintegrin and metalloproteinase (ADAM) protein family members ADAMTS5 and ADAM10. Their dysregulation is associated with increased tumor invasiveness and metastasis, then reduced patient prognosis in certain epithelial cancers. This discovery suggests that a PAX4-miR-144/451-ADAMs axis regulates human epithelial cancer metastasis, thus opening up therapeutic possibilities and predicting prognosis for those cancer types.	[Zhang, J.; Qin, X.; Sun, Q.; Wu, X.; Xie, F.; Xu, Q.; Yan, M.; Chen, W.] Shanghai Jiao Tong Univ, Sch Med, Dept Oral & Maxillofacial Head & Neck Oncol, Peoples Hosp 9, Shanghai 200011, Peoples R China; [Zhang, J.; Qin, X.; Sun, Q.; Wu, X.; Xie, F.; Xu, Q.; Yan, M.; Chen, W.] Shanghai Jiao Tong Univ, Sch Med, Fac Oral & Maxillofacial Surg, Peoples Hosp 9, Shanghai 200011, Peoples R China; [Guo, H.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 3, Dept Clin Lab, Shanghai 200011, Peoples R China; [Xu, Q.; Han, Z.; Chen, W.] Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Xu, Q.; Han, Z.; Chen, W.] Shanghai Res Inst Stomatol, Shanghai, Peoples R China; [Liu, J.] Fudan Univ, Zhongshan Hosp, Dept Integrat Med, Shanghai 200433, Peoples R China; [Han, Z.] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University	Chen, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Oral & Maxillofacial Head & Neck Oncol, Peoples Hosp 9, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	chenwantao196323@sjtu.edu.cn	建军, 张/R-3679-2019	Han, Ze-Guang/0000-0002-1018-1752	National Natural Science Foundation of China [91229103, 81101515, 81201912, 81272977]; Shanghai Municipal Education Commission [12YZ052, 12ZZ106]; Shanghai Science and Technology Committee [11DZ2291800, 10DZ1951300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This study was supported by the National Natural Science Foundation of China (grant no. 91229103, 81101515, 81201912 and 81272977), the Program of Shanghai Municipal Education Commission (12YZ052 and 12ZZ106) and Project of the Shanghai Science and Technology Committee (11DZ2291800 and 10DZ1951300). We appreciate Liu Jun and Shanghai Cancer Hospital affiliated to Fudan University for providing the 50 pairs of HNSCC tissues. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akiyoshi S, 2012, BRIT J CANCER, V107, P1345, DOI 10.1038/bjc.2012.326; Benfey PN, 2003, NATURE, V425, P244, DOI 10.1038/425244a; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Biason-Lauber A, 2005, DIABETOLOGIA, V48, P900, DOI 10.1007/s00125-005-1723-5; Brocker Chad N., 2009, Human Genomics, V4, P43; Cheng C, 2013, J BIOL CHEM, V288, P13748, DOI 10.1074/jbc.M112.381392; Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4; Cross NA, 2005, PROSTATE, V63, P269, DOI 10.1002/pros.20182; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; FABBRO D, 1994, CANCER RES, V54, P4744; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Guo HY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-77; Guo HY, 2012, INT J BIOCHEM CELL B, V44, P1465, DOI 10.1016/j.biocel.2012.05.015; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Iwaya T, 2012, CARCINOGENESIS, V33, P2391, DOI 10.1093/carcin/bgs288; Jeon HW, 2010, MOL CANCER THER, V9, P1361, DOI 10.1158/1535-7163.MCT-09-0717; Jerkeman M, 1999, EUR J HAEMATOL, V62, P184; Jones GC, 2006, CURR PHARM BIOTECHNO, V7, P25, DOI 10.2174/138920106775789656; Karan D, 2003, INT J ONCOL, V23, P1365; Kobayashi H, 2013, J BIOL CHEM, V288, P28620, DOI 10.1074/jbc.M113.452169; KOZMIK Z, 1995, P NATL ACAD SCI USA, V92, P5709, DOI 10.1073/pnas.92.12.5709; Kumar S, 2012, AM J PATHOL, V181, P1056, DOI 10.1016/j.ajpath.2012.05.022; Li YH, 2006, LEUKEMIA RES, V30, P1547, DOI 10.1016/j.leukres.2006.04.001; Liu PCC, 2006, CANCER BIOL THER, V5, P657, DOI 10.4161/cbt.5.6.2708; Lu XJ, 2008, CURR CANCER DRUG TAR, V8, P720, DOI 10.2174/156800908786733478; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; McCulloch DR, 2004, CLIN CANCER RES, V10, P314, DOI 10.1158/1078-0432.CCR-0846-3; Miller DJ, 2000, P NATL ACAD SCI USA, V97, P4475, DOI 10.1073/pnas.97.9.4475; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Miyamoto T, 2001, BIOCHEM BIOPH RES CO, V282, P34, DOI 10.1006/bbrc.2001.4552; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Park SY, 2011, ONCOL REP, V25, P1677, DOI 10.3892/or.2011.1236; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; Shikata K, 2013, CANCER SCI, V104, P9, DOI 10.1111/cas.12043; Sosa-Pineda B, 2004, MOL CELLS, V18, P289; Sun Q, 2013, INT J BIOCHEM CELL B, V45, P513, DOI 10.1016/j.biocel.2012.12.004; TAMURA T, 1994, CYTOGENET CELL GENET, V66, P132, DOI 10.1159/000133684; Tian Y, 2012, INT J ONCOL, V40, P1105, DOI 10.3892/ijo.2011.1306; Tokuyama Y, 2006, METABOLISM, V55, P213, DOI 10.1016/j.metabol.2005.08.014; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Xu Q, 2013, CARCINOGENESIS, V34, P539, DOI 10.1093/carcin/bgs374; Yan M, 2013, MOL CELL PROTEOMICS, V12, P3271, DOI 10.1074/mcp.M112.025460; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007	46	44	45	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3283	3295		10.1038/onc.2014.259	http://dx.doi.org/10.1038/onc.2014.259			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25151965				2022-12-25	WOS:000356592300007
J	Kuang, Y; Long, MJC; Zhou, J; Shi, JF; Gao, Y; Xu, C; Hedstrom, L; Xu, B				Kuang, Yi; Long, Marcus J. C.; Zhou, Jie; Shi, Junfeng; Gao, Yuan; Xu, Chen; Hedstrom, Lizbeth; Xu, Bing			Prion-like Nanofibrils of Small Molecules (PriSM) Selectively Inhibit Cancer Cells by Impeding Cytoskeleton Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PROTEIN; TAU; P53; ENDOCYTOSIS; DISRUPTION; INTERACTS; MECHANISM; APOPTOSIS; WATER	Emerging evidence reveals that prion-like structures play important roles to maintain the well-being of cells. Although self-assembly of small molecules also affords prion-like nanofibrils (PriSM), little is known about the functions and mechanisms of PriSM. Previous works demonstrated that PriSM formed by a dipeptide derivative selectively inhibiting the growth of glioblastoma cells over neuronal cells and effectively inhibiting xenograft tumor in animal models. Here we examine the protein targets, the internalization, and the cytotoxicity pathway of the PriSM. The results show that the PriSM selectively accumulate in cancer cells via macropinocytosis to impede the dynamics of cytoskeletal filaments via promiscuous interactions with cytoskeletal proteins, thus inducing apoptosis. Intriguingly, Tau proteins are able to alleviate the effect of the PriSM, thus protecting neuronal cells. This work illustrates PriSM as a new paradigm for developing polypharmacological agents that promiscuously interact with multiple proteins yet result in a primary phenotype, such as cancer inhibition	[Kuang, Yi; Zhou, Jie; Shi, Junfeng; Gao, Yuan; Hedstrom, Lizbeth; Xu, Bing] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Long, Marcus J. C.] Brandeis Univ, Grad Program Biochem & Biophys, Waltham, MA 02454 USA; [Xu, Chen] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Brandeis University; Brandeis University	Xu, B (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02454 USA.	bxu@brandeis.edu	Gao, Yuan/U-1539-2017; XU, Bing/A-7828-2008	Gao, Yuan/0000-0001-9714-4219; XU, Bing/0000-0002-4639-387X; Kuang, Yi/0000-0003-3643-2684; Long, marcus/0000-0002-0343-9671	National Institutes of Health [R01CA142746, P01 GM 62580]; Human Frontier Science Program (HFSP) [RGP0056/2008]; NATIONAL CANCER INSTITUTE [R01CA142746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program (HFSP)(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA142746 (to B. X.) and P01 GM 62580 (to Brandeis University) and by Human Frontier Science Program (HFSP) Grant (RGP0056/2008). J. Z. is a HHMI International Research Fellow.	Adler-Abramovich L, 2012, NAT CHEM BIOL, V8, P701, DOI [10.1038/NCHEMBIO.1002, 10.1038/nchembio.1002]; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Brown DR, 1998, J NEUROSCI RES, V52, P260, DOI 10.1002/(SICI)1097-4547(19980501)52:3<260::AID-JNR2>3.3.CO;2-P; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Davis FJ, 2005, AM J PHYSIOL-HEART C, V288, pH1477, DOI 10.1152/ajpheart.00789.2004; Debets AJM, 2012, P NATL ACAD SCI USA, V109, P10432, DOI 10.1073/pnas.1205333109; Dos Reis S, 2002, J BIOL CHEM, V277, P5703, DOI 10.1074/jbc.M110183200; Driver Jane A, 2012, BMJ, V344, pe1442, DOI 10.1136/bmj.e1442; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2040; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Griffin J. P., 2006, TXB PHARM MED, P96; Gustafsson L, 2005, J NUTR, V135, P1299, DOI 10.1093/jn/135.5.1299; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Khan SH, 1998, CANCER RES, V58, P396; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Koss DJ, 2007, J NEUROCHEM, V102, P1009, DOI 10.1111/j.1471-4159.2007.04579.x; Kuang Y, 2014, ADV HEALTHC MATER, V3, P1217, DOI 10.1002/adhm.201300645; Kuang Y, 2013, ANGEW CHEM INT EDIT, V52, P6944, DOI 10.1002/anie.201302658; Kuang Y, 2013, RSC ADV, V3, P7704, DOI 10.1039/c3ra41523f; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lodish H., 2004, MOL CELL BIOL, P79; MalchiodiAlbedi F, 1997, J NEUROSCI RES, V48, P425, DOI 10.1002/(SICI)1097-4547(19970601)48:5<425::AID-JNR4>3.0.CO;2-G; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mistry P, 2004, J BIOL CHEM, V279, P1482, DOI 10.1074/jbc.M310413200; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; Pauwels K, 2009, CURR GENE THER, V9, P459, DOI 10.2174/156652309790031120; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Sablina AA, 2001, ONCOGENE, V20, P899, DOI 10.1038/sj.onc.1204156; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; TISHLER RB, 1995, CANCER RES, V55, P6021; Trajkovska M., 2013, NAT CELL BIOL, V15, P729, DOI DOI 10.1038/ncb2809; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zhang Y, 2011, LANGMUIR, V27, P529, DOI 10.1021/la1020324; Zhou R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095759; Zorn JA, 2011, J AM CHEM SOC, V133, P19630, DOI 10.1021/ja208350u	51	41	41	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29208	29218		10.1074/jbc.M114.600288	http://dx.doi.org/10.1074/jbc.M114.600288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25157102	Green Published, hybrid			2022-12-25	WOS:000344141000036
J	Yuan, YK; Zhang, YG; Yao, SH; Shi, HS; Huang, X; Li, YH; Wei, YQ; Lin, S				Yuan, Yike; Zhang, Yaguang; Yao, Shaohua; Shi, Huashan; Huang, Xi; Li, Yuhao; Wei, Yuquan; Lin, Shuo			The Translation Initiation Factor eIF3i Up-regulates Vascular Endothelial Growth Factor A, Accelerates Cell Proliferation, and Promotes Angiogenesis in Embryonic Development and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; GENE-EXPRESSION; GENOME-WIDE; PROTEIN; IDENTIFICATION; TRANSFORMATION; MECHANISM; P150; AKT1; PHOSPHORYLATION	Vascular endothelial growth factor A (VEGFA) is a critical proangiogenic factor that is activated by hypoxia at both the transcriptional and post-transcriptional levels. In hypoxia conditions, stabilized hypoxia-inducible factor 1 alpha (HIF1A) is the key regulator for transcriptional activation of VEGFA. However, the post-transcriptional control of VEGFA expression remains poorly understood. Here, we report that the eukaryotic translation initiation factor 3i (eIF3i) is required for VEGFA protein expression in both normal embryonic and tumorigenic angiogenesis. eIF3i is dynamically expressed in the early stages of zebrafish embryogenesis and in human hepatocellular carcinoma tissues. eIF3i homozygous mutant zebrafish embryos show severe angiogenesis defects and human hepatocellular cancer cells with depletion of eIF3i to induce less angiogenesis in tumor models. Under hypoxia, the HIF1A protein can interact with its binding sequence in the eIF3i promoter and activate eIF3i transcription. The expression of VEGFA, which should rise in hypoxia, is significantly inhibited by eIF3i siRNA treatment. Moreover, eIF3i knockdown did not cause a general translation repression but specifically reduced the translation efficiency of the VEGFA mRNAs. Taken together, our results suggest that eIF3i is induced by HIF1A under hypoxia and controls normal and tumorigenic angiogenesis through regulating VEGFA protein translation.	[Yuan, Yike; Zhang, Yaguang; Yao, Shaohua; Shi, Huashan; Huang, Xi; Wei, Yuquan; Lin, Shuo] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Shi, Huashan] Sichuan Univ, West China Hosp, West China Med Sch, Dept Head & Neck Oncol, Chengdu 610041, Sichuan, Peoples R China; [Li, Yuhao] Nankai Univ, Sch Med, Key Lab Tumor Microenvironm & Neurovasc Regulat, Tianjin 300071, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Sichuan University; Sichuan University; Nankai University; University of California System; University of California Los Angeles	Yao, SH (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Lab Biotherapy,Natl Key Lab Biotherapy, Renmin Nanlu 17, Chengdu 610041, Sichuan, Peoples R China.	shaohuayao@scu.edu.cn	Zhang, Yaguang/GZM-9859-2022	Zhang, Yaguang/0000-0002-9216-1834; Shi, Hua-shan/0000-0002-9958-9892; Yao, Shaohua/0000-0002-0191-4889	National Institutes of Health [DK084349]; National Natural Science Foundation of China [81372143, 31000646, 81123003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084349 (to S. L.). This work was also supported by National Natural Science Foundation of China Grants 81372143, 31000646, and 81123003.	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Asano K, 1997, J BIOL CHEM, V272, P1101, DOI 10.1074/jbc.272.2.1101; Bachmann F, 1997, CANCER RES, V57, P988; Beitner-Johnson D, 2001, CELL SIGNAL, V13, P23, DOI 10.1016/S0898-6568(00)00128-5; Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5279; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Chen GP, 2004, INT J CANCER, V112, P393, DOI 10.1002/ijc.20443; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chen LM, 2012, ONCOTARGET, V3, P869, DOI 10.18632/oncotarget.598; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Dachs GU, 2000, EUR J CANCER, V36, P1649, DOI 10.1016/S0959-8049(00)00159-3; de Vries S, 2013, J BIOL CHEM, V288, P5815, DOI 10.1074/jbc.M112.420711; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Gort EH, 2006, ONCOGENE, V25, P6123, DOI 10.1038/sj.onc.1209643; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Huang JS, 2004, BIOCHEM BIOPH RES CO, V315, P950, DOI 10.1016/j.bbrc.2004.01.151; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Joseph P, 2004, MOL CELL BIOCHEM, V255, P93, DOI 10.1023/B:MCBI.0000007265.38475.f7; Kubota Yoshiaki, 2012, Keio Journal of Medicine, V61, P47; Kwon CS, 2006, DEVELOPMENT, V133, P3223, DOI 10.1242/dev.02508; Liu LX, 2002, BIOCHEM BIOPH RES CO, V291, P908, DOI 10.1006/bbrc.2002.6551; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda S, 2000, CANCER RES, V60, P13; Mentewab Ayalew B., BMC RES NOTES, V4, P93; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Rauch J, 2004, BIOCHEM BIOPH RES CO, V323, P156, DOI 10.1016/j.bbrc.2004.08.071; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Shek F. H., 2012, INT J HEPATOL, V9, P1016; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; Varshney GK, 2013, NUCLEIC ACIDS RES, V41, pD861, DOI 10.1093/nar/gks946; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Wang XL, 2012, WORLD J GASTROENTERO, V18, P2540, DOI 10.3748/wjg.v18.i20.2540; Wang YW, 2013, HEPATOLOGY, V58, P239, DOI 10.1002/hep.26352; Yin JY, 2011, BIOSCIENCE REP, V31, P1, DOI 10.1042/BSR20100077; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200	54	19	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28310	28323		10.1074/jbc.M114.571356	http://dx.doi.org/10.1074/jbc.M114.571356			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25147179	Green Published, hybrid			2022-12-25	WOS:000343765400026
J	Gallea, JI; Celej, MS				Ignacio Gallea, J.; Soledad Celej, M.			Structural Insights into Amyloid Oligomers of the Parkinson Disease-related Protein alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT-PROBE; FIBRIL FORMATION; AGGREGATION; DYNAMICS; NMR; PATHOGENESIS; POLYMORPHISM; TOXICITY	The presence of intraneuronal deposits mainly formed by amyloid fibrils of the presynaptic protein alpha-synuclein (AS) is a hallmark of Parkinson disease. Currently, neurotoxicity is attributed to prefibrillar oligomeric species rather than the insoluble aggregates, although their mechanisms of toxicity remain elusive. Structural details of the supramolecular organization of AS oligomers are critically needed to decipher the structure-toxicity relationship underlying their pathogenicity. In this study, we employed site-specific fluorescence to get a deeper insight into the internal architecture of AS oligomeric intermediates. We demonstrate that AS oligomers are ordered assemblies possessing a well defined pattern of intermolecular contacts. Some of these contacts involve regions that form the beta-sheet core in the fibrillar state, although their spatial arrangement may differ in the two aggregated forms. However, even though the two termini are excluded from the fibrillar core, they are engaged in a number of intermolecular interactions within the oligomer. Therefore, substantial structural remodeling of early oligomeric interactions is essential for fibril growth. The intermolecular contacts identified in AS oligomers can serve as targets for the rational design of anti-amyloid compounds directed at preventing oligomeric interactions/reorganizations.	[Ignacio Gallea, J.; Soledad Celej, M.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba, Dept Quim Biol,CONICET, RA-5000 Cordoba, Argentina	National University of Cordoba	Celej, MS (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba, Dept Quim Biol, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	mcelej@mail.fcq.unc.edu.ar	Gallea, Jose Ignacio/AAV-6058-2020; Celej, Maria Soledad/N-5709-2019	Celej, Maria Soledad/0000-0002-7831-9244	Agencia FONCYT [PICT 1913]; CONICET [PIP-2011-2013]; SECyT-UNC;  [ISN-CAEN-2012]	Agencia FONCYT(FONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); SECyT-UNC(Secretaria de Ciencia y Tecnologia (SECYT)); 	This work was supported in part by grants from Agencia FONCYT PICT 1913, CONICET PIP-2011-2013, SECyT-UNC, and ISN-CAEN-2012.	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2011, CURR PROTEIN PEPT SC, V12, P206; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Celej MS, 2009, BIOCHEMISTRY-US, V48, P7465, DOI 10.1021/bi9003843; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Esteban-Martin S, 2013, BIOPHYS J, V105, P1192, DOI 10.1016/j.bpj.2013.07.044; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee JC, 2005, J AM CHEM SOC, V127, P16388, DOI 10.1021/ja0561901; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mysling S, 2013, BIOCHEMISTRY-US, V52, P9097, DOI 10.1021/bi4009193; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; Rao JN, 2008, BIOCHEMISTRY-US, V47, P4651, DOI 10.1021/bi8002378; Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Thirunavukkuarasu S, 2008, J MOL BIOL, V378, P1064, DOI 10.1016/j.jmb.2008.03.034; Valeur B., 2001, MOL FLUORESCENCE PRI, DOI [10.1002/3527600248, DOI 10.1002/3527600248]; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; WU CW, 1976, BIOCHEMISTRY-US, V15, P2863, DOI 10.1021/bi00658a025; Wu KP, 2010, J AM CHEM SOC, V132, P5546, DOI 10.1021/ja9105495; Yap TL, 2011, BIOCHEMISTRY-US, V50, P1963, DOI 10.1021/bi2000824; Yushchenko DA, 2010, J AM CHEM SOC, V132, P7860, DOI 10.1021/ja102838n; Zijlstra N, 2014, BIOPHYS J, V106, P440, DOI 10.1016/j.bpj.2013.12.009; Zijlstra N, 2012, ANGEW CHEM INT EDIT, V51, P8821, DOI 10.1002/anie.201200813	49	39	39	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26733	26742		10.1074/jbc.M114.566695	http://dx.doi.org/10.1074/jbc.M114.566695			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25143382	Green Published, hybrid			2022-12-25	WOS:000342853900006
J	Clerico, V; Masini, L; Boni, A; Meucci, S; Cecchini, M; Recchia, FA; Tredicucci, A; Bifone, A				Clerico, Vito; Masini, Luca; Boni, Adriano; Meucci, Sandro; Cecchini, Marco; Recchia, Fabio A.; Tredicucci, Alessandro; Bifone, Angelo			Water-Dispersible Three-Dimensional LC-Nanoresonators	PLOS ONE			English	Article							NEGATIVE-INDEX METAMATERIAL; SHAPE; NANOPARTICLES	Nanolithography techniques enable the fabrication of complex nanodevices that can be used for biosensing purposes. However, these devices are normally supported by a substrate and their use is limited to in vitro applications. Following a top-down procedure, we designed and fabricated composite inductance-capacitance (LC) nanoresonators that can be detached from their substrate and dispersed in water. The multimaterial composition of these resonators makes it possible to differentially functionalize different parts of the device to obtain stable aqueous suspensions and multi-sensing capabilities. For the first time, we demonstrate detection of these devices in an aqueous environment, and we show that they can be sensitized to their local environment and to chemical binding of specific molecular moieties. The possibility to optically probe the nanoresonator resonance in liquid dispersions paves the way to a variety of new applications, including injection into living organisms for in vivo sensing and imaging.	[Clerico, Vito; Recchia, Fabio A.] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy; [Clerico, Vito; Masini, Luca; Boni, Adriano; Meucci, Sandro; Bifone, Angelo] Ist Italiano Tecnol, Ctr Nanotechnol Innovat NEST, Pisa, Italy; [Masini, Luca; Meucci, Sandro; Cecchini, Marco; Tredicucci, Alessandro] CNR, Ist Nanosci, NEST, I-56100 Pisa, Italy; [Masini, Luca; Meucci, Sandro; Cecchini, Marco; Tredicucci, Alessandro] Scuola Normale Super Pisa, Pisa, Italy; [Recchia, Fabio A.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA	Scuola Superiore Sant'Anna; Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Clerico, V (corresponding author), Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy.	v.clerico@sssup.it; Angelo.Bifone@iit.it	Tredicucci, Alessandro/M-6166-2015; Clericò, Vito/D-7988-2018; Clericò, Vito/AAQ-7426-2020	Tredicucci, Alessandro/0000-0003-3619-3011; Clericò, Vito/0000-0001-5364-6209; Clericò, Vito/0000-0001-6646-8309; Cecchini, Marco/0000-0002-9688-2356	European Research Council; NIH [P01 HL-74237, R01 HL108213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074237, R01HL108213] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the European Research Council through the advanced grant SouLMan. Fabio A. Recchia was supported by NIH grants P01 HL-74237 and R01 HL108213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameling R, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3530795; Andreone A, 2011, SELECTED TOPICS PHOT, P421; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Batt CA, 2007, SCIENCE, V316, P1579, DOI 10.1126/science.1140729; Cattoni A, 2011, NANO LETT, V11, P3557, DOI 10.1021/nl201004c; Chanda D, 2011, NAT NANOTECHNOL, V6, P402, DOI [10.1038/NNANO.2011.82, 10.1038/nnano.2011.82]; Crouse CA, 2010, ACS APPL MATER INTER, V2, P2560, DOI 10.1021/am100402z; Dicken MJ, 2009, OPT EXPRESS, V17, P18330, DOI 10.1364/OE.17.018330; Dolling G, 2007, OPT LETT, V32, P53, DOI 10.1364/OL.32.000053; Glangchai LC, 2008, J CONTROL RELEASE, V125, P263, DOI 10.1016/j.jconrel.2007.10.021; Guney DO, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.125129; Gutrath BS, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/22/225707; Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Hasan W, 2009, NANO LETT, V9, P1555, DOI 10.1021/nl803647n; Jaksic Z, 2007, J OPT A-PURE APPL OP, V9, pS377, DOI 10.1088/1464-4258/9/9/S16; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kim E, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801701; Kim YI, 2008, SENSOR ACTUAT A-PHYS, V143, P279, DOI 10.1016/j.sna.2007.11.014; Kumar S, 2007, NANO LETT, V7, P1338, DOI 10.1021/nl070365i; Lee J, 2008, ACCOUNTS CHEM RES, V41, P1762, DOI 10.1021/ar800126p; Lee SW, 2011, ACS NANO, V5, P897, DOI 10.1021/nn102041m; Lemoult F, 2013, NAT PHYS, V9, P55, DOI [10.1038/NPHYS2480, 10.1038/nphys2480]; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; Mark AG, 2013, NAT MATER, V12, P802, DOI [10.1038/NMAT3685, 10.1038/nmat3685]; Miyamaru F, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3327830; Neuert G, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1899503; Padilla WJ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.041102; Paniagua-Dominguez R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01507; Pendry J, 2006, NAT MATER, V5, P599, DOI 10.1038/nmat1697; Prahl S, 1999, MOLAR EXTINCTION COE; Rheims J, 1997, MEAS SCI TECHNOL, V8, P601, DOI 10.1088/0957-0233/8/6/003; Rodriguez-Canto PJ, 2011, OPT EXPRESS, V19, P7664, DOI 10.1364/OE.19.007664; Rodriguez-Lorenzo L, 2012, NAT MATER, V11, P604, DOI [10.1038/NMAT3337, 10.1038/nmat3337]; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Smith DR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195104; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Vos JG, 2003, INTERFACIAL SUPRAMOL, P88; Walther C, 2010, SCIENCE, V327, P1495, DOI 10.1126/science.1183167	39	1	1	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105474	10.1371/journal.pone.0105474	http://dx.doi.org/10.1371/journal.pone.0105474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153993	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200054
J	Sah, P; Dey, S				Sah, Pratha; Dey, Sutirth			Stabilizing Spatially-Structured Populations through Adaptive Limiter Control	PLOS ONE			English	Article							BIOLOGICAL POPULATIONS; CONTROLLING CHAOS; MIGRATION RATE; DYNAMICS; METAPOPULATIONS; DISPERSAL; MODELS; EXTINCTION; DROSOPHILA; SYNCHRONY	Stabilizing the dynamics of complex, non-linear systems is a major concern across several scientific disciplines including ecology and conservation biology. Unfortunately, most methods proposed to reduce the fluctuations in chaotic systems are not applicable to real, biological populations. This is because such methods typically require detailed knowledge of system specific parameters and the ability to manipulate them in real time; conditions often not met by most real populations. Moreover, real populations are often noisy and extinction-prone, which can sometimes render such methods ineffective. Here, we investigate a control strategy, which works by perturbing the population size, and is robust to reasonable amounts of noise and extinction probability. This strategy, called the Adaptive Limiter Control (ALC), has been previously shown to increase constancy and persistence of laboratory populations and metapopulations of Drosophila melanogaster. Here, we present a detailed numerical investigation of the effects of ALC on the fluctuations and persistence of metapopulations. We show that at high migration rates, application of ALC does not require a priori information about the population growth rates. We also show that ALC can stabilize metapopulations even when applied to as low as one-tenth of the total number of subpopulations. Moreover, ALC is effective even when the subpopulations have high extinction rates: conditions under which another control algorithm had previously failed to attain stability. Importantly, ALC not only reduces the fluctuation in metapopulation sizes, but also the global extinction probability. Finally, the method is robust to moderate levels of noise in the dynamics and the carrying capacity of the environment. These results, coupled with our earlier empirical findings, establish ALC to be a strong candidate for stabilizing real biological metapopulations.	[Sah, Pratha; Dey, Sutirth] Indian Inst Sci Educ & Res Pune, Div Biol, Populat Biol Lab, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Dey, S (corresponding author), Indian Inst Sci Educ & Res Pune, Div Biol, Populat Biol Lab, Pune, Maharashtra, India.	s.dey@iiserpune.ac.in	Sah, Pratha/H-5474-2019	Sah, Pratha/0000-0001-8936-5871	Extra-Mural Research Grant from Council of Scientific and Industrial Research, Govt. of India	Extra-Mural Research Grant from Council of Scientific and Industrial Research, Govt. of India	This study was supported by an Extra-Mural Research Grant from Council of Scientific and Industrial Research, Govt. of India and in-house funding by IISER-Pune. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrievskii BR, 2004, AUTOMAT REM CONTR+, V65, P505, DOI 10.1023/B:AURC.0000023528.59389.09; Andrievskii BR, 2003, AUTOMAT REM CONTR+, V64, P673, DOI 10.1023/A:1023684619933; Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; Ben Zion Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000643; Ben-Zion Y, 2011, THEOR BIOL, P1; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Brannstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2065, DOI 10.1098/rspb.2005.3185; CHEKE RA, 1993, ECOL ENTOMOL, V18, P109, DOI 10.1111/j.1365-2311.1993.tb01191.x; Corron NJ, 2000, PHYS REV LETT, V84, P3835, DOI 10.1103/PhysRevLett.84.3835; Dattani J, 2011, PHYS LETT A, V375, P3986, DOI 10.1016/j.physleta.2011.08.066; Denney NH, 2002, P ROY SOC B-BIOL SCI, V269, P2229, DOI 10.1098/rspb.2002.2138; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Dey S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01405; Dey S, 2008, J ANIM ECOL, V77, P670, DOI 10.1111/j.1365-2656.2008.01401.x; Dey S, 2006, SCIENCE, V314, DOI 10.1126/science.1131367; Dey S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000233; Doebeli M, 1997, B MATH BIOL, V59, P497, DOI 10.1016/S0092-8240(96)00097-3; Drake JM, 2009, ECOL LETT, V12, P772, DOI 10.1111/j.1461-0248.2009.01325.x; Earn DJD, 2000, SCIENCE, V290, P1360, DOI 10.1126/science.290.5495.1360; Franco D, 2013, J THEOR BIOL, V337, P161, DOI 10.1016/j.jtbi.2013.08.018; Franco D, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S021812741350003X; Fronhofer EA, 2012, ECOLOGY, V93, P1967, DOI 10.1890/11-1814.1; Fryxell JM, 2005, OIKOS, V111, P143, DOI 10.1111/j.0030-1299.2005.13840.x; Griffen BD, 2009, P ROY SOC B-BIOL SCI, V276, P4363, DOI 10.1098/rspb.2009.1153; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; GUEMEZ J, 1993, PHYS LETT A, V181, P29, DOI 10.1016/0375-9601(93)91119-P; GYLLENBERG M, 1993, MATH BIOSCI, V118, P25, DOI 10.1016/0025-5564(93)90032-6; Hanski I, 2002, OIKOS, V98, P87, DOI 10.1034/j.1600-0706.2002.980109.x; Hanski I., 1999, METAPOPULATION ECOLO; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Henson SM, 2001, SCIENCE, V294, P602, DOI 10.1126/science.1063358; Hilker F.M., 2005, BEITRAEGE I UMWELTSY; Hilker FM, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.052901; Ims RA, 2005, P ROY SOC B-BIOL SCI, V272, P913, DOI 10.1098/rspb.2004.3025; Ives AR, 2004, AM NAT, V163, P375, DOI 10.1086/381942; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Liz E, 2010, CHAOS, V20, DOI 10.1063/1.3432558; Matter SF, 2013, ECOL MODEL, V266, P68, DOI 10.1016/j.ecolmodel.2013.06.021; Matter SF, 2010, P ROY SOC B-BIOL SCI, V277, P729, DOI 10.1098/rspb.2009.1520; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MCCALLUM HI, 1992, J THEOR BIOL, V154, P277, DOI 10.1016/S0022-5193(05)80170-5; Parekh N, 1998, PHYS REV LETT, V81, P1401, DOI 10.1103/PhysRevLett.81.1401; Ponciano JM, 2005, APPL ENVIRON MICROB, V71, P2355, DOI 10.1128/AEM.71.5.2355-2364.2005; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Sah P, 2013, J THEOR BIOL, V320, P113, DOI 10.1016/j.jtbi.2012.12.014; Scholl E., 2008, HDB CHAOS CONTROL; Sheeba V, 1998, CURR SCI INDIA, V75, P1406; Sinha S., 1995, PHYS REV E, V51, P6239; Sole RV, 1999, B MATH BIOL, V61, P1187, DOI 10.1006/bulm.1999.0141; strom K. J. A, 2008, ADAPTIVE CONTROL, V2nd; Tung S, 2014, J THEOR BIOL, V356, P163, DOI 10.1016/j.jtbi.2014.04.036; Vogwill T, 2009, ECOL LETT, V12, P1194, DOI 10.1111/j.1461-0248.2009.01374.x; Wagner C, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.017201; Ylikarjula J, 2000, J THEOR BIOL, V207, P377, DOI 10.1006/jtbi.2000.2181; Zelinka I, 2005, HEURISTICA, V100	58	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105861	10.1371/journal.pone.0105861	http://dx.doi.org/10.1371/journal.pone.0105861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153073	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200087
J	Wolpaw, BJ; Mathews, C; Mtshizana, Y; Chopra, M; Hardie, D; Lurie, MN; De Azevedo, V; Jennings, K				Wolpaw, Benjamin J.; Mathews, Catherine; Mtshizana, Yolisa; Chopra, Mickey; Hardie, Diana; Lurie, Mark N.; De Azevedo, Virginia; Jennings, Karen			Patient Experiences following Acute HIV Infection Diagnosis and Counseling in South Africa	PLOS ONE			English	Article							TRANSMISSION; PREVENTION	Individuals in the acute stage of HIV infection (AHI) have an elevated potential to transmit HIV and play a critical role in the growth of the epidemic. Routine identification and counseling of individuals during AHI could decrease transmission behavior during this key period. However, diagnosis of AHI may present challenges distinct from those experienced through diagnosis of established HIV infection. A study was conducted in a public youth clinic outside of Cape Town, South Africa, to identify and counsel individuals with acute stage HIV infection. In-depth interviews were conducted with patients following diagnosis. After counseling, patients were accepting of the testing regimen used to diagnose AHI. They used the knowledge of having been recently infected to identify the source of their infection, but did not retain or place importance on information regarding the increased ability to transmit HIV during the acute stage. Future interventions directed at the reduction of HIV transmission following diagnosis with AHI will need to find ways of making this information more salient, possibly through more culturally meaningful educational approaches.	[Wolpaw, Benjamin J.; Mathews, Catherine; Mtshizana, Yolisa; Chopra, Mickey] S African MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Mathews, Catherine] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Hardie, Diana] Univ Cape Town, Dept Virol, ZA-7925 Cape Town, South Africa; [Lurie, Mark N.] Brown Univ, Sch Med, Dept Community Hlth, Providence, RI 02912 USA; [De Azevedo, Virginia; Jennings, Karen] Cape Town Municipal Hlth Directorate, Cape Town, South Africa	South African Medical Research Council; University of Cape Town; University of Cape Town; Brown University	Wolpaw, BJ (corresponding author), S African MRC, Hlth Syst Res Unit, Cape Town, South Africa.	ben.wolpaw@gmail.com	hardie, diana/R-6870-2019	Mathews, Catherine/0000-0001-5368-1127	Medical Research Council Health Systems Research Group; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020] Funding Source: NIH RePORTER	Medical Research Council Health Systems Research Group; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded internally by the Medical Research Council Health Systems Research Group, the research organization that employed several of the authors. The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Corneli A, 2014, AIDS BEHAV; Department of Social Services and Poverty Alleviation, 2006, POP REG UPD KHAYEL; Khayelitsha District Office Report, 2001, KHAYEL DISTR OFF REP; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; Pilcher C. D., 2006, Current HIV/AIDS Reports, V3, P150, DOI 10.1007/s11904-006-0011-4; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Remien RH, 2009, AIDS BEHAV, V13, P1046, DOI 10.1007/s10461-009-9581-7; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Ulin PR, 2005, QUALITATIVE METHODS; West GR, 2007, AIDS EDUC PREV, V19, P275, DOI 10.1521/aeap.2007.19.4.275; Wolpaw BJ, 2011, SEX TRANSM INFECT, V87, P71, DOI 10.1136/sti.2009.041475; Zetola NM, 2007, INFECT DIS CLIN N AM, V21, P19, DOI 10.1016/j.idc.2007.01.008	14	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105459	10.1371/journal.pone.0105459	http://dx.doi.org/10.1371/journal.pone.0105459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153674	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200051
J	Zhang, PP; Frankel, LK; Bricker, TM				Zhang, Pengpeng; Frankel, Laurie K.; Bricker, Terry M.			Integration of Apo-alpha-Phycocyanin into Phycobilisomes and Its Association with FNRL in the Absence of the Phycocyanin alpha-Subunit Lyase (CpcF) in Synechocystis sp PCC 6803	PLOS ONE			English	Article							SYNECHOCOCCUS SP PCC-7002; FERREDOXIN-NADP(+) OXIDOREDUCTASE; THYLAKOID MEMBRANES; PHOTOSYSTEM-II; BILIN LYASE; PETH GENE; CHLOROPHYLL; ATTACHMENT; CYANOBACTERIA; CONSTRUCTION	Phycocyanin is an important component of the phycobilisome, which is the principal light-harvesting complex in cyanobacteria. The covalent attachment of the phycocyanobilin chromophore to phycocyanin is catalyzed by the enzyme phycocyanin lyase. The photosynthetic properties and phycobilisome assembly state were characterized in wild type and two mutants which lack holo-alpha-phycocyanin. Insertional inactivation of the phycocyanin alpha-subunit lyase (Delta cpcF mutant) prevents the ligation of phycocyanobilin to alpha-phycocyanin (CpcA), while disruption of the cpcB/A/C2/C1 operon in the CK mutant prevents synthesis of both apo-alpha-phycocyanin (apo-CpcA) and apo-beta-phycocyanin (apo-CpcB). Both mutants exhibited similar light saturation curves under white actinic light illumination conditions, indicating the phycobilisomes in the Delta cpcF mutant are not fully functional in excitation energy transfer. Under red actinic light illumination, wild type and both phycocyanin mutant strains exhibited similar light saturation characteristics. This indicates that all three strains contain functional allophycocyanin cores associated with their phycobilisomes. Analysis of the phycobilisome content of these strains indicated that, as expected, wild type exhibited normal phycobilisome assembly and the CK mutant assembled only the allophycocyanin core. However, the Delta cpcF mutant assembled phycobilisomes which, while much larger than the allophycocyanin core observed in the CK mutant, were significantly smaller than phycobilisomes observed in wild type. Interestingly, the phycobilisomes from the Delta cpcF mutant contained holo-CpcB and apo-CpcA. Additionally, we found that the large form of FNR (FNRL) accumulated to normal levels in wild type and the Delta cpcF mutant. In the CK mutant, however, significantly less FNRL accumulated. FNRL has been reported to associate with the phycocyanin rods in phycobilisomes via its N-terminal domain, which shares sequence homology with a phycocyanin linker polypeptide. We suggest that the assembly of apo-CpcA in the phycobilisomes of Delta cpcF can stabilize FNRL and modulate its function. These phycobilisomes, however, inefficiently transfer excitation energy to Photosystem II.	[Zhang, Pengpeng; Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA.	btbric@lsu.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-98ER20310]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by Grant DE-FG02-98ER20310 provided by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy to TMB and LKF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AJLANI G, 1995, BBA-BIOENERGETICS, V1231, P189, DOI 10.1016/0005-2728(95)00086-X; Ajlani G, 1998, PLANT MOL BIOL, V37, P577, DOI 10.1023/A:1005924730298; Antal T, 2008, PHOTOSYNTH RES, V96, P217, DOI 10.1007/s11120-008-9301-6; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; Arteni A, 2009, BIOCHIM BIOPHYS ACTA, V1787, P222; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; Bolte K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-56; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FILLAT MF, 1993, PLANT MOL BIOL, V22, P725, DOI 10.1007/BF00047415; Gomez-Lojero C, 2003, BIOCHEMISTRY-US, V42, P13800, DOI 10.1021/bi0346998; Hu P, 2013, FEBS LETT, V587, P2340, DOI 10.1016/j.febslet.2013.05.040; Korn A, 2009, J BIOL CHEM, V284, P31789, DOI 10.1074/jbc.M109.024638; Liu HJ, 2013, SCIENCE, V342, P1104, DOI 10.1126/science.1242321; Nakajima M, 2002, PLANT CELL PHYSIOL, V43, P484, DOI 10.1093/pcp/pcf058; Omairi-Nasser A, 2011, MOL MICROBIOL, V81, P1178, DOI 10.1111/j.1365-2958.2011.07739.x; Page LE, 2012, APPL ENVIRON MICROB, V78, P6349, DOI 10.1128/AEM.00499-12; PLANK T, 1995, J BACTERIOL, V177, P6804, DOI 10.1128/jb.177.23.6804-6809.1995; Rehman AU, 2013, BBA-BIOENERGETICS, V1827, P689, DOI 10.1016/j.bbabio.2013.02.016; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; SCHLUCHTER WM, 1992, BIOCHEMISTRY-US, V31, P3092, DOI 10.1021/bi00127a009; SCHLUCHTER WM, 1992, BIOCHEMISTRY-US, V31, P5952, DOI 10.1021/bi00140a037; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Szymanska R, 2011, PHYSIOL PLANTARUM, V141, P289, DOI 10.1111/j.1399-3054.2010.01434.x; Thomas JC, 2006, P NATL ACAD SCI USA, V103, P18368, DOI 10.1073/pnas.0607718103; Toole CM, 1998, MOL MICROBIOL, V30, P475, DOI 10.1046/j.1365-2958.1998.01082.x; Ughy B, 2004, MICROBIOL-SGM, V150, P4147, DOI 10.1099/mic.0.27498-0; van Thor JJ, 1999, EMBO J, V18, P4128, DOI 10.1093/emboj/18.15.4128; van Thor JJ, 2000, BBA-BIOENERGETICS, V1457, P129, DOI 10.1016/S0005-2728(00)00072-4; Watanabe M, 2014, P NATL ACAD SCI USA, V111, P2512, DOI 10.1073/pnas.1320599111; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zhang PP, 2012, PLANT CELL, V24, P1952, DOI 10.1105/tpc.111.094417; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	38	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105952	10.1371/journal.pone.0105952	http://dx.doi.org/10.1371/journal.pone.0105952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153076	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200095
J	de Fraga, R; Stow, AJ; Magnusson, WE; Lima, AP				de Fraga, Rafael; Stow, Adam J.; Magnusson, William E.; Lima, Albertina P.			The Costs of Evaluating Species Densities and Composition of Snakes to Assess Development Impacts in Amazonia	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; INVENTORIES; EFFICIENCY; PATTERNS; ECOLOGY; BIRDS; WIDTH	Studies leading to decision-making for environmental licensing often fail to provide accurate estimates of diversity. Measures of snake diversity are regularly obtained to assess development impacts in the rainforests of the Amazon Basin, but this taxonomic group may be subject to poor detection probabilities. Recently, the Brazilian government tried to standardize sampling designs by the implementation of a system (RAPELD) to quantify biological diversity using spatially-standardized sampling units. Consistency in sampling design allows the detection probabilities to be compared among taxa, and sampling effort and associated cost to be evaluated. The cost effectiveness of detecting snakes has received no attention in Amazonia. Here we tested the effects of reducing sampling effort on estimates of species densities and assemblage composition. We identified snakes in seven plot systems, each standardised with 14 plots. The 250 m long centre line of each plot followed an altitudinal contour. Surveys were repeated four times in each plot and detection probabilities were estimated for the 41 species encountered. Reducing the number of observations, or the size of the sampling modules, caused significant loss of information on species densities and local patterns of variation in assemblage composition. We estimated the cost to find a snake as $ 120 U.S., but general linear models indicated the possibility of identifying differences in assemblage composition for half the overall survey costs. Decisions to reduce sampling effort depend on the importance of lost information to target-issues, and may not be the preferred option if there is the potential for identifying individual snake species requiring specific conservation actions. However, in most studies of human disturbance on species assemblages, it is likely to be more cost-effective to focus on other groups of organisms with higher detection probabilities.	[de Fraga, Rafael] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Stow, Adam J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Magnusson, William E.; Lima, Albertina P.] Inst Nacl Pesquisas Amazonia Coordenacao Biodiver, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Macquarie University	de Fraga, R (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	r.defraga@gmail.com		Lima, Albertina Pimentel/0000-0003-4586-5633; Stow, Adam/0000-0002-6796-4854	Programa de Pesquisa em Biodiversidade (PPBio); National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Instituto Nacional de Pesquisas da Amazonia (INPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES	Programa de Pesquisa em Biodiversidade (PPBio); National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Instituto Nacional de Pesquisas da Amazonia (INPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Programa de Pesquisa em Biodiversidade (PPBio), the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM) and the Instituto Nacional de Pesquisas da Amazonia (INPA) have funded field work. The Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES provided a scholarship to R. de Fraga. The funders played a role in financing the construction of plot systems and data collection, but they had no direct involvement in those and other tasks (e.g. analysis, decision to publish, preparation of the manuscript).	Abrahao C, 2007, THESIS INPA UFAM MAN; ANGERMEIER PL, 1994, BIOSCIENCE, V44, P690, DOI 10.2307/1312512; [Anonymous], BIOTA NEOTROPICA; Austin MP, 2013, J VEG SCI, V24, P251, DOI 10.1111/j.1654-1103.2012.01467.x; Bassler C, 2014, J APPL ECOL, V51, P939, DOI 10.1111/1365-2664.12267; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Bernarde PS, 2012, BIOTA NEOTROP, V12, P154, DOI 10.1590/S1676-06032012000300018; Bibby CJ, 1999, OSTRICH, V70, P81, DOI 10.1080/00306525.1999.9639752; Bueno AS, 2012, ECOL APPL, V22, P722, DOI 10.1890/11-0789.1; BURBIDGE AA, 1991, NATURE CONSERVATION, P3; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Horbe AMC, 2013, ACTA AMAZON, V43, P489, DOI 10.1590/S0044-59672013000400011; Colwell RK, 2000, P NATL ACAD SCI USA, V97, P13470, DOI 10.1073/pnas.250497697; Danielsen F, 2003, ORYX, V37, P407, DOI 10.1017/S0030605303000735; DASILVA NJ, 1995, CONSERV BIOL, V9, P873, DOI 10.1046/j.1523-1739.1995.09040873.x; De Fraga Rafael, 2013, Copeia, V4, P684; de Fraga R, 2011, HERPETOL J, V21, P51; de Freitas CG, 2012, ACTA OECOL, V39, P128, DOI 10.1016/j.actao.2012.01.007; Ernst R, 2007, ENVIRON SCI ENG, P61; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; GENTRY AH, 1982, EVOL BIOL, V15, P1; Giradoux P, 2013, MISCELLANEOUS FUNCTI; Gotelli N. J., 2010, BIOL DIVERSITY FRONT, P39, DOI DOI 10.1016/J.BAAE.2011.07.002; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Hartel T, 2009, BIOLOGIA ACTA SCIENT, V17, P61; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Hinds WT, 1984, ENVIRON CONSERV, V11, P11; IUCN, 2013, IUCN RED LIST THREAT; JAMES FC, 1990, ANNU REV ECOL SYST, V21, P129, DOI 10.1146/annurev.es.21.110190.001021; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Magnusson WE, 2005, ESTATISTICA SEM MATE, P103; Magnusson WE, 2013, BIODIVERSITY INTEGRA; MARGULES CR, 1991, NATURE CONSERVATION; Mesquita PCMD, 2013, AN ACAD BRAS CIENC, V85, P1127, DOI 10.1590/S0001-37652013005000040; Oksanen J, 2010, R PACKAGE VERSION 1; Pansonato MP, 2013, BIOTROPICA, V45, P299, DOI 10.1111/btp.12008; Patrick DA, 2009, J HERPETOL, V43, P716, DOI 10.1670/08-288.1; Pawar S, 2003, BIOSCIENCE, V53, P861, DOI 10.1641/0006-3568(2003)053[0861:TCATMC]2.0.CO;2; de Souza JLP, 2009, PESQUI AGROPECU BRAS, V44, P940, DOI 10.1590/S0100-204X2009000800021; Souza Jorge Luiz Pereira, 2007, Acta Amaz., V37, P649, DOI 10.1590/S0044-59672007000400022; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; Rojas-Ahumada DP, 2012, AUSTRAL ECOL, V37, P865, DOI 10.1111/j.1442-9993.2011.02330.x; Ruokolainen L, 2006, ANN BOT FENN, V43, P269; Santos EMR, 2008, BIOTROPICA, V40, P728, DOI 10.1111/j.1744-7429.2008.00425.x; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Steen DA, 2010, HERPETOL CONSERV BIO, V5, P183; Stork NE, 1995, GLOBAL BIODIVERSITY, P457; Stow AJ, 2012, WILDLIFE RES, V39, P290, DOI 10.1071/WR11150; Todd BD, 2008, CONSERV BIOL, V22, P753, DOI 10.1111/j.1523-1739.2008.00916.x	53	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105453	10.1371/journal.pone.0105453	http://dx.doi.org/10.1371/journal.pone.0105453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147930	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600048
J	Dempsey, SJ; Gese, EM; Kluever, BM				Dempsey, Steven J.; Gese, Eric M.; Kluever, Bryan M.			Finding a Fox: An Evaluation of Survey Methods to Estimate Abundance of a Small Desert Carnivore	PLOS ONE			English	Article							JOAQUIN KIT FOXES; GREAT-BASIN DESERT; VULPES-MACROTIS-MUTICA; SCAT DETECTION DOGS; HOME-RANGE SIZE; SWIFT FOXES; OCCUPANCY RATES; HABITAT USE; POPULATIONS; COYOTES	The status of many carnivore species is a growing concern for wildlife agencies, conservation organizations, and the general public. Historically, kit foxes (Vulpes macrotis) were classified as abundant and distributed in the desert and semi-arid regions of southwestern North America, but is now considered rare throughout its range. Survey methods have been evaluated for kit foxes, but often in populations where abundance is high and there is little consensus on which technique is best to monitor abundance. We conducted a 2-year study to evaluate four survey methods (scat deposition surveys, scent station surveys, spotlight survey, and trapping) for detecting kit foxes and measuring fox abundance. We determined the probability of detection for each method, and examined the correlation between the relative abundance as estimated by each survey method and the known minimum kit fox abundance as determined by radio-collared animals. All surveys were conducted on 15 5-km transects during the 3 biological seasons of the kit fox. Scat deposition surveys had both the highest detection probabilities (p = 0.88) and were most closely related to minimum known fox abundance (r(2) = 0.50, P = 0.001). The next best method for kit fox detection was the scent station survey (p = 0.73), which had the second highest correlation to fox abundance (r(2) = 0.46, P<0.001). For detecting kit foxes in a low density population we suggest using scat deposition transects during the breeding season. Scat deposition surveys have low costs, resilience to weather, low labor requirements, and pose no risk to the study animals. The breeding season was ideal for monitoring kit fox population size, as detections consisted of the resident population and had the highest detection probabilities. Using appropriate monitoring techniques will be critical for future conservation actions for this rare desert carnivore.	[Dempsey, Steven J.; Kluever, Bryan M.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Gese, Eric M.] Utah State Univ, USDA, Anim & Plant Hlth Inspect Serv, Wildlife Serv,Wildlife Res Ctr,Dept Wildland Reso, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University	Gese, EM (corresponding author), Utah State Univ, USDA, Anim & Plant Hlth Inspect Serv, Wildlife Serv,Wildlife Res Ctr,Dept Wildland Reso, Logan, UT 84322 USA.	eric.gese@usu.edu	Gese, Eric M/B-4578-2011		Department of Defense, United States Army Dugway Proving Ground, Environmental Programs, Dugway, Utah; United States Department of Agriculture, Wildlife Services, National Wildlife Research Center, Utah State University, Logan, Utah; Quinney College of Natural Resources, Utah State University, Logan, Utah; Endangered Species Mitigation Fund of the Utah Department of Natural Resources, Division of Wildlife Resources, Salt Lake City, Utah	Department of Defense, United States Army Dugway Proving Ground, Environmental Programs, Dugway, Utah; United States Department of Agriculture, Wildlife Services, National Wildlife Research Center, Utah State University, Logan, Utah; Quinney College of Natural Resources, Utah State University, Logan, Utah; Endangered Species Mitigation Fund of the Utah Department of Natural Resources, Division of Wildlife Resources, Salt Lake City, Utah	Funding and logistical support were provided by the Department of Defense, United States Army Dugway Proving Ground, Environmental Programs, Dugway, Utah, and the United States Department of Agriculture, Wildlife Services, National Wildlife Research Center, Utah State University, Logan, Utah. Additional funding was provided by the Quinney College of Natural Resources, Utah State University, Logan, Utah, and the Endangered Species Mitigation Fund of the Utah Department of Natural Resources, Division of Wildlife Resources, Salt Lake City, Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Arjo WM, 2007, WEST N AM NATURALIST, V67, P389, DOI 10.3398/1527-0904(2007)67[389:CIKFRI]2.0.CO;2; Arjo WM, 2003, CAN J ZOOL, V81, P96, DOI 10.1139/Z02-232; Beauvais GP, 2006, KIT FOX VULPES MACRO; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cypher BL, 2000, WILDLIFE MONOGR, P1; EBERHARDT LE, 1982, J WILDLIFE MANAGE, V46, P183, DOI 10.2307/3808421; EGOSCUE H. J., 1956, JOUR MAMMAL, V37, P351, DOI 10.2307/1376734; EGOSCUE HJ, 1962, ECOLOGY, V43, P481, DOI 10.2307/1933376; Finley DJ, 2005, J WILDLIFE MANAGE, V69, P861, DOI 10.2193/0022-541X(2005)069[0861:EOSFPS]2.0.CO;2; FITZGERALD JP, 1996, STATUS DISTRIBUTION; GESE EM, 1990, J WILDLIFE MANAGE, V54, P501, DOI 10.2307/3809665; Gese EM, 2001, CONSERV BIOL SER, V5, P372; GESE EM, 2004, CANIDS FOXES WOLVES, P273; Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2; Harrison RL, 2002, AM MIDL NAT, V148, P320, DOI 10.1674/0003-0031(2002)148[0320:ACOPST]2.0.CO;2; Jacques CN, 2009, J MAMMAL, V90, P433, DOI 10.1644/07-MAMM-A-395.1; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Knowlton FF, 1984, FEASIBILITY ASSESSSI; Koopman ME, 2000, J MAMMAL, V81, P213, DOI 10.1644/1545-1542(2000)081<0213:DPOSJK>2.0.CO;2; Kozlowski AJ, 2008, AM MIDL NAT, V160, P191, DOI 10.1674/0003-0031(2008)160[191:NOARPB]2.0.CO;2; Kozlowski AJ, 2003, WILDLIFE SOC B, V31, P630; Kozlowski AJ, 2012, INT J ECOL, V2012, P1, DOI [10.1155/2012/629246, DOI 10.1155/2012/629246]; LINHART S B, 1975, Wildlife Society Bulletin, V3, P119; List R, 2003, J ZOOL, V259, P1, DOI 10.1017/S0952836902002959; Long RA, 2007, J WILDLIFE MANAGE, V71, P2007, DOI 10.2193/2006-230; Long RA, 2007, J WILDLIFE MANAGE, V71, P2018, DOI 10.2193/2006-292; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McGrew JC, 1976, MAMMALIAN SPECIES, V123, P1; Moehrenschlager A, 2007, J MAMMAL, V88, P1029, DOI 10.1644/06-MAMM-A-159R.1; Ralls K, 1997, J MAMMAL, V78, P65, DOI 10.2307/1382639; Ralls K, 2010, J WILDLIFE MANAGE, V74, P1457, DOI 10.2193/2009-401; ROUGHTON RD, 1982, J WILDLIFE MANAGE, V46, P217, DOI 10.2307/3808424; Ruette S, 2003, J APPL ECOL, V40, P32, DOI 10.1046/j.1365-2664.2003.00776.x; SCHALLER GB, 1996, CARNIVORE BEHAV ECOL, V2; Schauster ER, 2002, WILDLIFE SOC B, V30, P464; Schauster ER, 2002, CAN J ZOOL, V80, P307, DOI 10.1139/Z02-009; Smith DA, 2005, WILDLIFE SOC B, V33, P897, DOI 10.2193/0091-7648(2005)33[897:AOSDST]2.0.CO;2; Steiniger S, 2012, WILDLIFE SOC B, V36, P600, DOI 10.1002/wsb.168; SWIHART RK, 1985, ECOLOGY, V66, P1176, DOI 10.2307/1939170; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thacker R. K., 1995, COMP USE 4 TECHNIQUE; Utah Department of Natural Resources, 2011, UT SENS SPEC LIST; Warrick GD, 2001, WILDLIFE SOC B, V29, P827; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WHITE PJ, 1994, CAN J ZOOL, V72, P1831, DOI 10.1139/z94-247; White PJ, 1997, CAN J ZOOL, V75, P1982, DOI 10.1139/z97-830; WHITE PJ, 1993, J WILDLIFE MANAGE, V57, P861, DOI 10.2307/3809090; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; ZOELLICK BW, 1992, J MAMMAL, V73, P83, DOI 10.2307/1381868; Zoellick BW, 2002, WEST N AM NATURALIST, V62, P151	52	25	25	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105873	10.1371/journal.pone.0105873	http://dx.doi.org/10.1371/journal.pone.0105873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148102	Green Published, gold			2022-12-25	WOS:000341230600092
J	Guan, Z; Chen, YL; Yuan, Y; Song, J; Yang, DC; Xue, Y; He, YH				Guan, Zhi; Chen, Yan-Li; Yuan, Yi; Song, Jian; Yang, Da-Cheng; Xue, Yang; He, Yan-Hong			Earthworm Is a Versatile and Sustainable Biocatalyst for Organic Synthesis	PLOS ONE			English	Article								A crude extract of earthworms was used as an eco-friendly, environmentally benign, and easily accessible biocatalyst for various organic synthesis including the asymmetric direct aldol and Mannich reactions, Henry and Biginelli reactions, direct three-component aza-Diels-Alder reactions for the synthesis of isoquinuclidines, and domino reactions for the synthesis of coumarins. Most of these reactions have never before seen in nature, and moderate to good enantioselectivities in aldol and Mannich reactions were obtained with this earthworm catalyst. The products can be obtained in preparatively useful yields, and the procedure does not require any additional cofactors or special equipment. This work provides an example of a practical way to use sustainable catalysts from nature.	[Guan, Zhi; Chen, Yan-Li; Yuan, Yi; Song, Jian; Yang, Da-Cheng; Xue, Yang; He, Yan-Hong] Southwest Univ, Sch Chem & Chem Engn, Chongqing, Peoples R China	Southwest University - China	He, YH (corresponding author), Southwest Univ, Sch Chem & Chem Engn, Chongqing, Peoples R China.	heyh@swu.edu.cn	guan, zhi/R-9965-2016	He, Yan-Hong/0000-0002-6405-285X	National Natural Science Foundation of China [21276211]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No 21276211), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend M, 1998, ANGEW CHEM INT EDIT, V37, P1044, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1044::AID-ANIE1044>3.0.CO;2-E; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Boeris V, 2009, PROCESS BIOCHEM, V44, P1260, DOI 10.1016/j.procbio.2009.07.001; Bommarius AS, 2004, BIOCATALYSIS FUNDAME; Cordell GA, 2007, J NAT PROD, V70, P478, DOI 10.1021/np0680634; Faber K, 2018, BIOTRANSFORMATIONS O, P134, DOI 10.1007/978-3-319-61590-5; Ishihara K, 2006, BIOSCI BIOTECH BIOCH, V70, P3077, DOI 10.1271/bbb.60408; Ishii Y, 2009, Patent US, Patent No. [20090238891A1, 20090238891]; Johannes T, 2006, ENCY CHEM PROCESSING, DOI [10.1081/E-ECHP-120017565, DOI 10.1081/E-ECHP-120017565]; Kittelmann M, 2003, ADV SYNTH CATAL, V345, P825, DOI 10.1002/adsc.200303044; Leutbecher H, 2009, GREEN CHEM, V11, P676, DOI 10.1039/b822977e; Maruoka K, 2012, CHEM COMMUN, V48, P10703, DOI 10.1039/c2cc90327j; Messing R. A., 1975, IMMOBILIZED ENZYMES; Mirabal-Gallardo Y, 2013, TETRAHEDRON-ASYMMETR, V24, P440, DOI 10.1016/j.tetasy.2013.03.003; Nakajima N, 2005, BIOSCI BIOTECH BIOCH, V69, P2009, DOI 10.1271/bbb.69.2009; Nakajima N, 2003, J MOL CATAL B-ENZYM, V23, P191, DOI 10.1016/S1381-1177(03)00082-1; Pan R., 2010, APPL ENV SOIL SCI, DOI [10.1155/2010/294258, DOI 10.1155/2010/294258]; Toscano MD, 2007, ANGEW CHEM INT EDIT, V46, P3212, DOI 10.1002/anie.200604205	18	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105284	10.1371/journal.pone.0105284	http://dx.doi.org/10.1371/journal.pone.0105284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148527	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600041
J	Kuo, HC; Huang, YH; Chien, SC; Yu, HR; Hsieh, KS; Hsu, YW; Chang, WC				Kuo, Ho-Chang; Huang, Ying-Hsien; Chien, Shu-Chen; Yu, Hong-Ren; Hsieh, Kai-Sheng; Hsu, Yu-Wen; Chang, Wei-Chiao			Genetic Variants of CD209 Associated with Kawasaki Disease Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IMMUNOGLOBULIN TREATMENT FAILURE; DC-SIGN; EPIDEMIOLOGIC FEATURES; INFECTION; VIRUS; TUBERCULOSIS; POLYMORPHISM; DIAGNOSIS; IMMUNITY	Background: Kawasaki disease (KD) is a systemic vasculitis with unknown etiology mainly affecting children in Asian countries. Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN, CD209) in humans was showed to trigger an anti-inflammatory cascade and associated with KD susceptibility. This study was conducted to investigate the association between genetic polymorphisms of CD209 and the risk KD. Methods: A total of 948 subjects (381 KD and 567 controls) were recruited. Nine tagging SNPs (rs8112310, rs4804800, rs11465421, rs1544766, rs4804801, rs2287886, rs735239, rs735240, rs4804804) were selected for TaqMan allelic discrimination assay. Clinical phenotypes, coronary artery lesions (CAL) and intravenous immunoglobulin (IVIG) treatment outcomes were collected for analysis. Results: Significant associations were found between CD209 polymorphisms (rs4804800, rs2287886, rs735240) and the risk of KD. Haplotype analysis for CD209 polymorphisms showed that A/A/G haplotype (P = 0.0002, OR = 1.61) and G/A/G haplotype (P = 0.0365, OR = 1.52) had higher risk of KD as compared with G/G/A haplotype in rs2287886/rs735239/rs735240 pairwise allele analysis. There were no significant association in KD with regards to CAL formation and IVIG treatment responses. Conclusion: CD209 polymorphisms were responsible for the susceptibility of KD, but not CAL formation and IVIG treatment responsiveness.	[Kuo, Ho-Chang; Huang, Ying-Hsien; Yu, Hong-Ren; Hsieh, Kai-Sheng] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Huang, Ying-Hsien; Yu, Hong-Ren; Hsieh, Kai-Sheng] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Huang, Ying-Hsien; Yu, Hong-Ren; Hsieh, Kai-Sheng] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chien, Shu-Chen; Hsu, Yu-Wen; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Hsu, Yu-Wen; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogenom & Pharmacoprote, Taipei, Taiwan; [Chien, Shu-Chen] Taipei Med Univ Hosp, Dept Pharm, Taipei, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw	Kuo, Ho-Chang/AAQ-6644-2020; 于, 鴻仁/AAW-6827-2021	Kuo, Ho-Chang/0000-0002-3295-2984; 于, 鴻仁/0000-0003-1242-8760; Hsieh, Kai-Sheng/0000-0002-0294-9872; Chang, Wei-Chiao/0000-0002-8573-5924	National Science Council, Taiwan (NSC) [102-2314-B-182-053-MY3]; Taipei Medical University, Taiwan [TMU101-AE1-B14]; Chang Gung Memorial Hospital, Taiwan [CMRPG8C1081, CMRPG8B0211]	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Taipei Medical University, Taiwan; Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by a grant from the National Science Council, Taiwan (NSC 102-2314-B-182-053-MY3), Taipei Medical University, Taiwan (Grant no. TMU101-AE1-B14) and grants from Chang Gung Memorial Hospital, Taiwan (CMRPG8C1081 and CMRPG8B0211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; de Witte L, 2006, J VIROL, V80, P3477, DOI 10.1128/JVI.80.7.3477-3486.2006; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; HR Yu, 2012, SCI WORLD J, V2012; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Koizumi Y, 2007, AIDS RES HUM RETROV, V23, P713, DOI 10.1089/aid.2006.0225; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2012, PEDIATR NEONATOL, V53, P4, DOI 10.1016/j.pedneo.2011.11.003; Kuo HC, 2011, J HUM GENET, V56, P161, DOI 10.1038/jhg.2010.154; Kuo HC, 2011, J CLIN IMMUNOL, V31, P240, DOI 10.1007/s10875-010-9484-4; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; Kuo Ho-Chang, 2007, Journal of Microbiology Immunology and Infection, V40, P395; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Liang CD, 2009, AM HEART J, V157, P584, DOI 10.1016/j.ahj.2008.11.020; Lidar M, 2009, AUTOIMMUNITY, V42, P432, DOI 10.1080/08916930802613210; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Mittal R, 2009, J IMMUNOL, V183, P6588, DOI 10.4049/jimmunol.0902029; Nakamura Y, 2008, J EPIDEMIOL, V18, P167, DOI 10.2188/jea.JE2008001; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Portman MA, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-32; Sarkar R., 2013, PLOS ONE, V8; SHULMAN ST, 1995, PEDIATR CLIN N AM, V42, P1205; Vannberg FO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001388; Wang CL, 2005, PEDIATR INFECT DIS J, V24, P998, DOI 10.1097/01.inf.0000183786.70519.fa; Yu HR, 2009, PEDIAT ALLERG IMM-UK, V20, P699, DOI 10.1111/j.1399-3038.2008.00844.x; Yu XJ, 2013, J MOL BIOL, V425, P1253, DOI 10.1016/j.jmb.2013.02.006; Zhou T, 2006, CELL MOL IMMUNOL, V3, P279	37	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105236	10.1371/journal.pone.0105236	http://dx.doi.org/10.1371/journal.pone.0105236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148534	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600035
J	Birol, M; Enchev, RI; Padilla, A; Stengel, F; Aebersold, R; Betzi, S; Yang, YS; Hoh, F; Peter, M; Dumas, C; Echalier, A				Birol, Melissa; Enchev, Radoslav Ivanov; Padilla, Andre; Stengel, Florian; Aebersold, Ruedi; Betzi, Stephane; Yang, Yinshan; Hoh, Francois; Peter, Matthias; Dumas, Christian; Echalier, Aude			Structural and Biochemical Characterization of the Cop9 Signalosome CSN5/CSN6 Heterodimer	PLOS ONE			English	Article							CROSS-LINKED PEPTIDES; ATOMIC STRUCTURES; CRYSTAL-STRUCTURE; H-1-NMR SPECTRA; PROTEIN; NEDD8; PROTEASOME; INSIGHTS; MODEL; ARCHITECTURE	The Cop9 signalosome complex (CSN) regulates the functional cycle of the major E3 ubiquitin ligase family, the cullin RING E3 ubiquitin ligases (CRLs). Activated CRLs are covalently modified by the ubiquitin-like protein Nedd8 (neural precursor cell expressed developmentally down-regulated protein 8). CSN serves an essential role in myriad cellular processes by reversing this modification through the isopeptidase activity of its CSN5 subunit. CSN5 alone is inactive due to an auto-inhibited conformation of its catalytic domain. Here we report the molecular basis of CSN5 catalytic domain activation and unravel a molecular hierarchy in CSN deneddylation activity. The association of CSN5 and CSN6 MPN (for Mpr1/Pad1 N-terminal) domains activates its isopeptidase activity. The CSN5/CSN6 module, however, is inefficient in CRL deneddylation, indicating a requirement of further elements in this reaction such as other CSN subunits. A hybrid molecular model of CSN5/CSN6 provides a structural framework to explain these functional observations. Docking this model into a published CSN electron density map and using distance constraints obtained from cross-linking coupled to mass-spectrometry, we find that the C-termini of the CSN subunits could form a helical bundle in the centre of the structure. They likely play a key scaffolding role in the spatial organization of CSN and precise positioning of the dimeric MPN catalytic core.	[Birol, Melissa; Padilla, Andre; Yang, Yinshan; Hoh, Francois; Dumas, Christian; Echalier, Aude] Univ Montpellier 2, Univ Montpellier 1, CNRS, UMR 5048,Ctr Biochim Struct, Montpellier, France; [Birol, Melissa; Padilla, Andre; Yang, Yinshan; Hoh, Francois; Dumas, Christian; Echalier, Aude] INSERM, U1054, Paris, France; [Enchev, Radoslav Ivanov; Peter, Matthias] Swiss Fed Inst Technol, Dept Biol, Inst Biochem, Zurich, Switzerland; [Stengel, Florian; Aebersold, Ruedi] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland; [Betzi, Stephane] Aix Marseille Univ, UM105, Unite Mixte Rech UMR 7258,Inst Paoli Calmettes, INSERM,U1068,Ctr Rech Cancerol Marseille,Ctr Bioc, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Echalier, A (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	aude.echalier-glazer@cbs.cnrs.fr	Betzi, Stephane/AAC-6103-2022	Betzi, Stephane/0000-0001-5935-5058; Birol, Melissa/0000-0003-3397-8446; PADILLA, ANDRE/0000-0001-9702-4612; Peter, Matthias/0000-0002-2160-6824; hoh, francois/0000-0002-2905-7081; Stengel, Florian/0000-0003-1447-4509	Swiss National Science Foundation: European Research Council; ETH-Zurich; Marie Curie; Sir Henry Wellcome Fellow; Wellcome Trust [095951]; European Research Council [233226]; University Montpellier I; Centre national de la recherche scientifique; GEFLUC Languedoc Roussillon;  [CBS2/UM2]	Swiss National Science Foundation: European Research Council; ETH-Zurich(ETH Zurich); Marie Curie(European Commission); Sir Henry Wellcome Fellow; Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); University Montpellier I; Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); GEFLUC Languedoc Roussillon; 	Funding provided by Swiss National Science Foundation: European Research Council senior award: MP, ETH-Zurich: MP RA, Marie Curie: RIE, Sir Henry Wellcome Fellow: FS (Wellcome Trust Grant 095951), European Research Council advanced grant Proteomics v3.0 (233226): RA, CBS2/UM2 PhD studentship: MB, University Montpellier I: AE, Centre national de la recherche scientifique: AE and GEFLUC Languedoc Roussillon: AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Birol M., 2014, CURR PROTEIN PEPT SC; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Crow A, 2012, P NATL ACAD SCI USA, V109, pE1830, DOI 10.1073/pnas.1112107109; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Dobbins SE, 2008, P NATL ACAD SCI USA, V105, P10390, DOI 10.1073/pnas.0802496105; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Echalier A, 2013, P NATL ACAD SCI USA, V110, P1273, DOI 10.1073/pnas.1209345110; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; ENGLANDER SW, 1987, BIOCHEMISTRY-US, V26, P5953, DOI 10.1021/bi00393a001; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Gracy J, 2005, NUCLEIC ACIDS RES, V33, pW65, DOI 10.1093/nar/gki455; Hollup SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-52; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee JHW, 2013, J HYDRO-ENVIRON RES, V7, P227, DOI 10.1016/j.jher.2013.10.003; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Lingaraju GW, 2014, NATURE IN PRESS; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Malliavin TE, 1998, BIOINFORMATICS, V14, P624, DOI 10.1093/bioinformatics/14.7.624; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; O'Donoghue JE, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-8; Pathare GR, 2014, P NATL ACAD SCI US; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Rodrigues JPGLM, 2014, FEBS J, V281, P1988, DOI 10.1111/febs.12771; ROTH SM, 1992, BIOCHEMISTRY-US, V31, P1443, DOI 10.1021/bi00120a022; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sanches M, 2007, J MOL BIOL, V370, P846, DOI 10.1016/j.jmb.2007.04.084; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Shrestha RK, 2014, BIOCHEMISTRY; SKLENAR V, 1993, J BIOMOL NMR, V3, P721, DOI 10.1007/BF00198375; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; Vashisth H, 2012, STRUCTURE, V20, P1453, DOI 10.1016/j.str.2012.08.007; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; WAND AJ, 1991, BIOPHYS J, V59, P1101, DOI 10.1016/S0006-3495(91)82325-6; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Worden EJ, 2014, NAT STRUCT MOL BIOL; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Zhang H, 2012, FEBS LETT, V586, P1147, DOI 10.1016/j.febslet.2012.03.029	59	21	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105688	10.1371/journal.pone.0105688	http://dx.doi.org/10.1371/journal.pone.0105688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144743	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000341106100109
J	Fulara, A; Hernik, A; Nieznanska, H; Dzwolak, W				Fulara, Aleksandra; Hernik, Agnieszka; Nieznanska, Hanna; Dzwolak, Wojciech			Covalent Defects Restrict Supramolecular Self-Assembly of Homopolypeptides: Case Study of beta(2)-Fibrils of Poly-L-Glutamic Acid	PLOS ONE			English	Article							POLY(L-GLUTAMIC ACID); SIDE-CHAINS; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; POLYAMINO ACIDS; POLYPEPTIDES; COMPLEXES; OLIGOMERS; PROTEINS; FIBRILS	Poly-L-glutamic acid (PLGA) often serves as a model in studies on amyloid fibrils and conformational transitions in proteins, and as a precursor for synthetic biomaterials. Aggregation of PLGA chains and formation of amyloid-like fibrils was shown to continue on higher levels of superstructural self-assembly coinciding with the appearance of so-called beta(2)-sheet conformation manifesting in dramatic redshift of infrared amide I' band below 1600 cm(-1). This spectral hallmark has been attributed to network of bifurcated hydrogen bonds coupling C = O and N-D (N-H) groups of the main chains to glutamate side chains. However, other authors reported that, under essentially identical conditions, PLGA forms the conventional in terms of infrared characteristics beta(1)-sheet structure (exciton-split amide I' band with peaks at ca. 1616 and 1683 cm(-1)). Here we attempt to shed light on this discrepancy by studying the effect of increasing concentration of intentionally induced defects in PLGA on the tendency to form beta(1)/beta(2)-type aggregates using infrared spectroscopy. We have employed carbodiimide-mediated covalent modification of Glu side chains with n-butylamine (NBA), as well as electrostatics-driven inclusion of polylysine chains, as two different ways to trigger structural defects in PLGA. Our study depicts a clear correlation between concentration of defects in PLGA and increasing tendency to depart from the beta(2)-structure toward the one less demanding in terms of chemical uniformity of side chains: beta(1)-structure. The varying predisposition to form beta(1)- or beta(2)-type aggregates assessed by infrared absorption was compared with the degree of morphological order observed in electron microscopy images. Our results are discussed in the context of latent covalent defects in homopolypeptides (especially with side chains capable of hydrogen-bonding) that could obscure their actual propensities to adopt different conformations, and limit applications in the field of synthetic biomaterials.	[Fulara, Aleksandra; Hernik, Agnieszka; Dzwolak, Wojciech] Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, Warsaw, Poland; [Nieznanska, Hanna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	University of Warsaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Dzwolak, W (corresponding author), Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, Warsaw, Poland.	wdzwolak@chem.uw.edu.pl		Nieznanska, Hanna/0000-0001-7055-5018	National Science Centre of Poland [DEC-2011/03/B/ST4/03063]	National Science Centre of Poland(National Science Centre, Poland)	Support from the National Science Centre of Poland, contract grant number DEC-2011/03/B/ST4/03063 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackels L, 2009, VIB SPECTROSC, V50, P2, DOI 10.1016/j.vibspec.2008.07.004; APPEL P, 1965, BIOCHEMISTRY-US, V4, P1244, DOI 10.1021/bi00883a005; Babenko V, 2011, CHEM COMMUN, V47, P10686, DOI 10.1039/c1cc14230e; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; BLOUT ER, 1954, J AM CHEM SOC, V76, P4492, DOI 10.1021/ja01646a078; BLOUT ER, 1962, J AM CHEM SOC, V84, P3193, DOI 10.1021/ja00875a038; Chen LL, 2013, BIOMACROMOLECULES, V14, P4320, DOI 10.1021/bm401215w; Chi H, 2013, BIOMACROMOLECULES, V14, P3880, DOI 10.1021/bm401015f; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DOMARD A, 1980, MACROMOLECULES, V13, P898, DOI 10.1021/ma60076a026; DOTY P, 1957, J POLYM SCI, V23, P851, DOI 10.1002/pol.1957.1202310429; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fasman GD, 1967, POLYALPHA AMINO ACID; Fulara A, 2011, J PHYS CHEM B, V115, P11010, DOI 10.1021/jp206271e; Fulara A, 2010, J PHYS CHEM B, V114, P8278, DOI 10.1021/jp102440n; Itoh K, 2008, LANGMUIR, V24, P13426, DOI 10.1021/la8015832; ITOH K, 1976, BIOPOLYMERS, V15, P419, DOI 10.1002/bip.1976.360150302; Iwata H, 1998, BIOMATERIALS, V19, P1869, DOI 10.1016/S0142-9612(98)00095-7; Kessler J, 2014, J PHYS CHEM B, V118, P6937, DOI 10.1021/jp502178d; Krejtschi C, 2011, EUR BIOPHYS J BIOPHY, V40, P673, DOI 10.1007/s00249-011-0673-8; Li C, 2002, ADV DRUG DELIVER REV, V54, P695, DOI 10.1016/S0169-409X(02)00045-5; Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178; RINAUDO M, 1976, J AM CHEM SOC, V98, P6360, DOI 10.1021/ja00436a048; RINAUDO M, 1977, MACROMOLECULES, V10, P720, DOI 10.1021/ma60057a052; SELA M, 1956, J AM CHEM SOC, V78, P746, DOI 10.1021/ja01585a015; Shoji O, 2001, MACROMOLECULES, V34, P4270, DOI 10.1021/ma001984f; SONG SH, 1989, J AM CHEM SOC, V111, P4295, DOI 10.1021/ja00194a022; Tansey W, 2004, J CONTROL RELEASE, V94, P39, DOI 10.1016/j.jconrel.2003.09.005; Tian HY, 2014, J CONTROL RELEASE, V174, P117, DOI 10.1016/j.jconrel.2013.11.008; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Yamaoki Y, 2012, J PHYS CHEM B, V116, P5172, DOI 10.1021/jp2125685; YAN JF, 1968, J CHEM PHYS, V49, P2713, DOI 10.1063/1.1670476	33	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105660	10.1371/journal.pone.0105660	http://dx.doi.org/10.1371/journal.pone.0105660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144464	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100105
J	Goessens, A; Satyanarayana, B; Van der Stocken, T; Zuniga, MQ; Mohd-Lokman, H; Sulong, I; Dahdouh-Guebas, F				Goessens, Arnaud; Satyanarayana, Behara; Van der Stocken, Tom; Zuniga, Melissa Quispe; Mohd-Lokman, Husain; Sulong, Ibrahim; Dahdouh-Guebas, Farid			Is Matang Mangrove Forest in Malaysia Sustainably Rejuvenating after More than a Century of Conservation and Harvesting Management?	PLOS ONE			English	Article							STRUCTURAL DEVELOPMENT; COASTAL VEGETATION; GAZI BAY; BIOMASS; PRODUCTIVITY; ASSEMBLAGES; ALLOMETRY; ECOSYSTEM; TREE; REGENERATION	Matang Mangrove Forest Reserve (MMFR) in Peninsular Malaysia is under systematic management since 1902 and still considered as the best managed mangrove forest in the world. The present study on silvimetrics assessed the ongoing MMFR forest management, which includes a first thinning after 15 years, a second thinning after 20 years and clear-felling of 30-year old forest blocks, for its efficiency and productivity in comparison to natural mangroves. The estimated tree structural parameters (e.g. density, frequency) from three different-aged mangrove blocks of fifteen (MF15), twenty (MF20), and thirty (MF30) years old indicated that Bruguiera and Excoecaria spp. did not constitute a significant proportion of the vegetation (<5%), and hence the results focused majorly on Rhizophora apiculata. The density of R. apiculata at MF15, MF20 and MF30 was 4,331, 2,753 and 1,767 stems ha 21, respectively. In relation to ongoing practices of the artificial thinnings at MMFR, the present study suggests that the first thinning could be made earlier to limit the loss of exploitable wood due to natural thinning. In fact, the initial density at MF15 was expected to drop down from 6,726 to 1,858 trees ha 21 before the first thinning. Therefore the trees likely to qualify for natural thinning, though having a smaller stem diameter, should be exploited for domestic/commercial purposes at an earlier stage. The clear-felling block (MF30) with a maximum stem diameter of 30 cm was estimated to yield 372 t ha(-1) of the above-ground biomass and suggests that the mangrove management based on a 30-year rotation is appropriate for the MMFR. Since Matang is the only iconic site that practicing sustainable wood production, it could be an exemplary to other mangrove locations for their improved management.	[Goessens, Arnaud; Satyanarayana, Behara; Van der Stocken, Tom; Zuniga, Melissa Quispe; Dahdouh-Guebas, Farid] Univ Libre Bruxelles, Lab Syst Ecol & Resource Management, Brussels, Belgium; [Goessens, Arnaud; Satyanarayana, Behara; Mohd-Lokman, Husain; Sulong, Ibrahim] Univ Malaysia Terengganu UMT, Mangrove Res Unit MARU, Inst Oceanog & Environm INOS, Kuala Terengganu, Malaysia; [Satyanarayana, Behara; Van der Stocken, Tom; Zuniga, Melissa Quispe; Dahdouh-Guebas, Farid] Vrije Univ Brussel, Lab Plant Biol & Nat Management, Brussels, Belgium	Universite Libre de Bruxelles; Universiti Malaysia Terengganu; Vrije Universiteit Brussel	Satyanarayana, B (corresponding author), Univ Libre Bruxelles, Lab Syst Ecol & Resource Management, CPI 264-1, Brussels, Belgium.	satyam2149@gmail.com	Satyanarayana, Behara/F-7694-2013	Satyanarayana, Behara/0000-0003-4191-2607; DAHDOUH-GUEBAS, Farid/0000-0002-5906-8996; Van der Stocken, Tom/0000-0002-1820-9123; Quispe-Zuniga, Melissa Roxana/0000-0002-1624-1867	Interuniversity Council of the French Community of Belgium - University Commission for Development (CIUF-CUD); Belgian National Science Foundation [FNRS-MIS F. 4508.11]; Flemish Interuniversity Cooperation - University Development Cooperation (VLIR-UOS)	Interuniversity Council of the French Community of Belgium - University Commission for Development (CIUF-CUD); Belgian National Science Foundation; Flemish Interuniversity Cooperation - University Development Cooperation (VLIR-UOS)	The travel grant of AG was sponsored by the Interuniversity Council of the French Community of Belgium - University Commission for Development (CIUF-CUD). BS FDG were supported by the Belgian National Science Foundation (FNRS-MIS F.4508.11). TVdS MQZ were supported by the Flemish Interuniversity Cooperation - University Development Cooperation (VLIR-UOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2012, APPL ENERG, V91, P173, DOI 10.1016/j.apenergy.2011.08.028; Alfaro AC, 2006, ESTUAR COAST SHELF S, V66, P97, DOI 10.1016/j.ecss.2005.07.024; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Alongi DM, 1998, J EXP MAR BIOL ECOL, V225, P197, DOI 10.1016/S0022-0981(97)00223-2; Alongi DM, 2004, MAR GEOL, V208, P383, DOI 10.1016/j.margeo.2004.04.016; Alongi DM, 2003, MAR ENVIRON RES, V55, P313, DOI 10.1016/S0141-1136(02)00276-3; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; AMARASINGHE MD, 1992, HYDROBIOLOGIA, V247, P37, DOI 10.1007/BF00008203; Amir AA, 2012, FOREST ECOL MANAG, V269, P60, DOI 10.1016/j.foreco.2011.12.040; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2007, WORLDS MANGR 1980 20; [Anonymous], 1988, BIOL SYSTEM MANGROVE; [Anonymous], 2005, FUNDAMENTALS ECOLOGY; Ashton EC, 1999, HYDROBIOLOGIA, V413, P77, DOI 10.1023/A:1003842910811; Aung TT, 2011, WETL ECOL MANAG, V19, P195, DOI 10.1007/s11273-011-9211-9; Azahar M., 2003, WORKING PLAN MATANG, P320; Bayas JCL, 2011, P NATL ACAD SCI USA, V108, P18612, DOI 10.1073/pnas.1013516108; Bosire JO, 2008, AQUAT BOT, V89, P251, DOI 10.1016/j.aquabot.2008.03.010; Bosire JO, 2006, MAR ECOL PROG SER, V325, P85, DOI 10.3354/meps325085; Bosire JO, 2005, MAR ECOL PROG SER, V299, P149, DOI 10.3354/meps299149; Bosire JO, 2003, AQUAT BOT, V76, P267, DOI 10.1016/S0304-3770(03)00054-8; Cannicci S, 2008, AQUAT BOT, V89, P186, DOI 10.1016/j.aquabot.2008.01.009; Cannicci S, 2009, ESTUAR COAST SHELF S, V84, P305, DOI 10.1016/j.ecss.2009.04.021; Chapin III SF, 2009, PRINCIPLES ECOSYSTEM; Chong V. C., 2006, Aquatic Ecosystem Health & Management, V9, P249, DOI 10.1080/14634980600717084; Choudhury JK, 1997, P 11 WORLD FOR C, V6, P266; Cohen R, 2013, FOREST ECOL MANAG, V310, P968, DOI 10.1016/j.foreco.2013.09.047; Coronado-Molina C., 2004, Wetlands Ecology and Management, V12, P157, DOI 10.1023/B:WETL.0000034071.17156.c0; Cox G.W., 1996, LAB MANUAL GEN ECOLO; Cunha-Lignon M, 2011, J COASTAL RES, P349; Cunha-Lignon M, 2011, J COASTAL RES, P344; Curtis JT, 1959, VEGETATION WISCONSIN; Dahdouh-Guebas F, 2011, J EXP MAR BIOL ECOL, V399, P188, DOI 10.1016/j.jembe.2010.11.012; Dahdouh-Guebas F, 2006, FOREST ECOL MANAG, V228, P1, DOI 10.1016/j.foreco.2005.10.076; DAHDOUHGUEBAS F, 2002, MEDED ZITT K ACAD OV, V48, P487; Das S, 2013, ESTUAR COAST SHELF S, V134, P98, DOI 10.1016/j.ecss.2013.09.021; De Ryck DJR, 2012, AQUAT BOT, V103, P66, DOI 10.1016/j.aquabot.2012.06.005; Di Nitto D, 2008, MAR ECOL PROG SER, V356, P175, DOI 10.3354/meps07228; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; Ellison J.C., 2000, CLIMATE CHANGE S PAC, P289, DOI [DOI 10.1007/0-306-47981-8, 10.1007/0-306-47981-8_16]; EONG OJ, 1993, CHEMOSPHERE, V27, P1097, DOI 10.1016/0045-6535(93)90070-L; Feagin RA, 2010, CONSERV LETT, V3, P1, DOI 10.1111/j.1755-263X.2009.00087.x; Fontalvo-Herazo ML, 2011, WETL ECOL MANAG, V19, P397, DOI 10.1007/s11273-011-9224-4; Gates GM, 2011, FUNGAL ECOL, V4, P68, DOI 10.1016/j.funeco.2010.08.001; GONG WK, 1990, ESTUAR COAST SHELF S, V31, P519, DOI 10.1016/0272-7714(90)90010-O; Haron HA, 1981, WORKING PLAN 2 30 YE; JUPEM, 2004, HDB TID TABL; Kairo J., 2002, AMBIO, V31, P7, DOI DOI 10.1579/0044-7447-31.7.562; Kairo J. G., 2009, Journal of Sustainable Forestry, V28, P395, DOI 10.1080/10549810902791523; Kairo JG, 2009, AQUAT CONSERV, V19, pS63, DOI 10.1002/aqc.1046; Kairo JG, 2008, FOREST ECOL MANAG, V255, P2670, DOI 10.1016/j.foreco.2008.01.031; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; KHOON GW, 1995, HYDROBIOLOGIA, V295, P255, DOI 10.1007/BF00029132; KOMIYAMA A, 1987, J TROP ECOL, V3, P97, DOI 10.1017/S0266467400001826; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Krauss KW, 2008, AQUAT BOT, V89, P105, DOI 10.1016/j.aquabot.2007.12.014; Lee SY, 2014, GLOBAL ECOL BIOGEOGR, V23, P726, DOI 10.1111/geb.12155; MALL L P, 1991, Tropical Ecology, V32, P144; Mukherjee N, 2014, ECOLOGY EVO IN PRESS; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nfotabong Atheull A, 2013, ESTUAR COAST, V36, P1181, DOI DOI 10.1007/s12237-013-9638-8; Nfotabong-Atheull A, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-41; Okamura K, 2010, JARQ-JPN AGR RES Q, V44, P325, DOI 10.6090/jarq.44.325; Ong J.E., 1985, 7 YEARS PRODUCTIVITY, P213; Ong JE, 2004, FOREST ECOL MANAG, V188, P395, DOI 10.1016/j.foreco.2003.08.002; PUTZ FE, 1986, FOREST ECOL MANAG, V17, P211, DOI 10.1016/0378-1127(86)90113-1; Quispe Zuniga M., 2014, VLIZ SPECIAL PUBLICA, V67, P87; Roslan A., 2014, WORKING PLAN MATANG; Sangil C, 2014, J SEA RES, V85, P92, DOI 10.1016/j.seares.2013.10.009; Satyanarayana B, 2013, OCEAN COAST MANAGE, V71, P225, DOI 10.1016/j.ocecoaman.2012.10.008; Satyanarayana B, 2012, AMBIO, V41, P513, DOI 10.1007/s13280-012-0248-7; Satyanarayana B, 2011, MAR ECOL PROG SER, V443, P51, DOI 10.3354/meps09397; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; United Nations Environment Programme (UNEP), 2014, IMPORTANCE MANGROVES; Van der Stocken T, 2013, BIOGEOSCIENCES, V10, P3635, DOI 10.5194/bg-10-3635-2013; Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009; Wang G, 2013, FOREST ECOL MANAG, V310, P539, DOI 10.1016/j.foreco.2013.08.045; Zhang KQ, 2012, ESTUAR COAST SHELF S, V102, P11, DOI 10.1016/j.ecss.2012.02.021	80	71	72	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105069	10.1371/journal.pone.0105069	http://dx.doi.org/10.1371/journal.pone.0105069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144689	Green Published, gold			2022-12-25	WOS:000341106100038
J	Linder, N; Turkki, R; Walliander, M; Martensson, A; Diwan, V; Rahtu, E; Pietikainen, M; Lundin, M; Lundin, J				Linder, Nina; Turkki, Riku; Walliander, Margarita; Martensson, Andreas; Diwan, Vinod; Rahtu, Esa; Pietikainen, Matti; Lundin, Mikael; Lundin, Johan			A Malaria Diagnostic Tool Based on Computer Vision Screening and Visualization of Plasmodium falciparum Candidate Areas in Digitized Blood Smears	PLOS ONE			English	Article							MICROSCOPY; CLASSIFICATION; TANZANIA; IMPACT	Introduction: Microscopy is the gold standard for diagnosis of malaria, however, manual evaluation of blood films is highly dependent on skilled personnel in a time-consuming, error-prone and repetitive process. In this study we propose a method using computer vision detection and visualization of only the diagnostically most relevant sample regions in digitized blood smears. Methods: Giemsa-stained thin blood films with P. falciparum ring-stage trophozoites (n = 27) and uninfected controls (n = 20) were digitally scanned with an oil immersion objective (0.1 mm/pixel) to capture approximately 50,000 erythrocytes per sample. Parasite candidate regions were identified based on color and object size, followed by extraction of image features (local binary patterns, local contrast and Scale-invariant feature transform descriptors) used as input to a support vector machine classifier. The classifier was trained on digital slides from ten patients and validated on six samples. Results: The diagnostic accuracy was tested on 31 samples (19 infected and 12 controls). From each digitized area of a blood smear, a panel with the 128 most probable parasite candidate regions was generated. Two expert microscopists were asked to visually inspect the panel on a tablet computer and to judge whether the patient was infected with P. falciparum. The method achieved a diagnostic sensitivity and specificity of 95% and 100% as well as 90% and 100% for the two readers respectively using the diagnostic tool. Parasitemia was separately calculated by the automated system and the correlation coefficient between manual and automated parasitemia counts was 0.97. Conclusion: We developed a decision support system for detecting malaria parasites using a computer vision algorithm combined with visualization of sample areas with the highest probability of malaria infection. The system provides a novel method for blood smear screening with a significantly reduced need for visual examination and has a potential to increase the throughput in malaria diagnostics.	[Linder, Nina; Turkki, Riku; Walliander, Margarita; Lundin, Mikael; Lundin, Johan] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Martensson, Andreas; Diwan, Vinod; Lundin, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Rahtu, Esa; Pietikainen, Matti] Univ Oulu, Dept Comp Sci & Engn, Oulu, Finland	University of Helsinki; Karolinska Institutet; University of Oulu	Linder, N (corresponding author), Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland.	nina.linder@helsinki.fi	Lundin, Johan/AAC-8510-2020; Lundin, Johan/I-1843-2018	Lundin, Johan/0000-0002-2681-4139; Lundin, Johan/0000-0002-2681-4139; Linder, Nina/0000-0003-3930-0513; Turkki, Riku/0000-0002-8690-6983; Rahtu, Esa/0000-0001-8767-0864	Swedish Research Council; Sigrid Juselius Foundation; Finska Lakaresallskapet; Dorothea Olivia, Karl Walter and Jarl Walter Perklen Foundation; "European Advanced Translational Research Infra Structure in Medicine'' (EATRIS)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Dorothea Olivia, Karl Walter and Jarl Walter Perklen Foundation; "European Advanced Translational Research Infra Structure in Medicine'' (EATRIS)	The study was supported by the Swedish Research Council, Sigrid Juselius Foundation, Finska Lakaresallskapet, and the Dorothea Olivia, Karl Walter and Jarl Walter Perklen Foundation. In addition, this study has received funding from the "European Advanced Translational Research Infra Structure in Medicine'' (EATRIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; [Anonymous], 2009, MAL MICR QUAL ASS MA; Bain BJ, 2005, NEW ENGL J MED, V353, P498, DOI 10.1056/NEJMra043442; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Di Ruberto C, 2002, IMAGE VISION COMPUT, V20, P133, DOI 10.1016/S0262-8856(01)00092-0; Diaz G, 2009, J BIOMED INFORM, V42, P296, DOI 10.1016/j.jbi.2008.11.005; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Frean J, 2012, B WORLD HEALTH ORGAN, V90, P191, DOI 10.2471/BLT.11.091876; Garcia LS, 2000, LAB DIAGNOSIS BLOOD; Kaewkamnerd S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S18; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le MT, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-15; Linder E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000315; Linder E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002547; Linder N, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-22; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Maity M., 2012, INT J COMPUTER APPL, V52, P31, DOI [10.5120/8279-1906, DOI 10.5120/8279-1906]; Mavandadi S, 2012, LAB CHIP, V12, P4102, DOI 10.1039/c2lc40614d; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Ngasala B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-199; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; O'Meara WP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-118; Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pang S, 2010, LAB CHIP, V10, P411, DOI 10.1039/b919004j; Prescott WR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-155; Purwar Y, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-364; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Tek FB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-153; Tek FB, 2010, COMPUT VIS IMAGE UND, V114, P21, DOI 10.1016/j.cviu.2009.08.003; Turkki R, 2013, DIAGNOSTIC PATHOL S1, pS30; Vedaldi A, 2010, VLFEAT OPEN PORTABLE, P1469; Vedaldi A, 2009, IEEE I CONF COMP VIS, P606, DOI 10.1109/ICCV.2009.5459183; Walliander M, 2013, DIAGNOSTIC PATHOLOGY, V8, pS37, DOI DOI 10.1186/1746-1596-8-S1-S37; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, BAS MAL MICR; WHO, 2010, GUID TREATM MAL, V2nd; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organisation, 2008, TASK SHIFT GLOB REC; Zhu HY, 2013, LAB CHIP, V13, P1282, DOI 10.1039/c3lc41408f	43	48	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104855	10.1371/journal.pone.0104855	http://dx.doi.org/10.1371/journal.pone.0104855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144549	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100026
J	Oth, T; Schnijderberg, MCA; Senden-Gijsbers, BLMG; Germeraad, WTV; Bos, GMJ; Vanderlocht, J				Oth, Tammy; Schnijderberg, Melanie C. A.; Senden-Gijsbers, Birgit L. M. G.; Germeraad, Wilfred T. V.; Bos, Gerard M. J.; Vanderlocht, Joris			Monitoring the Initiation and Kinetics of Human Dendritic Cell-Induced Polarization of Autologous Naive CD4(+) T Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR; CHROMATIN STATE; IFN-GAMMA; IN-VITRO; DIFFERENTIATION; TH1; ACTIVATION; EXPRESSION; TYPE-1	A crucial step in generating de novo immune responses is the polarization of naive cognate CD4(+) T cells by pathogen-triggered dendritic cells (DC). In the human setting, standardized DC-dependent systems are lacking to study molecular events during the initiation of a naive CD4(+) T cell response. We developed a TCR-restricted assay to compare different pathogen-triggered human DC for their capacities to instruct functional differentiation of autologous, naive CD4(+) T cells. We demonstrated that this methodology can be applied to compare differently matured DC in terms of kinetics, direction, and magnitude of the naive CD4(+) T cell response. Furthermore, we showed the applicability of this assay to study the T cell polarizing capacity of low-frequency blood-derived DC populations directly isolated ex vivo. This methodology for addressing APC-dependent instruction of naive CD4(+) T cells in a human autologous setting will provide researchers with a valuable tool to gain more insight into molecular mechanisms occurring in the early phase of T cell polarization. In addition, it may also allow the study of pharmacological agents on DC-dependent T cell polarization in the human system.	[Oth, Tammy; Schnijderberg, Melanie C. A.; Senden-Gijsbers, Birgit L. M. G.; Germeraad, Wilfred T. V.; Bos, Gerard M. J.] Maastricht Univ Med Ctr, Sch Oncol & Dev Biol, Dept Internal Med, Div Hematol, Maastricht, Netherlands; [Vanderlocht, Joris] Maastricht Univ Med Ctr, Sch Oncol & Dev Biol, Tissue Typing Lab, Dept Transplantat Immunol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Vanderlocht, J (corresponding author), Maastricht Univ Med Ctr, Sch Oncol & Dev Biol, Tissue Typing Lab, Dept Transplantat Immunol, Maastricht, Netherlands.	joris.vanderlocht@mumc.nl			"Fonds National de la Recherche,'' Luxembourg [1039369]	"Fonds National de la Recherche,'' Luxembourg(Luxembourg National Research Fund)	This work was supported by the "Fonds National de la Recherche,'' Luxembourg (project 1039369; T.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Athie-Morales V, 2004, J IMMUNOL, V172, P61, DOI 10.4049/jimmunol.172.1.61; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bellanger AP, 2013, CLIN VACCINE IMMUNOL, V20, P1133, DOI 10.1128/CVI.00043-13; Blom L, 2013, J IMMUNOLOGICAL METH; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Bryant CE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120015; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; DELPRETE G, 1993, J IMMUNOL, V150, P353; Donnelly RP, 2010, CYTOKINE GROWTH F R, V21, P393, DOI 10.1016/j.cytogfr.2010.09.001; Dzopalic T, 2012, IMMUNOL RES, V52, P20, DOI 10.1007/s12026-012-8279-5; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Evans CM, 2013, BRIEF FUNCT GENOMICS, V12, P499, DOI 10.1093/bfgp/elt025; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Frasca L, 2008, J IMMUNOL, V180, P1471, DOI 10.4049/jimmunol.180.3.1471; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hawkins RD, 2013, IMMUNITY, V38, P1271, DOI 10.1016/j.immuni.2013.05.011; Hayday AC, 2008, NAT IMMUNOL, V9, P575, DOI 10.1038/ni0608-575; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Josefowicz SZ, 2013, IMMUNOLOGY, V139, P299, DOI 10.1111/imm.12115; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Langenkamp A, 2002, EUR J IMMUNOL, V32, P2046, DOI 10.1002/1521-4141(200207)32:7<2046::AID-IMMU2046>3.0.CO;2-M; Lassmann H, 2004, TRENDS IMMUNOL, V25, P132, DOI 10.1016/j.it.2004.01.007; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; Lombardi V, 2009, J IMMUNOL, V182, P3372, DOI 10.4049/jimmunol.0801969; Luger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054879; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moser JM, 2010, J IMMUNOL METHODS, V353, P8, DOI 10.1016/j.jim.2009.11.006; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nembrini C, 2006, J IMMUNOL, V176, P7180, DOI 10.4049/jimmunol.176.12.7180; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Padovan E, 2007, TRENDS IMMUNOL, V28, P308, DOI 10.1016/j.it.2007.05.002; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Peters M, 2010, IMMUNOL CELL BIOL, V88, P537, DOI 10.1038/icb.2010.3; Placek K, 2009, J IMMUNOL, V183, P7743, DOI 10.4049/jimmunol.0803812; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; Rodriguez-Palmero M, 1999, EUR J IMMUNOL, V29, P3914; Rogge L, 1998, J IMMUNOL, V161, P6567; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; Scott K, 2005, IMMUNOLOGY, V116, P245, DOI 10.1111/j.1365-2567.2005.02218.x; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tuomela S, 2012, BLOOD, V119, pE151, DOI 10.1182/blood-2012-01-407528; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Van Elssen CHMJ, 2010, EUR J IMMUNOL, V40, P3138, DOI 10.1002/eji.201040496; Vanderlocht J, 2010, INT J IMMUNOPATH PH, V23, P35, DOI 10.1177/039463201002300104; Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	67	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103725	10.1371/journal.pone.0103725	http://dx.doi.org/10.1371/journal.pone.0103725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144736	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100009
J	Sheardova, K; Laczo, J; Vyhnalek, M; Andel, R; Mokrisova, I; Vlcek, K; Amlerova, J; Hort, J				Sheardova, Katerina; Laczo, Jan; Vyhnalek, Martin; Andel, Ross; Mokrisova, Ivana; Vlcek, Kamil; Amlerova, Jana; Hort, Jakub			Famous Landmark Identification in Amnestic Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; EMOTION RECOGNITION; NATIONAL INSTITUTE; SEMANTIC MEMORY; FACE PERCEPTION; DEMENTIA; DEFICITS; RECOMMENDATIONS; CORTEX	Background: Identification of famous landmarks (FLI), famous faces (FFI) and recognition of facial emotions (FER) is affected early in the course of Alzheimer's disease (AD). FFI, FER and FLI may represent domain specific tasks relying on activation of distinct regions of the medial temporal lobe, which are affected successively during the course of AD. However, the data on FFI and FER in MCI are controversial and FLI domain remains almost unexplored. Objectives: To determine whether and how are these three specific domains impaired in head to head comparison of patients with amnestic MCI (aMCI) single domain (SD-aMCI) and multiple domain (MD-aMCI). We propose that FLI might be most reliable in differentiating SD-aMCI, which is considered to be an earlier stage of AD pathology spread out, from the controls. Patients and Methods: A total of 114 patients, 13 with single domain (SD-aMCI) and 30 with multiple domains (MD-aMCI), 29 with mild AD and 42 controls underwent standard neurological and neuropsychological evaluations as well as tests of FLI, FER and FFI. Results: Compared to the control group, AD subjects performed worse on FFI (p = 0.020), FER (p<0.001) and FLI (p<0.001), MD-aMCI group had significantly worse scores only on FLI (p = 0.002) and approached statistical significance on FER (0.053). SD-aMCI group performed significantly worse only on FLI (p = 0.028) compared to controls. Conclusions: Patients with SD-aMCI had an isolated impairment restricted to FLI, while patients with MD-aMCI showed impairment in FLI as well as in FER. Patients with mild dementia due to AD have more extensive impairment of higher visual perception. The results suggest that FLI testing may contribute to identification of patients at risk of AD. We hypothesize that clinical examination of all three domains might reflect the spread of the disease from transentorhinal cortex, over amygdala to fusiform gyrus.	[Sheardova, Katerina; Laczo, Jan; Vyhnalek, Martin; Andel, Ross; Mokrisova, Ivana; Hort, Jakub] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Laczo, Jan; Vyhnalek, Martin; Mokrisova, Ivana; Vlcek, Kamil; Amlerova, Jana; Hort, Jakub] Charles Univ Prague, Dept Neurol, Memory Clin, Fac Med 2, Prague, Czech Republic; [Laczo, Jan; Vyhnalek, Martin; Mokrisova, Ivana; Vlcek, Kamil; Amlerova, Jana; Hort, Jakub] Univ Hosp Motol, Prague, Czech Republic; [Andel, Ross] Univ S Florida, Sch Aging Studies, Tampa, FL USA; [Vlcek, Kamil] Acad Sci Czech Republ, Inst Physiol, Dept Neurophysiol Memory, Prague, Czech Republic	St Anne's University Hospital Brno (FNUSA-ICRC); Charles University Prague; Motol University Hospital; State University System of Florida; University of South Florida; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Laczo, J (corresponding author), St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic.	janlaczo@gmail.com	Hort, Jakub/M-4011-2016; Amlerova, Jana/AAD-9766-2020; Vlcek, Kamil/B-9620-2012; Vyhnalek, Martin/R-3515-2019	Hort, Jakub/0000-0002-1080-3726; Vlcek, Kamil/0000-0001-7152-3093; Vyhnalek, Martin/0000-0002-5976-4932; Sheardova, Katerina/0000-0002-7731-1996; Andel, Ross/0000-0003-4083-4790	European Union Regional Development Fund-Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Grant Agency of Charles University [74308]; Ministry of Health, Czech Republic; Institutional Support of Laboratory Research Grant [2/2012 (699002)]; University Hospital Motol, Prague, Czech Republic [00064203]	European Union Regional Development Fund-Project FNUSA-ICRC; Grant Agency of Charles University; Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government); Institutional Support of Laboratory Research Grant; University Hospital Motol, Prague, Czech Republic(Czech Republic Government)	Funding provided by the European Union Regional Development Fund-Project FNUSA-ICRC (CZ. 1.05/1.1.00/02.0123)-JH; Grant Agency of Charles University (74308)-IM; Ministry of Health, Czech Republic-conceptual development of research organization, University Hospital Motol, Prague, Czech Republic 00064203-JH; Institutional Support of Laboratory Research Grant No. 2/2012 (699002)-JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Ahmed S, 2008, CORTEX, V44, P746, DOI 10.1016/j.cortex.2007.02.002; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], ALZHEIMERS DIS; Baudic S, 2006, ARCH CLIN NEUROPSYCH, V21, P15, DOI 10.1016/j.acn.2005.07.002; Bechyne K, 2008, CESK SLOV NEUROL N, V71, P675; Bezdicek O, 2014, AGING NEUROPSYCHOL C, V21, P693, DOI 10.1080/13825585.2013.865699; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bucks RS, 2004, AGING MENT HEALTH, V8, P222, DOI 10.1080/13607860410001669750; Chan E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00304; Cheng PJ, 2010, CLIN NEUROPHYSIOL, V121, P1519, DOI 10.1016/j.clinph.2010.03.033; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Dubois B, 2004, LANCET NEUROL, V3, P246, DOI 10.1016/S1474-4422(04)00710-0; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dudas RB, 2005, NEUROPSYCHOLOGIA, V43, P1266, DOI 10.1016/j.neuropsychologia.2004.12.005; Ekman P., 1976, PICTURES FACIAL AFFE; Estevez-Gonzalez A, 2004, DEMENT GERIATR COGN, V17, P188, DOI 10.1159/000076355; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallo DA, 2006, NEUROPSYCHOLOGY, V20, P625, DOI 10.1037/0894-4105.20.6.625; Gorno-Tempini ML, 2001, BRAIN, V124, P2087, DOI 10.1093/brain/124.10.2087; Gorno-Tempini ML, 2001, J NEUROL NEUROSUR PS, V70, P397, DOI 10.1136/jnnp.70.3.397; Grabowski TJ, 2001, HUM BRAIN MAPP, V13, P199, DOI 10.1002/hbm.1033; Greene JDW, 1996, BRAIN, V119, P111, DOI 10.1093/brain/119.1.111; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; HODGES JR, 1995, NEUROPSYCHOLOGIA, V33, P441, DOI 10.1016/0028-3932(94)00127-B; HODGES JR, 1993, NEUROPSYCHOLOGIA, V31, P775, DOI 10.1016/0028-3932(93)90128-M; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kaplan E, 1983, BOSTON DIAGNOSTIC AP; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; KERTESZ A, 1986, CAN J NEUROL SCI, V13, P415; Laczo J, 2009, BEHAV BRAIN RES, V202, P252, DOI 10.1016/j.bbr.2009.03.041; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lim TS, 2011, J NEUROL SCI, V309, P123, DOI 10.1016/j.jns.2011.07.001; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; McCade D, 2011, DEMENT GERIATR COGN, V32, P257, DOI 10.1159/000335009; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meyers J. E., 1995, REY COMPLEX FIGURE T; Mullally SL, 2011, J NEUROSCI, V31, P7441, DOI 10.1523/JNEUROSCI.0267-11.2011; Nedelska Z, 2012, P NATL ACAD SCI USA, V109, P2590, DOI 10.1073/pnas.1121588109; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Newsome RN, 2012, HIPPOCAMPUS, V22, P1990, DOI 10.1002/hipo.22071; Petersen RC, 2004, NEUROLOGY, V62, pA295; Petersen RC, 2003, MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER'S DISEASE, P15; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Rey A, 1964, LEXAMEN CLINIQUE PSY; Rosenbaum RS, 2005, J COGNITIVE NEUROSCI, V17, P446, DOI 10.1162/0898929053279496; Roudier M, 1998, J NEUROL SCI, V154, P151, DOI 10.1016/S0022-510X(97)00222-0; Sarazin M, 2007, NEUROLOGY, V69, P1859, DOI 10.1212/01.wnl.0000279336.36610.f7; Serra L, 2010, NEUROPSYCHOLOGY, V24, P316, DOI 10.1037/a0017654; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spoletini I, 2008, AM J GERIAT PSYCHIAT, V16, P389, DOI 10.1097/JGP.0b013e318165dbce; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Takahashi N, 2002, CORTEX, V38, P717, DOI 10.1016/S0010-9452(08)70039-X; Teipel SJ, 2007, BRAIN, V130, P1745, DOI 10.1093/brain/awm117; Teng E, 2007, DEMENT GERIATR COGN, V23, P271, DOI 10.1159/000100829; Thompson SA, 2002, NEUROPSYCHOLOGY, V16, P344, DOI 10.1037//0894-4105.16.3.344; Topinkova E, 2002, NEUROL PRAXI, V2, P232; Varjassyova A, 2013, J ALZHEIMERS DIS, V33, P273, DOI 10.3233/JAD-2012-120148; Vlcek K, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00089; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Weiss EM, 2008, AM J GERIAT PSYCHIAT, V16, P974, DOI 10.1097/JGP.0b013e318186bd53; Westerberg CE, 2006, NEUROPSYCHOLOGY, V20, P193, DOI 10.1037/0894-4105.20.2.193; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Young AW, 1996, NEUROPSYCHOLOGIA, V34, P31, DOI 10.1016/0028-3932(95)00062-3	67	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105623	10.1371/journal.pone.0105623	http://dx.doi.org/10.1371/journal.pone.0105623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WL	25144755	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100100
J	Wang, P; Wu, TH; Zhang, Y				Wang, Ping; Wu, Tun-Hua; Zhang, Yong			Direct Observation of the Photodegradation of Anthracene and Pyrene Adsorbed onto Mangrove Leaves	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; FIBEROPTIC SENSOR; PAHS; PHOTOLYSIS; SURFACES; FLUORESCENCE; PLANT; IRRADIATION; RADIATION; PROFILES	An established synchronous fluorimetry method was used for in situ investigation of the photodegradation of pyrene (PYR) and anthracene (ANT) adsorbed onto fresh leaves of the seedlings of two mangrove species, Aegiceras corniculatum (L.) Blanco (Ac) and Kandelia obovata (Ko) in multicomponent mixtures (mixture of the ANT and PYR). Experimental results indicated that photodegradation was the main transformation pathway for both ANT and PYR in multicomponent mixtures. The amount of the PAHs volatilizing from the leaf surfaces and entering the inner leaf tissues was negligible. Over a certain period of irradiation time, the photodegradation of both PYR and ANT adsorbed onto the leaves of Ac and Ko followed first-order kinetics, with faster rates being observed on Ac leaves. In addition, the photodegradation rate of PYR on the leaves of the mangrove species in multicomponent mixtures was much slower than that of adsorbed ANT. Compared with the PAHs adsorbed as single component, the photodegradation rate of ANT adsorbed in multicomponent mixtures was slower, while that of PYR was faster. Moreover, the photodegradation of PYR and ANT dissolved in water in multicomponent mixtures was investigated for comparison. The photodegradation rate on leaves was much slower than in water. Therefore, the physical-chemical properties of the substrate may strongly influence the photodegradation rate of adsorbed PAHs.	[Wang, Ping] Wenzhou Med Univ, Sch Environm Sci & Publ Hlth, Wenzhou, Peoples R China; [Wang, Ping] Xiamen Univ, Key Lab Coastal & Wetland Ecosyst, Minist Educ, Xiamen, Peoples R China; [Wu, Tun-Hua] Wenzhou Med Univ, Sch Informat & Engn, Wenzhou, Peoples R China; [Zhang, Yong] Xiamen Univ, Coll Environm & Ecol, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Wenzhou Medical University; Xiamen University; Wenzhou Medical University; Xiamen University	Zhang, Y (corresponding author), Xiamen Univ, Coll Environm & Ecol, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	fruitful@xmu.edu.cn	张, 勇/G-3426-2010; Wu, Tunhua/L-9511-2019; Wang, Ping/I-8405-2019		National Natural Science Foundation of China [21177102, 21207103]; Public Benefit Project of Zhejiang Province [2012C31025]; Natural Science Foundation of Zhejiang Province [LY13H180012]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201222932]; Specialized Research Fund for the Doctoral Program of Higher Education [20130121130005]; Undergraduate Scientific and Technological Innovation project of Zhejiang Province [2013R413010]; WEL Visiting Fellowship Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Benefit Project of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Scientific Research Fund of Zhejiang Provincial Education Department; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Undergraduate Scientific and Technological Innovation project of Zhejiang Province; WEL Visiting Fellowship Program	The funding of our manuscript include National Natural Science Foundation of China (21177102, 21207103), Public Benefit Project of Zhejiang Province (2012C31025), Natural Science Foundation of Zhejiang Province (LY13H180012), Scientific Research Fund of Zhejiang Provincial Education Department (Y201222932), Specialized Research Fund for the Doctoral Program of Higher Education (20130121130005), Undergraduate Scientific and Technological Innovation project of Zhejiang Province (2013R413010) and WEL Visiting Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saleh I, 2013, SCI TOTAL ENVIRON, V444, P565, DOI 10.1016/j.scitotenv.2012.12.021; Augusto S, 2010, ENVIRON POLLUT, V158, P483, DOI 10.1016/j.envpol.2009.08.016; Bamforth SM, 2005, J CHEM TECHNOL BIOT, V80, P723, DOI 10.1002/jctb.1276; Cai ZQ, 2006, J CLIN LAB ANAL, V25, P61; Chen L, 2011, J FLUORESC, V21, P765, DOI 10.1007/s10895-010-0769-z; Chen L, 2010, TALANTA, V83, P324, DOI 10.1016/j.talanta.2010.09.025; Collins C, 2006, ENVIRON SCI TECHNOL, V40, P45, DOI 10.1021/es0508166; Debestani R., 1995, J PHOTOCH PHOTOBIO A, V86, P231; Dittmar T, 2006, MAR CHEM, V102, P208, DOI 10.1016/j.marchem.2006.04.003; EHRHARDT M, 1991, FRESEN J ANAL CHEM, V339, P772, DOI 10.1007/BF00321742; Feilberg A, 2001, ENVIRON SCI TECHNOL, V35, P108, DOI 10.1021/es990834l; Henry KM, 2013, J COASTAL RES, V29, P1273, DOI 10.2112/JCOASTRES-D-12-00184.1; HUANG XD, 1993, ENVIRON TOXICOL CHEM, V12, P1067, DOI 10.1002/etc.5620120613; Kahan TF, 2007, J PHYS CHEM A, V111, P1277, DOI 10.1021/jp066660t; Ke L, 2002, MAR POLLUT BULL, V45, P339, DOI 10.1016/S0025-326X(02)00117-0; Kwon HO, 2014, SCI TOTAL ENVIRON, V470, P1494, DOI 10.1016/j.scitotenv.2013.08.031; Lehto KM, 2000, J PHOTOCH PHOTOBIO A, V136, P53, DOI 10.1016/S1010-6030(00)00321-X; LOW GKC, 1987, J CHROMATOGR, V392, P199, DOI 10.1016/S0021-9673(01)94266-9; Luiz FF, 2012, J COASTAL RES, V28, P156; Mallakin A, 2000, CHEMOSPHERE, V40, P1435, DOI 10.1016/S0045-6535(99)00331-8; NIESSNER R, 1991, ANAL CHIM ACTA, V255, P231, DOI 10.1016/0003-2670(91)80051-T; Niu JF, 2003, ENVIRON POLLUT, V123, P39, DOI 10.1016/S0269-7491(02)00362-7; PANNE U, 1993, SENSOR ACTUAT B-CHEM, V13, P288, DOI 10.1016/0925-4005(93)85383-L; Pongpiachan S, 2013, MAR POLLUT BULL, V76, P370, DOI 10.1016/j.marpolbul.2013.07.052; Reyes CA, 2000, ENVIRON SCI TECHNOL, V34, P415, DOI 10.1021/es9905391; Rogers KR, 1996, CHEMOSPHERE, V33, P1151, DOI 10.1016/0045-6535(96)00255-X; Schuler F, 1998, CHEMOSPHERE, V36, P21, DOI 10.1016/S0045-6535(97)00349-4; Sigman ME, 1996, J PHOTOCH PHOTOBIO A, V94, P149, DOI 10.1016/1010-6030(95)04099-4; SIMONICH SL, 1994, NATURE, V370, P49, DOI 10.1038/370049a0; Sojinu OS, 2013, INT J PHYTOREMEDIAT, V15, P439, DOI 10.1080/15226514.2012.716097; Tansel B, 2013, MAR POLLUT BULL, V73, P258, DOI 10.1016/j.marpolbul.2013.05.011; Wang DG, 2005, ATMOS ENVIRON, V39, P4583, DOI 10.1016/j.atmosenv.2005.04.008; Wang P, 2008, TALANTA, V76, P1177, DOI 10.1016/j.talanta.2008.05.021; Wang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084296; Wang P, 2012, MAR POLLUT BULL, V64, P1654, DOI 10.1016/j.marpolbul.2012.05.034; Wang P, 2012, J COASTAL RES, V28, P499, DOI 10.2112/JCOASTRES-D-11-00111.1; Wang Ping, 2010, Toxicological and Environmental Chemistry, V92, P1825, DOI 10.1080/02772248.2010.482833; Wang XT, 2013, SCI TOTAL ENVIRON, V447, P80, DOI 10.1016/j.scitotenv.2012.12.086; Wang Y, 2009, CHEMOSPHERE, V76, P999, DOI 10.1016/j.chemosphere.2009.04.010; Xiao X, 2015, ORAL LIT CONTINUUM C; Xu Z, 2004, THESIS DALIAN U TECH	41	3	3	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104903	10.1371/journal.pone.0104903	http://dx.doi.org/10.1371/journal.pone.0104903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144741	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100029
J	Osadchii, OE				Osadchii, Oleg E.			Impact of Hypokalemia on Electromechanical Window, Excitation Wavelength and Repolarization Gradients in Guinea-Pig and Rabbit Hearts	PLOS ONE			English	Article							TORSADES-DE-POINTES; POTASSIUM-DEPLETED SOLUTIONS; DELAYED RECTIFIER; PREDICTIVE-VALUE; SERUM POTASSIUM; K+ CURRENT; QT QS2; DRUG; RISK; PROLONGATION	Normal hearts exhibit a positive time difference between the end of ventricular contraction and the end of QT interval, which is referred to as the electromechanical (EM) window. Drug-induced prolongation of repolarization may lead to the negative EM window, which was proposed to be a novel proarrhythmic marker. This study examined whether abnormal changes in the EM window may account for arrhythmogenic effects produced by hypokalemia. Left ventricular pressure, electrocardiogram, and epicardial monophasic action potentials were recorded in perfused hearts from guinea-pig and rabbit. Hypokalemia (2.5 mM K+) was found to prolong repolarization, reduce the EM window, and promote tachyarrhythmia. Nevertheless, during both regular pacing and extrasystolic excitation, the increased QT interval invariably remained shorter than the duration of mechanical systole, thus yielding positive EM window values. Hypokalemia-induced arrhythmogenicity was associated with slowed ventricular conduction, and shortened effective refractory periods, which translated to a reduced excitation wavelength index. Hypokalemia also evoked non-uniform prolongation of action potential duration in distinct epicardial regions, which resulted in increased spatial variability in the repolarization time. These findings suggest that arrhythmogenic effects of hypokalemia are not accounted for by the negative EM window, and are rather attributed to abnormal changes in ventricular conduction times, refractoriness, excitation wavelength, and spatial repolarization gradients.	[Osadchii, Oleg E.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Osadchii, Oleg E.] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; Aalborg University	Osadchii, OE (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	osadchiy@hst.aau.dk	Osadchii, Oleg/P-3786-2017	Osadchii, Oleg/0000-0003-0222-3227	Novo Nordisk Foundation; Obel Family Foundation; Novo Nordisk Fonden [NNF12OC0000968] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Obel Family Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Novo Nordisk Foundation and the Obel Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akylbekova EL, 2014, AM HEART J, V167, P116, DOI 10.1016/j.ahj.2013.10.009; Alderman MH, 2012, HYPERTENSION, V59, P926, DOI 10.1161/HYPERTENSIONAHA.111.180554; Belardinelli L, 2005, HEART RHYTHM, V2, pS16, DOI 10.1016/j.hrthm.2004.10.032; BOUDOULAS H, 1981, CIRCULATION, V64, P28, DOI 10.1161/01.CIR.64.1.28; BOUDOULAS H, 1982, AM J CARDIOL, V50, P1229, DOI 10.1016/0002-9149(82)90454-4; BOUDOULAS H, 1981, CHEST, V80, P613, DOI 10.1378/chest.80.5.613; Bowling CB, 2010, CIRC-HEART FAIL, V3, P253, DOI 10.1161/CIRCHEARTFAILURE.109.899526; Brahmajothi MV, 1997, CIRC RES, V81, P128, DOI 10.1161/01.RES.81.1.128; CHAMBERS JB, 1987, AM HEART J, V114, P355, DOI 10.1016/0002-8703(87)90503-5; Cheng JH, 1999, CARDIOVASC RES, V43, P135, DOI 10.1016/S0008-6363(99)00061-9; DECAPRIO L, 1984, AM J CARDIOL, V53, P818, DOI 10.1016/0002-9149(84)90411-9; EISNER DA, 1979, J PHYSIOL-LONDON, V294, P279, DOI 10.1113/jphysiol.1979.sp012930; EISNER DA, 1979, J PHYSIOL-LONDON, V294, P255, DOI 10.1113/jphysiol.1979.sp012929; Goyal A, 2012, JAMA-J AM MED ASSOC, V307, P157, DOI 10.1001/jama.2011.1967; Guns PJ, 2012, J PHARMACOL TOX MET, V66, P125, DOI 10.1016/j.vascn.2012.03.007; Guns PJ, 2012, BRIT J PHARMACOL, V166, P689, DOI 10.1111/j.1476-5381.2011.01795.x; Killeen MJ, 2007, ACTA PHYSIOL, V189, P33, DOI 10.1111/j.1748-1716.2006.01643.x; Kirchhof PF, 1998, CIRCULATION, V97, P2567, DOI 10.1161/01.CIR.97.25.2567; KISHIDA H, 1979, CIRC RES, V44, P800, DOI 10.1161/01.RES.44.6.800; Laursen M, 2011, J PHARMACOL TOX MET, V64, P134, DOI 10.1016/j.vascn.2011.05.001; LI C, 1992, METHOD FIND EXP CLIN, V14, P107; Matthews GDK, 2013, J PHYSIOL-LONDON, V591, P4167, DOI 10.1113/jphysiol.2013.254938; Minami T, 2004, PACE, V27, P212, DOI 10.1111/j.1540-8159.2004.00412.x; Osadchii OE, 2009, ACTA PHYSIOL, V197, P273, DOI 10.1111/j.1748-1716.2009.02028.x; Osadchii OE, 2006, PFLUG ARCH EUR J PHY, V452, P155, DOI 10.1007/s00424-005-0025-6; Osadchii OE, 2011, AM J PHYSIOL-HEART C, V300, pH989, DOI 10.1152/ajpheart.00816.2010; Osadchii OE, 2010, AM J PHYSIOL-HEART C, V298, pH210, DOI 10.1152/ajpheart.00695.2009; Osadchii OE, 2009, EXP PHYSIOL, V94, P434, DOI 10.1113/expphysiol.2008.045567; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SANGUINETTI MC, 1992, PFLUG ARCH EUR J PHY, V420, P180, DOI 10.1007/BF00374988; SMEETS JLRM, 1986, CIRC RES, V58, P96, DOI 10.1161/01.RES.58.1.96; Su JL, 2012, AM J EMERG MED, V30, P1089, DOI 10.1016/j.ajem.2011.07.009; ter Bekke RMA, 2012, PROG BIOPHYS MOL BIO, V110, P347, DOI 10.1016/j.pbiomolbio.2012.07.007; Thomsen MB, 2006, PHARMACOL THERAPEUT, V112, P150, DOI 10.1016/j.pharmthera.2005.04.009; van der Linde HJ, 2010, BRIT J PHARMACOL, V161, P1444, DOI 10.1111/j.1476-5381.2010.00934.x; Vargas HM, 2010, BRIT J PHARMACOL, V161, P1441, DOI 10.1111/j.1476-5381.2010.00980.x; Veerman CC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1002, DOI 10.1161/CIRCEP.113.000239; VINCENT GM, 1991, AM J CARDIOL, V68, P498, DOI 10.1016/0002-9149(91)90785-J; Warren M, 2003, J CARDIOVASC ELECTR, V14, P621, DOI 10.1046/j.1540-8167.2003.03006.x; Yang T, 2014, CIRCULATION, V130, P224, DOI 10.1161/CIRCULATIONAHA.113.007765	40	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105599	10.1371/journal.pone.0105599	http://dx.doi.org/10.1371/journal.pone.0105599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141124	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200113
J	Paillon, C; Wantiez, L; Kulbicki, M; Labonne, M; Vigliola, L				Paillon, Christelle; Wantiez, Laurent; Kulbicki, Michel; Labonne, Maylis; Vigliola, Laurent			Extent of Mangrove Nursery Habitats Determines the Geographic Distribution of a Coral Reef Fish in a South-Pacific Archipelago	PLOS ONE			English	Article							PELAGIC LARVAL DURATION; ELEMENTAL CHEMISTRY; SPATIAL VARIATION; AGE VALIDATION; TURNEFFE ATOLL; MARINE FAUNA; RANGE SIZE; OTOLITHS; CONNECTIVITY; PATTERNS	Understanding the drivers of species' geographic distribution has fundamental implications for the management of biodiversity. For coral reef fishes, mangroves have long been recognized as important nursery habitats sustaining biodiversity in the Western Atlantic but there is still debate about their role in the Indo-Pacific. Here, we combined LA-ICP-MS otolith microchemistry, underwater visual censuses (UVC) and mangrove cartography to estimate the importance of mangroves for the Indo-Pacific coral reef fish Lutjanus fulviflamma in the archipelago of New Caledonia. Otolith elemental compositions allowed high discrimination of mangroves and reefs with 83.8% and 98.7% correct classification, respectively. Reefs were characterized by higher concentrations of Rb and Sr and mangroves by higher concentrations of Ba, Cr, Mn and Sn. All adult L. fulviflamma collected on reefs presented a mangrove signature during their juvenile stage with 85% inhabiting mangrove for their entire juvenile life (about 1 year). The analysis of 2942 UVC revealed that the species was absent from isolated islands of the New Caledonian archipelago where mangroves were absent. Furthermore, strong positive correlations existed between the abundance of L. fulviflamma and the area of mangrove (r = 0.84 for occurrence, 0.93 for density and 0.89 for biomass). These results indicate that mangrove forest is an obligatory juvenile habitat for L. fulviflamma in New Caledonia and emphasize the potential importance of mangroves for Indo-Pacific coral reef fishes.	[Paillon, Christelle; Vigliola, Laurent] IRD, Lab Excellence LABEX Corail, CoReUs UR227, Noumea, New Caledonia; [Paillon, Christelle; Wantiez, Laurent] UNC, LIVE EA4243, Noumea, New Caledonia; [Kulbicki, Michel] IRD, Lab Excellence LABEX Corail, CoReUs UR227, Lab Arago, Banyuls Sur Mer, France; [Labonne, Maylis] Inst Univ Europe Mer, IRD, LEMAR UMR 6539, Plouzane, France	Institut de Recherche pour le Developpement (IRD); Universite Nouvelle Caledonie; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Paillon, C (corresponding author), IRD, Lab Excellence LABEX Corail, CoReUs UR227, Noumea, New Caledonia.	christelle.paillon@gmail.com	Wantiez, Laurent/L-3343-2013; Vigliola, Laurent/J-7107-2016; Paillon, Christelle/HGB-2144-2022	Wantiez, Laurent/0000-0001-5024-2057; Vigliola, Laurent/0000-0003-4715-7470; Kulbicki, Michel/0000-0003-1258-5061	Developing Agency of New Caledonia (ADECAL); Economic Zone of New Caledonia program (ZONECO); South Province of New Caledonia; Total Foundation; Pristine Seas project by the National Geographic Society; UNESCO World heritage survey by the Governement of New Caledonia; Southern Province; Northern Province; Research Institute for Development (IRD); University of New Caledonia (UNC)	Developing Agency of New Caledonia (ADECAL); Economic Zone of New Caledonia program (ZONECO); South Province of New Caledonia; Total Foundation(Total SA); Pristine Seas project by the National Geographic Society(National Geographic Society); UNESCO World heritage survey by the Governement of New Caledonia; Southern Province; Northern Province; Research Institute for Development (IRD); University of New Caledonia (UNC)	This study was funded by the Developing Agency of New Caledonia (ADECAL), the Economic Zone of New Caledonia program (ZONECO) and the South Province of New Caledonia. Dive data from the remote reefs of New Caledonia were collected as part of the Pristine Reef project funded by the Total Foundation, the Pristine Seas project funded by the National Geographic Society, and the UNESCO World heritage survey funded by the Governement of New Caledonia. The rest of the UVC data was collected by various projects funded by the Southern Province and the Northern Province, and by the Research Institute for Development (IRD) and the University of New Caledonia (UNC) core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrefouet S, 2009, CORAL REEFS, V28, P691, DOI 10.1007/s00338-009-0503-y; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JA, 2006, MAR ECOL PROG SER, V306, P269, DOI 10.3354/meps306269; Bruland KW, 2003, TREATISE GEOCHEMISTR, P23, DOI DOI 10.1016/B0-08-043751-6/06105-3; Burke LM, 2011, REEFS AT RISK REVISI; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Carpenter K.E., 2001, LIVING MARINE RESO 3, V5; Chittaro PM, 2006, ESTUAR COAST SHELF S, V67, P673, DOI 10.1016/j.ecss.2005.12.014; Chittaro PM, 2013, CORAL REEFS, V32, P341, DOI 10.1007/s00338-012-0990-0; Chittaro PM, 2009, OECOLOGIA, V160, P49, DOI 10.1007/s00442-009-1282-4; Chittaro PM, 2005, ESTUARIES, V28, P373, DOI 10.1007/BF02693920; Chittaro PM, 2004, J EXP MAR BIOL ECOL, V308, P169, DOI 10.1016/j.jembe.2004.02.021; D'Agata S, CURRENT BIOLOGY IN P; de la Moriniere EC, 2003, MAR ECOL PROG SER, V246, P279; Dorenbosch M, 2006, BIOL CONSERV, V129, P277, DOI 10.1016/j.biocon.2005.10.032; Dove SG, 1998, MAR BIOL, V130, P377, DOI 10.1007/s002270050258; Gillanders BM, 2005, ESTUAR COAST SHELF S, V64, P47, DOI 10.1016/j.ecss.2005.02.005; Gillanders BM, 2003, ESTUAR COAST SHELF S, V57, P1049, DOI 10.1016/S0272-7714(03)00009-X; Gillanders BM, 2003, MAR ECOL PROG SER, V247, P281, DOI 10.3354/meps247281; Gillanders BM, 2000, MAR ECOL PROG SER, V201, P273, DOI 10.3354/meps201273; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Igulu MM, 2011, J EXP MAR BIOL ECOL, V401, P118, DOI 10.1016/j.jembe.2011.01.022; Jones DL, 2010, MAR ECOL PROG SER, V401, P245, DOI 10.3354/meps08404; Kulbicki M, 2005, CYBIUM, V29, P235; Labrosse P., 2002, UNDERWATER VISUAL FI; Laegdsgaard P, 2001, J EXP MAR BIOL ECOL, V257, P229, DOI 10.1016/S0022-0981(00)00331-2; Lea E., 1910, PUBLICATIONS CIRCONS, V53, P7; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; Loubens G., 1980, Cahiers de l'Indo-Pacifique, V2, P41; Lugendo BR, 2007, B MAR SCI, V80, P497; Lugendo BR, 2005, AQUAT LIVING RESOUR, V18, P149, DOI 10.1051/alr:2005016; Luiz OJ, 2013, P NATL ACAD SCI USA, V110, P16498, DOI 10.1073/pnas.1304074110; Macpherson E, 2006, MAR ECOL PROG SER, V327, P257, DOI 10.3354/meps327257; Mateo I, 2010, MAR ECOL PROG SER, V402, P197, DOI 10.3354/meps08445; McMahon KW, 2012, P NATL ACAD SCI USA, V109, P15372, DOI 10.1073/pnas.1206378109; Mellin C, 2007, ESTUAR COAST SHELF S, V75, P481, DOI 10.1016/j.ecss.2007.05.026; Mercier L, 2012, MAR ECOL PROG SER, V444, P175, DOI 10.3354/meps09444; Mercier L, 2011, ECOL APPL, V21, P1352, DOI 10.1890/09-1887.1; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nagelkerken I, 2000, MAR ECOL PROG SER, V202, P175, DOI 10.3354/meps202175; Newman SJ, 1996, MAR FRESHWATER RES, V47, P575, DOI 10.1071/MF9960575; Newman SJ, 2002, ESTUAR COAST SHELF S, V55, P67, DOI 10.1006/ecss.2001.0887; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Paris JP, 1981, GEOLOGIE DE LA NOUVE; PARRISH JD, 1989, MAR ECOL PROG SER, V58, P143, DOI 10.3354/meps058143; Pelletier B, 2012, ATLAS DE LA NOUVELLE, P33; Sale PF, 1991, THE ECOLOGY OF FISHE; Sale PF, 2010, PRESERVING REEF CONN; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sturrock AM, 2012, J FISH BIOL, V81, P766, DOI 10.1111/j.1095-8649.2012.03372.x; Thollot Pierre, 1992, Cybium, V16, P331; THRESHER RE, 1989, MAR ECOL PROG SER, V57, P187, DOI 10.3354/meps057187; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Tukey J. W., 1977, EXPLORATORY DATA ANA; Victor BC, 2000, MAR ECOL PROG SER, V205, P241, DOI 10.3354/meps205241; Virly S, 2007, TYPOLOGIES ET BIODIV; Wantiez L, 2006, J MAR BIOL ASSOC UK, V86, P1229, DOI 10.1017/S0025315406014238; Warner RR, 2005, LIMNOL OCEANOGR, V50, P1529, DOI 10.4319/lo.2005.50.5.1529	70	15	15	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105158	10.1371/journal.pone.0105158	http://dx.doi.org/10.1371/journal.pone.0105158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140697	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200055
J	Schurch, AC; Schipper, D; Bijl, MA; Dau, J; Beckmen, KB; Schapendonk, CME; Raj, VS; Osterhaus, ADME; Haagmans, BL; Tryland, M; Smits, SL				Schurch, Anita C.; Schipper, Debby; Bijl, Maarten A.; Dau, Jim; Beckmen, Kimberlee B.; Schapendonk, Claudia M. E.; Raj, V. Stalin; Osterhaus, Albert D. M. E.; Haagmans, Bart L.; Tryland, Morten; Smits, Saskia L.			Metagenomic Survey for Viruses in Western Arctic Caribou, Alaska, through Iterative Assembly of Taxonomic Units	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SEQUENCE; PAPILLOMAVIRUSES	Pathogen surveillance in animals does not provide a sufficient level of vigilance because it is generally confined to surveillance of pathogens with known economic impact in domestic animals and practically nonexistent in wildlife species. As most (re-) emerging viral infections originate from animal sources, it is important to obtain insight into viral pathogens present in the wildlife reservoir from a public health perspective. When monitoring living, free-ranging wildlife for viruses, sample collection can be challenging and availability of nucleic acids isolated from samples is often limited. The development of viral metagenomics platforms allows a more comprehensive inventory of viruses present in wildlife. We report a metagenomic viral survey of the Western Arctic herd of barren ground caribou (Rangifer tarandus granti) in Alaska, USA. The presence of mammalian viruses in eye and nose swabs of 39 free-ranging caribou was investigated by random amplification combined with a metagenomic analysis approach that applied exhaustive iterative assembly of sequencing results to define taxonomic units of each metagenome. Through homology search methods we identified the presence of several mammalian viruses, including different papillomaviruses, a novel parvovirus, polyomavirus, and a virus that potentially represents a member of a novel genus in the family Coronaviridae.	[Schurch, Anita C.; Schipper, Debby; Bijl, Maarten A.; Schapendonk, Claudia M. E.; Raj, V. Stalin; Osterhaus, Albert D. M. E.; Haagmans, Bart L.; Smits, Saskia L.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.; Smits, Saskia L.] Viroclin Biosci, Rotterdam, Netherlands; [Dau, Jim] Alaska Dept Fish & Game, Kotzebue, AK USA; [Beckmen, Kimberlee B.] Alaska Dept Fish & Game, Div Wildlife Conservat, Fairbanks, AK USA; [Tryland, Morten] UiT, Dept Arctic & Marine Biol, Res Grp Arctic Infect Biol, Tromso, Norway; [Tryland, Morten] Genok Ctr Biosafety, Tromso, Norway	Erasmus University Rotterdam; Erasmus MC; Alaska Department of Fish & Game; Alaska Department of Fish & Game; UiT The Arctic University of Tromso	Smits, SL (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	s.smits@erasmusmc.nl	Haagmans, Bart/E-9791-2015; Raj, Victor Stalin/E-9670-2016	Haagmans, Bart/0000-0001-6221-2015; Beckmen, Kimberlee/0000-0003-0747-7883; Schurch, Anita/0000-0003-1894-7545; Raj, Victor Stalin/0000-0003-2250-8481; Tryland, Morten/0000-0001-5394-5196	European Community under European Commission [223498]; Virgo Consortium; Dutch government [FES0908]; Netherlands Genomics Initiative (NGI) [050-060-452]	European Community under European Commission; Virgo Consortium; Dutch government; Netherlands Genomics Initiative (NGI)	This work was partially funded by the European Community's Seventh Framework Program (FP7/2007-2013) under the project "European Management Platform for Emerging and Reemerging Infectious disease Entities" European Commission agreement no. 223498 and the Virgo Consortium, funded by the Dutch government project number FES0908, and by the Netherlands Genomics Initiative (NGI) project number 050-060-452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bodewes R, 2013, J VIROL, V87, P7758, DOI 10.1128/JVI.00568-13; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Burns K, 2007, FIELDS VIROLOGY, P2437; Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465; Cotmore SF, 2013, ARCH VIROL, P1; das Neves CG, 2009, VIRUS RES, V145, P321, DOI 10.1016/j.virusres.2009.08.002; Dau J.R., 2007, CARIBOU MANAGEMENT R, P174; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Delbue S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/542092; Denisov G, 2008, BIOINFORMATICS, V24, P1035, DOI 10.1093/bioinformatics/btn074; ERIKSSON A, 1994, J VIROL, V68, P8365, DOI 10.1128/JVI.68.12.8365-8373.1994; Evans AL, 2008, J WILDLIFE DIS, V44, P1051, DOI 10.7589/0090-3558-44.4.1051; Evans AL, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-5; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Karlsson OE, 2013, BIOSECUR BIOTERROR, V11, pS146, DOI 10.1089/bsp.2012.0077; King AMQ., 2012, VIRUS TAXONOMY, P806, DOI 10.1016/ B978-0-12-384684-6.00068-9; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Loon SC, 2004, BRIT J OPHTHALMOL, V88, P861, DOI 10.1136/bjo.2003.035931; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Rector A, 2013, VIROLOGY, V445, P213, DOI 10.1016/j.virol.2013.05.007; Renshaw RW, 2012, J VIROL, V86, P8903, DOI 10.1128/JVI.01261-12; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; ROBBINS SG, 1990, LAB INVEST, V62, P417; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Rosseel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076144; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Shindler KS, 2008, J VIROL, V82, P8882, DOI 10.1128/JVI.00920-08; Smits SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069711; Stiles J, 2011, VET OPHTHALMOL, V14, P9, DOI 10.1111/j.1463-5224.2011.00901.x; Terai M, 2002, J VIROL, V76, P10020, DOI 10.1128/JVI.76.19.10020-10023.2002; van den Brand JMA, 2012, J VIROL, V86, P2360, DOI 10.1128/JVI.06373-11; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Vazquez-Castellanos JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-37; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wendl MC, 2012, J MATH BIOL, P1	45	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105227	10.1371/journal.pone.0105227	http://dx.doi.org/10.1371/journal.pone.0105227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140520	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200063
J	Skewes-Cox, P; Sharpton, TJ; Pollard, KS; DeRisi, JL				Skewes-Cox, Peter; Sharpton, Thomas J.; Pollard, Katherine S.; DeRisi, Joseph L.			Profile Hidden Markov Models for the Detection of Viruses within Metagenomic Sequence Data	PLOS ONE			English	Article							PROTEIN FAMILIES DATABASE; HOMOLOGY DETECTION; IDENTIFICATION; ALIGNMENT; VIROLOGY; ILLNESS; TRENDS; GENE; RNA	Rapid, sensitive, and specific virus detection is an important component of clinical diagnostics. Massively parallel sequencing enables new diagnostic opportunities that complement traditional serological and PCR based techniques. While massively parallel sequencing promises the benefits of being more comprehensive and less biased than traditional approaches, it presents new analytical challenges, especially with respect to detection of pathogen sequences in metagenomic contexts. To a first approximation, the initial detection of viruses can be achieved simply through alignment of sequence reads or assembled contigs to a reference database of pathogen genomes with tools such as BLAST. However, recognition of highly divergent viral sequences is problematic, and may be further complicated by the inherently high mutation rates of some viral types, especially RNA viruses. In these cases, increased sensitivity may be achieved by leveraging position-specific information during the alignment process. Here, we constructed HMMER3-compatible profile hidden Markov models (profile HMMs) from all the virally annotated proteins in RefSeq in an automated fashion using a custom-built bioinformatic pipeline. We then tested the ability of these viral profile HMMs ("vFams'') to accurately classify sequences as viral or non-viral. Cross-validation experiments with full-length gene sequences showed that the vFams were able to recall 91% of left-out viral test sequences without erroneously classifying any non-viral sequences into viral protein clusters. Thorough reanalysis of previously published metagenomic datasets with a set of the best-performing vFams showed that they were more sensitive than BLAST for detecting sequences originating from more distant relatives of known viruses. To facilitate the use of the vFams for rapid detection of remote viral homologs in metagenomic data, we provide two sets of vFams, comprising more than 4,000 vFams each, in the HMMER3 format. We also provide the software necessary to build custom profile HMMs or update the vFams as more viruses are discovered (http://derisilab.ucsf.edu/software/vFam).	[Skewes-Cox, Peter] Univ Calif San Francisco, Biol & Med Informat Grad Program, San Francisco, CA 94143 USA; [Skewes-Cox, Peter; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Med Biochem & Biophys, San Francisco, CA 94143 USA; [Skewes-Cox, Peter; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Sharpton, Thomas J.; Pollard, Katherine S.] Univ Calif San Francisco, J David Gladstone Inst, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Skewes-Cox, Peter; DeRisi, Joseph L.] Howard Hughes Med Inst, Bethesda, MD 20817 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute	DeRisi, JL (corresponding author), Univ Calif San Francisco, Dept Med Biochem & Biophys, San Francisco, CA 94143 USA.	joe@derisilab.ucsf.edu		Skewes-Cox, Peter/0000-0003-1633-5190; Sharpton, Thomas/0000-0002-5996-7764	Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [1660, 3300]; National Science Foundation [DMS-1069303]; Gladstone Institutes; Scleroderma Research Foundation; PhRMA Foundation Pre-Doctoral Bioinformatics Fellowship program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); Gladstone Institutes(University of California System); Scleroderma Research Foundation; PhRMA Foundation Pre-Doctoral Bioinformatics Fellowship program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (JLD), the Gordon and Betty Moore Foundation (Grants #1660 and #3300), the National Science Foundation (Grant #DMS-1069303), and Gladstone Institutes (KSP, TJS), the Scleroderma Research Foundation and the PhRMA Foundation Pre-Doctoral Bioinformatics Fellowship program (PS-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BACCHETTI S, 1986, J VIROL, V57, P1177, DOI 10.1128/JVI.57.3.1177-1181.1986; Bexfield N, 2010, VET J; Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108; Brenner SE, 1998, P NATL ACAD SCI USA, V95, P6073, DOI 10.1073/pnas.95.11.6073; Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Dong J, 2008, J MOL DIAGN, V10, P185, DOI 10.2353/jmoldx.2008.070063; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Iwamoto T, 2001, J GEN VIROL, V82, P2653, DOI 10.1099/0022-1317-82-11-2653; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kellam P, 1998, TRENDS MICROBIOL, V6, P160, DOI 10.1016/S0966-842X(98)01239-6; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Krishnamurthy N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PRESTON VG, 1984, VIROLOGY, V138, P58, DOI 10.1016/0042-6822(84)90147-8; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Ruby JG, 2013, PRICE SOFTWARE TARGE; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sjolander K, 1996, COMPUT APPL BIOSCI, V12, P327; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Woolhouse MEJ, 2008, P ROY SOC B-BIOL SCI, V275, P2111, DOI 10.1098/rspb.2008.0294; Yamashita T, 1998, J VIROL, V72, P8408, DOI 10.1128/JVI.72.10.8408-8412.1998; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10	45	97	98	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105067	10.1371/journal.pone.0105067	http://dx.doi.org/10.1371/journal.pone.0105067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140992	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200049
J	Chakraborty, S; Das, K; Saha, S; Mazumdar, M; Manna, A; Chakraborty, S; Mukherjee, S; Khan, P; Adhikary, A; Mohanty, S; Chattopadhyay, S; Biswas, SC; Sa, G; Das, T				Chakraborty, Samik; Das, Kaushik; Saha, Shilpi; Mazumdar, Minakshi; Manna, Argha; Chakraborty, Sreeparna; Mukherjee, Shravanti; Khan, Poulami; Adhikary, Arghya; Mohanty, Suchismita; Chattopadhyay, Samit; Biswas, Subhash C.; Sa, Gaurisankar; Das, Tanya			Nuclear Matrix Protein SMAR1 Represses c-Fos-mediated HPV18 E6 Transcription through Alteration of Chromatin Histone Deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER CELLS; APOPTOTIC PATHWAY; UTERINE CERVIX; BREAST-CANCER; GENE-PRODUCT; CROSS-TALK; P53; DNA; ADENOCARCINOMA	Matrix attachment region (MAR)-binding proteins have been implicated in the transcriptional regulation of host as well as viral genes, but their precise role in HPV-infected cervical cancer remains unclear. Here we show that HPV18 promoter contains consensus MAR element in the LCR and E6 sequences where SMAR1 binds and reinforces HPV18 E6 transcriptional silencing. In fact, curcumin-induced up-regulation of SMAR1 ensures recruitment ofSMAR1-HDAC1 repressor complex at the LCR and E6 MAR sequences, thereby decreasing histone acetylation at H3K9 and H3K18, leading to reorientation of the chromatin. As a consequence, c-Fos binding at the putative AP-1 sites on E6 promoter is inhibited. E6 depletion interrupts degradation of E6-mediated p53 and lysine acetyl transferase, Tip60. Tip60, in turn, acetylates p53, thereby restoring p53-mediated transactivation of proapoptotic genes to ensure apoptosis. This hitherto unexplained function of SMAR1 signifies the potential of this unique scaffold matrix-associated region-binding protein as a critical regulator of E6-mediated anti-apoptotic network in HPV18-infected cervical adenocarcinoma. These results also justify the candidature of curcumin for the treatment of HPV18-infected cervical carcinoma.	[Chakraborty, Samik; Das, Kaushik; Saha, Shilpi; Mazumdar, Minakshi; Manna, Argha; Chakraborty, Sreeparna; Mukherjee, Shravanti; Khan, Poulami; Adhikary, Arghya; Mohanty, Suchismita; Sa, Gaurisankar; Das, Tanya] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India; [Chattopadhyay, Samit] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; [Biswas, Subhash C.] SSKM Hosp, Inst Postgrad Med Educ & Res IPGMER, Dept Gynecol & Obstet, Kolkata 700020, W Bengal, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Das, T (corresponding author), Bose Inst, Div Mol Med, P-1-12 CIT Scheme VIIM, Kolkata 700054, W Bengal, India.	tanya@jcbose.ac.in	Chakraborty, Samik/Q-1779-2018	Chakraborty, Samik/0000-0002-5232-0474	University Grants Commission (UGC); Department of Science and Technology (DST); Council of Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR); Department of Biotechnology (DBT) of government of India	University Grants Commission (UGC)(University Grants Commission, India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Biotechnology (DBT) of government of India(Department of Biotechnology (DBT) India)	This work was supported by the grants from University Grants Commission (UGC), Department of Science and Technology (DST), Council of Scientific and Industrial Research (CSIR), and Indian Council of Medical Research (ICMR) and by the Department of Biotechnology (DBT) postdoctoral fellowship program of the government of India.	Amortegui AJ, 1995, MODERN PATHOL, V8, P907; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Chakraborty J, 2010, J BIOL CHEM, V285, P33104, DOI 10.1074/jbc.M110.122705; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; Dar A, 2013, MOL CELL BIOL, V33, P3309, DOI 10.1128/MCB.00358-13; de Wilde J, 2008, CELL ONCOL, V30, P77; Ferguson AW, 1998, MODERN PATHOL, V11, P11; Jalota-Badhwar A, 2007, J BIOL CHEM, V282, P9902, DOI 10.1074/jbc.M608434200; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Kehrmann A, 2013, CANCER GENET-NY, V206, P279, DOI 10.1016/j.cancergen.2013.06.002; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Kulkarni A, 2004, BIOCHEM BIOPH RES CO, V322, P672, DOI 10.1016/j.bbrc.2004.07.170; Li JJ, 1998, ONCOGENE, V16, P2711, DOI 10.1038/sj.onc.1201798; MacLaine NJ, 2008, J BIOL CHEM, V283, P28563, DOI 10.1074/jbc.M804433200; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Maher DM, 2011, MOL CARCINOGEN, V50, P47, DOI 10.1002/mc.20695; Malonia SK, 2011, BBA-REV CANCER, V1815, P1, DOI 10.1016/j.bbcan.2010.08.003; Mohanty S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.534; Narechania A, 2005, J VIROL, V79, P15503, DOI 10.1128/JVI.79.24.15503-15510.2005; PARAZZINI F, 1990, GYNECOL ONCOL, V39, P40, DOI 10.1016/0090-8258(90)90396-3; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Saha B, 2012, ONCOGENE, V31, P173, DOI 10.1038/onc.2011.234; Sen GS, 2011, J BIOL CHEM, V286, P42232, DOI 10.1074/jbc.M111.262295; Shukla S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067849; Singh AK, 2013, INTERDISCIP SCI, V5, P112, DOI 10.1007/s12539-013-0159-8; Singh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000660; Sinha S, 2012, INT J BIOCHEM CELL B, V44, P46, DOI 10.1016/j.biocel.2011.10.020; Sinitsyna NN, 2010, TOXICOL APPL PHARM, V243, P275, DOI 10.1016/j.taap.2009.12.006; Sreenath K, 2010, VIROLOGY, V400, P76, DOI 10.1016/j.virol.2010.01.017; Stunkel W, 2000, J VIROL, V74, P2489, DOI 10.1128/JVI.74.6.2489-2501.2000; Subbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tenti P, 1998, AM J PATHOL, V152, P1057; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Wang WM, 2011, J BIOL CHEM, V286, P40974, DOI 10.1074/jbc.M111.290874; YAMAKAWA Y, 1994, GYNECOL ONCOL, V53, P190, DOI 10.1006/gyno.1994.1114; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004	43	24	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29074	29085		10.1074/jbc.M114.564872	http://dx.doi.org/10.1074/jbc.M114.564872			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25157104	Green Published, hybrid			2022-12-25	WOS:000344141000025
J	Le, AH; Bonachea, LA; Cargill, SL				Le, Anna H.; Bonachea, Luis A.; Cargill, Shelley L.			Meloxicam and Buprenorphine Treatment after Ovarian Transplantation Does Not Affect Estrous Cyclicity and Follicular Integrity in Aged CBA/J Mice	PLOS ONE			English	Article							VAGINAL CYTOLOGY; MOUSE OVARIES; FEMALE RATS; ANGIOGENESIS; GROWTH; CYCLE; MORPHINE; STRAINS; CELLS; INHIBITION	Angiogenesis, the formation of new blood vessels, is important for the survival of ovarian transplants and the restoration of ovarian functions. Without angiogenesis, transplanted ovarian tissue becomes more susceptible to tissue damage and necrosis. Administration of analgesics for pain management has been shown to decrease angiogenesis, which can influence transplant success especially in aged animals. Aging and the effects of hypoxia after transplantation decrease reproductive viability of the ovarian transplant; therefore, it is important to understand the additional effects of analgesics on aged animal models. The present study investigated the effects of two analgesics, buprenorphine, an opiate, and meloxicam, a non-steroidal anti-inflammatory drug (NSAID), on the reproductive indicators related to estrous cyclicity and follicular integrity after ovarian transplantation of young ovaries into aged CBA/J mice. These aged females did not show any different reproductive responses when treated with either buprenorphine or meloxicam. No significant differences were observed in estrous cycle length, the onset of estrous cycling, the regularity of estrous cycles, and the proportion of viable follicles and total number of follicles per ovarian sample across treatment groups.	[Le, Anna H.; Bonachea, Luis A.; Cargill, Shelley L.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA	California State University System; San Jose State University	Cargill, SL (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	shelley.cargill@sjsu.edu			California State University Research Funds; Junior Faculty Career Development Grant; John and Betty Davison Fellowship	California State University Research Funds; Junior Faculty Career Development Grant; John and Betty Davison Fellowship	This work was supported by: California State University Research Funds to SC; Junior Faculty Career Development Grant to SC; John and Betty Davison Fellowship to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, VET DRUG HDB; Arias P, 1996, BRAIN RES, V740, P234, DOI 10.1016/S0006-8993(96)00862-1; Basset DL, 1943, AM J ANAT, V73, P251, DOI 10.1002/aja.1000730206; Cargill SL, 2003, AGING CELL, V2, P185, DOI 10.1046/j.1474-9728.2003.00049.x; Cargill SL, 1999, BIOL REPROD, V61, P283, DOI 10.1095/biolreprod61.1.283; COOPER RL, 1980, BIOL REPROD, V23, P611, DOI 10.1095/biolreprod23.3.611; Dai X, 2010, EUR J PHARMACOL, V628, P42, DOI 10.1016/j.ejphar.2009.11.035; DISSEN GA, 1994, ENDOCRINOLOGY, V134, P1146, DOI 10.1210/en.134.3.1146; Fevold HI, 1931, AM J PHYSIOL, V97, P291, DOI 10.1152/ajplegacy.1931.97.2.291; Flecknell PA., 2009, LAB ANIMAL ANESTHESI, V3rd edition; Fujino Y, 1996, HUM REPROD, V11, P1480; FULLER JL, 1967, J HERED, V58, P135, DOI 10.1093/oxfordjournals.jhered.a107565; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; GOSDEN RG, 1975, J REPROD FERTIL, V42, P423, DOI 10.1530/jrf.0.0420423; Gunasena KT, 1997, HUM REPROD, V12, P101, DOI 10.1093/humrep/12.1.101; Gupta K, 2002, CANCER RES, V62, P4491; HARRIS M, 1949, J EXP ZOOL, V112, P131, DOI 10.1002/jez.1401120110; Hsiao PN, 2009, TOXICOLOGY, V256, P83, DOI 10.1016/j.tox.2008.11.015; Israely T, 2003, BIOL REPROD, V68, P2055, DOI 10.1095/biolreprod.102.011734; Jones MK, 1999, NAT MED, V5, P1418; KAMEI J, 1995, LIFE SCI, V56, pPL285, DOI 10.1016/0024-3205(95)00078-X; Kim SS, 2004, FERTIL STERIL, V82, P679, DOI 10.1016/j.fertnstert.2004.05.022; Lam CF, 2008, ANESTH ANALG, V107, P686, DOI 10.1213/ane.0b013e31817e6719; Liu HC, 2004, J NEUROIMMUNOL, V146, P13, DOI 10.1016/j.jneuroim.2003.09.016; Liu L, 2008, HUM REPROD, V23, P122, DOI 10.1093/humrep/dem348; Lohff JC, 2005, COMPARATIVE MED, V55, P523; Mason JB, 2009, J GERONTOL A-BIOL, V64, P1207, DOI 10.1093/gerona/glp134; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Nugent D, 1998, J REPROD FERTIL, V114, P341, DOI 10.1530/jrf.0.1140341; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172/JCI116450; Tarnawski AS, 2003, J MOL MED, V81, P627, DOI 10.1007/s00109-003-0479-y; Vane JR, 1996, SCAND J RHEUMATOL, P9; Wang YR, 2012, REPROD BIOMED ONLINE, V24, P646, DOI 10.1016/j.rbmo.2012.02.025; WHITTEN WK, 1956, J ENDOCRINOL, V13, P399, DOI 10.1677/joe.0.0130399; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zuniga J, 2003, BIOL RES, V36, P233, DOI 10.4067/S0716-97602003000200013	39	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106013	10.1371/journal.pone.0106013	http://dx.doi.org/10.1371/journal.pone.0106013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153315	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200105
J	Luey, N; Toon, CW; Sioson, L; Clarkson, A; Watson, N; Cussigh, C; Kedziora, A; Pincott, S; Pillinger, S; Evans, J; Percy, J; Engel, A; Schnitzler, M; Gill, AJ				Luey, Nathan; Toon, Christopher W.; Sioson, Loretta; Clarkson, Adele; Watson, Nicole; Cussigh, Carmen; Kedziora, Andrew; Pincott, Stuart; Pillinger, Stephen; Evans, Justin; Percy, John; Engel, Alexander; Schnitzler, Margaret; Gill, Anthony J.			A Further Investigation of Combined Mismatch Repair and BRAFV600E Mutation Specific Immunohistochemistry as a Predictor of Overall Survival in Colorectal Carcinoma	PLOS ONE			English	Article							BRAF V600E MUTATION; LYNCH SYNDROME; THYROID-CARCINOMA; ANTIBODY; CANCER; ADENOCARCINOMA; VE1	Mutation specific immunohistochemistry (IHC) is a promising new technique to detect the presence of the BRAFV600E mutation in colorectal carcinoma (CRC). When performed in conjunction with mismatch repair (MMR) IHC, BRAFV600E IHC can help to further triage genetic testing for Lynch Syndrome. In a cohort of 1426 patients undergoing surgery from 2004 to 2009 we recently demonstrated that the combination of MMR and BRAFV600E IHC holds promise as a prognostic marker in CRC, particularly because of its ability to identify the poor prognosis MMR proficient (MMRp) BRAFV600E mutant subgroup. We attempted to validate combined MMR and BRAFV600E IHC as a prognostic indicator in a separate cohort comprising consecutive CRC patients undergoing surgery from 1998 to 2003. IHC was performed on a tissue microarray containing tissue from 1109 patients with CRC. The 5 year survivals stratified by staining patterns were: MMRd/BRAFwt 64%, MMRd/BRAFV600E 64%, MMRp/BRAFwt 60% and MMRp/BRAFV600E 53%. Using the poor prognosis MMRp/BRAFV600E phenotype as baseline, univariate Cox regression modelling demonstrated the following hazard ratios for death: MMRd/BRAFwt HR = 0.71 (95% CI = 0.40-1.27), p = 0.31; MMRd/BRAFV600E HR = 0.74 (95% CI = 0.51-1.07), p = 0.11 and MMRp/BRAFwt HR = 0.79 (95% CI = 0.60-1.04), p = 0.09. Although the findings did not reach statistical significance, this study supports the potential role of combined MMR and BRAF IHC as prognostic markers in CRC.	[Luey, Nathan; Toon, Christopher W.; Pincott, Stuart; Pillinger, Stephen; Evans, Justin; Percy, John; Engel, Alexander; Schnitzler, Margaret; Gill, Anthony J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Toon, Christopher W.; Sioson, Loretta; Clarkson, Adele; Watson, Nicole; Cussigh, Carmen; Kedziora, Andrew; Gill, Anthony J.] Royal N Shore Hosp, Kolling Inst Med Res, Canc Diag & Pathol Res Grp, St Leonards, NSW 2065, Australia; [Toon, Christopher W.; Clarkson, Adele] Histopath Pathol, N Ryde, NSW, Australia; [Toon, Christopher W.; Engel, Alexander; Gill, Anthony J.] Royal N Shore Hosp, Sydney Vital Translat Res Ctr, St Leonards, NSW 2065, Australia; [Engel, Alexander; Schnitzler, Margaret; Gill, Anthony J.] Royal N Shore Hosp, Dept Anat Pathol, St Leonards, NSW 2065, Australia; [Pincott, Stuart; Pillinger, Stephen; Evans, Justin; Percy, John] Royal N Shore Hosp, Dept Colorectal Surg, St Leonards, NSW 2065, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; Royal North Shore Hospital; Royal North Shore Hospital	Gill, AJ (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	affgill@med.usyd.edu.au	Gill, Anthony J./M-5015-2019; Gill, Anthony/D-4215-2015	Gill, Anthony/0000-0002-9447-1967; Toon, Christopher/0000-0002-0750-918X; Pincott, Stuart/0000-0001-5333-0183	Cancer Institute NSW	Cancer Institute NSW	This study was supported by funding from the Cancer Institute NSW as part of a translational research centre grant and internally by the department of anatomical pathology Royal North Shore Hospital. No other funding support was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adackapara CA, 2013, HISTOPATHOLOGY, V63, P187, DOI 10.1111/his.12154; Affolter K, 2013, GENE CHROMOSOME CANC, V52, P748, DOI 10.1002/gcc.22070; Bullock M, 2012, ENDOCR-RELAT CANCER, V19, P779, DOI 10.1530/ERC-12-0239; Capper D, 2013, INT J CANCER, V133, P1624, DOI 10.1002/ijc.28183; Edge SB, 2009, AJCC CANC STAGING MA, V7; Hall G, 2010, PATHOLOGY, V42, P409, DOI 10.3109/00313025.2010.493871; Ilie MI, 2014, PATHOLOGY, V46, P311, DOI 10.1097/PAT.0000000000000113; Kuan SF, 2014, HUM PATHOL, V45, P464, DOI 10.1016/j.humpath.2013.10.026; Lasota J, 2014, AM J SURG PATHOL; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Nolan S, 2014, APPL IMMUNOHISTO M M, V22, pE8, DOI 10.1097/PAI.0000000000000026; Rossle M, 2013, VIRCHOWS ARCH, V463, P623, DOI 10.1007/s00428-013-1492-3; Routhier CA, 2013, HUM PATHOL, V44, P2563, DOI 10.1016/j.humpath.2013.06.018; Sajanti S, 2014, VIRCHOWS ARCH, V464, P637, DOI 10.1007/s00428-014-1555-0; Sinicrope FA, 2013, CANCER-AM CANCER SOC, V119, P2765, DOI 10.1002/cncr.28133; Thiel A, 2013, VIRCHOWS ARCH, V463, P613, DOI 10.1007/s00428-013-1470-9; Toon CW, 2014, MODERN PATHOL, V27, P644, DOI 10.1038/modpathol.2013.200; Toon CW, 2013, AM J SURG PATHOL, V37, P1592, DOI 10.1097/PAS.0b013e31828f233d	18	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106105	10.1371/journal.pone.0106105	http://dx.doi.org/10.1371/journal.pone.0106105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153715	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200116
J	Amgalan, B; Lee, H				Amgalan, Bayarbaatar; Lee, Hyunju			WMAXC: A Weighted Maximum Clique Method for Identifying Condition-Specific Sub-Network	PLOS ONE			English	Article							PROSTATE-CANCER; SIGNALING PATHWAY; UP-REGULATION; EXPRESSION; TRANSCRIPTION	Sub-networks can expose complex patterns in an entire bio-molecular network by extracting interactions that depend on temporal or condition-specific contexts. When genes interact with each other during cellular processes, they may form differential co-expression patterns with other genes across different cell states. The identification of condition-specific sub-networks is of great importance in investigating how a living cell adapts to environmental changes. In this work, we propose the weighted MAXimum clique (WMAXC) method to identify a condition-specific sub-network. WMAXC first proposes scoring functions that jointly measure condition-specific changes to both individual genes and gene-gene co-expressions. It then employs a weaker formula of a general maximum clique problem and relates the maximum scored clique of a weighted graph to the optimization of a quadratic objective function under sparsity constraints. We combine a continuous genetic algorithm and a projection procedure to obtain a single optimal sub-network that maximizes the objective function (scoring function) over the standard simplex (sparsity constraints). We applied the WMAXC method to both simulated data and real data sets of ovarian and prostate cancer. Compared with previous methods, WMAXC selected a large fraction of cancer-related genes, which were enriched in cancer-related pathways. The results demonstrated that our method efficiently captured a subset of genes relevant under the investigated condition.	[Amgalan, Bayarbaatar; Lee, Hyunju] Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST)	Lee, H (corresponding author), Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea.	hyunjulee@gist.ac.kr		Lee, Hyunju/0000-0003-2389-7183	Gwangju Institute of Science Technology; MSIP (The Ministry of Science, ICT and Future Planning), Korea; Microsoft Research, under IT/SW Creative research program [NIPA-2013-H0503-13-1019]	Gwangju Institute of Science Technology; MSIP (The Ministry of Science, ICT and Future Planning), Korea; Microsoft Research, under IT/SW Creative research program	This work was supported by the Systems biology infrastructure establishment grant provided by Gwangju Institute of Science & Technology in 2014, and by the MSIP (The Ministry of Science, ICT and Future Planning), Korea and Microsoft Research, under IT/SW Creative research program supervised by the NIPA (National IT Industry Promotion Agency) (NIPA-2013-H0503-13-1019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143; Adler HL, 1999, J UROLOGY, V161, P182, DOI 10.1016/S0022-5347(01)62092-5; Backes C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1227; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BREITLING R, 2004, BMC BIOINFORMATICS, V5; Chen L, 2012, NUCLEIC ACIDS RES, V41, pe42; Chen L, 2010, BIOINFORMATICS, V26, P1416, DOI 10.1093/bioinformatics/btq144; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; da Silva HB, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/920612; de Graeff P, 2008, BRIT J CANCER, V99, P341, DOI 10.1038/sj.bjc.6604471; Du D.Z., 1999, HDB COMBINATORIAL OP; Gioeli D, 1999, CANCER RES, V59, P279; Guo Z, 2007, BIOINFORMATICS, V23, P2121, DOI 10.1093/bioinformatics/btm294; Gupta S, 2007, CANCER RES, V70, P6735; Haupt R, 2004, PRACTICAL GENETIC AL, P51, DOI DOI 10.1002/0471671746.CH3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ideker T, 2003, BIOINFORMATICS, V18, ps233; Kaur M, 2009, NUCLEIC ACIDS RES, V37, pD820, DOI 10.1093/nar/gkn593; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Kyrillidis A., 2013, INT C MACH LEARN ICM, V28, P235; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Ma HS, 2011, BIOINFORMATICS, V27, P1290, DOI 10.1093/bioinformatics/btr136; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; Maqungo M, 2011, NUCLEIC ACIDS RES, V39, pD980, DOI 10.1093/nar/gkq849; MICHELOT C, 1986, J OPTIMIZ THEORY APP, V50, P195, DOI 10.1007/BF00938486; MOTZKIN TS, 1965, CANADIAN J MATH, V17, P533, DOI 10.4153/CJM-1965-053-6; Nacu S, 2007, BIOINFORMATICS, V23, P850, DOI 10.1093/bioinformatics/btm019; Park J, NOTCH3 EXPRESSION RE; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qiu YQ, IET SYSTEMS BIOL, V3, P475; Rajagopalan D, 2005, BIOINFORMATICS, V21, P788, DOI 10.1093/bioinformatics/bti069; Resto VA, 2008, J BIOL CHEM, V283, P15816, DOI 10.1074/jbc.M708899200; Satoh F, 2001, INT J UROL, V8, pS28, DOI 10.1046/j.1442-2042.2001.00331.x; Shariat SF, 2001, J CLIN ONCOL, V19, P2856, DOI 10.1200/JCO.2001.19.11.2856; Songsiri J, 2011, AS S AUT CONTR VIETN; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Turan P, 1941, MAT FIZ LAPOK, V48, P435; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulitsky I, 2008, LECT N BIOINFORMAT, V4955, P347; Waaijenborg S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-315; Wang Q, 2010, PLOS ONE, pe10456; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wu YM, 2004, CANCER RES, V64, P7311, DOI 10.1158/0008-5472.CAN-04-0972; Yamamura S, 2012, INT J CANCER, V130, P20, DOI 10.1002/ijc.25961	48	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104993	10.1371/journal.pone.0104993	http://dx.doi.org/10.1371/journal.pone.0104993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148538	gold, Green Published			2022-12-25	WOS:000341230600029
J	Arnaud-Haond, S; Moalic, Y; Barnabe, C; Ayala, FJ; Tibayrenc, M				Arnaud-Haond, Sophie; Moalic, Yann; Barnabe, Christian; Ayala, Francisco Jose; Tibayrenc, Michel			Discriminating Micropathogen Lineages and Their Reticulate Evolution through Graph Theory-Based Network Analysis: The Case of Trypanosoma cruzi, the Agent of Chagas Disease	PLOS ONE			English	Article							COMPARED VECTORIAL TRANSMISSIBILITY; CLONAL EVOLUTION; GENETIC EXCHANGE; POPULATION STRUCTURES; NUCLEOTIDE-SEQUENCES; NATURAL-POPULATIONS; PARASITIC PROTOZOA; RECOMBINATION; HYBRIDIZATION; PLASMODIUM	Micropathogens (viruses, bacteria, fungi, parasitic protozoa) share a common trait, which is partial clonality, with wide variance in the respective influence of clonality and sexual recombination on the dynamics and evolution of taxa. The discrimination of distinct lineages and the reconstruction of their phylogenetic history are key information to infer their biomedical properties. However, the phylogenetic picture is often clouded by occasional events of recombination across divergent lineages, limiting the relevance of classical phylogenetic analysis and dichotomic trees. We have applied a network analysis based on graph theory to illustrate the relationships among genotypes of Trypanosoma cruzi, the parasitic protozoan responsible for Chagas disease, to identify major lineages and to unravel their past history of divergence and possible recombination events. At the scale of T. cruzi subspecific diversity, graph theory-based networks applied to 22 isoenzyme loci (262 distinct Multi-Locus-Enzyme-Electrophoresis -MLEE) and 19 microsatellite loci (66 Multi-Locus-Genotypes -MLG) fully confirms the high clustering of genotypes into major lineages or "near-clades''. The release of the dichotomic constraint associated with phylogenetic reconstruction usually applied to Multilocus data allows identifying putative hybrids and their parental lineages. Reticulate topology suggests a slightly different history for some of the main "near-clades'', and a possibly more complex origin for the putative hybrids than hitherto proposed. Finally the sub-network of the near-clade T. cruzi I (28 MLG) shows a clustering subdivision into three differentiated lesser near-clades ("Russian doll pattern''), which confirms the hypothesis recently proposed by other investigators. The present study broadens and clarifies the hypotheses previously obtained from classical markers on the same sets of data, which demonstrates the added value of this approach. This underlines the potential of graph theory-based network analysis for describing the nature and relationships of major pathogens, thereby opening stimulating prospects to unravel the organization, dynamics and history of major micropathogen lineages.	[Arnaud-Haond, Sophie; Moalic, Yann] IFREMER, Dept Ecosyst Marins Exploites, F-34203 Sete, France; [Barnabe, Christian] INTERTRYP IRD CIRAD, Montpellier, France; [Ayala, Francisco Jose] Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92717 USA; [Tibayrenc, Michel] IRD 224 CNRS 5290 UM1 UM2, MIVEGEC, Montpellier, France	Ifremer; CIRAD; Institut de Recherche pour le Developpement (IRD); University of California System; University of California Irvine; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Arnaud-Haond, S (corresponding author), IFREMER, Dept Ecosyst Marins Exploites, F-34203 Sete, France.	sarnaud@ifremer.fr	Moalic, Yann/G-6964-2015; Barnabé, Christian/R-2904-2016; Arnaud-Haond, Sophie/B-2479-2008; Tibayrenc, Michel/AAY-7494-2021	Moalic, Yann/0000-0001-7385-7484; Barnabé, Christian/0000-0003-1857-0741; Arnaud-Haond, Sophie/0000-0001-5814-8452; 	Clonix of the French National Agency for Research (ANR Clonix) [ANR-11-BSV7-007]	Clonix of the French National Agency for Research (ANR Clonix)(French National Research Agency (ANR))	This work was funded by the project Clonix of the French National Agency for Research (ANR Clonix (ANR-11-BSV7-007)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Avise JC, 2004, MOL MARKETS NATURAL; Awadalla P, 2003, NAT REV GENET, V4, P50, DOI 10.1038/nrg964; BarabuYSi A., 2003, LINKED EVERYTHING IS; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; Barnabe C, 2012, INFECT GENET EVOL, V12, P1879, DOI 10.1016/j.meegid.2012.08.018; Barton NH, 2010, PHILOS T R SOC B, V365, P2559, DOI 10.1098/rstb.2010.0106; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Batagelj V, 2002, LECT NOTES COMPUT SC, V2265, P477; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Breniere SF, 1998, ACTA TROP, V71, P269, DOI 10.1016/S0001-706X(98)00061-8; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; Burgos JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058967; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; Conway DJ, 2000, INT J PARASITOL, V30, P1423, DOI 10.1016/S0020-7519(00)00126-0; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; de Lana M, 1998, EXP PARASITOL, V90, P20, DOI 10.1006/expr.1998.4304; de Lana M, 2000, EXP PARASITOL, V96, P61, DOI 10.1006/expr.2000.4552; de Meeus T, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P133, DOI 10.1016/B978-0-12-384890-1.00005-4; Dos Santos DA, 2012, SYST BIOL, V61, P240, DOI 10.1093/sysbio/syr098; ESTOUP A, 1995, GENETICS, V140, P679; Flores-Lopez CA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001272; Fortuna MA, 2009, P NATL ACAD SCI USA, V106, P19044, DOI 10.1073/pnas.0907704106; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Grigg ME, 2003, MICROBES INFECT, V5, P685, DOI 10.1016/S1286-4579(03)00088-1; Guhl F, 2011, ACTA TROP, V119, P1, DOI 10.1016/j.actatropica.2011.04.002; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; KIRKPATRICK M, 1989, NATURE, V339, P300, DOI 10.1038/339300a0; Kivela M, 2015, MOL ECOL RESOUR, V15, P117, DOI 10.1111/1755-0998.12290; Laurent JP, 1997, PARASITOLOGY, V114, P213, DOI 10.1017/S0031182096008414; Lauthier JJ, 2012, INFECT GENET EVOL, V12, P350, DOI 10.1016/j.meegid.2011.12.008; Lawrence JG, 2005, CURR OPIN MICROBIOL, V8, P572, DOI 10.1016/j.mib.2005.08.005; Lewis MD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001363; Lewis MD, 2009, INT J PARASITOL, V39, P1305, DOI 10.1016/j.ijpara.2009.04.001; Llewellyn MS, 2011, INT J PARASITOL, V41, P609, DOI 10.1016/j.ijpara.2010.12.004; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Martin DP, 2010, BACTERIAL POPULATION, P61; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MILES MA, 1978, NATURE, V272, P819, DOI 10.1038/272819a0; Moalic Y, 2012, SYST BIOL, V61, P127, DOI 10.1093/sysbio/syr088; Moalic Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-33; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Ocana-Mayorga S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000915; Otto SP, 1998, TRENDS ECOL EVOL, V13, P145, DOI 10.1016/S0169-5347(97)01260-3; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; Pena SDJ, 2009, MEM I OSWALDO CRUZ, V104, P108, DOI 10.1590/S0074-02762009000900016; Pinto AD, 1998, PARASITOL RES, V84, P348, DOI 10.1007/s004360050409; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Revollo S, 1998, EXP PARASITOL, V89, P30, DOI 10.1006/expr.1998.4216; Rozenfeld AF, 2007, J R SOC INTERFACE, V4, P1093, DOI 10.1098/rsif.2007.0230; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; STAUFFER D, 1994, INTRO PERCOLATION TH; Subileau M, 2009, EXP PARASITOL, V122, P328, DOI 10.1016/j.exppara.2009.04.008; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Telleria J, 2010, P NATL ACAD SCI USA, V107, P20411, DOI 10.1073/pnas.1015496107; Tibayrenc M, 1998, INT J PARASITOL, V28, P85, DOI 10.1016/S0020-7519(97)00180-X; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115; Tibayrenc M, 2013, TRENDS PARA IN PRESS; Tibayrenc M, 2012, P NATL ACAD SCI USA, V109, pE3305, DOI 10.1073/pnas.1212452109; Venegas J, 2009, PARASITOL RES, V105, P191, DOI 10.1007/s00436-009-1386-0; Watts DJ, 2004, ANNU REV SOCIOL, V30, P243, DOI 10.1146/annurev.soc.30.020404.104342; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Yeo M, 2011, PLOS NEGLECTED TROPI, V5; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	75	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e103213	10.1371/journal.pone.0103213	http://dx.doi.org/10.1371/journal.pone.0103213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148574	Green Published, gold			2022-12-25	WOS:000341230600005
J	Siddiqui, T; Lively, S; Ferreira, R; Wong, R; Schlichter, LC				Siddiqui, Tamjeed; Lively, Starlee; Ferreira, Roger; Wong, Raymond; Schlichter, Lyanne C.			Expression and Contributions of TRPM7 and KCa2.3/SK3 Channels to the Increased Migration and Invasion of Microglia in Anti-Inflammatory Activation States	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; PRO-INFLAMMATORY CYTOKINES; WHITE-MATTER INJURY; SMALL-CONDUCTANCE; POTASSIUM CHANNELS; NITRIC-OXIDE; CL-CHANNELS; SK3 CHANNEL; INTERLEUKIN-10; CELLS	Microglia rapidly respond to CNS injury and disease and can assume a spectrum of activation states. While changes in gene expression and production of inflammatory mediators have been extensively described after classical (LPS-induced) and alternative (IL4-induced) microglial activation, less is known about acquired de-activation in response to IL10. It is important to understand how microglial activation states affect their migration and invasion; crucial functions after injury and in the developing CNS. We reported that LPS-treated rat microglia migrate very poorly, while IL4-treated cells migrate and invade much better. Having discovered that the lamellum of migrating microglia contains a large ring of podosomes - microscopic structures that are thought to mediate adhesion, migration and invasion - we hypothesized that IL4 and IL10 would differentially affect podosome expression, gene induction, migration and invasion. Further, based on the enrichment of the KCa2.3/SK3 Ca2+-activated potassium channel in microglial podosomes, we predicted that it regulates migration and invasion. We found both similarities and differences in gene induction by IL4 and IL10 and, while both cytokines increased migration and invasion, only IL10 affected podosome expression. KCa2.3 currents were recorded in microglia under all three activation conditions and KCNN3 (KCa2.3) expression was similar. Surprisingly then, of three KCa2.3 inhibitors (apamin, tamapin, NS8593), only NS8593 abrogated the increased migration and invasion of IL4 and IL10-treated microglia (and invasion of unstimulated microglia). This discrepancy was explained by the observed block of TRPM7 currents in microglia by NS8593, which occurred under all three activation conditions. A similar inhibition of both migration and invasion was seen with a TRPM7 inhibitor (AA-861) that does not block KCa2.3 channels. Thus, we conclude that TRPM7 (not KCa2.3) contributes to the enhanced ability of microglia to migrate and invade when in anti-inflammatory states. This will be an important consideration in developing TRPM7 inhibitors for treating CNS injury.	[Siddiqui, Tamjeed; Lively, Starlee; Ferreira, Roger; Wong, Raymond; Schlichter, Lyanne C.] Univ Hlth Network, Toronto Western Res Inst, Genes & Dev Div, Toronto, ON, Canada; [Siddiqui, Tamjeed; Ferreira, Roger; Wong, Raymond; Schlichter, Lyanne C.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Schlichter, LC (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Genes & Dev Div, Toronto, ON, Canada.	schlicht@uhnres.utoronto.ca			Heart & Stroke Foundation (HSF), Ontario chapter (HSFO) [T6766, 00493]; Ontario Graduate Scholarship; HSF, Canada	Heart & Stroke Foundation (HSF), Ontario chapter (HSFO); Ontario Graduate Scholarship(Ontario Graduate Scholarship); HSF, Canada	This work was funded by grants from the Heart & Stroke Foundation (HSF), Ontario chapter (HSFO #T6766, #00493). Trainee salary support was provided by an Ontario Graduate Scholarship (RF) and a post-doctoral fellowship from HSF, Canada (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MM, 2005, NEUROSCIENTIST, V11, P116, DOI 10.1177/1073858404272966; Asrar S, 2013, CHANNELS, V7, P6, DOI 10.4161/chan.22824; Bae CYJ, 2013, ACTA PHARMACOL SIN, V34, P10, DOI 10.1038/aps.2012.94; Bates-Withers C, 2011, ADV EXP MED BIOL, V704, P173, DOI 10.1007/978-94-007-0265-3_9; Bouhy D, 2011, J NEUROSCI, V31, P16298, DOI 10.1523/JNEUROSCI.0047-11.2011; Cayabyab FS, 2000, EUR J NEUROSCI, V12, P1949, DOI 10.1046/j.1460-9568.2000.00083.x; Cayabyab FS, 2002, J BIOL CHEM, V277, P48130, DOI 10.1074/jbc.M208448200; Cayabyab FS, 2002, J BIOL CHEM, V277, P13673, DOI 10.1074/jbc.M108211200; Chantome A, 2013, CANCER RES, V73, P4852, DOI 10.1158/0008-5472.CAN-12-4572; Chantome A, 2009, EXP CELL RES, V315, P3620, DOI 10.1016/j.yexcr.2009.07.021; Chen HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011161; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chubanov V, 2012, BRIT J PHARMACOL, V166, P1357, DOI 10.1111/j.1476-5381.2012.01855.x; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Ferreira R, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/fncel.2014.00183, 10.3389/fncel.2014.0018]; Ferreira R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062345; Foresti R, 2013, PHARMACOL RES, V76, P132, DOI 10.1016/j.phrs.2013.07.010; Fouda Abdelrahman Y, 2013, Exp Transl Stroke Med, V5, P12, DOI 10.1186/2040-7378-5-12; Girard S, 2013, GLIA, V61, P813, DOI 10.1002/glia.22478; Grunnet M, 2001, NEUROPHARMACOLOGY, V40, P879, DOI 10.1016/S0028-3908(01)00028-4; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jelassi B, 2011, ONCOGENE, V30, P2108, DOI 10.1038/onc.2010.593; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Koeberle PD, 2010, CHANNELS, V4, P337, DOI [10.4161/chan.4.5.12790, 10.1038/cdd.2009.113]; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kremlev SG, 2005, J NEUROIMMUNOL, V162, P71, DOI 10.1016/j.jneuroim.2005.01.010; Kuras Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043859; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; Liebau S, 2007, J NEUROCHEM, V101, P1338, DOI 10.1111/j.1471-4159.2006.04437.x; Lim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081218; Lindenberg JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070237; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Liu BS, 2013, J NEUROIMMUNE PHARM, V8, P227, DOI 10.1007/s11481-012-9365-0; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Luo XG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-9; Mashimo H, 2008, INVEST OPHTH VIS SCI, V49, P5450, DOI 10.1167/iovs.08-1878; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Moxon-Emre I, 2010, J NEUROPATH EXP NEUR, V69, P1, DOI 10.1097/NEN.0b013e3181c3ce6c; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Newell EW, 2005, J PHYSIOL-LONDON, V567, P869, DOI 10.1113/jphysiol.2005.092056; Ohana L, 2009, CHANNELS, V3, P129, DOI 10.4161/chan.3.2.8609; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Park HS, 2014, KOREAN J PHYSIOL PHA, V18, P15, DOI 10.4196/kjpp.2014.18.1.15; Pedarzani P, 2002, J BIOL CHEM, V277, P46101, DOI 10.1074/JBC.m206465200; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Penner R., 2007, V179, P313; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Pla AF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00311; Potier M, 2011, BRIT J PHARMACOL, V162, P464, DOI 10.1111/j.1476-5381.2010.01044.x; Potier M, 2006, MOL CANCER THER, V5, P2946, DOI 10.1158/1535-7163.MCT-06-0194; Qian L, 2006, J PHARMACOL EXP THER, V319, P44, DOI 10.1124/jpet.106.106351; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Schlichter LC, 1996, GLIA, V17, P225, DOI 10.1002/(SICI)1098-1136(199607)17:3<225::AID-GLIA5>3.0.CO;2-#; Schlichter LC, 2011, CHANNELS, V5, P128, DOI 10.4161/chan.5.2.14310; Schnitzler MMY, 2008, FASEB J, V22, P1540, DOI 10.1096/fj.07-9694com; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siddiqui TA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-250; Silva SL, 2012, NEUROPHARMACOLOGY, V62, P2398, DOI 10.1016/j.neuropharm.2012.02.002; Sivagnanam V, 2010, J NEUROIMMUNOL, V227, P111, DOI 10.1016/j.jneuroim.2010.06.021; Smith ME, 1998, J NEUROSCI RES, V54, P68, DOI 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F; Strobaek D, 2006, MOL PHARMACOL, V70, P1771, DOI 10.1124/mol.106.027110; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Szczepanik AM, 2001, J NEUROIMMUNOL, V113, P49, DOI 10.1016/S0165-5728(00)00404-5; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Vincent C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-190; Visser D, 2013, CELL CALCIUM, V54, P404, DOI 10.1016/j.ceca.2013.09.003; Wasserman JK, 2007, BRAIN RES, V1180, P140, DOI 10.1016/j.brainres.2007.08.058; Wasserman JK, 2008, EXP NEUROL, V214, P266, DOI 10.1016/j.expneurol.2008.08.010; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Won SY, 2013, J NEUROIMMUNOL, V265, P36, DOI 10.1016/j.jneuroim.2013.09.014; Yang MS, 2006, J IMMUNOL, V177, P1323, DOI 10.4049/jimmunol.177.2.1323; Zhao WH, 2006, J NEUROCHEM, V99, P1176, DOI 10.1111/j.1471-4159.2006.04172.x; Zhou W, 1998, J GEN PHYSIOL, V111, P781, DOI 10.1085/jgp.111.6.781	87	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106087	10.1371/journal.pone.0106087	http://dx.doi.org/10.1371/journal.pone.0106087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148577	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600113
J	Sorokowski, P; Koscinski, K; Sorokowska, A; Huanca, T				Sorokowski, Piotr; Koscinski, Krzysztof; Sorokowska, Agnieszka; Huanca, Tomas			Preference for Women's Body Mass and Waist-to-Hip Ratio in Tsimane' Men of the Bolivian Amazon: Biological and Cultural Determinants	PLOS ONE			English	Article							SEXUAL ATTRACTIVENESS; VARIABLE PREFERENCES; LEG LENGTH; FEMALE; JUDGMENTS; INDEX; SIZE; AMERINDIANS; PREDICTORS; PERCEPTION	The issue of cultural universality of waist-to-hip ratio (WHR) attractiveness in women is currently under debate. We tested men's preferences for female WHR in traditional society of Tsimane'(Native Amazonians) of the Bolivian rainforest (N = 66). Previous studies showed preferences for high WHR in traditional populations, but they did not control for the women's body mass. We used a method of stimulus creation that enabled us to overcome this problem. We found that WHR lower than the average WHR in the population is preferred independent of cultural conditions. Our participants preferred the silhouettes of low WHR, but high body mass index (BMI), which might suggest that previous results could be an artifact related to employed stimuli. We found also that preferences for female BMI are changeable and depend on environmental conditions and probably acculturation (distance from the city). Interestingly, the Tsimane' men did not associate female WHR with age, health, physical strength or fertility. This suggests that men do not have to be aware of the benefits associated with certain body proportions - an issue that requires further investigation.	[Sorokowski, Piotr; Sorokowska, Agnieszka] Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland; [Koscinski, Krzysztof] Adam Mickiewicz Univ, Inst Anthropol, Poznan, Poland; [Sorokowska, Agnieszka] Tech Univ Dresden, Ctr Smell & Taste, D-01062 Dresden, Germany; [Huanca, Tomas] Ctr Boliviano Invest & Desarrollo Socio Integral, San Borja, Bolivia	University of Wroclaw; Adam Mickiewicz University; Technische Universitat Dresden	Sorokowski, P (corresponding author), Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland.	sorokowskipiotr@yahoo.co.uk		Sorokowski, Piotr/0000-0001-9225-9965; Koscinski, Krzysztof/0000-0002-4748-903X; Sorokowska, Agnieszka/0000-0003-3999-8851	Polish Ministry of Science and Higher Education for science [IP 2011 051571]; Foundation for Polish Science START scholarship; National Science Centre ETIUDA [2013/08/T/HS6/00408]	Polish Ministry of Science and Higher Education for science; Foundation for Polish Science START scholarship; National Science Centre ETIUDA	The research was supported by funds of Polish Ministry of Science and Higher Education for science (research grant #IP 2011 051571 to P.S.; years 2012-2014) and Foundation for Polish Science START scholarship and National Science Centre ETIUDA (#2013/08/T/HS6/00408) scholarship to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JL, 1992, ETHOL SOCIOBIOL, V13, P197, DOI 10.1016/0162-3095(92)90033-Z; Apicella CL, 2004, EVOL HUM BEHAV, V25, P371, DOI 10.1016/j.evolhumbehav.2004.06.003; Bartali B, 2002, SOZ PRAVENTIV MED, V47, P336, DOI 10.1007/PL00012644; BJORNTORP P, 1991, INT J OBESITY, V15, P67; Brewis AA, 2000, ECOL FOOD NUTR, V39, P105, DOI 10.1080/03670244.2000.9991609; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Brown WJ, 1998, INT J OBESITY, V22, P520, DOI 10.1038/sj.ijo.0800617; Bye E., 2012, INT J FASHION DESIGN, V5, P117, DOI DOI 10.1080/17543266.2011.649792; Byron E, 2003, THESIS U FLORIDA; Case A, 2010, DEMOGRAPHY, V47, pS65, DOI 10.1353/dem.2010.0007; Cassidy C M, 1991, Med Anthropol, V13, P181; Choi J., 1988, HOWARD J COMMUN, V1, P57; CUNNINGHAM MR, 1986, J PERS SOC PSYCHOL, V50, P925, DOI 10.1037/0022-3514.50.5.925; Dixson BJ, 2010, CURR ZOOL, V56, P175, DOI 10.1093/czoolo/56.2.175; Dixson BJ, 2007, ARCH SEX BEHAV, V36, P369, DOI 10.1007/s10508-006-9093-8; Dixson BJ, 2010, AM J PHYS ANTHROPOL, V141, P620, DOI 10.1002/ajpa.21181; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; Fan JT, 2004, P ROY SOC B-BIOL SCI, V271, P347, DOI 10.1098/rspb.2003.2613; Ford C.S., 1951, PATTERNSEXUAL BEHA; Frederick DA, 2007, PERS SOC PSYCHOL B, V33, P1167, DOI 10.1177/0146167207303022; FURNHAM A, 1983, PSYCHOL MED, V13, P829, DOI 10.1017/S0033291700051540; FURNHAM A, 1994, INT J EAT DISORDER, V15, P81, DOI 10.1002/1098-108X(199401)15:1&lt;81::AID-EAT2260150110&gt;3.0.CO;2-D; Furnham A, 1997, PERS INDIV DIFFER, V22, P539, DOI 10.1016/S0191-8869(96)00241-3; Godoy R, 2005, ANNU REV ANTHROPOL, V34, P121, DOI 10.1146/annurev.anthro.34.081804.120412; Godoy R, 1998, LAND ECON, V74, P162, DOI 10.2307/3147048; Godoy R, 2012, INDIANS MARKETS RAIN; Godoy R, 2005, ECON HUM BIOL, V3, P136, DOI 10.1016/j.ehb.2005.01.001; Godoy R, 2010, J ECON PSYCHOL, V31, P587, DOI 10.1016/j.joep.2010.04.001; Godoy RA, 2006, ECON HUM BIOL, V4, P184, DOI 10.1016/j.ehb.2005.11.001; Gray Peter B., 2013, EVOLUTION HUMAN SEXU; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Harrison K, 2003, SEX ROLES, V48, P255, DOI 10.1023/A:1022825421647; HORVATH T, 1981, ARCH SEX BEHAV, V10, P21, DOI 10.1007/BF01542671; Huanca Tomas, 2008, TSIMANE ORAL TRADITI; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; Karremans JC, 2010, EVOL HUM BEHAV, V31, P182, DOI 10.1016/j.evolhumbehav.2009.10.001; KIRSCHNER MA, 1991, INT J OBESITY, V15, P101; Komlos J, 1994, STATURE LIVING STAND; Koscinski K, 2014, ARCH SEX BEHAV, V43, P989, DOI 10.1007/s10508-013-0166-1; Koscinski K, 2013, BEHAV ECOL, V24, P914, DOI 10.1093/beheco/art016; Lassek WD, 2008, EVOL HUM BEHAV, V29, P26, DOI 10.1016/j.evolhumbehav.2007.07.005; Leonard WR, 2008, ECON HUM BIOL, V6, P299, DOI 10.1016/j.ehb.2008.04.001; Lipson SF, 1996, HUM REPROD, V11, P2090; Marlowe FW, 2001, PERS INDIV DIFFER, V30, P481, DOI 10.1016/S0191-8869(00)00039-8; McDade TW, 2005, AM J PHYS ANTHROPOL, V128, P906, DOI 10.1002/ajpa.20222; Nelson LD, 2005, PSYCHOL SCI, V16, P167, DOI 10.1111/j.0956-7976.2005.00798.x; Nube M, 1998, EUR J CLIN NUTR, V52, P136, DOI 10.1038/sj.ejcn.1600528; Pawlowski B, 2005, HUM NATURE-INT BIOS, V16, P164, DOI 10.1007/s12110-005-1002-7; Pawlowski B, 2003, P ROY SOC B-BIOL SCI, V270, P709, DOI 10.1098/rspb.2002.2294; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; Pettijohn TF, 2004, PERS SOC PSYCHOL B, V30, P1186, DOI 10.1177/0146167204264078; Pisanski K, 2013, CROSS-CULT RES, V47, P162, DOI 10.1177/1069397112471806; Reyes-Garcia V, 2005, CURR ANTHROPOL, V46, P651, DOI 10.1086/432777; Rilling JK, 2009, EVOL HUM BEHAV, V30, P21, DOI 10.1016/j.evolhumbehav.2008.08.007; Ringhofer L, 2010, FISHING, FORAGING AND FARMING IN THE BOLIVIAN AMAZON, P1, DOI 10.1007/978-90-481-3487-8; Rozmus-Wrzesinska M, 2005, BIOL PSYCHOL, V68, P299, DOI 10.1016/j.biopsycho.2004.04.007; Sam DL, 2010, PERSPECT PSYCHOL SCI, V5, P472, DOI 10.1177/1745691610373075; Schutzwohl A, 2006, BIOL PSYCHOL, V71, P223, DOI 10.1016/j.biopsycho.2005.04.005; Singh D, 2004, J SEX RES, V41, P43, DOI 10.1080/00224490409552212; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; SINGH D, 1994, PERS INDIV DIFFER, V16, P123, DOI 10.1016/0191-8869(94)90116-3; SINGH D, 1995, HUM NATURE-INT BIOS, V6, P51, DOI 10.1007/BF02734135; Singh Devendra, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P81; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sorokowski P, 2008, EVOL HUM BEHAV, V29, P86, DOI 10.1016/j.evolhumbehav.2007.09.002; Sorokowski P, 2012, ARCH SEX BEHAV, V41, P1209, DOI 10.1007/s10508-012-9906-x; Sorokowski P, 2012, J CROSS CULT PSYCHOL, V43, P32, DOI 10.1177/0022022110395140; Sorokowski P, 2011, J CROSS CULT PSYCHOL, V42, P131, DOI 10.1177/0022022110392229; Southwell, 2004, ASIAN J COMMUN, V14, P81, DOI DOI 10.1080/01292980420001951512; Sugiyama LS, 2004, EVOL HUM BEHAV, V25, P51, DOI 10.1016/S1090-5138(03)00083-7; Swami V., 2006, J ARTIC SUPPORT NULL, V4, P17; Swami V, 2007, BODY IMAGE, V4, P219, DOI 10.1016/j.bodyim.2007.01.002; Swami Viren, 2005, Body Image, V2, P115, DOI 10.1016/j.bodyim.2005.02.002; Swami V, 2006, BRIT J PSYCHOL, V97, P353, DOI 10.1348/000712605X80713; Tassinary LG, 1998, PSYCHOL SCI, V9, P150, DOI 10.1111/1467-9280.00029; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Tovee MJ, 1999, NATURE, V399, P215, DOI 10.1038/20345; Vallve Frederic, 2010, THESIS GEORGETOWN U; Wass P, 1997, HUM REPROD, V12, P2057, DOI 10.1093/humrep/12.9.2057; Wetsman A, 1999, EVOL HUM BEHAV, V20, P219, DOI 10.1016/S1090-5138(99)00007-0; World Health Organization, 2013, GLOB DAT BOD MAX IND; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002; Yu DW, 1998, NATURE, V396, P321, DOI 10.1038/24512; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484	85	19	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105468	10.1371/journal.pone.0105468	http://dx.doi.org/10.1371/journal.pone.0105468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LL	25148034	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600049
J	Kallianpur, AR; Jia, PL; Ellis, RJ; Zhao, ZM; Bloss, C; Wen, WQ; Marra, CM; Hulgan, T; Simpson, DM; Morgello, S; McArthur, JC; Clifford, DB; Collier, AC; Gelman, BB; McCutchan, JA; Franklin, D; Samuels, DC; Rosario, D; Holzinger, E; Murdock, DG; Letendre, S; Grant, I				Kallianpur, Asha R.; Jia, Peilin; Ellis, Ronald J.; Zhao, Zhongming; Bloss, Cinnamon; Wen, Wanqing; Marra, Christina M.; Hulgan, Todd; Simpson, David M.; Morgello, Susan; McArthur, Justin C.; Clifford, David B.; Collier, Ann C.; Gelman, Benjamin B.; McCutchan, J. Allen; Franklin, Donald; Samuels, David C.; Rosario, Debralee; Holzinger, Emily; Murdock, Deborah G.; Letendre, Scott; Grant, Igor		CHARTER Study Grp	Genetic Variation in Iron Metabolism Is Associated with Neuropathic Pain and Pain Severity in HIV-Infected Patients on Antiretroviral Therapy	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; PERIPHERAL NEUROPATHY; SENSORY NEUROPATHY; MITOCHONDRIAL HAPLOGROUPS; OXIDATIVE STRESS; MODEL; MECHANISMS; PROTEIN; POLYNEUROPATHY; INTERFERENCE	HIV sensory neuropathy and distal neuropathic pain (DNP) are common, disabling complications associated with combination antiretroviral therapy (cART). We previously associated iron-regulatory genetic polymorphisms with a reduced risk of HIV sensory neuropathy during more neurotoxic types of cART. We here evaluated the impact of polymorphisms in 19 iron-regulatory genes on DNP in 560 HIV-infected subjects from a prospective, observational study, who underwent neurological examinations to ascertain peripheral neuropathy and structured interviews to ascertain DNP. Genotype-DNP associations were explored by logistic regression and permutation-based analytical methods. Among 559 evaluable subjects, 331 (59%) developed HIV-SN, and 168 (30%) reported DNP. Fifteen polymorphisms in 8 genes (p<0.05) and 5 variants in 4 genes (p<0.01) were nominally associated with DNP: polymorphisms in TF, TFRC, BMP6, ACO1, SLC11A2, and FXN conferred reduced risk (adjusted odds ratios [ORs] ranging from 0.2 to 0.7, all p<0.05); other variants in TF, CP, ACO1, BMP6, and B2M conferred increased risk (ORs ranging from 1.3 to 3.1, all p<0.05). Risks associated with some variants were statistically significant either in black or white subgroups but were consistent in direction. ACO1 rs2026739 remained significantly associated with DNP in whites (permutation p<0.0001) after correction for multiple tests. Several of the same iron-regulatory-gene polymorphisms, including ACO1 rs2026739, were also associated with severity of DNP (all p<0.05). Common polymorphisms in iron-management genes are associated with DNP and with DNP severity in HIV-infected persons receiving cART. Consistent risk estimates across population subgroups and persistence of the ACO1 rs2026739 association after adjustment for multiple testing suggest that genetic variation in iron-regulation and transport modulates susceptibility to DNP.	[Kallianpur, Asha R.] Cleveland Clin Fdn, Dept Genom Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Kallianpur, Asha R.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Ellis, Ronald J.] Univ Calif San Diego, Dept Neurol, San Diego, CA 92103 USA; [Bloss, Cinnamon] Scripps Translat Sci Inst, La Jolla, CA USA; [Bloss, Cinnamon] Scripps Hlth, La Jolla, CA USA; [Wen, Wanqing; Hulgan, Todd] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Marra, Christina M.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Simpson, David M.; Morgello, Susan] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [McArthur, Justin C.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Clifford, David B.] Washington Univ, Dept Neurol, St Louis, MO USA; [Collier, Ann C.] Univ Washington, Dept Med, Seattle, WA USA; [Gelman, Benjamin B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [McCutchan, J. Allen; Letendre, Scott] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Franklin, Donald; Rosario, Debralee] Univ Calif San Diego, HIV Neurobehav Res Ctr, San Diego, CA 92103 USA; [Franklin, Donald; Rosario, Debralee] Univ Calif San Diego, CHARTER Ctr, San Diego, CA 92103 USA; [Samuels, David C.; Holzinger, Emily; Murdock, Deborah G.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Samuels, David C.; Holzinger, Emily; Murdock, Deborah G.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA; [Grant, Igor] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Vanderbilt University; University of California System; University of California San Diego; Scripps Research Institute; Vanderbilt University; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego	Kallianpur, AR (corresponding author), Cleveland Clin Fdn, Dept Genom Med, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	kalliaa@ccf.org	Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022; Hulgan, Todd/AAG-7491-2019; Letendre, Scott L./GLU-6874-2022; Hulgan, Todd/B-3947-2014; Ellis, Ronald/K-3543-2015	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Hulgan, Todd/0000-0002-3339-067X; Ellis, Ronald/0000-0003-4931-752X; Bloss, Cinnamon/0000-0003-1315-8387	National Institutes of Health [N01 MH22005, HHSN271201000036C, 1R01 MH 095621]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH075673, N01MH022005, R01MH095621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The co-authors of this manuscript have no pertinent financial disclosures. Funding support for this work was provided by the following grants: National Institutes of Health contracts N01 MH22005 and HHSN271201000036C from the National Institutes of Health (to CHARTER PI Igor Grant) and 1R01 MH 095621 (to PIs Asha Kallianpur and Todd Hulgan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova N, 2011, TRENDS PHARMACOL SCI, V32, P715, DOI 10.1016/j.tips.2011.07.007; Ayton S, 2014, FREE RADIC BIOL MED; Backonja M, 2010, ONCOLOGIST, V15, P24, DOI 10.1634/theoncologist.2009-S502; Belfer I, 2010, CURR PAIN HEADACHE R, V14, P203, DOI 10.1007/s11916-010-0110-1; Bentley AJ, 2007, CLIN J PAIN, V23, P62, DOI 10.1097/01.ajp.0000210948.11805.69; Boelaert JR, 1996, INFECT AGENT DIS, V5, P36; Bulaj ZJ, 1996, NEW ENGL J MED, V335, P1799, DOI 10.1056/NEJM199612123352403; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Cano A, 2006, J PAIN, V7, P459, DOI 10.1016/j.jpain.2006.01.445; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Chetty S, 2012, SAMJ S AFR MED J, V102, P312, DOI 10.7196/SAMJ.5472; Connor JR, 2011, BRAIN, V134, P959, DOI 10.1093/brain/awr012; Davis L, 2004, AIDS CARE, V16, P395, DOI 10.1080/09540120410001665394; Derry S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010111; Dowling P, 2009, J NUTR, V139, P2087, DOI 10.3945/jn.109.112557; Drakesmith H, 2005, P NATL ACAD SCI USA, V102, P11017, DOI 10.1073/pnas.0504823102; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Dubovy P, 2011, ANN ANAT, V193, P267, DOI 10.1016/j.aanat.2011.02.011; El Boghdady NA, 2012, CELL BIOCHEM FUNCT, V30, P328, DOI 10.1002/cbf.2808; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; Ellis RJ, 2008, ANN NEUROL, V64, P566, DOI 10.1002/ana.21484; Evans SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000551; Fellows RP, 2012, J INT NEUROPSYCH SOC, V18, P898, DOI 10.1017/S1355617712000707; Finberg KE, 2013, CURR OPIN HEMATOL, V20, P208, DOI 10.1097/MOH.0b013e32835f5a47; Foulkes T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000086; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Gemignani F, 2013, SLEEP MED, V14, P79, DOI 10.1016/j.sleep.2012.08.013; Gille G, 2011, J NEURAL TRANSM, V118, P349, DOI 10.1007/s00702-010-0503-7; Grady BJ, 2009, GENET EPIDEMIOL, V33, P788; Hao SL, 2013, CURR NEUROPHARMACOL, V11, P499, DOI 10.2174/1570159X11311050005; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Hitchcock SA, 2008, SAMJ S AFR MED J, V98, P889; Holzinger ER, 2012, J NEUROVIROL, V18, P511, DOI 10.1007/s13365-012-0133-y; Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1; Hulgan T, 2008, J INFECT DIS, V197, P858, DOI 10.1086/528697; Jia PL, 2012, J MED GENET, V49, P96, DOI 10.1136/jmedgenet-2011-100397; Johnson EE, 2010, INFECT IMMUN, V78, P5099, DOI 10.1128/IAI.00498-10; Joseph EK, 2006, PAIN, V121, P105, DOI 10.1016/j.pain.2005.12.010; Kallianpur AR, 2006, AIDS, V20, P1503, DOI 10.1097/01.aids.0000237366.56864.3c; Kallianpur AR, 2009, PHARMACOGENOMICS, V10, P623, DOI [10.2217/pgs.09.14, 10.2217/PGS.09.14]; Kamerman PR, 2012, J PERIPHER NERV SYST, V17, P19, DOI 10.1111/j.1529-8027.2012.00373.x; Keltner JR, 2012, PSYCHOSOMATICS, V53, P380, DOI 10.1016/j.psym.2012.05.002; Keltner JR, 2014, J NEUROVIROL; Keswani SC, 2006, J NEUROSCI, V26, P10299, DOI 10.1523/JNEUROSCI.3135-06.2006; Kranick Sarah M, 2012, Continuum (Minneap Minn), V18, P1319, DOI 10.1212/01.CON.0000423849.24900.ec; Kumar KR, 2011, SEMIN NEUROL, V31, P433, DOI 10.1055/s-0031-1299782; Lawless MW, 2007, TISSUE ANTIGENS, V70, P294, DOI 10.1111/j.1399-0039.2007.00895.x; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li JY, 2012, NEUROSCI LETT, V531, P52, DOI 10.1016/j.neulet.2012.10.014; Li XQ, 2003, J PAIN, V4, P101, DOI 10.1054/jpai.2003.18; Lorber Margalit, 2013, J Int Assoc Provid AIDS Care, V12, P378, DOI 10.1177/2325957413488189; Lucey BP, 2011, AIDS CARE, V23, P921, DOI 10.1080/09540121.2010.543883; Maag Rainer, 2006, Curr Pain Headache Rep, V10, P191, DOI 10.1007/s11916-006-0045-8; Max MB, 2008, NAT REV DRUG DISCOV, V7, P647, DOI 10.1038/nrd2595; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Mitchell RM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-6; Mitchell RM, 2011, NEUROBIOL AGING, V32, P1114, DOI 10.1016/j.neurobiolaging.2009.05.016; Moos T, 2011, MOL CELL NEUROSCI, V46, P607, DOI 10.1016/j.mcn.2010.12.013; Moos Torben, 2006, Semin Pediatr Neurol, V13, P149, DOI 10.1016/j.spen.2006.08.003; Oshinaike O, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/961510; Pahuja M, 2012, ANTIVIR THER, V17, P737, DOI 10.3851/IMP2087; Patton SM, 2011, EUR J NEUROL, V18, P1329, DOI 10.1111/j.1468-1331.2011.03397.x; Phillips TJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014433; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Robinson-Papp J, 2010, PAIN, V151, P732, DOI 10.1016/j.pain.2010.08.045; Ropele S, 2013, MAGN RESON MED; Sheftel AD, 2009, ANN MED, V41, P82, DOI 10.1080/07853890802322229; Staats KA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00249; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Tan ECTH, 2009, J SURG RES, V152, P84, DOI 10.1016/j.jss.2008.03.035; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P516, DOI 10.1161/ATVBAHA.111.237040; Thaisetthawatkul P, 2004, NEUROLOGY, V63, P1462; Tramullas M, 2010, J NEUROSCI, V30, P1502, DOI 10.1523/JNEUROSCI.2584-09.2010; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Wandner LD, 2012, J PAIN, V13, P220, DOI 10.1016/j.jpain.2011.10.014; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wu XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044622; Yan XS, 2013, J PHYSIOL-LONDON, V591, P2001, DOI 10.1113/jphysiol.2012.250522; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Zhang XL, 2013, BIOL CHEM, V394, P231, DOI 10.1515/hsz-2012-0217	85	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103123	10.1371/journal.pone.0103123	http://dx.doi.org/10.1371/journal.pone.0103123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144566	Green Published, gold			2022-12-25	WOS:000341106100006
J	Matsumoto, Y; Inden, M; Tamura, A; Hatano, R; Tsukita, S; Asano, S				Matsumoto, Yosuke; Inden, Masatoshi; Tamura, Atsushi; Hatano, Ryo; Tsukita, Sachiko; Asano, Shinji			Ezrin Mediates Neuritogenesis via Down-Regulation of RhoA Activity in Cultured Cortical Neurons	PLOS ONE			English	Article							RADIXIN-MOESIN PROTEINS; GROWTH CONE MORPHOLOGY; EZRIN/RADIXIN/MOESIN PROTEINS; AXON OUTGROWTH; ERM PROTEINS; KINASE; PHOSPHORYLATION; ACTIVATION; CELLS; ACTIN	Neuronal morphogenesis is implicated in neuronal function and development with rearrangement of cytoskeletal organization. Ezrin, a member of Ezrin/Radixin/Moesin (ERM) proteins links between membrane proteins and actin cytoskeleton, and contributes to maintenance of cellular function and morphology. In cultured hippocampal neurons, suppression of both radixin and moesin showed deficits in growth cone morphology and neurite extensions. Downregulation of ezrin using siRNA caused impairment of netrin-1-induced axon outgrowth in cultured cortical neurons. However, roles of ezrin in the neuronal morphogenesis of the cultured neurons have been poorly understood. In this report, we performed detailed studies on the roles of ezrin in the cultured cortical neurons prepared from the ezrin knockdown (Vil2(kd/kd)) mice embryo that showed a very small amount of ezrin expression compared with the wild-type (Vil2(+/+)) neurons. Ezrin was mainly expressed in cell body in the cultured cortical neurons. We demonstrated that the cultured cortical neurons prepared from the Vil2(kd/kd) mice embryo exhibited impairment of neuritogenesis. Moreover, we observed increased RhoA activity and phosphorylation of myosin light chain 2 (MLC2), as a downstream effector of RhoA in the Vil2(kd/kd) neurons. In addition, inhibition of Rho kinase and myosin II rescued the impairment of neuritogenesis in the Vil2(kd/kd) neurons. These data altogether suggest a novel role of ezrin in the neuritogenesis of the cultured cortical neurons through down-regulation of RhoA activity.	[Matsumoto, Yosuke; Hatano, Ryo; Asano, Shinji] Ritsumeikan Univ, Coll Pharmaceut Sci, Dept Mol Physiol, Kusatsu, Shiga, Japan; [Inden, Masatoshi] Gifu Pharmaceut Univ, Lab Med Therapeut & Mol Therapeut, Gifu, Japan; [Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Biol Sci Lab, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan	Ritsumeikan University; Gifu Pharmaceutical University; Osaka University; Osaka University	Asano, S (corresponding author), Ritsumeikan Univ, Coll Pharmaceut Sci, Dept Mol Physiol, Kusatsu, Shiga, Japan.	ashinji@ph.ritsumei.ac.jp		Asano, Shinji/0000-0003-1443-8970; Inden, Masatoshi/0000-0002-7480-4920	JSPS KAKENHI [24790097, 21590082, 24590104]; Grants-in-Aid for Scientific Research [26860058] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Number 24790097;(http://kaken.nii.ac.jp/d/p/24790097.en.html, MI), 21590082; (http://kaken.nii.ac.jp/d/p/21590082.en.html, SA), 24590104; (http://kaken.nii.ac.jp/d/p/24590104.en.html, SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Baeyens N, 2013, BIOCHEM BIOPH RES CO, V441, P579, DOI 10.1016/j.bbrc.2013.10.118; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Casaletto JB, 2011, P NATL ACAD SCI USA, V108, P11924, DOI 10.1073/pnas.1103418108; Castelo L, 1999, MOL BIOL CELL, V10, P1511, DOI 10.1091/mbc.10.5.1511; Christie KJ, 2013, NEUROSCIENCE, V247, P75, DOI 10.1016/j.neuroscience.2013.05.019; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; DOTTI CG, 1988, J NEUROSCI, V8, P1454; EVERETT AW, 1990, J HISTOCHEM CYTOCHEM, V38, P1137, DOI 10.1177/38.8.2114439; Gallo G, 2008, DEV NEUROBIOL, V68, P926, DOI 10.1002/dneu.20631; Gimeno L, 2004, GENE EXPR PATTERNS, V4, P749, DOI 10.1016/j.modgep.2004.03.007; GonzalezAgosti C, 1996, CELL MOTIL CYTOSKEL, V34, P122, DOI 10.1002/(SICI)1097-0169(1996)34:2<122::AID-CM4>3.0.CO;2-D; GOSLIN K, 1989, J CELL BIOL, V109, P1621, DOI 10.1083/jcb.109.4.1621; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gronholm M, 2005, MOL CELL NEUROSCI, V28, P683, DOI 10.1016/j.mcn.2004.11.014; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hayashi K, 2007, DEV NEUROBIOL, V67, P655, DOI 10.1002/dneu.20363; Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jeon S, 2002, J BIOL CHEM, V277, P16576, DOI 10.1074/jbc.M110380200; Johnson MW, 2002, ACTA NEUROPATHOL, V104, P188, DOI 10.1007/s00401-002-0540-x; Kim HS, 2010, J NEUROCHEM, V113, P1565, DOI 10.1111/j.1471-4159.2010.06713.x; Kobayashi Y, 2013, J BIOCHEM, V153, P389, DOI 10.1093/jb/mvt005; Kollins KM, 2009, DEV NEUROBIOL, V69, P279, DOI 10.1002/dneu.20704; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Marsick BM, 2012, J NEUROSCI, V32, P282, DOI 10.1523/JNEUROSCI.4794-11.2012; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Peris B, 2012, J NEUROCHEM, V121, P903, DOI 10.1111/j.1471-4159.2012.07733.x; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Schulz A, 2010, J NEUROSCI, V30, P10177, DOI 10.1523/JNEUROSCI.0840-10.2010; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Viesselmann C, 2011, JOVE-J VIS EXP, DOI 10.3791/2373	43	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105435	10.1371/journal.pone.0105435	http://dx.doi.org/10.1371/journal.pone.0105435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144196	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100071
J	McFerrin, HE; Olson, SD; Gutschow, MV; Semon, JA; Sullivan, DE; Prockop, DJ				McFerrin, Harris E.; Olson, Scott D.; Gutschow, Miriam V.; Semon, Julie A.; Sullivan, Deborah E.; Prockop, Darwin J.			Rapidly Self-Renewing Human Multipotent Marrow Stromal Cells (hMSC) Express Sialyl Lewis X and Actively Adhere to Arterial Endothelium in a Chick Embryo Model System	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-UTERO TRANSPLANTATION; LUNG CLEARANCE RATE; METASTATIC ABILITY; PROGENITOR CELLS; PROTEIN; VIVO; REPAIR; MSCS; MICROCIRCULATION	Background: There have been conflicting observations regarding the receptors utilized by human multipotent mesenchymal bone marrow stromal cells (hMSC) to adhere to endothelial cells (EC). To address the discrepancies, we performed experiments with cells prepared with a standardized, low-density protocol preserving a sub-population of small cells that are rapidly self-renewing. Methods: Sialyl Lewis X (SLeX) and alpha 4 integrin expression were determined by flow cytometry. Fucosyltransferase expression was determined by quantitative realtime RT-PCR. Cell adhesion assays were carried out with a panel of endothelial cells from arteries, veins and the microvasculature in vitro. In vivo experiments were performed to determine single cell interactions in the chick embryo chorioallantoic membrane (CAM). The CAM is a well-characterized respiratory organ allowing for time-lapse image acquisition of large numbers of cells treated with blocking antibodies against adhesion molecules expressed on hMSC. Results: hMSC expressed alpha 4 integrin, SLeX and fucosyltransferase 4 and adhered to human EC from arteries, veins and the microvasculature under static conditions in vitro. In vivo, hMSC rolled on and adhered to arterioles in the chick embryo CAM, whereas control melanoma cells embolized. Inhibition of alpha 4 integrin and/or SLeX with blocking antibodies reduced rolling and adhesion in arterioles and increased embolism of hMSC. Conclusions: The results demonstrated that rapidly self-renewing hMSC were retained in the CAM because they rolled on and adhered to respiratory arteriolar EC in an alpha 4 integrin- and SLeX-dependent manner. It is therefore important to select cells based on their cell adhesion receptor profile as well as size depending on the intended target of the cell and the injection route.	[McFerrin, Harris E.] Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA; [Olson, Scott D.] Univ Texas Med Sch Houston, Program Regenerat Med, Houston, TX USA; [Gutschow, Miriam V.] Stanford Univ, Stanford Dept Bioengn, Stanford, CA 94305 USA; [McFerrin, Harris E.; Semon, Julie A.; Sullivan, Deborah E.] Tulane Univ, Sch Med, Ctr Stem Cell Res & Regenerat Med, New Orleans, LA 70112 USA; [McFerrin, Harris E.; Sullivan, Deborah E.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Prockop, Darwin J.] Scott & White Mem Hosp & Clin, Coll Med, Inst Regenerat Med, Texas A&M Hlth Sci Ctr, Temple, TX USA	Xavier University of Louisiana; University of Texas System; University of Texas Health Science Center Houston; Stanford University; Tulane University; Tulane University; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	McFerrin, HE (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA.	hmcferri@xula.edu		Olson, Scott/0000-0001-8032-3755	National Center for Research Resources [P20RR016456]; National Institute of General Medical Sciences [P20GM103424]; Louisiana Cancer Research Consortium; NIH-RCMI from the National Institute on Minority Health and Health Disparities [5G12RR026260]; National Institutes of Health [P40 RR 17447]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456, G12RR026260, P40RR017447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011050] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Louisiana Cancer Research Consortium; NIH-RCMI from the National Institute on Minority Health and Health Disparities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grants from the National Center for Research Resources (P20RR016456), the National Institute of General Medical Sciences (P20GM103424), Louisiana Cancer Research Consortium and the NIH-RCMI grant #5G12RR026260 from the National Institute on Minority Health and Health Disparities (HEM) and P40 RR 17447 from the National Institutes of Health (DJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, CIRC RES, V95, P671, DOI 10.1161/01.RES.0000143421.27684.12; Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Bobek V, 2004, CLIN EXP METASTAS, V21, P347, DOI 10.1023/B:CLIN.0000046138.58210.31; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; CHAMBERS A F, 1990, In Vivo (Attiki), V4, P215; CHAMBERS AF, 1984, CANCER RES, V44, P3970; CHAMBERS AF, 1982, CANCER RES, V42, P4018; Chambers AF, 1998, CANCER METAST REV, V17, P263, DOI 10.1023/A:1006136428254; Chambers AF, 2000, BREAST CANCER RES, V2, P400, DOI 10.1186/bcr86; Chou SH, 2006, J ORTHOP RES, V24, P301, DOI 10.1002/jor.20047; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Dani Sergio U., 2002, Genetics and Molecular Research, V1, P167; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fu XM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-175; Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101; Gibbins JM, 2004, PLATELETS MEGAKARYOC; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Greenberg AW, 2000, BLOOD, V95, P478, DOI 10.1182/blood.V95.2.478; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Kerkela E, 2013, STEM CELL TRANSL MED, V2, P510, DOI 10.5966/sctm.2012-0187; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; KOOP S, 1995, CANCER RES, V55, P2520; Koop S, 1996, P NATL ACAD SCI USA, V93, P11080, DOI 10.1073/pnas.93.20.11080; Lee RH, 2006, BLOOD, V107, P2153, DOI 10.1182/blood-2005-07-2701; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; MACDONALD IC, 1992, MICROVASC RES, V44, P185, DOI 10.1016/0026-2862(92)90079-5; MASTELLER EL, 1995, J IMMUNOL, V155, P5550; McIntyre BAS, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-21; Nystedt J, 2013, STEM CELLS, V31, P317, DOI 10.1002/stem.1271; Oskowitz A, 2011, STEM CELL RES, V6, P215, DOI 10.1016/j.scr.2011.01.004; Park HR, 1996, CANCER LETT, V106, P227, DOI 10.1016/0304-3835(96)04330-3; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Roth JM, 2006, AM J PATHOL, V168, P1576, DOI 10.2353/ajpath.2006.050176; Ruster B, 2006, BLOOD; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; Sackstein R, 2006, NATURE; Sarkar D, 2011, BLOOD, V118, pE184, DOI 10.1182/blood-2010-10-311464; Sarkar D, 2011, METHODS MOL BIOL, V698, P505, DOI 10.1007/978-1-60761-999-4_35; Schlosser S, 2012, MICROVASC RES, V83, P267, DOI 10.1016/j.mvr.2012.02.011; SCHRAUFNAGEL DE, 1987, SCANNING MICROSCOPY, V1, P1733; Schueller M, 2005, ENTWICKLUNG GEEIGNET; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Semon JA, 2010, CELL TISSUE RES, V341, P147, DOI 10.1007/s00441-010-0994-4; Shi RZ, 2008, BIOCHEM BIOPH RES CO, V376, P247, DOI 10.1016/j.bbrc.2008.09.004; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; STEPP MA, 1994, CELL ADHES COMMUN, V2, P359, DOI 10.3109/15419069409014210; vanGolde J, 1996, PEDIATR RES, V40, P867, DOI 10.1203/00006450-199612000-00016; Von Luttichau I, 2005, STEM CELLS DEV, V14, P329, DOI 10.1089/scd.2005.14.329; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; YABLONKAREUVENI Z, 1989, DEV BIOL, V132, P230, DOI 10.1016/0012-1606(89)90219-4; Zijlstra A, 2002, CANCER RES, V62, P7083	59	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105411	10.1371/journal.pone.0105411	http://dx.doi.org/10.1371/journal.pone.0105411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144321	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100063
J	Pujades-Rodriguez, M; Timmis, A; Stogiannis, D; Rapsomaniki, E; Denaxas, S; Shah, A; Feder, G; Kivimaki, M; Hemingway, H				Pujades-Rodriguez, Mar; Timmis, Adam; Stogiannis, Dimitris; Rapsomaniki, Eleni; Denaxas, Spiros; Shah, Anoop; Feder, Gene; Kivimaki, Mika; Hemingway, Harry			Socioeconomic Deprivation and the Incidence of 12 Cardiovascular Diseases in 1.9 Million Women and Men: Implications for Risk Prediction and Prevention	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENERAL-PRACTICE; MYOCARDIAL-INFARCTION; OUTCOMES FRAMEWORK; MORTALITY; HEALTH; NEIGHBORHOOD; INEQUALITIES; METAANALYSIS; FAILURE	Background: Recent experimental evidence suggests that socioeconomic characteristics of neighbourhoods influence cardiovascular health, but observational studies which examine deprivation across a wide range of cardiovascular diseases (CVDs) are lacking. Methods: Record-linkage cohort study of 1.93 million people to examine the association between small-area socioeconomic deprivation and 12 CVDs. Health records covered primary care, hospital admissions, a myocardial infarction registry and cause-specific mortality in England (CALIBER). Patients were aged >= 30 years and were initially free of CVD. Cox proportional hazard models stratified by general practice were used. Findings: During a median follow-up of 5.5 years 114,859 people had one of 12 initial CVD presentations. In women the hazards of all CVDs except abdominal aortic aneurysm increased linearly with higher small-area socioeconomic deprivation (adjusted HR for most vs. least deprived ranged from 1.05, 95%CI 0.83-1.32 for abdominal aortic aneurysm to 1.55, 95%CI 1.42-1.70 for heart failure; I-2 = 81.9%, tau(2) = 0.01). In men heterogeneity was higher (HR ranged from 0.89, 95%CI 0.75-1.06 for cardiac arrest to 1.85, 95%CI 1.67-2.04 for peripheral arterial disease; I-2 = 96.0%, tau(2) = 0.06) and no association was observed with stable angina, sudden cardiac death, subarachnoid haemorrhage, transient ischaemic attack and abdominal aortic aneurysm. Lifetime risk difference between least and most deprived quintiles was most marked for peripheral arterial disease in women (4.3% least deprived, 5.8% most deprived) and men (4.6% least deprived, 7.8% in most deprived); but it was small or negligible for sudden cardiac death, transient ischaemic attack, abdominal aortic aneurysm and ischaemic and intracerebral haemorrhage, in both women and men. Conclusions: Associations of small-area socioeconomic deprivation with 12 types of CVDs were heterogeneous, and in men absent for several diseases. Findings suggest that policies to reduce deprivation may impact more strongly on heart failure and peripheral arterial disease, and might be more effective in women.	[Pujades-Rodriguez, Mar; Stogiannis, Dimitris; Rapsomaniki, Eleni; Denaxas, Spiros; Shah, Anoop; Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, London, England; [Pujades-Rodriguez, Mar; Stogiannis, Dimitris; Rapsomaniki, Eleni; Denaxas, Spiros; Shah, Anoop; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, London, England; [Timmis, Adam] Barts & London Queen Marys Sch Med & Dent, Natl Inst Hlth Res, Biomed Res Unit, London, England; [Feder, Gene] Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England; [Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London; University of London; University College London; University of London; Queen Mary University London; University of Bristol; University of London; University College London	Pujades-Rodriguez, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	mar.pujades@ucl.ac.uk	Pujades-Rodriguez, Mar/T-1129-2018; Shah, Anoop Dinesh/D-4396-2014; Kivimaki, Mika/B-3607-2012; Hemingway, Harry/C-1219-2009	Pujades-Rodriguez, Mar/0000-0002-1375-1028; Shah, Anoop Dinesh/0000-0002-8907-5724; Kivimaki, Mika/0000-0002-4699-5627; Feder, Gene/0000-0002-7890-3926; Denaxas, Spiros/0000-0001-9612-7791; Hemingway, Harry/0000-0003-2279-0624	Welcome Trust [WT 086091/Z/08/Z]; United Kingdom National Institute for Health Research [RP-PG-0407-10314]; Farr Institute ofHealth Informatics Research at UCL Partners from the Medical Research Council [MR/K006584/1]; Arthritis Research United Kingdom; British Heart Foundation; Cancer Research United Kingdom; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust; Wellcome Trust Clinical Research Training Fellowship [0938/30/Z/10/Z]; Barts and the London Cardiovascular Biomedical Research Unit - National Institute for Health Research; MRC [K013351]; National Institute on Aging, National Institutes of Health; professorial fellowship from the ESRC; ESRC [ES/J023299/1, ES/L007517/1] Funding Source: UKRI; MRC [G0902393, MR/K013351/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1, ES/L007517/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1, G0902393, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10314] Funding Source: researchfish	Welcome Trust(Wellcome Trust); United Kingdom National Institute for Health Research(National Institute for Health Research (NIHR)); Farr Institute ofHealth Informatics Research at UCL Partners from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research United Kingdom(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research United Kingdom(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Clinical Research Training Fellowship(Wellcome Trust); Barts and the London Cardiovascular Biomedical Research Unit - National Institute for Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); professorial fellowship from the ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by grants from the Welcome Trust [WT 086091/Z/08/Z], the United Kingdom National Institute for Health Research (RP-PG-0407-10314), and by awards establishing the Farr Institute ofHealth Informatics Research at UCL Partners from the Medical Research Council (MR/K006584/1), in partnership with Arthritis Research United Kingdom, the British Heart Foundation, Cancer Research United Kingdom, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientific Office (Scottish Government Health Directorates), and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AS is supported by a Wellcome Trust Clinical Research Training Fellowship [0938/30/Z/10/Z], and AT by Barts and the London Cardiovascular Biomedical Research Unit funded by the National Institute for Health Research. MK is supported by the MRC (K013351), the National Institute on Aging, National Institutes of Health and a professorial fellowship from the ESRC. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR PHR P Programme or the Department of Health.	Albert MA, 2006, CIRCULATION, V114, P2619, DOI 10.1161/CIRCULATIONAHA.106.660043; Asaria P, 2012, INT J EPIDEMIOL, V41, P1737, DOI 10.1093/ije/dys151; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Badger SA, 2008, ANGIOLOGY, V59, P559, DOI 10.1177/0003319708321586; Bhattarai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029776; Boeckxstaens P, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-209; Breeze E, 2005, INT J EPIDEMIOL, V34, P276, DOI 10.1093/ije/dyh328; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Dixon A, 2012, EUR J PUBLIC HEALTH, V22, P9, DOI 10.1093/eurpub/ckq177; Dupre ME, 2012, ARCH INTERN MED, V172, P1731, DOI 10.1001/2013.jamainternmed.447; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Force SET, 2010, IMPR WAY WE MEET PRI; Ford I, 1995, J CLIN EPIDEMIOL, V48, P1441; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; Hemingway H, 2006, JAMA-J AM MED ASSOC, V295, P1404, DOI 10.1001/jama.295.12.1404; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kroger K, 2009, VASC MED, V14, P289, DOI 10.1177/1358863X09102294; Ludwig J, 2012, SCIENCE, V337, P1505, DOI 10.1126/science.1224648; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Major JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015538; McLennan D., 2011, ENGLISH INDICES DEPR; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; Noble M, 2008, ENGLISH INDICES DEPR; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; O'Flaherty M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2613; Pearson AL, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-38; Pearson-Stuttard J, 2012, HEART, V98, P1573, DOI 10.1136/heartjnl-2012-302435; Ramsay SE, 2013, EUR HEART J; Rapsomaniki E, 2014, LANCET; Reinier K, 2006, RESUSCITATION, V70, P186, DOI 10.1016/j.resuscitation.2005.11.018; Roberts CB, 2010, AM J EPIDEMIOL, V172, P717, DOI 10.1093/aje/kwq193; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Roux AVD, 2001, ANN EPIDEMIOL, V11, P395, DOI 10.1016/S1047-2797(01)00221-6; Salomaa V, 2000, CIRCULATION, V101, P1913, DOI 10.1161/01.CIR.101.16.1913; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; Stewart S, 2006, EUR J HEART FAIL, V8, P856, DOI 10.1016/j.ejheart.2006.02.008; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Thompson SG, 1997, STAT MED, V16, P2063, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2063::AID-SIM642>3.0.CO;2-8; Tunstall-Pedoe H, 2006, HEART, V92, P307, DOI 10.1136/hrt.2005.077289; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	52	83	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104671	10.1371/journal.pone.0104671	http://dx.doi.org/10.1371/journal.pone.0104671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144739	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100019
J	Qu, LN; Cui, HG; Wu, GW; Zhou, JF; Su, JM; Wang, GP; Hong, N				Qu, Linning; Cui, Hongguang; Wu, Guanwei; Zhou, Jufang; Su, Jiaming; Wang, Guoping; Hong, Ni			Genetic Diversity and Molecular Evolution of Plum bark necrosis stem pitting-associated virus from China	PLOS ONE			English	Article							APRICOT-LATENT-VIRUS; STONE FRUIT-TREES; 1ST REPORT; RECOMBINATION EVENTS; CHERRY; INSIGHTS; SWEET; PCR	Plum bark necrosis stem pitting-associated virus (PBNSPaV), a member of the genus Ampelovirus in the family Closteroviridae, infects different Prunus species and has a worldwide distribution. Yet the population structure and genetic diversity of the virus is still unclear. In this study, sequence analyses of a partial heat shock protein 70 homolog (HSP70h) gene and coat protein (CP) gene of PBNSPaV isolates from seven Prunus species grown in China revealed a highly divergent Chinese PBNSPaV population, sharing nucleotide similarities of 73.1-100% with HSP70h gene, and 83.9-98.6% with CP gene. Phylogenetic analysis of HSP70h and CP sequences revealed segregation of global PBNSPaV isolates into four phylo-groups (I-IV), of which two newly identified groups, II and IV, solely comprised Chinese isolates. Complete genome sequences of three PBNSPaV isolates, Pch-WH-1 and Pch-GS-3 from peaches, and Plm-WH-3 from a plum tree, were determined. The three isolates showed overall nucleotide identities of 90.0% (Pch-GS-3) and 96.4% (Pch-WH-1) with the type isolate PL186, and the lowest identity of 70.2-71.2% with isolate Nanjing. For the first time, to the best of our knowledge, we report evidence of significant recombination in the HSP70h gene of PBNSPaV variant Pch2 by using five programs implemented in RDP3; in addition, five codon positions in its CP gene (3, 8, 44, 57, and 88) were identified that appeared to be under positive selection. Collectively, these results indicate a divergent Chinese PBNSPaV population. In addition, our findings provide a foundation for elucidating the epidemiological characteristics of virus population.	[Qu, Linning; Cui, Hongguang; Wu, Guanwei; Zhou, Jufang; Wang, Guoping; Hong, Ni] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Qu, Linning; Wang, Guoping; Hong, Ni] Huazhong Agr Univ, Natl Key Lab Agromicrobiol, Wuhan, Hubei, Peoples R China; [Su, Jiaming] Yantai Acad Agr Sci, Yantai Agr Sci & Technol Inst, Yantai, Shandong, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Wang, GP (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	gpwang@mail.hzau.edu.cn; whni@mail.hzau.edu.cn			 [nyhyzx-201203076-03];  [nyhyzx-200903004]	; 	This work was financially supported by the agricultural projects (nyhyzx-201203076-03 and nyhyzx-200903004) administered by the Chinese Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Leal R, 2011, PHYTOPATHOLOGY, V101, P1136, DOI 10.1094/PHYTO-01-11-0017; AGRIOS GN, 1971, PLANT DIS REP, V55, P1049; Al Rwahnih M, 2007, ARCH VIROL, V152, P2197, DOI 10.1007/s00705-007-1064-4; Amenduni T, 2005, J PLANT PATHOL, V87, P131; Boscia D, 2010, VIRUS VIRUS LIKE DIS, P177; Bouani A, 2004, J PLANT PATHOL, V86, P91; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; Cui HG, 2011, PLANT DIS, V95, P1483, DOI 10.1094/PDIS-07-11-0548; DiTerlizzi B, 1995, ACTA HORTIC, P115, DOI 10.17660/ActaHortic.1995.386.12; El Maghraby I, 2006, J PLANT PATHOL, V88, pS69; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Elena SF, 2011, MOL PLANT MICROBE IN, V24, P287, DOI 10.1094/MPMI-09-10-0214; English H, 1996, PHYTOPATHOLOGY, V86, P804; Farooq AU, 2013, VIRUS RES, V171, P15, DOI 10.1016/j.virusres.2012.10.014; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Garcia-Ibarra A, 2010, PLANT DIS, V94, P275, DOI 10.1094/PDIS-94-2-0275A; Ghanem-Sabanadzovic N. Abou, 2001, Journal of Plant Pathology, V83, P125; Hadidi A, 2012, VIRUS VIRUS LIKE DIS, P1; Karasev AV, 2000, ANNU REV PHYTOPATHOL, V38, P293, DOI 10.1146/annurev.phyto.38.1.293; Li R, 2008, J VIROL METHODS, V154, P48, DOI 10.1016/j.jviromet.2008.09.008; LOTT T. B., 1962, Canadian Plant Disease Survey, V42, P229; Mandic B, 2007, J PLANT PATHOL, V89, P103; Mandic B, 2005, J PLANT PATHOL, V87, P246; Marais A., 2014, PHYTOPATHOLOGY; Marini DB, 2002, PLANT DIS, V86, P415, DOI 10.1094/PDIS.2002.86.4.415; Martelli GP., 2012, VIRUS TAXONOMY, P987, DOI DOI 10.1016/B978-0-12-384684-6.00085-9; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Matic S, 2010, J PLANT PATHOL, V92, P759; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; MIRCETICH SM, 1977, PLANT DIS REP, V61, P931; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rubio L, 2001, J VIROL, V75, P8054, DOI 10.1128/JVI.75.17.8054-8062.2001; Sanchez-Navarro JA, 2005, EUR J PLANT PATHOL, V111, P77, DOI 10.1007/s10658-004-1422-y; SIMON AE, 1994, ANNU REV PHYTOPATHOL, V32, P337, DOI 10.1146/annurev.py.32.090194.002005; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; STOUFFER R F, 1969, Plant Disease Reporter, V53, P434; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Usta M., 2007, Bulletin OEPP, V37, P181, DOI 10.1111/j.1365-2338.2007.01058.x; UYEMOTO JK, 1995, PLANT DIS, V79, P366, DOI 10.1094/PD-79-0366; Vives MC, 2005, VIROLOGY, V331, P232, DOI 10.1016/j.virol.2004.10.037; Weng ZM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000917; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; ZHANG JY, 1994, J VIROL, V68, P2409, DOI 10.1128/JVI.68.4.2409-2414.1994; Zhang YP, 1998, PLANT DIS, V82, P871, DOI 10.1094/PDIS.1998.82.8.871	45	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105443	10.1371/journal.pone.0105443	http://dx.doi.org/10.1371/journal.pone.0105443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144238	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100072
J	Wang, F; Wang, YY; Li, J; You, X; Qiu, XH; Wang, YN; Gao, FG				Wang, Fang; Wang, Yan Yan; Li, Juan; You, Xiang; Qiu, Xin Hui; Wang, Yi Nan; Gao, Feng Guang			Increased Antigen Presentation but Impaired T Cells Priming after Upregulation of Interferon-Beta Induced by Lipopolysaccharides Is Mediated by Upregulation of B7H1 and GITRL	PLOS ONE			English	Article							DENDRITIC CELLS; I INTERFERON; ENDOTOXIN TOLERANCE; ADAPTIVE IMMUNITY; EXPRESSION; NICOTINE; FAMILY; LUNG; ACTIVATION; INFECTION	Dendritic cells are able to present Ag-derived peptides on MHC class I and II molecules and induce T cells priming. Lipopolysaccharides (LPS), an activator of Toll-like 4 receptor (TLR4) signaling, has been demonstrated to facilitate Ag-presentation, up-regulate surface molecules expression but impair T cells priming. In this study, we investigated the effect of LPS on nicotine-enhanced DCs-dependent T cells priming and the mechanisms of LPS orchestrating the immunosuppressive program. We could demonstrate that the treatment with LPS resulted in increased surface molecules expression, enhanced Ag-presentation, up-regulated release of TGF-beta, TNF-alpha, IL-6, and IFN-beta. Concomititantly, the upregulation of IFN-beta in DCs induces the up-regulation of coinhibitory molecules B7H1 and GITRL, which cause an impaired activation of naive Ag-specific T cells and the induction of T cell tolerance by enhancing B7H1-PD-1 interactions and promoting GITRL-GITL facilitated Treg generation, respectively. These data provide a mechanistic basis for the immunomodulatory action of IFN-beta which might open new possibilities in the development of therapeutic approaches aimed at the control of excessive immune response and persistent infection.	[Wang, Fang; Wang, Yan Yan; Li, Juan; You, Xiang; Qiu, Xin Hui; Wang, Yi Nan; Gao, Feng Guang] Xiamen Univ, Coll Med, Dept Immunol, Xiamen, Peoples R China; [Wang, Fang] NanYang Med Coll, Dept Basic Med Sci, Nanyang, Peoples R China	Xiamen University; Nanyang Medical College	Gao, FG (corresponding author), Xiamen Univ, Coll Med, Dept Immunol, Xiamen, Peoples R China.	gfengguang@xmu.edu.cn	Wang, Yanbo/HFZ-8018-2022; wang, yan/GSE-6489-2022		State Key Laboratory of Oncogenes and Related Genes [90-14-05]; National Natural Science Foundation of China [81273203]	State Key Laboratory of Oncogenes and Related Genes; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the State Key Laboratory of Oncogenes and Related Genes (No. 90-14-05) and by grants from the National Natural Science Foundation of China (No. 81273203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D; Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; [Anonymous], 2011, CANCER-AM CANCER SOC, V117, P2357, DOI 10.1002/cncr.26212; Axtell RC, 2013, CLIN REV ALLERG IMMU, V44, P114, DOI 10.1007/s12016-011-8296-5; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen MY, 2012, J NEUROIMMUNOL, V242, P39, DOI 10.1016/j.jneuroim.2011.10.014; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Gao FG, 2007, CLIN CANCER RES, V13, P3706, DOI 10.1158/1078-0432.CCR-07-0028; Gao FG, 2011, J CLIN IMMUNOL, V31, P80, DOI 10.1007/s10875-010-9459-5; Geisel J, 2007, J IMMUNOL, V179, P5811, DOI 10.4049/jimmunol.179.9.5811; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Guo LL, 2012, BBA-MOL BASIS DIS, V1822, P852, DOI 10.1016/j.bbadis.2012.02.004; Hahm B, 2005, IMMUNITY, V22, P247, DOI 10.1016/j.immuni.2005.01.005; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hu SX, 2012, MOL MED REP, V5, P1005, DOI 10.3892/mmr.2012.751; Jin HJ, 2013, J CLIN IMMUNOL, V33, P246, DOI 10.1007/s10875-012-9761-5; Klotz L, 2009, J IMMUNOL, V183, P129, DOI 10.4049/jimmunol.0804260; Kole A, 2013, J IMMUNOL, V191, P2771, DOI 10.4049/jimmunol.1301093; Krausz LT, 2007, THESCIENTIFICWORLDJO, V7, P533, DOI 10.1100/tsw.2007.106; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604, 10.1371/journal.pone.0083037]; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Ni XY, 2012, ONCOL REP, V28, P615, DOI 10.3892/or.2012.1822; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Pauls E, 2012, J BIOL CHEM, V287, P19216, DOI 10.1074/jbc.M112.345405; Schaer DA, 2013, CANCER IMMUNOL RES, V1, P320, DOI 10.1158/2326-6066.CIR-13-0086; Schaer DA, 2012, CURR OPIN IMMUNOL, V24, P217, DOI 10.1016/j.coi.2011.12.011; Schwandt T, 2012, EMBO J, V31, P201, DOI 10.1038/emboj.2011.380; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Siegfried A, 2013, J IMMUNOL, V191, P3913, DOI 10.4049/jimmunol.1203305; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Tournier JM, 2011, CURR OPIN ONCOL, V23, P83, DOI 10.1097/CCO.0b013e3283412ea1; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; van Olffen RW, 2009, J IMMUNOL, V182, P7490, DOI 10.4049/jimmunol.0802751; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Zaric SS, 2011, J BIOL CHEM, V286, P29492, DOI 10.1074/jbc.M111.252791; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	47	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105636	10.1371/journal.pone.0105636	http://dx.doi.org/10.1371/journal.pone.0105636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144375	Green Published, gold			2022-12-25	WOS:000341106100104
J	Bansode, SB; Jana, AK; Batkulwar, KB; Warkad, SD; Joshi, RS; Sengupta, N; Kulkarni, MJ				Bansode, Sneha B.; Jana, Asis K.; Batkulwar, Kedar B.; Warkad, Shrikant D.; Joshi, Rakesh S.; Sengupta, Neelanjana; Kulkarni, Mahesh J.			Molecular Investigations of Protriptyline as a Multi-Target Directed Ligand in Alzheimer's Disease	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; AMYLOID-BETA-PROTEIN; DYNAMICS SIMULATIONS; CHOLINERGIC HYPOTHESIS; INHIBITORS; AGGREGATION; DOCKING; MECHANISMS; PROGRESS; ACCURACY	Alzheimer's disease (AD) is a complex neurodegenerative disorder involving multiple cellular and molecular processes. The discovery of drug molecules capable of targeting multiple factors involved in AD pathogenesis would greatly facilitate in improving therapeutic strategies. The repositioning of existing non-toxic drugs could dramatically reduce the time and costs involved in developmental and clinical trial stages. In this study, preliminary screening of 140 FDA approved nervous system drugs by docking suggested the viability of the tricyclic group of antidepressants against three major AD targets, viz. Acetylcholinesterase (AChE), beta-secretase (BACE-1), and amyloid beta (A beta) aggregation, with one member, protriptyline, showing highest inhibitory activity. Detailed biophysical assays, together with isothermal calorimetry, fluorescence quenching experiments, kinetic studies and atomic force microscopy established the strong inhibitory activity of protriptyline against all three major targets. The molecular basis of inhibition was supported with comprehensive molecular dynamics simulations. Further, the drug inhibited glycation induced amyloid aggregation, another important causal factor in AD progression. This study has led to the discovery of protriptyline as a potent multi target directed ligand and established its viability as a promising candidate for AD treatment.	[Bansode, Sneha B.; Batkulwar, Kedar B.; Warkad, Shrikant D.; Joshi, Rakesh S.; Kulkarni, Mahesh J.] CSIR Natl Chem Lab, Div Biochem Sci, Prote Facil, Pune, Maharashtra, India; [Jana, Asis K.; Sengupta, Neelanjana] CSIR Natl Chem Lab, Div Phys Chem, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Sengupta, N (corresponding author), CSIR Natl Chem Lab, Div Phys Chem, Pune, Maharashtra, India.	n.sengupta@ncl.res.in; mj.kulkarni@ncl.res.in	Bansode, Sneha/AGJ-7133-2022; Kulkarni, Mahesh J/G-1473-2010	Warkad, Shrikant/0000-0002-9683-6018; Batkulwar, Kedar/0000-0002-4115-7958; Joshi, Rakesh S./0000-0001-8016-1178	CSIR Network project [BSC0115]	CSIR Network project(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by CSIR Network project, BSC0115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboukhatwa M, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-10; Alzheimer's Association, FDA APPR TREATM ALZH; Anand P, 2013, ARCH PHARM RES, V36, P375, DOI 10.1007/s12272-013-0036-3; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Cappelli A, 2005, J MED CHEM, V48, P3564, DOI 10.1021/jm0493461; Caulfield T, 2011, J STRUCT BIOL, V176, P185, DOI 10.1016/j.jsb.2011.07.015; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Citron M, 2002, J NEUROSCI RES, V70, P373, DOI 10.1002/jnr.10393; COPELAND RA, 1995, BIOORG MED CHEM LETT, V5, P1947, DOI 10.1016/0960-894X(95)00330-V; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gotz J, 2012, BRIT J PHARMACOL, V165, P1246, DOI 10.1111/j.1476-5381.2011.01713.x; Golde TE, 2006, J NEUROCHEM, V99, P689, DOI 10.1111/j.1471-4159.2006.04211.x; Gulyaeva N, 2003, EUR J MED CHEM, V38, P391, DOI 10.1016/S0223-5234(03)00044-8; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hill EH, 2012, LANGMUIR, V28, P14849, DOI 10.1021/la303158c; Hills ID, 2007, CURR OPIN DRUG DISC, V10, P383; Hussain I, 2004, IDRUGS, V7, P653; Jana AK, 2012, BIOPHYS J, V102, P1889, DOI 10.1016/j.bpj.2012.03.036; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Lee C, 2011, J COMPUT CHEM, V32, P349, DOI 10.1002/jcc.21628; Lee S, 2014, J AM CHEM SOC, V136, P299, DOI 10.1021/ja409801p; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018; Li XH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.180; Mabanglo MF, 2012, BIOCHEMISTRY-US, V51, P917, DOI 10.1021/bi201662k; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Santini S, 2004, STRUCTURE, V12, P1245, DOI 10.1016/j.str.2004.04.018; Schenk D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006387; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Small David H, 2005, Expert Opin Emerg Drugs, V10, P817, DOI 10.1517/14728214.10.4.817; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Tai K, 2002, J AM CHEM SOC, V124, P6153, DOI 10.1021/ja017310h; Tamhane VA, 2005, BBA-GEN SUBJECTS, V1722, P156, DOI 10.1016/j.bbagen.2004.12.017; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Velazquez-Campoy A, 2005, BIOPHYS CHEM, V115, P115, DOI 10.1016/j.bpc.2004.12.015; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Youdim MBH, 2005, TRENDS PHARMACOL SCI, V26, P27, DOI 10.1016/j.tips.2004.11.007; Zhang C, 2012, DISCOV MED, V14, P189; Zhang HY, 2005, FEBS LETT, V579, P5260, DOI 10.1016/j.febslet.2005.09.006; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	56	27	28	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105196	10.1371/journal.pone.0105196	http://dx.doi.org/10.1371/journal.pone.0105196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141174	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200060
J	Emslie, MJ; Cheal, AJ; Johns, KA				Emslie, Michael J.; Cheal, Alistair J.; Johns, Kerryn A.			Retention of Habitat Complexity Minimizes Disassembly of Reef Fish Communities following Disturbance: A Large-Scale Natural Experiment	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; PHASE-SHIFTS; STRUCTURAL COMPLEXITY; HERBIVOROUS FISHES; SPECIES RICHNESS; IRIOMOTE ISLAND; LIVE CORAL; RESILIENCE; BIODIVERSITY	High biodiversity ecosystems are commonly associated with complex habitats. Coral reefs are highly diverse ecosystems, but are under increasing pressure from numerous stressors, many of which reduce live coral cover and habitat complexity with concomitant effects on other organisms such as reef fishes. While previous studies have highlighted the importance of habitat complexity in structuring reef fish communities, they employed gradient or meta-analyses which lacked a controlled experimental design over broad spatial scales to explicitly separate the influence of live coral cover from overall habitat complexity. Here a natural experiment using a long term (20 year), spatially extensive (similar to 115,000 kms(2)) dataset from the Great Barrier Reef revealed the fundamental importance of overall habitat complexity for reef fishes. Reductions of both live coral cover and habitat complexity had substantial impacts on fish communities compared to relatively minor impacts after major reductions in coral cover but not habitat complexity. Where habitat complexity was substantially reduced, species abundances broadly declined and a far greater number of fish species were locally extirpated, including economically important fishes. This resulted in decreased species richness and a loss of diversity within functional groups. Our results suggest that the retention of habitat complexity following disturbances can ameliorate the impacts of coral declines on reef fishes, so preserving their capacity to perform important functional roles essential to reef resilience. These results add to a growing body of evidence about the importance of habitat complexity for reef fishes, and represent the first large-scale examination of this question on the Great Barrier Reef.	[Emslie, Michael J.; Cheal, Alistair J.; Johns, Kerryn A.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Emslie, MJ (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	m.emslie@aims.gov.au			Australian Institute of Marine Science; Australian Government's Marine and Tropical Sciences Research Facility; Australian Government's National Environment Research Program (Tropical Ecosystems Hub)	Australian Institute of Marine Science; Australian Government's Marine and Tropical Sciences Research Facility(Australian Government); Australian Government's National Environment Research Program (Tropical Ecosystems Hub)(Australian Government)	The study was supported by Australian Institute of Marine Science and the Australian Government's Marine and Tropical Sciences Research Facility and National Environment Research Program (Tropical Ecosystems Hub). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEVIZON WS, 1989, B MAR SCI, V44, P646; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Burt JA, 2013, MAR POLLUT BULL, V72, P342, DOI 10.1016/j.marpolbul.2012.10.019; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Cheal AJ, 2008, MAR ECOL PROG SER, V372, P211, DOI 10.3354/meps07708; Coker DJ, 2012, CORAL REEFS, V31, P919, DOI 10.1007/s00338-012-0920-1; Cole AJ, 2009, CORAL REEFS, V28, P965, DOI 10.1007/s00338-009-0519-3; Cole AJ, 2012, FUNCT ECOL, V26, P307, DOI 10.1111/j.1365-2435.2011.01935.x; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Emslie MJ, 2011, CORAL REEFS, V30, P461, DOI 10.1007/s00338-011-0730-x; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Gelman A., 2007, DATA ANAL USING REGR; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2009, BIODIVERS CONSERV, V18, P3325, DOI 10.1007/s10531-009-9633-3; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Halford A. R., 1994, VISUAL CENSUS SURVEY; HECK KL, 1977, J BIOGEOGR, V4, P135, DOI 10.2307/3038158; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jonker M, 2013, SURVEYS BENTHIC REEF; Lewis AR, 1997, MAR ECOL PROG SER, V161, P37, DOI 10.3354/meps161037; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Mantyka CS, 2007, CORAL REEFS, V26, P435, DOI 10.1007/s00338-007-0214-1; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Noonan SHC, 2012, MAR ECOL PROG SER, V456, P127, DOI 10.3354/meps09687; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Pradella N, 2014, J FISH BIOL, V84, P247, DOI 10.1111/jfb.12274; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; R Core Team, 2021, R LANG ENV STAT COMP; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; RUSSELL BC, 1977, NEW ZEAL J MAR FRESH, V11, P23, DOI 10.1080/00288330.1977.9515659; SANO M, 1987, MAR ECOL PROG SER, V37, P191, DOI 10.3354/meps037191; Sano M, 2004, FISHERIES SCI, V70, P41, DOI 10.1111/j.1444-2906.2003.00768.x; Spies TA, 1998, NORTHWEST SCI, V72, P34; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Walker B. H., 1992, Conservation Biology, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; WELLINGTON GM, 1985, OECOLOGIA, V68, P15, DOI 10.1007/BF00379466; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2009, CORAL REEFS, V28, P3, DOI 10.1007/s00338-008-0431-2; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749; Zuur A.F, 2012, ZERO INFLATED MODELS	66	53	53	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105384	10.1371/journal.pone.0105384	http://dx.doi.org/10.1371/journal.pone.0105384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140801	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200083
J	Morimoto, K; Ozawa, T; Awazu, K; Ito, N; Honda, N; Matsumoto, S; Tsuruta, D				Morimoto, Kuniyuki; Ozawa, Toshiyuki; Awazu, Kunio; Ito, Nobuhisa; Honda, Norihiro; Matsumoto, Sohkichi; Tsuruta, Daisuke			Photodynamic Therapy Using Systemic Administration of 5-Aminolevulinic Acid and a 410-nm Wavelength Light-Emitting Diode for Methicillin-Resistant Staphylococcus aureus-Infected Ulcers in Mice	PLOS ONE			English	Article							ENDOGENOUS PROTOPORPHYRIN; MURINE MODEL; PHOTOSENSITIZER; INACTIVATION; EXPRESSION; EFFICACY	Bacterial resistance to antibiotics has become a worldwide problem. One potential alternative for bacterial control is photodynamic therapy. 5-aminolevulinic acid is a natural precursor of the photosensitizer protoporphyrin IX. Relatively little is known about the antibacterial efficacy of photodynamic therapy using the systemic administration of 5-aminolevulinic acid; a few reports have shown that 5-aminolevulinic acid exerts photodynamic effects on methicillin-resistant Staphylococcus aureus (MRSA) in vitro. In this study, we evaluated the effectiveness of photodynamic therapy using 5-aminolevulinic acid and a 410-nm wavelength light-emitting diode in vitro and in vivo for the treatment of MRSA. We found that 5-aminolevulinic acid photodynamic therapy with the light-emitting diode had an in-vitro bactericidal effect on MRSA. In vivo, protoporphyrin IX successfully accumulated in MRSA on ulcer surfaces after intraperitoneal administration of 5-aminolevulinic acid to mice. Furthermore, 5-aminolevulinic acid photodynamic therapy accelerated wound healing and decreased bacterial counts on ulcer surfaces; in contrast, vancomycin treatment did not accelerate wound healing. Our findings indicate that 5-aminolevulinic acid photodynamic therapy may be a new treatment option for MRSA-infected wounds.	[Morimoto, Kuniyuki; Ozawa, Toshiyuki; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan; [Awazu, Kunio; Ito, Nobuhisa; Honda, Norihiro] Osaka Univ, Grad Sch Engn, Med Beam Phys Lab, Osaka, Japan; [Matsumoto, Sohkichi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 558, Japan	Osaka Metropolitan University; Osaka University; Osaka Metropolitan University	Ozawa, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan.	ozawa@med.osaka-cu.ac.jp		Matsumoto, Sohkichi/0000-0002-6106-7538	MEXT KAKENHI [25861726]; Grants-in-Aid for Scientific Research [25861726] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT KAKENHI Grant Number 25861726 (http://www.jsps.go.jp/index1.html). KM received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERLIN NI, 1956, BIOCHEM J, V64, P80, DOI 10.1042/bj0640080; Bowler Philip G, 2003, Ostomy Wound Manage, V49, P44; CAIRNDUFF F, 1994, BRIT J CANCER, V69, P605, DOI 10.1038/bjc.1994.112; Dai TH, 2013, PHOTOMED LASER SURG, V31, P531, DOI 10.1089/pho.2012.3365; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Enwemeka CS, 2008, LASER SURG MED, V40, P734, DOI 10.1002/lsm.20724; Fotinos N, 2008, ANTIMICROB AGENTS CH, V52, P1366, DOI 10.1128/AAC.01372-07; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gollnick SO, 1997, CANCER RES, V57, P3904; GRANT WE, 1993, LANCET, V342, P147, DOI 10.1016/0140-6736(93)91347-O; Griffiths MA, 1997, J ANTIMICROB CHEMOTH, V40, P873, DOI 10.1093/jac/40.6.873; Guffey JS, 2006, PHOTOMED LASER SURG, V24, P684, DOI 10.1089/pho.2006.24.684; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Harris F, 2012, MED RES REV, V32, P1292, DOI 10.1002/med.20251; HENDERSON BW, 1992, PHOTOCHEM PHOTOBIOL, V55, P145, DOI 10.1111/j.1751-1097.1992.tb04222.x; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hongcharu W, 2000, J INVEST DERMATOL, V115, P183, DOI 10.1046/j.1523-1747.2000.00046.x; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; KENNEDY JC, 1992, J PHOTOCH PHOTOBIO B, V14, P275, DOI 10.1016/1011-1344(92)85108-7; KENNEDY JC, 1990, J PHOTOCH PHOTOBIO B, V6, P143, DOI 10.1016/1011-1344(90)85083-9; Kohl E, 2010, J EUR ACAD DERMATOL, V24, P1261, DOI 10.1111/j.1468-3083.2010.03625.x; Maclean M, 2008, J PHOTOCH PHOTOBIO B, V92, P180, DOI 10.1016/j.jphotobiol.2008.06.006; Maisch T, 2005, ANTIMICROB AGENTS CH, V49, P1542, DOI 10.1128/AAC.49.4.1542-1552.2005; Maisch T, 2007, LASER MED SCI, V22, P83, DOI 10.1007/s10103-006-0409-7; Maisch T, 2011, J DTSCH DERMATOL GES, V9, P360, DOI 10.1111/j.1610-0387.2010.07577.x; MANYAK MJ, 1988, J CLIN ONCOL, V6, P380, DOI 10.1200/JCO.1988.6.2.380; Morton CA, 2000, BRIT J DERMATOL, V143, P767, DOI 10.1046/j.1365-2133.2000.03773.x; Morton CA, 1998, ARCH DERMATOL, V134, P248, DOI 10.1001/archderm.134.2.248; Morton CA, 1996, BRIT J DERMATOL, V135, P766, DOI 10.1111/j.1365-2133.1996.tb03887.x; Ochsner M, 1997, J PHOTOCH PHOTOBIO B, V39, P1, DOI 10.1016/S1011-1344(96)07428-3; Ormrod D, 2000, Am J Clin Dermatol, V1, P133, DOI 10.2165/00128071-200001020-00009; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Perichon B, 2004, ANTIMICROB AGENTS CH, V48, P4281, DOI 10.1128/AAC.48.11.4281-4285.2004; Pollock B, 2004, BRIT J DERMATOL, V151, P616, DOI 10.1111/j.1365-2133.2004.06110.x; POTTIER RH, 1986, PHOTOCHEM PHOTOBIOL, V44, P679, DOI 10.1111/j.1751-1097.1986.tb04726.x; Reyes N, 2005, ANTIMICROB AGENTS CH, V49, P4344, DOI 10.1128/AAC.49.10.4344-4346.2005; Sieradzki K, 1999, NEW ENGL J MED, V340, P517, DOI 10.1056/NEJM199902183400704; Tanaka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039823; Tanaka M, 2011, LASER SURG MED, V43, P221, DOI 10.1002/lsm.21037; Tanaka M, 2010, PHOTOCHEM PHOTOBIOL, V86, P403, DOI 10.1111/j.1751-1097.2009.00658.x; Tang Hi M., 2007, Journal of Infection and Chemotherapy, V13, P87, DOI 10.1007/s10156-006-0501-8; Taub Amy Forman, 2004, J Drugs Dermatol, V3, pS10; Tubby S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-211; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; WILSON M, 1995, J MED MICROBIOL, V42, P62, DOI 10.1099/00222615-42-1-62; Yow CMN, 2012, PHOTOCHEM PHOTOBIOL, V88, P626, DOI 10.1111/j.1751-1097.2012.01085.x	47	48	52	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105173	10.1371/journal.pone.0105173	http://dx.doi.org/10.1371/journal.pone.0105173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140800	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200056
J	Wu, K; Liu, J; Zhuang, N; Wang, T				Wu, Kai; Liu, Jia; Zhuang, Na; Wang, Tao			UCP4A protects against mitochondrial dysfunction and degeneration in pink1/parkin models of Parkinson's disease	FASEB JOURNAL			English	Article						ROS; ETC; Drosophila	DOPAMINERGIC NEURON LOSS; UNCOUPLING PROTEIN-2; OXIDATIVE STRESS; DROSOPHILA-PINK1 MUTANTS; MUSCLE DEGENERATION; VCP MUTATIONS; PINK1; MECHANISMS; DEPOLARIZATION; MITOPHAGY	Genetic mutations in parkin or pink1 are the most common causes of familial Parkinson's disease. PINK1 and Parkin are components of a mitochondrial quality control pathway that degrades dysfunctional mitochondria via autophagy. Using a candidate gene approach, we discovered that overexpression of uncoupling protein 4A (ucp4A) suppresses a range of pink1 mutant phenotypes, including male sterility, locomotor defects, and muscle degeneration that result from abnormal mitochondrial morphology and function. Furthermore, UCP4A overexpression in pink1 mutants rescued mitochondria-specific phenotypes associated with mitochondrial membrane potential, production of reactive oxygen species, resistance to oxidative stress, efficiency of the electron transport chain, and mitochondrial morphology. Consistent with its role in protecting mitochondria, UCP4A rescued mitochondrial phenotypes of parkin mutant flies, as well. Finally, the genetic deletion of ucp4A resulted in increased sensitivity to oxidative stress, a phenotype that was enhanced by the loss of PINK1. Taken together, these results indicate that UCP4A prevents mitochondrial dysfunction and that modulation of UCP activity protects cells in a situation relevant for human Parkinson's disease.	[Wu, Kai; Liu, Jia; Zhuang, Na; Wang, Tao] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Liu, Jia] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Zhuang, Na] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	National Institute of Biological Sciences, Beijing; Beijing Normal University; Tsinghua University	Wang, T (corresponding author), Natl Inst Biol Sci, 7 Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	wangtao@nibs.ac.cn		Wang, Tao/0000-0002-2395-3483; Liu, Yasmine/0000-0002-6830-8023	973 grant from the Chinese Ministry of Science and Technology [2011CB812702]	973 grant from the Chinese Ministry of Science and Technology	The authors thank Y. Wang and Drs. J. Fang and Q. Bai for technical support and valuable comments. The authors thank the Bloomington Stock Center (Indiana University, Bloomington, IN, USA), Dr. Stephen Helfand (Brown University, Providence, RI, USA), Dr. Jongkyeong Chung (Seoul National University, Seoul, Korea), Dr. Leo J. Pallanck (University of Washington, Seattle, WA, USA), and Dr. Bingwei Lu (Stanford University School of Medicine, Stanford, CA, USA) for fly stocks. This work was supported by a 973 grant (2011CB812702) from the Chinese Ministry of Science and Technology (to T.W). The authors declare no conflicts of interest.	Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Chu ACY, 2009, FREE RADICAL BIO MED, V46, P810, DOI 10.1016/j.freeradbiomed.2008.12.015; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Collier TJ, 2011, NAT REV NEUROSCI, V12, P359, DOI 10.1038/nrn3039; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Esposito G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003478; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Grunewald A, 2014, ANTIOXID REDOX SIGN, V20, P1955, DOI 10.1089/ars.2013.5737; Hanak P, 2001, FEBS LETT, V495, P137, DOI 10.1016/S0014-5793(01)02338-9; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Ho JWM, 2012, FREE RADICAL BIO MED, V53, P383, DOI 10.1016/j.freeradbiomed.2012.05.002; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Islam R, 2012, NEUROBIOL DIS, V46, P137, DOI 10.1016/j.nbd.2011.12.055; Jaiswal M, 2012, ANNU REV GENET, V46, P371, DOI 10.1146/annurev-genet-110711-155456; Jin H., 2014, BIOCHIM BIOPHYS ACTA, V1842, P1282; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein P, 2014, EMBO J, V33, P341, DOI 10.1002/embj.201284290; Koh H, 2012, J BIOL CHEM, V287, P12750, DOI 10.1074/jbc.M111.337907; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021; Papkovskaia TD, 2012, HUM MOL GENET, V21, P4201, DOI 10.1093/hmg/dds244; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Plun-Favreau H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.77; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Sanchez-Blanco A, 2006, GENETICS, V172, P1699, DOI 10.1534/genetics.105.053389; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Tain LS, 2009, CELL DEATH DIFFER, V16, P1118, DOI 10.1038/cdd.2009.23; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; Wang DL, 2006, P NATL ACAD SCI USA, V103, P13520, DOI 10.1073/pnas.0604661103; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yun J, 2008, J NEUROSCI, V28, P14500, DOI 10.1523/JNEUROSCI.5141-08.2008	64	18	18	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5111	5121		10.1096/fj.14-255802	http://dx.doi.org/10.1096/fj.14-255802			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25145627				2022-12-25	WOS:000345894500008
J	Kossmann, S; Hu, HH; Steven, S; Schonfelder, T; Fraccarollo, D; Mikhed, Y; Brahler, M; Knorr, M; Brandt, M; Karbach, SH; Becker, C; Oelze, M; Bauersachs, J; Widder, J; Munzel, T; Daiber, A; Wenzel, P				Kossmann, Sabine; Hu, Hanhan; Steven, Sebastian; Schoenfelder, Tanja; Fraccarollo, Daniela; Mikhed, Yuliya; Braehler, Melanie; Knorr, Maike; Brandt, Moritz; Karbach, Susanne H.; Becker, Christian; Oelze, Matthias; Bauersachs, Johann; Widder, Julian; Muenzel, Thomas; Daiber, Andreas; Wenzel, Philip			Inflammatory Monocytes Determine Endothelial Nitric-oxide Synthase Uncoupling and Nitro-oxidative Stress Induced by Angiotensin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiotensin II; Endothelial Dysfunction; Inflammation; Monocyte; Nitric-oxide Synthase; Tetrahydrobiopterin (BH4)	GTP-CYCLOHYDROLASE-I; VASCULAR SUPEROXIDE-PRODUCTION; CELL-LINEAGE-ABLATION; INTERFERON-GAMMA; HUMAN ATHEROSCLEROSIS; DIABETES-MELLITUS; NAD(P)H OXIDASE; GENE-EXPRESSION; TETRAHYDROBIOPTERIN; DYSFUNCTION	Background: Inflammatory monocytes are drivers of vascular injury and disease. Results: Depletion of lysozyme M-positive monocytes prevents eNOS uncoupling and iNOS-derived nitro-oxidative stress. Conclusion: Monocytes determine eNOS and iNOS function by directly modulating tetrahydrobiopterin bioavailability. Significance: Understanding the impact of inflammation on endothelial function in detail is essential to identify tailored therapeutic strategies. Endothelial nitric-oxide synthase (eNOS) uncoupling and increased inducible NOS (iNOS) activity amplify vascular oxidative stress. The role of inflammatory myelomonocytic cells as mediators of these processes and their impact on tetrahydrobiopterin availability and function have not yet been defined. Angiotensin II (ATII, 1 mg/kg/day for 7 days) increased Ly6C(high) and CD11b(+)/iNOS(high) leukocytes and up-regulated levels of eNOS glutathionylation in aortas of C57BL/6 mice. Vascular iNOS-dependent NO formation was increased, whereas eNOS-dependent NO formation was decreased in aortas of ATII-infused mice as assessed by electron paramagnetic resonance (EPR) spectroscopy. Diphtheria toxin-mediated ablation of lysozyme M-positive (LysM(+)) monocytes in ATII-infused LysM(iDTR) transgenic mice prevented eNOS glutathionylation and eNOS-derived N-nitro-l-arginine methyl ester-sensitive superoxide formation in the endothelial layer. ATII increased vascular guanosine triphosphate cyclohydrolase I expression and biopterin synthesis in parallel, which was reduced in monocyte-depleted LysM(iDTR) mice. Vascular tetrahydrobiopterin was increased by ATII infusion but was even higher in monocyte-depleted ATII-infused mice, which was paralleled by a strong up-regulation of dihydrofolate reductase expression. EPR spectroscopy revealed that both vascular iNOS- and eNOS-dependent NO formation were normalized in ATII-infused mice following monocyte depletion. Additionally, deletion as well as pharmacologic inhibition of iNOS prevented ATII-induced endothelial dysfunction. In summary, ATII induces an inflammatory cell-dependent increase of iNOS, guanosine triphosphate cyclohydrolase I, tetrahydrobiopterin, NO formation, and nitro-oxidative stress as well as eNOS uncoupling in the vessel wall, which can be prevented by ablation of LysM(+) monocytes.	[Kossmann, Sabine; Steven, Sebastian; Mikhed, Yuliya; Knorr, Maike; Karbach, Susanne H.; Oelze, Matthias; Muenzel, Thomas; Daiber, Andreas; Wenzel, Philip] Univ Med Ctr Mainz, Med Clin 2, D-55131 Mainz, Germany; [Kossmann, Sabine; Hu, Hanhan; Steven, Sebastian; Schoenfelder, Tanja; Braehler, Melanie; Knorr, Maike; Brandt, Moritz; Becker, Christian; Wenzel, Philip] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, D-55131 Mainz, Germany; [Braehler, Melanie; Becker, Christian] Univ Med Ctr Mainz, Dept Dermatol, D-55131 Mainz, Germany; [Fraccarollo, Daniela; Bauersachs, Johann; Widder, Julian] Hannover Med Sch, Clin Cardiol & Angiol, D-30625 Hannover, Germany; [Brandt, Moritz] Stanford Sch Med, Stanford, CA 94305 USA	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Hannover Medical School; Stanford University	Wenzel, P (corresponding author), Univ Med Ctr Mainz, Dept Med 2, Langenbeckstr 1, D-55131 Mainz, Germany.	wenzelp@uni-mainz.de	Karbach, Susanne/GPC-8804-2022; Becker, Christian/AAD-4549-2020; Munzel, Thomas/A-2912-2014; Karbach, Susanne/X-8136-2019; Brandt, Moritz/ABB-5621-2021; Wenzel, Philip/HIA-0033-2022; Wenzel, Philip/Z-1503-2019; Steven, Sebastian/Z-1583-2019; Becker, Christian/GLS-0862-2022	Becker, Christian/0000-0002-1716-7208; Munzel, Thomas/0000-0001-5503-4150; Wenzel, Philip/0000-0002-5397-2781; Wenzel, Philip/0000-0002-5397-2781; Becker, Christian/0000-0002-1716-7208; Wild, Sabine/0000-0002-1403-0978; Steven, Sebastian/0000-0002-5332-9294	German Research Foundation DFG [WE 4361/3-1]; Stiftung Mainzer Herz; Federal Ministry of Education and Research [BMBF 01EO1003]	German Research Foundation DFG(German Research Foundation (DFG)); Stiftung Mainzer Herz; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the German Research Foundation DFG Grant WE 4361/3-1 (to P. W.). This work contains results that are part of the doctoral thesis of Hanhan Hu.; Supported by grants from the Stiftung Mainzer Herz.; Supported by Federal Ministry of Education and Research Grant BMBF 01EO1003. To whom correspondence should be addressed: Dept. of Medicine 2 and CTH Junior Group "Vascular Biology," University Medical Center Mainz, Langenbeckstr. 1, 55131 Mainz, Germany. Tel.: 49-6131-177695; Fax: 49-6131-175532; E-mail: wenzelp@uni-mainz.de.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Alp NJ, 2003, J CLIN INVEST, V112, P725, DOI 10.1172/JCI200317786; Antoniades C, 2007, CIRCULATION, V116, P2851, DOI 10.1161/CIRCULATIONAHA.107.704155; Antoniades C, 2011, CIRCULATION, V124, P335, DOI 10.1161/CIRCULATIONAHA.110.985150; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cortez-Retamozo V, 2013, IMMUNITY, V38, P296, DOI 10.1016/j.immuni.2012.10.015; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Gao L, 2012, HYPERTENSION, V59, P158, DOI 10.1161/HYPERTENSIONAHA.111.181644; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; Heitzer T, 2000, CIRC RES, V86, pE36, DOI 10.1161/01.RES.86.2.e36; Hink U, 2001, CIRC RES, V88, pE14; Ihlemann N, 2003, AM J PHYSIOL-HEART C, V285, pH875, DOI 10.1152/ajpheart.00008.2003; Kase H, 2005, J HYPERTENS, V23, P1375, DOI 10.1097/01.hjh.0000173520.13976.7d; Kessler P, 1997, ARTERIOSCL THROM VAS, V17, P1746, DOI 10.1161/01.ATV.17.9.1746; Kleschyov AL, 2002, METHOD ENZYMOL, V359, P42; Kossmann S, 2013, ARTERIOSCL THROM VAS, V33, P1313, DOI 10.1161/ATVBAHA.113.301437; Kroller-Schon S, 2014, ANTIOXID REDOX SIGN, V20, P247, DOI 10.1089/ars.2012.4953; Kuzkaya N, 2003, J BIOL CHEM, V278, P22546, DOI 10.1074/jbc.M302227200; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Landmesser U, 2007, ARTERIOSCL THROM VAS, V27, P943, DOI 10.1161/01.ATV.0000258415.32883.bf; Lee DY, 2013, J BIOL CHEM, V288, P28668, DOI 10.1074/jbc.M113.470971; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Puhakka A, 2002, MUTAT RES-GEN TOX EN, V514, P7, DOI 10.1016/S1383-5718(01)00322-9; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tan CK, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000269; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; WERNER ER, 1990, J BIOL CHEM, V265, P3189; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779	39	81	83	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27540	27550		10.1074/jbc.M114.604231	http://dx.doi.org/10.1074/jbc.M114.604231			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143378	Green Published, hybrid			2022-12-25	WOS:000342852800016
J	Honsa, ES; Maresso, AW; Highlander, SK				Honsa, Erin S.; Maresso, Anthony W.; Highlander, Sarah K.			Molecular and Evolutionary Analysis of NEAr-Iron Transporter (NEAT) Domains	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; SURFACE PROTEIN; HEMOGLOBIN RECEPTOR; HEME-BINDING; SORTASE-B; ANTHRAX HEMOPHORE; CRYSTAL-STRUCTURE; AFFINITY BINDING; STRUCTURAL BASIS; EXTRACT HEME	Iron is essential for bacterial survival, being required for numerous biological processes. NEAr-iron Transporter (NEAT) domains have been studied in pathogenic Gram-positive bacteria to understand how their proteins obtain heme as an iron source during infection. While a 2002 study initially discovered and annotated the NEAT domain encoded by the genomes of several Gram-positive bacteria, there remains a scarcity of information regarding the conservation and distribution of NEAT domains throughout the bacterial kingdom, and whether these domains are restricted to pathogenic bacteria. This study aims to expand upon initial bioinformatics analysis of predicted NEAT domains, by exploring their evolution and conserved function. This information was used to identify new candidate domains in both pathogenic and nonpathogenic organisms. We also searched metagenomic datasets, specifically sequence from the Human Microbiome Project. Here, we report a comprehensive phylogenetic analysis of 343 NEAT domains, encoded by Gram-positive bacteria, mostly within the phylum Firmicutes, with the exception of Eggerthella sp. (Actinobacteria) and an unclassified Mollicutes bacterium (Tenericutes). No new NEAT sequences were identified in the HMP dataset. We detected specific groups of NEAT domains based on phylogeny of protein sequences, including a cluster of novel clostridial NEAT domains. We also identified environmental and soil organisms that encode putative NEAT proteins. Biochemical analysis of heme binding by a NEAT domain from a protein encoded by the soil-dwelling organism Paenibacillus polymyxa demonstrated that the domain is homologous in function to NEAT domains encoded by pathogenic bacteria. Together, this study provides the first global bioinformatics analysis and phylogenetic evidence that NEAT domains have a strong conservation of function, despite group-specific differences at the amino acid level. These findings will provide information useful for future projects concerning the structure and function of NEAT domains, particularly in pathogens where they have yet to be studied.	[Honsa, Erin S.; Maresso, Anthony W.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Highlander, Sarah K.] J Craig Venter Inst, La Jolla, CA 92037 USA	Baylor College of Medicine; J. Craig Venter Institute	Highlander, SK (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.	shighlan@jcvi.org		Highlander, Sarah/0000-0002-3800-4950	National Institutes of Health (NIH) [A1097167, A1069697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109465, R01AI097167] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sources of funding for this study were National Institutes of Health (NIH) grants A1097167 and A1069697 awarded to AWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; AKATOV AK, 1981, ZH MIKROB EPID IMMUN, P45; Akiyama Hisanori, 1998, Journal of Dermatology (Tokyo), V25, P563; ALFERY DD, 1979, CRIT CARE MED, V7, P176, DOI 10.1097/00003246-197904000-00007; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade MA, 2002, GENOME BIOL, V3; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Bahl H, 1997, FEMS MICROBIOL REV, V20, P47, DOI 10.1016/S0168-6445(97)00050-8; Balderas MA, 2012, J BACTERIOL, V194, P5513, DOI 10.1128/JB.00685-12; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Benevides-Matos N, 2008, J BACTERIOL, V190, P21, DOI 10.1128/JB.01389-07; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P99, DOI 10.1016/S0168-6445(97)00043-0; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brook I, 2007, ANAEROBE, V13, P171, DOI 10.1016/j.anaerobe.2007.08.004; Caillet-Saguy C, 2008, J BIOL CHEM, V283, P5960, DOI 10.1074/jbc.M703795200; Crosa JH., 2004, IRON TRANSPORT BACTE; Czjzek M, 2007, J MOL BIOL, V365, P1176, DOI 10.1016/j.jmb.2006.10.063; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; EALES C E, 1947, Aust J Sci, V10, P20; Ebert Tim, 2010, Human Antibodies, V19, P113, DOI 10.3233/HAB-2010-0235; Ekworomadu MT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fouet A, 1999, J APPL MICROBIOL, V87, P251, DOI 10.1046/j.1365-2672.1999.00882.x; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Haggag WM, 2008, J APPL MICROBIOL, V104, P961, DOI 10.1111/j.1365-2672.2007.03611.x; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Honsa ES, 2013, J BIOL CHEM, V288, P8479, DOI 10.1074/jbc.M112.430009; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Honsa ES, 2011, BIOMETALS, V24, P533, DOI 10.1007/s10534-011-9413-x; HUSS HH, 1980, APPL ENVIRON MICROB, V39, P764, DOI 10.1128/AEM.39.4.764-769.1980; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jeong H, 2011, J BACTERIOL, V193, P5026, DOI 10.1128/JB.05447-11; Jepkorir G, 2010, J AM CHEM SOC, V132, P9857, DOI 10.1021/ja103498z; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Lal S, 2012, ARCH MICROBIOL, V194, P345, DOI 10.1007/s00203-011-0763-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letoffe S, 2004, J BACTERIOL, V186, P4067, DOI 10.1128/JB.186.13.4067-4074.2004; LETOFFE S, 1994, J BACTERIOL, V176, P5372; Letoffe S, 1999, MOL MICROBIOL, V33, P546, DOI 10.1046/j.1365-2958.1999.01499.x; Li T, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-13; Ma MC, 2011, J BACTERIOL, V193, P311, DOI 10.1128/JB.01234-10; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; MARTIN MA, 1989, ANN INTERN MED, V110, P9, DOI 10.7326/0003-4819-110-1-9; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mey AR, 2001, MOL MICROBIOL, V42, P835, DOI 10.1046/j.1365-2958.2001.02683.x; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nagano N, 2008, J CLIN MICROBIOL, V46, P1545, DOI 10.1128/JCM.01895-07; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Noone M, 2002, J CLIN PATHOL, V55, P141, DOI 10.1136/jcp.55.2.141; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; RIGGS A, 1965, PHYSIOL REV, V45, P619, DOI 10.1152/physrev.1965.45.4.619; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Seki H, 2003, PEDIATR INT, V45, P86, DOI 10.1046/j.1442-200X.2003.01671.x; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Smith K.M., 1975, PORPHYRINS METALLOPO; Song YL, 2004, ANAEROBE, V10, P179, DOI 10.1016/j.anaerobe.2004.04.004; Spirig T, 2012, BIOMOL NMR ASSIGN, V6, P169, DOI 10.1007/s12104-011-9348-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Voet D, 2011, BIOCHEMISTRY-US, P323; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yukl ET, 2010, BIOCHEMISTRY-US, V49, P6646, DOI 10.1021/bi100692f; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	95	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104794	10.1371/journal.pone.0104794	http://dx.doi.org/10.1371/journal.pone.0104794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153520	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200027
J	Li, C; Miao, HM; Wei, LB; Zhang, TD; Han, XH; Zhang, HY				Li, Chun; Miao, Hongmei; Wei, Libin; Zhang, Tide; Han, Xiuhua; Zhang, Haiyang			Association Mapping of Seed Oil and Protein Content in Sesamum indicum L. Using SSR Markers	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GERMPLASM COLLECTION; GENETIC DIVERSITY; BINDING PROTEIN; QUALITY TRAITS; SEQUENCE TAGS; ACID; IDENTIFICATION; EXPRESSION; TRANSPORTER	Sesame is an important oil crop for the high oil content and quality. The seed oil and protein contents are two important traits in sesame. To identify the molecular markers associated with the seed oil and protein contents in sesame, we systematically performed the association mapping among 369 worldwide germplasm accessions under 5 environments using 112 polymorphic SSR markers. The general linear model (GLM) was applied with the criteria of logP >= 3.0 and high stability under all 5 environments. Among the 369 sesame accessions, the oil content ranged from 27.89%-58.73% and the protein content ranged from 16.72%-27.79%. A significant negative correlation of the oil content with the protein content was found in the population. A total of 19 markers for oil content were detected with a R-2 value range from 4% to 29%; 24 markers for protein content were detected with a R-2 value range from 3% to 29%, of which 19 markers were associated with both traits. Moreover, partial markers were confirmed using mixed linear model (MLM) method, which suggested that the oil and protein contents are controlled mostly by major genes. Allele effect analysis showed that the allele associated with high oil content was always associated with low protein content, and vice versa. Of the 19 markers associated with oil content, 17 presented near the locations of the plant lipid pathway genes and 2 were located just next to a fatty acid elongation gene and a gene encoding Stearoyl-ACP Desaturase, respectively. The findings provided a valuable foundation for oil synthesis gene identification and molecular marker assistant selection (MAS) breeding in sesame.	[Li, Chun; Miao, Hongmei; Wei, Libin; Zhang, Tide; Han, Xiuhua; Zhang, Haiyang] Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Henan, Peoples R China	Henan Academy of Agricultural Sciences	Zhang, HY (corresponding author), Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Henan, Peoples R China.	zhy@hnagri.org.cn	Miao, Hongmei/AAQ-7525-2021	Li, Chun/0000-0002-9370-1775	China National "973'' Project [2011CB109304]; earmarked fund for the China Agriculture Research System [CARS-15]	China National "973'' Project(National Basic Research Program of China); earmarked fund for the China Agriculture Research System	This work was supported by China National "973'' Project (2011CB109304) and the earmarked fund for the China Agriculture Research System (CARS-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Anilakumar Kandangath Raghavan, 2010, Agriculturae Conspectus Scientificus, V75, P159; ARONDEL V, 1992, SCIENCE, V258, P1353, DOI 10.1126/science.1455229; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; BEDIGIAN D, 1986, ECON BOT, V40, P137, DOI 10.1007/BF02859136; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Brummer EC, 1997, CROP SCI, V37, P370, DOI 10.2135/cropsci1997.0011183X003700020011x; Chen G, 2010, EUPHYTICA, V175, P161, DOI 10.1007/s10681-010-0144-9; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Chen M, 2012, PLANT J, V69, P769, DOI 10.1111/j.1365-313X.2011.04829.x; Chen SiLong, 2009, Scientia Agricultura Sinica, V42, P3048; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Chun JA, 2003, PLANTA, V216, P874, DOI 10.1007/s00425-002-0940-0; Ecke W, 2010, THEOR APPL GENET, V120, P921, DOI 10.1007/s00122-009-1221-0; Eleuch L, 2008, J INTEGR PLANT BIOL, V50, P1004, DOI 10.1111/j.1744-7909.2008.00670.x; ELTINAY AH, 1976, J AM OIL CHEM SOC, V53, P648, DOI 10.1007/BF02586281; Engeseth NJ, 1996, ARCH BIOCHEM BIOPHYS, V331, P55, DOI 10.1006/abbi.1996.0282; Ersoz E.S., 2007, GENOMICS ASSISTED CR, P97, DOI DOI 10.1007/978-1-4020-6295-7_5; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Guo SX, 2011, THESIS SICHUAN AGR U; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Haselier A, 2010, PLANT PHYSIOL, V153, P1372, DOI 10.1104/pp.110.156422; He DaoHua, 2011, Journal of Northwest A & F University - Natural Science Edition, V39, P103; HEDRICK PW, 1987, GENETICS, V117, P331; Hobbs DH, 2004, PLANT PHYSIOL, V136, P3341, DOI 10.1104/pp.104.049486; Holland JB, 2002, PL BRED RE, V22, P9; Hwang EY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1; Jin UH, 2001, PLANT SCI, V161, P935, DOI 10.1016/S0168-9452(01)00489-7; JOHNSON LA, 1979, J AM OIL CHEM SOC, V56, P463, DOI 10.1007/BF02671542; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Ke T, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-180; Kim DH, 2002, PLANT BREEDING, V121, P259, DOI 10.1046/j.1439-0523.2002.00700.x; Kumar H, 2012, J CROP IMPROV, V26, P540, DOI 10.1080/15427528.2012.660563; Laurentin HE, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-10; Leduc V, 2006, ALLERGY, V61, P349, DOI 10.1111/j.1398-9995.2006.01013.x; Magni C, 2010, ANN ALLERG ASTHMA IM, V105, P458, DOI 10.1016/j.anai.2010.10.001; Miao H, 2014, INT PLANT ANIMAL GEN; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Monks DE, 1996, PLANT PHYSIOL, V110, P1197, DOI 10.1104/pp.110.4.1197; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Panikashvili D, 2011, NEW PHYTOL, V190, P113, DOI 10.1111/j.1469-8137.2010.03608.x; Pritchard JK, 2000, GENETICS, V155, P945; Quilichini TD, 2010, PLANT PHYSIOL, V154, P678, DOI 10.1104/pp.110.161968; Salas JJ, 2002, ARCH BIOCHEM BIOPHYS, V403, P25, DOI 10.1016/S0003-9861(02)00017-6; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Schnurr J, 2004, PLANT CELL, V16, P629, DOI 10.1105/tpc.017608; Shi A, 2010, PLANT BREEDING, V129, P250, DOI 10.1111/j.1439-0523.2010.01766.x; Singkham N, 2010, J AGR FOOD CHEM, V58, P6257, DOI 10.1021/jf903728e; Stankiewicz M, 2001, WEED RES, V41, P287, DOI 10.1046/j.1365-3180.2001.00238.x; Suh MC, 2003, PLANT MOL BIOL, V52, P1107, DOI 10.1023/B:PLAN.0000004304.22770.e9; Tilton G, 2000, BIOCHEM SOC T, V28, P946, DOI 10.1042/BST0280946; Turhan H, 2010, BULG J AGRIC SCI, V16, P553; Uzun B, 2008, J AM OIL CHEM SOC, V85, P1135, DOI 10.1007/s11746-008-1304-0; Wei LB, 2009, GENES GENOM, V31, P199, DOI 10.1007/BF03191152; Wei WL, 2013, J INTEGR PLANT BIOL, V55, P745, DOI 10.1111/jipb.12049; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Weir BS., 1996, METHODS DISCRETE POP; Xing S, 2008, PLANT J, V53, P790, DOI 10.1111/j.1365-313X.2007.03375.x; Xue HW, 2000, PLANT MOL BIOL, V42, P757, DOI 10.1023/A:1006308909105; Yamaoka Y, 2011, PLANT J, V67, P648, DOI 10.1111/j.1365-313X.2011.04624.x; Yasuno R, 2002, FEBS LETT, V517, P110, DOI 10.1016/S0014-5793(02)02589-9; YERMANOS DM, 1972, J AM OIL CHEM SOC, V49, P20, DOI 10.1007/BF02545131; Yu JW, 2012, EUPHYTICA, V187, P191, DOI 10.1007/s10681-012-0630-3; Yue WenDi, 2012, Acta Agronomica Sinica, V38, P2286; Zhang HY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-401; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang HY, 2013, 7 CHIN NAT OIL CROPS, P29; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhang Peng, 2007, Acta Agronomica Sinica, V33, P1696; Zhao JJ, 2010, GENOME, V53, P884, DOI 10.1139/G10-082; Zhao JY, 2006, THEOR APPL GENET, V113, P33, DOI 10.1007/s00122-006-0267-5; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85; Zou J, 2010, GENOME, V53, P908, DOI 10.1139/G10-075	75	25	32	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105757	10.1371/journal.pone.0105757	http://dx.doi.org/10.1371/journal.pone.0105757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153139	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200080
J	Libiakova, M; Flokova, K; Novak, O; Slovakova, L; Pavlovic, A				Libiakova, Michaela; Flokova, Kristyna; Novak, Ondrej; Slovakova, L'udmila; Pavlovic, Andrej			Abundance of Cysteine Endopeptidase Dionain in Digestive Fluid of Venus Flytrap (Dionaea muscipula Ellis) Is Regulated by Different Stimuli from Prey through Jasmonates	PLOS ONE			English	Article							SECRETORY CYCLE; TRAP CLOSURE; PHOTOSYNTHETIC EFFICIENCY; 12-OXO-PHYTODIENOIC ACID; ACTION-POTENTIALS; PITCHER FLUID; MECHANISM; PLANTS; GENES; ARABIDOPSIS	The trap of the carnivorous plant Venus flytrap (Dionaea muscipula) catches prey by very rapid closure of its modified leaves. After the rapid closure secures the prey, repeated mechanical stimulation of trigger hairs by struggling prey and the generation of action potentials (APs) result in secretion of digestive fluid. Once the prey's movement stops, the secretion is maintained by chemical stimuli released from digested prey. We investigated the effect of mechanical and chemical stimulation (NH4Cl, KH2PO4, further N(Cl) and P(K) stimulation) on enzyme activities in digestive fluid. Activities of beta-D-glucosidases and N-acetyl-beta-D-glucosaminidases were not detected. Acid phosphatase activity was higher in N(Cl) stimulated traps while proteolytic activity was higher in both chemically induced traps in comparison to mechanical stimulation. This is in accordance with higher abundance of recently described enzyme cysteine endopeptidase dionain in digestive fluid of chemically induced traps. Mechanical stimulation induced high levels of cis-12-oxophytodienoic acid (cis-OPDA) but jasmonic acid (JA) and its isoleucine conjugate (JA-Ile) accumulated to higher level after chemical stimulation. The concentration of indole-3-acetic acid (IAA), salicylic acid (SA) and abscisic acid (ABA) did not change significantly. The external application of JA bypassed the mechanical and chemical stimulation and induced a high abundance of dionain and proteolytic activity in digestive fluid. These results document the role of jasmonates in regulation of proteolytic activity in response to different stimuli from captured prey. The double trigger mechanism in protein digestion is proposed.	[Libiakova, Michaela; Slovakova, L'udmila; Pavlovic, Andrej] Comenius Univ, Fac Nat Sci, Dept Plant Physiol, Bratislava, Slovakia; [Flokova, Kristyna; Novak, Ondrej] Inst Expt Bot ASCR, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, Olomouc, Czech Republic; [Flokova, Kristyna; Novak, Ondrej] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Pavlovic, Andrej] Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic	Comenius University Bratislava; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc	Pavlovic, A (corresponding author), Comenius Univ, Fac Nat Sci, Dept Plant Physiol, Bratislava, Slovakia.	pavlovic@fns.uniba.sk	NOVAK, Ondrej/F-7031-2014; PAVLOVIČ, Andrej/AAG-8027-2020; Floková, Kristýna/K-2888-2014	NOVAK, Ondrej/0000-0003-3452-0154; Flokova, Kristyna/0000-0002-5558-0669; Pavlovic, Andrej/0000-0003-4274-2099; Slovakova, Ludmila/0000-0001-6162-5037	Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 1/0520/12]; Ministry of Education Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0057]; National Program of Sustainability I [LO1204]; Internal Grant Agency of Palacky University [IGA_PrF_2014006]	Ministry of Education, Science, Research and Sport of the Slovak Republic; Ministry of Education Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); National Program of Sustainability I; Internal Grant Agency of Palacky University	This work was financially supported by the Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 1/0520/12], Ministry of Education Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0057] and grant LO1204 from the National Program of Sustainability I. The Internal Grant Agency of Palacky University [IGA_PrF_2014006] is also kindly acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFOLTER JM, 1975, AM MIDL NAT, V93, P443, DOI 10.2307/2424177; Athauda SBP, 2004, BIOCHEM J, V381, P295, DOI 10.1042/BJ20031575; Ballare CL, 2011, TRENDS PLANT SCI, V16, P249, DOI 10.1016/j.tplants.2010.12.001; BALOTIN NM, 1962, SCIENCE, V138, P1338, DOI 10.1126/science.138.3547.1338; Brown WH, 1916, AM J BOT, V3, P68, DOI 10.2307/2435207; Burdon-Sanderson JI., 1873, P R SOC LOND, V21, P495, DOI DOI 10.1098/RSPL.1872.0092; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Darwin C., 1875, INSECTIVOROUS PLANTS; Dick CF, 2011, ENZYME RES, V2011; Eilenberg H, 2006, J EXP BOT, V57, P2775, DOI 10.1093/jxb/erl048; Ellison AM, 2006, PLANT BIOLOGY, V8, P740, DOI 10.1055/s-2006-923956; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; Farnsworth EJ, 2008, J ECOL, V96, P213, DOI 10.1111/j.1365-2745.2007.01313.x; Fisahn J, 2004, PLANT CELL PHYSIOL, V45, P456, DOI 10.1093/pcp/pch054; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; Gibson TC, 2009, NEW PHYTOL, V183, P575, DOI 10.1111/j.1469-8137.2009.02935.x; GIVNISH TJ, 1984, AM NAT, V124, P479, DOI 10.1086/284289; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Hatano N, 2008, J PROTEOME RES, V7, P809, DOI 10.1021/pr700566d; Hatano N, 2012, J PROTEOMICS, V75, P4844, DOI 10.1016/j.jprot.2012.05.048; Hlavackova V, 2006, PLANTA, V225, P235, DOI 10.1007/s00425-006-0325-x; HODICK D, 1988, PLANTA, V174, P8, DOI 10.1007/BF00394867; HODICK D, 1989, PLANTA, V179, P32, DOI 10.1007/BF00395768; JAFFE MJ, 1973, PLANT PHYSIOL, V51, P17, DOI 10.1104/pp.51.1.17; Juniper B.E., 1989, CARNIVOROUS PLANTS; Krol E, 2006, BIOL PLANTARUM, V50, P411, DOI 10.1007/s10535-006-0058-5; Kruse J, 2014, OECOLOGIA, V174, P839, DOI 10.1007/s00442-013-2802-9; LICHTNER FT, 1977, AM J BOT, V64, P881, DOI 10.2307/2442381; Markin VS, 2008, PLANT SIGNAL BEHAV, V3, P778, DOI 10.4161/psb.3.10.6041; Matusikova I, 2005, PLANTA, V222, P1020, DOI 10.1007/s00425-005-0047-5; Mithofer A, 2014, PLANT BIOLOGY, V16, P982, DOI 10.1111/plb.12148; Mithofer A, 2011, PHYTOCHEMISTRY, V72, P1678, DOI 10.1016/j.phytochem.2010.11.024; Monshausen GB, 2013, J EXP BOT, V64, P4663, DOI 10.1093/jxb/ert204; Mousavi SAR, 2013, NATURE, V500, P422, DOI 10.1038/nature12478; Nakamura Y, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0228; Nishimura E, 2013, PLANTA, V238, P955, DOI 10.1007/s00425-013-1945-6; Paszota P, 2014, BBA-PROTEINS PROTEOM, V1844, P374, DOI 10.1016/j.bbapap.2013.11.009; Pavlovic A, 2014, ANN BOT-LONDON, V113, P69, DOI 10.1093/aob/mct254; Pavlovic A, 2011, PLANT CELL ENVIRON, V34, P1865, DOI 10.1111/j.1365-3040.2011.02382.x; Pavlovic A, 2011, J EXP BOT, V62, P1991, DOI 10.1093/jxb/erq404; Pavlovic A, 2010, ANN BOT-LONDON, V105, P37, DOI 10.1093/aob/mcp269; Pavlovic A, 2009, ANN BOT-LONDON, V104, P307, DOI 10.1093/aob/mcp121; ROBINS RI, 1980, NEW PHYTOL, V86, P401, DOI 10.1111/j.1469-8137.1980.tb01681.x; ROBINS RJ, 1980, NEW PHYTOL, V86, P313, DOI 10.1111/j.1469-8137.1980.tb00791.x; ROBINS RJ, 1976, PLANTA, V128, P263, DOI 10.1007/BF00393238; ROBINS RJ, 1980, NEW PHYTOL, V86, P297, DOI 10.1111/j.1469-8137.1980.tb00790.x; Rottloff S, 2011, J EXP BOT, V62, P4639, DOI 10.1093/jxb/err173; SCALA J, 1969, PLANT PHYSIOL, V44, P367, DOI 10.1104/pp.44.3.367; Scherzer S, 2013, CURR BIOL, V23, P1649, DOI 10.1016/j.cub.2013.07.028; Schulze W, 2001, J EXP BOT, V52, P1041, DOI 10.1093/jexbot/52.358.1041; Schulze WX, 2012, MOL CELL PROTEOMICS, V11, P1306, DOI 10.1074/mcp.M112.021006; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stelmach BA, 1999, PHYTOCHEMISTRY, V51, P187, DOI 10.1016/S0031-9422(99)00017-5; Stephenson P, 2006, INT J PLANT SCI, V167, P239, DOI 10.1086/499284; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Takahashi K, 2012, CARNIVOROUS PLANT NE, V41, P132; Takahashi K, 2009, CARNIV PL NEWSL, V38, P75; Takahashi K, 2011, BIOSCI BIOTECH BIOCH, V75, P346, DOI 10.1271/bbb.100546; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Ueda M, 2010, CHEMBIOCHEM, V11, P2378, DOI 10.1002/cbic.201000392; Volkov AG, 2008, PLANT PHYSIOL, V146, P694, DOI 10.1104/pp.107.108241; Volkov AG, 2007, PLANT SIGNAL BEHAV, V2, P139, DOI 10.4161/psb.2.3.4217; Volkov AG, 2013, J PLANT PHYSIOL, V170, P25, DOI 10.1016/j.jplph.2012.08.009; Volkov AG, 2011, J PLANT PHYSIOL, V168, P109, DOI 10.1016/j.jplph.2010.06.007; Volkov AG, 2009, BIOELECTROCHEMISTRY, V75, P142, DOI 10.1016/j.bioelechem.2009.03.005; Volkov AG, 2009, PLANT PHYSIOL, V149, P1661, DOI 10.1104/pp.108.134536; Wang L, 2008, PLANT PHYSIOL, V146, P904, DOI 10.1104/pp.107.109264; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; WILLIAMS SE, 1982, SCIENCE, V218, P1120, DOI 10.1126/science.218.4577.1120	72	42	43	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104424	10.1371/journal.pone.0104424	http://dx.doi.org/10.1371/journal.pone.0104424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153528	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200019
J	Pelland, NA; Sterling, JT; Lea, MA; Bond, NA; Ream, RR; Lee, CM; Eriksen, CC				Pelland, Noel A.; Sterling, Jeremy T.; Lea, Mary-Anne; Bond, Nicholas A.; Ream, Rolf R.; Lee, Craig M.; Eriksen, Charles C.			Fortuitous Encounters between Seagliders and Adult Female Northern Fur Seals (Callorhinus ursinus) off the Washington (USA) Coast: Upper Ocean Variability and Links to Top Predator Behavior	PLOS ONE			English	Article							CALIFORNIA CURRENT SYSTEM; OCEANOGRAPHIC FEATURES; MESOSCALE EDDIES; TRANSITION ZONE; PUP PRODUCTION; MIXED-LAYER; RIVER PLUME; EDDY; GULF; PACIFIC	Behavioral responses by top marine predators to oceanographic features such as eddies, river plumes, storms, and coastal topography suggest that biophysical interactions in these zones affect predators' prey, foraging behaviors, and potentially fitness. However, examining these pathways is challenged by the obstacles inherent in obtaining simultaneous observations of surface and subsurface environmental fields and predator behavior. In this study, migratory movements and, in some cases, diving behavior of 40 adult female northern fur seals (NFS; Callorhinus ursinus) were quantified across their range and compared to remotely-sensed environmental data in the Gulf of Alaska and California Current ecosystems, with a particular focus off the coast of Washington State (USA) - a known foraging ground for adult female NFS and where autonomous glider sampling allowed opportunistic comparison of seal behavior to subsurface biophysical measurements. The results show that in these ecosystems, adult female habitat utilization was concentrated near prominent coastal topographic, riverine, or inlet features and within 200 km of the continental shelf break. Seal dive depths, in most ecosystems, were moderated by surface light level (solar or lunar), mirroring known behaviors of diel vertically-migrating prey. However, seal dives differed in the California Current ecosystem due to a shift to more daytime diving concentrated at or below the surface mixed layer base. Seal movement models indicate behavioral responses to season, ecosystem, and surface wind speeds; individuals also responded to mesoscale eddies, jets, and the Columbia River plume. Foraging within small scale surface features is consistent with utilization of the inner coastal transition zone and habitats near coastal capes, which are known eddy and filament generation sites. These results contribute to our knowledge of NFS migratory patterns by demonstrating surface and subsurface behavioral responses to a spatially and temporally dynamic ocean environment, thus reflecting its influence on associated NFS prey species.	[Pelland, Noel A.; Lee, Craig M.; Eriksen, Charles C.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Sterling, Jeremy T.; Ream, Rolf R.] NOAA, Natl Marine Mammal Lab, Natl Oceanog & Atmospher Adm, Seattle, WA USA; [Lea, Mary-Anne] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Bond, Nicholas A.] Univ Washington, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98195 USA; [Lee, Craig M.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; University of Tasmania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pelland, NA (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	nap2@u.washington.edu	Lea, Mary-Anne/E-9054-2013	Lea, Mary-Anne/0000-0001-8318-9299	NOAA; North Pacific Research Board; National Cooperative Research Program of the NOAA Fisheries Office of Science and Technology; Joint Institute for the Study of the Atmosphere and Ocean at the University of Washington; National Science Foundation [OCE9911036, OCE0095414, OCE0526634]; National Oceanographic Partnership Program; Division Of Ocean Sciences [1129090] Funding Source: National Science Foundation	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); North Pacific Research Board; National Cooperative Research Program of the NOAA Fisheries Office of Science and Technology; Joint Institute for the Study of the Atmosphere and Ocean at the University of Washington; National Science Foundation(National Science Foundation (NSF)); National Oceanographic Partnership Program; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Northern fur seal tagging, monitoring, and analysis was funded by NOAA (www.noaa.gov), the North Pacific Research Board (www.nprb.org), the National Cooperative Research Program of the NOAA Fisheries Office of Science and Technology (www.st.nmfs.noaa.gov/cooperative-research/index), and the Joint Institute for the Study of the Atmosphere and Ocean at the University of Washington (jisao.washington.edu). Northern fur seal research was performed under National Marine Mammal Laboratory permits 782-1455 and 782-1708. Seaglider field work and analysis was supported by National Science Foundation (www.nsf.gov) grants OCE9911036, OCE0095414, and OCE0526634, with assistance in Seaglider development from the Office of Naval Research (www.onr.navy. mil) and National Oceanographic Partnership Program (www.nopp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2009, MAR ECOL PROG SER, V389, P271, DOI 10.3354/meps08153; Ainley DG, 2005, DEEP-SEA RES PT II, V52, P123, DOI 10.1016/j.dsr2.2004.08.016; Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Allen SE, 2010, J GEOPHYS RES-OCEANS, V115, DOI [10.1029/2009JC00573, 10.1029/2009JC005731]; Alverson D. L., 1969, CAL COOP OCEAN FISH, V13, P24; APPENZELLER AR, 1992, CAN J FISH AQUAT SCI, V49, P2179, DOI 10.1139/f92-240; Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; Baker JD, 2007, MAR ECOL PROG SER, V341, P243, DOI 10.3354/meps341243; Baker JD, 2012, MAR ECOL PROG SER, V469, P175, DOI 10.3354/meps09987; Banas NS, 2009, CONT SHELF RES, V29, P292, DOI 10.1016/j.csr.2008.03.011; BARTH JA, 1994, J GEOPHYS RES-OCEANS, V99, P16095, DOI 10.1029/94JC01270; Barth JA, 2005, DEEP-SEA RES PT II, V52, P5, DOI 10.1016/j.dsr2.2004.09.026; Barth JA, 2000, DEEP-SEA RES PT II, V47, P783, DOI 10.1016/S0967-0645(99)00127-7; Benoit-Bird KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053348; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Berdeal IG, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000932; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Bigg M.A, 1990, CAN TECH REP FISH AQ, V1764; BIGG MA, 1986, FISH B-NOAA, V84, P383; Bigg MA, 1982, 25 ANN M N PAC FUR S; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boccaletti G, 2007, J PHYS OCEANOGR, V37, P2228, DOI 10.1175/JPO3101.1; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015; Carroll M, 2006, PERFORMANCE VERIFICA; Chaigneau A, 2009, PROG OCEANOGR, V83, P117, DOI 10.1016/j.pocean.2009.07.012; Chapman DG, 1961, FISH B, V63, P657; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Collins CA, 2003, DEEP-SEA RES PT II, V50, P2389, DOI 10.1016/S0967-0645(03)00134-6; Costa D.P., 1986, P79; Crawford WR, 2005, DEEP-SEA RES PT II, V52, P975, DOI 10.1016/j.dsr2.2005.02.011; Crawford WR, 2002, J OCEANOGR, V58, P703, DOI 10.1023/A:1022898424333; Dalton AJM, 2014, MAR MAMMAL SCI, V30, P994, DOI 10.1111/mms.12103; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; DeLong RL, 1991, PINNIPEDS EL NINO RE, P75; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dohan K, 2011, J PHYS OCEANOGR, V41, P42, DOI 10.1175/2010JPO4253.1; Eberhardt L.L., 1981, P197; Eriksen CC, 2001, IEEE J OCEANIC ENG, V26, P424, DOI 10.1109/48.972073; Feldman GC, 2013, OCEAN COLOR WEB SEA; Fong DA, 2001, J GEOPHYS RES-OCEANS, V106, P1067, DOI 10.1029/2000JC900134; Freeland HJ, 2005, PROG OCEANOGR, V64, P31, DOI 10.1016/j.pocean.2004.11.002; French DP, 1990, P 2 INT C MAR DEBR 2, P431, DOI [10.1051/0004-6361/201116485, DOI 10.1051/0004-6361/201116485]; Gentry R.L., 1998, BEHAV ECOLOGY NO SEA; Gentry R. L., 1986, FUR SEALS MATERNAL S, P61; Gentry RL, 1986, FUR SEALS MATERNAL S, P220; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; GOEBEL ME, 1991, FISH B-NOAA, V89, P171; HANEY JC, 1985, WILSON BULL, V97, P191; HAYWARD TL, 1990, J MAR RES, V48, P825, DOI 10.1357/002224090784988683; Henson SA, 2008, DEEP-SEA RES PT I, V55, P163, DOI 10.1016/j.dsr.2007.11.005; Hickey B.M., 1998, SEA, V11, P345; Hickey B. M., 1989, COASTAL OCEANOGRAPHY, P41, DOI DOI 10.1016/S0422-9894(08)70346-5; HOOPER C. L., 1895, P TRIBUNAL ARBITRATI, VVII, P228; Ichihara T., 1974, B FAR SEAS FISH RES, V11, P1; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kajimura H, 1984, SSRF779 NOAA NMFS; Kajimura H, 1982, THESIS U TOKYO TOKYO; Kajimura H, 1980, 23 ANN M N PAC SEA C; Kelly KA, 1998, J GEOPHYS RES-OCEANS, V103, P13067, DOI 10.1029/97JC03760; KENYON KW, 1953, J MAMMAL, V34, P86, DOI 10.2307/1375947; Kenyon KW, 1954, 12 US FISH WILD SERV; KOSRO PM, 1991, J GEOPHYS RES-OCEANS, V96, P14707, DOI 10.1029/91JC01210; Kuhn CE, 2014, J ANIM ECOL, V83, P1169, DOI 10.1111/1365-2656.12202; Kurian J, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006895; Ladd C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002710; Ladd C, 2007, DEEP-SEA RES PT I, V54, P487, DOI 10.1016/j.dsr.2007.01.006; Ladd C, 2009, DEEP-SEA RES PT II, V56, P2460, DOI 10.1016/j.dsr2.2009.02.007; Ladd C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029478; LANDER RH, 1979, FISH B-NOAA, V77, P311; LANDER RH, 1981, FISH RES, V1, P55, DOI 10.1016/0165-7836(81)90007-2; Lara-Lopez AL, 2012, J PLANKTON RES, V34, P828, DOI 10.1093/plankt/fbs016; LARGE WG, 1986, J PHYS OCEANOGR, V16, P1524, DOI 10.1175/1520-0485(1986)016<1524:UOTRTS>2.0.CO;2; Lea MA, 2010, MAR ECOL PROG SER, V419, P233, DOI 10.3354/meps08758; Lea MA, 2009, BIOL LETTERS, V5, P252, DOI 10.1098/rsbl.2008.0643; Li M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021911; Logerwell EA, 2001, FISH OCEANOGR, V10, P13, DOI 10.1046/j.1365-2419.2001.00152.x; Loughlin TR, 2003, FISH B-NOAA, V101, P566; Loughlin TR, 1999, DYNAMICS BERING SEA, P615; MacFadyen A, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004412; Mackas DL, 2005, DEEP-SEA RES PT II, V52, P1011, DOI 10.1016/j.dsr2.2005.02.008; Mahadevan A, 2008, SCIENCE, V320, DOI 10.1126/science.1152111; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marchesiello P, 2003, J PHYS OCEANOGR, V33, P753, DOI 10.1175/1520-0485(2003)33<753:ESADOT>2.0.CO;2; Melin SR, 2012, TALE 2 STOCKS STUDIE; Miller BS, 1980, 8001 U WASH FISH RES; Nel DC, 2001, MAR ECOL PROG SER, V217, P15, DOI 10.3354/meps217015; Niggol K, 1959, PELAGIC SEAL INVESTI; NIILER PP, 1969, J GEOPHYS RES, V74, P7048, DOI 10.1029/JC074i028p07048; Nishimoto MM, 2002, MAR ECOL PROG SER, V241, P183, DOI 10.3354/meps241183; NMFS, 2007, CONS PLAN E PAC STOC; Nordstrom CA, 2013, DEEP-SEA RES PT II, V88-89, P78, DOI 10.1016/j.dsr2.2012.07.010; Okkonen SR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001342; Olesiuk PF, 2012, 2012040 CAN SCI ADV; PADUAN JD, 1993, J PHYS OCEANOGR, V23, P585, DOI 10.1175/1520-0485(1993)023<0585:SOVATI>2.0.CO;2; Pelland NA, 2013, J PHYS OCEANOGR, V43, P2025, DOI 10.1175/JPO-D-12-086.1; Perry MJ, 2008, LIMNOL OCEANOGR, V53, P2169, DOI 10.4319/lo.2008.53.5_part_2.2169; Peterson R, 1965, THESIS J HOPKINS U B; PHILANDER SGH, 1983, NATURE, V302, P295, DOI 10.1038/302295a0; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Ream RR, 2005, DEEP-SEA RES PT II, V52, P823, DOI 10.1016/j.dsr2.2004.12.021; Ream RR, 1999, FUR SEAL INVESTIGATI, P81; Rosen DAS, 2014, MAR MAMMAL SCI, V30, P1014, DOI 10.1111/mms.12097; Sackmann B., 2008, BIOGEOSCI DISCUSS, V5, P2839, DOI [10.5194/bgd-5-2839-2008, DOI 10.5194/BGD-5-2839-2008]; Sackmann B, 2007, THESIS U MAINE ORONO; SCHEFFER VICTOR B., 1950, CALIFORNIA FISH AND GAME, V36, P378; SCHUSTERMAN RJ, 1971, ANN NY ACAD SCI, V188, P37, DOI 10.1111/j.1749-6632.1971.tb13088.x; SHERMAN K, 1991, ECOL APPL, V1, P349, DOI 10.2307/1941896; SINCLAIR E, 1994, FISH B-NOAA, V92, P144; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Staniland IJ, 2008, ANIM BEHAV, V75, P1581, DOI 10.1016/j.anbehav.2007.10.012; Sterling J.T., 2009, NO SEAL FORAGING BEH; Sterling JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093068; Sterling JT, 2004, CAN J ZOOL, V82, P1621, DOI 10.1139/Z04-136; Strub PT, 2000, DEEP-SEA RES PT II, V47, P831, DOI 10.1016/S0967-0645(99)00129-0; Suga T, 2004, J PHYS OCEANOGR, V34, P3, DOI 10.1175/1520-0485(2004)034<0003:TNPCOW>2.0.CO;2; Towell RG, 2006, MAR MAMMAL SCI, V22, P486, DOI 10.1111/j.1748-7692.2006.00026.x; Towell RG, 2011, 2010 NO FUR SEA PUP; Trillmich F., 1991, Ecological Studies, V88, P66; Trillmich F., 1986, P168; Trillmich F., 1991, PINNIPEDS NINO, DOI DOI 10.1007/978-3-642-76398-4; TRITES A W, 1992, Aquatic Mammals, V18, P3; TRITES AW, 1991, CAN J ZOOL, V69, P2608, DOI 10.1139/z91-367; Trites AW, 1996, J ZOOL, V238, P459, DOI 10.1111/j.1469-7998.1996.tb05406.x; US Senate, 1896, SEAL LIF ROOK PRIB I; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Weise MJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027113; Whitney FA, 2005, DEEP-SEA RES PT II, V52, P681, DOI 10.1016/j.dsr2.2004.12.023; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959; Yen PPW, 2006, DEEP-SEA RES PT II, V53, P399, DOI 10.1016/j.dsr2.2006.01.013; Yoda K, 2014, PROG OCEANOGR, V122, P54, DOI 10.1016/j.pocean.2013.12.002; YORK AE, 1981, CAN J FISH AQUAT SCI, V38, P84, DOI 10.1139/f81-011; York Anne E., 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P317; Zeppelin TK, 2010, MAR ECOL PROG SER, V409, P241, DOI 10.3354/meps08624	140	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e101268	10.1371/journal.pone.0101268	http://dx.doi.org/10.1371/journal.pone.0101268			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153524	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200003
J	Sakamoto, S; Tsuruda, T; Hatakeyama, K; Imamura, T; Asada, Y; Kitamura, K				Sakamoto, Sumiharu; Tsuruda, Toshihiro; Hatakeyama, Kinta; Imamura, Takuroh; Asada, Yujiro; Kitamura, Kazuo			Impact of Age-Dependent Adventitia Inflammation on Structural Alteration of Abdominal Aorta in Hyperlipidemic Mice	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE ENTERPRISES; LYMPHOTOXIN-BETA-RECEPTOR; MAJOR SHAREHOLDERS; ATHEROSCLEROSIS; ARTERIAL; EXPRESSION; PROGRESSION; ACTIVATION; MECHANISMS; LESIONS	Background: The adventitia is suggested to contribute to vascular remodeling; however, the site-selective inflammatory responses in association with the development of atherosclerosis remain to be elucidated. Methods and Results: Wild-type or apolipoprotein E knockout male C57BL/6J background mice were fed standard chow for 16, 32, and 52 weeks, and the morphology of the aortic arch, descending aorta, and abdominal aorta was compared. Atheromatous plaque formation progressed with age, particularly in the aortic arch and abdominal aorta but not in the descending aorta. In addition, we found that the numbers of macrophages, T-lymphocytes, and microvessels, assessed by anti-F4/80, CD3, and CD31 antibodies, were higher in the adventitia of the abdominal aorta at 52 weeks. These numbers were positively correlated with plaque formation, but negatively correlated with elastin content, resulting in the enlargement of the total vessel area. In aortic tissues, interleukin-6 levels increased in the atheromatous plaque with age, whereas the level of regulated on activation, normal T cell expressed and secreted (RANTES) increased with age, and compared with other sites, it was particularly distributed in inflammatory cells in the adventitia of the abdominal aorta. Conclusion: This study suggests that adventitial inflammation contributes to the age-dependent structural alterations, and that the activation/inactivation of cytokines/chemokines is involved in the process.	[Sakamoto, Sumiharu; Tsuruda, Toshihiro; Kitamura, Kazuo] Miyazaki Univ, Fac Med, Dept Internal Med Circulatory & Body Fluid Regula, Miyazaki, Japan; [Hatakeyama, Kinta; Asada, Yujiro] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki, Japan; [Imamura, Takuroh] Koga Gen Hosp, Dept Internal Med, Miyazaki, Japan	University of Miyazaki; University of Miyazaki	Tsuruda, T (corresponding author), Miyazaki Univ, Fac Med, Dept Internal Med Circulatory & Body Fluid Regula, Miyazaki, Japan.	ttsuruda@med.miyazaki-u.ac.jp	Tsuruda, Toshihiro/AAX-1255-2020		Ministry of Education, Culture, Sport, Science and Technology, Japan [20590830]; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; SENSHIN Medical Research Foundation	Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This study was supported by Grant-in-Aid for Scientific Research (C) (20590830) from the Ministry of Education, Culture, Sport, Science and Technology, Japan; Grant-in-Aid for the Japan Cardiovascular Research Foundation; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; SENSHIN Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler EP, 2003, IMMUNOL LETT, V90, P187, DOI 10.1016/j.imlet.2003.09.013; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Chiba T, 2003, ARTERIOSCL THROM VAS, V23, P1423, DOI 10.1161/01.ATV.0000085040.58340.36; DegliEsposti MA, 1997, J IMMUNOL, V158, P1756; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Gutterman DD, 1999, AM J PHYSIOL-HEART C, V277, pH1265, DOI 10.1152/ajpheart.1999.277.4.H1265; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; KUMAMOTO M, 1995, HUM PATHOL, V26, P450, DOI 10.1016/0046-8177(95)90148-5; Kuziel WA, 2003, ATHEROSCLEROSIS, V167, P25, DOI 10.1016/S0021-9150(02)00382-9; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Li GH, 2000, CIRCULATION, V101, P1362, DOI 10.1161/01.CIR.101.12.1362; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Malik N, 1996, J IMMUNOL, V156, P3952; Miles EA, 2008, ATHEROSCLEROSIS, V196, P298, DOI 10.1016/j.atherosclerosis.2006.11.002; Millonig G, 2002, ATHEROSCLEROSIS, V160, P441, DOI 10.1016/S0021-9150(01)00596-2; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Moreno PR, 2002, CIRCULATION, V105, P2504, DOI 10.1161/01.CIR.0000017265.52501.37; Nakashima Y, 2002, VIRCHOWS ARCH, V441, P279, DOI 10.1007/s00428-002-0605-1; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Oviedo-Orta E, 2008, IMMUNOLOGY, V124, P42, DOI 10.1111/j.1365-2567.2007.02728.x; Padilla J, 2013, AM J PHYSIOL-REG I, V304, pR543, DOI 10.1152/ajpregu.00567.2012; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Quinones Marlon P, 2007, Atherosclerosis, V195, pe92, DOI 10.1016/j.atherosclerosis.2007.03.026; Richard JF, 2012, CLIN EXPT CARDIOLOGY, V12; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakamoto S, 2011, MAST CELL DENSITY DI, P55; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Sawabe M, 2010, GERIATR GERONTOL INT, V10, pS213, DOI 10.1111/j.1447-0594.2010.00603.x; SPINA M, 1983, ARTERIOSCLEROSIS, V3, P64, DOI 10.1161/01.ATV.3.1.64; Stopfer P, 2004, J IMMUNOL, V172, P7459, DOI 10.4049/jimmunol.172.12.7459; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; Tsuruda T, 2012, ARTERIOSCL THROM VAS, V32, P1410, DOI 10.1161/ATVBAHA.111.237065; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Yamashita A, 2008, HISTOL HISTOPATHOL, V23, P127, DOI 10.14670/HH-23.127; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	50	9	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105739	10.1371/journal.pone.0105739	http://dx.doi.org/10.1371/journal.pone.0105739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153991	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200078
J	Wennerstro, AB; Lothe, IMB; Sandhu, V; Kure, EH; Myklebost, O; Munthe, E				Wennerstro, Anna B.; Lothe, Inger Marie Bowitz; Sandhu, Vandana; Kure, Elin H.; Myklebost, Ola; Munthe, Else			Generation and Characterisation of Novel Pancreatic Adenocarcinoma Xenograft Models and Corresponding Primary Cell Lines	PLOS ONE			English	Article							CANCER STEM-CELLS; MESENCHYMAL TRANSITION; SIDE POPULATION; TISSUE FACTOR; EXPRESSION; CARCINOMA; IDENTIFICATION; PROGNOSIS; SURVIVAL; MARKER	Pancreatic adenocarcinoma is one of the most lethal cancer types, currently lacking efficient treatment. The heterogeneous nature of these tumours are poorly represented by the classical pancreatic cell lines, which have been through strong clonal selection in vitro, and are often derived from metastases. Here, we describe the establishment of novel pancreatic adenocarcinoma models, xenografts and corresponding in vitro cell lines, from primary pancreatic tumours. The morphology, differentiation grade and gene expression pattern of the xenografts resemble the original tumours well. The cell lines were analysed for colony forming capacity, tumourigenicity and expression of known cancer cell surface markers and cancer stem-like characteristics. These primary cell models will be valuable tools for biological and preclinical studies for this devastating disease.	[Wennerstro, Anna B.; Myklebost, Ola; Munthe, Else] Oslo Univ Hosp, Norwegian Radium Hosp, Canc Stem Cell Innovat Ctr, Oslo, Norway; [Wennerstro, Anna B.; Myklebost, Ola; Munthe, Else] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Inst Canc Res, Oslo, Norway; [Lothe, Inger Marie Bowitz; Sandhu, Vandana; Kure, Elin H.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Lothe, Inger Marie Bowitz] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Sandhu, Vandana; Kure, Elin H.] Telemark Univ Coll, Dept Environm Hlth & Sci, Telemark, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University College of Southeast Norway	Munthe, E (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Canc Stem Cell Innovat Ctr, Oslo, Norway.	elsmun@rr-research.no	Munthe, Else/O-3576-2017; Myklebost, Ola/E-9335-2010	Munthe, Else/0000-0003-3859-1582; Myklebost, Ola/0000-0002-2866-3223; Wennerstrom, Anna Berit/0000-0001-8143-9944	Cancer Stem Cell Innovation Centre (CAST-SFI); HSO [2011090]	Cancer Stem Cell Innovation Centre (CAST-SFI); HSO	This work was financially supported by the Cancer Stem Cell Innovation Centre (CAST-SFI) and HSO (Grant nr. 2011090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Albores-Saavedra J, 2007, ANN DIAGN PATHOL, V11, P3, DOI 10.1016/j.anndiagpath.2006.06.008; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Flatmark K, 2004, TUMOR BIOL, V25, P31, DOI 10.1159/000077721; GEER RJ, 1993, AM J SURG, V165, P68, DOI 10.1016/S0002-9610(05)80406-4; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Khorana AA, 2007, CLIN CANCER RES, V13, P2870, DOI 10.1158/1078-0432.CCR-06-2351; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; KIMURA W, 1994, JPN J CANCER RES, V85, P161, DOI 10.1111/j.1349-7006.1994.tb02077.x; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Sobin L, 2009, TNM CLASSIFICATION M; Stratford EW, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-8; Tachezy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039018; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Virtanen C, 2002, P NATL ACAD SCI USA, V99, P12357, DOI 10.1073/pnas.192240599; Wang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057020; Wang YH, 2009, NEOPLASMA, V56, P371, DOI 10.4149/neo_2009_05_371; Wasif N, 2010, ANN SURG ONCOL, V17, P2312, DOI 10.1245/s10434-010-1071-7; Westgaard A, 2008, BMC CANC, V8; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamada S, 2013, SURGERY, V154, P946, DOI 10.1016/j.surg.2013.05.004	30	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e103873	10.1371/journal.pone.0103873	http://dx.doi.org/10.1371/journal.pone.0103873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148029	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600007
J	Zhang, FS; Li, XW; Li, ZY; Xu, XS; Peng, B; Qin, XM; Du, GH				Zhang, Fusheng; Li, Xiaowei; Li, Zhenyu; Xu, Xiaoshuang; Peng, Bing; Qin, Xuemei; Du, Guanhua			UPLC/Q-TOF MS-Based Metabolomics and qRT-PCR in Enzyme Gene Screening with Key Role in Triterpenoid Saponin Biosynthesis of Polygala tenuifolia	PLOS ONE			English	Article							TIME RT-PCR; VALID REFERENCE GENES; BETA-AMYRIN; CHEMICAL-CONSTITUENTS; SUCROSE ESTERS; EXPRESSION; ROOTS; GLYCOSIDES; CYTOCHROME-P450; IDENTIFICATION	Background: The dried root of Polygala tenuifolia, named Radix Polygalae, is a well-known traditional Chinese medicine. Triterpenoid saponins are some of the most important components of Radix Polygalae extracts and are widely studied because of their valuable pharmacological properties. However, the relationship between gene expression and triterpenoid saponin biosynthesis in P. tenuifolia is unclear. Methodology/Findings: In this study, ultra-performance liquid chromatography (UPLC) coupled with quadrupole time-of-flight mass spectrometry (Q-TOF MS)-based metabolomic analysis was performed to identify and quantify the different chemical constituents of the roots, stems, leaves, and seeds of P. tenuifolia. A total of 22 marker compounds (VIP>1) were explored, and significant differences in all 7 triterpenoid saponins among the different tissues were found. We also observed an efficient reference gene GAPDH for different tissues in this plant and determined the expression level of some genes in the triterpenoid saponin biosynthetic pathway. Results showed that MVA pathway has more important functions in the triterpenoid saponin biosynthesis of P. tenuifolia. The expression levels of squalene synthase (SQS), squalene monooxygenase (SQE), and beta-amyrin synthase (beta-AS) were highly correlated with the peak area intensity of triterpenoid saponins compared with data from UPLC/Q-TOF MS-based metabolomic analysis. Conclusions/Significance: This finding suggested that a combination of UPLC/Q-TOF MS-based metabolomics and gene expression analysis can effectively elucidate the mechanism of triterpenoid saponin biosynthesis and can provide useful information on gene discovery. These findings can serve as a reference for using the overexpression of genes encoding for SQS, SQE, and/or beta-AS to increase the triterpenoid saponin production of P. tenuifolia.	[Zhang, Fusheng; Li, Xiaowei; Li, Zhenyu; Xu, Xiaoshuang; Qin, Xuemei; Du, Guanhua] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan, Shanxi, Peoples R China; [Li, Xiaowei; Xu, Xiaoshuang] Shanxi Univ, Coll Chem & Chem Engn, Taiyuan, Shanxi, Peoples R China; [Peng, Bing] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Beijing Inst Tradit Chinese Med, Beijing, Peoples R China; [Du, Guanhua] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China	Shanxi University; Shanxi University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS	Peng, B (corresponding author), Capital Med Univ, Beijing Hosp Tradit Chinese Med, Beijing Inst Tradit Chinese Med, Beijing, Peoples R China.	pengbing123@hotmail.com; dugh@imm.ac.cn	张, 福生/AAA-5858-2021	Du, Guanhua/0000-0002-6896-0847; Li, Xiaowei/0000-0002-0718-1938	National Natural Sciences Foundation of China [31100244]; National Science-technology Support Plan Projects [2011BA107B05]; Technological Innovation Projects in Shanxi [2013007]; Construction Plan for Basic Condition Platform of Shanxi [2014091022]; Shanxi Science and Technology Development Program [20140313010-1]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science-technology Support Plan Projects; Technological Innovation Projects in Shanxi; Construction Plan for Basic Condition Platform of Shanxi; Shanxi Science and Technology Development Program	This study (PONE-D-14-14501) was supported by the National Natural Sciences Foundation of China (Grant No. 31100244), the National Science-technology Support Plan Projects (Grant No. 2011BA107B05), the Technological Innovation Projects in Shanxi (Grant No. 2013007), the Construction Plan for Basic Condition Platform of Shanxi (Grant No. 2014091022), and the Shanxi Science and Technology Development Program (Grant No. 20140313010-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; Arai M, 2011, J NAT MED-TOKYO, V65, P149, DOI 10.1007/s11418-010-0477-7; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Brent MR, 2008, NAT REV GENET, V9, P62, DOI 10.1038/nrg2220; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Carelli M, 2011, PLANT CELL, V23, P3070, DOI 10.1105/tpc.111.087312; Cheng MC, 2006, J NAT PROD, V69, P1305, DOI 10.1021/np060207r; Cheong MH, 2011, J ETHNOPHARMACOL, V137, P1402, DOI 10.1016/j.jep.2011.08.008; Choi JG, 2011, J ETHNOPHARMACOL, V134, P414, DOI 10.1016/j.jep.2010.12.030; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Han JY, 2010, PHYTOCHEMISTRY, V71, P36, DOI 10.1016/j.phytochem.2009.09.031; Haralampidis K, 2002, ADV BIOCHEM ENG BIOT, V75, P31; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; IKEYA Y, 1991, CHEM PHARM BULL, V39, P2600, DOI 10.1248/cpb.39.2600; Ikeya Y, 2004, BIOL PHARM BULL, V27, P1081, DOI 10.1248/bpb.27.1081; Jiang Y, 2005, CHEM PHARM BULL, V53, P1164, DOI 10.1248/cpb.53.1164; Jiang Y, 2005, J NAT PROD, V68, P875, DOI 10.1021/np050026+; Jiang Y, 2005, J LIQ CHROMATOGR R T, V28, P1583, DOI 10.1081/JLC-200058371; Jiang Y, 2002, PHYTOCHEMISTRY, V60, P813, DOI 10.1016/S0031-9422(02)00184-X; Kawashima K, 2004, BIOL PHARM BULL, V27, P1317, DOI 10.1248/bpb.27.1317; Kim TD, 2011, PLANT CELL PHYSIOL, V52, P125, DOI 10.1093/pcp/pcq179; Kumar S, 2013, PLANT MOL BIOL REP, V31, P569, DOI 10.1007/s11105-012-0524-5; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Li CJ, 2008, PLANTA MED, V74, P133, DOI 10.1055/s-2008-1034296; Li H, 2008, PHYTOTHER RES, V22, P159, DOI 10.1002/ptr.2262; Li XW, 2014, J PHARMACEUT BIOMED, V89, P42, DOI 10.1016/j.jpba.2013.10.023; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lin JT, 2009, J FOOD DRUG ANAL, V17, P116; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Ling Y, 2013, J PHARMACEUT BIOMED, V85, P1, DOI 10.1016/j.jpba.2013.06.011; Liu JY, 2007, J MASS SPECTROM, V42, P861, DOI 10.1002/jms.1210; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangas S, 2008, BIOTECHNOL LETT, V30, P1853, DOI 10.1007/s10529-008-9766-6; Meesapyodsuk D, 2007, PLANT PHYSIOL, V143, P959, DOI 10.1104/pp.106.088484; Miao WJ, 2013, J PHARMACEUT BIOMED, V72, P99, DOI 10.1016/j.jpba.2012.09.015; Miyase T, 1999, J NAT PROD, V62, P993, DOI 10.1021/np990084t; MIYASE T, 1991, CHEM PHARM BULL, V39, P3082, DOI 10.1248/cpb.39.3082; MIYASE T, 1992, CHEM PHARM BULL, V40, P2741, DOI 10.1248/cpb.40.2741; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Naoumkina MA, 2010, PLANT CELL, V22, P850, DOI 10.1105/tpc.109.073270; NDAMBA J, 1994, PHYTOCHEMISTRY, V35, P95, DOI 10.1016/S0031-9422(00)90515-6; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Sando T, 2008, BIOSCI BIOTECH BIOCH, V72, P2903, DOI 10.1271/bbb.80387; Seki H, 2008, P NATL ACAD SCI USA, V105, P14204, DOI 10.1073/pnas.0803876105; Seki H, 2011, PLANT CELL, V23, P4112, DOI 10.1105/tpc.110.082685; Shibuya M, 2006, FEBS J, V273, P948, DOI 10.1111/j.1742-4658.2006.05120.x; Shibuya M, 2010, FEBS LETT, V584, P2258, DOI 10.1016/j.febslet.2010.03.037; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tong W.Y, 2013, NAT PRODUCTS, P2733, DOI [10.1007/978-3-642-22144-6_122, DOI 10.1007/978-3-642-22144-6_122]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HL, 2006, CHEM PHARM BULL, V54, P1739, DOI 10.1248/cpb.54.1739; Wang YP, 2013, NEW PHYTOL, V198, P274, DOI 10.1111/nph.12137; WILLOW M, 1980, LIFE SCI, V26, P219, DOI 10.1016/0024-3205(80)90296-9; Woltedji D, 2012, J PROTEOME RES, V11, P4526, DOI 10.1021/pr300298w; Yang RL, 2013, PLANT CELL, V25, P71, DOI 10.1105/tpc.112.106716; Yao Y, 2010, PHARM BIOL, V48, P801, DOI 10.3109/13880200903280042; Zhou SJ, 2013, PHYTOCHEM ANALYSIS, V24, P527, DOI 10.1002/pca.2427	67	18	24	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105765	10.1371/journal.pone.0105765	http://dx.doi.org/10.1371/journal.pone.0105765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148032	Green Submitted, gold, Green Published			2022-12-25	WOS:000341230600079
J	Manawadu, D; Choyi, J; Kalra, L				Manawadu, Dulka; Choyi, Jithesh; Kalra, Lalit			The Impact of Early Specialist Management on Outcomes of Patients with In-Hospital Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; COMPUTED-TOMOGRAPHY; REGISTRY	Delays in treatment of in-hospital stroke (IHS) adversely affect patient outcomes. We hypothesised that early referral and specialist management of IHS patients will improve outcomes at 90 days. Baseline characteristics, assessment delays, thrombolysis eligibility, 90-day functional outcomes and all-cause mortality were compared between IHS patients referred for specialist stroke management within 3 hours of symptom onset (early referrals) and later referrals. Patients were identified from a prospective stroke registry between January 2009 and December 2010. Inclusion criteria were primary admission with a non-stroke diagnosis, onset of new neurological deficits after admission and early ischaemic changes on CT or MR imaging. Eighty four (4.6%) of 1836 stroke patients had IHS (mean age 74 year; 51% male, median NIHSS score 10). There were no significant differences in baseline characteristics between 53 (63%) early and 31 (37%) late referrals. Thrombolysis was performed in 29 (76%) of the 37/78 (47%) potentially eligible patients; 7 patients were excluded because specialist referral was delayed beyond 4.5 hours despite symptom recognition within 3 hours of onset. Early referral improved functional outcomes (modified Rankin Scale 0-2 at 90 days 40% v 7%, p = 0.001) and was an independent predictor of mRS 0-2 at 90 days after adjusting for age, pre-morbid function, primary cause for hospital admission and stroke severity [OR 1.13 (95% C.I. = 1.10-1.27), p = 0.002]. Early referral and specialist management of IHS patients that includes thrombolysis is associated with better functional outcomes at 90 days.	[Manawadu, Dulka; Choyi, Jithesh; Kalra, Lalit] Kings Coll London, Dept Clin Neurosci, London, England; [Manawadu, Dulka] Kings Coll Hosp London, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Manawadu, D (corresponding author), Kings Coll London, Dept Clin Neurosci, London, England.	dulka.manawadu@nhs.net						Alvaro LC, 2008, NEUROLOGIA, V23, P4; Cumbler E, 2011, STROKE, V42, P207, DOI 10.1161/STROKEAHA.110.590265; Demchuk AM, 2005, STROKE, V36, P2110, DOI 10.1161/01.STR.0000181116.15426.58; Evans A, 2001, LANCET, V358, P1586, DOI 10.1016/S0140-6736(01)06652-1; Farooq MU, 2008, CEREBROVASC DIS, V25, P12, DOI 10.1159/000111494; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Kim EY, 2005, STROKE, V36, P2745, DOI 10.1161/01.STR.0000185720.03803.41; Kimura K, 2006, EUR NEUROL, V55, P155, DOI 10.1159/000093574; Masjuan J, 2008, STROKE, V39, P2614, DOI 10.1161/STROKEAHA.107.512848; Park HJ, 2009, EUR J NEUROL, V16, P582, DOI 10.1111/j.1468-1331.2009.02538.x; Stroke Unit Trialists' Collaboration Organised inpatient (stroke unit) care for stroke, 2007, COCHRANE DATABASE SY; Vera R, 2011, EUR J NEUROL, V18, P170, DOI 10.1111/j.1468-1331.2010.03105.x	13	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104758	10.1371/journal.pone.0104758	http://dx.doi.org/10.1371/journal.pone.0104758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144197	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100021
J	Takahashi, S; Tomita, J; Nishioka, K; Hisada, T; Nishijima, M				Takahashi, Shunsuke; Tomita, Junko; Nishioka, Kaori; Hisada, Takayoshi; Nishijima, Miyuki			Development of a Prokaryotic Universal Primer for Simultaneous Analysis of Bacteria and Archaea Using Next-Generation Sequencing	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; RIBOSOMAL-RNA GENE; MICROBIAL COMMUNITIES; RELATIVE ABUNDANCE; COPY NUMBER; GENOME SIZE; DIVERSITY; PCR; QUANTIFICATION; MISMATCH	For the analysis of microbial community structure based on 16S rDNA sequence diversity, sensitive and robust PCR amplification of 16S rDNA is a critical step. To obtain accurate microbial composition data, PCR amplification must be free of bias; however, amplifying all 16S rDNA species with equal efficiency from a sample containing a large variety of microorganisms remains challenging. Here, we designed a universal primer based on the V3-V4 hypervariable region of prokaryotic 16S rDNA for the simultaneous detection of Bacteria and Archaea in fecal samples from crossbred pigs (LandracexLarge whitexDuroc) using an Illumina MiSeq next-generation sequencer. In-silico analysis showed that the newly designed universal prokaryotic primers matched approximately 98.0% of Bacteria and 94.6% of Archaea rRNA gene sequences in the Ribosomal Database Project database. For each sequencing reaction performed with the prokaryotic universal primer, an average of 69,330 (+/- 20,482) reads were obtained, of which archaeal rRNA genes comprised approximately 1.2% to 3.2% of all prokaryotic reads. In addition, the detection frequency of Bacteria belonging to the phylum Verrucomicrobia, including members of the classes Verrucomicrobiae and Opitutae, was higher in the NGS analysis using the prokaryotic universal primer than that performed with the bacterial universal primer. Importantly, this new prokaryotic universal primer set had markedly lower bias than that of most previously designed universal primers. Our findings demonstrate that the prokaryotic universal primer set designed in the present study will permit the simultaneous detection of Bacteria and Archaea, and will therefore allow for a more comprehensive understanding of microbial community structures in environmental samples.	[Takahashi, Shunsuke; Tomita, Junko; Nishioka, Kaori; Hisada, Takayoshi; Nishijima, Miyuki] TechnoSuruga Lab Co Ltd, Shizuoka, Japan		Takahashi, S (corresponding author), TechnoSuruga Lab Co Ltd, Shizuoka, Japan.	shunsuke.takahashi@tecsrg.co.jp		Takahashi, Shunsuke/0000-0002-4186-8119				Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Braker G, 2001, APPL ENVIRON MICROB, V67, P1893, DOI 10.1128/AEM.67.4.1893-1901.2001; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Caporaso JG, 2012, ISME J, V6, P1089, DOI 10.1038/ismej.2011.162; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Han MQ, 2012, MAR BIOTECHNOL, V14, P701, DOI 10.1007/s10126-012-9436-5; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Ishii K, 2001, APPL ENVIRON MICROB, V67, P3753, DOI 10.1128/AEM.67.8.3753-3755.2001; Kiyohara M, 2012, BIOSCI BIOTECH BIOCH, V76, P48, DOI 10.1271/bbb.110424; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Liu FH, 2009, J APPL MICROBIOL, V106, P952, DOI 10.1111/j.1365-2672.2008.04064.x; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakayama J., 2007, Journal of Intestinal Microbiology, V21, P129; Nakayama J., 2010, Bioscience and Microflora, V29, P83; Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09; Patra AK, 2012, APPL ENVIRON MICROB, V78, P4271, DOI 10.1128/AEM.00309-12; Silva MCPE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051554; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Suchankova P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076431, 10.1371/journal.pone.0071284]; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tang C, 2013, APPL ENVIRON MICROB, V79, P1034, DOI 10.1128/AEM.02336-12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Winter C, 2013, ISME J, V7, P1507, DOI 10.1038/ismej.2013.56; Wrede C, 2012, ARCHAEA, V2012, DOI 10.1155/2012/596846; Wu JH, 2009, J MICROBIOL METH, V77, P267, DOI 10.1016/j.mimet.2009.03.001; Xu YJ, 2012, J CLIN MICROBIOL, V50, P3901, DOI 10.1128/JCM.01237-12; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465; Zumsteg A, 2012, MICROB ECOL, V63, P552, DOI 10.1007/s00248-011-9991-8	49	701	716	16	211	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105592	10.1371/journal.pone.0105592	http://dx.doi.org/10.1371/journal.pone.0105592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144201	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100091
J	Sanchez, MV; Ebensen, T; Schulze, K; Cargnelutti, D; Blazejewska, P; Scodeller, EA; Guzman, CA				Sanchez, Maria Victoria; Ebensen, Thomas; Schulze, Kai; Cargnelutti, Diego; Blazejewska, Paulina; Scodeller, Eduardo A.; Guzman, Carlos A.			Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge	PLOS ONE			English	Article							CD4(+) T-CELLS; A VIRUS; INTRACELLULAR NEUTRALIZATION; MUCOSAL IMMUNITY; MAJOR TARGET; VACCINE; NUCLEOPROTEIN; ANTIGEN; MEMORY; IMMUNOGENICITY	There is a critical need for new influenza vaccines able to protect against constantly emerging divergent virus strains. This will be sustained by the induction of vigorous cellular responses and humoral immunity capable of acting at the portal of entry of this pathogen. In this study we evaluate the protective efficacy of intranasal vaccination with recombinant influenza nucleoprotein (rNP) co-administrated with bis-(3',5')-cyclic dimeric adenosine monophosphate (c-di-AMP) as adjuvant. Immunization of BALB/c mice with two doses of the formulation stimulates high titers of NP-specific IgG in serum and secretory IgA at mucosal sites. This formulation also promotes a strong Th1 response characterized by high secretion of INF-gamma and IL-2. The immune response elicited promotes efficient protection against virus challenge. These results suggest that c-di-AMP is a potent mucosal adjuvant which may significantly contribute towards the development of innovative mucosal vaccines against influenza.	[Sanchez, Maria Victoria; Cargnelutti, Diego; Scodeller, Eduardo A.] Consejo Nacl Invest Cient & Tecn, Inst Expt Med & Biol Cuyo IMBECU CCT, Virol Lab, Mendoza, Argentina; [Sanchez, Maria Victoria; Ebensen, Thomas; Schulze, Kai; Guzman, Carlos A.] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Blazejewska, Paulina] Boehringer Ingelheim Vet Res Ctr GmbH & Co KG, Hannover, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Helmholtz Association; Helmholtz-Center for Infection Research; Boehringer Ingelheim	Ebensen, T (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	Thomas.Ebensen@helmholtz-hzi.de		Cargnelutti, Diego Esteban/0000-0002-1246-7551; Sanchez, Maria/0000-0003-2252-959X	EU (PANFLUVAC); EU (TRANSVAC); BMBF; German Academic Exchange Service (DAAD); CONICET	EU (PANFLUVAC); EU (TRANSVAC); BMBF(Federal Ministry of Education & Research (BMBF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work at the HZI was supported in part by grants from the EU (PANFLUVAC, TRANSVAC); BMBF in the context of the programs Gerontosys 2 (Gerontoshield), EuroNanoMed (HCVAX) and ERANetRUS (HCRUS). Maria Victoria Sanchez had a fellowship from CONICET and was in part supported by a fellowship from the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyegbo MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061101; Belongia E., 2008, Morbidity and Mortality Weekly Report, V57, P393; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Boonnak K, 2012, J CLIN INVEST, V122, P2768, DOI 10.1172/JCI65208; Boyce TG, 2000, VACCINE, V19, P217, DOI 10.1016/S0264-410X(00)00171-7; Brokstad KA, 2002, J INFECT DIS, V185, P878, DOI 10.1086/339710; Cargnelutti DE, 2012, J MICROBIOL BIOTECHN, V22, P416, DOI 10.4014/jmb.1106.06021; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; Ebensen T, 2007, CLIN VACCINE IMMUNOL, V14, P952, DOI 10.1128/CVI.00119-07; Ebensen T, 2007, VACCINE, V25, P1464, DOI 10.1016/j.vaccine.2006.10.033; Ebensen T, 2011, VACCINE, V29, P5210, DOI 10.1016/j.vaccine.2011.05.026; Ebensen T, 2009, ADV EXP MED BIOL, V655, P171, DOI 10.1007/978-1-4419-1132-2_13; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; Ennis FA, 1999, VIROLOGY, V259, P256, DOI 10.1006/viro.1999.9765; Falkeborn T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070527; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Gopal R, 2014, AM J PATHOL, V184, P55, DOI 10.1016/j.ajpath.2013.09.012; Grant E, 2013, IMMUNOL CELL BIOL, V91, P184, DOI 10.1038/icb.2012.78; Guo LN, 2010, ARCH VIROL, V155, P1765, DOI 10.1007/s00705-010-0756-3; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Huang BY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-322; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; LaMere MW, 2011, J VIROL, V85, P5027, DOI 10.1128/JVI.00150-11; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Li CG, 2012, CELL RES, V22, P528, DOI 10.1038/cr.2011.165; Li CKF, 2013, CURR OPIN IMMUNOL, V25, P470, DOI 10.1016/j.coi.2013.07.005; Libanova R, 2010, VACCINE, V28, P2249, DOI 10.1016/j.vaccine.2009.12.045; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069649; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; MacLeod MKL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061775; Madhun AS, 2011, VACCINE, V29, P4973, DOI 10.1016/j.vaccine.2011.04.094; Margine I, 2013, J VIROL, V87, P10435, DOI 10.1128/JVI.01715-13; MAZANEC MB, 1992, P NATL ACAD SCI USA, V89, P6901, DOI 10.1073/pnas.89.15.6901; MAZANEC MB, 1995, J VIROL, V69, P1339, DOI 10.1128/JVI.69.2.1339-1343.1995; McKinstry KK, 2013, ARCH IMMUNOL THER EX, V61, P341, DOI 10.1007/s00005-013-0236-z; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; O'Donnell CD, 2012, MBIO, V3, DOI 10.1128/mBio.00120-12; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Patterson DP, 2013, ACS NANO, V7, P3036, DOI 10.1021/nn4006544; Pedersen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026973; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Rangel-Moreno J, 2008, J IMMUNOL, V180, P454, DOI 10.4049/jimmunol.180.1.454; Rimmelzwaan GF, 2000, VACCINE, V19, P1180, DOI 10.1016/S0264-410X(00)00310-8; Rose MA, 2012, EXPERT REV VACCINES, V11, P595, DOI [10.1586/erv.12.31, 10.1586/ERV.12.31]; Savard C, 2012, VACCINE, V30, P2535, DOI 10.1016/j.vaccine.2012.01.085; Schotsaert M, 2012, EXPERT REV VACCINES, V11, P949, DOI [10.1586/erv.12.71, 10.1586/ERV.12.71]; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Sun K, 2011, J IMMUNOL, V186, P987, DOI 10.4049/jimmunol.1002664; Svindland SC, 2013, INFLUENZA OTHER RESP, V7, P1181, DOI 10.1111/irv.12056; Tamura S, 1996, J IMMUNOL, V156, P3892; TAYLOR PM, 1986, IMMUNOLOGY, V58, P417; Vitelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055435; Wang W, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044883, 10.1371/journal.pone.0052488]; Wang XH, 2011, CELL MOL IMMUNOL, V8, P462, DOI 10.1038/cmi.2011.38; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Zhong WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010583; Zhou DH, 2011, J VIROL, V85, P11090, DOI 10.1128/JVI.00768-11	68	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104824	10.1371/journal.pone.0104824	http://dx.doi.org/10.1371/journal.pone.0104824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140692	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200037
J	Teh, JT; Zhu, WL; Ilkayeva, OR; Li, Y; Gooding, J; Casey, PJ; Summers, SA; Newgard, CB; Wang, M				Teh, J. T.; Zhu, W. L.; Ilkayeva, O. R.; Li, Y.; Gooding, J.; Casey, P. J.; Summers, S. A.; Newgard, C. B.; Wang, M.			Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism	ONCOGENE			English	Article							TANDEM MASS-SPECTROMETRY; SMALL-MOLECULE INHIBITOR; K-RAS; CARBOXYL METHYLTRANSFERASE; MAMMALIAN-CELLS; PHOSPHORYLATION; AUTOPHAGY; ENZYMES; GROWTH; AMPK	Isoprenylcysteine carboxylmethyltransferase (Icmt) catalyzes the last of the three-step posttranslational protein prenylation process for the so-called CaaX proteins, which includes many signaling proteins, such as most small GTPases. Despite extensive studies on Icmt and its regulation of cell functions, the mechanisms of much of the impact of Icmt on cellular functions remain unclear. Our recent studies demonstrated that suppression of Icmt results in induction of autophagy, inhibition of cell growth and inhibition of proliferation in various cancer cell types, prompting this investigation of potential metabolic regulation by Icmt. We report here the findings that Icmt inhibition reduces the function of mitochondrial oxidative phosphorylation in multiple cancer cell lines. In-depth oximetry analysis demonstrated that functions of mitochondrial complex I, II and III are subject to Icmt regulation. Consistently, Icmt inhibition decreased cellular ATP and depleted critical tricarboxylic acid cycle metabolites, leading to suppression of cell anabolism and growth, and marked autophagy. Several different approaches demonstrated that the impact of Icmt inhibition on cell proliferation and viability was largely mediated by its effect on mitochondrial respiration. This previously unappreciated function of Icmt, which can be therapeutically exploited, likely has a significant role in the impact of Icmt on tumorigenic processes.	[Teh, J. T.; Zhu, W. L.; Casey, P. J.; Wang, M.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Zhu, W. L.; Wang, M.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Ilkayeva, O. R.; Gooding, J.; Newgard, C. B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Ilkayeva, O. R.; Gooding, J.; Newgard, C. B.] Duke Univ, Med Ctr, Duke Inst Mol Physiol, Durham, NC USA; [Li, Y.; Summers, S. A.] Duke NUS Grad Med Sch, Program Cardiovasc & Metab Disorders, Singapore 169857, Singapore	National University of Singapore; National University of Singapore; Duke University; Duke University; National University of Singapore	Wang, M (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	mei.wang@duke-nus.edu.sg	/AAE-5384-2020; Zhu, Wan Long/GYA-3382-2022	Wang, Mei/0000-0001-6887-6840; zhu, Wanlong/0000-0003-0025-6674; Casey, Patrick/0000-0002-7366-9309	National Medical Research Council (NMRC); Duke-NUS	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Duke-NUS	These experiments were supported by grant from National Medical Research Council (NMRC) and Duke-NUS institutional funding. Wild-type and Icmt-null MEFs are from Dr M Bergo.	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; BERG P, 1953, NATURE, V172, P1008, DOI 10.1038/1721008a0; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; CHACE DH, 1993, CLIN CHEM, V39, P66; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Cordell RL, 2008, J CHROMATOGR B, V871, P115, DOI 10.1016/j.jchromb.2008.07.005; Cushman I, 2011, CELL ADHES MIGR, V5, P11, DOI 10.4161/cam.5.1.13196; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GREGOIRE M, 1984, EUR J BIOCHEM, V142, P49, DOI 10.1111/j.1432-1033.1984.tb08249.x; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KREBS HA, 1955, BIOCHEM J, V61, P435, DOI 10.1042/bj0610435; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Millington DS, 2011, METHODS MOL BIOL, V708, P55, DOI 10.1007/978-1-61737-985-7_3; MILLINGTON DS, 1992, PROG CLIN BIOL RES, V375, P339; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Neuzil J, 2007, MOL ASPECTS MED, V28, P607, DOI 10.1016/j.mam.2007.02.003; Pathania D, 2009, ADV DRUG DELIVER REV, V61, P1250, DOI 10.1016/j.addr.2009.05.010; POTTER VR, 1958, FED PROC, V17, P691; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang M, 2010, ONCOGENE, V29, P4959, DOI 10.1038/onc.2010.247; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Zhu WL, 2011, J BIOL CHEM, V286, P35291, DOI 10.1074/jbc.M111.280990	40	19	22	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3296	3304		10.1038/onc.2014.260	http://dx.doi.org/10.1038/onc.2014.260			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25151967				2022-12-25	WOS:000356592300008
J	Reissner, C; Stahn, J; Breuer, D; Klose, M; Pohlentz, G; Mormann, M; Missler, M				Reissner, Carsten; Stahn, Johanna; Breuer, Dorothee; Klose, Martin; Pohlentz, Gottfried; Mormann, Michael; Missler, Markus			Dystroglycan Binding to alpha-Neurexin Competes with Neurexophilin-1 and Neuroligin in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Adhesion; Autism; Disulfide; Glycomics; Molecular Modeling; Site-directed Mutagenesis	CONGENITAL MUSCULAR-DYSTROPHY; PROTEIN-STRUCTURE PREDICTION; EXCITATORY SYNAPSE FORMATION; CELL-SURFACE PROTEINS; CRYSTAL-STRUCTURE; LAMININ-BINDING; INHIBITORY SYNAPSES; BETA-NEUREXINS; ENDOPLASMIC-RETICULUM; LATROTOXIN RECEPTOR	Background: Extracellular matrix dystroglycan has essential functions at the neuromuscular junction and at inhibitory synapses in the brain. Results: Brain dystroglycan competes with neurexophilin-1 and neuroligins for binding to presynaptic -neurexins. Conclusion: Competition between -neurexin ligands in combination with alternative splicing determines formation of important trans-synaptic complexes. Significance: This is the first analysis of binding interference in -neurexin multiplexes. -Neurexins (-Nrxn) are mostly presynaptic cell surface molecules essential for neurotransmission that are linked to neuro-developmental disorders as autism or schizophrenia. Several interaction partners of -Nrxn are identified that depend on alternative splicing, including neuroligins (Nlgn) and dystroglycan (DAG). The trans-synaptic complex with Nlgn1 was extensively characterized and shown to partially mediate -Nrxn function. However, the interactions of -Nrxn with DAG, neurexophilins (Nxph1) and Nlgn2, ligands that occur specifically at inhibitory synapses, are incompletely understood. Using site-directed mutagenesis, we demonstrate the exact binding epitopes of DAG and Nxph1 on Nrxn1 and show that their binding is mutually exclusive. Identification of an unusual cysteine bridge pattern and complex type glycans in Nxph1 ensure binding to the second laminin/neurexin/sex hormone binding (LNS2) domain of Nrxn1, but this association does not interfere with Nlgn binding at LNS6. DAG, in contrast, interacts with both LNS2 and LNS6 domains without inserts in splice sites SS#2 or SS#4 mostly via LARGE (like-acetylglucosaminyltransferase)-dependent glycans attached to the mucin region. Unexpectedly, binding of DAG at LNS2 prevents interaction of Nlgn at LNS6 with or without splice insert in SS#4, presumably by sterically hindering each other in the u-form conformation of -Nrxn. Thus, expression of DAG and Nxph1 together with alternative splicing in Nrxn1 may prevent or facilitate formation of distinct trans-synaptic NrxnNlgn complexes, revealing an unanticipated way to contribute to the identity of synaptic subpopulations.	[Reissner, Carsten; Stahn, Johanna; Breuer, Dorothee; Klose, Martin; Missler, Markus] Univ Munster, Inst Anat & Mol Neurobiol, D-48149 Munster, Germany; [Pohlentz, Gottfried; Mormann, Michael] Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany; [Missler, Markus] Cells Mot, Cluster Excellence EXC 1003, D-48149 Munster, Germany	University of Munster; University of Munster	Missler, M (corresponding author), Univ Munster, Inst Anat & Mol Neurobiol, Vesaliusweg 2-4, D-48149 Munster, Germany.	markus.missler@uni-muenster.de	Mormann, Michael/T-4860-2017	Mormann, Michael/0000-0002-7428-7329; Reissner, Carsten/0000-0002-5496-9971; Missler, Markus/0000-0001-8008-984X; Stahn, Jochen/0000-0002-6711-0592	Deutsche Forschungsgemeinschaft [SFB492-TPA16, SFB629-TPB11, 492-Z2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in parts, by Deutsche Forschungsgemeinschaft Grants SFB492-TPA16 (to M. Missler), SFB629-TPB11 (M. Missler), and 492-Z2 (to M. Mormann).	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Batta G, 2009, FEBS J, V276, P2875, DOI 10.1111/j.1742-4658.2009.07011.x; BENHAM CJ, 1993, PROTEIN SCI, V2, P41; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Born G, 2014, P NATL ACAD SCI USA, V111, pE1274, DOI 10.1073/pnas.1312112111; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Bulleid NJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013219; Chang CEA, 2008, P NATL ACAD SCI USA, V105, P7456, DOI 10.1073/pnas.0800452105; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Chen WT, 2013, J AM CHEM SOC, V135, P9877, DOI 10.1021/ja4040472; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comim CM, 2013, MOL NEUROBIOL, V48, P71, DOI 10.1007/s12035-013-8415-9; Comoletti D, 2008, CHEM-BIOL INTERACT, V175, P150, DOI 10.1016/j.cbi.2008.04.040; Comoletti D, 2010, STRUCTURE, V18, P1044, DOI 10.1016/j.str.2010.06.005; De Rosa MC, 2011, J MOL GRAPH MODEL, V29, P1015, DOI 10.1016/j.jmgm.2011.04.008; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Flint J, 2005, J BIOL CHEM, V280, P23718, DOI 10.1074/jbc.M501551200; GEE SH, 1993, J BIOL CHEM, V268, P14972; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Grewal PK, 2002, BBA-GEN SUBJECTS, V1573, P216, DOI 10.1016/S0304-4165(02)00387-2; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Hussain NK, 2005, SCIENCE, V307, P1207, DOI 10.1126/science.1110011; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2010, J BIOL CHEM, V285, P31208, DOI 10.1074/jbc.M110.116343; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Koehnke J, 2008, P NATL ACAD SCI USA, V105, P1873, DOI 10.1073/pnas.0711701105; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Leone P, 2010, EMBO J, V29, P2461, DOI 10.1038/emboj.2010.123; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Lui L, 2010, J NEUROSCI RES, V88, P837, DOI 10.1002/jnr.22258; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROSCI, V18, P3630; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Montanaro F, 2003, NEURON, V37, P193, DOI 10.1016/S0896-6273(03)00032-1; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Mormann M, 2008, ANAL BIOANAL CHEM, V392, P831, DOI 10.1007/s00216-008-2258-7; Nakagawa N, 2013, GLYCOBIOLOGY, V23, P1066, DOI 10.1093/glycob/cwt043; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Neue K, 2011, J PROTEOME RES, V10, P2248, DOI 10.1021/pr101082c; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Patzke H, 2000, MOL CELL NEUROSCI, V15, P561, DOI 10.1006/mcne.2000.0853; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Pribiag H, 2014, P NATL ACAD SCI USA, V111, P6810, DOI 10.1073/pnas.1321774111; PUSCHEL AW, 1995, J NEUROSCI, V15, P2849; Reichelt AC, 2012, NEUROPHARMACOLOGY, V62, P1519, DOI 10.1016/j.neuropharm.2011.01.024; Reissner C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-213; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; REZNIK M, 2012, PLOS ONE, V7, P37894; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018579; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Saito F, 2008, FEBS LETT, V582, P439, DOI 10.1016/j.febslet.2008.01.006; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Saura CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019430; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Simons KT, 1999, PROTEINS, P171; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sons MS, 2006, NEUROSCIENCE, V138, P433, DOI 10.1016/j.neuroscience.2005.11.040; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Striegel AR, 2012, J NEUROSCI, V32, P1253, DOI 10.1523/JNEUROSCI.4652-11.2012; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tanaka H, 2012, CELL REPORTS, V2, P101, DOI 10.1016/j.celrep.2012.06.009; Tanaka H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019411; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Xu Jinbo, 2003, J Bioinform Comput Biol, V1, P95, DOI 10.1142/S0219720003000186; YOON HJ, 2013, PLOS CURR, V5, DOI DOI 10.1371/CURRENTS.MD.3756B4A389974DFF21C0CF13508D3F7B; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	119	43	45	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27585	27603		10.1074/jbc.M114.595413	http://dx.doi.org/10.1074/jbc.M114.595413			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25157101	hybrid, Green Published			2022-12-25	WOS:000342852800020
J	Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, AG; Calvez, V; Antinori, A; Ceccherini-Silberstein, F; Perno, CF; Santoro, MM				Armenia, Daniele; Soulie, Cathia; Di Carlo, Domenico; Fabeni, Lavinia; Gori, Caterina; Forbici, Federica; Svicher, Valentina; Bertoli, Ada; Sarmati, Loredana; Giuliani, Massimo; Latini, Alessandra; Boumis, Evangelo; Zaccarelli, Mauro; Bellagamba, Rita; Andreoni, Massimo; Marcelin, Anne-Genevieve; Calvez, Vincent; Antinori, Andrea; Ceccherini-Silberstein, Francesca; Perno, Carlo-Federico; Santoro, Maria Mercedes			A Very Low Geno2pheno False Positive Rate Is Associated with Poor Viro-Immunological Response in Drug-Naive Patients Starting a First-Line HAART	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; CD4 CELL COUNT; DISEASE PROGRESSION; CORECEPTOR TROPISM; TYPE-1 TROPISM; HIV-1-INFECTED PATIENTS; VIROLOGICAL RESPONSES; RESISTANCE MUTATIONS; CCR5 ANTAGONISTS	Background: We previously found that a very low geno2pheno false positive rate (FPR <= 2%) defines a viral population associated with low CD4 cell count and the highest amount of X4-quasispecies. In this study, we aimed at evaluating whether FPR <= 2% might impact on the viro-immunological response in HIV-1 infected patients starting a first-line HAART. Methods: The analysis was performed on 305 HIV-1 B subtype infected drug-naive patients who started their first-line HAART. Baseline FPR (%) values were stratified according to the following ranges: <= 2; 2-5; 5-10; 10-20; 20-60; >60. The impact of genotypically-inferred tropism on the time to achieve immunological reconstitution (a CD4 cell count gain from HAART initiation >= 150 cells/mm(3)) and on the time to achieve virological success (the first HIV-RNA measurement <50 copies/mL from HAART initiation) was evaluated by survival analyses. Results: Overall, at therapy start, 27% of patients had FPR <= 10 (6%, FPR <= 2; 7%, FPR 2-5; 14%, FPR 5-10). By 12 months of therapy the rate of immunological reconstitution was overall 75.5%, and it was significantly lower for FPR <= 2 (54.1%) in comparison to other FPR ranks (78.8%, FPR 2-5; 77.5%, FPR 5-10; 71.7%, FPR 10-20; 81.8%, FPR 20-60; 75.1%, FPR >60; p = 0.008). The overall proportion of patients achieving virological success was 95.5% by 12 months of therapy. Multivariable Cox analyses showed that patients having pre-HAART FPR <= 2% had a significant lower relative adjusted hazard [95% C. I.] both to achieve immunological reconstitution (0.37 [0.20-0.71], p = 0.003) and to achieve virological success (0.50 [0.26-0.94], p = 0.031) than those with pre-HAART FPR >60%. Conclusions: Beyond the genotypically-inferred tropism determination, FPR <= 2% predicts both a poor immunological reconstitution and a lower virological response in drug-naive patients who started their first-line therapy. This parameter could be useful to identify patients potentially with less chance of achieving adequate immunological reconstitution and virological undetectability.	[Armenia, Daniele; Di Carlo, Domenico; Svicher, Valentina; Bertoli, Ada; Ceccherini-Silberstein, Francesca; Perno, Carlo-Federico; Santoro, Maria Mercedes] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Soulie, Cathia; Marcelin, Anne-Genevieve; Calvez, Vincent] Univ Paris 06, Pierre Louis Inst Epidemiol & Publ Hlth, Unite Mixte Rech Sante UMR S 1136, Paris, France; [Soulie, Cathia; Marcelin, Anne-Genevieve; Calvez, Vincent] INSERM, Pierre Louis Inst Epidemiol & Publ Hlth, UMR S 1136, Paris, France; [Soulie, Cathia; Marcelin, Anne-Genevieve; Calvez, Vincent] Grp Hosp Pitie Salpetriere, AP HP, Virol Lab, F-75634 Paris, France; [Fabeni, Lavinia; Gori, Caterina; Forbici, Federica; Perno, Carlo-Federico] Ist Nazl Malattie Infett INMI Lazzaro Spallanzani, Antiviral Drug Monitoring Unit, Rome, Italy; [Bertoli, Ada; Perno, Carlo-Federico] Univ Hosp Tor Vergata, Rome, Italy; [Sarmati, Loredana; Andreoni, Massimo] Univ Hosp Tor Vergata, Infect Dis Unit, Rome, Italy; [Giuliani, Massimo; Latini, Alessandra] San Gallicano Hosp, Dept Infect Dermatol, Rome, Italy; [Boumis, Evangelo; Zaccarelli, Mauro; Bellagamba, Rita; Antinori, Andrea] Ist Nazl Malattie Infett INMI Lazzaro Spallanzani, Div Infect Dis, Rome, Italy	University of Rome Tor Vergata; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Santoro, MM (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy.	santormaria@gmail.com	FABENI, LAVINIA/J-6626-2016; Ceccherini-Silberstein, Francesca/K-4762-2016; Giuliani, Massimo/J-2788-2018; SOULIE, CATHIA/AIF-3965-2022; Di Maio, Velia Chiara/AGH-2628-2022; latini, alessandra/J-8186-2018; Armenia, Daniele/K-2009-2016; Antinori, Andrea/K-7125-2016; perno, carlo federico/O-1544-2016; Andreoni, Masimo/AAL-2214-2020; Zaccarelli, Mauro/GYV-1093-2022; SANTORO, MARIA/K-3250-2018; Marcelin, Anne-Genevieve/D-8272-2014; Forbici, Federica/B-6765-2017; gori, caterina/B-7836-2017	FABENI, LAVINIA/0000-0002-2975-8611; Giuliani, Massimo/0000-0002-4523-8261; Armenia, Daniele/0000-0002-3406-7014; Antinori, Andrea/0000-0003-2121-4684; SANTORO, MARIA/0000-0002-6228-1114; Marcelin, Anne-Genevieve/0000-0003-4808-8999; Forbici, Federica/0000-0002-3954-5679; BERTOLI, ADA/0000-0003-0663-2503; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; SVICHER, VALENTINA/0000-0002-2377-504X; Di Carlo, Domenico/0000-0002-8324-4873; Andreoni, Massimo/0000-0002-3205-9758; Latini, Alessandra/0000-0002-9421-6560; gori, caterina/0000-0002-6042-7570; PERNO, CARLO FEDERICO/0000-0002-0825-5388; sarmati, loredana/0000-0003-1452-0333	European Commission [223131]; European AIDS Treatment Network (NEAT) [LSHT/CT/2006/037570]; Italian Ministry of Health [CUP: E81J10000000001, 40H78]; AVIRALIA foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); European AIDS Treatment Network (NEAT); Italian Ministry of Health(Ministry of Health, Italy); AVIRALIA foundation	This work was financially supported by the European Commission Framework 7 Programme (CHAIN, the Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project no. 223131), and by the European AIDS Treatment Network (NEAT, contract number LSHT/CT/2006/037570); Italian Ministry of Health (CUP: E81J10000000001, Ricerca Corrente and Progetto AIDS grant no. n. 40H78); and by an unrestricted grant from AVIRALIA foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-111; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Carrillo A, 1996, J VIROL, V70, P1301, DOI 10.1128/JVI.70.2.1301-1309.1996; Ceccherini-Silberstein F, 2005, J VIROL, V79, P10718, DOI 10.1128/JVI.79.16.10718-10729.2005; Charpentier C, 2013, J ANTIMICROB CHEMOTH, V68, P690, DOI 10.1093/jac/dks455; Coakley E, 2009, ANTIMICROB AGENTS CH, V53, P4686, DOI 10.1128/AAC.00229-09; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Daar ES, 2007, CLIN INFECT DIS, V45, P643, DOI 10.1086/520650; Feinberg MB, 2002, NAT MED, V8, P537, DOI 10.1038/nm0602-537a; Foca E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-153; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Goetz MB, 2009, JAIDS-J ACQ IMM DEF, V50, P259, DOI 10.1097/QAI.0b013e3181989a8b; Hu QX, 2000, J MOL BIOL, V302, P359, DOI 10.1006/jmbi.2000.4076; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Lee GQ, 2013, AIDS RES HUM RETROV, V29, P979, DOI [10.1089/aid.2012.0338, 10.1089/AID.2012.0338]; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; McGovern RA, 2013, J ANTIMICROB CHEMOTH, V68, P2007, DOI 10.1093/jac/dkt153; McGovern RA, 2012, JAIDS-J ACQ IMM DEF, V61, P279, DOI 10.1097/QAI.0b013e31826249cf; Moore DM, 2006, AIDS, V20, P371, DOI 10.1097/01.aids.0000196180.11293.9a; Moore RD, 2008, CLIN INFECT DIS, V47, P1102, DOI 10.1086/592115; Nozza S, 2012, J ANTIMICROB CHEMOTH, V67, P1224, DOI 10.1093/jac/dkr600; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014, GUIDELINES USE ANTIR; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Poveda E, 2012, AIDS REV, V14, P208; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Ross TM, 1998, P NATL ACAD SCI USA, V95, P7682, DOI 10.1073/pnas.95.13.7682; Ruelle J, 2009, J CLIN VIROL, V44, P297, DOI 10.1016/j.jcv.2009.01.004; Santoro MM, 2012, CLIN MICROBIOL INFEC, V18, pE289, DOI 10.1111/j.1469-0691.2012.03905.x; Santoro MM, 2013, ANTIVIR THER, V18, P867, DOI 10.3851/IMP2531; Seclen E, 2011, J INFECT DIS, V204, P139, DOI 10.1093/infdis/jir218; Seclen E, 2010, J ANTIMICROB CHEMOTH, V65, P1486, DOI 10.1093/jac/dkq137; Sing T, 2007, ANTIVIR THER, V12, P1097; Sire JM, 2011, JAIDS-J ACQ IMM DEF, V56, P239, DOI 10.1097/QAI.0b013e3182099891; Soulie C, 2012, J MED VIROL, V84, P1853, DOI 10.1002/jmv.23362; Svicher V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053603; Svicher V, 2010, NEW MICROBIOL, V33, P195; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vandamme AM, 2011, AIDS REV, V13, P77; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Wirden M, 2011, J ANTIMICROB CHEMOTH, V66, P709, DOI 10.1093/jac/dkq544	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105853	10.1371/journal.pone.0105853	http://dx.doi.org/10.1371/journal.pone.0105853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153969	Green Published, gold			2022-12-25	WOS:000340952200086
J	Crichton, J; Hickman, M; Campbell, R; Heron, J; Horner, P; Macleod, J				Crichton, Joanna; Hickman, Matthew; Campbell, Rona; Heron, Jon; Horner, Paddy; Macleod, John			Prevalence of Chlamydia in Young Adulthood and Association with Life Course Socioeconomic Position: Birth Cohort Study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; TRACHOMATIS GENITAL-INFECTION; POPULATION-BASED SURVEY; RISK; ATTITUDES; BEHAVIOR; BRITAIN; STYLES; WOMEN	Background: Few estimates are available of chlamydia prevalence in the general population. Existing studies have limited scope to explore potential selection bias or associations with socioeconomic position. Methods: We examined the prevalence of Chlamydia trachomatis infection and associations with life-course socioeconomic position in the Avon Longitudinal Study of Parents and Children in England. Chlamydia infection was measured through nucleic acid amplification test of urine specimens. Results: 4864 (51%) of those invited attended the clinic (mean age 17.8; SD 0.37 years). (60%) provided a urine specimen. Prevalence was 1.0% (95% CI 0.6 to 1.6) among participants reporting sexual activity. Risk of infection was strongly associated with life course social disadvantage and with recent sexual behaviour. After adjustment for other measures of disadvantage and for sexual behaviour the strongest risk factors for infection were lower maternal educational attainment (OR 9.1 (1.1, 76.7)) and lower participant educational attainment at age 11 (OR 5.0 (1.5, 16.5)). Both clinic attendance and agreement to test were lower amongst the disadvantaged. Adjustment for selective participation based on detailed information on non-participants approximately doubled prevalence estimates. Prevalence was higher in sexually active women (1.4% (0.7 to 2.4) than men (0.5% (0.1 to 1.3)). Conclusions: Chlamydia prevalence in this general population sample was low even after adjustment for selective participation in testing. These estimates of prevalence and patterns of association with socioeconomic position may both reflect recent screening efforts. Prevalence was higher amongst the disadvantaged who were also less likely to engage in testing. Our results reveal the importance of monitoring and addressing inequalities in screening programme participation and outcomes.	[Crichton, Joanna; Hickman, Matthew; Campbell, Rona; Heron, Jon; Horner, Paddy; Macleod, John] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Bristol	Macleod, J (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	john.macleod@bristol.ac.uk	Hickman, Matthew/Y-2400-2019; Fazli, Ghazal/AAE-8320-2022; Heron, Jon/D-5884-2011	Hickman, Matthew/0000-0001-9864-459X; Heron, Jon/0000-0001-6199-5644; Horner, Paddy/0000-0003-0411-8332; Macleod, John/0000-0001-8202-1144	Wellcome Trust [092731]; Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation [MR/KO232331/1]; Cancer Research UK [MR/KO232331/1]; Economic and Social Research Council [MR/KO232331/1]; Medical Research Council [MR/KO232331/1]; Welsh Government [MR/KO232331/1]; Wellcome Trust under UK Clinical Research Collaboration [MR/KO232331/1]; UK Medical Research Council; University of Bristol; MRC [MR/K023233/1] Funding Source: UKRI; Economic and Social Research Council [1013622] Funding Source: researchfish; Medical Research Council [MC_PC_15018, MR/K023233/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Government; Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. The work was undertaken with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence. Joint funding (MR/KO232331/1) from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAC, 2013, ALSPAC DAT DICT; [Anonymous], 2013, FRAM SEX HLTH IMPR E; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Cumberlege J., 2010, FAIR SOC HEARLY LIVE; Datta SD, 2007, ANN INTERN MED, V147, P89, DOI 10.7326/0003-4819-147-2-200707170-00007; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Gottlieb SL, 2010, J INFECT DIS, V201, pS190, DOI 10.1086/652401; Gottlieb SL, 2010, J INFECT DIS, V201, pS156, DOI 10.1086/652396; Gotz HM, 2005, SEX TRANSM INFECT, V81, P24, DOI 10.1136/sti.2004.010181; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Horner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072001; Johnson SA, 2010, SEX TRANSM INFECT, V86, P217, DOI 10.1136/sti.2009.037283; Klausner JD, 2001, J INFECT DIS, V183, P1087, DOI 10.1086/319276; Low N, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11080; Low N, 2007, BMJ-BRIT MED J, V334, P725, DOI 10.1136/bmj.39154.378079.BE; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; McCadden A, 2005, SEX TRANSM DIS, V32, P387, DOI 10.1097/01.olq.0000162364.65643.08; McNulty CA, 2013, SEX TRANSM INFECT; Price MJ, 2013, EPIDEMIOL INFECT, P1; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Rubin DB, 2004, MULTIPLE IMPUTATION; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Sheringham J, 2013, SEX TRANSM INFECT, V89, P175, DOI 10.1136/sextrans-2011-050223; Sheringham J, 2011, SEX TRANSM DIS, V38, P677, DOI 10.1097/OLQ.0b013e31821597ca; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stein CR, 2008, ANN EPIDEMIOL, V18, P560, DOI 10.1016/j.annepidem.2008.03.002; Susser M, 2000, J EPIDEMIOL COMMUN H, V54, P882, DOI 10.1136/jech.54.12.882; Turner KME, 2013, SEX TRANSM INFECT, V89, P70, DOI 10.1136/sextrans-2012-050696; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Washbrook, 2008, UNDERSTANDING RELATI	33	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104943	10.1371/journal.pone.0104943	http://dx.doi.org/10.1371/journal.pone.0104943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153124	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200032
J	Zegeye, H; Rasheed, A; Makdis, F; Badebo, A; Ogbonnaya, FC				Zegeye, Habtemariam; Rasheed, Awais; Makdis, Farid; Badebo, Ayele; Ogbonnaya, Francis C.			Genome-Wide Association Mapping for Seedling and Adult Plant Resistance to Stripe Rust in Synthetic Hexaploid Wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; YELLOW RUST; LEAF RUST; LINKAGE DISEQUILIBRIUM; PUCCINIA-STRIIFORMIS; TRITICUM-TURGIDUM; GENETIC DIVERSITY; CHROMOSOMAL LOCATION; POPULATION-STRUCTURE; DURABLE RESISTANCE	Use of genetic diversity from related wild and domesticated species has made a significant contribution to improving wheat productivity. Synthetic hexaploid wheats (SHWs) exhibit natural genetic variation for resistance and/or tolerance to biotic and abiotic stresses. Stripe rust caused by (Puccinia striiformis f. sp. tritici; Pst), is an important disease of wheat worldwide. To characterise loci conferring resistance to stripe rust in SHWs, we conducted a genome-wide association study (GWAS) with a panel of 181 SHWs using the wheat 9K SNP iSelect array. The SHWs were evaluated for their response to the prevailing races of Pst at the seedling and adult plant stages, the latter in replicated field trials at two sites in Ethiopia in 2011. About 28% of the SHWs exhibited immunity at the seedling stage while 56% and 83% were resistant to Pst at the adult plant stage at Meraro and Arsi Robe, respectively. A total of 27 SNPs in nine genomic regions (1BS, 2AS, 2BL, 3BL, 3DL, 5A, 5BL, 6DS and 7A) were linked with resistance to Pst at the seedling stage, while 38 SNPs on 18 genomic regions were associated with resistance at the adult plant stage. Six genomic regions were commonly detected at both locations using a mixed linear model corrected for population structure, kinship relatedness and adjusted for false discovery rate (FDR). The loci on chromosome regions 1AS, 3DL, 6DS and 7AL appeared to be novel QTL; our results confirm that resynthesized wheat involving its progenitor species is a rich source of new stripe (yellow) rust resistance that may be useful in choosing SHWs and incorporating diverse yellow rust (YR) resistance loci into locally adapted wheat cultivars.	[Zegeye, Habtemariam; Badebo, Ayele] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia; [Rasheed, Awais] Chinese Acad Agr Sci, Crop Sci Res Inst, Natl Wheat Improvement Ctr, Beijing 100193, Peoples R China; [Rasheed, Awais] Quaid I Azam Univ, Dept Plant Sci, Islamabad, Pakistan; [Makdis, Farid] Univ Aleppo, Fac Agr, Dept Field Crops, Aleppo, Syria; [Ogbonnaya, Francis C.] Int Ctr Agr Res Dry Areas, Aleppo, Syria; [Makdis, Farid; Ogbonnaya, Francis C.] Grains Res & Dev Corp, Res Program, Canberra, ACT, Australia	Ethiopian Institute of Agricultural Research (EIAR); Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Quaid I Azam University; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Ogbonnaya, FC (corresponding author), Int Ctr Agr Res Dry Areas, POB 5466, Aleppo, Syria.	Francis.Ogbonnaya@grdc.com.au	Rasheed, Awais/A-1623-2010; Ogbonnaya, Francis C/C-5237-2014	Rasheed, Awais/0000-0003-2528-708X; Ogbonnaya, Francis C/0000-0002-8596-7362; Huluka, Ayele Badebo/0000-0001-6574-2724	Grains Research and Development Corporation (GRDC), Australia; International Centre for Agricultural Research in the Dryland Agriculture, Aleppo, Syria; Ethiopian Institute for Agricultural Research	Grains Research and Development Corporation (GRDC), Australia(Grains R&D Corp); International Centre for Agricultural Research in the Dryland Agriculture, Aleppo, Syria; Ethiopian Institute for Agricultural Research	The authors would like to thank Grains Research and Development Corporation (GRDC), Australia, International Centre for Agricultural Research in the Dryland Agriculture, Aleppo, Syria and Ethiopian Institute for Agricultural Research for providing financial support to carry out the research. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Qamar M, 2008, THEOR APPL GENET, V117, P1261, DOI 10.1007/s00122-008-0860-x; Ahmed S, 2014, AUSTRALAS PLANT PATH, V43, P109, DOI 10.1007/s13313-013-0237-8; Allen AM, 2013, PLANT BIOTECHNOL J, V11, P279, DOI 10.1111/pbi.12009; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; ANDERSON LH, 1993, J ANIM SCI, V71, P1566, DOI 10.2527/1993.7161566x; [Anonymous], 2014, ANN WHEAT NEWSL; Badebo A., 2005, ETHIOP J AGR SCI, V18, P129; Bariana HS, 2010, EUPHYTICA, V176, P251, DOI 10.1007/s10681-010-0240-x; Bariana HS, 2006, THEOR APPL GENET, V112, P1143, DOI 10.1007/s00122-006-0216-3; Boukhatem N, 2002, THEOR APPL GENET, V104, P111, DOI 10.1007/s001220200013; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Caldwell KS, 2004, GENETICS, V167, P941, DOI 10.1534/genetics.103.016303; Camus-Kulandaivelu L, 2007, CROP SCI, V47, P887, DOI 10.2135/cropsci2006.06.0366N; Carter AH, 2009, THEOR APPL GENET, V119, P1119, DOI 10.1007/s00122-009-1114-2; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Chao SM, 2009, MOL BREEDING, V23, P23, DOI 10.1007/s11032-008-9210-6; Chen X. M., 2002, Phytopathology, V92, pS14; Chen XM, 1996, PHYTOPATHOLOGY, V86, P1228, DOI 10.1094/Phyto-86-1228; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P375, DOI 10.1094/Phyto-85-375; COX TS, 1994, CROP SCI, V34, P958, DOI 10.2135/cropsci1994.0011183X003400020005x; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Dedryver F, 2009, PHYTOPATHOLOGY, V99, P968, DOI 10.1094/PHYTO-99-8-0968; Emebiri LC, 2010, MOL BREEDING, V26, P39, DOI 10.1007/s11032-009-9375-7; Emebiri LC, 2014, J SCI FOOD AGR, V94, P1422, DOI 10.1002/jsfa.6434; Eriksen L, 2004, THEOR APPL GENET, V108, P567, DOI [10.1007/s00122-003-1456-0, 10.1007/s00122-003-1573-9]; Flor HH, 1942, PHYTOPATHOLOGY, V32, P653; Fu YP, 2014, PLANT J, V78, P16, DOI [10.1111/tpj.12457, 10.1111/tpj.12355]; Guo J, 2013, PLANT PHYSIOL BIOCH, V71, P164, DOI 10.1016/j.plaphy.2013.07.009; Hadi Bux, 2012, Australian Journal of Crop Science, V6, P116; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Joukhadar R, 2013, MOL BREEDING, V32, P943, DOI 10.1007/s11032-013-9924-y; KEMA GHJ, 1992, EUPHYTICA, V63, P207; Khlestkina EK, 2007, EUPHYTICA, V153, P1, DOI 10.1007/s10681-006-9182-8; Knott DR, 1989, WHEAT RUSTS BREEEDIN; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Lan CX, 2010, PHYTOPATHOLOGY, V100, P313, DOI 10.1094/PHYTO-100-4-0313; Li CL, 2013, THEOR APPL GENET, V126, P2065, DOI 10.1007/s00122-013-2118-5; Li GQ, 2006, THEOR APPL GENET, V112, P1434, DOI 10.1007/s00122-006-0245-y; Li Q, 2011, THEOR APPL GENET, V122, P189, DOI 10.1007/s00122-010-1435-1; Lin F, 2008, THEOR APPL GENET, V116, P797, DOI 10.1007/s00122-008-0713-7; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lowe I, 2011, THEOR APPL GENET, V123, P143, DOI 10.1007/s00122-011-1573-0; Lu B. R., 2001, J GENET MOL GENET, V12, P190; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; MA H, 1995, EUPHYTICA, V83, P87, DOI 10.1007/BF01678034; MA H, 1995, EUPHYTICA, V82, P117, DOI 10.1007/BF00027057; Ma JX, 2001, EUPHYTICA, V120, P219, DOI 10.1023/A:1017510331721; Macharia KG, 2013, THESIS U MINNESOTA U; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Mallard S, 2005, THEOR APPL GENET, V110, P1401, DOI 10.1007/s00122-005-1954-3; Marais F, 2009, CROP SCI, V49, P871, DOI 10.2135/cropsci2008.06.0317; Marais GF, 2006, EUPHYTICA, V149, P373, DOI 10.1007/s10681-006-9092-9; Marais GF, 2005, PLANT BREEDING, V124, P538, DOI 10.1111/j.1439-0523.2005.01116.x; Marone D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-562; Marone D, 2012, MOL GENET GENOMICS, V287, P741, DOI 10.1007/s00438-012-0714-8; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; McIntosh RA, 2000, PLANT BREEDING, V119, P81, DOI 10.1046/j.1439-0523.2000.00449.x; McIntosh RA, 2011, THEOR APPL GENET, V123, P359, DOI 10.1007/s00122-011-1589-5; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Mulki MA, 2013, MOL BREEDING, V31, P299, DOI 10.1007/s11032-012-9790-z; Murphy LR, 2009, CROP SCI, V49, P1786, DOI 10.2135/cropsci2008.10.0621; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Ogbonnaya FC, 2008, AUST J AGR RES, V59, P421, DOI 10.1071/AR07227; Ogbonnaya FC, 2001, AUST J AGR RES, V52, P1367, DOI 10.1071/AR01031; Ogbonnaya FC, 2013, PL BRED RE, V37, P35; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rakshit S, 2012, J GENET, V91, P111, DOI 10.1007/s12041-012-0144-8; Rasheed A, 2014, BMC PLANT B IN PRESS; RAUPP WJ, 1993, J HERED, V84, P142, DOI 10.1093/oxfordjournals.jhered.a111300; Ren Y, 2012, THEOR APPL GENET, V125, P1211, DOI 10.1007/s00122-012-1907-6; RILEY R, 1968, NATURE, V217, P383, DOI 10.1038/217383a0; Rosewarne GM, 2008, THEOR APPL GENET, V116, P1027, DOI 10.1007/s00122-008-0736-0; Rosewarne GM, 2013, THEOR APPL GENET, V126, P2427, DOI 10.1007/s00122-013-2159-9; Rosewarne GM, 2012, THEOR APPL GENET, V124, P1283, DOI 10.1007/s00122-012-1786-x; Rosewarne GM, 2006, THEOR APPL GENET, V112, P500, DOI 10.1007/s00122-005-0153-6; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Sharma-Poudyal D, 2013, PLANT DIS, V97, P379, DOI 10.1094/PDIS-01-12-0078-RE; Singh R. P., 2000, Acta Phytopathologica et Entomologica Hungarica, V35, P133; Singh R. P., 2012, M CHALL YELL RUST CE, P25; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Singh RP, 2000, CROP SCI, V40, P1148, DOI 10.2135/cropsci2000.4041148x; Sohail Q, 2012, BREEDING SCI, V62, P38, DOI 10.1270/jsbbs.62.38; Solh M., 2012, GROWING THREAT STRIP; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun GL, 1997, THEOR APPL GENET, V95, P622, DOI 10.1007/s001220050604; Sun Q, 2002, PLANT BREEDING, V121, P539, DOI 10.1046/j.1439-0523.2002.00754.x; Tadesse W, 2014, CROP SCI, V54, P607, DOI 10.2135/cropsci2013.05.0289; Trethowan RM, 2008, CROP SCI, V48, P1255, DOI 10.2135/cropsci2007.08.0477; van Ginkel M, 2007, FIELD CROP RES, V104, P86, DOI 10.1016/j.fcr.2007.02.005; Vazquez MD, 2012, THEOR APPL GENET, V124, P1, DOI 10.1007/s00122-011-1681-x; Verslues PE, 2014, PLANT PHYSIOL, V164, P144, DOI 10.1104/pp.113.224014; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Wang LF, 2002, EUPHYTICA, V124, P71, DOI 10.1023/A:1015689817857; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058969; Warburton ML, 2006, EUPHYTICA, V149, P289, DOI 10.1007/s10681-005-9077-0; Weir BS, 1996, GENETIC DATA ANAL; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; Wen WE, 2008, MOL BREEDING, V22, P507, DOI 10.1007/s11032-008-9194-2; WILCOXSON RD, 1975, ANN APPL BIOL, V80, P275, DOI 10.1111/j.1744-7348.1975.tb01633.x; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Yang WY, 2009, J GENET GENOMICS, V36, P539, DOI 10.1016/S1673-8527(08)60145-9; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zeller F. J., 1973, Proceedings of the fourth international wheat genetics symposium. Alien genetic material., P209; Zhang JJ, 2013, MOL BREEDING, V32, P771, DOI 10.1007/s11032-013-9905-1; Zhang P, 2009, THEOR APPL GENET, V120, P25, DOI 10.1007/s00122-009-1156-5; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao YS, 2013, J EXP BOT, V64, P4453, DOI 10.1093/jxb/ert259; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zwart RS, 2010, MOL BREEDING, V26, P107, DOI 10.1007/s11032-009-9381-9	117	128	135	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105593	10.1371/journal.pone.0105593	http://dx.doi.org/10.1371/journal.pone.0105593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153126	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200064
J	Hwang, CC; Nieh, S; Lai, CH; Tsai, CS; Chang, LC; Hua, CC; Chi, WY; Chien, HP; Wang, CW; Chan, SC; Hsieh, TY; Chen, JR				Hwang, Cheng-Cheng; Nieh, Shin; Lai, Chien-Hong; Tsai, Chien-Sheng; Chang, Liang-Che; Hua, Chung-Ching; Chi, Wen-Ying; Chien, Hui-Ping; Wang, Chih-Wei; Chan, Siu-Cheung; Hsieh, Tsan-Yu; Chen, Jim-Ray			A Retrospective Review of the Prognostic Value of ALDH-1, Bmi-1 and Nanog Stem Cell Markers in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; CHEMORADIOTHERAPY; HETEROGENEITY; METASTASIS; SURVIVAL; TARGET; BREAST	Stem cell markers are upregulated in various cancers and have potential as prognostic indicators. The objective of this study was to determine the expression of three stem cell markers, aldehyde dehydrogenase 1 (ALDH-1), B cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1), and Nanog, in esophageal squamous cell carcinoma (ESCC) tissues. Immunohistochemistry was used to measure the expression of ALDH-1, Bmi-1, and Nanog in ESCC tissues from 41 patients who received pre-operative chemoradiation. We evaluated the relationship between expression of these markers, and clinicopathological features, tumor regression grade (TRG), and 5-year overall survival (OS). There were no significant associations of ALDH-1 or Bmi-1 expression with age, gender, clinical stage, and treatments (p>0.05). However, patients with Nanog-positive tumors were significantly older than those whose tumors were Nanog-negative (p = 0.033). TRG after treatment was significantly associated with expression of ALDH-1 (p = 0.001), Bmi-1 (p = 0.004), and Nanog (p<0.001). Although OS was significantly better in patients with low TRGs (p = 0.001), there were no significant correlations between ALDH-1, Bmi-1, or Nanog with OS. Expression of ALDH-1, Bmi-1, and Nanog correlated with TRG, but not OS. Further large studies are necessary to fully elucidate the prognostic value of these stem cell markers for ESCC patients.	[Hwang, Cheng-Cheng; Chang, Liang-Che; Chi, Wen-Ying; Chien, Hui-Ping; Hsieh, Tsan-Yu; Chen, Jim-Ray] Chang Gung Mem Hosp, Dept Pathol, Keelung, Taiwan; [Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Nieh, Shin] Natl Def Med Ctr, Grad Inst Pathol, Taipei, Taiwan; [Nieh, Shin] Tri Serv Gen Hosp, Taipei, Taiwan; [Lai, Chien-Hong] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Keelung, Taiwan; [Tsai, Chien-Sheng] Chang Gung Mem Hosp, Dept Radiat Oncol, Keelung, Taiwan; [Hua, Chung-Ching] Chang Gung Mem Hosp, Div Pulm Crit Care & Sleep Med, Keelung, Taiwan; [Chan, Siu-Cheung] Chang Gung Mem Hosp, Dept Diagnost Radiol, Keelung, Taiwan; [Wang, Chih-Wei] Chang Gung Mem Hosp, Dept Anat Pathol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, JR (corresponding author), Chang Gung Mem Hosp, Dept Pathol, Keelung, Taiwan.	rrooyyaall@yahoo.com			Chang Gung Memorial Hospital, Keelung, Taiwan [CMRPG290391]	Chang Gung Memorial Hospital, Keelung, Taiwan(Chang Gung Memorial Hospital)	This study was supported by grant CMRPG290391 to C.-C. Hwang from Chang Gung Memorial Hospital, Keelung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Cao LX, 2011, J CELL BIOCHEM, V112, P2729, DOI 10.1002/jcb.23234; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Choy B, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-146; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Du YM, 2012, J CANCER RES CLIN, V138, P1759, DOI 10.1007/s00432-012-1253-8; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Gore RM, 1997, RADIOL CLIN N AM, V35, P243; Hang D, 2012, DIS ESOPHAGUS, V25, P638, DOI 10.1111/j.1442-2050.2011.01298.x; He XT, 2009, WORLD J GASTROENTERO, V15, P2389, DOI 10.3748/wjg.15.2389; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KASTAN MB, 1990, BLOOD, V75, P1947; Kelsen DP, 2008, PRINCIPLES PRACTICE; Li SH, 2012, J THORAC CARDIOV SUR, V144, P1352, DOI 10.1016/j.jtcvs.2012.06.049; Lin Y, 2013, J EPIDEMIOL; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056141; Liu WL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-467; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Nomura M, 2012, INT J RADIAT ONCOL, V82, P946, DOI 10.1016/j.ijrobp.2010.12.045; Oze I, 2012, JPN J CLIN ONCOL, V42, P63, DOI 10.1093/jjco/hyr170; Shimada H, 2003, SURGERY, V133, P24, DOI 10.1067/msy.2003.31; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Sudo T, 2012, ANN SURG ONCOL; Tu SM, 2002, LANCET ONCOL, V3, P508, DOI 10.1016/S1470-2045(02)00820-3; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wang Y, 2012, DIS ESOPHAGUS, V25, P560, DOI 10.1111/j.1442-2050.2011.01279.x; Wieder HA, 2004, J CLIN ONCOL, V22, P900, DOI 10.1200/JCO.2004.07.122	32	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105676	10.1371/journal.pone.0105676	http://dx.doi.org/10.1371/journal.pone.0105676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148045	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600067
J	Ianiri, G; Abhyankar, R; Kihara, A; Idnurm, A				Ianiri, Giuseppe; Abhyankar, Ritika; Kihara, Akio; Idnurm, Alexander			Phs1 and the Synthesis of Very Long Chain Fatty Acids Are Required for Ballistospore Formation	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-DIVISION; GENE-FUNCTION; ARABIDOPSIS; GENOME; YEASTS; DIFFERENTIATION; TRANSFORMATION; PROLIFERATION; PASTICCINO2	The production and dissemination of spores by members of the fungal kingdom is a major reason for the success of this eukaryotic lineage in colonizing most terrestrial ecosystems. Ballistospores are a type of spore produced by basidiomycete fungi, such as the mushrooms and plant pathogenic rusts. These spores are forcefully discharged through a unique liquid-drop fusion mechanism, enabling the aerosolization of these particles that can contribute to plant disease and human allergies. The genes responsible for this process are unknown due to technical challenges in studying many of the fungi that produce ballistospores. Here, we applied newly-developed techniques in a forward genetic screen to identify genes required for ballistospore formation or function in a tractable red yeast, a species of Sporobolomyces. One strain bearing a mutation in the PHS1 gene was identified as a mirror mutant. PHS1 encodes 3-hydroxyacyl-CoA dehydratase required for the third step in very long chain fatty acid biosynthesis. The Sporobolomyces PHS1 gene complements the essential functions of a S. cerevisiae phs1 mutant. The Sporobolomyces phs1 mutant strain has less dehydratase activity and a reduction in very long chain fatty acids compared to wild type. The mutant strain also exhibits sensitivity to cell wall stress agents and loss of shooting due to a delay in ballistospore formation, indicating that the role of Phs1 in spore dissemination may be primarily in cellular integrity.	[Ianiri, Giuseppe; Abhyankar, Ritika; Idnurm, Alexander] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; [Ianiri, Giuseppe] Univ Molise, Fac Agr, Dipartimento Agr Ambiente & Alimenti, Campobasso, Italy; [Abhyankar, Ritika] Pembroke Hill Sch, Kansas City, MO USA; [Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Sapporo, Hokkaido 060, Japan; [Idnurm, Alexander] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia	University of Missouri System; University of Missouri Kansas City; University of Molise; Hokkaido University; University of Melbourne	Idnurm, A (corresponding author), Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA.	alexander.idnurm@unimelb.edu.au	Idnurm, Alexander/GPX-9055-2022; Idnurm, Alexander/AAC-9614-2019; Idnurm, Alexander/K-8558-2013; KIHARA, AKIO/A-3802-2012	Idnurm, Alexander/0000-0001-5995-7040; Idnurm, Alexander/0000-0001-5995-7040; KIHARA, AKIO/0000-0001-5889-0788; Ianiri, Giuseppe/0000-0002-3278-8678	Japan Society for the Promotion of Science (JSPS) [23370057]; University of Missouri Research Board, National Science Foundation [MCB-0920581]; National Institutes of Health (NIAID) [R21 AI094364]; Grants-in-Aid for Scientific Research [26251010] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094364] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Missouri Research Board, National Science Foundation; National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a Grant-in-Aid for Scientific Research (B) (23370057) from the Japan Society for the Promotion of Science (JSPS), the University of Missouri Research Board, National Science Foundation (grant MCB-0920581) and National Institutes of Health (NIAID grant R21 AI094364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott EP, 2013, APPL MICROBIOL BIOT, V97, P283, DOI 10.1007/s00253-012-4561-7; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Bellec Y, 2002, PLANT J, V32, P713, DOI 10.1046/j.1365-313X.2002.01456.x; Boger P, 2000, PEST MANAG SCI, V56, P497; Brachmann CB, 1998, YEAST, V14, P115; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Buller AHR, 1909, RES FUNGI, VI; Buller ArthurHenryReginald., 1933, RES FUNGI, V5; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Faure JD, 1998, DEVELOPMENT, V125, P909; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; GREGORY PH, 1957, NATURE, V180, P330, DOI 10.1038/180330a0; Haberer G, 2002, DEV GENES EVOL, V212, P542, DOI 10.1007/s00427-002-0273-9; Harashima T, 2005, MOL BIOL CELL, V16, P4557, DOI 10.1091/mbc.E05-05-0403; Horner WE, 1998, ALLERGY, V53, P1114, DOI 10.1111/j.1398-9995.1998.tb03830.x; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Ianiri G, 2011, FUNGAL GENET BIOL, V48, P685, DOI 10.1016/j.fgb.2011.03.003; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Ingold C., 1971, MYCOLOGIA; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Lin XP, 2014, FEMS YEAST RES, V14, P547, DOI 10.1111/1567-1364.12140; Liu YB, 2013, APPL MICROBIOL BIOT, V97, P719, DOI 10.1007/s00253-012-4223-9; MIOSGA T, 1994, YEAST, V10, P1481, DOI 10.1002/yea.320101112; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Noblin X, 2009, J EXP BIOL, V212, P2835, DOI 10.1242/jeb.029975; Nobusawa T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001531; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Pashley CH, 2012, FUNGAL BIOL-UK, V116, P214, DOI 10.1016/j.funbio.2011.11.004; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Pringle A, 2005, MYCOLOGIA, V97, P866, DOI 10.3852/mycologia.97.4.866; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Stolze-Rybczynski JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004163; Takahashi H, 2001, Z NATURFORSCH C, V56, P781; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; WEBSTER J, 1988, T BRIT MYCOL SOC, V91, P193, DOI 10.1016/S0007-1536(88)80205-5; YAMAZAKI M, 1983, J GEN APPL MICROBIOL, V29, P115, DOI 10.2323/jgam.29.115; Yazawa T, 2013, FEBS LETT, V587, P804, DOI 10.1016/j.febslet.2013.02.006; Yu L, 2006, MOL BIOL CELL, V17, P4736, DOI 10.1091/mbc.E06-04-0368	43	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105147	10.1371/journal.pone.0105147	http://dx.doi.org/10.1371/journal.pone.0105147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148260	Green Published, gold			2022-12-25	WOS:000341230600033
J	Lechtermann, C; Hauffa, BP; Herrmann, R; Schuendeln, MM; Gellhaus, A; Schmidt, M; Grasemann, C				Lechtermann, Carolin; Hauffa, Berthold P.; Herrmann, Ralf; Schuendeln, Michael M.; Gellhaus, Alexandra; Schmidt, Markus; Grasemann, Corinna			Maternal Vitamin D Status in Preeclampsia: Seasonal Changes Are Not Influenced by Placental Gene Expression of Vitamin D Metabolizing Enzymes	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; 1,25-DIHYDROXYVITAMIN-D; CALCIUM; METAANALYSIS; ASSOCIATION; CYP27B1	Preeclampsia, a hypertensive disorder in pregnancy develops in 2-8% of pregnancies worldwide. Winter season and vitamin D deficiency have been associated with its onset. Objective: To investigate the influence of season on maternal vitamin D status and placental vitamin D metabolism. Methods: 25-OH vitamin D and 1,25-(OH)(2) vitamin D were measured in maternal serum obtained during the winter or summer months from 63 pregnant women at delivery (43 healthy, 20 preeclampsia). In a subgroup, mRNA expression of CYP24A1 (24-hydroxylase), CYP27B1 (1 alpha-hydroxylase) and VDR (vitamin D receptor) were quantified by real time PCR in placental samples of 14 women with normal pregnancies and 13 with preeclampsia. Results: In patients with preeclampsia,25-OH vitamin D levels were lower, but differed significantly from controls only in summer (18.21 +/- 17.1 vs 49.2 +/- 29.2 ng/mL, P<0.001), whereas 1,25-(OH)(2) vitamin D levels were significantly lower only in winter (291 +/- 217 vs 612.3 +/- 455 pmol/mL, P<0.05). A two-factorial analysis of variance produced a statistically significant model (P<0.0001) with an effect of season (P<0.01) and preeclampsia (P = 0.01) on maternal 25-OH vitamin D levels, as well as a significant interaction between the two variables (P = 0.02). Placental gene expression of CYP24A1, CYP27B1, and VDR did not differ between groups or seasons. A negative correlation between placental gene expression of CYP24A1 and CYP27B1 was observed only in healthy controls (r = -0.81, P<0.0001). Summary: Patients with preeclampsia displayed lower vitamin D serum levels in response to seasonal changes. The regulation of placental CYP24A1, but not of the VDR or CYP27B1 might be altered in preeclampsia.	[Lechtermann, Carolin; Hauffa, Berthold P.; Herrmann, Ralf; Grasemann, Corinna] Univ Klinikum Essen, Kinderklin 2, Dept Pediat Endocrinol & Diabetol, Essen, Germany; [Lechtermann, Carolin; Hauffa, Berthold P.; Herrmann, Ralf; Schuendeln, Michael M.; Gellhaus, Alexandra; Grasemann, Corinna] Univ Duisburg Essen, Essen, Germany; [Herrmann, Ralf] Univ Klinikum Essen, Kinderklin 1, Dept Neonatol, Essen, Germany; [Schuendeln, Michael M.] Univ Klinikum Essen, Kinderklin 3, Dept Pediat Oncol & Hematol, Essen, Germany; [Gellhaus, Alexandra] Univ Klinikum Essen, Inst Mol Biol, Essen, Germany; [Schmidt, Markus] Klinikum Duisburg, Dept Gynecol & Obstet, Duisburg, Germany; [Schmidt, Markus] Univ Duisburg Essen, Duisburg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Grasemann, C (corresponding author), Univ Klinikum Essen, Kinderklin 2, Dept Pediat Endocrinol & Diabetol, Essen, Germany.	corinna.grasemann@uk-essen.de	Grasemann, Corinna/AAG-3861-2021; Schündeln, Michael M/W-3455-2018	Schündeln, Michael M/0000-0001-7495-9060; Grasemann, Corinna/0000-0003-1793-4603	IFORES stipend of the 'Faculty of Medicine, University of Duisburg-Essen'	IFORES stipend of the 'Faculty of Medicine, University of Duisburg-Essen'	CG and MS were supported by an IFORES stipend of the 'Faculty of Medicine, University of Duisburg-Essen'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; AUGUST P, 1992, AM J OBSTET GYNECOL, V166, P1295, DOI 10.1016/S0002-9378(11)90625-5; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Diaz L, 2002, J CLIN ENDOCR METAB, V87, P3876, DOI 10.1210/jc.87.8.3876; Fischer D, 2007, CLIN EXP OBSTET GYN, V34, P80; FROLICH A, 1992, EUR J OBSTET GYN R B, V47, P25, DOI 10.1016/0028-2243(92)90210-P; Gellhaus A, 2006, MOL HUM REPROD, V12, P389, DOI 10.1093/molehr/gal044; Halhali A, 2000, J CLIN ENDOCR METAB, V85, P1828, DOI 10.1210/jc.85.5.1828; Halhali A, 2013, J STEROID BIOCH MOL; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; LALAU JD, 1993, AM J HYPERTENS, V6, P522, DOI 10.1093/ajh/6.6.522; Liu NQ, 2013, ENDOCRINOLOGY, V154, P2270, DOI 10.1210/en.2012-2270; Ma R, 2012, AM J PHYSIOL-ENDOC M, V303, pE928, DOI 10.1152/ajpendo.00279.2012; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; Pospechova K, 2009, MOL CELL ENDOCRINOL, V299, P178, DOI 10.1016/j.mce.2008.12.003; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; SEKI K, 1991, AM J OBSTET GYNECOL, V164, P1248, DOI 10.1016/0002-9378(91)90694-M; Sharma S, 2009, BJOG-INT J OBSTET GY, V116, P1678, DOI 10.1111/j.1471-0528.2009.02285.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Tabesh M, 2013, J CLIN ENDOCR METAB, V98, P3165, DOI 10.1210/jc.2013-1257; TePoel MRW, 2011, J REPROD IMMUNOL, V89, P140, DOI 10.1016/j.jri.2011.01.020; Weisse K, 2013, ALLERGY, V68, P220, DOI 10.1111/all.12081	24	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105558	10.1371/journal.pone.0105558	http://dx.doi.org/10.1371/journal.pone.0105558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148115	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600056
J	Lee, SW; Geller, JT; Torok, T; Wu, CH; Singer, M; Reid, FC; Tarjan, DR; Hazen, TC; Arkin, AP; Hillson, NJ				Lee, Sangwon; Geller, Jil T.; Torok, Tamas; Wu, Cindy H.; Singer, Mary; Reid, Francine C.; Tarjan, Daniel R.; Hazen, Terry C.; Arkin, Adam P.; Hillson, Nathan J.			Characterization of Wastewater Treatment Plant Microbial Communities and the Effects of Carbon Sources on Diversity in Laboratory Models	PLOS ONE			English	Article							SYNTHETIC-BIOLOGY; SUBSTRATE-SPECIFICITY; PSEUDOMONAS-PUTIDA; BACTERIA; GENE; DEHALOGENASE; BIOCHEMISTRY; DATABASE; INSIGHT; ENZYMES	We are developing a laboratory-scale model to improve our understanding and capacity to assess the biological risks of genetically engineered bacteria and their genetic elements in the natural environment. Our hypothetical scenario concerns an industrial bioreactor failure resulting in the introduction of genetically engineered bacteria to a downstream municipal wastewater treatment plant (MWWTP). As the first step towards developing a model for this scenario, we sampled microbial communities from the aeration basin of a MWWTP at three seasonal time points. Having established a baseline for community composition, we investigated how the community changed when propagated in the laboratory, including cell culture media conditions that could provide selective pressure in future studies. Specifically, using PhyloChip 16S-rRNA-gene targeting microarrays, we compared the compositions of sampled communities to those of inocula propagated in the laboratory in simulated wastewater conditionally amended with various carbon sources (glucose, chloroacetate, D-threonine) or the ionic liquid 1-ethyl-3-methylimidazolium chloride ([C2mim]Cl). Proteobacteria, Bacteroidetes, and Actinobacteria were predominant in both aeration basin and laboratory-cultured communities. Laboratory-cultured communities were enriched in gamma-Proteobacteria. Enterobacteriaceae, and Aeromonadaceae were enriched by glucose, Pseudomonadaceae by chloroacetate and D-threonine, and Burkholderiacea by high (50 mM) concentrations of chloroacetate. Microbial communities cultured with chloroacetate and D-threonine were more similar to sampled field communities than those cultured with glucose or [C2mim]Cl. Although observed relative richness in operational taxonomic units (OTUs) was lower for laboratory cultures than for field communities, both flask and reactor systems supported phylogenetically diverse communities. These results importantly provide a foundation for laboratory models of industrial bioreactor failure scenarios.	[Lee, Sangwon; Tarjan, Daniel R.; Arkin, Adam P.; Hillson, Nathan J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Geller, Jil T.; Torok, Tamas; Wu, Cindy H.; Singer, Mary; Reid, Francine C.; Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hillson, NJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	njhillson@lbl.gov	Hazen, Terry C/C-1076-2012; Arkin, Adam/M-9941-2019; Torok, Tamas/E-9450-2015; Arkin, Adam P/A-6751-2008	Hazen, Terry C/0000-0002-2536-9993; Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931	Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy(United States Department of Energy (DOE))	This work, performed in part at the Joint BioEnergy Institute, was supported by the Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy (http://science.energy.gov/ber/) under Contract No. DE-AC02-05CH11231 to Lawrence Berkeley National Laboratory (to TCH, APA, and NJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Bokinsky G, 2011, P NATL ACAD SCI USA, V108, P19949, DOI 10.1073/pnas.1106958108; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Dana GV, 2012, NATURE, V483, P29, DOI 10.1038/483029a; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2005, FEMS MICROBIOL LETT, V245, P271, DOI 10.1016/j.femsle.2005.03.016; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falk MW, 2013, WATER RES, V47, P7109, DOI 10.1016/j.watres.2013.08.040; Falk MW, 2009, WATER RES, V43, P842, DOI 10.1016/j.watres.2008.11.021; FETZNER S, 1994, MICROBIOL REV, V58, P641, DOI 10.1128/MMBR.58.4.641-685.1994; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Handley KM, 2012, FEMS MICROBIOL ECOL, V81, P188, DOI 10.1111/j.1574-6941.2012.01363.x; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hisano T, 1996, J BIOL CHEM, V271, P20322, DOI 10.1074/jbc.271.34.20322; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; JANSSEN DB, 1994, ANNU REV MICROBIOL, V48, P163, DOI 10.1146/annurev.mi.48.100194.001115; KAWASAKI H, 1994, BIOSCI BIOTECH BIOCH, V58, P160, DOI 10.1271/bbb.58.160; Kimura T, 1997, J AM CHEM SOC, V119, P11734, DOI 10.1021/ja9720422; Kurihara T, 2000, J MOL CATAL B-ENZYM, V10, P57, DOI 10.1016/S1381-1177(00)00108-9; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu JQ, 2000, APPL MICROBIOL BIOT, V54, P44, DOI 10.1007/s002539900301; McCune B, 2002, ANAL ECOLOGICAL COMM, DOI [10.1016/S0022-0981(03)00091-1, DOI 10.1016/S0022-0981(03)00091-1]; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Mielke PW, 2001, PERMUTATION METHODS, P9; Moe-Behrens GG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00005; Nakayama T, 2012, CHEM-EUR J, V18, P8392, DOI 10.1002/chem.201103369; Parnell JJ, 2010, BIODEGRADATION, V21, P147, DOI 10.1007/s10532-009-9289-4; Parsley LC, 2010, APPL ENVIRON MICROB, V76, P3753, DOI 10.1128/AEM.03080-09; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Probst AJ, 2013, ISME J, V7, P635, DOI 10.1038/ismej.2012.133; Ruegg TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4490; Secher C, 2013, BIODEGRADATION, V24, P549, DOI 10.1007/s10532-013-9625-6; Seo SW, 2013, BIOTECHNOL ADV, V31, P811, DOI 10.1016/j.biotechadv.2013.03.012; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Szczepanowski R, 2008, J BIOTECHNOL, V136, P54, DOI 10.1016/j.jbiotec.2008.03.020; Vyazmensky M, 1998, ENZYME MICROB TECH, V22, P323, DOI 10.1016/S0141-0229(97)00181-6; Wakasa Y, 2013, BIOTECHNOL J, V8, P1133, DOI 10.1002/biot.201300065; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; ZIMMERMAN GM, 1985, ECOLOGY, V66, P606, DOI 10.2307/1940409	41	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105689	10.1371/journal.pone.0105689	http://dx.doi.org/10.1371/journal.pone.0105689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148472	Green Published, gold			2022-12-25	WOS:000341230600070
J	Andraud, M; Casas, M; Pavio, N; Rose, N				Andraud, Mathieu; Casas, Maribel; Pavio, Nicole; Rose, Nicolas			Early-Life Hepatitis E Infection in Pigs: The Importance of Maternally-Derived Antibodies	PLOS ONE			English	Article							CLASSICAL SWINE FEVER; E VIRUS-INFECTION; BAYESIAN-ANALYSIS; VACCINE RESPONSES; IMMUNE-RESPONSE; EPIDEMIC MODELS; TRANSMISSION; PROTECTION; ANIMALS; INTERFERENCE	Passive immunity (PI), acquired through colostrum intake, is essential for piglet protection against pathogens. Maternally-derived antibodies (MDAs) can decrease the transmission of pathogens between individuals by reducing shedding from infected animals and/or susceptibility of naive animals. Only a limited number of studies, however, have been carried out to quantify the level of protection conferred by PI in terms of transmission. In the present study, an original modeling framework was designed to estimate parameters governing the transmission of infectious agents in the presence and absence of PI. This epidemiological model accounts for the distribution of PI duration and two different forces of infection depending on the serological status of animals after colostrum intake. A Bayesian approach (Metropolis-Hastings algorithm) was used for parameter estimation. The impact of PI on hepatitis E virus transmission in piglets was investigated using longitudinal serological data from six pig farms. A strong impact of PI was highlighted, the efficiency of transmission being on average 13 times lower in piglets with maternally-derived antibodies than in fully susceptible animals (range: 5-21). Median infection-free survival ages, based on herd-specific estimates, ranged between 8.7 and 13.8 weeks in all but one herd. Indeed, this herd exhibited a different profile with a relatively low prevalence of infected pigs (50% at slaughter age) despite the similar proportions of passively immune individuals after colostrum intake. These results suggest that the age at HEV infection is not strictly dependent upon the proportion of piglets with PI but is also linked to farm-specific husbandry (mingling of piglets after weaning) and hygiene practices. The original methodology developed here, using population-based longitudinal serological data, was able to demonstrate the relative impact of MDAs on the transmission of infectious agents.	[Andraud, Mathieu; Rose, Nicolas] Anses, Pig Epidemiol & Welf Unit, Lab Ploufragan Plouzane, Ploufragan, France; [Andraud, Mathieu; Rose, Nicolas] Univ Europeenne Bretagne, Rennes, France; [Pavio, Nicole] Anses, UMR Virol 1161, Lab Sante Anim, Maisons Alfort, France; [Pavio, Nicole] INRA, UMR Virol 1161, Maisons Alfort, France; [Pavio, Nicole] Univ Paris Est, UMR Virol 1161, Ecole Natl Vet Alfort, Maisons Alfort, France; [Casas, Maribel] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Casas, Maribel] Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ploufragan-Plouzane Niort Laboratory; Universite de Bretagne Occidentale; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; INRAE; Ecole Nationale Veterinaire d'Alfort (ENVA); Pompeu Fabra University; IRTA	Andraud, M (corresponding author), Anses, Pig Epidemiol & Welf Unit, Lab Ploufragan Plouzane, Ploufragan, France.	mathieu.andraud@anses.fr	Casas, Maribel/T-5643-2017; Andraud, Mathieu/AAD-5844-2022	Casas, Maribel/0000-0002-2112-6740; Andraud, Mathieu/0000-0003-2891-2901	French Research Agency (ANR) as part of the research project called "HEVECODYN'' [ANR-10-CESA-0010]	French Research Agency (ANR) as part of the research project called "HEVECODYN''(French National Research Agency (ANR))	This study was funded by the French Research Agency (ANR) as part of the research project called "HEVECODYN'' (ANR-10-CESA-0010; http://www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2[CODE] = ANR-10-CESA-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson M, 2013, VACCINE, V31, P500, DOI 10.1016/j.vaccine.2012.11.023; ANDERSON RM, 2004, INFECT DIS HUMANS DY; Andraud M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-102; Backer JA, 2012, EPIDEMICS-NETH, V4, P86, DOI 10.1016/j.epidem.2012.02.002; Barnaud E, 2012, APPL ENVIRON MICROB, V78, P5153, DOI 10.1128/AEM.00436-12; Bouma A, 1997, VACCINE, V15, P287, DOI 10.1016/S0264-410X(96)00179-X; Brinkhof MWG, 2013, VACCINE, V31, P1490, DOI 10.1016/j.vaccine.2013.01.011; Britton T, 2011, SCAND J STAT, V38, P578, DOI 10.1111/j.1467-9469.2010.00726.x; Casas M, 2011, VET MICROBIOL, V148, P27, DOI 10.1016/j.vetmic.2010.08.010; Cauchemez S, 2008, J R SOC INTERFACE, V5, P885, DOI 10.1098/rsif.2007.1292; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Courcoul A, 2010, P ROY SOC B-BIOL SCI, V277, P2857, DOI 10.1098/rspb.2010.0575; de Deus N, 2008, VET MICROBIOL, V132, P19, DOI 10.1016/j.vetmic.2008.04.036; Efron B., 1994, INTRO BOOTSTRAP; Elbers ARW, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-103; Elderd BD, 2013, EPIDEMICS-NETH, V5, P146, DOI 10.1016/j.epidem.2013.07.001; Fernandez-Barredo S, 2006, J VET DIAGN INVEST, V18, P462, DOI 10.1177/104063870601800506; FRANCIS MJ, 1986, RES VET SCI, V41, P33, DOI 10.1016/S0034-5288(18)30568-X; Hassig M, 2007, VET REC, V160, P234, DOI 10.1136/vr.160.7.234; Jewell CP, 2009, BAYESIAN ANAL, V4, P465, DOI 10.1214/09-BA417; Kanai Y, 2010, J MED VIROL, V82, P69, DOI 10.1002/jmv.21647; KITCHING RP, 1995, BRIT VET J, V151, P379, DOI 10.1016/S0007-1935(95)80127-8; Kitikoon P, 2006, VET IMMUNOL IMMUNOP, V112, P117, DOI 10.1016/j.vetimm.2006.02.008; Klinkenberg D, 2002, VACCINE, V20, P3005, DOI 10.1016/S0042-207X(02)00283-X; Lavielle M, 2007, J PHARMACOKINET PHAR, V34, P229, DOI 10.1007/s10928-006-9043-z; Loeffen WLA, 2003, VET IMMUNOL IMMUNOP, V92, P23, DOI 10.1016/S0165-2427(03)00019-9; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; McBryde ES, 2006, B MATH BIOL, V68, P889, DOI 10.1007/s11538-005-9005-4; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; O'Neill PD, 2002, MATH BIOSCI, V180, P103, DOI 10.1016/S0025-5564(02)00109-8; Pastoret PP, 2007, J COMP PATHOL, V137, pS2, DOI 10.1016/j.jcpa.2007.04.003; Pavio N, 2010, VET RES, V41, DOI 10.1051/vetres/2010018; Peralta B, 2009, VET MICROBIOL, V137, P66, DOI 10.1016/j.vetmic.2009.01.006; Pluske J, 2003, WEANING THE PIG: CONCEPTS AND CONSEQUENCES, P15; Pravieux JJ, 2007, J COMP PATHOL, V137, pS32, DOI 10.1016/j.jcpa.2007.04.009; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; Rose N, 2007, J COMP PATHOL, V136, P133, DOI 10.1016/j.jcpa.2007.01.006; Rose N, 2011, COMP IMMUNOL MICROB, V34, P419, DOI 10.1016/j.cimid.2011.07.003; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L; Snoeck E, 2010, CLIN PHARMACOL THER, V87, P706, DOI 10.1038/clpt.2010.35; Streftaris G, 2004, P ROY SOC B-BIOL SCI, V271, P1111, DOI 10.1098/rspb.2004.2715; Swain P, 2009, FISH SHELLFISH IMMUN, V27, P89, DOI 10.1016/j.fsi.2009.04.008; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Tomlinson A, 2012, VET IMMUNOL IMMUNOP, V148, P326, DOI 10.1016/j.vetimm.2012.04.024; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; Vandeputte J, 2001, AM J VET RES, V62, P1805, DOI 10.2460/ajvr.2001.62.1805; Walachowski S, 2014, EPIDEMIOL INFECT, V142, P1934, DOI 10.1017/S0950268813003063; Ward LA, 1996, J INFECT DIS, V174, P276, DOI 10.1093/infdis/174.2.276	49	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105527	10.1371/journal.pone.0105527	http://dx.doi.org/10.1371/journal.pone.0105527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144763	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100080
J	Gatta, C; Russo, F; Russolillo, MG; Varricchio, E; Paolucci, M; Castaldo, L; Lucini, C; de Girolamo, P; Cozzi, B; Maruccio, L				Gatta, Claudia; Russo, Finizia; Russolillo, Maria Grazia; Varricchio, Ettore; Paolucci, Marina; Castaldo, Luciana; Lucini, Carla; de Girolamo, Paolo; Cozzi, Bruno; Maruccio, Lucianna			The Orexin System in the Enteric Nervous System of the Bottlenose Dolphin (Tursiops truncatus)	PLOS ONE			English	Article							MIGRATING MYOELECTRIC COMPLEX; GASTROINTESTINAL-TRACT; TYPE-2 RECEPTOR; EXPRESSION; RAT; SECRETION; LOCALIZATION; MOTILITY; BRAIN; BLOOD	This study provides a general approach to the presence and possible role of orexins and their receptors in the gut ( three gastric chambers and intestine) of confined environment bottlenose dolphin. The expression of prepro-orexin, orexin A and B and orexin 1 and 2 receptors were investigated by single immunostaining and western blot analysis. The co-localization of vasoactive intestinal peptide and orexin 1 receptor in the enteric nervous system was examined by double immunostaining. Also, orexin A concentration were measured in plasma samples to assess the possible diurnal variation of the plasma level of peptide in this species. Our results showed that the orexin system is widely distributed in bottlenose dolphin enteric nervous system of the all gastrointestinal tract examined. They are very peculiar and partially differs from that of terrestrial mammals. Orexin peptides and prepro-orexin were expressed in the main stomach, pyloric stomach and proximal intestine; while orexin receptors were expressed in the all examined tracts, with the exception of main stomach where found no evidence of orexin 2 receptor. Co-localization of vasoactive intestinal peptide and orexin 1 receptor were more evident in the pyloric stomach and proximal intestine. These data could suggest a possible role of orexin system on the contractility of bottlenose dolphin gastrointestinal districts. Finally, in agreement with several reports, bottlenose dolphin orexin A plasma level was higher in the morning during fasting. Our results emphasize some common features between bottlenose dolphin and terrestrial mammals. Certainly, further functional investigations may help to better explain the role of the orexin system in the energy balance of bottlenose dolphin and the complex interaction between feeding and digestive physiology.	[Gatta, Claudia; Castaldo, Luciana; Lucini, Carla; de Girolamo, Paolo; Maruccio, Lucianna] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, NA, Italy; [Russo, Finizia; Russolillo, Maria Grazia; Varricchio, Ettore; Paolucci, Marina] Univ Sannio, Dept Sci & Technol, Benevento, BN, Italy; [Cozzi, Bruno] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy	University of Naples Federico II; University of Sannio; University of Padua	Russo, F (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, NA, Italy.	finiziarusso@unisannio.it	Cozzi, Bruno/H-9618-2019; Varricchio, Ettore/GQZ-1929-2022; Lucini, Carla/E-6828-2013	Cozzi, Bruno/0000-0002-7531-7040; Varricchio, Ettore/0000-0001-6241-7096; Lucini, Carla/0000-0003-2216-6338; de girolamo, paolo/0000-0003-1557-4763; Paolucci, Marina/0000-0002-1784-3843				Ballarin C, 2011, OPEN NEUROENDOCRINOL, V500, P9; Barreiro ML, 2005, ENDOCRINOLOGY, V146, P5164, DOI 10.1210/en.2005-0455; Barros NB, 2008, ENCY MARINE MAMMALS, P311; Bulbul M, 2010, AUTON NEUROSCI-BASIC, V158, P24, DOI 10.1016/j.autneu.2010.05.009; Bulbul M, 2010, PEPTIDES, V31, P1099, DOI 10.1016/j.peptides.2010.03.007; Chaleek N, 2011, NEUROGASTROENT MOTIL, V24, P94; Dall'Aglio C, 2013, RES VET SCI, V95, P8, DOI 10.1016/j.rvsc.2013.02.001; Dall'Aglio C, 2008, EUR J HISTOCHEM, V52, P229; Dall'Aglio C, 2012, ACTA HISTOCHEM, V114, P74, DOI 10.1016/j.acthis.2011.02.006; Dall'Aglio C, 2009, RES VET SCI, V86, P189, DOI 10.1016/j.rvsc.2008.07.001; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Digby JE, 2006, J ENDOCRINOL, V191, P129, DOI 10.1677/joe.1.06886; Ehrstrom M, 2005, J CLIN ENDOCR METAB, V90, P2370, DOI 10.1210/jc.2004-1408; Facciolo RM, 2011, NEUROTOXICOL TERATOL, V33, P641, DOI 10.1016/j.ntt.2011.09.008; Flemstrom G, 2010, ACTA PHYSIOL, V198, P373, DOI 10.1111/j.1748-1716.2009.02067.x; Guimaraes JP, 2012, MICROSC RES TECHNIQ, V75, P737, DOI 10.1002/jemt.21119; HARRISON RJ, 1970, J ZOOL, V160, P377; Hellstrom PM, 1996, NEUROGASTROENT MOTIL, V8, P299, DOI 10.1111/j.1365-2982.1996.tb00268.x; Houser DS, 2010, J ACOUST SOC AM, V128, P1460, DOI 10.1121/1.3442572; Johren O, 2001, ENDOCRINOLOGY, V142, P3324, DOI 10.1210/en.142.8.3324; Kastin AJ, 1999, J PHARMACOL EXP THER, V289, P219; Kirchgessner AL, 1999, NEURON, V24, P941, DOI 10.1016/S0896-6273(00)81041-7; Kirchgessner AL, 2002, ENDOCR REV, V23, P1, DOI 10.1210/er.23.1.1; Kobashi M, 2002, NEUROSCI LETT, V332, P171, DOI 10.1016/S0304-3940(02)00958-8; Komaki G, 2001, EUR J ENDOCRINOL, V144, P645, DOI 10.1530/eje.0.1440645; Korczynski W, 2006, J PHYSIOL PHARMACOL, V57, P17; Kukkonen JP, 2002, AM J PHYSIOL-CELL PH, V283, pC1567, DOI 10.1152/ajpcell.00055.2002; Kunii K, 1999, BRAIN RES, V842, P256, DOI 10.1016/S0006-8993(99)01884-3; Kuru M, 2000, NEUROREPORT, V11, P1977, DOI 10.1097/00001756-200006260-00034; Ljung T, 1999, ACTA PHYSIOL SCAND, V165, P225; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; MacDonald EE, 2010, GEN COMP ENDOCR, V169, P192, DOI 10.1016/j.ygcen.2010.09.014; Matsuda K, 2012, VITAM HORM, V89, P341, DOI 10.1016/B978-0-12-394623-2.00018-4; Miranda B, 2013, BRAIN RES, V1513, P34, DOI 10.1016/j.brainres.2013.03.036; Miyasaka K, 2002, PANCREAS, V25, P400, DOI 10.1097/00006676-200211000-00013; Nakabayashi M, 2003, MOL CELL ENDOCRINOL, V205, P43, DOI 10.1016/S0303-7207(03)00206-5; Nakayama S, 2011, J PHYSIOL-LONDON, V589, P5907, DOI 10.1113/jphysiol.2011.220962; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Naslund E, 2002, AM J PHYSIOL-GASTR L, V282, pG470, DOI 10.1152/ajpgi.00219.2001; Nowak KW, 2005, INT J MOL MED, V15, P969; Nozu T, 2011, NEUROSCI LETT, V498, P143, DOI 10.1016/j.neulet.2011.04.078; Okumura T, 2008, J GASTROENTEROL, V43, P652, DOI 10.1007/s00535-008-2218-1; Ouedraogo R, 2003, DIABETES, V52, P111, DOI 10.2337/diabetes.52.1.111; Panin M, 2012, GEN COMP ENDOCR, V177, P238, DOI 10.1016/j.ygcen.2012.04.012; Piper DC, 2000, EUR J NEUROSCI, V12, P726, DOI 10.1046/j.1460-9568.2000.00919.x; Randeva HS, 2001, J CLIN ENDOCR METAB, V86, P4808, DOI 10.1210/jc.86.10.4808; Reidenerg JS, 2007, ANAT REC, V290, P507, DOI 10.1002/ar.20541; Ridgway S, 2006, J EXP BIOL, V209, P2902, DOI 10.1242/jeb.02348; Russo F, 2008, ANAT REC, V291, P169, DOI 10.1002/ar.20641; Russo F, 2014, ACTA HISTOCHEM, V116, P286, DOI 10.1016/j.acthis.2013.04.012; Russo F, 2012, ANAT REC, V295, P1482, DOI 10.1002/ar.22532; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai Takeshi, 2006, CNS & Neurological Disorders-Drug Targets, V5, P313, DOI 10.2174/187152706777452218; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Tafuri S, 2009, REGUL PEPTIDES, V155, P1, DOI 10.1016/j.regpep.2009.03.010; Takahashi K, 2006, PEPTIDES, V27, P871, DOI 10.1016/j.peptides.2005.08.008; Venn-Watson Stephanie, 2013, Front Endocrinol (Lausanne), V4, P136, DOI 10.3389/fendo.2013.00136; Venn-Watson S, 2011, GEN COMP ENDOCR, V170, P193, DOI 10.1016/j.ygcen.2010.10.005; Worthy GAJ, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P791, DOI 10.1201/9781420041637.ch36; Yokobori E, 2011, PEPTIDES, V32, P1357, DOI 10.1016/j.peptides.2011.05.010	60	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105009	10.1371/journal.pone.0105009	http://dx.doi.org/10.1371/journal.pone.0105009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144456	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100035
J	Head, DA; Marsh, PD; Devine, DA				Head, David A.; Marsh, Phil D.; Devine, Deirdre A.			Non-Lethal Control of the Cariogenic Potential of an Agent-Based Model for Dental Plaque	PLOS ONE			English	Article							MICROBIAL COMMUNITIES INVITRO; STREPTOCOCCUS-MUTANS; POPULATION SHIFTS; ACID PRODUCTION; BIOFILMS; FLUORIDE; DIFFUSION; SANGUIS; PH; CARIES	Dental caries or tooth decay is a prevalent global disease whose causative agent is the oral biofilm known as plaque. According to the ecological plaque hypothesis, this biofilm becomes pathogenic when external challenges drive it towards a state with a high proportion of acid-producing bacteria. Determining which factors control biofilm composition is therefore desirable when developing novel clinical treatments to combat caries, but is also challenging due to the system complexity and the existence of multiple bacterial species performing similar functions. Here we employ agent-based mathematical modelling to simulate a biofilm consisting of two competing, distinct types of bacterial populations, each parameterised by their nutrient uptake and aciduricity, periodically subjected to an acid challenge resulting from the metabolism of dietary carbohydrates. It was found that one population was progressively eliminated from the system to give either a benign or a pathogenic biofilm, with a tipping point between these two fates depending on a multiplicity of factors relating to microbial physiology and biofilm geometry. Parameter sensitivity was quantified by individually varying the model parameters against putative experimental measures, suggesting non-lethal interventions that can favourably modulate biofilm composition. We discuss how the same parameter sensitivity data can be used to guide the design of validation experiments, and argue for the benefits of in silico modelling in providing an additional predictive capability upstream from in vitro experiments.	[Head, David A.] Univ Leeds, Sch Comp, Leeds, W Yorkshire, England; [Marsh, Phil D.] PHE Porton, Microbiol Serv, Salisbury, Wilts, England; [Marsh, Phil D.; Devine, Deirdre A.] Univ Leeds, Dept Oral Biol, Sch Dent, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Head, DA (corresponding author), Univ Leeds, Sch Comp, Leeds, W Yorkshire, England.	d.head@leeds.ac.uk	Head, David/E-8707-2010	Head, David/0000-0003-0216-6787	BHRC, University of Leeds	BHRC, University of Leeds	DAH was funded by the BHRC, University of Leeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison D.G., 2000, COMMUNITY STRUCTURE; [Anonymous], 2009, ORAL MICROBIOLOGY; BRADSHAW DJ, 1989, J DENT RES, V68, P1298, DOI 10.1177/00220345890680090101; BRADSHAW DJ, 1990, J DENT RES, V69, P436, DOI 10.1177/00220345900690020301; Bradshawa DJ, 2002, CARIES RES, V36, P81, DOI 10.1159/000057864; Chambless JD, 2007, BIOTECHNOL BIOENG, V97, P1573, DOI 10.1002/bit.21363; DAWES C, 1986, J DENT RES, V65, P89, DOI 10.1177/00220345860650021701; DAWES C, 1989, J DENT RES, V68, P1483, DOI 10.1177/00220345890680110301; DIBDIN GH, 1990, J DENT RES, V69, P1324, DOI 10.1177/00220345900690062001; Dibdin GH, 1998, CARIES RES, V32, P70, DOI 10.1159/000016432; Dibdin GH, 1992, BIOINFORMATICS, V8, P489; DIRKSEN TR, 1963, ARCH ORAL BIOL, V8, P91, DOI 10.1016/0003-9969(63)90046-3; EISENBERG AD, 1980, ARCH ORAL BIOL, V25, P133, DOI 10.1016/0003-9969(80)90089-8; Ellwood DC, 1982, PROPERTIES STREPTOCO; Ellwood DC, 1979, EFFECT GROWTH RATE G; Filoche S, 2010, J DENT RES, V89, P8, DOI 10.1177/0022034509351812; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Hamilton IR, 1979, EFFECT GROWTH RATE G; Hamilton IR, 1983, CARBOHYDRATE METABOL; HATA S, 1990, J DENT RES, V69, P1244, DOI 10.1177/00220345900690060401; He Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063750; Head DA, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032702; Hoeven JS, 1985, FEMS MICROBIOLOGY LE, V31, P373; Ilie O, 2012, J THEOR BIOL, V309, P159, DOI 10.1016/j.jtbi.2012.05.024; Kinniment SL, 1996, MICROBIOL-SGM, V142, P631, DOI 10.1099/13500872-142-3-631; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x; Laspidou CS, 2010, DESALINATION, V250, P390, DOI 10.1016/j.desal.2009.09.062; Lau PCY, 2009, BIOPHYS J, V96, P2935, DOI 10.1016/j.bpj.2008.12.3943; Liu JM, 2011, MICROBIOL-SGM, V157, P2433, DOI 10.1099/mic.0.048314-0; Marsh P D, 1994, Adv Dent Res, V8, P263; MARSH PD, 1989, J DENT RES, V68, P1151, DOI 10.1177/00220345890680070301; MARSH PD, 1985, J DENT RES, V64, P85, DOI 10.1177/00220345850640021501; Marsh PD, 1985, ENV REGULATION CARBO; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; MCDERMID AS, 1985, CARIES RES, V19, P64, DOI 10.1159/000260830; Metcalf D, 2006, J ANTIMICROB CHEMOTH, V58, P190, DOI 10.1093/jac/dkl205; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; PEARCE EIF, 1995, J DENT RES, V74, P691, DOI 10.1177/00220345950740021101; Phan TN, 2000, ARCH MICROBIOL, V174, P248, DOI 10.1007/s002030000202; Picioreanu C, 2004, APPL ENVIRON MICROB, V70, P3024, DOI 10.1128/AEM.70.5.3024-3040.2004; Rudge TJ, 2012, ACS SYNTH BIOL, V1, P345, DOI 10.1021/sb300031n; STRALFORS A, 1948, J DENT RES, V27, P587, DOI 10.1177/00220345480270050601; Tanzer JM, 2012, J DENT RES, V91, P513, DOI 10.1177/0022034512442894; Wang Q, 2010, SOLID STATE COMMUN, V150, P1009, DOI 10.1016/j.ssc.2010.01.021; Wolff D, 2013, CARIES RES, V47, P69, DOI 10.1159/000344022; Xavier JB, 2005, ENVIRON MICROBIOL, V7, P1085, DOI 10.1111/j.1462-2920.2005.00787.x; Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269	50	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105012	10.1371/journal.pone.0105012	http://dx.doi.org/10.1371/journal.pone.0105012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144538	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000341106100036
J	Ishii, D; Matsuzawa, D; Matsuda, S; Tomizawa, H; Sutoh, C; Shimizu, E				Ishii, Daisuke; Matsuzawa, Daisuke; Matsuda, Shingo; Tomizawa, Haruna; Sutoh, Chihiro; Shimizu, Eiji			Methyl Donor-Deficient Diet during Development Can Affect Fear and Anxiety in Adulthood in C57BL/6J Mice	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DNA METHYLTRANSFERASES DNMT3A; MONOZYGOTIC TWINS DISCORDANT; NATIONAL COMORBIDITY SURVEY; REGULATES MEMORY FORMATION; EMBRYONIC STEM-CELLS; EPIGENETIC ALTERATIONS; LIFETIME PREVALENCE; UP-REGULATION; GENE	DNA methylation is one of the essential factors in the control of gene expression. Folic acid, methionine and choline (methyl donors)-all nutrients related to one-carbon metabolism-are known as important mediators of DNA methylation. A previous study has shown that long-term administration of a diet lacking in methyl donors caused global DNA hypermethylation in the brain (Pogribny et al., 2008). However, no study has investigated the effects of a diet lacking in methyl donors during the developmental period on emotional behaviors such as fear and anxiety-like behavior in association with gene expressions in the brain. In addition, it has not been elucidated whether a diet supplemented with methyl donors later in life can reverse these changes. Therefore, we examined the effects of methyl donor deficiency during the developmental period on fear memory acquisition/extinction and anxiety-like behavior, and the relevant gene expressions in the hippocampus in juvenile (6-wk) and adult (12-wk) mice. We found that juvenile mice fed a methyl-donor-deficient diet had impaired fear memory acquisition along with decreases in the gene expressions of Dnmt3a and Dnmt3b. In addition, reduced anxiety-like behavior with decreased gene expressions of Grin2b and Gabar2 was observed in both the methyl-donor-deficient group and the body-weight-matched food-restriction group. After being fed a diet supplemented with methyl donors ad libitum, adult mice reversed the alteration of gene expression of Dnmt3a, Dnmt3b, Grin2b and Gabar2, but anxiety-like behavior became elevated. In addition, impaired fear-memory formation was observed in the adult mice fed the methyl-donor-deficient diet during the developmental period. Our study suggested that developmental alterations in the one-carbon metabolic pathway in the brain could have effects on emotional behavior and memory formation that last into adulthood.	[Ishii, Daisuke; Matsuzawa, Daisuke; Matsuda, Shingo; Tomizawa, Haruna; Sutoh, Chihiro; Shimizu, Eiji] Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan; [Matsuzawa, Daisuke; Sutoh, Chihiro; Shimizu, Eiji] Chiba Univ, Grad Sch Med, Res Ctr Child Mental Dev, Chiba, Japan; [Matsuda, Shingo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan	Chiba University; Chiba University; National Center for Neurology & Psychiatry - Japan	Ishii, D (corresponding author), Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan.	dishii85@gmail.com	Shimizu, Eiji/K-4637-2017	Shimizu, Eiji/0000-0002-6741-9338; Sutoh, Chihiro/0000-0002-5191-8220	Japan Society for the Promotion of Science KAKENHI [24791196]; Grants-in-Aid for Scientific Research [26860912] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 24791196. DM received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bossenmeyer-Pourie C, 2010, AM J PATHOL, V176, P270, DOI 10.2353/ajpath.2010.090153; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Daval JL, 2009, P NATL ACAD SCI USA, V106, pE1, DOI 10.1073/pnas.0809217106; de Vries GJ, 2009, J TRAUMA STRESS, V22, P259, DOI 10.1002/jts.20429; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Fuchikami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023881; Fuchikami M, 2010, PSYCHIAT INVEST, V7, P251, DOI 10.4306/pi.2010.7.4.251; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Genn RF, 2003, NEUROPSYCHOPHARMACOL, V28, P1257, DOI 10.1038/sj.npp.1300168; Gervin K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002454; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Gurba K.N., 2010, VANDERBILT REV NEURO, V2, P25; He S, 2010, J NEUROSCI, V30, P7910, DOI 10.1523/JNEUROSCI.6375-09.2010; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Inoue K, 2004, BIOL PSYCHIAT, V55, P1075, DOI 10.1016/j.biopsych.2004.01.026; Jacobson-Pick S, 2012, NEUROSCIENCE, V215, P114, DOI 10.1016/j.neuroscience.2012.04.038; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; Javelot H, 2014, BEHAV BRAIN RES, V261, P8, DOI 10.1016/j.bbr.2013.11.047; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lalonde R, 2008, BRAIN RES, V1188, P122, DOI 10.1016/j.brainres.2007.10.068; Lei H, 1996, DEVELOPMENT, V122, P3195; Levay EA, 2007, PHYSIOL BEHAV, V92, P889, DOI 10.1016/j.physbeh.2007.06.018; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li SF, 2003, GYNECOL ONCOL, V90, P123, DOI 10.1016/S0090-8258(03)00194-X; Liu QC, 2011, TOXICOL LETT, V205, P235, DOI 10.1016/j.toxlet.2011.05.1039; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pogribny IP, 2008, BRAIN RES, V1237, P25, DOI 10.1016/j.brainres.2008.07.077; Qiang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008798; Regier DA, 1998, BRIT J PSYCHIAT, V173, P24, DOI 10.1192/S0007125000293483; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Rusiecki JA, 2012, EPIGENOMICS-UK, V4, P29, DOI [10.2217/EPI.11.116, 10.2217/epi.11.116]; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TURNER BM, 1991, J CELL SCI, V99, P13; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317; WISDEN W, 1992, J NEUROSCI, V12, P1040; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100	57	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105750	10.1371/journal.pone.0105750	http://dx.doi.org/10.1371/journal.pone.0105750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144567	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100116
J	Kashima, Y; Kanematsu, S; Asai, S; Kusada, M; Watanabe, S; Kawashima, T; Nakamura, T; Shimada, M; Goto, T; Nagaoka, S				Kashima, Yuri; Kanematsu, Satoshi; Asai, Saori; Kusada, Mio; Watanabe, Suzuyo; Kawashima, Takuji; Nakamura, Tadashi; Shimada, Masaya; Goto, Tsuyoshi; Nagaoka, Satoshi			Identification of a Novel Hypocholesterolemic Protein, Major Royal Jelly Protein 1, Derived from Royal Jelly	PLOS ONE			English	Article							PLASMA-CHOLESTEROL LEVELS; AMINO-ACID MIXTURES; MICELLAR SOLUBILITY; SERUM-CHOLESTEROL; DIETARY PROTEINS; SOY PROTEIN; IN-VITRO; ABSORPTION; RATS; METABOLISM	Royal jelly (RJ) intake lowers serum cholesterol levels in animals and humans, but the active component in RJ that lowers serum cholesterol level and its molecular mechanism are unclear. In this study, we set out to identify the bile acid-binding protein contained in RJ, because dietary bile acid-binding proteins including soybean protein and its peptide are effective in ameliorating hypercholesterolemia. Using a cholic acid-conjugated column, we separated some bile acid-binding proteins from RJ and identified the major RJ protein 1 (MRJP1), MRJP2, and MRJP3 as novel bile acid-binding proteins from RJ, based on matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Purified MRJP1, which is the most abundant protein of the bile acid-binding proteins in RJ, exhibited taurocholate-binding activity in vitro. The micellar solubility of cholesterol was significantly decreased in the presence of MRJP1 compared with casein in vitro. Liver bile acids levels were significantly increased, and cholesterol 7 alpha-hydroxylase (CYP7A1) mRNA and protein tended to increase by MRJP1 feeding compared with the control. CYP7A1 mRNA and protein levels were significantly increased by MRJP1 tryptic hydrolysate treatment compared with that of casein tryptic hydrolysate in hepatocytes. MRJP1 hypocholesterolemic effect has been investigated in rats. The cholesterol-lowering action induced by MRJP1 occurs because MRJP1 interacts with bile acids induces a significant increase in fecal bile acids excretion and a tendency to increase in fecal cholesterol excretion and also enhances the hepatic cholesterol catabolism. We have identified, for the first time, a novel hypocholesterolemic protein, MRJP1, in RJ. Interestingly, MRJP1 exhibits greater hypocholesterolemic activity than the medicine beta-sitosterol in rats.	[Kashima, Yuri; Kanematsu, Satoshi; Asai, Saori; Watanabe, Suzuyo; Kawashima, Takuji; Nakamura, Tadashi] Akitaya Honten Co Ltd, Kano, Gifu, Japan; [Kusada, Mio; Shimada, Masaya; Goto, Tsuyoshi; Nagaoka, Satoshi] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Yanagi, Gifu, Japan	Gifu University	Nagaoka, S (corresponding author), Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Yanagi, Gifu, Japan.	nagaoka@gifu-u.ac.jp	Goto, Tsuyoshi/AAY-2344-2020	Goto, Tsuyoshi/0000-0003-1283-147X	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by grants from the Seeds Validation Exploratory Research of Japan Science and Technology Agency, and High-risk Challenge of Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association of Official Analytical Chemists, 2016, OFFICIAL METHODS ANA; CARROLL KK, 1975, J FOOD SCI, V40, P18, DOI 10.1111/j.1365-2621.1975.tb03726.x; Cochran W.G., 1967, STAT METHODS; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Folin O, 1915, J BIOL CHEM, V22, P305; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Furusawa T, 2008, J PROTEOME RES, V7, P3194, DOI 10.1021/pr800061j; Guo H, 2007, J NUTR SCI VITAMINOL, V53, P345, DOI 10.3177/jnsv.53.345; Hasler CM, 2002, J NUTR, V132, P3772, DOI 10.1093/jn/132.12.3772; HAYTER AJ, 1984, ANN STAT, V12, P61, DOI 10.1214/aos/1176346392; HIROSE N, 1991, J LIPID RES, V32, P629; Hodge JE, 1962, METHODS CARBOHYDRATE, DOI DOI 10.1371/JOURNAL.PONE.0065418; Hosomi R, 2012, J MED FOOD, V15, P299, DOI 10.1089/jmf.2011.1620; HUFF JW, 1963, P SOC EXP BIOL MED, V114, P352; HUFF MW, 1980, J NUTR, V110, P1676, DOI 10.1093/jn/110.8.1676; IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2; IKEDA I, 1988, J LIPID RES, V29, P1573; IWAMI K, 1986, AGR BIOL CHEM TOKYO, V50, P1217, DOI 10.1080/00021369.1986.10867551; JACQUES H, 1986, ATHEROSCLEROSIS, V61, P89, DOI 10.1016/0021-9150(86)90067-5; Kamakura M, 2006, J PHARM PHARMACOL, V58, P1683, DOI 10.1211/jpp.58.12.0017; Krauss RM, 1996, CIRCULATION, V94, P1795, DOI 10.1161/01.CIR.94.7.1795; Li XA, 2013, J MED FOOD, V16, P96, DOI 10.1089/jmf.2012.2425; MAKINO S, 1988, AGR BIOL CHEM TOKYO, V52, P803; Mishima S, 2005, J ETHNOPHARMACOL, V101, P215, DOI 10.1016/j.jep.2005.04.012; Morikawa K, 2007, BIOCHEM BIOPH RES CO, V352, P697, DOI 10.1016/j.bbrc.2006.11.090; Moutsatsou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015594; Nagaoka S., 2006, Dietary fats and risk of chronic disease, P168; Nagaoka S, 1999, J NUTR, V129, P1725, DOI 10.1093/jn/129.9.1725; Nagaoka S, 2002, LIPIDS, V37, P267, DOI 10.1007/s11745-002-0890-6; NAGAOKA S, 1990, J NUTR, V120, P1134, DOI 10.1093/jn/120.10.1134; Nagaoka S, 2001, BIOCHEM BIOPH RES CO, V281, P11, DOI 10.1006/bbrc.2001.4298; Nagaoka S, 2005, J NUTR, V135, P2425, DOI 10.1093/jn/135.10.2425; Nagaoka S, 2010, BIOSCI BIOTECH BIOCH, V74, P1738, DOI 10.1271/bbb.100338; NAGATA Y, 1982, J NUTR, V112, P1614, DOI 10.1093/jn/112.8.1614; NAKAJIN S, 1982, Shoyakugaku Zasshi, V36, P65; Nuttall ME, 1998, ENDOCRINOLOGY, V139, P5224, DOI 10.1210/en.139.12.5224; Okamoto I, 2003, LIFE SCI, V73, P2029, DOI 10.1016/S0024-3205(03)00562-9; OLIVER MF, 1981, BRIT MED BULL, V37, P49, DOI 10.1093/oxfordjournals.bmb.a071675; Park Y, 2011, J NUTR, V141, P1424, DOI 10.3945/jn.111.138875; PATTINSON N, 1980, J CHROMATOGR, V187, P409, DOI 10.1016/S0021-9673(00)80473-2; Rosmilah M, 2008, TROP BIOMED, V25, P243; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; SPADY DK, 1995, J CLIN INVEST, V96, P700, DOI 10.1172/JCI118113; Spady DK, 1998, J BIOL CHEM, V273, P126, DOI 10.1074/jbc.273.1.126; Stein S, 2010, METABOLISM, V59, P33, DOI 10.1016/j.metabol.2009.07.003; SUGIYAMA K, 1986, J NUTR SCI VITAMINOL, V32, P413, DOI 10.3177/jnsv.32.413; Tamura S, 2009, PROTEOMICS, V9, P5534, DOI 10.1002/pmic.200900541; Tamura S, 2009, FOOD CHEM, V114, P1491, DOI 10.1016/j.foodchem.2008.11.058; Townsend GF, 1940, BIOCHEM J, V34, P1155, DOI 10.1042/bj0341155; VITTEK J, 1995, EXPERIENTIA, V51, P927, DOI 10.1007/BF01921742; WILSON MD, 1994, J LIPID RES, V35, P943	53	40	45	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105073	10.1371/journal.pone.0105073	http://dx.doi.org/10.1371/journal.pone.0105073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144734	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100039
J	Heimesaat, MM; Dunay, IR; Alutis, M; Fischer, A; Mohle, L; Gobel, UB; Kuhl, AA; Bereswill, S				Heimesaat, Markus M.; Dunay, Ildiko R.; Alutis, Marie; Fischer, Andre; Moehle, Luisa; Goebel, Ulf B.; Kuehl, Anja A.; Bereswill, Stefan			Nucleotide-Oligomerization-Domain-2 Affects Commensal Gut Microbiota Composition and Intracerebral Immunopathology in Acute Toxoplasma gondii Induced Murine Ileitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; KAPPA-B ACTIVATION; NOD-LIKE RECEPTORS; PERORAL INFECTION; ORAL INFECTION; EARLY SURVIVAL; MODEL; MICE; IMMUNITY	Background: Within one week following peroral high dose infection with Toxoplasma (T.) gondii, susceptible mice develop non-selflimiting acute ileitis due to an underlying Th1-type immunopathology. The role of the innate immune receptor nucleotide-oligomerization-domain-2 (NOD2) in mediating potential extra-intestinal inflammatory sequelae including the brain, however, has not been investigated so far. Methodology/Principal Findings: Following peroral infection with 100 cysts of T. gondii strain ME49, NOD2(-/-) mice displayed more severe ileitis and higher small intestinal parasitic loads as compared to wildtype (WT) mice. However, systemic (i. e. splenic) levels of pro-inflammatory cytokines such as TNF-a and IFN-gamma were lower in NOD2(-/-) mice versus WT controls at day 7 p. i. Given that the immunopathological outcome might be influenced by the intestinal microbiota composition, which is shaped by NOD2, we performed a quantitative survey of main intestinal bacterial groups by 16S rRNA analysis. Interestingly, Bifidobacteria were virtually absent in NOD2(-/-) but not WT mice, whereas differences in remaining bacterial species were rather subtle. Interestingly, more distinct intestinal inflammation was accompanied by higher bacterial translocation rates to extra-intestinal tissue sites such as liver, spleen, and kidneys in T. gondii infected NOD2 -/mice. Strikingly, intracerebral inflammatory foci could be observed as early as seven days following T. gondii infection irrespective of the genotype of animals, whereas NOD2(-/-) mice exhibited higher intracerebral parasitic loads, higher F4/80 positive macrophage and microglia numbers as well as higher IFN-gamma mRNA expression levels as compared to WT control animals. Conclusion/Significance: NOD2 signaling is involved in protection of mice from T. gondii induced acute ileitis. The parasiteinduced Th1-type immunopathology at intestinal as well as extra-intestinal sites including the brain is modulated in a NOD2-dependent manner.	[Heimesaat, Markus M.; Alutis, Marie; Fischer, Andre; Goebel, Ulf B.; Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Dunay, Ildiko R.; Moehle, Luisa] Univ Magdeburg, Dept Microbiol & Hyg, D-39106 Magdeburg, Germany; [Kuehl, Anja A.] Charite, Dept Internal Med Rheumatol & Clin Immunol, Res Ctr ImmunoSci RCIS, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heimesaat, MM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de		Kuhl, Anja/0000-0003-2293-5387; Heimesaat, Markus/0000-0001-6399-651X; Mohle, Luisa/0000-0002-4535-9952	German Research Foundation (DFG) [SFB633, DU 1112/3-1, SFB854]; German Federal Ministry of Education and Research (BMBF) [TP 1.1, TP 8.2]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to UBG, SB and AF (SFB633, TP A7), MMH (SFB633, TP B6), MA (SFB633, IMMUCO), IRD (DFG DU 1112/3-1, SFB854) and from the German Federal Ministry of Education and Research (BMBF) to SB ("Lab in a hanky" projects TP 1.1 and TP 8.2). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Biswas A, 2012, J MOL MED, V90, P15, DOI 10.1007/s00109-011-0802-y; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Caetano BC, 2011, EUR J IMMUNOL, V41, P3627, DOI 10.1002/eji.201141876; Coudeyras S, 2010, CAN J MICROBIOL, V56, P611, DOI 10.1139/w10-052; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Dunay IR, 2009, ANTIMICROB AGENTS CH, V53, P4450, DOI 10.1128/AAC.00502-09; Dunay IR, 2004, ANTIMICROB AGENTS CH, V48, P4848, DOI 10.1128/AAC.48.12.4848-4854.2004; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Ge ZM, 2006, APPL ENVIRON MICROB, V72, P5100, DOI 10.1128/AEM.01934-05; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Grimes CL, 2012, J AM CHEM SOC, V134, P13535, DOI 10.1021/ja303883c; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2011, EUR J MICROBIOL IMMU, V1, P302, DOI 10.1556/EuJMI.1.2011.4.6; Heimesaat MM, 2013, EUR J MICROBIOL IMMU, V3, P36, DOI 10.1556/EuJMI.3.2013.1.5; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2013, EUR J MICROBIOL IMMU, V3, P174, DOI 10.1556/EuJMI.3.2013.3.4; Heimesaat MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040758; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; MCLEOD R, 1989, J IMMUNOL, V143, P3031; MCLEOD R, 1989, J IMMUNOL, V142, P3247; Mohle L, 2014, EUR J MICROBIOL IMMU, V4, P65, DOI 10.1556/EuJMI.4.2014.1.6; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; O'Mahony D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-63; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Parlog A, 2014, DIS MODEL MECH, V7, P459, DOI 10.1242/dmm.014183; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Rubino SJ, 2012, CURR OPIN IMMUNOL, V24, P398, DOI 10.1016/j.coi.2012.04.010; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Struck D, 2012, EUR J MICROBIOL IMMU, V2, P249, DOI 10.1556/EuJMI.2.2012.3.11; Sydora BC, 2007, INFLAMM BOWEL DIS, V13, P947, DOI 10.1002/ibd.20155; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018	53	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105120	10.1371/journal.pone.0105120	http://dx.doi.org/10.1371/journal.pone.0105120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141224	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200052
J	Lange, D; Del-Claro, K				Lange, Denise; Del-Claro, Kleber			Ant-Plant Interaction in a Tropical Savanna: May the Network Structure Vary over Time and Influence on the Outcomes of Associations?	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; EXTRAFLORAL NECTARIES; ECOLOGICAL NETWORKS; CERRADO VEGETATION; SEED DISPERSAL; FOOD RESOURCES; FRUIT-SET; SPECIALIZATION; HERBIVORE; ARCHITECTURE	Plant-animal interactions occur in a community context of dynamic and complex ecological interactive networks. The understanding of who interacts with whom is a basic information, but the outcomes of interactions among associates are fundamental to draw valid conclusions about the functional structure of the network. Ecological networks studies in general gave little importance to know the true outcomes of interactions and how they may change over time. We evaluate the dynamic of an interaction network between ants and plants with extrafloral nectaries, by verifying the temporal variation in structure and outcomes of mutualism for the plant community (leaf herbivory). To reach this goal, we used two tools: bipartite network analysis and experimental manipulation. The networks exhibited the same general pattern as other mutualistic networks: nestedness, asymmetry and low specialization and this pattern was maintained over time, but with internal changes (species degree, connectance and ant abundance). These changes influenced the protection effectiveness of plants by ants, which varied over time. Our study shows that interaction networks between ants and plants are dynamic over time, and that these alterations affect the outcomes of mutualisms. In addition, our study proposes that the set of single systems that shape ecological networks can be manipulated for a greater understanding of the entire system.	[Lange, Denise; Del-Claro, Kleber] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil	Universidade Federal de Uberlandia	Del-Claro, K (corresponding author), Univ Fed Uberlandia, Inst Biol, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	kdelclaro@gmail.com	Del-Claro, Kleber/N-3700-2019; Del-Claro, K/C-5570-2013	Del-Claro, K/0000-0001-8886-9568	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301605/2013-0, 473055/2012-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors had financial support of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - for K Del Claro 301605/2013-0; 473055/2012-0) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - dor D. Lange PNPD). The authors ensure that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; [Anonymous], 2010, 2010 GLOBECOM; Appolinario V., 2002, Boletim do Herbario Ezechias Paulo Heringer, V10, P57; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Benadi G, 2013, ECOL MODEL, V258, P65, DOI 10.1016/j.ecolmodel.2013.03.002; BENTLEY BL, 1977, J ECOL, V65, P27, DOI 10.2307/2259060; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Byk J, 2010, ACTA ETHOL, V13, P33, DOI 10.1007/s10211-010-0071-8; Chamberlain SA, 2008, ECOLOGY, V89, P1364, DOI 10.1890/07-1139.1; Chamberlain SA, 2010, OECOLOGIA, V164, P741, DOI 10.1007/s00442-010-1673-6; Dattilo W, 2014, PLOS ONE IN PRESS; Dattilo W, 2014, J TROP ECOL, V30, P165, DOI 10.1017/S0266467413000813; Dattilo W, 2013, OIKOS, V122, P1643, DOI 10.1111/j.1600-0706.2013.00562.x; Dattilo W, 2013, ECOL ENTOMOL, V38, P374, DOI 10.1111/een.12029; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Del-Claro K, 2000, OECOLOGIA, V124, P156, DOI 10.1007/s004420050002; Del-Claro K, 2013, BIOSCI J, V29, P439; Del-Claro K, 2009, NEOTROP ENTOMOL, V38, P159, DOI 10.1590/S1519-566X2009000200001; DelClaro K, 1996, J TROP ECOL, V12, P887, DOI 10.1017/S0266467400010142; Diaz-Castelazo C, 2013, ANN BOT-LONDON, V111, P1285, DOI 10.1093/aob/mct071; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Dirzo Rodolfo, 1995, P304, DOI 10.1017/CBO9780511753398.012; Dormann C. F., 2009, OPEN ECOL J, V2, P7, DOI DOI 10.2174/1874213000902010007; Dunne JA, 2006, ECOLOGICAL NETWORKS, P325; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Gibb H, 2009, INSECT SOC, V56, P405, DOI 10.1007/s00040-009-0038-9; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Holland JN, 2011, OIKOS, V120, P381, DOI 10.1111/j.1600-0706.2010.18958.x; Holldobler B., 1990, pi; HORVITZ CC, 1984, ECOLOGY, V65, P1369, DOI 10.2307/1939117; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Lach L, 2009, POPUL ECOL, V51, P237, DOI 10.1007/s10144-008-0132-2; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Machado SR, 2008, PLANT BIOLOGY, V10, P660, DOI 10.1111/j.1438-8677.2008.00068.x; Mello MAR, 2011, ACTA OECOL, V37, P37, DOI 10.1016/j.actao.2010.11.004; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; OLIVEIRA PS, 1987, BIOTROPICA, V19, P140, DOI 10.2307/2388736; OLIVEIRA PS, 1987, OECOLOGIA, V74, P228, DOI 10.1007/BF00379363; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; RASHBROOK VK, 1992, ECOLOGY, V73, P2167, DOI 10.2307/1941464; Rico-Gray V, 1998, AM MIDL NAT, V140, P21, DOI 10.1674/0003-0031(1998)140[0021:RASVOA]2.0.CO;2; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; RICOGRAY V, 1993, BIOTROPICA, V25, P301, DOI 10.2307/2388788; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; SCHEMSKE DW, 1982, ECOLOGY, V63, P932, DOI 10.2307/1937233; Sendoya SF, 2009, AM NAT, V174, P134, DOI 10.1086/599302; Stanton ML, 2011, ECOLOGY, V92, P1073, DOI 10.1890/i0012-9658-92-5-1073; Suzuki N, 2004, ECOL RES, V19, P275, DOI 10.1111/j.1440-1703.2004.00636.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057	73	55	56	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105574	10.1371/journal.pone.0105574	http://dx.doi.org/10.1371/journal.pone.0105574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141007	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200103
J	Tang, CH; Fang, LS; Fan, TY; Wang, LH; Lin, CY; Lee, SH; Wang, WH				Tang, Chuan-Ho; Fang, Lee-Shing; Fan, Tung-Yung; Wang, Li-Hsueh; Lin, Ching-Yu; Lee, Shu-Hui; Wang, Wei-Hsien			Cellular Membrane Accommodation to Thermal Oscillations in the Coral Seriatopora caliendrum	PLOS ONE			English	Article							2-PHOTON FLUORESCENCE MICROSCOPY; SUBCLASS-SPECIFIC ALTERATIONS; LIPID-COMPOSITION; CLIMATE-CHANGE; LONG-TERM; BILAYERS; VESICLES; CELLS; PHOSPHOLIPIDS; PERMEABILITY	In the present study, the membrane lipid composition of corals from a region with tidally induced upwelling was investigated. The coral community is subject to strong temperature oscillations yet flourishes as a result of adaptation. Glycerophosphocholine profiling of the dominant pocilloporid coral, Seriatopora caliendrum, was performed using a validated method. The coral inhabiting the upwelling region shows a definite shift in the ratio of lipid molecular species, covering several subclasses. Mainly, the coral possesses a higher percentage of saturated, monounsaturated and polyunsaturated plasmanylcholines and a lower percentage of polyunsaturated phosphatidylcholines. Higher levels of lyso-plasmanylcholines containing saturated or monounsaturated fatty acid chains were also revealed in coral tissue at the distal portion of the branch. Based on the physicochemical properties of these lipids, we proposed mechanisms for handling cellular membrane perturbations, such as tension, induced by thermal oscillation to determine how coral cells are able to spontaneously maintain their physiological functions, in both molecular and physical terms. Interestingly, the biochemical and biophysical properties of these lipids also have beneficial effects on the resistance, maintenance, and growth of the corals. The results of this study suggest that lipid metabolic adjustment is a major factor in the adaption of S. caliendrum in upwelling regions.	[Tang, Chuan-Ho; Fan, Tung-Yung; Wang, Wei-Hsien] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Tang, Chuan-Ho; Fan, Tung-Yung; Wang, Li-Hsueh] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolutionary Biol, Pingtung, Taiwan; [Fang, Lee-Shing] Cheng Shiu Univ, Dept Sport Hlth & Leisure, Kaohsiung, Taiwan; [Wang, Li-Hsueh] Natl Dong Hwa Univ, Inst Marine Biotechnol, Pingtung, Taiwan; [Lin, Ching-Yu] Natl Taiwan Univ, Inst Environm Hlth, Taipei 10764, Taiwan; [Lee, Shu-Hui] Natl Kaohsiung Marine Univ, Kaohsiung, Taiwan; [Wang, Wei-Hsien] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Wang, Wei-Hsien] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; Cheng Shiu University; National Dong Hwa University; National Taiwan University; National Kaohsiung University of Science & Technology; National Sun Yat Sen University; National Sun Yat Sen University	Tang, CH (corresponding author), Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan.	chtang@nmmba.gov.tw; whw@nmmba.gov.tw		LIN, CHING-YU/0000-0002-7144-0383	National Science Council in Taiwan [NSC101-2313-B-291-003]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by National Science Council (NSC101-2313-B-291-003) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT DH, 1977, LIPIDS, V12, P188, DOI 10.1007/BF02533292; Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; Bagatolli LA, 2000, BIOPHYS J, V79, P434, DOI 10.1016/S0006-3495(00)76305-3; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; CHABOT MC, 1990, CANCER RES, V50, P7174; Chen C.T.A., 2004, J MAR SCI TECHNOL, V12, P442; Chen CS, 2012, SCI CHINA LIFE SCI, V55, P599, DOI 10.1007/s11427-012-4345-4; CHEN X, 1994, BIOCHEMISTRY-US, V33, P13769, DOI 10.1021/bi00250a030; Clode PL, 2002, J EXP BIOL, V205, P3543; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; Frolov VA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004747; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Gandhavadi M, 2002, BIOPHYS J, V82, P1469, DOI 10.1016/S0006-3495(02)75501-X; Grosman N, 2001, INT IMMUNOPHARMACOL, V1, P1321, DOI 10.1016/S1567-5769(01)00064-9; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Kraichely RE, 2009, AM J PHYSIOL-GASTR L, V296, pG833, DOI 10.1152/ajpgi.90610.2008; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; KWOK R, 1981, BIOPHYS J, V35, P637, DOI 10.1016/S0006-3495(81)84817-5; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee HJ, 1999, ESTUAR COAST SHELF S, V49, P775, DOI 10.1006/ecss.1999.0524; Liu PJ, 2012, MAR POLLUT BULL, V64, P1129, DOI 10.1016/j.marpolbul.2012.03.031; LUNDBAEK JA, 1994, J GEN PHYSIOL, V104, P645, DOI 10.1085/jgp.104.4.645; Luo YJ, 2009, CORAL REEFS, V28, P289, DOI 10.1007/s00338-008-0462-8; Matsuki H, 2007, BBA-BIOMEMBRANES, V1768, P479, DOI 10.1016/j.bbamem.2006.10.005; Mayfield AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026529; Milkevitch M, 2005, BBA-MOL CELL BIOL L, V1734, P1, DOI 10.1016/j.bbalip.2005.01.008; Olbrich K, 2000, BIOPHYS J, V79, P321, DOI 10.1016/S0006-3495(00)76294-1; Ollila S, 2007, J PHYS CHEM B, V111, P3139, DOI 10.1021/jp065424f; Pandey PR, 2011, J PHYS CHEM B, V115, P3155, DOI 10.1021/jp1090203; Putnam HM, 2010, INVERTEBR BIOL, V129, P199, DOI 10.1111/j.1744-7410.2010.00199.x; Roth MS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00240; Saltveit ME, 2000, DISCOVERIES PLANT BI, P423; Shoemaker SD, 2002, IND ENG CHEM RES, V41, P324, DOI 10.1021/ie010049t; Soong K, 2003, CORAL REEFS, V22, P224, DOI 10.1007/s00338-003-0311-8; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Tang CH, 2012, ANAL BIOANAL CHEM, V404, P2949, DOI 10.1007/s00216-012-6414-8; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vigh L, 2005, PROG LIPID RES, V44, P303, DOI 10.1016/j.plipres.2005.08.001; Yamashiro H, 2001, J EXP MAR BIOL ECOL, V265, P171, DOI 10.1016/S0022-0981(01)00333-1; Zeng YC, 1998, BIOCHEMISTRY-US, V37, P2346, DOI 10.1021/bi9725172	49	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105345	10.1371/journal.pone.0105345	http://dx.doi.org/10.1371/journal.pone.0105345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140803	Green Submitted, gold, Green Published			2022-12-25	WOS:000342687200074
J	Gibellini, L; Pinti, M; Boraldi, F; Giorgio, V; Bernardi, P; Bartolomeo, R; Nasi, M; De Biasi, S; Missiroli, S; Carnevale, G; Losi, L; Tesei, A; Pinton, P; Quaglino, D; Cossarizza, A				Gibellini, Lara; Pinti, Marcello; Boraldi, Federica; Giorgio, Valentina; Bernardi, Paolo; Bartolomeo, Regina; Nasi, Milena; De Biasi, Sara; Missiroli, Sonia; Carnevale, Gianluca; Losi, Lorena; Tesei, Anna; Pinton, Paolo; Quaglino, Daniela; Cossarizza, Andrea			Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells	FASEB JOURNAL			English	Article						respiration; oxphos; RKO cells; mtDNA; mtRNA	QUALITY CONTROL; SUBSTRATE PROTEINS; GENERATION; APOPTOSIS; IDENTIFICATION; PROTEOLYSIS; SUPEROXIDE; BLOCKADE; STRESS	Lon is a nuclear-encoded, mitochondrial protease that assists protein folding, degrades oxidized/damaged proteins, and participates in maintaining mtDNA levels. Here we show that Lon is up-regulated in several human cancers and that its silencing in RKO colon cancer cells causes profound alterations of mitochondrial proteome and function, and cell death. We silenced Lon in RKO cells by constitutive or inducible expression of Lon shRNA. Lon-silenced cells displayed altered levels of 39 mitochondrial proteins (26% related to stress response, 14.8% to ribosome assembly, 12.7% to oxidative phosphorylation, 8.5% to Krebs cycle, 6.3% to beta-oxidation, and 14.7% to crista integrity, ketone body catabolism, and mtDNA maintenance), low levels of mtDNA transcripts, and reduced levels of oxidative phosphorylation complexes (with >90% reduction of complex I). Oxygen consumption rate decreased 7.5-fold in basal conditions, and ATP synthesis dropped from 0.25 +/- 0.04 to 0.03 +/- 0.001 nmol/mg proteins, in the presence of 2-deoxy-D-glucose. Hydrogen peroxide and mitochondrial superoxide anion levels increased by 3-and 1.3-fold, respectively. Mitochondria appeared fragmented, heterogeneous in size and shape, with dilated cristae, vacuoles, and electrondense inclusions. The triterpenoid 2-cyano3,12-dioxooleana-1,9,-dien-28-oic acid, a Lon inhibitor, partially mimics Lon silencing. In summary, Lon is essential for maintaining mitochondrial shape and function, and for survival of RKO cells.	[Gibellini, Lara; Bartolomeo, Regina; Nasi, Milena; De Biasi, Sara; Carnevale, Gianluca; Cossarizza, Andrea] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, I-41125 Modena, Italy; [Pinti, Marcello; Boraldi, Federica; Losi, Lorena; Quaglino, Daniela] Univ Modena & Reggio Emilia, Dept Life Sci, I-41125 Modena, Italy; [Giorgio, Valentina; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Missiroli, Sonia; Pinton, Paolo] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Tesei, Anna] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Biosci Lab, Meldola, Italy; [Cossarizza, Andrea] Univ Modena & Reggio Emilia, Dipartimento Sperimentale Interaziendale, Reggio Emilia, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; University of Padua; University of Ferrara; IRCCS Meldola (IRST); Universita di Modena e Reggio Emilia	Cossarizza, A (corresponding author), Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, Via Campi 287, I-41125 Modena, Italy.	andrea.cossarizza@unimore.it	Bernardi, Paolo/C-3656-2008; Carnevale, Gianluca/F-8416-2017; Missiroli, Sonia/K-5769-2016; Carnevale, Gianluca/ABF-7872-2021; Pinton, Paolo/J-8025-2012; Losi, Lorena/B-2583-2012; Giorgio, Valentina/O-1969-2015; Quaglino, Daniela/A-9381-2010; Tesei, Anna/C-7748-2016; Giorgio, Valentina/I-6110-2016; Pinti, Marcello/C-9351-2015; Boraldi, Federica/D-1263-2015; Nasi, Milena/J-4425-2016; De Biasi, Sara/AAB-7520-2019	Bernardi, Paolo/0000-0001-9187-3736; Carnevale, Gianluca/0000-0002-5348-5991; Carnevale, Gianluca/0000-0002-5348-5991; Pinton, Paolo/0000-0001-7108-6508; Losi, Lorena/0000-0002-8483-3936; Giorgio, Valentina/0000-0002-4229-3054; Quaglino, Daniela/0000-0002-4302-5078; Tesei, Anna/0000-0002-8351-5952; Pinti, Marcello/0000-0001-9118-1262; Boraldi, Federica/0000-0002-0277-9017; Nasi, Milena/0000-0003-3079-8001; De Biasi, Sara/0000-0002-3217-9821; Missiroli, Sonia/0000-0003-4530-617X; Cossarizza, Andrea/0000-0002-5381-1558	Associazione Italiana Ricerca sul Cancro [11341]; Ministero Istruzione, Universita, Ricerca [RBAP11S8C3]; Fondazione Cassa di Risparmio di Vignola	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero Istruzione, Universita, Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondazione Cassa di Risparmio di Vignola	This work was supported by grants from Associazione Italiana Ricerca sul Cancro (grant 11341 to A.C.), Ministero Istruzione, Universita, Ricerca (grant RBAP11S8C3 to A.C. and P.B.), and Fondazione Cassa di Risparmio di Vignola (grant to M.P.).	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; Bayot A, 2010, J BIOL CHEM, V285, P11445, DOI 10.1074/jbc.M109.065425; Bender T, 2010, PROTEOMICS, V10, P1426, DOI 10.1002/pmic.200800619; Bernstein SH, 2012, BLOOD, V119, P3321, DOI 10.1182/blood-2011-02-340075; Chen SH, 2008, NUCLEIC ACIDS RES, V36, P1273, DOI 10.1093/nar/gkm1140; Cheng CW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.204; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Cossarizza A, 2003, ANTIVIR THER, V8, P315; Cossarizza A, 2009, NAT PROTOC, V4, P1790, DOI 10.1038/nprot.2009.189; Friguet Bertrand, 2008, Biotechnology Journal, V3, P757, DOI 10.1002/biot.200800041; Giorgio V, 2012, BBA-BIOENERGETICS, V1817, P363, DOI 10.1016/j.bbabio.2011.10.012; Goard CA, 2014, ONCOGENE, V33, P2690, DOI 10.1038/onc.2013.228; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Huang CY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.149; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Luce K, 2010, ADV EXP MED BIOL, V694, P108; Major T, 2006, MOL CELL BIOL, V26, P762, DOI 10.1128/MCB.26.3.762-776.2006; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Ngo JK, 2009, FREE RADICAL BIO MED, V46, P1042, DOI 10.1016/j.freeradbiomed.2008.12.024; Nie XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081084; Pinti M, 2010, AIDS, V24, P841, DOI 10.1097/QAD.0b013e32833779a3; Rasheed S, 2009, BRIT J CANCER, V100, P1666, DOI 10.1038/sj.bjc.6605026; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; Troiano L, 2007, NAT PROTOC, V2, P2719, DOI 10.1038/nprot.2007.405; VANDYCK L, 1994, J BIOL CHEM, V269, P238; von Janowsky B, 2005, BIOL CHEM, V386, P1307, DOI 10.1515/BC.2005.149; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Xu J, 2013, MOL CANCER THER, V12, P717, DOI 10.1158/1535-7163.MCT-12-1016-T	31	51	54	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5122	5135		10.1096/fj.14-255869	http://dx.doi.org/10.1096/fj.14-255869			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25154874	Bronze			2022-12-25	WOS:000345894500009
J	Sobradillo, D; Hernandez-Morales, M; Ubierna, D; Moyer, MP; Nunez, L; Villalobos, C				Sobradillo, Diego; Hernandez-Morales, Miriam; Ubierna, Daniel; Moyer, Mary P.; Nunez, Luca; Villalobos, Carlos			A Reciprocal Shift in Transient Receptor Potential Channel 1 (TRPC1) and Stromal Interaction Molecule 2 (STIM2) Contributes to Ca2+ Remodeling and Cancer Hallmarks in Colorectal Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; ION CHANNELS; ORAI1; PROLIFERATION; EXPRESSION; TARGET; INHIBITION; MIGRATION; STORES; TUMORS	We have investigated the molecular basis of intracellular Ca2+ handling in human colon carcinoma cells (HT29) versus normal human mucosa cells (NCM460) and its contribution to cancer features. We found that Ca2+ stores in colon carcinoma cells are partially depleted relative to normal cells. However, resting Ca2+ levels, agonist-induced Ca2+ increases, store-operated Ca2+ entry (SOCE), and store-operated currents (I-SOC) are largely enhanced in tumor cells. Enhanced SOCE and depleted Ca2+ stores correlate with increased cell proliferation, invasion, and survival characteristic of tumor cells. Normal mucosa cells displayed small, inward Ca2+ release-activated Ca2+ currents (I-CRAC) mediated by ORAI1. In contrast, colon carcinoma cells showed mixed currents composed of enhanced I-CRAC plus a nonselective ISOC mediated by TRPC1. Tumor cells display increased expression of TRPC1, ORAI1, ORAI2, ORAI3, and STIM1. In contrast, STIM2 protein was nearly depleted in tumor cells. Silencing data suggest that enhanced ORAI1 and TRPC1 contribute to enhanced SOCE and differential store-operated currents in tumor cells, whereas ORAI2 and -3 are seemingly less important. In addition, STIM2 knockdown decreases SOCE and Ca2+ store content in normal cells while promoting apoptosis resistance. These data suggest that loss of STIM2 may underlie Ca2+ store depletion and apoptosis resistance in tumor cells. We conclude that a reciprocal shift in TRPC1 and STIM2 contributes to Ca2+ remodeling and tumor features in colon cancer.	[Sobradillo, Diego; Hernandez-Morales, Miriam; Ubierna, Daniel; Villalobos, Carlos] CSIC, Inst Mol Biol & Genet IBGM, Valladolid 47003, Spain; [Moyer, Mary P.] INCELL Corp, San Antonio, TX 78249 USA; [Nunez, Luca] Univ Valladolid, Dept Biochem & Mol Biol & Physiol, Valladolid 47003, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Villalobos, C (corresponding author), Inst Mol Biol & Genet, C Sanz & Fores 3, Valladolid 47003, Spain.	carlosv@ibgm.uva.es	Hernández-Morales, M/AAC-7682-2019; nunez, lucia/AAG-8018-2019; Villalobos, Carlos/M-9839-2017	Hernández-Morales, M/0000-0001-6487-1735; Villalobos, Carlos/0000-0002-0429-3846; Nunez, Lucia/0000-0002-9638-5747; DEL BOSQUE FERNANDEZ, DAVID/0000-0002-5204-1010	Ministerio de Economia y Competitividad, Spain [BFU2009-08967, BFU2012-37146]; Regional Government of Castilla y Leon, Spain [VA145U13]; Spanish National Research Council	Ministerio de Economia y Competitividad, Spain; Regional Government of Castilla y Leon, Spain; Spanish National Research Council	This work was supported in part by Grants BFU2009-08967 and BFU2012-37146 from Ministerio de Economia y Competitividad, Spain (to C. V.), and Ref VA145U13 from Regional Government of Castilla y Leon, Spain (to L. N.).; Supported by the JAE program from the Spanish National Research Council.	Alcarraz-Vizan G, 2014, BBA-GEN SUBJECTS, V1840, P1634, DOI 10.1016/j.bbagen.2013.12.024; Alicia S, 2008, CELL CALCIUM, V44, P479, DOI 10.1016/j.ceca.2008.03.001; Ashida S, 2012, CLIN CANCER RES, V18, P1578, DOI 10.1158/1078-0432.CCR-11-2535; Ay AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072889; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Aytes A, 2012, MOL CARCINOGEN, V51, P746, DOI 10.1002/mc.20843; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Bell N, 2013, BBA-MOL CELL RES, V1833, P643, DOI 10.1016/j.bbamcr.2012.11.025; Bergmeier W, 2013, CHANNELS, V7, P379, DOI 10.4161/chan.24302; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Cheng KT, 2013, CURR TOP MEMBR, V71, P149, DOI 10.1016/B978-0-12-407870-3.00007-X; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; Gusev K, 2003, J GEN PHYSIOL, V122, P81, DOI 10.1085/jgp.200308815; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1993, ANN NY ACAD SCI, V707, P198, DOI 10.1111/j.1749-6632.1993.tb38053.x; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Jiang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067637; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Lehen'kyi V, 2011, ADV EXP MED BIOL, V704, P929, DOI 10.1007/978-94-007-0265-3_48; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu HL, 2011, EXP MOL PATHOL, V91, P753, DOI 10.1016/j.yexmp.2011.09.005; Madsen CP, 2012, AM J PHYSIOL-CELL PH, V303, pC625, DOI 10.1152/ajpcell.00287.2011; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Motiani RK, 2013, PFLUG ARCH EUR J PHY, V465, P1249, DOI 10.1007/s00424-013-1254-8; Motiani RK, 2013, FASEB J, V27, P63, DOI 10.1096/fj.12-213801; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; Pani B, 2006, MOL BIOL CELL, V17, P4446, DOI 10.1091/mbc.E06-03-0251; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pigozzi D, 2006, CELL CALCIUM, V39, P401, DOI 10.1016/j.ceca.2006.01.003; Prevarskaya N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0097; Rao JN, 2012, AM J PHYSIOL-CELL PH, V303, pC308, DOI 10.1152/ajpcell.00120.2012; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Saul S, 2014, EUR J PHARMACOL, V739, P49, DOI 10.1016/j.ejphar.2013.10.071; Schindl R, 2009, P NATL ACAD SCI USA, V106, P19623, DOI 10.1073/pnas.0907714106; Skopin A, 2013, BIOCHIMIE, V95, P347, DOI 10.1016/j.biochi.2012.10.004; Smaili SS, 2013, CURR MOL MED, V13, P252; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Valero RA, 2008, CELL CALCIUM, V44, P259, DOI 10.1016/j.ceca.2007.12.002; Vanden Abeele F, 2003, CELL CALCIUM, V33, P357, DOI 10.1016/S0143-4160(03)00049-6; Wang XT, 2000, AM J PATHOL, V157, P1549, DOI 10.1016/S0002-9440(10)64792-X; Yang N, 2013, CANCER LETT, V330, P163, DOI 10.1016/j.canlet.2012.11.040; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshida J, 2012, BIOCHEM PHARMACOL, V84, P1592, DOI 10.1016/j.bcp.2012.09.021; Zeng B, 2013, CURR CANCER DRUG TAR, V13, P103, DOI 10.2174/156800913804486629; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	60	78	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28765	28782		10.1074/jbc.M114.581678	http://dx.doi.org/10.1074/jbc.M114.581678			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25143380	hybrid, Green Published			2022-12-25	WOS:000344141000002
J	Hersch, SJ; Elgamal, S; Katz, A; Ibba, M; Navarre, WW				Hersch, Steven J.; Elgamal, Sara; Katz, Assaf; Ibba, Michael; Navarre, William Wiley			Translation Initiation Rate Determines the Impact of Ribosome Stalling on Bacterial Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-P; FACTOR EF-P; ESCHERICHIA-COLI; CODON USAGE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; SEQUENCE; PROLINE; POXA; SECM	Ribosome stalling during translation can be caused by a number of characterized mechanisms. However, the impact of elongation stalls on protein levels is variable, and the reasons for this are often unclear. To investigate this relationship, we examined the bacterial translation elongation factor P (EF-P), which plays a critical role in rescuing ribosomes stalled at specific amino acid sequences including polyproline motifs. In previous proteomic analyses of both Salmonella and Escherichia coli efp mutants, it was evident that not all proteins containing a polyproline motif were dependent on EF-P for efficient expression in vivo. The alpha- and beta-subunits of ATP synthase, AtpA and AtpD, are translated from the same mRNA transcript, and both contain a PPG motif; however, proteomic analysis revealed that AtpD levels are strongly dependent on EF-P, whereas AtpA levels are independent of EF-P. Using these model proteins, we systematically determined that EF-P dependence is strongly influenced by elements in the 5'-untranslated region of the mRNA. By mutating either the Shine-Dalgarno sequence or the start codon, we find that EF-P dependence correlates directly with the rate of translation initiation where strongly expressed proteins show the greatest dependence on EF-P. Our findings demonstrate that polyproline-induced stalls exert a net effect on protein levels only if they limit translation significantly more than initiation. This model can be generalized to explain why sequences that induce pauses in translation elongation to, for example, facilitate folding do not necessarily exact a penalty on the overall production of the protein.	[Hersch, Steven J.; Navarre, William Wiley] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Elgamal, Sara; Katz, Assaf; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University of Toronto; University System of Ohio; Ohio State University	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 West 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu; william.navarre@utoronto.ca	Elgamal, Sara/GQH-4293-2022; Katz, Assaf/K-7130-2018; Katz, Assaf/R-7504-2019	Katz, Assaf/0000-0001-5481-7399; Elgamal, Sara/0000-0003-2274-9891; Hersch, Steven/0000-0001-6186-0133; Navarre, William/0000-0002-9293-9220	National Institutes of Health [GM065183]; Natural Sciences and Engineering Research Council of Canada [RGPIN 386286-10]; Vanier Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Vanier Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065183. This work was also supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN 386286-10 (to W. W. N.) and a Vanier Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada (to S. J. H.).	Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chartier M, 2012, BIOINFORMATICS, V28, P1438, DOI 10.1093/bioinformatics/bts149; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Choi S, 2011, PROTEINS, V79, P1688, DOI 10.1002/prot.22992; Chu D, 2014, EMBO J, V33, P21, DOI 10.1002/embj.201385651; Ciandrini L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002866; Corcoran CP, 2012, MOL MICROBIOL, V84, P428, DOI 10.1111/j.1365-2958.2012.08031.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Elgamal S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004553; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Giudice E, 2013, TRENDS BIOCHEM SCI, V38, P403, DOI 10.1016/j.tibs.2013.06.002; GOLDMAN E, 1995, J MOL BIOL, V245, P467, DOI 10.1006/jmbi.1994.0038; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Kemp AJ, 2013, MOL MICROBIOL, V87, P284, DOI 10.1111/mmi.12096; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Qing GL, 2003, J MOL MICROB BIOTECH, V6, P133, DOI 10.1159/000077244; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Sussman JK, 1996, MOL MICROBIOL, V21, P347, DOI 10.1046/j.1365-2958.1996.6371354.x; Takahashi S, 2013, J AM CHEM SOC, V135, P13096, DOI 10.1021/ja405967h; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Urban Johannes H., 2009, V540, P301, DOI 10.1007/978-1-59745-558-9_22; Vimberg V, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-100; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Yap MN, 2011, MOL MICROBIOL, V81, P540, DOI 10.1111/j.1365-2958.2011.07713.x; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	61	37	37	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28160	28171		10.1074/jbc.M114.593277	http://dx.doi.org/10.1074/jbc.M114.593277			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148683	Green Published, hybrid			2022-12-25	WOS:000343765400013
J	Kloepper, LN; Smith, AB; Nachtigall, PE; Buck, JR; Simmons, JA; Pacini, AF				Kloepper, Laura N.; Smith, Adam B.; Nachtigall, Paul E.; Buck, John R.; Simmons, James A.; Pacini, Aude F.			Cognitive Adaptation of Sonar Gain Control in the Bottlenose Dolphin	PLOS ONE			English	Article							FALSE KILLER WHALE; PORPOISES PHOCOENA-PHOCOENA; PERCEIVED ECHO AMPLITUDES; BIG BROWN BAT; ECHOLOCATING BATS; TURSIOPS-TRUNCATUS; PSEUDORCA-CRASSIDENS; EPTESICUS-FUSCUS; TARGET DETECTION; LAGENORHYNCHUS-ALBIROSTRIS	Echolocating animals adjust the transmit intensity and receive sensitivity of their sonar in order to regulate the sensation level of their echoes; this process is often termed automatic gain control. Gain control is considered not to be under the animal's cognitive control, but previous investigations studied animals ensonifying targets or hydrophone arrays at predictable distances. To test whether animals maintain gain control at a fixed level in uncertain conditions, we measured changes in signal intensity for a bottlenose dolphin (Tursiops truncatus) detecting a target at three target distances (2.5, 4 and 7 m) in two types of sessions: predictable and unpredictable. Predictable sessions presented the target at a constant distance; unpredictable sessions moved the target randomly between the three target positions. In the predictable sessions the dolphin demonstrated intensity distance compensation, increasing the emitted click intensity as the target distance increased. Additionally, as trials within sessions progressed, the animal adjusted its click intensity even from the first click in a click train, which is consistent with the animal expecting a target at a certain range. In the unpredictable sessions there was no significant difference of intensity with target distance until after the 7th click in a click train. Together, these results demonstrate that the bottlenose dolphin uses learning and expectation for sonar gain control.	[Kloepper, Laura N.; Simmons, James A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Kloepper, Laura N.; Buck, John R.] Univ Massachusetts, Dartmouth, MA USA; [Smith, Adam B.; Nachtigall, Paul E.; Pacini, Aude F.] Univ Hawaii, Dept Zool, Honolulu, HI 96822 USA	Brown University; University of Massachusetts System; University Massachusetts Dartmouth; University of Hawaii System	Kloepper, LN (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	laura_kloepper@brown.edu	Pacini, Aude/GYQ-6700-2022		National Science Foundation Postdoctoral Research Fellowship in Biology [DBI-120833]; Office of Naval Research grant [N00014-12-1-02-12]	National Science Foundation Postdoctoral Research Fellowship in Biology; Office of Naval Research grant(Office of Naval Research)	This was partially funded by the National Science Foundation Postdoctoral Research Fellowship in Biology DBI-120833 awarded to L.N.K. and an Office of Naval Research grant N00014-12-1-02-12 awarded to P.E.N. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie MA, 1998, J ACOUST SOC AM, V103, P1671, DOI 10.1121/1.421258; Atem ACG, 2009, BIOACOUSTICS, V19, P49, DOI 10.1080/09524622.2009.9753614; AU WWL, 1980, J ACOUST SOC AM, V68, P1077, DOI 10.1121/1.384993; AU WWL, 1974, J ACOUST SOC AM, V56, P1280, DOI 10.1121/1.1903419; AU WWL, 1981, J ACOUST SOC AM, V70, P687, DOI 10.1121/1.386931; AU WWL, 1988, J ACOUST SOC AM, V83, P662, DOI 10.1121/1.396161; AU WWL, 1983, J ACOUST SOC AM, V73, P1676, DOI 10.1121/1.389389; Au WWL, 2003, NATURE, V423, P861, DOI 10.1038/nature01727; Au WWL, 1990, SONAR DOLPHINS; Aubauer R, 2000, J ACOUST SOC AM, P1; Beedholm Kristian, 2007, Aquatic Mammals, V33, P69, DOI 10.1578/AM.33.1.2007.69; Boonman A, 2002, J EXP BIOL, V205, P2865; Brinklov S, 2010, BEHAV ECOL SOCIOBIOL, V64, P1867, DOI 10.1007/s00265-010-0998-9; Efron B, 1998, INTRO BOOTSTRAP; EVANS WE, 1967, ANIMAL SONAR SYSTEMS, P363; Fay R. R, 1994, COMP HEARING MAMMALS; Finneran JJ, 2013, J ACOUST SOC AM, V133, P1796, DOI 10.1121/1.4788997; Gorospe Kelvin D., 2011, Journal of Marine Biology, V2011, P1; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1120, DOI 10.1121/1.402639; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1133, DOI 10.1121/1.402640; Hiryu S, 2007, J ACOUST SOC AM, V121, P1749, DOI 10.1121/1.2431337; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Ibsen SD, 2007, J ACOUST SOC AM, V122, P2446, DOI 10.1121/1.2772213; Jensen FH, 2009, J EXP BIOL, V212, P1078, DOI 10.1242/jeb.025619; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; KICK SA, 1984, J NEUROSCI, V4, P2725; Kloepper LN, 2010, J EXP BIOL, V213, P3717, DOI 10.1242/jeb.042788; Kloepper LN, 2012, J EXP BIOL, V215, P1306, DOI 10.1242/jeb.066605; Kloepper LN, 2012, J ACOUST SOC AM, V131, P577, DOI 10.1121/1.3664076; Koblitz JC, 2010, J EXP BIOL, V213, P3263, DOI 10.1242/jeb.045450; LEATHERWOOD S, 1975, MAR FISH REV, V37, P10; Li SH, 2011, J EXP BIOL, V214, P2027, DOI 10.1242/jeb.053397; Linnenschmidt M, 2012, NATURWISSENSCHAFTEN, V99, P767, DOI 10.1007/s00114-012-0948-7; Linnenschmidt M, 2012, P ROY SOC B-BIOL SCI, V279, P2237, DOI 10.1098/rspb.2011.2465; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; McCormick JG, 1970, J ACOUST SOC AM, P1; Morozov BP, 1972, BIOFIZIKA, V17, P139; Muller MW, 2007, J ACOUST SOC AM, V122, P2255, DOI 10.1121/1.2769973; Nachtigall PE, 2008, J EXP BIOL, V211, P1714, DOI 10.1242/jeb.013862; Nachtigall PE, 2013, J EXP BIOL, V216, P3062, DOI 10.1242/jeb.085068; NEUWEILER G, 1990, PHYSIOL REV, V70, P615, DOI 10.1152/physrev.1990.70.3.615; Norum U, 2012, J EXP BIOL, V215, P3045, DOI 10.1242/jeb.069427; PENNER RH, 1988, ANIMAL SONAR PROCESS, P707; Posner MI, 1979, J EXPT ANAL BEHAV, V32, P363; Purves P E, 1966, WHALES DOLPHINS PORP, P321; Rasmussen MH, 2002, J ACOUST SOC AM, V111, P1122, DOI 10.1121/1.1433814; Schusterman R. J., 1980, ANIMAL SONAR SYSTEMS, P14; Schwartz CP, 2011, BEHAV BRAIN RES, V224, P358, DOI 10.1016/j.bbr.2011.06.023; SIMMONS JA, 1992, J ACOUST SOC AM, V91, P1150, DOI 10.1121/1.402641; SUGA N, 1975, J EXP BIOL, V62, P277; Supin AY, 2005, J ACOUST SOC AM, V117, P3928, DOI 10.1121/1.1914150; Supin AY, 2003, J ACOUST SOC AM, V113, P2408, DOI 10.1121/1.1561497; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; TAYLER C K, 1972, Annals of the Cape Provincial Museums Natural History, V9, P11; Tian B, 1997, J ACOUST SOC AM, V101, P2347, DOI 10.1121/1.418272; TURL CW, 1989, J ACOUST SOC AM, V86, P497, DOI 10.1121/1.398229; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Van Trees H.L., 2002, DETECTION ESTIMATION, P710; WURSIG B, 1979, FISH B-NOAA, V77, P399; [No title captured]	60	10	11	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105938	10.1371/journal.pone.0105938	http://dx.doi.org/10.1371/journal.pone.0105938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153530	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200091
J	Shang, DS; Li, CQ; Yao, QL; Yang, HX; Xu, YJ; Han, JW; Li, J; Su, F; Zhang, YP; Zhang, CL; Li, DG; Li, X				Shang, Desi; Li, Chunquan; Yao, Qianlan; Yang, Haixiu; Xu, Yanjun; Han, Junwei; Li, Jing; Su, Fei; Zhang, Yunpeng; Zhang, Chunlong; Li, Dongguo; Li, Xia			Prioritizing Candidate Disease Metabolites Based on Global Functional Relationships between Metabolites in the Context of Metabolic Pathways	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SYSTEMS BIOLOGY; D-GALACTOSE; PROSTATE; PROLIFERATION; GLUTAMATE; RISK; LINK	Identification of key metabolites for complex diseases is a challenging task in today's medicine and biology. A special disease is usually caused by the alteration of a series of functional related metabolites having a global influence on the metabolic network. Moreover, the metabolites in the same metabolic pathway are often associated with the same or similar disease. Based on these functional relationships between metabolites in the context of metabolic pathways, we here presented a pathway-based random walk method called PROFANCY for prioritization of candidate disease metabolites. Our strategy not only takes advantage of the global functional relationships between metabolites but also sufficiently exploits the functionally modular nature of metabolic networks. Our approach proved successful in prioritizing known metabolites for 71 diseases with an AUC value of 0.895. We also assessed the performance of PROFANCY on 16 disease classes and found that 4 classes achieved an AUC value over 0.95. To investigate the robustness of the PROFANCY, we repeated all the analyses in two metabolic networks and obtained similar results. Then we applied our approach to Alzheimer's disease (AD) and found that a top ranked candidate was potentially related to AD but had not been reported previously. Furthermore, our method was applicable to prioritize the metabolites from metabolomic profiles of prostate cancer. The PROFANCY could identify prostate cancer related-metabolites that are supported by literatures but not considered to be significantly differential by traditional differential analysis. We also developed a freely accessible web-based and R-based tool at http://bioinfo.hrbmu.edu.cn/PROFANCY.	[Shang, Desi; Li, Chunquan; Yao, Qianlan; Yang, Haixiu; Xu, Yanjun; Han, Junwei; Li, Jing; Su, Fei; Zhang, Yunpeng; Zhang, Chunlong; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Li, Chunquan] Harbin Med Univ, Sch Med Informat, Harbin, Peoples R China; [Li, Dongguo] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China	Harbin Medical University; Harbin Medical University; Capital Medical University	Li, DG (corresponding author), Capital Med Univ, Sch Biomed Engn, 10 You An Men Wai Xi Tou Tiao, Beijing, Peoples R China.	ldg213@ccmu.edu.cn; lixia@hrbmu.edu.cn	Li, Chunquan/AAI-1072-2020; Han, Junwei/T-9849-2018; li, xia/HHZ-7468-2022; shang, desi/GOJ-9200-2022	Li, Chunquan/0000-0002-4700-5496; Han, Junwei/0000-0002-3276-0819; qianlan, yao/0000-0003-0737-4147	Funds for Creative Research Groups of the National Natural Science Foundation of China [81121003]; National Program on Key Basic Research Project [2014CB910504]; National Natural Science Foundation of China [61170154, 61073136, 31200996]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307120027, 20102307110022]	Funds for Creative Research Groups of the National Natural Science Foundation of China; National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported in part by the Funds for Creative Research Groups of the National Natural Science Foundation of China (Grant No. 81121003), the National Program on Key Basic Research Project (Grant No. 2014CB910504), the National Natural Science Foundation of China (Grant Nos. 61170154, 61073136 and 31200996), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant Nos. 20102307120027 and 20102307110022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r179; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Cottret L, 2010, NUCLEIC ACIDS RES, V38, pW132, DOI 10.1093/nar/gkq312; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fu YM, 2010, J CELL PHYSIOL, V224, P491, DOI 10.1002/jcp.22148; Giovannucci E, 1998, CANCER RES, V58, P442; Gu M, 2009, CANCER RES, V69, P9465, DOI 10.1158/0008-5472.CAN-09-2805; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hakim S, 2012, CURR TOP MICROBIOL, V362, P246, DOI 10.1007/978-94-007-5025-8_12; Hao T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-393; Hassan GS, 2013, CHEM PHARM BULL, V61, P212, DOI 10.1248/cpb.c12-00881; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Hook G, 2011, J ALZHEIMERS DIS, V26, P387, DOI 10.3233/JAD-2011-110101; Hua XD, 2008, EXP NEUROL, V210, P709, DOI 10.1016/j.expneurol.2008.01.009; Hua XD, 2007, LIFE SCI, V80, P1897, DOI 10.1016/j.lfs.2007.02.030; Jamshidi N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100077; Joseloff E, 2013, PEDIAT PULMONOL; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012; Kitzmueller E, 2001, J NEURAL TRANSM-SUPP, P203; Kivipelto M, 2006, ACTA NEUROL SCAND, V114, P50, DOI 10.1111/j.1600-0404.2006.00685.x; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Koochekpour S, 2013, ASIAN J ANDROL, V15, P212, DOI 10.1038/aja.2012.145; Koochekpour S, 2012, CLIN CANCER RES, V18, P5888, DOI 10.1158/1078-0432.CCR-12-1308; Krysiak Robert, 2012, Wiad Lek, V65, P108; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee SI, 2008, J ANESTH, V22, P385, DOI 10.1007/s00540-008-0646-y; Levin YS, 2009, MAGN RESON MED, V62, P1091, DOI 10.1002/mrm.22120; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021131; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Michel TM, 2010, J ALZHEIMERS DIS, V19, P1295, DOI 10.3233/JAD-2010-1326; Mishur RJ, 2012, MASS SPECTROM REV, V31, P70, DOI 10.1002/mas.20338; Naj AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001130; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Picklo MJ, 2001, J NEUROPATH EXP NEUR, V60, P686, DOI 10.1093/jnen/60.7.686; Serkova NJ, 2008, PROSTATE, V68, P620, DOI 10.1002/pros.20727; SHERIF FM, 1995, CLIN BIOCHEM, V28, P145, DOI 10.1016/0009-9120(94)00074-6; Singh G, 1999, J CELL PHYSIOL, V180, P431, DOI 10.1002/(SICI)1097-4652(199909)180:3<431::AID-JCP14>3.0.CO;2-O; Singh RP, 2003, CARCINOGENESIS, V24, P555, DOI 10.1093/carcin/24.3.555; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stenman K, 2011, BIOMARK INSIGHTS, V6, P39, DOI 10.4137/BMI.S6794; SZABO S, 1989, TOXICOL PATHOL, V17, P317, DOI 10.1177/019262338901700208; Szabo Z, 2010, ONCOL REP, V23, P1233, DOI 10.3892/or_00000755; Taylor BS, 2008, MOL CELL PROTEOMICS, V7, P600, DOI 10.1074/mcp.M700263-MCP200; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; Trock BJ, 2011, UROL ONCOL-SEMIN ORI, V29, P572, DOI 10.1016/j.urolonc.2011.08.002; Wilson ID, 2005, J CHROMATOGR B, V817, P67, DOI 10.1016/j.jchromb.2004.07.045; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004	55	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104934	10.1371/journal.pone.0104934	http://dx.doi.org/10.1371/journal.pone.0104934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153931	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200030
J	Cosgrove, C; Berger, CT; Kroy, DC; Cheney, PC; Ghebremichael, M; Aneja, J; Tomlinson, M; Kim, AY; Lauer, GM; Alter, G				Cosgrove, Cormac; Berger, Christoph T.; Kroy, Daniela C.; Cheney, Patrick C.; Ghebremichael, Musie; Aneja, Jasneet; Tomlinson, Michelle; Kim, Arthur Y.; Lauer, Georg M.; Alter, Galit			Chronic HCV Infection Affects the NK Cell Phenotype in the Blood More than in the Liver	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NATURAL-KILLER-CELLS; INHIBITORY RECEPTOR GENES; IG-LIKE RECEPTORS; T-CELLS; ACTIVATION; EXPRESSION; REPLICATION; RESPONSES; IMMUNITY	Although epidemiological and functional studies have implicated NK cells in protection and early clearance of HCV, the mechanism by which they may contribute to viral control is poorly understood, particularly at the site of infection, the liver. We hypothesized that a unique immunophenotypic/functional NK cell signature exists in the liver that may provide insights into the contribution of NK cells to viral control. Intrahepatic and blood NK cells were profiled from chronically infected HCV-positive and HCV-negative individuals. Baseline expression of activating and inhibitory receptors was assessed, as well as functional responses following stimulation through classic NK cell pathways. Independent of HCV infection, the liver was enriched for the immunoregulatory CD56(bright) NK cell population, which produced less IFN gamma and CD107a but comparable levels of MIP1 beta, and was immunophenotypically distinct from their blood counterparts. This profile was mostly unaltered in chronic HCV infection, though different expression levels of NKp46 and NKG2D were associated with different grades of fibrosis. In contrast to the liver, chronic HCV infection associated with an enrichment of CD161(low) perforin(high) NK cells in the blood correlated with increased AST and 2B4 expression. However, the association of relatively discrete changes in the NK cell phenotype in the liver with the fibrosis stage nevertheless suggests an important role for the NK response. Overall these data suggest that tissue localization has a more pervasive effect on NK cells than the presence of chronic viral infection, during which these cells might be mostly attuned to limiting immunopathology. It will be important to characterize NK cells during early HCV infection, when they should have a critical role in limiting infection.	[Cosgrove, Cormac; Berger, Christoph T.; Cheney, Patrick C.; Ghebremichael, Musie; Alter, Galit] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA; [Kroy, Daniela C.; Aneja, Jasneet; Tomlinson, Michelle; Kim, Arthur Y.; Lauer, Georg M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kroy, Daniela C.] Rhein Westfal TH Aachen, Univ Hosp, D-52062 Aachen, Germany; [Kim, Arthur Y.; Lauer, Georg M.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Harvard University; Harvard Medical School	Alter, G (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA.	galter@mgh.harvard.edu	Berger, Christoph T/I-6126-2019; Lauer, Georg/J-1467-2018	Berger, Christoph T/0000-0002-1730-8824; Lauer, Georg/0000-0002-9792-4271	National Institutes of Health [AI08230, AI066345]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from the National Institutes of Health U19 #AI08230 and U19 #AI066345. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Alter G, 2011, J HEPATOL, V55, P278, DOI 10.1016/j.jhep.2010.11.030; [Anonymous], 1925, J CLIN INVEST, V120, P1925, DOI [10.1172/JCI41264, DOI 10.1172/JCI41264]; Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Burt BM, 2009, J IMMUNOL, V183, P1789, DOI 10.4049/jimmunol.0900541; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Carrega P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00347; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Farag MMS, 2011, CLIN EXP IMMUNOL, V165, P352, DOI 10.1111/j.1365-2249.2011.04431.x; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Fogli M, 2004, EUR J IMMUNOL, V34, P2313, DOI 10.1002/eji.200425251; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Glassner A, 2012, LAB INVEST, V92, P967, DOI 10.1038/labinvest.2012.54; Golden-Mason L, 2013, IMMUNOL REV, V255, P68, DOI 10.1111/imr.12090; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Kawarabayashi N, 2000, HEPATOLOGY, V32, P962, DOI 10.1053/jhep.2000.19362; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Khashab M, 2010, ENDOSCOPY, V42, P228, DOI 10.1055/s-0029-1243859; Klugewitz K, 2004, TRENDS IMMUNOL, V25, P590, DOI 10.1016/j.it.2004.09.006; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Kroy DC, 2014, GASTROENTEROLOGY, V146, P550, DOI 10.1053/j.gastro.2013.10.022; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lang PA, 2010, HEPATOLOGY, V52, P25, DOI 10.1002/hep.23640; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lauer GM, 2013, J INFECT DIS, V207, pS7, DOI 10.1093/infdis/jis762; Liang TJ, 2013, NAT MED, V19, P869, DOI 10.1038/nm.3183; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Nattermann J, 2006, GUT; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Parsons MS, 2014, J IMMUNOL, V192, P308, DOI 10.4049/jimmunol.1301247; Pelletier S, 2010, J HEPATOL, V53, P805, DOI 10.1016/j.jhep.2010.05.013; Pembroke T, 2014, GUT, V63, P515, DOI 10.1136/gutjnl-2013-304472; Romero V, 2008, MOL IMMUNOL, V45, P2429, DOI 10.1016/j.molimm.2008.01.002; Stegmann KA, 2010, GASTROENTEROLOGY, V138, P1885, DOI 10.1053/j.gastro.2010.01.051; Stepp SE, 2000, IMMUNOL TODAY, V21, P254, DOI 10.1016/S0167-5699(00)01622-4; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; Varchetta S, 2012, HEPATOLOGY, V56, P841, DOI 10.1002/hep.25723; Waggoner SN, 2012, NATURE, V481, P394, DOI [10.1038/nature10624, DOI 10.1038/nature10624]; Yamagiwa S, 2008, HEPATOL RES, V38, P664, DOI 10.1111/j.1872-034X.2008.00317.x; YANG YP, 1995, P NATL ACAD SCI USA, V92, P7257, DOI 10.1073/pnas.92.16.7257	45	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105950	10.1371/journal.pone.0105950	http://dx.doi.org/10.1371/journal.pone.0105950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148254	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600099
J	Ebrahimi, M; Bull, CM				Ebrahimi, Mehregan; Bull, C. Michael			Short-Term Dispersal Response of an Endangered Australian Lizard Varies with Time of Year	PLOS ONE			English	Article							BLUE-TONGUE LIZARD; PYGMY BLUETONGUE LIZARDS; TILIQUA-ADELAIDENSIS; ANIMAL TRANSLOCATION; BREEDING DISPERSAL; ARTIFICIAL BURROWS; BIASED DISPERSAL; GENE FLOW; CONSERVATION; MOVEMENT	Dispersal is an important component in the demography of animal populations. Many animals show seasonal changes in their tendency to disperse, reflecting changes in resource availability, mating opportunities, or in population age structure at the time when new offspring enter the population. Understanding when and why dispersal occurs can be important for the management of endangered species. The pygmy bluetongue lizard is an endangered Australian species that occupies and defends single burrow refuges for extended periods of time, rarely moving far from the burrow entrance. However, previous pitfall trapping data have suggested movement of adult males in spring and of juveniles in autumn of each year. In the current study we compared behaviours of adult lizards each month, over the spring-summer activity period over two consecutive field seasons, to provide deeper understanding of the seasonal dispersal pattern. We released adult pygmy bluetongue lizards into a central area, provided with artificial burrows, within large enclosures, and monitored the behaviour and movements of the released lizards over a four day period. There was a consistent decline in time spent basking, amount of movement around burrow entrances, and rates of dispersal from the central release area from early spring to late summer. Results could be relevant to understanding and managing natural populations and for any translocation attempts of this endangered lizard species.	[Ebrahimi, Mehregan; Bull, C. Michael] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Ebrahimi, Mehregan] Shiraz Univ, Dept Biol, Shiraz, Fars Province, Iran	Flinders University South Australia; Shiraz University	Ebrahimi, M (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	mehregan.ebrahimi@flinders.edu.au	Ebrahimi, Mehregan/H-3614-2013	Ebrahimi, Mehregan/0000-0002-7140-047X; Ebrahimi, Mehregan/0000-0003-1897-9694; Bull, Michael/0000-0002-9350-5950	Australian Research Council [LP0883495]; SA Department of the Environment, Water and Natural Resources; Field Naturalists Society of SA; SA Museum; Northern and Yorke NRM Board; SA Murray-Darling NRM Board; Holsworth Wildlife Research Endowment; Sir Mark Mitchell Research Foundation; Ministry of Sciences, Research and Technology of Iran; Zoos SA	Australian Research Council(Australian Research Council); SA Department of the Environment, Water and Natural Resources; Field Naturalists Society of SA; SA Museum; Northern and Yorke NRM Board; SA Murray-Darling NRM Board; Holsworth Wildlife Research Endowment; Sir Mark Mitchell Research Foundation; Ministry of Sciences, Research and Technology of Iran; Zoos SA	There are no current external funding sources for this study. This research was supported by funding from the Australian Research Council: Linkage grant LP0883495 "Translocation as a conservation strategy for the Pygmy Bluetongue Lizard.'' Partner organizations who also provided funding to the same grant were Zoos SA (http://www.zoossa.com.au), the SA Department of the Environment, Water and Natural Resources (http://www.environment.sa.gov.au), the Field Naturalists Society of SA (http://www.fnssa.org.au), the SA Museum (http://www.samuseum.sa.gov.au), the Northern and Yorke NRM Board and the SA Murray-Darling NRM Board (http://www.naturalresources.sa.gov.au). Other research student grants were awarded to Mehregan Ebrahimi by the Holsworth Wildlife Research Endowment (http://www.anz.com.au/personal/private-banktrustees/trustees/granting/granting-programs/small-grants/) and the Sir Mark Mitchell Research Foundation (http://www.aetlimited.com.au). The Ministry of Sciences, Research and Technology of Iran (http://www.msrt.ir/) sponsored the PhD studies of Mehregan Ebrahimi. No individuals employed or contracted by any of the funders played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodinof CM, 2012, HERPETOLOGICA, V68, P160, DOI 10.1655/HERPETOLOGICA-D-11-00033.1; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; BRIGHT PW, 1994, J APPL ECOL, V31, P699, DOI 10.2307/2404160; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Ebrahimi M, 2013, J ARID ENV IN PRESS; Ebrahimi M, 2014, APPL ANIM BEHAV SCI, V156, P94, DOI 10.1016/j.applanim.2014.04.013; Ebrahimi M, 2013, AMPHIBIA-REPTILIA, V34, P31, DOI 10.1163/15685381-00002863; Ebrahimi Mehregan, 2012, Endangered Species Research, V18, P169, DOI 10.3354/esr00446; Ebrahimi M, 2012, WILDLIFE RES, V39, P295, DOI 10.1071/WR11155; Fellows HL, 2009, J ZOOL, V279, P156, DOI 10.1111/j.1469-7998.2009.00600.x; Fenner AL, 2011, J ZOOL, V283, P45, DOI 10.1111/j.1469-7998.2010.00742.x; Fenner AL, 2008, WILDLIFE RES, V35, P158, DOI 10.1071/WR07103; Fenner AL, 2008, COMP PARASITOL, V75, P69, DOI 10.1654/4316.1; Fenner AL, 2010, WILDLIFE RES, V37, P582, DOI 10.1071/WR10122; Fenner Aaron L., 2009, Herpetological Review, V40, P91; Fenner AL, 2014, HERPETOFAUN IN PRESS; Gandon Sylvain, 2001, P155; Gilliam JF, 2001, ECOLOGY, V82, P258, DOI 10.2307/2680101; Hanski I., 1999, METAPOPULATION ECOLO; Hardman B, 2006, BIOL CONSERV, V128, P403, DOI 10.1016/j.biocon.2005.10.006; HEDRICK PW, 1995, CONSERV BIOL, V9, P996, DOI 10.1046/j.1523-1739.1995.9050988.x-i1; Hutchinson Mark N., 1994, Transactions of the Royal Society of South Australia, V118, P217; KLEIMAN DG, 1989, BIOSCIENCE, V39, P152, DOI 10.2307/1311025; Macdonald David W., 2001, P358; Milne T, 2003, J HERPETOL, V37, P762, DOI 10.1670/38-03N; Milne T, 2003, WILDLIFE RES, V30, P523, DOI 10.1071/WR02087; Milne T, 2002, J HERPETOL, V36, P110, DOI 10.2307/1565812; Olsson M, 2003, BIOL J LINN SOC, V79, P277, DOI 10.1046/j.1095-8312.2003.00116.x; Olsson M, 1997, BIOL J LINN SOC, V60, P243; Railsback SF, 1999, ECOL MODEL, V123, P73, DOI 10.1016/S0304-3800(99)00124-6; Rosatte R, 2002, ANN NY ACAD SCI, V969, P358, DOI 10.1111/j.1749-6632.2002.tb04405.x; Schaefer J, 2001, FRESHWATER BIOL, V46, P379, DOI 10.1046/j.1365-2427.2001.00685.x; Schofield JA, 2012, WILDLIFE RES, V39, P677, DOI 10.1071/WR12098; Scillitani L, 2013, J WILDLIFE MANAGE, V77, P761, DOI 10.1002/jwmg.517; Shier DM, 2006, CONSERV BIOL, V20, P1780, DOI 10.1111/j.1523-1739.2006.00512.x; Smith AL, 2009, WILDLIFE RES, V36, P466, DOI 10.1071/WR08171; Souter NJ, 2004, BIOL CONSERV, V116, P403, DOI 10.1016/S0006-3207(03)00232-5; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Tucker AD, 1998, BEHAV ECOL SOCIOBIOL, V44, P85, DOI 10.1007/s002650050519; Wallace M.P, 2000, BEHAV CONSERVATION, P300	42	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106002	10.1371/journal.pone.0106002	http://dx.doi.org/10.1371/journal.pone.0106002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147949	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600108
J	Patra, D; DeLassus, E; Liang, GS; Sandell, LJ				Patra, Debabrata; DeLassus, Elizabeth; Liang, Guosheng; Sandell, Linda J.			Cartilage-Specific Ablation of Site-1 Protease in Mice Results in the Endoplasmic Reticulum Entrapment of Type IIB Procollagen and Down-Regulation of Cholesterol and Lipid Homeostasis	PLOS ONE			English	Article							ASPARAGINE SYNTHETASE GENE; TRANSCRIPTION FACTOR; ER STRESS; TARGETED DISRUPTION; BONE-DEVELOPMENT; CELL-DEATH; PROTEOLYSIS; EXPRESSION; ATF6; ACTIVATION	The proprotein convertase site-1 protease (S1P) converts latent ER-membrane bound transcription factors SREBPs and ATF6 to their active forms. SREBPs are involved in cholesterol and fatty acid homeostasis whereas ATF6 is involved in unfolded protein response pathways (UPR). Cartilage-specific ablation of S1P in mice (S1P(cko)) results in abnormal cartilage devoid of type II collagen protein (Col II). S1P(cko) mice also lack endochondral bone development. To analyze S1P(cko) cartilage we performed double-labeled immunofluorescence studies for matrix proteins that demonstrated that type IIB procollagen is trapped inside the ER in S1P(cko) chondrocytes. This retention is specific to type IIB procollagen; other cartilage proteins such as type IIA procollagen, cartilage oligomeric matrix protein (COMP) and aggrecan are not affected. The S1P(cko) cartilage thus exhibits COMP-, aggrecan-, and type IIA procollagen-derived matrices but is characterized by the absence of a type IIB procollagen-derived matrix. To understand the molecular reason behind S1P(cko) phenotypes we performed genome-wide transcriptional profiling of cartilage isolated from S1P(cko) and wild type littermates. While the UPR pathways are unaffected, the SREBPs-directed cholesterol and fatty acid pathways are significantly down-regulated in S1P(cko) chondrocytes, with maximal down-regulation of the stearoyl-CoA desaturase-1 (Scd1) gene. However, mouse models that lack Scd1 or exhibit reduction in lipid homeostasis do not suffer from the ER retention of Col II or lack endochondral bone. These studies indicate an indispensable role for S1P in type IIB procollagen trafficking from the ER. This role appears not to be related to lipid pathways or other current known functions of S1P and is likely dependent on additional, yet unknown, S1P substrates in chondrocytes.	[Patra, Debabrata; DeLassus, Elizabeth; Sandell, Linda J.] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Sandell, Linda J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Liang, Guosheng] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas	Patra, D (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA.	patrad@wudosis.wustl.edu			National Institutes of Health [RO1 AR050847, RO1 AR045550, HL020948, 1P30AR057235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045550, P30AR057235, R01AR050847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health RO1 AR050847 and RO1 AR045550 to L. J. Sandell and HL020948 to G. Liang and by a 1P30AR057235 to the Musculoskeletal Research Center at Washington University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Barbosa-Tessmann IP, 1999, J BIOL CHEM, V274, P31139, DOI 10.1074/jbc.274.44.31139; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Caplan AI, 1987, BONE MINERAL RES, P117; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Gartel AL, 2002, MOL CANCER THER, V1, P639; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Horton W. A., 1993, EXTRACELLULAR MATRIX, P73; Khan SU, 2008, CYTOTECHNOLOGY, V57, P207, DOI 10.1007/s10616-008-9157-9; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Li LX, 2011, J BIOL CHEM, V286, P17809, DOI 10.1074/jbc.M110.180893; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Long FX, 2001, DEVELOPMENT, V128, P5099; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okayasu M, 2012, J BIOL CHEM, V287, P19229, DOI 10.1074/jbc.M111.323600; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Patra D, 2014, MATRIX BIOL, V34, P154, DOI 10.1016/j.matbio.2013.10.014; Patra D, 2011, J BIOL CHEM, V286, P29227, DOI 10.1074/jbc.M110.208686; POOLE AR, 1991, CARTILAGE MOL ASPECT, P179; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Wu SF, 2004, J BIOL CHEM, V279, P4642, DOI 10.1074/jbc.M305518200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	55	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105674	10.1371/journal.pone.0105674	http://dx.doi.org/10.1371/journal.pone.0105674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147951	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600066
J	Suzuki, K; Fukuda, T; Liao, YJ				Suzuki, Katsumi; Fukuda, Takeshi; Liao, Yingjie			Electrosprayed Molybdenum Trioxide Aqueous Solution and Its Application in Organic Photovoltaic Cells	PLOS ONE			English	Article							SOLUTION-PROCESSED MOO3; SOLAR-CELLS; HOLE-INJECTION; METAL-OXIDES; DEPOSITION; LAYER; FILMS; TRANSISTORS; EFFICIENCY	A molybdenum trioxide thin film with smooth surface and uniform thickness was successfully achieved by an electrospray deposition method using an aqueous solution with a drastically low concentration of 0.05 wt%. Previous papers demonstrated that an additive solvent technique is useful for depositing the thin film by the electrospray deposition, and the high vapor pressure and a low surface tension of an additive solvent were found to be important factors. As a result, the smooth molybdenum trioxide thin film was obtained when the acetonitrile was used as the additive solvent. Furthermore, the vapor pressure of acetone is much higher than that of aqueous solution, and this indicates that the acetone is easily evaporated after spraying from the glass capillary. By optimizing a concentration of acetone in the molybdenum aqueous solution, a minimum root mean square roughness of the MoO3 thin film became 3.7 nm. In addition, an organic photovoltaic cell was also demonstrated using the molybdenum trioxide as a hole transport layer. Highest photoconversion efficiency was 1.72%, a value comparable to that using conventional thermal evaporation process even though the aqueous solution was used for the solution process. The photovonversion efficiency was not an optimized value, and the higher value can be achieved by optimizing the coating condition of the active layer.	[Suzuki, Katsumi; Fukuda, Takeshi; Liao, Yingjie] Saitama Univ, Grad Sch Sci & Engn, Dept Funct Mat Sci, Saitama 3388570, Japan	Saitama University	Fukuda, T (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Dept Funct Mat Sci, Saitama 3388570, Japan.	fukuda@fms.saitama-u.ac.jp	Liao, Yingjie/L-8678-2013; Fukuda, Takeshi/G-8647-2011		JSPS KAKENHI [26420267]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number (26420267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2011, J APPL PHYS, V110, DOI 10.1063/1.3633519; Ali M, 2012, ORG ELECTRON, V13, P2130, DOI 10.1016/j.orgel.2012.06.016; Ameri T, 2013, ADV MATER, V25, P4245, DOI 10.1002/adma.201300623; Balendhran S, 2013, ADV FUNCT MATER, V23, P3952, DOI 10.1002/adfm.201300125; Bodnar E, 2013, J COLLOID INTERF SCI, V407, P536, DOI 10.1016/j.jcis.2013.06.013; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Fujita K, 2002, JPN J APPL PHYS 2, V41, pL70, DOI 10.1143/JJAP.41.L70; Fukuda T, 2013, PHYS STATUS SOLIDI-R, V7, P1055, DOI 10.1002/pssr.201308167; Fukuda T, 2012, PHYS STATUS SOLIDI A, V209, P2324, DOI 10.1002/pssa.201228242; Fukuda T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BK12; Fukuda T, 2011, THIN SOLID FILMS, V520, P600, DOI 10.1016/j.tsf.2011.07.048; Fukuda T, 2011, PHYS STATUS SOLIDI-R, V5, P229, DOI 10.1002/pssr.201105232; Fukuda T, 2009, THIN SOLID FILMS, V518, P575, DOI 10.1016/j.tsf.2009.07.020; Ganan-Calvo AM., 1994, J AEROSOL SCI, V25S, pS309, DOI [10.1016/0021-8502(94)90384-0, DOI 10.1016/0021-8502(94)90384-0]; Girotto C, 2011, ACS APPL MATER INTER, V3, P3244, DOI 10.1021/am200729k; Green MA, 2011, PROG PHOTOVOLTAICS, V19, P84, DOI 10.1002/pip.1088; Grimaldi IA, 2012, SYNTHETIC MET, V161, P2618, DOI 10.1016/j.synthmet.2011.08.004; Han S, 2009, ORG ELECTRON, V10, P791, DOI 10.1016/j.orgel.2009.03.016; Jaworek A, 2008, J ELECTROSTAT, V66, P197, DOI 10.1016/j.elstat.2007.10.001; Jaworek A, 2007, J MATER SCI, V42, P266, DOI 10.1007/s10853-006-0842-9; Jaworek A, 2014, J ELECTROSTAT, V72, P166, DOI 10.1016/j.elstat.2014.01.004; Ju J, 2009, ADV MATER, V21, P4343, DOI 10.1002/adma.200900444; Koishikawa Y, 2013, THIN SOLID FILMS, V545, P527, DOI 10.1016/j.tsf.2013.07.083; Krebs FC, 2004, SOL ENERG MAT SOL C, V83, P293, DOI 10.1016/j.solmat.2004.02.031; Ku BK, 2002, J AEROSOL SCI, V33, P1361, DOI 10.1016/S0021-8502(02)00075-7; Liao Y, 2014, THIN SOLID FILMS, V554, P132, DOI 10.1016/j.tsf.2013.08.019; Lim YF, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3021022; Meyer J, 2011, ADV MATER, V23, P70, DOI 10.1002/adma.201003065; Nakayama K, 2011, ADV MATER, V23, P1626, DOI 10.1002/adma.201004387; Nasu K, 2013, CHEM COMMUN, V49, P10385, DOI 10.1039/c3cc44179b; Ozden-Yenigun E, 2013, PHYS CHEM CHEM PHYS, V15, P17862, DOI 10.1039/c3cp53079e; Radacsi N, 2012, CRYST GROWTH DES, V12, P3514, DOI 10.1021/cg300285w; RAYLEIGH FRS, 1882, PHILOS MAG, V14, P184, DOI DOI 10.1080/14786448208628425; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Seo H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.024103; Steirer KX, 2009, SOL ENERG MAT SOL C, V93, P447, DOI 10.1016/j.solmat.2008.10.026; Steirer KX, 2009, THIN SOLID FILMS, V517, P2781, DOI 10.1016/j.tsf.2008.10.124; Takayama M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05DC15; Teichler A, 2013, J MATER CHEM C, V1, P1910, DOI 10.1039/c2tc00255h; Tekin E, 2008, SOFT MATTER, V4, P703, DOI 10.1039/b711984d; Tokito S, 1996, J PHYS D APPL PHYS, V29, P2750, DOI 10.1088/0022-3727/29/11/004; Torsi L, 2013, CHEM SOC REV, V42, P8612, DOI 10.1039/c3cs60127g; Tseng YC, 2012, SOL ENERG MAT SOL C, V99, P235, DOI 10.1016/j.solmat.2011.12.004; Walia S, 2013, PROG MATER SCI, V58, P1443, DOI 10.1016/j.pmatsci.2013.06.003; Xu MF, 2013, ORG ELECTRON, V14, P657, DOI 10.1016/j.orgel.2012.12.016; Yamauchi H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.01AB16; Zhao XY, 2014, SOL ENERG MAT SOL C, V121, P119, DOI 10.1016/j.solmat.2013.10.020	47	5	5	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106012	10.1371/journal.pone.0106012	http://dx.doi.org/10.1371/journal.pone.0106012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148047	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600109
J	Wuest, SC; Mexhitaj, I; Chai, NR; Romm, E; Scheffel, J; Xu, BY; Lane, K; Wu, TX; Bielekova, B				Wuest, Simone C.; Mexhitaj, Ina; Chai, Noo Ri; Romm, Elena; Scheffel, Joerg; Xu, Biying; Lane, Kelly; Wu, Tianxia; Bielekova, Bibiana			A Complex Role of Herpes Viruses in the Disease Process of Multiple Sclerosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID; T-CELLS; DEMYELINATING DISEASES; ISLET AUTOANTIBODIES; DACLIZUMAB; PROGRESSION; SERUM; RISK	Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system (CNS). Neither the antigenic target(s) nor the cell population(s) responsible for CNS tissue destruction in MS have been fully defined. The objective of this study was to simultaneously determine the antigen (Ag)-specificity and phenotype of un-manipulated intrathecal CD4(+) and CD8(+) T cells of patients with relapsing-remitting and progressive MS compared to subjects with other inflammatory neurological diseases. We applied a novel Ag-recognition assay based on co-cultures of freshly obtained cerebrospinal fluid T cells and autologous dendritic cells pre-loaded with complex candidate Ag's. We observed comparably low T cell responses to complex auto-Ag's including human myelin, brain homogenate, and cell lysates of apoptotically modified oligodendroglial and neuronal cells in all cohorts and both compartments. Conversely, we detected a strong intrathecal enrichment of Epstein-Barr virus- and human herpes virus 6-specific (but not cytomegalovirus-specific) reactivities of the Th1-phenotype throughout all patients. Qualitatively, the intrathecal enrichment of herpes virus reactivities was more pronounced in MS patients. This enrichment was completely reversed by long-term treatment with the IL-2 modulating antibody daclizumab, which strongly inhibits MS disease activity. Finally, we observed a striking discrepancy between diminished intrathecal T cell proliferation and enhanced cytokine production of herpes virus-specific T cells among progressive MS patients, consistent with the phenotype of terminally differentiated cells. The data suggest that intrathecal administration of novel therapeutic agents targeting immune cells outside of the proliferation cycle may be necessary to effectively eliminate intrathecal inflammation in progressive MS.	[Wuest, Simone C.; Mexhitaj, Ina; Chai, Noo Ri; Romm, Elena; Bielekova, Bibiana] NINDS, Neuroimmunol Dis Unit, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Scheffel, Joerg] NIAMSD, Mol Immunol Sect, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Xu, Biying; Lane, Kelly] NHLBI, Imaging Probe Dev Ctr, NIH, Bethesda, MD 20892 USA; [Wu, Tianxia] NINDS, Clin Neurosci Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bielekova, B (corresponding author), NINDS, Neuroimmunol Dis Unit, Neuroimmunol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	Bibi.Bielekova@nih.gov	Bielekova, Bibiana/V-1452-2017; Bielekova, Bibiana/AAA-8115-2020	Bielekova, Bibiana/0000-0002-0959-9430; Bielekova, Bibiana/0000-0002-0959-9430	NINDS intramural program; NINDS competitive fellowship; AbbVie Biotherapeutics and Biogen/IDEC [CRADA 2010-0039]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003055, ZIANS003056] Funding Source: NIH RePORTER	NINDS intramural program; NINDS competitive fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AbbVie Biotherapeutics and Biogen/IDEC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the NINDS intramural program, the NINDS competitive fellowship to S.C.W., and by AbbVie Biotherapeutics and Biogen/IDEC (CRADA# 2010-0039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour N, 2003, J NEUROIMMUNOL, V137, P197, DOI 10.1016/S0165-5728(03)00080-8; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Banwell B, 2008, ANN NEUROL, V63, P98, DOI 10.1002/ana.21244; BAXEVANIS CN, 1989, J NEUROIMMUNOL, V22, P23, DOI 10.1016/0165-5728(89)90005-2; Becker KJ, 2012, J NEUROCHEM, V123, P148, DOI 10.1111/j.1471-4159.2012.07953.x; Becker KJ, 2011, STROKE, V42, P2763, DOI 10.1161/STROKEAHA.111.619593; Bickham K, 2001, J CLIN INVEST, V107, P121, DOI 10.1172/JCI10209; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bielekova B, 2011, NEUROLOGY, V77, P1877, DOI 10.1212/WNL.0b013e318239f7ef; Bielekova B, 2004, J IMMUNOL, V172, P3893, DOI 10.4049/jimmunol.172.6.3893; Bielekova B, 2009, ARCH NEUROL-CHICAGO, V66, P483, DOI 10.1001/archneurol.2009.50; Buljevac D, 2005, J NEUROL NEUROSUR PS, V76, P1377, DOI 10.1136/jnnp.2004.048504; Castellazzi M, 2010, MULT SCLER J, V16, P883, DOI 10.1177/1352458510368051; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Derfuss T, 2005, J NEUROL, V252, P968, DOI 10.1007/s00415-005-0794-z; Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; Edwards LJ, 2013, AM J CLIN EXP IMMUNO, V2, P234; Hall JC, 2004, RHEUM DIS CLIN N AM, V30, P455, DOI 10.1016/j.rdc.2004.04.012; HAN S, 2014, J IMMUNOL; Hufner K, 2007, J NEUROVIROL, V13, P462, DOI 10.1080/13550280701447059; Hummel M, 2004, ANN INTERN MED, V140, P882, DOI 10.7326/0003-4819-140-11-200406010-00009; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Jaeger LB, 2009, BRAIN BEHAV IMMUN, V23, P507, DOI 10.1016/j.bbi.2009.01.017; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Lunemann JD, 2007, CURR NEUROL NEUROSCI, V7, P253, DOI 10.1007/s11910-007-0038-y; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; MAIMONE D, 1991, J NEUROIMMUNOL, V32, P67, DOI 10.1016/0165-5728(91)90073-G; Ngono AE, 2012, CLIN IMMUNOL, V144, P117, DOI 10.1016/j.clim.2012.05.009; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Connor KC, 2003, J NEUROIMMUNOL, V136, P140, DOI 10.1016/S0165-5728(03)00002-X; OLSSON T, 1992, EUR J IMMUNOL, V22, P1083, DOI 10.1002/eji.1830220431; Peferoen LAN, 2010, BRAIN, V133, DOI 10.1093/brain/awp296; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Pohl D, 2010, J NEUROL, V257, P212, DOI 10.1007/s00415-009-5296-y; Reindl M, 2013, NAT REV NEUROL, V9, P455, DOI 10.1038/nrneurol.2013.118; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawtell NA, 2004, J VIROL, V78, P7784, DOI 10.1128/JVI.78.14.7784-7794.2004; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Soldan SS, 2001, ADV VIRUS RES, V56, P517, DOI 10.1016/S0065-3527(01)56037-6; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; TSUKADA N, 1991, J NEUROL SCI, V104, P230, DOI 10.1016/0022-510X(91)90315-X; Utz PJ, 2000, ARTHRITIS RES, V2, P101, DOI 10.1186/ar75; VILLEGAS E, 2011, DIAGN MICROBIOL INFE; Virtanen JO, 2011, J NEUROIMMUNOL, V237, P93, DOI 10.1016/j.jneuroim.2011.06.012; von Budingen HC, 2012, J CLIN INVEST, V122, P4533, DOI 10.1172/JCI63842; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	51	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105434	10.1371/journal.pone.0105434	http://dx.doi.org/10.1371/journal.pone.0105434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148387	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600046
J	Akbar, H; Hayat, K; ul Haq, N; Bajwa, UI				Akbar, Habib; Hayat, Khizar; ul Haq, Nuhman; Bajwa, Usama Ijaz			Bilateral Symmetry Detection on the Basis of Scale Invariant Feature Transform	PLOS ONE			English	Article								The automatic detection of bilateral symmetry is a challenging task in computer vision and pattern recognition. This paper presents an approach for the detection of bilateral symmetry in digital single object images. Our method relies on the extraction of Scale Invariant Feature Transform (SIFT) based feature points, which serves as the basis for the ascertainment of the centroid of the object; the latter being the origin under the Cartesian coordinate system to be converted to the polar coordinate system in order to facilitate the selection symmetric coordinate pairs. This is followed by comparing the gradient magnitude and orientation of the corresponding points to evaluate the amount of symmetry exhibited by each pair of points. The experimental results show that our approach draw the symmetry line accurately, provided that the observed centroid point is true.	[Akbar, Habib; Hayat, Khizar; ul Haq, Nuhman; Bajwa, Usama Ijaz] COMSATS Inst Informat Technol, Abbottabad, Pakistan; [Hayat, Khizar] Univ Nizwa, Coll Arts & Sci, Nizwa, Oman	COMSATS University Islamabad (CUI); University of Nizwa	Hayat, K (corresponding author), COMSATS Inst Informat Technol, Abbottabad, Pakistan.	khizarhayat@ciit.net.pk	Ul Haq, Nuhman/AGY-8616-2022; Hayat, Khizar/P-8954-2019	Bajwa, Usama/0000-0001-5755-1194; Hayat, Khizar/0000-0001-5216-6019				Davis LS, 1977, IEEE T SYST MAN CYB, V7; Keller Y, 2004, INT C PATT RECOG, P186, DOI 10.1109/ICPR.2004.1334499; Kootstra G., 2008, P BRIT MACH VIS C BM; KUEHNLE A, 1991, PATTERN RECOGN LETT, V12, P249, DOI 10.1016/0167-8655(91)90039-O; Lee S, 2012, IEEE T PATTERN ANAL, V34, P266, DOI 10.1109/TPAMI.2011.118; Li WH, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P4867, DOI 10.1109/IROS.2006.282442; Liu J, 2010, COMPUTER VISION ACCV, P102; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; LOWE DG, 2004, INT J COMPUTER VISIO; Loy G, 2003, IEEE T PATTERN ANAL, V25, P959, DOI 10.1109/TPAMI.2003.1217601; Loy G, 2006, LECT NOTES COMPUT SC, V3952, P508; Lu YX, 2009, FOUND TRENDS COMPUT, V5, P1, DOI 10.1561/0600000008; Mancas M, 2005, INT CONF ACOUST SPEE, P725; MAROLA G, 1989, IEEE T PATTERN ANAL, V11, P104, DOI 10.1109/34.23119; MASUDA T, 1993, PATTERN RECOGN, V26, P1245, DOI 10.1016/0031-3203(93)90209-F; Mitra S, 2007, STAT COMPUT, V17, P57, DOI 10.1007/s11222-006-9004-9; Park M., P 2008 IEEE 19 INT S, P1, DOI [10.1109/PIMRC.2008.4699890, DOI 10.1109/PIMRC.2008.4699890]; REISFELD D, 1995, INT J COMPUT VISION, V14, P119, DOI 10.1007/BF01418978; Sharvit D, 1998, IEEE WORKSHOP ON CONTENT-BASED ACCESS OF IMAGE AND VIDEO LIBRARIES - PROCEEDINGS, P56, DOI 10.1109/IVL.1998.694496; WH Li, 2005, P AUSTR C ROB AUT; Zabrodsky H., 1993, Proceedings. 1993 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.93CH3309-2), P678, DOI 10.1109/CVPR.1993.341031	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103561	10.1371/journal.pone.0103561	http://dx.doi.org/10.1371/journal.pone.0103561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144655	gold, Green Submitted, Green Published			2022-12-25	WOS:000341106100007
J	Dhal, PK; Barman, RK; Saha, S; Das, S				Dhal, Paltu Kumar; Barman, Ranjan Kumar; Saha, Sudipto; Das, Santasabuj			Dynamic Modularity of Host Protein Interaction Networks in Salmonella Typhi Infection	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; DILATED CARDIOMYOPATHY; COMPLEX NETWORKS; COEXPRESSION; CYTOSCAPE; REGULON; IDENTIFICATION; PROLIFERATION	Background: Salmonella Typhi is a human-restricted pathogen, which causes typhoid fever and remains a global health problem in the developing countries. Although previously reported host expression datasets had identified putative biomarkers and therapeutic targets of typhoid fever, the underlying molecular mechanism of pathogenesis remains incompletely understood. Methods: We used five gene expression datasets of human peripheral blood from patients suffering from S. Typhi or other bacteremic infections or non-infectious disease like leukemia. The expression datasets were merged into human protein interaction network (PIN) and the expression correlation between the hubs and their interacting proteins was measured by calculating Pearson Correlation Coefficient (PCC) values. The differences in the average PCC for each hub between the disease states and their respective controls were calculated for studied datasets. The individual hubs and their interactors with expression, PCC and average PCC values were treated as dynamic subnetworks. The hubs that showed unique trends of alterations specific to S. Typhi infection were identified. Results: We identified S. Typhi infection-specific dynamic subnetworks of the host, which involve 81 hubs and 1343 interactions. The major enriched GO biological process terms in the identified subnetworks were regulation of apoptosis and biological adhesions, while the enriched pathways include cytokine signalling in the immune system and downstream TCR signalling. The dynamic nature of the hubs CCR1, IRS2 and PRKCA with their interactors was studied in detail. The difference in the dynamics of the subnetworks specific to S. Typhi infection suggests a potential molecular model of typhoid fever. Conclusions: Hubs and their interactors of the S. Typhi infection-specific dynamic subnetworks carrying distinct PCC values compared with the non-typhoid and other disease conditions reveal new insight into the pathogenesis of S. Typhi.	[Dhal, Paltu Kumar; Barman, Ranjan Kumar; Das, Santasabuj] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata, W Bengal, India; [Das, Santasabuj] Natl Inst Cholera & Enter Dis, Div Clin Med, Kolkata, W Bengal, India; [Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Science & Technology (India); Bose Institute	Saha, S (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India.	ssaha4@jcbose.ac.in; dasss@icmr.org.in	Dhal, Paltu Kumar/AAA-2895-2022; Barman, Ranjan Kumar/GXZ-8073-2022; Saha, Sudipto/AAF-1034-2020	Dhal, Paltu Kumar/0000-0001-5790-3268; Barman, Ranjan Kumar/0000-0001-9901-3108; Saha, Sudipto/0000-0001-9433-8894	Indian Council of Medical Research (IRIS) [2013-1551G]; Department of Biotechnology [BT/RLF/Re-entry/11/2011]	Indian Council of Medical Research (IRIS)(Indian Council of Medical Research (ICMR)); Department of Biotechnology	This work was supported by Indian Council of Medical Research [extramural project (IRIS ID: 2013-1551G)]. SS thanks the Department of Biotechnology for Ramalingaswami fellowship (BT/RLF/Re-entry/11/2011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amundsen SS, 2010, GENES IMMUN, V11, P79, DOI 10.1038/gene.2009.67; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Bhardwaj Nitin, 2009, Journal of Bioinformatics and Computational Biology, V7, P1, DOI 10.1142/S0219720009003959; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Camargo A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001347; Camargo A, 2008, GENOMICS, V92, P404, DOI 10.1016/j.ygeno.2008.05.007; Charles RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006994; Cooke Fiona J, 2004, Travel Med Infect Dis, V2, P67, DOI 10.1016/j.tmaid.2004.04.005; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Ghosh S, 2011, P NATL ACAD SCI USA, V108, P3348, DOI 10.1073/pnas.1016180108; Giallourakis C, 2000, J BIOL CHEM, V275, P29275, DOI 10.1074/jbc.M002853200; Gingras SB, 2001, J STEROID BIOCHEM, V76, P213, DOI 10.1016/S0960-0760(00)00148-5; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; Gustin MP, 2008, PHYSIOL GENOMICS, V34, P34, DOI 10.1152/physiolgenomics.00008.2008; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Harrell F. E., 2006, HMISC HARRELL MISCEL; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Khoo SK, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-241; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lin CC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-138; Lutay N, 2013, J CLIN INVEST, V123, P2366, DOI 10.1172/JCI66451; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-99; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Porwollik S, 2004, J BACTERIOL, V186, P5883, DOI 10.1128/JB.186.17.5883-5898.2004; Pritykin Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003243; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheikh A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001419; Stirewalt DL, 2008, GENE CHROMOSOME CANC, V47, P8, DOI 10.1002/gcc.20500; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Thompson LJ, 2009, P NATL ACAD SCI USA, V106, P22433, DOI 10.1073/pnas.0912386106; Uthe JJ, 2011, ANIM GENET, V42, P521, DOI 10.1111/j.1365-2052.2010.02171.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winter SE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001060; Winter SE, 2009, MOL MICROBIOL, V74, P175, DOI 10.1111/j.1365-2958.2009.06859.x; Wu C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-182; Wurster AL, 2002, MOL CELL BIOL, V22, P117, DOI 10.1128/MCB.22.1.117-126.2002; Xiaotu M, 2013, BRIEF BIOINFORM, V2013; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yeung KY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r48	51	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104911	10.1371/journal.pone.0104911	http://dx.doi.org/10.1371/journal.pone.0104911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144185	Green Submitted, gold, Green Published			2022-12-25	WOS:000341106100031
J	Jansson, EKH; Clemens, LE; Riess, O; Nguyen, HP				Jansson, Erik Karl Hakan; Clemens, Laura Emily; Riess, Olaf; Huu Phuc Nguyen			Reduced Motivation in the BACHD Rat Model of Huntington Disease Is Dependent on the Choice of Food Deprivation Strategy	PLOS ONE			English	Article							MONOSODIUM GLUTAMATE; MOUSE MODEL; WEIGHT-LOSS; HYPOTHALAMIC OBESITY; MUTANT HUNTINGTIN; NEUROPEPTIDE-Y; BODY-WEIGHT; MOTOR; LESIONS; LEPTIN	Huntington disease (HD) is an inherited neurodegenerative disease characterized by motor, cognitive, psychiatric and metabolic symptoms. Animal models of HD show phenotypes that can be divided into similar categories, with the metabolic phenotype of certain models being characterized by obesity. Although interesting in terms of modeling metabolic symptoms of HD, the obesity phenotype can be problematic as it might confound the results of certain behavioral tests. This concerns the assessment of cognitive function in particular, as tests for such phenotypes are often based on food depriving the animals and having them perform tasks for food rewards. The BACHD rat is a recently established animal model of HD, and in order to ensure that behavioral characterization of these rats is done in a reliable way, a basic understanding of their physiology is needed. Here, we show that BACHD rats are obese and suffer from discrete developmental deficits. When assessing the motivation to lever push for a food reward, BACHD rats were found to be less motivated than wild type rats, although this phenotype was dependent on the food deprivation strategy. Specifically, the phenotype was present when rats of both genotypes were deprived to 85% of their respective free-feeding body weight, but not when deprivation levels were adjusted in order to match the rats' apparent hunger levels. The study emphasizes the importance of considering metabolic abnormalities as a confounding factor when performing behavioral characterization of HD animal models.	[Huu Phuc Nguyen] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; Univ Tubingen, Ctr Rare Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Nguyen, HP (corresponding author), Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany.	hoa.nguyen@med.uni-tuebingen.de	Nguyen, Huu Phuc/HDO-3462-2022	Nguyen, Huu Phuc/0000-0001-6139-788X; Clemensson, Erik/0000-0002-5158-6924	Medical Faculty of the University of Tuebingen; German Academic Exchange Program (DAAD) [54366469]; Deutsche Forschungsgemeinschaft; Tuebingen University	Medical Faculty of the University of Tuebingen; German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	The study was funded by yearly funds allocated to the Institute of Medical Genetics and Applied Genomics by the Medical Faculty of the University of Tuebingen, to maintain animals. Erik Jansson received a stipend from the German Academic Exchange Program (DAAD: https://www.daad.de/en/) under the Procope program, project number: 54366469. The authors also acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University for publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YSK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068584, 10.1371/journal.pone.0071633]; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Aziz NA, 2008, J NEUROL, V255, P1872, DOI 10.1007/s00415-009-0062-8; Bergen HT, 1998, ENDOCRINOLOGY, V139, P4483, DOI 10.1210/en.139.11.4483; Bradbury MJ, 2005, J PHARMACOL EXP THER, V313, P395, DOI 10.1124/jpet.104.076406; Chen W, 2013, N-S ARCH PHARMACOL, V386, P721, DOI 10.1007/s00210-013-0875-y; Clemens LE, 2014, GENES BRAIN BEHAV, V13, P305, DOI 10.1111/gbb.12093; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Eagle DM, 1999, BEHAV NEUROSCI, V113, P718, DOI 10.1037/0735-7044.113.4.718; Enkel T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00010; Fielding SA, 2012, BRAIN RES BULL, V88, P223, DOI 10.1016/j.brainresbull.2011.09.011; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Harrington DL, 2012, J NEUROL NEUROSUR PS, V83, P612, DOI 10.1136/jnnp-2011-301732; Hollopeter G, 1998, INT J OBESITY, V22, P506, DOI 10.1038/sj.ijo.0800615; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Kanoski SE, 2014, NEUROPSYCHOPHARMACOL, V39, P605, DOI 10.1038/npp.2013.235; Kirkwood SC, 2001, ARCH NEUROL-CHICAGO, V58, P273, DOI 10.1001/archneur.58.2.273; Kudwa AE, 2013, PLOS CURR, V30, P5; Lawrence AD, 1996, BRAIN, V119, P1633, DOI 10.1093/brain/119.5.1633; Lee JK, 2012, NEUROLOGY, V79, P668, DOI 10.1212/WNL.0b013e3182648b65; Lemiere J, 2004, J NEUROL, V251, P935, DOI 10.1007/s00415-004-0461-9; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; Meyer C, 2012, MOVEMENT DISORD, V27, P118, DOI 10.1002/mds.23847; Morris MJ, 1998, REGUL PEPTIDES, V75-6, P441, DOI 10.1016/S0167-0115(98)00100-1; Naarding P, 2009, J NEUROPSYCH CLIN N, V21, P266, DOI 10.1176/appi.neuropsych.21.3.266; Nguyen GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064368; Oakeshott Stephen, 2012, PLoS Curr, V4, pe4f972cffe82c0, DOI 10.1371/4f972cffe82c0; Oakeshott Stephen, 2013, PLoS Curr, V5, DOI 10.1371/currents.hd.fe74c94bdd446a0470f6f905a30b5dd1; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Remmers F, 2008, PHYSIOL BEHAV, V95, P208, DOI 10.1016/j.physbeh.2008.05.021; Robbins AO, 2006, EUR J NEUROL, V13, pE7, DOI 10.1111/j.1468-1331.2006.01319.x; Roth JD, 2012, DIABETES OBES METAB, V14, P608, DOI 10.1111/j.1463-1326.2012.01570.x; SCALLET AC, 1986, BRAIN RES, V374, P380, DOI 10.1016/0006-8993(86)90434-8; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schmelzeis MC, 1996, BEHAV NEUROSCI, V110, P1049; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; SKJOLDAGER P, 1993, LEARN MOTIV, V24, P303, DOI 10.1006/lmot.1993.1019; TANAKA K, 1978, EXP NEUROL, V62, P191, DOI 10.1016/0014-4886(78)90050-X; Trueman RC, 2012, BRAIN RES BULL, V88, P261, DOI 10.1016/j.brainresbull.2011.03.015; Trueman RC, 2009, BEHAV BRAIN RES, V203, P215, DOI 10.1016/j.bbr.2009.05.006; Vaccarino AL, 2011, MOVEMENT DISORD, V26, P877, DOI 10.1002/mds.23574; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; WHISHAW IQ, 1988, PHYSIOL BEHAV, V43, P397, DOI 10.1016/0031-9384(88)90205-3; Youn J, 2012, BEHAV BRAIN RES, V226, P397, DOI 10.1016/j.bbr.2011.09.034; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	55	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105662	10.1371/journal.pone.0105662	http://dx.doi.org/10.1371/journal.pone.0105662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144554	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100106
J	Wang, Y; Li, C; Duan, N; Li, B; Ding, XM; Yao, YF; Hu, J; Zhao, GP; Wang, J				Wang, Ying; Li, Chen; Duan, Na; Li, Bin; Ding, Xiao-Ming; Yao, Yu-Feng; Hu, Jun; Zhao, Guo-Ping; Wang, Jin			GInR Negatively Regulates the Transcription of the Alanine Dehydrogenase Encoding Gene ald in Amycolatopsis mediterranei U32 under Nitrogen Limited Conditions via Specific Binding to Its Major Transcription Initiation Site	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; STREPTOMYCES-COELICOLOR; MYCOBACTERIUM-SMEGMATIS; ESCHERICHIA-COLI; GLNR; METABOLISM; PROTEIN; IDENTIFICATION; ACTIVATION; EXPRESSION	Ammonium assimilation is catalyzed by two enzymatic pathways, i.e., glutamine synthetase/glutamate synthase (GS/GOGAT) and alanine dehydrogenase (AlaDH) in Amycolatopsis mediterranei U32. Under nitrogen-rich conditions, the AlaDH pathway is the major route for ammonium assimilation, while the GS/GOGAT pathway takes over when the extracellular nitrogen supply is limited. The global nitrogen regulator GlnR was previously characterized to activate the transcription of the GS encoding gene glnA in response to nitrogen limitation and is demonstrated in this study as a repressor for the transcription of the AlaDH encoding gene ald, whose regulation is consistent with the switch of the ammonium assimilation pathways from AlaDH to GS/GOGAT responding to nitrogen limitation. Three transcription initiation sites (TISs) of ald were determined with primer extension assay, among which transcription from aldP2 contributed the major transcripts under nitrogen-rich conditions but was repressed to an undetectable level in response to nitrogen limitation. Through DNase I footprinting assay, two separate regions were found to be protected by GlnR within ald promoter, within which three GlnR binding sites (a1, b1 sites in region I and a2 site in region II) were defined. Interestingly, the major TIS aldP2 is located in the middle of a2 site within region II. Therefore, one may easily conclude that GlnR represses the transcription of ald via specific binding to the GlnR binding sites, which obviously blocks the transcription initiation from aldP2 and therefore reduces ald transcripts.	[Wang, Ying; Zhao, Guo-Ping; Wang, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Wang, Ying; Li, Chen; Ding, Xiao-Ming; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol, Shanghai 200433, Peoples R China; [Duan, Na; Li, Bin; Hu, Jun] Chinese Acad Sci, Shanghai Inst Appl Phys, Phys Biol Lab, Shanghai, Peoples R China; [Yao, Yu-Feng] Shanghai Jiao Tong Univ, Sch Med, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Shanghai Jiao Tong University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Hu, J (corresponding author), Chinese Acad Sci, Shanghai Inst Appl Phys, Phys Biol Lab, Shanghai, Peoples R China.	hujun@sinap.ac.cn; gpzhao@sibs.ac.cn; cmg.wangjin@gmail.com	WANG, Jin/K-2085-2016; Wang, Jin/P-5458-2019	WANG, Jin/0000-0003-4008-9284; Wang, Jin/0000-0003-4008-9284; Zhao, Guo-Ping/0000-0002-7621-6620; Wang, Ying/0000-0003-2311-015X	National Natural Science Foundation of China [31121001]; National Basic Research Program of China [2012CB721102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	The work was supported by National Natural Science Foundation of China (31121001) and National Basic Research Program of China (2012CB721102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon J, 2008, J BACTERIOL, V190, P7108, DOI 10.1128/JB.00855-08; BENDER RA, 1991, MOL MICROBIOL, V5, P2575, DOI 10.1111/j.1365-2958.1991.tb01965.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Fink D, 2002, MOL MICROBIOL, V46, P331, DOI 10.1046/j.1365-2958.2002.03150.x; FISHER SH, 1989, J BACTERIOL, V171, P2372, DOI 10.1128/jb.171.5.2372-2377.1989; Jenkins VA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-301; Jenkins VA, 2012, FEMS MICROBIOL LETT, V330, P38, DOI 10.1111/j.1574-6968.2012.02530.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Lewis Richard A, 2011, BMC Res Notes, V4, P78, DOI 10.1186/1756-0500-4-78; Lin W, 2014, J BIOL CHEM, V289, P15413, DOI 10.1074/jbc.M113.543504; Lloyd G, 2001, ESSAYS BIOCHEM, V37, P17, DOI 10.1042/bse0370017; Mejia A, 1998, J ANTIBIOT, V51, P58, DOI 10.7164/antibiotics.51.58; Ni LY, 1984, ACTA MICROBIOL SIN, V24, P217; Pullan ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-175; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Semsey S, 2005, TRENDS BIOCHEM SCI, V30, P334, DOI 10.1016/j.tibs.2005.04.009; Shao ZH, 2009, IDENTIFICATION NITRA, P65; Tiffert Y, 2008, MOL MICROBIOL, V67, P861, DOI 10.1111/j.1365-2958.2007.06092.x; van Hijum SAFT, 2009, MICROBIOL MOL BIOL R, V73, P481, DOI 10.1128/MMBR.00037-08; Wang J, 2009, BIOCHEM BIOPH RES CO, V386, P77, DOI 10.1016/j.bbrc.2009.05.147; Wang Y, 2013, J BACTERIOL, V195, P2595, DOI 10.1128/JB.00182-13; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Yu H, 2007, ARCH MICROBIOL, V188, P89, DOI 10.1007/s00203-007-0228-7; Yu H, 2006, ACTA BIOCH BIOPH SIN, V38, P831, DOI 10.1111/j.1745-7270.2006.00238.x; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	28	6	7	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104811	10.1371/journal.pone.0104811	http://dx.doi.org/10.1371/journal.pone.0104811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144373	Green Submitted, gold, Green Published			2022-12-25	WOS:000341106100024
J	Zhang, PP; Liu, X; Wang, CB; Zhao, Y; Hua, F; Li, CF; Yang, RF; Zhou, L				Zhang, Pingping; Liu, Xiao; Wang, Chengbin; Zhao, Yong; Hua, Fei; Li, Chunfeng; Yang, Ruifu; Zhou, Lei			Evaluation of Up-Converting Phosphor Technology-Based Lateral Flow Strips for Rapid Detection of Bacillus anthracis Spore, Brucella spp., and Yersinia pestis	PLOS ONE			English	Article							QUANTITATIVE DETECTION; ASSAY; DIAGNOSIS; IMMUNOASSAY; ANTIBODIES; PLAGUE; REPORTERS; ANTIGEN; PCR	Bacillus anthracis, Brucella spp., and Yersinia pestis are zoonotic pathogens and biowarfare- or bioterrorism-associated agents that must be detected rapidly on-site from various samples (e.g., viscera and powders). An up-converting phosphor technology-based lateral flow (UPT-LF) strip was developed as a point-of-care testing (POCT) to satisfy the requirements of first-level emergency response. We developed UPT-LF POCT to quantitatively detect the three pathogens within 15 min. Sample and operation-error tolerances of the assay were comprehensively evaluated. The sensitivity of UPT-LF assay to bacterial detection reached 10(4) cfu.mL(-1) (100 cfu/test), with a linear quantitative range of 4 to 6 orders of magnitude. Results revealed that the UPT-LF assay exhibited a high specificity with the absence of false-positive results even at 10(9) cfu.mL(-1) of non-specific bacterial contamination. The assay could tolerate samples with a wide pH range (2 to 12), high ion strengths (>= 4 mol.L-1 of NaCl), high viscosities (>= 25 mg.mL(-1) of PEG20000 or >= 20% of glycerol), and high concentrations of bio-macromolecule (<= 200 mg.mL(-1) of bovine serum albumin or >= 80 mg.mL(-1) of casein). The influence of various types of powders and viscera (fresh and decomposed) on the performance of UPT-LF assay was determined. The operational error of liquid measurement exhibited few effects on sensitivity and specificity. The developed UPT-LF POCT assay is applicable under field conditions with excellent tolerance to sample complexity and operational error.	[Zhang, Pingping; Liu, Xiao; Zhao, Yong; Yang, Ruifu; Zhou, Lei] Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Liu, Xiao] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Wang, Chengbin; Li, Chunfeng] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Lab, Beijing, Peoples R China; [Hua, Fei] Taishan Med Univ, Dept Etiol, Tai An, Shandong, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Chongqing Medical University; Chinese People's Liberation Army General Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences	Yang, RF (corresponding author), Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; ammszhoulei@aliyun.com	Yang, Ruifu/A-2273-2011	Yang, Ruifu/0000-0003-3219-7269	National Natural Science Foundation of China [81000774]; National High Technology Research and Development Program of China [2013AA032205]; Major National Science and Technology Programs of China [2011ZX10004, 2012ZX1004801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major National Science and Technology Programs of China	This study was supported by the National Natural Science Foundation of China (Grant No. 81000774), the National High Technology Research and Development Program of China (Grant No. 2013AA032205) and the Major National Science and Technology Programs of China (Grant Nos. 2011ZX10004 and 2012ZX1004801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoako KK, 2012, J MICROBIOL METH, V90, P228, DOI 10.1016/j.mimet.2012.05.012; Begier EM, 2006, EMERG INFECT DIS, V12, P460, DOI 10.3201/eid1203.051051; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; Chanteau S, 2000, INT J MED MICROBIOL, V290, P279; Corstjens P, 2001, CLIN CHEM, V47, P1885; Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07; Corstjens PLAM, 2011, CLIN BIOCHEM, V44, P1241, DOI 10.1016/j.clinbiochem.2011.06.983; Derzelle S, 2011, J MICROBIOL METH, V87, P195, DOI 10.1016/j.mimet.2011.08.005; Dichtwald S, 2008, BEST PRACT RES-CLIN, V22, P477, DOI 10.1016/j.bpa.2008.05.004; Garin-Bastuji B, 2006, SMALL RUMINANT RES, V62, P63, DOI 10.1016/j.smallrumres.2005.08.004; Genc O, 2011, J VET DIAGN INVEST, V23, P49, DOI 10.1177/104063871102300107; Gomes-Solecki MJC, 2005, CLIN DIAGN LAB IMMUN, V12, P339, DOI 10.1128/CDLI.12.2.339-346.2005; Hampl J, 2001, ANAL BIOCHEM, V288, P176, DOI 10.1006/abio.2000.4902; Hong WY, 2010, J MICROBIOL METH, V83, P133, DOI 10.1016/j.mimet.2010.08.005; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Koehler TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/j.mam.2009.07.004; Kuehn A, 2009, CLIN VACCINE IMMUNOL, V16, P1728, DOI 10.1128/CVI.00235-09; Li LP, 2009, DIAGN MICR INFEC DIS, V63, P165, DOI 10.1016/j.diagmicrobio.2008.10.020; Li Wei, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P761; Makino S, 2003, J MICROBIOL METH, V53, P141, DOI 10.1016/S0167-7012(03)00019-8; Niedbala RS, 2001, ANAL BIOCHEM, V293, P22, DOI 10.1006/abio.2001.5105; Nielsen K, 2007, VET MICROBIOL, V124, P173, DOI 10.1016/j.vetmic.2007.03.023; Nielsen K, 2007, J IMMUNOASS IMMUNOCH, V28, P61, DOI 10.1080/15321810601026125; Ongagna-Yhombi SY, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-74; Ouellette AL, 2009, ANAL CHEM, V81, P3216, DOI 10.1021/ac900475u; Porche Demetrius J, 2002, J Assoc Nurses AIDS Care, V13, P57, DOI 10.1177/105532902236783; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Qu Q, 2009, J MICROBIOL METH, V79, P121, DOI 10.1016/j.mimet.2009.07.015; Rao SS, 2010, BIOCHEM BIOPH RES CO, V395, P93, DOI 10.1016/j.bbrc.2010.03.145; Senior K, 2012, LANCET INFECT DIS, V12, P436, DOI 10.1016/S1473-3099(12)70128-7; Shott JP, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/651927; Simon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054947; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; Tamborrini M, 2010, CLIN VACCINE IMMUNOL, V17, P1446, DOI 10.1128/CVI.00205-10; Tuemmers C, 2013, REV CHIL INFECTOL, V30, P395, DOI 10.4067/S0716-10182013000400007; van Dam GJ, 2013, EXP PARASITOL, V135, P274, DOI 10.1016/j.exppara.2013.06.017; Wang DB, 2013, BIOSENS BIOELECTRON, V42, P661, DOI 10.1016/j.bios.2012.10.088; Yan ZQ, 2006, SENSOR ACTUAT B-CHEM, V119, P656, DOI 10.1016/j.snb.2006.01.029	38	34	41	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105305	10.1371/journal.pone.0105305	http://dx.doi.org/10.1371/journal.pone.0105305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144726	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100049
J	Gong, YH; Yu, XR; Shang, QL; Shi, XY; Gao, XW				Gong, You-Hui; Yu, Xin-Rui; Shang, Qing-Li; Shi, Xue-yan; Gao, Xi-Wu			Oral Delivery Mediated RNA Interference of a Carboxylesterase Gene Results in Reduced Resistance to Organophosphorus Insecticides in the Cotton Aphid, Aphis gossypii Glover	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MALATHION RESISTANCE; MOLECULAR-BASIS; ESTERASE GENES; PEA APHID; HOMOPTERA; AMPLIFICATION; EXPRESSION; STRAINS; DSRNA	Background: RNA interference (RNAi) is an effective tool to examine the function of individual genes. Carboxylesterases (CarE, EC 3.1.1.1) are known to play significant roles in the metabolism of xenobiotic compounds in many insect species. Previous studies in our laboratory found that CarE expression was up-regulated in Aphis gossypii (Glover) (Hemiptera: Aphididae) adults of both omethoate and malathion resistant strains, indicating the potential involvement of CarE in organophosphorus (OP) insecticide resistance. Functional analysis (RNAi) is therefore warranted to investigate the role of CarE in A. gossypii to OPs resistance. Result: CarE expression in omethoate resistant individuals of Aphis gossypii was dramatically suppressed following ingestion of dsRNA-CarE. The highest knockdown efficiency (33%) was observed at 72 h after feeding when dsRNA-CarE concentration was 100 ng/mL. The CarE activities from the CarE knockdown aphids were consistent with the correspondingly significant reduction in CarE expression. The CarE activity in the individuals of control aphids was concentrated in the range of 650-900 mOD/per/min, while in the individuals of dsRNA-CarE-fed aphids, the CarE activity was concentrated in the range of 500-800 mOD/per/min. In vitro inhibition experiments also demonstrated that total CarE activity in the CarE knockdown aphids decreased significantly as compared to control aphids. Bioassay results of aphids fed dsRNA-CarE indicated that suppression of CarE expression increased susceptibility to omethoate in individuals of the resistant aphid strains. Conclusion: The results of this study not only suggest that ingestion of dsRNA through artificial diet could be exploited for functional genomic studies in cotton aphids, but also indicate that CarE can be considered as a major target of organophosphorus insecticide (OPs) resistance in A. gossypii. Further, our results suggest that the CarE would be a propitious target for OPs resistant aphid control, and insect-resistant transgenic plants may be obtained through plant RNAi-mediated silencing of insect CarE expression.	[Gong, You-Hui; Yu, Xin-Rui; Shi, Xue-yan; Gao, Xi-Wu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Shang, Qing-Li] Jilin Univ, Coll Plant Sci & Technol, Changchun 130023, Peoples R China	China Agricultural University; Jilin University	Shi, XY (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	shixueyan@cau.edu.cn; gaoxiwu@263.net.cn			National Basic Research and Development Program of China [2012CB114103]; National Natural Science Foundation of China [31330064, 30871661]	National Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Basic Research and Development Program of China (Contract No. 2012CB114103) (http://program.most.gov.cn/) and the National Natural Science Foundation of China (31330064 and 30871661) (http://isisn.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Alon M, 2008, INSECT BIOCHEM MOLEC, V38, P940, DOI 10.1016/j.ibmb.2008.07.007; de Carvalho RA, 2006, VET PARASITOL, V140, P344, DOI 10.1016/j.vetpar.2006.04.010; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bizzaro D, 2005, PESTIC BIOCHEM PHYS, V81, P51, DOI 10.1016/j.pestbp.2004.09.005; Blackman R.L., 1984, APHIDS WORLDS CROPS; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao CW, 2008, INSECT SCI, V15, P209, DOI 10.1111/j.1744-7917.2008.00202.x; Cao CW, 2008, PESTIC BIOCHEM PHYS, V90, P175, DOI 10.1016/j.pestbp.2007.11.004; Claudianos C, 1999, INSECT BIOCHEM MOLEC, V29, P675, DOI 10.1016/S0965-1748(99)00035-1; Cui F, 2007, FASEB J, V21, P3584, DOI 10.1096/fj.07-8237com; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; DEVONSHIRE AL, 1991, ANNU REV ENTOMOL, V36, P1, DOI 10.1146/annurev.en.36.010191.000245; Field LM, 1997, BIOCHEM J, V322, P867, DOI 10.1042/bj3220867; Field LM, 1999, BIOCHEM J, V339, P737, DOI 10.1042/0264-6021:3390737; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heidari R, 2004, INSECT BIOCHEM MOLEC, V34, P353, DOI 10.1016/j.ibmb.2004.01.001; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hemingway J, 1998, PHILOS T ROY SOC B, V353, P1695, DOI 10.1098/rstb.1998.0320; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Karunaratne SHPP, 1995, J BIOL CHEM, V270, P31124, DOI 10.1074/jbc.270.52.31124; Karunaratne SHPP, 1994, THESIS U LONDON; Liu YY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-236; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Moores GD, 1996, PESTIC BIOCHEM PHYS, V56, P102, DOI 10.1006/pest.1996.0064; MOUCHES C, 1986, SCIENCE, V233, P778, DOI 10.1126/science.3755546; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Oakeshott J.G, 2005, COMPREHENSIVE MOL IN, V5, P309, DOI [DOI 10.1016/B0-44-451924-6/00073-9, 10.1016/B0-44-451924-6/00073-9]; Oakeshott JG, 1999, BIOESSAYS, V21, P1031; OBRIEN PJ, 1992, J ECON ENTOMOL, V85, P651, DOI 10.1093/jee/85.3.651; Owusu EO, 1996, J ECON ENTOMOL, V89, P302, DOI 10.1093/jee/89.2.302; Pan YO, 2009, COMP BIOCHEM PHYS B, V152, P266, DOI 10.1016/j.cbpb.2008.12.002; Paton MG, 2000, BIOCHEM J, V346, P17, DOI 10.1042/0264-6021:3460017; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; SAITO T, 1993, APPL ENTOMOL ZOOL, V28, P263, DOI 10.1303/aez.28.263; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Soares CAG, 2005, INSECT MOL BIOL, V14, P443, DOI 10.1111/j.1365-2583.2005.00575.x; Sun LJ, 2005, J ECON ENTOMOL, V98, P1325, DOI 10.1603/0022-0493-98.4.1325; SUN YQ, 1987, ACTA ENTOMOL SINICA, V30, P13; Suzuki K, 1998, APPL ENTOMOL ZOOL, V33, P11, DOI 10.1303/aez.33.11; SUZUKI K, 1993, APPL ENTOMOL ZOOL, V28, P439, DOI 10.1303/aez.28.439; TAKADA H, 1988, ENTOMOL EXP APPL, V48, P37, DOI 10.1007/BF00343382; Taskin V, 2004, RUSS J GENET+, V40, P1215, DOI 10.1023/B:RUGE.0000048663.17417.97; Taskin V, 2004, RUSS J GENET+, V40, P377, DOI 10.1023/B:RUGE.0000024974.58424.f9; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; VANASPEREN K, 1962, J INSECT PHYSIOL, V8, P401, DOI 10.1016/0022-1910(62)90074-4; VAUGHAN A, 1995, J BIOL CHEM, V270, P17044, DOI 10.1074/jbc.270.28.17044; Vaughan A, 1997, BIOCHEM J, V325, P359, DOI 10.1042/bj3250359; Vontas JG, 2000, INSECT MOL BIOL, V9, P655, DOI 10.1046/j.1365-2583.2000.00228.x; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Young SJ, 2005, PEST MANAG SCI, V61, P397, DOI 10.1002/ps.996; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x; Zhang JZ, 2011, PEST MANAG SCI, V67, P183, DOI 10.1002/ps.2049	64	80	86	4	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e102823	10.1371/journal.pone.0102823	http://dx.doi.org/10.1371/journal.pone.0102823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140535	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200001
J	Novotna, A; Dvorak, Z				Novotna, Aneta; Dvorak, Zdenek			Omeprazole and Lansoprazole Enantiomers Induce CYP3A4 in Human Hepatocytes and Cell Lines via Glucocorticoid Receptor and Pregnane X Receptor Axis	PLOS ONE			English	Article							PROTON PUMP INHIBITOR; EXPRESSION; PHARMACOKINETICS; ESOMEPRAZOLE; ARTICLE; ENZYMES; ISOMER	Benzimidazole drugs lansoprazole and omeprazole are used for treatment of various gastrointestinal pathologies. Both compounds cause drug-drug interactions because they activate aryl hydrocarbon receptor and induce CYP1A genes. In the current paper, we examined the effects of lansoprazole and omeprazole enantiomers on the expression of key drug-metabolizing enzyme CYP3A4 in human hepatocytes and human cancer cell lines. Lansoprazole enantiomers, but not omeprazole, were equipotent inducers of CYP3A4 mRNA in HepG2 cells. All forms (S-, R-, rac-) of lansoprazole and omeprazole induced CYP3A4 mRNA and protein in human hepatocytes. The quantitative profiles of CYP3A4 induction by individual forms of lansoprazole and omeprazole exerted enantiospecific patterns. Lansoprazole dose-dependently activated pregnane X receptor PXR in gene reporter assays, and slightly modulated rifampicin-inducible PXR activity, with similar potency for each enantiomer. Omeprazole dose-dependently activated PXR and inhibited rifampicin-inducible PXR activity. The effects of S- omeprazole were much stronger as compared to those of R- omeprazole. All forms of lansoprazole, but not omeprazole, slightly activated glucocorticoid receptor and augmented dexamethasone-induced GR transcriptional activity. Omeprazole and lansoprazole influenced basal and ligand inducible expression of tyrosine aminotransferase, a GR-target gene, in HepG2 cells and human hepatocytes. Overall, we demonstrate here that omeprazole and lansoprazole enantiomers induce CYP3A4 in HepG2 cells and human hepatocytes. The induction comprises differential interactions of omeprazole and lansoprazole with transcriptional regulators PXR and GR, and some of the effects were enantiospecific. The data presented here might be of toxicological and clinical importance, since the effects occurred in therapeutically relevant concentrations.	[Novotna, Aneta; Dvorak, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic.	moulin@email.cz	Grycova, Aneta/AGH-1515-2022	Grycova, Aneta/0000-0002-2134-1125; Dvorak, Zdenek/0000-0002-3938-3585	Czech Science Agency [GACR 13-01809S]; Palacky University [PrF-2014-004]	Czech Science Agency; Palacky University	This research was supported by the Czech Science Agency [Grant GACR 13-01809S] and by the student project from Palacky University [PrF-2014-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2001, ALIMENT PHARM THERAP, V15, P1563, DOI 10.1046/j.1365-2036.2001.01087.x; Andersson T, 2008, CLIN DRUG INVEST, V28, P263, DOI 10.2165/00044011-200828050-00001; Dvorak Z, 2010, DRUG METAB REV, V42, P621, DOI 10.3109/03602532.2010.484462; Fery Y, 2010, TOXICOLOGY, V277, P11, DOI 10.1016/j.tox.2010.08.008; Gerbal-Chaloin S, 2006, CELL SIGNAL, V18, P740, DOI 10.1016/j.cellsig.2005.07.007; Katsuki H, 1996, PHARMACEUT RES, V13, P611, DOI 10.1023/A:1016062508580; Kendall MJ, 2003, ALIMENT PHARM THERAP, V17, P1, DOI 10.1046/j.1365-2036.17.s1.1.x; Metz DC, 2009, ALIMENT PHARM THER, V29, P928, DOI 10.1111/j.1365-2036.2009.03984.x; Niioka T, 2008, EUR J CLIN PHARMACOL, V64, P503, DOI 10.1007/s00228-007-0455-5; Novotna A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098711; Novotna A, 2012, EUR J PHARM SCI, V47, P842, DOI 10.1016/j.ejps.2012.10.003; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Raucy J, 2002, J PHARMACOL EXP THER, V303, P412, DOI 10.1124/jpet.102.038653; Raucy JL, 2003, DRUG METAB DISPOS, V31, P533, DOI 10.1124/dmd.31.5.533; Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441; Vrzal R, 2013, J BIOCHEM MOL TOXIC, V27, P515, DOI 10.1002/jbt.21516; Yoshinari K, 2008, BIOCHEM PHARMACOL, V76, P139, DOI 10.1016/j.bcp.2008.04.005	17	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105580	10.1371/journal.pone.0105580	http://dx.doi.org/10.1371/journal.pone.0105580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141173	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200105
J	Zhu, YJ; Hanafy, MA; Killingsworth, CR; Walcott, GP; Young, ME; Pogwizd, SM				Zhu, Yujie; Hanafy, Mohamed A.; Killingsworth, Cheryl R.; Walcott, Gregory P.; Young, Martin E.; Pogwizd, Steven M.			Morning Surge of Ventricular Arrhythmias in a New Arrhythmogenic Canine Model of Chronic Heart Failure Is Associated with Attenuation of Time-Of-Day Dependence of Heart Rate and Autonomic Adaptation, and Reduced Cardiac Chaos	PLOS ONE			English	Article							FREQUENCY-DOMAIN MEASURES; RATE-VARIABILITY ANALYSIS; R INTERVAL DYNAMICS; CIRCADIAN VARIATION; SPONTANEOUS ONSET; NERVE ACTIVITY; MYOCARDIAL-INFARCTION; INDEPENDENT PREDICTOR; CORRELATION DIMENSION; STELLATE GANGLION	Patients with chronic heart failure (CHF) exhibit a morning surge in ventricular arrhythmias, but the underlying cause remains unknown. The aim of this study was to determine if heart rate dynamics, autonomic input (assessed by heart rate variability (HRV)) and nonlinear dynamics as well as their abnormal time-of-day-dependent oscillations in a newly developed arrhythmogenic canine heart failure model are associated with a morning surge in ventricular arrhythmias. CHF was induced in dogs by aortic insufficiency & aortic constriction, and assessed by echocardiography. Holter monitoring was performed to study time-of-day-dependent variation in ventricular arrhythmias (PVCs, VT), traditional HRV measures, and nonlinear dynamics (including detrended fluctuations analysis alpha 1 and alpha 2 (DFA alpha 1 & DFA alpha 2), correlation dimension (CD), and Shannon entropy (SE)) at baseline, as well as 240 days (240d) and 720 days (720d) following CHF induction. LV fractional shortening was decreased at both 240d and 720d. Both PVCs and VT increased with CHF duration and showed a morning rise (2.5-fold & 1.8-fold increase at 6 AM-noon vs midnight-6 AM) during CHF. The morning rise in HR at baseline was significantly attenuated by 52% with development of CHF (at both 240d & 720d). Morning rise in the ratio of low frequency to high frequency (LF/HF) HRV at baseline was markedly attenuated with CHF. DFA alpha 1, DFA alpha 2, CD and SE all decreased with CHF by 31, 17, 34 and 7%, respectively. Time-of-day-dependent variations in LF/HF, CD, DFA alpha 1 and SE, observed at baseline, were lost during CHF. Thus in this new arrhythmogenic canine CHF model, attenuated morning HR rise, blunted autonomic oscillation, decreased cardiac chaos and complexity of heart rate, as well as aberrant time-of-day-dependent variations in many of these parameters were associated with a morning surge of ventricular arrhythmias.	[Zhu, Yujie; Hanafy, Mohamed A.; Killingsworth, Cheryl R.; Walcott, Gregory P.; Young, Martin E.; Pogwizd, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Pogwizd, SM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	spogwizd@uab.edu			National Heart, Lung, and Blood Institute [HL-097268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097268] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute Grant HL-097268, SMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Almoznino-Sarafian D, 2009, EUR J INTERN MED, V20, P779, DOI 10.1016/j.ejim.2009.08.006; ARNTZ HR, 1993, CIRCULATION, V88, P2284, DOI 10.1161/01.CIR.88.5.2284; Arzeno NM, 2007, P ANN INT IEEE EMBS, P5051, DOI 10.1109/IEMBS.2007.4353475; Baumert M, 2004, METHOD INFORM MED, V43, P202, DOI 10.1055/s-0038-1633859; Beckers F, 2006, BIOMED TECH, V51, P194, DOI 10.1515/BMT.2006.035; Billman GE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00086; Boudreau P, 2011, IEEE ENG MED BIO, P681, DOI 10.1109/IEMBS.2011.6090153; Ceyhan M, 2003, CHRONOBIOL INT, V20, P337, DOI 10.1081/CBI-120019342; Chattipakorn N, 2007, INT J CARDIOL, V120, P289, DOI 10.1016/j.ijcard.2006.11.221; Cohen MC, 1997, AM J CARDIOL, V79, P1512, DOI 10.1016/S0002-9149(97)00181-1; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Dvir H, 2013, BIOPHYS J, V105, P533, DOI 10.1016/j.bpj.2013.06.012; Elliott WJ, 1998, STROKE, V29, P992, DOI 10.1161/01.STR.29.5.992; Englund A, 1999, J AM COLL CARDIOL, V34, P1560, DOI 10.1016/S0735-1097(99)00369-1; Frenneaux MP, 2004, HEART, V90, P1248, DOI 10.1136/hrt.2003.026146; Fries Roland, 2002, Med Sci Monit, V8, pCR751; Galinier M, 2000, EUR HEART J, V21, P475, DOI 10.1053/euhj.1999.1875; Garber JC, 2011, GUIDE FOR THE CARE A; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; GOLDBERGER AL, 1990, ANN NY ACAD SCI, V591, P402; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; GUEVARA MR, 1995, CHAOS, V5, P174, DOI 10.1063/1.166065; Guzzetti S, 2005, EUR HEART J, V26, P357, DOI 10.1093/eurheartj/ehi067; Guzzetti S, 1996, CARDIOVASC RES, V31, P441; Hu K, 2004, P NATL ACAD SCI USA, V101, P18223, DOI 10.1073/pnas.0408243101; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; HUIKURI HV, 1994, CIRCULATION, V90, P121, DOI 10.1161/01.CIR.90.1.121; Huikuri HV, 1996, CIRCULATION, V93, P1836, DOI 10.1161/01.CIR.93.10.1836; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; La Rocca HPB, 2001, EUR HEART J, V22, P1136, DOI 10.1053/euhj.2000.2407; La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17; Liu C, 2012, HEART RHYTHM, V9, pS407; Makikallio TH, 1997, AM J CARDIOL, V80, P779; Makikallio TH, 2001, AM J CARDIOL, V87, P178, DOI 10.1016/S0002-9149(00)01312-6; Makikallio TH, 1999, AM J CARDIOL, V83, P880, DOI 10.1016/S0002-9149(98)01068-6; Makikallio TH, 1999, AM J CARDIOL, V83, P836, DOI 10.1016/S0002-9149(98)01076-5; Manolis AG, 1997, PACE, V20, P203, DOI 10.1111/j.1540-8159.1997.tb04843.x; Matveev M, 2006, NORMAL AND ABNORMAL; Moak JP, 2007, HEART RHYTHM, V4, P1523, DOI 10.1016/j.hrthm.2007.07.019; Moe GW, 1999, CARDIOVASC RES, V42, P591, DOI 10.1016/S0008-6363(99)00032-2; MULLER JE, 1987, CIRCULATION, V75, P131, DOI 10.1161/01.CIR.75.1.131; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; Muller JE, 1999, AM HEART J, V137, pS1, DOI 10.1016/S0002-8703(99)70390-X; Notarius CF, 1999, CLIN SCI, V96, P557, DOI 10.1042/CS19980347; Ogawa M, 2007, J AM COLL CARDIOL, V50, P335, DOI 10.1016/j.jacc.2007.03.045; Opthof T, 2000, CIRCULATION, V101, P2975, DOI 10.1161/01.CIR.101.25.2975; PACKER M, 1985, CIRCULATION, V72, P681, DOI 10.1161/01.CIR.72.4.681; PANINA G, 1995, AM HEART J, V129, P748, DOI 10.1016/0002-8703(95)90325-9; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Perkiomaki JS, 2005, CLIN EXP HYPERTENS, V27, P149, DOI 10.1081/CEH-200048742; Piccirillo G, 2009, HEART RHYTHM, V6, P546, DOI 10.1016/j.hrthm.2009.01.006; Platisa MM, 2008, EUR BIOPHYS J BIOPHY, V37, P1247, DOI 10.1007/s00249-007-0254-z; POGWIZD SM, 1995, CIRCULATION, V92, P1034, DOI 10.1161/01.CIR.92.4.1034; Ponard JGC, 2007, BIOPHYS J, V92, P3734, DOI 10.1529/biophysj.106.091892; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; QUYYUMI AA, 1992, CIRCULATION, V86, P22, DOI 10.1161/01.CIR.86.1.22; RAEDER EA, 1988, J AM COLL CARDIOL, V12, P656, DOI 10.1016/S0735-1097(88)80052-4; Sandercock GRH, 2006, PACE, V29, P892, DOI 10.1111/j.1540-8159.2006.00457.x; Segerson NM, 2008, J CARDIOVASC ELECTR, V19, P1031, DOI 10.1111/j.1540-8167.2008.01174.x; SIEGEL D, 1992, AM J CARDIOL, V69, P344, DOI 10.1016/0002-9149(92)90231-M; Singh RB, 2003, INT J CARDIOL, V87, P9, DOI 10.1016/S0167-5273(02)00308-X; SKINNER JE, 1991, CIRC RES, V68, P966, DOI 10.1161/01.RES.68.4.966; SKINNER JE, 1993, AM HEART J, V125, P731, DOI 10.1016/0002-8703(93)90165-6; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; TWIDALE N, 1989, AM J CARDIOL, V64, P1204, DOI 10.1016/0002-9149(89)90881-3; vandeBorne P, 1997, CIRCULATION, V95, P1449; Verkerk AO, 2003, CIRCULATION, V108, P760, DOI 10.1161/01.CIR.0000083719.51661.B9; Vikman S, 1999, CIRCULATION, V100, P2079, DOI 10.1161/01.CIR.100.20.2079; Vybiral T, 1993, J AM COLL CARDIOL, V22, P557, DOI 10.1016/0735-1097(93)90064-8; Wagner CD, 1998, CARDIOVASC RES, V40, P257, DOI 10.1016/S0008-6363(98)00251-X; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Wessel N, 2000, PHYS REV E, V61, P733, DOI 10.1103/PhysRevE.61.733; WILDERS R, 1993, BIOPHYS J, V65, P2601, DOI 10.1016/S0006-3495(93)81289-X; Yan J, 2013, HEART RHYTHM, V10, pS416; Zhou S, 2008, HEART RHYTHM, V5, P131, DOI 10.1016/j.hrthm.2007.09.007	78	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105379	10.1371/journal.pone.0105379	http://dx.doi.org/10.1371/journal.pone.0105379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140699	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200082
J	Meiselbach, H; Vogel, N; Langlhofer, G; Stangl, S; Schleyer, B; Bahnassawy, L; Sticht, H; Breitinger, HG; Becker, CM; Villmann, C				Meiselbach, Heike; Vogel, Nico; Langlhofer, Georg; Stangl, Sabine; Schleyer, Barbara; Bahnassawy, Lamia'a; Sticht, Heinrich; Breitinger, Hans-Georg; Becker, Cord-Michael; Villmann, Carmen			Single Expressed Glycine Receptor Domains Reconstitute Functional Ion Channels without Subunit-specific Desensitization Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEBRILE SEIZURES PLUS; CYS-LOOP RECEPTOR; CHROMOSOMAL LOCALIZATION; ACETYLCHOLINE-RECEPTOR; GENERALIZED EPILEPSY; FRAMESHIFT MUTATION; ALPHA-1; HYPEREKPLEXIA; DETERMINES; GENE	Cys loop receptors are pentameric arrangements of independent subunits that assemble into functional ion channels. Each subunit shows a domain architecture. Functional ion channels can be reconstituted even from independent, nonfunctional subunit domains, as shown previously for GlyR alpha 1 receptors. Here, we demonstrate that this reconstitution is not restricted to alpha 1 but can be transferred to other members of the Cys loop receptor family. A nonfunctional GlyR subunit, truncated at the intracellular TM3-4 loop by a premature stop codon, can be complemented by co-expression of the missing tail portion of the receptor. Compared with alpha 1 subunits, rescue by domain complementation was less efficient when GlyR alpha 3 or the GABA(A/C) subunit rho 1 was used. If truncation disrupted an alternative splicing cassette within the intracellular TM3-4 loop of alpha 3 subunits, which also regulates receptor desensitization, functional rescue was not possible. When alpha 3 receptors were restored by complementation using domains with and without the spliced insert, no difference in desensitization was found. In contrast, desensitization properties could even be transferred between alpha 1/alpha 3 receptor chimeras harboring or lacking the alpha 3 splice cassette proving that functional rescue depends on the integrity of the alternative splicing cassette in alpha 3. Thus, an intact alpha 3 splicing cassette in the TM3-4 loop environment is indispensable for functional rescue, and the quality of receptor restoration can be assessed from desensitization properties.	[Meiselbach, Heike; Sticht, Heinrich] Univ Erlangen Nurnberg, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Vogel, Nico; Stangl, Sabine; Becker, Cord-Michael; Villmann, Carmen] Univ Erlangen Nurnberg, Emil Fischer Ctr, Inst Biochem, D-91054 Erlangen, Germany; [Langlhofer, Georg; Schleyer, Barbara; Villmann, Carmen] Univ Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany; [Bahnassawy, Lamia'a; Breitinger, Hans-Georg] German Univ Cairo, Dept Biochem, Cairo 11835, Egypt	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Wurzburg; Egyptian Knowledge Bank (EKB); German University in Cairo	Villmann, C (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, Versbacherstr 5, D-97078 Wurzburg, Germany.	Villmann_C@ukw.de	Breitinger, Hans-Georg/ABD-3247-2021	Breitinger, Hans-Georg/0000-0003-0111-3528; Langlhofer, Georg/0000-0003-4386-8777; Sticht, Heinrich/0000-0001-5644-045X	Deutsche Forschungsgemeinschaft [VI586, BR 1507]; Johannes and Frieda Marohn Stiftung.; Graduate School of Life Science, Wurzburg, Germany; Science and Technology Development Fund [1785]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Johannes and Frieda Marohn Stiftung.; Graduate School of Life Science, Wurzburg, Germany; Science and Technology Development Fund(Science and Technology Development Fund (STDF))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant VI586 and the Johannes and Frieda Marohn Stiftung.; Supported by the Graduate School of Life Science, Wurzburg, Germany.; Supported by Deutsche Forschungsgemeinschaft Grant BR 1507 and Science and Technology Development Fund Grant 1785.	Accelrys Inc, 2005, DS VIEWERPRO SUIT 6; Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; Bode A, 2013, J BIOL CHEM, V288, P33745, DOI 10.1074/jbc.M113.509240; Breitinger HG, 2009, J BIOL CHEM, V284, P28624, DOI 10.1074/jbc.M109.043174; Breitinger HG, 2002, J NEUROCHEM, V83, P30, DOI 10.1046/j.1471-4159.2002.01109.x; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; Chen XB, 2009, MOL MEMBR BIOL, V26, P321, DOI 10.1080/09687680903120319; Cheng MHY, 2007, PROTEINS, V68, P581, DOI 10.1002/prot.21435; Enz R, 1996, J NEUROSCI, V16, P4479; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Han L, 2013, ACS CHEM NEUROSCI, V4, P1361, DOI 10.1021/cn400097j; Han L, 2013, ACS CHEM NEUROSCI, V4, P248, DOI 10.1021/cn300177g; Harkin LA, 2002, AM J HUM GENET, V70, P530, DOI 10.1086/338710; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang RQ, 2007, BIOCHEMISTRY-US, V46, P11484, DOI 10.1021/bi701093j; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kang JQ, 2009, J NEUROSCI, V29, P2845, DOI 10.1523/JNEUROSCI.4772-08.2009; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kling C, 1997, NEUROSCIENCE, V78, P411, DOI 10.1016/S0306-4522(96)00567-2; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; MATZENBACH B, 1994, J BIOL CHEM, V269, P2607; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; Nicholas K. B., 1997, EMBNEW NEWS, V4, P97; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Sanchez R, 2000, METH MOL B, V143, P97; Schaefer N, 2013, BRIT J PHARMACOL, V170, P933, DOI 10.1111/bph.12335; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripos Inc, 2002, SYB 6 9 REL 7 0A; Tsai CH, 2004, NEUROLOGY, V63, P893, DOI 10.1212/01.WNL.0000138566.65519.67; Unterer B, 2012, J BIOL CHEM, V287, P39205, DOI 10.1074/jbc.M112.376053; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Vogel N, 2009, J BIOL CHEM, V284, P36128, DOI 10.1074/jbc.M109.043448; Yevenes GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023886; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200	45	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29135	29147		10.1074/jbc.M114.559138	http://dx.doi.org/10.1074/jbc.M114.559138			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25143388	hybrid, Green Published			2022-12-25	WOS:000344141000030
J	Lim, KP; Chun, NAL; Ismail, SM; Abraham, MT; Yusoff, MN; Zain, RB; Ngeow, WC; Ponniah, S; Cheong, SC				Lim, Kue Peng; Chun, Nicole Ai Leng; Ismail, Siti Mazlipah; Abraham, Mannil Thomas; Yusoff, Mohd Nury; Zain, Rosnah Binti; Ngeow, Wei Cheong; Ponniah, Sathibalan; Cheong, Sok Ching			CD4(+)CD25(hi)CD127(low) Regulatory T Cells Are Increased in Oral Squamous Cell Carcinoma Patients	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR-INFILTRATING LYMPHOCYTES; PERIPHERAL-CIRCULATION; INCREASED FREQUENCY; IMPROVED SURVIVAL; ADVANCED-STAGE; BREAST-CANCER; COLON-CANCER; NECK-CANCER; HEAD	Regulatory T cells (Tregs), a subset of CD4(+) T cells plays a pivotal role in regulating the immune system. An increase in Treg numbers enables cancer progression by dampening the immune system and allowing tumor cells to evade immune detection and destruction. An increase in Treg numbers and expression of inhibitory cytokines including TGF-beta and IL-10 are mechanisms by which Tregs exert their immune suppressive function. However, the presence of Tregs and inhibitory cytokines in oral cancer patients is still unclear. In this study, the presence of circulating Tregs in 39 oral cancer patients and 24 healthy donors was examined by studying the presence of the CD4(+)CD25(hi)CD127(low) cell population in their peripheral blood mononuclear cells using flow cytometry. Serum levels of TGF-beta and IL-10 were measured by ELISA. T cell subsets of OSCC patients were found to differ significantly from healthy donors where a decrease in CD8(+) cytotoxic T cells and an increase in Tregs (CD4(+)CD25(hi)CD127(low\)) were observed. Further, the ratio of CD8(+) T cells/Tregs was also decreased in patients compared to healthy donors. The presence of Tregs was accompanied by a decrease in IL-10 but not TGF-beta secretion in OSCC patients when compared to donors; in addition, the analysis also revealed that an increased presence of Tregs was accompanied by better patient survival. Amongst OSCC patients, smokers had significantly higher levels of TGF-beta. It is apparent that the immune system is compromised in OSCC patients and the characterization of the Treg subpopulation could form a basis for improving our understanding of the perturbations in the immune system that occur during OSCC tumorigenesis.	[Lim, Kue Peng; Chun, Nicole Ai Leng; Cheong, Sok Ching] Canc Res Initiat Fdn CARIF, Oral Canc Res Team, Subang Jaya, Selangor, Malaysia; [Chun, Nicole Ai Leng; Zain, Rosnah Binti] Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia; [Ismail, Siti Mazlipah; Zain, Rosnah Binti; Ngeow, Wei Cheong; Cheong, Sok Ching] Univ Malaya, Fac Dent, Dept Oromaxillofacial Surg & Med Sci, Kuala Lumpur, Malaysia; [Abraham, Mannil Thomas; Yusoff, Mohd Nury] Tengku Ampuan Rahimah Hosp, Dept Oral & Maxillofacial Surg, Klang, Malaysia; [Ponniah, Sathibalan] Uniformed Serv Univ Hlth Sci, Canc Vaccine Dev Program, Bethesda, MD 20814 USA	Universiti Malaya; Universiti Malaya; Uniformed Services University of the Health Sciences - USA	Cheong, SC (corresponding author), Canc Res Initiat Fdn CARIF, Oral Canc Res Team, 2nd Floor Outpatient Ctr, Subang Jaya, Selangor, Malaysia.	sokching.cheong@carif.com.my	Cheong, Ngeow Wei/A-2530-2009; Zain, Rosnah/B-8054-2010	Cheong, Ngeow Wei/0000-0003-4354-3518; 	University of Malaya Research Grant (UMRG) [RG289/11HTM]; Ministry of Science, Technology and Innovation (MOSTI) of Malaysia (e-Science Fund) [02-04-03-SF0011]; Cancer Research Initiatives Foundation (CARIF)	University of Malaya Research Grant (UMRG); Ministry of Science, Technology and Innovation (MOSTI) of Malaysia (e-Science Fund); Cancer Research Initiatives Foundation (CARIF)	This study was funded by the University of Malaya Research Grant (UMRG), RG289/11HTM, the Ministry of Science, Technology and Innovation (MOSTI) of Malaysia (e-Science Fund, 02-04-03-SF0011) and other sponsors of the Cancer Research Initiatives Foundation (CARIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamarneh O, 2011, HEAD NECK-J SCI SPEC, V33, P415, DOI 10.1002/hed.21464; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Cacev T, 2008, CARCINOGENESIS, V29, P1572, DOI 10.1093/carcin/bgn164; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Chan SL, 2012, CANCER-AM CANCER SOC, V118, P3984, DOI 10.1002/cncr.26726; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dhooge IJ, 1998, LARYNGOSCOPE, V108, P250, DOI 10.1097/00005537-199802000-00017; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Drennan S, 2013, IMMUNOLOGY, V140, P335, DOI 10.1111/imm.12144; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fox SB, 2007, PROSTATE, V67, P623, DOI 10.1002/pros.20538; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Fujieda S, 1999, CANCER LETT, V136, P1, DOI 10.1016/S0304-3835(98)00281-X; Gaiolla RD, 2011, ARCH PATHOL LAB MED, V135, P483, DOI 10.1043/2010-0060-OA.1; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gasparoto TH, 2010, CANCER IMMUNOL IMMUN, V59, P819, DOI 10.1007/s00262-009-0803-7; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gholamin M, 2009, WORLD J SURG, V33, P1439, DOI 10.1007/s00268-009-0070-y; Green VL, 2012, INT J ONCOL, V40, P833, DOI 10.3892/ijo.2011.1259; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatanaka H, 2000, ANN ONCOL, V11, P815, DOI 10.1023/A:1008375208574; Heckel MC, 2011, CELL IMMUNOL, V266, P143, DOI 10.1016/j.cellimm.2010.09.010; Hoffmann TK, 2007, HEAD NECK-J SCI SPEC, V29, P472, DOI 10.1002/hed.20533; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jordanova ES, 2008, CLIN CANCER RES, V14, P2028, DOI 10.1158/1078-0432.CCR-07-4554; Julie R, 2012, J CLIN ONCOLOGY OF S, V30; Kaskas NM, 2013, JAMA OTOLARYNGOLOGY; Katz LH, 2013, EXPERT OPIN THER TAR, V17, P743, DOI 10.1517/14728222.2013.782287; Kmieciak M, 2007, EUR J IMMUNOL, V37, P675, DOI 10.1002/eji.200636639; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kuss I, 2004, CLIN CANCER RES, V10, P3755, DOI 10.1158/1078-0432.CCR-04-0054; Laurent J, 2010, J IMMUNOTHER, V33, P723, DOI 10.1097/CJI.0b013e3181ea7e6e; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Liu Li, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P548, DOI 10.1007/s11596-006-0516-5; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Manjili MH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/641079; MASHBERG A, 1989, CA-CANCER J CLIN, V39, P67, DOI 10.3322/canjclin.39.2.67; Matsuura K, 2006, CANCER-AM CANCER SOC, V106, P1227, DOI 10.1002/cncr.21729; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Menetrier-Caux C, 2012, TARGET ONCOL, V7, P15, DOI 10.1007/s11523-012-0208-y; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Okita R, 2005, ONCOL REP, V14, P1269; Powell DJ, 2008, J IMMUNOTHER, V31, P189, DOI 10.1097/CJI.0b013e31815dc0e8; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reiman JM, 2007, SEMIN CANCER BIOL, V17, P275, DOI 10.1016/j.semcancer.2007.06.009; Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schaefer C, 2005, BRIT J CANCER, V92, P913, DOI 10.1038/sj.bjc.6602407; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seddon B, 1999, J EXP MED, V189, P279, DOI 10.1084/jem.189.2.279; SILVERMAN S, 1990, J AM DENT ASSOC, V120, P495, DOI 10.14219/jada.archive.1990.0082; Sparano A, 2004, OTOLARYNG HEAD NECK, V131, P573, DOI 10.1016/j.otohns.2004.03.016; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; van Monsjou HS, 2010, ORAL ONCOL, V46, P780, DOI 10.1016/j.oraloncology.2010.08.011; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	80	47	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103975	10.1371/journal.pone.0103975	http://dx.doi.org/10.1371/journal.pone.0103975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153698	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200012
J	Polakovicova, I; Draberova, L; Simicek, M; Draber, P				Polakovicova, Iva; Draberova, Lubica; Simicek, Michal; Draber, Petr			Multiple Regulatory Roles of the Mouse Transmembrane Adaptor Protein NTAL in Gene Transcription and Mast Cell Physiology	PLOS ONE			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; TYROSINE PHOSPHORYLATION; NEUTROPHIL CHEMOTAXIS; NEGATIVE REGULATION; CHOLESTEROL; ACTIVATION; DEGRANULATION; MIGRATION; MOLECULE	Non-T cell activation linker (NTAL; also called LAB or LAT2) is a transmembrane adaptor protein that is expressed in a subset of hematopoietic cells, including mast cells. There are conflicting reports on the role of NTAL in the high affinity immunoglobulin E receptor (FceRI) signaling. Studies carried out on mast cells derived from mice with NTAL knock out (KO) and wild type mice suggested that NTAL is a negative regulator of FceRI signaling, while experiments with RNAi-mediated NTAL knockdown (KD) in human mast cells and rat basophilic leukemia cells suggested its positive regulatory role. To determine whether different methodologies of NTAL ablation (KO vs KD) have different physiological consequences, we compared under well defined conditions FceRI-mediated signaling events in mouse bone marrow-derived mast cells (BMMCs) with NTAL KO or KD. BMMCs with both NTAL KO and KD exhibited enhanced degranulation, calcium mobilization, chemotaxis, tyrosine phosphorylation of LAT and ERK, and depolymerization of filamentous actin. These data provide clear evidence that NTAL is a negative regulator of FceRI activation events in murine BMMCs, independently of possible compensatory developmental alterations. To gain further insight into the role of NTAL in mast cells, we examined the transcriptome profiles of resting and antigen-activated NTAL KO, NTAL KD, and corresponding control BMMCs. Through this analysis we identified several genes that were differentially regulated in nonactivated and antigen-activated NTAL-deficient cells, when compared to the corresponding control cells. Some of the genes seem to be involved in regulation of cholesterol-dependent events in antigen-mediated chemotaxis. The combined data indicate multiple regulatory roles of NTAL in gene expression and mast cell physiology.	[Polakovicova, Iva; Draberova, Lubica; Simicek, Michal; Draber, Petr] Acad Sci Czech Republ, Inst Mol Genet, Dept Signal Transduct, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Draber, P (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Dept Signal Transduct, Prague, Czech Republic.	draberpe@img.cas.cz	Draber, Petr/E-1119-2018; Simicek, Michal/C-2514-2019; Polakovicova, Iva/AAF-6990-2019	Draber, Petr/0000-0002-3986-2025; Simicek, Michal/0000-0003-2388-2723; Polakovicova, Iva/0000-0002-4505-9896	Grant Agency of the Czech Republic [P302/12/G101, P302-14-09807S, P305-14-00703S]; Ministry of Education of the Czech Republic [LD12073 COST-CZ-MAST]; Academy of Sciences of the Czech Republic [RVO 68378050]; European Cooperation in Science and Technology [Action BM1007]; Faculty of Science, Charles University, Prague	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Faculty of Science, Charles University, Prague	This work was supported by project P302/12/G101, P302-14-09807S, and P305-14-00703S from the Grant Agency of the Czech Republic (URL: http://www.gacr.cz/); project LD12073 COST-CZ-MAST from Ministry of Education of the Czech Republic (URL: http://www.msmt.cz/); Institutional project RVO 68378050 from Academy of Sciences of the Czech Republic (URL: http://www.cas.cz/); and Action BM1007 from European Cooperation in Science and Technology (URL: http://www.cost.eu/). I. P. was supported in part by the Faculty of Science, Charles University, Prague (URL: http://www.natur.cuni.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Bugajev V, 2010, FEBS LETT, V584, P4949, DOI 10.1016/j.febslet.2010.08.045; Cavnar PJ, 2011, J CELL BIOL, V193, P465, DOI 10.1083/jcb.201010143; DASTYCH J, 1994, J IMMUNOL, V152, P213; Draber P, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00095; DRABEROVA L, 1995, ADV EXP MED BIOL, V371, P297; Draberova L, 2007, J IMMUNOL, V179, P5169, DOI 10.4049/jimmunol.179.8.5169; EISEMAN E, 1992, J BIOL CHEM, V267, P21027; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Fernandes AR, 2012, EUR J NEUROSCI, V35, P1344, DOI 10.1111/j.1460-9568.2012.08028.x; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Frigeri L, 1999, J IMMUNOL, V162, P2243; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Hajkova Z, 2011, J IMMUNOL, V186, P913, DOI 10.4049/jimmunol.1002074; Horakova H, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-41; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Ishizaki H, 2006, J IMMUNOL, V177, P8512, DOI 10.4049/jimmunol.177.12.8512; Iwaki S, 2008, CELL SIGNAL, V20, P195, DOI 10.1016/j.cellsig.2007.10.013; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kovarova M, 2006, J EXP MED, V203, P1161, DOI 10.1084/jem.20051701; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Lindquist JA, 2003, IMMUNOL REV, V191, P165, DOI 10.1034/j.1600-065X.2003.00007.x; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Nguyen DH, 2004, MECH AGEING DEV, V125, P641, DOI 10.1016/j.mad.2004.08.002; Nocka KH, 1997, BLOOD, V90, P3874, DOI 10.1182/blood.V90.10.3874; Orr SJ, 2011, J LEUKOCYTE BIOL, V89, P11, DOI 10.1189/jlb.0410221; Pagler TA, 2011, CIRC RES, V108, P194, DOI 10.1161/CIRCRESAHA.110.228619; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Pierini LM, 2003, J BIOL CHEM, V278, P10831, DOI 10.1074/jbc.M212386200; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Surviladze Z, 2001, EUR J IMMUNOL, V31, P1, DOI 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.CO;2-W; THOMPSON HL, 1993, CLIN EXP ALLERGY, V23, P270, DOI 10.1111/j.1365-2222.1993.tb00321.x; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; Tolar P, 2001, FOLIA BIOL-PRAGUE, V47, P215; Tolarova H, 2004, EUR J IMMUNOL, V34, P1627, DOI 10.1002/eji.200424991; Tumova M, 2010, EUR J IMMUNOL, V40, P3235, DOI 10.1002/eji.201040403; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Wang ZL, 2009, J BIOL CHEM, V284, P28599, DOI 10.1074/jbc.M109.047282; Wright J, 2008, PHYSIOL GENOMICS, V33, P341, DOI 10.1152/physiolgenomics.00024.2008; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325	50	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105539	10.1371/journal.pone.0105539	http://dx.doi.org/10.1371/journal.pone.0105539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153696	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200059
J	Alpay, K; Farshchian, M; Tuomela, J; Sandholm, J; Aittokallio, K; Siljamaki, E; Kallio, M; Kahari, VM; Hietanen, S				Alpay, Kemal; Farshchian, Mehdi; Tuomela, Johanna; Sandholm, Jouko; Aittokallio, Kaappo; Siljamaki, Elina; Kallio, Marko; Kahari, Veli-Matti; Hietanen, Sakari			Inhibition of c-Abl Kinase Activity Renders Cancer Cells Highly Sensitive to Mitoxantrone	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; TYROSINE KINASE; IN-VITRO; PROSTATE-CANCER; MULTIDRUG-RESISTANCE; CELLULAR-RESPONSE; IMATINIB; DRUGS; P53; COMBINATION	Although c-Abl has increasingly emerged as a key player in the DNA damage response, its role in this context is far from clear. We studied the effect of inhibition of c-Abl kinase activity by imatinib with chemotherapy drugs and found a striking difference in cell survival after combined mitoxantrone (MX) and imatinib treatment compared to a panel of other chemotherapy drugs. The combinatory treatment induced apoptosis in HeLa cells and other cancer cell lines but not in primary fibroblasts. The difference in MX and doxorubicin was related to significant augmentation of DNA damage. Transcriptionally active p53 accumulated in cells in which human papillomavirus E6 normally degrades p53. The combination treatment resulted in caspase activation and apoptosis, but this effect did not depend on either p53 or p73 activity. Despite increased p53 activity, the cells arrested in G2 phase became defective in this checkpoint, allowing cell cycle progression. The effect after MX treatment depended partially on c-Abl: Short interfering RNA knockdown of c-Abl rendered HeLa cells less sensitive to MX. The effect of imatinib was decreased by c-Abl siRNA suggesting a role for catalytically inactive c-Abl in the death cascade. These findings indicate that MX has a unique cytotoxic effect when the kinase activity of c-Abl is inhibited. The treatment results in increased DNA damage and c-Abl-dependent apoptosis, which may offer new possibilities for potentiation of cancer chemotherapy.	[Alpay, Kemal; Aittokallio, Kaappo; Hietanen, Sakari] Univ Turku, Turku Univ Hosp, Med Res Lab, Dept Obstet & Gynecol, Turku, Finland; [Alpay, Kemal; Aittokallio, Kaappo; Hietanen, Sakari] Univ Turku, Turku Univ Hosp, Med Res Lab, Joint Clin Biochem Lab, Turku, Finland; [Farshchian, Mehdi; Siljamaki, Elina; Kahari, Veli-Matti] Univ Turku, Dept Dermatol, Turku, Finland; [Farshchian, Mehdi; Siljamaki, Elina; Kahari, Veli-Matti] Univ Turku, Med Res Lab, Turku, Finland; [Farshchian, Mehdi; Siljamaki, Elina; Kahari, Veli-Matti] Turku Univ Hosp, FIN-20520 Turku, Finland; [Tuomela, Johanna] Univ Turku, Dept Cell Biol & Anat, Turku, Finland; [Sandholm, Jouko] Univ Turku, Turku Ctr Biotechnol, Cell Imaging Core, Turku, Finland; [Sandholm, Jouko] Abo Akad Univ, Turku, Finland; [Kallio, Marko] VTT Hlth, VTT Tech Res Ctr Finland, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; Abo Akademi University; VTT Technical Research Center Finland	Hietanen, S (corresponding author), Univ Turku, Turku Univ Hosp, Med Res Lab, Dept Obstet & Gynecol, Turku, Finland.	sakari.hietanen@utu.fi	Kahari, Veli-Matti/T-4925-2019; Hietanen, Sakari/AAD-2858-2021; Hietanen, Sakari/N-6849-2016; Kähäri, Veli-Matti/E-5144-2011	Kahari, Veli-Matti/0000-0003-2421-9368; Hietanen, Sakari/0000-0003-4734-4743; Hietanen, Sakari/0000-0003-4734-4743; Kähäri, Veli-Matti/0000-0003-2421-9368; Kallio, Marko/0000-0002-6345-1680; Tuomela, Johanna/0000-0003-4390-4563; Siljamaki, Elina/0000-0003-1709-8633; Alpay, Kemal/0000-0002-8129-2273; Sandholm, Jouko/0000-0003-0638-2444	Finnish Medical Society; Turku University Foundation and Cancer Society of South-Western Finland; Academy of Finland [137687, 268360]; Finnish Cancer Research Foundation; Sigrid Juselius Foundation; Turku University Hospital EVO [13336]; Cancer Foundation Finland sr [120097, 130107] Funding Source: researchfish	Finnish Medical Society; Turku University Foundation and Cancer Society of South-Western Finland; Academy of Finland(Academy of Finland); Finnish Cancer Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Hospital EVO; Cancer Foundation Finland sr	This study was financially supported by grants from Finnish Medical Society, Turku University Foundation and Cancer Society of South-Western Finland, the Academy of Finland (projects 137687 and 268360), the Finnish Cancer Research Foundation, Sigrid Juselius Foundation, Turku University Hospital EVO grant (project 13336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agami R, 1999, NATURE, V399, P809; Buchdunger E, 2002, EUR J CANCER, V38, pS28, DOI 10.1016/S0959-8049(02)80600-1; Chan AL, 2013, BIOCHEMISTRY-US, V52, P3119, DOI 10.1021/bi301710c; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Chen XA, 2006, MOL CELL, V22, P489, DOI 10.1016/j.molcel.2006.04.021; Choudhury A, 2009, MOL CANCER THER, V8, P203, DOI 10.1158/1535-7163.MCT-08-0959; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Fanta S, 2008, ONCOGENE, V27, P4380, DOI 10.1038/onc.2008.68; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Hande KR, 2008, UPDATE CANC THERAPEU, V3, P13, DOI DOI 10.1016/J.UCT.2008.02.001; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; Hietanen S, 1998, INT J CANCER, V78, P338, DOI 10.1002/(SICI)1097-0215(19981029)78:3<338::AID-IJC14>3.0.CO;2-2; Hietanen Sakari, 2009, P51, DOI 10.1007/978-1-4020-9597-9_3; Hoeijmakers JHJ, 2007, MECH AGEING DEV, V128, P460, DOI 10.1016/j.mad.2007.05.002; Houghton PJ, 2004, CANCER RES, V64, P2333, DOI 10.1158/0008-5472.CAN-03-3344; Huang DY, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-35; Villar VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037735; Kerr JB, 2012, NAT MED, V18, P1170, DOI 10.1038/nm.2889; Kharbanda S, 1997, BBA-REV CANCER, V1333, pO1, DOI 10.1016/S0304-419X(97)00020-6; Koivusalo R, 2002, CANCER RES, V62, P7364; Koivusalo R, 2005, MOL PHARMACOL, V68, P372, DOI 10.1124/mol.105.011189; Koivusalo R, 2004, CANCER BIOL THER, V3, P1177, DOI 10.4161/cbt.3.11.1340; Kubler HR, 2005, PROSTATE, V63, P385, DOI 10.1002/pros.20201; Labib K, 2011, PHILOS T R SOC B, V366, P3554, DOI 10.1098/rstb.2011.0071; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Maiani E, 2011, BIOCHEM PHARMACOL, V82, P1269, DOI 10.1016/j.bcp.2011.07.001; Meltser V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.21; Morrow CS, 2006, MOL PHARMACOL, V69, P1499, DOI 10.1124/mol.105.017988; Nagar B, 2007, J NUTR, V137, p1518S, DOI 10.1093/jn/137.6.1518S; Pinto AC, 2011, CANCER CHEMOTH PHARM, V67, P275, DOI 10.1007/s00280-010-1315-z; Pinto AC, 2011, PROSTATE, V71, P81, DOI 10.1002/pros.21224; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Potter AJ, 2005, MUTAT RES-FUND MOL M, V572, P27, DOI 10.1016/j.mrfmmm.2004.11.018; Russell JS, 2003, CANCER RES, V63, P7377; Sims JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055509; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Wang JYJ, 2004, NAT CELL BIOL, V6, P3, DOI 10.1038/ncb0104-3; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Wang-Rodriguez J, 2006, LARYNGOSCOPE, V116, P1409, DOI 10.1097/01.mlg.0000225895.40732.52; White E, 1999, NATURE, V399, P734, DOI 10.1038/21539; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	45	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105526	10.1371/journal.pone.0105526	http://dx.doi.org/10.1371/journal.pone.0105526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148385	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600052
J	Iannella, N; Launey, T; Abbott, D; Tanaka, S				Iannella, Nicolangelo; Launey, Thomas; Abbott, Derek; Tanaka, Shigeru			A Nonlinear Cable Framework for Bidirectional Synaptic Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; CALCIUM DYNAMICS; LATE-ASSOCIATIVITY; LATE MAINTENANCE; AREA CA1; MODEL; DEPRESSION; HIPPOCAMPUS; NEURONS	Finding the rules underlying how axons of cortical neurons form neural circuits and modify their corresponding synaptic strength is the still subject of intense research. Experiments have shown that internal calcium concentration, and both the precise timing and temporal order of pre and postsynaptic action potentials, are important constituents governing whether the strength of a synapse located on the dendrite is increased or decreased. In particular, previous investigations focusing on spike timing-dependent plasticity (STDP) have typically observed an asymmetric temporal window governing changes in synaptic efficacy. Such a temporal window emphasizes that if a presynaptic spike, arriving at the synaptic terminal, precedes the generation of a postsynaptic action potential, then the synapse is potentiated; however if the temporal order is reversed, then depression occurs. Furthermore, recent experimental studies have now demonstrated that the temporal window also depends on the dendritic location of the synapse. Specifically, it was shown that in distal regions of the apical dendrite, the magnitude of potentiation was smaller and the window for depression was broader, when compared to observations from the proximal region of the dendrite. To date, the underlying mechanism(s) for such a distance-dependent effect is (are) currently unknown. Here, using the ionic cable theory framework in conjunction with the standard calcium based plasticity model, we show for the first time that such distance-dependent inhomogeneities in the temporal learning window for STDP can be largely explained by both the spatial and active properties of the dendrite.	[Iannella, Nicolangelo; Abbott, Derek] Univ Adelaide SA, Ctr Biomed Engn CBME, Adelaide, SA, Australia; [Iannella, Nicolangelo; Abbott, Derek] Univ Adelaide SA, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Iannella, Nicolangelo] Univ South Australia, Inst Telecommun Res, Computat & Theoret Neurosci Lab, Mawson Lakes, SA, Australia; [Iannella, Nicolangelo; Launey, Thomas] Brain Sci Inst, RIKEN, Launey Res Unit, Saitama, Japan; [Tanaka, Shigeru] Univ Electrocommun, Fac Elect Commun, Tokyo, Japan	University of Adelaide; University of Adelaide; University of South Australia; RIKEN; University of Electro-Communications - Japan	Iannella, N (corresponding author), Univ Adelaide SA, Ctr Biomed Engn CBME, Adelaide, SA, Australia.	nicolangelo.iannella@gmail.com	Iannella, Nicolangelo/A-1026-2009; Abbott, Derek/E-8352-2011; Launey, Thomas/A-2605-2010	Iannella, Nicolangelo/0000-0002-1983-9071; Abbott, Derek/0000-0002-0945-2674; Launey, Thomas/0000-0001-9153-9260	RIKEN, Brain Science Institute; Australian Research Council (ARC) for support through an APD fellowship [DP1096083]	RIKEN, Brain Science Institute; Australian Research Council (ARC) for support through an APD fellowship(Australian Research Council)	The authors (NI and TL) wish to thank the support of the RIKEN, Brain Science Institute. NI further wishes to thank the Australian Research Council (ARC) for support through an APD fellowship DP1096083. Furthermore, the authors would like to express their gratitude to Prof SM Korogod for critically reading and providing useful feedback and suggestions which led to improvements to the original manuscript.	ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; BARRIONUEVO G, 1980, LIFE SCI, V27, P2385, DOI 10.1016/0024-3205(80)90509-3; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Debanne D, 1995, CAN J PHYSIOL PHARM, V73, P1295, DOI 10.1139/y95-185; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Evans J, 2005, MODELING NEUROSCIENC, P117; Evans JD, 2005, BIOL CYBERN, V92, P164, DOI 10.1007/s00422-004-0536-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Glenn L, 2005, MODELING NEUROSCIENC, P179; Gutman A, 2005, MODELING NEUROSCIENC, P145; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Iannella N, 2004, MATH BIOSCI, V188, P117, DOI 10.1016/j.mbs.2003.10.002; Iannella Nicolangelo, 2007, Journal of Integrative Neuroscience, V6, P241, DOI 10.1142/S0219635207001489; Iannella Nicolangelo, 2006, Journal of Integrative Neuroscience, V5, P249, DOI 10.1142/S0219635206001124; Isomura Y, 1999, J NEUROPHYSIOL, V82, P1993, DOI 10.1152/jn.1999.82.4.1993; Isomura Y, 2002, J NEUROPHYSIOL, V87, P1169, DOI 10.1152/jn.00536.2001; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Karmarkar UR, 2002, J NEUROPHYSIOL, V88, P507, DOI 10.1152/jn.2002.88.1.507; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kupferman R, 1997, BIOPHYS J, V72, P2430, DOI 10.1016/S0006-3495(97)78888-X; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larsson HP, 1997, BIOPHYS J, V72, P1193, DOI 10.1016/S0006-3495(97)78767-8; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; MOZRZYMAS JW, 1993, J THEOR BIOL, V162, P371, DOI 10.1006/jtbi.1993.1093; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; Poznanski Roman R., 2004, Journal of Integrative Neuroscience, V3, P267, DOI 10.1142/S0219635204000439; Poznanski RR, 2000, MATH BIOSCI, V166, P101, DOI 10.1016/S0025-5564(00)00031-6; Poznanski RR, 2000, MATH BIOSCI, V166, P123, DOI 10.1016/S0025-5564(00)00032-8; Poznanski RR, 2001, BIOPHYSICAL NEURAL N, P177; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; Rall W, 1964, NEURAL THEORY MODELI, P73; RALL WILFRID, 1962, BIOPHYS JOUR, V2, P145; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Rubin JE, 2005, J NEUROPHYSIOL, V93, P2600, DOI 10.1152/jn.00803.2004; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Sajikumar S, 2004, NEUROSCIENCE, V129, P503, DOI 10.1016/j.neuroscience.2004.08.014; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; Schutter E. D. E., 1998, METHODS NEURONAL MOD, P211; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Smolen P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000445; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Traub RD, 2003, J NEUROPHYSIOL, V89, P909, DOI 10.1152/jn.00573.2002; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Tsukada M, 2005, HIPPOCAMPUS, V15, P104, DOI 10.1002/hipo.20035; Tuckwell H. C., 1988, INTRO THEORETICAL NE, V1; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	72	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e102601	10.1371/journal.pone.0102601	http://dx.doi.org/10.1371/journal.pone.0102601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148478	Green Published, gold, Green Accepted			2022-12-25	WOS:000341230600004
J	Xu, T; Pang, QY; Zhou, D; Zhang, AQ; Luo, SM; Wang, Y; Yan, XF				Xu, Tao; Pang, Qiuying; Zhou, Dong; Zhang, Aiqin; Luo, Shaman; Wang, Yang; Yan, Xiufeng			Proteomic Investigation into Betulinic Acid-Induced Apoptosis of Human Cervical Cancer HeLa Cells	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN-MELANOMA; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; ACTIVATION; INHIBITION; GROWTH; PHOSPHORYLATION; PROLIFERATION; CYTOTOXICITY	Betulinic acid is a pentacyclic triterpenoid that exhibits anticancer functions in human cancer cells. This study provides evidence that betulinic acid is highly effective against the human cervical cancer cell line HeLa by inducing dose- and time-dependent apoptosis. The apoptotic process was further investigated using a proteomics approach to reveal protein expression changes in HeLa cells following betulinic acid treatment. Proteomic analysis revealed that there were six up- and thirty down-regulated proteins in betulinic acid-induced HeLa cells, and these proteins were then subjected to functional pathway analysis using multiple analysis software. UDP-glucose 6-dehydrogenase, 6-phosphogluconate dehydrogenase decarboxylating, chain A Horf6-a novel human peroxidase enzyme that involved in redox process, was found to be down-regulated during the apoptosis process of the oxidative stress response pathway. Consistent with our results at the protein level, an increase in intracellular reactive oxygen species was observed in betulinic acid-treated cells. The proteins glucose-regulated protein and cargo-selection protein TIP47, which are involved in the endoplasmic reticulum pathway, were up-regulated by betulinic acid treatment. Meanwhile, 14-3-3 family proteins, including 14-3-3 beta and 14-3-3 epsilon, were down-regulated in response to betulinic acid treatment, which is consistent with the decrease in expression of the target genes 14-3-3 beta and 14-3-3 epsilon. Furthermore, it was found that the antiapoptotic bcl-2 gene was down-regulated while the proapoptotic bax gene was up-regulated after betulinic acid treatment in HeLa cells. These results suggest that betulinic acid induces apoptosis of HeLa cells by triggering both the endoplasmic reticulum pathway and the ROS-mediated mitochondrial pathway.	[Xu, Tao; Pang, Qiuying; Zhou, Dong; Zhang, Aiqin; Luo, Shaman; Wang, Yang; Yan, Xiufeng] Northeast Forestry Univ, Alkali Soil Nat Environm Sci Ctr, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Yan, XF (corresponding author), Northeast Forestry Univ, Alkali Soil Nat Environm Sci Ctr, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Harbin, Heilongjiang, Peoples R China.	xfyan@nefu.edu.cn		Yan, Xiufeng/0000-0001-5127-494X	Forestry Industry Research Special Fund for Public Welfare [201004069]; Fundamental Research Funds for the Central Universities [DL13EA02-03]	Forestry Industry Research Special Fund for Public Welfare; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was financially supported by the the Forestry Industry Research Special Fund for Public Welfare (201004069) and the Fundamental Research Funds for the Central Universities (DL13EA02-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Eiznhamer DA, 2004, IDRUGS, V7, P359; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 2000, MED PEDIATR ONCOL, V35, P616, DOI 10.1002/1096-911X(20001201)35:6<616::AID-MPO27>3.0.CO;2-N; Gheorgheosu D, 2014, ANTICANCER AGENTS ME; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hwang CC, 1998, BIOCHEMISTRY-US, V37, P12596, DOI 10.1021/bi980611s; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kessler JH, 2007, CANCER LETT, V251, P132, DOI 10.1016/j.canlet.2006.11.003; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Q, 2011, MOL CARCINOGEN, V50, P760, DOI 10.1002/mc.20673; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089962; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mullauer FB, 2011, ANTI-CANCER DRUG, V22, P223, DOI 10.1097/CAD.0b013e3283421035; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Pandey MK, 2010, INT J CANCER, V127, P282, DOI 10.1002/ijc.25059; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Puren AJ, 1998, J CLIN INVEST, V101, P711, DOI 10.1172/JCI1379; Rabi T, 2008, MOL CARCINOGEN, V47, P964, DOI 10.1002/mc.20447; Rzeski W, 2006, N-S ARCH PHARMACOL, V374, P11, DOI 10.1007/s00210-006-0090-1; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Santos RC, 2011, BIOCHIMIE, V93, P1065, DOI 10.1016/j.biochi.2011.02.014; Santos RC, 2009, BIOORGAN MED CHEM, V17, P6241, DOI 10.1016/j.bmc.2009.07.050; Schettino M T, 2013, Minerva Ginecol, V65, P661; Selzer E, 2000, J INVEST DERMATOL, V114, P935, DOI 10.1046/j.1523-1747.2000.00972.x; Shen LM, 2009, SCI CHINA SER B, V52, P1814, DOI 10.1007/s11426-009-0272-z; Shen LM, 2009, CHEM-BIOL INTERACT, V181, P455, DOI 10.1016/j.cbi.2009.07.013; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Takada Y, 2003, J IMMUNOL, V171, P3278, DOI 10.4049/jimmunol.171.6.3278; Tan YM, 2003, CLIN CANCER RES, V9, P2866; Theo A, 2009, TOHOKU J EXP MED, V217, P93, DOI 10.1620/tjem.217.93; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Wang Y, 2006, PROTEOMICS, V6, P2422, DOI 10.1002/pmic.200500595; Wick W, 1999, J PHARMACOL EXP THER, V289, P1306; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Wong CC, 2008, J PROTEOME RES, V7, P2050, DOI 10.1021/pr800019k; Yang LJ, 2010, ACTA PHARMACOL SIN, V31, P66, DOI 10.1038/aps.2009.177; Yang XJ, 2008, INVEST OPHTH VIS SCI, V49, P2483, DOI 10.1167/iovs.07-1344; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2	47	38	45	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105768	10.1371/journal.pone.0105768	http://dx.doi.org/10.1371/journal.pone.0105768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148076	gold, Green Submitted, Green Published			2022-12-25	WOS:000341230600080
J	Yang, ZF; Zhao, PX; Wang, JW; Tong, LP; Cao, JY; Tian, Y; Yao, ZP; Wang, JB; Zhu, YR; Jia, YY; Wen, AD				Yang, Zhifu; Zhao, Peixi; Wang, Jingwen; Tong, Liping; Cao, Jinyi; Tian, Yun; Yao, Zhanpeng; Wang, Jingbo; Zhu, Yanrong; Jia, Yanyan; Wen, Aidong			DRUGS System Enhancing Adherence of Chinese Surgeons to Antibiotic Use Guidelines during Perioperative Period	PLOS ONE			English	Article							ANTIMICROBIAL PROPHYLAXIS; MANAGEMENT; DIAGNOSIS; UPDATE	Objective: Irrational use of antimicrobial agents for preventing postoperative SSIs is a common phenomenon in China, which results in more bacterial resistance, higher hospital infection rates, extra costs of antimicrobial agents. The aim of the study is to evaluate the effect of Drug Rational Usage Guidelines System (DRUGS) on the surgeon's prescription behavior of antimicrobial agents. Methods: 10 common surgical operations which included 1543 cases (where 778 cases using paper-based guidelines and 765 cases using DRUGS) were selected and their demographic and clinical data were collected. The selected operations include thyroid resection, breast mass resection, myomectomy, etc. The evaluation criteria were antibiotic administrative categories, the time of initial dose, duration of administration, length of stay, the costs of antibiotics, SSIs and drug adverse reactions(ADR). Results: The antimicrobial agents were mostly administrated within 0.5 h to 2 h before incision, 656 patients (85.75%) were intervened with DRUGS and 256 (32.90%) with paper-based guidelines according to the protocol. For the clean wounds incision, 547 patients (91.62%) were within 24 h of withdrawal antibiotics with using paper-based guidelines versus 91 (14.79%) with using DRUGS. A total of 19 kinds of antibiotics were used in the 1543 cases. The leading three on the list of frequency were piperacillin and sulbactam sodium, cefathiamidine and cefoperazone. While after the intervention, the list of frequency changed to cefazolin, cefathiamidine, cefoperazone. The average hospital stay was (7.00 +/- 4.31)d with paper-based guidelines and (2.54 +/- 1.57)d with DRUGS, respectively. The average cost of antibiotics was (sic)(3481.36 +/- 2584.46) with paper-based guidelines and (sic)(1693.39 +/- 1478.27) with DRUGS, respectively. However, there were no significant differences in the incidence of SSIs and ADR between two groups. Conclusion: In this study, the increased availability of antibiotic guidelines at the time of drug ordering, combined with DRUGS, was associated with an enhanced surgeon adherence to guidelines.	[Yang, Zhifu; Wang, Jingwen; Cao, Jinyi; Zhu, Yanrong; Jia, Yanyan; Wen, Aidong] Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian 710032, Shaanxi, Peoples R China; [Zhao, Peixi; Tian, Yun] Shaanxi Prov Tumor Hosp, Dept Pharm, Xian, Shaanxi, Peoples R China; [Tong, Liping; Yao, Zhanpeng; Wang, Jingbo] Fourth Mil Med Univ, Xijing Hosp, Dept Med Affair, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Jia, YY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian 710032, Shaanxi, Peoples R China.	jiayanyan-2004@hotmail.com; adwen@fmmu.edu.cn	wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022; Wen, Aidong/P-2654-2019	Wen, Aidong/0000-0002-4535-0501	National High Technology Research and Development Program of China [2012AA02A603]; Army Science and Technology Major Project in the 11th Five-year Plan [06D007]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Army Science and Technology Major Project in the 11th Five-year Plan	This study was conducted under contract by the National High Technology Research and Development Program of China (2012AA02A603) and the Army Science and Technology Major Project in the 11th Five-year Plan (06D007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrajati R, 2005, PHARM WORLD SCI, V27, P436, DOI 10.1007/s11096-005-5971-8; Ansari F, 2003, J ANTIMICROB CHEMOTH, V52, P842, DOI 10.1093/jac/dkg459; Ashraf M, 2009, INT J SURG, V7, P543, DOI 10.1016/j.ijsu.2009.08.012; BOOKER R, 2005, NURS STAND, V19, P54; Booker Rachel, 2005, Nurs Stand, V19, P43; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Bull AL, 2006, J HOSP INFECT, V63, P140, DOI 10.1016/j.jhin.2006.01.018; Bunn F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005360.pub3; Chueh H, 1997, ACAD MED, V72, P512, DOI 10.1097/00001888-199706000-00016; *ED BOARD CHIN J O, 2013, ZHONGHUA ER BI YAN H, V48, P180; FEDERSPIL P, 1991, HNO, V39, P371; Goins WP, 2010, OBSTET GYNECOL, V115, P1217, DOI 10.1097/AOG.0b013e3181dd916f; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Hu Xiang, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P113; Knox K, 2003, J HOSP INFECT, V53, P85, DOI 10.1053/jhin.2002.1350; Li YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054842; LUO Z, 2006, 4 KINDS PRESCRIPTION; Mahdaviazad Hamideh, 2011, J Infect Public Health, V4, P253, DOI 10.1016/j.jiph.2011.08.004; Owens CD, 2008, J HOSP INFECT, V70, P3, DOI 10.1016/S0195-6701(08)60017-1; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rodrigues Camilla, 2010, J Assoc Physicians India, V58 Suppl, P51; Saizy-Callaert S, 2003, J HOSP INFECT, V53, P177, DOI 10.1053/jhin.2002.1307; Shiffman RN, 1999, J AM MED INFORM ASSN, V6, P104, DOI 10.1136/jamia.1999.0060104; Shojania KG, 1998, J AM MED INFORM ASSN, V5, P554, DOI 10.1136/jamia.1998.0050554; Shojarna KG, 2001, EVID REP TECHNOL ASS, P1; Tourmousoglou CE, 2008, J ANTIMICROB CHEMOTH, V61, P214, DOI 10.1093/jac/dkm406; Tremolieres F, 2003, CLIN MICROBIOL INFEC, V9, P1162, DOI 10.1111/j.1469-0691.2003.00798.x; Westphal JF, 2011, PHARMACOEPIDEM DR S, V20, P162, DOI 10.1002/pds.2078; Yang ZP, 2012, LANCET, V379, pE13, DOI 10.1016/S0140-6736(11)60137-2; Young RP, 2012, ANN INTERN MED, V156, P68, DOI 10.7326/0003-4819-156-1-201201030-00021; Zielstorff RD, 1998, J AM MED INFORM ASSN, V5, P227, DOI 10.1136/jamia.1998.0050227	32	10	11	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e102226	10.1371/journal.pone.0102226	http://dx.doi.org/10.1371/journal.pone.0102226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148306	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600003
J	Tan, RH; Devenney, E; Dobson-Stone, C; Kwok, JB; Hodges, JR; Kiernan, MC; Halliday, GM; Hornberger, M				Tan, Rachel H.; Devenney, Emma; Dobson-Stone, Carol; Kwok, John B.; Hodges, John R.; Kiernan, Matthew C.; Halliday, Glenda M.; Hornberger, Michael			Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ADDENBROOKES COGNITIVE EXAMINATION; MOTOR-NEURON DISEASE; BEHAVIORAL VARIANT; LOBAR DEGENERATION; BRAIN ATROPHY; FUNCTIONAL CONNECTIVITY; REPEAT EXPANSION; CORTICAL ATROPHY; WHOLE-BRAIN	Amyotrophic lateral sclerosis (ALS) and behavioural variant frontotemporal dementia (bvFTD) are multisystem neurodegenerative disorders that manifest overlapping cognitive, neuropsychiatric and motor features. The cerebellum has long been known to be crucial for intact motor function although emerging evidence over the past decade has attributed cognitive and neuropsychiatric processes to this structure. The current study set out i) to establish the integrity of cerebellar subregions in the amyotrophic lateral sclerosis-behavioural variant frontotemporal dementia spectrum (ALS-bvFTD) and ii) determine whether specific cerebellar atrophy regions are associated with cognitive, neuropsychiatric and motor symptoms in the patients. Seventy-eight patients diagnosed with ALS, ALS-bvFTD, behavioural variant frontotemporal dementia (bvFTD), most without C9ORF72 gene abnormalities, and healthy controls were investigated. Participants underwent cognitive, neuropsychiatric and functional evaluation as well as structural imaging using voxel-based morphometry (VBM) to examine the grey matter subregions of the cerebellar lobules, vermis and crus. VBM analyses revealed: i) significant grey matter atrophy in the cerebellum across the whole ALS-bvFTD continuum; ii) atrophy predominantly of the superior cerebellum and crus in bvFTD patients, atrophy of the inferior cerebellum and vermis in ALS patients, while ALS-bvFTD patients had both patterns of atrophy. Post-hoc covariance analyses revealed that cognitive and neuropsychiatric symptoms were particularly associated with atrophy of the crus and superior lobule, while motor symptoms were more associated with atrophy of the inferior lobules. Taken together, these findings indicate an important role of the cerebellum in the ALS-bvFTD disease spectrum, with all three clinical phenotypes demonstrating specific patterns of subregional atrophy that associated with different symptomology.	[Tan, Rachel H.; Devenney, Emma; Dobson-Stone, Carol; Kwok, John B.; Hodges, John R.; Kiernan, Matthew C.; Halliday, Glenda M.; Hornberger, Michael] Neurosci Res Australia, Randwick, NSW, Australia; [Tan, Rachel H.; Devenney, Emma; Dobson-Stone, Carol; Kwok, John B.; Hodges, John R.; Halliday, Glenda M.] Univ New S Wales, Sch Med Sci, Randwick, NSW, Australia; [Hodges, John R.; Hornberger, Michael] ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Kiernan, Matthew C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Hornberger, Michael] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; University of Cambridge	Hornberger, M (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.	m.hornberger@neura.edu.au	Hornberger, Michael/C-9610-2011; Halliday, Glenda M/E-8555-2011; Kiernan, Matthew C/E-4460-2011	Hornberger, Michael/0000-0002-2214-3788; Halliday, Glenda M/0000-0003-0422-8398; Kwok, John/0000-0001-9574-6195; Tan, Rachel/0000-0002-0385-4090; Kiernan, Matthew/0000-0001-9054-026X; Dobson-Stone, Carol/0000-0002-2211-0257	Motor Neurone Disease Research Institute of Australia (MNDRIA); Mick Rodger Benalla MND Research Grant; Ian Potter Foundation; National Health Medical Research Council [630440]; Australian Research Council [DP110104202, FF0776229]; NHMRC Program Grant [1037746]	Motor Neurone Disease Research Institute of Australia (MNDRIA); Mick Rodger Benalla MND Research Grant; Ian Potter Foundation; National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia)	R. H. T. gratefully acknowledges funding support from Motor Neurone Disease Research Institute of Australia (MNDRIA), the Mick Rodger Benalla MND Research Grant and The Ian Potter Foundation. G. M. H. is a NHMRC Senior Principal Research Fellow (#630434). M. K. is supported by the National Health Medical Research Council #630440. J. R. H. and M. H. are supported by the Australian Research Council (DP110104202 to M. H. and FF0776229 to J. R. H.). This research was performed under Forefront, a collaborative research partnership in Australia funded by the NHMRC Program Grant (#1037746). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MP, 2012, CORTEX, V48, P980, DOI 10.1016/j.cortex.2011.03.012; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Baillieux H, 2010, CORTEX, V46, P869, DOI 10.1016/j.cortex.2009.09.002; Bak TH, 2001, J NEUROL, V248, P260, DOI 10.1007/s004150170199; Balsters JH, 2011, J NEUROSCI, V31, P2305, DOI 10.1523/JNEUROSCI.4358-10.2011; Begeti F, 2013, J NEUROL, V260, P2777, DOI 10.1007/s00415-013-7061-5; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen ZY, 2010, AMYOTROPH LATERAL SC, V11, P549, DOI 10.3109/17482968.2010.516265; Clark CM, 2006, ARCH NEUROL-CHICAGO, V63, P489, DOI 10.1001/archneur.63.4.489; Dobson-Stone C, 2012, NEUROLOGY, V79, P995, DOI 10.1212/WNL.0b013e3182684634; Garibotto V, 2011, NEUROBIOL AGING, V32, P875, DOI 10.1016/j.neurobiolaging.2009.05.004; Giordano A, 2013, PARKINSONISM RELAT D, V19, P590, DOI 10.1016/j.parkreldis.2013.02.005; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hornberger M, 2012, HUM BRAIN MAPP; Irish M, 2013, NEUROIMAGE-CLIN, V2, P836, DOI 10.1016/j.nicl.2013.06.005; Irwin DJ, 2013, J NEUROL NEUROSUR PS, V84, P163, DOI 10.1136/jnnp-2012-303507; Josephs KA, 2006, ARCH NEUROL-CHICAGO, V63, P1632, DOI 10.1001/archneur.63.11.1632; Kanda T, 2008, EUR J NUCL MED MOL I, V35, P2227, DOI 10.1007/s00259-008-0871-5; Kassubek J, 2005, AMYOTROPH LATERAL SC, V6, P213, DOI 10.1080/14660820510038538; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Lauterbach EC, 2010, COGN BEHAV NEUROL, V23, P63, DOI 10.1097/WNN.0b013e3181cfb541; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Lillo P, 2010, ARCH NEUROL-CHICAGO, V67, P826, DOI 10.1001/archneurol.2010.146; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Mahoney CJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt144; McColgan P, 2012, MOVEMENT DISORD, V27, P1172, DOI 10.1002/mds.25084; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mioshi E, 2013, NEUROLOGY, V80, P1117, DOI 10.1212/WNL.0b013e31828869da; Mottolese C, 2013, BRAIN, V136, P330, DOI 10.1093/brain/aws186; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Halloran CJ, 2012, J CLIN EXP NEUROPSYC, V34, P35, DOI 10.1080/13803395.2011.614599; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Sbardella E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063250; Schmahmann JD, 2009, NEUROSCIENCE, V162, P852, DOI 10.1016/j.neuroscience.2009.06.023; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Senda J, 2011, AMYOTROPH LATERAL SC, V12, P59, DOI 10.3109/17482968.2010.517850; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Strong MJ, 2003, ANN NEUROL, V54, pS20, DOI 10.1002/ana.10574; Takada LT, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt141; Terpening Z, 2011, AUSTRALAS J AGEING, V30, P113, DOI 10.1111/j.1741-6612.2010.00446.x; Thivard L, 2007, J NEUROL NEUROSUR PS, V78, P889, DOI 10.1136/jnnp.2006.101758; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Villanueva R, 2012, PSYCHIAT RES, V198, P527, DOI 10.1016/j.psychres.2012.02.023; Wedderburn C, 2008, J NEUROL NEUROSUR PS, V79, P500, DOI 10.1136/jnnp.2007.122028; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001; Whitwell JL, 2009, BRAIN, V132, P2932, DOI 10.1093/brain/awp232; Whitwell JL, 2006, NEUROLOGY, V66, P102, DOI 10.1212/01.wnl.0000191395.69438.12; Yi Dong Seok, 2013, Dement. neuropsychol., V7, P75, DOI 10.1590/S1980-57642013DN70100012; Yoshida H, 2011, PSYCHIAT RES, V185, P211, DOI 10.1016/j.psychres.2009.06.012; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	72	69	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105632	10.1371/journal.pone.0105632	http://dx.doi.org/10.1371/journal.pone.0105632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144223	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000341106100102
J	Zheng, LH; Wu, LM; Yao, Y; Chen, WS; Bao, JR; Huang, W; Shi, R; Zhang, KJ; Zhang, S				Zheng, Li-hui; Wu, Ling-min; Yao, Yan; Chen, Wen-sheng; Bao, Jing-ru; Huang, Wen; Shi, Rui; Zhang, Kui-jun; Zhang, Shu			Impact of Body Mass Index on Plasma N-Terminal ProB-Type Natriuretic Peptides in Chinese Atrial Fibrillation Patients without Heart Failure	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; OBESITY; POPULATION; DISEASE; ADULTS; LEVEL; RISK; SIZE	Background: An inverse relationship between body mass index (BMI) and circulating levels of N-terminal proB-type natriuretic peptide (NT-proBNP) has been demonstrated in subjects with and without heart failure. Obesity also has been linked with increased incidence of atrial fibrillation (AF), but its influence on NT-proBNP concentrations in AF patients remains unclear. This study aimed to investigate the effect of BMI on NT-proBNP levels in AF patients without heart failure. Methods: A total of 239 consecutive patients with AF undergoing catheter ablation were evaluated. Levels of NT-proBNP and clinical characteristics were compared in overweight or obese (BMI >= 25 kg/m(2)) and normal weight (BMI<25 kg/m(2)) patients. Results: Of 239 patients, 129 (54%) were overweight or obese. Overweight or obese patients were younger, more likely to have a history of nonparoxysmal AF, hypertension, and diabetes mellitus. Levels of NT-proBNP were significantly lower in overweight or obese than in normal weight subjects (P<0.05). The relationship of obesity and decreased NT-proBNP levels persisted in subgroup of hypertension, both gender and both age levels (>= 65 yrs and <65 yrs). Multivariate linear regression identified BMI as an independent negative correlate of LogNT-proBNP level. Conclusions: An inverse relationship between BMI and plasma NT-proBNP concentrations have been demonstrated in AF patients without heart failure. Overweight or obese patients with AF appear to have lower NT-proBNP levels than normal weight patients.	[Zheng, Li-hui; Wu, Ling-min; Yao, Yan; Chen, Wen-sheng; Bao, Jing-ru; Huang, Wen; Shi, Rui; Zhang, Kui-jun; Zhang, Shu] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Clin EP Lab, Beijing 100730, Peoples R China; [Zheng, Li-hui; Wu, Ling-min; Yao, Yan; Chen, Wen-sheng; Bao, Jing-ru; Huang, Wen; Shi, Rui; Zhang, Kui-jun; Zhang, Shu] Chinese Acad Med Sci, Arrhythmia Ctr, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Zheng, Li-hui; Wu, Ling-min; Yao, Yan; Chen, Wen-sheng; Bao, Jing-ru; Huang, Wen; Shi, Rui; Zhang, Kui-jun; Zhang, Shu] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yao, Y (corresponding author), Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Clin EP Lab, Beijing 100730, Peoples R China.	ianyao@263.net.cn	Yao, Yan/AAL-3060-2020	Yao, Yan/0000-0002-4003-4323				Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Cortes R, 2008, AM J HYPERTENS, V21, P820, DOI 10.1038/ajh.2008.173; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1161/CIRCULATIONAHA.105.555573; Deftereos S, 2011, HEART, V97, P914, DOI 10.1136/hrt.2010.214742; den Uijl DW, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.031; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; Gibson PH, 2009, AM HEART J, V158, P244, DOI 10.1016/j.ahj.2009.04.026; Hense HW, 1998, J AM COLL CARDIOL, V32, P451, DOI 10.1016/S0735-1097(98)00240-X; Hong SN, 2008, INT HEART J, V49, P403, DOI 10.1536/ihj.49.403; Karthikeyan G, 2009, J AM COLL CARDIOL, V54, P1599, DOI 10.1016/j.jacc.2009.06.028; Krauser DG, 2005, AM HEART J, V149, P744, DOI 10.1016/j.ahj.2004.07.010; Lorgis L, 2011, HEART, V97, P551, DOI 10.1136/hrt.2010.213041; Malavazos AE, 2006, CLIN CHEM, V52, P1211, DOI 10.1373/clinchem.2006.067736; Mollmann H, 2008, CIRC J, V72, P921, DOI 10.1253/circj.72.921; Patton KK, 2009, CIRCULATION, V120, P1768, DOI 10.1161/CIRCULATIONAHA.109.873265; Raymond I, 2003, HEART, V89, P745, DOI 10.1136/heart.89.7.745; Rivera M, 2005, EUR J HEART FAIL, V7, P1168, DOI 10.1016/j.ejheart.2005.04.003; Rutten FH, 2007, EUR J HEART FAIL, V9, P651, DOI 10.1016/j.ejheart.2007.01.010; Sarzani R, 1996, J ENDOCRINOL INVEST, V19, P581; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Sugisawa T, 2010, ENDOCR J, V57, P727, DOI 10.1507/endocrj.K10E-067; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Zhou ZQ, 2003, CHIN J INTERN MED CH, V43, P491	26	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105249	10.1371/journal.pone.0105249	http://dx.doi.org/10.1371/journal.pone.0105249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144363	Green Submitted, gold, Green Published			2022-12-25	WOS:000341106100044
J	Bruschi, DP; Lucas, EM; Garcia, PCA; Recco-Pimentel, SM				Bruschi, Daniel P.; Lucas, Elaine M.; Garcia, Paulo C. A.; Recco-Pimentel, Shirlei M.			Molecular and Morphological Evidence Reveals a New Species in the Phyllomedusa hypochondrialis Group (Hylidae, Phyllomedusinae) from the Atlantic Forest of the Highlands of Southern Brazil	PLOS ONE			English	Article							NUCLEOLUS ORGANIZER REGIONS; LATE QUATERNARY VEGETATION; ARAUCARIA FOREST; CYTOGENETIC ANALYSIS; TAXONOMIC STATUS; ANURA; CONSERVATION; DIVERSITY; FROGS; AMPHIBIA	The taxonomic status of a disjunctive population of Phyllomedusa from southern Brazil was diagnosed using molecular, chromosomal, and morphological approaches, which resulted in the recognition of a new species of the P. hypochondrialis group. Here, we describe P. rustica sp. n. from the Atlantic Forest biome, found in natural highland grassland formations on a plateau in the south of Brazil. Phylogenetic inferences placed P. rustica sp. n. in a subclade that includes P. rhodei + all the highland species of the clade. Chromosomal morphology is conservative, supporting the inference of homologies among the karyotypes of the species of this genus. Phyllomedusa rustica is apparently restricted to its type-locality, and we discuss the potential impact on the strategies applied to the conservation of the natural grassland formations found within the Brazilian Atlantic Forest biome in southern Brazil. We suggest that conservation strategies should be modified to guarantee the preservation of this species.	[Bruschi, Daniel P.; Recco-Pimentel, Shirlei M.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Estrutural & Func, Sao Paulo, Brazil; [Lucas, Elaine M.] Univ Comunitaria Regiao Chapeco UNOCHAPECO, Area Ciencias Exatas & Ambientais Mestrado Cienci, Chapeco, SC, Brazil; [Garcia, Paulo C. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Comunitaria Regional de Chapeco; Universidade Federal de Minas Gerais	Bruschi, DP (corresponding author), Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Estrutural & Func, Sao Paulo, Brazil.	daniel_bruschi@hotmail.com	Garcia, Paulo/A-9983-2010	Garcia, Paulo/0000-0002-4789-7033	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/11300-7, 2010/17464-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grants 2010/11300-7 and 2010/17464-1), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for DPB scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeta D, 2009, ZOOTAXA, P58, DOI 10.11646/zootaxa.2226.1.5; Barrio-Amoros CL, 2006, ZOOTAXA, P55, DOI 10.11646/zootaxa.1309.1.5; Barth A, 2013, GEN MOL RES, V12, P2400; Barth A, 2009, J HERPETOL, V43, P676, DOI 10.1670/08-210.1; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Behling H, 1997, QUATERNARY RES, V48, P348, DOI 10.1006/qres.1997.1932; Behling H, 2004, PALAEOGEOGR PALAEOCL, V203, P277, DOI 10.1016/S0031-0182(03)00687-4; Behling H, 1997, REV PALAEOBOT PALYNO, V97, P109, DOI 10.1016/S0034-6667(96)00065-6; Behling H, 2007, PHILOS T R SOC B, V362, P243, DOI 10.1098/rstb.2006.1984; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brandao RA, 2009, ZOOTAXA, P61, DOI 10.11646/zootaxa.2044.1.4; Bruschi DP, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-70; Bruschi DP, 2012, HEREDITAS, V149, P34, DOI 10.1111/j.1601-5223.2010.02236.x; CANNATELLA DC, 1982, COPEIA, P501, DOI 10.2307/1444649; Caramaschi U, 2007, B MUS NAC, V524, P1; Caramaschi Ulisses, 2006, Arquivos do Museu Nacional Rio de Janeiro, V64, P159; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Costa LP, 2000, BIOTROPICA, V32, P872; da Silva JMC, 2004, GLOBAL ECOL BIOGEOGR, V13, P85, DOI 10.1111/j.1466-882X.2004.00077.x; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; Duellman William E., 2005, pi; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2011, J MORPHOL, V272, P354, DOI 10.1002/jmor.10919; Faivovich J, 2010, CLADISTICS, V26, P227, DOI 10.1111/j.1096-0031.2009.00287.x; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2013, MOL PHYLOGENET EVOL, V67, P445, DOI 10.1016/j.ympev.2013.02.009; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Frost D. R., 2014, AMPHIBIAN SPECIES WO; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Fusinatto LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079504; Garcia PCA, 2003, HERPETOLOGICA, V59, P350, DOI 10.1655/01-54; GATESY J, 1993, MOL PHYLOGENET EVOL, V2, P152, DOI 10.1006/mpev.1993.1015; Gehara M, 2013, CONSERV GENET, V14, P973, DOI 10.1007/s10592-013-0488-5; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Giaretta Ariovaldo A., 2007, Zootaxa, V1614, P31; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Goloboff P.A., 2003, T N T TREE ANAL USIN; Green D. M, 1991, AMPHIBIAN CYTOGENETI, P431, DOI [DOI 10.1016/B978-0-12-297880-7.50021-4, 10.1016/B978-0-12-297880-7.50021-4]; Gruber SL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-75; Hall T, 1999, BIOEDIT; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Jansen M, 2011, ZOOL SCR, V40, P567, DOI 10.1111/j.1463-6409.2011.00498.x; Jungfer KH, 2013, ZOOL SCR, V42, P351, DOI 10.1111/zsc.12015; KING M, 1976, CHROMOSOMA, V54, P75, DOI 10.1007/BF00331835; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Loyola RD, 2008, DIVERS DISTRIB, V14, P949, DOI 10.1111/j.1472-4642.2008.00508.x; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Lucas Elaine M., 2010, Check List, V6, P164; Maack V, 1981, GEOGRAFIA FISICA EST; McLeod DS, 2010, MOL PHYLOGENET EVOL, V56, P991, DOI 10.1016/j.ympev.2010.04.004; MEUNIERROTIVAL M, 1979, NUCLEIC ACIDS RES, V6, P2109, DOI 10.1093/nar/6.6.2109; Morand Mariana, 1997, Cuadernos de Herpetologia, V11, P31; MYERS C W, 1982, American Museum Novitates, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Napoli MF, 2005, HERPETOLOGICA, V61, P63, DOI 10.1655/03-41; Nylander J. A. A., 2004, MRMODELTEST V2; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Overbeck SCM, 2009, CAMPOS SULINOS CONSE; Paiva CR, 2010, ITAL J ZOOL, V77, P116, DOI 10.1080/11250000903187585; Pombal-Jr Jose P., 1992, Revista Brasileira de Biologia, V52, P217; Rambaut A, 2014, TRACER V1 6; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Tonini JFR, 2013, J ZOOL SYST EVOL RES, V51, P114, DOI 10.1111/jzs.12014; Rolland Jonathan, 2012, Biol Lett, V8, P692, DOI 10.1098/rsbl.2011.1024; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savage J. M., 1967, BEITR NEOTROP FAUNA, V5, P111, DOI DOI 10.1080/01650526709360400; SCHMID M, 1978, CHROMOSOMA, V66, P361, DOI 10.1007/BF00328536; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teixeira M, 2013, ZOOTAXA, V3702, P459, DOI 10.11646/zootaxa.3702.5.5; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toledo LF, 2010, J NAT HIST, V44, P1979, DOI 10.1080/00222931003624804; Viegas-Pequignot E, 1992, IN SITU HYBRIDIZATIO, P137	81	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105608	10.1371/journal.pone.0105608	http://dx.doi.org/10.1371/journal.pone.0105608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141279	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200115
J	Shen, YX; Liu, WL; Li, YH; Guan, HL				Shen, You-xin; Liu, Wei-li; Li, Yu-hui; Guan, Hui-lin			Large Sample Area and Size Are Needed for Forest Soil Seed Bank Studies to Ensure Low Discrepancy with Standing Vegetation	PLOS ONE			English	Article							SPECIES-AREA; RAIN-FORESTS; DENSITY; COMMUNITIES; RICHNESS	A large number of small-sized samples invariably shows that woody species are absent from forest soil seed banks, leading to a large discrepancy with the seedling bank on the forest floor. We ask: 1) Does this conventional sampling strategy limit the detection of seeds of woody species? 2) Are large sample areas and sample sizes needed for higher recovery of seeds of woody species? We collected 100 samples that were 10 cm (length) x10 cm (width) x10 cm (depth), referred to as larger number of small-sized samples (LNSS) in a 1 ha forest plot, and placed them to germinate in a greenhouse, and collected 30 samples that were 1 m x 1 m x10 cm, referred to as small number of large-sized samples (SNLS) and placed them (10 each) in a nearby secondary forest, shrub land and grass land. Only 15.7% of woody plant species of the forest stand were detected by the 100 LNSS, contrasting with 22.9%, 37.3% and 20.5% woody plant species being detected by SNLS in the secondary forest, shrub land and grassland, respectively. The increased number of species vs. sampled areas confirmed power-law relationships for forest stand, the LNSS and SNLS at all three recipient sites. Our results, although based on one forest, indicate that conventional LNSS did not yield a high percentage of detection for woody species, but SNLS strategy yielded a higher percentage of detection for woody species in the seed bank if samples were exposed to a better field germination environment. A 4 m(2) minimum sample area derived from power equations is larger than the sampled area in most studies in the literature. Increased sample size also is needed to obtain an increased sample area if the number of samples is to remain relatively low.	[Shen, You-xin] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun, Yunnan, Peoples R China; [Shen, You-xin] Chinese Acad Sci, Restorat Ecol Grp, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Liu, Wei-li] Kunming Met Res Inst, Kunming, Peoples R China; [Li, Yu-hui; Guan, Hui-lin] Yunnan Normal Univ, Kunming, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Normal University	Shen, YX (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun, Yunnan, Peoples R China.	yxshen@xtbg.ac.cn			"Light in Western China" Program of Chinese Academy of Sciences; National Nature Scientific Foundation of China [41262013, 41371514, 41361075]	"Light in Western China" Program of Chinese Academy of Sciences; National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by grants from the "Light in Western China" Program of Chinese Academy of Sciences and the National Nature Scientific Foundation of China (41262013, 41371514, 41361075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BIGWOOD DW, 1988, ECOLOGY, V69, P497, DOI 10.2307/1940448; Bossuyt B, 2000, FUNCT ECOL, V14, P766, DOI 10.1046/j.1365-2435.2000.00483.x; Bossuyt B, 2008, J VEG SCI, V19, P875, DOI 10.3170/2008-8-18462; Butler BJ, 1998, BIOTROPICA, V30, P214, DOI 10.1111/j.1744-7429.1998.tb00056.x; CAIN STANLEY A., 1938, AMER MIDI NAT, V19, P573, DOI 10.2307/2420468; Cannone N, 2004, ANTARCT SCI, V16, P157, DOI 10.1017/S0954102004001956; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2013, ESTIMATES STAT ESTIM; Dainou K, 2011, ECOL ENG, V37, P1499, DOI 10.1016/j.ecoleng.2011.05.004; Darwin C., 1859, ORIGIN SPECIES MEANS; DENSLOW JS, 1995, ECOL APPL, V5, P962, DOI 10.2307/2269347; Du XJ, 2007, FOREST ECOL MANAG, V238, P212, DOI 10.1016/j.foreco.2006.10.018; Dupuy JM, 1998, BIOTROPICA, V30, P223, DOI 10.1111/j.1744-7429.1998.tb00057.x; Esmailzadeh O, 2011, J AGR SCI TECH-IRAN, V13, P411; Ferner M, 2005, ECOLOGY SEEDS; FORCELLA F, 1984, AUST J AGR RES, V35, P645, DOI 10.1071/AR9840645; Forey E, 2012, COMMUNITY ECOL, V13, P194, DOI 10.1556/ComEc.13.2012.2.9; Garcia-Orth X, 2008, RESTOR ECOL, V16, P435, DOI 10.1111/j.1526-100X.2007.00320.x; Garwood N.C., 1989, ECOLOGY SOIL SEED BA, V1, P149, DOI DOI 10.1016/B978-0-12-440405-2.50014-2; GROSS KL, 1990, J ECOL, V78, P1079, DOI 10.2307/2260953; He FL, 1996, AM NAT, V148, P719, DOI 10.1086/285950; Hopfensperger KN, 2007, OIKOS, V116, P1438, DOI [10.1111/j.2007.0030-1299.15818.x, 10.1111/j.0030-1299.2007.15818.x]; Jin Z., 1998, VEGETATION KUNMING; Pereira-Diniz SG, 2006, PLANT ECOL, V183, P337, DOI 10.1007/s11258-005-9044-9; Plue J, 2012, J VEG SCI, V23, P505, DOI 10.1111/j.1654-1103.2011.01361.x; Plue J, 2010, SEED SCI RES, V20, P13, DOI 10.1017/S0960258509990201; Shen YX, 2007, SEED SCI RES, V17, P99, DOI 10.1017/S0960258507708139; [沈有信 Shen Youxin], 2005, [广西植物, Guihaia], V25, P321; Storch D, 2012, NATURE, V488, P78, DOI 10.1038/nature11226; TerHeerdt GNJ, 1996, FUNCT ECOL, V10, P144, DOI 10.2307/2390273; Thompson K., 2000, Seeds: the ecology of regeneration in plant communities, P215, DOI 10.1079/9780851994321.0215; Triantis KA, 2012, J BIOGEOGR, V39, P215, DOI 10.1111/j.1365-2699.2011.02652.x; Wu, 1980, VEGETATION CHINA; Zhang F.M., 1997, STUDY LUNAN STONE FO	37	6	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105235	10.1371/journal.pone.0105235	http://dx.doi.org/10.1371/journal.pone.0105235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140738	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200065
J	Goncalves, VL; Vicente, JB; Pinto, L; Romao, CV; Frazao, C; Sarti, P; Giuffre, A; Teixeira, M				Goncalves, Vera L.; Vicente, Joao B.; Pinto, Liliana; Romao, Celia V.; Frazao, Carlos; Sarti, Paolo; Giuffre, Alessandro; Teixeira, Miguel			Flavodiiron Oxygen Reductase from Entamoeba histolytica MODULATION OF SUBSTRATE PREFERENCE BY TYROSINE 271 AND LYSINE 53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE REDUCTASE; FLAVO-DIIRON PROTEIN; ESCHERICHIA-COLI FLAVORUBREDOXIN; PARASITE GIARDIA-INTESTINALIS; ENTERICA SEROVAR TYPHIMURIUM; CYTOCHROME-C-OXIDASE; MOORELLA-THERMOACETICA; ENTAMOEBA-HISTOLYTICA; DESULFOVIBRIO-GIGAS; ACTIVE-SITE	Flavodiiron proteins (FDPs) are a family of enzymes endowed with bona fide oxygen- and/or nitric-oxide reductase activity, although their substrate specificity determinants remain elusive. After a comprehensive comparison of available three-dimensional structures, particularly of FDPs with a clear preference toward either O-2 or NO, two main differences were identified near the diiron active site, which led to the construction of site-directed mutants of Tyr(271) and Lys(53) in the oxygen reducing Entamoeba histolytica EhFdp1. The biochemical and biophysical properties of these mutants were studied by UV-visible and electron paramagnetic resonance (EPR) spectroscopies coupled to potentiometry. Their reactivity with O-2 and NO was analyzed by stopped-flow absorption spectroscopy and amperometric methods. These mutations, whereas keeping the overall properties of the redox cofactors, resulted in increased NO reductase activity and faster inactivation of the enzyme in the reaction with O-2, pointing to a role of the mutated residues in substrate selectivity.	[Goncalves, Vera L.; Pinto, Liliana; Romao, Celia V.; Frazao, Carlos; Teixeira, Miguel] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2781901 Oeiras, Portugal; [Goncalves, Vera L.; Vicente, Joao B.] Univ Lisbon, Res Inst Med iMed ULisboa, Metab & Genet Grp, Fac Pharm, P-1649003 Lisbon, Portugal; [Vicente, Joao B.] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1649003 Lisbon, Portugal; [Sarti, Paolo] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Sarti, Paolo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Sarti, Paolo; Giuffre, Alessandro] CNR, Inst Biol Mol Med & Nanobiotechnol, I-00185 Rome, Italy	Universidade Nova de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR)	Vicente, JB (corresponding author), Univ Lisbon, Inst Med & Pharmaceut Sci iMed ULisboa, Metab & Genet Grp, Ave Prof Gama Pinto, P-1649003 Lisbon, Portugal.	joaovicente@ff.ul.pt; miguel@itqb.unl.pt	Romao, Celia V/G-7013-2011; Giuffrè, Alessandro/K-4341-2015; Teixeira, Miguel/A-9098-2011; Teixeira, Miguel/M-1509-2019; Vicente, Joao B/L-8732-2016; iMed.ULisboa, MetGen/B-5293-2014; Frazao, Carlos/C-1965-2008	Romao, Celia V/0000-0002-9474-2405; Giuffrè, Alessandro/0000-0001-5301-0681; Teixeira, Miguel/0000-0003-4124-6237; Teixeira, Miguel/0000-0003-4124-6237; Frazao, Carlos/0000-0002-7725-1671; Vicente, Joao/0000-0001-5244-8059; Sarti, Paolo/0000-0002-8219-4827	Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/QUI-BIQ/111080/2009, PTDC/SAU-MIC/111447/2009]; Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PNR-CNR Aging Program) [PTDC/QUI-BIQ/111080/2009, PTDC/SAU-MIC/111447/2009, SFRH/BPD/94050/2013]; Fondo per gli Investimenti della Ricerca di Base [RBIN06E9Z8, PRIN 20107Z8XBW_005]; Fundacao para a Ciencia e Tecnologia-Consiglio Nazionale delle Ricerche Portugal-Italy bilateral project; Federation of the European Biochemical Societies	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PNR-CNR Aging Program); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Fundacao para a Ciencia e Tecnologia-Consiglio Nazionale delle Ricerche Portugal-Italy bilateral project; Federation of the European Biochemical Societies	This work was supported by the Portuguese Fundacao para a Ciencia e Tecnologia project Grants PTDC/QUI-BIQ/111080/2009 and PTDC/SAU-MIC/111447/2009 (to J. B. V. and M. T.), Grants SFRH/BPD/94050/2013 (to C. V. R.), PEST-OE/EQB/LA0004/2013, PEST-OE/SAU/UI4013/2011 from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PNR-CNR Aging Program 2012-2014 (to A. G.), Fondo per gli Investimenti della Ricerca di Base Grants RBIN06E9Z8 and PRIN 20107Z8XBW_005 (to P. S.), and grants from the Fundacao para a Ciencia e Tecnologia-Consiglio Nazionale delle Ricerche Portugal-Italy bilateral project (to A. G. and M. T.), and a Federation of the European Biochemical Societies short-term fellowship (to J. B. V.).	Allahverdiyeva Y, 2011, J BIOL CHEM, V286, P24007, DOI 10.1074/jbc.M111.223289; Baptista JM, 2012, J BACTERIOL, V194, P3611, DOI 10.1128/JB.00140-12; Beckman JS, 1996, METHODS NITRIC OXIDE, P61; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Caranto JD, 2014, J AM CHEM SOC, V136, P7981, DOI 10.1021/ja5022443; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Di Matteo A, 2008, J BIOL CHEM, V283, P4061, DOI 10.1074/jbc.M705605200; Ducluzeau AL, 2009, TRENDS BIOCHEM SCI, V34, P9, DOI 10.1016/j.tibs.2008.10.005; Ermakova M, 2013, FEBS LETT, V587, P82, DOI 10.1016/j.febslet.2012.11.006; Fang H, 2012, J BIOL INORG CHEM, V17, P1231, DOI 10.1007/s00775-012-0938-4; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Gomes CM, 2000, BIOCHEMISTRY-US, V39, P16230, DOI 10.1021/bi001844y; Goncalves VL, 2011, BIOENERGETIC PROCESSES OF CYANOBACTERIA: FROM EVOLUTIONARY SINGULARITY TO ECOLOGICAL DIVERSITY, P631, DOI 10.1007/978-94-007-0388-9_22; Goncalves VL, 2011, BIOCHEM SOC T, V39, P216, DOI 10.1042/BST0390216; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; HOSLER JP, 1995, BIOCHEMISTRY-US, V34, P7586, DOI 10.1021/bi00023a004; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; Kurtz DM, 2007, DALTON T, P4115, DOI 10.1039/b710047g; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Mills PC, 2008, MICROBIOL-SGM, V154, P1218, DOI 10.1099/mic.0.2007/014290-0; Mills PC, 2005, BIOCHEM SOC T, V33, P198, DOI 10.1042/BST0330198; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Pfitzner U, 1998, J BIOENERG BIOMEMBR, V30, P89, DOI 10.1023/A:1020515713103; Rodrigues R, 2006, J BACTERIOL, V188, P2745, DOI 10.1128/JB.188.8.2745-2751.2006; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saraiva LM, 2004, ADV MICROB PHYSIOL, V49, P77, DOI 10.1016/S0065-2911(04)49002-X; Seedorf H, 2007, FEBS J, V274, P1588, DOI 10.1111/j.1742-4658.2007.05706.x; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P6492, DOI 10.1021/bi0473049; Silaghi-Dumitrescu R, 2003, BIOCHEMISTRY-US, V42, P2806, DOI 10.1021/bi027253k; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P3572, DOI 10.1021/bi0477337; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smutna T, 2009, EUKARYOT CELL, V8, P47, DOI 10.1128/EC.00276-08; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; SUSIN S, 1993, J BIOL CHEM, V268, P20958; Thomas D. D., 2010, NITRIC OXIDE BIOL PA, P3; Vicente J. B., 2011, ENCY INORGANIC BIOIN, P1; Vicente JB, 2005, J BIOL CHEM, V280, P34599, DOI 10.1074/jbc.M506349200; Vicente JB, 2008, METHOD ENZYMOL, V437, P47, DOI 10.1016/S0076-6879(07)37003-1; Vicente JB, 2008, METHOD ENZYMOL, V437, P21, DOI 10.1016/S0076-6879(07)37002-X; Vicente JB, 2008, METHOD ENZYMOL, V437, P3, DOI 10.1016/S0076-6879(07)37001-8; Vicente JB, 2012, EUKARYOT CELL, V11, P1112, DOI 10.1128/EC.00149-12; Vicente JB, 2009, ARCH BIOCHEM BIOPHYS, V488, P9, DOI 10.1016/j.abb.2009.06.011; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Zhang PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005331; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	50	16	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28260	28270		10.1074/jbc.M114.579086	http://dx.doi.org/10.1074/jbc.M114.579086			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25151360	hybrid, Green Published			2022-12-25	WOS:000343765400022
J	Kent, ST; Shimbo, D; Huang, L; Diaz, KM; Kilgore, ML; Oparil, S; Muntner, P				Kent, Shia T.; Shimbo, Daichi; Huang, Lei; Diaz, Keith M.; Kilgore, Meredith L.; Oparil, Suzanne; Muntner, Paul			Antihypertensive Medication Classes Used among Medicare Beneficiaries Initiating Treatment in 2007-2010	PLOS ONE			English	Article							JOINT NATIONAL COMMITTEE; LIPID-LOWERING TREATMENT; NEWLY TREATED PATIENTS; HEART-ATTACK TRIAL; HYPERTENSION CONTROL; 7TH REPORT; PREVENTION; DISEASE; ADULTS; HEALTH	Background: After the 2003 publication of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines, there was a 5-10% increase in patients initiating antihypertensive medication with a thiazide-type diuretic, but most patients still did not initiate treatment with this class. There are few contemporary published data on antihypertensive medication classes filled by patients initiating treatment. Methods and Findings: We used the 5% random Medicare sample to study the initiation of antihypertensive medication between 2007 and 2010. Initiation was defined by the first antihypertensive medication fill preceded by 365 days with no antihypertensive medication fills. We restricted our analysis to beneficiaries >= 65 years who had two or more outpatient visits with a hypertension diagnosis and full Medicare fee-for-service coverage for the 365 days prior to initiation of antihypertensive medication. Between 2007 and 2010, 32,142 beneficiaries in the 5% Medicare sample initiated antihypertensive medication. Initiation with a thiazide-type diuretic decreased from 19.2% in 2007 to 17.9% in 2010. No other changes in medication classes initiated occurred over this period. Among those initiating antihypertensive medication in 2010, 31.3% filled angiotensin-converting enzyme inhibitors (ACE-Is), 26.9% filled beta blockers, 17.2% filled calcium channel blockers, and 14.4% filled angiotensin receptor blockers (ARBs). Initiation with >1 antihypertensive medication class decreased from 25.6% in 2007 to 24.1% in 2010. Patients initiated >1 antihypertensive medication class most commonly with a thiazide-type diuretic and either an ACE-I or ARB. Conclusion: These results suggest that JNC 7 had a limited long-term impact on the choice of antihypertensive medication class and provide baseline data prior to the publication of the 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).	[Kent, Shia T.; Huang, Lei; Muntner, Paul] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Shimbo, Daichi; Diaz, Keith M.] Columbia Univ, Dept Med, Med Ctr, Ctr Behav Cardiovasc Hlth, New York, NY USA; [Kilgore, Meredith L.] Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL USA; [Oparil, Suzanne; Muntner, Paul] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Columbia University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kent, ST (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.	shia@uab.edu		Diaz, Keith/0000-0003-0190-0548	National Heart, Lung, and Blood Institute (NHLBI) [T32-HL007457-33]; NHLBI program [P01-HL047540]; NHLBI Diversity Supplement [P01-HL047540-19S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007457, P01HL047540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI Diversity Supplement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	STK was supported by a National Heart, Lung, and Blood Institute (NHLBI) training grant (T32-HL007457-33). DS was supported by an NHLBI program grant (P01-HL047540). KMD was supported by a NHLBI Diversity Supplement (P01-HL047540-19S1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Berndt ER, 2011, INT J ECON BUS, V18, P177, DOI 10.1080/13571516.2011.584423; Bien BY, 2010, J MANAGE CARE PHARM, V16, P671, DOI 10.18553/jmcp.2010.16.9.671; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; Carson AP, 2011, HYPERTENSION, V57, P1101, DOI 10.1161/HYPERTENSIONAHA.110.168005; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Egan BM, 2012, HYPERTENSION, V59, P1124, DOI 10.1161/HYPERTENSIONAHA.112.194167; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2013, JAMA            1218; Krousel-Wood M, 2012, J CLIN HYPERTENS, V14, P277, DOI 10.1111/j.1751-7176.2012.00609.x; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Malacco E, 2003, BLOOD PRESSURE, V12, P160, DOI 10.1080/08037050310009545; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Muntner P, 2009, HYPERTENSION, V53, P617, DOI 10.1161/HYPERTENSIONAHA.108.120154; Player Marty S, 2006, J Clin Hypertens (Greenwich), V8, P860, DOI 10.1111/j.1524-6175.2006.05781.x; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Xie FG, 2005, AM J HYPERTENS, V18, P464, DOI 10.1016/j.amjhyper.2004.11.004; Yun HF, 2013, PHARMACOEPIDEM DR S, V22, P55, DOI 10.1002/pds.3361	23	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105888	10.1371/journal.pone.0105888	http://dx.doi.org/10.1371/journal.pone.0105888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153199	Green Published, gold			2022-12-25	WOS:000340952200089
J	Klumbies, E; Braeuer, D; Hoyer, J; Kirschbaum, C				Klumbies, Elisabeth; Braeuer, David; Hoyer, Juergen; Kirschbaum, Clemens			The Reaction to Social Stress in Social Phobia: Discordance between Physiological and Subjective Parameters	PLOS ONE			English	Article							SALIVARY CORTISOL-LEVELS; URINARY FREE CORTISOL; PSYCHOSOCIAL STRESS; ALPHA-AMYLASE; PSYCHOLOGICAL STRESSOR; ANXIETY SENSITIVITY; YOUNGER ADULTS; ELDERLY ADULTS; AXIS RESPONSE; HAIR CORTISOL	Background: Research on the biopsychological background of social phobia (SP) is scarce and inconsistent. We investigated endocrine and autonomic markers along with subjective responses to a standardized stress situation (Trier Social Stress Test, TSST) in SP patients and healthy controls (HC). Methods: We examined 88 patients with the primary diagnosis of SP as well as 78 age and sex comparable HCs with the TSST. Blood and saliva samples were obtained before and after the TSST for the assessment of salivary cortisol, plasma cortisol, salivary alpha-amylase (sAA), and prolactin. Heart rate (HR) and heart rate variability (HRV) were recorded continuously. Scalp-near hair samples were collected for the assessment of long-term cortisol secretion. The self-reported stress response was measured with different state and trait scales. Results: While self-reported anxiety was elevated in SP before, during, immediately after, and one week after the TSST, no significant differences in biological stress responses were observed between SP and HC. There was a trend for SP to show higher baseline stress markers. Also long-term cortisol deposition in hair remained unaltered. Conclusions: Our results suggest that the excessive self-reported stress in SP is not reflected by a respective biological stress response. Patients with SP apparently show neither an extreme form of focused fear reactivity nor excessive defensive impairment.	[Klumbies, Elisabeth; Kirschbaum, Clemens] Tech Univ Dresden, Inst Biopsychol, D-01062 Dresden, Germany; [Braeuer, David; Hoyer, Juergen] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Klumbies, E (corresponding author), Tech Univ Dresden, Inst Biopsychol, D-01062 Dresden, Germany.	klumbies@biopsych.tu-dresden.de	Hoyer, Juergen/D-3619-2011; Hoyer, Juergen/AAP-6071-2020; Kirschbaum, Clemens/AAB-1752-2020	Hoyer, Juergen/0000-0002-1697-6732; Hoyer, Juergen/0000-0002-1697-6732; 	Deutsche Forschungsgemeinschaft [KI 537/26-1, HO1900/6-1]; Evangelisches Studienwerk eV Villigst	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evangelisches Studienwerk eV Villigst	This work was supported by grants from the Deutsche Forschungsgemeinschaft (KI 537/26-1 and HO1900/6-1) and a scholarship from Evangelisches Studienwerk eV Villigst to EK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson ER, 2009, J ANXIETY DISORD, V23, P18, DOI 10.1016/j.janxdis.2008.03.011; Beaton EA, 2006, PERS INDIV DIFFER, V41, P1217, DOI 10.1016/j.paid.2006.02.020; BEATTY MJ, 1991, HUM COMMUN RES, V18, P147, DOI 10.1111/j.1468-2958.1991.tb00542.x; BEIDEL DC, 1985, BEHAV RES THER, V23, P109, DOI 10.1016/0005-7967(85)90019-1; Camm AJ, 1996, CIRCULATION, V93, P1043; Chong RY, 2008, PSYCHONEUROENDOCRINO, V33, P246, DOI 10.1016/j.psyneuen.2007.10.014; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO, P69, DOI DOI 10.1017/S1352465808004487; Condren RM, 2002, PSYCHONEUROENDOCRINO, V27, P693, DOI 10.1016/S0306-4530(01)00070-1; Edelmann RJ, 2002, BRIT J CLIN PSYCHOL, V41, P1, DOI 10.1348/014466502163732; Fehm L, 2005, EUR NEUROPSYCHOPHARM, V15, P453, DOI 10.1016/j.euroneuro.2005.04.002; Fehm L, 2008, ANXIETY STRESS COPIN, V21, P129, DOI 10.1080/10615800701424672; Furlan PM, 2001, BIOL PSYCHIAT, V50, P254, DOI 10.1016/S0006-3223(00)01126-4; Fydrich T., 2002, DIAGNOSTISCHE VERFAH, P335; Gaab J, 2005, PSYCHONEUROENDOCRINO, V30, P599, DOI 10.1016/j.psyneuen.2005.02.001; Gentle J. E., 2004, HDB COMPUTATIONAL ST; Gerlach AL, 2003, J ANXIETY DISORD, V17, P197, DOI 10.1016/S0887-6185(02)00197-4; Gerlach AL, 2001, J ABNORM PSYCHOL, V110, P247, DOI 10.1037/0021-843X.110.2.247; Gerra G, 2001, PSYCHONEUROENDOCRINO, V26, P91, DOI 10.1016/S0306-4530(00)00046-9; Grossman P, 2001, PSYCHOSOM MED, V63, P765, DOI 10.1097/00006842-200109000-00010; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Heiser NA, 2009, J ANXIETY DISORD, V23, P469, DOI 10.1016/j.janxdis.2008.10.002; Kessler RC, 2003, ACTA PSYCHIAT SCAND, V108, P19, DOI 10.1034/j.1600-0447.108.s417.2.x; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kramer M, 2012, J ABNORM CHILD PSYCH, V40, P95, DOI 10.1007/s10802-011-9548-9; Kudielka B. M., 2007, 10 YEARS RES TRIER S; Kudielka BM, 2004, INT J BEHAV MED, V11, P116, DOI 10.1207/s15327558ijbm1102_8; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P83, DOI 10.1016/S0306-4530(02)00146-4; Lang PJ, 2009, ANXIETY STRESS COPIN, V22, P5, DOI 10.1080/10615800802478247; Laux L., 1981, STATE TRAIT ANGSTINV; Lennartsson AK, 2011, PSYCHONEUROENDOCRINO, V36, P1530, DOI 10.1016/j.psyneuen.2011.04.007; LEVIN AP, 1993, J ANXIETY DISORD, V7, P207, DOI 10.1016/0887-6185(93)90003-4; Lorberbaum JP, 2004, NEUROREPORT, V15, P2701; Martel FL, 1999, DEPRESS ANXIETY, V10, P25, DOI 10.1002/(SICI)1520-6394(1999)10:1<25::AID-DA4>3.0.CO;2-O; Penttila J, 2001, CLIN PHYSIOL, V21, P365, DOI 10.1046/j.1365-2281.2001.00337.x; POTTS NLS, 1991, J CLIN PSYCHIAT, V52, P41; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Roelofs K, 2009, BIOL PSYCHIAT, V65, P336, DOI 10.1016/j.biopsych.2008.08.022; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Ruscio AM, 2008, PSYCHOL MED, V38, P15, DOI 10.1017/S0033291707001699; Schmitz J, 2011, J CHILD PSYCHOL PSYC, V52, P1203, DOI 10.1111/j.1469-7610.2011.02417.x; Stalder T, 2012, PSYCHONEUROENDOCRINO, V37, P602, DOI 10.1016/j.psyneuen.2011.08.007; Stangier U., 2005, INT SKALEN F R PSYCH, P299; Steudte S, 2013, BIOL PSYCHIAT, V74, P639, DOI 10.1016/j.biopsych.2013.03.011; Steyer, 1997, MEHRDIMENSIONALE BEF; Strahler J, 2010, PSYCHOPHYSIOLOGY, V47, P587, DOI 10.1111/j.1469-8986.2009.00957.x; Thibodeau MA, 2012, J BEHAV THER EXP PSY, V43, P967, DOI 10.1016/j.jbtep.2012.03.001; UHDE TW, 1994, J AFFECT DISORDERS, V30, P155, DOI 10.1016/0165-0327(94)90076-0; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Veen JF, 2008, PSYCHONEUROENDOCRINO, V33, P1313, DOI 10.1016/j.psyneuen.2008.07.004; van West D, 2008, J AFFECT DISORDERS, V111, P281, DOI 10.1016/j.jad.2008.03.006; Wennig R, 2000, FORENSIC SCI INT, V107, P5, DOI 10.1016/S0379-0738(99)00146-2; WEYERS P, 1995, PERS INDIV DIFFER, V19, P853, DOI 10.1016/S0191-8869(95)00128-X; Wittchen H-U, 1997, INFORMATIONSMATERIAL; Wittchen HU., 1997, DIA X SCREENING VERF; Yoon KL, 2012, J ABNORM PSYCHOL, V121, P250, DOI 10.1037/a0025079	57	51	52	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105670	10.1371/journal.pone.0105670	http://dx.doi.org/10.1371/journal.pone.0105670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153526	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200067
J	Lopez, Y; Vandenbon, A; Nakai, K				Lopez, Yosvany; Vandenbon, Alexis; Nakai, Kenta			A Set of Structural Features Defines the Cis-Regulatory Modules of Antenna-Expressed Genes in Drosophila melanogaster	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; RNA-SEQ; PROTEIN; IDENTIFICATION; MOTIFS; DISCOVERY; PATTERNS; SEQUENCE; GENOMES; DNA	Unraveling the biological information within the regulatory region (RR) of genes has become one of the major focuses of current genomic research. It has been hypothesized that RRs of co-expressed genes share similar architecture, but to the best of our knowledge, no studies have simultaneously examined multiple structural features, such as positioning of cis-regulatory elements relative to transcription start sites and to each other, and the order and orientation of regulatory motifs, to accurately describe overall cis-regulatory structure. In our work we present an improved computational method that builds a feature collection based on all of these structural features. We demonstrate the utility of this approach by modeling the cis-regulatory modules of antenna-expressed genes in Drosophila melanogaster. Six potential antenna-related motifs were predicted initially, including three that appeared to be novel. A feature set was created with the predicted motifs, where a correlation-based filter was used to remove irrelevant features, and a genetic algorithm was designed to optimize the feature set. Finally, a set of eight highly informative structural features was obtained for the RRs of antenna-expressed genes, achieving an area under the curve of 0.841. We used these features to score all D. melanogaster RRs for potentially unknown antenna-expressed genes sharing a similar regulatory structure. Validation of our predictions with an independent RNA sequencing dataset showed that 76.7% of genes with high scoring RRs were expressed in antenna. In addition, we found that the structural features we identified are highly conserved in RRs of orthologs in other Drosophila sibling species. This approach to identify tissue-specific regulatory structures showed comparable performance to previous approaches, but also uncovered additional interesting features because it also considered the order and orientation of motifs.	[Lopez, Yosvany] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Chiba, Japan; [Lopez, Yosvany; Nakai, Kenta] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Tokyo, Japan; [Vandenbon, Alexis] Osaka Univ, Immunol Frontier Res Ctr, Osaka, Japan	University of Tokyo; University of Tokyo; Osaka University	Nakai, K (corresponding author), Univ Tokyo, Ctr Human Genome, Inst Med Sci, Tokyo, Japan.	knakai@ims.u-tokyo.ac.jp	Nakai, Kenta/B-7293-2009; Vandenbon, Alexis/A-8430-2017; Vandenbon, Alexis/N-4428-2019	Nakai, Kenta/0000-0002-8721-8883; Lopez, Yosvany/0000-0002-9550-0053	JSPS [25290067]; MEXT scholarship	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT scholarship	This work was partly supported by Grants-in-Aid for Scientific Research from JSPS (25290067). Yosvany Lopez thanks the support of the MEXT scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bajic VB, 2003, SILICO BIOL, V4, P1; Biryukova I, 2008, DEV BIOL, V323, P64, DOI 10.1016/j.ydbio.2008.08.014; Bodai L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040565; Boyle SM, 2013, ELIFE, V2, DOI 10.7554/eLife.01120; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fujisawa K, 2009, COMP BIOCHEM PHYS B, V153, P29, DOI 10.1016/j.cbpb.2009.01.006; Fuller SB, 2014, P NATL ACAD SCI USA, V111, pE1182, DOI 10.1073/pnas.1323529111; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hatini V, 2013, DEV BIOL, V378, P38, DOI 10.1016/j.ydbio.2013.02.016; Hoeppner DJ, 2004, DEV BIOL, V274, P125, DOI 10.1016/j.ydbio.2004.06.022; Jeong MH, 2010, DEV DYNAM, V239, P1931, DOI 10.1002/dvdy.22322; Jory A, 2012, CELL REP, V2, P1014, DOI 10.1016/j.celrep.2012.09.010; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lopez Y, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S3-S10; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mitchell M., 1998, INTRO GENETIC ALGORI; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Obayashi T, 2012, NUCLEIC ACIDS RES, V41, P1; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Pavesi G., 2001, BIOINFORMATICS, V17, pS207; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Shiao MS, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-42; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vandenbon A, 2010, NUCLEIC ACIDS RES, V38, P17, DOI 10.1093/nar/gkp866; Vandenbon A, 2008, GENOME INFORM SER, V21, P188; Yokoyama KD, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp423; Yu L., 2003, 20 INT C MACH LEARN; Zhao GY, 2007, GENOME RES, V17, P348, DOI 10.1101/gr.5989907; Zheng WW, 2013, INT J MOL SCI, V14, P14936, DOI 10.3390/ijms140714936	45	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104342	10.1371/journal.pone.0104342	http://dx.doi.org/10.1371/journal.pone.0104342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153327	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200018
J	Fornasero, LV; Del Papa, MF; Lopez, JL; Albicoro, FJ; Zabala, JM; Toniutti, MA; Pensiero, JF; Lagares, A				Viviana Fornasero, Laura; Florencia Del Papa, Maria; Luis Lopez, Jose; Javier Albicoro, Francisco; Marcelo Zabala, Juan; Antonieta Toniutti, Maria; Francisco Pensiero, Jose; Lagares, Antonio			Phenotypic, Molecular and Symbiotic Characterization of the Rhizobial Symbionts of Desmanthus paspalaceus (Lindm.) Burkart That Grow in the Province of Santa Fe, Argentina	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI; ILLINOIS BUNDLEFLOWER; NITROGEN-FIXATION; NODULE BACTERIA; STRAIN CB3126; ROOT-NODULES; SP NOV.; VIRGATUS; INOCULATION; QUEENSLAND	Desmanthus paspalaceus (Lindm.) Burkart belongs to the D. virgatus complex, subfamily Mimosoidae. The known potential as livestock fodder of several of these legumes prompted us to undertake a phenotypic, molecular, and symbiotic characterization of the D. paspalaceus symbionts in the Santa Fe province, Argentina. The rhizobia collected-containing isolates with different abiotic-stress tolerances-showed a remarkable genetic diversity by PCR fingerprinting, with 11 different amplification profiles present among 20 isolates. In selected isolates 16S-rDNA sequencing detected mesorhizobia (60%) and rhizobia (40%) within the collection, in contrast to the genus of the original inoculant strain CB3126-previously isolated from Leucaena leucocephala-that we typified here through its 16S rDNA as Sinorhizobium terangae. The results revealed the establishment by diverse bacterial genera -rhizobia, sinorhizobia, and mesorhizobia-of full N-2-fixing symbiotic associations with D. paspalaceus. This diversity was paralleled by the presence of at least two different nodC allelic variants. The identical nodC alleles of the Mesorhizobia sp. 10.L.4.2 and 10.L.5.3 notably failed to group within any of the currently described rhizo-/brady-/azorhizobial nodC clades. Interestingly, the nodC from S. terangae CB3126 clustered close to homologs from common bean nodulating rhizobia, but not with the nodC from S. terangae WSM1721 that nodulates Acacia. No previous data were available on nod-gene phylogeny for Desmanthus symbionts. A field assay indicated that inoculation of D. paspalaceus with the local Rhizobium sp. 10L.11.4 produced higher aerial-plant dry weights compared to S. teranga CB3126-inoculated plants. Neither the mesorhizobia 10.L.4.2 or 10.L.5.3 nor the rhizobium 10L.11.4 induced root nodules in L. leucocephala or P. vulgaris. The results show that some of the local isolates have remarkable tolerances to several abiotic stresses including acidity, salt, and temperature; while exhibiting prominent N-2 fixation; thus indicating suitability as candidates for inoculation of D. paspalaceus.	[Florencia Del Papa, Maria; Luis Lopez, Jose; Javier Albicoro, Francisco; Lagares, Antonio] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, IBBM Inst Biotecnol & Biol Mol,CONICET, La Plata, Buenos Aires, Argentina; [Viviana Fornasero, Laura; Marcelo Zabala, Juan; Antonieta Toniutti, Maria; Francisco Pensiero, Jose] Univ Nacl Litoral, Fac Ciencias Agr, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of the Littoral	Lagares, A (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, IBBM Inst Biotecnol & Biol Mol,CONICET, La Plata, Buenos Aires, Argentina.	lagares@biol.unlp.edu.ar	Del Papa, María Florencia/AAQ-3046-2021	Del Papa, María Florencia/0000-0003-0088-6756; Lopez Arcondo, Jose Luis/0000-0002-6942-7032; Albicoro, Francisco/0000-0001-5460-3534	National Science and Technology Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas-CONICET, Argentina); Ministry of Science Technology and Productive Innovation (Ministerio de Ciencia Tecnolologia e Innovacion Productiva-MinCyT, Argentina) [PICT 2008-0736, PICT 2012-1719]; Agencia de Promocion Cientifica y Tecnologica (ANPCyT-MinCyT, Argentina); CONICET	National Science and Technology Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas-CONICET, Argentina); Ministry of Science Technology and Productive Innovation (Ministerio de Ciencia Tecnolologia e Innovacion Productiva-MinCyT, Argentina); Agencia de Promocion Cientifica y Tecnologica (ANPCyT-MinCyT, Argentina); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by the National Science and Technology Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas-CONICET, Argentina), and the Ministry of Science Technology and Productive Innovation (Ministerio de Ciencia Tecnolologia e Innovacion Productiva-MinCyT, Argentina: grants PICT 2008-0736 and PICT 2012-1719 to AL). LVF and MAT were supported with a full-time position as Laboratory Instructors at the Facultad de Agronomia-Universidad Nacional del Litoral (UNL), Argentina. JLL and FA were supported by fellowships from the Agencia de Promocion Cientifica y Tecnologica (ANPCyT-MinCyT, Argentina) and CONICET, respectively. MFDP, JFP, and AL are Researchers at CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ON, 1981, LEGUMINOSAE SOURCE B, P227; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amarger N, 1997, INT J SYST BACTERIOL, V47, P996, DOI 10.1099/00207713-47-4-996; Bahnisch GA, 1998, TROP GRASSLANDS, V32, P13; Berge O, 2009, INT J SYST EVOL MICR, V59, P367, DOI 10.1099/ijs.0.000521-0; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Beyhaut E, 2006, CAN J PLANT SCI, V86, P919, DOI 10.4141/P05-097; Bhattacharyya R. N., 2000, Acta Microbiologica et Immunologica Hungarica, V47, P41; Boiero L, 2007, APPL MICROBIOL BIOT, V74, P874, DOI 10.1007/s00253-006-0731-9; Brandon NJ, 1998, TROP GRASSLANDS, V32, P20; Burt R. L., 1993, Herbage Abstracts, V63, P401; DATE RA, 1991, TROP GRASSLANDS, V25, P47; Date RA, 1997, TROP GRASSLANDS, V31, P350; Datta C, 2000, MICROBIOL RES, V155, P123, DOI 10.1016/S0944-5013(00)80047-6; DAVIS PE, 1982, SOIL BIOL BIOCHEM, V14, P313, DOI 10.1016/0038-0717(82)90045-1; de Lajudie P, 1998, INT J SYST BACTERIOL, V48, P369, DOI 10.1099/00207713-48-2-369; DELAJUDIE P, 1994, INT J SYST BACTERIOL, V44, P715, DOI 10.1099/00207713-44-4-715; DOYLE JJ, 1994, ANNU REV ECOL SYST, V25, P325; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fischbach JA, 2005, AGRON J, V97, P895, DOI 10.2134/agronj2004.0139; GARDINER CP, 1995, TROP GRASSLANDS, V29, P183; Gardiner CP, 2004, P 4 INT CROP SCI C B; Ghosh S, 2008, DEUT VIER LIT GEIST, V82, P3; Hopkinson JM, 2004, TROP GRASSLANDS, V38, P1; Howard RA, 1988, DICOTYLEDONEAE; Jensen H., 1942, P LINN SOC N S W, V66, P98; Jones RM, 1997, TROP GRASSLANDS, V31, P315; Jones RM, 1998, TROP GRASSLANDS, V32, P145; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; Lewis G.P., 2005, LEGUMES WORLD, P187; Lin DX, 2009, INT J SYST EVOL MICR, V59, P1919, DOI 10.1099/ijs.0.006387-0; Liogier H.A., 1988, EDITORIAL U PUERTO R, V2, P481; Luckow M., 1993, Systematic Botany Monographs, V38, DOI 10.2307/25027822; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; Ocumpaugh WR, 2004, CROP SCI, V44, P1860, DOI 10.2135/cropsci2004.1860; Rogel MA, 2011, SYST APPL MICROBIOL, V34, P96, DOI 10.1016/j.syapm.2010.11.015; Sambrook J., 2002, MOL CLONING LAB MANU; Sinsuwongwat S, 2002, SOIL SCI PLANT NUTR, V48, P719, DOI 10.1080/00380768.2002.10409262; Skerman PJ, 1988, TROPICAL FORAGE LEGU; Somasegaran P., 1994, HDB RHIZOBIA, DOI [10.1007/978-1-4613-8375-8, DOI 10.1007/978-1-4613-8375-8]; Spaepen S, 2009, FEMS MICROBIOL LETT, V291, P195, DOI 10.1111/j.1574-6968.2008.01453.x; Sprent J.I., 1990, NITROGEN FIXING ORGA; THOMPSON JA, 1991, EXPERT CONSULTATION, P113; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Vincent J. M., 1970, HANDBOOK, V15; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu LJ, 2011, FEMS MICROBIOL ECOL, V76, P439, DOI 10.1111/j.1574-6941.2011.01064.x; Xu J, 2012, APPL ENVIRON MICROB, V78, P8056, DOI 10.1128/AEM.01276-12; Zabala JM, 2008, TROP GRASSLANDS, V42, P229; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; Zamora Natera F, 2002, REV FITOTEC MEX, V25, P317; Zuckerkandl E., 1965, EVOLVING GENES PROTE; Zuloaga FO, 1999, DICOTYLEDONEAE MONOG	57	6	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104636	10.1371/journal.pone.0104636	http://dx.doi.org/10.1371/journal.pone.0104636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153989	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200022
J	Yamashiro, T; Miyara, T; Honda, O; Kamiya, H; Murata, K; Ohno, Y; Tomiyama, N; Moriya, H; Koyama, M; Noma, S; Kamiya, A; Tanaka, Y; Murayama, S				Yamashiro, Tsuneo; Miyara, Tetsuhiro; Honda, Osamu; Kamiya, Hisashi; Murata, Kiyoshi; Ohno, Yoshiharu; Tomiyama, Noriyuki; Moriya, Hiroshi; Koyama, Mitsuhiro; Noma, Satoshi; Kamiya, Ayano; Tanaka, Yuko; Murayama, Sadayuki		Investigators ACTIve Study Grp	Adaptive Iterative Dose Reduction Using Three Dimensional Processing (AIDR3D) Improves Chest CT Image Quality and Reduces Radiation Exposure	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; DUAL SOURCE CT; RECONSTRUCTION TECHNIQUE; COMPUTED-TOMOGRAPHY; INITIAL-EXPERIENCE; DIFFERENT KERNELS; 3D; SPACE; ANGIOGRAPHY; VOLTAGE	Objective: To assess the advantages of Adaptive Iterative Dose Reduction using Three Dimensional Processing (AIDR3D) for image quality improvement and dose reduction for chest computed tomography (CT). Methods: Institutional Review Boards approved this study and informed consent was obtained. Eighty-eight subjects underwent chest CT at five institutions using identical scanners and protocols. During a single visit, each subject was scanned using different tube currents: 240, 120, and 60 mA. Scan data were converted to images using AIDR3D and a conventional reconstruction mode (without AIDR3D). Using a 5-point scale from 1 (non-diagnostic) to 5 (excellent), three blinded observers independently evaluated image quality for three lung zones, four patterns of lung disease (nodule/mass, emphysema, bronchiolitis, and diffuse lung disease), and three mediastinal measurements (small structure visibility, streak artifacts, and shoulder artifacts). Differences in these scores were assessed by Scheffe's test. Results: At each tube current, scans using AIDR3D had higher scores than those without AIDR3D, which were significant for lung zones (p<0.0001) and all mediastinal measurements (p<0.01). For lung diseases, significant improvements with AIDR3D were frequently observed at 120 and 60 mA. Scans with AIDR3D at 120 mA had significantly higher scores than those without AIDR3D at 240 mA for lung zones and mediastinal streak artifacts (p<0.0001), and slightly higher or equal scores for all other measurements. Scans with AIDR3D at 60 mA were also judged superior or equivalent to those without AIDR3D at 120 mA. Conclusion: For chest CT, AIDR3D provides better image quality and can reduce radiation exposure by 50%.	[Yamashiro, Tsuneo; Miyara, Tetsuhiro; Kamiya, Hisashi; Kamiya, Ayano; Tanaka, Yuko; Murayama, Sadayuki] Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Nishihara, Okinawa 90301, Japan; [Honda, Osamu; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka, Japan; [Murata, Kiyoshi] Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga 52021, Japan; [Ohno, Yoshiharu] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan; [Moriya, Hiroshi] Ohara Gen Hosp, Dept Radiol, Fukushima, Japan; [Koyama, Mitsuhiro] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 569, Japan; [Noma, Satoshi] Tenri Hosp, Dept Radiol, Tenri, Nara 632, Japan; [Tanaka, Yuko] Fujieda Municipal Gen Hosp, Ctr Clin Training, Fujieda, Shizuoka, Japan	University of the Ryukyus; Osaka University; Shiga University of Medical Science; Kobe University; Osaka Medical College; Tenri Hospital	Yamashiro, T (corresponding author), Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Nishihara, Okinawa 90301, Japan.	clatsune@yahoo.co.jp	Ohno, Yoshiharu/AAE-2970-2020; Yamashiro, Tsuneo/H-6409-2019	Yamashiro, Tsuneo/0000-0002-1904-2548	Toshiba Medical Systems	Toshiba Medical Systems	Each participating institution has a research grant from Toshiba Medical Systems. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Chen MY, 2013, INT J CARDIOVAS IMAG, V29, P1167, DOI 10.1007/s10554-013-0190-1; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Eldevik K, 2010, RADIAT PROT DOSIM, V139, P430, DOI 10.1093/rpd/ncq063; Fleischmann D, 2011, EUR RADIOL, V21, P510, DOI 10.1007/s00330-011-2056-z; Funabashi N, 2013, INT J CARDIOL, V168, P601, DOI 10.1016/j.ijcard.2013.01.230; Higuchi K, 2013, RADIOL PHYS TECHNOL, V6, P299, DOI 10.1007/s12194-013-0200-y; Hu XH, 2011, CLIN RADIOL, V66, P1023, DOI 10.1016/j.crad.2011.04.008; Hwang HJ, 2012, KOREAN J RADIOL, V13, P711, DOI 10.3348/kjr.2012.13.6.711; Hwang HJ, 2012, KOREAN J RADIOL, V13, P720, DOI 10.3348/kjr.2012.13.6.720; Jang KJ, 2011, J KOREAN PHYS SOC, V58, P334, DOI 10.3938/jkps.58.334; Juri H, 2013, J COMPUT ASSIST TOMO, V37, P52, DOI 10.1097/RCT.0b013e3182742c0e; Katsura M, 2013, INVEST RADIOL, V48, P206, DOI 10.1097/RLI.0b013e31827efc3a; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Kim H, 2014, EUR J RADIO IN PRESS; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Leipsic J, 2010, AM J ROENTGENOL, V195, P1095, DOI 10.2214/AJR.09.4050; Li Q, 2013, CLIN RADIOL, V68, pE249, DOI 10.1016/j.crad.2012.12.009; Neroladaki A, 2013, EUR RADIOL, V23, P360, DOI 10.1007/s00330-012-2627-7; Nishio M, 2012, AM J ROENTGENOL, V199, P595, DOI 10.2214/AJR.11.8174; Ohno Y, 2012, AM J ROENTGENOL, V199, pW477, DOI 10.2214/AJR.11.8275; Pontana F, 2013, RADIOLOGY, V267, P609, DOI 10.1148/radiol.12120414; Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Vardhanabhuti V, 2013, AM J ROENTGENOL, V200, P545, DOI 10.2214/AJR.12.9424; Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y; Willemink MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058053; Yamada Y, 2012, EUR J RADIOL, V81, P4185, DOI 10.1016/j.ejrad.2012.07.013; Yamada Y, 2012, INVEST RADIOL, V47, P482, DOI 10.1097/RLI.0b013e3182562a89; Yanagawa M, 2012, EUR J RADIOL, V81, P2877, DOI 10.1016/j.ejrad.2011.09.011; Yanagawa M, 2010, ACAD RADIOL, V17, P1259, DOI 10.1016/j.acra.2010.05.014; Yang WJ, 2013, J COMPUT ASSIST TOMO, V37, P301, DOI 10.1097/RCT.0b013e31827b8c66	33	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105735	10.1371/journal.pone.0105735	http://dx.doi.org/10.1371/journal.pone.0105735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153797	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200076
J	Chang, CH; Tsai, MS; Lin, CL; Hou, JW; Wang, TH; Tsai, YA; Liao, KW; Mao, IF; Chen, ML				Chang, Chia-Huang; Tsai, Ming-Song; Lin, Ching-Ling; Hou, Jia-Woei; Wang, Tzu-Hao; Tsai, Yen-An; Liao, Kai-Wei; Mao, I-Fang; Chen, Mei-Lien			The Association between Nonylphenols and Sexual Hormones Levels among Pregnant Women: A Cohort Study in Taiwan	PLOS ONE			English	Article							BISPHENOL-A; GESTATIONAL EXPOSURE; ESTROGENIC ACTIVITY; NEGATIVE FEEDBACK; DRUG DISPOSITION; RAINBOW-TROUT; P-NONYLPHENOL; HUMAN URINE; MALE RATS; 4-NONYLPHENOL	Background: Nonylphenol (NP) has been proven as an endocrine disrupter and had the ability to interfere with the endocrine system. Though the health effects of NP on pregnant women and their fetuses are sustained, these negative associations related to the mechanisms of regulation for estrogen during pregnancy need to be further clarified. The objective of this study is to explore the association between maternal NP and hormonal levels, such as estradiol, testosterone, luteinizing hormone (LH) and follicle stimulating hormone (FSH), and progesterone. Methods: A pregnant women cohort was established in North Taiwan between March and December 2010. Maternal urine and blood samples from the first, second, and third trimesters of gestation were collected. Urinary NP concentration was measured by high-performance liquid chromatography coupled with fluorescent detection. A mixed-effects model using a generalised estimating equation (GEE) was applied to assess the associations between maternal NP concentration and plasma hormones throughout the three trimesters. Results: In total, 162 singleton pregnant women completed this study through delivery. The geometric mean of creatinine-adjusted urinary NP concentrations were 4.27, 4.21, and 4.10 mu g/g cre. in the first, second, and third trimesters respectively. A natural log-transformation of urinary NP concentrations were significantly associated with LH in the GEE model (beta= -20.23 mIU/ml, p<0.01). Conclusion: This perspective cohort study demonstrates that negative association occurs between maternal NP exposure and plasma LH levels. The estrogen-mimic effect of NP might influence the negative feedback on LH during pregnancy.	[Chang, Chia-Huang; Tsai, Yen-An; Liao, Kai-Wei; Chen, Mei-Lien] Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan; [Chang, Chia-Huang; Tsai, Ming-Song] Cathay Gen Hosp, Dept OBS & GYN, Taipei, Taiwan; [Tsai, Ming-Song] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Lin, Ching-Ling] Cathay Gen Hosp, Dept Endocrinol & Metab, Taipei, Taiwan; [Hou, Jia-Woei] Cathay Gen Hosp, Dept Pediat, Taipei, Taiwan; [Wang, Tzu-Hao] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Obstet & Gynecol,GMRCL, Taoyuan, Taiwan; [Mao, I-Fang] Chung Shan Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan	National Yang Ming Chiao Tung University; Cathay General Hospital; Fu Jen Catholic University; Cathay General Hospital; Cathay General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University	Chen, ML (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan.	mlchen7239@gmail.com	Liao, Kai-Wei/AAW-5992-2020	Liao, Kai-Wei/0000-0003-3842-416X	National Science Council of the Republic of China, Taiwan [NSC 99-2314-B-010-018-MY3, NSC 100-2314B-281-001-MY3]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by the National Science Council of the Republic of China, Taiwan, NSC 99-2314-B-010-018-MY3 and NSC 100-2314B-281-001-MY3. The funders had no role in study design, data collection and analysis, decision	Albrecht ED, 2010, INT J DEV BIOL, V54, P397, DOI 10.1387/ijdb.082758ea; Balakrishnan B, 2011, PLACENTA, V32, P788, DOI 10.1016/j.placenta.2011.07.014; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Chang CH, 2013, CHEMOSPHERE; Charles SM, 2014, J CLIN ENDOCR METAB; Chen HW, 2013, SCI TOTAL ENVIRON, V449, P20, DOI 10.1016/j.scitotenv.2013.01.038; Chen ML, 2008, CHEMOSPHERE, V73, pS239, DOI 10.1016/j.chemosphere.2007.04.091; Chen ML, 2009, CHEMOSPHERE, V76, P927, DOI 10.1016/j.chemosphere.2009.04.054; Chen ML, 2005, INT J ENVIRON AN CH, V85, P335, DOI 10.1080/03067310412331315575; Chen TC, 2009, J ENVIRON SCI HEAL A, V44, P1244, DOI 10.1080/10934520903139977; Coldham NG, 1998, DRUG METAB DISPOS, V26, P347; Crozier SR, 2009, J NUTR, V139, P1956, DOI 10.3945/jn.109.109579; Cunningham FG, 2001, WILLIAMS OBSTET, V23rd; de Jager C, 1999, ANDROLOGIA, V31, P107, DOI 10.1046/j.1439-0272.1999.00246.x; EVAINBRION D, 1994, HORM RES, V42, P207, DOI 10.1159/000184195; Fan Qiyuan, 2001, Zhonghua Yufang Yixue Zazhi, V35, P344; Ferguson SA, 2000, NEUROTOXICOL TERATOL, V22, P583, DOI 10.1016/S0892-0362(00)00071-4; Fernandes AR, 2008, FOOD ADDIT CONTAM, V25, P364, DOI 10.1080/02652030701564548; Frederiksen MC, 2001, SEMIN PERINATOL, V25, P120, DOI 10.1053/sper.2001.24565; Fujimoto J, 2005, J STEROID BIOCHEM, V94, P67, DOI 10.1016/j.jsbmb.2004.12.030; Furuta M, 2006, NEUROENDOCRINOLOGY, V84, P14, DOI 10.1159/000096093; Gascon M, 2011, ENVIRON INT, V37, P605, DOI 10.1016/j.envint.2010.12.005; Guenther K, 2002, ENVIRON SCI TECHNOL, V36, P1676, DOI 10.1021/es010199v; Harris CA, 2001, ENVIRON SCI TECHNOL, V35, P2909, DOI 10.1021/es0002619; HIRANO M, 1976, TOHOKU J EXP MED, V118, P275, DOI 10.1620/tjem.118.275; Holdway DA, 2008, ENVIRON TOXICOL, V23, P253, DOI 10.1002/tox.20329; Hossaini A, 2001, REPROD TOXICOL, V15, P537, DOI 10.1016/S0890-6238(01)00155-1; Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205; Huang WR, 2010, FISH PHYSIOL BIOCHEM, V36, P237, DOI 10.1007/s10695-008-9280-8; Inoue K, 2001, FOOD ADDIT CONTAM, V18, P157, DOI 10.1080/02652030010018930; Iqbal J, 2009, ENDOCRINOLOGY, V150, P4213, DOI 10.1210/en.2009-0092; Isoherranen N, 2013, DRUG METAB DISPOS, V41, P256, DOI 10.1124/dmd.112.050245; Jarvela IY, 2012, PRENATAL DIAG, V32, P160, DOI 10.1002/pd.2921; Jie X, 2010, BIRTH DEFECTS RES B, V89, P418, DOI 10.1002/bdrb.20268; Kawaguchi M, 2005, J CHROMATOGR B, V820, P49, DOI 10.1016/j.jchromb.2005.03.019; Kimura N, 2006, J REPROD DEVELOP, V52, P789, DOI 10.1262/jrd.18007; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; LeBlanc GA, 2000, ENVIRON HEALTH PERSP, V108, P1133, DOI 10.2307/3434824; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lu J, 2008, CHEMOSPHERE, V71, P345, DOI 10.1016/j.chemosphere.2007.08.068; Lu YY, 2007, ENVIRON INT, V33, P903, DOI 10.1016/j.envint.2007.04.008; Mahoney MM, 2010, TOXICOL APPL PHARM, V247, P98, DOI 10.1016/j.taap.2010.05.017; Mao LH, 2004, ANAL CHIM ACTA, V522, P241, DOI 10.1016/j.aca.2004.04.071; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McCarthy MM, 2009, NEUROSCIENTIST, V15, P599, DOI 10.1177/1073858409340924; MITANI GM, 1987, CLIN PHARMACOKINET, V12, P253, DOI 10.2165/00003088-198712040-00002; Moller UK, 2013, OSTEOPOROSIS INT, V24, P1307, DOI 10.1007/s00198-012-2062-2; Muller S, 1998, ENVIRON TOXICOL PHAR, V5, P257, DOI 10.1016/S1382-6689(98)00009-X; Nagao T, 2001, REPROD TOXICOL, V15, P293, DOI 10.1016/S0890-6238(01)00123-X; Nagata C, 2006, CANCER CAUSE CONTROL, V17, P1107, DOI 10.1007/s10552-006-0044-4; OLEARY P, 1991, CLIN CHEM, V37, P667; Pan YP, 2009, CHEMOSPHERE, V76, P381, DOI 10.1016/j.chemosphere.2009.03.034; Ren LF, 1996, CHEM-BIOL INTERACT, V100, P67, DOI 10.1016/0009-2797(95)03686-5; Sayed AEH, 2012, ECOTOX ENVIRON SAFE, V78, P310, DOI 10.1016/j.ecoenv.2011.11.041; Shaw ND, 2010, J CLIN ENDOCR METAB, V95, P1955, DOI 10.1210/jc.2009-2108; Shue MF, 2010, ENVIRON MONIT ASSESS, V168, P91, DOI 10.1007/s10661-009-1093-4; Shue MF, 2009, WATER SCI TECHNOL, V59, P2055, DOI 10.2166/wst.2009.168; Soares A, 2008, ENVIRON INT, V34, P1033, DOI 10.1016/j.envint.2008.01.004; SOTO AM, 1991, ENVIRON HEALTH PERSP, V92, P167, DOI 10.1289/ehp.9192167; Takeda T, 2009, J PHARMACOL EXP THER, V329, P1091, DOI 10.1124/jpet.109.151282; Thomson BM, 2003, J ENVIRON MONITOR, V5, P229, DOI 10.1039/b211323f; Torgersen CKL, 2006, CRIT CARE NURS Q, V29, P2, DOI 10.1097/00002727-200601000-00002; Tsai MS, 2013, SCI TOTAL ENVIRON, V458, P367, DOI [10.1016/j.scitotenv.2013.04,039, 10.1016/j.scitotenv.2013.04.039]; Vonnahme KA, 2013, ANIM REPROD SCI, V141, P131, DOI 10.1016/j.anireprosci.2013.07.010; Wang CH, 2001, TAIWAN J PUBLIC HLTH, V20, pP202; Weissgerber TL, 2006, APPL PHYSIOL NUTR ME, V31, P1, DOI 10.1139/H05-003; Wilson CA, 2007, REPRODUCTION, V133, P331, DOI 10.1530/REP-06-0078; Wu JJ, 2010, TOXICOLOGY, V268, P1, DOI 10.1016/j.tox.2009.10.030; Yokota H, 2001, ENVIRON TOXICOL CHEM, V20, P2552, DOI [10.1897/1551-5028(2001)020&lt;2552:LCTONT&gt;2.0.CO;2, 10.1002/etc.5620201122]	69	8	8	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104245	10.1371/journal.pone.0104245	http://dx.doi.org/10.1371/journal.pone.0104245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148048	gold, Green Submitted, Green Published			2022-12-25	WOS:000341230600013
J	Chylek, LA; Akimov, V; Dengjel, J; Rigbolt, KTG; Hu, B; Hlavacek, WS; Blagoev, B				Chylek, Lily A.; Akimov, Vyacheslav; Dengjel, Joern; Rigbolt, Kristoffer T. G.; Hu, Bin; Hlavacek, William S.; Blagoev, Blagoy			Phosphorylation Site Dynamics of Early T-cell Receptor Signaling	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; TERMINAL SRC KINASE; QUANTITATIVE PHOSPHOPROTEOMIC ANALYSIS; PROLINE-RICH SEQUENCE; TANDEM SH2 DOMAINS; ANTIGEN RECEPTOR; ADAPTER PROTEIN; PHOSPHOLIPASE C-GAMMA-1; BINDING-SPECIFICITY; CRYSTAL-STRUCTURE	In adaptive immune responses, T-cell receptor (TCR) signaling impacts multiple cellular processes and results in T-cell differentiation, proliferation, and cytokine production. Although individual protein-protein interactions and phosphorylation events have been studied extensively, we lack a systems-level understanding of how these components cooperate to control signaling dynamics, especially during the crucial first seconds of stimulation. Here, we used quantitative proteomics to characterize reshaping of the T-cell phosphoproteome in response to TCR/CD28 co-stimulation, and found that diverse dynamic patterns emerge within seconds. We detected phosphorylation dynamics as early as 5 s and observed widespread regulation of key TCR signaling proteins by 30 s. Development of a computational model pointed to the presence of novel regulatory mechanisms controlling phosphorylation of sites with central roles in TCR signaling. The model was used to generate predictions suggesting unexpected roles for the phosphatase PTPN6 (SHP-1) and shortcut recruitment of the actin regulator WAS. Predictions were validated experimentally. This integration of proteomics and modeling illustrates a novel, generalizable framework for solidifying quantitative understanding of a signaling network and for elucidating missing links.	[Chylek, Lily A.; Hu, Bin; Hlavacek, William S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Chylek, Lily A.; Hlavacek, William S.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Chylek, Lily A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Akimov, Vyacheslav; Blagoev, Blagoy] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark; [Dengjel, Joern; Rigbolt, Kristoffer T. G.] Univ Freiburg, ZBSA Ctr Biol Syst Anal, BIOSS Ctr Biol Signalling Studies, Freiburg Inst Adv Studies FRIAS,Med Ctr,Dept Derm, D-79106 Freiburg, Germany; [Hu, Bin; Hlavacek, William S.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Cornell University; University of Southern Denmark; University of Freiburg; University of New Mexico	Hlavacek, WS (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	wish@lanl.gov; bab@bmb.sdu.dk	Dengjel, Joern/AAI-3682-2020	Dengjel, Joern/0000-0002-9453-4614; Blagoev, Blagoy/0000-0002-3596-0066; Hu, Bin/0000-0002-0278-8466; Hlavacek, William/0000-0003-4383-8711	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [P50GM085273, R01GM076570]; US Department of Energy [DE-AC52-06NA25396]; Excellence Initiative of the German Federal and State Governments through the Freiburg Institute for Advanced Studies (FRIAS) in the School of Life Sciences-LifeNet; Center for Biological Signalling Studies (BIOSS); Danish Council for Independent Research/Natural Sciences; Lundbeck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273, R01GM076570] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy(United States Department of Energy (DOE)); Excellence Initiative of the German Federal and State Governments through the Freiburg Institute for Advanced Studies (FRIAS) in the School of Life Sciences-LifeNet; Center for Biological Signalling Studies (BIOSS); Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) grants P50GM085273 and R01GM076570; US Department of Energy Contract DE-AC52-06NA25396 through the Los Alamos Center for Nonlinear Studies and the Laboratory-directed Research and Development (LDRD) Program; the Excellence Initiative of the German Federal and State Governments through the Freiburg Institute for Advanced Studies (FRIAS) in the School of Life Sciences-LifeNet, and the Center for Biological Signalling Studies (BIOSS); the Danish Council for Independent Research/Natural Sciences; and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Alarcon B, 2003, IMMUNOL REV, V191, P38, DOI 10.1034/j.1600-065X.2003.00017.x; ALARCON B, 1988, J BIOL CHEM, V263, P2953; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; AUGUST A, 1994, BIOCHEM BIOPH RES CO, V199, P1466, DOI 10.1006/bbrc.1994.1396; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; Banin S, 1999, MOL BIOL REP, V26, P173, DOI 10.1023/A:1006954206151; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barua D, 2012, J IMMUNOL, V189, P646, DOI 10.4049/jimmunol.1102003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Berkovitz L. D., 2012, NONLINEAR OPTIMAL CO; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Blundell MP, 2009, P NATL ACAD SCI USA, V106, P15738, DOI 10.1073/pnas.0904346106; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Borgeson G, 1998, GOLDEN AGE AM RACING; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Brodovitch A, 2013, J IMMUNOL, V191, P2064, DOI 10.4049/jimmunol.1300523; Brown K, 2004, J BIOL CHEM, V279, P18727, DOI 10.1074/jbc.M400031200; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Cao LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046725; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chiang GG, 2001, J BIOL CHEM, V276, P23173, DOI 10.1074/jbc.M101219200; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Chylek LA, 2013, SYSTEMS BIOL INTEGRA, V1, P273; Chylek LA, 2014, SYSTEMS BIOL APPROAC; Chylek LA, 2014, WIRES SYST BIOL MED, V6, P13, DOI 10.1002/wsbm.1245; Chylek LA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004061; Chylek LA, 2011, MOL BIOSYST, V7, P2779, DOI 10.1039/c1mb05077j; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Colvin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-404; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Danos V, 2007, LECT NOTES COMPUT SC, V4703, P17; Davidon WC, 1991, SIAM J OPTIMIZ, V1, P1, DOI 10.1137/0801001; de la Cruz J, 2011, J IMMUNOL, V186, P2282, DOI 10.4049/jimmunol.1003225; DeBell K, 2007, MOL CELL BIOL, V27, P854, DOI 10.1128/MCB.01400-06; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; DENNIS EA, 1991, FASEB J, V5, P2068, DOI 10.1096/fasebj.5.7.1901288; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; DIANZANI U, 1992, J IMMUNOL, V148, P678; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Doro U, 1996, MOL CELL BIOL, V16, P4996; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Evren S, 2012, EXP HEMATOL, V40, P1055, DOI 10.1016/j.exphem.2012.08.007; Facchetti F, 1998, J PATHOL, V185, P99, DOI 10.1002/(SICI)1096-9896(199805)185:1<99::AID-PATH48>3.0.CO;2-L; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Faeder JR, 2003, J IMMUNOL, V170, P3769, DOI 10.4049/jimmunol.170.7.3769; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Fowler CC, 2010, J IMMUNOL, V185, P3256, DOI 10.4049/jimmunol.1001362; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Gallego MD, 1997, BLOOD, V90, P3089, DOI 10.1182/blood.V90.8.3089; Garcon F, 2004, EUR J IMMUNOL, V34, P1972, DOI 10.1002/eji.200324777; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Gibson S, 1996, J IMMUNOL, V156, P2716; Gibson S, 1996, J BIOL CHEM, V271, P7079, DOI 10.1074/jbc.271.12.7079; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gil D, 2001, J BIOL CHEM, V276, P11174, DOI 10.1074/jbc.M010114200; GILLILAND LK, 1992, J BIOL CHEM, V267, P13610; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Guirado M, 2002, BIOCHEM BIOPH RES CO, V291, P574, DOI 10.1006/bbrc.2002.6492; HARA T, 1985, J EXP MED, V161, P1513, DOI 10.1084/jem.161.6.1513; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Iwai LK, 2010, J PROTEOME RES, V9, P3135, DOI 10.1021/pr100035b; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Johnson DJ, 2013, J EXP MED, V210, P1419, DOI 10.1084/jem.20122239; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; JUNE CH, 1990, J IMMUNOL, V144, P1591; KENNEY D, 1986, BLOOD, V68, P1329; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; Koretzky Gary A, 2009, Immune Netw, V9, P75, DOI 10.4110/in.2009.9.3.75; Krivine J, 2009, LECT NOTES COMPUT SC, V5643, P17; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lettau M, 2010, PROTEIN SCI, V19, P658, DOI 10.1002/pro.334; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Lock P, 1999, J BIOL CHEM, V274, P22775, DOI 10.1074/jbc.274.32.22775; Logue JS, 2012, GENE DEV, V26, P641, DOI 10.1101/gad.186965.112; LORENZ U, 1994, MOL CELL BIOL, V14, P1824, DOI 10.1128/MCB.14.3.1824; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Love PE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002485; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; Malissen B, 2005, ADV IMMUNOL, V87, P1, DOI 10.1016/S0065-2776(05)87001-4; Marengere LEM, 1997, J IMMUNOL, V159, P3220; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mege D, 1996, J BIOL CHEM, V271, P32644, DOI 10.1074/jbc.271.51.32644; MOLINA IJ, 1992, J EXP MED, V176, P867, DOI 10.1084/jem.176.3.867; Moran O, 2008, BIOPHYS J, V94, P1766, DOI 10.1529/biophysj.107.116590; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Mukherjee S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003220; Mukhopadhyay H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003004; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; O'Neill SK, 2011, IMMUNITY, V35, P746, DOI 10.1016/j.immuni.2011.10.011; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Qi Q, 2007, SCI STKE, V2007, pe39; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rigbolt KTG, 2012, SEMIN CELL DEV BIOL, V23, P863, DOI 10.1016/j.semcdb.2012.05.006; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rigbolt KTG, 2011, MOL CELLULAR PROTEOM, V10, P1, DOI [10.1074/mcp.O1110.0075450, DOI 10.1074/MCP.O1110.0075450]; Risueno RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001747; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; RUDD CE, 1991, ADV EXP MED BIOL, V292, P85; Ruperez P, 2012, MOL CELL PROTEOMICS, V11, P171, DOI 10.1074/mcp.M112.017863; SABE H, 1992, MOL CELL BIOL, V12, P4706, DOI 10.1128/MCB.12.10.4706; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Seet BT, 2007, EMBO J, V26, P678, DOI 10.1038/sj.emboj.7601535; Sekar John A P, 2012, Methods Mol Biol, V880, P139, DOI 10.1007/978-1-61779-833-7_9; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Sneddon MW, 2011, NAT METHODS, V8, P177, DOI [10.1038/nmeth.1546, 10.1038/NMETH.1546]; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stover DR, 1996, J BIOL CHEM, V271, P12481, DOI 10.1074/jbc.271.21.12481; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; STRAUS DB, 1993, J EXP MED, V178, P1523, DOI 10.1084/jem.178.5.1523; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; Tailor P, 2008, J IMMUNOL, V181, P243, DOI 10.4049/jimmunol.181.1.243; Takeuchi K, 2008, J MOL BIOL, V380, P704, DOI 10.1016/j.jmb.2008.05.037; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VEILLETTE A, 1990, ONCOGENE, V5, P1455; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wall ME, 2004, NAT REV GENET, V5, P34, DOI 10.1038/nrg1244; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; WATTS JD, 1992, J BIOL CHEM, V267, P901; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; WEISSMAN AM, 1989, EMBO J, V8, P3651, DOI 10.1002/j.1460-2075.1989.tb08539.x; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Wofsy C, 1997, J IMMUNOL, V159, P5984; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu H, 1995, ANN NY ACAD SCI, V766, P99, DOI 10.1111/j.1749-6632.1995.tb26655.x; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; Yang J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031910; Yang WC, 1999, J BIOL CHEM, V274, P607, DOI 10.1074/jbc.274.2.607; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325	221	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104240	10.1371/journal.pone.0104240	http://dx.doi.org/10.1371/journal.pone.0104240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147952	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600012
J	Gnanapragassam, VS; Bork, K; Galuska, CE; Galuska, SP; Glanz, D; Nagasundaram, M; Bache, M; Vordermark, D; Kohla, G; Kannicht, C; Schauer, R; Horstkorte, R				Gnanapragassam, Vinayaga S.; Bork, Kaya; Galuska, Christina E.; Galuska, Sebastian P.; Glanz, Dagobert; Nagasundaram, Manimozhi; Bache, Matthias; Vordermark, Dirk; Kohla, Guido; Kannicht, Christoph; Schauer, Roland; Horstkorte, Ruediger			Sialic Acid Metabolic Engineering: A Potential Strategy for the Neuroblastoma Therapy	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; POLYSIALIC ACID; CANCER PROGRESSION; BREAST-CANCER; IN-VITRO; SYNCAM 1; SIALYLTRANSFERASE; POLYSIALYLATION; GLYCOPROTEINS; SIALYLATION	Background: Sialic acids (Sia) represent negative-charged terminal sugars on most glycoproteins and glycolipids on the cell surface of vertebrates. Aberrant expression of tumor associated sialylated carbohydrate epitopes significantly increases during onset of cancer. Since Sia contribute towards cell migration (= metastasis) and to chemo- and radiation resistance. Modulation of cellular Sia concentration and composition poses a challenge especially for neuroblastoma therapy, due to the high heterogeneity and therapeutic resistance of these cells. Here we propose that Metabolic Sia Engineering (MSE) is an effective strategy to reduce neuroblastoma progression and metastasis. Methods: Human neuroblastoma SH-SY5Y cells were treated with synthetic Sia precursors N-propanoyl mannosamine (ManNProp) or N-pentanoyl mannosamine (ManNPent). Total and Polysialic acids (PolySia) were investigated by high performance liquid chromatography. Cell surface polySia were examined by flow-cytometry. Sia precursors treated cells were examined for the migration, invasion and sensitivity towards anticancer drugs and radiation treatment. Results: Treatment of SH-SY5Y cells with ManNProp or ManNPent (referred as MSE) reduced their cell surface sialylation significantly. We found complete absence of polysialylation after treatment of SH-SY5Y cells with ManNPent. Loss of polysialylation results in a reduction of migration and invasion ability of these cells. Furthermore, radiation of Sia-engineered cells completely abolished their migration. In addition, MSE increases the cytotoxicity of anti-cancer drugs, such as 5-fluorouracil or cisplatin. Conclusions: Metabolic Sia Engineering (MSE) of neuroblastoma cells using modified Sia precursors reduces their sialylation, metastatic potential and increases their sensitivity towards radiation or chemotherapeutics. Therefore, MSE may serve as an effective method to treat neuroblastoma.	[Gnanapragassam, Vinayaga S.; Bork, Kaya; Glanz, Dagobert; Nagasundaram, Manimozhi; Horstkorte, Ruediger] Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Germany; [Galuska, Christina E.; Galuska, Sebastian P.] Univ Giessen, Fac Med, Inst Biochem, D-35390 Giessen, Germany; [Bache, Matthias; Vordermark, Dirk] Univ Hosp Halle, Clin Radiotherapy, Halle, Germany; [Kohla, Guido; Kannicht, Christoph] Octapharma R&D, Mol Biochem, Berlin, Germany; [Schauer, Roland] Univ Kiel, Inst Biochem, Kiel, Germany	Martin Luther University Halle Wittenberg; Justus Liebig University Giessen; Martin Luther University Halle Wittenberg; Octapharma; University of Kiel	Gnanapragassam, VS (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Germany.	vinayaga.gnanapragassam@medizin.uni-halle.de						Almaraz RT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.017558; Amoureux MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-91; Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bork K, 2007, J NEUROCHEM, V103, P65, DOI 10.1111/j.1471-4159.2007.04711.x; Campbell CT, 2008, J MED CHEM, V51, P8135, DOI 10.1021/jm800873k; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; Inoue S, 2001, GLYCOBIOLOGY, V11, P759, DOI 10.1093/glycob/11.9.759; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; KOMMINOTH P, 1994, AM J SURG PATHOL, V18, P399, DOI 10.1097/00000478-199404000-00008; Lee M, 2008, MOL CANCER RES, V6, P1316, DOI 10.1158/1541-7786.MCR-07-2209; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Muhlenhoff M, 2013, NEUROCHEM RES, V38, P1134, DOI 10.1007/s11064-013-0979-2; Park JJ, 2013, GUT LIVER, V7, P629, DOI 10.5009/gnl.2013.7.6.629; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; REUTER G, 1994, METHOD ENZYMOL, V230, P168; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Tanaka F, 2001, CANCER RES, V61, P1666; Ulm C, 2013, CELL MOL LIFE SCI, V70, P3695, DOI 10.1007/s00018-013-1342-0; Valentiner U, 2011, INT J ONCOL, V39, P417, DOI 10.3892/ijo.2011.1038; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1099; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	33	18	19	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105403	10.1371/journal.pone.0105403	http://dx.doi.org/10.1371/journal.pone.0105403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148252	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600045
J	Jalava, K; Rintala, H; Ollgren, J; Maunula, L; Gomez-Alvarez, V; Revez, J; Palander, M; Antikainen, J; Kauppinen, A; Rasanen, P; Siponen, S; Nyholm, O; Kyyhkynen, A; Hakkarainen, S; Merentie, J; Parnanen, M; Loginov, R; Ryu, H; Kuusi, M; Siitonen, A; Miettinen, I; Domingo, JWS; Hanninen, ML; Pitkanen, T				Jalava, Katri; Rintala, Hanna; Ollgren, Jukka; Maunula, Leena; Gomez-Alvarez, Vicente; Revez, Joana; Palander, Marja; Antikainen, Jenni; Kauppinen, Ari; Rasanen, Pia; Siponen, Sallamaari; Nyholm, Outi; Kyyhkynen, Aino; Hakkarainen, Sirpa; Merentie, Juhani; Parnanen, Martti; Loginov, Raisa; Ryu, Hodon; Kuusi, Markku; Siitonen, Anja; Miettinen, Ilkka; Domingo, Jorge W. Santo; Hanninen, Marja-Liisa; Pitkanen, Tarja			Novel Microbiological and Spatial Statistical Methods to Improve Strength of Epidemiological Evidence in a Community-Wide Waterborne Outbreak	PLOS ONE			English	Article							REAL-TIME PCR; FIELD GEL-ELECTROPHORESIS; CAMPYLOBACTER-JEJUNI; DISTRIBUTION-SYSTEM; HUMAN SAPOVIRUSES; WASTE-WATER; RIVER WATER; DRINKING; GASTROENTERITIS; IDENTIFICATION	Failures in the drinking water distribution system cause gastrointestinal outbreaks with multiple pathogens. A water distribution pipe breakage caused a community-wide waterborne outbreak in Vuorela, Finland, July 2012. We investigated this outbreak with advanced epidemiological and microbiological methods. A total of 473/2931 inhabitants (16%) responded to a web-based questionnaire. Water and patient samples were subjected to analysis of multiple microbial targets, molecular typing and microbial community analysis. Spatial analysis on the water distribution network was done and we applied a spatial logistic regression model. The course of the illness was mild. Drinking untreated tap water from the defined outbreak area was significantly associated with illness (RR 5.6, 95% CI 1.9-16.4) increasing in a dose response manner. The closer a person lived to the water distribution breakage point, the higher the risk of becoming ill. Sapovirus, enterovirus, single Campylobacter jejuni and EHEC O157:H7 findings as well as virulence genes for EPEC, EAEC and EHEC pathogroups were detected by molecular or culture methods from the faecal samples of the patients. EPEC, EAEC and EHEC virulence genes and faecal indicator bacteria were also detected in water samples. Microbial community sequencing of contaminated tap water revealed abundance of Arcobacter species. The polyphasic approach improved the understanding of the source of the infections, and aided to define the extent and magnitude of this outbreak.	[Jalava, Katri; Ollgren, Jukka; Palander, Marja; Rasanen, Pia; Siponen, Sallamaari; Nyholm, Outi; Kyyhkynen, Aino; Kuusi, Markku; Siitonen, Anja] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Rintala, Hanna; Hakkarainen, Sirpa; Merentie, Juhani; Parnanen, Martti] Siilinjarvi Municipal, Siilinjarvi, Finland; [Maunula, Leena; Revez, Joana; Hanninen, Marja-Liisa] Univ Helsinki, Dept Food Hyg & Environm Hlth, Helskinki, Finland; [Gomez-Alvarez, Vicente; Ryu, Hodon; Domingo, Jorge W. Santo] US EPA, Off Res & Dev, Cincinnati, OH 45268 USA; [Antikainen, Jenni; Loginov, Raisa] Helsinki Univ Hosp, Lab HUSLAB, Helsinki, Finland; [Kauppinen, Ari; Miettinen, Ilkka; Pitkanen, Tarja] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland	Finland National Institute for Health & Welfare; University of Helsinki; United States Environmental Protection Agency; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare	Jalava, K (corresponding author), Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland.	katri.jalava@thl.fi	Pitkänen, Tarja/D-1657-2014; Ryu, Hodon/HIA-0534-2022	Pitkänen, Tarja/0000-0002-7591-9148; Ryu, Hodon/0000-0002-6992-2519; Maunula, Leena/0000-0002-0841-5353; Kauppinen, Ari/0000-0001-7354-5595; Siponen, Sallamaari/0000-0002-9206-7979				[Anonymous], 2012, ISO93082A; [Anonymous], 1985, 7393 ISO; [Anonymous], 2002, 64612 ISOCD; [Anonymous], 2005, 164A NMKL; Antikainen J, 2009, EUR J CLIN MICROBIOL, V28, P899, DOI 10.1007/s10096-009-0720-x; Antikainen J, 2013, CLIN GASTROENTEROL H, V11, P1300, DOI 10.1016/j.cgh.2013.03.037; Bessong PO, 2009, J HEALTH POPUL NUTR, V27, P652; Bopp DJ, 2003, J CLIN MICROBIOL, V41, P174, DOI 10.1128/JCM.41.1.174-180.2003; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Cox MJ, 2013, HUM MOL GENET, V22, pR88, DOI 10.1093/hmg/ddt398; Dangendorf F, 2002, INT J HYG ENVIR HEAL, V205, P183, DOI 10.1078/1438-4639-00151; DEV VJ, 1991, LANCET, V337, P1412, DOI 10.1016/0140-6736(91)93092-N; Di Bella JM, 2013, J MICROBIOL METH, V95, P401, DOI 10.1016/j.mimet.2013.08.011; European U, 1998, OFFICIAL J EUROPEA L, V330, P32; Fong TT, 2007, ENVIRON HEALTH PERSP, V115, P856, DOI 10.1289/ehp.9430; Gubbels SM, 2012, SCAND J INFECT DIS, V44, P586, DOI 10.3109/00365548.2012.655773; Guy RA, 2003, APPL ENVIRON MICROB, V69, P5178, DOI 10.1128/AEM.69.9.5178-5185.2003; Harmon KM, 1996, LETT APPL MICROBIOL, V23, P241, DOI 10.1111/j.1472-765X.1996.tb00074.x; Hijnen WAM, 2009, ENVIRON SCI TECHNOL, V43, P4890, DOI 10.1021/es900037x; Hill VR, 2007, APPL ENVIRON MICROB, V73, P4218, DOI 10.1128/AEM.02713-06; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Houf K, 2000, FEMS MICROBIOL LETT, V193, P89, DOI 10.1111/j.1574-6968.2000.tb09407.x; ISO, 2006, ISO15553; Jakopanec I, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-128; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Jong B. de, 2008, Eurosurveillance, V13, P18847; Kauppinen A, 2014, J ENVIRON MANAGE, V133, P206, DOI 10.1016/j.jenvman.2013.12.008; Kauppinen A, 2012, J WATER HEALTH, V10, P406, DOI 10.2166/wh.2012.003; Kildare BJ, 2007, WATER RES, V41, P3701, DOI 10.1016/j.watres.2007.06.037; Kitajima M, 2010, APPL ENVIRON MICROB, V76, P2461, DOI 10.1128/AEM.02739-09; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Laine J, 2011, EPIDEMIOL INFECT, V139, P1105, DOI 10.1017/S0950268810002141; LAURSEN E, 1994, J EPIDEMIOL COMMUN H, V48, P453, DOI 10.1136/jech.48.5.453; Lautenschlager K, 2013, WATER RES, V47, P3015, DOI 10.1016/j.watres.2013.03.002; Lee LE, 2012, EMERG INFECT DIS, V18, P873, DOI 10.3201/eid1805.111843; Martikainen P, 2007, SCAND J PUBLIC HEALT, V35, P212, DOI 10.1080/14034940600996563; Maurer AM, 2000, EPIDEMIOL INFECT, V125, P325, DOI 10.1017/S0950268899004495; Merga JY, 2011, APPL ENVIRON MICROB, V77, P1646, DOI 10.1128/AEM.01964-10; Miettinen I.T., 2006, 5 NORD DRINK WAT C 8; Miettinen IT, 2001, WATER SCI TECHNOL, V43, P67, DOI 10.2166/wst.2001.0713; Mikula C, 2010, EMERG INFECT DIS, V16, P1186, DOI 10.3201/eid1607.091789; Murray TY, 2013, WATER SCI TECHNOL, V67, P2776, DOI 10.2166/wst.2013.203; Nakari UM, 2011, FOODBORNE PATHOG DIS, V8, P1143, DOI 10.1089/fpd.2011.0882; Nenonen NP, 2012, APPL ENVIRON MICROB, V78, P1846, DOI 10.1128/AEM.07350-11; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Oxenford CJ, 2005, COMMUN DIS INTELL, V29, P379; Parshionikar SU, 2003, APPL ENVIRON MICROB, V69, P5263, DOI 10.1128/AEM.69.9.5263-5268.2003; Pinto AJ, 2012, ENVIRON SCI TECHNOL, V46, P8851, DOI 10.1021/es302042t; Pitkanen T, 2008, J WATER HEALTH, V6, P365, DOI 10.2166/wh.2008.050; Pitkanen T, 2013, ENVIRON SCI TECHNOL, V47, P13611, DOI 10.1021/es403489b; Pitkanen T, 2013, J MICROBIOL METH, V95, P39, DOI 10.1016/j.mimet.2013.06.008; Polaczyk AL, 2008, J MICROBIOL METH, V73, P92, DOI 10.1016/j.mimet.2008.02.014; Pradhan SK, 2013, J WATER HEALTH, V11, P581, DOI 10.2166/wh.2013.241; R Core Team R, 2013, R LANG ENV STAT COMP; Rasanen S, 2010, EPIDEMIOL INFECT, V138, P1227, DOI 10.1017/S0950268809991671; Reuter G, 2010, J CLIN MICROBIOL, V48, P363, DOI 10.1128/JCM.01279-09; Revez J, 2013, J FOOD PROTECT, V76, P1630, DOI 10.4315/0362-028X.JFP-13-083; Rhodes ER, 2011, J VIROL METHODS, V176, P38, DOI 10.1016/j.jviromet.2011.05.031; Richardson G, 2007, EPIDEMIOL INFECT, V135, P1151, DOI 10.1017/S0950268807007960; Riera-Montes M, 2011, EPIDEMIOL INFECT, V139, P1928, DOI 10.1017/S0950268810003146; Rimhanen-Finne R, 2010, SCAND J INFECT DIS, V42, P613, DOI 10.3109/00365541003774608; Ronnqvist M, 2013, J FOOD PROTECT, V76, P1421, DOI 10.4315/0362-028X.JFP-12-371; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siefring S, 2008, J WATER HEALTH, V6, P225, DOI 10.2166/wh.2008.022; Summa M, 2012, J CLIN VIROL, V53, P244, DOI 10.1016/j.jcv.2011.12.014; Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ter Waarbeek HLG, 2010, J CLIN VIROL, V47, P268, DOI 10.1016/j.jcv.2009.12.002; Teunis P, 2005, EPIDEMIOL INFECT, V133, P583, DOI 10.1017/S0950268805003912; Tillett HE, 1998, EPIDEMIOL INFECT, V120, P37, DOI 10.1017/S0950268897008431; Toledo-Hernandez C, 2013, APPL ENVIRON MICROB, V79, P1689, DOI 10.1128/AEM.03070-12; Tuite AR, 2011, ANN INTERN MED, V154, P593, DOI 10.7326/0003-4819-154-9-201105030-00334; van Maarseveen NM, 2010, J CLIN VIROL, V49, P205, DOI 10.1016/j.jcv.2010.07.019; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Volken T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-167; Zacheus O, 2011, J WATER HEALTH, V9, P763, DOI 10.2166/wh.2011.021	79	30	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104713	10.1371/journal.pone.0104713	http://dx.doi.org/10.1371/journal.pone.0104713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147923	Green Submitted, gold, Green Published			2022-12-25	WOS:000341230600018
J	Maharani, A; Tampubolon, G				Maharani, Asri; Tampubolon, Gindo			Unmet Needs for Cardiovascular Care in Indonesia	PLOS ONE			English	Article							RISK-FACTORS; HEALTH-CARE; GLOBAL BURDEN; DISEASE; PREVENTION; PREDICTION; POVERTY; IMPACT; ADULTS; WOMEN	Background: In the past twenty years the heaviest burden of cardiovascular diseases has begun to shift from developed to developing countries. However, little is known about the real needs for cardiovascular care in these countries and how well those needs are being met. This study aims to investigate the prevalence and determinants of unmet needs for cardiovascular care based on objective assessment. Methods and Findings: Multilevel analysis is used to analyse the determinants of met needs and multilevel multiple imputation is applied to manage missing data. The 2008 Indonesian Family Life Survey (IFLS4) survey is the source of the household data used in this study, while district data is sourced from the Ministry of Health and Ministry of Finance. The data shows that nearly 70% of respondents with moderate to high cardiovascular risk failed to receive cardiovascular care. Higher income, possession of health insurance and residence in urban areas are significantly associated with met needs for cardiovascular care, while health facility density and physician density show no association with them. Conclusions: The prevalence of unmet needs for cardiovascular care is considerable in Indonesia. Inequality persists as a factor in meeting needs for cardiovascular care as the needs of people with higher incomes and those living in urban areas are more likely to be met. Alleviation of poverty, provision of health care insurance for the poor, and improvement in the quality of healthcare providers are recommended in order to meet this ever-increasing need.	[Maharani, Asri] Univ Brawijaya, Fac Med, Malang, Indonesia; [Maharani, Asri; Tampubolon, Gindo] Univ Manchester, Inst Social Change, Manchester, Lancs, England	Brawijaya University; University of Manchester	Maharani, A (corresponding author), Univ Brawijaya, Fac Med, Malang, Indonesia.	asri.maharani@postgrad.manchester.ac.uk	Maharani, Asri/U-7663-2017	Maharani, Asri/0000-0002-5931-8692				Aji B, 2013, INT J ENV RES PUB HE, V10, P2995, DOI 10.3390/ijerph10072995; Allin S., 2009, Eurohealth, V15, P7; [Anonymous], INT J VASC MED, DOI DOI 10.1155/2013/786801); Asparouhov T., 2010, SIMPLE 2 ORDER CHI S, P1; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Bank Indonesia, 2007, EXCH RAT T BANK IND; Carpenter JR, 2010, MULTILEVEL MULTIPLE; Castro-Leal F, 1999, WORLD BANK RES OBSER, V14, P49, DOI 10.1093/wbro/14.1.49; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; CUTLER DM, 1992, AM ECON REV, V82, P546; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Duncan C, 1996, SOC SCI MED, V42, P817, DOI 10.1016/0277-9536(95)00181-6; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Filmer D, 2000, WORLD BANK RES OBSER, V15, P199, DOI 10.1093/wbro/15.2.199; Ford ES, 1998, J WOMENS HEALTH, V7, P997, DOI 10.1089/jwh.1998.7.997; Garcia-Gomez P, 2014, INEQUITY LONG TERM C; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; Heo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051004; Herr M, 2013, EUROPEAN J PUBLIC HL, P1; Hong Wang, 2009, PRIVATE SECTOR HLTH; Hu P, 2013, RAND LABOR POPULATIO; Institute for Health Metrics and Evaluation, 2014, GLOB BURD DIS PATT; Joshi R, 2008, J AM COLL CARDIOL, V52, P1817, DOI 10.1016/j.jacc.2008.08.049; Litaker D, 2005, HEALTH POLICY, V73, P183, DOI 10.1016/j.healthpol.2004.11.010; Manning C, 2011, INDONESIA UPDATE SER, P1; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Ministry of Health Republic of Indonesia, 2008, IND HLTH PROF 2008; Organisation for Economic Co-operation and Development (OECD), 2013, STRUCT POL COUNTR NO; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Peterson LE, 2010, J RURAL HEALTH, V26, P373, DOI 10.1111/j.1748-0361.2010.00309.x; POTERBA JM, 1989, AM ECON REV, V79, P325; Rannan-Eliya RP, 2010, ESTIMATING OUT OF PO; Ricketts T, 1999, POPULATIONS PLACES R; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rokx C, 2010, DIR DEV, P1, DOI 10.1596/978-0-8213-8298-1; Tattersall MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044347; The World Bank, 2008, DAT GDP PER CAP COUN; The World Bank, 2008, DAT POP COUNTR; WHO, 2003, NEGL GLOB EP 3 GROW; World Bank, 2008, INV IND HLTH CHALL O; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zaidi S., 2002, GUIDELINES CONSTRUCT	46	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105831	10.1371/journal.pone.0105831	http://dx.doi.org/10.1371/journal.pone.0105831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LL	25148389	Green Submitted, gold, Green Published			2022-12-25	WOS:000341230600088
J	Roxo, FF; Albert, JS; Silva, GSC; Zawadzki, CH; Foresti, F; Oliveira, C				Roxo, Fabio F.; Albert, James S.; Silva, Gabriel S. C.; Zawadzki, Claudio H.; Foresti, Fausto; Oliveira, Claudio			Molecular Phylogeny and Biogeographic History of the Armored Neotropical Catfish Subfamilies Hypoptopomatinae, Neoplecostominae and Otothyrinae (Siluriformes: Loricariidae)	PLOS ONE			English	Article							FRESH-WATER FISHES; GEOGRAPHIC RANGE; SOUTHERN BRAZIL; RIVER CAPTURE; EVOLUTION; EXTINCTION; DIVERSIFICATION; INFERENCE; GENUS; DISPERSAL	The main objectives of this study are estimate a species-dense, time-calibrated molecular phylogeny of Hypoptopomatinae, Neoplecostominae, and Otothyrinae, which together comprise a group of armoured catfishes that is widely distributed across South America, to place the origin of major clades in time and space, and to demonstrate the role of river capture on patterns of diversification in these taxa. We used maximum likelihood and Bayesian methods to estimate a time-calibrated phylogeny of 115 loricariid species, using three mitochondrial and one nuclear genes to generate a matrix of 4,500 base pairs, and used parametric biogeographic analyses to estimate ancestral geographic ranges and to infer the effects of river capture events on the geographic distributions of these taxa. Our analysis recovered Hypoptopomatinae, Neoplecostominae, and Otothyrinae as monophyletic with strong statistical support, and Neoplecostominae as more closely related to Otothyrinae than to Hypoptopomatinae. Our time-calibrated phylogeny and ancestral-area estimations indicate an origin of Hypoptopomatinae, Neoplecostominae, and Otothyrinae during the Lower Eocene in the Atlantic Coastal Drainages, from which it is possible to infer several dispersal events to adjacent river basins during the Neogene. In conclusion we infer a strong influence of river capture in: (1) the accumulation of modern clade species-richness values; (2) the formation of the modern basin-wide species assemblages, and (3) the presence of many low-diversity, early-branching lineages restricted to the Atlantic Coastal Drainages. We further infer the importance of headwater stream capture and marine transgressions in shaping patterns in the distributions of Hypoptopomatinae, Neoplecostominae and Otothyrinae throughout South America.	[Roxo, Fabio F.; Silva, Gabriel S. C.; Foresti, Fausto; Oliveira, Claudio] Univ Estadual Paulista, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil; [Albert, James S.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Zawadzki, Claudio H.] Univ Estadual Maringa, Nupelia, Maringa, PR, Brazil	Universidade Estadual Paulista; University of Louisiana Lafayette; Universidade Estadual de Maringa	Roxo, FF (corresponding author), Univ Estadual Paulista, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil.	roxoff@hotmail.com.br	Oliveira, Claudio/D-7713-2012; Zawadzki, Claudio H/X-2699-2018	Oliveira, Claudio/0000-0002-7010-8880; 	Brazilian agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/01610-9, 2012/01622-2]	Brazilian agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by the Brazilian agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, proc. 2010/01610-9 to FFR and proc. 2012/01622-2 to GSCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'saber AN, 1957, B PAULISTA GEOGRAFIA, V26, P38; Ab'Saber AN, 1998, GEOMORFOLOGIA BRASIL, P71; Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Albert J.S., 2010, NAT ED KNOWL, V3, P13; Albert JS, 2006, J S AM EARTH SCI, V21, P14, DOI 10.1016/j.jsames.2005.07.010; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P1; ALMEIDA Fernando F. M., 1998, REV BRAS GEOCIENC, V28, P135, DOI DOI 10.25249/0375-7536.1998135150; Armbruster JW, 2004, ZOOL J LINN SOC-LOND, V141, P1, DOI 10.1111/j.1096-3642.2004.00109.x; Armbruster JW, 1998, COPEIA, P663, DOI 10.2307/1447796; Arratia G, 1987, BONN ZOOL MONOGR, V24, P1, DOI DOI 10.1093/NAR/25.22.4692; Beheregaray LB, 2002, P ROY SOC B-BIOL SCI, V269, P65, DOI 10.1098/rspb.2001.1838; Bertuzzo E, 2009, WATER RESOUR RES, V45; Bishop P, 1995, PROG PHYS GEOG, V19, P449, DOI 10.1177/030913339501900402; Bizerril CRSF, 1994, ACTA BIOL LEOPOLDENS, V16, P51; Blakey R, 2006, PLATE TECTONICS CONT; Bloom DD, 2013, EVOLUTION, V67, P2040, DOI 10.1111/evo.12074; Bloom DD, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P137; Buckup PA, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P203; Carvalho TP, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P193; Chiachio MC, 2008, MOL PHYLOGENET EVOL, V49, P606, DOI 10.1016/j.ympev.2008.08.013; Cockerell TDA, 1925, SCIENCE, V62, P397, DOI 10.1126/science.62.1609.397-a; Covain R, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1462.1.1; Cox CB, 2005, BIOGEOGRAPHY ECOLOGI, P498; Cramer C.A., 2008, B FISH BIOL, V9, P51; Cramer CA, 2011, MOL PHYLOGENET EVOL, V59, P43, DOI 10.1016/j.ympev.2011.01.002; Silva José Francisco Pezzi da, 2004, Neotrop. ichthyol., V2, P55, DOI 10.1590/S1679-62252004000200002; de Pinna M. C. C., 1993, THESIS CITY U NEW YO; de Pinna Mario C.C., 1998, P279; do Amaral PG, 2012, QUATERN INT, V279, P120; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eigenmann C. H., 1891, Proceedings of the United States National Museum, Vxiv, P1; Eigenmann C.H., 1890, THESIS CALIFORNIA AC; Eigenmann Carl R., 1906, Popular Science Monthly, V68; Eschmeyer W. N. E., 2013, CATALOG FISHES; Eschmeyer WN, 2013, SPECIES FAMILY SUBFA; Fagan WF, 2002, ECOLOGY, V83, P3243, DOI 10.2307/3072074; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GOSLINE WA, 1947, ARQUIVOS MUSEU NACIO, V41, P79; Grande L., 1987, Journal of Vertebrate Paleontology, V7, P24; Grande L, 1998, J VERTEBR PALEONTOL, V18, P451, DOI 10.1080/02724634.1998.10011074; Grant EHC, 2007, ECOL LETT, V10, P165, DOI 10.1111/j.1461-0248.2006.01007.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hocutt CH, 1986, ZOOGEOGRAPHY FRESHWA; Howes G.J., 1983, Bulletin of the British Museum (Natural History) Zoology, V45, P309; Hubbell Stephen P., 2001, V32, pi; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ISBRUCKER I.J.H., 1980, VERSLAGEN TECHNISCHE, V22, P1; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jordan DS, 1896, SCI SKETCHES; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langeani F., 1990, COMUN MUS CIENC PU Z, V3, P3; Lieberman B. S., 2008, Proceedings of the Royal Society of Victoria, V120, P51; Lima FCT, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P145; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Lopez-Fernandez H, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P105; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Lucinda Paulo H. F., 2005, Neotrop. ichthyol., V3, P259, DOI 10.1590/S1679-62252005000200003; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; Lundberg John G., 1998, P13; Lundberg JG, 2007, P ACAD NAT SCI PHILA, V156, P39, DOI 10.1635/0097-3157(2007)156[39:DOARFT]2.0.CO;2; Malabarba LR, 2013, GUIA IDENTIFICACAO P; Marshall LG, 1997, J S AM EARTH SCI, V10, P49, DOI 10.1016/S0895-9811(97)00005-9; MAYDEN RL, 1988, SYST ZOOL, V37, P329, DOI 10.2307/2992197; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mo T, 1991, THESIS; Montoya-Burgos Juan-Ignacio, 1998, P363; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Nelson JA, 1999, J FISH BIOL, V54, P1069, DOI 10.1111/j.1095-8649.1999.tb00858.x; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Pearson N. E., 1937, Proceedings of the California Academy of Sciences, V23, P99; Pereira TL, 2013, J BIOGEOGR, V40, P905, DOI 10.1111/jbi.12044; Perez MHS, 2007, P ACAD NAT SCI PHILA, V156, P157, DOI 10.1635/0097-3157(2007)156[157:FCOTFD]2.0.CO;2; PITMAN WC, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P15; Ponte F.C., 1997, B GEOCIENCIAS PETROB, V11, P1; Pyron RA, 2013, TRENDS ECOL EVOL, V28, P729, DOI 10.1016/j.tree.2013.09.007; Rabosky DL, 2013, ANN REV ECOL EVOL SY, V44; Rambaut A, 2007, TREEANNOTATOR V1 7 5; Rambaut A, 2007, TRACERV1 5; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; REGAN C.T., 1904, T ZOOL SOC LONDON, V17, P191, DOI [DOI 10.1111/J.1096-3642.1904.TB00040.X, 10.1111/j.1096-3642.1904.tbOO040.x]; Reis R. E., 2013, International Zoo Yearbook, V47, P65, DOI 10.1111/izy.12000; Reis R. E., 2003, CLOFFSCA CHECK LIST; Reis RE, 2006, ZOOL J LINN SOC-LOND, V147, P277, DOI 10.1111/j.1096-3642.2006.00229.x; REIS RE, 1990, REV SUISSE ZOOL, V97, P729, DOI 10.5962/bhl.part.79760; Reis Roberto E., 1998, American Museum Novitates, V0, P1; Ribeiro AC, 2013, NEOTROP ICHTHYOL, V11, P319, DOI 10.1590/S1679-62252013000200010; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; Rosa RS, 2004, ECOLOGIA CONSERVACAO, P135; Roxo FF, 2012, ZOOTAXA, P33, DOI 10.11646/zootaxa.3390.1.3; Roxo FF, 2012, ECOL EVOL, V2, P2438, DOI 10.1002/ece3.368; Sabaj Mark H., 1999, Ichthyological Exploration of Freshwaters, V10, P217; SCHAEFER SA, 1991, ZOOL J LINN SOC-LOND, V102, P1, DOI 10.1111/j.1096-3642.1991.tb01535.x; Schaefer SA, 1987, NAT HIST MUS LOS ANG, V394, P1; Schaefer Scott A., 1998, P375; Scotese CR, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P9; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SMITH GR, 1981, ANNU REV ECOL SYST, V12, P163, DOI 10.1146/annurev.es.12.110181.001115; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vari Richard P., 1998, P1; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; VRBA ES, 1984, SYST ZOOL, V33, P318, DOI 10.2307/2413077; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waters JM, 2006, BIOL J LINN SOC, V88, P367, DOI 10.1111/j.1095-8312.2004.00622.x; Wilkinson MJ, 2006, J S AM EARTH SCI, V21, P151, DOI 10.1016/j.jsarnes.2005.08.002; Wilkinson MJ, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P162; Winemiller KO, 2008, J BIOGEOGR, V35, P1551, DOI 10.1111/j.1365-2699.2008.01917.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	124	78	81	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105564	10.1371/journal.pone.0105564	http://dx.doi.org/10.1371/journal.pone.0105564			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148406	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600058
J	Speth, RC; Carrera, EJ; Breton, C; Linares, A; Gonzalez-Reiley, L; Swindle, JD; Santos, KL; Schadock, I; Bader, M; Karamyan, VT				Speth, Robert C.; Carrera, Eduardo J.; Breton, Catalina; Linares, Andrea; Gonzalez-Reiley, Luz; Swindle, Jamala D.; Santos, Kira L.; Schadock, Ines; Bader, Michael; Karamyan, Vardan T.			Distribution of Non-AT(1), Non-AT(2) Binding of I-125-Sarcosine(1), Isoleucine(8) Angiotensin II in Neurolysin Knockout Mouse Brains	PLOS ONE			English	Article							RECEPTOR SUBTYPES; CONVERTING ENZYME; AT(2) RECEPTOR; RAT-BRAIN; PROLYL ENDOPEPTIDASE; TYPE-2 RECEPTOR; AT(1) RECEPTOR; UP-REGULATION; 3-7 FRAGMENT; SYSTEM	The recent identification of a novel binding site for angiotensin (Ang) II as the peptidase neurolysin (E.C. 3.4.24.16) has implications for the renin-angiotensin system (RAS). This report describes the distribution of specific binding of I-125-Sarcosine(1), Isoleucine(8) Ang II (I-125-SI Ang II) in neurolysin knockout mouse brains compared to wild-type mouse brains using quantitative receptor autoradiography. In the presence of p-chloromercuribenzoic acid (PCMB), which unmasks the novel binding site, widespread distribution of specific (3 mu M Ang II displaceable) I-125-SI Ang II binding in 32 mouse brain regions was observed. Highest levels of binding >700 fmol/g initial wet weight were seen in hypothalamic, thalamic and septal regions, while the lowest level of binding <300 fmol/g initial wet weight was in the mediolateralmedulla. I-125-SI Ang II binding was substantially higher by an average of 85% in wild-type mouse brains compared to neurolysin knockout brains, suggesting the presence of an additional non-AT(1), non-AT(2), non-neurolysin Ang II binding site in the mouse brain. Binding of I-125-SI Ang II to neurolysin in the presence of PCMB was highest in hypothalamic and ventral cortical brain regions, but broadly distributed across all regions surveyed. Non-AT(1), non-AT(2), non-neurolysin binding was also highest in the hypothalamus but had a different distribution than neurolysin. There was a significant reduction in AT(2) receptor binding in the neurolysin knockout brain and a trend towards decreased AT(1) receptor binding. In the neurolysin knockout brains, the size of the lateral ventricles was increased by 56% and the size of the mid forebrain (-22.72 to +1.48 relative to Bregma) was increased by 12%. These results confirm the identity of neurolysin as a novel Ang II binding site, suggesting that neurolysin may play a significant role in opposing the pathophysiological actions of the brain RAS and influencing brain morphology.	[Speth, Robert C.; Carrera, Eduardo J.; Breton, Catalina] Nova SE Univ, Dept Pharmaceut Sci, Ft Lauderdale, FL 33314 USA; [Speth, Robert C.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Carrera, Eduardo J.; Breton, Catalina; Linares, Andrea; Gonzalez-Reiley, Luz; Swindle, Jamala D.; Santos, Kira L.] Nova SE Univ, Farquhar Coll Arts & Sci, Ft Lauderdale, FL 33314 USA; [Santos, Kira L.] Univ Florida, Coll Dent, Gainesville, FL USA; [Schadock, Ines; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Karamyan, Vardan T.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX USA; [Karamyan, Vardan T.] Texas Tech Univ, Hlth Sci Ctr, Ctr Blood Brain Barrier Res, Amarillo, TX USA	Nova Southeastern University; State University System of Florida; University of Florida; Nova Southeastern University; State University System of Florida; University of Florida; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Speth, RC (corresponding author), Nova SE Univ, Dept Pharmaceut Sci, Ft Lauderdale, FL 33314 USA.	rs1251@nova.edu	Bader, Michael/K-2124-2013	Bader, Michael/0000-0003-4780-4164; Schadock, Ines/0000-0002-6717-6276	 [HL-096357];  [HL-113905]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL096357, R15HL113905] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by HL-096357 https://www.nhlbi.nih.gov/ and HL-113905 https://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENELLI G, 1964, BRIT J PHARM CHEMOTH, V22, P211, DOI 10.1111/j.1476-5381.1964.tb01561.x; BRASZKO JJ, 1995, BRAIN RES BULL, V37, P627, DOI 10.1016/0361-9230(95)00056-K; BRASZKO JJ, 1991, BRAIN RES, V542, P49, DOI 10.1016/0006-8993(91)90996-9; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; BROWNLEES J, 1993, J NEUROCHEM, V60, P793, DOI 10.1111/j.1471-4159.1993.tb03223.x; Brunton L, 2011, GOODMAN GILMANS PHAR, P721; CAMPBELL DJ, 1987, J CLIN INVEST, V79, P1, DOI 10.1172/JCI112768; Cavalcanti DMLP, 2014, J BIOL CHEM, V289, P15426, DOI 10.1074/jbc.M113.539148; CHAUVEL EN, 1994, J MED CHEM, V37, P2950, DOI 10.1021/jm00044a016; Coleman CG, 2009, NEUROSCIENCE, V163, P129, DOI 10.1016/j.neuroscience.2009.06.032; Cote F, 1999, J BIOL CHEM, V274, P31686, DOI 10.1074/jbc.274.44.31686; Cunningham DF, 1998, INT J BIOCHEM CELL B, V30, P99, DOI 10.1016/S1357-2725(97)00076-9; DAHMS P, 1992, EUR J BIOCHEM, V208, P145, DOI 10.1111/j.1432-1033.1992.tb17168.x; Daubert DL, 1999, BRAIN RES, V816, P8, DOI 10.1016/S0006-8993(98)00930-5; DAVIS JO, 1962, J CLIN INVEST, V41, P378, DOI 10.1172/JCI104492; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Epstein A.N., 1978, FRONT NEUROENDOCRIN, VVolume 5, P101; FELDBERG W, 1964, J PHYSIOL-LONDON, V171, P98, DOI 10.1113/jphysiol.1964.sp007364; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; Fleegal-DeMotta MA, 2009, J CEREBR BLOOD F MET, V29, P640, DOI 10.1038/jcbfm.2008.158; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GANTEN D, 1971, SCIENCE, V173, P64, DOI 10.1126/science.173.3991.64; Guimond MO, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/351758; Hauser W, 1998, EUR J PHARMACOL, V348, P101, DOI 10.1016/S0014-2999(98)00134-4; Jenkins TA, 1997, BRAIN RES, V748, P137, DOI 10.1016/S0006-8993(96)01276-0; JOHNSTON CI, 1990, DRUGS, V39, P21, DOI 10.2165/00003495-199000391-00005; Johren O, 1997, BRAIN RES, V757, P218, DOI 10.1016/S0006-8993(97)00220-5; Karamyan V, 2009, EXP BIOL M APR 2009; Karamyan VT, 2008, LIFE SCI, V83, P421, DOI 10.1016/j.lfs.2008.07.003; Karamyan VT, 2008, EUR J PHARMACOL, V590, P87, DOI 10.1016/j.ejphar.2008.05.035; Karamyan VT, 2007, REGUL PEPTIDES, V143, P15, DOI 10.1016/j.regpep.2007.03.006; Karamyan VT, 2007, BRAIN RES, V1143, P83, DOI 10.1016/j.brainres.2007.01.051; Karamyan VT, 2009, J PHARMACOL EXP THER, V331, P170, DOI 10.1124/jpet.109.157461; Karamyan VT, 2008, NEUROENDOCRINOLOGY, V88, P256, DOI 10.1159/000140635; KATO A, 1994, EUR J BIOCHEM, V221, P159, DOI 10.1111/j.1432-1033.1994.tb18725.x; KONO T, 1985, ENDOCRINOL JAPON, V32, P767; Kumar R, 2007, TRENDS ENDOCRIN MET, V18, P208, DOI 10.1016/j.tem.2007.05.001; LARAGH JH, 1960, JAMA-J AM MED ASSOC, V174, P234, DOI 10.1001/jama.1960.03030030014003; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; NAKAJIMA M, 1995, P NATL ACAD SCI USA, V92, P10663, DOI 10.1073/pnas.92.23.10663; OBERMULLER N, 1991, NEUROSCI LETT, V132, P11, DOI 10.1016/0304-3940(91)90420-X; ODYA CE, 1978, J BIOL CHEM, V253, P5927; OLeary RM, 1996, INT J BIOCHEM CELL B, V28, P441, DOI 10.1016/1357-2725(95)00154-9; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; Rashid M, 2014, J NEUROCHEM, V129, P179, DOI 10.1111/jnc.12513; Rashid M, 2010, J PHARMACOL EXP THER, V335, P754, DOI 10.1124/jpet.110.171439; Re RN, 2008, J CLIN PHARMACOL, V48, P344, DOI 10.1177/0091270007312155; Reinecke K, 2003, FASEB J, V17, P2094, DOI 10.1096/fj.02-1193fje; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; ROWE BP, 1990, EUR J PHARMACOL, V186, P339, DOI 10.1016/0014-2999(90)90457-H; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; SERIZAWA A, 1995, J BIOL CHEM, V270, P2092, DOI 10.1074/jbc.270.5.2092; SEVERS WB, 1966, J PHARMACOL EXP THER, V153, P530; SONG KF, 1991, CLIN EXP PHARMACOL P, V18, P93, DOI 10.1111/j.1440-1681.1991.tb01414.x; Speth RC, 2003, REGUL PEPTIDES, V115, P203, DOI 10.1016/S0167-0115(03)00172-1; Speth RC, 2001, METH MOLEC MED, V51, P275, DOI 10.1385/1-59259-087-X:275; Speth RC, 1999, AM J PHYSIOL-REG I, V277, pR904, DOI 10.1152/ajpregu.1999.277.3.R904; Steckelings UM, 2010, J RENIN-ANGIO-ALDO S, V11, P67, DOI 10.1177/1470320309347791; STRITTMATTER SM, 1984, P NATL ACAD SCI-BIOL, V81, P1599, DOI 10.1073/pnas.81.5.1599; TSUTSUMI K, 1991, J NEUROCHEM, V56, P348, DOI 10.1111/j.1471-4159.1991.tb02602.x; Unger T, 1999, J HYPERTENS, V17, P1775, DOI 10.1097/00004872-199917121-00001; Wangler NJ, 2012, J BIOL CHEM, V287, P114, DOI 10.1074/jbc.M111.273052; Wright JW, 2013, PFLUG ARCH EUR J PHY, V465, P133, DOI 10.1007/s00424-012-1102-2; YANG HYT, 1972, J NEUROCHEM, V19, P2443, DOI 10.1111/j.1471-4159.1972.tb01298.x; Zhang M, 2010, NEUROSCIENCE, V171, P852, DOI 10.1016/j.neuroscience.2010.09.029; ZIMMERMAN B. G., 1967, INT J NEUROPHARMACOL, V6, P27, DOI 10.1016/0028-3908(67)90039-1	69	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105762	10.1371/journal.pone.0105762	http://dx.doi.org/10.1371/journal.pone.0105762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147932	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000341230600078
J	Sasore, T; Kennedy, B				Sasore, Temitope; Kennedy, Breandan			Deciphering Combinations of PI3K/AKT/mTOR Pathway Drugs Augmenting Anti-Angiogenic Efficacy In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; RENAL-CELL CARCINOMA; MACULAR DEGENERATION; PHOSPHOINOSITIDE 3-KINASE; INTRAVITREAL INJECTION; VISUAL FUNCTION; ZEBRAFISH; EXPRESSION; VEGF	Ocular neovascularization is a common pathology associated with human eye diseases e.g. age-related macular degeneration and proliferative diabetic retinopathy. Blindness represents one of the most feared disabilities and remains a major burden to health-care systems. Current approaches to treat ocular neovascularisation include laser photocoagulation, photodynamic therapy and anti-VEGF therapies: Ranibizumab (Lucentis) and Aflibercept (Eylea). However, high clinical costs, frequent intraocular injections, and increased risk of infections are challenges related with these standards of care. Thus, there is a clinical need to develop more effective drugs that overcome these challenges. Here, we focus on an alternative approach by quantifying the in vivo anti-angiogenic efficacy of combinations of phosphatidylinositol-3-kinase (PI3K) pathway inhibitors. The PI3K/AKT/mTOR pathway is a complex signalling pathway involved in crucial cellular functions such as cell proliferation, migration and angiogenesis. RT-PCR confirms the expression of PI3K target genes (pik3ca, pik3r1, mtor and akt1) in zebrafish trunks from 6 hours post fertilisation (hpf) and in eyes from 2 days post fertilisation (dpf). Using both the zebrafish intersegmental vessel and hyaloid vessel assays to measure the in vivo anti-angiogenic efficacy of PI3K/Akt/mTOR pathway inhibitors, we identified 5 mu M combinations of i) NVP-BEZ235 (dual PI3K-mTOR inhibitor) + PI-103 (dual PI3K-mTOR inhibitor); or ii) LY-294002 (pan-PI3K inhibitor) + NVP-BEZ235; or iii) NVP-BEZ235 + rapamycin (mTOR inhibitor); or iv) LY-294002 + rapamycin as the most anti-angiogenic. Treatment of developing larvae from 2-5 dpf with 5 mu M NVP-BEZ235 plus PI-103 resulted in an essentially intact ocular morphology and visual behaviour, whereas other combinations severely disrupted the developing retinal morphology and visual function. In human ARPE19 retinal pigment epithelium cells, however, no significant difference in cell number was observed following treatment with the inhibitor combinations. Collectively, these results highlight the potential of combinations of PI3K/AKT/mTOR pathway inhibitors to safely and effectively treat ocular neovascularization.	[Sasore, Temitope; Kennedy, Breandan] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland	University College Dublin	Kennedy, B (corresponding author), Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland.	brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019	kennedy, Breandan/0000-0001-7991-4689	Irish Research Council; Marie Curie Actions- Industry-Academia Partnerships and Pathways (IAPP) [612218 (3D-NET)]	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Marie Curie Actions- Industry-Academia Partnerships and Pathways (IAPP)	This research was supported by an Irish Research Council postgraduate scholarship (TS) and a Marie Curie Actions- Industry-Academia Partnerships and Pathways (IAPP) grant #612218 (3D-NET) (BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Bowles DW, 2014, CLIN CANCER RES, V20, P1656, DOI 10.1158/1078-0432.CCR-13-2506; Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255; Cai J, 2003, DIABETES, V52, P2959, DOI 10.2337/diabetes.52.12.2959; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Childs S, 2002, DEVELOPMENT, V129, P973; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Dalal M, 2013, GRAEF ARCH CLIN EXP, V251, P2705, DOI 10.1007/s00417-013-2375-7; Dejneka NS, 2004, MOL VIS, V10, P964; Dhakal S, 2013, INVEST OPHTHALMOL VI; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Frost, 2011, US RETINAL THERAPEUT; Gao GQ, 2002, DRUG DISCOV TODAY, V7, P171, DOI 10.1016/S1359-6446(01)02160-2; Georgopoulos M, 2009, BRIT J OPHTHALMOL, V93, P457, DOI 10.1136/bjo.2008.138479; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kidd KR, 2003, BRIT J PHARMACOL, V140, P585, DOI 10.1038/sj.bjp.0705496; Kilarski WW, 2012, ANGIOGENESIS, V15, P643, DOI 10.1007/s10456-012-9287-8; Kim SY, 2002, RETINA-J RET VIT DIS, V22, P464, DOI 10.1097/00006982-200208000-00011; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krishnadev N, 2011, GRAEF ARCH CLIN EXP, V249, P1627, DOI 10.1007/s00417-011-1694-9; Lang I, 2013, LANCET ONCOL, V14, P125, DOI 10.1016/S1470-2045(12)70566-1; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lien S., 2008, V181, P131; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Mazzoletti M, 2011, CANCER RES, V71, P4573, DOI 10.1158/0008-5472.CAN-10-4322; MEYER FA, 1990, ARTHRITIS RHEUM, V33, P1518, DOI 10.1002/art.1780331009; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2005, OPHTHAL SURG LAS IM, V36, P331, DOI 10.3928/1542-8877-20050701-14; Roulin D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-90; Sampat KM, 2010, CURR OPIN OPHTHALMOL, V21, P178, DOI 10.1097/ICU.0b013e328338679a; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Short BG, 2008, TOXICOL PATHOL, V36, P49, DOI 10.1177/0192623307310955; Stevens CB, 2012, INVEST OPHTHALMOL VI, P3960; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Werzowa J, 2011, J INVEST DERMATOL, V131, P495, DOI 10.1038/jid.2010.327; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-50; Yu WZ, 2008, OPHTHALMIC RES, V40, P19, DOI 10.1159/000111154; Zhao SL, 2001, MOL VIS, V7, P277	55	32	33	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105280	10.1371/journal.pone.0105280	http://dx.doi.org/10.1371/journal.pone.0105280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144531	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100046
J	Kiss, A; Tratsiakovich, Y; Gonon, AT; Fedotovskaya, O; Lanner, JT; Andersson, DC; Yang, JN; Pernow, J				Kiss, Attila; Tratsiakovich, Yahor; Gonon, Adrian T.; Fedotovskaya, Olga; Lanner, Johanna T.; Andersson, Daniel C.; Yang, Jiangning; Pernow, John			The Role of Arginase and Rho Kinase in Cardioprotection from Remote Ischemic Perconditioning in Non-Diabetic and Diabetic Rat In Vivo	PLOS ONE			English	Article							PPAR-ALPHA ACTIVATION; REDUCES INFARCT SIZE; NITRIC-OXIDE; MYOCARDIAL-ISCHEMIA; REPERFUSION INJURY; UP-REGULATION; INHIBITION; HEART; PEROXYNITRITE; DYSFUNCTION	Background: Pharmacological inhibition of arginase and remote ischemic perconditioning (RIPerc) are known to protect the heart against ischemia/reperfusion (IR) injury. Purpose: The objective of this study was to investigate whether (1) peroxynitrite-mediated RhoA/Rho associated kinase (ROCK) signaling pathway contributes to arginase upregulation following myocardial IR; (2) the inhibition of this pathway is involved as a cardioprotective mechanism of remote ischemic perconditioning and (3) the influence of diabetes on these mechanisms. Methods: Anesthetized rats were subjected to 30 min left coronary artery ligation followed by 2 h reperfusion and included in two protocols. In protocol 1 rats were randomized to 1) control IR, 2) RIPerc induced by bilateral femoral artery occlusion for 15 min during myocardial ischemia, 3) RIPerc and administration of the nitric oxide synthase inhibitor N-G-monomethyl-L-arginine (L-NMMA), 4) administration of the ROCK inhibitor hydroxyfasudil or 5) the peroxynitrite decomposition catalyst FeTPPS. In protocol 2 non-diabetic and type 1 diabetic rats were randomosed to IR or RIPerc as described above. Results: Infarct size was significantly reduced in rats treated with FeTPPS, hydroxyfasudil and RIPerc compared to controls (P<0.001). FeTPPS attenuated both ROCK and arginase activity (P<0.001 vs. control). Similarly, RIPerc reduced arginase and ROCK activity, peroxynitrite formation and enhanced phospho-eNOS expression (P<0.05 vs. control). The cardioprotective effect of RIPerc was abolished by L-NMMA. The protective effect of RIPerc and its associated changes in arginase and ROCK activity were abolished in diabetes. Conclusion: Arginase is activated by peroxynitrite/ROCK signaling cascade in myocardial IR. RIPerc protects against IR injury via a mechanism involving inhibition of this pathway and enhanced eNOS activation. The beneficial effect and associated molecular changes of RIPerc is abolished in type 1 diabetes.	[Kiss, Attila; Tratsiakovich, Yahor; Andersson, Daniel C.; Yang, Jiangning; Pernow, John] Karolinska Inst, Karolinska Univ Hosp, Div Cardiol, Dept Med, Stockholm, Sweden; [Gonon, Adrian T.] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Physiol, Stockholm, Sweden; [Fedotovskaya, Olga; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Kiss, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Div Cardiol, Dept Med, Stockholm, Sweden.	attila.kiss@ki.se	Kiss, Attila/ABF-3583-2021; Andersson, Daniel/AAE-9968-2019	Kiss, Attila/0000-0003-4652-1998; Andersson, Daniel/0000-0003-4548-702X; Lanner, Johanna/0000-0002-1222-9473; Pernow, John/0000-0003-4766-0922; GONON, ADRIAN/0000-0002-9337-3679	Swedish Research Council Medicine [10857]; Swedish Heart and Lung Foundation; Stockholm County Council (ALF); Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme; Gustav V and Queen Victoria Foundation; European Foundation for the Study of Diabetes; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF14OC0010417] Funding Source: researchfish	Swedish Research Council Medicine(Swedish Research Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council (ALF)(Stockholm County Council); Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme; Gustav V and Queen Victoria Foundation; European Foundation for the Study of Diabetes; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work supported by the Swedish Research Council Medicine (10857), the Swedish Heart and Lung Foundation, the Stockholm County Council (ALF), Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme, Gustav V and Queen Victoria Foundation, European Foundation for the Study of Diabetes and Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnost T, 2008, J HYPERTENS, V26, P1110, DOI 10.1097/HJH.0b013e3282fcc357; Basalay M, 2012, EXP PHYSIOL, V97, P908, DOI 10.1113/expphysiol.2012.064923; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Bulhak A, 2006, BASIC RES CARDIOL, V101, P244, DOI 10.1007/s00395-005-0580-1; Bulhak AA, 2009, AM J PHYSIOL-HEART C, V296, pH719, DOI 10.1152/ajpheart.00394.2008; Chandra S, 2012, BRIT J PHARMACOL, V165, P506, DOI 10.1111/j.1476-5381.2011.01584.x; Cicek FA, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-51; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Ferdinandy P, 2003, BRIT J PHARMACOL, V138, P532, DOI 10.1038/sj.bjp.0705080; Gonon AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042038; Gonon AT, 2000, J CARDIOVASC PHARM, V36, P405, DOI 10.1097/00005344-200009000-00018; Gronros J, 2013, ACTA PHYSIOL, V208, P172, DOI 10.1111/apha.12097; Hamid SA, 2007, AM J PHYSIOL-HEART C, V292, pH2598, DOI 10.1152/ajpheart.01393.2006; JOHNSON G, 1991, CRIT CARE MED, V19, P244, DOI 10.1097/00003246-199102000-00021; Zhang J, 2010, MOL MED, V16, P307, DOI 10.2119/molmed.2009.00121; Jung C, 2010, CARDIOVASC RES, V85, P147, DOI 10.1093/cvr/cvp303; Kristiansen SB, 2004, DIABETOLOGIA, V47, P1716, DOI 10.1007/s00125-004-1514-4; LEFER DJ, 1993, CIRCULATION, V88, P2337, DOI 10.1161/01.CIR.88.5.2337; Loukili N, 2011, CARDIOVASC RES, V89, P586, DOI 10.1093/cvr/cvq373; Maliszewska-Scislo M, 2003, AM J PHYSIOL-HEART C, V284, pH1601, DOI 10.1152/ajpheart.00578.2002; Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pernow J, 2013, CARDIOVASC RES, V98, P334, DOI 10.1093/cvr/cvt036; Przyklenk K, 2011, DRUG AGING, V28, P331, DOI 10.2165/11587190-000000000-00000; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Schmidt MR, 2007, AM J PHYSIOL-HEART C, V292, pH1883, DOI 10.1152/ajpheart.00617.2006; Tang YH, 2011, CHINESE MED J-PEKING, V124, P1683, DOI 10.3760/cma.j.issn.0366-6999.2011.11.015; Tratsiakovich Y, 2013, EUR J PHARMACOL, V712, P16, DOI 10.1016/j.ejphar.2013.04.044; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Utsunomiya T, 2001, BRIT J PHARMACOL, V134, P1724, DOI 10.1038/sj.bjp.0704410; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Zhao JL, 2009, INT J CARDIOL, V133, P179, DOI 10.1016/j.ijcard.2007.12.024; Zhou H, 2012, CURR PHARM DESIGN, V18, P2964, DOI 10.2174/138161212800672688	34	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104731	10.1371/journal.pone.0104731	http://dx.doi.org/10.1371/journal.pone.0104731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140754	Green Submitted, gold, Green Published			2022-12-25	WOS:000342687200029
J	Sabour, D; Xu, XP; Chung, ACK; Le Menuet, D; Ko, K; Tapia, N; Arauzo-Bravo, MJ; Gentile, L; Greber, B; Hubner, K; Sebastiano, V; Wu, GM; Scholer, HR; Cooney, AJ				Sabour, Davood; Xu, Xueping; Chung, Arthur C. K.; Le Menuet, Damien; Ko, Kinarm; Tapia, Natalia; Arauzo-Bravo, Marcos J.; Gentile, Luca; Greber, Boris; Huebner, Karin; Sebastiano, Vittorio; Wu, Guangming; Schoeler, Hans R.; Cooney, Austin J.			Germ Cell Nuclear Factor Regulates Gametogenesis in Developing Gonads	PLOS ONE			English	Article							MOUSE PROTAMINE GENES; ORPHAN RECEPTOR; RETINOIC ACID; DNA-BINDING; MEIOTIC INITIATION; EXPRESSION; GCNF; PLURIPOTENCY; REPRESSION; CLONING	Expression of germ cell nuclear factor (GCNF; Nr6a1), an orphan member of the nuclear receptor gene family of transcription factors, during gastrulation and neurulation is critical for normal embryogenesis in mice. Gcnf represses the expression of the POU-domain transcription factor Oct4 (Pou5f1) during mouse post-implantation development. Although Gcnf expression is not critical for the embryonic segregation of the germ cell lineage, we found that sexually dimorphic expression of Gcnf in germ cells correlates with the expression of pluripotency-associated genes, such as Oct4, Sox2, and Nanog, as well as the early meiotic marker gene Stra8. To elucidate the role of Gcnf during mouse germ cell differentiation, we generated an ex vivo Gcnf-knockdown model in combination with a regulated CreLox mutation of Gcnf. Lack of Gcnf impairs normal spermatogenesis and oogenesis in vivo, as well as the derivation of germ cells from embryonic stem cells (ESCs) in vitro. Inactivation of the Gcnf gene in vivo leads to loss of repression of Oct4 expression in both male and female gonads.	[Sabour, Davood; Tapia, Natalia; Arauzo-Bravo, Marcos J.; Gentile, Luca; Greber, Boris; Huebner, Karin; Wu, Guangming; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Xu, Xueping; Chung, Arthur C. K.; Le Menuet, Damien; Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Chung, Arthur C. K.] Univ Hong Kong, Ctr Inflammatory Dis & Mol Therapies, Pokfulam, Hong Kong, Peoples R China; [Le Menuet, Damien] Fac Med Paris Sud, INSERM, U693, Paris, France; [Ko, Kinarm] Konkuk Univ, Inst Biomed Sci & Technol, Ctr Stem Cell Res, Seoul, South Korea; [Ko, Kinarm] Konkuk Univ, Inst Biomed Sci & Technol, Sch Med, Dept Neurosci, Seoul, South Korea; [Arauzo-Bravo, Marcos J.] Biodonostia Hlth Res Inst, Grp Computat Biol & Syst Biomed, San Sebastian, Spain; [Sebastiano, Vittorio] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Baylor College of Medicine; University of Hong Kong; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Konkuk University; Konkuk University; Konkuk University Medical Center; Instituto de Investigacion Sanitaria Biodonostia; Stanford University; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de; acooney@bcm.edu	, HS/AAB-4434-2019; Le Menuet, Damien/B-1489-2019; Marcos, Arauzo-Bravo/A-1706-2011; Gentile, Luca/E-4908-2019; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Le Menuet, Damien/0000-0002-0802-7190; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Gentile, Luca/0000-0002-7393-7502; Wu, Guangming/0000-0003-1923-7609; Greber, Boris/0000-0002-9404-7293; Tapia, Natalia/0000-0003-0226-1952	Max Planck Society; DFG [FOR 1041]; National Institutes of Health grant [NIH P01 GM081627]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Max Planck Society and the DFG grant for research unit germ cell potential, FOR 1041 (HSR) and National Institutes of Health grant NIH P01 GM081627 (AJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik IY, 1998, FEBS LETT, V424, P73, DOI 10.1016/S0014-5793(98)00142-2; Akamatsu W, 2009, J NEUROSCI, V29, P2113, DOI 10.1523/JNEUROSCI.4527-08.2009; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Barreto G, 2003, MECH DEVELOP, V120, P415, DOI 10.1016/S0925-4773(03)00018-2; Braat AK, 1999, MOL REPROD DEV, V53, P369, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;369::AID-MRD1&gt;3.0.CO;2-U; CHEN F, 1994, MOL ENDOCRINOL, V8, P1434, DOI 10.1210/me.8.10.1434; Chung ACK, 2006, DEV BIOL, V293, P13, DOI 10.1016/j.ydbio.2005.12.017; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; Chung ACK, 2001, INT J BIOCHEM CELL B, V33, P1141, DOI 10.1016/S1357-2725(01)00081-4; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Gu PL, 2011, STEM CELLS, V29, P1041, DOI 10.1002/stem.652; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; HIROSE T, 1995, GENE, V152, P247, DOI 10.1016/0378-1119(94)00656-D; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Hummelke GC, 2004, MOL REPROD DEV, V68, P394, DOI 10.1002/mrd.20092; Hummelke GC, 2001, FRONT BIOSCI, V6, pD1186, DOI 10.2741/Hummelke; Hummelke GC, 1998, MOL REPROD DEV, V50, P396, DOI 10.1002/(SICI)1098-2795(199808)50:4<396::AID-MRD3>3.0.CO;2-D; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Joos TO, 1996, MECH DEVELOP, V60, P45, DOI 10.1016/S0925-4773(96)00599-0; Katz D, 1997, ENDOCRINOLOGY, V138, P4364, DOI 10.1210/en.138.10.4364; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lan ZJ, 2003, EMBO J, V22, P4070, DOI 10.1093/emboj/cdg405; Lan ZJ, 2003, BIOL REPROD, V68, P282, DOI 10.1095/biolreprod.102.008151; Lan ZJ, 2002, J BIOL CHEM, V277, P50660, DOI 10.1074/jbc.M209586200; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Okumura LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066062; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Sabour D, 2011, HUM MOL GENET, V20, P115, DOI 10.1093/hmg/ddq450; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Schmitz TP, 1999, BBA-GENE STRUCT EXPR, V1446, P173, DOI 10.1016/S0167-4781(99)00079-2; Susens U, 1997, DEV NEUROSCI-BASEL, V19, P410, DOI 10.1159/000111238; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wu GM, 2005, GENETICS, V170, P327, DOI 10.1534/genetics.104.039479; Yan ZH, 1997, J BIOL CHEM, V272, P10565; Yang GY, 2003, BIOL REPROD, V68, P1620, DOI 10.1095/biolreprod.102.012013; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhang YL, 1998, MOL REPROD DEV, V50, P93, DOI 10.1002/(SICI)1098-2795(199805)50:1&lt;93::AID-MRD12&gt;3.0.CO;2-Z	50	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103985	10.1371/journal.pone.0103985	http://dx.doi.org/10.1371/journal.pone.0103985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140725	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200010
J	Spencer, AJ; Furze, J; Honeycutt, JD; Calvert, A; Saurya, S; Colloca, S; Wyllie, DH; Gilbert, SC; Bregu, M; Cottingham, MG; Hill, AVS				Spencer, Alexandra J.; Furze, Julie; Honeycutt, Jared D.; Calvert, Alice; Saurya, Saroj; Colloca, Stefano; Wyllie, David H.; Gilbert, Sarah C.; Bregu, Migena; Cottingham, Matthew G.; Hill, Adrian V. S.			4-1BBL Enhances CD8(+) T Cell Responses Induced by Vectored Vaccines in Mice but Fails to Improve Immunogenicity in Rhesus Macaques	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; DENDRITIC CELLS; COSTIMULATORY MOLECULES; PROTECTIVE IMMUNITY; ADENOVIRAL VECTOR; MALARIA VACCINES; VIRUS ANKARA; DNA VACCINE; IN-VIVO; EXPRESSION	T cells play a central role in the immune response to many of the world's major infectious diseases. In this study we investigated the tumour necrosis factor receptor superfamily costimulatory molecule, 4-1BBL (CD137L, TNFSF9), for its ability to increase T cell immunogenicity induced by a variety of recombinant vectored vaccines. To efficiently test this hypothesis, we assessed a number of promoters and developed a stable bi-cistronic vector expressing both the antigen and adjuvant. Co-expression of 4-1BBL, together with our model antigen TIP, was shown to increase the frequency of murine antigen-specific IFN-gamma secreting CD8(+) T cells in three vector platforms examined. Enhancement of the response was not limited by co-expression with the antigen, as an increase in CD8(+) immunogenicity was also observed by co-administration of two vectors each expressing only the antigen or adjuvant. However, when this regimen was tested in non-human primates using a clinical malaria vaccine candidate, no adjuvant effect of 4-1BBL was observed limiting its potential use as a single adjuvant for translation into a clinical vaccine.	[Spencer, Alexandra J.; Furze, Julie; Honeycutt, Jared D.; Calvert, Alice; Saurya, Saroj; Wyllie, David H.; Gilbert, Sarah C.; Bregu, Migena; Cottingham, Matthew G.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Colloca, Stefano] Okairos, Rome, Italy	University of Oxford; Jenner Institute	Spencer, AJ (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	alex.spencer@ndm.ox.ac.uk	Spencer, Alexandra/AAE-6494-2019; Gilbert, Sarah C./H-2857-2019	Spencer, Alexandra/0000-0001-7958-6961; Gilbert, Sarah C./0000-0002-6823-9750; Cottingham, Matthew/0000-0003-0766-6465	Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative [HILL05GCGH0]; Wellcome Trust [095540/Z/11/Z]; National Center for Research Resources (NCRR) [P51 RR000167];  [RR15459];  [RR020141]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, P51RR000167, C06RR015459] Funding Source: NIH RePORTER; Wellcome Trust [104750/Z/14/Z] Funding Source: researchfish	Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work has been funded by grants from the Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative (HILL05GCGH0) with additional funding from the Wellcome Trust (095540/Z/11/Z). Non-human primate studies were supported by National Center for Research Resources (NCRR) grant number P51 RR000167, and was conducted at a facility constructed with support from grants RR15459 and RR020141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Belousova N, 2006, MOL PHARMACOL, V70, P1488, DOI 10.1124/mol.106.025619; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020977; BLUMTIROUVANZIAM U, 1994, J IMMUNOL, V153, P4134; Bukczynski J, 2005, J IMMUNOL, V175, P6378, DOI 10.4049/jimmunol.175.10.6378; Calarota SA, 2008, VACCINE, V26, P3121, DOI 10.1016/j.vaccine.2008.02.017; Cannons JL, 2001, J IMMUNOL, V167, P1313, DOI 10.4049/jimmunol.167.3.1313; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; Cottingham MG, 2012, BIOTECHNOL BIOENG, V109, P719, DOI 10.1002/bit.24342; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dawicki W, 2004, EUR J IMMUNOL, V34, P743, DOI 10.1002/eji.200324278; DeBenedette MA, 1999, J IMMUNOL, V163, P4833; Denis O, 1998, INFECT IMMUN, V66, P1527, DOI 10.1128/IAI.66.4.1527-1533.1998; Diehl L, 2002, J IMMUNOL, V168, P3755, DOI 10.4049/jimmunol.168.8.3755; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Forbes EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044943; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Ganguly S, 2010, VACCINE, V28, P1300, DOI 10.1016/j.vaccine.2009.11.020; Harrison JM, 2006, VIRAL IMMUNOL, V19, P593, DOI 10.1089/vim.2006.19.593; Harrison JM, 2006, VACCINE, V24, P6867, DOI 10.1016/j.vaccine.2006.06.007; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hirao LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024250; Hodge JW, 1999, CANCER RES, V59, P5800; Humphreys IR, 2010, EUR J IMMUNOL, V40, P2762, DOI 10.1002/eji.200940256; JEANG KT, 1984, MOL CELL BIOL, V4, P2214, DOI 10.1128/MCB.4.10.2214; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; Kanagavelu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090100; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kuang YL, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.02.054; Kuang YL, 2010, CANCER LETT, V293, P254, DOI 10.1016/j.canlet.2010.01.011; Kudo-Saito C, 2006, VACCINE, V24, P4975, DOI 10.1016/j.vaccine.2006.03.042; Larsen KC, 2009, VACCINE, V27, P5589, DOI 10.1016/j.vaccine.2009.07.025; Madan RA, 2012, SEMIN ONCOL, V39, P296, DOI 10.1053/j.seminoncol.2012.02.010; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Munks MW, 2004, IMMUNOLOGY, V112, P559, DOI 10.1111/j.1365-2567.2004.01917.x; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Pauly S, 2002, J LEUKOCYTE BIOL, V72, P35; POLLOK KE, 1995, EUR J IMMUNOL, V25, P488, DOI 10.1002/eji.1830250227; POLLOK KE, 1993, J IMMUNOL, V150, P771; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Serghides L, 2005, J IMMUNOL, V175, P6368, DOI 10.4049/jimmunol.175.10.6368; Sharma RK, 2009, CANCER RES, V69, P4319, DOI 10.1158/0008-5472.CAN-08-3141; Sheehy SH, 2011, MOL THERAPY IN PRESS; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wiethe C, 2003, J IMMUNOL, V170, P2912, DOI 10.4049/jimmunol.170.6.2912; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Xiao C, 2007, ANTIVIR RES, V76, P11, DOI 10.1016/j.antiviral.2007.04.002	61	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105520	10.1371/journal.pone.0105520	http://dx.doi.org/10.1371/journal.pone.0105520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140889	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200093
J	Quilter, CR; Cooper, WN; Cliffe, KM; Skinner, BM; Prentice, PM; Nelson, L; Bauer, J; Ong, KK; Constancia, M; Lowe, WL; Affara, NA; Dunger, DB				Quilter, Claire R.; Cooper, Wendy N.; Cliffe, Kerry M.; Skinner, Benjamin M.; Prentice, Philippa M.; Nelson, LaTasha; Bauer, Julien; Ong, Ken K.; Constancia, Miguel; Lowe, William L.; Affara, Nabeel A.; Dunger, David B.			Impact on offspring methylation patterns of maternal gestational diabetes mellitus and intrauterine growth restraint suggest common genes and pathways linked to subsequent type 2 diabetes risk	FASEB JOURNAL			English	Article						fetal programming; epigenetics; maternal environment	GENOME-WIDE ASSOCIATION; MICRONUTRIENT SUPPLEMENTATION; POSTNATAL-GROWTH; INSULIN; PREGNANCY; GLUCOSE; OBESITY; FETAL; BIRTH; LOCI	Size at birth, postnatal weight gain, and adult risk for type 2 diabetes may reflect environmental exposures during developmental plasticity and may be mediated by epigenetics. Both low birth weight (BW), as a marker of fetal growth restraint, and high birth weight (BW), especially after gestational diabetes mellitus (GDM), have been linked to increased risk of adult type 2 diabetes. We assessed DNA methylation patterns using a bead chip in cord blood samples from infants of mothers with GDM (group 1) and infants with prenatal growth restraint indicated by rapid postnatal catch-up growth (group 2), compared with infants with normal postnatal growth (group 3). Seventy-five CpG loci were differentially methylated in groups 1 and 2 compared with the controls (group 3), representing 72 genes, many relevant to growth and diabetes. In replication studies using similar methodology, many of these differentially methylated regions were associated with levels of maternal glucose exposure below that defined by GDM [the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study] or were identified as changes observed after randomized periconceptional nutritional supplementation in a Gambian cohort characterized by maternal deprivation. These studies provide support for the concept that similar epigenetic modifications may underpin different prenatal exposures and potentially increase long-term risk for diseases such as type 2 diabetes.Quilter, C. R., Cooper, W. N., Cliffe, K. M., Skinner, B. M., Prentice, P. M., Nelson, L., Bauer, J., Ong, K. K., Constancia, M., Lowe, W. L., Affara, N. A., Dunger, D. B. Impact on offspring methylation patterns of maternal gestational diabetes mellitus and intrauterine growth restraint suggest common genes and pathways linked to subsequent type 2 diabetes risk.	[Quilter, Claire R.; Cliffe, Kerry M.; Skinner, Benjamin M.; Bauer, Julien; Affara, Nabeel A.] Univ Cambridge, Dept Pathol, Mammalian Mol Genet Grp, Cambridge CB2 1QP, England; [Cooper, Wendy N.; Constancia, Miguel] Univ Cambridge, Metab Res Labs, MRC, Metab Dis Unit,Dept Obstet & Gynaecol, Cambridge CB2 1QP, England; [Cooper, Wendy N.; Prentice, Philippa M.; Ong, Ken K.; Constancia, Miguel; Dunger, David B.] Univ Cambridge, Natl Inst Hlth Res, Cambridge Biomed Res Ctr, Cambridge CB2 1QP, England; [Cooper, Wendy N.; Constancia, Miguel] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 1QP, England; [Prentice, Philippa M.; Ong, Ken K.; Dunger, David B.] Univ Cambridge, Dept Paediat, Wellcome Trust MRC Inst Metab Sci, Cambridge CB2 1QP, England; [Nelson, LaTasha; Lowe, William L.] Northwestern Univ, Dept Med, Feinberg Sch Med Chicago, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Northwestern University; Feinberg School of Medicine	Quilter, CR (corresponding author), Univ Cambridge, Dept Pathol, Mammalian Mol Genet Grp, Tennis Court Rd, Cambridge CB2 1QP, England.	crq20@cam.ac.uk	Constancia, Miguel/F-6654-2013; Skinner, Benjamin M/A-5265-2010	Skinner, Benjamin M/0000-0002-7152-1167; Constancia, Miguel/0000-0002-8976-1679; Dunger, Professor David/0000-0002-2566-9304	UK National Institute for Health Research Cambridge Comprehensive Biomedical Research Centre; American Diabetes Association; Biotechnology and Biological Sciences Research Council [BB/F02293X/1, BB/H003312/1] Funding Source: researchfish; British Heart Foundation [FS/09/029/27902] Funding Source: researchfish; Medical Research Council [G0600717, G0600717B, MC_UU_12012/4, G1001995, MC_U106179472, MC_UU_12012/5/B, MC_UU_12015/2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10274, NF-SI-0513-10012] Funding Source: researchfish; Wellbeing of Women [RG1644] Funding Source: researchfish; BBSRC [BB/F02293X/1, BB/H003312/1] Funding Source: UKRI; MRC [MC_U106179472, G0600717, MC_UU_12012/4, G1001995, MC_UU_12015/2] Funding Source: UKRI	UK National Institute for Health Research Cambridge Comprehensive Biomedical Research Centre; American Diabetes Association(American Diabetes Association); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellbeing of Women(Wellbeing of Women (WoW)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK National Institute for Health Research Cambridge Comprehensive Biomedical Research Centre and grants from the American Diabetes Association and of Friends of Prentice. The authors declare no conflicts of interest.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amine K, 2011, ANN BIOL CLIN-PARIS, V69, P671, DOI 10.1684/abc.2011.0648; Amitani M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00051; Aouizerat BE, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-29; Astorri E, 2010, HORM METAB RES, V42, P955, DOI 10.1055/s-0030-1267206; Bouqbis L, 2003, TISSUE ANTIGENS, V61, P72, DOI 10.1034/j.1399-0039.2003.610106.x; Chen YA, 2011, GENOMICS, V97, P214, DOI 10.1016/j.ygeno.2010.12.004; Contreras M, 2002, INT J GYNECOL OBSTET, V78, P69; Cooper WN, 2012, FASEB J, V26, P1782, DOI 10.1096/fj.11-192708; Coyle CA, 2002, PHYSIOL BEHAV, V77, P387, DOI 10.1016/S0031-9384(02)00885-5; Ergun MA, 2011, BIOCHEM GENET, V49, P1, DOI 10.1007/s10528-010-9376-6; Fatima W, 2011, INT J PEDIATR OBES, V6, P419, DOI 10.3109/17477166.2011.608431; Finkenstedt A, 2010, J HEPATOL, V53, P1101, DOI 10.1016/j.jhep.2010.04.039; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Genevieve D, 2005, EUR J HUM GENET, V13, P1033, DOI 10.1038/sj.ejhg.5201448; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Good DJ, 2008, EXERC SPORT SCI REV, V36, P187, DOI 10.1097/JES.0b013e31818782dd; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hall E., 2013, BMC MED GENET, V23, p[14, 76]; Hamada T, 2011, NUTRITION, V27, P34, DOI 10.1016/j.nut.2009.10.012; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heneghan C, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000155; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Ichimura A, 2009, PROSTAG OTH LIPID M, V89, P82, DOI 10.1016/j.prostaglandins.2009.05.003; Kanaka-Gantenbein C, 2010, ANN NY ACAD SCI, V1205, P99, DOI 10.1111/j.1749-6632.2010.05683.x; Khulan B, 2012, HUM MOL GENET, V21, P2086, DOI 10.1093/hmg/dds026; Lillycrop KA, 2012, BEST PRACT RES CL EN, V26, P667, DOI 10.1016/j.beem.2012.03.009; Maiti A, 2012, P NATL ACAD SCI USA, V109, P8091, DOI 10.1073/pnas.1201010109; Mallone R, 2006, DIABETES-METAB RES, V22, P284, DOI 10.1002/dmrr.626; McLean M, 2006, DIABETIC MED, V23, P1213, DOI 10.1111/j.1464-5491.2006.01979.x; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; Meloni Gianfranco, 2003, Med Sci Monit, V9, pCR105; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Murea M, 2011, AM J NEPHROL, V33, P502, DOI 10.1159/000327985; Murthi P, 2006, MOL HUM REPROD, V12, P335, DOI 10.1093/molehr/gal037; National Heart Lung and Blood Institute, 2011, NHLBI FAM HEART STUD; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Ng M. C., DIABET MED, V27, P1443; Ong KK, 2008, DIABETES CARE, V31, P2193, DOI 10.2337/dc08-1111; Ong KK, 2009, AM J CLIN NUTR, V90, P156, DOI 10.3945/ajcn.2008.27408; Ong KK, 2004, DIABETOLOGIA, V47, P1064, DOI 10.1007/s00125-004-1405-8; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Pan H, 2012, LMSGROWTH MICROSOFT; Proshchina AE, 2010, B EXP BIOL MED+, V149, P763, DOI 10.1007/s10517-010-1047-4; Seghieri G, 2002, DIABETES CARE, V25, P1761, DOI 10.2337/diacare.25.10.1761; Sobngwi E, 2003, LANCET, V361, P1861, DOI 10.1016/S0140-6736(03)13505-2; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; van Abeelen AFM, 2012, DIABETES, V61, P2255, DOI 10.2337/db11-1559; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Yang HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005459	53	65	67	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4868	4879		10.1096/fj.14-255240	http://dx.doi.org/10.1096/fj.14-255240			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25145626				2022-12-25	WOS:000344050900024
J	El Hiani, Y; Linsdell, P				El Hiani, Yassine; Linsdell, Paul			Metal Bridges Illuminate Transmembrane Domain Movements during Gating of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE CHARGES; WILD-TYPE; PORE; REGIONS; ROLES; PYROPHOSPHATE; SEGMENT; MODEL	Opening and closing of the cystic fibrosis transmembrane conductance regulator are controlled by ATP binding and hydrolysis by the cytoplasmic nucleotide-binding domains. Different conformational changes in the channel pore have been described during channel opening and closing; however, the relative importance of these changes to the process of gating the pore is not known. We have used patch clamp recording to identify high affinity Cd2+ bridges formed between pairs of pore-lining cysteine residues introduced into different transmembrane alpha-helices (TMs). Seven Cd2+ bridges were identified forming between cysteines in TMs 6 and 12. Interestingly, each of these Cd2+ bridges apparently formed only in closed channels, and their formation stabilized the closed state. In contrast, a single Cd2+ bridge identified between cysteines in TMs 1 and 12 stabilized the channel open state. Analysis of the pattern of Cd2+ bridge formation in different channel states suggests that lateral separation and convergence of different TMs, rather than relative rotation or translation of different TMs, is the key conformational change that causes the channel pore to open and close.	[El Hiani, Yassine; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	paul.linsdell@dal.ca		El Hiani, Yassine/0000-0002-1251-5066; Linsdell, Paul/0000-0001-6257-6273	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; CARSON MR, 1995, J BIOL CHEM, V270, P20466, DOI 10.1074/jbc.270.35.20466; Choi LS, 2013, BIOPHYS J, V105, P356, DOI 10.1016/j.bpj.2013.04.046; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; El Hiani Y, 2012, BIOPHYS J, V103, P1719, DOI 10.1016/j.bpj.2012.09.020; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Gao X, 2013, BIOPHYS J, V104, P786, DOI 10.1016/j.bpj.2012.12.048; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Henrion U, 2012, P NATL ACAD SCI USA, V109, P8552, DOI 10.1073/pnas.1116938109; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Li MS, 2009, BRIT J PHARMACOL, V157, P1065, DOI 10.1111/j.1476-5381.2009.00258.x; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Linsdell P, 2014, PFLUG ARCH EUR J PHY, V466, P2243, DOI 10.1007/s00424-014-1501-7; Linsdell P, 2014, MOL MEMBR BIOL, V31, P1, DOI 10.3109/09687688.2013.868055; Lubamba B, 2012, CLIN BIOCHEM, V45, P1132, DOI 10.1016/j.clinbiochem.2012.05.034; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Wang WY, 2014, PFLUG ARCH EUR J PHY, V466, P477, DOI 10.1007/s00424-013-1317-x; Wang WY, 2012, J BIOL CHEM, V287, P32136, DOI 10.1074/jbc.M112.385096; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wang WY, 2012, BBA-BIOMEMBRANES, V1818, P851, DOI 10.1016/j.bbamem.2011.12.025; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	33	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28149	28159		10.1074/jbc.M114.593103	http://dx.doi.org/10.1074/jbc.M114.593103			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25143385	Green Published, hybrid			2022-12-25	WOS:000343765400012
J	Mahajan, K; Lawrence, HR; Lawrence, NJ; Mahajan, NP				Mahajan, Kiran; Lawrence, Harshani R.; Lawrence, Nicholas J.; Mahajan, Nupam P.			ACK1 Tyrosine Kinase Interacts with Histone Demethylase KDM3A to Regulate the Mammary Tumor Oncogene HOXA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURGICAL ADJUVANT BREAST; BOWEL PROJECT P-1; ANDROGEN RECEPTOR; ESTROGEN-RECEPTOR; TAMOXIFEN RESISTANCE; PROSTATE-CANCER; DASATINIB BMS-354825; PHOSPHORYLATION; ACTIVATION; MECHANISMS	Hormone therapy with the selective estrogen-receptor modulator tamoxifen provides a temporary relief for patients with estrogen receptor alpha (ER)-positive breast cancers. However, a subset of patients exhibiting overexpression of the HER2 receptor tyrosine kinase displays intrinsic resistance to tamoxifen therapy. Therefore, elucidating the mechanisms promoting the estrogen (E-2)-independent ER-regulated gene transcription in tamoxifen-resistant breast tumors is essential to identify new therapeutic avenues to overcome drug resistance and ameliorate poor prognosis. The non-receptor tyrosine kinase, ACK1 (also known as TNK2), has emerged as a major integrator of signaling from various receptor tyrosine kinases including HER2. We have uncovered that heregulin-mediated ACK1 activation promoted ER activity in the presence of tamoxifen, which was significantly down-regulated upon ACK1 knockdown or inhibition of ACK1 by small molecule inhibitors, AIM-100 or Dasatinib. We report that ACK1 phosphorylates the ER co-activator, KDM3A, a H3K9 demethylase, at an evolutionary conserved tyrosine 1114 site in a heregulin-dependent manner, even in the presence of tamoxifen. Consistent with this finding, ACK1 activation resulted in a significant decrease in the deposition of dimethyl H3K9 epigenetic marks. Conversely, inhibition of ACK1 by AIM-100 or Dasatinib restored dimethyl H3K9 methylation marks and caused transcriptional suppression of the ER-regulated gene HOXA1. Thus, by its ability to regulate the epigenetic activity of an ER co-activator KDM3A, ACK1 modulates HOXA1 expression in the absence of E-2, conferring tamoxifen resistance. These data reveal a novel therapeutic option, suppression of ACK1 signaling by AIM-100 or Dasatinib, to mitigate HOXA1 up-regulation in breast cancer patients displaying tamoxifen resistance.	[Mahajan, Kiran; Lawrence, Harshani R.; Lawrence, Nicholas J.; Mahajan, Nupam P.] Univ S Florida, H Lee Moffitt Canc Ctr, Drug Discovery Dept, Tampa, FL 33682 USA; [Mahajan, Kiran; Lawrence, Harshani R.; Lawrence, Nicholas J.; Mahajan, Nupam P.] Univ S Florida, Dept Oncol Sci, Coll Med, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Mahajan, K (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Drug Discovery Dept, 12902 Magnolia Dr, Tampa, FL 33682 USA.	kiran.mahajan@moffitt.org; nupam.mahajan@moffitt.org	Mahajan, Kiran/ABA-3013-2020	Mahajan, Kiran/0000-0001-7192-396X	Department of Defense [W81XWH-12-1-0248, W81XWH-14-1-0002, W81XWH-14-1-0003]; NCI, National Institutes of Health [1R01CA135328]; NATIONAL CANCER INSTITUTE [R01CA135328, P30CA076292] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Department of Defense Grant W81XWH-12-1-0248 (to K. M.) and by NCI, National Institutes of Health Grant 1R01CA135328 and Department of Defense Grants W81XWH-14-1-0002 and W81XWH-14-1-0003 (to N. P. M.).	BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brock A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007048; Buchwald M, 2013, ONCOGENE, V32, P4913, DOI 10.1038/onc.2012.515; Chen HX, 2003, J MAMMARY GLAND BIOL, V8, P159, DOI 10.1023/A:1025996707117; Cho HS, 2012, INT J CANCER, V131, pE179, DOI 10.1002/ijc.26501; Clarke R, 2001, PHARMACOL REV, V53, P25; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; GOTTARDIS MM, 1988, CANCER RES, V48, P5183; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Hopp TA, 2004, CLIN CANCER RES, V10, P7490, DOI 10.1158/1078-0432.CCR-04-1114; HOWELL A, 1995, LANCET, V345, P29, DOI 10.1016/S0140-6736(95)91156-1; Johnston SRD, 1997, ANTI-CANCER DRUG, V8, P911, DOI 10.1097/00001813-199711000-00002; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; Liu Y, 2010, ONCOGENE, V29, P3208, DOI 10.1038/onc.2010.103; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mahajan K, 2013, CANCER LETT, V338, P185, DOI 10.1016/j.canlet.2013.04.004; Mahajan K, 2012, NAT STRUCT MOL BIOL, V19, P930, DOI 10.1038/nsmb.2356; Mahajan K, 2012, J BIOL CHEM, V287, P22112, DOI 10.1074/jbc.M112.357384; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Mahajan K, 2012, AM J PATHOL, V180, P1386, DOI 10.1016/j.ajpath.2011.12.028; Mahajan K, 2010, PROSTATE, V70, P1274, DOI 10.1002/pros.21163; Mahajan K, 2010, J CELL PHYSIOL, V224, P327, DOI 10.1002/jcp.22162; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Massarweh S, 2007, CLIN CANCER RES, V13, P1950, DOI 10.1158/1078-0432.CCR-06-2540; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Robertson SC, 2000, TRENDS GENET, V16, P368, DOI 10.1016/S0168-9525(00)02077-1; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Skorski T, 2002, NAT REV CANCER, V2, P351, DOI 10.1038/nrc799; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200	53	40	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28179	28191		10.1074/jbc.M114.584425	http://dx.doi.org/10.1074/jbc.M114.584425			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148682	hybrid, Green Published			2022-12-25	WOS:000343765400015
J	Buckley, MW; Arandjelovic, S; Trampont, PC; Kim, TS; Braciale, TJ; Ravichandran, KS				Buckley, Monica W.; Arandjelovic, Sanja; Trampont, Paul C.; Kim, Taeg S.; Braciale, Thomas J.; Ravichandran, Kodi S.			Unexpected Phenotype of Mice Lacking Shcbp1, a Protein Induced during T Cell Proliferation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; PRE-TCR; GENE-EXPRESSION; IN-VIVO; THYMOCYTE DIFFERENTIATION; CLINICAL-FEATURES; ACTIVATION; PATHOGENESIS; LEUKEMIA	T cell development and activation are highly regulated processes, and their proper execution is important for a competent immune system. Shc SH2-domain binding protein-1 (Shcbp1) is an evolutionarily conserved protein that binds to the adaptor protein ShcA. Studies in Drosophila and in cell lines have strongly linked Shcbp1 to cell proliferation, embryonic development, growth factor signaling, and tumorigenesis. Here we show that Shcbp1 expression is strikingly upregulated during the beta-selection checkpoint in thymocytes, and that its expression tightly correlates with proliferative stages of T cell development. To evaluate the role for Shcbp1 during thymic selection and T cell function in vivo, we generated mice with global and conditional deletion of Shcbp1. Surprisingly, the loss of Shcbp1 expression did not have an obvious effect during T cell development. However, in a mouse model of experimental autoimmune encephalomyelitis (EAE), which depends on CD4(+) T cell function and mimics multiple features of the human disease multiple sclerosis, Shcbp1 deficient mice had reduced disease severity and improved survival, and this effect was T cell intrinsic. These data suggest that despite the striking upregulation of Shcbp1 during T cell proliferation, loss of Shcbp1 does not directly affect T cell development, but regulates CD4(+) T cell effector function in vivo.	[Buckley, Monica W.; Arandjelovic, Sanja; Trampont, Paul C.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Buckley, Monica W.; Arandjelovic, Sanja; Trampont, Paul C.; Ravichandran, Kodi S.] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Buckley, Monica W.; Arandjelovic, Sanja; Trampont, Paul C.; Kim, Taeg S.; Braciale, Thomas J.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.	Ravi@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410; Trampont, Paul/0000-0002-3643-8472	National Institute of General Medical Sciences [GM55761]; F30 Fellowship; MSTP program; T32 Immunology Training Grant; NATIONAL CANCER INSTITUTE [F30CA177173, P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496, R01AI015608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055761, T32GM007267] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); F30 Fellowship; MSTP program; T32 Immunology Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of General Medical Sciences - GM55761 funding to Kodi S. Ravichandran. Support to MWB via a F30 Fellowship and the MSTP program and the T32 Immunology Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Asano E, 2013, J CELL SCI, V126, P3263, DOI 10.1242/jcs.124875; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Chen JF, 2012, GENE DEV, V26, P803, DOI 10.1101/gad.187641.112; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; CRIST WM, 1988, BLOOD, V72, P1891; Eckerle S, 2009, LEUKEMIA, V23, P2129, DOI 10.1038/leu.2009.161; Fink PJ, 2011, NAT REV IMMUNOL, V11, P544, DOI 10.1038/nri3028; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; GALLO P, 1989, J NEUROL SCI, V92, P9, DOI 10.1016/0022-510X(89)90171-8; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gold R, 2013, LANCET, V381, P2167, DOI 10.1016/S0140-6736(12)62190-4; Hardy WR, 2007, SCIENCE, V317, P251, DOI 10.1126/science.1140114; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Ito M, 2013, J VIROL, V87, P9633, DOI 10.1128/JVI.00714-13; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; KENNEDY MK, 1992, J IMMUNOL, V149, P2496; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kreslavsky T, 2012, IMMUNITY, V37, P840, DOI 10.1016/j.immuni.2012.08.020; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lai KMV, 2000, GENE DEV, V14, P1132; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Matesanz F, 2004, J NEUROIMMUNOL, V148, P212, DOI 10.1016/j.jneuroim.2003.12.001; Matesanz F, 2001, J NEUROIMMUNOL, V119, P101, DOI 10.1016/S0165-5728(01)00354-X; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; McFarland KN, 2006, J NEUROSCI, V26, P7885, DOI 10.1523/JNEUROSCI.3524-05.2006; McNally JP, 2014, J IMMUNOL, V192, P73, DOI 10.4049/jimmunol.1301891; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Misslitz A, 2006, IMMUNOL REV, V209, P115, DOI 10.1111/j.0105-2896.2006.00351.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Montembault E, 2010, J CELL BIOL, V191, P1351, DOI 10.1083/jcb.201007060; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Petitto JM, 2000, NEUROSCI LETT, V285, P66, DOI 10.1016/S0304-3940(00)00996-4; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schmandt R, 1999, ONCOGENE, V18, P1867, DOI 10.1038/sj.onc.1202507; Schulze-Topphoff U, 2013, J EXP MED, V210, P1301, DOI 10.1084/jem.20121611; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tao HC, 2013, ASIAN PAC J CANCER P, V14, P5645, DOI 10.7314/APJCP.2013.14.10.5645; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Trampont P, 2006, MOL CELL BIOL, V26, P9035, DOI 10.1128/MCB.00988-06; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Trigueros C, 2003, EUR J IMMUNOL, V33, P1968, DOI 10.1002/eji.200323831; Truffinet V, 2007, J IMMUNOL, V179, P6033, DOI 10.4049/jimmunol.179.9.6033; Uckun FM, 1997, J CLIN ONCOL, V15, P2214, DOI 10.1200/JCO.1997.15.6.2214; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Zhang L, 2003, IMMUNOL REV, V191, P183, DOI 10.1034/j.1600-065X.2003.00025.x; Zhang L, 2002, NAT IMMUNOL, V3, P749, DOI 10.1038/ni820; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	69	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105576	10.1371/journal.pone.0105576	http://dx.doi.org/10.1371/journal.pone.0105576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153088	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200063
J	Glabska, H; Potworowski, J; Leski, S; Wojcik, DK				Glabska, Helena; Potworowski, Jan; Leski, Szymon; Wojcik, Daniel K.			Independent Components of Neural Activity Carry Information on Individual Populations	PLOS ONE			English	Article							LOCAL-FIELD POTENTIALS; SOURCE DENSITY METHOD; ARTIFACTS; MODEL; 3D	Local field potential (LFP), the low-frequency part of the potential recorded extracellularly in the brain, reflects neural activity at the population level. The interpretation of LFP is complicated because it can mix activity from remote cells, on the order of millimeters from the electrode. To understand better the relation between the recordings and the local activity of cells we used a large-scale network thalamocortical model to compute simultaneous LFP, transmembrane currents, and spiking activity. We used this model to study the information contained in independent components obtained from the reconstructed Current Source Density (CSD), which smooths transmembrane currents, decomposed further with Independent Component Analysis (ICA). We found that the three most robust components matched well the activity of two dominating cell populations: superior pyramidal cells in layer 2/3 (rhythmic spiking) and tufted pyramids from layer 5 (intrinsically bursting). The pyramidal population from layer 2/3 could not be well described as a product of spatial profile and temporal activation, but by a sum of two such products which we recovered in two of the ICA components in our analysis, which correspond to the two first principal components of PCA decomposition of layer 2/3 population activity. At low noise one more cell population could be discerned but it is unlikely that it could be recovered in experiment given typical noise ranges.	[Glabska, Helena; Potworowski, Jan; Leski, Szymon; Wojcik, Daniel K.] M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Wojcik, DK (corresponding author), M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland.	d.wojcik@nencki.gov.pl	Leski, Szymon/A-8931-2008; Wojcik, Daniel/C-6334-2008	Wojcik, Daniel/0000-0003-0812-9872; Leski, Szymon/0000-0003-1764-1907	Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw [G35-7]; Polish Ministry of Regional Development [POIG.02.03.00-00-003/09, POIG.02.03.00-00-018/08]; Polish Ministry of Science and Higher Education [5428/B/P01/2010/39, IP2011similar to030971, 2948/7.PR/2013/2]	Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw; Polish Ministry of Regional Development; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Numerical simulations were in part performed in the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw, under grant G35-7. Research supported by the grants from the Polish Ministry of Regional Development, POIG.02.03.00-00-003/09, POIG.02.03.00-00-018/08, and from the Polish Ministry of Science and Higher Education: 5428/B/P01/2010/39, IP2011 similar to 030971,and 2948/7.PR/2013/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; DI S, 1990, J NEUROPHYSIOL, V63, P832, DOI 10.1152/jn.1990.63.4.832; Einevoll GT, 2007, J NEUROPHYSIOL, V97, P2174, DOI 10.1152/jn.00845.2006; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Einevoll GT, 2013, PRINCIPLES OF NEURAL CODING, P37; Gleeson P, 2007, NEURON, V54, P219, DOI 10.1016/j.neuron.2007.03.025; Goto T, 2010, J NEUROPHYSIOL, V104, P3388, DOI 10.1152/jn.00122.2010; Gratiy Sergey L, 2011, Front Neuroinform, V5, P32, DOI 10.3389/fninf.2011.00032; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holt, 1998, THESIS CALTECH; Hunt MJ, 2011, J PSYCHOPHARMACOL, V25, P808, DOI 10.1177/0269881110362126; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; LAY DC, 1997, LINEAR ALGEBRA ITS A; Leski S, 2007, NEUROINFORMATICS, V5, P207, DOI 10.1007/s12021-007-9000-z; Leski S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003137; Leski S, 2011, NEUROINFORMATICS, V9, P401, DOI 10.1007/s12021-011-9111-4; Leski S, 2010, J COMPUT NEUROSCI, V29, P459, DOI 10.1007/s10827-009-0203-1; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Makarov VA, 2010, J COMPUT NEUROSCI, V29, P445, DOI 10.1007/s10827-009-0206-y; Makarova J, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00077; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; Nelson MJ, 2013, J NEUROSCI, V33, P2821, DOI 10.1523/JNEUROSCI.3502-12.2013; NICHOLSON C, 1973, IEEE T BIO-MED ENG, VBM20, P278, DOI 10.1109/TBME.1973.324192; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; Pitts W.H., 1952, CYBERNETICS, P159; Potworowski J, 2012, NEURAL COMPUT, V24, P541, DOI 10.1162/NECO_a_00236; Press W, 1989, NUMERICAL RECIPIES C; Reimann MW, 2013, NEURON, V79, P375, DOI 10.1016/j.neuron.2013.05.023; Stevens CF, 1966, NEUROPHYSIOLOGY PRIM; Stone J.V., 2004, INDEPENDENT COMPONEN; Stone JV, 2002, NEUROIMAGE, V15, P407, DOI 10.1006/nimg.2001.0986; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Wojcik DK, 2010, NEURAL COMPUT, V22, P48, DOI 10.1162/neco.2009.07-08-831	39	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105071	10.1371/journal.pone.0105071	http://dx.doi.org/10.1371/journal.pone.0105071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153730	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200036
J	Vaezghasemi, M; Ohman, A; Eriksson, M; Hakimi, M; Weinehall, L; Kusnanto, H; Ng, N				Vaezghasemi, Masoud; Ohman, Ann; Eriksson, Malin; Hakimi, Mohammad; Weinehall, Lars; Kusnanto, Hari; Ng, Nawi			The Effect of Gender and Social Capital on the Dual Burden of Malnutrition: A Multilevel Study in Indonesia	PLOS ONE			English	Article							NUTRITION TRANSITION; SOCIOECONOMIC-STATUS; HEALTH; OBESITY; HOUSEHOLDS; OVERWEIGHT; COUNTRIES; PATTERNS	Introduction: The paradoxical phenomenon of the coexistence of overweight and underweight individuals in the same household, referred to as the "dual burden of malnutrition'', is a growing nutrition dilemma in low-and middle-income countries (LMICs). Aims: The objectives of this study were (i) to examine the extent of the dual burden of malnutrition across different provinces in Indonesia and (ii) to determine how gender, community social capital, place of residency and other socioeconomic factors affect the prevalence of the dual burden of malnutrition. Methods: The current study utilized data from the fourth wave of the Indonesian Family Life Survey (IFLS) conducted between November 2007 and April 2008. The dataset contains information from 12,048 households and 45,306 individuals of all ages. This study focused on households with individuals over two years old. To account for the multilevel nature of the data, a multilevel multiple logistic regression was conducted. Results: Approximately one-fifth of all households in Indonesia exhibited the dual burden of malnutrition, which was more prevalent among male-headed households, households with a high Socio-economic status (SES), and households in urban areas. Minimal variation in the dual burden of malnutrition was explained by the community level differences (<4%). Living in households with a higher SES resulted in higher odds of the dual burden of malnutrition but not among female-headed households and communities with the highest social capital. Conclusion: To improve household health and reduce the inequality across different SES groups, this study emphasizes the inclusion of women's empowerment and community social capital into intervention programs addressing the dual burden of malnutrition.	[Vaezghasemi, Masoud; Ohman, Ann; Eriksson, Malin; Weinehall, Lars; Ng, Nawi] Umea Univ, Dept Publ Hlth & Clin Med, Div Epidemiol & Global Hlth, Umea, Sweden; [Vaezghasemi, Masoud; Ohman, Ann; Eriksson, Malin; Weinehall, Lars; Ng, Nawi] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [Vaezghasemi, Masoud; Ohman, Ann] Umea Univ, Umea Ctr Gender Studies, Umea, Sweden; [Hakimi, Mohammad] Gadjah Mada Univ, Fac Med, Ctr Hlth & Nutr Res Lab, Yogyakarta, Indonesia; [Kusnanto, Hari] Gadjah Mada Univ, Fac Med, Ctr Environm Studies, Yogyakarta, Indonesia	Umea University; Umea University; Umea University; Gadjah Mada University; Gadjah Mada University	Vaezghasemi, M (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Div Epidemiol & Global Hlth, Umea, Sweden.	masoud.vaezghasemi@umu.se	Hakimi, Mohammad/GOV-6587-2022; Ng, Nawi/F-8373-2011	Ng, Nawi/0000-0003-0556-1483; Weinehall, Lars/0000-0003-3025-2690	Swedish International Development Cooperation Agency (Sida) [AKT-2010-048]	Swedish International Development Cooperation Agency (Sida)	The project has been funded through a grant from the Swedish International Development Cooperation Agency (Sida) (Grant number: AKT-2010-048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, FAO Food Nutr Pap, V84, P1; [Anonymous], 1983, WOMENS WORK WOMENS R; [Anonymous], 2008, DUAL BURDEN MALNUTRI; Buvinic M, 2012, ECON DEV CULT CHANGE, V45, P259; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Connell R., 2013, GENDER POWER SOC PER; Connell R.W., 1995, MASCULINITIES; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Doak C, 2002, PUBLIC HEALTH NUTR, V5, P215, DOI 10.1079/PHN2001296; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Doak CM, 2000, J NUTR, V130, P2965, DOI 10.1093/jn/130.12.2965; Eriksson M., 2010, SOCIAL CAPITAL HLTH; Garrett James L., 2005, Food and Nutrition Bulletin, V26, P209; GILLESPIE S, 2001, ATTACKING DOUBLE BUR; Harpham T, 2002, J TROP PEDIATRICS, V48, P128, DOI 10.1093/tropej/48.3.128; International IDEA Institute for Democracy and Electorial Assistance, 2000, GEND DEM IND ASS; Kim D, 2006, SOC SCI MED, V63, P1045, DOI 10.1016/j.socscimed.2006.02.017; Maluccio J.A., 1999, INTRAHOUSEHOLD ALLOC; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Miller DL, 2006, WORLD DEV, V34, P1084, DOI 10.1016/j.worlddev.2005.11.006; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Oddo VM, 2012, AM J CLIN NUTR, V95, P951, DOI 10.3945/ajcn.111.026070; Ohman A, 2008, SCAND J PUBLIC HEALT, V36, P449, DOI 10.1177/1403494808094242; Okin, 1989, JUSTICE GENDER FAMIL; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; PAPANEK H, 1988, ECON POLIT WEEKLY, V23, pWS73; Poortinga W, 2006, SOC SCI MED, V63, P255, DOI 10.1016/j.socscimed.2005.11.039; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Putnam R.D., 1993, AM PROSPECT, V4, P35, DOI DOI 10.1287/mnsc.1120.1644; Rae AN, 1999, AUST J AGR RESOUR EC, V43, P359, DOI 10.1111/1467-8489.00084; Roemling C, 2013, ECON HUM BIOL, V11, P563, DOI 10.1016/j.ehb.2013.07.001; Schuller T, 2000, SOCIAL CAPITAL CRITI, P1; Statistics Indonesia, 2012, TRENDS SEL SOC IND I; Strauss J., 2009, 4 WAVE INDONESIA FAM; The Asia Foundation ADB Canadian International Development Agency National Democratic Institute TWB, 2006, IND COUNTR GEND ASS; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029	40	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103849	10.1371/journal.pone.0103849	http://dx.doi.org/10.1371/journal.pone.0103849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153321	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200010
J	Joncourt, R; Eberle, AB; Rufener, SC; Muhlemann, O				Joncourt, Raphael; Eberle, Andrea B.; Rufener, Simone C.; Muehlemann, Oliver			Eukaryotic Initiation Factor 4G Suppresses Nonsense-Mediated mRNA Decay by Two Genetically Separable Mechanisms	PLOS ONE			English	Article							POLY(A) BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; TRANSLATION INITIATION; MAMMALIAN-CELLS; UPF1 PHOSPHORYLATION; CORE DOMAIN; IN-VIVO; COMPLEX; EIF4G; TERMINATION	Nonsense-mediated mRNA decay (NMD), which is best known for degrading mRNAs with premature termination codons (PTCs), is thought to be triggered by aberrant translation termination at stop codons located in an environment of the mRNP that is devoid of signals necessary for proper termination. In mammals, the cytoplasmic poly(A)-binding protein 1 (PABPC1) has been reported to promote correct termination and therewith antagonize NMD by interacting with the eukaryotic release factors 1 (eRF1) and 3 (eRF3). Using tethering assays in which proteins of interest are recruited as MS2 fusions to a NMD reporter transcript, we show that the three N-terminal RNA recognition motifs (RRMs) of PABPC1 are sufficient to antagonize NMD, while the eRF3-interacting C-terminal domain is dispensable. The RRM1-3 portion of PABPC1 interacts with eukaryotic initiation factor 4G (eIF4G) and tethering of eIF4G to the NMD reporter also suppresses NMD. We identified the interactions of the eIF4G N-terminus with PABPC1 and the eIF4G core domain with eIF3 as two genetically separable features that independently enable tethered eIF4G to inhibit NMD. Collectively, our results reveal a function of PABPC1, eIF4G and eIF3 in translation termination and NMD suppression, and they provide additional evidence for a tight coupling between translation termination and initiation.	[Joncourt, Raphael; Eberle, Andrea B.; Rufener, Simone C.; Muehlemann, Oliver] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Joncourt, Raphael; Rufener, Simone C.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	University of Bern; University of Bern	Muhlemann, O (corresponding author), Univ Bern, Dept Chem & Biochem, Bern, Switzerland.	oliver.muehlemann@dcb.unibe.ch		Rufener, Simone Carla/0000-0001-7477-2407; Muhlemann, Oliver/0000-0003-0657-1368	European Research Council [StG 207419]; Swiss National Science Foundation [31003A-127614, 31003A-143717]; canton of Bern	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); canton of Bern(Japanese Urological Association)	This work was supported by grants to OM from the European Research Council (http://erc.europa.eu/; StG 207419), the Swiss National Science Foundation (http://www.snf.ch; grants 31003A-127614 and 31003A-143717), and the canton of Bern (http://www.be.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; Beznoskova P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003962; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Bushell M, 2001, J BIOL CHEM, V276, P23922, DOI 10.1074/jbc.M100384200; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Choe J, 2012, J BIOL CHEM, V287, P18500, DOI 10.1074/jbc.M111.327528; Coldwell MJ, 2006, MOL CELL BIOL, V26, P8448, DOI 10.1128/MCB.01248-06; Coldwell MJ, 2004, J CELL SCI, V117, P2545, DOI 10.1242/jcs.01106; Cosson B, 2002, BIOL CELL, V94, P205, DOI 10.1016/S0248-4900(02)01194-2; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Durand S, 2013, NAT STRUCT MOL BIOL, V20, P702, DOI 10.1038/nsmb.2575; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Hurt JA, 2013, GENOME RES, V23, P1636, DOI 10.1101/gr.157354.113; Hwang J, 2010, MOL CELL, V39, P396, DOI 10.1016/j.molcel.2010.07.004; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kervestin S, 2012, BIOCHIMIE, V94, P1560, DOI 10.1016/j.biochi.2011.12.021; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010169; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Loh B, 2013, GENE DEV, V27, P2125, DOI 10.1101/gad.226951.113; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; McIlwain DR, 2010, P NATL ACAD SCI USA, V107, P12186, DOI 10.1073/pnas.1007336107; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Moriarty PM, 1997, RNA, V3, P1369; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Muhlemann O, 2012, TRENDS GENET, V28, P70, DOI 10.1016/j.tig.2011.11.001; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; Nicholson P, 2012, CURR PROTOC CELL BIO; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Peixeiro I, 2012, NUCLEIC ACIDS RES, V40, P1160, DOI 10.1093/nar/gkr820; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Roy B, 2013, TRENDS GENET, V29, P691, DOI 10.1016/j.tig.2013.09.002; Roy G, 2002, MOL CELL BIOL, V22, P3769, DOI 10.1128/MCB.22.11.3769-3782.2002; Rufener SC, 2013, NAT STRUCT MOL BIOL, V20, P710, DOI 10.1038/nsmb.2576; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Tani H, 2012, RNA BIOL, V9, P1370, DOI 10.4161/rna.22360; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Uchida N, 2004, J BIOL CHEM, V279, P1383, DOI 10.1074/jbc.M309125200; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Welnowska E, 2009, J MOL BIOL, V394, P506, DOI 10.1016/j.jmb.2009.09.036; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Yepiskoposyan H, 2011, RNA, V17, P2108, DOI 10.1261/rna.030247.111; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826; Zund D, 2013, NAT STRUCT MOL BIOL, V20, P936, DOI 10.1038/nsmb.2635	80	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104391	10.1371/journal.pone.0104391	http://dx.doi.org/10.1371/journal.pone.0104391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148142	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600014
J	Jakobs, HH; Mikula, M; Havemeyer, A; Strzalkowska, A; Borowa-Chmielak, M; Dzwonek, A; Gajewska, M; Hennig, EE; Ostrowski, J; Clement, B				Jakobs, Heyka H.; Mikula, Michal; Havemeyer, Antje; Strzalkowska, Adriana; Borowa-Chmielak, Monika; Dzwonek, Artur; Gajewska, Marta; Hennig, Ewa E.; Ostrowski, Jerzy; Clement, Bernd			The N-Reductive System Composed of Mitochondrial Amidoxime Reducing Component (mARC), Cytochrome b5 (CYB5B) and Cytochrome b5 Reductase (CYB5R) Is Regulated by Fasting and High Fat Diet in Mice	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; PROTEIN; INVOLVEMENT; ENZYMES; B(5)	The mitochondrial amidoxime reducing component mARC is the fourth mammalian molybdenum enzyme. The protein is capable of reducing N-oxygenated structures, but requires cytochrome b5 and cytochrome b5 reductase for electron transfer to catalyze such reactions. It is well accepted that the enzyme is involved in N-reductive drug metabolism such as the activation of amidoxime prodrugs. However, the endogenous function of the protein is not fully understood. Among other functions, an involvement in lipogenesis is discussed. To study the potential involvement of the protein in energy metabolism, we tested whether the mARC protein and its partners are regulated due to fasting and high fat diet in mice. We used qRT-PCR for expression studies, Western Blot analysis to study protein levels and an N-reductive biotransformation assay to gain activity data. Indeed all proteins of the N-reductive system are regulated by fasting and its activity decreases. To study the potential impact of these changes on prodrug activation in vivo, another mice experiment was conducted. Model compound benzamidoxime was injected to mice that underwent fasting and the resulting metabolite of the N-reductive reaction, benzamidine, was determined. Albeit altered in vitro activity, no changes in the metabolite concentration in vivo were detectable and we can dispel concerns that fasting alters prodrug activation in animal models. With respect to high fat diet, changes in the mARC proteins occur that result in increased N-reductive activity. With this study we provide further evidence that the endogenous function of the mARC protein is linked with lipid metabolism.	[Jakobs, Heyka H.; Havemeyer, Antje; Clement, Bernd] Univ Kiel, Dept Pharmaceut & Med Chem, Kiel, Germany; [Mikula, Michal; Strzalkowska, Adriana; Borowa-Chmielak, Monika; Dzwonek, Artur; Gajewska, Marta; Hennig, Ewa E.; Ostrowski, Jerzy] Maria Sklodowska Curie Mem Canc Ctr, Dept Genet, Warsaw, Poland; [Mikula, Michal; Strzalkowska, Adriana; Borowa-Chmielak, Monika; Dzwonek, Artur; Gajewska, Marta; Hennig, Ewa E.; Ostrowski, Jerzy] Inst Oncol, Warsaw, Poland; [Hennig, Ewa E.; Ostrowski, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland	University of Kiel; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Centre of Postgraduate Medical Education - Poland	Clement, B (corresponding author), Univ Kiel, Dept Pharmaceut & Med Chem, Kiel, Germany.	bclement@pharmazie.uni-kiel.de	Hennig, Ewa E/N-6459-2013; Mikula, Michal/G-8276-2011	Hennig, Ewa E/0000-0002-6388-2237; Mikula, Michal/0000-0003-3447-7328; Ostrowski, Jerzy/0000-0003-1363-3766	Polish Ministry of Science and Higher Education [N N401 017436, N N401 532240]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by N N401 017436 and N N401 532240 grants from Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslibekyan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048663; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Froriep D, 2013, XENOBIOTICA, V43, P780, DOI 10.3109/00498254.2013.767481; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Havemeyer A, 2010, DRUG METAB DISPOS, V38, P1917, DOI 10.1124/dmd.110.032813; Hennig EE, 2014, J CELL MOL MED, V18, P1762, DOI 10.1111/jcmm.12328; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Klein JM, 2012, J BIOL CHEM, V287, P42795, DOI 10.1074/jbc.M112.419424; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; Krompholz N, 2012, CHEM RES TOXICOL, V25, P2443, DOI 10.1021/tx300298m; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malhotra P, 2013, AM J PHYSIOL-GASTR L, V304, pG203, DOI 10.1152/ajpgi.00288.2012; Malik AN, 2007, BIOCHEM BIOPH RES CO, V357, P237, DOI 10.1016/j.bbrc.2007.03.132; Mikula M, 2011, FUNCT INTEGR GENOMIC, V11, P215, DOI 10.1007/s10142-010-0200-5; Nesteruk M, 2014, FUNCT INTEGR GENOMIC, V14, P245, DOI 10.1007/s10142-013-0342-3; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Newton BW, 2011, J PROTEOME RES, V10, P4692, DOI 10.1021/pr200491h; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Paton CM, 2009, ENDOCR REV, V31, P364; Plitzko B, 2013, J BIOL CHEM, V288, P20228, DOI 10.1074/jbc.M113.474916; Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064; Sparacino-Watkins CE, 2014, J BIOL CHEM, V289, P10345, DOI 10.1074/jbc.M114.555177; Stark AM, 2006, NEUROL RES, V28, P787, DOI 10.1179/016164106X110364; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	29	15	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105371	10.1371/journal.pone.0105371	http://dx.doi.org/10.1371/journal.pone.0105371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144769	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100060
J	Kuksis, M; Smith, PM; Ferguson, AV				Kuksis, Markus; Smith, Pauline M.; Ferguson, Alastair V.			Hydrogen Sulfide Regulates Cardiovascular Function by Influencing the Excitability of Subfornical Organ Neurons	PLOS ONE			English	Article							HYPERTENSION; H2S; INHIBITION; MECHANISM; CHANNELS; CYSTEINE; RELEASE; BRAIN; ACTS; TONE	Hydrogen sulfide (H2S), a gasotransmitter endogenously found in the central nervous system, has recently been suggested to act as a signalling molecule in the brain having beneficial effects on cardiovascular function. This study was thus undertaken to investigate the effect of NaHS (an H2S donor) in the subfornical organ (SFO), a central nervous system site important to blood pressure regulation. We used male Sprague-Dawley rats for both in vivo and in vitro experiments. We first used RT-PCR to confirm our previous microarray analyses showing that mRNAs for the enzymes required to produce H2S are expressed in the SFO. We then used microinjection techniques to investigate the physiological effects of NaHS in SFO, and found that NaHS microinjection (5 nmol) significantly increased blood pressure (mean AUC = 853.5 +/- 105.7 mmHg*s, n = 5). Further, we used patch-clamp electrophysiology and found that 97.8% (88 of 90) of neurons depolarized in response to NaHS. This response was found to be concentration dependent with an EC50 of 35.6 mu M. Coupled with the depolarized membrane potential, we observed an overall increase in neuronal excitability using an analysis of rheobase and action potential firing patterns. This study has provided the first evidence of NaHS and thus H2S actions and their cellular correlates in SFO, implicating this brain area as a site where H2S may act to control blood pressure.	[Kuksis, Markus; Smith, Pauline M.; Ferguson, Alastair V.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Ferguson, AV (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	avf@queensu.ca			Canadian Institutes for Health Research [12192]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research, Grant 12192 (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Ahmad FUD, 2012, RENAL FAILURE, V34, P203, DOI 10.3109/0886022X.2011.643365; Andersson DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046917; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Bianca RDD, 2011, J PHARMACOL EXP THER, V337, P59, DOI 10.1124/jpet.110.176016; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Dai L, 2013, J PHYSIOL-LONDON, V591, P3421, DOI 10.1113/jphysiol.2013.254144; DeLeon ER, 2012, ANAL BIOCHEM, V421, P203, DOI 10.1016/j.ab.2011.10.016; Dombkowski RA, 2004, AM J PHYSIOL-REG I, V286, pR678, DOI 10.1152/ajpregu.00419.2003; Feng XM, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-4; Ferguson AV, 1997, NEUROENDOCRINOLOGY, V66, P409, DOI 10.1159/000127266; Fry M, 2007, PHYSIOL BEHAV, V91, P413, DOI 10.1016/j.physbeh.2007.04.003; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gan XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050102; Guo Q, 2011, J PHARMACOL EXP THER, V338, P458, DOI 10.1124/jpet.111.180711; Hendel MD, 2005, AM J PHYSIOL-HEART C, V288, pH680, DOI 10.1152/ajpheart.00823.2004; Hindmarch C, 2008, AM J PHYSIOL-REG I, V295, pR1914, DOI 10.1152/ajpregu.90560.2008; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; ISHIBASHI S, 1981, BRAIN RES BULL, V6, P135, DOI 10.1016/S0361-9230(81)80038-X; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Khademullah CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064495; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; KUO SM, 1983, BIOL NEONATE, V43, P23; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Li Q, 2010, ANTIOXID REDOX SIGN, V12, P1179, DOI 10.1089/ars.2009.2926; Lob HE, 2013, HYPERTENSION, V61, P382, DOI 10.1161/HYPERTENSIONAHA.111.00546; Luo JL, 2011, J PAIN, V12, P600, DOI 10.1016/j.jpain.2010.11.005; MANGIAPANE ML, 1980, NEUROENDOCRINOLOGY, V31, P380, DOI 10.1159/000123107; Mani S, 2014, NITRIC OXIDE-BIOL CH, V41, P62, DOI 10.1016/j.niox.2014.02.006; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10; Paxinos G., 2004, J CHEM INF MODEL, V5th; Ren YS, 2011, CHINESE MED J-PEKING, V124, P3468, DOI 10.3760/cma.j.issn.0366-6999.2011.21.006; SAAVEDRA JM, 1986, CIRC RES, V58, P389, DOI 10.1161/01.RES.58.3.389; Sekiguchi F, 2014, BIOCHEM BIOPH RES CO, V445, P225, DOI 10.1016/j.bbrc.2014.01.185; Smith PM, 2007, J NEUROENDOCRINOL, V19, P7, DOI 10.1111/j.1365-2826.2006.01497.x; Smith PM, 2012, J NEUROENDOCRINOL, V24, P504, DOI 10.1111/j.1365-2826.2011.02257.x; Smith PM, 1997, NEUROENDOCRINOLOGY, V66, P130, DOI 10.1159/000127230; Streeter E, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00055; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; Washburn DLS, 1999, NEUROSCIENCE, V93, P349, DOI 10.1016/S0306-4522(99)00125-6; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zimmerman MC, 2004, CIRC RES, V95, P210, DOI 10.1161/01.RES.0000135483.12297.e4	50	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105772	10.1371/journal.pone.0105772	http://dx.doi.org/10.1371/journal.pone.0105772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144759	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100120
J	Moroco, JA; Craigo, JK; Iacob, RE; Wales, TE; Engen, JR; Smithgall, TE				Moroco, Jamie A.; Craigo, Jodi K.; Iacob, Roxana E.; Wales, Thomas E.; Engen, John R.; Smithgall, Thomas E.			Differential Sensitivity of Src-Family Kinases to Activation by SH3 Domain Displacement	PLOS ONE			English	Article							HCK TYROSINE KINASE; FC-GAMMA-RI; C-SRC; CRYSTAL-STRUCTURE; ABL KINASE; PP60(C-SRC); AFFINITY; PROTEIN; PHOSPHORYLATION; IDENTIFICATION	Src-family kinases (SFKs) are non-receptor protein-tyrosine kinases involved in a variety of signaling pathways in virtually every cell type. The SFKs share a common negative regulatory mechanism that involves intramolecular interactions of the SH3 domain with the PPII helix formed by the SH2-kinase linker as well as the SH2 domain with a conserved phosphotyrosine residue in the C-terminal tail. Growing evidence suggests that individual SFKs may exhibit distinct activation mechanisms dictated by the relative strengths of these intramolecular interactions. To elucidate the role of the SH3:linker interaction in the regulation of individual SFKs, we used a synthetic SH3 domain-binding peptide (VSL12) to probe the sensitivity of downregulated c-Src, Hck, Lyn and Fyn to SH3-based activation in a kinetic kinase assay. All four SFKs responded to VSL12 binding with enhanced kinase activity, demonstrating a conserved role for SH3:linker interaction in the control of catalytic function. However, the sensitivity and extent of SH3-based activation varied over a wide range. In addition, autophosphorylation of the activation loops of c-Src and Hck did not override regulatory control by SH3: linker displacement, demonstrating that these modes of activation are independent. Our results show that despite the similarity of their downregulated conformations, individual Src-family members show diverse responses to activation by domain displacement which may reflect their adaptation to specific signaling environments in vivo.	[Moroco, Jamie A.; Craigo, Jodi K.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Craigo, Jodi K.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA USA; [Iacob, Roxana E.; Wales, Thomas E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northeastern University	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	tsmithga@pitt.edu		Engen, John R./0000-0002-6918-9476; Wales, Thomas E./0000-0001-6133-5689; Moroco, Jamie/0000-0001-8250-5923	National Institutes of Health [AI057083, AI102724]; Pittsburgh AIDS Research Training Program [T32 AI065380]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057083, R01AI102724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh AIDS Research Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants AI057083 and AI102724 (to TES) and the Pittsburgh AIDS Research Training Program (T32 AI065380 to JAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Bhattacharjee A, 2011, J BIOL CHEM, V286, P36709, DOI 10.1074/jbc.M111.291492; Boerner RJ, 1995, BIOCHEMISTRY-US, V34, P16419, DOI 10.1021/bi00050a024; Boerner RJ, 1996, BIOCHEMISTRY-US, V35, P9519, DOI 10.1021/bi960248u; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Briggs SD, 2000, BIOCHEMISTRY-US, V39, P489, DOI 10.1021/bi992504j; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Charter NW, 2006, J BIOMOL SCREEN, V11, P390, DOI 10.1177/1087057106286829; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; DURDEN DL, 1995, J IMMUNOL, V154, P4039; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Kedzierska K, 2001, J LEUKOCYTE BIOL, V70, P322; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; LAM KS, 1995, INT J PEPT PROT RES, V45, P587; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Meyn MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000311; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Sancier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017237; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; WANG AVT, 1994, J EXP MED, V180, P1165, DOI 10.1084/jem.180.3.1165; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang X, 2014, ACS CHEM BIOL, V9, P139, DOI 10.1021/cb400249b	44	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105629	10.1371/journal.pone.0105629	http://dx.doi.org/10.1371/journal.pone.0105629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144189	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000341106100101
J	Loberto, N; Tebon, M; Lampronti, I; Marchetti, N; Aureli, M; Bassi, R; Giri, MG; Bezzerri, V; Lovato, V; Cantu, C; Munari, S; Cheng, SH; Cavazzini, A; Gambari, R; Sonnino, S; Cabrini, G; Dechecchi, MC				Loberto, Nicoletta; Tebon, Maela; Lampronti, Ilaria; Marchetti, Nicola; Aureli, Massimo; Bassi, Rosaria; Giri, Maria Grazia; Bezzerri, Valentino; Lovato, Valentina; Cantu, Cinzia; Munari, Silvia; Cheng, Seng H.; Cavazzini, Alberto; Gambari, Roberto; Sonnino, Sandro; Cabrini, Giulio; Dechecchi, Maria Cristina			GBA2-Encoded beta-Glucosidase Activity Is Involved in the Inflammatory Response to Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS; CERAMIDE; MIGLUSTAT; INFECTION; GBA2; SPHINGOLIPIDS; NASAL; INHIBITION; METABOLISM; DISEASE	Current anti-inflammatory strategies for the treatment of pulmonary disease in cystic fibrosis (CF) are limited; thus, there is continued interest in identifying additional molecular targets for therapeutic intervention. Given the emerging role of sphingolipids (SLs) in various respiratory disorders, including CF, drugs that selectively target the enzymes associated with SL metabolism are under development. Miglustat, a well-characterized iminosugar-based inhibitor of beta-glucosidase 2 (GBA2), has shown promise in CF treatment because it reduces the inflammatory response to infection by P. aeruginosa and restores F508del-CFTR chloride channel activity. This study aimed to probe the molecular basis for the anti-inflammatory activity of miglustat by examining specifically the role of GBA2 following the infection of CF bronchial epithelial cells by P. aeruginosa. We also report the anti-inflammatory activity of another potent inhibitor of GBA2 activity, namely N-(5-adamantane-1-yl-methoxy) pentyl)-deoxynojirimycin (Genz-529648). In CF bronchial cells, inhibition of GBA2 by miglustat or Genz-529648 significantly reduced the induction of IL-8 mRNA levels and protein release following infection by P. aeruginosa. Hence, the present data demonstrate that the anti-inflammatory effects of miglustat and Genz-529648 are likely exerted through inhibition of GBA2.	[Tebon, Maela; Bezzerri, Valentino; Lovato, Valentina; Cantu, Cinzia; Munari, Silvia; Cabrini, Giulio; Dechecchi, Maria Cristina] Univ Hosp Verona, Dept Pathol & Diagnost, Lab Mol Pathol, Verona, Italy; [Loberto, Nicoletta; Aureli, Massimo; Bassi, Rosaria; Sonnino, Sandro] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Lampronti, Ilaria; Gambari, Roberto] Univ Ferrara, Sect Biochem & Mol Biol, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Marchetti, Nicola; Cavazzini, Alberto] Univ Ferrara, Dept Chem & Pharmaceut Sci, I-44100 Ferrara, Italy; [Giri, Maria Grazia] Univ Hosp Verona, Dept Pathol & Diagnost, Med Phys Unit, Verona, Italy; [Cheng, Seng H.] Genzyme, Framingham, MA USA	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Milan; University of Ferrara; University of Ferrara; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Sanofi-Aventis; Genzyme Corporation	Dechecchi, MC (corresponding author), Univ Hosp Verona, Dept Pathol & Diagnost, Lab Mol Pathol, Verona, Italy.	cristina.dechecchi@ospedaleuniverona.it	Aureli, Massimo/G-3876-2014; Cavazzini, Alberto/B-7051-2015; Bezzerri, Valentino/AFW-5965-2022; Cheng, Seng H/AAC-6564-2022; Dechecchi, Maria Cristina/K-5139-2016; Cabrini, Giulio/K-4761-2016; Sonnino, Sandro/R-4154-2017; Gambari, Roberto/F-9555-2015; Marchetti, Nicola/G-4933-2010; Bezzerri, Valentino/K-8132-2016; Lampronti, Ilaria/F-5522-2016	Aureli, Massimo/0000-0003-1916-2440; Cavazzini, Alberto/0000-0002-2510-0871; Bezzerri, Valentino/0000-0002-6849-4487; Dechecchi, Maria Cristina/0000-0002-5005-6585; Cabrini, Giulio/0000-0003-2720-0742; Sonnino, Sandro/0000-0001-8180-5908; Gambari, Roberto/0000-0001-9205-6033; Marchetti, Nicola/0000-0001-5595-570X; Bezzerri, Valentino/0000-0002-5937-378X; BASSI, ROSARIA/0000-0001-7409-4730; Lampronti, Ilaria/0000-0002-1972-7766	Italian Cystic Fibrosis Research Foundation (grant FFC) [14/2012]	Italian Cystic Fibrosis Research Foundation (grant FFC)	This research was supported by Italian Cystic Fibrosis Research Foundation (grant FFC # 14/2012) with the contribution of "Picasso. Capolavori dal Museo Nazionale Picasso di Parigi", Festa d'Estate Villa Sigurta Verona, Delegazione FFC Lago di Garda e Arezzo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Akha AAS, 2013, IMMUNOLOGY, V140, P111, DOI 10.1111/imm.12122; Ashe KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021758; Aureli M, 2012, NEUROCHEM RES, V37, P1296, DOI 10.1007/s11064-012-0725-1; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Brodlie M, 2010, AM J RESP CRIT CARE, V182, P369, DOI 10.1164/rccm.200905-0799OC; Caretti A, 2014, BBA-GEN SUBJECTS, V1840, P586, DOI 10.1016/j.bbagen.2013.10.018; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Dechecchi MC, 2011, AM J RESP CELL MOL, V45, P825, DOI 10.1165/rcmb.2010-0457OC; Dechecchi MC, 2008, J CYST FIBROS, V7, P555, DOI 10.1016/j.jcf.2008.06.002; Dechecchi MC, 2012, CYSTIC FIBROSIS HUMA; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Guilbault C, 2008, AM J RESP CELL MOL, V38, P47, DOI 10.1165/rcmb.2007-0036OC; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoffman LR, 2013, CHEST, V143, P207, DOI 10.1378/chest.12-1639; Hollak CEM, 2009, PHARMACOEPIDEM DR S, V18, P770, DOI 10.1002/pds.1779; INOKUCHI J, 1987, CANCER LETT, V38, P23, DOI 10.1016/0304-3835(87)90196-0; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Konstan MW, 2007, AM J RESP CRIT CARE, V176, P1084, DOI 10.1164/rccm.200702-181OC; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Leonard A, 2012, J CYST FIBROS, V11, P231, DOI 10.1016/j.jcf.2011.12.004; Lubamba B, 2009, AM J RESP CRIT CARE, V179, P1022, DOI 10.1164/rccm.200901-0049OC; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Nahrlich L, 2013, CELL PHYSIOL BIOCHEM, V31, P505, DOI 10.1159/000350071; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/FMC.11.117, 10.4155/fmc.11.117]; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; PLATT FM, 1994, J BIOL CHEM, V269, P27108; Platt FM, 1997, J BIOL CHEM, V272, P19365, DOI 10.1074/jbc.272.31.19365; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ridley CM, 2013, J BIOL CHEM, V288, P26052, DOI 10.1074/jbc.M113.463562; Scudieri P, 2012, J PHYSIOL-LONDON, V590, P6141, DOI 10.1113/jphysiol.2012.240838; Sorli SC, 2013, FASEB J, V27, P489, DOI 10.1096/fj.12-215152; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Uhlig S, 2008, AM J RESP CRIT CARE, V178, P1100, DOI 10.1164/rccm.200804-595SO; Weenekes T, 2010, J MED CHEM, V53, P689; WELSH JM, 2001, METABOLIC MOL BASES; Yang Y, 2001, THER ADV RESPIR DIS, V5, P325; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Yu H, 2009, AM J RESP CELL MOL, V41, P367, DOI 10.1165/rcmb.2008-0295OC; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	48	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104763	10.1371/journal.pone.0104763	http://dx.doi.org/10.1371/journal.pone.0104763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141135	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200033
J	Malinska, H; Kahleova, H; Topolcan, O; Vrzalova, J; Oliyarnyk, O; Kazdova, L; Belinova, L; Hill, M; Pelikanova, T				Malinska, Hana; Kahleova, Hana; Topolcan, Ondrej; Vrzalova, Jindra; Oliyarnyk, Olena; Kazdova, Ludmila; Belinova, Lenka; Hill, Martin; Pelikanova, Terezie			Postprandial Oxidative Stress and Gastrointestinal Hormones: Is There a Link?	PLOS ONE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; TYPE-2 DIABETES-MELLITUS; INDUCED WEIGHT-LOSS; BETA-CELL FUNCTION; PANCREATIC-POLYPEPTIDE; GLUCOSE-TOLERANCE; INSULIN-SECRETION; BLOOD-GLUCOSE; GIP; GHRELIN	Background: Abnormal postprandial elevation of plasma glucose and lipids plays an important role in the pathogenesis of diabetes and strongly predicts cardiovascular mortality. In patients suffering from type 2 diabetes (T2D) postprandial state is associated with oxidative stress, cardiovascular risk and, probably, with impairment of both secretion and the effect of gastrointestinal peptides. Evaluating postprandial changes of gastrointestinal hormones together with changes in oxidative stress markers may help to understand the mechanisms behind the postprandial state in diabetes as well as suggest new preventive and therapeutical strategies. Methods: A standard meal test has been used for monitoring the postprandial concentrations of gastrointestinal hormones and oxidative stress markers in patients with T2D (n = 50) compared to healthy controls (n = 50). Blood samples were drawn 0, 30, 60, 120 and 180 minutes after the standard meal. Results: Both basal and postprandial plasma concentrations of glucose and insulin proved to be significantly higher in patients with T2D, whereas plasma concentrations of ghrelin showed significantly lower values during the whole meal test. In comparison with healthy controls, both basal and postprandial concentrations of almost all other gastrointestinal hormones and lipoperoxidation were significantly increased while ascorbic acid, reduced glutathione and superoxide dismutase activity were decreased in patients with T2D. A positive relationship was found between changes in GIP and those of glucose and immunoreactive insulin in diabetic patients (p<0.001 and p<0.001, respectively) and between changes in PYY and those of glucose (p<0.01). There was a positive correlation between changes in GIP and PYY and changes in ascorbic acid in patients with T2D (p<0.05 and p<0.001, respectively). Conclusion/Interpretation: Apart from a positive relationship of postprandial changes in GIP and PYY with changes in ascorbic acid, there was no direct link observed between gastrointestinal hormones and oxidative stress markers in diabetic patients.	[Malinska, Hana; Kahleova, Hana; Oliyarnyk, Olena; Kazdova, Ludmila; Belinova, Lenka; Pelikanova, Terezie] Inst Clin & Expt Med, Prague, Czech Republic; [Topolcan, Ondrej; Vrzalova, Jindra] Fac Hosp Pilsen, Plzen, Czech Republic; [Hill, Martin] Inst Endocrinol, Prague, Czech Republic; [Belinova, Lenka] Charles Univ Prague, Fac Med 1, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Institute of Endocrinology - Prague; Charles University Prague	Kahleova, H (corresponding author), Inst Clin & Expt Med, Prague, Czech Republic.	hana.kahleova@gmail.com; terezie.pelikanova@ikem.cz	Hill, Martin/G-7699-2019; Topolcan, Ondrej/K-7753-2017	Topolcan, Ondrej/0000-0001-6622-390X; Kahleova, Hana/0000-0003-0491-3993; Oliyarnyk, Olena/0000-0002-4912-6187; Hill, Martin/0000-0002-1705-0835; Windrichova, Jindra/0000-0003-0365-0968	Ministry of Health, Czech Republic, conceptual development of research organisation ("Institute for Clinical and Experimental Medicine - IKEM") [IN 00023001]; Internal Grant Agency of the Ministry of Health of the Czech Republic [NT/11238-4]; Grant Agency of Charles University - GAUK [702312]	Ministry of Health, Czech Republic, conceptual development of research organisation ("Institute for Clinical and Experimental Medicine - IKEM"); Internal Grant Agency of the Ministry of Health of the Czech Republic; Grant Agency of Charles University - GAUK	This work was supported by Ministry of Health, Czech Republic, conceptual development of research organisation ("Institute for Clinical and Experimental Medicine - IKEM, IN 00023001''), by the Internal Grant Agency of the Ministry of Health of the Czech Republic (NT/11238-4) and by the Grant Agency of Charles University - GAUK No 702312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alssema M, 2013, EUR J ENDOCRINOL, V169, P421, DOI 10.1530/EJE-13-0487; Anderson RA, 2006, DIABETIC MED, V23, P258, DOI 10.1111/j.1464-5491.2005.01767.x; Ashby D, 2007, PEPTIDES, V28, P198, DOI 10.1016/j.peptides.2006.10.019; Barazzoni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026224; Beisswenger PJ, 2001, DIABETES CARE, V24, P726, DOI 10.2337/diacare.24.4.726; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Ceriello A, 1998, DIABETES CARE, V21, P1529, DOI 10.2337/diacare.21.9.1529; Ceriello A, 2012, VASC PHARMACOL, V57, P133, DOI 10.1016/j.vph.2012.05.005; Ceriello A, 2011, DIABETES CARE, V34, P697, DOI 10.2337/dc10-1949; De Vriese C, 2010, NUTRITION, V26, P579, DOI 10.1016/j.nut.2009.09.013; Drucker DJ, 2010, DIABETES CARE, V33, P428, DOI 10.2337/dc09-1499; English PJ, 2007, DIABETES-METAB RES, V23, P299, DOI 10.1002/dmrr.681; Feinle-Bisset C, 2005, AM J PHYSIOL-ENDOC M, V289, pE948, DOI 10.1152/ajpendo.00220.2005; Flatt PR, 2008, DIABETIC MED, V25, P759, DOI 10.1111/j.1464-5491.2008.02455.x; Flatt Peter R, 2007, Diab Vasc Dis Res, V4, P151; Gault VA, 2005, DIABETES, V54, P2436, DOI 10.2337/diabetes.54.8.2436; Hamed EA, 2011, DIABETES RES CLIN PR, V94, P434, DOI 10.1016/j.diabres.2011.08.023; Holst JJ, 2011, DIABETES CARE, V34, pS251, DOI 10.2337/dc11-s227; Hou XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024815; Irwin N, 2009, DIABETOLOGIA, V52, P1724, DOI 10.1007/s00125-009-1422-8; Kahleova H, 2012, J DIABETES COMPLICAT, V26, P442, DOI 10.1016/j.jdiacomp.2012.05.003; Knop FK, 2007, REGUL PEPTIDES, V144, P123, DOI 10.1016/j.regpep.2007.07.002; Lutz TA, 2013, DIABETES OBES METAB, V15, P99, DOI 10.1111/j.1463-1326.2012.01670.x; Mather KJ, 2002, DIABETES-METAB RES, V18, P118, DOI 10.1002/dmrr.263; Meier JJ, 2005, DIABETOLOGIA, V48, P1872, DOI 10.1007/s00125-005-1863-7; Meier Juris J, 2006, Curr Diab Rep, V6, P194, DOI 10.1007/s11892-006-0034-7; Nakagawa K, 1997, ANAL BIOCHEM, V254, P31, DOI 10.1006/abio.1997.2372; PADH H, 1985, CELL BIOL INT REP, V9, P531, DOI 10.1016/0309-1651(85)90017-7; Ranganath LR, 2008, CLIN CHEM LAB MED, V46, P43, DOI 10.1515/CCLM.2008.008; Rigamonti AE, 2011, HORM METAB RES, V43, P569, DOI 10.1055/s-0031-1280783; Runchey SS, 2013, METABOLISM, V62, P188, DOI 10.1016/j.metabol.2012.07.006; Sampson MJ, 2002, DIABETES CARE, V25, P537, DOI 10.2337/diacare.25.3.537; Skrha J, 2010, PHYSIOL RES, V59, P749, DOI 10.33549/physiolres.931893; Small CJ, 2004, CNS NEUROL DISORD-DR, V3, P379, DOI 10.2174/1568007043336950; Solomon TPJ, 2010, DIABETES CARE, V33, P1561, DOI 10.2337/dc09-2021; Teff KL, 2004, J CLIN ENDOCR METAB, V89, P2963, DOI 10.1210/jc.2003-031855; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; Vilsboll T, 2004, DIABETOLOGIA, V47, P357, DOI 10.1007/s00125-004-1342-6; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; YOKODE M, 1988, J CLIN INVEST, V81, P720, DOI 10.1172/JCI113377	41	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103565	10.1371/journal.pone.0103565	http://dx.doi.org/10.1371/journal.pone.0103565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141237	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200008
J	Wang, N; Liang, HW; Zhou, Y; Wang, C; Zhang, SY; Pan, Y; Wang, YB; Yan, X; Zhang, JF; Zhang, CY; Zen, K; Li, DH; Chen, X				Wang, Nan; Liang, Hongwei; Zhou, Yong; Wang, Chen; Zhang, Suyang; Pan, Yi; Wang, Yanbo; Yan, Xin; Zhang, Junfeng; Zhang, Chen-Yu; Zen, Ke; Li, Donghai; Chen, Xi			miR-203 Suppresses the Proliferation and Migration and Promotes the Apoptosis of Lung Cancer Cells by Targeting SRC	PLOS ONE			English	Article							MICRORNA; EXPRESSION; ACTIVATION; KINASES; BIOGENESIS	SRC, also known as proto-oncogene c-Src, is a non-receptor tyrosine kinase that plays an important role in cancer progression by promoting survival, angiogenesis, proliferation, and invasion pathways. In this study, we found that SRC protein levels were consistently upregulated in lung cancer tissues, but that SRC mRNA levels varied randomly, suggesting that a post-transcriptional mechanism was involved in SRC regulation. Because microRNAs (miRNAs) are powerful post-transcriptional regulators of gene expression, we used bioinformatic analyses to search for miRNAs that potentially target SRC. We identified specific targeting sites for miR-203 in the 3'-untranslated region (3'-UTR) of SRC. We then experimentally validated miR-203 as a direct regulator of SRC using cell transfection and luciferase assays and showed that miR-203 inhibited SRC expression and consequently triggered suppression of the SRC/Ras/ERK pathway. Finally, we demonstrated that the repression of SRC by miR-203 suppressed the proliferation and migration and promoted the apoptosis of lung cancer cells. In summary, this study provides the first clues regarding the role of miR-203 as a tumor suppressor in lung cancer cells through the inhibition of SRC translation.	[Wang, Nan; Liang, Hongwei; Wang, Chen; Zhang, Suyang; Pan, Yi; Wang, Yanbo; Zhang, Junfeng; Zhang, Chen-Yu; Zen, Ke; Li, Donghai; Chen, Xi] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr microRNA Biol & Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yong] Nanjing Univ, Coll Med, Affiliated Gulou Hosp, Dept Thorac & Cardiovasc Surg, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Xin] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Xin] Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Li, DH (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr microRNA Biol & Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	donghaili@nju.edu.cn; xichen@nju.edu.cn	Pan, Yi/AAJ-2341-2021; wang, chen/GWM-9481-2022		National Basic Research Program of China (973 Program) [2014CB542300]; National Natural Science Foundation of China [81101330, 31271378, 81250044]; Natural Science Foundation of Jiangsu Province [BK2011013, BK2012014]; Research Special Fund for Public Welfare Industry of Health [201302018]; program for New Century Excellent Talents in University from the Ministry of Education, China [NCET-12-0261]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Research Special Fund for Public Welfare Industry of Health; program for New Century Excellent Talents in University from the Ministry of Education, China	This work was supported by grants from the National Basic Research Program of China (973 Program) (No. 2014CB542300), the National Natural Science Foundation of China (No. 81101330, 31271378, and 81250044), the Natural Science Foundation of Jiangsu Province (No. BK2011013 and BK2012014), and the Research Special Fund for Public Welfare Industry of Health (No. 201302018). This work was also supported by the program for New Century Excellent Talents in University from the Ministry of Education, China (NCET-12-0261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bian K, 2012, FEBS LETT, V586, P804, DOI 10.1016/j.febslet.2012.01.050; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; Di Stefano P, 2007, EMBO J, V26, P2843, DOI 10.1038/sj.emboj.7601724; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; HE L, 2004, NAT REV GENET, V5, P522; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson FM, 2007, ANTI-CANCER AGENT ME, V7, P651, DOI 10.2174/187152007784111278; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Masaki T, 2003, EUR J CANCER, V39, P1447, DOI 10.1016/S0959-8049(03)00276-4; MAZURENKO NN, 1992, EUR J CANCER, V28A, P372, DOI 10.1016/S0959-8049(05)80056-5; Ramalingam S, 1998, J CLIN ONCOL, V16, P651, DOI 10.1200/JCO.1998.16.2.651; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wang C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-58; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Zhou LY, 2008, J BIOL CHEM, V283, P28274, DOI 10.1074/jbc.M802663200; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	34	70	72	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105570	10.1371/journal.pone.0105570	http://dx.doi.org/10.1371/journal.pone.0105570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140799	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200101
J	Wu, CH; Sui, GP; Archer, SN; Sassone-Corsi, P; Aitken, K; Bagli, D; Chen, Y				Wu, Changhao; Sui, Guiping; Archer, Simon N.; Sassone-Corsi, Paolo; Aitken, Karen; Bagli, Darius; Chen, Ying			Local receptors as novel regulators for peripheral clock expression	FASEB JOURNAL			English	Article						circadian; muscarinic; purinergic; aging	NONNEURONAL CHOLINERGIC SYSTEM; CIRCADIAN CLOCK; ATP RELEASE; ACETYLCHOLINE-RELEASE; UROTHELIAL ATP; METABOLISM; RHYTHMS; EPIGENETICS; MODULATION; CHROMATIN	Mammalian circadian control is determined by a central clock in the brain suprachiasmatic nucleus (SCN) and synchronized peripheral clocks in other tissues. Increasing evidence suggests that SCN-independent regulation of peripheral clocks also occurs. We examined how activation of excitatory receptors influences the clock protein PERIOD 2 (PER2) in a contractile organ, the urinary bladder. PERIOD2::LUCIFERASE-knock-in mice were used to report real-time PER2 circadian dynamics in the bladder tissue. Rhythmic PER2 activities occurred in the bladder wall with a cycle of approximate to 24 h and peak at approximate to 12 h. Activation of the muscarinic and purinergic receptors by agonists shifted the peak to an earlier time (7.2 +/- 2.0 and 7.2 +/- 0.9 h, respectively). PER2 expression was also sensitive to mechanical stimulation. Aging significantly dampened PER2 expression and its response to the agonists. Finally, muscarinic agonist-induced smooth muscle contraction also exhibited circadian rhythm. These data identified novel regulators, endogenous receptors, in determining local clock activity, in addition to mediating the central control. Furthermore, the local clock appears to reciprocally align receptor activity to circadian rhythm for muscle contraction. The interaction between receptors and peripheral clock represents an important mechanism for maintaining physiological functions and its dysregulation may contribute to age-related organ disorders.Wu, C., Sui, G., Archer, S. N., Sassone-Corsi, P., Aitken, K., Bagli, D., Chen, Y. Local receptors as novel regulators for peripheral clock expression.	[Wu, Changhao; Archer, Simon N.; Chen, Ying] Univ Surrey, Dept Biochem & Physiol, Guildford GU2 7XH, Surrey, England; [Sui, Guiping] Guys & St Thomas Hosp Natl Hlth Serv Trust, Oesophageal Lab, London, England; [Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Aitken, Karen; Bagli, Darius] Univ Toronto, Hosp Sick Children, Dept Urol, Toronto, ON M5G 1X8, Canada	University of Surrey; University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Wu, CH (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Dept Biochem & Physiol, Guildford GU2 7XH, Surrey, England.	c.wu@surrey.ac.uk	Aitken, KJ/AAC-5383-2019		UK Biotechnology and Biological Sciences Research Council [BB/G015554/1, BB/E010296/1, BB/E003672/1]; BBSRC [BB/E003672/1, BB/I025379/1, BB/G015554/1, BB/E010296/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025379/1, BB/E010296/1, BB/G015554/1, BB/E003672/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by UK Biotechnology and Biological Sciences Research Council grants BB/G015554/1 (to Y. C.), BB/E010296/1 (to C. W.), and BB/E003672/1 (to S.N.A.). The authors thank Daan van der Veen for help with breeding the transgenic mice.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Andersson KE, 1999, SCAND J UROL NEPHROL, V33, P67, DOI 10.1080/003655999750042178; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bayliss M, 1999, J UROLOGY, V162, P1833, DOI 10.1016/S0022-5347(05)68247-X; Birder LA, 2010, NEUROUROL URODYNAM, V29, P598, DOI 10.1002/nau.20914; Birder LA, 2003, AM J PHYSIOL-RENAL, V285, pF423, DOI 10.1152/ajprenal.00056.2003; Birder Lori A, 2011, Handb Exp Pharmacol, P207, DOI 10.1007/978-3-642-16499-6_10; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Chopra B, 2005, J PHYSIOL-LONDON, V562, P859, DOI 10.1113/jphysiol.2004.071159; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Diaz-Munoz M, 2000, AM J PHYSIOL-REG I, V279, pR2048, DOI 10.1152/ajpregu.2000.279.6.R2048; Duguay D, 2009, CHRONOBIOL INT, V26, P1479, DOI 10.3109/07420520903497575; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.118; Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007; Gimble JM, 2011, CURR OPIN CLIN NUTR, V14, P554, DOI 10.1097/MCO.0b013e32834ad94b; Hanna-Mitchell AT, 2007, LIFE SCI, V80, P2298, DOI 10.1016/j.lfs.2007.02.010; Hasan S, 2012, FASEB J, V26, P2414, DOI 10.1096/fj.11-201699; Herrera GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012298; Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63; Kanazawa T, 2012, J ORTHOP RES, V30, P468, DOI 10.1002/jor.21528; Kang SH, 2013, EUR J PHARMACOL, V700, P102, DOI 10.1016/j.ejphar.2012.11.053; Khapre RV, 2010, ANN MED, V42, P404, DOI 10.3109/07853890.2010.499134; Li JD, 2012, PROG BRAIN RES, V199, P119, DOI 10.1016/B978-0-444-59427-3.00028-9; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Mansfield KJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/182862; Masri S, 2013, NAT REV NEUROSCI, V14, P69, DOI 10.1038/nrn3393; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Mills IW, 2000, BJU INT, V86, P538, DOI 10.1046/j.1464-410X.2000.00768.x; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moro C, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.08.039; Negoro H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1812; Nishii K, 2006, NEUROSCI LETT, V401, P44, DOI 10.1016/j.neulet.2006.03.022; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Rosbash M, 2007, COLD SPRING HARB SYM, V72, P75, DOI 10.1101/sqb.2007.72.062; Sahar S, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00037; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Sassone-Corsi P, 2013, SCIENCE, V339, P148, DOI 10.1126/science.1233423; SHINKAI M, 1993, BRIT J PHARMACOL, V108, P759, DOI 10.1111/j.1476-5381.1993.tb12874.x; Siepka SM, 2007, COLD SPRING HARB SYM, V72, P251, DOI 10.1101/sqb.2007.72.052; Smith CP, 2008, NEUROCHEM INT, V52, P1068, DOI 10.1016/j.neuint.2007.11.006; Smith CP, 2005, NEUROCHEM INT, V47, P291, DOI 10.1016/j.neuint.2005.04.021; Stranahan AM, 2012, CURR ALZHEIMER RES, V9, P93; Sui GP, 2008, AM J PHYSIOL-RENAL, V295, pF688, DOI 10.1152/ajprenal.00133.2008; Sui GP, 2014, AM J PHYSIOL-RENAL, V306, pF286, DOI 10.1152/ajprenal.00291.2013; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Tsimakouridze EV, 2012, CHRONOBIOL INT, V29, P810, DOI 10.3109/07420528.2012.691145; Wessler I, 2003, LIFE SCI, V72, P2055, DOI 10.1016/S0024-3205(03)00083-3; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida J, 2007, NEUROUROL URODYNAM, V26, P1050, DOI 10.1002/nau.20438; Yoshida M, 2006, UROLOGY, V67, P425, DOI 10.1016/j.urology.2005.08.014; Young JS, 2012, BJU INT, V110, pE397, DOI 10.1111/j.1464-410X.2012.10966.x; Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995	55	11	11	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4610	4616		10.1096/fj.13-243295	http://dx.doi.org/10.1096/fj.13-243295			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25145629	Green Published			2022-12-25	WOS:000344050900003
J	Zhu, X; Zhang, JF; Fan, WG; Gong, YG; Yan, JH; Yuan, ZD; Wu, L; Cui, HJ; Luo, HQ; Kong, QM; Tang, L; Leng, SL; Liao, YF; Fu, WM; Xiao, Q; Li, DP				Zhu, Xiao; Zhang, Jinfang; Fan, Wenguo; Gong, Yunguo; Yan, Jianhua; Yuan, Zhidong; Wu, Lang; Cui, Hongjing; Luo, Haiqing; Kong, Qingming; Tang, Li; Leng, Shuilong; Liao, Yufeng; Fu, Weiming; Xiao, Qin; Li, Dongpei			MAPKAP1 rs10118570 Polymorphism Is Associated with Anti-Infection and Anti-Hepatic Fibrogenesis in Schistosomiasis Japonica	PLOS ONE			English	Article							CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; CHROMOSOMAL INSTABILITY; 3' UTR; GRP78; CHINA; INFECTION; RISK; SUSCEPTIBILITY; INFLAMMATION	Chronic infection with Schistosoma japonicum is an important cause of hepatic fibrosis (HF). Human 9q33.3 is one of the most important loci for stress-related diseases. We examined the potential associations of 43 single-nucleotide polymorphisms (SNPs) with S. japonicum infection and HF in epidemic region in China. We identified a SNP (rs10118570 GG in mitogen-activated protein kinase associated protein 1, MAPKAP1) contributes to anti-infection (adjusted OR = 0.35) and anti-fibrogenesis (adjusted RR = 0.44) in the discovery study. Replicative and combined studies showed consistent protective quality for this genotype (replicative: adjusted OR = 0.37 for anti-infection, and adjusted RR = 0.40 for anti-fibrogenesis; Combined: adjusted OR = 0.45 for anti-infection, and adjusted RR = 0.42 for anti-fibrogenesis). Univariate and multivariate analysis in the discovery, replicative and combined studies, suggested that durations (years), splenomegaly, serum ALB and rs10118570 were independent predictors influencing the fibrogenesis. The analysis of gene-gene interaction showed rs10118570 functions independently. We conclude that MAPKAP1 may represent a novel anti-infection and anti-fibrogenesis genomic locus in chronic schistosomiasis japonica. And rs10118570 may be a potential biomarker and target for the treatment of this life-threatening ancient disease.	[Zhu, Xiao; Cui, Hongjing; Luo, Haiqing; Li, Dongpei] Guangdong Med Coll, Dept Clin Oncol, Guangdong Prov Key Lab Med Mol Diag, Zhanjiang Dongguan, Peoples R China; [Zhu, Xiao; Xiao, Qin] Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ, Hong Kong Univ Sci & Technol,Med Ctr, Shenzhen, Peoples R China; [Zhang, Jinfang; Fu, Weiming] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Fan, Wenguo] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Gong, Yunguo] Univ Texas Houston, Sch Biomed Informat, Houston, TX USA; [Yan, Jianhua] A STAR NUS, Clin Imaging Res Ctr, Singapore, Singapore; [Yuan, Zhidong] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Peoples R China; [Wu, Lang] Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN USA; [Kong, Qingming] Zhejiang Acad Med Sci, Immun & Biochem Res Lab, Hangzhou, Zhejiang, Peoples R China; [Tang, Li] Hubei Acad Prevent Med, Hubei Prov Ctr Dis Control & Prevent, Schistosomiasis Inst, Wuhan, Peoples R China; [Leng, Shuilong] Guangzhou Med Univ, Dept Human Anat, Guangzhou, Guangdong, Peoples R China; [Liao, Yufeng] Ningbo 2 Hosp, Dept Lab Med, Ningbo, Zhejiang, Peoples R China; [Fu, Weiming] Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou, Guangdong, Peoples R China; [Li, Dongpei] Georgia Regents Univ, Dept Neurosci & Regenerat Med, Inst Mol Med & Genet, Augusta, GA USA	Guangdong Medical University; Hong Kong University of Science & Technology; Peking University; Chinese University of Hong Kong; Prince of Wales Hospital; Sun Yat Sen University; University of Texas System; University of Texas Health Science Center Houston; Hunan University of Science & Technology; Mayo Clinic; Zhejiang Academy of Medical Sciences; Guangzhou Medical University; Chinese Academy of Sciences; University System of Georgia; Augusta University	Zhu, X (corresponding author), Guangdong Med Coll, Dept Clin Oncol, Guangdong Prov Key Lab Med Mol Diag, Zhanjiang Dongguan, Peoples R China.	bioxzhu@yahoo.com; qin_xiao_sz@163.com; dliimmag@gmail.com	Wu, Lang/M-4053-2017		National Natural Science Foundation of China [81071697, 31100914, 30700436, 81271166, 81201831]; Natural Science Foundation of Guangdong Province [S2011040003694]; Research Project of Science and Information Technology of Guangzhou City Grant [2012J4100075, 12C22061657]; Research Project of Initial for Talent Research in Guangdong Medical College [XB1382, GZ1131-B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Research Project of Science and Information Technology of Guangzhou City Grant; Research Project of Initial for Talent Research in Guangdong Medical College	This work was supported by National Natural Science Foundation of China Grants 81071697, 31100914, 30700436, 81271166 and 81201831; Natural Science Foundation of Guangdong Province Grant S2011040003694; Research Project of Science and Information Technology of Guangzhou City Grant 2012J4100075, 12C22061657; Research Project of Initial for Talent Research in Guangdong Medical College XB1382, GZ1131-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ouf E, 2012, J INFECT DIS, V206, P562, DOI 10.1093/infdis/jis396; Antony JS, 2013, J INFECT DIS, V207, P1675, DOI 10.1093/infdis/jit081; BEWTRA M, 2009, GASTROENTEROLOGY, V136, P731; Bewtra Meenakshi, 2009, Gastroenterology, V136, P731, DOI 10.1053/j.gastro.2008.05.043; BORDA C E, 1971, Revista do Instituto de Medicina Tropical de Sao Paulo, V13, P71; Camacho-Lobato L, 1998, J HEPATOL, V29, P233, DOI 10.1016/S0168-8278(98)80008-1; Carneiro-Santos P, 2002, PARASITE IMMUNOL, V24, P493, DOI 10.1046/j.1365-3024.2002.00487.x; Cheng J, 2005, MOL CELL BIOL, V25, P5955, DOI 10.1128/MCB.25.14.5955-5964.2005; Coutinho HM, 2005, J INFECT DIS, V192, P528, DOI 10.1086/430929; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Ellis MK, 2009, PARASITOLOGY, V136, P699, DOI 10.1017/S003118200900612X; Fairfax KC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002490; FAUST EC, 1946, ANN INTERN MED, V25, P585, DOI 10.7326/0003-4819-25-4-585; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jenkins J., 1996, 2 INT WORKSH NIAM NI; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Knopp S, 2013, EXPERT REV ANTI INFE; Latif B, 2013, EMERG INFECT DIS, V19, P1340, DOI 10.3201/eid1908.121710; LI YS, 1991, T ROY SOC TROP MED H, V85, P623, DOI 10.1016/0035-9203(91)90370-E; Lu DB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001960; Lubeya M, 2010, LANCET, V376, P1645, DOI 10.1016/S0140-6736(10)62095-8; Makino C, 2006, GENES CELLS, V11, P1239, DOI 10.1111/j.1365-2443.2006.01016.x; Nair SS, 2011, HEPATOLOGY, V54, P285, DOI 10.1002/hep.24354; Poynard T, 2013, J HEPATOL, V58, P928, DOI 10.1016/j.jhep.2012.12.021; Reddy M, 2007, JAMA-J AM MED ASSOC, V298, P1911, DOI 10.1001/jama.298.16.1911; Riley S, 2008, PLOS MED, V5, P70, DOI 10.1371/journal.pmed.0050018; ROSIN MP, 1994, CANCER RES, V54, pS1929; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Winder T, 2011, ANN ONCOL, V22, P2431, DOI 10.1093/annonc/mdq771; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Xiao Hui, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P288; Xiao Q, 2014, J THORAC ONCOL, V9, P1041, DOI 10.1097/JTO.0000000000000195; Yoshida T, 2010, INT J MOL MED, V25, P649, DOI 10.3892/ijmm_00000388; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhu X, 2013, CARCINOGENESIS, V34, P1273, DOI 10.1093/carcin/bgt061; Zhu X, 2012, CHEST, V142, P1691, DOI 10.1378/chest.12-1513; Zhu X, 2012, CHEST, V141, P1466, DOI 10.1378/chest.11-0469; Zhu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021997; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zhu X, 2010, HEPATO-GASTROENTEROL, V57, P1191; Zhu X, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-83; Zhu X, 2009, WORLD J GASTROENTERO, V15, P4958, DOI 10.3748/wjg.15.4958; Zhu X, 2009, INT J CANCER, V125, P1352, DOI 10.1002/ijc.24487	46	11	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105995	10.1371/journal.pone.0105995	http://dx.doi.org/10.1371/journal.pone.0105995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153992	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200102
J	Antunes, G; Sebastiao, AM; de Souza, FMS				Antunes, Gabriela; Sebastiao, Ana Maria; Simoes de Souza, Fabio Marques			Mechanisms of Regulation of Olfactory Transduction and Adaptation in the Olfactory Cilium	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; PROTEIN-COUPLED RECEPTORS; ACTIVATED CHLORIDE CHANNEL; LIGHT-CHAIN KINASE; C-TERMINAL DOMAIN; EF-HAND PROTEINS; SENSORY NEURONS; CA2+ BINDING; RESPONSE TERMINATION; CALCIUM-BINDING	Olfactory adaptation is a fundamental process for the functioning of the olfactory system, but the underlying mechanisms regulating its occurrence in intact olfactory sensory neurons (OSNs) are not fully understood. In this work, we have combined stochastic computational modeling and a systematic pharmacological study of different signaling pathways to investigate their impact during short-term adaptation (STA). We used odorant stimulation and electroolfactogram (EOG) recordings of the olfactory epithelium treated with pharmacological blockers to study the molecular mechanisms regulating the occurrence of adaptation in OSNs. EOG responses to paired-pulses of odorants showed that inhibition of phosphodiesterases (PDEs) and phosphatases enhanced the levels of STA in the olfactory epithelium, and this effect was mimicked by blocking vesicle exocytosis and reduced by blocking cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) and vesicle endocytosis. These results suggest that G-coupled receptors (GPCRs) cycling is involved with the occurrence of STA. To gain insights on the dynamical aspects of this process, we developed a stochastic computational model. The model consists of the olfactory transduction currents mediated by the cyclic nucleotide gated (CNG) channels and calcium ion (Ca2+)-activated chloride (CAC) channels, and the dynamics of their respective ligands, cAMP and Ca2+, and it simulates the EOG results obtained under different experimental conditions through changes in the amplitude and duration of cAMP and Ca2+ response, two second messengers implicated with STA occurrence. The model reproduced the experimental data for each pharmacological treatment and provided a mechanistic explanation for the action of GPCR cycling in the levels of second messengers modulating the levels of STA. All together, these experimental and theoretical results indicate the existence of a mechanism of regulation of STA by signaling pathways that control GPCR cycling and tune the levels of second messengers in OSNs, and not only by CNG channel desensitization as previously thought.	[Sebastiao, Ana Maria] Univ Lisbon, Fac Med, Inst Pharmacol & Neurosci, P-1699 Lisbon, Portugal; [Antunes, Gabriela; Sebastiao, Ana Maria; Simoes de Souza, Fabio Marques] Univ Lisbon, Inst Mol Med, Neurosci Unit, P-1699 Lisbon, Portugal; [Simoes de Souza, Fabio Marques] Fed Univ ABC, Ctr Math Computat & Cognit, Sao Bernardo Do Campo, Brazil; [Antunes, Gabriela] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Psychol, Lab Neural Syst,Psychobiol Sect, Ribeirao Preto, Brazil	Universidade de Lisboa; Universidade de Lisboa; Universidade de Sao Paulo	de Souza, FMS (corresponding author), Univ Lisbon, Inst Mol Med, Neurosci Unit, P-1699 Lisbon, Portugal.	fabio.souza@ufabc.edu.br	de Souza, Fabio Simoes/B-8773-2015	de Souza, Fabio Simoes/0000-0001-8329-0311; Sebastiao, Ana M/0000-0001-9030-6115	European Union [PCOFUND-GA-2009-246542]; Foundation for Science and Technology of Portugal; Foundation for Science and Technology of Portugal [SFRH/BI/52112/2013]	European Union(European Commission); Foundation for Science and Technology of Portugal(Portuguese Foundation for Science and Technology); Foundation for Science and Technology of Portugal(Portuguese Foundation for Science and Technology)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. PCOFUND-GA-2009-246542 and from the Foundation for Science and Technology of Portugal. GA has received the fellowship SFRH/BI/52112/2013 of the Foundation for Science and Technology of Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEK GD, 1984, BRAIN RES, V310, P87, DOI 10.1016/0006-8993(84)90012-X; Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Antolin S, 2010, J GEN PHYSIOL, V135, P367, DOI 10.1085/jgp.200910337; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; Ben-Chaim Y, 2011, P NATL ACAD SCI USA, V108, P822, DOI 10.1073/pnas.1017983108; Benmerah A, 2013, CURR OPIN CELL BIOL, V25, P78, DOI 10.1016/j.ceb.2012.10.011; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bhandawat V, 2005, SCIENCE, V308, P1931, DOI 10.1126/science.1109886; Bhandawat V, 2010, P NATL ACAD SCI USA, V107, P18682, DOI 10.1073/pnas.1004571107; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Biekofsky RR, 2004, BIOCHEMISTRY-US, V43, P6554, DOI 10.1021/bi0497852; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Biel M, 2009, J BIOL CHEM, V284, P9017, DOI 10.1074/jbc.R800075200; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Biskup C, 2007, NATURE, V446, P440, DOI 10.1038/nature05596; Bloodgood RA, 2012, MOL BIOL CELL, V23, P2407, DOI 10.1091/mbc.E12-01-0073; Boccaccio A, 2006, J GEN PHYSIOL, V128, P171, DOI 10.1085/jgp.200609555; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P11983, DOI 10.1073/pnas.89.24.11983; Boekhoff I, 1997, J BIOL CHEM, V272, P4606, DOI 10.1074/jbc.272.7.4606; BORISY FF, 1992, J NEUROSCI, V12, P915; Boschek CB, 2007, BIOCHEMISTRY-US, V46, P4580, DOI 10.1021/bi6025402; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; Castillo K, 2007, EUR J NEUROSCI, V26, P2524, DOI 10.1111/j.1460-9568.2007.05863.x; Castillo K, 2010, EUR J NEUROSCI, V32, P932, DOI 10.1111/j.1460-9568.2010.07393.x; Cenedese V, 2012, J GEN PHYSIOL, V139, P285, DOI 10.1085/jgp.201110764; Chen TC, 1998, LAB INVEST, V78, P165; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Cygnar K. D., 2010, J VIS EXP; Cygnar KD, 2012, J NEUROSCI, V32, P14557, DOI 10.1523/JNEUROSCI.0559-12.2012; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; DAVIDSON HW, 1992, J CELL BIOL, V116, P1343, DOI 10.1083/jcb.116.6.1343; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; De Palo G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01251; De Palo G, 2012, BIOPHYS J, V102, P2677, DOI 10.1016/j.bpj.2012.04.040; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dolzer J, 2008, CHEM SENSES, V33, P803, DOI 10.1093/chemse/bjn043; Dougherty DP, 2005, P NATL ACAD SCI USA, V102, P10415, DOI 10.1073/pnas.0504099102; Evenas J, 1998, BIOCHEMISTRY-US, V37, P13744, DOI 10.1021/bi9806448; Evenas J, 2001, STRUCTURE, V9, P185, DOI 10.1016/S0969-2126(01)00575-5; Evenas J, 1997, BIOCHEMISTRY-US, V36, P3448, DOI 10.1021/bi9628275; Evenas J, 1999, J MOL BIOL, V289, P603, DOI 10.1006/jmbi.1999.2770; French DA, 2006, MATH COMPUT MODEL, V43, P945, DOI 10.1016/j.mcm.2005.11.010; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Ghossoub R, 2011, BIOL CELL, V103, P131, DOI 10.1042/BC20100128; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Griff ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037148; HAIECH J, 1981, BIOCHEMISTRY-US, V20, P3890, DOI 10.1021/bi00516a035; Halnes G, 2009, J COMPUT NEUROSCI, V27, P471, DOI 10.1007/s10827-009-0162-6; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; Katanosaka K, 2002, J BIOCHEM, V132, P301, DOI 10.1093/oxfordjournals.jbchem.a003224; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kent E, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-91; Kerr RA, 2008, SIAM J SCI COMPUT, V30, P3126, DOI 10.1137/070692017; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kleene SJ, 1997, BIOPHYS J, V73, P1110, DOI 10.1016/S0006-3495(97)78143-8; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Kleene SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005266; Klimmeck D, 2008, NEUROSCIENCE, V151, P901, DOI 10.1016/j.neuroscience.2007.11.023; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Kroner C, 1996, BBA-MOL CELL RES, V1312, P169, DOI 10.1016/0167-4889(96)00030-4; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Lagostena L, 2003, CHEM SENSES, V28, P705, DOI 10.1093/chemse/bjg063; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Li J, 1999, MOL PHARMACOL, V55, P883; LIDOW MS, 1984, J ULTRA MOL STRUCT R, V86, P18, DOI 10.1016/S0022-5320(84)90092-3; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; LINSE S, 1991, J BIOL CHEM, V266, P8050; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; LOWE G, 1995, P NATL ACAD SCI USA, V92, P7864, DOI 10.1073/pnas.92.17.7864; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malmendal A, 1999, BIOCHEMISTRY-US, V38, P11844, DOI 10.1021/bi9909288; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; Mashukova A, 2006, J NEUROSCI, V26, P9902, DOI 10.1523/JNEUROSCI.2897-06.2006; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; MAUNE JF, 1992, BIOCHEMISTRY-US, V31, P7779, DOI 10.1021/bi00149a006; Mayer U, 2008, CHEM SENSES, V33, P145, DOI 10.1093/chemse/bjm073; MENCO B, 1992, MICROSC RES TECHNIQ, V22, P215; Menco BPM, 1997, CHEM SENSES, V22, P295, DOI 10.1093/chemse/22.3.295; MENCO BPM, 1980, CELL TISSUE RES, V207, P183; MENCO BPM, 1984, CELL TISSUE RES, V235, P225; MENINI A, 1995, NATURE, V373, P435, DOI 10.1038/373435a0; Menini A, 1999, CURR OPIN NEUROBIOL, V9, P419, DOI 10.1016/S0959-4388(99)80063-4; Nache V, 2005, J PHYSIOL-LONDON, V569, P91, DOI 10.1113/jphysiol.2005.092304; Nache V, 2008, BIOPHYS J, V95, P2750, DOI 10.1529/biophysj.108.129718; Nache V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003110; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; O'Donnell SE, 2011, PROTEINS, V79, P765, DOI 10.1002/prot.22917; OLWIN BB, 1984, J BIOL CHEM, V259, P949; OTTOSON D, 1955, Acta Physiol Scand Suppl, V35, P1; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; PERSAUD KC, 1988, BIOCHIM BIOPHYS ACTA, V944, P49, DOI 10.1016/0005-2736(88)90315-X; Poll F, 2011, J BIOL CHEM, V286, P32931, DOI 10.1074/jbc.M111.224899; Pun RYK, 2003, BIOPHYS J, V84, P3425, DOI 10.1016/S0006-3495(03)70064-2; Pyrski M, 2007, J COMP NEUROL, V501, P944, DOI 10.1002/cne.21290; Rankin ML, 1999, J NEUROCHEM, V72, P541, DOI 10.1046/j.1471-4159.1999.0720541.x; Reidl J, 2006, BIOPHYS J, V90, P1147, DOI 10.1529/biophysj.104.058545; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; RESTREPO D, 1993, J GEN PHYSIOL, V102, P907, DOI 10.1085/jgp.102.5.907; Saidu SP, 2009, CHEM SENSES, V34, P349, DOI 10.1093/chemse/bjp008; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; SCHNETKAMP PPM, 1991, ANN NY ACAD SCI, V639, P10, DOI 10.1111/j.1749-6632.1991.tb17285.x; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Shea MA, 1996, BIOCHEMISTRY-US, V35, P2943, DOI 10.1021/bi951934g; Simpson ML, 2009, WIRES NANOMED NANOBI, V1, P214, DOI 10.1002/wnan.22; Song Y, 2008, NEURON, V58, P374, DOI 10.1016/j.neuron.2008.02.029; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Suzuki N, 2004, CHEM SENSES, V29, P411, DOI 10.1093/chemse/bjh042; Suzuki N, 2002, CHEM SENSES, V27, P789, DOI 10.1093/chemse/27.9.789; Takeuchi H, 2002, J PHYSIOL-LONDON, V541, P825, DOI 10.1113/jphysiol.2002.016600; Tan RY, 1996, J BIOL CHEM, V271, P7479, DOI 10.1074/jbc.271.13.7479; TAREILUS E, 1995, BBA-MOL CELL RES, V1269, P129, DOI 10.1016/0167-4889(95)00105-2; Theoharis NT, 2008, BIOCHEMISTRY-US, V47, P112, DOI 10.1021/bi7013129; Ungerer N, 2011, BIOCHEMISTRY-US, V50, P3221, DOI 10.1021/bi200115m; Wachowiak M, 2011, NEURON, V71, P962, DOI 10.1016/j.neuron.2011.08.030; Waldeck C, 2009, J GEN PHYSIOL, V134, P397, DOI 10.1085/jgp.200910296; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; WILEMAN T, 1984, BIOCHEM J, V220, P665, DOI 10.1042/bj2200665; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	146	11	12	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105531	10.1371/journal.pone.0105531	http://dx.doi.org/10.1371/journal.pone.0105531			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144232	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100082
J	Derkarabetian, S; Hedin, M				Derkarabetian, Shahan; Hedin, Marshal			Integrative Taxonomy and Species Delimitation in Harvestmen: A Revision of the Western North American Genus Sclerobunus (Opiliones: Laniatores: Travunioidea)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; HIDDEN DIVERSITY; ARACHNIDA; DIVERSIFICATION; CYPHOPHTHALMI; INFERENCE; ROBUSTUS; TREES; CAVE	Alpha taxonomy, and specifically the delimitation of species, is becoming increasingly objective and integrative. The use of coalescent-based methods applied to genetic data is providing new tools for the discovery and delimitation of species. Here, we use an integrative approach via a combination of discovery-based multivariate morphological analyses to detect potential new species. These potential species are then used as a priori species in hypothesis-driven validation analyses with genetic data. This research focuses on the harvestmen genus Sclerobunus found throughout the mountainous regions of western North America. Based on our analyses, we conduct a revision of Sclerobunus resulting in synonymy of Cyptobunus with Sclerobunus including transfer of S. cavicolens comb. nov. and elevation of both subspecies of S. ungulatus: S. ungulatus comb. nov. and S. madhousensis comb. nov., stat. nov. The three subspecies of S. robustus are elevated, S. robustus, S. glorietus stat. nov., and S. idahoensis stat. nov. Additionally, five new species of Sclerobunus are described from New Mexico and Colorado, including S. jemez sp. nov., S. klomax sp. nov., S. skywalkeri sp. nov., S. speoventus sp. nov., and S. steinmanni sp. nov. Several of the newly described species are single-cave endemics, and our findings suggest that further exploration of western North American cave habitats will likely yield additional new species.	[Derkarabetian, Shahan; Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Derkarabetian, Shahan] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	California State University System; San Diego State University; University of California System; University of California Riverside	Derkarabetian, S (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	sderkarabetian@gmail.com			Cave Conservancy Foundation; Society of Systematic Biologists; American Arachnological Society	Cave Conservancy Foundation; Society of Systematic Biologists; American Arachnological Society	This research was funded by the Cave Conservancy Foundation (Doctoral Fellowship in Karst Studies), Society of Systematic Biologists (Graduate Student Research Award), and the American Arachnological Society (Vincent Roth Fund for Systematics Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Arthofer W, 2013, MOL ECOL, V22, P3850, DOI 10.1111/mec.12340; Banks N, 1901, AM NAT, V35, P669, DOI 10.1086/277984; Banks N., 1905, Entomological News Philadelphia, Vxvi, P251; Banks N, 1902, P ACAD NAT SCI PHILA, V53, P568; Banks N., 1894, CAN ENTOMOL, V26, P160; Banks N, 1893, T AM ENTOMOL SOC, V20, P149; Banks Nathan, 1911, Pomona College Journal of Entomology, V3; Barley AJ, 2013, EVOLUTION, V67, P3556, DOI 10.1111/evo.12219; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boyer SL, 2007, MOL ECOL, V16, P4999, DOI 10.1111/j.1365-294X.2007.03555.x; BRAGG P D, 1972, Journal of the Entomological Society of British Columbia, V69, P67; Bragg Philip D., 2009, Journal of the Entomological Society of British Columbia, V106, P29; Briggs T. S., 1971, Occasional Papers Calif Acad Sci, VNo. 90, P1; Briggs TS, 1974, J ARACHNOL, V1, P205; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; Camargo A, 2013, SPECIES PROBLEM ONGO; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; COKENDOLPHER JC, 1993, SOUTHWEST NAT, V38, P236, DOI 10.2307/3671428; Crosby C. R., 1924, Entomological News Philadelphia, V35, P104; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Derkarabetian S, 2011, MOL PHYLOGENET EVOL, V61, P844, DOI 10.1016/j.ympev.2011.08.004; Derkarabetian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010388; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; DUMITRESCU D, 1976, Travaux du Museum d'Histoire Naturelle "Grigore Antipa", V17, P17; Edgar A.L., 1990, P529; EKPA O, 1984, TETRAHEDRON LETT, V25, P1315, DOI 10.1016/S0040-4039(01)80145-3; Elliott WR, 2000, ECOSY WORLD, V30, P665; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Ezard THG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-175; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Giarla TC, 2014, MOL PHYLOGENET EVOL, V70, P137, DOI 10.1016/j.ympev.2013.09.019; Giribet Gonzalo, 2010, Bulletin of the Museum of Comparative Zoology, V160, P1, DOI 10.3099/0027-4100-160.1.1; Goodnight Clarence J., 1943, AMER MIDLAND NAT, V29, P643, DOI 10.2307/2421154; GOODNIGHT CLARENCE J., 1960, AMER MIDLAND NAE, V64, P34, DOI 10.2307/2422891; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Hedin M, 2010, MOL PHYLOGENET EVOL, V54, P107, DOI 10.1016/j.ympev.2009.08.020; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Knowles L.L., 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701701091, DOI 10.1080/10635150701701091]; Kury Adriano B., 2003, Revista Iberica de Aracnologia Volumen Especial Monografico, V1, P1; Kury AB, 2013, ZOOTAXA, V3703, P27; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Near TJ, 2013, MOL PHYLOGENET EVOL, V66, P868, DOI 10.1016/j.ympev.2012.11.009; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Packard AS, 1877, B US GEOLOGICAL SURV, V3, P157; Packard AS, 1888, MEM NAT ACAD SCI; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paquin P, 2004, MOL ECOL, V13, P3239, DOI 10.1111/j.1365-294X.2004.02296.x; Parmakelis A, 2013, BIOL J LINN SOC, V110, P728, DOI 10.1111/bij.12170; Pearson PN, 2014, PALEOBIOLOGY, V40, P130, DOI 10.1666/13004; Rambla Maria, 1994, P215; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Richart CH, 2013, ZOOKEYS, DOI 10.3897/zookeys.311.2920; Roewer C. F., 1915, Archiv fuer Naturgeschichte Berlin, V80; Roewer C. F., 1923, WEBERKNECHTE ERDE SY; Rower CF, 1931, Z WISS ZOOL ABT A, V138, P137; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Seifert B, 2014, MYRMECOL NEWS, V19, P1; Shear W.A., 1977, Journal Arachnol, V3, P177; Shear William A., 2008, Zootaxa, V1809, P67; Simon E, 1879, ARACHNIDES FRANCE, V7; SIMON E., 1879, ANN SOC ENTOMOLOGIQU, V22, P183; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taylor SJ, 2008, 200825 INHS DIV BIOD; Welbourn W. Calvin, 1999, Journal of Caves and Karst Studies, V61, P93; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	77	36	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104982	10.1371/journal.pone.0104982	http://dx.doi.org/10.1371/journal.pone.0104982			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144370	gold, Green Submitted, Green Published			2022-12-25	WOS:000341106100034
J	Gole, HKA; Tharp, DL; Bowles, DK				Gole, Hope K. A.; Tharp, Darla L.; Bowles, Douglas K.			Upregulation of Intermediate-Conductance Ca2+-Activated K+ Channels (KCNN4) in Porcine Coronary Smooth Muscle Requires NADPH Oxidase 5 (NOX5)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; ANGIOTENSIN-II; POTASSIUM CHANNEL; SUPEROXIDE-PRODUCTION; NAD(P)H OXIDASE; MOLECULAR REGULATION; SIGNALING PATHWAYS; HYDROGEN-PEROXIDE; REDOX REGULATION	Aims: NADPH oxidase (NOX) is the primary source of reactive oxygen species (ROS) in vascular smooth muscle cells (SMC) and is proposed to play a key role in redox signaling involved in the pathogenesis of cardiovascular disease. Growth factors and cytokines stimulate coronary SMC (CSMC) phenotypic modulation, proliferation, and migration during atherosclerotic plaque development and restenosis. We previously demonstrated that increased expression and activity of intermediate-conductance Ca2+-activated K+ channels (KCNN4) is necessary for CSMC phenotypic modulation and progression of stenotic lesions. Therefore, the purpose of this study was to determine whether NOX is required for KCNN4 upregulation induced by mitogenic growth factors. Methods and Results: Dihydroethidium micro-fluorography in porcine CSMCs demonstrated that basic fibroblast growth factor (bFGF) increased superoxide production, which was blocked by the NOX inhibitor apocynin (Apo). Apo also blocked bFGF-induced increases in KCNN4 mRNA levels in both right coronary artery sections and CSMCs. Similarly, immunohistochemistry and whole cell voltage clamp showed bFGF-induced increases in CSMC KCNN4 protein expression and channel activity were abolished by Apo. Treatment with Apo also inhibited bFGF-induced increases in activator protein-1 promoter activity, as measured by luciferase activity assay. qRT-PCR demonstrated porcine coronary smooth muscle expression of NOX1, NOX2, NOX4, and NOX5 isoforms. Knockdown of NOX5 alone prevented both bFGF-induced upregulation of KCNN4 mRNA and CSMC migration. Conclusions: Our findings provide novel evidence that NOX5-derived ROS increase functional expression of KCNN4 through activator protein-1, providing another potential link between NOX, CSMC phenotypic modulation, and atherosclerosis.	[Gole, Hope K. A.; Tharp, Darla L.; Bowles, Douglas K.] Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA; [Bowles, Douglas K.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA; [Bowles, Douglas K.] Univ Missouri, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Bowles, DK (corresponding author), Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA.	BowlesD@missouri.edu	Gole, Hope/B-9196-2015	Gole, Hope/0000-0001-8550-0853; Bowles, Doug/0000-0003-2043-7368	National Institutes of Health [HL52490, RR18276]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR018276] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL052490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [HL52490, RR18276](http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; Adhikari Neeta, 2006, Curr Atheroscler Rep, V8, P252, DOI 10.1007/s11883-006-0081-1; Aliev G., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P225; Ambasta RK, 2006, FREE RADICAL BIO MED, V41, P193, DOI 10.1016/j.freeradbiomed.2005.12.035; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; Bowles DK, 2004, AM J PHYSIOL-HEART C, V287, pH2091, DOI 10.1152/ajpheart.00258.2004; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Bowles DK, 1998, J APPL PHYSIOL, V84, P1225, DOI 10.1152/jappl.1998.84.4.1225; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Channon KM, 2002, ARTERIOSCL THROM VAS, V22, P1751, DOI 10.1161/01.ATV.0000042203.08210.17; Chen Gregory J, 2006, Recent Pat Cardiovasc Drug Discov, V1, P211, DOI 10.2174/157489006777442478; Cheong A, 2006, CELL CYCLE, V5, P129, DOI 10.4161/cc.5.2.2310; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Cui XL, 2010, BIOL REPROD, V82, P305, DOI 10.1095/biolreprod.109.080275; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; De Keulenaer GW, 2000, ARTERIOSCL THROM VAS, V20, P385, DOI 10.1161/01.ATV.20.2.385; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Dikalova AE, 2010, AM J PHYSIOL-HEART C, V299, pH673, DOI 10.1152/ajpheart.00242.2010; Fan CY, 2005, FEBS LETT, V579, P1301, DOI 10.1016/j.febslet.2005.01.021; Fike CD, 2008, AM J PHYSIOL-LUNG C, V295, pL881, DOI 10.1152/ajplung.00047.2008; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Griendling KK, 2006, ANTIOXID REDOX SIGN, V8, P1443, DOI 10.1089/ars.2006.8.1443; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Guzik TJ, 2008, J AM COLL CARDIOL, V52, P1803, DOI 10.1016/j.jacc.2008.07.063; Harrison DG, 2002, J RENIN-ANGIO-ALDO S, V4, P51; Hayabuchi Y, 2006, J MOL CELL CARDIOL, V41, P972, DOI 10.1016/j.yjmcc.2006.07.010; Heaps CL, 2005, AM J PHYSIOL-HEART C, V288, pH568, DOI 10.1152/ajpheart.00157.2004; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hu QH, 2000, J BIOL CHEM, V275, P15749, DOI 10.1074/jbc.M000381200; Hwang J, 2003, CIRC RES, V93, P1225, DOI 10.1161/01.RES.0000104087.29395.66; Hwang JN, 2005, AM J PHYSIOL-CELL PH, V288, pC899, DOI 10.1152/ajpcell.00474.2004; Jay DB, 2008, FREE RADICAL BIO MED, V45, P329, DOI 10.1016/j.freeradbiomed.2008.04.024; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kawahara T, 2008, MOL BIOL CELL, V19, P4020, DOI 10.1091/mbc.E07-12-1223; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kim SY, 2012, IMMUNOL CELL BIOL, V90, P441, DOI 10.1038/icb.2011.60; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Lapperre TS, 1999, FEBS LETT, V443, P235, DOI 10.1016/S0014-5793(98)01723-2; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Li JM, 2010, GENE THER, V17, P1279, DOI 10.1038/gt.2010.69; Li JM, 2002, CIRC RES, V90, P143, DOI 10.1161/hh0202.103615; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loppnow H, 2008, INNATE IMMUN-LONDON, V14, P63, DOI 10.1177/1753425908091246; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Manea A, 2012, FREE RADICAL BIO MED, V52, P1497, DOI 10.1016/j.freeradbiomed.2012.02.018; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Miller FJ, 2009, CIRC RES, V105, P209, DOI 10.1161/CIRCRESAHA.109.202986; Montezano AC, 2010, CIRC RES, V106, P1363, DOI 10.1161/CIRCRESAHA.109.216036; Munzel T, 2002, ARTERIOSCL THROM VAS, V22, P1761, DOI 10.1161/01.ATV.0000034022.11764.EC; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; San Martin A, 2007, FREE RADICAL BIO MED, V42, P1671, DOI 10.1016/j.freeradbiomed.2007.02.002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Schulz E, 2008, J AM COLL CARDIOL, V52, P1810, DOI 10.1016/j.jacc.2008.08.040; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Sung HJ, 2005, ANN BIOMED ENG, V33, P1546, DOI 10.1007/s10439-005-7545-2; Szocs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Takac I, 2012, CURR HYPERTENS REP, V14, P70, DOI 10.1007/s11906-011-0238-3; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Terashima M, 2006, KOBE J MED SCI, V53, P107; Terashima M, 2009, CIRC-CARDIOVASC INTE, V2, P196, DOI 10.1161/CIRCINTERVENTIONS.108.799502; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Tharp D. L., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P1; Touyz RM, 2008, HYPERTENSION, V51, P172, DOI 10.1161/HYPERTENSIONAHA.107.103200; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trebak M, 2010, ANTIOXID REDOX SIGN, V12, P657, DOI 10.1089/ars.2009.2842; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Weber DS, 2005, AM J PHYSIOL-HEART C, V288, pH37, DOI 10.1152/ajpheart.00638.2004; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Yamakawa T, 2002, ARTERIOSCL THROM VAS, V22, P752, DOI 10.1161/01.ATV.0000015903.02749.71; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zhan YM, 2002, ARTERIOSCL THROM VAS, V22, P82, DOI 10.1161/hq0102.101821	99	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105337	10.1371/journal.pone.0105337	http://dx.doi.org/10.1371/journal.pone.0105337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144362	gold, Green Submitted, Green Published			2022-12-25	WOS:000341106100054
J	Han, KA; Kang, HS; Lee, JW; Yoo, L; Im, E; Hong, A; Lee, YJ; Shin, WH; Chung, KC				Han, Kyung Ah; Kang, Hye Seon; Lee, Jee Won; Yoo, Lang; Im, Eunju; Hong, Ahyoung; Lee, Yun Ju; Shin, Woo Hyun; Chung, Kwang Chul			Histone Deacetylase 3 Promotes RCAN1 Stability and Nuclear Translocation	PLOS ONE			English	Article							SYNDROME CRITICAL REGION; REGULATES SUBCELLULAR-LOCALIZATION; DOWN-SYNDROME; PROTEASOMAL DEGRADATION; UBIQUITIN LIGASE; PROTEIN; ACETYLATION; CALCINEURIN; PHOSPHORYLATION; DSCR1	Regulator of calcineurin 1 (RCAN1; also referred as DSCR1 or MCIP1) is located in close proximity to a Down syndrome critical region of human chromosome 21. Although RCAN1 is an endogenous inhibitor of calcineurin signaling that controls lymphocyte activation, apoptosis, heart development, skeletal muscle differentiation, and cardiac function, it is not yet clear whether RCAN1 might be involved in other cellular activities. In this study, we explored the extra-functional roles of RCAN1 by searching for novel RCAN1-binding partners. Using a yeast two-hybrid assay, we found that RCAN1 (RCAN1-1S) interacts with histone deacetylase 3 (HDAC3) in mammalian cells. We also demonstrate that HDAC3 deacetylates RCAN1. In addition, HDAC3 increases RCAN1 protein stability by inhibiting its poly-ubiquitination. Furthermore, HDAC3 promotes RCAN1 nuclear translocation. These data suggest that HDAC3, a new binding regulator of RCAN1, affects the protein stability and intracellular localization of RCAN1.	[Han, Kyung Ah; Kang, Hye Seon; Lee, Jee Won; Yoo, Lang; Im, Eunju; Hong, Ahyoung; Lee, Yun Ju; Shin, Woo Hyun; Chung, Kwang Chul] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Chung, KC (corresponding author), Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Im, Eunju/GPJ-9628-2022; Im, Eunju/Y-2601-2018; rchnds, rchnds/D-7595-2016	Im, Eunju/0000-0002-7839-8878; Im, Eunju/0000-0002-7839-8878; 	Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare [H09C1311]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea [2007-0056092];  [NRF-2012R1A1A2021749];  [H11C1606];  [H14C0093]	Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea; ; ; 	This research was supported by grants from the Korea Healthcare Technology R&D Project (H09C1311 to KCC) through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, and from the National Research Foundation of Korea (NRF) (2007-0056092 to KCC) funded by the Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea. This work was also partially supported by grants (NRF-2012R1A1A2021749, H11C1606, and H14C0093 to KCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Asada S, 2008, INT J MOL MED, V22, P95; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Epstein C J, 1995, Prog Clin Biol Res, V393, P241; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Gay F, 2003, GENE DEV, V17, P717, DOI 10.1101/gad.1042403; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Ishfaq M, 2012, FEBS LETT, V586, P3236, DOI 10.1016/j.febslet.2012.06.042; Jeyakumar M, 2007, J BIOL CHEM, V282, P9312, DOI 10.1074/jbc.M609009200; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Kim SS, 2012, BIOCHEM BIOPH RES CO, V418, P657, DOI 10.1016/j.bbrc.2012.01.071; Kim SS, 2010, GENES GENOM, V32, P578, DOI 10.1007/s13258-010-0109-3; Kishi T, 2007, P NATL ACAD SCI USA, V104, P17418, DOI 10.1073/pnas.0704951104; Lee JY, 2009, BBA-GEN SUBJECTS, V1790, P1673, DOI 10.1016/j.bbagen.2009.08.005; Lee JW, 2012, BIOCHEM BIOPH RES CO, V420, P404, DOI 10.1016/j.bbrc.2012.03.007; Lee J, 2008, J BIOL CHEM, V283, P3392, DOI 10.1074/jbc.M706707200; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; Marks Paul A, 2004, Novartis Found Symp, V259, P269; Moser MA, 2014, CHROMOSOMA, V123, P67, DOI 10.1007/s00412-013-0441-x; Nicolas E, 2001, NUCLEIC ACIDS RES, V29, P3131, DOI 10.1093/nar/29.15.3131; Noh EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048315; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Pfister SC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-24; Pickard A, 2010, J CELL SCI, V123, P3718, DOI 10.1242/jcs.068924; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Seo SR, 2008, FEBS LETT, V582, P1889, DOI 10.1016/j.febslet.2008.04.059; Takami Y, 2000, J BIOL CHEM, V275, P16191, DOI 10.1074/jbc.M908066199; Vidal-Laliena M, 2013, J BIOL CHEM, V288, P21096, DOI 10.1074/jbc.M113.458323; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105416	10.1371/journal.pone.0105416	http://dx.doi.org/10.1371/journal.pone.0105416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144594	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100066
J	Jonatan, D; Spence, JR; Method, AM; Kofron, M; Sinagoga, K; Haataja, L; Arvan, P; Deutsch, GH; Wells, JM				Jonatan, Diva; Spence, Jason R.; Method, Anna M.; Kofron, Matthew; Sinagoga, Katie; Haataja, Leena; Arvan, Peter; Deutsch, Gail H.; Wells, James M.			Sox17 Regulates Insulin Secretion in the Normal and Pathologic Mouse beta Cell	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; DISPROPORTIONATELY ELEVATED PROINSULIN; PROTEIN-KINASE-C; IMPAIRED GLUCOSE-TOLERANCE; TRANSCRIPTION FACTOR SOX4; ENDOPLASMIC-RETICULUM; SELECTIVE DELETION; EXOCRINE PANCREAS; REDUNDANT ROLES; KDEL RECEPTOR	SOX17 is a key transcriptional regulator that can act by regulating other transcription factors including HNF1 beta and FOXA2, which are known to regulate postnatal beta cell function. Given this, we investigated the role of SOX17 in the developing and postnatal pancreas and found a novel role for SOX17 in regulating insulin secretion. Deletion of the Sox17 gene in the pancreas (Sox17-paLOF) had no observable impact on pancreas development. However, Sox17-paLOF mice had higher islet proinsulin protein content, abnormal trafficking of proinsulin, and dilated secretory organelles suggesting that Sox17-paLOF adult mice are prediabetic. Consistant with this, Sox17-paLOF mice were more susceptible to aged-related and high fat diet-induced hyperglycemia and diabetes. Overexpression of Sox17 in mature beta cells using Ins2-rtTA driver mice resulted in precocious secretion of proinsulin. Transcriptionally, SOX17 appears to broadly regulate secretory networks since a 24-hour pulse of SOX17 expression resulted in global transcriptional changes in factors that regulate hormone transport and secretion. Lastly, transient SOX17 overexpression was able to reverse the insulin secretory defects observed in MODY4 animals and restored euglycemia. Together, these data demonstrate a critical new role for SOX17 in regulating insulin trafficking and secretion and that modulation of Sox17-regulated pathways might be used therapeutically to improve cell function in the context of diabetes.	[Jonatan, Diva; Method, Anna M.; Kofron, Matthew; Sinagoga, Katie; Wells, James M.] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Wells, James M.] Cincinnati Childrens Hosp, Med Ctr, Div Endocrinol, Cincinnati, OH USA; [Spence, Jason R.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA; [Spence, Jason R.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Spence, Jason R.] Univ Michigan, Sch Med, Ctr Organogenesis, Ann Arbor, MI USA; [Haataja, Leena; Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI USA; [Deutsch, Gail H.] Seattle Childrens Hosp, Seattle, WA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Seattle Children's Hospital	Wells, JM (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	James.Wells@cchmc.org		Kofron, Matthew/0000-0001-6427-4148; Deutsch, Gail/0000-0002-0571-0285	NIH [R01DK080823, R01DK092456]; Cincinnati Digestive Disease Center Award [P30 DK0789392]; Clinical Translational Science Award [U54 RR025216]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080823, P30DK020572, R01DK092456, P30DK078392, R01DK048280] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Digestive Disease Center Award; Clinical Translational Science Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported from NIH grants R01DK080823, and R01DK092456. The authors also acknowledge core support from the Cincinnati Digestive Disease Center Award (P30 DK0789392) and the Clinical Translational Science Award (U54 RR025216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Arvan P, 2004, CELL BIOCHEM BIOPHYS, P169; Arvan P, 2004, TRAFFIC, V5, P53, DOI 10.1111/j.1600-0854.2004.00152.x; Basu A, 2012, DIABETES, V61, P270, DOI 10.2337/db11-1677; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Chen R, 2008, PEDIATRICS, V121, pE1541, DOI 10.1542/peds.2007-3543; Corada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3609; Dubois CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023131; Engert S, 2009, GENESIS, V47, P603, DOI 10.1002/dvg.20540; GANESAN S, 1990, P NATL ACAD SCI USA, V87, P9893, DOI 10.1073/pnas.87.24.9893; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Goldsworthy M, 2008, DIABETES, V57, P2234, DOI 10.2337/db07-0337; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Haataja L, 2013, J BIOL CHEM, V288, P1896, DOI 10.1074/jbc.M112.420018; Hartling SG, 1997, EUR J ENDOCRINOL, V137, P490, DOI 10.1530/eje.0.1370490; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Iguchi H, 2005, J BIOL CHEM, V280, P37669, DOI 10.1074/jbc.M505392200; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JOHNSON JH, 1990, SCIENCE, V250, P546, DOI 10.1126/science.2237405; Kahn SE, 1997, DIABETES, V46, P1725, DOI 10.2337/diabetes.46.11.1725; Kaimal V, 2011, METHODS MOL BIOL, V700, P241, DOI 10.1007/978-1-61737-954-3_16; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kanat M, 2012, DIABETES, V61, P447, DOI 10.2337/db11-0995; Ketola I, 2004, MOL CELL ENDOCRINOL, V226, P51, DOI 10.1016/j.mce.2004.06.007; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kobayashi M, 2012, AM J PHYSIOL-ENDOC M, V302, pE603, DOI 10.1152/ajpendo.00469.2011; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Lange AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005711; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; MAKO ME, 1977, AM J MED, V63, P865, DOI 10.1016/0002-9343(77)90538-1; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McDonald E, 2009, STEM CELLS DEV, V18, P1379, DOI 10.1089/scd.2009.0240; Mendez CF, 2003, J BIOL CHEM, V278, P44753, DOI 10.1074/jbc.M308664200; MILBURN JL, 1993, DIABETES METAB REV, V9, P231, DOI 10.1002/dmr.5610090306; Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Okamoto M, 2012, J CELL SCI; ORCI L, 1990, P NATL ACAD SCI USA, V87, P9953, DOI 10.1073/pnas.87.24.9953; ORCI L, 1984, J CELL BIOL, V99, P2187, DOI 10.1083/jcb.99.6.2187; Park KS, 2006, DEV BIOL, V294, P192, DOI 10.1016/j.ydbio.2006.02.038; Regazzi R, 1996, J CELL SCI, V109, P2265; RODER ME, 1994, J CLIN ENDOCR METAB, V79, P1570, DOI 10.1210/jc.79.6.1570; Roder ME, 1998, J CLIN ENDOCR METAB, V83, P604, DOI 10.1210/jc.83.2.604; SAAD MF, 1990, J CLIN ENDOCR METAB, V70, P1247, DOI 10.1210/jcem-70-5-1247; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Sinner D, 2006, DEVELOPMENT, V133, P1955, DOI 10.1242/dev.02358; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Steiner P, 2004, J NEUROCHEM, V89, P569, DOI 10.1111/j.1471-4159.2004.02345.x; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TANG BL, 1993, J CELL BIOL, V120, P325, DOI 10.1083/jcb.120.2.325; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; Wang L, 2004, ENDOCRINOLOGY, V145, P3941, DOI 10.1210/en.2004-0281; Wells JM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-4; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Yanh H, 2013, J CLIN INVEST, V123, P418, DOI 10.1172/JCI64547; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2; Zuber C, 2004, FASEB J, V18, P917, DOI 10.1096/fj.03-1210fje	73	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104675	10.1371/journal.pone.0104675	http://dx.doi.org/10.1371/journal.pone.0104675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144761	Green Submitted, gold, Green Published			2022-12-25	WOS:000341106100020
J	Mccoy, SI; Buzdugan, R; Ralph, LJ; Mushavi, A; Mahomva, A; Hakobyan, A; Watadzaushe, C; Dirawo, J; Cowan, FM; Padian, NS				McCoy, Sandra I.; Buzdugan, Raluca; Ralph, Lauren J.; Mushavi, Angela; Mahomva, Agnes; Hakobyan, Anna; Watadzaushe, Constancia; Dirawo, Jeffrey; Cowan, Frances M.; Padian, Nancy S.			Unmet Need for Family Planning, Contraceptive Failure, and Unintended Pregnancy among HIV-Infected and HIV-Uninfected Women in Zimbabwe	PLOS ONE			English	Article							TRANSMISSION; FERTILITY	Background: Prevention of unintended pregnancies among women living with HIV infection is a strategy recommended by the World Health Organization for prevention of mother-to-child transmission of HIV (PMTCT). We assessed pregnancy intentions and contraceptive use among HIV-positive and HIV-negative women with a recent pregnancy in Zimbabwe. Methods: We analyzed baseline data from the evaluation of Zimbabwe's Accelerated National PMTCT Program. Eligible women were randomly sampled from the catchment areas of 157 health facilities offering PMTCT services in five provinces. Eligible women were >= 16 years old and mothers of infants (alive or deceased) born 9 to 18 months prior to the interview. Participants were interviewed about their HIV status, intendedness of the birth, and contraceptive use. Results: Of 8,797 women, the mean age was 26.7 years, 92.8% were married or had a regular sexual partner, and they had an average of 2.7 lifetime births. Overall, 3,090 (35.1%) reported that their births were unintended; of these women, 1,477 (47.8%) and 1,613 (52.2%) were and were not using a contraceptive method prior to learning that they were pregnant, respectively. Twelve percent of women reported that they were HIV-positive at the time of the survey; women who reported that they were HIV-infected were significantly more likely to report that their pregnancy was unintended compared to women who reported that they were HIV-uninfected (44.9% vs. 33.8%, p<0.01). After adjustment for covariates, among women with unintended births, there was no association between self-reported HIV status and lack of contraception use prior to pregnancy. Conclusions: Unmet need for family planning and contraceptive failure contribute to unintended pregnancies among women in Zimbabwe. Both HIV-infected and HIV-uninfected women reported unintended pregnancies despite intending to avoid or delay pregnancy, highlighting the need for effective contraceptive methods that align with pregnancy intentions.	[McCoy, Sandra I.; Buzdugan, Raluca; Ralph, Lauren J.; Padian, Nancy S.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Mushavi, Angela] Minist Hlth & Child Care, Harare, Zimbabwe; [Mahomva, Agnes] Elizabeth Glaser Pediat AIDS Fdn, Harare, Zimbabwe; [Hakobyan, Anna] Childrens Investment Fund Fdn, London, England; [Watadzaushe, Constancia; Dirawo, Jeffrey; Cowan, Frances M.] Ctr Sexual Hlth & HIV Res, Harare, Zimbabwe; [Cowan, Frances M.] UCL, London, England	University of California System; University of California Berkeley; University of London; University College London	Mccoy, SI (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	smccoy@berkeley.edu		Cowan, Frances/0000-0003-3087-4422	Children's Investment Fund Foundation (CIFF); National Institute of Mental Health [K01MH094246]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH094246] Funding Source: NIH RePORTER	Children's Investment Fund Foundation (CIFF); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The evaluation of Zimbabwe's Accelerated National PMTCT Program was supported by the Children's Investment Fund Foundation (CIFF, www.ciff.org) in a grant to NSP. AH (from CIFF) contributed to the study and is included as a co-author. SIM is supported by Award Number K01MH094246 from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in data collection and analysis or the decision to publish. AH (from CIFF) participated in designing the impact evaluation and preparation of this manuscript.	AHPRA, 2012, 201112 ANN REP AHPR; [Anonymous], 2020, HIGH POSS COST COVID; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Brown S.S., 1995, BEST INTENTIONS UNIN; Buzdugan R, 2013, 7 IAS C HIV PATH TRE; Espey E, 2011, OBSTET GYNECOL, V117, P705, DOI 10.1097/AOG.0b013e31820ce2f0; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; GREENLAND S, 1987, AM J EPIDEMIOL, V125, P761, DOI 10.1093/oxfordjournals.aje.a114593; Grieser M, 2001, J S AFR STUD, V27, P225, DOI 10.1080/03057070120049949; Hayford SR, 2012, STUD FAMILY PLANN, V43, P191, DOI 10.1111/j.1728-4465.2012.00317.x; Hladik W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007691; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Inter-agency task team for prevention and treatment of HIV infection in preg-nant women m and their children, 2012, PREV HIV UN PREGN ST; Jhangri GS, 2012, J FAM PLAN REPROD H, V38, P23, DOI 10.1136/jfprhc-2011-0108; Koenig MA, 2006, POP STUD-J DEMOG, V60, P243, DOI 10.1080/00324720600895819; Kolenikov S, 2004, USE DISCRETE DATA PR; Kutner M., 2005, APPL LINEAR STAT MOD; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Petruney Tricia, 2008, Bull World Health Organ, V86, pb; Policar M., 2011, CONTRACEPTIVE TECHNO; Reynolds HW, 2008, SEX TRANSM INFECT, V84, pII49, DOI 10.1136/sti.2008.030049; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Reynolds HW, 2005, SEX TRANSM INFECT, V81, P184, DOI 10.1136/sti.2004.012013; Robinson Jennifer A, 2012, Infect Dis Obstet Gynecol, V2012, P890160, DOI 10.1155/2012/890160; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Schaan MM, 2012, AIDS CARE, V24, P1120, DOI 10.1080/09540121.2012.672814; Schwartz SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036039; Singh S, 2012, ADDING IT COSTS BENE; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Trinitapoli J, 2011, AM SOCIOL REV, V76, P935, DOI 10.1177/0003122411427672; Trussell J, 2007, CONTRACEPTIVE TECHNO, P221; UNAIDS, 2012, REP GLOB AIDS EP; UNAIDS, 2010, REP GLOB AIDS EP; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD CONTR US 2011; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wanyenze RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-98; *WHO, 2009, RAP ADV US ANT DRUGS; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wilcher R, 2008, SEX TRANSM INFECT, V84, pII54, DOI 10.1136/sti.2008.030098; World Health Organization, 2011, WHO UNICEF EST NAT I; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2007, GUID GLOB SCAL UP PR; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Yamey G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4160; Zimbabwe Ministry of Health and Child Welfare, 2012, NAT SEX REPR HLTH PO; Zimbabwe National Family Planning Council (ZNFPC), ZIMB NAT FAM PLANN S; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	48	51	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105320	10.1371/journal.pone.0105320	http://dx.doi.org/10.1371/journal.pone.0105320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WL	25144229	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100052
J	Thierfelder, KM; von Baumgarten, L; Baumann, AB; Meinel, FG; Helck, AD; Opherk, C; Straube, A; Reiser, MF; Sommer, WH				Thierfelder, Kolja M.; von Baumgarten, Louisa; Baumann, Alena B.; Meinel, Felix G.; Helck, Andreas D.; Opherk, Christian; Straube, Andreas; Reiser, Maximilian F.; Sommer, Wieland H.			Penumbra Pattern Assessment in Acute Stroke Patients: Comparison of Quantitative and Non-Quantitative Methods in Whole Brain CT Perfusion	PLOS ONE			English	Article							EVALUATION TRIAL EPITHET; ACUTE ISCHEMIC-STROKE; COMBINED THROMBOLYSIS; IMAGING EVALUATION; EVOLUTION DEFUSE; MISMATCH; REPERFUSION; DIFFUSION; RECANALIZATION; SELECTION	Background and Purpose: While penumbra assessment has become an important part of the clinical decision making for acute stroke patients, there is a lack of studies measuring the reliability and reproducibility of defined assessment techniques in the clinical setting. Our aim was to determine reliability and reproducibility of different types of three-dimensional penumbra assessment methods in stroke patients who underwent whole brain CT perfusion imaging (WB-CTP). Materials and Methods: We included 29 patients with a confirmed MCA infarction who underwent initial WB-CTP with a scan coverage of 100 mm in the z-axis. Two blinded and experienced readers assessed the flow-volume-mismatch twice and in two quantitative ways: Performing a volumetric mismatch analysis using OsiriX imaging software (MMVOL) and visual estimation of mismatch (MMEST). Complementarily, the semiquantitative Alberta Stroke Programme Early CT Score for CT perfusion was used to define mismatch (MMASPECTS). A favorable penumbral pattern was defined by a mismatch of >= 30% in combination with a cerebral blood flow deficit of <= 90 ml and an MMASPECTS score of >= 1, respectively. Inter-and intrareader agreement was determined by Kappa-values and ICCs. Results: Overall, MMVOL showed considerably higher inter-/intrareader agreement (ICCs: 0.751/0.843) compared to MMEST (0.292/0.749). In the subgroup of large (>= 50 mL) perfusion deficits, inter-and intrareader agreement of MMVOL was excellent (ICCs: 0.961/0.942), while MMEST interreader agreement was poor (0.415) and intrareader agreement was good (0.919). With respect to penumbra classification, MMVOL showed the highest agreement (interreader agreement: 25 agreements/4 non-agreements/kappa: 0.595; intrareader agreement 27/2/0.833), followed by MMEST (22/7/0.471; 23/6/0.577), and MMASPECTS (18/11/0.133; 21/8/0.340). Conclusion: The evaluated approach of volumetric mismatch assessment is superior to pure visual and ASPECTS penumbra pattern assessment in WB-CTP and helps to precisely judge the extent of 3-dimensional mismatch in acute stroke patients.	[Thierfelder, Kolja M.; Baumann, Alena B.; Meinel, Felix G.; Helck, Andreas D.; Reiser, Maximilian F.; Sommer, Wieland H.] Ludwig Maximilians Univ Munich Hosp, Dept Clin Radiol, Munich, Germany; [von Baumgarten, Louisa; Opherk, Christian; Straube, Andreas] Ludwig Maximilians Univ Munich Hosp, Dept Neurol, Munich, Germany; [Opherk, Christian] Ludwig Maximilians Univ Munich Hosp, Inst Stroke & Dementia Res, Munich, Germany	University of Munich; University of Munich; University of Munich	Thierfelder, KM (corresponding author), Ludwig Maximilians Univ Munich Hosp, Dept Clin Radiol, Munich, Germany.	kolja.thierfelder@med.uni-muenchen.de	von Baumgarten, Louisa/A-4636-2016	Meinel, Felix/0000-0002-3201-1033; Baumann, Alena/0000-0002-2067-1616				Abels B, 2011, AM J NEURORADIOL, V32, P1632, DOI 10.3174/ajnr.A2576; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Bivard A., 2012, RADIOLOGY; Butcher KS, 2005, STROKE, V36, P1153, DOI 10.1161/01.STR.0000166181.86928.8b; Coutts SB, 2003, STROKE, V34, P1681, DOI 10.1161/01.STR.0000078840.96473.20; De Silva DA, 2009, STROKE, V40, P2872, DOI 10.1161/STROKEAHA.108.543595; Diekmann S, 2010, AM J NEURORADIOL, V31, P1003, DOI 10.3174/ajnr.A1971; Hesselmann V, 2012, AM J NEURORADIOL, V33, P336, DOI 10.3174/ajnr.A2746; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kim JT, 2009, CEREBROVASC DIS, V28, P259, DOI 10.1159/000228256; Lansberg MG, 2011, STROKE, V42, P1608, DOI 10.1161/STROKEAHA.110.609008; Lin K, 2009, NEURORADIOLOGY, V51, P17, DOI 10.1007/s00234-008-0454-y; Murayama K, 2009, RADIOLOGY, V250, P202, DOI 10.1148/radiol.2501071809; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842; Parsons MW, 2008, INT J STROKE, V3, P41, DOI 10.1111/j.1747-4949.2008.00175.x; Parsons MW, 2005, ANN NEUROL, V58, P672, DOI 10.1002/ana.20638; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; Sillanpaa N, 2011, CEREBROVASC DIS EXTR, V1, P6, DOI 10.1159/000324324; Thierfelder KM, 2013, NEURORADIOLOGY; van Seeters T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075615; Weir NU, 2006, NEUROLOGY, V67, P516, DOI 10.1212/01.wnl.0000228221.44334.73; Wintermark M, 2005, AM J NEURORADIOL, V26, P104	23	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105413	10.1371/journal.pone.0105413	http://dx.doi.org/10.1371/journal.pone.0105413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144396	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100064
J	Adams, KM; Abraham, V; Spielman, D; Kolls, JK; Rubenstein, RC; Conner, GE; Cohen, NA; Kreindler, JL				Adams, Kelly M.; Abraham, Valsamma; Spielman, Daniel; Kolls, Jay K.; Rubenstein, Ronald C.; Conner, Gregory E.; Cohen, Noam A.; Kreindler, James L.			IL-17A Induces Pendrin Expression and Chloride-Bicarbonate Exchange in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; HYPER-IGE SYNDROME; CYSTIC-FIBROSIS; TRANSPORT PROTEIN; ANION-EXCHANGERS; MUCIN SECRETION; SURFACE LIQUID; MUCUS RELEASE; SYNDROME GENE; HOST-DEFENSE	The epithelium plays an active role in the response to inhaled pathogens in part by responding to signals from the immune system. Epithelial responses may include changes in chemokine expression, increased mucin production and antimicrobial peptide secretion, and changes in ion transport. We previously demonstrated that interleukin-17A (IL-17A), which is critical for lung host defense against extracellular bacteria, significantly raised airway surface pH in vitro, a finding that is common to a number of inflammatory diseases. Using microarray analysis of normal human bronchial epithelial (HBE) cells treated with IL-17A, we identified the electroneutral chloride-bicarbonate exchanger Pendrin (SLC26A4) as a potential mediator of this effect. These data were verified by real-time, quantitative PCR that demonstrated a time-dependent increase in Pendrin mRNA expression in HBE cells treated with IL-17A up to 48 h. Using immunoblotting and immunofluorescence, we confirmed that Pendrin protein expression is increased in IL-17 treated HBE cells and that it is primarily localized to the mucosal surface of the cells. Functional studies using live-cell fluorescence to measure intracellular pH demonstrated that IL-17A induced chloride-bicarbonate exchange in HBE cells that was not present in the absence of IL-17A. Furthermore, HBE cells treated with short interfering RNA against Pendrin showed substantially reduced chloride-bicarbonate exchange. These data suggest that Pendrin is part of IL-17A-dependent epithelial changes and that Pendrin may therefore be a therapeutic target in IL-17A-dependent lung disease.	[Adams, Kelly M.; Abraham, Valsamma; Rubenstein, Ronald C.; Kreindler, James L.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Adams, Kelly M.; Rubenstein, Ronald C.; Kreindler, James L.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Spielman, Daniel] Univ Penn, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Kolls, Jay K.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Kolls, Jay K.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Conner, Gregory E.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA; [Cohen, Noam A.] Univ Penn, Dept Otorhinolaryngol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Miami; University of Pennsylvania; Pennsylvania Medicine	Kreindler, JL (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.	kreindler@email.chop.edu	Kolls, Jay/AAH-1829-2019; Conner, Gregory/AAI-1285-2021	Kolls, Jay/0000-0001-5151-6304; Conner, Gregory/0000-0003-2217-2252; Cohen, Noam/0000-0002-9462-3932; Spielman, Daniel/0000-0003-2602-0416; Rubenstein, Ronald/0000-0002-3138-4006	National Institutes of Health [K08 HL081080]; Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health K08 HL081080 and by funds from the Children's Hospital of Philadelphia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Aujla SJ, 2011, BBA-GEN SUBJECTS, V1810, P1066, DOI 10.1016/j.bbagen.2011.02.002; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Conner GE, 2007, FEBS LETT, V581, P271, DOI 10.1016/j.febslet.2006.12.025; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Danahay H, 2006, AM J PHYSIOL-LUNG C, V290, pL558, DOI 10.1152/ajplung.00351.2005; Danahay H, 2002, AM J PHYSIOL-LUNG C, V282, pL226, DOI 10.1152/ajplung.00311.2001; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Dossena S, 2006, CELL PHYSIOL BIOCHEM, V18, P67, DOI 10.1159/000095164; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Fujisawa T, 2009, J IMMUNOL, V183, P6236, DOI 10.4049/jimmunol.0900614; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Garnett JP, 2011, J BIOL CHEM, V286, P41069, DOI 10.1074/jbc.M111.266734; Garnett JP, 2011, J BIOL CHEM; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Kreindler JL, 2009, AM J PHYSIOL-LUNG C, V296, pL257, DOI 10.1152/ajplung.00344.2007; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Muchekehu RW, 2010, J PHYSIOL-LONDON, V588, P2329, DOI 10.1113/jphysiol.2010.187237; Nakagami Y, 2008, J IMMUNOL, V181, P2203, DOI 10.4049/jimmunol.181.3.2203; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Pedemonte N, 2007, J IMMUNOL, V178, P5144, DOI 10.4049/jimmunol.178.8.5144; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; SILBERG DG, 1995, J BIOL CHEM, V270, P11897, DOI 10.1074/jbc.270.20.11897; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Wheat VJ, 2000, AM J PHYSIOL-CELL PH, V279, pC62, DOI 10.1152/ajpcell.2000.279.1.C62; Xie C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015255	48	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103263\	10.1371/journal.pone.0103263	http://dx.doi.org/10.1371/journal.pone.0103263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141009	Green Accepted, Green Published, gold			2022-12-25	WOS:000342687200005
J	Cameron, DR; Marty, J; Holland, RF				Cameron, D. Richard; Marty, Jaymee; Holland, Robert F.			Whither the Rangeland?: Protection and Conversion in California's Rangeland Ecosystems	PLOS ONE			English	Article							LAND-USE CHANGE; UNITED-STATES; CONSERVATION EASEMENTS; CARBON SEQUESTRATION; EXURBAN DEVELOPMENT; BIODIVERSITY; DIVERSITY; SERVICES; TRENDS	Land use change in rangeland ecosystems is pervasive throughout the western United States with widespread ecological, social and economic implications. In California, rangeland habitats have high biodiversity value, provide significant habitat connectivity and form the foundation for a number of ecosystem services. To comprehensively assess the conservation status of these habitats, we analyzed the extent and drivers of habitat loss and the degree of protection against future loss across a 13.5 M ha study area in California. We analyzed rangeland conversion between 1984 and 2008 using time series GIS data and classified resulting land uses with aerial imagery. In total, over 195,000 hectares of rangeland habitats were converted during this period. The majority of conversions were to residential and associated commercial development (49% of the area converted), but agricultural intensification was surprisingly extensive and diverse (40% across six categories). Voluntary enrollment in an agricultural tax incentive program provided widespread protection from residential and commercial conversions across 37% of the remaining rangeland habitat extent (7.5 M ha), though this program did not protect rangeland from conversion to more intensive agricultural uses. Additionally, 24% of the remaining rangeland was protected by private conservation organizations or public agencies through land or easement ownership while 38% had no protection status at all. By developing a spatial method to analyze the drivers of loss and patterns of protection, this study demonstrates a novel approach to prioritize conservation strategies and implementation locations to avert habitat conversion. We propose that this approach can be used in other ecosystem types, and can serve as a regional conservation baseline assessment to focus strategies to effect widespread, cost-effective conservation solutions.	[Cameron, D. Richard; Marty, Jaymee] Nature Conservancy, San Francisco, CA 94125 USA; [Holland, Robert F.] Geobot Phenomenol, Auburn, CA USA	Nature Conservancy	Cameron, DR (corresponding author), Nature Conservancy, San Francisco, CA 94125 USA.	dcameron@tnc.org						AECOM, 2009, LOSS CENTR VALL VERN; Belsky AJ, 1999, J SOIL WATER CONSERV, V54, P419; Blench R, 1999, UNDERSTANDING RANGEL; Booker K, 2013, GLOBAL ENVIRON CHANG, V23, P240, DOI 10.1016/j.gloenvcha.2012.10.001; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Brunson MW, 2008, RANGELAND ECOL MANAG, V61, P137, DOI 10.2111/07-063.1; Calfire, 2006, MULT LAND COV DAT FV; Calfire, 2010, CAL FOR RANG 2010 AS; CDOC, 2008, FARML MAPP MON PROGR; CDOC, 2010, CAL LAND CONS WILL A; CDOC, 2010, WILL ACT LAND STAT; CDOC, 2013, CAL LAND CONS ACT 20; Chaplin-Kramer Rebecca, 2011, Rangelands, V33, P33; CHARBONNEAU R, 1993, ENVIRON MANAGE, V17, P453, DOI 10.1007/BF02394661; Christensen G. A., 2008, CALIFORNIA FOREST RE; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Davis F., 1998, CALIFORNIA GAP ANAL; Derner JD, 2007, J SOIL WATER CONSERV, V62, P77; Diaz D., 2012, EVALUATION AVOIDED G; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Food and Agriculture Organization (FAO), 2011, WORLD LIV 2011 LIV F, DOI DOI 10.1080/; FSA, 2009, NAT AGR IM PROGR; George M, 2001, ANN RANGE FORAGE PRO; GIN, 2011, CAL PROT AR DAT; Gosnell H, 2011, RANGELANDS, V33, P20, DOI 10.2111/1551-501X-33.5.20; Gosnell H, 2006, SOC NATUR RESOUR, V19, P743, DOI 10.1080/08941920600801181; Greene RP, 2001, SOC SCI J, V38, P543, DOI 10.1016/S0362-3319(01)00150-1; Grismer M, 2012, CALIF AGR, V66, P144, DOI 10.3733/ca.v066n04p144; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Havstad KM, 2007, ECOL ECON, V64, P261, DOI 10.1016/j.ecolecon.2007.08.005; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Huntsinger L, 2010, RANGELAND ECOL MANAG, V63, P324, DOI 10.2111/08-166.1; Huston MA, 2005, ECOL APPL, V15, P1864, DOI 10.1890/03-5281; Knight RL, 2007, RANGELANDS, V29, P4, DOI DOI 10.2111/1551-501X(2007)29[4:RAAKSI]2.0.CO;2; Kucera T. E., 1995, California Agriculture, V49, P23, DOI 10.3733/ca.v049n06p23; Liffmann RH, 2000, J RANGE MANAGE, V53, P362, DOI 10.2307/4003745; Maestas JD, 2003, CONSERV BIOL, V17, P1425, DOI 10.1046/j.1523-1739.2003.02371.x; Marty JT, 2005, CONSERV BIOL, V19, P1626, DOI 10.1111/j.1523-1739.2005.00198.x; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; Merenlender AM, 2004, CONSERV BIOL, V18, P65, DOI 10.1111/j.1523-1739.2004.00401.x; Mitchell J. E., 2002, Rangelands, V24, P3, DOI 10.1071/RJv24n1_ED; MURPHY DD, 1988, BIOL CONSERV, V46, P183, DOI 10.1016/0006-3207(88)90067-5; NASS, 2011, CAL HIST COMM DAT AL; NRCS, 2012, SOIL SURV; Odell EA, 2001, CONSERV BIOL, V15, P1143, DOI 10.1046/j.1523-1739.2001.0150041143.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Rass N., 2006, POLICIES STRATEGIES; Rissman A.R., 2007, RANGELANDS, V29, P21; Rissman AR, 2007, CONSERV BIOL, V21, P709, DOI 10.1111/j.1523-1739.2007.00660.x; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Silver WL, 2010, RANGELAND ECOL MANAG, V63, P128, DOI 10.2111/REM-D-09-00106.1; Sleeter B.M., 2008, CALIFORNIA GEOGRAPHE, V48; Sleeter BM, 2011, ENVIRON MONIT ASSESS, V173, P251, DOI 10.1007/s10661-010-1385-8; Sokolow A. D., 2002, California Agriculture, V56, P9, DOI 10.3733/ca.v056n01p9; Soulard CE, 2013, J LAND USE SCI, P1; Theobald D.M., 2005, ECOL SOC, V10, P34, DOI [10.5751/ES-01390-100132, DOI 10.5751/ES-01390-100132]; TNC, 2006, CAL EC; USDA, 2011, CAL WIN GRAP 1920 20; USFS, 1989, AN LAND BAS SIT US 1; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Volpe RJ, 2010, CALIF AGR, V64, P42, DOI 10.3733/ca.v064n01p42; Wetzel WC, 2012, CALIFORNIA AGR, P66	63	30	32	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103468	10.1371/journal.pone.0103468	http://dx.doi.org/10.1371/journal.pone.0103468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141171	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200007
J	Chen, R; Jiang, N; Jiang, QY; Sun, XJ; Wang, Y; Zhang, H; Hu, Z				Chen, Rui; Jiang, Nan; Jiang, Qiyan; Sun, Xianjun; Wang, Yong; Zhang, Hui; Hu, Zheng			Exploring MicroRNA-Like Small RNAs in the Filamentous Fungus Fusarium oxysporum	PLOS ONE			English	Article							PARALLEL ANALYSIS; GENE-EXPRESSION; MESSENGER-RNAS; MIRNA TARGETS; IDENTIFICATION; DNA; NEUROSPORA; ROLES; ACCUMULATION; METHYLATION	RNA silencing such as quelling and meiotic silencing by unpaired DNA (MSUD) and several other classes of special small RNAs have been discovered in filamentous fungi recently. More than four different mechanisms of microRNA-like RNAs (milRNAs) production have been illustrated in the model fungus Neurospora crassa including a dicer-independent pathway. To date, very little work focusing on small RNAs in fungi has been reported and no universal or particular characteristic of milRNAs were defined clearly. In this study, small RNA and degradome libraries were constructed and subsequently deep sequenced for investigating milRNAs and their potential cleavage targets on the genome level in the filamentous fungus F. oxysporum f. sp. lycopersici. As a result, there is no intersection of conserved miRNAs found by BLASTing against the miRBase. Further analysis showed that the small RNA population of F. oxysporum shared many common features with the small RNAs from N. crassa and other fungi. According to the known standards of miRNA prediction in plants and animals, milRNA candidates from 8 families (comprising 19 members) were screened out and identified. However, none of them could trigger target cleavage based on the degradome data. Moreover, most major signals of cleavage in transcripts could not match appropriate complementary small RNAs, suggesting that other predominant modes for milRNA-mediated gene regulation could exist in F. oxysporum. In addition, the PAREsnip program was utilized for comprehensive analysis and 3 families of small RNAs leading to transcript cleavage were experimentally validated. Altogether, our findings provided valuable information and important hints for better understanding the functions of the small RNAs and milRNAs in the fungal kingdom.	[Chen, Rui; Wang, Yong] Tianjin Acad Agr Sci, Tianjin Inst Agr Qual Standard & Testing Technol, Tianjin, Peoples R China; [Jiang, Qiyan; Sun, Xianjun; Zhang, Hui; Hu, Zheng] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Genet Resources & Improvement, Beijing 100193, Peoples R China; [Jiang, Nan] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Chen, R (corresponding author), Tianjin Acad Agr Sci, Tianjin Inst Agr Qual Standard & Testing Technol, Tianjin, Peoples R China.	chenrui.taas@gmail.com; huzheng@caas.cn	Sun, xianjun/AAG-1739-2020; 陈, 锐/AAA-2120-2020; JIANG, NAN/AHB-1945-2022		National Natural Science Foundation of China [31000356]; Presidential Foundation of the Tianjin Academy of Agricultural Sciences [13002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Presidential Foundation of the Tianjin Academy of Agricultural Sciences	This work was supported by National Natural Science Foundation of China (No. 31000356) and the Presidential Foundation of the Tianjin Academy of Agricultural Sciences (No. 13002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Albisetti M, 2004, INFECTION, V32, P364, DOI 10.1007/s15010-004-3135-8; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; CAMBARERI EB, 1991, GENETICS, V127, P699; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055252; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Cogoni C, 1997, TRENDS PLANT SCI, V2, P438, DOI 10.1016/S1360-1385(97)90028-5; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; de Haro JP, 2009, EUKARYOT CELL, V8, P1486, DOI 10.1128/EC.00191-09; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Folkes L, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks277; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Gordon TR, 1997, ANNU REV PHYTOPATHOL, V35, P111, DOI 10.1146/annurev.phyto.35.1.111; Hinas A, 2007, NUCLEIC ACIDS RES, V35, P6714, DOI 10.1093/nar/gkm707; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jiang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052734; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076288; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC., 2001, SCIENCE, V294, P858, DOI [DOI 10.1126/SCIENCE.1065062, 10.1126/science.1065062, DOI 10.1126/science.1065062]; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Laurie JD, 2008, CURR GENET, V53, P49, DOI 10.1007/s00294-007-0165-7; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; MARASAS WFO, 1984, TOXIGENIC FUSARIUM S; MATZKE MA, 1995, PLANT PHYSIOL, V107, P679, DOI 10.1104/pp.107.3.679; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Nakayashiki H, 2008, CURR OPIN MICROBIOL, V11, P494, DOI 10.1016/j.mib.2008.10.001; Nicolas FE, 2010, NUCLEIC ACIDS RES, V38, P5535, DOI 10.1093/nar/gkq301; O'Donnell K, 2004, J CLIN MICROBIOL, V42, P5109, DOI 10.1128/JCM.42.11.5109-5120.2004; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Richardson BC, 2014, NAT REV RHEUMATOL, V10, P72, DOI 10.1038/nrrheum.2013.211; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Yang QY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003227; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zhou Q, 2012, FUNGAL BIOL-UK, V116, P1156, DOI 10.1016/j.funbio.2012.09.001; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	61	55	75	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104956	10.1371/journal.pone.0104956	http://dx.doi.org/10.1371/journal.pone.0104956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141304	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200044
J	Ding, R; Chen, XH; Zhang, LJ; Yu, XD; Qu, B; Duan, R; Xu, YF				Ding, Rui; Chen, Xu-Hui; Zhang, Li-Jun; Yu, Xiao-Dan; Qu, Bo; Duan, Ru; Xu, Yu-Feng			Identity and Specificity of Rhizoctonia-Like Fungi from Different Populations of Liparis japonica (Orchidaceae) in Northeast China	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; DIVERSITY; ENDOPHYTES; PREFERENCE; TOLERANCE; SYMBIOSIS; MARRIAGE; GENETICS; PLANTS; WATER	Mycorrhizal association is known to be important to orchid species, and a complete understanding of the fungi that form mycorrhizas is required for orchid ecology and conservation. Liparis japonica (Orchidaceae) is a widespread terrestrial photosynthetic orchid in Northeast China. Previously, we found the genetic diversity of this species has been reduced recent years due to habitat destruction and fragmentation, but little was known about the relationship between this orchid species and the mycorrhizal fungi. The Rhizoctonia-like fungi are the commonly accepted mycorrhizal fungi associated with orchids. In this study, the distribution, diversity and specificity of culturable Rhizoctonia-like fungi associated with L. japonica species were investigated from seven populations in Northeast China. Among the 201 endophytic fungal isolates obtained, 86 Rhizoctonia-like fungi were identified based on morphological characters and molecular methods, and the ITS sequences and phylogenetic analysis revealed that all these Rhizoctonia-like fungi fell in the same main clade and were closely related to those of Tulasnella calospora species group. These findings indicated the high mycorrhizal specificity existed in L. japonica species regardless of habitats at least in Northeast China. Our results also supported the wide distribution of this fungal partner, and implied that the decline of L. japonica in Northeast China did not result from high mycorrhizal specificity. Using culture-dependent technology, these mycorrhizal fungal isolates might be important sources for the further utilizing in orchids conservation.	[Ding, Rui; Chen, Xu-Hui; Zhang, Li-Jun; Yu, Xiao-Dan; Qu, Bo; Duan, Ru; Xu, Yu-Feng] Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang 110161, Liaoning, Peoples R China	Shenyang Agricultural University	Chen, XH (corresponding author), Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang 110161, Liaoning, Peoples R China.	chenxh017@163.com			National Natural Science Foundation of China [31100299, 31200011]; China Postdoctoral Science Foundation [2012M510835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was funded by the National Natural Science Foundation of China (No. 31100299 and No. 31200011), (URL: http://www.nsfc.gov.cn/), and China Postdoctoral Science Foundation (No. 2012M510835) (URL: http://res.chinapostdoctor.org.cn/Program/Main.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MF, 2007, VADOSE ZONE J, V6, P291, DOI 10.2136/vzj2006.0068; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Bidartondo MI, 2008, MOL ECOL, V17, P3707, DOI 10.1111/j.1365-294X.2008.03848.x; Bonnardeaux Y, 2007, MYCOL RES, V111, P51, DOI 10.1016/j.mycres.2006.11.006; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058268; Chen XH, 2013, PLANT SYST EVOL, V299, P691, DOI 10.1007/s00606-012-0744-z; CURRAH RS, 1992, MYCOL RES, V96, P583, DOI 10.1016/S0953-7562(09)80984-2; Curtis JT, 1939, AM J BOT, V26, P390, DOI 10.2307/2436839; De Long JR, 2013, ANN BOT-LONDON, V111, P409, DOI 10.1093/aob/mcs294; Dearnaley JDW, 2012, FUNGAL ASS, VIX, P207, DOI DOI 10.1007/978-3-642-30826-0_12; Dearnaley JDW, 2007, MYCORRHIZA, V17, P475, DOI 10.1007/s00572-007-0138-1; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Editorial Committee of the Flora of China, 1992, FLORA CHINA, V18, P62; Fomina MA, 2005, SOIL BIOL BIOCHEM, V37, P851, DOI 10.1016/j.soilbio.2004.10.013; Gardes M, 2002, NEW PHYTOL, V154, P4, DOI 10.1046/j.1469-8137.2002.00386.x; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Illyes Z, 2009, J APPL BOT FOOD QUAL, V83, P28; Irwin Mathew John, 2007, Mycoscience, V48, P231, DOI 10.1007/s10267-007-0360-x; Jacquemyn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042212; Kohout P, 2013, FUNGAL ECOL, V6, P50, DOI 10.1016/j.funeco.2012.08.005; Leigh J, 2009, NEW PHYTOL, V181, P199, DOI 10.1111/j.1469-8137.2008.02630.x; Ma M, 2003, MYCOL RES, V107, P1041, DOI 10.1017/S0953756203008281; MASUHARA G, 1994, NEW PHYTOL, V127, P711, DOI 10.1111/j.1469-8137.1994.tb02974.x; McCormick MK, 2014, NEW PHYTOL, V202, P392, DOI 10.1111/nph.12639; McCormick MK, 2004, NEW PHYTOL, V163, P425, DOI 10.1111/j.1469-8137.2004.01114.x; McCormick MK, 2006, ECOLOGY, V87, P903, DOI 10.1890/0012-9658(2006)87[903:OFAMMT]2.0.CO;2; Nontachaiyapoom S, 2010, MYCORRHIZA, V20, P459, DOI 10.1007/s00572-010-0297-3; Oliveira SF, 2014, MYCORRHIZA, V24, P55, DOI 10.1007/s00572-013-0512-0; Otero JT, 2007, AM J BOT, V94, P1944, DOI 10.3732/ajb.94.12.1944; Pandey M, 2013, MOL ECOL, V22, P2341, DOI 10.1111/mec.12249; Porras-Soriano A, 2009, J PLANT PHYSIOL, V166, P1350, DOI 10.1016/j.jplph.2009.02.010; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rasmussen HN, 2002, PLANT SOIL, V244, P149, DOI 10.1023/A:1020246715436; Roche SA, 2010, AM J BOT, V97, P1313, DOI 10.3732/ajb.1000049; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Marquez SS, 2008, FUNGAL DIVERS, V33, P87; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Suarez JP, 2006, MYCOL RES, V110, P1257, DOI 10.1016/j.mycres.2006.08.004; Swarts ND, 2010, MOL ECOL, V19, P3226, DOI 10.1111/j.1365-294X.2010.04736.x; Swarts ND, 2009, TRENDS PLANT SCI, V14, P590, DOI 10.1016/j.tplants.2009.07.008; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor DL, 2008, NEW PHYTOL, V177, P1020, DOI 10.1111/j.1469-8137.2007.02320.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tondello A, 2012, FUNGAL BIOL-UK, V116, P543, DOI 10.1016/j.funbio.2012.02.004; Wei YK, 2007, FUNGAL DIVERS, V24, P329; Xing XK, 2013, MYCORRHIZA, V23, P317, DOI 10.1007/s00572-012-0473-8; Yao MK, 2002, MYCORRHIZA, V12, P235, DOI 10.1007/s00572-002-0176-7; Yukawa T, 2009, AM J BOT, V96, P1997, DOI 10.3732/ajb.0900101; Zeng Y, 2013, MYCORRHIZA, V23, P253, DOI 10.1007/s00572-013-0484-0; Zettler LW, 2011, AM MIDL NAT, V166, P29, DOI 10.1674/0003-0031-166.1.29	54	12	18	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105573	10.1371/journal.pone.0105573	http://dx.doi.org/10.1371/journal.pone.0105573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140872	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200102
J	Hobson, C; Dortch, J; Baslanti, TO; Layon, DR; Roche, A; Rioux, A; Harman, JS; Fahy, B; Bihorac, A				Hobson, Charles; Dortch, John; Baslanti, Tezcan Ozrazgat; Layon, Daniel R.; Roche, Alina; Rioux, Alison; Harman, Jeffrey S.; Fahy, Brenda; Bihorac, Azra			Insurance Status Is Associated with Treatment Allocation and Outcomes after Subarachnoid Hemorrhage	PLOS ONE			English	Article							UNITED-STATES; PAYER STATUS; MYOCARDIAL-INFARCTION; CEREBRAL ANEURYSMS; OLDER PATIENTS; DISPARITIES; MORTALITY; CANCER; CARE; DISABILITIES	Objective: Subarachnoid hemorrhage (SAH) is a particularly devastating type of stroke which is responsible for one third of all stroke-related years of potential life lost before age 65. Surgical treatment has been shown to decrease both morbidity and mortality after subarachnoid hemorrhage. We hypothesized that payer status other than private insurance is associated with lower allocation to surgical treatment for patients with SAH and worse outcomes. Design: We examined the association between insurance type and surgical treatment allocation and outcomes for patients with SAH while adjusting for a wide range of patient and hospital factors. We analyzed the Nationwide Inpatient Sample hospital discharge database using survey procedures to produce weighted estimates representative of the United States population. Patients: We studied 21047 discharges, representing a weighted estimate of 102595 patients age 18 and above with a discharge diagnosis of SAH between 2003 and 2008. Measurements: Multivariable logistic and generalized linear regression analyses were used to assess for any associations between insurance status and surgery allocation and outcomes. Main Results: Despite the benefits of surgery 66% of SAH patients did not undergo surgical treatment to prevent rebleeding. Mortality was more than twice as likely for patients with no surgical treatment compared to those who received surgery. Medicare patients were significantly less likely to receive surgical treatment. Conclusions: Nearly two thirds of patients with SAH don't receive operative care, and Medicare patients were significantly less likely to receive surgical treatment than other patients. Bias against the elderly and those with chronic illness and disability may play a part in these findings. A system of regionalized care for patients presenting with SAH may reduce disparities and improve appropriate allocation to surgical care and deserves prospective study.	[Hobson, Charles] Malcom Randall VA Med Ctr, Dept Surg, Gainesville, FL USA; [Dortch, John; Baslanti, Tezcan Ozrazgat; Layon, Daniel R.; Roche, Alina; Rioux, Alison; Fahy, Brenda; Bihorac, Azra] Univ Florida, Dept Anesthesiol, Gainesville, FL 32603 USA; [Hobson, Charles; Harman, Jeffrey S.] Univ Florida, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bihorac, A (corresponding author), Univ Florida, Dept Anesthesiol, Gainesville, FL 32603 USA.	abihorac@anest.ufl.edu	Bihorac, Azra/Q-6500-2016	Bihorac, Azra/0000-0002-5745-2863; Fahy, Brenda/0000-0002-5248-5164	National Institutes of Health [K23GM087709]; Astute Medical, Inc.; Foundation for Anesthesia Education and Research Medical Student Research Fellowship; University of Florida University Scholars' fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM087709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astute Medical, Inc.; Foundation for Anesthesia Education and Research Medical Student Research Fellowship; University of Florida University Scholars' fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AB is supported by Award Number K23GM087709 from the National Institutes of Health and has received grant funding from Astute Medical, Inc. JD was supported by the Foundation for Anesthesia Education and Research Medical Student Research Fellowship. AR and AR were supported by the University of Florida University Scholars' fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2010, PAT SAF IND TECHN SP; Agency for Healthcare Research and Quality, 2008, HCUP NAT INP SAMP NI; Andaluz N, 2008, J NEUROSURG, V108, P1163, DOI 10.3171/JNS/2008/108/6/1163; Andersen R, 2005, MILBANK Q, V83; [Anonymous], 2005, HCUP METH SER REP 20; Babu MA, 2011, NEUROSURGERY, V69, P659, DOI 10.1227/NEU.0b013e31821bc667; Balsa AI, 2003, J HEALTH ECON, V22, P89, DOI 10.1016/S0167-6296(02)00098-X; Bardach NS, 2004, CIRCULATION, V109, P2207, DOI 10.1161/01.CIR.0000126433.12527.E6; BECKER G, 1994, J AGING STUD, V8, P271, DOI 10.1016/0890-4065(94)90004-3; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Brinjikji W, 2011, AM J NEURORADIOL, V32, P1071, DOI 10.3174/ajnr.A2453; Burgess DJ, 2004, J GEN INTERN MED, V19, P1154, DOI 10.1111/j.1525-1497.2004.30227.x; Canto JG, 2000, ARCH INTERN MED, V160, P817, DOI 10.1001/archinte.160.6.817; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cram P, 2008, MED CARE, V46, P467, DOI 10.1097/MLR.0b013e31816c43d9; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Downs A, 2004, REHABIL PSYCHOL, V49, P303, DOI 10.1037/0090-5550.49.4.303; Drum C., 2005, CALIFORNIAN J HLTH P, V3, P29, DOI 10.32398/cjhp.v3i3.647; Earnshaw VA, 2012, J HEALTH PSYCHOL, V17, P157, DOI 10.1177/1359105311414952; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elixhauser A, 2005, CLIN CLASSIFICATIONS; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Ghebre RG, 2011, GYNECOL ONCOL, V121, P595, DOI 10.1016/j.ygyno.2011.02.005; Groth SS, 2013, ANN THORACIC SURG; Hanmer J, 2014, ANN INTERN MED, V160, P81, DOI 10.7326/M12-1977; Iezzoni LL, 2008, ARCH PHYS MED REHAB, V89, P595, DOI 10.1016/j.apmr.2007.09.042; Keith D, 2008, CLIN J AM SOC NEPHRO, V3, P463, DOI 10.2215/CJN.02220507; Khatri R, 2011, NEUROCRIT CARE, V15, P34, DOI 10.1007/s12028-010-9423-5; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; LaPar DJ, 2012, CIRCULATION, V126, pS132, DOI 10.1161/CIRCULATIONAHA.111.083782; Lavie CJ, 2011, CURR CARDIOVASC RISK, V5, P432, DOI 10.1007/s12170-011-0192-2; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Lee ES, 2006, ANAL COMPLEX SURVEY, pvii; McCarthy EP, 2006, ANN INTERN MED, V145, P637, DOI 10.7326/0003-4819-145-9-200611070-00005; McPhee J, 2009, J VASC SURG, V49, P817, DOI 10.1016/j.jvs.2008.11.002; Mills AM, 2012, COLORECTAL DIS; Momin EN, 2012, ARCH SURG-CHICAGO, V147, P1017, DOI 10.1001/archsurg.2012.1459; Muss HB, 2012, J CLIN ONCOL, V30, P2576, DOI 10.1200/JCO.2012.42.3780; Nathens AB, 2001, J TRAUMA, V50, P776, DOI 10.1097/00005373-200105000-00002; Norris K, 2008, J AM SOC NEPHROL, V19, P1261, DOI 10.1681/ASN.2008030276; Nuno M, 2012, NEUROCRIT CARE, V17, P312, DOI 10.1007/s12028-012-9740-y; Qureshi AI, 2011, J NEUROSURG, V114, P834, DOI 10.3171/2010.6.JNS091486; Shea AM, 2007, NEUROSURGERY, V61, P1131, DOI 10.1227/01.neu.0000306090.30517.ae; Smith GA, 2011, J NEUROSURG, V114, P1768, DOI 10.3171/2011.1.JNS101528; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; United States Bureau of Labor Statistics, 2013, CONS PRIC IND CALC	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105124	10.1371/journal.pone.0105124	http://dx.doi.org/10.1371/journal.pone.0105124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25141303	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200053
J	Kim, H; Terazono, H; Nakamura, Y; Sakai, K; Hattori, A; Odaka, M; Girault, M; Arao, T; Nishio, K; Miyagi, Y; Yasuda, K				Kim, Hyonchol; Terazono, Hideyuki; Nakamura, Yoshiyasu; Sakai, Kazuko; Hattori, Akihiro; Odaka, Masao; Girault, Mathias; Arao, Tokuzo; Nishio, Kazuto; Miyagi, Yohei; Yasuda, Kenji			Development of On-Chip Multi-Imaging Flow Cytometry for Identification of Imaging Biomarkers of Clustered Circulating Tumor Cells	PLOS ONE			English	Article							NUCLEAR MORPHOMETRY; SIZE; CANCER; SYSTEM; SURVIVAL; BLOOD	An on-chip multi-imaging flow cytometry system has been developed to obtain morphometric parameters of cell clusters such as cell number, perimeter, total cross-sectional area, number of nuclei and size of clusters as "imaging biomarkers'', with simultaneous acquisition and analysis of both bright-field (BF) and fluorescent (FL) images at 200 frames per second (fps); by using this system, we examined the effectiveness of using imaging biomarkers for the identification of clustered circulating tumor cells (CTCs). Sample blood of rats in which a prostate cancer cell line (MAT-LyLu) had been pre-implanted was applied to a microchannel on a disposable microchip after staining the nuclei using fluorescent dye for their visualization, and the acquired images were measured and compared with those of healthy rats. In terms of the results, clustered cells having (1) cell area larger than 200 mu m(2) and (2) nucleus area larger than 90 mu m(2) were specifically observed in cancer cell-implanted blood, but were not observed in healthy rats. In addition, (3) clusters having more than 3 nuclei were specific for cancer-implanted blood and (4) a ratio between the actual perimeter and the perimeter calculated from the obtained area, which reflects a shape distorted from ideal roundness, of less than 0.90 was specific for all clusters having more than 3 nuclei and was also specific for cancer-implanted blood. The collected clusters larger than 300 mu m(2) were examined by quantitative gene copy number assay, and were identified as being CTCs. These results indicate the usefulness of the imaging biomarkers for characterizing clusters, and all of the four examined imaging biomarkers-cluster area, nuclei area, nuclei number, and ratio of perimeter-can identify clustered CTCs in blood with the same level of preciseness using multi-imaging cytometry.	[Kim, Hyonchol; Terazono, Hideyuki; Hattori, Akihiro; Odaka, Masao; Girault, Mathias; Yasuda, Kenji] Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa, Japan; [Terazono, Hideyuki; Yasuda, Kenji] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Div Biosyst, Dept Biomed Informat,Chiyoda Ku, Tokyo, Japan; [Nakamura, Yoshiyasu; Miyagi, Yohei] Kanagawa Canc Ctr, Res Inst, Mol Pathol & Genet Div, Asahi Ku, Yokohama, Kanagawa 2410815, Japan; [Sakai, Kazuko; Arao, Tokuzo; Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan	Kanagawa Academy Science & Technology; Tokyo Medical & Dental University (TMDU); Kanagawa Prefectural Cancer Center; Kindai University (Kinki University)	Yasuda, K (corresponding author), Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa, Japan.	yasuda.bmi@tmd.ac.jp	Kim, Hyonchol/R-9922-2017; Yasuda, Kenji/L-6520-2016	Kim, Hyonchol/0000-0002-1786-648X; Terazono, Hideyuki/0000-0002-2657-4454; Yasuda, Kenji/0000-0002-1433-4509	Kanagawa Prefector's local basic science funding for the On-chip Cellomics Project at the Kanagawa Academy of Science and Technology	Kanagawa Prefector's local basic science funding for the On-chip Cellomics Project at the Kanagawa Academy of Science and Technology	This work was supported by Kanagawa Prefector's local basic science funding for the On-chip Cellomics Project at the Kanagawa Academy of Science and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla F, 2009, ANTICANCER RES, V29, P1771; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Buhmeida A, 2006, ANTICANCER RES, V26, P455; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; Davis JA, 2006, P NATL ACAD SCI USA, V103, P14779, DOI 10.1073/pnas.0605967103; de Andrea CE, 2011, INT J CLIN EXP PATHO, V4, P169; DEANS GT, 1993, DIS COLON RECTUM, V36, P450, DOI 10.1007/BF02050010; Desitter I, 2011, ANTICANCER RES, V31, P427; DUNDAS SAC, 1988, J CLIN PATHOL, V41, P1273, DOI 10.1136/jcp.41.12.1273; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; Hattori A, 2014, JAPANESE J IN PRESS; Hattori A, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.06GM04; Hayashi M, 2011, INT J MOL SCI, V12, P3618, DOI 10.3390/ijms12063618; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Hosokawa M, 2013, ANAL CHEM, V85, P5692, DOI 10.1021/ac400167x; KINOSITA K, 1991, J CELL BIOL, V115, P67, DOI 10.1083/jcb.115.1.67; Meachem MD, 2012, J VET DIAGN INVEST, V24, P525, DOI 10.1177/1040638712440988; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nomura F., 2011, J BIOPROCESS BIOTECH, VS3, P003; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Sokmen S, 2001, ANTICANCER RES, V21, P4341; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Takahashi Kazunori, 2004, J Nanobiotechnology, V2, P5, DOI 10.1186/1477-3155-2-5; Tennant TR, 2000, PROSTATE, V43, P295, DOI 10.1002/1097-0045(20000601)43:4<295::AID-PROS9>3.0.CO;2-W; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Yasuda K, 2013, MICROFLUID NANOFLUID, V14, P907, DOI 10.1007/s10404-012-1112-6; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	29	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104372	10.1371/journal.pone.0104372	http://dx.doi.org/10.1371/journal.pone.0104372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140522	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200018
J	Lin, P; Bach, M; Asquith, M; Lee, AY; Akileswaran, L; Stauffer, P; Davin, S; Pan, YZ; Cambronne, ED; Dorris, M; Debelius, JW; Lauber, CL; Ackermann, G; Baeza, YV; Gill, T; Knight, R; Colbert, RA; Taurog, JD; Van Gelder, RN; Rosenbaum, JT				Lin, Phoebe; Bach, Mary; Asquith, Mark; Lee, Aaron Y.; Akileswaran, Lakshmi; Stauffer, Patrick; Davin, Sean; Pan, Yuzhen; Cambronne, Eric D.; Dorris, Martha; Debelius, Justine W.; Lauber, Christian L.; Ackermann, Gail; Baeza, Yoshiki V.; Gill, Tejpal; Knight, Rob; Colbert, Robert A.; Taurog, Joel D.; Van Gelder, Russell N.; Rosenbaum, James T.			HLA-B27 and Human beta 2-Microglobulin Affect the Gut Microbiota of Transgenic Rats	PLOS ONE			English	Article							HUMAN MONOCYTIC CELLS; KLEBSIELLA-PNEUMONIAE NITROGENASE; ANKYLOSING-SPONDYLITIS; HLA-B27-TRANSGENIC RATS; SALMONELLA-ENTERITIDIS; BACTEROIDES-VULGATUS; INFLAMMATORY DISEASE; AUTOIMMUNE-DISEASE; REACTIVE ARTHRITIS; MOLECULAR MIMICRY	The HLA-B27 gene is a major risk factor for clinical diseases including ankylosing spondylitis, acute anterior uveitis, reactive arthritis, and psoriatic arthritis, but its mechanism of risk enhancement is not completely understood. The gut microbiome has recently been shown to influence several HLA-linked diseases. However, the role of HLA-B27 in shaping the gut microbiome has not been previously investigated. In this study, we characterize the differences in the gut microbiota mediated by the presence of the HLA-B27 gene. We identified differences in the cecal microbiota of Lewis rats transgenic for HLA-B27 and human beta 2-microglobulin (h beta 2m), compared with wild-type Lewis rats, using biome representational in situ karyotyping (BRISK) and 16S rRNA gene sequencing. 16S sequencing revealed significant differences between transgenic animals and wild type animals by principal coordinates analysis. Further analysis of the data set revealed an increase in Prevotella spp. and a decrease in Rikenellaceae relative abundance in the transgenic animals compared to the wild type animals. By BRISK analysis, species-specific differences included an increase in Bacteroides vulgatus abundance in HLA-B27/h beta 2m and h beta 2m compared to wild type rats. The finding that HLA-B27 is associated with altered cecal microbiota has not been shown before and can potentially provide a better understanding of the clinical diseases associated with this gene.	[Lin, Phoebe; Stauffer, Patrick; Davin, Sean; Pan, Yuzhen; Rosenbaum, James T.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Asquith, Mark; Rosenbaum, James T.] Oregon Hlth & Sci Univ, Div Rheumatol, Portland, OR 97201 USA; [Bach, Mary] Univ Washington, Div Rheumatol, VA Med Ctr, Seattle, WA 98195 USA; [Lee, Aaron Y.] Moorfields Eye Inst London, London, England; [Akileswaran, Lakshmi; Van Gelder, Russell N.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Dorris, Martha; Taurog, Joel D.] Univ Texas Southwestern, Dept Rheumatol, Dallas, TX USA; [Debelius, Justine W.; Lauber, Christian L.; Ackermann, Gail; Baeza, Yoshiki V.; Knight, Rob] Univ Colorado, Boulder, CO 80309 USA; [Rosenbaum, James T.] Devers Eye Inst, Portland, OR USA; [Cambronne, Eric D.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Gill, Tejpal; Colbert, Robert A.] NIAMSD, Pediat Translat Res Branch, NIH, Baltimore, MD USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Boulder; Devers Eye Institute; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); NIH National Institute on Aging (NIA); Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Lin, P (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	linp@ohsu.edu	Van Gelder, Russell/ABB-4225-2021; Asquith, Mark/M-1741-2019; Knight, Rob/D-1299-2010; Lee, Aaron/AAT-2839-2020; Gill, Tejpal/A-1139-2014; Pan, YZ/GVS-2269-2022; Gill, Tejpal/AAV-1659-2020; Debelius, Justine/ABE-7272-2021	Van Gelder, Russell/0000-0001-5368-3659; Gill, Tejpal/0000-0001-6248-132X; Knight, Rob/0000-0002-0975-9019; Debelius, Justine/0000-0002-8605-3546	Research to Prevent Blindness Career Development Award; NIH [K08EY022948, P30 EY001730, T32 AR 007108]; Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; Burroughs-Wellcome Translational Scientist Award; Research to Prevent Blindness; NIAMS [Z01 AR041184]; NATIONAL EYE INSTITUTE [K08EY022948, P30EY001730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007108, ZIAAR041184] Funding Source: NIH RePORTER	Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; Burroughs-Wellcome Translational Scientist Award(Burroughs Wellcome Fund); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	PL is supported by a Research to Prevent Blindness Career Development Award and an NIH award K08EY022948. JTR is supported by the Stan and Madelle Rosenfeld Family Trust and the William and Mary Bauman Foundation. RK is an HHMI Early Career Scientist. RVG and LA were supported by the Burroughs-Wellcome Translational Scientist Award, an unrestricted award from Research to Prevent Blindness, and by NIH P30 EY001730. MB was supported by NIH T32 AR 007108. TG and RAC were supported by the NIAMS Intramural Research Program Z01 AR041184. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carvalho FA, 2012, GUT, V61, P373, DOI 10.1136/gut.2011.240556; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; DEVRIES DD, 1992, ANN RHEUM DIS, V51, P783, DOI 10.1136/ard.51.6.783; Dhaenens M, 2009, ARTHRITIS RHEUM-US, V60, P2622, DOI 10.1002/art.24780; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; EWING C, 1990, J EXP MED, V171, P1635, DOI 10.1084/jem.171.5.1635; Fert I, 2008, ARTHRITIS RHEUM-US, V58, P3425, DOI 10.1002/art.24023; Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P431, DOI 10.1016/j.copbio.2011.11.017; Gough SCL, 2007, CURR GENOMICS, V8, P453, DOI 10.2174/138920207783591690; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Hansen JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042645; Hoentjen F, 2005, INFLAMM BOWEL DIS, V11, P977, DOI 10.1097/01.MIB.0000183421.02316.d5; Hoentjen F, 2007, INFLAMM BOWEL DIS, V13, P317, DOI 10.1002/ibd.20040; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003; LAHESMAA R, 1993, IMMUNOL RES, V12, P193, DOI 10.1007/BF02918304; Laitio P, 1997, EUR J IMMUNOL, V27, P1331, DOI 10.1002/eji.1830270606; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Luckey D, 2013, INDIAN J MED RES, V138, P732; May E, 2003, J IMMUNOL, V170, P1099, DOI 10.4049/jimmunol.170.2.1099; McHugh K, 2012, RHEUMATOLOGY, V51, P1529, DOI 10.1093/rheumatology/kes061; Mertz AKH, 2000, J IMMUNOL, V164, P1529, DOI 10.4049/jimmunol.164.3.1529; Muthappan V, 2011, GENOME RES, V21, P626, DOI 10.1101/gr.115758.110; Navidshad B, 2012, INT J MOL SCI, V13, P2119, DOI 10.3390/ijms13022119; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Penttinen MA, 2004, ARTHRITIS RHEUM, V50, P2255, DOI 10.1002/art.20336; Penttinen MA, 2002, ARTHRITIS RHEUM-US, V46, P2172, DOI 10.1002/art.10557; Rath HC, 1999, INFECT IMMUN, V67, P2969, DOI 10.1128/IAI.67.6.2969-2974.1999; Rosenbaum JT, 2011, ARTHRITIS RHEUM-US, V63, P3195, DOI 10.1002/art.30558; Ruuska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050684; Ruuska M, 2012, ARTHRITIS RHEUM-US, V64, P772, DOI 10.1002/art.33391; Sahlberg AS, 2007, ARTHRITIS RHEUM, V56, P2652, DOI 10.1002/art.22746; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; SCHWIMMBECK PL, 1987, J EXP MED, V166, P173, DOI 10.1084/jem.166.1.173; SCOFIELD RH, 1993, P NATL ACAD SCI USA, V90, P9330, DOI 10.1073/pnas.90.20.9330; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Taurog JD, 2012, ARTHRITIS RHEUM-US, V64, P2518, DOI 10.1002/art.34480; Taurog JD, 2009, ARTHRITIS RHEUM, V60, P1977, DOI 10.1002/art.24599; Tran TM, 2006, ARTHRITIS RHEUM-US, V54, P1317, DOI 10.1002/art.21740; Utriainen L, 2012, ARTHRITIS RHEUM-US, V64, P3199, DOI 10.1002/art.34561; VANBOHEMEN CG, 1986, IMMUNOL LETT, V13, P71, DOI 10.1016/0165-2478(86)90128-8; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yu D, 2003, RHEUM DIS CLIN N AM, V29, P21, DOI 10.1016/S0889-857X(02)00082-0	55	152	158	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105684	10.1371/journal.pone.0105684	http://dx.doi.org/10.1371/journal.pone.0105684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140823	Green Published, gold			2022-12-25	WOS:000342687200120
J	McKinnon, EA; Fraser, KC; Stanley, CQ; Stutchbury, BJM				McKinnon, Emily A.; Fraser, Kevin C.; Stanley, Calandra Q.; Stutchbury, Bridget J. M.			Tracking from the Tropics Reveals Behaviour of Juvenile Songbirds on Their First Spring Migration	PLOS ONE			English	Article							AMERICAN REDSTARTS; STOPOVER SITE; ARRIVAL DATE; AGE; BIRDS; ORIENTATION; WARBLERS; COMPETITION; PHENOLOGY; MOVEMENT	Juvenile songbirds on spring migration travel from tropical wintering sites to temperate breeding destinations thousands of kilometres away with no prior experience to guide them. We provide a first glimpse at the migration timing, routes, and stopover behaviour of juvenile wood thrushes (Hylocichla mustelina) on their inaugural spring migration by using miniaturized archival geolocators to track them from Central America to the U.S. and Canada. We found significant differences between the timing of juvenile migration and that of more experienced adults: juveniles not only departed later from tropical wintering sites relative to adults, they also became progressively later as they moved northward. The increasing delay was driven by more frequent short stops by juveniles along their migration route, particularly in the U.S. as they got closer to breeding sites. Surprisingly, juveniles were just as likely as adults to cross the Gulf of Mexico, an open-water crossing of 800-1000 km, and migration route at the Gulf was not significantly different for juveniles relative to adults. To determine if the later departure of juveniles was related to poor body condition in winter relative to adults, we examined percent lean body mass, fat scores, and pectoral muscle scores of juvenile versus adult birds at a wintering site in Belize. We found no age-related differences in body condition. Later migration timing of juveniles relative to adults could be an adaptive strategy (as opposed to condition-dependent) to avoid the high costs of fast migration and competition for breeding territories with experienced and larger adults. We did find significant differences in wing size between adults and juveniles, which could contribute to lower flight efficiency of juveniles and thus slower overall migration speed. We provide the first step toward understanding the "black box" of juvenile songbird migration by documenting their migration timing and en route performance.	[McKinnon, Emily A.; Fraser, Kevin C.; Stanley, Calandra Q.; Stutchbury, Bridget J. M.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	McKinnon, EA (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	emilymck@yorku.ca		McKinnon, Emily/0000-0003-3631-0644; Stanley, Calandra Q./0000-0003-1588-2248				ALATALO RV, 1984, IBIS, V126, P410, DOI 10.1111/j.1474-919X.1984.tb00264.x; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Alerstam T, 2006, ARDEA, V94, P347; Arlt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082316; Bayly NJ, 2013, IBIS, V155, P271, DOI 10.1111/ibi.12029; Berthold P, 2001, AUK, V2nd; Berthold P, 1996, CONTROL BIRD MIGRATI; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bowlin MS, 2007, AUK, V124, P1388, DOI 10.1642/0004-8038(2007)124[1388:SWSAWP]2.0.CO;2; Bridge ES, 2013, J FIELD ORNITHOL, V84, P121, DOI 10.1111/jofo.12011; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Clausen KK, 2013, OECOLOGIA, V173, P1101, DOI 10.1007/s00442-013-2681-0; de la Hera I, 2014, IBIS, V156, P209, DOI 10.1111/ibi.12112; DeSante DF, 2009, MOSI MONITOREO SOBRE; FRANCIS CM, 1986, AUK, V103, P548; FRANCIS CM, 1990, J FIELD ORNITHOL, V61, P404; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; GOSLER AG, 1991, BIRD STUDY, V38, P1, DOI 10.1080/00063659109477061; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Gwinner E, 2003, CURR OPIN NEUROBIOL, V13, P770, DOI 10.1016/j.conb.2003.10.010; Hake M, 2003, OIKOS, V103, P385, DOI 10.1034/j.1600-0706.2003.12145.x; Healy SD, 1996, BEHAV BRAIN RES, V81, P61, DOI 10.1016/S0166-4328(96)00044-7; Helm B, 2005, ANN NY ACAD SCI, V1046, P216, DOI 10.1196/annals.1343.019; HILL GE, 1989, ANIM BEHAV, V37, P665, DOI 10.1016/0003-3472(89)90045-6; Hockey PAR, 1998, J AVIAN BIOL, V29, P325, DOI 10.2307/3677117; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Lemke HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079209; Lindstrom A, 2011, CONDOR, V113, P129, DOI 10.1525/cond.2011.090171; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; Maggini I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031271; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; McKinney AM, 2012, ECOLOGY, V93, P1987, DOI 10.1890/12-0255.1; McKinnon Emily A., 2013, Animal Migration, V1, P31, DOI 10.2478/ami-2013-0001; McKinnon EA, 2013, AUK, V130, P211, DOI 10.1525/auk.2013.12226; Mellone U, 2013, J AVIAN BIOL, V44, P417, DOI 10.1111/j.1600-048X.2013.00139.x; Moore F, 2003, AVIAN MIGRATION, P281; MORTON ES, 1990, CONDOR, V92, P1040, DOI 10.2307/1368740; Mouritsen H, 1998, J EXP BIOL, V201, P2927; Mukhin A, 2005, P ROY SOC B-BIOL SCI, V272, P1535, DOI 10.1098/rspb.2005.3120; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; Paxton KL, 2008, CONDOR, V110, P672, DOI 10.1525/cond.2008.8602; PERDECK AC, 1983, ARDEA, V71, P255; Pyle P, 1997, IDENTIFICATION GUIDE, VI; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Sandberg R, 1996, BEHAV ECOL SOCIOBIOL, V39, P1, DOI 10.1007/s002650050261; Saracco JF, 2010, ECOLOGY, V91, P1885, DOI 10.1890/09-0705.1; Sauer JR, 2012, N AM BREEDING BIRD S; Seewagen CL, 2013, BEHAV ECOL, V24, P634, DOI 10.1093/beheco/ars225; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Sirot E, 2014, J AVIAN BIOL, V45, P109, DOI 10.1111/j.1600-048X.2013.00184.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Stanley CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040688; Stewart RLM, 2002, WILSON BULL, V114, P264, DOI 10.1676/0043-5643(2002)114[0264:ARDTOS]2.0.CO;2; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Thorup K, 2010, INTEGR COMP BIOL, V50, P315, DOI 10.1093/icb/icq065; Townsend AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059467; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wiltschko R, 2003, AVIAN MIGRATION, P433; WINKER K, 1990, CONDOR, V92, P444, DOI 10.2307/1368241	63	54	55	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105605	10.1371/journal.pone.0105605	http://dx.doi.org/10.1371/journal.pone.0105605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141193	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200114
J	Dayan, O; Ben-Yona, A; Kanner, BI				Dayan, Oshrat; Ben-Yona, Assaf; Kanner, Baruch I.			The Aromatic and Charge Pairs of the Thin Extracellular Gate of the gamma-Aminobutyric Acid Transporter GAT-1 Are Differently Impacted by Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; NEUROTRANSMITTER TRANSPORTERS; XENOPUS OOCYTES; SUBTYPE-A; SODIUM; IDENTIFICATION; SITE; EXPRESSION; GLUTAMATE; HOMOLOG	GAT-1 is a sodium-and chloride-coupled GABA transporter and a member of the neurotransmitter: sodium: symporters, which are crucial for synaptic transmission. The structure of bacterial homologue LeuT shows a thin extracellular gate consisting of a charge and an aromatic pair. Here we addressed the question of whether mutation of the aromatic and charge pair residues of GAT-1 has similar consequences. In contrast to charge pair mutants, significant radioactive GABA transport was retained by mutants of the aromatic pair residue Phe-294. Moreover, the magnitude of maximal transport currents induced by GABA by these mutants was comparable with those by wild type GAT-1. However, the apparent affinity of the non-conserved mutants for GABA was reduced up to 20-fold relative to wild type. The voltage dependence of the sodium-dependent transient currents of the Phe-294 mutants was similar to that of the wild type. On the other hand, the conserved charge pair mutant D451E exhibited a right-shifted voltage dependence, indicating an increased apparent affinity for sodium. In further contrast to D451E, whereas the extracellular aqueous accessibility of an endogenous cysteine residue to a membrane-impermeant sulfhydryl reagent was increased relative to wild type, this was not the case for the aromatic pair mutants. Our data indicate that, in contrast to the charge pair, the aromatic pair is not essential for gating. Instead they are compatible with the idea that they serve to diminish dissociation of the substrate from the binding pocket.	[Dayan, Oshrat; Ben-Yona, Assaf; Kanner, Baruch I.] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Hadassah Med Sch, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Hadassah Med Sch, POB 12272, IL-91120 Jerusalem, Israel.	baruch.kanner@mail.huji.ac.il			Israel Science Foundation [804/11]; Rosetrees Trust	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust)	This work was supported by Grant 804/11 from the Israel Science Foundation and by a grant from the Rosetrees Trust.	Ben-Yona A, 2012, J BIOL CHEM, V287, P7159, DOI 10.1074/jbc.M111.323634; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KANNER BI, 1994, J EXP BIOL, V196, P237; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Nelson N, 1998, J NEUROCHEM, V71, P1785; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Wang H, 2012, EMBO REP, V13, P861, DOI 10.1038/embor.2012.110; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	29	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28172	28178		10.1074/jbc.M114.589721	http://dx.doi.org/10.1074/jbc.M114.589721			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25143384	Green Published, hybrid			2022-12-25	WOS:000343765400014
J	Cai, DM; Jia, YM; Song, HG; Sui, SY; Lu, JY; Jiang, Z; Zhao, RQ				Cai, Demin; Jia, Yimin; Song, Haogang; Sui, Shiyan; Lu, Jingyu; Jiang, Zheng; Zhao, Ruqian			Betaine Supplementation in Maternal Diet Modulates the Epigenetic Regulation of Hepatic Gluconeogenic Genes in Neonatal Piglets	PLOS ONE			English	Article							GLOBAL DNA METHYLATION; GLUCOSE-PRODUCTION; METHIONINE METABOLISM; CHOLINE DEFICIENCY; FOLIC-ACID; PROTEIN; METHYLTRANSFERASE; HOMOCYSTEINE; LIVER; EXPRESSION	In this study, gestational sows were fed control or betaine-supplemented diets (3 g/kg) throughout the pregnancy, and the newborn piglets were used to elucidate whether maternal dietary betaine affected offspring hepatic gluconeogenic genes through epigenetic mechanisms. Neonatal piglets born to betaine-supplemented sows had significantly higher serum and hepatic betaine contents, together with significantly greater expression of methionine metabolic enzymes in the liver. Interestingly, significantly higher serum concentrations of lactic acid and glucogenic amino acids, including serine, glutamate, methionine and histidine, were detected in the piglets born to betaine-supplemented sows, which were coincident with higher hepatic glycogen content and PEPCK1 enzyme activity, as well as greater protein expression of gluconeogenic enzymes, pyruvate carboxylase (PC), cytoplasmic phosphoenolpyruvate carboxykinase (PEPCK1), mitochondrional phosphoenolpyruvate carboxykinase (PEPCK2) and fructose-1, 6-bisphosphatase (FBP1). Moreover, maternal betaine significantly changed the methylation status of both CpGs and histones on the promoter of gluconeogenic genes. The lower PEPCK1 mRNA was associated with DNA hypermethylation and more enriched repression histone mark H3K27me3, while the up-regulated PEPCK2 and FBP1 mRNA was associated with DNA hypomethylation and more enriched activation histone mark H3K4me3. Furthermore, the expression of two miRNAs predicted to target PC and 6 miRNAs predicted to target PEPCK1 was dramatically suppressed in the liver of piglets born to betaine-supplemented sows. Our results provide the first evidence that maternal betaine supplementation affects hepatic gluconeogenic genes expression in newborn piglets through enhanced hepatic methionine metabolism and epigenetic regulations, which involve DNA and histone methylations, and possibly miRNAs-mediated post-transcriptional mechanism.	[Cai, Demin; Jia, Yimin; Song, Haogang; Sui, Shiyan; Lu, Jingyu; Jiang, Zheng; Zhao, Ruqian] Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhao, RQ (corresponding author), Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	zhao.ruqian@gmail.com	Sui, Shiyan/AAW-7836-2021; Cai, Demin/AAT-7742-2021	Cai, Demin/0000-0003-0500-5292	National Basic Research Program of China [2012CB124703]; Special Fund for Agro-scientific Research in the Public Interest [201003011]; Fundamental Research Funds for the Central Universities [KYZ200913]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Innovation Project of Jiangsu Province Postgraduate Education [2013CXLX13_292]	National Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions; Innovation Project of Jiangsu Province Postgraduate Education	This work was supported by the National Basic Research Program of China (2012CB124703), the Special Fund for Agro-scientific Research in the Public Interest (201003011), the Fundamental Research Funds for the Central Universities (KYZ200913), the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Innovation Project of Jiangsu Province Postgraduate Education (2013CXLX13_292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Altern Med Rev, V8, P193; Bennett LW, 2007, POULTRY SCI, V86, P2653, DOI 10.3382/ps.2007-00303; Burdge GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028282; Calvisi DF, 2007, INT J CANCER, V121, P2410, DOI 10.1002/ijc.22940; Cordero P, 2013, GENES NUTR, V8, P105, DOI 10.1007/s12263-012-0300-z; Corssmit EPM, 2001, METABOLISM, V50, P742, DOI 10.1053/meta.2001.24195; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Eklund M, 2005, NUTR RES REV, V18, P31, DOI 10.1079/NRR200493; FINKELSTEIN JD, 1983, J NUTR, V113, P519, DOI 10.1093/jn/113.3.519; Horowitz S, 2011, J BIOL CHEM, V286, P18658, DOI 10.1074/jbc.M111.232876; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Jackson MI, 2012, J BIOL CHEM, V287, P36455, DOI 10.1074/jbc.M112.412932; Jia YM, 2012, J NUTR, V142, P1659, DOI 10.3945/jn.112.160341; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kathirvel E, 2010, AM J PHYSIOL-GASTR L, V299, pG1068, DOI 10.1152/ajpgi.00249.2010; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kharbanda KK, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/962183; Kirsch SH, 2010, J CHROMATOGR B, V878, P3338, DOI 10.1016/j.jchromb.2010.10.016; KORNHAUSER D, 1970, PEDIATR RES, V4, P120, DOI 10.1203/00006450-197003000-00002; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; KUMAR S, 1980, NEUROCHEM RES, V5, P453, DOI 10.1007/BF00964233; Lee JK, 2013, BIOCHEM BIOPH RES CO, V438, P647, DOI 10.1016/j.bbrc.2013.07.128; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lillycrop KA, 2010, BRIT J NUTR, V103, P1711, DOI 10.1017/S0007114509993795; Liu XJ, 2011, EPIGENETICS-US, V6, P899, DOI 10.4161/epi.6.7.16005; Liu Y, 2012, J NUTR SCI VITAMINOL, V58, P69, DOI 10.3177/jnsv.58.69; Medici V, 2013, HEPATOLOGY, V57, P555, DOI 10.1002/hep.26047; Molloy AM, 2005, AM J CLIN NUTR, V82, P836, DOI 10.1093/ajcn/82.4.836; Mori S, 2010, BIOORGAN MED CHEM, V18, P8158, DOI 10.1016/j.bmc.2010.10.022; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Pan SF, 2013, BRIT J NUTR, V109, P1731, DOI 10.1017/S0007114512003728; PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7; Powell CL, 2010, TOXICOL SCI, V115, P131, DOI 10.1093/toxsci/kfq031; Ratriyanto A, 2009, ASIAN AUSTRAL J ANIM, V22, P1461, DOI 10.5713/ajas.2009.80659; ROSENSWE.NS, 1970, BIOCHIM BIOPHYS ACTA, V208, P373, DOI 10.1016/0304-4165(70)90209-6; Sangokoya C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003408; Sharma P, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-1; STORCH KJ, 1991, AM J CLIN NUTR, V54, P386, DOI 10.1093/ajcn/54.2.386; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Strakovsky RS, 2011, J PHYSIOL-LONDON, V589, P2707, DOI 10.1113/jphysiol.2010.203950; Surtees R, 1997, PEDIATR RES, V42, P577, DOI 10.1203/00006450-199711000-00004; van Poelje PD, 2011, HANDB EXP PHARMACOL, V203, P279, DOI 10.1007/978-3-642-17214-4_12; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Villamor E, 2012, PAEDIATR PERINAT EP, V26, P328, DOI 10.1111/j.1365-3016.2012.01264.x; Wagner T, 2012, NAT BIOTECHNOL, V30, P622, DOI 10.1038/nbt.2300; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9	48	45	52	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105504	10.1371/journal.pone.0105504	http://dx.doi.org/10.1371/journal.pone.0105504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153319	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200057
J	Chen, WG; Xiao, HB; Rizzo, AN; Zhang, W; Mai, YF; Ye, M				Chen, Weiguo; Xiao, Hongbing; Rizzo, Alicia N.; Zhang, Wei; Mai, Yifeng; Ye, Meng			Endothelial Nitric Oxide Synthase Dimerization Is Regulated by Heat Shock Protein 90 Rather than by Phosphorylation	PLOS ONE			English	Article							ENOS ACTIVATION; NO SYNTHASE; IN-VIVO; CELLS; TETRAHYDROBIOPTERIN; EXPRESSION; VEGF; DEPHOSPHORYLATION; DYSFUNCTION; INHIBITION	Endothelial nitric oxide synthase (eNOS) is a multifunctional enzyme with roles in diverse cellular processes including angiogenesis, tissue remodeling, and the maintenance of vascular tone. Monomeric and dimeric forms of eNOS exist in various tissues. The dimeric form of eNOS is considered the active form and the monomeric form is considered inactive. The activity of eNOS is also regulated by many other mechanisms, including amino acid phosphorylation and interactions with other proteins. However, the precise mechanisms regulating eNOS dimerization, phosphorylation, and activity remain incompletely characterized. We utilized purified eNOS and bovine aorta endothelial cells (BAECs) to investigate the mechanisms regulating eNOS degradation. Both eNOS monomer and dimer existed in purified bovine eNOS. Incubation of purified bovine eNOS with protein phosphatase 2A (PP2A) resulted in dephosphorylation at Serine 1179 (Ser1179) in both dimer and monomer and decrease in eNOS activity. However, the eNOS dimer: monomer ratio was unchanged. Similarly, protein phosphatase 1 (PP1) induced dephosphorylation of eNOS at Threonine 497 (Thr497), without altering the eNOS dimer: monomer ratio. Different from purified eNOS, in cultured BAECs eNOS existed predominantly as dimers. However, eNOS monomers accumulated following treatment with the proteasome inhibitor lactacystin. Additionally, treatment of BAECs with vascular endothelial growth factor (VEGF) resulted in phosphorylation of Ser1179 in eNOS dimers without altering the phosphorylation status of Thr497 in either form. Inhibition of heat shock protein 90 (Hsp90) or Hsp90 silencing destabilized eNOS dimers and was accompanied by dephosphorylation both of Ser1179 and Thr497. In conclusion, our study demonstrates that eNOS monomers, but not eNOS dimers, are degraded by ubiquitination. Additionally, the dimeric eNOS structure is the predominant condition for eNOS amino acid modification and activity regulation. Finally, destabilization of eNOS dimers not only results in eNOS degradation, but also causes changes in eNOS amino acid modifications that further affect eNOS activity.	[Chen, Weiguo; Zhang, Wei; Mai, Yifeng; Ye, Meng] Ningbo Univ, Sch Med, Affiliated Hosp, Dept Med, Ningbo 315211, Zhejiang, Peoples R China; [Chen, Weiguo; Xiao, Hongbing; Rizzo, Alicia N.; Zhang, Wei] Univ Illinois, Coll Med, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Rizzo, Alicia N.] Univ Illinois, Dept Pharmacol, Chicago, IL USA	Ningbo University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chen, WG (corresponding author), Ningbo Univ, Sch Med, Affiliated Hosp, Dept Med, Ningbo 315211, Zhejiang, Peoples R China.	chen_weiguo@hotmail.com		Rizzo, Alicia/0000-0001-9289-4635	National Natural Scientific Foundation of China [NSFC-81270133]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Scientific Foundation of China (NSFC-81270133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2002, STROKE, V33, P1071, DOI 10.1161/hs0402.105553; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Antoniades C, 2006, CIRCULATION, V114, P1193, DOI 10.1161/CIRCULATIONAHA.106.612325; Benson MA, 2013, J BIOL CHEM, V288, P29836, DOI 10.1074/jbc.M113.493023; Bhat TA, 2013, CANCER PREV RES, V6, P1128, DOI 10.1158/1940-6207.CAPR-13-0209; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; Chen YM, 2006, AM J PHYSIOL-LUNG C, V291, pL378, DOI 10.1152/ajplung.00424.2005; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; Di Lorenzo A, 2013, J CELL SCI; Feliers D, 2005, KIDNEY INT, V68, P1648, DOI 10.1111/j.1523-1755.2005.00575.x; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Garcia C, 2013, ENDOCRINE; Gelinas DS, 2002, BRIT J PHARMACOL, V137, P1021, DOI 10.1038/sj.bjp.0704956; Gopalakrishnan B, 2012, JOVE-J VIS EXP, DOI 10.3791/2810; Govers R, 2003, LIFE SCI, V73, P2225, DOI 10.1016/S0024-3205(03)00644-1; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Hatakeyama T, 2006, J PHYSIOL-LONDON, V574, P275, DOI 10.1113/jphysiol.2006.108175; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Komarov AM, 2000, FREE RADICAL BIO MED, V28, P739, DOI 10.1016/S0891-5849(00)00156-8; Komers R, 2006, DIABETES, V55, P1651, DOI 10.2337/db05-1595; Kupatt C, 2004, ARTERIOSCL THROM VAS, V24, P1435, DOI 10.1161/01.ATV.0000134300.87476.d1; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Looft-Wilson R, 2007, J CLIN INVEST, V117, P1961, DOI 10.1172/JCI29877; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Persechini A, 2013, FEBS LETT, V587, P297, DOI 10.1016/j.febslet.2012.12.012; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Ramirez V, 2008, AM J PHYSIOL-RENAL, V295, pF1044, DOI 10.1152/ajprenal.90278.2008; Ruan L, 2013, VASC PHARMACOL, V59, P27, DOI 10.1016/j.vph.2013.05.004; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Scotland RS, 2002, CIRC RES, V90, P904, DOI 10.1161/01.RES.0000016506.04193.96; Sorenson J, 2005, STROKE, V36, P158, DOI 10.1161/01.STR.0000150489.47080.67; Stangl V, 2004, FASEB J, V18, P272, DOI 10.1096/fj.03-0054com; Taverne YJ, 1985, J APPL PHYSIOL, V112, P1644; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Venema RC, 1997, J BIOL CHEM, V272, P1276, DOI 10.1074/jbc.272.2.1276; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Zhang QJ, 2012, DIABETES, V61, P1848, DOI 10.2337/db11-1399	41	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105479	10.1371/journal.pone.0105479	http://dx.doi.org/10.1371/journal.pone.0105479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153129	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200056
J	Koike, H; Ouchi, R; Ueno, Y; Nakata, S; Obana, Y; Sekine, K; Zheng, YW; Takebe, T; Isono, K; Koseki, H; Taniguchi, H				Koike, Hiroyuki; Ouchi, Rie; Ueno, Yasuharu; Nakata, Susumu; Obana, Yuta; Sekine, Keisuke; Zheng, Yun-Wen; Takebe, Takanori; Isono, Kyoichi; Koseki, Haruhiko; Taniguchi, Hideki			Polycomb Group Protein Ezh2 Regulates Hepatic Progenitor Cell Proliferation and Differentiation in Murine Embryonic Liver	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; GROUP-COMPLEXES; SELF-RENEWAL; MAINTENANCE; EXPRESSION; CANCER; PLURIPOTENCY; METHYLATION; TRANSITION; IDENTITY	In embryonic liver, hepatic progenitor cells are actively proliferating and generate a fundamental cellular pool for establishing parenchymal components. However, the molecular basis for the expansion of the progenitors maintaining their immature state remains elusive. Polycomb group proteins regulate gene expression throughout the genome by modulating of chromatin structure and play crucial roles in development. Enhancer of zeste homolog 2 (Ezh2), a key component of polycomb group proteins, catalyzes tri-methylation of lysine 27 of histone H3 (H3K27me3), which trigger the gene suppression. In the present study, we investigated a role of Ezh2 in the regulation of the expanding hepatic progenitor population in vivo. We found that Ezh2 is highly expressed in the actively proliferating cells at the early developmental stage. Using a conditional knockout mouse model, we show that the deletion of the SET domain of Ezh2, which is responsible for catalytic induction of H3K27me3, results in significant reduction of the total liver size, absolute number of liver parenchymal cells, and hepatic progenitor cell population in size. A clonal colony assay in the hepatic progenitor cells directly isolated from in vivo fetal livers revealed that the bi-potent clonogenicity was significantly attenuated by the Ezh2 loss of function. Moreover, a marker expression based analysis and a global gene expression analysis showed that the knockout of Ezh2 inhibited differentiation to hepatocyte with reduced expression of a number of liver-function related genes. Taken together, our results indicate that Ezh2 is required for the hepatic progenitor expansion in vivo, which is essential for the functional maturation of embryonic liver, through its activity for catalyzing H3K27me3.	[Koike, Hiroyuki; Ouchi, Rie; Ueno, Yasuharu; Obana, Yuta; Sekine, Keisuke; Zheng, Yun-Wen; Takebe, Takanori; Taniguchi, Hideki] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Nakata, Susumu] Aichi Canc Ctr, Res Inst, Div Oncol Pathol, Chikusa Ku, Nagoya, Aichi 464, Japan; [Takebe, Takanori; Taniguchi, Hideki] Yokohama City Univ, Adv Med Res Ctr, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Takebe, Takanori] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Isono, Kyoichi; Koseki, Haruhiko] RIKEN, Res Ctr Allergy & Immunol, Lab Dev Genet, Tsurumi Ku, Yokohama, Kanagawa, Japan	Yokohama City University; Aichi Cancer Center; Yokohama City University; Japan Science & Technology Agency (JST); RIKEN	Taniguchi, H (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan.	rtanigu@med.yokohama-cu.ac.jp	Koseki, Haruhiko/I-3825-2014; Koike, Hiroyuki/AAT-6065-2020; Koike, Hiroyuki/R-5103-2018; Zheng, Yun-Wen/R-2874-2019; Koike, Hiroyuki/AAZ-9941-2020	Koseki, Haruhiko/0000-0001-8424-5854; Koike, Hiroyuki/0000-0001-9934-6930; Koike, Hiroyuki/0000-0001-9934-6930; Zheng, Yun-Wen/0000-0001-9002-3190; Koike, Hiroyuki/0000-0001-9934-6930; Isono, Kyoichi/0000-0002-4609-8985; Sekine, Keisuke/0000-0001-5133-0876	Special Coordination Funds for Promoting Science [11800122]; Stategic Promotion of Innovative Research and Development (S-innovation) [62890004]; Japan Health Sciences Foundation of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [20591532, 21249071, 22390260, 23791490, 23791491, 24106510, 24689052, 25253079, 25461956]; Takeda Science Foundation; Yokohama Foundation for Advanced Medical Science; Japan Insulin Dependent Diabetes Mellitus (IDDM) network; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the MEXT; Centers for Clinical Application Research on Specific Disease/Organ of the MEXT; Pancreas Research Foundation of Japan	Special Coordination Funds for Promoting Science; Stategic Promotion of Innovative Research and Development (S-innovation); Japan Health Sciences Foundation of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yokohama Foundation for Advanced Medical Science; Japan Insulin Dependent Diabetes Mellitus (IDDM) network; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the MEXT; Centers for Clinical Application Research on Specific Disease/Organ of the MEXT; Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan)	This work was supported by grants from the Special Coordination Funds for Promoting Science (11800122), grants from Stategic Promotion of Innovative Research and Development (S-innovation, 62890004), the Grant-in-Aid for Scientific Research on Innovative Areas, and the Japan Health Sciences Foundation of the Japan Science and Technology Agency (JST). This work was also supported by the Grants-in-Aid No. 20591532, 21249071, 22390260, 23791490, 23791491, 24106510, 24689052, 25253079, and 25461956 of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; by the Specified Research Grant from Takeda Science Foundation; by a grant from Yokohama Foundation for Advanced Medical Science; and by a grant from Japan Insulin Dependent Diabetes Mellitus (IDDM) network. This work was partially supported by funding from Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the MEXT, by funding from Centers for Clinical Application Research on Specific Disease/Organ of the MEXT, and by the Grants-in-Aid for Pancreas Research 2013 from Pancreas Research Foundation of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chiba T, 2012, INT J CANCER, V130, P2557, DOI 10.1002/ijc.26264; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Hidalgo I, 2012, CELL STEM CELL, V11, P649, DOI 10.1016/j.stem.2012.08.001; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hirao A, 2004, CELL CYCLE, V3, P1481, DOI 10.4161/cc.3.12.1281; Insco ML, 2012, CELL STEM CELL, V11, P689, DOI 10.1016/j.stem.2012.08.012; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Koike H, 2014, HEPATOLOGY; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mochizuki-Kashio M, 2011, BLOOD, V118, P6553, DOI 10.1182/blood-2011-03-340554; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Prezioso C, 2011, FEBS LETT, V585, P2067, DOI 10.1016/j.febslet.2011.04.062; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349; Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; van Vlerken LE, 2013, STEM CELL TRANSL MED, V2, P43, DOI 10.5966/sctm.2012-0036; Yadirgi G, 2011, STEM CELLS, V29, P700, DOI 10.1002/stem.614; Yonemitsu Y, 2009, HUM PATHOL, V40, P1304, DOI 10.1016/j.humpath.2009.01.017	35	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104776	10.1371/journal.pone.0104776	http://dx.doi.org/10.1371/journal.pone.0104776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153170	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200025
J	Zhou, P; An, Y; Wang, ZL; Du, HM; Huang, BR				Zhou, Peng; An, Yuan; Wang, Zhaolong; Du, Hongmei; Huang, Bingru			Characterization of Gene Expression Associated with Drought Avoidance and Tolerance Traits in a Perennial Grass Species	PLOS ONE			English	Article							RESPONSIVE GENES; CRYOPROTECTIVE ACTIVITY; TRANSCRIPTION FACTORS; DESICCATION-TOLERANT; PROLINE ACCUMULATION; STRESS TOLERANCE; IDENTIFICATION; PLANTS; BERMUDAGRASS; DIVERSITY	To understand molecular mechanisms of perennial grass adaptation to drought stress, genes associated with drought avoidance or tolerance traits were identified and their expression patterns were characterized in C4 hybrid bermudagrass [Cynodon dactylon (L.) Pers.xC. transvaalensis Burtt Davy, cv. Tifway] and common bermudagrass (C. dactylon, cv. C299). Plants of drought-tolerant 'Tifway' and drought-sensitive 'C299' were exposed to drought for 5 d (mild stress) and 10 d (severe stress) by withholding irrigation in a growth chamber. 'Tifway' maintained significantly lower electrolyte leakage and higher relative water content than 'C299' at both 5 and 10 d of drought stress. Four cDNA libraries via suppression subtractive hybridization analysis were constructed and identified 277 drought-responsive genes in the two genotypes at 5 and 10 d of drought stress, which were mainly classified into the functional categories of stress defense, metabolism, osmoregulation, membrane system, signal and regulator, structural protein, protein synthesis and degradation, and energy metabolism. Quantitative-PCR analysis confirmed the expression of 36 drought up-regulated genes that were more highly expressed in drought-tolerant 'Tifway' than drought-sensitive 'C299', including those for drought avoidance traits, such as cuticle wax formation (CER1 and sterol desaturase), for drought tolerance traits, such as dehydration-protective proteins (dehydrins, HVA-22-like protein) and oxidative stress defense (superoxide dismutase, dehydroascorbate reductase, 2-Cys peroxiredoxins), and for stress signaling (EREBP-4 like protein and WRKY transcription factor). The results suggest that the expression of genes for stress signaling, cuticle wax accumulation, antioxidant defense, and dehydration-protective protein accumulation could be critically important for warm-season perennial grass adaptation to long-term drought stress.	[Zhou, Peng; An, Yuan; Wang, Zhaolong; Du, Hongmei] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Zhou, Peng; Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Shanghai Jiao Tong University; Rutgers State University New Brunswick	Huang, BR (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	huang@aesop.rutgers.edu	Wang, Zhaolong/I-5598-2019	Wang, Zhaolong/0000-0001-5843-8687	Joint Research Fund for the Chinese Natural Science Foundation [31128016]; Chinese Natural Science Foundation Projects [31072071, 31272198]	Joint Research Fund for the Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Natural Science Foundation Projects	The authors wish to thank the Joint Research Fund for the Chinese Natural Science Foundation (Grant No. 31128016) and Chinese Natural Science Foundation Projects (Grant No. 31072071 and No. 31272198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; BADWEY JA, 1981, J BIOL CHEM, V256, P3479; Baier M, 1999, PLANT PHYSIOL, V119, P1407, DOI 10.1104/pp.119.4.1407; Blomstedt CK, 1998, AUST J PLANT PHYSIOL, V25, P937, DOI 10.1071/PP98113; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Bravo LA, 2003, PHYSIOL PLANTARUM, V118, P262, DOI 10.1034/j.1399-3054.2003.00060.x; Chen CH, 2009, J AM SOC HORTIC SCI, V134, P22, DOI 10.21273/JASHS.134.1.22; Chen D, 2008, ACTA PHYSIOL PLANT, V30, P183, DOI 10.1007/s11738-007-0107-5; Chen Z, 2006, PLANT PHYSIOL, V142, P775, DOI 10.1104/pp.106.085506; Clarke AK, 1999, ANN BOT-LONDON, V83, P593, DOI 10.1006/anbo.1999.0878; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Dastoor Z, 2001, J CELL SCI, V114, P1643; Davies WJ, 2002, NEW PHYTOL, V153, P449, DOI 10.1046/j.0028-646X.2001.00345.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gaff DF, 1997, AUST J PLANT PHYSIOL, V24, P617, DOI 10.1071/PP96073; Gorantla M, 2007, J EXP BOT, V58, P253, DOI 10.1093/jxb/erl213; Hancock JT, 2005, PLANT PHYSIOL BIOCH, V43, P828, DOI 10.1016/j.plaphy.2005.07.012; Hanna W., 1998, GOLF COURSE MANAGE, V66, P49; Hara M, 2001, J PLANT PHYSIOL, V158, P1333, DOI 10.1078/0176-1617-00600; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hincha DK, 2004, BIOCHEM J, V383, P277, DOI 10.1042/BJ20040746; Hu LX, 2010, J PLANT PHYSIOL, V167, P103, DOI 10.1016/j.jplph.2009.07.008; Hu LX, 2009, CROP SCI, V49, P1902, DOI 10.2135/cropsci2008.12.0697; Islam MA, 2009, PLANT MOL BIOL, V70, P443, DOI 10.1007/s11103-009-9483-0; Jewell MC, 2012, CROP SCI, V52, P879, DOI 10.2135/cropsci2011.09.0497; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Lai LB, 2002, PLANT PHYSIOL, V128, P140, DOI 10.1104/pp.010449; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mundree Sagadevan G., 2002, African Journal of Biotechnology, V1, P28; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Nilsen ET, 1996, FIELD CROP RES, P192; Oliver MJ, 2000, PLANT ECOL, V151, P85, DOI 10.1023/A:1026550808557; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; RoyChoudhury A, 2008, PLANT CELL REP, V27, P779, DOI 10.1007/s00299-007-0498-1; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Shen QX, 2001, PLANT MOL BIOL, V45, P327, DOI 10.1023/A:1006460231978; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Somssich I. E., 2006, Regulation of transcription in plants, P266; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; TALIAFERRO CM, 1995, CROP SCI, V35, P327, DOI 10.2135/cropsci1995.0011183X003500020006x; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Watt DA, 2003, J EXP BOT, V54, P1163, DOI 10.1093/jxb/erg128; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Wu YQ, 2007, CROP SCI, V47, P1985, DOI 10.2135/cropsci2007.01.0047; Xue GP, 2008, PLANT MOL BIOL, V67, P197, DOI 10.1007/s11103-008-9311-y; Yang JC, 2001, AGRON J, V93, P196, DOI 10.2134/agronj2001.931196x; Zhang Y, 2005, J EXP BOT, V56, P897, DOI 10.1093/jxb/eri082; Zhao Y, 2011, PHYSIOL PLANTARUM, V141, P40, DOI 10.1111/j.1399-3054.2010.01419.x	58	18	19	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103611	10.1371/journal.pone.0103611	http://dx.doi.org/10.1371/journal.pone.0103611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153119	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200008
J	Shimazu, T; Barjau, J; Sohtome, Y; Sodeoka, M; Shinkai, Y				Shimazu, Tadahiro; Barjau, Joaquin; Sohtome, Yoshihiro; Sodeoka, Mikiko; Shinkai, Yoichi			Selenium-Based S-Adenosylmethionine Analog Reveals the Mammalian Seven-Beta-Strand Methyltransferase METTL10 to Be an EF1A1 Lysine Methyltransferase	PLOS ONE			English	Article							BIOORTHOGONAL CHEMICAL REPORTERS; PROTEIN METHYLATION; HISTONE METHYLTRANSFERASE; IDENTIFICATION; RNA; REPLICATION; THINKING; HSP90; CELLS; YEAST	Lysine methylation has been extensively studied in histones, where it has been shown to provide specific epigenetic marks for the regulation of gene expression; however, the molecular mechanism and physiological function of lysine methylation in proteins other than histones remains to be fully addressed. To better understand the substrate diversity of lysine methylation, S-adenosylmethionine (SAM) derivatives with alkyne-moieties have been synthesized. A selenium-based SAM analog, propargylic Se-adenosyl-L-selenomethionine (ProSeAM), has a wide spectrum of reactivity against various lysine methyltransferases (KMTs) with sufficient stability to support enzymatic reactions in vitro. By using ProSeAM as a chemical probe for lysine methylation, we identified substrates for two seven-beta-strand KMTs, METTL21A and METTL10, on a proteomic scale in mammalian cells. METTL21A has been characterized as a heat shock protein (HSP)-70 methyltransferase. Mammalian METTL10 remains functionally uncharacterized, although its ortholog in yeast, See1, has been shown to methylate the translation elongation factor eEF1A. By using ProSeAM-mediated alkylation followed by purification and quantitative MS analysis, we confirmed that METTL21A labels HSP70 family proteins. Furthermore, we demonstrated that METTL10 also methylates the eukaryotic elongation factor EF1A1 in mammalian cells. Subsequent biochemical characterization revealed that METTL10 specifically trimethylates EF1A1 at lysine 318 and that siRNA-mediated knockdown of METTL10 decreases EF1A1 methylation levels in vivo. Thus, our study emphasizes the utility of the synthetic cofactor ProSeAM as a chemical probe for the identification of non-histone substrates of KMTs.	[Shimazu, Tadahiro; Shinkai, Yoichi] RIKEN, Cellular Memory Lab, Wako, Saitama, Japan; [Barjau, Joaquin; Sohtome, Yoshihiro; Sodeoka, Mikiko] RIKEN, Synthet Organ Chem Lab, Wako, Saitama, Japan	RIKEN; RIKEN	Shinkai, Y (corresponding author), RIKEN, Cellular Memory Lab, Wako, Saitama, Japan.	yshinkai@riken.jp	Shinkai, Yoichi/N-3909-2014; SHIMAZU, Tadahiro/ABC-3950-2020; Sodeoka, Mikiko/A-9952-2008; Sohtome, Yoshihiro/F-8010-2012	Shinkai, Yoichi/0000-0002-6051-2484; Sodeoka, Mikiko/0000-0002-1344-364X; Sohtome, Yoshihiro/0000-0002-9165-6720	RIKEN's Strategic Programs for R&D "Inter-disciplinary and beyond-/cross-hierarchy research to elucidate higher biological functions"	RIKEN's Strategic Programs for R&D "Inter-disciplinary and beyond-/cross-hierarchy research to elucidate higher biological functions"	This work was supported by a RIKEN's Strategic Programs for R&D "Inter-disciplinary and beyond-/cross-hierarchy research to elucidate higher biological functions.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; Binda O, 2011, CHEMBIOCHEM, V12, P330, DOI 10.1002/cbic.201000433; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLUMENTHAL T, 1976, J BIOL CHEM, V251, P2740; Bothwell IR, 2012, J AM CHEM SOC, V134, P14905, DOI 10.1021/ja304782r; Brinton MA, 2001, ANN NY ACAD SCI, V951, P207; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Chang PV, 2009, ANGEW CHEM INT EDIT, V48, P4030, DOI 10.1002/anie.200806319; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; DEVER TE, 1989, J BIOL CHEM, V264, P20518; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Grosshans H, 2000, J STRUCT BIOL, V129, P288, DOI 10.1006/jsbi.2000.4226; Guo A, 2013, MOL CELLULAR PROTEOM; Hang HC, 2011, ACCOUNTS CHEM RES, V44, P699, DOI 10.1021/ar200063v; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Li ZH, 2014, VIROLOGY, V448, P43, DOI 10.1016/j.virol.2013.09.012; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Nishikiori M, 2006, J VIROL, V80, P8459, DOI 10.1128/JVI.00545-06; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tollervey JR, 2012, EPIGENETICS-US, V7, P823, DOI 10.4161/epi.21141; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Vermillion KL, 2014, J CELL BIOL, V204, P95, DOI 10.1083/jcb.201306071; Wang R, 2013, CURR OPIN CHEM BIOL, V17, P729, DOI 10.1016/j.cbpa.2013.08.007; Willnow S, 2012, CHEMBIOCHEM, V13, P1167, DOI 10.1002/cbic.201100781; Yang YY, 2010, J AM CHEM SOC, V132, P3640, DOI 10.1021/ja908871t	45	66	68	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105394	10.1371/journal.pone.0105394	http://dx.doi.org/10.1371/journal.pone.0105394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144183	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100061
J	Takei, H; Morishita, S; Araki, M; Edahiro, Y; Sunami, Y; Hironaka, Y; Noda, N; Sekiguchi, Y; Tsuneda, S; Ohsaka, A; Komatsu, N				Takei, Hiraku; Morishita, Soji; Araki, Marito; Edahiro, Yoko; Sunami, Yoshitaka; Hironaka, Yumi; Noda, Naohiro; Sekiguchi, Yuji; Tsuneda, Satoshi; Ohsaka, Akimichi; Komatsu, Norio			Detection of MPLW515L/K Mutations and Determination of Allele Frequencies with a Single-Tube PCR Assay	PLOS ONE			English	Article							CHRONIC MYELOPROLIFERATIVE DISORDERS; JAK2 V617F MUTATION; ESSENTIAL THROMBOCYTHEMIA; MARROW FIBROSIS; NEOPLASMS; MPL; MYELOFIBROSIS; BURDEN; PROBES	A gain-of-function mutation in the myeloproliferative leukemia virus (MPL) gene, which encodes the thrombopoietin receptor, has been identified in patients with essential thrombocythemia and primary myelofibrosis, subgroups of classic myeloproliferative neoplasms (MPNs). The presence of MPL gene mutations is a critical diagnostic criterion for these diseases. Here, we developed a rapid, simple, and cost-effective method of detecting two major MPL mutations, MPLW515L/K, in a single PCR assay; we termed this method DARMS (dual amplification refractory mutation system)-PCR. DARMS-PCR is designed to produce three different PCR products corresponding to MPLW515L, MPLW515K, and all MPL alleles. The amplicons are later detected and quantified using a capillary sequencer to determine the relative frequencies of the mutant and wild-type alleles. Applying DARMS-PCR to human specimens, we successfully identified MPL mutations in MPN patients, with the exception of patients bearing mutant allele frequencies below the detection limit (5%) of this method. The MPL mutant allele frequencies determined using DARMS-PCR correlated strongly with the values determined using deep sequencing. Thus, we demonstrated the potential of DARMS-PCR to detect MPL mutations and determine the allele frequencies in a timely and cost-effective manner.	[Takei, Hiraku; Edahiro, Yoko; Sunami, Yoshitaka; Hironaka, Yumi; Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan; [Takei, Hiraku; Tsuneda, Satoshi] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Morishita, Soji; Araki, Marito; Ohsaka, Akimichi] Juntendo Univ, Grad Sch Med, Dept Transfus Med & Stem Cell Regulat, Tokyo, Japan; [Noda, Naohiro; Sekiguchi, Yuji] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Ibaraki, Japan	Juntendo University; Waseda University; Juntendo University; National Institute of Advanced Industrial Science & Technology (AIST)	Komatsu, N (corresponding author), Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan.	komatsun@juntendo.ac.jp	NODA, Naohiro/M-2383-2018; Araki, Marito/T-4283-2019	NODA, Naohiro/0000-0001-7592-5495; Araki, Marito/0000-0002-3502-5000	Japan Society for the promotion of science (JSPS) KAKENHI [25860416]	Japan Society for the promotion of science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Japan Society for the promotion of science (JSPS) (http://www.jsps.go.jp/english/e-grants/) KAKENHI grant #25860416 (SM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioli E, 2005, LEUKEMIA, V19, P1847, DOI 10.1038/sj.leu.2403902; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; Chaligne R, 2008, LEUKEMIA, V22, P1557, DOI 10.1038/leu.2008.137; Edahiro Y, 2014, INT J HEMATOL, V99, P625, DOI 10.1007/s12185-014-1567-1; Guglielmelli P, 2014, AM J HEMATOL; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Lee TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023396; Milosevic JD, 2013, INT J HEMATOL, V97, P183, DOI 10.1007/s12185-012-1235-2; Morishita S, 2011, LEUKEMIA RES, V35, P1632, DOI 10.1016/j.leukres.2011.06.016; Pancrazzi A, 2008, J MOL DIAGN, V10, P435, DOI 10.2353/jmoldx.2008.080015; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pietra D, 2011, HAEMATOL-HEMATOL J, V96, P607, DOI 10.3324/haematol.2010.034793; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Ruan GR, 2010, HEMATOL ONCOL, V28, P33, DOI 10.1002/hon.899; Rumi E, 2013, BLOOD, V121, P4388, DOI 10.1182/blood-2013-02-486050; Schnittger S, 2009, HAEMATOL-HEMATOL J, V94, P141, DOI 10.3324/haematol.13224; Skoda RC, 2010, BLOOD, V116, P1392, DOI 10.1182/blood-2010-06-287318; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Teofili L, 2010, HAEMATOL-HEMATOL J, V95, P65, DOI 10.3324/haematol.2009.007542; Vannucchi AM, 2006, LEUKEMIA, V20, P1055, DOI 10.1038/sj.leu.2404209	22	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104958	10.1371/journal.pone.0104958	http://dx.doi.org/10.1371/journal.pone.0104958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144224	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100032
J	Gilley, DC				Gilley, David C.			Hydrocarbons Emitted by Waggle-Dancing Honey Bees Increase Forager Recruitment by Stimulating Dancing	PLOS ONE			English	Article							STINGLESS BEE; FOOD SOURCES; SCENT MARKS; INFORMATION-FLOW; FLORAL ODORS; COMMUNICATION; BUMBLEBEES; HYMENOPTERA; PHEROMONE; BEHAVIOR	Hydrocarbons emitted by waggle-dancing honey bees are known to reactivate experienced foragers to visit known food sources. This study investigates whether these hydrocarbons also increase waggle-dance recruitment by observing recruitment and dancing behavior when the dance compounds are introduced into the hive. If the hydrocarbons emitted by waggle-dancing bees affect the recruitment of foragers to a food source, then the number of recruits arriving at a food source should be greater after introduction of dance compounds versus a pure-solvent control. This prediction was supported by the results of experiments in which recruits were captured at a feeder following introduction of dance-compounds into a hive. This study also tested two nonexclusive behavioral mechanism(s) by which the compounds might stimulate recruitment; 1) increased recruitment could occur by means of increasing the recruitment effectiveness of each dance and/or 2) increased recruitment could occur by increasing the intensity of waggle-dancing. These hypotheses were tested by examining video records of the dancing and recruitment behavior of individually marked bees following dance-compound introduction. Comparisons of numbers of dance followers and numbers of recruits per dance and waggle run showed no significant differences between dance-compound and solvent-control introduction, thus providing no support for the first hypothesis. Comparison of the number of waggle-dance bouts and the number of waggle runs revealed significantly more dancing during morning dance-compound introduction than morning solvent-control introduction, supporting the second hypothesis. These results suggest that the waggle-dance hydrocarbons play an important role in honey bee foraging recruitment by stimulating foragers to perform waggle dances following periods of inactivity.	William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA		Gilley, DC (corresponding author), William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA.	gilleyd@wpunj.edu			Center for Research, College of Science and Health, William Paterson University of New Jersey; Assigned Release Time Program of William Paterson University	Center for Research, College of Science and Health, William Paterson University of New Jersey; Assigned Release Time Program of William Paterson University	This research was supported by grants from the Center for Research, College of Science and Health, William Paterson University of New Jersey, and by the Assigned Release Time Program of William Paterson University. Erin Crehan Raza Elias, Roy Feliciano, Brian Johnson, Jessika Santamaria, employed by the William Paterson University College of Science and Health, helped collect and analyze the data for this research. Field experiments were conducted on land owned by LANXESS Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2007, NATURWISSENSCHAFTEN, V94, P218, DOI 10.1007/s00114-006-0176-0; Beekman M, 2005, J COMP PHYSIOL A, V191, P1115, DOI 10.1007/s00359-005-0033-1; Biesmeijer JC, 2004, APIDOLOGIE, V35, P143, DOI 10.1051/apido:2004003; Breed MD, 1998, BIOSCIENCE, V48, P463, DOI 10.2307/1313244; CAMERON SA, 1981, BEHAV ECOL SOCIOBIOL, V9, P257, DOI 10.1007/BF00299880; Diaz PC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1589, DOI 10.1007/s00265-007-0391-5; Dornhaus A, 2004, BEHAV ECOL SOCIOBIOL, V55, P395, DOI 10.1007/s00265-003-0726-9; Dornhaus A, 2003, APIDOLOGIE, V34, P87, DOI 10.1051/apido:2002045; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Farina WM, 2005, P ROY SOC B-BIOL SCI, V272, P1923, DOI 10.1098/rspb.2005.3172; FERGUSON AW, 1979, J APICULT RES, V18, P128, DOI 10.1080/00218839.1979.11099956; Fernandez PC, 2001, INSECT SOC, V48, P366, DOI 10.1007/PL00001793; Free J. B., 1987, PHEROMONES SOCIAL BE; FREE JB, 1972, BEHAVIOUR, V41, P314, DOI 10.1163/156853972X00086; FREE JB, 1983, J APICULT RES, V22, P86, DOI 10.1080/00218839.1983.11100564; FREE JB, 1982, J APICULT RES, V21, P151, DOI 10.1080/00218839.1982.11100532; Gilley DC, 2012, APIDOLOGIE, V43, P85, DOI 10.1007/s13592-011-0080-2; GIURFA M, 1993, INSECT SOC, V40, P59, DOI 10.1007/BF01338832; GOULD JL, 1970, SCIENCE, V169, P544, DOI 10.1126/science.169.3945.544; GOULD JL, 1976, Q REV BIOL, V51, P211, DOI 10.1086/409309; Goulson D, 2000, J CHEM ECOL, V26, P2897, DOI 10.1023/A:1026406330348; Goulson D, 2001, J INSECT BEHAV, V14, P669, DOI 10.1023/A:1012231419067; HOWARD RW, 1982, ANNU REV ENTOMOL, V27, P149, DOI 10.1146/annurev.en.27.010182.001053; Hrncir M, 2004, APIDOLOGIE, V35, P3, DOI 10.1051/apido:2003069; Jarau S, 2004, J CHEM ECOL, V30, P793, DOI 10.1023/B:JOEC.0000028432.29759.ed; KERR WE, 1994, J INSECT BEHAV, V7, P123, DOI 10.1007/BF01989832; Kirchner WH, 1998, J INSECT BEHAV, V11, P169, DOI 10.1023/A:1021098405564; LINDAUER M, 1971, AM NAT, V105, P89, DOI 10.1086/282708; LINDAUER M., 1960, BEE WORLD, V41, P29; Nieh JC, 2004, BEHAV ECOL SOCIOBIOL, V56, P435, DOI 10.1007/s00265-004-0804-7; OLDHAM NJ, 1994, PHYSIOL ENTOMOL, V19, P115, DOI 10.1111/j.1365-3032.1994.tb01084.x; Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a; Renner MA, 2008, INSECT SOC, V55, P417, DOI 10.1007/s00040-008-1021-6; Ribbands C. R., 1954, Proceedings of the Royal Entomological Society of London (A), V29, P141; Saleh N, 2007, ARTHROPOD-PLANT INTE, V1, P119, DOI 10.1007/s11829-007-9011-6; Schmitt T, 2007, APIDOLOGIE, V38, P164, DOI 10.1051/apido:2006067; Schmitt U., 1991, Chemoecology, V2, P35, DOI 10.1007/BF01240664; SCHMITT U, 1990, OECOLOGIA, V82, P137, DOI 10.1007/BF00318545; Seeley TD, 1998, APIDOLOGIE, V29, P67, DOI 10.1051/apido:19980104; Stout JC, 1998, BEHAV ECOL SOCIOBIOL, V43, P317, DOI 10.1007/s002650050497; Stout JC, 2001, ANIM BEHAV, V62, P183, DOI 10.1006/anbe.2001.1729; Thom C, 2007, PLOS BIOL, V5, P1862, DOI 10.1371/journal.pbio.0050228; VALLET A, 1991, J INSECT PHYSIOL, V37, P789, DOI 10.1016/0022-1910(91)90076-C; von Frisch K., 1967, DANCE LANGUAGE ORIEN; VONFRISCH K, 1967, SCIENCE, V158, P1072; WENNER AM, 1969, SCIENCE, V164, P84, DOI 10.1126/science.164.3875.84; West B. T., 2006, LINEAR MIXED MODELS, P180	49	10	11	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105671	10.1371/journal.pone.0105671	http://dx.doi.org/10.1371/journal.pone.0105671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140740	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200119
J	Rejno, G; Lundholm, C; Gong, T; Larsson, K; Saltvedt, S; Almqvist, C				Rejno, Gustaf; Lundholm, Cecilia; Gong, Tong; Larsson, Kjell; Saltvedt, Sissel; Almqvist, Catarina			Asthma during Pregnancy in a Population-Based Study Pregnancy Complications and Adverse Perinatal Outcomes	PLOS ONE			English	Article							MATERNAL ASTHMA; ANTIASTHMATIC DRUGS; INTRAUTERINE GROWTH; WOMEN; SEVERITY; RISK; EXACERBATIONS; VALIDATION; DISEASE; RACE	Background: Asthma is one of the most common chronic diseases, and prevalence, severity and medication may have an effect on pregnancy. We examined maternal asthma, asthma severity and control in relation to pregnancy complications, labour characteristics and perinatal outcomes. Methods: We retrieved data on all singleton births from July 1, 2006 to December 31, 2009, and prescribed drugs and physician-diagnosed asthma on the same women from multiple Swedish registers. The associations were estimated with logistic regression. Results: In total, 266 045 women gave birth to 284 214 singletons during the study period. Maternal asthma was noted in 26 586 (9.4%) pregnancies. There was an association between maternal asthma and increased risks of pregnancy complications including preeclampsia or eclampsia (adjusted OR 1.15; 95% CI 1.06-1.24) and premature contractions (adj OR 1.52; 95% CI 1.29-1.80). There was also a significant association between maternal asthma and emergency caesarean section (adj OR 1.29; 95% CI 1.23-1.34), low birth weight, and small for gestational age (adj OR 1.23; 95% CI 1.13-1.33). The risk of adverse outcomes such as low birth weight increased with increasing asthma severity. For women with uncontrolled compared to those with controlled asthma the results for adverse outcomes were inconsistent displaying both increased and decreased OR for some outcomes. Conclusion: Maternal asthma is associated with a number of serious pregnancy complications and adverse perinatal outcomes. Some complications are even more likely with increased asthma severity. With greater awareness and proper management, outcomes would most likely improve.	[Rejno, Gustaf; Lundholm, Cecilia; Gong, Tong; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Rejno, Gustaf] Soder Sjukhuset, Obstet & Gynaecol Unit, Stockholm, Sweden; [Larsson, Kjell] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Saltvedt, Sissel] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Saltvedt, Sissel] Karolinska Univ Hosp, Obstet & Gynaecol Unit, Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Rejno, G (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	gustaf.rejno@ki.se	Rejnö, Gustaf/N-7198-2014; Gong, Tong/HDM-8653-2022	Rejnö, Gustaf/0000-0002-8095-5629; Lundholm, Cecilia/0000-0002-6546-3650	Stockholm County Council; Karolinska Institutet; Swedish Research Council [2011-3060]; Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) [340-2013-5867]; Swedish Heart-Lung Foundation; Strategic Research Program in Epidemiology at Karolinska Institutet	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Strategic Research Program in Epidemiology at Karolinska Institutet	This work was supported by the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet (http://www.forskningsstod.sll.se), the Swedish Research Council (http://www.vr.se/) [grant number 2011-3060] and through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework (http://simsam.nu/) [grant number 340-2013-5867], the Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se/HLF/Om-Hjart-lungfonden/About-HLF/), and the Strategic Research Program in Epidemiology at Karolinska Institutet (http://ki.se/en/research/the-strategic-research-programme-in-epidemiology-sfoepi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 1998, OBSTET GYNECOL, V92, P435, DOI 10.1016/S0029-7844(98)00191-4; Aly H, 2011, EARLY HUM DEV, V87, P457, DOI 10.1016/j.earlhumdev.2011.03.007; Axelsson O, 2003, ACTA OBSTET GYN SCAN, V82, P491, DOI 10.1034/j.1600-0412.2003.00172.x; BAHNA SL, 1972, ACTA ALLERGOL, V27, P397, DOI 10.1111/j.1398-9995.1972.tb01439.x; Borthen I, 2011, BJOG-INT J OBSTET GY, V118, P956, DOI 10.1111/j.1471-0528.2011.03004.x; Breton MC, 2009, THORAX, V64, P101, DOI 10.1136/thx.2008.102970; Clifton VL, 2009, AUST NZ J OBSTET GYN, V49, P619, DOI 10.1111/j.1479-828X.2009.01077.x; Dombrowski MP, 2004, OBSTET GYNECOL, V103, P5, DOI 10.1097/01.AOG.0000103994.75162.16; DOUCETTE JT, 1993, EPIDEMIOLOGY, V4, P143, DOI 10.1097/00001648-199303000-00010; Enriquez R, 2007, J ALLERGY CLIN IMMUN, V120, P625, DOI 10.1016/j.jaci.2007.05.044; Firoozi F, 2007, THORAX, V62, P581, DOI 10.1136/thx.2006.061572; Getahun D, 2006, AM J OBSTET GYNECOL, V195, P1180, DOI 10.1016/j.ajog.2006.07.027; Global Initiative for Asthma (GINA), 2012, GLOB STRAT ASTHM MAN; Kallen B, 2000, EUR J EPIDEMIOL, V16, P167, DOI 10.1023/A:1007678404911; Kallen B, 2007, EUR J CLIN PHARMACOL, V63, P363, DOI 10.1007/s00228-006-0257-1; Kallen B, 2007, EUR J CLIN PHARMACOL, V63, P375, DOI 10.1007/s00228-006-0258-0; KRAMER MS, 1995, AM J EPIDEMIOL, V142, P1078, DOI 10.1093/oxfordjournals.aje.a117561; Kwon HL, 2003, ANN EPIDEMIOL, V13, P317, DOI 10.1016/S1047-2797(03)00008-5; Linton A, 2004, BIRTH-ISS PERINAT C, V31, P165, DOI 10.1111/j.0730-7659.2004.00301.x; Liu SL, 2001, AM J OBSTET GYNECOL, V184, P90, DOI 10.1067/mob.2001.108073; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Manderbacka K, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-16; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Murphy VE, 2011, BJOG-INT J OBSTET GY, V118, P1314, DOI 10.1111/j.1471-0528.2011.03055.x; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Namazy JA, 2013, EUR RESPIR J, V41, P1082, DOI 10.1183/09031936.00195111; Ortqvist AK, 2013, PHARMACOEPIDEM DR S, V22, P850, DOI 10.1002/pds.3465; PERLOW JH, 1992, AM J OBSTET GYNECOL, V167, P963, DOI 10.1016/S0002-9378(12)80020-2; Raju TNK, 2006, CLIN PERINATOL, V33, P751, DOI 10.1016/j.clp.2006.09.009; SCHATZ M, 1990, CHEST, V98, P389, DOI 10.1378/chest.98.2.389; SCHATZ M, 1988, Journal of Allergy and Clinical Immunology, V81, P509, DOI 10.1016/0091-6749(88)90187-X; Schatz M, 2003, J ALLERGY CLIN IMMUN, V112, P283, DOI 10.1067/mai.2003.1516; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Sorensen TK, 2003, ANN EPIDEMIOL, V13, P267, DOI 10.1016/S1047-2797(02)00413-1; Stephansson O, 2010, INFLAMM BOWEL DIS; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Stephansson O, 2010, CLIN GASTROENTEROL H, V8, P509, DOI 10.1016/j.cgh.2010.02.014; Swedish National Board of Health and Welfare, 2003, SWED MED BIRTH REG S; Tata LJ, 2007, AM J RESP CRIT CARE, V175, P991, DOI 10.1164/rccm.200611-1641OC; Ungar WJ, 2002, AM J RESP CRIT CARE, V165, P190, DOI 10.1164/ajrccm.165.2.2102012; Wen SW, 2001, ANN EPIDEMIOL, V11, P7, DOI 10.1016/S1047-2797(00)00077-6; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	43	66	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104755	10.1371/journal.pone.0104755	http://dx.doi.org/10.1371/journal.pone.0104755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141021	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200032
J	Chung, FZ; Sahasrabuddhe, AA; Ma, KY; Chen, XF; Basrur, V; Lim, MS; Elenitoba-Johnson, KSJ				Chung, Fu-Zon; Sahasrabuddhe, Anagh A.; Ma, Kaiyu; Chen, Xiaofei; Basrur, Venkatesha; Lim, Megan S.; Elenitoba-Johnson, Kojo S. J.			Fbxo45 Inhibits Calcium-sensitive Proteolysis of N-cadherin and Promotes Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE COMPLEX; STRUCTURAL BASIS; SYNAPTIC ACTIVITY; CELL MOTILITY; DEGRADATION; ADHESION; PROTEIN; DOMAIN; ORGANIZATION; RECOGNITION	Fbxo45 is an atypical E3 ubiquitin ligase, which specifically targets proteins for ubiquitin-mediated degradation. Fbxo45 ablation results in defective neuronal differentiation and abnormal formation of neural connections; however, the mechanisms underlying these defects are poorly understood. Using an unbiased mass spectrometry-based proteomic screen, we show here that N-cadherin is a novel interactor of Fbxo45. N-cadherin specifically interacts with Fbxo45 through two consensus motifs overlapping the site of calcium-binding and dimerization of the cadherin molecule. N-cadherin interaction with Fbxo45 is significantly abrogated by calcium treatment. Surprisingly, Fbxo45 depletion by RNAi-mediated silencing results in enhanced proteolysis of N-cadherin. Conversely, ectopic expression of Fbxo45 results in decreased proteolysis of N-cadherin. Fbxo45 depletion results in dramatic reduction in N-cadherin expression, impaired neuronal differentiation, and diminished formation of neuronal processes. Our studies reveal an unanticipated role for an F-box protein that inhibits proteolysis in the regulation of a critical biological process.	[Chung, Fu-Zon; Sahasrabuddhe, Anagh A.; Ma, Kaiyu; Chen, Xiaofei; Basrur, Venkatesha; Lim, Megan S.; Elenitoba-Johnson, Kojo S. J.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Lim, Megan S.; Elenitoba-Johnson, Kojo S. J.] Univ Michigan, Sch Med, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Elenitoba-Johnson, Kojo S. J.] Univ Michigan, Sch Med, Prot Folding Dis Initiat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Elenitoba-Johnson, KSJ (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 2037 BSRB 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	kojoelen@umich.edu		Sahasrabuddhe, Anagh/0000-0002-3040-0019; Elenitoba-Johnson, Kojo/0000-0002-1082-1545; Lim, Megan/0000-0002-0415-2867	National Institutes of Health [R01 DE119249, R01 CA136905, R01 CA140806]; NATIONAL CANCER INSTITUTE [R01CA136905, R01CA140806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DE119249, R01 CA136905 (to K. S. J. E.-J.), and R01 CA140806 (to M. S. L.).	Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Filippakopoulos P, 2010, J MOL BIOL, V401, P389, DOI 10.1016/j.jmb.2010.06.017; Foster MW, 2013, NITRIC OXIDE-BIOL CH, V34, P37, DOI 10.1016/j.niox.2013.02.079; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kaido M, 2009, GENES CELLS, V14, P1067, DOI 10.1111/j.1365-2443.2009.01335.x; Kawauchi T, 2012, INT J MOL SCI, V13, P4564, DOI 10.3390/ijms13044564; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Kuang ZH, 2009, J MOL BIOL, V386, P662, DOI 10.1016/j.jmb.2008.12.078; Lelievre EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033206; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Marrs GS, 2009, MOL CELL NEUROSCI, V40, P390, DOI 10.1016/j.mcn.2008.12.007; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Nishiya T, 2011, J BIOL CHEM, V286, P9009, DOI 10.1074/jbc.M110.190678; Qian LW, 2008, J VIROL, V82, P11902, DOI 10.1128/JVI.01042-08; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Reines A, 2012, J NEUROSCI, V32, P6323, DOI 10.1523/JNEUROSCI.0916-12.2012; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Su HX, 2013, STEM CELL RES, V10, P338, DOI 10.1016/j.scr.2013.01.003; Suzuki SC, 2008, DEV GROWTH DIFFER, V50, pS119, DOI 10.1111/j.1440-169X.2008.01002.x; Tada H, 2010, J BIOL CHEM, V285, P3840, DOI 10.1074/jbc.M109.046284; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Vunnam N, 2011, BBA-PROTEINS PROTEOM, V1814, P1841, DOI 10.1016/j.bbapap.2011.08.002; Vunnam N, 2011, BIOCHEMISTRY-US, V50, P8437, DOI 10.1021/bi200902s; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Xu X, 2001, J CELL BIOL, V154, P217, DOI 10.1083/jcb.200105047; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Zhang JN, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-7	38	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28448	28459		10.1074/jbc.M114.561241	http://dx.doi.org/10.1074/jbc.M114.561241			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25143387	Green Published, hybrid			2022-12-25	WOS:000343765400037
J	Anwar, N; Rouf, SF; Romling, U; Rhen, M				Anwar, Naeem; Rouf, Syed Fazle; Romling, Ute; Rhen, Mikael			Modulation of Biofilm-Formation in Salmonella enterica Serovar Typhimurium by the Periplasmic DsbA/DsbB Oxidoreductase System Requires the GGDEF-EAL Domain Protein STM3615	PLOS ONE			English	Article							CYCLIC-DI-GMP; ESCHERICHIA-COLI O157-H7; MULTICELLULAR BEHAVIOR; STAPHYLOCOCCUS-AUREUS; EXTRACELLULAR DNA; GENE-EXPRESSION; NITRIC-OXIDE; AGGREGATIVE BEHAVIOR; MATRIX PRODUCTION; RDAR MORPHOTYPE	In Salmonella enterica serovar Typhimurium (S. Typhimurium), biofilm-formation is controlled by the cytoplasmic intracellular small-molecular second messenger cyclic 3', 5'-di-guanosine monophosphate (c-di-GMP) through the activities of GGDEF and EAL domain proteins. Here we describe that deleting either dsbA or dsbB, respectively encoding a periplasmic protein disulfide oxidase and a cytoplasmic membrane disulfide oxidoreductase, resulted in increased biofilm-formation on solid medium. This increased biofilm-formation, defined as a red, dry and rough (rdar) colony morphotype, paralleled with enhanced expression of the biofilm master regulator CsgD and the biofilm-associated fimbrial subunit CsgA. Deleting csgD in either dsb mutant abrogated the enhanced biofilm-formation. Likewise, overexpression of the c-di-GMP phosphodiesterase YhjH, or mutationally inactivating the CsgD activator EAL-domain protein YdiV, reduced biofilm-formation in either of the dsb mutants. Intriguingly, deleting the GGDEF-EAL domain protein gene STM3615 (yhjK), previously not connected to rdar morphotype development, also abrogated the escalated rdar morphotype formation in dsb mutant backgrounds. Enhanced biofilm-formation in dsb mutants was furthermore annulled by exposure to the protein disulfide catalyst copper chloride. When analyzed for the effect of exogenous reducing stress on biofilm-formation, both dsb mutants initially showed an escalated rdar morphotype development that later dissolved to reveal a smooth mucoid colony morphotype. From these results we conclude that biofilm-development in S. Typhimurium is affected by periplasmic protein disulphide bond status through CsgD, and discuss the involvement of selected GGDEF/EAL domain protein(s) as signaling mediators.	[Anwar, Naeem; Rouf, Syed Fazle; Romling, Ute; Rhen, Mikael] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Anwar, Naeem] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan	Karolinska Institutet; Lahore University of Management Sciences	Rouf, SF (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Syed.rouf@gmail.com; mikael.rhen@ki.se	Anwar, Naeem/A-6945-2011	Anwar, Naeem/0000-0001-8638-2158; Romling, Ute/0000-0003-3812-6621	Vetenskapsradet (Swedish Research Council) [VR-2011-3379]	Vetenskapsradet (Swedish Research Council)(Swedish Research Council)	This study was supported by grants from Vetenskapsradet (Swedish Research Council) to MR with grant number VR-2011-3379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Ahmad I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028351; Ahmed I, 2013, THESIS KAROLINSKA I, P27; Anwar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064948; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Aussel L, 2011, MOL MICROBIOL, V80, P628, DOI 10.1111/j.1365-2958.2011.07611.x; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bijtenhoorn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026278; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; BUCHWALD DS, 1984, REV INFECT DIS, V6, P345; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; COLLINSON SK, 1993, J BACTERIOL, V175, P12, DOI 10.1128/JB.175.1.12-18.1993; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; Dinesh SD, 2003, CLIN MICROBIOL INFEC, V9, P1228, DOI 10.1111/j.1469-0691.2003.00793.x; EDELMAN R, 1986, REV INFECT DIS, V8, P329; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; Gast RK, 2013, J FOOD PROTECT, V76, P108, DOI 10.4315/0362-028X.JFP-12-268; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Gerstel U, 2006, FEMS MICROBIOL LETT, V261, P109, DOI 10.1111/j.1574-6968.2006.00332.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jansen A, 2011, ANN EPIDEMIOLOGICAL; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Kim YH, 2006, PROTEOMICS, V6, P6181, DOI 10.1002/pmic.200600320; Kolker S, 2012, CLIN MICROBIOL INFEC, V18, P167, DOI 10.1111/j.1469-0691.2011.03533.x; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee Y, 2008, FEMS MICROBIOL LETT, V278, P213, DOI 10.1111/j.1574-6968.2007.00993.x; Lee Y, 2009, FEMS MICROBIOL LETT, V297, P38, DOI 10.1111/j.1574-6968.2009.01650.x; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; Lin DX, 2009, MICROBIOL-SGM, V155, P4014, DOI 10.1099/mic.0.032904-0; Lippa AM, 2012, J BACTERIOL, V194, P1457, DOI 10.1128/JB.06055-11; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Negrea A, 2009, J BACTERIOL, V191, P6918, DOI 10.1128/JB.00532-09; Ogasawara H, 2007, J BACTERIOL, V189, P4791, DOI 10.1128/JB.00319-07; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; Pang T, 1998, TRENDS MICROBIOL, V6, P131, DOI 10.1016/S0966-842X(98)01236-0; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Romling U, 2003, INT J MED MICROBIOL, V293, P273, DOI 10.1078/1438-4221-00268; Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Romling U, 1999, FEMS MICROBIOL LETT, V180, P91; Romling U., 2003, MED IMPLICATIONS BIO, P231; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ruby T, 2012, FEMS MICROBIOL REV, V36, P600, DOI 10.1111/j.1574-6976.2012.00332.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sambrook J, 2001, MOL CLONING, V3; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Simm R, 2007, J BACTERIOL, V189, P3613, DOI 10.1128/JB.01719-06; Simm R, 2009, J BACTERIOL, V191, P3928, DOI 10.1128/JB.00290-09; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Suo YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048467; Tagliabue L, 2010, FEMS IMMUNOL MED MIC, V59, P477, DOI 10.1111/j.1574-695X.2010.00702.x; TINGE SA, 1990, J BACTERIOL, V172, P5266, DOI 10.1128/jb.172.9.5266-5277.1990; Vianney A, 2005, MICROBIOL-SGM, V151, P2487, DOI 10.1099/mic.0.27913-0; Wang SY, 2010, APPL ENVIRON MICROB, V76, P5013, DOI 10.1128/AEM.00823-10; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Zakikhany K, 2010, MOL MICROBIOL, V77, P771, DOI 10.1111/j.1365-2958.2010.07247.x; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	86	25	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106095	10.1371/journal.pone.0106095	http://dx.doi.org/10.1371/journal.pone.0106095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153529	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200115
J	Ren, JY; Cone, A; Willmot, R; Jones, IM				Ren, Junyuan; Cone, Abigail; Willmot, Rebecca; Jones, Ian M.			Assembly of Recombinant Israeli Acute Paralysis Virus Capsids	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; VESICULAR DISEASE VIRUS; APIS-MELLIFERA; HONEY-BEE; VARROA-DESTRUCTOR; GENETIC-ANALYSIS; BACULOVIRUS; EXPRESSION; PROTEINS; PREVALENCE	The dicistrovirus Israeli Acute Paralysis Virus (IAPV) has been implicated in the worldwide decline of honey bees. Studies of IAPV and many other bee viruses in pure culture are restricted by available isolates and permissive cell culture. Here we show that coupling the IAPV major structural precursor protein ORF2 to its cognate 3C-like processing enzyme results in processing of the precursor to the individual structural proteins in a number of insect cell lines following expression by a recombinant baculovirus. The efficiency of expression is influenced by the level of IAPV 3C protein and moderation of its activity is required for optimal expression. The mature IAPV structural proteins assembled into empty capsids that migrated as particles on sucrose velocity gradients and showed typical dicistrovirus like morphology when examined by electron microscopy. Monoclonal antibodies raised to recombinant capsids were configured into a diagnostic test specific for the presence of IAPV. Recombinant capsids for each of the many bee viruses within the picornavirus family may provide virus specific reagents for the on-going investigation of the causes of honeybee loss.	[Ren, Junyuan; Cone, Abigail; Willmot, Rebecca; Jones, Ian M.] Univ Reading, Sch Biol Sci, Reading, Berks, England	University of Reading	Jones, IM (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	i.m.jones@rdg.ac.uk		Jones, Ian/0000-0002-7738-2516	UK Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/G02040X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G02040X/1] Funding Source: researchfish; Medical Research Council [979666] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC), www.bbsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2003, VIROLOGY, V308, P157, DOI 10.1016/S0042-6822(02)00141-1; Agirre J, 2011, VIROLOGY, V409, P91, DOI 10.1016/j.virol.2010.09.034; Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; Anderson D, 2008, SCIENCE, V319, P724, DOI 10.1126/science.319.5864.724c; Antunez K, 2012, RES VET SCI, V93, P1441, DOI 10.1016/j.rvsc.2012.03.006; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Blanchard P, 2008, J INVERTEBR PATHOL, V99, P348, DOI 10.1016/j.jip.2008.07.006; BRAUTIGAM S, 1993, VIROLOGY, V192, P512, DOI 10.1006/viro.1993.1067; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cornman RS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-154; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Dinman JD, 2012, ADV PROTEIN CHEM STR, V86, P129, DOI 10.1016/B978-0-12-386497-0.00004-9; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Ferris NP, 2010, J VIROL METHODS, V163, P477, DOI 10.1016/j.jviromet.2009.09.023; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Ghildyal R, 2009, J VIROL, V83, P7349, DOI 10.1128/JVI.01748-08; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Hunter WB, 2010, IN VITRO CELL DEV-AN, V46, P83, DOI 10.1007/s11626-009-9246-x; Kitagishi Y, 2011, IN VITRO CELL DEV-AN, V47, P451, DOI 10.1007/s11626-011-9431-6; Ko YJ, 2005, CLIN DIAGN LAB IMMUN, V12, P922, DOI 10.1128/CDLI.12.8.922-929.2005; Kojima Y, 2011, MICROB ECOL, V62, P895, DOI 10.1007/s00248-011-9947-z; Levy S, 2011, NATURE, V479, P164, DOI 10.1038/479164a; Li ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077354; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002273; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Oem JK, 2007, VACCINE, V25, P4112, DOI 10.1016/j.vaccine.2006.08.046; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Pengelley SC, 2006, PROTEIN EXPRES PURIF, V48, P173, DOI 10.1016/j.pep.2006.04.016; Porta Claudine, 2013, J Virol Methods, V187, P406, DOI 10.1016/j.jviromet.2012.11.011; Porta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003255; Reynaldi FJ, 2011, REV ARGENT MICROBIOL, V43, P84, DOI 10.1590/S0325-75412011000200003; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Squires G, 2013, ACTA CRYSTALLOGR D, V69, P1026, DOI 10.1107/S0907444913004617; Tate J, 1999, NAT STRUCT BIOL, V6, P765, DOI 10.1038/11543; Tomkies V, 2009, APIDOLOGIE, V40, P63, DOI 10.1051/apido:2008060; Valles SM, 2008, VIRUS RES, V136, P189, DOI 10.1016/j.virusres.2008.04.009; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7; Xie L, 2009, SCI CHINA SER C, V52, P1186, DOI 10.1007/s11427-009-0151-z; Yang B, 2013, ECOL EVOL, V3, P298, DOI 10.1002/ece3.464; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	50	4	4	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105943	10.1371/journal.pone.0105943	http://dx.doi.org/10.1371/journal.pone.0105943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153716	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000340952200092
J	Tseng, SP; Tsai, WC; Liang, CY; Lin, YS; Huang, JW; Chang, CY; Tyan, YC; Lu, PL				Tseng, Sung-Pin; Tsai, Wan-Chi; Liang, Chih-Yuan; Lin, Yin-Shiou; Huang, Jun-Wei; Chang, Chung-Yu; Tyan, Yu-Chang; Lu, Po-Liang			The Contribution of Antibiotic Resistance Mechanisms in Clinical Burkholderia cepacia Complex Isolates: An Emphasis on Efflux Pump Activity	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; CENOCEPACIA; BACTEREMIA; GENE; IDENTIFICATION; VIETNAMIENSIS; EPIDEMIOLOGY; INTEGRONS	Due to the limited information of the contribution of various antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates, Antibiotic resistance mechanisms, including integron analysis, identification of quinolone resistance-determining region mutations, measurement of efflux pump activity, and sequence analysis of efflux pump regulators, were investigated in 66 clinical B. cepacia complex isolates. Species were identified via recA-RFLP and MALDI-TOF. Four genomovars were identified by recA-RFLP. B. cenocepacia (genomovar III) was the most prevalent genomovar (90.1%). Most isolates (60/66, 90.9%) were correctly identified by MALDI-TOF analysis. Clonal relatedness determined by PFGE analysis revealed 30 pulsotypes, including two major pulsotypes that comprised 22.7% and 18.2% of the isolates, respectively. Seventeen (25.8%) isolates harboured class 1 integron with various combinations of resistance genes. Among six levofloxacin-resistant isolates, five had single-base substitutions in the gyrA gene and three demonstrated efflux pump activities. Among the 42 isolates exhibiting resistance to at least one antimicrobial agent, 94.4% ceftazidime-resistant isolates (17/18) and 72.7% chloramphenicol-resistant isolates (16/22) demonstrated efflux pump activity. Quantitation of efflux pump RNA level and sequence analysis revealed that over-expression of the RND-3 efflux pump was attributable to specific mutations in the RND-3 efflux pump regulator gene. In conclusion, high-level expression of efflux pumps is prevalent in B. cepacia complex isolates. Mutations in the RND-3 efflux pump regulator gene are the major cause of efflux pump activity, resulting in the resistance to antibiotics in clinical B. cepacia complex isolates.	[Tseng, Sung-Pin; Tsai, Wan-Chi; Liang, Chih-Yuan; Lin, Yin-Shiou; Huang, Jun-Wei] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Tseng, Sung-Pin; Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Chang, Chung-Yu; Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lu, PL (corresponding author), Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.	d830166@cc.kmu.edu.tw	Lu, Po-Liang/D-4499-2009	Lu, Po-Liang/0000-0002-7423-6783; Tseng, sung-pin/0000-0001-8915-5268	Kaohsiung Medical University Research Foundation [KMU-Q102005]; NSYSU-KMU Joint Research Project, Taiwan [NSYSUKMU102-I004]	Kaohsiung Medical University Research Foundation; NSYSU-KMU Joint Research Project, Taiwan	This work was supported by KMU-Q102005 from Kaohsiung Medical University Research Foundation and NSYSUKMU102-I004 from the NSYSU-KMU Joint Research Project, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewoye L, 2002, J BACTERIOL, V184, P4308, DOI 10.1128/JB.184.15.4308-4312.2002; ARONOFF SC, 1988, ANTIMICROB AGENTS CH, V32, P1636, DOI 10.1128/AAC.32.11.1636; Bazzini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018902; BISSONNETTE L, 1992, J BACTERIOL, V174, P1248, DOI 10.1128/jb.174.4.1248-1257.1992; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Coenye T, 2011, ANTIMICROB AGENTS CH, V55, P1912, DOI 10.1128/AAC.01571-10; Crowley D, 2002, J APPL MICROBIOL, V92, P992, DOI 10.1046/j.1365-2672.2002.01612.x; Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Fehlner-Gardiner CC, 2002, FEMS MICROBIOL LETT, V215, P279, DOI 10.1111/j.1574-6968.2002.tb11403.x; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Guglierame P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-66; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Huang Chien-Hsien, 2001, Journal of Microbiology Immunology and Infection, V34, P215; Ku NS, 2011, SCAND J INFECT DIS, V43, P792, DOI 10.3109/00365548.2011.589076; Liao CH, 2011, DIAGN MICR INFEC DIS, V70, P260, DOI 10.1016/j.diagmicrobio.2011.01.008; LiPuma JJ, 2002, LANCET, V359, P2002, DOI 10.1016/S0140-6736(02)08836-0; Lu DCT, 1997, J FORMOS MED ASSOC, V96, P972; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P3165, DOI 10.1128/JCM.38.9.3165-3173.2000; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; MOORE RA, 1986, ANTIMICROB AGENTS CH, V30, P923, DOI 10.1128/AAC.30.6.923; Nair BM, 2004, J CLIN INVEST, V113, P464, DOI 10.1172/JCi200419710; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Perrin E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-164; Petrucca A, 2003, RES MICROBIOL, V154, P491, DOI 10.1016/S0923-2508(03)00145-1; Pope CF, 2008, ANTIMICROB AGENTS CH, V52, P1201, DOI 10.1128/AAC.00799-07; Ramirez MS, 2005, ANTIMICROB AGENTS CH, V49, P4418, DOI 10.1128/AAC.49.10.4418-4420.2005; Rushton L, 2013, ANTIMICROB AGENTS CH, V57, P2972, DOI 10.1128/AAC.00140-13; Sass A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-373; Siddiqui AH, 2001, INFECT CONT HOSP EP, V22, P419, DOI 10.1086/501927; Ramirez MS, 2010, ANTIMICROB AGENTS CH, V54, P699, DOI 10.1128/AAC.01392-08; Vettoretti L, 2009, ANTIMICROB AGENTS CH, V53, P1987, DOI 10.1128/AAC.01024-08; Yu WL, 1999, SCAND J INFECT DIS, V31, P293, DOI 10.1080/00365549950163608; Zhang Y, 2010, ANTIMICROB AGENTS CH, V54, P4772, DOI 10.1128/AAC.00009-10	38	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104986	10.1371/journal.pone.0104986	http://dx.doi.org/10.1371/journal.pone.0104986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153194	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200033
J	Wheat, JC; Krause, DS; Shin, TH; Chen, X; Wang, JF; Ding, DC; Yamin, R; Sweetser, DA				Wheat, Justin C.; Krause, Daniela S.; Shin, Thomas H.; Chen, Xi; Wang, Jianfeng; Ding, Dacheng; Yamin, Rae'e; Sweetser, David A.			The Corepressor Tle4 Is a Novel Regulator of Murine Hematopoiesis and Bone Development	PLOS ONE			English	Article							STEM-CELLS; TRANSCRIPTIONAL REPRESSION; B LYMPHOPOIESIS; PAX5 BSAP; GROUCHO; FAMILY; DIFFERENTIATION; PATHWAYS; PROTEIN; MICE	Hematopoiesis is a complex process that relies on various cell types, signaling pathways, transcription factors and a specific niche. The integration of these various components is of critical importance to normal blood development, as deregulation of these may lead to bone marrow failure or malignancy. Tle4, a transcriptional corepressor, acts as a tumor suppressor gene in a subset of acute myeloid leukemia, yet little is known about its function in normal and malignant hematopoiesis or in mammalian development. We report here that Tle4 knockout mice are runted and die at around four weeks with defects in bone development and BM aplasia. By two weeks of age, Tle4 knockout mice exhibit leukocytopenia, B cell lymphopenia, and significant reductions in hematopoietic stem and progenitor cells. Tle4 deficient hematopoietic stem cells are intrinsically defective in B lymphopoiesis and exhaust upon stress, such as serial transplantation. In the absence of Tle4 there is a profound decrease in bone mineralization. In addition, Tle4 knockout stromal cells are defective at maintaining wild-type hematopoietic stem cell function in vitro. In summary, we illustrate a novel and essential role for Tle4 in the extrinsic and intrinsic regulation of hematopoiesis and in bone development.	[Wheat, Justin C.; Shin, Thomas H.; Chen, Xi; Wang, Jianfeng; Ding, Dacheng; Yamin, Rae'e; Sweetser, David A.] Massachusetts Gen Hosp, Dept Pediat, Div Pediat Hematol Oncol, Boston, MA 02114 USA; [Wheat, Justin C.; Shin, Thomas H.; Chen, Xi; Wang, Jianfeng; Ding, Dacheng; Yamin, Rae'e; Sweetser, David A.] Massachusetts Gen Hosp, Div Med Genet, Boston, MA 02114 USA; [Krause, Daniela S.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Krause, Daniela S.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Krause, Daniela S.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shin, Thomas H.] Boston Univ, Sch Med, Dept Mol & Translat Med, Boston, MA 02118 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University	Sweetser, DA (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Div Pediat Hematol Oncol, Boston, MA 02114 USA.	dsweetser@partners.org	Sweetser, David/ABB-9347-2021	Sweetser, David/0000-0002-1621-3284; Wheat, Justin/0000-0003-0018-4981	National Institutes of Health [K08 CA138916-02, R01 CA115772, T32 CA071345]; Hyundai Hope on Wheels; Mattina Proctor Foundation (75 Federal St, Boston, Massachusetts 02110); NATIONAL CANCER INSTITUTE [K08CA138916, R01CA115772, T32CA071345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels; Mattina Proctor Foundation (75 Federal St, Boston, Massachusetts 02110); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants K08 CA138916-02 (DSK), R01 CA115772 (DAS, JCW, XC, JW), and T32 CA071345 (JW) as well as funding by Hyundai Hope on Wheels (DAS; http://www.hyundaihopeonwheels.org) and the Mattina Proctor Foundation (DAS; 75 Federal St, Boston, Massachusetts 02110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Beagle B, 2010, DEV DYNAM, V239, P2795, DOI 10.1002/dvdy.22439; Brunquell C, 2012, MOL CANCER RES, V10, P1482, DOI 10.1158/1541-7786.MCR-12-0144; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Dayyani F, 2008, BLOOD, V111, P4338, DOI 10.1182/blood-2007-07-103291; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Krause DS, 2013, NAT MED IN PRESS; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Milili M, 2002, IMMUNOLOGY, V106, P447, DOI 10.1046/j.1365-2567.2002.01456.x; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nwajei Felix, 2013, Adv Hematol, V2013, P953982, DOI 10.1155/2013/953982; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Seo SW, 2011, J ORTHOP RES, V29, P1131, DOI 10.1002/jor.21318; Turki-Judeh W, 2012, CURR TOP DEV BIOL, V98, P65, DOI 10.1016/B978-0-12-386499-4.00003-3; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang WF, 2002, DEV DYNAM, V224, P79, DOI 10.1002/dvdy.10089; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	29	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105557	10.1371/journal.pone.0105557	http://dx.doi.org/10.1371/journal.pone.0105557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153823	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200060
J	Wang, RR; Yang, QH; Luo, RH; Peng, YM; Dai, SX; Zhang, XJ; Chen, H; Cui, XQ; Liu, YJ; Huang, JF; Chang, JB; Zheng, YT				Wang, Rui-Rui; Yang, Qing-Hua; Luo, Rong-Hua; Peng, You-Mei; Dai, Shao-Xing; Zhang, Xing-Jie; Chen, Huan; Cui, Xue-Qing; Liu, Ya-Juan; Huang, Jing-Fei; Chang, Jun-Biao; Zheng, Yong-Tang			Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; QUANTITATIVE-ANALYSIS; ANTIVIRAL ACTIVITY; 3TC RESISTANCE; HIV TYPE-1; ANALOGS; REPLICATION; COMPLEX; PROTEIN; DESIGN	Azvudine is a novel nucleoside reverse transcriptase inhibitor with antiviral activity on human immunodeficiency virus, hepatitis B virus and hepatitis C virus. Here we reported the in vitro activity of azvudine against HIV-1 and HIV-2 when used alone or in combination with other antiretroviral drugs and its drug resistance features. Azvudine exerted highly potent inhibition on HIV-1 (EC(50)s ranging from 0.03 to 6.92 nM) and HIV-2 (EC(50)s ranging from 0.018 to 0.025 nM). It also showed synergism in combination with six approved anti-HIV drugs on both C8166 and PBMC. In combination assay, the concentrations of azvudine used were 1000 or 500 fold lower than other drugs. Azvudine also showed potent inhibition on NRTI-resistant strains (L74V and T69N). Although M184V caused 250 fold reduction in susceptibility, azvudine remained active at nanomolar range. In in vitro induced resistant assay, the frequency of M184I mutation increased with induction time which suggests M184I as the key mutation in azvudine treatment. As control, lamivudine treatment resulted in a higher frequency of M184I/V given the same induction time and higher occurrence of M184V was found. Molecular modeling analysis suggests that steric hindrance is more pronounced in mutant M184I than M184V due to the azido group of azvudine. The present data demonstrates the potential of azvudine as a complementary drug to current anti-HIV drugs. M184I should be the key mutation, however, azvudine still remains active on HIV-1(LAI-M184V) at nanomolar range.	[Wang, Rui-Rui; Luo, Rong-Hua; Zhang, Xing-Jie; Chen, Huan; Cui, Xue-Qing; Liu, Ya-Juan; Zheng, Yong-Tang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Wang, Rui-Rui; Luo, Rong-Hua; Zhang, Xing-Jie; Chen, Huan; Cui, Xue-Qing; Liu, Ya-Juan; Zheng, Yong-Tang] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Yang, Qing-Hua; Peng, You-Mei; Chang, Jun-Biao] Zhengzhou Univ, Coll Chem & Mol Engn, Zhengzhou 450052, Henan, Peoples R China; [Zhang, Xing-Jie; Chen, Huan; Liu, Ya-Juan] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Dai, Shao-Xing; Huang, Jing-Fei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Cui, Xue-Qing] Dali Univ, Coll Pharm & Chem, Dali, Yunnan, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Zhengzhou University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Dali University	Chang, JB (corresponding author), Zhengzhou Univ, Coll Chem & Mol Engn, Zhengzhou 450052, Henan, Peoples R China.	changjunbiao@zzu.edu.cn; zhengyt@mail.kiz.ac.cn	Dai, shaoxing/ABA-8699-2020	Dai, Shao-Xing/0000-0002-6919-2034	Twelfth Five-Year Key Scientific and Technological Program of China [2012ZX10001-006, 2012ZX10001-007, 2012ZX09103-101-022]; National Natural Science Foundation of China [21172202, 81001462, 81102483]; Yunnan Province [2010GA001, Y103951111]	Twelfth Five-Year Key Scientific and Technological Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province	This work was supported in part by grants from the Twelfth Five-Year Key Scientific and Technological Program of China (2012ZX10001-006, 2012ZX10001-007, 2012ZX09103-101-022), the National Natural Science Foundation of China (21172202, 81001462, 81102483), Yunnan Province (2010GA001, Y103951111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Peter L, 2010, Clin Med Rev Ther, V2, pa2004; Barnas D, 2010, ANTIVIR THER, V15, P437, DOI 10.3851/IMP1539; Boyer PL, 2012, J VIROL, V86, P5885, DOI 10.1128/JVI.06597-11; Chesney MA, 2006, JAIDS-J ACQ IMM DEF, V43, pS149, DOI 10.1097/01.qai.0000243112.91293.26; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cihlar T, 2008, ANTIMICROB AGENTS CH, V52, P655, DOI 10.1128/AAC.01215-07; Das K, 2012, NAT STRUCT MOL BIOL, V19, P253, DOI 10.1038/nsmb.2223; GU ZX, 1995, P NATL ACAD SCI USA, V92, P2760, DOI 10.1073/pnas.92.7.2760; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Kodama EI, 2001, ANTIMICROB AGENTS CH, V45, P1539, DOI 10.1128/AAC.45.5.1539-1546.2001; Lacombe K, 2010, J ANTIMICROB CHEMOTH, V65, P10, DOI 10.1093/jac/dkp414; Li L, 2010, AIDS RES HUM RETROV, V26, P711, DOI 10.1089/aid.2010.0001; Liu GJ, 2007, CELL MOL IMMUNOL, V4, P203; Lu XF, 2012, ANTIMICROB AGENTS CH, V56, P341, DOI 10.1128/AAC.05537-11; Murphy R L, 1999, AIDS Clin Care, V11, P47; Murphy RL, 1999, AIDS CLIN CARE, V11, P51; Murphy RL, 1999, AIDS CLIN CARE, V11, P53; Ntemgwa M, 2007, ANTIMICROB AGENTS CH, V51, P3861, DOI 10.1128/AAC.00646-07; Ohrui H, 2000, J MED CHEM, V43, P4516, DOI 10.1021/jm000209n; Pannecouque C, 2008, NAT PROTOC, V3, P427, DOI 10.1038/nprot.2007.517; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Rando RF, 2000, DRUG DISCOV TODAY, V5, P465, DOI 10.1016/S1359-6446(00)01558-0; Rezende LF, 1998, NUCLEIC ACIDS RES, V26, P3066, DOI 10.1093/nar/26.12.3066; Richman DD, 2001, ANTIVIR THER, V6, P83; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Scaglione F, 2012, INT J ANTIMICROB AG, V39, P458, DOI 10.1016/j.ijantimicag.2011.11.013; SCHINAZI RF, 1992, ANTIMICROB AGENTS CH, V36, P2423, DOI 10.1128/AAC.36.11.2423; Schrodinger, 2010, PYMOL MOL GRAPHICS S; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Smith DB, 2009, J MED CHEM, V52, P2971, DOI 10.1021/jm801595c; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; Tuccinardi T, 2010, J CHEM INF MODEL, V50, P1432, DOI 10.1021/ci100161z; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; WAINBERG MA, 1995, AIDS, V9, P351, DOI 10.1097/00002030-199509040-00006; Wang Q, 2011, EUR J MED CHEM, V46, P4178, DOI 10.1016/j.ejmech.2011.06.020; Wang QA, 2011, BIOCHEM PHARMACOL, V81, P848, DOI 10.1016/j.bcp.2011.01.001; Wang RR, 2009, BIOCHEM BIOPH RES CO, V382, P540, DOI 10.1016/j.bbrc.2009.03.057; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; Wu J, 2013, EUR J MED CHEM, V63, P739, DOI 10.1016/j.ejmech.2013.02.042; Yoder KE, 2008, J VIROL METHODS, V153, P253, DOI 10.1016/j.jviromet.2008.07.032; Zhang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081489; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zheng LY, 2012, ANTIVIR THER, V17, P679, DOI 10.3851/IMP2094; Zhou YB, 2012, ANTIVIR THER, V17, P1593, DOI 10.3851/IMP2292	46	41	48	45	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105617	10.1371/journal.pone.0105617	http://dx.doi.org/10.1371/journal.pone.0105617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144636	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100097
J	Corrochano, S; Renna, M; Osborne, G; Carter, S; Stewart, M; May, J; Bates, GP; Brown, SDM; Rubinsztein, DC; Acevedo-Arozena, A				Corrochano, Silvia; Renna, Maurizio; Osborne, Georgina; Carter, Sarah; Stewart, Michelle; May, Joel; Bates, Gillian P.; Brown, Steve D. M.; Rubinsztein, David C.; Acevedo-Arozena, Abraham			Reducing Igf-1r Levels Leads To Paradoxical and Sexually Dimorphic Effects in HD Mice	PLOS ONE			English	Article							GROWTH-FACTOR-I; HUNTINGTIN-INDUCED TOXICITY; MOUSE MODELS; MOLECULAR-MECHANISMS; REGULATE AUTOPHAGY; MUTANT HUNTINGTIN; TRANSGENIC MICE; SELF-DIGESTION; DISEASE; AKT	Many of the neurodegenerative diseases that afflict people in later life are associated with the formation of protein aggregates. These so-called "proteinopathies" include Alzheimer's disease (AD) and Huntington's disease (HD). The insulin/insulin-like growth factor signalling (IIS) pathway has been proposed to modulate such diseases in model organisms, as well as the general ageing process. In this pathway, insulin-like growth factor binds to insulin-like growth factor receptors, such as the insulin-like growth factor 1 receptor (IGF-1R). Heterozygous deletion of Igf-1r has been shown to lead to increased lifespan in mice. Reducing the activity of this pathway had benefits in a HD C. elegans model, and some of these may be attributed to the expected inhibition of mTOR activity resulting in an increase in autophagy, which would enhance mutant huntingtin clearance. Thus, we tested if heterozygous deletion of Igf-1r would lead to benefits in HD related phenotypes in the mouse. Surprisingly, reducing Igf-1r levels led to some beneficial effects in HD females, but also led to some detrimental effects in HD males. Interestingly, Igf-1r deficiency had no discernible effects on downstream mTOR signalling in HD mice. These results do not support a broad beneficial effect of diminishing the IIS pathway in HD pathology in a mammalian system.	[Corrochano, Silvia; Carter, Sarah; Stewart, Michelle; May, Joel; Brown, Steve D. M.; Acevedo-Arozena, Abraham] MRC Mammalian Genet Unit, Harwell, Oxon, England; [Renna, Maurizio; Rubinsztein, David C.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2QQ, England; [Osborne, Georgina; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England	MRC Harwell; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London	Acevedo-Arozena, A (corresponding author), MRC Mammalian Genet Unit, Harwell, Oxon, England.	a.acevedo@har.mrc.ac.uk	Arozena, Abraham Acevedo/L-6584-2018; Corrochano, Silvia/L-2687-2015; Rubinsztein, David C/C-3472-2011; Bates, Gillian/E-1146-2012	Arozena, Abraham Acevedo/0000-0001-6127-7116; Corrochano, Silvia/0000-0003-0958-0083; Osborne, Georgina/0000-0001-8308-3179; Renna, Maurizio/0000-0001-6522-1750; Bates, Gillian/0000-0002-4041-6305	Wellcome Trust; M.R.C. Programme Grant; CHDI Foundation; MRC [G0600194, MC_UP_A390_1106, MC_U142684172, MC_UP_1502/1] Funding Source: UKRI; Medical Research Council [MC_UP_A390_1106, MC_U142684172, 1330882, G0600194, MC_UP_1502/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); M.R.C. Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CHDI Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful for a Wellcome Trust Principal Fellowship in Clinical Science (DCR), an M.R.C. Programme Grant (DCR and SB), and the CHDI Foundation (GPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891; Burgunder JM, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-2; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Corrochano S, 2012, HUM MOL GENET, V21, P485, DOI 10.1093/hmg/ddr477; Duarte AI, 2011, EXP NEUROL, V231, P314, DOI 10.1016/j.expneurol.2011.06.016; Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043; Gatchel JR, 2008, P NATL ACAD SCI USA, V105, P1291, DOI 10.1073/pnas.0711257105; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lopes C, 2014, MOL NEUROBIOL, V49, P1126, DOI 10.1007/s12035-013-8585-5; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Nadjar A, 2009, NEUROBIOL AGING, V30, P2021, DOI 10.1016/j.neurobiolaging.2008.02.009; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Pouladi MA, 2010, HUM MOL GENET, V19, P1528, DOI 10.1093/hmg/ddq026; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Renna M, 2013, HUM MOL GENET; Rosen CJ, 1997, BONE, V21, P217, DOI 10.1016/S8756-3282(97)00143-9; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saleh N, 2010, NEUROLOGY, V75, P57, DOI 10.1212/WNL.0b013e3181e62076; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Sobolewska A, 2009, EUR J CELL BIOL, V88, P117, DOI 10.1016/j.ejcb.2008.09.004; Wood NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009077; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009; 1993, CELL, V72, P971	48	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105595	10.1371/journal.pone.0105595	http://dx.doi.org/10.1371/journal.pone.0105595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140802	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200110
J	Salas, R; Bibiloni, MD; Ramos, E; Villarreal, JZ; Pons, A; Tur, JA; Sureda, A				Salas, Rogelio; del Mar Bibiloni, Maria; Ramos, Esteban; Villarreal, Jesus Z.; Pons, Antoni; Tur, Josep A.; Sureda, Antoni			Metabolic Syndrome Prevalence among Northern Mexican Adult Population	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; RISK-FACTORS; INSULIN-RESISTANCE; DIETARY PATTERNS; NATIONAL-HEALTH; SYNDROME DIFFER; WOMEN; PREVENTION; OBESITY; ASSOCIATION	Background and Aims: Dietary habits in the Mexican population have changed dramatically over the last few years, which are reflected in increased overweight and obesity prevalence. The aim was to examine the prevalence of metabolic syndrome (MetS) and associated risk factors in Northern Mexican adults aged >= 16 years. Methods and Results: The study was a population-based cross-sectional nutritional survey carried out in the State of Nuevo Leon, Mexico. The study included a sub-sample of 1,200 subjects aged 16 and over who took part in the State Survey of Nutrition and Health-Nuevo Leon 2011/2012. Anthropometric measurements, physical activity, blood pressure and fasting blood tests for biochemical analysis were obtained from all subjects. The prevalence of MetS in Mexican adults aged >= 16 years was 54.8%, reaching 73.8% in obese subjects. This prevalence was higher in women (60.4%) than in men (48.9%) and increased with age in both genders. Multivariate analyses showed no evident relation between MetS components and the level of physical activity. Conclusions: Obese adults, mainly women, are particularly at risk of developing MetS, with the associated implications for their health. The increasing prevalence of MetS highlights the need for developing strategies for its early detection and prevention.	[Salas, Rogelio; Ramos, Esteban] Autonomous Univ Nuevo Leon, Fac Publ Hlth Nutr, Monterrey, Mexico; [del Mar Bibiloni, Maria; Pons, Antoni; Tur, Josep A.; Sureda, Antoni] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain; [del Mar Bibiloni, Maria; Pons, Antoni; Tur, Josep A.; Sureda, Antoni] CIBERobn Physiopathol Obes & Nutr, Palma De Mallorca, Spain; [Villarreal, Jesus Z.] State Nuevo Leon, Dept Hlth, Monterrey, Mexico	Universidad Autonoma de Nuevo Leon; Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Tur, JA (corresponding author), Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain.	pep.tur@uib.es	Gomila, Antonio Sureda/L-7191-2014; Bibiloni, Maria del Mar/H-9734-2015; Pons, Antoni/L-4844-2014; Sureda, Antoni/N-9588-2019; del Mar Bibiloni, Maria/M-3123-2014; Tur, Josep Antoni/F-5576-2014; Tur, Josep/AAE-5748-2020; , Antoni/AAB-5250-2019	Gomila, Antonio Sureda/0000-0003-2101-616X; Pons, Antoni/0000-0003-2447-3868; Sureda, Antoni/0000-0001-8656-6838; del Mar Bibiloni, Maria/0000-0001-8926-9206; Tur, Josep Antoni/0000-0002-6940-0761; Tur, Josep/0000-0002-6940-0761; , Antoni/0000-0001-8656-6838; /0000-0001-9835-1594	Department of Health, Government of the State of Nuevo Leon (Mexico): State Survey of Nutrition and Health-Nuevo Leon; Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences) [11/01791]; Red Predimed [RETIC RD06/0045/1004]; CIBERobn [CB12/03/30038]; Balearic Islands Gov. [35/2011]; EU FEDER funds	Department of Health, Government of the State of Nuevo Leon (Mexico): State Survey of Nutrition and Health-Nuevo Leon; Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences); Red Predimed; CIBERobn; Balearic Islands Gov.; EU FEDER funds(European Commission)	This work was supported by the Department of Health, Government of the State of Nuevo Leon (Mexico): State Survey of Nutrition and Health- Nuevo Leon 2011/2012 (EESN-NL 2011/2012). Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences, Projects 11/01791, Red Predimed-RETIC RD06/0045/1004, and CIBERobn CB12/03/30038). Grant of support to research groups no. 35/2011 (Balearic Islands Gov. and EU FEDER funds). The Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands, coming under the Centre Catala de la Nutricio (IEC) and Exernet Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay LR, 2013, NUTR REV, V71, P168, DOI 10.1111/j.1753-4887.2012.00533.x; Aguilar-Salinas CA, 2004, ARCH MED RES, V35, P76, DOI 10.1016/j.arcmed.2003.06.006; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Balkau B, 2002, DIABETES METAB, V28, P364; Barquera S, 2003, SALUD PUBLICA MEXICO, V45, pS530; Buckland G, 2008, PUBLIC HEALTH NUTR, V11, P1372, DOI 10.1017/S1368980008003492; Cuevas A, 2011, CURR OPIN ENDOCRINOL, V18, P134, DOI 10.1097/MED.0b013e3283449167; Denova-Gutierrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671; Denova-Gutierrez E, 2010, PUBLIC HEALTH NUTR, V13, P835, DOI 10.1017/S1368980009991145; Duclos M, 2007, SCI SPORT, V22, P129, DOI 10.1016/j.scispo.2007.06.001; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gregory CO, 2009, BRIT J NUTR, V101, P1805, DOI 10.1017/S000711450813584X; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Gutierrez-Salmean G, 2012, CLIN INVEST ARTERIOS, V24, P204, DOI 10.1016/j.arteri.2011.11.002; Holme I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-154; Isordia-Salas I, 2012, EXP DIABETES RES, DOI 10.1155/2012/202540; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Ma X, 2013, EUR J CLIN NUTR, V67, P518, DOI 10.1038/ejcn.2013.24; Marquez-Sandoval F, 2011, PUBLIC HEALTH NUTR, V14, P1702, DOI 10.1017/S1368980010003320; Mattei J, 2011, AM J CLIN NUTR, V94, P869, DOI 10.3945/ajcn.111.013219; Meaney Alejandra, 2013, Arch. Cardiol. Méx., V83, P249, DOI 10.1016/j.acmx.2013.05.002; Mendez-Hernandez P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-276; Mirmiran P, 2008, NUTR METAB CARDIOVAS, V18, P567, DOI 10.1016/j.numecd.2007.06.002; Orantes CM, 2011, MEDICC REV, V13, P14, DOI 10.37757/MR2011V13.N4.5; Queen Saulette R, 2012, World J Cardiovasc Dis, V2, P50; Redinger Richard N, 2007, Gastroenterol Hepatol (N Y), V3, P856; Rojas R, 2010, SALUD PUBLICA MEXICO, V52, pS11, DOI 10.1590/s0036-36342010000700004; Rojas-Martinez R, 2012, SALUD PUBLICA MEXICO, V54, P7; Romieu I, 2012, PUBLIC HEALTH NUTR, V15, P116, DOI 10.1017/S1368980011001182; Spalding A, 2009, J CLIN HYPERTENS, V11, P755, DOI 10.1111/j.1751-7176.2009.00191.x; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Vella CA, 2011, J IMMIGR MINOR HEALT, V13, P119, DOI 10.1007/s10903-009-9299-7; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS72; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	38	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105581	10.1371/journal.pone.0105581	http://dx.doi.org/10.1371/journal.pone.0105581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141255	Green Submitted, gold, Green Published			2022-12-25	WOS:000342687200106
J	Straub, C; Granger, AJ; Saulnier, JL; Sabatini, BL				Straub, Christoph; Granger, Adam J.; Saulnier, Jessica L.; Sabatini, Bernardo L.			CRISPR/Cas9-Mediated Gene Knock-Down in Post-Mitotic Neurons	PLOS ONE			English	Article							CRISPR-CAS9 SYSTEM; NMDA RECEPTORS; HUMAN-CELLS; GENOME; MICE; BRAIN; CAS9; SUPPRESSION; GENERATION	The prokaryotic adaptive immune system CRISPR/Cas9 has recently been adapted for genome editing in eukaryotic cells. This technique allows for sequence-specific induction of double-strand breaks in genomic DNA of individual cells, effectively resulting in knock-out of targeted genes. It thus promises to be an ideal candidate for application in neuroscience where constitutive genetic modifications are frequently either lethal or ineffective due to adaptive changes of the brain. Here we use CRISPR/Cas9 to knock-out Grin1, the gene encoding the obligatory NMDA receptor subunit protein GluN1, in a sparse population of mouse pyramidal neurons. Within this genetically mosaic tissue, manipulated cells lack synaptic current mediated by NMDA-type glutamate receptors consistent with complete knock-out of the targeted gene. Our results show the first proof-of-principle demonstration of CRISPR/Cas9-mediated knock-down in neurons in vivo, where it can be a useful tool to study the function of specific proteins in neuronal circuits.	[Straub, Christoph; Granger, Adam J.; Saulnier, Jessica L.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu		Granger, Adam/0000-0002-3953-6764	National Institute of Neurological Disorders and Stroke [NS077907]; Howard Hughes Medical Institute; DAAD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077907] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institute of Neurological Disorders and Stroke NS077907; Howard Hughes Medical Institute; DAAD Postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chen PE, 2009, LEARN MEMORY, V16, P635, DOI 10.1101/lm.1316909; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Granger AJ, 2011, J PHYSIOL-LONDON, V589, P4095, DOI 10.1113/jphysiol.2011.213033; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Picciotto MR, 1998, PHYSIOL REV, V78, P1131, DOI 10.1152/physrev.1998.78.4.1131; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu X, 2014, NAT BIOTECHNOL; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	29	72	84	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105584	10.1371/journal.pone.0105584	http://dx.doi.org/10.1371/journal.pone.0105584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140704	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200109
J	Ali, M; Chernova, TA; Newnam, GP; Yin, LM; Shanks, J; Karpova, TS; Lee, A; Laur, O; Subramanian, S; Kim, D; McNally, JG; Seyfried, NT; Chernoff, YO; Wilkinson, KD				Ali, Moiez; Chernova, Tatiana A.; Newnam, Gary P.; Yin, Luming; Shanks, John; Karpova, Tatiana S.; Lee, Andrew; Laur, Oskar; Subramanian, Sindhu; Kim, Dami; McNally, James G.; Seyfried, Nicholas T.; Chernoff, Yury O.; Wilkinson, Keith D.			Stress-dependent Proteolytic Processing of the Actin Assembly Protein Lsb1 Modulates a Yeast Prion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Endoplasmic Reticulum (ER); Prion; Proteasome; Ubiquitylation (Ubiquitination); Rsp5; Sup35; Heat Shock	TAIL-ANCHORED PROTEINS; DAMAGED PROTEINS; IN-VIVO; CYTOSKELETON; AGGREGATION; SEGREGATION; PROTEASOME; UBIQUITINATION; INHERITANCE; ACTIVATION	Background: Thermal stress affects inheritance of prion amyloids in budding yeast. Results: Heat shock-induced processing of actin assembly protein Lsb1 is involved in yeast prion inheritance. Conclusion: Components of the actin cytoskeleton affect prion dynamics in response to heat shock. Significance: Understanding the mechanisms of aggregate segregation in response to stress may present new opportunities for pharmacological interventions aimed at protein aggregation disorders. Yeast prions are self-propagating amyloid-like aggregates of Q/N-rich protein that confer heritable traits and provide a model of mammalian amyloidoses. [PSI+] is a prion isoform of the translation termination factor Sup35. Propagation of [PSI+] during cell division under normal conditions and during the recovery from damaging environmental stress depends on cellular chaperones and is influenced by ubiquitin proteolysis and the actin cytoskeleton. The paralogous yeast proteins Lsb1 and Lsb2 bind the actin assembly protein Las17 (a yeast homolog of human Wiskott-Aldrich syndrome protein) and participate in the endocytic pathway. Lsb2 was shown to modulate maintenance of [PSI+] during and after heat shock. Here, we demonstrate that Lsb1 also regulates maintenance of the Sup35 prion during and after heat shock. These data point to the involvement of Lsb proteins in the partitioning of protein aggregates in stressed cells. Lsb1 abundance and cycling between actin patches, endoplasmic reticulum, and cytosol is regulated by the Guided Entry of Tail-anchored proteins pathway and Rsp5-dependent ubiquitination. Heat shock-induced proteolytic processing of Lsb1 is crucial for prion maintenance during stress. Our findings identify Lsb1 as another component of a tightly regulated pathway controlling protein aggregation in changing environments.	[Ali, Moiez; Chernova, Tatiana A.; Yin, Luming; Shanks, John; Lee, Andrew; Subramanian, Sindhu; Kim, Dami; Seyfried, Nicholas T.; Wilkinson, Keith D.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA; [Newnam, Gary P.; Chernoff, Yury O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Newnam, Gary P.; Chernoff, Yury O.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Karpova, Tatiana S.; McNally, James G.] NCI, Ctr Canc Res Core Fluorescence Imaging Facil, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Laur, Oskar] Emory Univ, Div Microbiol, Yerkes Res Ctr, Atlanta, GA 30329 USA; [Chernoff, Yury O.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg 199034, Russia	Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; Saint Petersburg State University	Chernova, TA (corresponding author), 1510 Clifton Rd, Atlanta, GA 30322 USA.	tcherno@emory.edu; genekdw@emory.edu	Chernova, Tatiana/AAR-5007-2020; Chernoff, Yury O/J-2833-2014	Chernova, Tatiana/0000-0003-1966-0159; Chernoff, Yury/0000-0002-8934-9051; Karpova, Tatiana/0000-0001-6025-2128	National Institutes of Health [GM093294]; St. Petersburg State University [1.50.2218.2013]; NATIONAL CANCER INSTITUTE [ZICBC011574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Petersburg State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM093294 (to K. D. W., T. A. C., and Y. O. C.) and Project 1.50.2218.2013 from St. Petersburg State University (to Y. O. C.).	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Allen KD, 2007, J BIOL CHEM, V282, P3004, DOI 10.1074/jbc.M609597200; Bailleul-Winslett PA, 2000, GENE EXPRESSION, V9, P145; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chernova TA, 2014, FEMS MICROBIOL REV, V38, P326, DOI 10.1111/1574-6976.12053; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Ghahramani S., 2000, FUNDAMENTALS PROBABI; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Guarente L, 2010, CELL, V140, P176, DOI 10.1016/j.cell.2010.01.015; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Howard GC, 2012, YEAST, V29, P93, DOI 10.1002/yea.1919; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; James P, 1996, GENETICS, V144, P1425; Kabani M, 2014, MOL MICROBIOL, V92, P507, DOI 10.1111/mmi.12572; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaminska J, 2011, EUR J CELL BIOL, V90, P1016, DOI 10.1016/j.ejcb.2011.08.002; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Li LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002973; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Liu BD, 2011, CELL, V147, P959, DOI 10.1016/j.cell.2011.11.018; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Newnam G. P., 2011, J MOL BIOL; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Nystrom T, 2014, CURR OPIN MICROBIOL, V18, P61, DOI 10.1016/j.mib.2014.02.003; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rieder S E, 2001, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0307s07; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shcherbik N, 2003, CURR BIOL, V13, P1227, DOI 10.1016/S0960-9822(03)00457-3; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smethurst D. G., 2011, FEMS YEAST RES, V408, P432; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Spiess M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061147; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002	64	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27625	27639		10.1074/jbc.M114.582429	http://dx.doi.org/10.1074/jbc.M114.582429			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143386	Green Published, hybrid			2022-12-25	WOS:000342852800023
J	Bisio, A; Sciutti, A; Nori, F; Metta, G; Fadiga, L; Sandini, G; Pozzo, T				Bisio, Ambra; Sciutti, Alessandra; Nori, Francesco; Metta, Giorgio; Fadiga, Luciano; Sandini, Giulio; Pozzo, Thierry			Motor Contagion during Human-Human and Human-Robot Interaction	PLOS ONE			English	Article							PREMOTOR CORTEX; MOVEMENT; MIRROR; PERCEPTION; IMITATION; EXCITABILITY; RECOGNITION; MODULATION; MECHANISMS; INTENTION	Motor resonance mechanisms are known to affect humans' ability to interact with others, yielding the kind of "mutual understanding'' that is the basis of social interaction. However, it remains unclear how the partner's action features combine or compete to promote or prevent motor resonance during interaction. To clarify this point, the present study tested whether and how the nature of the visual stimulus and the properties of the observed actions influence observer's motor response, being motor contagion one of the behavioral manifestations of motor resonance. Participants observed a humanoid robot and a human agent move their hands into a pre-specified final position or put an object into a container at various velocities. Their movements, both in the object-and non-object-directed conditions, were characterized by either a smooth/curvilinear or a jerky/segmented trajectory. These trajectories were covered with biological or non-biological kinematics (the latter only by the humanoid robot). After action observation, participants were requested to either reach the indicated final position or to transport a similar object into another container. Results showed that motor contagion appeared for both the interactive partner except when the humanoid robot violated the biological laws of motion. These findings suggest that the observer may transiently match his/her own motor repertoire to that of the observed agent. This matching might mediate the activation of motor resonance, and modulate the spontaneity and the pleasantness of the interaction, whatever the nature of the communication partner.	[Bisio, Ambra; Sciutti, Alessandra; Nori, Francesco; Metta, Giorgio; Fadiga, Luciano; Sandini, Giulio; Pozzo, Thierry] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Metta, Giorgio] Ist Italiano Tecnol, iCub Unit, Genoa, Italy; [Fadiga, Luciano] Univ Ferrara, Dipartimento Sci Biomed & Terapie Avanzate, Sez Fisiol Umana, I-44100 Ferrara, Italy; [Pozzo, Thierry] INSERM, U1093, Dijon, France; [Pozzo, Thierry] Univ Bourgogne, Inst Univ France, UFR STAPS Dijon, F-21004 Dijon, France	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT; University of Ferrara; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut Universitaire de France; Universite de Bourgogne	Bisio, A (corresponding author), Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy.	ambra.bisio@gmail.com	Fadiga, Luciano/AAC-7404-2022; Sciutti, Alessandra/E-4291-2017; Bisio, Ambra/AAM-4979-2020; Bisio, Ambra/N-4309-2013	Sciutti, Alessandra/0000-0002-1056-3398; Bisio, Ambra/0000-0002-9385-1714; Sandini, Giulio/0000-0003-3324-985X; Pozzo, Thierry/0000-0002-0585-7965; fadiga, luciano/0000-0001-5691-5080	European projects ITALK [ICT-FP7-214668]	European projects ITALK	The work has been conducted in the framework of the European projects ITALK (Grant ICT-FP7-214668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONCOHEN S, 1995, BRIT J DEV PSYCHOL, V13, P379, DOI 10.1111/j.2044-835X.1995.tb00687.x; Bekkering H, 2000, Q J EXP PSYCHOL-A, V53, P153, DOI 10.1080/027249800390718; Bisio A, 2012, NEUROSCIENCE, V222, P58, DOI 10.1016/j.neuroscience.2012.07.017; Bisio A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013506; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Castiello U, 2002, ATTENTION PERFORM, V19, P315; Castiello U, 2003, J EXP PSYCHOL HUMAN, V29, P416, DOI 10.1037/0096-1523.29.2.416; Cavallo A, 2011, COGN NEUROSCI-UK, V2, P83, DOI 10.1080/17588928.2010.533163; Cavallo A, 2012, CEREB CORTEX, V22, P710, DOI 10.1093/cercor/bhr157; Chaminade T, 2009, J PHYSIOL-PARIS, V103, P286, DOI 10.1016/j.jphysparis.2009.08.011; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cross ES, 2012, HUM BRAIN MAPP, V33, P2238, DOI 10.1002/hbm.21361; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gowen E, 2012, PSYCHOL RES-PSYCH FO, V76, P407, DOI 10.1007/s00426-011-0389-5; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jonas M, 2007, NEUROIMAGE, V36, pT44, DOI 10.1016/j.neuroimage.2007.03.028; Kilner J, 2007, SOC NEUROSCI-UK, V2, P158, DOI 10.1080/17470910701428190; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Kupferberg A, 2011, AI SOC, V26, P339, DOI 10.1007/s00146-010-0314-2; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Manera V, 2011, EXP BRAIN RES, V211, P547, DOI 10.1007/s00221-011-2649-4; Metta G, 2010, NEURAL NETWORKS, V23, P1125, DOI 10.1016/j.neunet.2010.08.010; Oberman LM, 2007, NEUROCOMPUTING, V70, P2194, DOI 10.1016/j.neucom.2006.02.024; Pozzo T, 2006, BEHAV BRAIN RES, V169, P75, DOI 10.1016/j.bbr.2005.12.005; Premack D, 1997, J COGNITIVE NEUROSCI, V9, P848, DOI 10.1162/jocn.1997.9.6.848; Press C, 2005, COGNITIVE BRAIN RES, V25, P632, DOI 10.1016/j.cogbrainres.2005.08.020; Press C, 2011, NEUROSCI BIOBEHAV R, V35, P1410, DOI 10.1016/j.neubiorev.2011.03.004; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1999, ARCH ITAL BIOL, V137, P85; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Sartori L, 2012, NEUROPSYCHOLOGIA, V50, P2341, DOI 10.1016/j.neuropsychologia.2012.06.002; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Sciutti A, INTERACT ST IN PRESS; Sciutti A, 2012, WORKSH 7 ACM IEEE IN; Sciutti A, 2012, INT J SOC ROBOT, V4, P223, DOI 10.1007/s12369-012-0143-1; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005; Tessari A, 2004, J EXP PSYCHOL HUMAN, V30, P1107, DOI 10.1037/0096-1523.30.6.1107; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Watanabe K, 2008, COGNITION, V106, P1514, DOI 10.1016/j.cognition.2007.06.001; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257; Wykowska Agnieszka, 2012, Social Robotics. 4th International Conference (ICSR 2012). Proceedings, P327, DOI 10.1007/978-3-642-34103-8_33	48	57	57	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106172	10.1371/journal.pone.0106172	http://dx.doi.org/10.1371/journal.pone.0106172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153990	Green Published, gold			2022-12-25	WOS:000340952200118
J	Cho, Y; Lee, DH; Lee, YB; Lee, M; Yoo, JJ; Choi, WM; Cho, YY; Paeng, JC; Kang, KW; Chung, JK; Yu, SJ; Lee, JH; Yoon, JH; Lee, HS; Kim, YJ				Cho, Yuri; Lee, Dong Hyeon; Lee, Yun Bin; Lee, Minjong; Yoo, Jeong-ju; Choi, Won-Mook; Cho, Young Youn; Paeng, Jin Chul; Kang, Keon Wook; Chung, June-Key; Yu, Su Jong; Lee, Jeong-Hoon; Yoon, Jung-Hwan; Lee, Hyo-Suk; Kim, Yoon Jun			Does F-18-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma?	PLOS ONE			English	Article							LIVER-TRANSPLANT CANDIDATES; EXTRAHEPATIC METASTASES; F-18-FLUORODEOXYGLUCOSE UPTAKE; PET; RECURRENCE; CT; FLUORINE-18-FLUORODEOXYGLUCOSE; MANAGEMENT; SORAFENIB; RESECTION	Background and Aim: The utility of fluorine-18 fluorodeoxyglucose (F-18-FDG) positron emission tomography-computed tomography (PET/CT) in initial staging of hepatocellular carcinoma (HCC) has yet to be fully explored. We assessed the usefulness of F-18-FDG PET/CT in initial staging of HCC. Methods: A total of 457 consecutive patients initially diagnosed with HCC at Seoul National University Hospital between 2006 and 2012 were evaluated retrospectively to assess the impact of F-18-FDG PET/CT on staging and compliancy with Milan criteria, relative to dynamic CT of liver and chest x-ray. Results: Seven among the 457 patients studied showed a shift in Barcelona Clinic Liver Cancer [BCLC] stage (A -> C: 6 patients; B -> C: 1 patient) and 5 patients who had originally met Milan criteria no longer qualified. F-18-FDG PET/CT had value in initial staging of early (stage A) or intermediate (stage B) HCC, as determined by dynamic CT of liver and BCLC or AJCC classifications, whereas BCLC stage 0 and stage C tumors were unchanged (P<0.001). F-18-FDG PET/CT disclosed additional metastases in patients with American Joint Committee on Cancer [AJCC] T2 (2.7%), T3a (5.3%), and T3b (4.8%) classifications. Conclusions: In initial staging of HCC, F-18-FDG PET/CT provided additional information, impacting the patients with BCLC (stages A and B) and AJCC (T2 and T3) classifications. Its use might be thus appropriate for these patient subsets, especially if hepatic resection or liver transplantation is planned.	[Cho, Yuri; Lee, Dong Hyeon; Lee, Yun Bin; Lee, Minjong; Yoo, Jeong-ju; Choi, Won-Mook; Cho, Young Youn; Yu, Su Jong; Lee, Jeong-Hoon; Yoon, Jung-Hwan; Lee, Hyo-Suk; Kim, Yoon Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Paeng, Jin Chul; Kang, Keon Wook; Chung, June-Key] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, YJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	yoonjun@snu.ac.kr	Kang, Keon Wook/J-1385-2012; Lee, Jeong-Hoon/Q-1055-2018	Kang, Keon Wook/0000-0003-2622-9017; Lee, Jeong-Hoon/0000-0002-0315-2080; Yu, Su Jong/0000-0001-8888-7977; , minjong/0000-0002-3159-5444; Lee, Yun Bin/0000-0002-3193-9745; Cho, Young Youn/0000-0002-9384-5357; Yoo, Jeong-Ju/0000-0002-7802-0381; Kim, Yoon Jun/0000-0001-9141-7773; Yoon, Jung-Hwan/0000-0002-9128-3610				[Anonymous], 2012, J HEPATOL, V56, P908; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Choi D, 2001, J COMPUT ASSIST TOMO, V25, P777, DOI 10.1097/00004728-200109000-00018; Choi GH, 2013, RADIOLOGY; Delbeke D, 1998, ARCH SURG-CHICAGO, V133, P510, DOI 10.1001/archsurg.133.5.510; Dierckx R, 2009, Q J NUCL MED MOL IM, V53, P336; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fartoux L, 2012, NUCL MED COMMUN, V33, P757, DOI 10.1097/MNM.0b013e328350fb9f; Haydon GH, 1996, EUR J GASTROEN HEPAT, V8, P856; Ho CL, 2003, J NUCL MED, V44, P213; HONDA H, 1992, GASTROINTEST RADIOL, V17, P245, DOI 10.1007/BF01888559; Iglehart JK, 2006, NEW ENGL J MED, V354, P2822, DOI 10.1056/NEJMhpr061219; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Kim BK, 2011, CANCER-AM CANCER SOC, V117, P4779, DOI 10.1002/cncr.26099; Kim YK, 2010, LIVER TRANSPLANT, V16, P767, DOI 10.1002/lt.22069; Koneru B, 2005, ANN SURG, V241, P622, DOI 10.1097/01.sla.0000157267.27356.80; Lee JH, 2011, LIVER INT, V31, P1144, DOI 10.1111/j.1478-3231.2011.02541.x; Lee JD, 2004, EUR J NUCL MED MOL I, V31, P1621, DOI 10.1007/s00259-004-1602-1; Lee JY, 2009, CHICAGO REV, V54, P50; Lee SD, 2013, TRANSPL INT, V26, P50, DOI 10.1111/j.1432-2277.2012.01572.x; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; NAKASHIMA T, 1983, CANCER, V51, P863, DOI 10.1002/1097-0142(19830301)51:5<863::AID-CNCR2820510520>3.0.CO;2-D; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; OKAZUMI S, 1992, J NUCL MED, V33, P333; Rigo P, 1996, EUR J NUCL MED, V23, P1641, DOI 10.1007/BF01249629; Shiomi S, 2001, AM J GASTROENTEROL, V96, P1877, DOI 10.1016/S0002-9270(01)02451-0; Strauss LG, 1996, EUR J NUCL MED, V23, P1409, DOI 10.1007/BF01367602; Sugiyama M, 2004, J GASTROENTEROL, V39, P961, DOI 10.1007/s00535-004-1427-5; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Teefey SA, 2003, RADIOLOGY, V226, P533, DOI 10.1148/radiol.2262011980; Trojan J, 1999, AM J GASTROENTEROL, V94, P3314, DOI 10.1111/j.1572-0241.1999.01544.x; Yamamoto Y, 2008, J NUCL MED, V49, P1245, DOI 10.2967/jnumed.108.052639; Yoon KT, 2007, ONCOLOGY-BASEL, V72, P104, DOI 10.1159/000111715; YUKI K, 1990, CANCER-AM CANCER SOC, V66, P2174, DOI 10.1002/1097-0142(19901115)66:10<2174::AID-CNCR2820661022>3.0.CO;2-A	37	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105679	10.1371/journal.pone.0105679	http://dx.doi.org/10.1371/journal.pone.0105679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153834	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200069
J	Israelsson, C; Kylberg, A; Bengtsson, H; Hillered, L; Ebendal, T				Israelsson, Charlotte; Kylberg, Annika; Bengtsson, Henrik; Hillered, Lars; Ebendal, Ted			Interacting Chemokine Signals Regulate Dendritic Cells in Acute Brain Injury	PLOS ONE			English	Article							IFN-GAMMA; MONOCYTES; MOUSE; BLOOD; MICE; CNS; HETEROGENEITY; MACROPHAGES; MECHANISMS; DISEASE	Brain trauma is known to activate inflammatory cells via various chemokine signals although their interactions remain to be characterized. Mice deficient in Ccl3, Ccr2 or Cxcl10 were compared with wildtype mice after controlled cortical impact injury. Expression of Ccl3 in wildtypes was rapidly upregulated in resident, regularly spaced reactive microglia. Ccl3-deficiency enhanced endothelial expression of platelet selectin and invasion of peripheral inflammatory cells. Appearance of Ccr2 transcripts, encoding the Ccl2 receptor, reflected invasion of lysozyme 2-expressing phagocytes and classical antigen-presenting dendritic cells expressing major histocompatibility complex class II. Ccr2 also directed clustered plasmacytoid dendritic cells positive for the T-cell attracting chemokine Cxcl10. A reduction in Ccr2 and dendritic cells was found in injured wildtype cortex after cyclophosphamide treatment resembling effects of Ccr2-deficiency. The findings demonstrate the feasibility to control inflammation in the injured brain by regulating chemokine-dependent pathways.	[Israelsson, Charlotte; Kylberg, Annika; Bengtsson, Henrik; Ebendal, Ted] Uppsala Univ, Biomed Ctr, Dept Neurosci, Uppsala, Sweden; [Hillered, Lars] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University; Uppsala University	Ebendal, T (corresponding author), Uppsala Univ, Biomed Ctr, Dept Neurosci, Uppsala, Sweden.	Ted.Ebendal@neuro.uu.se		Hillered, Lars/0000-0002-2808-9292	Swedish Research Council [K2010-62X-20383-04-3]; Swedish Brain Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation	This work was supported by The Swedish Research Council, K2010-62X-20383-04-3, http://www.vr.se/ (TE); and The Swedish Brain Foundation, http://www.hjarnfonden.se/ (TE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bendriss-Vermare N, 2005, J LEUKOCYTE BIOL, V78, P954, DOI 10.1189/jlb.0704383; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Colton CA, 2013, J NEUROIMMUNE PHARM, V8, P145, DOI 10.1007/s11481-012-9414-8; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Huyan XH, 2011, INT IMMUNOPHARMACOL, V11, P1293, DOI 10.1016/j.intimp.2011.04.011; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lasky-Su J, 2012, CLIN EXP ALLERGY, V42, P1724, DOI 10.1111/cea.12000; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Megiorni F, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-88; Megjugorac NJ, 2004, J LEUKOCYTE BIOL, V75, P504, DOI 10.1189/jlb.0603291; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pan JL, 1998, J BIOL CHEM, V273, P10058, DOI 10.1074/jbc.273.16.10058; Pashenkov M, 2001, BRAIN, V124, P480, DOI 10.1093/brain/124.3.480; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Zhu WH, 2012, J NEUROIMMUNOL, V247, P81, DOI 10.1016/j.jneuroim.2012.03.018	47	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104754	10.1371/journal.pone.0104754	http://dx.doi.org/10.1371/journal.pone.0104754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153123	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200024
J	Menzler, J; Channappa, L; Zeck, G				Menzler, Jacob; Channappa, Lakshmi; Zeck, Guenther			Rhythmic Ganglion Cell Activity in Bleached and Blind Adult Mouse Retinas	PLOS ONE			English	Article							OSCILLATORY ACTIVITY; DEGENERATION RD1; NETWORK; RESPONSES; CHANNELS; MUTANT; MODEL	In retinitis pigmentosa - a degenerative disease which often leads to incurable blindness-the loss of photoreceptors deprives the retina from a continuous excitatory input, the so-called dark current. In rodent models of this disease this deprivation leads to oscillatory electrical activity in the remaining circuitry, which is reflected in the rhythmic spiking of retinal ganglion cells (RGCs). It remained unclear, however, if the rhythmic RGC activity is attributed to circuit alterations occurring during photoreceptor degeneration or if rhythmic activity is an intrinsic property of healthy retinal circuitry which is masked by the photoreceptor's dark current. Here we tested these hypotheses by inducing and analysing oscillatory activity in adult healthy (C57/Bl6) and blind mouse retinas (rd10 and rd1). Rhythmic RGC activity in healthy retinas was detected upon partial photoreceptor bleaching using an extracellular high-density multi-transistor-array. The mean fundamental spiking frequency in bleached retinas was 4.3 Hz; close to the RGC rhythm detected in blind rd10 mouse retinas (6.5 Hz). Crosscorrelation analysis of neighbouring wild-type and rd10 RGCs (separation distance <200 mu m) reveals synchrony among homologous RGC types and a constant phase shift (similar to 70 msec) among heterologous cell types (ON versus OFF). The rhythmic RGC spiking in these retinas is driven by a network of presynaptic neurons. The inhibition of glutamatergic ganglion cell input or the inhibition of gap junctional coupling abolished the rhythmic pattern. In rd10 and rd1 retinas the presynaptic network leads to local field potentials, whereas in bleached retinas additional pharmacological disinhibition is required to achieve detectable field potentials. Our results demonstrate that photoreceptor bleaching unmasks oscillatory activity in healthy retinas which shares many features with the functional phenotype detected in rd10 retinas. The quantitative physiological differences advance the understanding of the degeneration process and may guide future rescue strategies.	[Menzler, Jacob; Channappa, Lakshmi; Zeck, Guenther] Univ Tubingen, Nat & Med Sci Inst, Neurochip Res Grp, Reutlingen, Germany; [Menzler, Jacob] Helmholtz Zentrum Munchen, Deutsch Forschungszentrum Gesundheit & Umwelt, Neuherberg, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Zeck, G (corresponding author), Univ Tubingen, Nat & Med Sci Inst, Neurochip Res Grp, Reutlingen, Germany.	guenther.zeck@nmi.de	Zeck, Günther/H-7419-2013	Zeck, Günther/0000-0003-3998-9883	German Ministry for Research and Education (BMBF) [FKZ: 1312038]; Pro Retina Network of RP patients	German Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Pro Retina Network of RP patients	This study was supported by a grant of the German Ministry for Research and Education (BMBF, FKZ: 1312038) to LC and GZ and by a grant from the Pro Retina Network of RP patients to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CL, 2013, J NEUROPHYSIOL, V109, P1589, DOI 10.1152/jn.00786.2012; Avoli M, 2011, PROG NEUROBIOL, V95, P104, DOI 10.1016/j.pneurobio.2011.07.003; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cameron MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068882; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Choi H, 2014, J NEUROPHYSIOL, V112, P1491, DOI 10.1152/jn.00437.2014; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; FAIN GL, 1993, EXP EYE RES, V57, P335, DOI 10.1006/exer.1993.1132; Farrow K, 2011, J NEUROPHYSIOL, V105, P1516, DOI 10.1152/jn.00331.2010; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Goo YS, 2011, KOREAN J PHYSIOL PHA, V15, P415, DOI 10.4196/kjpp.2011.15.6.415; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lambacher A, 2011, APPL PHYS A-MATER, V102, P1, DOI 10.1007/s00339-010-6046-9; Luo DG, 2005, J GEN PHYSIOL, V126, P263, DOI 10.1085/jgp.200509342; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086253; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Petit-Jacquea J, 2005, J NEUROPHYSIOL, V94, P1770, DOI 10.1152/jn.00279.2005; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Reimann MW, 2013, NEURON, V79, P375, DOI 10.1016/j.neuron.2013.05.023; Soto F, 2012, J NEUROSCI, V32, P5426, DOI 10.1523/JNEUROSCI.0194-12.2012; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Stasheff SF, 2011, J NEUROPHYSIOL, V105, P3002, DOI 10.1152/jn.00704.2010; Toychiev AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077658; Trenholm S, 2012, J PHYSIOL-LONDON, V590, P2501, DOI 10.1113/jphysiol.2011.225060; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012; Ye JH, 2007, PHYSIOL MEAS, V28, P1079, DOI 10.1088/0967-3334/28/9/009; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008; Zeck G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020810; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	34	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106047	10.1371/journal.pone.0106047	http://dx.doi.org/10.1371/journal.pone.0106047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153888	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200109
J	Navarro, JM; Gonzalez, K; Cisternas, B; Lopez, JA; Chaparro, OR; Segura, CJ; Cordova, M; Suarez-Isla, B; Fernandez-Reiriz, MJ; Labarta, U				Navarro, Jorge M.; Gonzalez, Katerina; Cisternas, Barbara; Lopez, Jorge A.; Chaparro, Oscar R.; Segura, Cristian J.; Cordova, Marco; Suarez-Isla, Benjamin; Fernandez-Reiriz, Maria J.; Labarta, Uxio			Contrasting Physiological Responses of Two Populations of the Razor Clam Tagelus dombeii with Different Histories of Exposure to Paralytic Shellfish Poisoning (PSP)	PLOS ONE			English	Article							DINOFLAGELLATE ALEXANDRIUM-TAMARENSE; MYTILUS-CHILENSIS; GYRODINIUM-AUREOLUM; FEEDING RESPONSE; MUSSEL; TOXINS; OYSTER; RESISTANCE; INGESTION; SELECTION	This study describes the physiological performance of two populations of the razor clam Tagelus dombeii from two geographic areas with different histories of exposure to paralytic shellfish poisoning (PSP) linked to the toxic dinoflagellate Alexandrium catenella. Clams from Melinka-Aysen, which are frequently exposed to PSP, were not affected by the presence of toxins in the diet. However, clams from Corral-Valdivia, which have never been exposed to PSP, exhibited significantly reduced filtration activity and absorption, affecting the energy allocated to scope for growth (SFG). Ammonia excretion and oxygen uptake were not affected significantly by the presence of A. catenella in the diet. Measurements of energy acquisition and expenditure were performed during a 12-day intoxication period. According to three-way repeated measure ANOVAs, the origin of the clams had a highly significant effect on all physiological variables, and the interaction between diet and origin was significant for the clearance and absorption rates and for the scope for growth. The scope for growth index showed similar positive values for both the toxic and non-toxic individuals from the Melinka-Aysen population. However, it was significantly reduced in individuals from Corral-Valdivia when exposed to the diet containing A. catenella. The absence of differences between the physiological response of the toxic and non-toxic clams from Melinka-Aysen may be related to the frequent presence of A. catenella in the environment, indicating that this bivalve does not suffer negative consequences from PSP. By contrast, A. catenella has a negative effect on the physiological performance, primarily on the energy gained from the environment, on T. dombeii from Corral-Valdivia. This study supports the hypothesis that the history of PSP exposure plays an important role in the physiological performance and fitness of filter feeding bivalves.	[Navarro, Jorge M.; Cisternas, Barbara; Lopez, Jorge A.; Chaparro, Oscar R.; Segura, Cristian J.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Gonzalez, Katerina] Univ Catolica Temuco, Escuela Acuicultura, Temuco, Chile; [Cordova, Marco; Suarez-Isla, Benjamin] Univ Chile, Fac Med, Lab Toxinas Marinas, Santiago 7, Chile; [Fernandez-Reiriz, Maria J.; Labarta, Uxio] CSIC, Inst Invest Marinas, Vigo, Spain	Universidad Austral de Chile; Universidad Catolica de Temuco; Universidad de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Navarro, JM (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	jnavarro@uach.cl	Navarro, Jorge/B-7928-2008; Labarta, Uxio/D-5644-2012; Fernandez-Reiriz, MJ/B-9014-2013; Chaparro, Oscar R/A-5070-2009	Navarro, Jorge/0000-0001-9920-190X; Cordova, Marco/0000-0002-8352-1340	Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT-CHILE) [FONDECYT 1080127, FONDECYT 1120470]	Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT-CHILE)	This study was funded by the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT-CHILE), by research grants to JMN (FONDECYT 1080127 and FONDECYT 1120470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.M., 1989, P11; ANDERSON DM, 1994, MAR BIOL, V120, P467, DOI 10.1007/BF00680222; Bardouil M, 1996, OCEANOL ACTA, V19, P177; BARDOUIL M, 1993, J SHELLFISH RES, V12, P417; BAYNE BL, 1982, PHILOS T ROY SOC B, V297, P219, DOI 10.1098/rstb.1982.0039; BOALCH GT, 1979, J MAR BIOL ASSOC UK, V59, P515, DOI 10.1017/S0025315400042818; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; Bricelj VM, 2005, NATURE, V434, P763, DOI 10.1038/nature03415; BRICELJ VM, 1990, MAR ECOL PROG SER, V63, P177, DOI 10.3354/meps063177; Chen CY, 1998, TOXICON, V36, P515, DOI 10.1016/S0041-0101(97)00093-7; Clement A, 2002, 22 JORN CIENC MAR; Colin SP, 2007, HARMFUL ALGAE, V6, P875, DOI 10.1016/j.hal.2007.05.003; Colin SP, 2004, EVOL ECOL, V18, P355, DOI 10.1007/s10682-004-2369-3; Connell LB, 2007, MAR BIOL, V150, P1227, DOI 10.1007/s00227-006-0432-z; COUGHLAN J, 1969, MAR BIOL, V2, P356, DOI 10.1007/BF00355716; Dam HG, 2013, ANNU REV MAR SCI, V5, P349, DOI 10.1146/annurev-marine-121211-172229; Dupuy J. L., 1968, Proceedings of the National Shellfisheries Association, V58, P2; ELLIOTT JM, 1975, OECOLOGIA, V19, P195, DOI 10.1007/BF00345305; Fernandez-Reiriz MJ, 2013, HELGOLAND MAR RES, V67, P653, DOI 10.1007/s10152-013-0351-6; Gainey LF., 1988, J SHELLFISH RES, V7, P623; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guillard R.R.L., 1995, MANUAL HARMFUL MARIN, P45; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Lassus P, 2004, AQUAT LIVING RESOUR, V17, P207, DOI 10.1051/alr:2004012; Li SC, 2002, MAR ENVIRON RES, V53, P145, DOI 10.1016/S0141-1136(01)00117-9; MacQuarrie SP, 2008, MAR ECOL PROG SER, V366, P59, DOI 10.3354/meps07538; MacQuarrie SP, 2002, THESIS DALHOUSIE U H; MARSDEN ID, 1992, NEW ZEAL J MAR FRESH, V26, P371, DOI 10.1080/00288330.1992.9516530; McLusky D.S., 1981, ESTUARINE ECOSYSTEM, V2, P37; Molinet C, 2003, REV CHIL HIST NAT, V76, P681; Navarro JM, 2006, HARMFUL ALGAE, V5, P762, DOI 10.1016/j.hal.2006.04.001; NAVARRO JM, 1982, MAR BIOL, V67, P255, DOI 10.1007/BF00397666; Navarro JM, 2008, REV CHIL HIST NAT, V81, P41; Navarro JM, 2010, MAR BIOL, V157, P1967, DOI 10.1007/s00227-010-1465-x; Navarro Jorge M., 1994, Revista de Biologia Marina, V29, P57; Perez M, 1998, THESIS ESCUELA BIOL; Quinn GP, 2003, EXPT DESIGN DATA ANA; SHUMWAY SE, 1985, J EXP MAR BIOL ECOL, V91, P77, DOI 10.1016/0022-0981(85)90222-9; SHUMWAY SE, 1987, AQUAT TOXICOL, V10, P9, DOI 10.1016/0166-445X(87)90024-5; Smolowitz R, 1997, AQUACULT INT, V5, P291, DOI 10.1023/A:1018355905598; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; TANGEN K, 1977, SARSIA, V63, P123, DOI 10.1080/00364827.1977.10411330; Velez P, 2001, TOXICON, V39, P929, DOI 10.1016/S0041-0101(00)00230-0; Widdows J., 1985, P161; WIDDOWS J, 1978, J MAR BIOL ASSOC UK, V58, P125, DOI 10.1017/S0025315400024450; WIDDOWS J, 1979, J MAR BIOL ASSOC UK, V59, P522, DOI 10.1017/S0025315400042843; WIKFORS GH, 1993, DEV MAR BIO, V3, P447; Wildish D, 1998, AQUAT LIVING RESOUR, V11, P35, DOI 10.1016/S0990-7440(99)80029-1; Wilson JA, 1996, AQUACULTURE, V139, P63, DOI 10.1016/0044-8486(95)01159-5; Zar J. H., 2009, BIOSTATISTICAL ANAL	50	20	20	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105794	10.1371/journal.pone.0105794	http://dx.doi.org/10.1371/journal.pone.0105794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153329	Green Submitted, gold, Green Published			2022-12-25	WOS:000340952200082
J	Seo, JA; Song, SW; Han, K; Lee, KJ; Kim, HN				Seo, Jin-A; Song, Sang-Wook; Han, Kyungdo; Lee, Kyung-Jin; Kim, Ha-Na			The Associations between Serum Zinc Levels and Metabolic Syndrome in the Korean Population: Findings from the 2010 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; SUPPLEMENTATION; GLUCOSE; CHOLESTEROL; PREVALENCE; MECHANISM; TRANSPORT; LIVER	The prevalence of metabolic syndrome has been increasing rapidly worldwide. The functions of zinc may have a potential association with metabolic syndrome, but such associations have not been investigated extensively. Therefore, we examined the relationship between serum zinc levels and metabolic syndrome or metabolic risk factors among South Korean adults >= 20 years of age. The analysis used data from the Korean National Health and Nutrition Examination Survey, a cross-sectional survey of Korean civilians, conducted from January to December 2010. A total of 1,926 participants were analyzed in this study. Serum zinc levels in men were negatively associated with elevated fasting glucose (adjusted odds ratio [aOR], 0.58; 95% confidence interval [CI], 0.36-0.93) and positively associated with elevated triglycerides (aOR, 1.47; 95% CI, 1.01-2.13). A difference in serum zinc levels was detected in women, depending on the number of metabolic syndrome components (p = 0.002). Furthermore, serum zinc levels showed a decreasing trend with increasing numbers of metabolic syndrome components in women with metabolic syndrome. These findings suggest that serum zinc levels might be associated with metabolic syndrome or metabolic risk factors. Further gender-specific studies are needed to evaluate the effect of dietary or supplemental zinc intake on metabolic syndrome.	[Seo, Jin-A; Song, Sang-Wook; Lee, Kyung-Jin; Kim, Ha-Na] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kim, HN (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea.	onef01@catholic.ac.kr						Abiaka C, 2003, J CLIN LAB ANAL, V17, P61, DOI 10.1002/jcla.10069; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arnaud J, 2012, NUTR METAB CARDIOVAS, V22, P517, DOI 10.1016/j.numecd.2010.09.005; Balasoiu M, 2014, ROM J MORPHOL EMBRYO, V55, P29; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chevalier CA, 2002, J RENAL NUTR, V12, P183, DOI 10.1053/jren.2002.33515; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Farvid MS, 2004, DIABETES RES CLIN PR, V65, P21, DOI 10.1016/j.diabres.2003.11.009; Foster M, 2010, ATHEROSCLEROSIS, V210, P344, DOI 10.1016/j.atherosclerosis.2009.11.038; Ghasemi A, 2014, ANN HUM BIOL, V41, P436, DOI 10.3109/03014460.2013.870228; Ghayour-Mobarhan M, 2009, J TRACE ELEM MED BIO, V23, P167, DOI 10.1016/j.jtemb.2009.03.006; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Gill H, 2005, AM J MED SCI, V330, P290, DOI 10.1097/00000441-200512000-00006; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Hambidge KM, 2010, AM J CLIN NUTR, V91, p1478S, DOI 10.3945/ajcn.2010.28674I; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Ilouz R, 2002, BIOCHEM BIOPH RES CO, V295, P102, DOI 10.1016/S0006-291X(02)00636-8; Islam MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061776; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Lowe NM, 2009, AM J CLIN NUTR, V89, p2040S, DOI 10.3945/ajcn.2009.27230G; Lowe NM, 2004, J NUTR, V134, P2178, DOI 10.1093/jn/134.9.2178; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Obeid O, 2008, BIOL TRACE ELEM RES, V123, P58, DOI 10.1007/s12011-008-8112-0; Otto MCD, 2012, J NUTR, V142, P526, DOI 10.3945/jn.111.149781; Partida-Hernandez G, 2006, BIOMED PHARMACOTHER, V60, P161, DOI 10.1016/j.biopha.2006.02.004; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Roozbeh J, 2009, RENAL FAILURE, V31, P798, DOI 10.3109/08860220903216055; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sutherland JP, 2004, METAB SYNDR RELAT D, V2, P82, DOI 10.1089/met.2004.2.82; Tang XH, 2001, J NUTR, V131, P1414, DOI 10.1093/jn/131.5.1414; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Vashum KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083944; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yu YH, 2012, NUTR RES, V32, P71, DOI 10.1016/j.nutres.2011.12.004; Zangger K, 2001, FASEB J, V15, P1303, DOI 10.1096/fj.00-0641fje	48	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105990	10.1371/journal.pone.0105990	http://dx.doi.org/10.1371/journal.pone.0105990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153887	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200101
J	Kim, JY; Goo, YK; Ji, SY; Shin, HI; Han, ET; Hong, Y; Chung, DI; Cho, SH; Lee, WJ				Kim, Jung-Yeon; Goo, Youn-Kyoung; Ji, So-Young; Shin, Hyun-Il; Han, Eun-Taek; Hong, Yeonchul; Chung, Dong-Il; Cho, Shin-Hyung; Lee, Won-Ja			Development and Efficacy of Real-Time PCR in the Diagnosis of Vivax Malaria Using Field Samples in the Republic of Korea	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PLASMODIUM-FALCIPARUM; ASSAY; MICROSCOPY; TESTS; IDENTIFICATION; AMPLIFICATION; ACCURACY; OVALE	The development of sensitive, rapid, and accurate diagnostic methods for vivax malaria is essential for the effective control of malaria in the Republic of Korea, where vivax malaria patients usually show low parasitemia. In this study, a TaqMan-based real-time polymerase chain reaction (PCR) method was established and compared with other PCR-based assays, including nested PCR, loop-mediated isothermal amplification, and multiplex PCR, using samples from febrile patients with suspected vivax malaria. The established real-time PCR had a high sensitivity (99.6%) and specificity (100%). Therefore, this sensitive, specific, rapid, and quantitative real-time PCR method could be used for the routine diagnosis of vivax malaria in the laboratory of the Korea National Institute of Health.	[Kim, Jung-Yeon; Goo, Youn-Kyoung; Ji, So-Young; Shin, Hyun-Il; Cho, Shin-Hyung; Lee, Won-Ja] Korea CDC, Natl Inst Hlth, Div Malaria & Parasit Dis, Osong, South Korea; [Goo, Youn-Kyoung; Hong, Yeonchul; Chung, Dong-Il] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Taegu, South Korea; [Han, Eun-Taek] Kangwon Natl Univ, Coll Med, Dept Parasitol, Chunchon, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Kyungpook National University; Kangwon National University	Lee, WJ (corresponding author), Korea CDC, Natl Inst Hlth, Div Malaria & Parasit Dis, Osong Saeng Myeong 2 Ro, Osong, South Korea.	leewonja@gmail.com			Korea National Institute of Health, Korea CDC [4847-311-210-13]	Korea National Institute of Health, Korea CDC	This work was supported by funding (4847-311-210-13) from the Korea National Institute of Health, Korea CDC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-175; Alemu A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-174; APMEN, 2013, EL MAL REP KOR; Barber BE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-8; Bates I, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-38; Berry A, 2005, Med Trop (Mars), V65, P176; Chen JH, 2010, ACTA TROP, V113, P61, DOI 10.1016/j.actatropica.2009.09.007; Chew CH, 2012, J CLIN MICROBIOL, V50, P4012, DOI 10.1128/JCM.06454-11; Coleman RE, 2002, AM J TROP MED HYG, V67, P141, DOI 10.4269/ajtmh.2002.67.141; Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011; Haanshuus CG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-26; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Han Eun-Taek, 2006, Korean Journal of Parasitology, V44, P285, DOI 10.3347/kjp.2006.44.4.285; Hwang SY, 2011, ACTA TROP, V120, P40, DOI 10.1016/j.actatropica.2011.05.006; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; Kawamoto F, 1996, J CLIN MICROBIOL, V34, P2287, DOI 10.1128/JCM.34.9.2287-2289.1996; KIM J, 2013, NATL GEOGR, V224, P8; Krogstad DJ, 1996, EPIDEMIOL REV, V18, P77, DOI 10.1093/oxfordjournals.epirev.a017918; Kuamsab N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-190; Lee MA, 2002, J CLIN MICROBIOL, V40, P4343, DOI 10.1128/JCM.40.11.4343-4345.2002; Linard C, 2009, ECOHEALTH, V6, P135, DOI 10.1007/s10393-009-0236-y; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Rubio JM, 2001, J CLIN MICROBIOL, V39, P2736, DOI 10.1128/JCM.39.7.2736-2737.2001; Santana-Morales MA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-199; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; WHO, 2013, WHO MAL REP; WHO, 2012, REG ACT PLAN MAL CON; Zhong KJY, 1999, J CLIN MICROBIOL, V37, P339, DOI 10.1128/JCM.37.2.339-341.1999	30	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105871	10.1371/journal.pone.0105871	http://dx.doi.org/10.1371/journal.pone.0105871			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148038	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600091
J	Zhang, Y; Dai, SL; Hong, Y; Song, XB				Zhang, Yuan; Dai, Silan; Hong, Yan; Song, Xuebin			Application of Genomic SSR Locus Polymorphisms on the Identification and Classification of Chrysanthemum Cultivars in China	PLOS ONE			English	Article							POPULATION-STRUCTURE; RAPD ANALYSIS; MARKERS; DIVERSITY; INFERENCE; ORIGIN; NUMBER	The Chinese traditional chrysanthemum is a notable group of chrysanthemums (Chrysanthemum x morifolium Ramat.) in which the phenotypic characteristics richly vary. At present, there is a serious controversy regarding homonyms and synonyms within this group. Moreover, the current international chrysanthemum classification systems are not comprehensive enough to be used on Chinese traditional chrysanthemums. Thus, we first identified a broad collection of 480 Chinese traditional chrysanthemum cultivars using the unique DNA fingerprints and molecular identities that were established by 20 simple sequence repeat markers. Five loci, which distinguished all of the selected cultivars, were identified as the core loci to establish unique fingerprints and molecular identities with 19 denary digits for each cultivar. A cluster analysis based on Nei's genetic distance indicated that the selected cultivars were clustered according to their horticultural classification. Population structure analysis was subsequently performed with K values ranging from 2 to 14, and the most likely estimate for the population structure was ten subpopulations, which was nearly consistent with the clustering result. Principal component analysis was further performed to verify the classification results. On the basis of the Q-matrices of K = 10, a total of 19 traits were found to be associated with 42 markers. Taken together, these results can serve as starting points for the identification and classification of chrysanthemums based on the polymorphism of microsatellite markers, which is beneficial to promote the marker-assisted breeding and international communication of this marvelous crop.	[Zhang, Yuan; Dai, Silan; Hong, Yan; Song, Xuebin] Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China	Beijing Forestry University	Dai, SL (corresponding author), Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China.	silandai@sina.com			National Special Research Project for Forestry Public Affairs [200904050]; Important Research Project for Knowledge Innovation of Chinese Academy of Sciences [2A2011311211021]	National Special Research Project for Forestry Public Affairs; Important Research Project for Knowledge Innovation of Chinese Academy of Sciences	This study was supported by the National Special Research Project for Forestry Public Affairs (Grant No. 200904050) and the Important Research Project for Knowledge Innovation of Chinese Academy of Sciences (Grant No. 2A2011311211021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NO, 2006, FLOWER BREEDING AND GENETICS: ISSUES, CHALLENGES AND OPPORTUNITIES FOR THE 21ST CENTURY, P389; Barakat MN, 2010, AFR J AGR RES, V5, P748; Boran FE, 2009, EXPERT SYST APPL, V36, P11363, DOI 10.1016/j.eswa.2009.03.039; Braglia L, 2010, SCI HORTIC-AMSTERDAM, V123, P372, DOI 10.1016/j.scienta.2009.10.003; Chen JY., 2001, TAXONOMY FLOWER CULT; Colburn J.C., 1992, CAPILLARY ELECTROPHO; Dai SL, 1998, ACTA BOT SIN, V40, P1053; De Castro O, 2013, ANN BOT-LONDON, V112, P589, DOI 10.1093/aob/mct134; DOWRICK GJ, 1966, EUPHYTICA, V15, P32; DREWLOW LW, 1973, THEOR APPL GENET, V43, P1, DOI 10.1007/BF00277824; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Garibaldi A, 2009, Commun Agric Appl Biol Sci, V74, P651; Gawenda I, 2012, MOL BREEDING, V30, P305, DOI 10.1007/s11032-011-9620-8; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Hong Yan, 2012, Acta Horticulturae Sinica, V39, P1330; Huang SC, 2000, BOT BULL ACAD SINICA, V41, P257; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kang EJ, 2013, HORTIC ENVIRON BIOTE, V54, P76, DOI 10.1007/s13580-013-0124-9; Klie M, 2013, MOL BREEDING, V32, P339, DOI 10.1007/s11032-013-9874-4; Lema-Ruminska J, 2004, PLANT BREEDING, V123, P290, DOI 10.1111/j.1439-0523.2004.00996.x; Li N, 2011, HUNAN AGR SCI, V8, P27; Li RenWei, 2012, Scientia Agricultura Sinica, V45, P1355; Li Y, 2012, NO HORT, V13, P127; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Martin C, 2002, EUPHYTICA, V127, P247, DOI 10.1023/A:1020215016347; Masuda Y., 2009, CHROMOSOME BOT, V4, P25; Mezmouk S, 2011, THEOR APPL GENET, V122, P1149, DOI 10.1007/s00122-010-1519-y; Ministry of Agriculture Forestry and Fisheries of Japan, 2012, CHRYS CHRYS MOR RAM; Ministry of Agriculture of the People's Republic of China, 2002, HDB DIST UN STAB TES; National Chrysanthemum Society of the United Kingdom, 2013, CHRYS CLASS; National Chrysanthemum Society of the United States of America, 2012, HDB CHRYS CLASS; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2001, GENETICS, V159, P699; Ruan CJ, 2009, MOL BREEDING, V24, P255, DOI 10.1007/s11032-009-9288-5; Sehrawat SK, 2003, ACTA HORTIC, P479, DOI 10.17660/ActaHortic.2003.624.66; Shao QS, 2010, BIOCHEM SYST ECOL, V38, P1160, DOI 10.1016/j.bse.2010.11.002; Torfi F, 2010, APPL SOFT COMPUT, V10, P520, DOI 10.1016/j.asoc.2009.08.021; Uysal H, 2010, GENET RESOUR CROP EV, V57, P1109, DOI 10.1007/s10722-010-9551-y; WOLFF K, 1995, THEOR APPL GENET, V91, P439, DOI 10.1007/BF00222971; Wolff K, 1996, EUPHYTICA, V89, P159, DOI 10.1007/BF00034601; Xie RJ, 2011, PLANT MOL BIOL REP, V29, P554, DOI 10.1007/s11105-010-0261-6; Yang WH, 2006, NEW PHYTOL, V171, P875, DOI 10.1111/j.1469-8137.2006.01779.x; Yuan JH, 2014, MOL ECOL, V23, P82, DOI 10.1111/mec.12567; Zhang F, 2012, SCI HORTIC-AMSTERDAM, V139, P39, DOI 10.1016/j.scienta.2012.03.002; Zhang F, 2011, MOL BREEDING, V27, P11, DOI 10.1007/s11032-010-9409-1; Zhang F, 2010, SCI HORTIC-AMSTERDAM, V125, P422, DOI 10.1016/j.scienta.2010.03.028; Zhang Y, 2014, J SYST EVOL IN PRESS; Zhang Y, 2013, J AM SOC HORTIC SCI, V138, P38, DOI 10.21273/JASHS.138.1.38; Zhang Y, 2013, J SYST EVOL, V51, P335, DOI 10.1111/j.1759-6831.2012.00235.x	52	27	31	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104856	10.1371/journal.pone.0104856	http://dx.doi.org/10.1371/journal.pone.0104856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148046	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600025
J	Kamel, W; Segerman, B; Punga, T; Akusjarvi, G				Kamel, Wael; Segerman, Bo; Punga, Tanel; Akusjarvi, Goran			Small RNA Sequence Analysis of Adenovirus VA RNA-Derived MiRNAs Reveals an Unexpected Serotype-Specific Difference in Structure and Abundance	PLOS ONE			English	Article							VIRUS-ASSOCIATED RNA; INDUCED SILENCING COMPLEX; MICRORNA BIOGENESIS; CELLS; INTERFERENCE; TRANSCRIPTION; RECOGNITION; TRANSLATION; EVOLUTION; INFECTION	Human adenoviruses (HAds) encode for one or two highly abundant virus-associated RNAs, designated VA RNAI and VA RNAII, which fold into stable hairpin structures resembling miRNA precursors. Here we show that the terminal stem of the VA RNAs originating from Ad4, Ad5, Ad11 and Ad37, all undergo Dicer dependent processing into virus-specific miRNAs (so-called mivaRNAs). We further show that the mivaRNA duplex is subjected to a highly asymmetric RISC loading with the 3'-strand from all VA RNAs being the favored strand, except for the Ad37 VA RNAII, where the 5'-mivaRNAII strand was preferentially assembled into RISC. Although the mivaRNA seed sequences are not fully conserved between the HAds a bioinformatics prediction approach suggests that a large fraction of the VA RNAII-, but not the VA RNAI-derived mivaRNAs still are able to target the same cellular genes. Using small RNA deep sequencing we demonstrate that the Dicer processing event in the terminal stem of the VA RNAs is not unique and generates 3'-mivaRNAs with a slight variation of the position of the 5'-terminal nucleotide in the RISC loaded guide strand. Also, we show that all analyzed VA RNAs, except Ad37 VA RNAI and Ad5 VA RNAII, utilize an alternative upstream A start site in addition to the classical +1 G start site. Further, the 5'-mivaRNAs with an A start appears to be preferentially incorporated into RISC. Although the majority of mivaRNA research has been done using Ad5 as the model system our analysis demonstrates that the mivaRNAs expressed in Ad11- and Ad37-infected cells are the most abundant mivaRNAs associated with Ago2-containing RISC. Collectively, our results show an unexpected variability in Dicer processing of the VA RNAs and a serotype-specific loading of mivaRNAs into Ago2-based RISC.	[Kamel, Wael; Punga, Tanel; Akusjarvi, Goran] Uppsala Univ, Sci Life Lab, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Segerman, Bo] Natl Vet Inst, S-75007 Uppsala, Sweden	Uppsala University; National Veterinary Institute SVA	Akusjarvi, G (corresponding author), Uppsala Univ, Sci Life Lab, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.	goran.akusjarvi@imbim.uu.se	Kamel, Wael/AAD-4645-2022; Punga, Tanel/K-9844-2019	Kamel, Wael/0000-0002-7625-2648; Punga, Tanel/0000-0002-0561-367X	Swedish Cancer Society [13 0469, 12 0504]; Swedish Research Council [K2012-99X-21959-01-3, 2006-5038-36531-16]; Ake Wibergs Foundation [924563923]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wibergs Foundation	This study was supported by the Swedish Cancer Society (http://Cancerfonden.se; GA 13 0469, TP 12 0504), The Swedish Research Council (http://vr.se; TP K2012-99X-21959-01-3), The Swedish Research Council through a grant to the Uppsala RNA Research Centre (URRC) (http://urrc-linnaeuscentre.uu.se; GA and TP, 2006-5038-36531-16), and the Ake Wibergs Foundation (http://ake-wiberg.se; TP 924563923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Aparicio O, 2010, NUCLEIC ACIDS RES, V38, P750, DOI 10.1093/nar/gkp1028; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BHAT RA, 1984, NUCLEIC ACIDS RES, V12, P7377, DOI 10.1093/nar/12.19.7377; Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07; Enright AJ, 2004, GENOME BIOL, V5; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Furuse Y, 2013, VIROLOGY, V447, P140, DOI 10.1016/j.virol.2013.08.024; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Kamel W, 2013, NUCLEIC ACIDS RES, V41, P4802, DOI 10.1093/nar/gkt172; KITAJEWSKI J, 1986, CELL, V45, P195, DOI 10.1016/0092-8674(86)90383-1; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Ma YL, 1996, J VIROL, V70, P5083, DOI 10.1128/JVI.70.8.5083-5099.1996; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; OMALLEY RP, 1986, CELL, V44, P391, DOI 10.1016/0092-8674(86)90460-5; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; PHILIPSON L, 1961, VIROLOGY, V15, P263, DOI 10.1016/0042-6822(61)90357-9; Punga T, 2013, FUTURE VIROL, V8, P343, DOI 10.2217/FVL.13.19; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Sano M, 2006, FEBS LETT, V580, P1553, DOI 10.1016/j.febslet.2006.01.085; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; THIMMAPPAYA B, 1982, CELL, V31, P543, DOI 10.1016/0092-8674(82)90310-5; VENNSTROM B, 1978, NUCLEIC ACIDS RES, V5, P205, DOI 10.1093/nar/5.1.205; WARREN D, 1989, J INFECT DIS, V160, P938, DOI 10.1093/infdis/160.6.938; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Xu N, 2007, J VIROL, V81, P10540, DOI 10.1128/JVI.00885-07; Xu N, 2011, METHODS MOL BIOL, V721, P183, DOI 10.1007/978-1-61779-037-9_11; Xu N, 2009, NUCLEIC ACIDS RES, V37, P6950, DOI 10.1093/nar/gkp764; Zhao HX, 2013, VIROLOGY, V442, P148, DOI 10.1016/j.virol.2013.04.006	34	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105746	10.1371/journal.pone.0105746	http://dx.doi.org/10.1371/journal.pone.0105746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144466	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100115
J	Lien, HM; Tseng, CJ; Huang, CL; Lin, YT; Chen, CC; Lai, YY				Lien, Hsiu-Man; Tseng, Chin-Jui; Huang, Chao-Lu; Lin, Yu-Ting; Chen, Chia-Chang; Lai, Ya-Yun			Antimicrobial Activity of Antrodia camphorata Extracts against Oral Bacteria	PLOS ONE			English	Article							DENTAL-CARIES PREVENTION; KAPPA-B ACTIVATION; STREPTOCOCCUS-MUTANS; MEDICINES; MYCELIA; DAMAGE	Antrodia camphorata (A. camphorata) is a unique, endemic and extremely rare mushroom species native to Taiwan, and both crude extracts of and purified chemical compounds from A. camphorata have been reported to have a variety of significant beneficial effects, such as anti-tumor and anti-inflammatory activity. However, reports on the effects of A. camphorata against dental pathogens have been limited. Oral health is now recognized as important for overall general health, including conditions such as dental caries, periodontal disease and rheumatoid arthritis. Streptococcus mutans (S. mutans) and Porphyromonas gingivalis (P. gingivalis) are the most common bacteria associated with dental plaque and periodontopathic diseases, respectively. Thus, our study examined the ability of five various crude extracts of A. camphorata to inhibit the growth of dental bacteria and anti-adherence in vitro. Among the extracts, the ethanol, ethyl acetate and chloroform extracts exhibited the lowest MICs against P. gingivalis and S. mutans (MIC = 4 similar to 16 mu g/mL). The MIC of the aqueous extract was greater than 2048 mu g/mL against both P. gingivalis and S. mutans. In vitro adherence of S. mutans was significantly inhibited by the addition of either the ethyl acetate extract or chloroform extract (MIC = 16 similar to 24 mu g/mL), while the ethanol extract (MIC = 32 similar to 64 mu g/mL) exhibited moderate inhibitory activity. Based on the result of this study, the ethyl acetate and chloroform extracts of A. camphorata may be good candidates for oral hygiene agents to control dental caries and periodontopathic conditions.	[Lien, Hsiu-Man] Tunghai Univ, Dept Chem, Taichung 40704, Taiwan; [Tseng, Chin-Jui] Natl Chung Hsing Univ, Dept Chem, Taichung 40227, Taiwan; [Huang, Chao-Lu] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lin, Yu-Ting] Natl Ilan Univ, Dept Food Sci, Ilan, Taiwan; [Chen, Chia-Chang] Feng Chia Univ, Sch Management Dept, Taichung 40724, Taiwan; [Lai, Ya-Yun] Natl Tainan Inst Nursing, Dept Appl Cosmetol, Tainan, Taiwan; [Chen, Chia-Chang] Yusheng Biotechnol Co Ltd, Taichung, Taiwan	Tunghai University; National Chung Hsing University; National Chung Hsing University; National Ilan University; Feng Chia University	Lai, YY (corresponding author), Natl Tainan Inst Nursing, Dept Appl Cosmetol, Tainan, Taiwan.	yayun819@gmail.com			Yusheng Biotechnology Co. Ltd.	Yusheng Biotechnology Co. Ltd.	The study is funded by Yusheng Biotechnology Co. Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlutti F, 2010, INT J IMMUNOPATH PH, V23, P1253, DOI 10.1177/039463201002300430; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Chen CC, 2007, J AGR FOOD CHEM, V55, P5007, DOI 10.1021/jf063484c; Chen YC, 2011, ACTA PHARMACOL SIN, V32, P904, DOI 10.1038/aps.2011.36; Chien SC, 2008, J AGR FOOD CHEM, V56, P7017, DOI 10.1021/jf801171x; GIBBONS RJ, 1974, INFECT IMMUN, V9, P481, DOI 10.1128/IAI.9.3.481-488.1974; HOMER KA, 1990, ARCH ORAL BIOL, V35, P421, DOI 10.1016/0003-9969(90)90203-M; Hseu YC, 2002, LIFE SCI, V71, P469, DOI 10.1016/S0024-3205(02)01686-7; Hseu YC, 2008, FOOD CHEM TOXICOL, V46, P2680, DOI 10.1016/j.fct.2008.04.036; Hseu YC, 2008, J ETHNOPHARMACOL, V118, P237, DOI 10.1016/j.jep.2008.04.004; Hseu YC, 2010, FOOD CHEM TOXICOL, V48, P2319, DOI 10.1016/j.fct.2010.05.066; KAKIUCHI N, 1986, CHEM PHARM BULL, V34, P720; Kang MS, 2008, J MICROBIOL, V46, P744, DOI 10.1007/s12275-008-0235-7; Lee YP, 2012, ANTICANCER RES, V32, P2727; LIEN HM, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEP020; Lu MC, 2009, ARCH TOXICOL, V83, P121, DOI 10.1007/s00204-008-0337-3; MCDONALD JL, 1978, J DENT RES, V57, P349, DOI 10.1177/00220345780570023501; NAMBA T, 1982, PLANTA MED, V44, P100, DOI 10.1055/s-2007-971412; Sheu F, 2009, J AGR FOOD CHEM, V57, P4130, DOI 10.1021/jf900469a; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Wong RWK, 2010, INT J ORAL MAX SURG, V39, P599, DOI 10.1016/j.ijom.2010.02.024; Woods R, 1971, Aust Dent J, V16, P116; Xu X, 2011, ANTIMICROB AGENTS CH, V55, P1229, DOI 10.1128/AAC.01016-10	23	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105286	10.1371/journal.pone.0105286	http://dx.doi.org/10.1371/journal.pone.0105286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144619	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100047
J	Mukai, T; Gallant, R; Ishida, S; Yoshitaka, T; Kittaka, M; Nishida, K; Fox, DA; Morita, Y; Ueki, Y				Mukai, Tomoyuki; Gallant, Richard; Ishida, Shu; Yoshitaka, Teruhito; Kittaka, Mizuho; Nishida, Keiichiro; Fox, David A.; Morita, Yoshitaka; Ueki, Yasuyoshi			SH3BP2 Gain-Of-Function Mutation Exacerbates Inflammation and Bone Loss in a Murine Collagen-Induced Arthritis Model	PLOS ONE			English	Article							ADAPTER PROTEIN 3BP2; COLONY-STIMULATING FACTOR; KAPPA-B LIGAND; T-CELLS; RHEUMATOID-ARTHRITIS; RECEPTOR ACTIVATOR; NUCLEAR-FACTOR; M-CSF; MICE; CHERUBISM	Objective: SH3BP2 is a signaling adapter protein which regulates immune and skeletal systems. Gain-of-function mutations in SH3BP2 cause cherubism, characterized by jawbone destruction. This study was aimed to examine the role of SH3BP2 in inflammatory bone loss using a collagen-induced arthritis (CIA) model. Methods: CIA was induced in wild-type (Sh3bp2(+/+)) and heterozygous P416R SH3BP2 cherubism mutant knock-in (Sh3bp2(KI/+)) mice, an SH3BP2 gain-of-function model. Severity of the arthritis was determined by assessing the paw swelling and histological analyses of the joints. Micro-CT analysis was used to determine the levels of bone loss. Inflammation and osteoclastogenesis in the joints were evaluated by quantitating the gene expression of inflammatory cytokines and osteoclast markers. Furthermore, involvement of the T- and B-cell responses was determined by draining lymph node cell culture and measurement of the serum anti-mouse type II collagen antibody levels, respectively. Finally, roles of the SH3BP2 mutation in macrophage activation and osteoclastogenesis were determined by evaluating the TNF-alpha production levels and osteoclast formation in bone marrow-derived M-CSF-dependent macrophage (BMM) cultures. Results: Sh3bp2(KI/+) mice exhibited more severe inflammation and bone loss, accompanying an increased number of osteoclasts. The mRNA levels for TNF-alpha and osteoclast marker genes were higher in the joints of Sh3bp2(KI/+) mice. Lymph node cell culture showed that lymphocyte proliferation and IFN-gamma and IL-17 production were comparable between Sh3bp(2+/+) and Sh3bp2(KI/+) cells. Serum anti-type II collagen antibody levels were comparable between Sh3bp(2+/+) and Sh3bp2(KI/+) mice. In vitro experiments showed that TNF-alpha production in Sh3bp2(KI/+) BMMs is elevated compared with Sh3bp(2+/+) BMMs and that RANKL-induced osteoclastogenesis is enhanced in Sh3bp2(KI/+) BMMs associated with increased NFATc1 nuclear localization. Conclusion: Gain-of-function of SH3BP2 augments inflammation and bone loss in the CIA model through increased macrophage activation and osteoclast formation. Therefore, modulation of the SH3BP2 expression may have therapeutic potential for the treatment of rheumatoid arthritis.	[Mukai, Tomoyuki; Gallant, Richard; Ishida, Shu; Yoshitaka, Teruhito; Kittaka, Mizuho; Ueki, Yasuyoshi] Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 64110 USA; [Ishida, Shu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Inst Biomed & Hlth Sci, Dept Periodontal Med, Hiroshima, Japan; [Nishida, Keiichiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg, Okayama, Japan; [Nishida, Keiichiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Morphol, Okayama, Japan; [Fox, David A.] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Morita, Yoshitaka] Kawasaki Med Sch, Dept Rheumatol, Kurashiki, Okayama, Japan	University of Missouri System; University of Missouri Kansas City; Hiroshima University; Okayama University; Okayama University; University of Michigan System; University of Michigan; Kawasaki Medical School	Ueki, Y (corresponding author), Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 64110 USA.	uekiy@umkc.edu	Mukai, Tomoyuki/AAP-5771-2021; Kittaka, Mizuho/AAT-7398-2021; NISHIDA, Keiichiro/B-2014-2011	Nishida, Keiichiro/0000-0003-1260-586X; Mukai, Tomoyuki/0000-0002-0103-1621	National Institute of Health [R01DE020835]; Japan Rheumatism Foundation; Kawasaki Medical School [25-83]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020835] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Rheumatism Foundation(Japan Rheumatism Foundation); Kawasaki Medical School; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants from the National Institute of Health (R01DE020835) to YU, the Japan Rheumatism Foundation (Rheumatology Traveling Fellowship) to TM, and Research Project Grants from Kawasaki Medical School (No. 25-83) to YM. The URLs of the funders' website are http://www.nih.gov/, http://www.rheuma-net.or.jp/rheuma/e-rheuma/e-index.htm, and http://www.kawasaki-m.ac.jp/med/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; BRUCE KW, 1953, ORAL SURG ORAL MED O, V6, P995, DOI 10.1016/0898-1221(53)90139-4; Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144; Campbell IK, 2000, EUR J IMMUNOL, V30, P1568, DOI 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; Chen G, 2012, J IMMUNOL, V189, P2138, DOI 10.4049/jimmunol.1103184; Chihara K, 2014, EXP CELL RES, V322, P99, DOI 10.1016/j.yexcr.2013.12.026; Cho YG, 2007, AUTOIMMUN REV, V7, P65, DOI 10.1016/j.autrev.2007.08.001; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Geusens P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3375; Gizinski AM, 2014, CURR OPIN RHEUMATOL, V26, P204, DOI 10.1097/BOR.0000000000000036; GOUGH AKS, 1994, LANCET, V344, P23, DOI 10.1016/S0140-6736(94)91049-9; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; GuezGuez A, 2010, J BIOL CHEM, V285, P20952, DOI 10.1074/jbc.M109.091124; Hatani T, 2008, CURR MED CHEM, V15, P549; Hutamekalin P, 2009, J IMMUNOL METHODS, V343, P49, DOI 10.1016/j.jim.2009.01.009; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Jevremovic D, 2001, J IMMUNOL, V166, P7219, DOI 10.4049/jimmunol.166.12.7219; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; Knevel R, 2013, ANN RHEUM DIS; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Levaot N, 2011, J CLIN INVEST, V121, P3244, DOI 10.1172/JCI45843; McClendon JL, 1962, ORAL SURG         S2, V15, P17; Morita Y, 2001, J CLIN INVEST, V107, P1275, DOI 10.1172/JCI11490; Mukai T, 2014, J BONE MINER RES, V29, P2618, DOI 10.1002/jbmr.2295; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakano K, 2007, RHEUMATOLOGY, V46, P597, DOI 10.1093/rheumatology/kel356; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Gradaigh D, 2004, ANN RHEUM DIS, V63, P354, DOI 10.1136/ard.2003.008458; Ogi K, 2011, GENES CELLS, V16, P951, DOI 10.1111/j.1365-2443.2011.01539.x; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Papadaki ME, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-S1-S6; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Proulx ST, 2007, ARTHRITIS RHEUM-US, V56, P4024, DOI 10.1002/art.23128; Proulx-Bonneau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021511; Qu XJ, 2005, BIOCHEMISTRY-US, V44, P3891, DOI 10.1021/bi048353o; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Rioja I, 2004, CLIN EXP IMMUNOL, V137, P65, DOI 10.1111/j.1365-2249.2004.02499.x; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; Southgate J, 1998, J CLIN PATHOL, V51, P831, DOI 10.1136/jcp.51.11.831; STUART JM, 1982, J CLIN INVEST, V69, P673, DOI 10.1172/JCI110495; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061045; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Tada Y, 1996, J IMMUNOL, V156, P4520; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Tanabe N, 2011, J BIOL CHEM, V286, P39871, DOI 10.1074/jbc.M111.295048; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721; van Staa TP, 2006, ARTHRITIS RHEUM-US, V54, P3104, DOI 10.1002/art.22117; Wang CCJ, 2010, BONE, V46, P1306, DOI 10.1016/j.bone.2010.01.380; WAYMAN JB, 1978, BRIT J ORAL SURG, V16, P47, DOI 10.1016/S0007-117X(78)80055-9; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang PT, 2006, ANN RHEUM DIS, V65, P1671, DOI 10.1136/ard.2006.054874; Yoshitaka T, 2014, J BONE MINER RES, V29, P1170, DOI 10.1002/jbmr.2125	68	15	39	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105518	10.1371/journal.pone.0105518	http://dx.doi.org/10.1371/journal.pone.0105518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144740	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100079
J	Sakai, F; Hosoya, T; Ono-Ohmachi, A; Ukibe, K; Ogawa, A; Moriya, T; Kadooka, Y; Shiozaki, T; Nakagawa, H; Nakayama, Y; Miyazaki, T				Sakai, Fumihiko; Hosoya, Tomohiro; Ono-Ohmachi, Aiko; Ukibe, Ken; Ogawa, Akihiro; Moriya, Tomohiro; Kadooka, Yukio; Shiozaki, Takuya; Nakagawa, Hisako; Nakayama, Yosuke; Miyazaki, Tadaaki			Lactobacillus gasseri SBT2055 Induces TGF-beta Expression in Dendritic Cells and Activates TLR2 Signal to Produce IgA in the Small Intestine	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; INDUCED CYTIDINE DEAMINASE; NAIVE B-CELLS; AUTOCRINE/PARACRINE TGF-BETA-1; IMMUNE-RESPONSE; ADIPOCYTE SIZE; MILK; BAFF; TACI; LYMPHOCYTES	Probiotic bacteria provide benefits in enhancing host immune responses and protecting against infection. Induction of IgA production by oral administration of probiotic bacteria in the intestine has been considered to be one reason for this beneficial effect, but the mechanisms of the effect are poorly understood. Lactobacillus gasseri SBT2055 (LG2055) is a probiotic bacterium with properties such as bile tolerance, ability to improve the intestinal environment, and it has preventive effects related to abdominal adiposity. In this study, we have found that oral administration of LG2055 induced IgA production and increased the rate of IgA(+) cell population in Peyer's patch and in the lamina propria of the mouse small intestine. The LG2055 markedly increased the amount of IgA in a co-culture of B cells and bone marrow derived dendritic cells (BMDC), and TLR2 signal is critical for it. In addition, it is demonstrated that LG2055 stimulates BMDC to promote the production of TGF-beta, BAFF, IL-6, and IL-10, all critical for IgA production from B cells. Combined stimulation of B cells with BAFF and LG2055 enhanced the induction of IgA production. Further, TGF-beta signal was shown to be critical for LG2055-induced IgA production in the B cell and BMDC co-culture system, but TGF-beta did not induce IgA production in a culture of only B cells stimulated with LG2055. Furthermore, TGF-beta was critical for the production of BAFF, IL-6, IL-10, and TGF-beta itself from LG2055-stimulated BMDC. These results demonstrate that TGF-beta was produced by BMDC stimulated with LG2055 and it has an autocrine/paracrine function essential for BMDC to induce the production of BAFF, IL-6, and IL-10.	[Sakai, Fumihiko; Hosoya, Tomohiro; Ono-Ohmachi, Aiko; Ukibe, Ken; Ogawa, Akihiro; Moriya, Tomohiro; Kadooka, Yukio] Megmilk Snow Brand Co Ltd, Milk Sci Res Inst, Kawagoe, Saitama, Japan; [Shiozaki, Takuya; Nakagawa, Hisako; Nakayama, Yosuke; Miyazaki, Tadaaki] Hokkaido Univ, Dept Probiot Immunol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University	Miyazaki, T (corresponding author), Hokkaido Univ, Dept Probiot Immunol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan.	miyazaki@pop.med.hokudai.ac.jp	Ono-Ohmachi, A./ABE-9461-2021	Omachi, Aiko/0000-0002-8272-3071	Megmilk Snow Brand Co., Ltd.	Megmilk Snow Brand Co., Ltd.	This study was funded by Megmilk Snow Brand Co., Ltd. The funder provided support in the form of salaries for authors (Fumihiko Sakai, Tomohiro Hosoya, Aiko Ono-Ohmachi, Ken Ukibe, Akihiro Ogawa, Tomohiro Moriya, and Yukio Kadooka), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Belladonna ML, 2008, J IMMUNOL, V181, P5194, DOI 10.4049/jimmunol.181.8.5194; Bobr A, 2012, P NATL ACAD SCI USA, V109, P10492, DOI 10.1073/pnas.1119178109; Burt JR RW, 1999, TXB GASTROENTEROLOGY, P1995; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CONLEY ME, 1987, ANN INTERN MED, V106, P892, DOI 10.7326/0003-4819-106-6-892; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Dongarra ML, 2013, CURR ALLERGY ASTHM R, V13, P19, DOI 10.1007/s11882-012-0313-0; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2008, CURR OPIN IMMUNOL, V20, P170, DOI 10.1016/j.coi.2008.04.002; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fayette J, 1998, SCAND J IMMUNOL, V48, P563; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Feng T, 2010, J IMMUNOL, V185, P5915, DOI 10.4049/jimmunol.1001233; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Fujiwara S, 2001, J APPL MICROBIOL, V90, P343, DOI 10.1046/j.1365-2672.2001.01251.x; Galdeano CM, 2006, CLIN VACCINE IMMUNOL, V13, P219, DOI 10.1128/CVI.13.2.219-226.2006; group RoajFWw, 2002, GUID EV PROB FOOD; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; Harata G, 2009, MICROBIOL IMMUNOL, V53, P475, DOI 10.1111/j.1348-0421.2009.00146.x; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kadooka Y, 2012, J PEDIATR GASTR NUTR, V55, P66, DOI 10.1097/MPG.0b013e3182533a2b; Kajimoto O HH, 2002, JPN J LACTIC ACID BA, V13, P114; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kim HA, 2008, J LEUKOCYTE BIOL, V83, P1431, DOI 10.1189/jlb.1007676; Galdeano CM, 2009, J DAIRY RES, V76, P446, DOI 10.1017/S0022029909990021; Massacand JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002588; Matsuzaki T, 2007, J NUTR, V137, p798S, DOI 10.1093/jn/137.3.798S; MESTECKY J, 1986, CLIN IMMUNOL IMMUNOP, V40, P105, DOI 10.1016/0090-1229(86)90073-5; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Nakanishi Y, 2005, CYTOTECHNOLOGY, V47, P69, DOI 10.1007/s10616-005-3776-1; Ouwehand AC, 2007, J NUTR, V137, p794S, DOI 10.1093/jn/137.3.794S; Park JH, 2005, J FOOD PROTECT, V68, P571, DOI 10.4315/0362-028X-68.3.571; Park JH, 2002, CELL IMMUNOL, V219, P22, DOI 10.1016/S0008-8749(02)00579-8; Perdigon G, 2001, Curr Issues Intest Microbiol, V2, P27; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Sasaki M, 1996, MICROBIOL-UK, V142, P799, DOI 10.1099/00221287-142-4-799; Sashihara T, 2006, J DAIRY SCI, V89, P2846, DOI 10.3168/jds.S0022-0302(06)72557-7; Sato M, 2008, BRIT J NUTR, V99, P1013, DOI 10.1017/S0007114507839006; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Takahashi H, 2006, MICROBIOL IMMUNOL, V50, P867, DOI 10.1111/j.1348-0421.2006.tb03862.x; Takiguchi R., 1998, Journal of Intestinal Microbiology, V11, P117; Talham GL, 1999, INFECT IMMUN, V67, P1992; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Usman, 1999, J DAIRY SCI, V82, P243, DOI 10.3168/jds.S0022-0302(99)75229-X; Vinderola G, 2006, CYTOKINE, V36, P254, DOI 10.1016/j.cyto.2007.01.003; Yanagibashi T, 2009, BIOSCI BIOTECH BIOCH, V73, P372, DOI 10.1271/bbb.80612; Zan H, 1998, J IMMUNOL, V161, P5217	56	62	68	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105370	10.1371/journal.pone.0105370	http://dx.doi.org/10.1371/journal.pone.0105370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144744	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100059
J	Cao, F; Zhang, C; Doan, TTV; Li, Y; Sangi, DH; Koh, JS; Huynh, NA; Bin Aziz, MF; Choo, HY; Ikeda, K; Abbeel, P; Maharbiz, MM; Sato, H				Cao, Feng; Zhang, Chao; Tat Thang Vo Doan; Li, Yao; Sangi, Daniyal Haider; Koh, Jie Sheng; Ngoc Anh Huynh; Bin Aziz, Mohamed Fareez; Choo, Hao Yu; Ikeda, Kazuo; Abbeel, Pieter; Maharbiz, Michel M.; Sato, Hirotaka			A Biological Micro Actuator: Graded and Closed-Loop Control of Insect Leg Motion by Electrical Stimulation of Muscles	PLOS ONE			English	Article							CARBON-DIOXIDE; LOCUST FLIGHT; BIOFUEL CELL; STICK INSECT; COCKROACH; WALKING; KINEMATICS; FREQUENCY	In this study, a biological microactuator was demonstrated by closed-loop motion control of the front leg of an insect (Mecynorrhina torquata, beetle) via electrical stimulation of the leg muscles. The three antagonistic pairs of muscle groups in the front leg enabled the actuator to have three degrees of freedom: protraction/retraction, levation/depression, and extension/flexion. We observed that the threshold amplitude (voltage) required to elicit leg motions was approximately 1.0 V; thus, we fixed the stimulation amplitude at 1.5 V to ensure a muscle response. The leg motions were finely graded by alternation of the stimulation frequencies: higher stimulation frequencies elicited larger leg angular displacement. A closed-loop control system was then developed, where the stimulation frequency was the manipulated variable for leg-muscle stimulation (output from the final control element to the leg muscle) and the angular displacement of the leg motion was the system response. This closed-loop control system, with an optimized proportional gain and update time, regulated the leg to set at predetermined angular positions. The average electrical stimulation power consumption per muscle group was 148 mu W. These findings related to and demonstrations of the leg motion control offer promise for the future development of a reliable, low-power, biological legged machine (i.e., an insect-machine hybrid legged robot).	[Cao, Feng; Zhang, Chao; Tat Thang Vo Doan; Li, Yao; Sangi, Daniyal Haider; Koh, Jie Sheng; Bin Aziz, Mohamed Fareez; Choo, Hao Yu; Sato, Hirotaka] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Ngoc Anh Huynh] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Ikeda, Kazuo] City Hope Natl Med Ctr, Div Neurosci, Duarte, CA 91010 USA; [Abbeel, Pieter; Maharbiz, Michel M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; City of Hope; University of California System; University of California Berkeley	Sato, H (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.	hirosato@ntu.edu.sg	Sato, Hirotaka/D-5203-2014; Vo-Doan, T. Thang/Y-9994-2019	Sato, Hirotaka/0000-0003-4634-1639; Vo-Doan, T. Thang/0000-0002-5065-5887	Nanyang Assistant Professorship (NAP) [M4080740]; Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF) [M4070190]; A*STAR-JST (The Japan Science and Technology Agency) [M4070198]	Nanyang Assistant Professorship (NAP); Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF)(Agency for Science Technology & Research (A*STAR)); A*STAR-JST (The Japan Science and Technology Agency)(Agency for Science Technology & Research (A*STAR))	The work is finacially supported by Nanyang Assistant Professorship (NAP, M4080740), Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF, M4070190), and A*STAR-JST (The Japan Science and Technology Agency) joint grant, M4070198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktakka EE, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/9/095016; Altendorfer R, 2001, AUTON ROBOT, V11, P207, DOI 10.1023/A:1012426720699; Badre NH, 2005, COMP BIOCHEM PHYS A, V140, P363, DOI 10.1016/j.cbpb.2005.01.019; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Branscome DD, 2005, PHYSIOL ENTOMOL, V30, P144, DOI 10.1111/j.1365-3032.2005.00439.x; BURNS MD, 1978, COMP BIOCHEM PHYS A, V61, P85, DOI 10.1016/0300-9629(78)90282-7; Buschges A, 2004, EUR J NEUROSCI, V19, P1856, DOI 10.1111/j.1460-9568.2004.03312.x; Colinet H, 2012, BIOL LETTERS, V8, P1050, DOI 10.1098/rsbl.2012.0601; Daly DC, 2010, IEEE J SOLID-ST CIRC, V45, P153, DOI 10.1109/JSSC.2009.2034433; de Haan A, 1998, EXP PHYSIOL, V83, P77, DOI 10.1113/expphysiol.1998.sp004093; DEBRODT B, 1990, ZOOL JAHRB ALLG ZOOL, V94, P101; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Fischer H, 1999, J EXP BIOL, V202, P711; FRIEDLANDER A, 1979, INSECT BIOCHEM, V9, P79, DOI 10.1016/0020-1790(79)90029-5; Guschlbauer C, 2007, J EXP BIOL, V210, P1092, DOI 10.1242/jeb.02729; Halamkova L, 2012, J AM CHEM SOC, V134, P5040, DOI 10.1021/ja211714w; Hinterwirth AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052725; Holzer R., 1997, Proceedings of the 1997 IEEE/RSJ International Conference on Intelligent Robot and Systems. Innovative Robotics for Real-World Applications. IROS '97 (Cat. No.97CH36108), P1514, DOI 10.1109/IROS.1997.656559; Kohut NJ, 2012, PROC SPIE, V8373, DOI 10.1117/12.917874; MALAMUD JG, 1991, J EXP BIOL, V159, P65; Milton CC, 2008, J INSECT PHYSIOL, V54, P32, DOI 10.1016/j.jinsphys.2007.08.001; Mu LY, 2005, J COMP PHYSIOL A, V191, P1037, DOI 10.1007/s00359-005-0029-x; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Rasmussen M, 2012, J AM CHEM SOC, V134, P1458, DOI 10.1021/ja210794c; Reissman T, 2011, PROC SPIE, V7977, DOI 10.1117/12.880702; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Shoji K., 2012, 2012 IEEE 25th International Conference on Micro Electro Mechanical Systems (MEMS), P1249, DOI 10.1109/MEMSYS.2012.6170415; Shoji K, 2012, BIOMED MICRODEVICES, V14, P1063, DOI 10.1007/s10544-012-9706-z; STEVENSON RD, 1990, J EXP BIOL, V149, P61; Tsang WM, 2010, IEEE T BIO-MED ENG, V57, P1757, DOI 10.1109/TBME.2010.2041778; Tubbs TB, 2011, INT J MICRO AIR VEH, V3, P101, DOI 10.1260/1756-8293.3.2.101; Wang HZ, 2008, J EXP BIOL, V211, P423, DOI 10.1242/jeb.011791; Watson JT, 1998, J COMP PHYSIOL A, V182, P11, DOI 10.1007/s003590050153	33	29	29	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105389	10.1371/journal.pone.0105389	http://dx.doi.org/10.1371/journal.pone.0105389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140875	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200084
J	Fuller, JC; Martinez, M; Wade, RC				Fuller, Jonathan C.; Martinez, Michael; Wade, Rebecca C.			On Calculation of the Electrostatic Potential of a Phosphatidylinositol Phosphate-Containing Phosphatidylcholine Lipid Membrane Accounting for Membrane Dynamics	PLOS ONE			English	Article							AMBER FORCE-FIELD; MOLECULAR-DYNAMICS; SIMULATIONS; CHARMM; BILAYERS; DOMAINS; RECOGNITION; VALIDATION; PROGRAM; ENERGY	Many signaling events require the binding of cytoplasmic proteins to cell membranes by recognition of specific charged lipids, such as phosphoinositol-phosphates. As a model for a protein-membrane binding site, we consider one charged phosphoinositol phosphate (PtdIns(3)P) embedded in a phosphatidylcholine bilayer. As the protein-membrane binding is driven by electrostatic interactions, continuum solvent models require an accurate representation of the electrostatic potential of the phosphoinositol phosphate-containing membrane. We computed and analyzed the electrostatic potentials of snapshots taken at regular intervals from molecular dynamics simulations of the bilayer. We observe considerable variation in the electrostatic potential of the bilayer both along a single simulation and between simulations performed with the GAFF or CHARMM c36 force fields. However, we find that the choice of GAFF or CHARMM c36 parameters has little effect on the electrostatic potential of a given configuration of the bilayer with a PtdIns(3)P embedded in it. From our results, we propose a remedian averaging method for calculating the electrostatic potential of a membrane system that is suitable for simulations of protein-membrane binding with a continuum solvent model.	[Fuller, Jonathan C.; Martinez, Michael; Wade, Rebecca C.] Heidelberg Inst Theoret Studies, Mol & Cellular Modeling Grp, Heidelberg, Germany; [Wade, Rebecca C.] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany	Heidelberg Institute for Theoretical Studies; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Fuller, JC (corresponding author), Heidelberg Inst Theoret Studies, Mol & Cellular Modeling Grp, Heidelberg, Germany.	jonathan.fuller@h-its.org; rebecca.wade@h-its.org	Wade, Rebecca/L-1489-2019	Wade, Rebecca/0000-0001-5951-8670; Fuller, Jonathan/0000-0001-8801-149X	Bundesministerium fur Bildung und Forschung (BMBF) Virtual Liver Network [0313076, 0313078C]; Klaus Tschira Foundation	Bundesministerium fur Bildung und Forschung (BMBF) Virtual Liver Network; Klaus Tschira Foundation	The authors gratefully acknowledge the financial support of the Bundesministerium fur Bildung und Forschung (BMBF) Virtual Liver Network (grant nos. 0313076 and 0313078C) and the Klaus Tschira Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Bockmann RA, 2003, BIOPHYS J, V85, P1647, DOI 10.1016/S0006-3495(03)74594-9; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Dickson CJ, 2012, SOFT MATTER, V8, P9617, DOI 10.1039/c2sm26007g; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Hatcher ER, 2009, J CHEM THEORY COMPUT, V5, P1315, DOI 10.1021/ct9000608; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jambeck JPM, 2013, J CHEM THEORY COMPUT, V9, P774, DOI 10.1021/ct300777p; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; Jojart B, 2007, J COMPUT CHEM, V28, P2051, DOI 10.1002/jcc.20748; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li Z, 2009, BIOPHYS J, V97, P155, DOI 10.1016/j.bpj.2009.04.037; Lumb CN, 2011, STRUCTURE, V19, P1338, DOI 10.1016/j.str.2011.04.010; Lupyan D, 2010, BIOPHYS J, V98, P240, DOI 10.1016/j.bpj.2009.09.063; LUTY BA, 1992, J COMPUT CHEM, V13, P1114, DOI 10.1002/jcc.540130911; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piggot TJ, 2012, J CHEM THEORY COMPUT, V8, P4593, DOI 10.1021/ct3003157; ROUSSEEUW PJ, 1990, J AM STAT ASSOC, V85, P97, DOI 10.2307/2289530; Skjevik AA, 2012, J PHYS CHEM B, V116, P11124, DOI 10.1021/jp3059992; Spaar A, 2009, BIOPHYS J, V96, P1721, DOI 10.1016/j.bpj.2008.11.052; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vanquelef E, 2010, RED SERVER; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	44	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104778	10.1371/journal.pone.0104778	http://dx.doi.org/10.1371/journal.pone.0104778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141217	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200034
J	Saa, P; Yakovleva, O; de Castro, J; Vasilyeva, I; De Paoli, SH; Simak, J; Cervenakova, L				Saa, Paula; Yakovleva, Oksana; de Castro, Jorge; Vasilyeva, Irina; De Paoli, Silvia H.; Simak, Jan; Cervenakova, Larisa			First Demonstration of Transmissible Spongiform Encephalopathy-associated Prion Protein (PrPTSE) in Extracellular Vesicles from Plasma of Mice Infected with Mouse-adapted Variant Creutzfeldt-Jakob Disease by in Vitro Amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CHRONIC WASTING DISEASE; MESENCHYMAL STEM-CELLS; NEURODEGENERATIVE DISEASES; SELECTIVE EXTERNALIZATION; TRANSFERRIN RECEPTOR; NEUROBLASTOMA-CELLS; CEREBROSPINAL-FLUID; PROTEOMIC ANALYSIS; ENDOTHELIAL-CELLS	The development of variant Creutzfeldt-Jakob disease (vCJD) in three recipients of non-leukoreduced red blood cells from asymptomatic donors who subsequently developed the disease has confirmed existing concerns about the possible spread of transmissible spongiform encephalopathies (TSEs) via blood products. In addition, the presence of disease-associated misfolded prion protein (PrPTSE), generally associated with infectivity, has been demonstrated in the blood of vCJD patients. However, its origin and distribution in this biological fluid are still unknown. Various studies have identified cellular prion protein (PrPC) among the protein cargo in human blood-circulating extracellular vesicles released from endothelial cells and platelets, and exosomes isolated from the conditioned media of TSE-infected cells have caused the disease when injected into experimental mice. In this study, we demonstrate the detection of PrPTSE in extracellular vesicles isolated from plasma samples collected during the preclinical and clinical phases of the disease from mice infected with mouse-adapted vCJD and confirm the presence of the exosomal marker Hsp70 in these preparations.	[Saa, Paula; Yakovleva, Oksana; de Castro, Jorge; Vasilyeva, Irina; Cervenakova, Larisa] Amer Natl Red Cross, Holland Lab, Biomed Serv, Transmissible Dis Dept, Rockville, MD 20855 USA; [De Paoli, Silvia H.; Simak, Jan] US FDA, Lab Cellular Hematol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	American Red Cross; US Food & Drug Administration (FDA)	Saa, P (corresponding author), Amer Natl Red Cross, Holland Lab, Biomed Serv, Transmissible Dis Dept, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.	Paula.Saa@redcross.org	Saa, Paula/AAB-6607-2019; Simak, Jan/C-1153-2011	Saa, Paula/0000-0001-6077-4532; Simak, Jan/0000-0001-8910-7362	American National Red Cross; Fondation Alliance BioSecure	American National Red Cross; Fondation Alliance BioSecure	This study was supported by research funding from the American National Red Cross (to L. C.) and the Fondation Alliance BioSecure (to P. S.).	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Akimov S, 2008, J VIROL, V82, P10959, DOI 10.1128/JVI.01085-08; Akimov S, 2009, FOLIA NEUROPATHOL, V47, P205; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Andreoletti O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002782; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Bannach O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036620; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Brandel JP, 2009, ANN NEUROL, V65, P249, DOI 10.1002/ana.21583; Brouckova A, 2009, THROMB HAEMOSTASIS, V102, P966, DOI 10.1160/TH09-02-0074; Brown P, 2001, J LAB CLIN MED, V137, P5, DOI 10.1067/mlc.2001.111951; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castro-Seoane R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002538; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Cervenakova L, 2003, ELECTROPHORESIS, V24, P853, DOI 10.1002/elps.200390107; Cervenakova L, 2011, TRANSFUSION, V51, P1755, DOI 10.1111/j.1537-2995.2010.03041.x; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Dabaghian R, 2008, PRION, V2, P170, DOI 10.4161/pri.2.4.8068; de Marco MF, 2010, J PATHOL, V222, P380, DOI 10.1002/path.2767; Dorsey K, 2009, TRANSFUSION, V49, P977, DOI 10.1111/j.1537-2995.2008.02056.x; Douet JY, 2014, EMERG INFECT DIS, V20, P114, DOI 10.3201/eid2001.130353; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Ecroyd H, 2004, BIOL REPROD, V71, P993, DOI 10.1095/biolreprod.104.029801; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Elder AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080203; Epple LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042064; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2005, TRAFFIC, V6, P10, DOI 10.1111/j.1600-0854.2004.00247.x; Fujihara A, 2009, FEBS J, V276, P2841, DOI 10.1111/j.1742-4658.2009.07007.x; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Haney MJ, 2012, NANOMEDICINE-UK, V7, P815, DOI [10.2217/NNM.11.156, 10.2217/nnm.11.156]; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Jackson GS, 2014, JAMA NEUROL, V71, P421, DOI 10.1001/jamaneurol.2013.6001; Jackson GS, 2014, BLOOD, V123, P452, DOI 10.1182/blood-2013-11-539239; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kalani A, 2014, MOL NEUROBIOL, V49, P590, DOI 10.1007/s12035-013-8544-1; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Knight R, 2010, TRANSFUS APHER SCI, V43, P387, DOI 10.1016/j.transci.2010.09.003; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Mattei V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005057; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; PAN BT, 1984, J BIOL CHEM, V259, P9776; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ritchie AJ, 2013, BRIT J HAEMATOL, V163, P678, DOI 10.1111/bjh.12543; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Rubenstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066352; Rubenstein R, 2011, J VIROL, V85, P9031, DOI 10.1128/JVI.05111-11; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Safar JG, 2006, P NATL ACAD SCI USA, V103, P11312, DOI 10.1073/pnas.0604021103; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Silva CJ, 2013, BIOCHEMISTRY-US, V52, P2139, DOI 10.1021/bi3016795; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Surgucheva I, 2012, BIOCHEMISTRY-US, V51, P4743, DOI 10.1021/bi300478w; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Tasaki M, 2010, BIOCHEM BIOPH RES CO, V400, P559, DOI 10.1016/j.bbrc.2010.08.101; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Terry LA, 2009, J VIROL, V83, P12552, DOI 10.1128/JVI.00311-09; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; Vingtdeux V., 2012, FRONT PHYSIOL, V3, P1; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wadsworth JDF, 2011, J PATHOL, V223, P511, DOI 10.1002/path.2821; Wik L, 2012, PRION, V6, DOI 10.4161/pri.22588; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	95	40	41	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29247	29260		10.1074/jbc.M114.589564	http://dx.doi.org/10.1074/jbc.M114.589564			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25157106	Green Published, hybrid			2022-12-25	WOS:000344141000039
J	Allman, D; Calzavara, L; Worthington, C; Tyndall, M; Adrien, A; Walters, M; White, S; Jones, MK				Allman, Dan; Calzavara, Liviana; Worthington, Catherine; Tyndall, Mark; Adrien, Alix; Walters, Melissa; White, Samantha; Jones, Marcella K.			Charitable Giving for HIV and AIDS: Results from a Canadian National Survey	PLOS ONE			English	Article							PHILANTHROPY; PREDICTORS; RESOURCES	Background: For the first time, a national survey of adults in Canada posed questions on charitable giving for HIV and AIDS. The objective of this analysis was to explore the behaviour and attitudes of this population in terms of charitable giving. Methods: In 2011, individuals in Canada 16 years of age or older were recruited for a survey from an online panel supplemented by random digit dial telephone interviewing. The margin of error was +/-2.1 percentage points (95%). Chisquare tests were used to detect bivariate associations. A multivariate logistic regression model was fit to compare those who had donated to HIV and AIDS in the past 12 months with those who had donated to other disease or illness charities. Results: 2,139 participated. 82.5% had donated to a charitable cause in the past 12 months. 22.2% had ever donated to HIV and AIDS, with 7.8% doing so in the past 12 months. Individuals who had donated to HIV and AIDS versus other disease or illness charities tended to be younger (p<0.05), single (p<0.005), more highly educated (p<0.001) and to self-identify as a member of a sexual minority group (p<0.001). Multivariate analysis revealed individuals who self-identified as a member of a sexual minority group were significantly much more likely to have donated to HIV and AIDS than to other disease or illness charities in the past 12 months (OR, 7.73; p<0.001; CI 4.32-13.88). Discussion: Despite a generally philanthropic orientation, relatively few respondents had ever been involved in charitable giving for HIV and AIDS. Those who had could be understood relationally as individuals at closer social proximity to HIV and AIDS such as members of sexual minority groups.	[Allman, Dan; Calzavara, Liviana; Walters, Melissa; White, Samantha] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Worthington, Catherine] Univ Victoria, Sch Publ Hlth & Social Policy, Victoria, BC, Canada; [Tyndall, Mark] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Adrien, Alix] McGill Univ, Fac Med, Montreal, PQ, Canada; [Jones, Marcella K.] Univ Toronto, Fac Med, Toronto, ON, Canada	University of Toronto; University of Victoria; University of Ottawa; McGill University; University of Toronto	Allman, D (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	dan.allman@utoronto.ca	Allman, Dan/B-5086-2012	Allman, Dan/0000-0001-5198-751X; Tyndall, Mark/0000-0003-4450-5679; Worthington, Catherine/0000-0003-3075-8229; Jones, Marcella/0000-0003-0609-1188	Canadian Institutes for Health Research (CIHR)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was made possible through a generous donation from Andy Pringle and in-kind support from The CIHR Social Research Centre in HIV Prevention(SRC), which is funded by a grant from the Canadian Institutes for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KG, 2009, AM J SOCIOL, V114, P1129, DOI 10.1086/595945; [Anonymous], HIV AIDS EP UPD; Arumi A. M., 2005, CHARITABLE IMPULSE; Babbie E., 2012, PRACTICE SOCIAL RES; Batson CD., 1991, PSYCHOL INQ, V2, P107, DOI [10.1207/s15327965pli0202_1, DOI 10.1207/S15327965PLI0202_1]; Bekkers R, 2006, SOC PSYCHOL QUART, V69, P349, DOI 10.1177/019027250606900404; Bekkers R, 2011, VOLUNT SECT REV, V2, P337, DOI 10.1332/204080511X6087712; Bekkers R, 2011, NONPROF VOLUNT SEC Q, V40, P924, DOI 10.1177/0899764010380927; Bekkers R, 2011, QUAL QUANT, V45, P1369, DOI 10.1007/s11135-010-9341-9; Bennett R., 2003, INT J NONPROFIT VOLU, V8, P12, DOI [10.1002/nvsm.198, DOI 10.1002/NVSM.198]; Boyle J, 2009, SURVEY PRACTICE, V9; Breeze B, 2013, VOLUNT SECT REV, V4, P165, DOI 10.1332/204080513X667792; Burgoyne CB, 2005, J COMMUNITY APPL SOC, V15, P383, DOI 10.1002/casp.832; Calzavara L, 2012, HIV AIDS CANADA NATL; Canada Mortgage and Housing Corporation, 2013, HOUS INC WEALTH; Canadian Public Health Association, 2005, LEAD TOG CAN TAK ACT; Eckel C, 2007, SOUTH ECON J, V74, P388, DOI 10.2307/20111974; Einstein M., 2012, CORPORATE AM BLURS L; EKOS Research Associates, 2013, SEC RES BEST PRACT M; EKOS Research Associates Inc, 2006, HIV AIDS ATT T UNPUB; EKOS Research Associates Inc, 2003, HIV AIDS ATT S UNPUB; Eveland VB, 2007, INT J NONPROFIT VOLU, V12, P1, DOI 10.1002/nvsm.7; Fink A, 2008, CONDUCT SURVEYS STEP; Gabb J, 2008, RESEARCHING INTIMACY IN FAMILIES, P1, DOI 10.1057/9780230227668; Hall M., 2009, CARING CANADIANS INV; Hu SS, 2011, AM J EPIDEMIOL, V173, P703, DOI 10.1093/aje/kwq442; Human Resources and Skills Development Canada, 2013, LEAN ED ATT; Mathur A, 1996, PSYCHOL MARKET, V13, P107, DOI 10.1002/(SICI)1520-6793(199601)13:1<107::AID-MAR6>3.0.CO;2-K; Menard SW., 2008, HDB LONGITUDINAL RES; Merchant A, 2011, J BUS RES, V64, P610, DOI 10.1016/j.jbusres.2010.06.013; Ornstein M, 1989, AIDS CANADA KNOWLEDG, DOI North York; Phoenix Strategic Perspectives, 2012, SEC RES CELL PHON TE; Polonsky M.J., 2002, J NONPROFIT PUBLIC S, V10, P67, DOI [10.1300/J054v10n02_04, DOI 10.1300/J054V10N02_04]; Public Works and Government Services Canada, 2014, PUB OP RES NON UNPUB; Public Works and Government Services Canada, 2007, BEST PRACT PUBL OP R; Public Works and Government Services Canada, 2013, STAND COND GOV CAN P; Public Works and Government Services Canada, 2012, RESP RAT TEL OTH SUR; RADLEY A, 1995, HUM RELAT, V48, P685, DOI 10.1177/001872679504800605; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; SCHWARTZ RA, 1970, J POLIT ECON, V78, P1264, DOI 10.1086/259708; Small DA, 2008, J CONSUM RES, V35, P532, DOI 10.1086/527268; Statistics Canada, 2012, CAN POP 2011 AG SEX; Statistics Canada, 2013, CAN POP 2011 POP COU; van Leeuwen MHD, 2013, NONPROF VOLUNT SEC Q, V42, P219, DOI 10.1177/0899764012467084; Voigt LF, 2011, AM J EPIDEMIOL, V173, P118, DOI 10.1093/aje/kwq322; Wiepking P, 2012, VOLUNT SECT REV, V3, P217, DOI 10.1332/204080512X649379; Wiepking P, 2009, SOC FORCES, V87, P1973; Woodliffe, 2005, NONPROFIT MANAGEMENT, V16, P61, DOI [10.1002/nml.90, DOI 10.1002/NML.90]	48	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103184	10.1371/journal.pone.0103184	http://dx.doi.org/10.1371/journal.pone.0103184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153827	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200005
J	Kadoya, M; Koyama, H; Kanzaki, A; Kurajoh, M; Hatayama, M; Shiraishi, J; Okazaki, H; Shoji, T; Moriwaki, Y; Yamamoto, T; Inaba, M; Namba, M				Kadoya, Manabu; Koyama, Hidenori; Kanzaki, Akinori; Kurajoh, Masafumi; Hatayama, Miki; Shiraishi, Jun; Okazaki, Hirokazu; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Inaba, Masaaki; Namba, Mitsuyoshi			Plasma Brain-Derived Neurotrophic Factor and Reverse Dipping Pattern of Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; HYPERTENSIVE PATIENTS; CLINICAL-SIGNIFICANCE; BDNF; TIME; DYSFUNCTION; RESPONSES; DISEASE	Context: Basic studies have shown that brain-derived neurotrophic factor (BDNF) has critical roles in the survival, growth, maintenance, and death of central and peripheral neurons, while it is also involved in regulation of the autonomic nervous system. Furthermore, recent clinical studies have suggested potential role of plasma BDNF in the circulatory system. Objective: We investigated the mutual relationships among plasma BDNF, patterns of nocturnal blood pressure changes (dippers, non-dippers, extra-dippers, and reverse-dippers), and cardiac autonomic function as determined by heart rate variability (HRV). Design: This was a cross-sectional study of patients registered in the Hyogo Sleep Cardio-Autonomic Atherosclerosis (HSCAA) Study from October 2010 to November 2012. Patients: Two-hundred fifty patients with 1 or more cardiovascular risk factor(s) (obesity, smoking, presence of cardiovascular event history, hypertension, dyslipidemia, diabetes mellitus, chronic kidney disease) were enrolled. Results: Plasma BDNF levels (natural logarithm transformed) were significantly (p = 0.001) lower in reverse-dipper patients (7.18 +/- 0.69 pg/ml, mean +/- SD, n = 36) as compared to dippers (7.86 +/- 0.86 pg/ml, n = 100). Multiple logistic regression analysis showed that BDNF (odds ratios: 0.417, 95% confidence interval: 0.228-0.762, P = 0.004) was the sole factor significantly and independently associated with the reverse-dippers as compared with dippers. Furthermore, plasma BDNF level was significantly and positively correlated with the time-domain (SDNN, SDANN5, CVRR) and frequency-domain (LF) of HRV parameters. Finally, multiple logistic regression analyses showed that the relationship between plasma BDNF and the reverse-dippers was weakened, yet remained significant or borderline significant even after adjusting for HRV parameters. Conclusions: Low plasma BDNF was independently associated with patients showing a reverse-dipper pattern of nocturnal blood pressure, in which an imbalance of cardiac autonomic function may be partly involved.	[Kadoya, Manabu; Koyama, Hidenori; Kanzaki, Akinori; Kurajoh, Masafumi; Hatayama, Miki; Shiraishi, Jun; Okazaki, Hirokazu; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Namba, Mitsuyoshi] Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Nishinomiya, Hyogo 6638501, Japan; [Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Endocrinol Metab & Mol Med, Osaka 558, Japan	Hyogo College of Medicine; Osaka Metropolitan University	Koyama, H (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Nishinomiya, Hyogo 6638501, Japan.	hkoyama@hyo-med.ac.jp	Koyama, Hidenori/AAU-2346-2020	Koyama, Hidenori/0000-0001-7930-2228	Ministry of Education, Culture, Sports, Science and Technology of Japan [26461371]; Hyogo College of Medicine	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo College of Medicine	Grant-in-Aid for Scientific Research (26461371 to H. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A Grant-in-Aid for Promotion of Technological Seeds in Advanced Medicine, Hyogo College of Medicine (to T.Y.). A Grant-in-Aid for Graduate Students, Hyogo College of Medicine (to M. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Brady R, 1999, J NEUROSCI, V19, P2131; Camm AJ, 1996, EUR HEART J, V17, P354; Eissa MAH, 2001, BLOOD PRESS MONIT, V6, P21, DOI 10.1097/00126097-200102000-00004; Ejiri J, 2005, CIRCULATION, V112, P2114, DOI 10.1161/CIRCULATIONAHA.104.476903; Fujii H, 2013, J RENAL NUTR, V23, P340, DOI 10.1053/j.jrn.2012.12.008; Furmaga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034844; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Grassi G, 2008, HYPERTENSION, V52, P925, DOI 10.1161/HYPERTENSIONAHA.108.116368; Gray J, 2006, DANCING TIMES, V96, P55; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kario K, 2005, AM J HYPERTENS, V18, P149, DOI 10.1016/j.amjhyper.2004.09.007; Kario K, 1997, HYPERTENSION, V30, P1504, DOI 10.1161/01.HYP.30.6.1504; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; Marosi K, 2014, TRENDS ENDOCRIN MET, V25, P89, DOI 10.1016/j.tem.2013.10.006; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mogensen UM, 2012, DIABETES, V61, P1822, DOI 10.2337/db11-1235; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Okada S, 2012, ARTERIOSCL THROM VAS, V32, P1902, DOI 10.1161/ATVBAHA.112.248930; Okamoto LE, 2009, HYPERTENSION, V53, P363, DOI 10.1161/HYPERTENSIONAHA.108.124552; Orlov S, 2012, DIABETES CARE, V35, P809, DOI 10.2337/dc11-1652; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; PICKERING TG, 1990, CIRCULATION, V81, P700, DOI 10.1161/01.CIR.81.2.700; Rakugi H, 2012, HYPERTENS RES, V35, P552, DOI 10.1038/hr.2012.8; Sairaku A, 2013, SLEEP MED, V14, P622, DOI 10.1016/j.sleep.2013.04.003; Takagi T, 2006, HYPERTENS RES, V29, P977, DOI 10.1291/hypres.29.977; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Vermehren-Schmaedick A, 2013, J NEUROSCI RES, V91, P220, DOI 10.1002/jnr.23158; Wang H, 2002, NEUROSCIENCE, V112, P967, DOI 10.1016/S0306-4522(02)00085-4; Yamaguchi K, 2014, SLEEP MED, V15, P33, DOI 10.1016/j.sleep.2013.10.005; Yang B, 2002, NAT NEUROSCI, V5, P539, DOI 10.1038/nn853; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yoshida T, 2001, J NEUROL SCI, V184, P77, DOI 10.1016/S0022-510X(00)00505-0	41	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105977	10.1371/journal.pone.0105977	http://dx.doi.org/10.1371/journal.pone.0105977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153796	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200100
J	Packer, RMA; Shihab, NK; Torres, BBJ; Volk, HA				Packer, Rowena M. A.; Shihab, Nadia K.; Torres, Bruno B. J.; Volk, Holger A.			Clinical Risk Factors Associated with Anti-Epileptic Drug Responsiveness in Canine Epilepsy	PLOS ONE			English	Article							QUALITY-OF-LIFE; IDIOPATHIC EPILEPSY; LABRADOR RETRIEVERS; STATUS EPILEPTICUS; POTASSIUM-BROMIDE; DOGS; SEIZURE; REMISSION; PROGNOSIS; LEVETIRACETAM	The nature and occurrence of remission, and conversely, pharmacoresistance following epilepsy treatment is still not fully understood in human or veterinary medicine. As such, predicting which patients will have good or poor treatment outcomes is imprecise, impeding patient management. In the present study, we use a naturally occurring animal model of pharmacoresistant epilepsy to investigate clinical risk factors associated with treatment outcome. Dogs with idiopathic epilepsy, for which no underlying cause was identified, were treated at a canine epilepsy clinic and monitored following discharge from a small animal referral hospital. Clinical data was gained via standardised owner questionnaires and longitudinal follow up data was gained via telephone interview with the dogs' owners. At follow up, 14% of treated dogs were in seizure-free remission. Dogs that did not achieve remission were more likely to be male, and to have previously experienced cluster seizures. Seizure frequency or the total number of seizures prior to treatment were not significant predictors of pharmacoresistance, demonstrating that seizure density, that is, the temporal pattern of seizure activity, is a more influential predictor of pharmacoresistance. These results are in line with clinical studies of human epilepsy, and experimental rodent models of epilepsy, that patients experiencing episodes of high seizure density (cluster seizures), not just a high seizure frequency pre-treatment, are at an increased risk of drug-refractoriness. These data provide further evidence that the dog could be a useful naturally occurring epilepsy model in the study of pharmacoresistant epilepsy.	[Packer, Rowena M. A.; Shihab, Nadia K.; Volk, Holger A.] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Shihab, Nadia K.] Southern Counties Vet Specialists, Dept Neurol Neurosurg, Ringwood, Hants, England; [Torres, Bruno B. J.] Univ Fed Minas Gerais, Dept Vet Med & Surg, Belo Horizonte, MG, Brazil	University of London; University of London Royal Veterinary College; Universidade Federal de Minas Gerais	Volk, HA (corresponding author), Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England.	hvolk@rvc.ac.uk	Volk, Holger Andreas/B-9965-2011; Torres, Bruno Benetti Junta/AAX-9672-2020	Volk, Holger Andreas/0000-0002-7312-638X; Torres, Bruno Benetti Junta/0000-0002-6400-046X; Packer, Rowena/0000-0002-9988-9828				Andrew SE, 2008, VET CLIN N AM-SMALL, V38, P269, DOI 10.1016/j.cvsm.2007.11.007; Arrol L, 2012, VET REC, V170, P335, DOI 10.1136/vr.100316; Avanzini G, 2013, EPILEPSIA, V54, P14, DOI 10.1111/epi.12418; BEGHI E, 1992, EPILEPSIA, V33, P45; Berendt M, 2002, J VET INTERN MED, V16, P262, DOI 10.1892/0891-6640(2002)016&lt;0262:ACSOEI&gt;2.3.CO;2; Berendt M, 1999, ACTA NEUROL SCAND, V99, P276, DOI 10.1111/j.1600-0404.1999.tb00676.x; Berendt M, 2007, J VET INTERN MED, V21, P754, DOI 10.1892/0891-6640(2007)21[754:PDRFAL]2.0.CO;2; Berg AT, 1997, J CLIN NEUROPHYSIOL, V14, P102, DOI 10.1097/00004691-199703000-00003; BIELFELT SW, 1971, AM J VET RES, V32, P2039; Birbeck GL, 2002, EPILEPSIA, V43, P535, DOI 10.1046/j.1528-1157.2002.32201.x; Blumenfeld H, 2008, EPILEPSIA, V49, P400, DOI 10.1111/j.1528-1167.2007.01458.x; Bonnett LJ, 2014, J NEUROL NEUROSUR PS, V85, P603, DOI 10.1136/jnnp-2013-306040; Boothe DM, 2012, JAVMA-J AM VET MED A, V240, P1073, DOI 10.2460/javma.240.9.1073; Callaghan BC, 2007, ANN NEUROL, V62, P382, DOI 10.1002/ana.21166; Camfield C, 1996, NEUROLOGY, V46, P41, DOI 10.1212/WNL.46.1.41; Chang Y, 2006, J SMALL ANIM PRACT, V47, P574, DOI 10.1111/j.1748-5827.2006.00203.x; COCKERELL OC, 1995, LANCET, V346, P140, DOI 10.1016/S0140-6736(95)91208-8; Cockerell OC, 1997, EPILEPSIA, V38, P31, DOI 10.1111/j.1528-1157.1997.tb01075.x; Dewey CW, 2009, JAVMA-J AM VET MED A, V235, P1442, DOI 10.2460/javma.235.12.1442; Dewey CW, 2004, J AM ANIMAL HOSP ASS, V40; HAUSER WA, 1990, NEUROLOGY, V40, P9; Heynold Y, 1997, J SMALL ANIM PRACT, V38, P7, DOI 10.1111/j.1748-5827.1997.tb02977.x; Hulsmeyer V, 2010, J VET INTERN MED, V24, P171, DOI 10.1111/j.1939-1676.2009.0438.x; Kearsley-Fleet L, 2013, VET REC, V172, DOI 10.1136/vr.101133; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Loscher W, 2006, EPILEPSIA, V47, P1253, DOI 10.1111/j.1528-1167.2006.00607.x; Loscher W, 2010, EPILEPSIA, V51, P89, DOI 10.1111/j.1528-1167.2009.02183.x; LOSCHER W, 1985, ARZNEIMITTEL-FORSCH, V35, P82; MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.3.CO;2-L; Marson AG, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01920.x; Martle V, 2014, VET J, V199, P332, DOI 10.1016/j.tvjl.2013.09.055; Monteiro R, 2012, J SMALL ANIM PRACT, V53, P526, DOI 10.1111/j.1748-5827.2012.01251.x; Munana KR, 2012, J VET INTERN MED, V26, P1358, DOI 10.1111/j.1939-1676.2012.01006.x; Munana KR, 2012, J VET INTERN MED, V26, P341, DOI 10.1111/j.1939-1676.2011.00866.x; Musicco M, 1997, NEUROLOGY, V49, P991, DOI 10.1212/WNL.49.4.991; PLACENCIA M, 1993, EPILEPSY RES, V14, P237, DOI 10.1016/0920-1211(93)90048-C; Platt SR, 2006, VET REC, V159, P881; PODELL M, 1993, J VET INTERN MED, V7, P318, DOI 10.1111/j.1939-1676.1993.tb01025.x; Poochikian-Sarkissian S, 2008, CAN J NEUROL SCI, V35, P280, DOI 10.1017/S0317167100008842; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; Ramey WL, 2013, CLIN NEUROL NEUROSUR, V115, P2411, DOI 10.1016/j.clineuro.2013.09.035; Regesta G, 1999, EPILEPSY RES, V34, P109, DOI 10.1016/S0920-1211(98)00106-5; REYNOLDS EH, 1983, LANCET, V2, P952; Saito M, 2001, J AM VET MED ASSOC, V219, P618, DOI 10.2460/javma.2001.219.618; Sander JWAS, 1996, J NEUROL NEUROSUR PS, V61, P433, DOI 10.1136/jnnp.61.5.433; SCHWARTZPORSCHE D, 1985, J VET PHARMACOL THER, V8, P113, DOI 10.1111/j.1365-2885.1985.tb00934.x; Short AD, 2011, VET REC, V169, P48, DOI 10.1136/vr.d1901; SILLANPAA M, 1993, EPILEPSIA, V34, P930, DOI 10.1111/j.1528-1157.1993.tb02114.x; Sillanpaa M, 2008, BRAIN, V131, P938, DOI 10.1093/brain/awn037; Trepanier LA, 1998, J AM VET MED ASSOC, V213, P1449; Volk HA, 2008, VET J, V176, P310, DOI 10.1016/j.tvjl.2007.03.002; von Klopmann T, 2007, J SMALL ANIM PRACT, V48, P134, DOI 10.1111/j.1748-5827.2006.00290.x; Weissl J, 2012, J VET INTERN MED, V26, P116, DOI 10.1111/j.1939-1676.2011.00853.x; Wessmann A, 2012, J VET INTERN MED, V26, P823	55	39	39	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106026	10.1371/journal.pone.0106026	http://dx.doi.org/10.1371/journal.pone.0106026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153799	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000340952200108
J	Bauerl, C; Collado, MC; Zuniga, M; Blas, E; Martinez, GP				Baeuerl, Christine; Carmen Collado, M.; Zuniga, Manuel; Blas, Enrique; Perez Martinez, Gaspar			Changes in Cecal Microbiota and Mucosal Gene Expression Revealed New Aspects of Epizootic Rabbit Enteropathy	PLOS ONE			English	Article							METHANOBREVIBACTER-SMITHII; AKKERMANSIA-MUCINIPHILA; INTESTINAL MICROBIOTA; GUT MICROBIOTA; ACID; RECOGNITION; DIVERSITY; ECOLOGY; ABILITY; TOXIN	Epizootic Rabbit Enteropathy (ERE) is a severe disease of unknown aetiology that mainly affects post-weaning animals. Its incidence can be prevented by antibiotic treatment suggesting that bacterial elements are crucial for the development of the disease. Microbial dynamics and host responses during the disease were studied. Cecal microbiota was characterized in three rabbit groups (ERE-affected, healthy and healthy pretreated with antibiotics), followed by transcriptional analysis of cytokines and mucins in the cecal mucosa and vermix by q-rtPCR. In healthy animals, cecal microbiota with or without antibiotic pretreatment was very similar and dominated by Alistipes and Ruminococcus. Proportions of both genera decreased in ERE rabbits whereas Bacteroides, Akkermansia and Rikenella increased, as well as Clostridium, gamma-Proteobacteria and other opportunistic and pathogenic species. The ERE group displayed remarkable dysbiosis and reduced taxonomic diversity. Transcription rate of mucins and inflammatory cytokines was very high in ERE rabbits, except IL-2, and its analysis revealed the existence of two clearly different gene expression patterns corresponding to Inflammatory and (mucin) Secretory Profiles. Furthermore, these profiles were associated to different bacterial species, suggesting that they may correspond to different stages of the disease. Other data obtained in this work reinforced the notion that ERE morbidity and mortality is possibly caused by an overgrowth of different pathogens in the gut of animals whose immune defence mechanisms seem not to be adequately responding.	[Baeuerl, Christine; Carmen Collado, M.; Zuniga, Manuel; Perez Martinez, Gaspar] CSIC, Inst Agroquim & Tecnol Alimentos, Spanish Natl Res Council, Dept Biotecnol,Lab Bacterias Lact & Probiot, E-46010 Valencia, Spain; [Blas, Enrique] Univ Politecn Valencia, Inst Anim Sci & Technol, Anim Nutr Res Grp, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universitat Politecnica de Valencia	Martinez, GP (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Spanish Natl Res Council, Dept Biotecnol,Lab Bacterias Lact & Probiot, Jaime Roig 11, E-46010 Valencia, Spain.	gaspar.perez@iata.csic.es	Zúñiga, Manuel/AAI-4370-2021; COLLADO, MARIA CARMEN/H-4924-2012; Zúñiga, Manuel/A-7519-2012; Martinez, Gaspar Perez/H-4167-2012; Bäuerl, Christine/A-4334-2017	COLLADO, MARIA CARMEN/0000-0002-6204-4864; Zúñiga, Manuel/0000-0003-1750-6975; Martinez, Gaspar Perez/0000-0003-3501-1626; Bäuerl, Christine/0000-0002-5226-9920; Blas, Enrique/0000-0002-4054-3929	Fun-C-Food from the Consolider-Ingenio programme [CSD2007-00063]; Spanish Ministry of Science and Innovation;  [AGL2010-22211];  [AGL2006-07596]	Fun-C-Food from the Consolider-Ingenio programme; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ; 	This work was supported by the grants AGL2010-22211, AGL2006-07596 and by the Fun-C-Food CSD2007-00063 project from the Consolider-Ingenio programme, both from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecia L, 2007, J APPL MICROBIOL, V103, P787, DOI 10.1111/j.1365-2672.2007.03309.x; Abecia L, 2005, FEMS MICROBIOL LETT, V244, P111, DOI 10.1016/j.femsle.2005.01.028; Abell GCJ, 2011, BRIT J NUTR, V105, P1480, DOI 10.1017/S0007114510005349; An C, 2013, APPL ENVIRON MICROB, V79, P860, DOI 10.1128/AEM.02354-12; Bangsgaard Bendtsen K.M., 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231.e46231; Berry D, 2013, BEST PRACT RES CL GA, V27, P47, DOI 10.1016/j.bpg.2013.03.005; BORRIELLO SP, 1983, J CLIN MICROBIOL, V17, P414, DOI 10.1128/JCM.17.3.414-418.1983; Carson CA, 2005, APPL ENVIRON MICROB, V71, P4945, DOI 10.1128/AEM.71.8.4945-4949.2005; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Combes S, 2011, FEMS MICROBIOL ECOL, V77, P680, DOI 10.1111/j.1574-6941.2011.01148.x; Comito D, 2012, INT J INFLAM, V687143, P20; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Dewree R, 2007, WORLD RABBIT SCI, V15, P91; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P177, DOI 10.1016/j.cbpa.2010.10.019; From C, 2005, APPL ENVIRON MICROB, V71, P1178, DOI 10.1128/AEM.71.3.1178-1183.2005; Ganesh BP, 2013, PLOS ONE, V8; Hanifin CT, 2010, MAR DRUGS, V8, P577, DOI 10.3390/md8030577; Harcourt-Brown F, 2002, TXB RABBIT MED, P249; Hasegawa M, 2011, J IMMUNOL, V186, P4872, DOI 10.4049/jimmunol.1003761; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hotchkiss CE, 1996, LAB ANIM SCI, V46, P174; Huybens N, 2013, VET J, V196, P109, DOI 10.1016/j.tvjl.2012.08.014; Huybens N, 2009, WORLD RABBIT SCI, V17, P185; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Lapthorne S, 2013, GUT MICROBES, V4, P212, DOI 10.4161/gmic.24372; LARSON G, 1988, J BIOL CHEM, V263, P10790; Lau SKP, 2004, DIAGN MICR INFEC DIS, V49, P255, DOI 10.1016/j.diagmicrobio.2004.04.012; Lebas F, 2001, CUNICULTURE, V28, P183; LELKES L, 1987, LAB ANIM SCI, V37, P757; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Licois D, 2005, VET RES, V36, P601, DOI 10.1051/vetres:2005021; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Marlier D, 2006, VET J, V172, P493, DOI 10.1016/j.tvjl.2005.07.011; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Michelland R, 2008, CHARACTERIZATION BAC, P1025; Monteils V, 2008, FEMS MICROBIOL ECOL, V66, P620, DOI 10.1111/j.1574-6941.2008.00611.x; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Rodriguez-Romero N, 2012, ANAEROBE, V18, P602, DOI 10.1016/j.anaerobe.2012.10.006; Rychlik JL, 2000, CURR MICROBIOL, V40, P176, DOI 10.1007/s002849910035; Sahl JW, 2012, INFECT IMMUN, V80, P1232, DOI 10.1128/IAI.06138-11; Scott KP, 2011, BIOCHEM SOC T, V39, P1073, DOI 10.1042/BST0391073; Sekirov I, 2009, J PHYSIOL-LONDON, V587, P4159, DOI 10.1113/jphysiol.2009.172742; SINKOVICS G, 1976, VET REC, V98, P151, DOI 10.1136/vr.98.8.151; Uehara A, 2006, J IMMUNOL, V177, P1796, DOI 10.4049/jimmunol.177.3.1796; Ufnar JA, 2006, J APPL MICROBIOL, V101, P44, DOI 10.1111/j.1365-2672.2006.02989.x; Wang J, 2010, TOXICON, V56, P640, DOI 10.1016/j.toxicon.2010.05.011; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	56	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105707	10.1371/journal.pone.0105707	http://dx.doi.org/10.1371/journal.pone.0105707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147938	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600072
J	Iniguez-Armijos, C; Leiva, A; Frede, HG; Hampel, H; Breuer, L				Iniguez-Armijos, Carlos; Leiva, Adrian; Frede, Hans-Georg; Hampel, Henrietta; Breuer, Lutz			Deforestation and Benthic Indicators: How Much Vegetation Cover Is Needed to Sustain Healthy Andean Streams?	PLOS ONE			English	Article							LAND-USE; ASSEMBLAGE STRUCTURE; WATER-QUALITY; IMPACTS; MACROINVERTEBRATES; BIODIVERSITY; COMMUNITIES; FOREST; ECOSYSTEMS; CATCHMENTS	Deforestation in the tropical Andes is affecting ecological conditions of streams, and determination of how much forest should be retained is a pressing task for conservation, restoration and management strategies. We calculated and analyzed eight benthic metrics (structural, compositional and water quality indices) and a physical-chemical composite index with gradients of vegetation cover to assess the effects of deforestation on macroinvertebrate communities and water quality of 23 streams in southern Ecuadorian Andes. Using a geographical information system (GIS), we quantified vegetation cover at three spatial scales: the entire catchment, the riparian buffer of 30 m width extending the entire stream length, and the local scale defined for a stream reach of 100 m in length and similar buffer width. Macroinvertebrate and water quality metrics had the strongest relationships with vegetation cover at catchment and riparian scales, while vegetation cover did not show any association with the macroinvertebrate metrics at local scale. At catchment scale, the water quality metrics indicate that ecological condition of Andean streams is good when vegetation cover is over 70%. Further, macroinvertebrate community assemblages were more diverse and related in catchments largely covered by native vegetation (>70%). Our results suggest that retaining an important quantity of native vegetation cover within the catchments and a linkage between headwater and riparian forests help to maintain and improve stream biodiversity and water quality in Andean streams affected by deforestation. This research proposes that a strong regulation focused to the management of riparian buffers can be successful when decision making is addressed to conservation/restoration of Andean catchments.	[Iniguez-Armijos, Carlos; Leiva, Adrian] UTPL, Dept Ciencias Nat, Secc Ecol, Loja, Ecuador; [Iniguez-Armijos, Carlos; Frede, Hans-Georg; Breuer, Lutz] Univ Giessen, Res Ctr Bio Syst Land Use & Nutr IFZ, Inst Landscape Ecol & Resources Management ILR, D-35390 Giessen, Germany; [Hampel, Henrietta] Univ Cuenca, Cuenca, Ecuador	Universidad Tecnica Particular de Loja; Justus Liebig University Giessen; Universidad de Cuenca	Iniguez-Armijos, C (corresponding author), UTPL, Dept Ciencias Nat, Secc Ecol, Loja, Ecuador.	cainiguez@utpl.edu.ec	Breuer, Lutz/C-6652-2013; Iñiguez Armijos, Carlos/I-8920-2014; Armijos, Carlos/HCJ-0327-2022	Breuer, Lutz/0000-0001-9720-1076; Iñiguez Armijos, Carlos/0000-0002-9787-3451; 	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador (SENACYT); DFG (Deutsche Forschungsgemeinschaft) [FR615/28-1/-2]; Universidad Tecnica Partucular de Loja (UTPL); Henrietta Hampel	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador (SENACYT); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Universidad Tecnica Partucular de Loja (UTPL); Henrietta Hampel	This research was funded through a scholarship of the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador (SENACYT), a DFG (Deutsche Forschungsgemeinschaft) grant (FR615/28-1/-2) and by the Universidad Tecnica Partucular de Loja (UTPL). The support from Henrietta Hampel was thanks to the PROMETEO Program of SENESCYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Allan JD, 1997, FRESHWATER BIOL, V37, P149, DOI 10.1046/j.1365-2427.1997.d01-546.x; American Public Health Association A., 1995, STANDARD METHODS EXA; Barbour M. T., 1999, RAPID BIOASSESSMENT, V2; Bocard D., 2011, NUMERICAL ECOLOGY R; Bojsen BH, 2003, ARCH HYDROBIOL, V158, P317, DOI 10.1127/0003-9136/2003/0158-0317; Borbor-Cordova MJ, 2006, BIOGEOCHEMISTRY, V79, P135, DOI 10.1007/s10533-006-9009-7; Bucker A, 2010, FUND APPL LIMNOL, V177, P267, DOI 10.1127/1863-9135/2010/0177-0267; Buytaert W, 2011, GLOBAL ECOL BIOGEOGR, V20, P19, DOI 10.1111/j.1466-8238.2010.00585.x; Collier KJ, 2012, TECHNICAL REPORT; Couceiro SRM, 2007, HYDROBIOLOGIA, V575, P271, DOI 10.1007/s10750-006-0373-z; Crespo PJ, 2011, J HYDROL, V407, P164, DOI 10.1016/j.jhydrol.2011.07.021; Cummins KW, 2005, STUD NEOTROP FAUNA E, V40, P69, DOI 10.1080/01650520400025720; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; Death RG, 2010, FRESHWATER BIOL, V55, P1447, DOI 10.1111/j.1365-2427.2009.02233.x; Encalada AC, 2010, FRESHWATER BIOL, V55, P1719, DOI 10.1111/j.1365-2427.2010.02406.x; Environmental Protection Agency, 2013, NAT RIV STREAMS ASS; European Environment Agency, 2012, 8 EEA; Fernadez HR, 2001, GUIA DETERMINACION A; Gergel SE, 2002, AQUAT SCI, V64, P118, DOI 10.1007/s00027-002-8060-2; Gottlicher D, 2009, INT J REMOTE SENS, V30, P1867, DOI 10.1080/01431160802541531; Harden CP, 2006, GEOMORPHOLOGY, V79, P249, DOI 10.1016/j.geomorph.2006.06.021; Harding JS, 2006, HYDROBIOLOGIA, V568, P391, DOI 10.1007/s10750-006-0206-0; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Hauer F. Richard, 2007, P435, DOI 10.1016/B978-012332908-0.50028-0; Hladyz S, 2011, J APPL ECOL, V48, P443, DOI 10.1111/j.1365-2664.2010.01924.x; Iwata T, 2003, ECOL APPL, V13, P461, DOI 10.1890/1051-0761(2003)013[0461:IOPRDO]2.0.CO;2; Jacobsen D, 2004, FRESHWATER BIOL, V49, P1293, DOI 10.1111/j.1365-2427.2004.01274.x; Jacobsen D, 1998, ARCH HYDROBIOL, V142, P53; Jones JA, 2000, CONSERV BIOL, V14, P76, DOI 10.1046/j.1523-1739.2000.99083.x; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Miserendino ML, 2011, SCI TOTAL ENVIRON, V409, P612, DOI 10.1016/j.scitotenv.2010.10.034; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Lecerf A, 2005, OECOLOGIA, V146, P432, DOI 10.1007/s00442-005-0212-3; Lecerf A, 2010, FOREST ECOL MANAG, V259, P2433, DOI 10.1016/j.foreco.2010.03.022; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LENAT D R, 1988, Journal of the North American Benthological Society, V7, P222, DOI 10.2307/1467422; Lorion CM, 2009, FRESHWATER BIOL, V54, P165, DOI 10.1111/j.1365-2427.2008.02092.x; McClelland N.I., 1970, WATER SEWAGE WORKS, V117, P339, DOI DOI 10.1007/S13201-015-0318-7; Molina A, 2012, J HYDROL, V472, P25, DOI 10.1016/j.jhydrol.2012.09.012; Ordonez MV, 2011, INFLUENCIA USO SUELO; Parkyn SM, 2003, RESTOR ECOL, V11, P436, DOI 10.1046/j.1526-100X.2003.rec0260.x; Perrie A., 2012, GREATER WELLINGTON R; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rios SL, 2006, HYDROBIOLOGIA, V553, P153, DOI 10.1007/s10750-005-0868-z; Rios-Touma B, 2011, INT REV HYDROBIOL, V96, P667, DOI 10.1002/iroh.201111342; Roldan Perez G, 2003, BIOINDICACION CALIDA; Sarr DA, 2002, ENVIRON MANAGE, V30, P516, DOI 10.1007/s00267-002-2608-8; Shandas V, 2009, LANDSCAPE URBAN PLAN, V90, P66, DOI 10.1016/j.landurbplan.2008.10.016; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Sites RW, 2003, BIOTROPICA, V35, P226; Sponseller R, 2001, FRESHW BIOL; Stein H, 2008, ECOL ENG, V34, P267, DOI 10.1016/j.ecoleng.2007.06.010; Stewart JS, 2001, J AM WATER RESOUR AS, V37, P1475, DOI 10.1111/j.1752-1688.2001.tb03654.x; Suga CM, 2013, HYDROBIOLOGIA, V703, P203, DOI 10.1007/s10750-012-1360-1; Sutherland AB, 2002, FRESHWATER BIOL, V47, P1791, DOI 10.1046/j.1365-2427.2002.00927.x; Tarras-Wahlberg NH, 2001, SCI TOTAL ENVIRON, V278, P239, DOI 10.1016/S0048-9697(01)00655-6; Thies B, 2014, J LAND USE SCI, V9, P1, DOI 10.1080/1747423X.2012.718378; Tomanova S, 2006, HYDROBIOLOGIA, V556, P251, DOI 10.1007/s10750-005-1255-5; Torrachi S., 2013, AVANCES AN LISIS ESP, P275; Van Sickle J, 2004, ECOL APPL, V14, P368, DOI 10.1890/02-5009; Villamarin C, 2013, ECOL INDIC, V29, P79, DOI 10.1016/j.ecolind.2012.12.006; Wantzen KM, 2006, J N AM BENTHOL SOC, V25, P216, DOI 10.1899/0887-3593(2006)25[216:DPBISA]2.0.CO;2	64	46	47	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105869	10.1371/journal.pone.0105869	http://dx.doi.org/10.1371/journal.pone.0105869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147941	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600090
J	Speck, S; Courtiol, A; Junkes, C; Dathe, M; Muller, K; Schulze, M				Speck, Stephanie; Courtiol, Alexandre; Junkes, Christof; Dathe, Margitta; Mueller, Karin; Schulze, Martin			Cationic Synthetic Peptides: Assessment of Their Antimicrobial Potency in Liquid Preserved Boar Semen	PLOS ONE			English	Article							ARTIFICIAL-INSEMINATION; BACTERIA; ANTIBACTERIAL; ANTIBIOTICS; RESISTANCE; SYNERGY	Various semen extender formulas are in use to maintain sperm longevity and quality whilst acting against bacterial contamination in liquid sperm preservation. Aminoglycosides are commonly supplemented to aid in the control of bacteria. As bacterial resistance is increasing worldwide, antimicrobial peptides (AMPs) received lively interest as alternatives to overcome multi-drug resistant bacteria. We investigated, whether synthetic cationic AMPs might be a suitable alternative for conventional antibiotics in liquid boar sperm preservation. The antibacterial activity of two cyclic AMPs (c-WWW, c-WFW) and a helical magainin II amide analog (MK5E) was studied in vitro against two Gram-positive and eleven Gram-negative bacteria. Isolates included ATCC reference strains, multi-resistant E. coli and bacteria cultured from boar semen. Using broth microdilution, minimum inhibitory concentrations were determined for all AMPs. All AMPs revealed activity towards the majority of bacteria but not against Proteus spp. (all AMPs) and Staphylococcus aureus ATCC 29213 (MK5E). We could also demonstrate that c-WWW and c-WFW were effective against bacterial growth in liquid preserved boar semen in situ, especially when combined with a small amount of gentamicin. Our results suggest that albeit not offering a complete alternative to traditional antibiotics, the use of AMPs offers a promising solution to decrease the use of conventional antibiotics and thereby limit the selection of multi-resistant strains.	[Speck, Stephanie; Courtiol, Alexandre; Mueller, Karin] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Junkes, Christof; Dathe, Margitta] Leibniz Inst Mol Pharmacol, Berlin, Germany; [Schulze, Martin] Inst Reprod Farm Animals Schoenow EV, Bernau, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Speck, S (corresponding author), Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, D-04109 Leipzig, Germany.	stephanie.speck@vetmed.uni-leipzig.de	Schulze, Martin/AAR-3244-2020; Courtiol, Alexandre/O-3040-2017; 郑, 丽丽/HGE-2239-2022	Courtiol, Alexandre/0000-0003-0637-2959; 	AiF e.V. PRO INNO II [KF0376101MD6]; Leibniz Institute of Zoo and Wildlife Research	AiF e.V. PRO INNO II; Leibniz Institute of Zoo and Wildlife Research	The study was funded by AiF e.V. (www.aif.de) PRO INNO II Grant KF0376101MD6 and the Leibniz Institute of Zoo and Wildlife Research (www.izwberlin.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse GC, 2008, THERIOGENOLOGY, V70, P1317, DOI 10.1016/j.theriogenology.2008.07.010; Althouse GC, 2008, REPROD DOMEST ANIM, V43, P374, DOI 10.1111/j.1439-0531.2008.01187.x; Althouse GC, 2011, REPROD DOMEST ANIM, V46, P64, DOI 10.1111/j.1439-0531.2011.01863.x; Althouse GC, 2005, THERIOGENOLOGY, V63, P573, DOI 10.1016/j.theriogenology.2004.09.031; Althouse GC, 2000, THERIOGENOLOGY, V53, P1167, DOI 10.1016/S0093-691X(00)00261-2; Anantharaman A, 2010, ANTIMICROB AGENTS CH, V54, P1693, DOI 10.1128/AAC.01231-09; Arouri A, 2009, BBA-BIOMEMBRANES, V1788, P650, DOI 10.1016/j.bbamem.2008.11.022; Brunner E, 2002, NONPARAMETRIC ANAL L; Clinical and Laboratory Standards Institute (CLSI), 2008, PERF STAND ANT DISK, V28, pM31; DAGNALL GJR, 1986, THESIS ROYAL VET COL; Danowski K.M., 1989, THESIS TIERARZTLICHE; Dathe M, 2001, FEBS LETT, V501, P146, DOI 10.1016/S0014-5793(01)02648-5; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Junkes C, 2008, J PEPT SCI, V14, P535, DOI 10.1002/psc.940; Junkes C, 2011, EUR BIOPHYS J BIOPHY, V40, P515, DOI 10.1007/s00249-011-0671-x; Kraus D, 2006, CURR TOP MICROBIOL, V306, P231; Maes D, 2008, THERIOGENOLOGY, V70, P1337, DOI 10.1016/j.theriogenology.2008.06.018; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Martin LOM, 2010, ANIM REPROD SCI, V120, P95, DOI 10.1016/j.anireprosci.2010.03.008; Matsuzaki K, 1999, FEBS LETT, V449, P221, DOI 10.1016/S0014-5793(99)00443-3; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Okazaki T, 2010, THERIOGENOLOGY, V74, P1691, DOI 10.1016/j.theriogenology.2010.05.019; R Core Team, 2021, R LANG ENV STAT COMP; SONE M, 1982, VET REC, V111, P11, DOI 10.1136/vr.111.1.11; Theuretzbacher U, 2011, CURR OPIN PHARMACOL, V11, P433, DOI 10.1016/j.coph.2011.07.008; Wolska KI, 2012, POL J MICROBIOL, V61, P95, DOI 10.33073/pjm-2012-012; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	29	25	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105949	10.1371/journal.pone.0105949	http://dx.doi.org/10.1371/journal.pone.0105949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148109	Green Published, gold			2022-12-25	WOS:000341230600098
J	Fan, YH; Chen, M; Meng, J; Yu, L; Tu, YF; Wan, L; Fang, K; Zhu, WL				Fan, Yuhua; Chen, Meng; Meng, Jia; Yu, Lei; Tu, Yingfeng; Wan, Lin; Fang, Kun; Zhu, Wenliang			Arsenic Trioxide and Resveratrol Show Synergistic Anti-Leukemia Activity and Neutralized Cardiotoxicity	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; OXIDATIVE STRESS; CELL-DEATH; CANCER-CELLS; QT INTERVAL; APOPTOSIS; AUTOPHAGY; DRUG; GENISTEIN; PATHWAY	Cardiotoxicity is an aggravating side effect of many clinical antineoplastic agents such as arsenic trioxide (As2O3), which is the first-line treatment for acute promyelocytic leukemia (APL). Clinically, drug combination strategies are widely applied for complex disease management. Here, an optimized, cardiac-friendly therapeutic strategy for APL was investigated using a combination of As2O3 and genistein or resveratrol. Potential combinations were explored with respect to their effects on mitochondrial membrane potential, reactive oxygen species, superoxide dismutase activity, autophagy, and apoptosis in both NB4 cells and neonatal rat left ventricular myocytes. All experiments consistently suggested that 5 mu M resveratrol remarkably alleviates As2O3-induced cardiotoxicity. To achieve an equivalent effect, a 10-fold dosage of genistein was required, thus highlighting the dose advantage of resveratrol, as poor bioavailability is a common concern for its clinical application. Co-administration of resveratrol substantially amplified the anticancer effect of As2O3 in NB4 cells. Furthermore, resveratrol exacerbated oxidative stress, mitochondrial damage, and apoptosis, thereby reflecting its full range of synergism with As2O3. Addition of 5 mM resveratrol to the single drug formula of As2O3 also further increased the expression of LC3, a marker of cellular autophagy activity, indicating an involvement of autophagy-mediated tumor cell death in the synergistic action. Our results suggest a possible application of an As2O3 and resveratrol combination to treat APL in order to achieve superior therapeutics effects and prevent cardiotoxicity.	[Fan, Yuhua; Yu, Lei; Fang, Kun] Harbin Med Univ Daqing, Coll Pharm, Daqing, Peoples R China; [Chen, Meng] Harbin Med Univ, Dept Resp Med, Hosp 4, Harbin, Peoples R China; [Meng, Jia] Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin, Peoples R China; [Tu, Yingfeng] Harbin Med Univ, Dept Cardiol, Hosp 4, Harbin, Peoples R China; [Wan, Lin] Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Peoples R China; [Wan, Lin] Harbin Med Univ, Hosp 4, Key Lab Mol Imaging, Harbin, Peoples R China; [Zhu, Wenliang] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhu, WL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China.	wenzwl@yeah.net			National Natural Science Foundation of China [31301136]; Foundation of Health Department of Heilongjiang Province of China [2011-233]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Health Department of Heilongjiang Province of China	This work was supported by National Natural Science Foundation of China (No. 31301136) and Foundation of Health Department of Heilongjiang Province of China (No. 2011-233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbey JT, 2003, J CLIN ONCOL, V21, P3609, DOI 10.1200/JCO.2003.10.009; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chu WF, 2012, CARDIOVASC RES, V96, P90, DOI 10.1093/cvr/cvs230; Drolet B, 2004, CIRCULATION, V109, P26, DOI 10.1161/01.CIR.0000109484.00668.CE; Ducas RA, 2011, J ROY COLL PHYS EDIN, V41, P117, DOI 10.4997/JRCPE.2011.204; Fan YH, 2013, CELL PHYSIOL BIOCHEM, V31, P80, DOI 10.1159/000343351; Fox E, 2008, BLOOD, V111, P566, DOI 10.1182/blood-2007-08-107839; Gao F, 2004, CELL RES, V14, P81, DOI 10.1038/sj.cr.7290206; Ghaffari SH, 2012, TUMOR BIOL, V33, P157, DOI 10.1007/s13277-011-0259-1; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Hirano S, 2003, ARCH TOXICOL, V77, P305, DOI 10.1007/s00204-003-0447-x; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; Hwang JT, 2008, GENES NUTR, V2, P323, DOI 10.1007/s12263-007-0069-7; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Jiang SG, 2008, INT J ONCOL, V33, P103; Kanamori H, 2013, AM J PATHOL, V182, P701, DOI 10.1016/j.ajpath.2012.11.009; LANOTTE M, 1991, BLOOD, V77, P1080; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Li Yan, 2002, Cardiovasc Toxicol, V2, P63, DOI 10.1385/CT:2:1:63; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Manna P, 2008, ARCH TOXICOL, V82, P137, DOI 10.1007/s00204-007-0272-8; Mathews V, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.056; Mumford JL, 2007, ENVIRON HEALTH PERSP, V115, P690, DOI 10.1289/ehp.9686; Nadal-Serrano M, 2013, INT J BIOCHEM CELL B, V45, P2045, DOI 10.1016/j.biocel.2013.07.002; Nencioni A, 2013, HAEMATOLOGICA, V98, P1335, DOI 10.3324/haematol.2012.079061; Park SY, 2011, N-S ARCH PHARMACOL, V383, P191, DOI 10.1007/s00210-010-0594-6; Pereira GC, 2011, CURR PHARM DESIGN, V17, P2113; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Ravindranath MH, 2004, ADV EXP MED BIOL, V546, P121; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Sun WM, 2008, ADV EXP MED BIOL, V614, P179, DOI 10.1007/978-0-387-74911-2_21; Ullah MF, 2011, MOL NUTR FOOD RES, V55, P553, DOI 10.1002/mnfr.201000329; Vizzardi E, 2008, CARDIOVASC TOXICOL, V8, P41, DOI 10.1007/s12012-007-9009-4; Xuan WL, 2012, CRIT CARE MED, V40, P3026, DOI 10.1097/CCM.0b013e31825fd7da; Zhang WQ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/407839; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	39	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105890	10.1371/journal.pone.0105890	http://dx.doi.org/10.1371/journal.pone.0105890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144547	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100126
J	Nobrega, C; Nascimento-Ferreira, I; Onofre, I; Albuquerque, D; Deglon, N; de Almeida, LP				Nobrega, Clevio; Nascimento-Ferreira, Isabel; Onofre, Isabel; Albuquerque, David; Deglon, Nicole; de Almeida, Luis Pereira			RNA Interference Mitigates Motor and Neuropathological Deficits in a Cerebellar Mouse Model of Machado-Joseph Disease	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SCA3 TRANSGENIC MICE; SPINOCEREBELLAR ATAXIA; MUTANT ATAXIN-3; RAT MODEL; NUCLEAR-LOCALIZATION; CAG EXPANSIONS; KNOCKOUT MICE; PROTEIN; SYMPTOMS	Machado-Joseph disease or Spinocerebellar ataxia type 3 is a progressive fatal neurodegenerative disorder caused by the polyglutamine-expanded protein ataxin-3. Recent studies demonstrate that RNA interference is a promising approach for the treatment of Machado-Joseph disease. However, whether gene silencing at an early time-point is able to prevent the appearance of motor behavior deficits typical of the disease when initiated before onset of the disease had not been explored. Here, using a lentiviral-mediated allele-specific silencing of mutant ataxin-3 in an early pre-symptomatic cerebellar mouse model of Machado-Joseph disease we show that this strategy hampers the development of the motor and neuropathological phenotypic characteristics of the disease. At the histological level, the RNA-specific silencing of mutant ataxin-3 decreased formation of mutant ataxin-3 aggregates, preserved Purkinje cell morphology and expression of neuronal markers while reducing cell death. Importantly, gene silencing prevented the development of impairments in balance, motor coordination, gait and hyperactivity observed in control mice. These data support the therapeutic potential of RNA interference for Machado-Joseph disease and constitute a proof of principle of the beneficial effects of early allele-specific silencing for therapy of this disease.	[Nobrega, Clevio; Nascimento-Ferreira, Isabel; Onofre, Isabel; de Almeida, Luis Pereira] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Nascimento-Ferreira, Isabel; Onofre, Isabel; de Almeida, Luis Pereira] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Albuquerque, David] Univ Coimbra, Fac Sci & Technol, Coimbra, Portugal; [Deglon, Nicole] Univ Lausanne Hosp, Lab Cellular & Mol Neurotherapies, Dept Clin Neurosci, Lausanne, Switzerland	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	de Almeida, LP (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	luispa@cnc.uc.pt	Deglon, Nicole/A-2265-2012; de Almeida, Luis Pereira/A-4605-2009; de Almeida, Luis Pereira/O-8196-2019; Nobrega, Clévio/M-6047-2013; Albuquerque, David/S-5586-2017	Deglon, Nicole/0000-0003-4475-9476; de Almeida, Luis Pereira/0000-0001-5831-3307; de Almeida, Luis Pereira/0000-0001-5831-3307; Nobrega, Clévio/0000-0002-8312-5292; Albuquerque, David/0000-0001-8899-9020; Onofre, Isabel/0000-0002-4937-448X	Portuguese Foundation for Science and Technology; Programa Operacional Factores de Competitividade - COMPETE [PTDC/SAU-NEU/099307/2008, PTDC/SAU-FAR/116535/2010, PEst-C/SAU/LA0001/2013-2014]; Richard Chin and Lily Lock Machado-Joseph Research Fund; National Ataxia Foundation; Association Francaise pour les Myopathies (SB/NF) [15079CA]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Programa Operacional Factores de Competitividade - COMPETE; Richard Chin and Lily Lock Machado-Joseph Research Fund; National Ataxia Foundation; Association Francaise pour les Myopathies (SB/NF)(Association Francaise contre les Myopathies)	We thank the Portuguese Foundation for Science and Technology and FEDER funds by Programa Operacional Factores de Competitividade - COMPETE (PTDC/SAU-NEU/099307/2008, PTDC/SAU-FAR/116535/2010 and PEst-C/SAU/LA0001/2013-2014), the Richard Chin and Lily Lock Machado-Joseph Research Fund, the National Ataxia Foundation, and the Association Francaise pour les Myopathies (SB/NF/2010/2008 Number 15079CA) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2008, HUM MOL GENET, V17, P2071, DOI 10.1093/hmg/ddn106; Alves S, 2010, HUM MOL GENET, V19, P2380, DOI 10.1093/hmg/ddq111; Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Balemans MCM, 2010, BEHAV BRAIN RES, V208, P47, DOI 10.1016/j.bbr.2009.11.008; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Boy J, 2010, NEUROBIOL DIS, V37, P284, DOI 10.1016/j.nbd.2009.08.002; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chou AH, 2008, NEUROBIOL DIS, V31, P89, DOI 10.1016/j.nbd.2008.03.011; Costa MD, 2013, MOL THER, V21, P1898, DOI 10.1038/mt.2013.144; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; D'Abreu A, 2009, ACTA NEUROL SCAND, V119, P277, DOI 10.1111/j.1600-0404.2008.01092.x; D'Abreu A, 2010, PARKINSONISM RELAT D, V16, P2, DOI 10.1016/j.parkreldis.2009.08.012; de Almeida LP, 2002, J NEUROSCI, V22, P3473; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Friedland DR, 2006, J NEUROSCI METH, V150, P90, DOI 10.1016/j.jneumeth.2005.06.004; Gaspar C, 1996, HUM GENET, V98, P620, DOI 10.1007/s004390050270; Globas C, 2008, MOVEMENT DISORD, V23, P2232, DOI 10.1002/mds.22288; Goncalves N, 2013, ANN NEUROLOGY; Gonzalez-Alegre P, 2007, NAT CLIN PRACT NEURO, V3, P394, DOI 10.1038/ncpneuro0551; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Kalueff AV, 2007, BRAIN RES, V1169, P87, DOI 10.1016/j.brainres.2007.07.009; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047; Nobrega C, 2012, CEREBELLUM; Nobrega C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052396; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; RANUM LPW, 1995, AM J HUM GENET, V57, P603; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Rodrigues AJ, 2010, BBA-MOL CELL RES, V1803, P1154, DOI 10.1016/j.bbamcr.2010.07.004; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Rodriguez-Lebron E, 2013, MOL THER, V21, P1909, DOI 10.1038/mt.2013.152; Rodriguez-Lebron E, 2009, MOL THER, V17, P1563, DOI 10.1038/mt.2009.123; ROSENBERG RN, 1992, MOVEMENT DISORD, V7, P193, DOI 10.1002/mds.870070302; Schilling G, 2001, NEUROBIOL DIS, V8, P405, DOI 10.1006/nbdi.2001.0385; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Schols L, 1996, J NEUROL NEUROSUR PS, V61, P466, DOI 10.1136/jnnp.61.5.466; Simoes AT, 2012, BRAIN, V135, P2428, DOI 10.1093/brain/aws177; SUDARSKY L, 1995, CLIN NEUROSCI, V3, P17; Switonski PM, 2011, NEUROMOL MED, V13, P54, DOI 10.1007/s12017-010-8137-3; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; Taniwaki T, 1997, J NEUROL SCI, V145, P63, DOI 10.1016/S0022-510X(96)00242-0; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; VANDERSTAAY FJ, 1990, BEHAV GENET, V20, P51; Wullner U, 2005, ARCH NEUROL-CHICAGO, V62, P1280, DOI 10.1001/archneur.62.8.1280; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yen TC, 2000, J NUCL MED, V41, P994; Zawacki TM, 2002, MOVEMENT DISORD, V17, P1004, DOI 10.1002/mds.10033; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	55	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e100086	10.1371/journal.pone.0100086	http://dx.doi.org/10.1371/journal.pone.0100086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144231	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100002
J	Ou, WJ; Liu, X; Shen, Y; Li, JN; He, LB; Yuan, Y; Tan, XR; Liu, LS; Zhao, JB; Wang, XY				Ou, Wenjing; Liu, Xin; Shen, Yue; Li, Jiana; He, Lingbin; Yuan, Yuan; Tan, Xuerui; Liu, Lisheng; Zhao, Jingbo; Wang, Xingyu			Association of CVD Candidate Gene Polymorphisms with Ischemic Stroke and Cerebral Hemorrhage in Chinese Individuals	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; REPUBLIC-OF-CHINA; C677T POLYMORPHISM; BLOOD-PRESSURE; RISK-FACTOR; FUNCTIONAL SNP; CONFERS RISK; HYPERTENSION; ATHEROSCLEROSIS	Background: Contribution of cardiovascular disease related genetic risk factors for stroke are not clearly defined. We performed a genetic association study to assess the association of 56 previously characterized gene variants in 34 candidate genes from cardiovascular disease related biological pathways with ischemic stroke and cerebral hemorrhage in a Chinese population. Methods: There were 1280 stroke patients (1101 with ischemic stroke and 179 with cerebral hemorrhage) and 1380 controls in the study. The genotypes for 56 polymorphisms of 34 candidate genes were determined by the immobilized probe approach and the associations of gene polymorphisms with ischemic stroke and cerebral hemorrhage were performed by logistic regression under an allelic model. Results: After adjusting for age, sex, BMI and hypertension status by logistic regression analysis, we found that NPPA rs5063 was significantly associated with both ischemic stroke (odds ratio [OR] 0.69; 95% confidence interval [CI], 0.52 to 0.90; P = 0.006) and cerebral hemorrhage(OR = 0.39; 95%CI, 0.19 to 0.78; P = 0.007). In addition, MTHFR rs1801133 also was associated with cerebral hemorrhage (OR = 1.48; 95%CI, 1.16 to 1.89; P = 0.001) but not with ischemic stroke (OR = 1.08; 95%CI, 0.96 to 1.22; P = 0.210). After false discovery rate (FDR) correction, the association of NPPA rs5063 and MTHFR rs1801133 with cerebral hemorrhage remained significant. Conclusions: The NPPA rs5063 is associated with reduced risk for cerebral hemorrhage and MTHFR rs1801133 is associated with increased risk of cerebral hemorrhage in a Chinese population.	[Ou, Wenjing; Li, Jiana; Zhao, Jingbo] Harbin Med Univ, Sch Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang, Peoples R China; [He, Lingbin; Yuan, Yuan; Tan, Xuerui; Wang, Xingyu] Shantou Univ, Coll Med, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China; [Liu, Xin; Shen, Yue; Liu, Lisheng; Wang, Xingyu] Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China	Harbin Medical University; Shantou University; Chinese Hypertension League	Zhao, JB (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang, Peoples R China.	zhaojb168@sina.com; xngyuw@yahoo.com			Beijing Hypertension League Institute; National Infrastructure Program of Chinese Genetic Resources [2005DKA21300]	Beijing Hypertension League Institute; National Infrastructure Program of Chinese Genetic Resources	This study was supported by the Beijing Hypertension League Institute and National Infrastructure Program of Chinese Genetic Resources (2005DKA21300). F. Hoffmann-La Roche partly funded this study through an unrestricted educational grant. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN U, 1986, CLIN CHEM, V32, P241; Barcellos LF, 2004, ANN NEUROL, V55, P793, DOI 10.1002/ana.20092; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonita R, 2004, LANCET NEUROL, V3, P391, DOI 10.1016/S1474-4422(04)00800-2; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Cheng S, 1999, GENOME RES, V9, P936, DOI 10.1101/gr.9.10.936; Conen D, 2007, HYPERTENSION, V50, P1114, DOI 10.1161/HYPERTENSIONAHA.107.097634; Cronin S, 2005, STROKE, V36, P1581, DOI 10.1161/01.STR.0000169946.31639.af; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Franco RF, 1998, THROMB HAEMOSTASIS, V79, P119, DOI 10.1055/s-0037-1614230; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; HE J, 1995, STROKE, V26, P2228; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kannel WB, 2008, JAMA-J AM MED ASSOC, V300, P2545, DOI 10.1001/jama.2008.759; Kohara K, 2003, STROKE, V34, P1130, DOI 10.1161/01.STR.0000069163.02611.B0; Kubo M, 2007, NAT GENET, V39, P212, DOI 10.1038/ng1945; Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Maack T, 1992, HDB PHYSL RENAL PHYS, P1577; Matsushita T, 2010, HUM MOL GENET, V19, P1137, DOI 10.1093/hmg/ddp582; Mazighi M, 2008, STROKE, V39, P1142, DOI 10.1161/STROKEAHA.107.496513; *NAT 8 5 CVD COLL, 1998, CHIN J PREVENT MED S, V32, P3; NEEDLEMAN P, 1986, NEW ENGL J MED, V314, P828; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Peck G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003691; Qian XQ, 2007, EUR J HUM GENET, V15, P1239, DOI 10.1038/sj.ejhg.5201914; Rubattu S, 1999, CIRCULATION, V100, P1722, DOI 10.1161/01.CIR.100.16.1722; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Sazci A, 2006, BRAIN RES BULL, V71, P45, DOI 10.1016/j.brainresbull.2006.07.014; SHI FL, 1989, STROKE, V20, P1581, DOI 10.1161/01.STR.20.11.1581; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Somarajan BI, 2011, J NEUROL SCI, V304, P67, DOI 10.1016/j.jns.2011.02.010; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Sun HX, 2013, J STROKE, V15, P109, DOI 10.5853/jos.2013.15.2.109; Tawakol A, 1997, CIRCULATION, V95, P1119; Wang XY, 2009, STROKE, V40, P683, DOI 10.1161/STROKEAHA.108.524587; Yang QD, 2004, CEREBROVASC DIS, V17, P303, DOI 10.1159/000077341; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C	42	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105516	10.1371/journal.pone.0105516	http://dx.doi.org/10.1371/journal.pone.0105516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144711	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100078
J	Zhou, HX; Ma, YZ; Liu, YL; Chen, Y; Zhou, CJ; Wu, SN; Shen, JP; Liang, CG				Zhou, Hong-Xia; Ma, Yu-Zhen; Liu, Ying-Lei; Chen, Ying; Zhou, Cheng-Jie; Wu, Sha-Na; Shen, Jiang-Peng; Liang, Cheng-Guang			Assessment of Mouse Germinal Vesicle Stage Oocyte Quality by Evaluating the Cumulus Layer, Zona Pellucida, and Perivitelline Space	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; MEIOTIC MATURATION; MAMMALIAN OVARY; COMPLEX; EMBRYO; CELLS; MORPHOLOGY; THICKNESS; IVF; COMMUNICATION	To improve the outcome of assisted reproductive technology (ART) for patients with ovulation problems, it is necessary to retrieve and select germinal vesicle (GV) stage oocytes with high developmental potential. Oocytes with high developmental potential are characterized by their ability to undergo proper maturation, fertilization, and embryo development. In this study, we analyzed morphological traits of GV stage mouse oocytes, including cumulus cell layer thickness, zona pellucida thickness, and perivitelline space width. Then, we assessed the corresponding developmental potential of each of these oocytes and found that it varies across the range measured for each morphological trait. Furthermore, by manipulating these morphological traits in vitro, we were able to determine the influence of morphological variation on oocyte developmental potential. Manually altering the thickness of the cumulus layer showed strong effects on the fertilization and embryo development potentials of oocytes, whereas manipulation of zona pellucida thickness effected the oocyte maturation potential. Our results provide a systematic detailed method for selecting GV stage oocytes based on a morphological assessment approach that would benefit for several downstream ART applications.	[Zhou, Hong-Xia; Liu, Ying-Lei; Chen, Ying; Zhou, Cheng-Jie; Wu, Sha-Na; Shen, Jiang-Peng; Liang, Cheng-Guang] Inner Mongolia Univ, Key Lab Natl Educ Minist Mammalian Reprod Biol &, Hohhot, Inner Mongolia, Peoples R China; [Ma, Yu-Zhen] Inner Mongolia Peoples Hosp, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia University	Liang, CG (corresponding author), Inner Mongolia Univ, Key Lab Natl Educ Minist Mammalian Reprod Biol &, Hohhot, Inner Mongolia, Peoples R China.	liangchengguang@gmail.com	liang, chengguang/E-4837-2011	liang, chengguang/0000-0003-4407-7766; Zhou, Cheng-Jie/0000-0002-0575-5037	Open Major Basic Research Projects in Inner Mongolia [20102008]; National Natural Science Foundation of China [31160243, 31371454]; Program for New Century Excellent Talents in University [NCET-11-1014]; Inner Mongolia University [Z20100125]; Inner Mongolia Natural Science Foundation [20120516]	Open Major Basic Research Projects in Inner Mongolia; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Inner Mongolia University; Inner Mongolia Natural Science Foundation	This research was supported by: Open Major Basic Research Projects in Inner Mongolia (20102008) to CL, http://nsbr.nmkjt.gov.cn/index.aspx; The National Natural Science Foundation of China (31160243, 31371454) to CL, http://www.nsfc.gov.cn/; Program for New Century Excellent Talents in University (NCET-11-1014) to CL, http://www.moe.edu.cn/; Program of Higher Level Talents of Inner Mongolia University (Z20100125) to CL, http://www.imu.edu.cn/; Inner Mongolia Natural Science Foundation (20120516) to YM, http://nsbr.nmkjt.gov.cn/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong S, 2013, J ASSIST REPROD GEN, V30, P667, DOI 10.1007/s10815-013-9980-6; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Bao SQ, 2003, THERIOGENOLOGY, V59, P1231, DOI 10.1016/S0093-691X(02)01174-3; Chamayou S, 2006, REPROD BIOMED ONLINE, V13, P661, DOI 10.1016/S1472-6483(10)60656-6; Cheng Y, 2009, BIOL REPROD, V80, P464, DOI 10.1095/biolreprod.108.073593; Choi JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056158; DANDEKAR P, 1992, MOL REPROD DEV, V31, P135, DOI 10.1002/mrd.1080310208; DEAN J, 1992, J CLIN INVEST, V89, P1055, DOI 10.1172/JCI115684; Deb GK, 2012, J ANIM SCI, V90, P1798, DOI 10.2527/jas.2011-4340; Demant M, 2012, HUM REPROD, V27, P1096, DOI 10.1093/humrep/der453; Dunning KR, 2007, HUM REPROD, V22, P2842, DOI 10.1093/humrep/dem277; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Farhi J, 2002, J ASSIST REPROD GEN, V19, P545, DOI 10.1023/A:1021243530358; Fragouli E, 2014, HUM REPROD UPDATE, V20, P1, DOI 10.1093/humupd/dmt044; Gao SR, 2004, BIOL REPROD, V70, P1162, DOI 10.1095/biolreprod.103.024216; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; de Souza JMG, 2013, ANIM REPROD SCI, V138, P82, DOI 10.1016/j.anireprosci.2013.02.012; Goud PT, 1998, HUM REPROD, V13, P1638, DOI 10.1093/humrep/13.6.1638; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; HOWARD JG, 1993, BIOL REPROD, V49, P131, DOI 10.1095/biolreprod49.1.131; Huang HL, 2014, NEW ENGL J MED, V370, P1220, DOI 10.1056/NEJMoa1308851; Janssenswillen C, 1997, FERTIL STERIL, V67, P769, DOI 10.1016/S0015-0282(97)81381-7; Janvier A, 2011, J PEDIATR-US, V159, P409, DOI 10.1016/j.jpeds.2011.02.017; Lay KM, 2013, ANIM SCI J, V84, P8, DOI 10.1111/j.1740-0929.2012.01027.x; Li QL, 2008, MOL HUM REPROD, V14, P673, DOI 10.1093/molehr/gan064; Liang CG, 2009, HUM REPROD, V24, P2718, DOI 10.1093/humrep/dep286; Liu S, 2010, FERTIL STERIL, V93, P2202, DOI 10.1016/j.fertnstert.2009.01.062; Marco-Jimenez F, 2012, ANIM REPROD SCI, V132, P96, DOI 10.1016/j.anireprosci.2012.04.008; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201; Nawroth F, 2001, GYNECOL OBSTET INVES, V52, P55, DOI 10.1159/000052942; OKADA A, 1993, ANAT RECORD, V237, P518, DOI 10.1002/ar.1092370412; Gomes LMO, 2009, REV BRAS GINECOL OBS, V31, P230, DOI 10.1590/S0100-72032009000500005; Palmstierna M, 1998, J ASSIST REPROD GEN, V15, P70, DOI 10.1007/BF02766828; PIERCE KE, 1990, DEV BIOL, V141, P381, DOI 10.1016/0012-1606(90)90392-V; Rienzi L, 2008, FERTIL STERIL, V90, P1692, DOI 10.1016/j.fertnstert.2007.09.024; Rienzi L, 2011, HUM REPROD UPDATE, V17, P34, DOI 10.1093/humupd/dmq029; Shi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089409; Shimada M, 2013, AM J REPROD IMMUNOL, V69, P168, DOI 10.1111/aji.12024; SKUTELSKY E, 1992, HISTOCHEMISTRY, V98, P299, DOI 10.1007/BF00270013; Smolikova K, 2012, Endocr Regul, V46, P237; Sutton ML, 2003, HUM REPROD UPDATE, V9, P35, DOI 10.1093/humupd/dmg009; Ten J, 2007, REPROD BIOMED ONLINE, V14, P40, DOI 10.1016/S1472-6483(10)60762-6; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063173; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; Wassarman PM, 2012, INT J DEV BIOL, V56, P833, DOI 10.1387/ijdb.120136pw; Wassarman PM, 2009, J REPROD IMMUNOL, V83, P45, DOI 10.1016/j.jri.2009.06.259; Wassarman PM, 2002, MT SINAI J MED, V69, P148; Wasserman PM, 2013, CURR TOP DEV BIOL, V102, P243, DOI 10.1016/B978-0-12-416024-8.00009-X; Zhang AJ, 2012, J ASSIST REPROD GEN, V29, P313, DOI 10.1007/s10815-012-9712-3; ZHANG L, 1995, MOL REPROD DEV, V40, P338, DOI 10.1002/mrd.1080400310; Zhang Lun, 2010, Sichuan Da Xue Xue Bao Yi Xue Ban, V41, P810; Zou LP, 2013, J IMMUNOASS IMMUNOCH, V34, P134, DOI 10.1080/15321819.2012.690358	54	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105812	10.1371/journal.pone.0105812	http://dx.doi.org/10.1371/journal.pone.0105812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144310	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100123
J	Akada, J; Okuda, M; Hiramoto, N; Kitagawa, T; Zhang, XL; Kamei, S; Ito, A; Nakamura, M; Uchida, T; Hiwatani, T; Fukuda, Y; Nakazawa, T; Kuramitsu, Y; Nakamura, K				Akada, Junko; Okuda, Masumi; Hiramoto, Narumi; Kitagawa, Takao; Zhang, Xiulian; Kamei, Shuichi; Ito, Akane; Nakamura, Mikiko; Uchida, Tomohisa; Hiwatani, Tomoko; Fukuda, Yoshihiro; Nakazawa, Teruko; Kuramitsu, Yasuhiro; Nakamura, Kazuyuki			Proteomic Characterization of Helicobacter pylori CagA Antigen Recognized by Child Serum Antibodies and Its Epitope Mapping by Peptide Array	PLOS ONE			English	Article							STRAIN-SPECIFIC ANTIGEN; GASTRIC-CANCER; DUODENAL-ULCER; PROTEIN; IDENTIFICATION; INFECTION; CELLS; IMMUNOPROTEOMICS; CARCINOMA; DIAGNOSIS	Serum antibodies against pathogenic bacteria play immunologically protective roles, and can be utilized as diagnostic markers of infection. This study focused on Japanese child serum antibodies against Helicobacter pylori, a chronically-infected gastric bacterium which causes gastric cancer in adults. Serological diagnosis for H. pylori infection is well established for adults, but it needs to be improved for children. Serum samples from 24 children, 22 H. pylori (Hp)-positive and 2 Hp-negative children, were used to catalogue antigenic proteins of a Japanese strain CPY2052 by two-dimensional electrophoresis followed by immunoblot and LC-MS/MS analysis. In total, 24 proteins were identified as candidate antigen proteins. Among these, the major virulence factor, cytotoxin-associated gene A protein (CagA) was the most reactive antigen recognized by all the Hp-positive sera even from children under the age of 3 years. The major antigenic part of CagA was identified in the middle region, and two peptides containing CagA epitopes were identified using a newly developed peptide/protein-combined array chip method, modified from our previous protein chip method. Each of the epitopes was found to contain amino acid residue(s) unique to East Asian CagA. Epitope analysis of CagA indicated importance of the regional CagA antigens for serodiagnosis of H. pylori infection in children.	[Akada, Junko; Hiramoto, Narumi; Kitagawa, Takao; Zhang, Xiulian; Kuramitsu, Yasuhiro; Nakamura, Kazuyuki] Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 755, Japan; [Okuda, Masumi; Fukuda, Yoshihiro] Hyogo Coll Med, Sasayama Med Ctr, Sasayama, Hyogo, Japan; [Okuda, Masumi; Fukuda, Yoshihiro] Hyogo Coll Med, Dept Gen Med & Community Hlth Sci, Nishinomiya, Hyogo 6638501, Japan; [Kamei, Shuichi; Ito, Akane] Toyo Kohan Co Ltd, Tech Res Lab, Yamaguchi, Japan; [Nakamura, Mikiko] Yamaguchi Univ, Innovat Ctr Univ Ind Publ Cooperat, Org Res Initiat, Ube, Yamaguchi 755, Japan; [Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Oita 87011, Japan; [Hiwatani, Tomoko] Wakayama Rosai Hosp, Wakayama, Japan; [Nakazawa, Teruko] Yamaguchi Univ, Grad Sch Med, Dept Microbiol & Immunol, Ube, Yamaguchi 755, Japan	Yamaguchi University; Hyogo College of Medicine; Hyogo College of Medicine; Yamaguchi University; Oita University; Yamaguchi University	Akada, J (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 755, Japan.	akadajk@yamaguchi-u.ac.jp; nakamura@yamaguchi-u.ac.jp			KAKEN-HI from JSPS of Japan [24590919]; Yamaguchi University Innovation Center Foundation grant [2010-03]; Yamaguchi University Yobimizu Project; Grants-in-Aid for Scientific Research [24590919] Funding Source: KAKEN	KAKEN-HI from JSPS of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamaguchi University Innovation Center Foundation grant; Yamaguchi University Yobimizu Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKEN-HI No. 24590919 from JSPS of Japan, by Yamaguchi University Innovation Center Foundation grant No. 2010-03, and partially by Yamaguchi University Yobimizu Project 2013, to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Akada J, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-33; Akada JK, 2010, DIS MODEL MECH, V3, P605, DOI 10.1242/dmm.004879; Arnold IC, 2011, J IMMUNOL, V186, P6165, DOI 10.4049/jimmunol.1003472; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Barabino A, 1999, J PEDIATR GASTR NUTR, V28, P116, DOI 10.1097/00005176-199901000-00027; Bumann D, 2004, PROTEOMICS, V4, P2843, DOI 10.1002/pmic.200400909; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Cardenas-Mondragon MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062850; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; de Angelis GL, 2007, DIGEST DIS, V25, P206, DOI 10.1159/000103886; Furuta Y, 2011, P NATL ACAD SCI USA, V108, P1501, DOI 10.1073/pnas.1012579108; Haas G, 2002, PROTEOMICS, V2, P313, DOI 10.1002/1615-9861(200203)2:3<313::AID-PROT313>3.0.CO;2-7; Hayashi T, 2012, CELL HOST MICROBE, V12, P20, DOI 10.1016/j.chom.2012.05.010; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; Ichihara T, 2006, J PROTEOME RES, V5, P2144, DOI 10.1021/pr0504889; Jungblut PR, 2000, MOL MICROBIOL, V36, P710, DOI 10.1046/j.1365-2958.2000.01896.x; Kido M, 2011, BIOCHEM BIOPH RES CO, V412, P266, DOI 10.1016/j.bbrc.2011.07.081; Kimmel B, 2000, INFECT IMMUN, V68, P915, DOI 10.1128/IAI.68.2.915-920.2000; Krah A, 2004, INT J CANCER, V108, P456, DOI 10.1002/ijc.11557; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Lin YF, 2007, MOL CELL PROTEOMICS, V6, P1018, DOI 10.1074/mcp.M700009-MCP200; Lin YF, 2006, MOL CELL PROTEOMICS, V5, P1484, DOI 10.1074/mcp.M600111-MCP200; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lock RA, 2002, HELICOBACTER, V7, P175, DOI 10.1046/j.1523-5378.2002.00078.x; Marchildon PA, 2003, J CLIN MICROBIOL, V41, P1480, DOI 10.1128/JCM.41.4.1480-1485.2003; McAtee CP, 1998, HELICOBACTER, V3, P163; Mini R, 2005, PROTEOMICS, V5, P777, DOI 10.1002/pmic.200401094; Mizuno S, 2010, DIGEST DIS SCI, V55, P3132, DOI 10.1007/s10620-010-1154-0; Moese S, 2001, PROTEOMICS, V1, P618, DOI 10.1002/1615-9861(200104)1:4<618::AID-PROT618>3.0.CO;2-C; Okuda M, 2005, CLIN DIAGN LAB IMMUN, V12, P1280, DOI 10.1128/CDLI.12.11.1280-1284.2005; Okuda M, 2004, AM J MED, V116, P209, DOI 10.1016/j.amjmed.2003.05.005; Okuda M, 2013, PEDIATR INT, V55, P337, DOI 10.1111/ped.12057; Ozturk A, 2007, SEIZURE-EUR J EPILEP, V16, P147, DOI 10.1016/j.seizure.2006.10.015; Price JV, 2012, NAT MED, V18, P1434, DOI 10.1038/nm.2913; Shiota S, 2010, FUTURE MICROBIOL, V5, P1885, DOI 10.2217/FMB.10.135; Tatemichi M, 2009, HELICOBACTER, V14, P231, DOI 10.1111/j.1523-5378.2009.00681.x; TSUDA M, 1993, MICROBIOL IMMUNOL, V37, P85, DOI 10.1111/j.1348-0421.1993.tb03184.x; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Wang YF, 2012, ANTICANCER RES, V32, P3219; Winkler Dirk F. H., 2008, V494, P47, DOI 10.1007/978-1-59745-419-3_4; Woon AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079367; Yahiro K, 1999, J BIOL CHEM, V274, P36693, DOI 10.1074/jbc.274.51.36693; Yamada K, 2012, HELICOBACTER, V17, P187, DOI 10.1111/j.1523-5378.2011.00930.x	46	14	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104611	10.1371/journal.pone.0104611	http://dx.doi.org/10.1371/journal.pone.0104611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141238	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200025
J	Marionnet, C; Pierrard, C; Golebiewski, C; Bernerd, F				Marionnet, Claire; Pierrard, Cecile; Golebiewski, Christelle; Bernerd, Francoise			Diversity of Biological Effects Induced by Longwave UVA Rays (UVA1) in Reconstructed Skin	PLOS ONE			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; DELAYED-TYPE HYPERSENSITIVITY; LANGERHANS CELL DEPLETION; IN-VITRO; HUMAN KERATINOCYTES; HUMAN-EPIDERMIS; CONTACT HYPERSENSITIVITY; GENE-EXPRESSION; MESSENGER-RNA; BASAL LAYER	Despite their preponderance amongst the ultraviolet (UV) range received on Earth, the biological impacts of longwave UVA1 rays (340-400 nm) upon human skin have not been investigated so thoroughly. Nevertheless, recent studies have proven their harmful effects and involvement in carcinogenesis and immunosuppression. In this work, an in vitro reconstructed human skin model was used for exploring the effects of UVA1 at molecular, cellular and tissue levels. A biological impact of UVA1 throughout the whole reconstructed skin structure could be evidenced, from morphology to gene expression analysis. UVA1 induced immediate injuries such as generation of reactive oxygen species and thymine dimers DNA damage, accumulating preferentially in dermal fibroblasts and basal keratinocytes, followed by significant cellular alterations, such as fibroblast apoptosis and lipid peroxidation. The full genome transcriptomic study showed a clear UVA1 molecular signature with the modulation of expression of 461 and 480 genes in epidermal keratinocytes and dermal fibroblasts, respectively (fold change >= 1.5 and adjusted p value<0.001). Functional enrichment analysis using GO, KEGG pathways and bibliographic analysis revealed a real stress with up-regulation of genes encoding heat shock proteins or involved in oxidative stress response. UVA1 also affected a wide panel of pathways and functions including cancer, proliferation, apoptosis and development, extracellular matrix and metabolism of lipids and glucose. Strikingly, one quarter of modulated genes was related to innate immunity: genes involved in inflammation were strongly up-regulated while genes involved in antiviral defense were severely down-regulated. These transcriptomic data were confirmed in dose-response and time course experiments using quantitative PCR and protein quantification. Links between the evidenced UVA1-induced impacts and clinical consequences of UVA1 exposure such as photo-aging, photo-immunosuppression and cancer are discussed. These early molecular events support the contribution of UVA1 to long term harmful consequences of UV exposure and underline the need of an adequate UVA1 photoprotection.	[Marionnet, Claire; Pierrard, Cecile; Golebiewski, Christelle; Bernerd, Francoise] LOreal Res & Innovat, Aulnay Sous Bois, France	L'Oreal Group	Marionnet, C (corresponding author), LOreal Res & Innovat, Aulnay Sous Bois, France.	cmarionnet@rd.loreal.com			L'Oreal	L'Oreal(L'Oreal Group)	L'Oreal provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aragane Y, 1997, P NATL ACAD SCI USA, V94, P11490, DOI 10.1073/pnas.94.21.11490; Aragane Y, 1997, J IMMUNOL, V158, P5393; ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; Bernerd F, 1998, CELL DEATH DIFFER, V5, P792, DOI 10.1038/sj.cdd.4400413; Bernerd F, 2000, PHOTOCHEM PHOTOBIOL, V71, P314, DOI 10.1562/0031-8655(2000)071<0314:EOTPEO>2.0.CO;2; Besaratinia A, 2005, P NATL ACAD SCI USA, V102, P10058, DOI 10.1073/pnas.0502311102; Bestak R, 1996, PHOTOCHEM PHOTOBIOL, V64, P969, DOI 10.1111/j.1751-1097.1996.tb01863.x; Breuckmann F, 2003, J EUR ACAD DERMATOL, V17, P418, DOI 10.1046/j.1468-3083.2003.00761.x; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P485, DOI 10.1111/j.1751-1097.1984.tb04622.x; BRUNET S, 1989, MUTAT RES, V219, P217, DOI 10.1016/0921-8734(89)90003-9; Commission Internationale de l'Eclairage, 1989, SOL SPECTR IRR; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Damian DL, 2011, BRIT J DERMATOL, V164, P657, DOI 10.1111/j.1365-2133.2010.10161.x; Dekker P, 2005, PHOTOCHEM PHOTOBIOL, V81, P837, DOI 10.1562/2005-02-03-RA-432R.1; deLaat A, 1997, CARCINOGENESIS, V18, P1013, DOI 10.1093/carcin/18.5.1013; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dissemond J, 2003, BRIT J DERMATOL, V149, P341, DOI 10.1046/j.1365-2133.2003.05457.x; Dumay O, 2001, BRIT J DERMATOL, V144, P1161, DOI 10.1046/j.1365-2133.2001.04225.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Ghorr AA, 1999, J INVEST DERMATOL, V112, P757, DOI 10.1046/j.1523-1747.1999.00565.x; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feingold KR, 2009, J LIPID RES, V50, pS417, DOI 10.1194/jlr.R800039-JLR200; Feldmeyer L, 2010, EUR J CELL BIOL, V89, P638, DOI 10.1016/j.ejcb.2010.04.008; France The International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer, 2007, International Journal of Cancer, V120, P1116, DOI 10.1002/ijc.22453; Frederick JE, 1992, BIOL RESPONSES ULTRA, P7; GARMYN M, 1991, LAB INVEST, V65, P471; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godar DE, 1999, J INVEST DERMATOL, V112, P3, DOI 10.1046/j.1523-1747.1999.00474.x; Gordon JRS, 2012, NEW ENGL J MED, V366, pE25, DOI 10.1056/NEJMicm1104059; Gruber F, 2010, FASEB J, V24, P39, DOI 10.1096/fj.09-133520; Halliday GM, 2012, J INVEST DERMATOL, V132, P265, DOI 10.1038/jid.2011.281; Huang XX, 2009, AM J PATHOL, V174, P1534, DOI 10.2353/ajpath.2009.080318; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Katsuta Y, 2005, J INVEST DERMATOL, V124, P1008, DOI 10.1111/j.0022-202X.2005.23682.x; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kerr AC, 2012, CLIN EXP DERMATOL, V37, P219, DOI 10.1111/j.1365-2230.2011.04256.x; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim EJ, 2010, J DERMATOL SCI, V57, P19, DOI 10.1016/j.jdermsci.2009.10.008; KLIGMAN LH, 1991, PHOTOCHEM PHOTOBIOL, V54, P233, DOI 10.1111/j.1751-1097.1991.tb02011.x; Kondo S, 1999, J INVEST DERM SYMP P, V4, P177, DOI 10.1038/sj.jidsp.5640205; Leccia MT, 1999, BIOL TRACE ELEM RES, V69, P177, DOI 10.1007/BF02783870; Ley RD, 2000, PHOTOCHEM PHOTOBIOL, V72, P485, DOI 10.1562/0031-8655(2000)072<0485:UIEAPD>2.0.CO;2; Lim HW, 2001, J AM ACAD DERMATOL, V44, P505, DOI 10.1067/mjd.2001.112913; MAGNALDO T, 1992, DIFFERENTIATION, V49, P39, DOI 10.1111/j.1432-0436.1992.tb00767.x; Marionnet C, 2006, EXP DERMATOL, V15, P625, DOI 10.1111/j.1600-0625.2006.00454.x; Marionnet C, 2012, J DERMATOL SCI, V66, P238, DOI 10.1016/j.jdermsci.2012.02.018; Marionnet C, 2011, EXP DERMATOL, V20, P477, DOI 10.1111/j.1600-0625.2011.01265.x; Marionnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012059; Matthews YJ, 2010, J DERMATOL SCI, V59, P192, DOI 10.1016/j.jdermsci.2010.07.005; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Morita A, 1997, J EXP MED, V186, P1763, DOI 10.1084/jem.186.10.1763; Moyal DD, 2001, J INVEST DERMATOL, V117, P1186, DOI 10.1046/j.0022-202x.2001.01545.x; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Persson AE, 2002, PHOTODERMATOL PHOTO, V18, P287, DOI 10.1034/j.1600-0781.2002.02781.x; Racz E, 2011, BRIT J DERMATOL, V164, P838, DOI 10.1111/j.1365-2133.2010.10169.x; Randhawa M, 2013, MOL BIOSYST, V9, P2045, DOI 10.1039/c3mb25537a; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rochette PJ, 2003, NUCLEIC ACIDS RES, V31, P2786, DOI 10.1093/nar/gkg402; Runger TM, 2012, PHOTOCH PHOTOBIO SCI, V11, P207, DOI 10.1039/c1pp05232b; Rundhaug JE, 2008, PHOTOCHEM PHOTOBIOL, V84, P322, DOI 10.1111/j.1751-1097.2007.00261.x; Sabziparvar AA, 1999, PHOTOCHEM PHOTOBIOL, V69, P193, DOI 10.1111/j.1751-1097.1999.tb03273.x; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Seite S, 2006, J EUR ACAD DERMATOL, V20, P980, DOI 10.1111/j.1468-3083.2006.01706.x; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Smit N, 2010, PHOTOCHEM PHOTOBIOL, V86, P360, DOI 10.1111/j.1751-1097.2009.00650.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tewari A, 2013, PHOTOCH PHOTOBIO SCI, V12, P95, DOI 10.1039/c2pp25323b; Tewari A, 2012, J INVEST DERMATOL, V132, P394, DOI 10.1038/jid.2011.283; TOVEY MG, 1987, P NATL ACAD SCI USA, V84, P5038, DOI 10.1073/pnas.84.14.5038; Trautinger F, 1999, EXP DERMATOL, V8, P187, DOI 10.1111/j.1600-0625.1999.tb00369.x; Trautinger F, 2001, J PHOTOCH PHOTOBIO B, V63, P70, DOI 10.1016/S1011-1344(01)00203-2; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vielhaber G, 2006, PHOTOCH PHOTOBIO SCI, V5, P275, DOI 10.1039/b516702g; Vioux-Chagnoleau C, 2006, J DERMATOL SCI, pS1, DOI 10.1016/j.descs.2006.08.001; Wang F, 2014, JAMA DERMATOL, V150, P401, DOI 10.1001/jamadermatol.2013.8417; Williams IR, 1996, LIFE SCI, V58, P1485, DOI 10.1016/0024-3205(96)00042-2; WLASCHEK M, 1994, PHOTOCHEM PHOTOBIOL, V59, P550, DOI 10.1111/j.1751-1097.1994.tb02982.x; York NR, 2010, INT J DERMATOL, V49, P623, DOI 10.1111/j.1365-4632.2009.04427.x; Yuen KS, 2002, NITRIC OXIDE-BIOL CH, V6, P313, DOI 10.1006/niox.2001.0414; Zhou XW, 1998, J INVEST DERMATOL, V111, P194, DOI 10.1046/j.1523-1747.1998.00266.x	86	59	62	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105263	10.1371/journal.pone.0105263	http://dx.doi.org/10.1371/journal.pone.0105263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140898	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200067
J	Rommelaere, S; Millet, V; Manh, TPV; Gensollen, T; Andreoletti, P; Cherkaoui-Malki, M; Bourges, C; Escaliere, B; Du, X; Xia, Y; Imbert, J; Beutler, B; Kanai, Y; Malissen, B; Malissen, M; Tailleux, A; Staels, B; Galland, F; Naquet, P				Rommelaere, Samuel; Millet, Virginie; Thien-Phong Vu Manh; Gensollen, Thomas; Andreoletti, Pierre; Cherkaoui-Malki, Mustapha; Bourges, Christophe; Escaliere, Bertrand; Du, Xin; Xia, Yu; Imbert, Jean; Beutler, Bruce; Kanai, Yoshiakira; Malissen, Bernard; Malissen, Marie; Tailleux, Anne; Staels, Bart; Galland, Franck; Naquet, Philippe			Sox17 Regulates Liver Lipid Metabolism and Adaptation to Fasting	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; ACYL-COA THIOESTERASE; PPAR-ALPHA; TRANSCRIPTION FACTORS; BETA-OXIDATION; MOUSE; GENE; TRANSREPRESSION; RESISTANCE; LIPOLYSIS	Liver is a major regulator of lipid metabolism and adaptation to fasting, a process involving PPARalpha activation. We recently showed that the Vnn1 gene is a PPARalpha target gene in liver and that release of the Vanin-1 pantetheinase in serum is a biomarker of PPARalpha activation. Here we set up a screen to identify new regulators of adaptation to fasting using the serum Vanin-1 as a marker of PPARalpha activation. Mutagenized mice were screened for low serum Vanin-1 expression. Functional interactions with PPARalpha were investigated by combining transcriptomic, biochemical and metabolic approaches. We characterized a new mutant mouse in which hepatic and serum expression of Vanin-1 is depressed. This mouse carries a mutation in the HMG domain of the Sox17 transcription factor. Mutant mice display a metabolic phenotype featuring lipid abnormalities and inefficient adaptation to fasting. Upon fasting, a fraction of the PPAR alpha-driven transcriptional program is no longer induced and associated with impaired fatty acid oxidation. The transcriptional phenotype is partially observed in heterozygous Sox17+/- mice. In mutant mice, the fasting phenotype but not all transcriptomic signature is rescued by the administration of the PPARalpha agonist fenofibrate. These results identify a novel role for Sox17 in adult liver as a modulator of the metabolic adaptation to fasting.	[Rommelaere, Samuel; Millet, Virginie; Thien-Phong Vu Manh; Gensollen, Thomas; Bourges, Christophe; Escaliere, Bertrand; Malissen, Bernard; Malissen, Marie; Galland, Franck; Naquet, Philippe] Aix Marseille Univ, UM2, CIML, Marseille, France; [Rommelaere, Samuel; Millet, Virginie; Thien-Phong Vu Manh; Gensollen, Thomas; Bourges, Christophe; Escaliere, Bertrand; Malissen, Bernard; Malissen, Marie; Galland, Franck; Naquet, Philippe] INSERM, U1104, F-13258 Marseille, France; [Rommelaere, Samuel; Millet, Virginie; Thien-Phong Vu Manh; Gensollen, Thomas; Bourges, Christophe; Escaliere, Bertrand; Malissen, Bernard; Malissen, Marie; Galland, Franck; Naquet, Philippe] CNRS, UMR7280, Marseille, France; [Kanai, Yoshiakira] Univ Tokyo, Dept Vet Anat, Bunkyo Ku, Tokyo, Japan; [Imbert, Jean] Aix Marseille Univ, INSERM, TGML TAGC, UMR S 1090, Marseille, France; [Du, Xin; Xia, Yu; Beutler, Bruce] Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Tailleux, Anne; Staels, Bart] Univ Lille 2, INSERM, U1011, Inst Pasteur Lille,EGID, Lille, France; [Andreoletti, Pierre; Cherkaoui-Malki, Mustapha] Univ Bourgogne, Lab BioPeroxIL, EA7270, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Tokyo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Texas System; University of Texas Southwestern Medical Center Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Bourgogne	Naquet, P (corresponding author), Aix Marseille Univ, UM2, CIML, Marseille, France.	fgpn@ciml.univ-mrs.fr	TAILLEUX, Anne/R-5530-2018; Staels, Bart/N-9497-2016; ANDREOLETTI, PIERRE/B-5245-2012; Imbert, Jean/G-3248-2013; Imbert, Jean/AAG-1165-2020; Malissen, Bernard/AAK-4659-2020	TAILLEUX, Anne/0000-0003-1430-2627; Staels, Bart/0000-0002-3784-1503; ANDREOLETTI, PIERRE/0000-0003-2118-7858; Imbert, Jean/0000-0002-0478-9593; Imbert, Jean/0000-0002-0478-9593; Malissen, Bernard/0000-0003-1340-9342; Malissen, Marie/0000-0003-2331-1445; Kanai, Yoshiakira/0000-0003-2116-7806; /0000-0002-9834-5490; Vu Manh, Thien-Phong/0000-0002-0294-342X	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; INCA; European Communities MUGEN; Ministry of Research; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche (ANR) (PhyloGenDC) [ANR-09-BLAN-0073-02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); INCA(Institut National du Cancer (INCA) France); European Communities MUGEN; Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR) (PhyloGenDC)(French National Research Agency (ANR))	This work was supported by funds from the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, INCA, European Communities MUGEN projects. S. R. and T. G. were supported by funds from the Ministry of Research and Fondation pour la Recherche Medicale. T.-P. V. M. was supported by the Agence Nationale de la Recherche (ANR) (PhyloGenDC, ANR-09-BLAN-0073-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Gartner J, 1993, Semin Cell Biol, V4, P45, DOI 10.1006/scel.1993.1006; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hosking BM, 2004, J BIOL CHEM, V279, P5314, DOI 10.1074/jbc.M308512200; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Kovacs WJ, 2004, MOL CELL BIOL, V24, P1, DOI 10.1128/MCB.24.1.1-13.2004; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liang YM, 2013, NAT IMMUNOL, V14, P858, DOI 10.1038/ni.2634; Martin F, 2001, IMMUNOGENETICS, V53, P296, DOI 10.1007/s002510100327; Martinez-Jimenez CP, 2010, MOL CELL BIOL, V30, P565, DOI 10.1128/MCB.00927-09; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pfister S, 2011, INT J DEV BIOL, V55, P45, DOI 10.1387/ijdb.103158sp; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rommelaere S, 2013, FEBS LETT; Schrader M, 2006, INT REV CYTOL, V255, P237, DOI 10.1016/S0074-7696(06)55005-3; Shimizu M, 2006, J BIOCHEM, V139, P563, DOI 10.1093/jb/mvj053; SLAUTER RW, 1984, ARCH BIOCHEM BIOPHYS, V233, P197, DOI 10.1016/0003-9861(84)90617-9; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Uemura M, 2013, DEVELOPMENT, V140, P639, DOI 10.1242/dev.086702; Wilson MJ, 2005, J BIOL CHEM, V280, P5917, DOI 10.1074/jbc.M412806200; Yao CX, 2012, J MOL BIOL, V415, P143, DOI 10.1016/j.jmb.2011.11.011; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; Zaidi N, 2013, PROG LIPID RES, V52, P585, DOI 10.1016/j.plipres.2013.08.005	36	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104925	10.1371/journal.pone.0104925	http://dx.doi.org/10.1371/journal.pone.0104925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141153	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200042
J	Lopes, MH; Santos, TG; Rodrigues, BR; Queiroz-Hazarbassanov, N; Cunha, IW; Wasilewska-Sampaio, AP; Costa-Silva, B; Marchi, FA; Bleggi-Torres, LF; Sanematsu, PI; Suzuki, SH; Oba-Shinjo, SM; Marie, SKN; Toulmin, E; Hill, AF; Martins, VR				Lopes, M. H.; Santos, T. G.; Rodrigues, B. R.; Queiroz-Hazarbassanov, N.; Cunha, I. W.; Wasilewska-Sampaio, A. P.; Costa-Silva, B.; Marchi, F. A.; Bleggi-Torres, L. F.; Sanematsu, P. I.; Suzuki, S. H.; Oba-Shinjo, S. M.; Marie, S. K. N.; Toulmin, E.; Hill, A. F.; Martins, V. R.			Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival	ONCOGENE			English	Article							STRESS-INDUCIBLE PROTEIN-1; INDUCED PHOSPHOPROTEIN 1; CANCER-CELL-LINES; SIGNALING PATHWAYS; COLORECTAL-CANCER; PANCREATIC-CANCER; CLINICAL-TRIALS; BREAST-CANCER; BRAIN-TUMOR; PRO-PRION	Glioblastomas (GBMs) are resistant to current therapy protocols and identification of molecules that target these tumors is crucial. Interaction of secreted heat-shock protein 70 (Hsp70)-Hsp90-organizing protein (HOP) with cellular prion protein (PrPC) triggers a large number of trophic effects in the nervous system. We found that both PrPC and HOP are highly expressed in human GBM samples relative to non-tumoral tissue or astrocytoma grades I-III. High levels of PrPC and HOP were associated with greater GBM proliferation and lower patient survival. HOP-PrPC binding increased GBM proliferation in vitro via phosphatidylinositide 3-kinase and extracellular-signal-regulated kinase pathways, and a HOP peptide mimicking the PrPC binding site (HOP230-245) abrogates this effect. PrPC knockdown impaired tumor growth and increased survival of mice with tumors. In mice, intratumor delivery of HOP230-245 peptide impaired proliferation and promoted apoptosis of GBM cells. In addition, treatment with HOP230-245 peptide inhibited tumor growth, maintained cognitive performance and improved survival. Thus, together, the present results indicate that interfering with PrPC-HOP engagement is a promising approach for GBM therapy.	[Lopes, M. H.; Santos, T. G.; Rodrigues, B. R.; Queiroz-Hazarbassanov, N.; Wasilewska-Sampaio, A. P.; Costa-Silva, B.; Marchi, F. A.; Martins, V. R.] AC Camargo Canc Ctr, Int Res Ctr, BR-01508010 Sao Paulo, Brazil; [Lopes, M. H.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil; [Lopes, M. H.; Santos, T. G.; Rodrigues, B. R.; Queiroz-Hazarbassanov, N.; Wasilewska-Sampaio, A. P.; Costa-Silva, B.; Marchi, F. A.; Martins, V. R.] CNPq MCT FAPESP, Nat Inst Translat Neurosci, Sao Paulo, Brazil; [Lopes, M. H.; Santos, T. G.; Rodrigues, B. R.; Queiroz-Hazarbassanov, N.; Wasilewska-Sampaio, A. P.; Costa-Silva, B.; Marchi, F. A.; Martins, V. R.] CNPq MCT FAPESP, Natl Inst Oncogen, Sao Paulo, Brazil; [Cunha, I. W.] AC Camargo Canc Ctr, Dept Pathol, BR-01508010 Sao Paulo, Brazil; [Marchi, F. A.] Univ Sao Paulo, Inst Math & Stat, Interinst Grad Program Bioinformat, Sao Paulo, Brazil; [Bleggi-Torres, L. F.] Univ Fed Parana, Dept Pathol, BR-80060000 Curitiba, Parana, Brazil; [Bleggi-Torres, L. F.] Pele Pequeno Principe Res Inst, Curitiba, Parana, Brazil; [Sanematsu, P. I.; Suzuki, S. H.] AC Camargo Canc Ctr, Dept Neurosurg, BR-01508010 Sao Paulo, Brazil; [Oba-Shinjo, S. M.; Marie, S. K. N.] Univ Sao Paulo, Sch Med, Dept Neurol, BR-05508 Sao Paulo, Brazil; [Toulmin, E.; Hill, A. F.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Martins, V. R.] Ludwig Inst Canc Res, Sao Paulo, Brazil	A.C.Camargo Cancer Center; Universidade de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade Federal do Parana; Hospital Pequeno Principe; A.C.Camargo Cancer Center; Universidade de Sao Paulo; University of Melbourne; Ludwig Institute for Cancer Research	Martins, VR (corresponding author), AC Camargo Canc Ctr, Int Res Ctr, Rua Tagua 440, BR-01508010 Sao Paulo, Brazil.	vmartins@cipe.accamargo.org.br	Santos, Tiago Goss/AAQ-4272-2020; Martins, Vilma/N-5446-2019; Hill, Andrew F/B-4527-2009; Marchi, Fabio Albuquerque/AAC-1380-2021; Martins, Vilma R/E-2547-2012; Hill, Andrew F./AAH-2854-2020; Hill, Andrew F./GZL-4124-2022; Marchi, Fabio A/N-9288-2018; Cunha, Isabela/H-3013-2012; Santos, Tiago/F-2387-2012; Oba-Shinjo, Sueli M./C-4017-2012; Lopes, Marilene/GLV-4734-2022; Queiroz-Hazarbassanov, Nicolle/Q-6901-2019; Costa-Silva, Bruno/AAY-2266-2020; Queiroz-Hazarbassanov, Nicolle/P-4333-2014; dos Santos, Tiago Goss/A-1538-2019; Marie, Suely Kazue Nagahashi/D-1870-2012	Santos, Tiago Goss/0000-0001-6641-7413; Hill, Andrew F/0000-0001-5581-2354; Marchi, Fabio Albuquerque/0000-0001-5815-8423; Martins, Vilma R/0000-0002-2909-8502; Hill, Andrew F./0000-0001-5581-2354; Marchi, Fabio A/0000-0001-5815-8423; Cunha, Isabela/0000-0002-2029-5139; Santos, Tiago/0000-0001-6641-7413; Oba-Shinjo, Sueli M./0000-0002-1650-5973; Lopes, Marilene/0000-0003-2496-0674; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; dos Santos, Tiago Goss/0000-0001-6641-7413; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Costa-Silva, Bruno/0000-0002-5932-6211	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 09/14027-2, 07/08410-2, 04/12133-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP [2009/51653-9, 2009/51751-0, 2008/55381-0, 2010-13654-0, 2012/19019-0, 2010/20796-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 09/14027-2, 07/08410-2 and 04/12133-6) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). Fellowships from FAPESP (to TGS) (2009/51653-9), NGQ (2009/51751-0), BC-S (2008/55381-0), BRR (2010-13654-0, 2012/19019-0), APW-S (2010/20796-6), and from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (to APW-S) are gratefully acknowledged. We are thankful for Maria Del Mar Inda and Severino da Silva Ferreira for technical assistance. Drs Maria Dirlei Begnami, Victor Piana de Andrade and Martin Roffe contributed with helpful discussions. We thank the AC Camargo Biobank for providing the astrocytoma samples used in this study.	Allhenn D, 2012, INT J PHARMACEUT, V436, P299, DOI 10.1016/j.ijpharm.2012.06.025; Alvarenga AW, 2013, J HISTOCHEM CYTOCHEM, V61, P272, DOI 10.1369/0022155413477661; Antonacopoulou AG, 2008, ANTICANCER RES, V28, P1221; Antonacopoulou AG, 2010, MOL CARCINOGEN, V49, P693, DOI 10.1002/mc.20642; Barbieri G, 2011, AUTOPHAGY, V7, P840, DOI 10.4161/auto.7.8.15615; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Butowski N, 2012, CURR OPIN NEUROL, V25, P780, DOI 10.1097/WCO.0b013e328359b45e; Caine C, 2012, EXPERT REV ANTICANC, V12, P655, DOI [10.1586/ERA.12.34, 10.1586/era.12.34]; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Erlich RB, 2007, GLIA, V55, P1690, DOI 10.1002/glia.20579; Eustace BK, 2004, CELL CYCLE, V3, P1098; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gehring K, 2008, LANCET NEUROL, V7, P548, DOI 10.1016/S1474-4422(08)70111-X; Hajj GNM, 2013, CELL MOL LIFE SCI, V70, P3211, DOI 10.1007/s00018-013-1328-y; Horibe T, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-59; Horibe T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-8; Jones TS, 2012, ONCOGENE, V31, P1995, DOI 10.1038/onc.2011.398; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kubota H, 2010, CELL STRESS CHAPERON, V15, P1003, DOI 10.1007/s12192-010-0211-0; Lal S, 2000, J NEUROSURG, V92, P326, DOI 10.3171/jns.2000.92.2.0326; Lee CT, 2012, EMBO J, V31, P1518, DOI 10.1038/emboj.2012.37; Li CY, 2010, J BIOL CHEM, V285, P30328, DOI 10.1074/jbc.M110.147413; Li CY, 2009, J CLIN INVEST, V119, P2725, DOI 10.1172/JCI39542; Li QQ, 2011, CANCER SCI, V102, P400, DOI 10.1111/j.1349-7006.2010.01811.x; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Maciejewski A, 2013, BIOMOL NMR ASSIGN, V7, P305, DOI 10.1007/s12104-012-9433-7; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Meslin F, 2007, ANN ONCOL, V18, P1793, DOI 10.1093/annonc/mdm406; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Pimienta G, 2011, MOL PHARMACEUT, V8, P2252, DOI 10.1021/mp200346y; Quant EC, 2010, NEUROIMAG CLIN N AM, V20, P425, DOI 10.1016/j.nic.2010.04.007; Ruckova E, 2012, CELL MOL BIOL LETT, V17, P446, DOI 10.2478/s11658-012-0021-8; Santos TG, 2011, STEM CELLS, V29, P1126, DOI 10.1002/stem.664; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Sy MS, 2011, CANCER BIOMARK, V10, P251, DOI 10.3233/CBM-2012-0256; Tsai CL, 2012, CELL REP, V2, P283, DOI 10.1016/j.celrep.2012.07.002; Walsh N, 2011, CANCER LETT, V306, P180, DOI 10.1016/j.canlet.2011.03.004; Walsh N, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-3; Wang TH, 2010, MOL CELL PROTEOMICS, V9, P1873, DOI 10.1074/mcp.M110.000802; Wasilewska-Sampaio AP, 2013, PHYSL BEHAV C, V123C, P55; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Willmer T, 2013, CANCER LETT, V328, P252, DOI 10.1016/j.canlet.2012.09.021; Yu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048146; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zhuang DX, 2012, INT J CANCER, V130, P309, DOI 10.1002/ijc.25985	53	36	36	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3305	3314		10.1038/onc.2014.261	http://dx.doi.org/10.1038/onc.2014.261			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25151961				2022-12-25	WOS:000356592300009
J	Emperle, M; Rajavelu, A; Reinhardt, R; Jurkowska, RZ; Jeltsch, A				Emperle, Max; Rajavelu, Arumugam; Reinhardt, Richard; Jurkowska, Renata Z.; Jeltsch, Albert			Cooperative DNA Binding and Protein/DNA Fiber Formation Increases the Activity of the Dnmt3a DNA Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cooperativity; DNA Enzyme; DNA Methylation; DNA Methyltransferase; Enzyme Kinetics; Enzyme Mechanism	DE-NOVO METHYLTRANSFERASE; PROCESSIVE METHYLATION; CATALYTIC MECHANISM; INDIVIDUAL CLONES; MODIFIES DNA; SITES; PREFERENCE; ENZYME; DOMAIN; DNA-(CYTOSINE-C5)-METHYLTRANSFERASES	Background: Dnmt3a has been reported to multimerize on DNA and methylate DNA processively, which is contradicting. Results: We show that multimerization of Dnmt3a on DNA increases its activity, but processive DNA methylation is not detectable. Conclusion: Dnmt3a forms enzyme/DNA fibers. Significance: Our results help to understand the mechanism of DNA methylation and the effects of Dnmt3a somatic cancer mutations. The Dnmt3a DNA methyltransferase has been shown to bind cooperatively to DNA and to form large multimeric protein/DNA fibers. However, it has also been reported to methylate DNA in a processive manner, a property that is incompatible with protein/DNA fiber formation. We show here that the DNA methylation rate of Dnmt3a increases more than linearly with increasing enzyme concentration on a long DNA substrate, but not on a short 30-mer oligonucleotide substrate. We also show that addition of a catalytically inactive Dnmt3a mutant, which carries an amino acid exchange in the catalytic center, increases the DNA methylation rate by wild type Dnmt3a on the long substrate but not on the short one. In agreement with this finding, preincubation experiments indicate that stable protein/DNA fibers are formed on the long, but not on the short substrate. In addition, methylation experiments with substrates containing one or two CpG sites did not provide evidence for a processive mechanism over a wide range of enzyme concentrations. These data clearly indicate that Dnmt3a binds to DNA in a cooperative reaction and that the formation of stable protein/DNA fibers increases the DNA methylation rate. Fiber formation occurs at low m concentrations of Dnmt3a, which are in the range of Dnmt3a concentrations in the nucleus of embryonic stem cells. Understanding the mechanism of Dnmt3a is of vital importance because Dnmt3a is a hotspot of somatic cancer mutations one of which has been implicated in changing Dnmt3a processivity.	[Emperle, Max; Rajavelu, Arumugam; Jurkowska, Renata Z.; Jeltsch, Albert] Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany; [Reinhardt, Richard] Max Planck Genomzentrum Koln, D-50829 Cologne, Germany	University of Stuttgart; Max Planck Society	Jurkowska, RZ (corresponding author), Univ Stuttgart, Fac Chem, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	renata.jurkowska@ibc.uni-stuttgart.de; albert.jeltsch@ibc.uni-stuttgart.de	Jurkowska, Renata/AAE-2504-2020; Jeltsch, Albert/O-7404-2014	Jurkowska, Renata/0000-0002-4507-2222; Jeltsch, Albert/0000-0001-6113-9290; Reinhardt, Richard/0000-0001-9376-2132; Rajavelu, Arumugam/0000-0001-6666-8925	Deutsche Forschungsgemeinschaft [JE 252/10]; Bundesministerium fur Bildung und Forschung [FKZ 01GS0805]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft Grant JE 252/10 (to A. J.) and Bundesministerium fur Bildung und Forschung Grant FKZ 01GS0805 (to R. R.).	Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Handa V, 2005, J MOL BIOL, V348, P1103, DOI 10.1016/j.jmb.2005.02.044; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Holz-Schietinger C, 2012, J BIOL CHEM, V287, P30941, DOI 10.1074/jbc.M112.366625; Holz-Schietinger C, 2011, J BIOL CHEM, V286, P41479, DOI 10.1074/jbc.M111.284687; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jurkowska RZ, 2011, J BIOL CHEM, V286, P24200, DOI 10.1074/jbc.M111.254987; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P1589, DOI 10.1002/cbic.201000673; Jurkowska RZ, 2008, NUCLEIC ACIDS RES, V36, P6656, DOI 10.1093/nar/gkn747; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lin IG, 2002, MOL CELL BIOL, V22, P704, DOI 10.1128/MCB.22.3.704-723.2002; Martinez-Rucobo FW, 2013, BBA-GENE REGUL MECH, V1829, P9, DOI 10.1016/j.bbagrm.2012.09.002; McHenry CS, 2011, CURR OPIN CHEM BIOL, V15, P587, DOI 10.1016/j.cbpa.2011.07.018; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Perry JJP, 2010, J BIOL CHEM, V285, P25699, DOI 10.1074/jbc.M110.124941; Rajavelu A, 2012, NUCLEIC ACIDS RES, V40, P569, DOI 10.1093/nar/gkr753; Rathert P, 2007, CHEMBIOCHEM, V8, P202, DOI 10.1002/cbic.200600358; Reither S, 2003, J MOL BIOL, V329, P675, DOI 10.1016/S0022-2836(03)00509-6; RENBAUM P, 1992, FEBS LETT, V313, P243, DOI 10.1016/0014-5793(92)81201-V; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Seidel R, 2004, NAT STRUCT MOL BIOL, V11, P838, DOI 10.1038/nsmb816; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869; Xu J, 2014, P NATL ACAD SCI USA, V111, P2620, DOI 10.1073/pnas.1400150111; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhang Yingying, 2009, V507, P177, DOI 10.1007/978-1-59745-522-0_14	42	36	36	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29602	29613		10.1074/jbc.M114.572032	http://dx.doi.org/10.1074/jbc.M114.572032			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25147181	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000344370800011
J	Panagos, CG; Thomson, DS; Moss, C; Hughes, AD; Kelly, MS; Liu, Y; Chai, WG; Venkatasamy, R; Spina, D; Page, CP; Hogwood, J; Woods, RJ; Mulloy, B; Bavington, CD; Uhrin, D				Panagos, Charalampos G.; Thomson, Derek S.; Moss, Claire; Hughes, Adam D.; Kelly, Maeve S.; Liu, Yan; Chai, Wengang; Venkatasamy, Radhakrishnan; Spina, Domenico; Page, Clive P.; Hogwood, John; Woods, Robert J.; Mulloy, Barbara; Bavington, Charlie D.; Uhrin, Dusan			Fucosylated Chondroitin Sulfates from the Body Wall of the Sea Cucumber Holothuria forskali CONFORMATION, SELECTIN BINDING, AND BIOLOGICAL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-RADICAL DEPOLYMERIZATION; RESIDUAL DIPOLAR COUPLINGS; HUMAN-LEUKOCYTE ELASTASE; STICHOPUS-JAPONICUS; P-SELECTIN; LEWIS-X; ANTICOAGULANT ACTIVITIES; NMR-SPECTROSCOPY; HEPARAN-SULFATE	Fucosylated chondroitin sulfate (fCS) extracted from the sea cucumber Holothuria forskali is composed of the following repeating trisaccharide unit: -> 3)GalNAc beta 4,6S(1 -> 4) [Fuc alpha X(1 -> 3)]GlcA beta(1 ->, where X stands for different sulfation patterns of fucose (X = 3,4S (46%), 2,4S (39%), and 4S (15%)). As revealed by NMR and molecular dynamics simulations, the fCS repeating unit adopts a conformation similar to that of the Le(x) blood group determinant, bringing several sulfate groups into close proximity and creating large negative patches distributed along the helical skeleton of the CS backbone. This may explain the high affinity of fCS oligosaccharides for L-and P-selectins as determined by microarray binding of fCS oligosaccharides prepared by Cu2+-catalyzed Fenton-type and photochemical depolymerization. No binding to E-selectin was observed. fCS poly- and oligosaccharides display low cytotoxicity in vitro, inhibit human neutrophil elastase activity, and inhibit the migration of neutrophils through an endothelial cell layer in vitro. Although the polysaccharide showed some anti-coagulant activity, small oligosaccharide fCS fragments had much reduced anticoagulant properties, with activity mainly via heparin cofactor II. The fCS polysaccharides showed prekallikrein activation comparable with dextran sulfate, whereas the fCS oligosaccharides caused almost no effect. The H. forskali fCS oligosaccharides were also tested in a mouse peritoneal inflammation model, where they caused a reduction in neutrophil infiltration. Overall, the data presented support the action of fCS as an inhibitor of selectin interactions, which play vital roles in inflammation and metastasis progression. Future studies of fCS-selectin interaction using fCS fragments or their mimetics may open new avenues for therapeutic intervention.	[Uhrin, Dusan] Univ Edinburgh, EaStCHEM Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland; [Thomson, Derek S.; Moss, Claire; Bavington, Charlie D.; Uhrin, Dusan] GlycoMar Ltd, European Ctr Marine Biotechnol, Dunstaffnage Marine Lab, Oban PA37 1QA, Argyll, Scotland; [Hughes, Adam D.; Kelly, Maeve S.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban PA37, Argyll, Scotland; [Liu, Yan; Chai, Wengang; Mulloy, Barbara] Univ London Imperial Coll Sci Technol & Med, Glycosci Lab, London W12 0NN, England; [Venkatasamy, Radhakrishnan; Spina, Domenico; Page, Clive P.; Mulloy, Barbara] Kings Coll London, Inst Pharmaceut Sci, Sackler Inst Pulm Pharmacol, London SE1 9NH, England; [Hogwood, John] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; [Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Woods, Robert J.] Natl Univ Ireland Galway, Sch Chem, Galway, Ireland	University of Edinburgh; Imperial College London; University of London; King's College London; National Institute for Biological Standards & Control; University System of Georgia; University of Georgia; Ollscoil na Gaillimhe-University of Galway	Uhrin, D (corresponding author), Univ Edinburgh, EaStCHEM Sch Chem, Joseph Black Bldg,Kings Bldg, Edinburgh EH9 3JJ, Midlothian, Scotland.	dusan.uhrin@ed.ac.uk	Woods, Robert/F-4962-2015; Liu, Yan/D-9117-2013	Liu, Yan/0000-0002-2566-6867; Spina, Domenico/0000-0002-6815-1564; Page, Clive Peter/0000-0002-9358-3799; Woods, Robert/0000-0002-2400-6293	Wellcome Trust [093378/Z/10/Z, 099197/Z/Z]; National Institutes of Health from NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094919, P41GM103390, P41GM103311] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/G037604/1, EP/K039717/1, GR/S79268/02] Funding Source: researchfish; EPSRC [EP/K039717/1, EP/G037604/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful to members of the Glycosciences Laboratory, especially Robert Childs and Angelina Palma, who contributed to the microarray experiment and data analyses for this study. The microarray facility at the Glycosciences Laboratory is supported by Wellcome Trust Grants 093378/Z/10/Z and 099197/Z/Z. The UCSF Chimera package was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41-GM103311 from NIGMS). We thank Prof. Ten Feizi for critical reading of the manuscript.	Azurmendi HF, 2002, BIOPOLYMERS, V63, P89, DOI 10.1002/bip.10015; BARTOLUCCI C, 1995, CARBOHYD RES, V276, P401, DOI 10.1016/0008-6215(95)00179-W; Beccati D, 2010, CARBOHYD POLYM, V82, P699, DOI 10.1016/j.carbpol.2010.05.038; BECHTEL B, 1990, J BIOL CHEM, V265, P2028; BEUTLER JA, 1993, ANTIVIR CHEM CHEMOTH, V4, P167, DOI 10.1177/095632029300400306; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Borsig L, 2007, J BIOL CHEM, V282, P14984, DOI 10.1074/jbc.M610560200; Brown RA, 2003, BRIT J PHARMACOL, V139, P845, DOI 10.1038/sj.bjp.0705291; CAEL JJ, 1978, J MOL BIOL, V125, P21, DOI 10.1016/0022-2836(78)90252-8; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2014, AMBER 14; Cesaretti M, 2003, CARBOHYD POLYM, V54, P59, DOI 10.1016/S0144-8617(03)00144-9; Chai WG, 1996, ANAL BIOCHEM, V237, P88, DOI 10.1006/abio.1996.0205; Chai WG, 2003, METHOD ENZYMOL, V362, P160; Chen SG, 2013, BBA-GEN SUBJECTS, V1830, P3054, DOI 10.1016/j.bbagen.2013.01.001; Chen SG, 2011, CARBOHYD POLYM, V83, P688, DOI 10.1016/j.carbpol.2010.08.040; Feizi T, 2013, ANN NY ACAD SCI, V1292, P33, DOI 10.1111/nyas.12210; Fonseca RJC, 2006, THROMB HAEMOSTASIS, V96, P822, DOI 10.1160/TH06-06-0304; Fonseca RJC, 2010, THROMB HAEMOSTASIS, V103, P994, DOI 10.1160/TH09-10-0734; Fonseca RJC, 2009, THROMB HAEMOSTASIS, V102, P829, DOI 10.1160/TH08-11-0773; Galustian C, 2002, IMMUNOLOGY, V105, P350, DOI 10.1046/j.1365-2567.2002.01369.x; Glauser BF, 2008, THROMB HAEMOSTASIS, V100, P420, DOI 10.1160/TH08-04-0210; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gray E, 2008, THROMB HAEMOSTASIS, V99, P807, DOI 10.1160/TH08-01-0032; Herencia F, 1998, LIFE SCI, V62, pPL115, DOI 10.1016/S0024-3205(97)01188-0; Higashi K, 2012, CARBOHYD POLYM, V87, P1737, DOI 10.1016/j.carbpol.2011.09.087; Huang N, 2013, CARBOHYD RES, V380, P64, DOI 10.1016/j.carres.2013.07.010; Jin L, 2009, GLYCOBIOLOGY, V19, P1185, DOI 10.1093/glycob/cwp105; Kaplan AP, 2002, J ALLERGY CLIN IMMUN, V109, P195, DOI 10.1067/mai.2002.121316; Kariya Y, 2004, CARBOHYD RES, V339, P1339, DOI 10.1016/j.carres.2004.02.025; Kariya Y, 2002, J BIOCHEM, V132, P335; KARIYA Y, 1990, J BIOL CHEM, V265, P5081; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509; Kogelberg H, 1996, BIOCHEMISTRY-US, V35, P1954, DOI 10.1021/bi9521598; LEMIEUX RU, 1980, CAN J CHEM, V58, P631, DOI 10.1139/v80-098; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Lever R, 2000, BRIT J PHARMACOL, V129, P533, DOI 10.1038/sj.bjp.0703099; Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012; LI JZ, 1988, THROMB HAEMOSTASIS, V59, P435; Lian W, 2013, BBA-GEN SUBJECTS, V1830, P4681, DOI 10.1016/j.bbagen.2013.06.003; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Liu Y, 2012, METHODS MOL BIOL, V808, P117, DOI 10.1007/978-1-61779-373-8_8; Luo L, 2013, MAR DRUGS, V11, P399, DOI 10.3390/md11020399; Manzi A., 1995, CURR PROTOC MOL S32, V32; MCCLURE MO, 1992, AIDS RES HUM RETROV, V8, P19, DOI 10.1089/aid.1992.8.19; Melo NM, 2010, AM J PHYSIOL-RENAL, V299, pF1299, DOI 10.1152/ajprenal.00217.2010; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; MILLER KE, 1992, BIOCHEMISTRY-US, V31, P6703, DOI 10.1021/bi00144a009; Moffatt JD, 2004, BRIT J PHARMACOL, V143, P269, DOI 10.1038/sj.bjp.0705926; Mourao PAS, 1996, J BIOL CHEM, V271, P23973, DOI 10.1074/jbc.271.39.23973; Mourao PAS, 2001, THROMB RES, V102, P167, DOI 10.1016/S0049-3848(01)00230-4; Mourao PAS, 1998, BRIT J HAEMATOL, V101, P647, DOI 10.1046/j.1365-2141.1998.00769.x; Mulloy B, 2000, J BIOTECHNOL, V77, P123, DOI 10.1016/S0168-1656(99)00211-4; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; NAGASE H, 1995, BLOOD, V85, P1527, DOI 10.1182/blood.V85.6.1527.bloodjournal8561527; Pacheco RG, 2000, BLOOD COAGUL FIBRIN, V11, P563, DOI 10.1097/00001721-200009000-00009; Panagos C, 2012, CARBOHYD POLYM, V87, P2086, DOI 10.1016/j.carbpol.2011.10.031; Perez S, 1996, GLYCOBIOLOGY, V6, P537, DOI 10.1093/glycob/6.5.537; Petit AC, 2006, CARBOHYD POLYM, V64, P597, DOI 10.1016/j.carbpol.2005.11.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poppe L, 1997, J AM CHEM SOC, V119, P1727, DOI 10.1021/ja9610702; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; RIBEIRO AC, 1994, CARBOHYD RES, V255, P225, DOI 10.1016/S0008-6215(00)90981-9; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sattelle BM, 2010, CARBOHYD RES, V345, P291, DOI 10.1016/j.carres.2009.11.013; Silipo A, 2008, CHEMBIOCHEM, V9, P240, DOI 10.1002/cbic.200700400; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; TERHO TT, 1971, ANAL BIOCHEM, V41, P471, DOI 10.1016/0003-2697(71)90167-9; Turnbull J E, 2001, Methods Mol Biol, V171, P141; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; VANDERGRAAF F, 1982, BLOOD, V59, P1225; VIEIRA RP, 1988, J BIOL CHEM, V263, P18176; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; Volpi N, 1997, CHEM-BIOL INTERACT, V105, P157, DOI 10.1016/S0009-2797(97)00045-8; Wu MY, 2012, CARBOHYD POLYM, V87, P862, DOI 10.1016/j.carbpol.2011.08.082; Wu MY, 2010, FOOD CHEM, V122, P716, DOI 10.1016/j.foodchem.2010.03.042; Wu MY, 2010, CARBOHYD POLYM, V80, P1116, DOI 10.1016/j.carbpol.2010.01.032; Wu N, 2013, CARBOHYD POLYM, V93, P604, DOI 10.1016/j.carbpol.2012.12.044; YOSHIDA K, 1992, TETRAHEDRON LETT, V33, P4959, DOI 10.1016/S0040-4039(00)61245-5; Yu F, 2007, J AM CHEM SOC, V129, P13288, DOI 10.1021/ja075272h; Zierke M, 2013, J AM CHEM SOC, V135, P13464, DOI 10.1021/ja4054702	84	80	84	2	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28284	28298		10.1074/jbc.M114.572297	http://dx.doi.org/10.1074/jbc.M114.572297			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25147180	Green Published, hybrid			2022-12-25	WOS:000343765400024
J	Ting, SY; Schilke, BA; Hayashi, M; Craig, EA				Ting, See-Yeun; Schilke, Brenda A.; Hayashi, Masaya; Craig, Elizabeth A.			Architecture of the TIM23 Inner Mitochondrial Translocon and Interactions with the Matrix Import Motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; PRESEQUENCE TRANSLOCASE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; PREPROTEIN TRANSLOCASE; CROSS-LINKING; J-DOMAIN; COMPLEX; MEMBRANE; HSP70	Translocation of proteins from the cytosol across the mitochondrial inner membrane is driven by action of the matrix-localized multi-subunit import motor, which is associated with the TIM23 translocon. The architecture of the import apparatus is not well understood. Here, we report results of site-specific in vivo photocross-linking along with genetic and coimmunoprecipitation analyses dissecting interactions between import motor subunits and the translocon. The translocon is composed of the two integral membrane proteins Tim23 and Tim17, each containing four membrane-spanning segments. We found that Tim23 having a photoactivatable cross-linker in the matrix exposed loop between transmembrane domains 1 and 2 (loop 1) cross-linked to Tim44. Alterations in this loop destabilized interaction of Tim44 with the translocon. Analogously, Tim17 having a photoactivatable cross-linker in the matrix exposed loop between transmembrane segments 1 and 2 (loop 1) cross-linked to Pam17. Alterations in this loop caused destabilization of the interaction of Pam17 with the translocon. Substitution of individual photoactivatable residues in Tim44 and Pam17 in regions we previously identified as important for translocon association resulted in cross-linking to Tim23 and Tim17, respectively. Our results are consistent with a model in which motor association is achieved via interaction of Tim23 with Tim44, which serves as a scaffold for association of other motor components, and of Tim17 with Pam17. As both Tim44 and Pam17 have been implicated as regulatory subunits of the motor, this positioning is conducive for responding to conformational changes in the translocon upon a translocating polypeptide entering the channel.	[Ting, See-Yeun; Schilke, Brenda A.; Hayashi, Masaya; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ecraig@wisc.edu	Ting, See-Yeun/AAY-6883-2021; Ting, See-Yeun/Y-9684-2019	Ting, See-Yeun/0000-0001-8472-7204; 	National Institutes of Health [GM27870]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM27870 (to E. A. C).	Alder NN, 2008, MOL BIOL CELL, V19, P159, DOI 10.1091/mbc.E07-07-0669; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2010, MOL CELL BIOL, V30, P307, DOI 10.1128/MCB.00749-09; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Krimmer T, 2000, MOL CELL BIOL, V20, P5879, DOI 10.1128/MCB.20.16.5879-5887.2000; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Majmudar CY, 2009, J AM CHEM SOC, V131, P14240, DOI 10.1021/ja904378z; Marom M, 2011, BBA-BIOMEMBRANES, V1808, P990, DOI 10.1016/j.bbamem.2010.07.011; Martinez-Caballero S, 2007, J BIOL CHEM, V282, P3584, DOI 10.1074/jbc.M607551200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meier S, 2005, J BIOL CHEM, V280, P7777, DOI 10.1074/jbc.M412158200; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2007, J BIOL CHEM, V282, P18037, DOI 10.1074/jbc.M701895200; Moro F, 2002, J BIOL CHEM, V277, P6874, DOI 10.1074/jbc.M107935200; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pareek G, 2013, MOL CELL BIOL, V33, P4641, DOI 10.1128/MCB.00876-13; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Popov-Celeketic D, 2011, EMBO REP, V12, P542, DOI 10.1038/embor.2011.72; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Ryan KR, 1998, MOL CELL BIOL, V18, P178, DOI 10.1128/MCB.18.1.178; Schilke BA, 2012, GENETICS, V190, P1341, DOI 10.1534/genetics.112.138743; Schiller D, 2008, MOL CELL BIOL, V28, P4424, DOI 10.1128/MCB.00007-08; Schiller D, 2009, INT J BIOCHEM CELL B, V41, P2343, DOI 10.1016/j.biocel.2009.06.011; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2005, MOL CELL BIOL, V25, P7449, DOI 10.1128/MCB.25.17.7449-7458.2005; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; Wang Q, 2008, J AM CHEM SOC, V130, P6066, DOI 10.1021/ja800894n; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087	46	25	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28689	28696		10.1074/jbc.M114.588152	http://dx.doi.org/10.1074/jbc.M114.588152			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25157107	Green Published, hybrid			2022-12-25	WOS:000343765400056
J	Bordin, AI; Pillai, SD; Brake, C; Bagley, KB; Bourquin, JR; Coleman, M; Oliveira, FN; Mwangi, W; McMurray, DN; Love, CC; Felippe, MJB; Cohen, ND				Bordin, Angela I.; Pillai, Suresh D.; Brake, Courtney; Bagley, Kaytee B.; Bourquin, Jessica R.; Coleman, Michelle; Oliveira, Fabiano N.; Mwangi, Waithaka; McMurray, David N.; Love, Charles C.; Felippe, Maria Julia B.; Cohen, Noah D.			Immunogenicity of an Electron Beam Inactivated Rhodococcus equi Vaccine in Neonatal Foals	PLOS ONE			English	Article							VIRULENCE-ASSOCIATED PROTEIN; IMMUNOGLOBULIN-G; INFLUENZA-VIRUS; BRONCHOALVEOLAR LAVAGE; ADULT HORSES; PNEUMONIA; RESPONSES; IMMUNIZATION; IRRADIATION; EXPRESSION	Rhodococcus equi is an important pathogen of foals that causes severe pneumonia. To date, there is no licensed vaccine effective against R. equi pneumonia of foals. The objectives of our study were to develop an electron beam (eBeam) inactivated vaccine against R. equi and evaluate its immunogenicity. A dose of eBeam irradiation that inactivated replication of R. equi while maintaining outer cell wall integrity was identified. Enteral administration of eBeam inactivated R. equi increased interferon-gamma production by peripheral blood mononuclear cells in response to stimulation with virulent R. equi and generated naso-pharyngeal R. equi-specific IgA in newborn foals. Our results indicate that eBeam irradiated R. equi administered enterally produce cell-mediated and upper respiratory mucosal immune responses, in the face of passively transferred maternal antibodies, similar to those produced in response to enteral administration of live organisms (a strategy which previously has been documented to protect foals against intrabronchial infection with virulent R. equi). No evidence of adverse effects was noted among vaccinated foals.	[Bordin, Angela I.; Brake, Courtney; Bagley, Kaytee B.; Bourquin, Jessica R.; Coleman, Michelle; Cohen, Noah D.] Texas A&M Univ, Dept Large Anim Clin Sci, Coll Vet Med & Biomed Sci, Equine Infect Dis Lab, College Stn, TX 77843 USA; [Pillai, Suresh D.] Texas A&M Univ, Natl Ctr Electon Beam Res, College Stn, TX USA; [Pillai, Suresh D.] Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA; [Pillai, Suresh D.] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Oliveira, Fabiano N.] Antech Diagnost, College Stn, TX USA; [Mwangi, Waithaka] Texas A&M Univ, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX USA; [McMurray, David N.] Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, Texas A&M Hlth Sci Ctr, College Stn, TX USA; [Love, Charles C.] Texas A&M Univ, Dept Large Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX USA; [Felippe, Maria Julia B.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Cornell University	Cohen, ND (corresponding author), Texas A&M Univ, Dept Large Anim Clin Sci, Coll Vet Med & Biomed Sci, Equine Infect Dis Lab, College Stn, TX 77843 USA.	ncohen@cvm.tamu.edu			Morris Animal Foundation [D13EQ-0001]; Link Equine Research Endowment, Texas AM University; Boehringer-Ingelheim; Zoetis	Morris Animal Foundation; Link Equine Research Endowment, Texas AM University; Boehringer-Ingelheim(Boehringer Ingelheim); Zoetis	This work was supported by the Morris Animal Foundation (D13EQ-0001). Additional funding was provided by the Link Equine Research Endowment, Texas A&M University. AIB was supported by a fellowship from Fort Dodge Animal Health/Pfizer Animal Health (now Zoetis). An unrestricted gift from Boehringer-Ingelheim to the Equine Infectious Disease Laboratory at Texas A&M University provided partial support to this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anosova NG, 2008, MUCOSAL IMMUNOL, V1, P59, DOI 10.1038/mi.2007.7; Baffa O, 2014, RADIAT ENVIRON BIOPH, V53, P233, DOI 10.1007/s00411-013-0509-2; Becu T, 1997, VET MICROBIOL, V56, P193, DOI 10.1016/S0378-1135(97)00088-6; Boyd NK, 2003, VET IMMUNOL IMMUNOP, V92, P75, DOI 10.1016/S0165-2427(03)00021-7; Brahmakshatriya V, 2009, AVIAN PATHOL, V38, P245, DOI 10.1080/03079450902912150; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; BROWN F, 1993, DEV BIOL STAND, V81, P103; Cabeza MC, 2010, FOOD MICROBIOL, V27, P777, DOI 10.1016/j.fm.2010.03.018; Cauchard J, 2004, VET MICROBIOL, V104, P73, DOI 10.1016/j.vetmic.2004.09.006; Chaffin MK, 2008, JAVMA-J AM VET MED A, V232, P1035, DOI 10.2460/javma.232.7.1035; CHIRINOTREJO JM, 1987, CAN J VET RES, V51, P444; Collie DDS, 1999, RES VET SCI, V67, P137, DOI 10.1053/rvsc.1999.0290; Darrah PA, 2000, INFECT IMMUN, V68, P3587, DOI 10.1128/IAI.68.6.3587-3593.2000; Demicheli MC, 2007, MYCOSES, V50, P397, DOI 10.1111/j.1439-0507.2007.01389.x; Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x; Fernandez-Bustamante A, 2012, RESP PHYSIOL NEUROBI, V183, P149, DOI 10.1016/j.resp.2012.06.015; Fiester S. E., 2012, INT J MICROBIOL, V2012; Flaminio MJBF, 1999, J VET INTERN MED, V13, P206, DOI 10.1892/0891-6640(1999)013&lt;0206:PBLSAI&gt;2.3.CO;2; GALAN JE, 1986, INFECT IMMUN, V54, P202, DOI 10.1128/IAI.54.1.202-206.1986; Gans HA, 1999, J IMMUNOL, V162, P5569; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; GARRISON RG, 1983, MICROBIOS, V36, P183; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Grasso EM, 2011, J FOOD PROTECT, V74, P115, DOI 10.4315/0362-028X.JFP-10-281; Grimm MB, 2007, AM J VET RES, V68, P63, DOI 10.2460/ajvr.68.1.63; Helfinstine SL, 2005, APPL ENVIRON MICROB, V71, P7029, DOI 10.1128/AEM.71.11.7029-7032.2005; Hines MT, 2001, VET IMMUNOL IMMUNOP, V79, P101, DOI 10.1016/S0165-2427(01)00258-6; Hooper-McGrevy KE, 2005, VACCINE, V23, P5760, DOI 10.1016/j.vaccine.2005.07.050; Hooper-McGrevy KE, 2003, CLIN DIAGN LAB IMMUN, V10, P345, DOI 10.1128/CDLI.10.3.345-351.2003; Horowitz ML, 2001, J VET INTERN MED, V15, P171, DOI 10.1892/0891-6640(2001)015&lt;0171:AOSMLD&gt;2.3.CO;2; Khan F.H., 2009, ELEMENTS IMMUNOLOGY; LAVOIE JP, 1989, AM J VET RES, V50, P466; Lewis MJ, 2008, MOL IMMUNOL, V45, P818, DOI 10.1016/j.molimm.2007.06.158; Lopez AM, 2008, VACCINE, V26, P998, DOI 10.1016/j.vaccine.2007.10.069; Lopez AM, 2003, VACCINE, V21, P3815, DOI 10.1016/S0264-410X(03)00329-3; Lopez AM, 2002, CLIN DIAGN LAB IMMUN, V9, P1270, DOI 10.1128/CDLI.9.6.1270-1276.2002; MADIGAN JE, 1991, J REPROD FERTIL, P571; Martens RJ, 1991, EQUINE VET J S, V12, P19; Mealey RH, 2007, VACCINE, V25, P7582, DOI 10.1016/j.vaccine.2007.07.055; Meijer WG, 2004, VET RES, V35, P383, DOI 10.1051/vetres:2004024; Molecular Probes Inc, 2004, PROD INF, P1; Murphy K., 2012, JANEWAYS IMMUNOBIOLO, P387; Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217; Nelson KM, 1998, VACCINE, V16, P1306, DOI 10.1016/S0264-410X(98)00009-7; Paillot R, 2013, VET MICROBIOL, V162, P396, DOI 10.1016/j.vetmic.2012.10.019; Pei Y, 2007, VET MICROBIOL, V125, P100, DOI 10.1016/j.vetmic.2007.05.007; Pillai S, 2007, ELECT PASTEURIZATION; Pillai SD, 2008, FOOD IRRADIATION, P375; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poon PWB, 2004, ADV EXP MED BIOL, V542, P101; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; Prescott JF, 1997, AM J VET RES, V58, P356; Quan FS, 2012, VACCINE, V30, P180, DOI 10.1016/j.vaccine.2011.11.028; Rodriguez O, 2006, INT J FOOD MICROBIOL, V110, P117, DOI 10.1016/j.ijfoodmicro.2006.01.041; Sealy R, 2013, INT IMMUNOL, V25, P183, DOI 10.1093/intimm/dxs107; Sheoran AS, 2000, AM J VET RES, V61, P1099, DOI 10.2460/ajvr.2000.61.1099; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Smith PD, 2013, PRINCIPLES OF MUCOSAL IMMUNOLOGY, P1; Sommers C. H., 2006, FOOD IRR RES TECHN; Rivera CS, 2011, FOOD MICROBIOL, V28, P141, DOI 10.1016/j.fm.2010.09.008; TAKAI S, 1992, INFECT IMMUN, V60, P2995, DOI 10.1128/IAI.60.7.2995-2997.1992; Takai S, 1999, FEMS IMMUNOL MED MIC, V24, P1; Takai S, 1997, VET MICROBIOL, V56, P167, DOI 10.1016/S0378-1135(97)00085-0; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; Varga J, 1997, VET MICROBIOL, V56, P205, DOI 10.1016/S0378-1135(97)00089-8; WALTERS EH, 1991, THORAX, V46, P613, DOI 10.1136/thx.46.9.613; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014	67	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105367	10.1371/journal.pone.0105367	http://dx.doi.org/10.1371/journal.pone.0105367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153708	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200044
J	Meneghini, C; Leboffe, L; Bionducci, M; Fanali, G; Meli, M; Colombo, G; Fasano, M; Ascenzi, P; Mobilio, S				Meneghini, Carlo; Leboffe, Loris; Bionducci, Monica; Fanali, Gabriella; Meli, Massimiliano; Colombo, Giorgio; Fasano, Mauro; Ascenzi, Paolo; Mobilio, Settimio			The Five-To-Six-Coordination Transition of Ferric Human Serum Heme-Albumin Is Allosterically-Modulated by Ibuprofen and Warfarin: A Combined XAS and MD Study	PLOS ONE			English	Article							RAY-ABSORPTION SPECTROSCOPY; FREE-ENERGY CALCULATIONS; DRUG-BINDING; CRYSTALLOGRAPHIC ANALYSIS; MOLECULAR-DYNAMICS; NO DISSOCIATION; FINE-STRUCTURE; UCSF CHIMERA; PRE-EDGE; K-EDGE	Human serum albumin (HSA) is involved physiologically in heme scavenging; in turn, heme-albumin (HSA-heme-Fe) displays globin-like properties. Here, the allosteric effect of ibuprofen and warfarin on the local atomic structure around the ferric heme-Fe (heme-Fe(III)) atom of HSA-heme-Fe (HSA-heme-Fe(III)) has been probed by Fe-K edge X-ray absorption spectroscopy (XAS). The quantitative analysis of the Fe-K edge extended X-ray absorption fine structure (EXAFS) signals and modeling of the near edge (XANES) spectral features demonstrated that warfarin and ibuprofen binding modify the local structure of the heme-Fe(III). Combined XAS data analysis and targeted molecular dynamics (MD) simulations provided atomic resolution insights of protein structural rearrangements required to accommodate the heme-Fe(III) upon ibuprofen and warfarin binding. In the absence of drugs, the heme-Fe(III) atom is penta-coordinated having distorted 4+1 configuration made by the nitrogen atoms of the porphyrin ring and the oxygen phenoxy atom of the Tyr161 residue. MD simulations show that ibuprofen and warfarin association to the secondary fatty acid (FA) binding site 2 (FA2) induces a reorientation of domain I of HSA-heme-Fe(III), this leads to the redirection of the His146 residue providing an additional bond to the heme-Fe(III) atom, providing the 5+1 configuration. The comparison of Fe-K edge XANES spectra calculated using MD structures with those obtained experimentally confirms the reliability of the proposed structural model. As a whole, combining XAS and MD simulations it has been possible to provide a reliable model of the heme-Fe(III) atom coordination state and to understand the complex allosteric transition occurring in HSA-heme-Fe(III) upon ibuprofen and warfarin binding.	[Meneghini, Carlo; Leboffe, Loris; Bionducci, Monica; Mobilio, Settimio] Roma Tre Univ, Dept Sci, Rome, Italy; [Leboffe, Loris; Ascenzi, Paolo] Natl Inst Biostruct & Biosyst, Rome, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Dept Theoret & Appl Sci, Biomed Res Div, Busto Arsizio, VA, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Ctr Neurosci, Busto Arsizio, VA, Italy; [Meli, Massimiliano; Colombo, Giorgio] CNR, Inst Mol Recognit Chem, Milan, Italy; [Ascenzi, Paolo] Roma Tre Univ, Interdept Lab Electron Microscopy, Rome, Italy	Italfarmaco; Roma Tre University; University of Insubria; University of Insubria; Consiglio Nazionale delle Ricerche (CNR); Roma Tre University	Ascenzi, P (corresponding author), Natl Inst Biostruct & Biosyst, Rome, Italy.	ascenzi@uniroma3.it	Meli, Massimiliano/AAY-8570-2020; Fasano, Mauro/A-7100-2008; Colombo, Giorgio/A-2730-2012; Leboffe, Loris/K-7838-2016; meneghini, carlo/F-7761-2013	Meli, Massimiliano/0000-0003-3304-6104; Fasano, Mauro/0000-0003-0628-5871; Colombo, Giorgio/0000-0002-1318-668X; Leboffe, Loris/0000-0001-8272-1896; meneghini, carlo/0000-0003-4846-8422	Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy (Universita Roma Tre, Roma, Italy) [CLAR 2012]; European Synchrotron Radiation Facility (ESRF, Grenoble, France) [MX1275]; AIRC (Associazione Italiana Ricerca sul Cancro) [IG.11775]; Flagship "INTEROMICS'' project - Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy [PB.P05]; National Research Council of Italy	Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy (Universita Roma Tre, Roma, Italy); European Synchrotron Radiation Facility (ESRF, Grenoble, France); AIRC (Associazione Italiana Ricerca sul Cancro); Flagship "INTEROMICS'' project - Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy; National Research Council of Italy	This work was supported by a grant from Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy (Universita Roma Tre, Roma, Italy; CLAR 2012 to P.A.). The EXAFS experiments have been supported by the European Synchrotron Radiation Facility (ESRF, Grenoble, France; exp. number MX1275). GC gratefully acknowledges AIRC (Associazione Italiana Ricerca sul Cancro) for support through the grant IG.11775 and the Flagship "INTEROMICS'' project (PB.P05) funded by Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy and National Research Council of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448; Ascenzi P, 2008, BIOCHEM BIOPH RES CO, V369, P686, DOI 10.1016/j.bbrc.2008.02.077; Ascenzi P, 2011, BIOCHEM BIOPH RES CO, V411, P185, DOI 10.1016/j.bbrc.2011.06.130; Ascenzi P, 2010, IUBMB LIFE, V62, P776, DOI 10.1002/iub.381; Ascenzi P, 2010, BIOPHYS CHEM, V148, P16, DOI 10.1016/j.bpc.2010.03.001; Ascenzi P, 2009, IUBMB LIFE, V61, P1118, DOI 10.1002/iub.263; Ascenzi P, 2009, J BIOL CHEM, V284, P31006, DOI 10.1074/jbc.M109.010736; Ascenzi P, 2009, BIOCHEM BIOPH RES CO, V387, P83, DOI 10.1016/j.bbrc.2009.06.117; Baroni S, 2001, EUR J BIOCHEM, V268, P6214, DOI 10.1046/j.0014-2956.2001.02569.x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Besio R, 2010, EUR BIOPHYS J BIOPHY, V39, P935, DOI 10.1007/s00249-009-0459-4; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bocedi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058842; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Cabaret D, 2010, PHYS CHEM CHEM PHYS, V12, P5619, DOI 10.1039/b926499j; Curry S, 2002, VOX SANG, V83, P315, DOI 10.1111/j.1423-0410.2002.tb05326.x; Curry S, 2009, DRUG METAB PHARMACOK, V24, P342, DOI 10.2133/dmpk.24.342; D'Angelo P, 2004, BIOPHYS J, V86, P3882, DOI 10.1529/biophysj.103.034876; D'Angelo P, 2012, BIOCHEMISTRY-US, V51, P6068, DOI 10.1021/bi300233n; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Beer SBA, 2012, J CHEM INF MODEL, V52, P2139, DOI 10.1021/ci300243n; Della Longa S, 2003, BIOPHYS J, V85, P549, DOI 10.1016/S0006-3495(03)74499-3; di Masi A, 2011, FEBS J, V278, P654, DOI 10.1111/j.1742-4658.2010.07986.x; Fanali G, 2005, FEBS J, V272, P4672, DOI 10.1111/j.1742-4658.2005.04883.x; Fanali G, 2007, BIOPHYS CHEM, V129, P29, DOI 10.1016/j.bpc.2007.05.002; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fanali G, 2009, FEBS J, V276, P2241, DOI 10.1111/j.1742-4658.2009.06952.x; Fasano M, 2002, J INORG BIOCHEM, V91, P487, DOI 10.1016/S0162-0134(02)00473-7; Fasano M, 2001, J BIOL INORG CHEM, V6, P650, DOI 10.1007/s007750100242; Fasano M, 2007, IUBMB LIFE, V59, P436, DOI 10.1080/15216540701474523; Fitos I, 2002, CHIRALITY, V14, P442, DOI 10.1002/chir.10113; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Giuli G, 2011, AM MINERAL, V96, P631, DOI 10.2138/am.2011.3464; HEDIN L, 1971, J PHYS PART C SOLID, V4, P2064, DOI 10.1088/0022-3719/4/14/022; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9; Kaneko K, 2011, IUBMB LIFE, V63, P277, DOI 10.1002/iub.457; Koningsberger DC, 1988, XRAY ABSORPTION PRIN, P1; LEE PA, 1975, PHYS REV B, V11, P2795, DOI 10.1103/PhysRevB.11.2795; LEE PA, 1981, REV MOD PHYS, V53, P769, DOI 10.1103/RevModPhys.53.769; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Meneghini C, 2012, NUCL INSTRUM METH B, V285, P153, DOI 10.1016/j.nimb.2012.05.027; Meneghini C, 1998, BIOPHYS J, V75, P1953, DOI 10.1016/S0006-3495(98)77636-2; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; MOMENTEAU M, 1994, CHEM REV, V94, P659, DOI 10.1021/cr00027a006; Monesi C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174104; Nagy G, 2012, EUR BIOPHYS J BIOPHY, V41, P1065, DOI 10.1007/s00249-012-0865-x; Nicoletti FP, 2008, J AM CHEM SOC, V130, P11677, DOI 10.1021/ja800966t; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Peters Jr Th, 1996, ALL ALBUMIN BIOCH GE; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rich AM, 1998, J AM CHEM SOC, V120, P10827, DOI 10.1021/ja980253g; Roccatano D, 2008, CURR PROTEIN PEPT SC, V9, P407, DOI 10.2174/138920308785132686; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; Silaghi-Dumitrescu R, 2007, BIOCHEM J, V403, P391, DOI 10.1042/BJ20061421; Smith LJ, 2006, PROTEINS, V65, P702, DOI 10.1002/prot.21141; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	68	26	26	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104231	10.1371/journal.pone.0104231	http://dx.doi.org/10.1371/journal.pone.0104231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153171	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200017
J	Simmons, DA; Knowles, JK; Belichenko, NP; Banerjee, G; Finkle, C; Massa, SM; Longo, FM				Simmons, Danielle A.; Knowles, Juliet K.; Belichenko, Nadia P.; Banerjee, Gargi; Finkle, Carly; Massa, Stephen M.; Longo, Frank M.			A Small Molecule p75(NTR) Ligand, LM11A-31, Reverses Cholinergic Neurite Dystrophy in Alzheimer's Disease Mouse Models with Mid- to Late-Stage Disease Progression	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; NERVE GROWTH-FACTOR; AMYLOID PRECURSOR PROTEIN; BASAL FOREBRAIN NEURONS; TRANSGENIC MICE; COGNITIVE IMPAIRMENT; BETA PROTEIN; EXPRESSION; BRAIN; DEFICITS	Degeneration of basal forebrain cholinergic neurons contributes significantly to the cognitive deficits associated with Alzheimer's disease (AD) and has been attributed to aberrant signaling through the neurotrophin receptor p75 (p75(NTR)). Thus, modulating p75(NTR) signaling is considered a promising therapeutic strategy for AD. Accordingly, our laboratory has developed small molecule p75(NTR) ligands that increase survival signaling and inhibit amyloid-beta-induced degenerative signaling in in vitro studies. Previous work found that a lead p75(NTR) ligand, LM11A-31, prevents degeneration of cholinergic neurites when given to an AD mouse model in the early stages of disease pathology. To extend its potential clinical applications, we sought to determine whether LM11A-31 could reverse cholinergic neurite atrophy when treatment begins in AD mouse models having mid-to late stages of pathology. Reversing pathology may have particular clinical relevance as most AD studies involve patients that are at an advanced pathological stage. In this study, LM11A-31 (50 or 75 mg/kg) was administered orally to two AD mouse models, Thy-1 hAPP(Lond/Swe) (APP(L/S)) and Tg2576, at age ranges during which marked AD-like pathology manifests. In mid-stage male APP(L/S) mice, LM11A-31 administered for 3 months starting at 6-8 months of age prevented and/or reversed atrophy of basal forebrain cholinergic neurites and cortical dystrophic neurites. Importantly, a 1 month LM11A-31 treatment given to male APP(L/S) mice (12-13 months old) with late-stage pathology reversed the degeneration of cholinergic neurites in basal forebrain, ameliorated cortical dystrophic neurites, and normalized increased basal forebrain levels of p75(NTR). Similar results were seen in female Tg2576 mice. These findings suggest that LM11A-31 can reduce and/or reverse fundamental AD pathologies in late-stage AD mice. Thus, targeting p75(NTR) is a promising approach to reducing AD-related degenerative processes that have progressed beyond early stages.	[Simmons, Danielle A.; Knowles, Juliet K.; Belichenko, Nadia P.; Banerjee, Gargi; Finkle, Carly; Longo, Frank M.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Knowles, Juliet K.; Longo, Frank M.] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA; [Massa, Stephen M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Massa, Stephen M.] Univ Calif San Francisco, Lab Computat Neurochem & Drug Discovery, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94143 USA	Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Longo, FM (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	longo@stanford.edu	Banerjee, Gargi/AAU-3081-2020	Banerjee, Gargi/0000-0003-0190-7782; Knowles, Juliet/0000-0002-9214-2991	Veteran's Administration;  [NIA UO1 AG032225];  [NINDS F30 NA051971]; NATIONAL INSTITUTE ON AGING [U01AG032225] Funding Source: NIH RePORTER	Veteran's Administration(US Department of Veterans Affairs); ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants NIA UO1 AG032225 (FML), NINDS F30 NA051971 (JKK) and the Veteran's Administration (SMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar A, 2006, INT J DEV NEUROSCI, V24, P133, DOI 10.1016/j.ijdevneu.2005.11.008; Apelt J, 2002, BRAIN RES, V953, P17, DOI 10.1016/S0006-8993(02)03262-6; BUELL SJ, 1981, BRAIN RES, V214, P23, DOI 10.1016/0006-8993(81)90436-4; Chakravarthy B, 2010, J ALZHEIMERS DIS, V19, P915, DOI 10.3233/JAD-2010-1288; Coulson EJ, 2009, NEUROSCIENTIST, V15, P317, DOI 10.1177/1073858408331376; Coulson EJ, 2000, CLIN EXP PHARMACOL P, V27, P537, DOI 10.1046/j.1440-1681.2000.03295.x; Coulson EJ, 2006, J NEUROCHEM, V98, P654, DOI 10.1111/j.1471-4159.2006.03905.x; Cuello AC, 2010, J MOL NEUROSCI, V40, P230, DOI 10.1007/s12031-009-9238-z; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Diarra Adama, 2009, Biochem Biophys Res Commun, V390, P352, DOI 10.1016/j.bbrc.2009.09.116; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Faizi M, 2012, BRAIN BEHAV, V2, P142, DOI 10.1002/brb3.41; Frade JM, 1998, BIOESSAYS, V20, P137, DOI 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; German DC, 2003, J COMP NEUROL, V462, P371, DOI 10.1002/cne.10737; GIBBS RB, 1989, MOL BRAIN RES, V6, P275, DOI 10.1016/0169-328X(89)90073-9; Ginsberg SD, 2006, J NEUROCHEM, V97, P475, DOI 10.1111/j.1471-4159.2006.03764.x; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Havas D, 2011, J ALZHEIMERS DIS, V25, P231, DOI 10.3233/JAD-2011-101866; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu XY, 2002, EXP NEUROL, V178, P104, DOI 10.1006/exnr.2002.8018; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Jaffar S, 2000, EXP NEUROL, V170, P227, DOI 10.1006/exnr.2001.7710; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Knowles JK, 2013, NEUROBIOL AGING, V34, P2052, DOI 10.1016/j.neurobiolaging.2013.02.015; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; LAMOUR Y, 1982, NEUROSCI LETT, V34, P117, DOI 10.1016/0304-3940(82)90162-8; Longo FM, 2008, CNS NEUROL DISORD-DR, V7, P63, DOI 10.2174/187152708783885093; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; MUFSON EJ, 1992, P NATL ACAD SCI USA, V89, P569, DOI 10.1073/pnas.89.2.569; MUFSON EJ, 1992, BRAIN RES, V589, P115, DOI 10.1016/0006-8993(92)91169-F; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Perez RG, 1997, J NEUROSCI, V17, P9407; Perez SE, 2014, BIOL PSYCHIAT; Perez SE, 2007, NEUROBIOL DIS, V28, P3, DOI 10.1016/j.nbd.2007.06.015; Perez SE, 2011, NEUROBIOL DIS, V41, P338, DOI 10.1016/j.nbd.2010.10.002; Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Vana L, 2011, AM J PATHOL, V179, P2533, DOI 10.1016/j.ajpath.2011.07.044; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Yaar M, 2002, J BIOL CHEM, V277, P7720, DOI 10.1074/jbc.M110929200; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604; Yeo TT, 1997, J NEUROSCI, V17, P7594	56	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e102136	10.1371/journal.pone.0102136	http://dx.doi.org/10.1371/journal.pone.0102136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153701	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200004
J	Henninger, AMJ; Eliasson, B; Jenndahl, LE; Hammarstedt, A				Henninger, A. M. Josefin; Eliasson, Bjorn; Jenndahl, Lachmi E.; Hammarstedt, Ann			Adipocyte Hypertrophy, Inflammation and Fibrosis Characterize Subcutaneous Adipose Tissue of Healthy, Non-Obese Subjects Predisposed to Type 2 Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; 1ST-DEGREE RELATIVES; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; GENE-EXPRESSION; OBESITY; FAT; DIFFERENTIATION; ADIPOGENESIS; MECHANISMS	Background: The adipose tissue is important for development of insulin resistance and type 2 diabetes and adipose tissue dysfunction has been proposed as an underlying cause. In the present study we investigated presence of adipocyte hypertrophy, and gene expression pattern of adipose tissue dysfunction in the subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes compared to matched control subjects with no known genetic predisposition for type 2 diabetes. Method: Seventeen healthy and non-obese subjects with known genetic predisposition for type 2 diabetes (first-degree relatives, FDRs) and 17 control subjects were recruited. The groups were matched for gender and BMI and had similar age. Glucose tolerance was determined by an oral glucose tolerance test and insulin sensitivity was calculated using HOMA-index. Blood samples were collected and subcutaneous abdominal adipose tissue biopsies obtained for gene expression analysis and adipocyte cell size measurement. Results: Our findings show that, in spite of similar age, BMI and percent body fat, FDRs displayed adipocyte hypertrophy, as well as higher waist/hip ratio, fasting insulin levels, HOMA-IR and serum triglycerides. Adipocyte hypertrophy in the FDR group, but not among controls, was associated with measures of impaired insulin sensitivity. The adipocyte hypertrophy was accompanied by increased inflammation and Wnt-signal activation. In addition, signs of tissue remodeling and fibrosis were observed indicating presence of early alterations associated with adipose tissue dysfunction in the FDRs. Conclusion: Genetic predisposition for type 2 diabetes is associated with impaired insulin sensitivity, adipocyte hypertrophy and other markers of adipose tissue dysfunction. A dysregulated subcutaneous adipose tissue may be a major susceptibility factor for later development of type 2 diabetes.	[Henninger, A. M. Josefin; Eliasson, Bjorn; Jenndahl, Lachmi E.; Hammarstedt, Ann] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden	University of Gothenburg	Hammarstedt, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden.	ann.hammarstedt@medic.gu.se	Eliasson, Bjorn/H-5783-2016	Eliasson, Bjorn/0000-0003-2569-4160	Magn Bergvall Foundation; Swedish Diabetes Association; Wilhelm and Martina Lundgren Foundation	Magn Bergvall Foundation; Swedish Diabetes Association; Wilhelm and Martina Lundgren Foundation	Magn Bergvall Foundation, Swedish Diabetes Association, Wilhelm and Martina Lundgren Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Arner P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018284; Bluher M, 2013, BEST PRACT RES CL EN, V27, P163, DOI 10.1016/j.beem.2013.02.005; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Dubois SG, 2006, OBESITY, V14, P1543, DOI 10.1038/oby.2006.178; Ehrlund A, 2013, J CLIN ENDOCR METAB, V98, pE503, DOI 10.1210/jc.2012-3416; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jansson PA, 2003, FASEB J, V17, P1434, DOI 10.1096/fj.02-1132com; Kelley DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE941, DOI 10.1152/ajpendo.2000.278.5.E941; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Koska J, 2009, INT J OBESITY, V33, P842, DOI 10.1038/ijo.2009.106; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Marinou K, 2014, DIABETES CARE, V37, P821, DOI 10.2337/dc13-1353; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murdolo G, 2007, J CLIN ENDOCR METAB, V92, P2688, DOI 10.1210/jc.2006-2814; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pellme F, 2003, DIABETES, V52, P1182, DOI 10.2337/diabetes.52.5.1182; Pessin JE, 2012, J INVEST MED, V60, P1147, DOI 10.2310/JIM.0b013e318271fdb9; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Ruotsalainen E, 2006, DIABETES CARE, V29, P2714, DOI 10.2337/dc06-0147; Saltevo J, 2008, DIABETES-METAB RES, V24, P378, DOI 10.1002/dmrr.831; Schafer SA, 2011, DIABETES RES CLIN PR, V93, pS9, DOI 10.1016/S0168-8227(11)70008-0; Smith U, 2001, FASEB J, V15, P215, DOI 10.1096/fj.00-0020com; Snijder MB, 2003, OBES RES, V11, P104, DOI 10.1038/oby.2003.18; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Van Hul M, 2008, J THROMB HAEMOST, V6, P1198, DOI 10.1111/j.1538-7836.2008.02988.x; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang J, 2012, OBESITY, V20, P932, DOI 10.1038/oby.2011.371	46	75	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105262	10.1371/journal.pone.0105262	http://dx.doi.org/10.1371/journal.pone.0105262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148116	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600038
J	Reichwald, K; Jorgensen, TZ; Skov, S				Reichwald, Kirsten; Jorgensen, Tina Z.; Skov, Soren			TL1A Increases Expression of CD25, LFA-1, CD134 and CD154, and Induces IL-22 and GM-CSF Production from Effector CD4 T-Cells	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; CYTOKINE 1A TL1A; RHEUMATOID-ARTHRITIS; NK CELLS; OX40 CD134; ACTIVATION; IL-15; DR3; SUPPRESSION; MEMORY	Elevated levels of the cytokine TL1A is associated with several autoimmune diseases e.g. rheumatoid arthritis and inflammatory bowel disease. However, the exact role of TL1A remains elusive. In this study, we investigated the function of TL1A in a pro-inflammatory setting. We show that TL1A together with IL-12, IL-15 and IL-18 increases expression of the co-stimulatory molecules CD154 (CD40 ligand) and CD134 (OX40) on previously activated CD4(+) T cells. This indicates that TL1A functions as a co-stimulatory molecule, decreasing the activation threshold of T-cells. We have previously shown that TL1A co-stimulation strongly induces IL-6 in human healthy leukocytes. Interestingly, the cytokine-activated effector T-cells did not produce IL-6 in response to TL1A, indicating distinct effects of TL1A on different cell populations. We further show that this co-stimulation increases the expression of CD25 (IL-2R alpha) and CD11a (alpha-chain of LFA-1) on CD4 T-cells, likely governing increased IL-2/IL-15 sensitivity and cell-cell contact. Along with this, TL1A co-stimulation caused a specific induction of IL-22 and GM-CSF from the activated T-cells. These results substantially contribute to the explanation of TL1A's role in inflammation. Our results suggest that TL1A should be considered as a target for immunotherapeutic treatment of rheumatoid arthritis and inflammatory bowel disease.	[Reichwald, Kirsten; Jorgensen, Tina Z.; Skov, Soren] Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Copenhagen, Denmark	University of Copenhagen	Reichwald, K (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Copenhagen, Denmark.	kirstenreichwald@gmail.com; sosk@sund.ku.dk		Jorgensen, Tina Zenia/0000-0003-3586-2332; Skov, Soren/0000-0003-0732-0026	University of Copenhagen	University of Copenhagen	This work was funded by a PhD scholarship granted by The University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RL, 2012, EUR J IMMUNOL, V42, P672, DOI 10.1002/eji.201142071; Bamias G, 2008, CLIN IMMUNOL, V129, P249, DOI 10.1016/j.clim.2008.07.014; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Bamias G, 2011, EXP DERMATOL, V20, P725, DOI 10.1111/j.1600-0625.2011.01304.x; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Boot EPJ, 2005, ARTHRITIS RES THER, V7, pR604, DOI 10.1186/ar1722; Boyman O, 2010, EUR J IMMUNOL, V40, P936, DOI 10.1002/eji.201040466; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hassan GS, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4153; Itsumi M, 2009, EUR J IMMUNOL, V39, P1784, DOI 10.1002/eji.200839106; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Niu Q, 2012, RHEUMATOL INT, V32, P2731, DOI 10.1007/s00296-011-1984-x; Pan HF, 2013, CYTOKINE GROWTH F R, V24, P51, DOI 10.1016/j.cytogfr.2012.07.002; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Piconese S, 2009, BLOOD, V114, P2639, DOI 10.1182/blood-2009-05-220004; Reichwald K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085793; Roeleveld DM, 2014, ANN RHEUM DIS, V73, pA9, DOI 10.1136/annrheumdis-2013-205124.21; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Salek-Ardakani S, 2006, VACCINE, V24, P872, DOI 10.1016/j.vaccine.2005.07.108; Skov S, 2000, J IMMUNOL, V164, P3500, DOI 10.4049/jimmunol.164.7.3500; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105627	10.1371/journal.pone.0105627	http://dx.doi.org/10.1371/journal.pone.0105627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148371	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600063
J	Zucchini, S; Marucci, G; Paradiso, B; Lanza, G; Roncon, P; Cifelli, P; Ferracin, M; Giulioni, M; Michelucci, R; Rubboli, G; Simonato, M				Zucchini, Silvia; Marucci, Gianluca; Paradiso, Beatrice; Lanza, Giovanni; Roncon, Paolo; Cifelli, Pierangelo; Ferracin, Manuela; Giulioni, Marco; Michelucci, Roberto; Rubboli, Guido; Simonato, Michele			Identification of miRNAs Differentially Expressed in Human Epilepsy with or without Granule Cell Pathology	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; HIPPOCAMPAL SCLEROSIS; CLINICOPATHOLOGICAL CLASSIFICATION; CONSENSUS CLASSIFICATION; TASK-FORCE; MICRORNAS; DISPERSION; SYSTEM	The microRNAs (miRNAs) are small size non-coding RNAs that regulate expression of target mRNAs at post-transcriptional level. miRNAs differentially expressed under pathological conditions may help identifying mechanisms underlying the disease and may represent biomarkers with prognostic value. However, this kind of studies are difficult in the brain because of the cellular heterogeneity of the tissue and of the limited access to fresh tissue. Here, we focused on a pathology affecting specific cells in a subpopulation of epileptic brains (hippocampal granule cells), an approach that bypasses the above problems. All patients underwent surgery for intractable temporal lobe epilepsy and had hippocampal sclerosis associated with no granule cell pathology in half of the cases and with type-2 granule cell pathology (granule cell layer dispersion or bilamination) in the other half. The expression of more than 1000 miRNAs was examined in the laser-microdissected dentate granule cell layer. Twelve miRNAs were differentially expressed in the two groups. One of these, miR487a, was confirmed to be expressed at highly differential levels in an extended cohort of patients, using RT-qPCR. Bioinformatics searches and RT-qPCR verification identified ANTXR1 as a possible target of miR487a. ANTXR1 may be directly implicated in granule cell dispersion because it is an adhesion molecule that favors cell spreading. Thus, miR487a could be the first identified element of a miRNA signature that may be useful for prognostic evaluation of post-surgical epilepsy and may drive mechanistic studies leading to the identification of therapeutic targets.	[Zucchini, Silvia; Paradiso, Beatrice; Roncon, Paolo; Cifelli, Pierangelo; Simonato, Michele] Univ Ferrara, Dept Med Sci, Pharmacol Sect, I-44100 Ferrara, Italy; [Zucchini, Silvia; Paradiso, Beatrice; Roncon, Paolo; Cifelli, Pierangelo; Simonato, Michele] Univ Ferrara, Neurosci Ctr, I-44100 Ferrara, Italy; [Zucchini, Silvia; Paradiso, Beatrice; Roncon, Paolo; Simonato, Michele] Natl Inst Neurosci, Turin, Italy; [Zucchini, Silvia; Ferracin, Manuela; Simonato, Michele] Univ Ferrara, Lab Technol Adv Therapies LTTA, I-44100 Ferrara, Italy; [Marucci, Gianluca] Bellaria Hosp, Sect Pathol, Dept Biomed & NeuroMotor Sci DiBiNeM, Bologna, Italy; [Paradiso, Beatrice; Lanza, Giovanni] Univ Ferrara, Sect Pathol, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Cifelli, Pierangelo] Ri MED Fdn, Palermo, Italy; [Ferracin, Manuela] Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Giulioni, Marco] Bellaria Hosp, Sect Neurosurg, IRCCS Inst Neurol Sci, Bologna, Italy; [Michelucci, Roberto; Rubboli, Guido] Bellaria Hosp, Neurol Sect, IRCCS Inst Neurol Sci, Bologna, Italy; [Rubboli, Guido] Epilepsihosp, Danish Epilepsy Ctr, Dianalund, Denmark	University of Ferrara; University of Ferrara; University of Ferrara; AUSL di Bologna; University of Ferrara; University of Ferrara; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB)	Simonato, M (corresponding author), Univ Ferrara, Dept Med Sci, Pharmacol Sect, I-44100 Ferrara, Italy.	michele.simonato@unife.it	Ferracin, Manuela/K-2097-2016; Paradiso, Beatrice/AAL-2442-2020; Simonato, Michele/AIA-0028-2022; Marucci, Gianluca/F-1426-2019; Michelucci, Roberto/AAB-9074-2020; Paradiso, Beatrice/AAO-6555-2020; Lanza, Giovanni/K-6635-2016; cifelli, pierangelo/AAC-4700-2020	Ferracin, Manuela/0000-0002-1595-6887; Simonato, Michele/0000-0002-3586-2693; Marucci, Gianluca/0000-0003-4508-3359; Paradiso, Beatrice/0000-0002-4319-4832; Lanza, Giovanni/0000-0002-5362-1236; cifelli, pierangelo/0000-0002-7430-7641; Michelucci, Roberto/0000-0002-9655-7940	European Community [FP7] [285827, 602102]; Ri.MED foundation	European Community [FP7]; Ri.MED foundation	This work has been supported by grants from the European Community [FP7-PEOPLE-2011-IAPP project 285827 (EPIXCHANGE) and FP7-HEALTH project 602102 (EPITARGET), to MS], and from the Ri.MED foundation (to PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beveridge NJ, 2012, NEUROBIOL DIS, V46, P263, DOI 10.1016/j.nbd.2011.12.029; Blumcke I, 2007, ACTA NEUROPATHOL, V113, P235, DOI 10.1007/s00401-006-0187-0; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Blumcke I, 2009, ACTA NEUROPATHOL, V117, P535, DOI 10.1007/s00401-009-0512-5; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Chen DH, 2013, CANCER RES, V73, P5821, DOI 10.1158/0008-5472.CAN-13-1080; Neves RSD, 2013, CLIN NEUROPATHOL, V32, P24, DOI 10.5414/NP300509; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Engel J, 1993, SURG TREATMENT EPILE, P609; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Gu JS, 2010, EXP CELL RES, V316, P1946, DOI 10.1016/j.yexcr.2010.03.026; Gutwein LG, 2011, ANTICANCER RES, V31, P3417; Henshall DC, 2014, CURR OPIN NEUROL, V27, P199, DOI 10.1097/WCO.0000000000000079; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Marucci G, 2010, CLIN NEUROPATHOL, V29, P32; Maurer-Morelli CV, 2012, J NEUROSCI METH, V208, P44, DOI 10.1016/j.jneumeth.2012.04.020; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Peiro-Chova L, 2013, VIRCHOWS ARCH, V463, P765, DOI 10.1007/s00428-013-1485-2; Shizu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041291; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Thom M, 2010, EPILEPSIA, V51, P1801, DOI 10.1111/j.1528-1167.2010.02681.x; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; WYLER AR, 1992, J EPILEPSY, V5, P220, DOI 10.1016/S0896-6974(05)80120-3; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	31	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105521	10.1371/journal.pone.0105521	http://dx.doi.org/10.1371/journal.pone.0105521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148080	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600050
J	Brown, KA; Lambert, LJ; Brophy, JM; Nasmith, J; Rinfret, S; Segal, E; Kouz, S; Ross, D; Harvey, R; Maire, S; Boothroyd, LJ; Bogaty, P				Brown, Kevin A.; Lambert, Laurie J.; Brophy, James M.; Nasmith, James; Rinfret, Stephane; Segal, Eli; Kouz, Simon; Ross, Dave; Harvey, Richard; Maire, Sebastien; Boothroyd, Lucy J.; Bogaty, Peter			Impact of ECG Findings and Process-Of-Care Characteristics on the Likelihood of Not Receiving Reperfusion Therapy in Patients with ST-Elevation Myocardial Infarction: Results of a Field Evaluation	PLOS ONE			English	Article							BUNDLE-BRANCH BLOCK; SEGMENT-ELEVATION; NATIONAL-REGISTRY; UNITED-STATES; CHEST-PAIN; MANAGEMENT; OUTCOMES; ASSOCIATION; GUIDELINE; DIAGNOSIS	Background: Many patients with ST-elevation myocardial infarction (STEMI) do not receive reperfusion therapy and are known hospital characteristics associated with non-receipt of reperfusion therapy in patients with STEMI. Methods and Results: This systematic evaluation of STEMI care in 82 hospitals in Quebec included all patients with a discharge diagnosis of myocardial infarction, presenting with characteristic symptoms and an ECG showing STEMI as attested by at least one of two study cardiologists or left bundle branch block (LBBB). Excluding LBBB, an ECG was considered a definite STEMI diagnosis if both cardiologists scored 'certain STEMI' and ambiguous if one scored 'uncertain' or 'not STEMI'. Centers were classified according to accessibility to primary percutaneous coronary intervention (PPCI): 1) on-site PPCI; 2) routine transfer for PPCI; 3) varying mix of PPCI transfer and on-site fibrinolysis; and 4) routine on-site fibrinolysis. Of 3730 STEMI/LBBB patients, 812 (21.8%) did not receive reperfusion therapy. In multivariate analysis, likelihood of no reperfusion therapy was a function of PPCI accessibility (odds ratio [OR] for fibrinolysis versus PPCI centers = 3.1; 95% CI: 2.2-4.4), presence of LBBB (OR = 24.1; 95% CI: 17.8-32.9) and an ECG ambiguous for STEMI (OR = 4.1; 95% CI: 3.3-5.1). When the ECG was ambiguous, likelihood of no reperfusion therapy was highest in hospitals most distant from PPCI centers. Conclusions: ECG diagnostic ambiguity, LBBB and PPCI accessibility are important predictors of not receiving reperfusion therapy, suggesting opportunities for improving outcomes.	[Brown, Kevin A.; Lambert, Laurie J.; Boothroyd, Lucy J.; Bogaty, Peter] INESSS, Montreal, PQ, Canada; [Brophy, James M.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Nasmith, James] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Rinfret, Stephane; Bogaty, Peter] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Segal, Eli] Sir Mortimer B Davis Jewish Hosp, Montreal, PQ, Canada; [Segal, Eli; Ross, Dave] Corp Urgences Sante, Montreal, PQ, Canada; [Kouz, Simon] Ctr Hosp Reg Lanaudiere, Joliette, PQ, Canada; [Ross, Dave] Serv Prehosp Urgence Monteregie, Longueuil, PQ, Canada; [Ross, Dave] Hop Sacre Coeur, Dept Med Prehosp, Montreal, PQ H4J 1C5, Canada; [Harvey, Richard] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Maire, Sebastien] Univ Hotel Dieu Levis, Ctr Hosp, Levis, PQ, Canada	McGill University; St. Paul's Hospital; University of Saskatchewan; McGill University; Universite de Montreal; University of Sherbrooke	Lambert, LJ (corresponding author), INESSS, Montreal, PQ, Canada.	laurie.lambert@inesss.qc.ca	brophy, james/H-6673-2019; Segal, Eli/GPW-8146-2022	brophy, james/0000-0001-8049-6875; Brown, Kevin Antoine/0000-0002-1483-2188	Quebec Ministry of Health	Quebec Ministry of Health	This study was supported by an operating grant from the Quebec Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence d'evaluation des technologies et des modes d'intervention en sante (AETMIS), 2008, ETMIS, V4, P1; Alter DA, 2006, EUR HEART J, V27, P1539, DOI 10.1093/eurheartj/ehl066; [Anonymous], 2010, R LANG ENV STAT COMP; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Balzi D, 2008, INTERN EMERG MED, V3, P109, DOI 10.1007/s11739-008-0090-x; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; Cai QJ, 2013, AM HEART J, V166, P409, DOI 10.1016/j.ahj.2013.03.032; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eagle KA, 2008, EUR HEART J, V29, P609, DOI 10.1093/eurheartj/ehn069; Forman DE, 2010, AM J CARDIOL, V106, P1382, DOI 10.1016/j.amjcard.2010.07.008; Gharacholou SM, 2010, AM HEART J, V159, P757, DOI 10.1016/j.ahj.2010.02.009; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huynh T, 2006, CAN MED ASSOC J, V175, P1527, DOI 10.1503/cmaj.060359; Jollis JG, 2012, CIRCULATION, V126, P189, DOI 10.1161/CIRCULATIONAHA.111.068049; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lambert L, 2012, CAN J CARDIOL, V28, P162, DOI 10.1016/j.cjca.2011.10.005; Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712; Lambert LJ, 2009, CIRC-CARDIOVASC QUAL, V2, pe40; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Neeland IJ, 2012, J AM COLL CARDIOL, V60, P96, DOI 10.1016/j.jacc.2012.02.054; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Rajagopal V, 2006, EUR HEART J, V27, P1513, DOI 10.1093/eurheartj/ehl007; Sgarbossa EB, 1996, NEW ENGL J MED, V334, P481, DOI 10.1056/NEJM199602223340801; Shlipak MG, 2000, J AM COLL CARDIOL, V36, P706, DOI 10.1016/S0735-1097(00)00789-0; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Tricomi AJ, 2008, AM HEART J, V155, P471, DOI 10.1016/j.ahj.2007.10.023; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Tran V, 2011, AM J CARDIOL, V108, P1096, DOI 10.1016/j.amjcard.2011.06.008	30	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104874	10.1371/journal.pone.0104874	http://dx.doi.org/10.1371/journal.pone.0104874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144645	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100027
J	Gao, JJ; Wu, YM; Su, ZL; Barnie, PA; Jiao, ZJ; Bie, QL; Lu, LW; Wang, SJ; Xu, HX				Gao, Jingjing; Wu, Yumin; Su, Zhaoliang; Barnie, Prince Amoah; Jiao, Zhijun; Bie, Qingli; Lu, Liwei; Wang, Shengjun; Xu, Huaxi			Infiltration of Alternatively Activated Macrophages in Cancer Tissue Is Associated with MDSC and Th2 Polarization in Patients with Esophageal Cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; SUPPRESSOR-CELLS; SCAVENGER RECEPTOR; DENDRITIC CELLS; CROSS-TALK; EXPRESSION; MARKER	Myeloid derived suppressor cells (MDSCs) expand in cancer bearing hosts and contribute to tumor immune evasion. M2 macrophages constitute a major cellular component of cancer-related inflammation. However, the correlation between circulating MDSCs and infiltrating M2 macrophages in tumor tissues from patients with esophageal cancer (ECA), and its potential relationship with the polarization of Th2 cells remain unclear. In the present study, we showed the level of MDSCs in PBMC and Arg1 in plasma were significantly elevated in ECA patients, and the increased ratio of MDSC in PBMC was closely related to the expression of CD163 in cancer tissues. In addition, the ECA patients exhibited remarkable increases in the mRNA levels of IL-4 and GATA3, as well as the protein levels of IL-13 and IL-6, but IFN-gamma and IL-12 in peripheral blood were decreased. Our data indicate that the increased Th2 cytokines are associated with MDSCs and M2 macrophages polarization, and foster the infiltration of CD163(+)M2 macrophages in cancer tissues, which promote the formation of immunosuppressive microenvironment in ECA patients.	[Gao, Jingjing; Wu, Yumin; Su, Zhaoliang; Barnie, Prince Amoah; Bie, Qingli; Wang, Shengjun; Xu, Huaxi] Jiangsu Univ, Sch Med Sci & Lab Med, Dept Immunol, Zhenjiang, Peoples R China; [Jiao, Zhijun] Jiangsu Univ, Affiliated Hosp, Dept Lab Med, Zhenjiang, Peoples R China; [Gao, Jingjing] Nanjing Med Univ, Suzhou Hosp, Dept Lab Med, Suzhou, Peoples R China; [Lu, Liwei] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lu, Liwei] Univ Hong Kong, Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China	Jiangsu University; Jiangsu University; Nanjing Medical University; University of Hong Kong; University of Hong Kong	Wang, SJ (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, Dept Immunol, Zhenjiang, Peoples R China.	sjwjs@ujs.edu.cn; xuhx@ujs.edu.cn	SU, Zhaoliang/ABD-9062-2021; Lu, Liwei/C-4357-2009	SU, Zhaoliang/0000-0002-5998-5575; Lu, Liwei/0000-0002-8634-0967	National Natural Science Foundation of China [31270947, 31170849, 30972748]; Natural Science Foundation of Jiangsu Province [BK2011472]; Postdoctoral Foundation of China [2012M511705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Postdoctoral Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (31270947, 31170849 and 30972748, http://www.nsfc.gov.cn/), Natural Science Foundation of Jiangsu Province (BK2011472) and the Postdoctoral Foundation of China (2012M511705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Arantes Vitor, 2012, Rev. Col. Bras. Cir., V39, P534; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Crew KD, 2004, SEMIN ONCOL, V31, P450, DOI 10.1053/j.seminoncol.2004.04.021; Cui YL, 2013, ASIAN PAC J CANCER P, V14, P1003, DOI 10.7314/APJCP.2013.14.2.1003; Delpisheh Ali, 2014, Gastroenterol Hepatol Bed Bench, V7, P101; Fujiwara Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/348539; Gabitass RF, 2011, CANCER IMMUNOL IMMUN, V60, P1419, DOI 10.1007/s00262-011-1028-0; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ghosh AK, 2012, CANCER LETT, V324, P91, DOI 10.1016/j.canlet.2012.05.002; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gu M, 2012, ASIAN PAC J CANCER P, V13, P5587, DOI 10.7314/APJCP.2012.13.11.5587; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Hajian-Tilaki KO, 2001, BRIT J CANCER, V85, P1671, DOI 10.1054/bjoc.2001.2153; HOLNESS CL, 1993, BLOOD, V81, P1607; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Ma J, 2011, CANCER LETT, V301, P142, DOI 10.1016/j.canlet.2010.11.005; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Nguyen TDT, 2005, AM J SURG PATHOL, V29, P617, DOI 10.1097/01.pas.0000157940.80538.ec; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Teramoto K, 2013, J CANCER RES CLIN, V139, P861, DOI 10.1007/s00432-013-1394-4; Xu Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/949821; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	32	38	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104453	10.1371/journal.pone.0104453	http://dx.doi.org/10.1371/journal.pone.0104453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144454	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100015
J	He, YL; Gao, H; Li, XM; Zhao, YR				He, YingLi; Gao, Heng; Li, XiaoMei; Zhao, YingRen			Psychological Stress Exerts Effects on Pathogenesis of Hepatitis B via Type-1/Type-2 Cytokines Shift toward Type-2 Cytokine Response	PLOS ONE			English	Article							PSYCHOSOCIAL STRESS; LYMPHOCYTES; INFECTION; VERSION; SCALE; CELL; SEVERITY; HBSAG	Background: Psychological and physical stress has been demonstrated to have an impact on health through modulation of immune function. Despite high prevalence of stress among patients with hepatitis B virus (HBV) infection, little is known about whether and how stress exerts an effect on the course of hepatitis B. Methods: Eighty patients with chronic hepatitis B(CHB) completed the Perceived Stress Scale-10(PSS-10) and State-Trait Anxiety Inventory(STAI). Fresh whole blood was subject to flow cytometry for lymphocytes count. Plasma samples frozen at -80 degrees C were thawed for cytokines, alanine aminotransferase (ALT), and virus load. These patients were grouped into high or low perceived stress, state anxiety and trait anxiety groups according to the scale score. Sociodemographic, disease-specific characteristics, lymphocytes count and cytokines were compared. Results: Firstly, a negative association between ALT and stress (t = -4.308; p = .000), state anxiety (t = -3.085; p = .003) and trait anxiety (t = -4.925; p = .000) were found. As ALT is a surrogate marker of hepatocytes injury, and liver injury is a consequence of immune responses. Next, we tested the relationship between stress/anxiety and lymphocytes. No statistical significance were found with respect to counts of total T cells, CD4+ T cell, CD8+ T cell, NK cell, and B cell count between high and low stress group. Type-2 cytokine interleukin-10 (IL-10) level was significantly higher in high stress group relative to lower counterpart (t = 6.538; p = 0.000), and type-1 cytokine interferon-gamma (IFN-gamma) level shown a decreased tendency in high stress group (t = -1.702; p = 0.093). Finally, INF-gamma:IL-10 ratio displayed significant decrease in high perceived stress(t = -4.606; p = 0.000), state anxiety(t = -5.126; p = 0.000) and trait anxiety(t = -4.670; p = 0.000) groups relative to low counterparts. Conclusion: Our data show stress is not related to the lymphocyte cells count in CHB patients, however, stress induces a shift in the type-1/type-2 cytokine balance towards a type-2 response, which implicated a role of psychological stress in the course of HBV related immune-pathogenesis.	[He, YingLi; Zhao, YingRen] Xi An Jiao Tong Univ, Sch Med, Affiliated Teaching Hosp 1, Dept Infect Dis, Xian 710049, Shaanxi Provinc, Peoples R China; [Gao, Heng] Xian Municipal Hlth Coll, Xian, Shaanxi Provinc, Peoples R China; [Li, XiaoMei] Xi An Jiao Tong Univ, Sch Med, Dept Psychol & Nursing, Xian 710049, Shaanxi Provinc, Peoples R China; [He, YingLi; Zhao, YingRen] Xi An Jiao Tong Univ, Affiliated Hosp 1, Inst Hepatol, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Zhao, YR (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Teaching Hosp 1, Dept Infect Dis, Xian 710049, Shaanxi Provinc, Peoples R China.	zhaoyingren@mail.xjtu.edu.cn			China National Natural Science Foundation [30700712]; Major National Science and Technology Projects for Infectious Diseases (China) [2008ZX10002-007, 2012ZX10002007]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Major National Science and Technology Projects for Infectious Diseases (China)	This study was supported by grants from the China National Natural Science Foundation (No. 30700712) and The Major National Science and Technology Projects for Infectious Diseases (11th and 12th Five Year, China) (No. 2008ZX10002-007, No. 2012ZX10002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Atesci FC, 2005, PSYCHOSOMATICS, V46, P142, DOI 10.1176/appi.psy.46.2.142; Burns VE, 2002, PSYCHOSOM MED, V64, P287, DOI 10.1097/00006842-200203000-00012; Cao W, 2011, WORLD J GASTROENTERO, V17, P2191, DOI 10.3748/wjg.v17.i17.2191; Chaaya M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-111; Chen TY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-524; Chida Y, 2004, HEPATOLOGY, V39, P1131, DOI 10.1002/hep.20158; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Greeson JM, 2008, BRAIN BEHAV IMMUN, V22, P901, DOI 10.1016/j.bbi.2008.01.001; Hyodo N, 2003, HEPATOL RES, V27, P109, DOI 10.1016/S1386-6346(03)00199-2; Ioannou GN, 2013, HEPATOLOGY, V58, P839, DOI 10.1002/hep.26516; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Lee J, 2012, ASIA-PAC PSYCHIAT, V4, P108; Lee M, 1999, J KOREAN MED SCI, V14, P175, DOI 10.3346/jkms.1999.14.2.175; Loggi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065327; Luo Guang-han, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P147; M'Kada H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042418; MARINOS G, 1995, HEPATOLOGY, V22, P1040, DOI 10.1016/0270-9139(95)90607-X; Marshall GD, 1998, BRAIN BEHAV IMMUN, V12, P297, DOI 10.1006/brbi.1998.0537; Mimura C, 2004, INT J NURS STUD, V41, P379, DOI 10.1016/j.ijnurstu.2003.10.009; Nagano J, 2004, PSYCHOSOMATICS, V45, P100, DOI 10.1176/appi.psy.45.2.100; Niu YH, 2013, WORLD J GASTROENTERO, V19, P4146, DOI 10.3748/wjg.v19.i26.4146; Palumbo ML, 2010, J NEUROIMMUNOL, V218, P12, DOI 10.1016/j.jneuroim.2009.11.005; Pan LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035303; Remor E, 2006, SPAN J PSYCHOL, V9, P86, DOI 10.1017/S1138741600006004; Rico MA, 2001, HEPATOLOGY, V33, P295, DOI 10.1053/jhep.2001.21147; Szkaradkiewicz A, 2003, VIRUS RES, V97, P127, DOI 10.1016/j.virusres.2003.08.013; Vere CC, 2009, WORLD J GASTROENTERO, V15, P2980, DOI 10.3748/wjg.15.2980; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028610; Yang Y, 2013, J MED VIROL, V85, P1893, DOI 10.1002/jmv.23649; YingLi H, 2008, INT J INFECT DIS, V12, pE417, DOI 10.1016/j.ijid.2008.05.1099	32	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105530	10.1371/journal.pone.0105530	http://dx.doi.org/10.1371/journal.pone.0105530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144199	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100081
J	Langhorst, J; Frede, A; Knott, M; Pastille, E; Buer, J; Dobos, GJ; Westendorf, AM				Langhorst, Jost; Frede, Annika; Knott, Markus; Pastille, Eva; Buer, Jan; Dobos, Gustav J.; Westendorf, Astrid M.			Distinct Kinetics in the Frequency of Peripheral CD4(+) T Cells in Patients with Ulcerative Colitis Experiencing a Flare during Treatment with Mesalazine or with a Herbal Preparation of Myrrh, Chamomile, and Coffee Charcoal	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ALTERNATIVE MEDICINE USE; PHARMACOLOGICAL INVESTIGATIONS; 5-AMINOSALICYLIC ACID; ANTIINFLAMMATORY ACTIVITY; INTESTINAL INFLAMMATION; MAINTAINING REMISSION; BISABOLOL OXIDES; HEME OXYGENASE-1; NATIONAL-SURVEY	Background: We found the first evidence of the efficacy of a herbal treatment with myrrh, dry extract of chamomile flowers, and coffee charcoal for ulcerative colitis (UC). However, the impact of the herbal treatment on the CD4(+) T-cell compartment, which is essential for both the induction of UC and the maintenance of tolerance in the gut, is not well understood. Aim: To analyze the frequency and functional phenotype of CD4(+) T cells and of immune-suppressive CD4+CD25(high) regulatory T cells (Tregs) in healthy control subjects, patients with UC in remission, and patients with clinical flare of UC. Methods: Patients in clinical remission were treated with either mesalazine or the herbal preparation for 12 months. The frequencies of whole CD4(+) T cells, CD4(+)CD25(med) effector T cells, and Tregs and the expression of Foxp3 within the CD4(+)CD25(hig) Tregs were determined by flow cytometry at 6 time points. We determined the suppressive capability of Tregs from healthy control subjects and from patients in remission or clinical flare. Results: A total of 79 patients (42 women, 37 men; mean age, 48.5 years; 38 with clinical flare) and 5 healthy control subjects were included in the study. At baseline the frequencies of whole CD4(+) T cells, CD4(+)CD25(med) effector cells, and Tregs did not differ between the two treatment groups and the healthy control subjects. In addition, patients with UC in sustained clinical remission showed no alteration from baseline after 1, 3, 6, 9, or 12 months of either treatment. In contrast, CD4(+) T cells, CD4(+)CD25(med) effector T cells, and Tregs demonstrated distinctly different patterns at time points pre-flare and flare. The mesalazine group showed a continuous but not statistically significant increase from baseline to pre-flare and flare (p = ns). In the herbal treatment group, however, the percentage of the CD4(+) T cells was lower at pre-flare than at baseline. This decrease was completely reversed after flare, when a significant increase was seen (CD4(+)CD25(med) pre-flare/flare p = 0.0461; CD4(+)CD25(high) baseline/flare p = 0.0269 and pre-flare/flare p = 0.0032). In contrast, no changes in the expression of Foxp3 cells were detected within the subsets of CD4(+)CD25(high) regulatory T cells. Of note, no alterations were detected in the suppressive capability of CD4(+)CD25(high) regulatory T cells isolated from the peripheral blood of healthy donors, from patients in remission, or from patients with clinical flare. Conclusions: In patients with UC experiencing acute flare, the CD4(+) T compartment demonstrates a distinctly different pattern during treatment with myrrh, chamomile extract, and coffee charcoal than during treatment with mesalazine. These findings suggest an active repopulation of regulatory T cells during active disease.	[Langhorst, Jost] Univ Duisburg Essen, Kliniken Essen Mitte, Dept Integrat Gastroenterol, Essen, Germany; [Langhorst, Jost; Dobos, Gustav J.] Univ Duisburg Essen, Kliniken Essen Mitte, Dept Internal & Integrat Med, Essen, Germany; [Frede, Annika; Knott, Markus; Pastille, Eva; Buer, Jan; Westendorf, Astrid M.] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany	Kliniken Essen-Mitte; University of Duisburg Essen; Kliniken Essen-Mitte; University of Duisburg Essen; University of Duisburg Essen	Langhorst, J (corresponding author), Univ Duisburg Essen, Kliniken Essen Mitte, Dept Integrat Gastroenterol, Essen, Germany.	jost.langhorst@gmx.de	Knott, Markus/AAE-7076-2020; Westendorf, Astrid M./AAX-1937-2020	Buer, Jan/0000-0002-7602-1698; Frede, Annika/0000-0002-0075-6874	REPHA GmbH Biologische Arzneimittel, Hannover, Germany; IFORES program of the University of Duisburg-Essen, Germany	REPHA GmbH Biologische Arzneimittel, Hannover, Germany; IFORES program of the University of Duisburg-Essen, Germany	This study was performed as an independent sub-study of a drug trial comparing the efficacy of a herbal preparation of myrrh, dry extract of chamomile flowers and coffee charcoal to mesalamine as treatment for maintaining remission in ulcerative colitis which was funded in full by REPHA GmbH Biologische Arzneimittel, Hannover, Germany. The presented study was funded in part by the IFORES program of the University of Duisburg-Essen, Germany. No additional external or internal funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; ACHTERRATHTUCKERMANN U, 1980, PLANTA MED, V39, P38, DOI 10.1055/s-2008-1074901; Ammon HPT, 1992, KAMILLE PHARMAKOLOGI; Bhaskaran N, 2012, LIFE SCI, V90, P1027, DOI 10.1016/j.lfs.2012.05.019; Cheng YW, 2011, J PHARM PHARMACOL, V63, P1211, DOI 10.1111/j.2042-7158.2011.01329.x; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Della Loggia R, 1985, DTSCH APOTH ZTG S1, V125, P9; Dignass A, 2011, Z GASTROENTEROL, V49, P1276, DOI 10.1055/s-0031-1281666; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Dolara P, 2000, PLANTA MED, V66, P356, DOI 10.1055/s-2000-8532; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Ford AC, 2011, AM J GASTROENTEROL, V106, P601, DOI 10.1038/ajg.2011.67; Galvez J, 2003, INFLAMM BOWEL DIS, V9, P363, DOI 10.1097/00054725-200311000-00004; Ganguli SC, 2004, AM J GASTROENTEROL, V99, P319, DOI 10.1111/j.1572-0241.2004.04046.x; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hansen W, 2007, J IMMUNOL, V179, P8059, DOI 10.4049/jimmunol.179.12.8059; HAWKEY CJ, 1985, DIGEST DIS SCI, V30, P1161, DOI 10.1007/BF01314051; Hilsden RJ, 1998, AM J GASTROENTEROL, V93, P697; Hilsden RJ, 2003, AM J GASTROENTEROL, V98, P1563, DOI 10.1016/S0002-9270(03)00301-0; Hilsden RJ, 2011, INFLAMM BOWEL DIS, V17, P655, DOI 10.1002/ibd.21360; Himmel ME, 2012, IMMUNOLOGY, V136, P115, DOI 10.1111/j.1365-2567.2012.03572.x; ISAAC O, 1979, PLANTA MED, V35, P118, DOI 10.1055/s-0028-1097193; JAKOVLEV V, 1979, PLANTA MED, V35, P125, DOI 10.1055/s-0028-1097194; Janicke C., 2003, HDB PHYTOTHERAPIE IN; Kao J, 2010, J CLIN GASTROENTEROL, V44, P531, DOI 10.1097/MCG.0b013e3181db1a61; Kuhn A., 1939, SUDD APOTH ZTG, V79, P434; La Scaleia R, 2010, J PEDIATR GASTR NUTR, V51, P563, DOI 10.1097/MPG.0b013e3181e4d323; Langhorst J, 2005, INFLAMM BOWEL DIS, V11, P287, DOI 10.1097/01.MIB.0000160771.71328.6c; Langhorst J, 2013, ALIMENT PHARM THER, V38, P490, DOI 10.1111/apt.12397; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; Langhorsta J, 2007, COMPLEMENT THER MED, V15, P30, DOI 10.1016/j.ctim.2006.03.008; Langmead L, 2002, INFLAMM BOWEL DIS, V8, P174, DOI 10.1097/00054725-200205000-00003; Li Z, 2010, INFLAMM BOWEL DIS, V16, P1299, DOI 10.1002/ibd.21229; Loggia R. della, 1990, Planta Medica, V56, P657, DOI 10.1055/s-2006-961313; MACDERMOTT RP, 1989, GASTROENTEROLOGY, V96, P442, DOI 10.1016/0016-5085(89)91569-2; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; NIELSEN OH, 1988, ALIMENT PHARM THERAP, V2, P203; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; Rahimi R, 2009, DIGEST DIS SCI, V54, P471, DOI 10.1007/s10620-008-0368-x; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; SAFAYHI H, 1994, PLANTA MED, V60, P410, DOI 10.1055/s-2006-959520; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Simmonds NJ, 1999, ALIMENT PHARM THER, V13, P363; SIMMONDS NJ, 1993, GUT, V34, P865, DOI 10.1136/gut.34.7.865; Sutherland LR, 1997, INFLAMM BOWEL DIS, V3, P65, DOI 10.1002/ibd.3780030202; Takahashi M, 2006, DIGEST DIS SCI, V51, P677, DOI 10.1007/s10620-006-3191-2; TARIQ M, 1986, AGENTS ACTIONS, V17, P381, DOI 10.1007/BF01982655; TRAVIS SPL, 1994, PHARMACOL THERAPEUT, V63, P135, DOI 10.1016/0163-7258(94)90042-6; Veltkamp C, 2011, GUT, V60, P1345, DOI 10.1136/gut.2010.217117; Weizman AV, 2012, ALIMENT PHARM THER, V35, P342, DOI 10.1111/j.1365-2036.2011.04956.x; Westendorf AM, 2006, GASTROENTEROLOGY, V131, P510, DOI 10.1053/j.gastro.2006.05.015; Whittle BJR, 2010, PHARMACOL REP, V62, P548; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Zhu NQ, 2003, FLAVOUR FRAG J, V18, P282, DOI 10.1002/ffj.1193	55	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104257	10.1371/journal.pone.0104257	http://dx.doi.org/10.1371/journal.pone.0104257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144293	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100013
J	Nimeskern, L; Feldmann, EM; Kuo, W; Schwarz, S; Goldberg-Bockhorn, E; Durr, S; Muller, R; Rotter, N; Stok, KS				Nimeskern, Luc; Feldmann, Eva-Maria; Kuo, Willy; Schwarz, Silke; Goldberg-Bockhorn, Eva; Duerr, Susanne; Mueller, Ralph; Rotter, Nicole; Stok, Kathryn S.			Magnetic Resonance Imaging of the Ear for Patient-Specific Reconstructive Surgery	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; AURICULAR RECONSTRUCTION; IN-VITRO; REPRODUCIBILITY; FABRICATION; EXPERIENCE; MORPHOLOGY; MICROTIA; AURICLE; GRAFTS	Introduction: Like a fingerprint, ear shape is a unique personal feature that should be reconstructed with a high fidelity during reconstructive surgery. Ear cartilage tissue engineering (TE) advantageously offers the possibility to use novel 3D manufacturing techniques to reconstruct the ear, thus allowing for a detailed auricular shape. However it also requires detailed patient-specific images of the 3D cartilage structures of the patient's intact contralateral ear (if available). Therefore the aim of this study was to develop and evaluate an imaging strategy for acquiring patient-specific ear cartilage shape, with sufficient precision and accuracy for use in a clinical setting. Methods and Materials: Magnetic resonance imaging (MRI) was performed on 14 volunteer and six cadaveric auricles and manually segmented. Reproducibility of cartilage volume (Cg.V), surface (Cg.S) and thickness (Cg.Th) was assessed, to determine whether raters could repeatedly define the same volume of interest. Additionally, six cadaveric auricles were harvested, scanned and segmented using the same procedure, then dissected and scanned using high resolution micro-CT. Correlation between MR and micro-CT measurements was assessed to determine accuracy. Results: Good inter-and intra-rater reproducibility was observed (precision errors <4% for Cg.S and <9% for Cg.V and Cg.Th). Intraclass correlations were good for Cg.V and Cg.S (>0.82), but low for Cg.Th (<0.23) due to similar average Cg.Th between patients. However Pearson's coefficients showed that the ability to detect local cartilage shape variations is unaffected. Good correlation between clinical MRI and micro-CT (r>0.95) demonstrated high accuracy. Discussion and Conclusion: This study demonstrated that precision and accuracy of the proposed method was high enough to detect patient-specific variation in ear cartilage geometry. The present study provides a clinical strategy to access the necessary information required for the production of 3D ear scaffolds for TE purposes, including detailed patient-specific shape. Furthermore, the protocol is applicable in daily clinical practice with existing infrastructure.	[Nimeskern, Luc; Kuo, Willy; Mueller, Ralph; Stok, Kathryn S.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Feldmann, Eva-Maria; Schwarz, Silke; Rotter, Nicole] Univ Ulm, Med Ctr, Dept Otorhinolaryngol, D-89069 Ulm, Germany; [Goldberg-Bockhorn, Eva; Duerr, Susanne] Univ Ulm, Med Ctr, Dept Diagnost & Intervent Radiol, D-89069 Ulm, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Ulm University; Ulm University	Stok, KS (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	kas@ethz.ch	Müller, Ralph/A-1198-2008; Stok, Kathryn S/A-4871-2011; Stok, Kathryn/AAA-2667-2021	Müller, Ralph/0000-0002-5811-7725; Stok, Kathryn S/0000-0002-0522-4180; Stok, Kathryn/0000-0002-0522-4180; Rotter, Nicole/0000-0003-1537-8340; Kuo, Willy/0000-0002-0870-7997	Swiss National Science Foundation [NRP63]; ERANET/EuroNanoMed [EAREG-406340-131009/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERANET/EuroNanoMed	This study was supported by the Swiss National Science Foundation (NRP63) and ERANET/EuroNanoMed (EAREG-406340-131009/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Bauer JS, 2008, INVEST RADIOL, V43, P604, DOI 10.1097/RLI.0b013e31817e9ada; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BRENT B, 1992, PLAST RECONSTR SURG, V90, P355, DOI 10.1097/00006534-199209000-00001; Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc; Constantine KK, 2014, JAMA FACIAL PLAST SU; Coward TJ, 1999, INT J PROSTHODONT, V12, P20; Cummings AH, 2011, PATTERN RECOGN LETT, V32, P2053, DOI 10.1016/j.patrec.2011.08.020; Dinis P. Borges, 1998, Rhinology (Utrecht), V36, P32; Eckstein F, 2006, OSTEOARTHR CARTILAGE, V14, pA46, DOI 10.1016/j.joca.2006.02.026; Firmin F, 1998, SCAND J PLAST RECONS, V32, P35, DOI 10.1080/02844319850158930; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Golas AR, 2014, AESTHET PLAST SURG, V38, P207, DOI 10.1007/s00266-013-0255-5; Kamil SH, 2004, LARYNGOSCOPE, V114, P867, DOI 10.1097/00005537-200405000-00015; Kasrai L, 2014, PLAST RECONSTR SURG, V133, P652, DOI 10.1097/PRS.0000000000000063; Kludt NA, 2014, ANN PLAS SURG, V72, pS14, DOI 10.1097/SAP.0000000000000178; Kohler T, 2005, CALCIFIED TISSUE INT, V77, P281, DOI 10.1007/s00223-005-0039-2; Ledgerwood LG, 2014, JAMA FACIAL PLAST SU, V16, P153, DOI 10.1001/jamafacial.2013.2058; Liu Y, 2010, BIOMATERIALS, V31, P2176, DOI 10.1016/j.biomaterials.2009.11.080; Meijerman L, 2007, J FORENSIC SCI, V52, P286, DOI 10.1111/j.1556-4029.2006.00376.x; Mueller TL, 2009, BONE, V44, P364, DOI 10.1016/j.bone.2008.10.045; NAGATA S, 1993, PLAST RECONSTR SURG, V92, P187, DOI 10.1097/00006534-199308000-00001; Ohara K, 1997, PLAST RECONSTR SURG, V99, P1030, DOI 10.1097/00006534-199704000-00017; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506; Sforza C, 2009, FORENSIC SCI INT, V187, DOI 10.1016/j.forsciint.2009.02.019; Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5; Steffen Armin, 2008, Aesthet Surg J, V28, P404, DOI 10.1016/j.asj.2008.06.003; Stok KS, 2009, MICROSC RES TECHNIQ, V72, P650, DOI 10.1002/jemt.20713; Storck K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/373286; Trattnig S, 2000, INVEST RADIOL, V35, P595, DOI 10.1097/00004424-200010000-00006; Turgut G, 2009, J CRANIOFAC SURG, V20, P321, DOI 10.1097/SCS.0b013e3181992266; Walton RL, 2002, PLAST RECONSTR SURG, V110, P234, DOI 10.1097/00006534-200207000-00041; Xie L, 2009, OSTEOARTHR CARTILAGE, V17, P313, DOI 10.1016/j.joca.2008.07.015; Zhou LB, 2011, TISSUE ENG PT A, V17, P1573, DOI 10.1089/ten.tea.2010.0627	35	11	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104975	10.1371/journal.pone.0104975	http://dx.doi.org/10.1371/journal.pone.0104975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144306	Green Published, gold			2022-12-25	WOS:000341106100033
J	Plecenikova, A; Slaninova, M; Riha, K				Plecenikova, Andrea; Slaninova, Miroslava; Riha, Karel			Characterization of DNA Repair Deficient Strains of Chlamydomonas reinhardtii Generated by Insertional Mutagenesis	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; NUCLEAR TRANSFORMATION; HUMAN CTIP; GENE; ARABIDOPSIS; GENOME; PLANTS; MECHANISMS; RESPONSES; DISRUPTION	While the mechanisms governing DNA damage response and repair are fundamentally conserved, cross-kingdom comparisons indicate that they differ in many aspects due to differences in life-styles and developmental strategies. In photosynthetic organisms these differences have not been fully explored because gene-discovery approaches are mainly based on homology searches with known DDR/DNA repair proteins. Here we performed a forward genetic screen in the green algae Chlamydomonas reinhardtii to identify genes deficient in DDR/DNA repair. We isolated five insertional mutants that were sensitive to various genotoxic insults and two of them exhibited altered efficiency of transgene integration. To identify genomic regions disrupted in these mutants, we established a novel adaptor-ligation strategy for the efficient recovery of the insertion flanking sites. Four mutants harbored deletions that involved known DNA repair factors, DNA Pol zeta, DNA Pol theta, SAE2/COM1, and two neighbouring genes encoding ERCC1 and RAD17. Deletion in the last mutant spanned two Chlamydomonas-specific genes with unknown function, demonstrating the utility of this approach for discovering novel factors involved in genome maintenance.	[Plecenikova, Andrea; Riha, Karel] Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst, A-1010 Vienna, Austria; [Plecenikova, Andrea; Slaninova, Miroslava] Comenius Univ, Dept Genet, Fac Nat Sci, Bratislava, Slovakia; [Riha, Karel] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Comenius University Bratislava; Masaryk University Brno	Riha, K (corresponding author), Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst, A-1010 Vienna, Austria.	karel.riha@gmi.oeaw.ac.at	Riha, Karel/P-9614-2018; Melicharkova, Andrea/G-4491-2016; Riha, Karel/A-7717-2008; Riha, Karel/AAM-4429-2021	Riha, Karel/0000-0002-6124-0118; Melicharkova, Andrea/0000-0003-4986-3774; Riha, Karel/0000-0002-6124-0118; Slaninova, Miroslava/0000-0001-9385-0343	Slovak Agency for Research and Development [SK-AT-0023-10, APVV-0661-10]; Comenius University [UK/63/2012]; Austrian Agency for International Cooperation (OeAD) [SK12/2011]; Austrian Science Fund (FWF) [Y418-B03]; Austrian Science Fund (FWF) [Y 418] Funding Source: researchfish	Slovak Agency for Research and Development(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Comenius University; Austrian Agency for International Cooperation (OeAD); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by grants from the Slovak Agency for Research and Development (SK-AT-0023-10; APVV-0661-10; www.apvv.sk), Comenius University (UK/63/2012), Austrian Agency for International Cooperation (OeAD, SK12/2011; www.oead.at), and Austrian Science Fund (FWF; Y418-B03; www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bray CM, 2005, NEW PHYTOL, V168, P511, DOI 10.1111/j.1469-8137.2005.01548.x; Cenkci B, 2003, J BIOL CHEM, V278, P22574, DOI 10.1074/jbc.M303249200; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; DAVIES AA, 1995, J BIOL CHEM, V270, P24638, DOI 10.1074/jbc.270.42.24638; De Muyt A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000654; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Doonan JH, 2010, NAT REV CANCER, V10, P793, DOI 10.1038/nrc2942; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Goff JP, 2009, RADIAT RES, V172, P165, DOI 10.1667/RR1598.1; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gutman BL, 2004, PLANT PHYSIOL, V135, P607, DOI 10.1104/pp.104.041491; Hefner E, 2003, J EXP BOT, V54, P669, DOI 10.1093/jxb/erg069; Heitzeberg F, 2004, PLANT J, V38, P954, DOI 10.1111/j.1365-313X.2004.02097.x; Helle F, 2012, CANCER GENE THER, V19, P299, DOI 10.1038/cgt.2012.1; Higgins GS, 2010, CANCER RES, V70, P2984, DOI 10.1158/0008-5472.CAN-09-4040; Inagaki S, 2006, PLANT CELL, V18, P879, DOI 10.1105/tpc.105.036798; Kazda A, 2012, GENE DEV, V26, P1703, DOI 10.1101/gad.194944.112; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kirik A, 2006, PLANT CELL, V18, P2431, DOI 10.1105/tpc.106.045088; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Liu J, 2010, PLANT J, V61, P36, DOI 10.1111/j.1365-313X.2009.04026.x; Mages W, 2007, PROTIST, V158, P435, DOI 10.1016/j.protis.2007.05.001; Mannuss A, 2012, BBA-GENE REGUL MECH, V1819, P154, DOI 10.1016/j.bbagrm.2011.08.003; Matsuo T, 2008, GENE DEV, V22, P918, DOI 10.1101/gad.1650408; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Nagaria P, 2013, BBA-GEN SUBJECTS, V1830, P2345, DOI 10.1016/j.bbagen.2012.09.001; NELSON JAE, 1995, MOL CELL BIOL, V15, P5762; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Plecenikova A, 2013, PROTIST, V164, P570, DOI 10.1016/j.protis.2013.05.004; Prinz S, 1997, GENETICS, V146, P781; PURTON S, 1995, EUR J PHYCOL, V30, P141, DOI 10.1080/09670269500650901; Riha K, 2001, SCIENCE, V291, P1797, DOI 10.1126/science.1057110; Sakamoto A, 2003, PLANT CELL, V15, P2042, DOI 10.1105/tpc.012369; Sambrook J, 2001, MOL CLONING LAB MANU; Sarkar N, 2005, EUKARYOT CELL, V4, P262, DOI 10.1128/EC.4.2.262-273.2005; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaefer DG, 2001, CURR OPIN PLANT BIOL, V4, P143, DOI 10.1016/S1369-5266(00)00150-3; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shen X, 2006, J BIOL CHEM, V281, P13869, DOI 10.1074/jbc.C600071200; Singh SK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-443; SODEINDE OA, 1993, P NATL ACAD SCI USA, V90, P9199, DOI 10.1073/pnas.90.19.9199; Takeda S, 2004, GENE DEV, V18, P782, DOI 10.1101/gad.295404; Timofejeva L, 2013, G3-GENES GENOM GENET, V3, P231, DOI 10.1534/g3.112.004465; Tuncay H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074763; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Ulm R, 2001, GENE DEV, V15, P699, DOI 10.1101/gad.192601; Vlcek D, 2008, CURR GENET, V53, P1, DOI 10.1007/s00294-007-0163-9; Waterworth WM, 2011, NEW PHYTOL, V192, P805, DOI 10.1111/j.1469-8137.2011.03926.x; Wu F, 2004, CANCER RES, V64, P8029, DOI 10.1158/0008-5472.CAN-03-3942; Yoshiyama K, 2009, P NATL ACAD SCI USA, V106, P12843, DOI 10.1073/pnas.0810304106; Zorin B, 2005, EUKARYOT CELL, V4, P1264, DOI 10.1128/EC.4.7.1264-1272.2005; Zorin B, 2009, GENE, V432, P91, DOI 10.1016/j.gene.2008.11.028	58	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105482	10.1371/journal.pone.0105482	http://dx.doi.org/10.1371/journal.pone.0105482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144319	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100073
J	Berglin, L; Bergquist, A; Johansson, H; Glaumann, H; Jorns, C; Lunemann, S; Wedemeyer, H; Ellis, EC; Bjorkstrom, NK				Berglin, Lena; Bergquist, Annika; Johansson, Helene; Glaumann, Hans; Jorns, Carl; Lunemann, Sebastian; Wedemeyer, Heiner; Ellis, Ewa C.; Bjorkstrom, Niklas K.			In Situ Characterization of Intrahepatic Non-Parenchymal Cells in PSC Reveals Phenotypic Patterns Associated with Disease Severity	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; LIVER; PATHOGENESIS; LYMPHOCYTES; STIMULATION; CALDESMON	Liver-infiltrating T cells have been implicated in the pathogenesis of primary sclerosing cholangitis (PSC), however little information is available about changes in other cellular compartments in the liver during PSC. This study aimed to characterize non-parenchymal intrahepatic cells in PSC livers and to find associations between phenotypes and disease severity. Using immunohistochemistry, followed by automated image analysis and quantification and a principal component analysis, we have studied non-parenchymal intrahepatic cells in PSC-patient livers (n = 17) and controls (n = 17). We observed a significant increase of T cells in the PSC patients, localized to the fibrotic areas. MAIT cells, normally present at high numbers in the liver, were not increased to the same extent. PSC patients had lower expression of MHC class I than controls. However, the levels of NKp46+ NK cells were similar between patients and controls, nevertheless, NKp46 was identified as a phenotypic marker that distinguished PSC patients with mild from those with severe fibrosis. Beyond that, a group of PSC patients had lost expression of Caldesmon and this was associated with more extensive bile duct proliferation and higher numbers of T cells. Our data reveals phenotypic patterns in PSC patients associated with disease severity.	[Berglin, Lena; Bergquist, Annika; Bjorkstrom, Niklas K.] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Liver Immunol Lab,Unit Gastroenterol & Hepatol, Stockholm, Sweden; [Johansson, Helene; Ellis, Ewa C.] Karolinska Inst, Karolinska Univ Hosp, Div Transplantat Surg, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Glaumann, Hans] Karolinska Univ Hosp, Dept Med Clin Pathol & Cytol, Stockholm, Sweden; [Lunemann, Sebastian; Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Bjorkstrom, Niklas K.] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Infect Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Hannover Medical School; Karolinska Institutet; Karolinska University Hospital	Bjorkstrom, NK (corresponding author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Liver Immunol Lab,Unit Gastroenterol & Hepatol, Stockholm, Sweden.	niklas.bjorkstrom@ki.se	Björkström, Niklas/N-2919-2017; Jorns, Carl/AAE-6925-2021; Ellis, Ewa C S/D-5370-2014	Björkström, Niklas/0000-0002-0967-076X; Jorns, Carl/0000-0001-7727-8113; Ellis, Ewa C S/0000-0002-3057-5337; Johansson, Helene/0000-0001-5519-0401; Bergquist, Annika/0000-0002-3858-6241	Swedish Cancer Society; Karolinska Institutet; Swedish Society for Medical Research; Alex and Eva Wallstrom Foundation; Cancer Research Foundations of Radiumhemmet; Swedish Society of Medicine; Jeansson Foundation; Bengt Ihre Foundation; Groschinsky Foundation; Hedlunds Foundation; Mag-tarmfonden; Magnus Bergvall Foundation; Nanna Svartz Foundation; Julin Foundation; Novo Nordisk Fonden [NNF14OC0009347] Funding Source: researchfish	Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet); Swedish Society for Medical Research; Alex and Eva Wallstrom Foundation; Cancer Research Foundations of Radiumhemmet; Swedish Society of Medicine; Jeansson Foundation; Bengt Ihre Foundation; Groschinsky Foundation; Hedlunds Foundation; Mag-tarmfonden; Magnus Bergvall Foundation; Nanna Svartz Foundation; Julin Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was funded by the the Swedish Cancer Society, the Karolinska Institutet, the Swedish Society for Medical Research, the Alex and Eva Wallstrom Foundation, the Cancer Research Foundations of Radiumhemmet, the Swedish Society of Medicine, the Jeansson Foundation, the Bengt Ihre Foundation, the Groschinsky Foundation, the Hedlunds Foundation, Mag-tarmfonden, Magnus Bergvall Foundation, the Nanna Svartz Foundation, and the Julin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CALMUS Y, 1991, BIOCHIMIE, V73, P1335, DOI 10.1016/0300-9084(91)90098-L; Cerbonil C, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00508; Chapman R, 2008, WORLD J GASTROENTERO, V14, P3350, DOI 10.3748/wjg.14.3350; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Deng M, 2007, CELL MOTIL CYTOSKEL, V64, P951, DOI 10.1002/cm.20236; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Eksteen B, 2004, J EXP MED, V200, P1511, DOI 10.1084/jem.20041035; Fabris L, 2011, SEMIN LIVER DIS, V31, P11, DOI 10.1055/s-0031-1272832; Glassner A, 2012, LAB INVEST, V92, P967, DOI 10.1038/labinvest.2012.54; Grant AJ, 2002, LANCET, V359, P150, DOI 10.1016/S0140-6736(02)07374-9; Grant AJ, 2001, HEPATOLOGY, V33, P1065, DOI 10.1053/jhep.2001.24231; HATA K, 1992, HEPATOLOGY, V15, P816, DOI 10.1002/hep.1840150512; Katt J, 2013, HEPATOLOGY, V58, P1084, DOI 10.1002/hep.26447; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Numaguchi Yasushi, 2003, Angiogenesis, V6, P55, DOI 10.1023/A:1025821517679; Parekh A, 2009, J UROLOGY, V182, P1210, DOI 10.1016/j.juro.2009.05.002; Pollheimer MJ, 2011, BEST PRACT RES CL GA, V25, P727, DOI 10.1016/j.bpg.2011.10.009; Ponsioen CY, 1999, EUR J GASTROEN HEPAT, V11, P769, DOI 10.1097/00042737-199907000-00015; SAEKI R, 1995, J GASTROENTEROL, V30, P739, DOI 10.1007/BF02349640; Seidel D, 2014, HEPATOLOGY, V59, P601, DOI 10.1002/hep.26702; SI L, 1984, J CLIN IMMUNOL, V4, P262, DOI 10.1007/BF00915293; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0	24	14	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105375	10.1371/journal.pone.0105375	http://dx.doi.org/10.1371/journal.pone.0105375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141347	gold, Green Submitted, Green Published			2022-12-25	WOS:000342687200080
J	Eisma, MC; Schut, HAW; Stroebe, MS; van den Bout, J; Stroebe, W; Boelen, PA				Eisma, Maarten C.; Schut, Henk A. W.; Stroebe, Margaret S.; van den Bout, Jan; Stroebe, Wolfgang; Boelen, Paul A.			Is Rumination after Bereavement Linked with Loss Avoidance? Evidence from Eye-Tracking	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS; COGNITIVE AVOIDANCE; DEPRESSION; GRIEF; WORRY; ATTENTION; DISTRESS; VALIDITY; STATES	Rumination is a risk factor in adjustment to bereavement. It is associated with and predicts psychopathology after loss. Yet, the function of rumination in bereavement remains unclear. In the past, researchers often assumed rumination to be a maladaptive confrontation process. However, based on cognitive avoidance theories of worry in generalised anxiety disorder (GAD) and rumination after post-traumatic stress disorder (PTSD), others have suggested that rumination may serve to avoid painful aspects of the loss, thereby contributing to complicated grief. To examine if rumination is linked with loss avoidance, an eye-tracking study was conducted with 54 bereaved individuals (27 high and 27 low ruminators). On 24 trials, participants looked for 10 seconds at a picture of the deceased and a picture of a stranger, randomly combined with negative, neutral or loss-related words. High ruminators were expected to show initial vigilance followed by subsequent disengagement for loss stimuli (i.e., picture deceased with a loss word) in the first 1500 ms. Additionally, we expected high ruminators to avoid these loss stimuli and to show attentional preference for non-loss-related negative stimuli (i.e., picture stranger with a negative word) on longer exposure durations (1500-10000 ms). Contrary to expectations, we found no evidence for an effect of rumination on vigilance and disengagement of loss stimuli in the first 1500 ms. However, in the 1500-10000 ms interval, high ruminators showed shorter gaze times for loss stimuli and longer gaze times for negative (and neutral) non-loss-related stimuli, even when controlling for depression and complicated grief symptom levels. Effects of rumination on average fixation times mirrored these findings. This suggests that rumination and loss avoidance are closely associated. A potential clinical implication is that rumination and grief complications after bereavement may be reduced through the use of exposure and acceptance-based therapeutic techniques.	[Eisma, Maarten C.; Schut, Henk A. W.; Stroebe, Margaret S.; van den Bout, Jan; Boelen, Paul A.] Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands; [Stroebe, Margaret S.] Univ Groningen, Dept Expt Psychopathol & Clin Psychol, Groningen, Netherlands; [Stroebe, Wolfgang] Univ Groningen, Dept Social & Org Psychol, Groningen, Netherlands; [Stroebe, Wolfgang] Univ Groningen, Dept Social Psychol, Groningen, Netherlands	Utrecht University; University of Groningen; University of Groningen; University of Groningen	Eisma, MC (corresponding author), Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands.	m.c.eisma@uu.nl	Schut, Henk/E-7487-2013	Eisma, Maarten/0000-0002-6109-2274; Stroebe, Margaret/0000-0002-8468-3317	Zon-MW TOP Grant of the Dutch Society for Scientific Research (NWO) [91208009]	Zon-MW TOP Grant of the Dutch Society for Scientific Research (NWO)	This research was funded by a Zon-MW TOP Grant of the Dutch Society for Scientific Research (NWO) under Grant number 91208009. Website: www.zonmw.nl. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armstrong T, 2012, CLIN PSYCHOL REV, V32, P704, DOI 10.1016/j.cpr.2012.09.004; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; BODNAR JC, 1994, PSYCHOL AGING, V9, P372; Boelen PA, 2003, J BEHAV THER EXP PSY, V34, P225, DOI 10.1016/j.jbtep.2003.08.001; Boelen PA, 2003, DEATH STUD, V27, P227, DOI 10.1080/07481180302889; Boelen PA, 2006, CLIN PSYCHOL-SCI PR, V13, P109, DOI 10.1111/j.1468-2850.2006.00013.x; Bonanno GA, 2005, J CONSULT CLIN PSYCH, V73, P86, DOI 10.1037/0022-006X.73.1.86; Borkovec TD, 1998, COGNITIVE THER RES, V22, P561, DOI 10.1023/A:1018790003416; Calvo MG, 2005, COGNITION EMOTION, V19, P433, DOI 10.1080/02699930441000157; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cribb G, 2006, BEHAV CHANGE, V23, P165, DOI 10.1375/bech.23.3.165; Dickson KS, 2012, BEHAV THER, V43, P629, DOI 10.1016/j.beth.2011.11.002; Donaldson C, 2007, BEHAV RES THER, V45, P2664, DOI 10.1016/j.brat.2007.07.002; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Eisma MC, 2014, J PSYCHOPATHOL BEHAV, V36, P165, DOI 10.1007/s10862-013-9377-y; Eisma MC, 2013, J ABNORM PSYCHOL, V122, P961, DOI 10.1037/a0034051; Eisma MC, 2012, GEDRAGSTHERAPIE, V43, P369; ERBER R, 1996, ADV SOC COG, V9, P73; Giorgio JM, 2010, BEHAV RES THER, V48, P1021, DOI 10.1016/j.brat.2010.07.004; Gundel H, 2003, AM J PSYCHIAT, V160, P1946, DOI 10.1176/appi.ajp.160.11.1946; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Joormann J, 2006, BEHAV THER, V37, P269, DOI 10.1016/j.beth.2006.01.002; Koster EHW, 2011, CLIN PSYCHOL REV, V31, P138, DOI 10.1016/j.cpr.2010.08.005; Lee Jonathan K., 2010, Cognitive Behaviour Therapy, V39, P126, DOI 10.1080/16506070902966918; Liverant GI, 2011, COGNITIVE THER RES, V35, P253, DOI 10.1007/s10608-010-9304-4; LYUBOMIRSKY S, 1993, J PERS SOC PSYCHOL, V65, P339, DOI 10.1037/0022-3514.65.2.339; Lyubomirsky S, 2003, COGNITIVE THER RES, V27, P309, DOI 10.1023/A:1023918517378; Maccallum F, 2010, J AFFECT DISORDERS, V125, P316, DOI 10.1016/j.jad.2010.01.070; Martell C. R., 2001, DEPRESSION CONTEXT S; Martin L.L., 1996, ADV SOC COG, V9, P1; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Michael T, 2007, DEPRESS ANXIETY, V24, P307, DOI 10.1002/da.20228; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Morina N, 2011, J NERV MENT DIS, V199, P921, DOI 10.1097/NMD.0b013e3182392aae; Moulds ML, 2007, BEHAV RES THER, V45, P251, DOI 10.1016/j.brat.2006.03.003; Newman MG, 2011, CLIN PSYCHOL REV, V31, P371, DOI 10.1016/j.cpr.2011.01.008; Nolen-Hoeksema S., 2001, HDB BEREAVEMENT RES, P545, DOI DOI 10.1037/10436-023; Nolen-Hoeksema S., 1999, COPING LOSS; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NolenHoeksema S, 1997, J PERS SOC PSYCHOL, V72, P855, DOI 10.1037/0022-3514.72.4.855; NOLENHOEKSEMA S, 1994, J PERS SOC PSYCHOL, V67, P92, DOI 10.1037/0022-3514.67.1.92; Ouimet AJ, 2009, CLIN PSYCHOL REV, V29, P459, DOI 10.1016/j.cpr.2009.05.004; Prigerson H.G., 2001, HDB BEREAVEMENT RES, P613, DOI DOI 10.1037/10436-026; Querstret D, 2013, CLIN PSYCHOL REV, V33, P996, DOI 10.1016/j.cpr.2013.08.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; Rinck M, 2006, J ABNORM PSYCHOL, V115, P231, DOI 10.1037/0021-843X.115.2.231; Scheres Anouk, 2010, Biol Psychiatry, V68, pe17, DOI 10.1016/j.biopsych.2010.05.021; Sexton KA, 2009, COGNITIVE THER RES, V33, P150, DOI 10.1007/s10608-007-9177-3; Stroebe M., 2001, REV GEN PSYCHOL, V5, P62, DOI [DOI 10.1037/1089-2680.5.1.62, 10.1037/1089-2680.5.1.62]; Stroebe M, 2007, EUR ARCH PSY CLIN N, V257, P462, DOI 10.1007/s00406-007-0746-y; TAIT R, 1989, P351; Tull Matthew T., 2011, Cognitive Behaviour Therapy, V40, P5, DOI 10.1080/16506073.2010.515187; Waechter S, 2014, COGNITIVE THER RES, V38, P313, DOI 10.1007/s10608-013-9588-2; Wenzlaff EM, 2000, ANNU REV PSYCHOL, V51, P59, DOI 10.1146/annurev.psych.51.1.59; Wenzlaff RM, 2003, COGNITIVE THER RES, V27, P293, DOI 10.1023/A:1023966400540; Wisco BE, 2013, CLIN PSYCHOL SCI, V1, P435, DOI 10.1177/2167702613486630; Worden JW, 2009, HDB MENTAL HLTH PRAC	58	37	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104980	10.1371/journal.pone.0104980	http://dx.doi.org/10.1371/journal.pone.0104980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25140524	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200045
J	Enserink, R; Lugner, A; Suijkerbuijk, A; Bruijning-Verhagen, P; Smit, HA; van Pelt, W				Enserink, Remko; Lugner, Anna; Suijkerbuijk, Anita; Bruijning-Verhagen, Patricia; Smit, Henriette A.; van Pelt, Wilfrid			Gastrointestinal and Respiratory Illness in Children That Do and Do Not Attend Child Day Care Centers: A Cost-of-Illness Study	PLOS ONE			English	Article							INFECTIOUS-DISEASE; YOUNG-CHILDREN; EAR INFECTIONS; GASTROENTERITIS; NETHERLANDS; RISK; HEALTH; ARRANGEMENTS; AGE; HOSPITALIZATION	Background: Gastrointestinal and respiratory diseases are major causes of morbidity for young children, particularly for those children attending child day care centers (DCCs). Although both diseases are presumed to cause considerable societal costs for care and treatment of illness, the extent of these costs, and the difference of these costs between children that do and do not attend such centers, is largely unknown. Objective: Estimate the societal costs for care and treatment of episodes of gastroenteritis (GE) and influenza-like illness (ILI) experienced by Dutch children that attend a DCC, compared to children that do not attend a DCC. Methods: A web-based monthly survey was conducted among households with children aged 0-48 months from October 2012 to October 2013. Households filled-in a questionnaire on the incidence of GE and ILI episodes experienced by their child during the past 4 weeks, on the costs related to care and treatment of these episodes, and on DCC arrangements. Costs and incidence were adjusted for socioeconomic characteristics including education level, nationality and monthly income of parents, number of children in the household, gender and age of the child and month of survey conduct. Results: Children attending a DCC experienced higher rates of GE (aIRR 1.4 [95% CI: 1.2-1.9]) and ILI (aIRR: 1.4 [95% CI: 1.2-1.6]) compared to children not attending a DCC. The societal costs for care and treatment of an episode of GE and ILI experienced by a DCC-attending child were estimated at (sic)215.45 [(sic)115.69-(sic)315.02] and (sic)196.32 [(sic)161.58-(sic)232.74] respectively, twice as high as for a non-DCC-attending child. The DCC-attributable economic burden of GE and ILI for the Netherlands was estimated at (sic)25 million and (sic)72 million per year. Conclusions: Although children attending a DCC experience only slightly higher rates of GE and ILI compared to children not attending a DCC, the costs involved per episode are substantially higher.	[Enserink, Remko; Lugner, Anna; Bruijning-Verhagen, Patricia; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Bruijning-Verhagen, Patricia; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Suijkerbuijk, Anita] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Enserink, R (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	remko.enserink@rivm.nl	Bruijning-Verhagen, Patricia C.J.L./E-4134-2015	Bruijning-Verhagen, Patricia C.J.L./0000-0003-4105-9669				ALEXANDER CS, 1990, AM J EPIDEMIOL, V131, P124, DOI 10.1093/oxfordjournals.aje.a115465; ANDERSON LJ, 1988, PEDIATRICS, V82, P300; ARNOLD C, 1993, AM J EPIDEMIOL, V138, P333, DOI 10.1093/oxfordjournals.aje.a116863; Augustine JM, 2013, J HLTH SOCIAL BEHAV; Ball, 2002, INFLUENCE ATTENDANCE; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Ball TM, 2002, ARCH PEDIAT ADOL MED, V156, P121, DOI 10.1001/archpedi.156.2.121; Beijers R, 2011, EARLY HUM DEV, V87, P9, DOI 10.1016/j.earlhumdev.2010.09.003; Belotti F, 2015, STATA J, V15, P3, DOI 10.1177/1536867X1501500102; Bloomfield SF, 2006, CLIN EXP ALLERGY, V36, P402, DOI 10.1111/j.1365-2222.2006.02463.x; Bradley RH, 2003, ARCH PEDIAT ADOL MED, V157, P196, DOI 10.1001/archpedi.157.2.196; Bradley RH, 2001, ARCH PEDIAT ADOL MED, V155, P481, DOI 10.1001/archpedi.155.4.481; Brady MT, 2005, AM J INFECT CONTROL, V33, P276, DOI 10.1016/j.ajic.2004.11.007; COLLET JP, 1994, PEDIATRICS, V94, P997; Cordell RL, 1999, ARCH PEDIAT ADOL MED, V153, P275; Cordell RL, 1997, PEDIATRICS, V100, P850, DOI 10.1542/peds.100.5.850; Cote SM, 2010, ARCH PEDIAT ADOL MED, V164, P1132, DOI 10.1001/archpediatrics.2010.216; de Meer G, 2005, ALLERGY, V60, P619, DOI 10.1111/j.1398-9995.2005.00746.x; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; de Wit MAS, 2001, EMERG INFECT DIS, V7, P82, DOI 10.3201/eid0701.010113; Donker GA, 2012, CONTINUOUS MORBIDITY; Dunder T, 2007, ARCH PEDIAT ADOL MED, V161, P972, DOI 10.1001/archpedi.161.10.972; Enserink R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089496; Enserink R, 2013, PEDIATR INFECT DIS J, V32, pE334, DOI 10.1097/INF.0b013e318290601e; Friesema IHM, 2012, EUR J CLIN MICROBIOL, V31, P1895, DOI 10.1007/s10096-011-1518-1; Giaquinto C, 2007, J INFECT DIS, V195, pS36, DOI 10.1086/516716; Groot W, 1993, KINDEROPVANG NEDERLA; Haby MM, 2000, PEDIATR PULM, V30, P377, DOI 10.1002/1099-0496(200011)30:5<377::AID-PPUL3>3.3.CO;2-V; HARDY AM, 1993, AM J PUBLIC HEALTH, V83, P1321, DOI 10.2105/AJPH.83.9.1321; HASKINS R, 1986, PEDIATRICS, V77, P951; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Hildesheim ME, 1999, PAEDIATR PERINAT EP, V13, P466; HURWITZ ES, 1991, PEDIATRICS, V87, P62; JB O, 2008, GUIDELINES COST RES; JOHANSEN AS, 1988, AM J PUBLIC HEALTH, V78, P1175, DOI 10.2105/AJPH.78.9.1175; Kamper-Jorgensen M, 2006, PEDIATRICS, V118, P1439, DOI 10.1542/peds.2006-0373; Kamper-Jorgensen M, 2008, PEDIATRICS, V122, pE1168, DOI 10.1542/peds.2008-1757; Koningstein M ea, 2013, MVNA C COP DENM; Lambert Stephen, 2004, Commun Dis Intell Q Rep, V28, P510; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Mangen MJJ, 2010, VACCINE, V28, P2624, DOI 10.1016/j.vaccine.2010.01.014; Mangen MJ, 2013, 330331007 RIVM; McCutcheon H, 1996, AUST NZ J PUBL HEAL, V20, P49, DOI 10.1111/j.1467-842X.1996.tb01335.x; Nafstad P, 1999, PEDIATRICS, V103, P753, DOI 10.1542/peds.103.4.753; Nesti MMM, 2007, J PEDIAT-BRAZIL, V83, P299, DOI [10.2223/JPED.1649, 10.1590/S0021-75572007000500004]; RASMUSSEN F, 1990, ACTA PAEDIATR SCAND, V79, P838, DOI 10.1111/j.1651-2227.1990.tb11563.x; Rijksoverheid, 2014, WELK VORM KIND ZIJN; Shope TR, 2014, PEDIATR REV, V35, P182, DOI 10.1542/pir.35-5-182; Silverstein M, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e371; Szajewska H, 2014, J PEDIATR GASTR NUTR, V58, P531, DOI 10.1097/MPG.0000000000000320; van de Pol AC, 2013, INT J PEDIATR OTORHI, V77, P906, DOI 10.1016/j.ijporl.2013.03.003; van den Brandhof WE, 2004, EPIDEMIOL INFECT, V132, P211, DOI 10.1017/S0950268803001559; Wald ER, 1991, FREQUENCY SEVERITY I, P509	53	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104940	10.1371/journal.pone.0104940	http://dx.doi.org/10.1371/journal.pone.0104940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25141226	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200043
J	Rivolta, MW; Stampalija, T; Casati, D; Richardson, BS; Ross, MG; Frasch, MG; Bauer, A; Ferrazzi, E; Sassi, R				Rivolta, Massimo W.; Stampalija, Tamara; Casati, Daniela; Richardson, Bryan S.; Ross, Michael G.; Frasch, Martin G.; Bauer, Axel; Ferrazzi, Enrico; Sassi, Roberto			Acceleration and Deceleration Capacity of Fetal Heart Rate in an In-Vivo Sheep Model	PLOS ONE			English	Article							RATE-VARIABILITY; SPECTRAL-ANALYSIS; SURVEILLANCE; PREDICTOR; VAGAL	Background: Fetal heart rate (FHR) variability is an indirect index of fetal autonomic nervous system (ANS) integrity. FHR variability analysis in labor fails to detect early hypoxia and acidemia. Phase-rectified signal averaging (PRSA) is a new method of complex biological signals analysis that is more resistant to non-stationarities, signal loss and artifacts. It quantifies the average cardiac acceleration and deceleration (AC/DC) capacity. Objective: The aims of the study were: (1) to investigate AC/DC in ovine fetuses exposed to acute hypoxic-acidemic insult; (2) to explore the relation between AC/DC and acid-base balance; and (3) to evaluate the influence of FHR decelerations and specific PRSA parameters on AC/DC computation. Methods: Repetitive umbilical cord occlusions (UCOs) were applied in 9 pregnant near-term sheep to obtain three phases of MILD, MODERATE, and SEVERE hypoxic-acidemic insult. Acid-base balance was sampled and fetal ECGs continuously recorded. AC/DC were calculated: (1) for a spectrum of T values (T= 1 divided by 50 beats; the parameter limits the range of oscillations detected by PRSA); (2) on entire series of fetal RR intervals or on "stable'' series that excluded FHR decelerations caused by UCOs. Results: AC and DC progressively increased with UCOs phases (MILD vs. MODERATE and MODERATE vs. SEVERE, p < 0.05 for DC T = 2-5, and AC T = 1-3). The time evolution of AC/DC correlated to acid-base balance (0.4 <vertical bar rho vertical bar <0.9, p < 0.05) with the highest D r D for 2 <= T <= 7. PRSA was not independent from FHR decelerations caused by UCOs. Conclusions: This is the first in-vivo evaluation of PRSA on FHR analysis. In the presence of acute hypoxic-acidemia we found increasing values of AC/DC suggesting an activation of ANS. This correlation was strongest on time scale dominated by parasympathetic modulations. We identified the best performing T parameters (3 <= T <= 5), and found that AC/DC computation is not independent from FHR decelerations. These findings establish the basis for future clinical studies.	[Rivolta, Massimo W.; Sassi, Roberto] Univ Milan, Dept Comp Sci, Milan, Italy; [Stampalija, Tamara] IRCCS Burlo Garofolo, Unit Prenatal Diag, Inst Maternal & Child Hlth, Trieste, Italy; [Casati, Daniela; Ferrazzi, Enrico] Univ Milan, Dept Woman Mother & Neonate, Buzzi Childrens Hosp, Biomed & Clin Sci Sch Med, Milan, Italy; [Richardson, Bryan S.] Univ Western Ontario, Dept Obstet & Gynecol, London, ON, Canada; [Ross, Michael G.] Harbor UCLA Med Ctr, LA BioMed, Dept Obstet & Gynecol, Torrance, CA USA; [Frasch, Martin G.] Univ Montreal, CHU Ste Justine Res Ctr, Dept Obstet Gynaecol, St Hyacinthe, PQ, Canada; [Frasch, Martin G.] Univ Montreal, CHU Ste Justine Res Ctr, Dept Neurosci, St Hyacinthe, PQ, Canada; [Frasch, Martin G.] Univ Montreal, Anim Reprod Res Ctr CRRA, St Hyacinthe, PQ, Canada; [Bauer, Axel] Univ Munich, Munich Univ Clin, Dept Cardiol, Munich, Germany; [Bauer, Axel] DZHK German Ctr Cardiovasc Res, Lubeck, Germany	University of Milan; IRCCS Burlo Garofolo; University of Milan; Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Munich; German Centre for Cardiovascular Research	Stampalija, T (corresponding author), IRCCS Burlo Garofolo, Unit Prenatal Diag, Inst Maternal & Child Hlth, Trieste, Italy.	tamara.stampalija@burlo.trieste.it	Stampalija, Tamara/K-4900-2014; Rivolta, Massimo/J-6542-2019; Casati, Daniela/AAE-6011-2022; Frasch, Martin/AAN-8507-2020; Ferrazzi, Enrico Mario/AAB-9416-2019; Sassi, Roberto/B-8136-2008	Rivolta, Massimo/0000-0002-8553-2414; Casati, Daniela/0000-0002-8856-442X; Frasch, Martin/0000-0003-3159-6321; Ferrazzi, Enrico Mario/0000-0001-5243-0537; Sassi, Roberto/0000-0001-9729-2641; stampalija, tamara/0000-0002-9080-3848; Bauer, Axel/0000-0001-9201-8555	Fondazione Cure Onlus	Fondazione Cure Onlus	This study was supported by Fondazione Cure Onlus. The funders supported the networking and publications fees. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfirevic Z, 1996, COCHRANE DB SYST REV; Bauer A, 2006, PHYSICA A, V364, P423, DOI 10.1016/j.physa.2005.08.080; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; Camm AJ, 1996, CIRCULATION, V93, P1043; Casati D, 2014, EXP PHYSIOL, V99, P466, DOI 10.1113/expphysiol.2013.076539; Chung DY, 2001, INT J GYNECOL OBSTET, V73, P109, DOI 10.1016/S0020-7292(01)00348-4; Eick C, 2014, ANN NONINVAS ELECTRO, V19, P122, DOI 10.1111/anec.12107; Fletcher AJW, 2006, AM J PHYSIOL-HEART C, V291, pH3023, DOI 10.1152/ajpheart.00504.2006; Frasch MG, 2009, AM J PHYSIOL-REG I, V296, pR702, DOI 10.1152/ajpregu.90474.2008; Frasch MG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.022; Graatsma EM, 2012, J MATERN-FETAL NEO M, V25, P2517, DOI 10.3109/14767058.2012.704446; Green LR, 1999, J SOC GYNECOL INVEST, V6, P56, DOI 10.1016/S1071-5576(98)00055-0; Groome LJ, 1999, DEV PSYCHOBIOL, V35, P25, DOI 10.1002/(SICI)1098-2302(199907)35:1<25::AID-DEV4>3.0.CO;2-Q; Huhn EA, 2011, PRENATAL DIAG, V31, P509, DOI 10.1002/pd.2728; ITSKOVITZ J, 1982, AM J PHYSIOL, V242, pH916, DOI 10.1152/ajpheart.1982.242.5.H916; Kantelhardt JW, 2007, CHAOS, V17, DOI 10.1063/1.2430636; Lobmaier SM, 2012, J MATERN-FETAL NEO M, V25, P2523, DOI 10.3109/14767058.2012.696163; Murotsuki J, 1997, AM J OBSTET GYNECOL, V176, P282, DOI 10.1016/S0002-9378(97)70486-1; Neilson JP, 1996, COCHRANE DB SYST REV; PARER JT, 1980, EUR J OBSTET GYN R B, V10, P393, DOI 10.1016/0028-2243(80)90025-8; Prout AP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.020; Rantonen T, 2001, EARLY HUM DEV, V60, P233, DOI 10.1016/S0378-3782(00)00124-9; Ross MG, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.883; Sabir H, 2010, OBSTET GYNECOL, V115, P419, DOI 10.1097/AOG.0b013e3181c51aeb; Siira SM, 2013, EARLY HUM DEV, V89, P739, DOI 10.1016/j.earlhumdev.2013.05.007; Van Laar JOEH, 2008, ACTA OBSTET GYN SCAN, V87, P300, DOI 10.1080/00016340801898950; Westerhuis MEMH, 2007, BJOG-INT J OBSTET GY, V114, P1194, DOI 10.1111/j.1471-0528.2007.01236.x	27	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104193	10.1371/journal.pone.0104193	http://dx.doi.org/10.1371/journal.pone.0104193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141131	gold, Green Submitted, Green Published			2022-12-25	WOS:000342687200014
J	Zhou, Z; Li, YD; Sun, N; Sun, ZH; Lv, LX; Wang, YF; Shen, LB; Li, YQ				Zhou, Zhan; Li, Yudong; Sun, Ning; Sun, Zhihao; Lv, Longxian; Wang, Yufeng; Shen, Libing; Li, Yong-Quan			Function and Evolution of Two Forms of SecDF Homologs in Streptomyces coelicolor	PLOS ONE			English	Article							PROTEIN EXPORT; ESCHERICHIA-COLI; SIGNAL PEPTIDES; TRANSLOCATION; SECRETION; EXPRESSION; LIVIDANS; SECYEG; PHYLOGENIES; RESISTANCE	The general secretion (Sec) pathway plays a prominent role in bacterial protein export, and the accessory component SecDF has been shown to improve transportation efficiency. Inspection of Streptomyces coelicolor genome reveals the unexpected presence of two different forms of secDF homologous genes: one in fused form (secDF) and the other in separated form (secD and secF). However, the functional role of two SecDF homologs in S. coelicolor has not yet been determined. Transcriptional analysis of secDF homologs reveals that these genes are constitutively expressed. However, the transcript levels of secD and secF are much higher than that of secDF in S. coelicolor. Deletion of secDF or/and secD/secF in S. coelicolor did result in reduced secretion efficiency of Xylanase A and Amylase C, suggesting that they may have redundant functions for Sec-dependent translocation pathway. Moreover, our results also indicate that SecD/SecF plays a more prominent role than SecDF in protein translocation. Evolutionary analysis suggests that the fused and separated SecDF homologs in Streptomyces may have disparate evolutionary ancestries. SecD/SecF may be originated from vertical transmission of existing components from ancestor of Streptomyces species. However, SecDF may be derived from bacterial ancestors through horizontal gene transfer. Alternately, it is also plausible that SecDF may have arisen through additional gene duplication and fusion events. The acquisition of a second copy may confer a selective benefit to Streptomyces by enhancing protein transport capacity. Taken together, our results provide new insights into the potential biological function and evolutionary aspects of the prokaryotic SecDF complex.	[Zhou, Zhan; Sun, Ning; Sun, Zhihao; Lv, Longxian; Li, Yong-Quan] Zhejiang Univ, Coll Life Sci, Prov Key Lab Microbial Biochem & Metab Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Yudong] Zhejiang Gongshang Univ, Sch Food Sci & Biotechnol, Dept Bioengn, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhan; Wang, Yufeng] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Zhou, Zhan; Wang, Yufeng] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Zhou, Zhan; Shen, Libing] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhou, Zhan; Shen, Libing] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China	Zhejiang University; Zhejiang Gongshang University; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Fudan University; Fudan University	Li, YD (corresponding author), Zhejiang Gongshang Univ, Sch Food Sci & Biotechnol, Dept Bioengn, Hangzhou, Zhejiang, Peoples R China.	lyd@zjsu.edu.cn; lyq@zju.edu.cn	li, yu/HGL-9518-2022; Zhou, Zhan/I-2372-2013; Li, Yudong/GSN-4036-2022; li, Yu/HCI-9086-2022	Zhou, Zhan/0000-0002-2730-5483; Sun, Zhihao/0000-0001-5753-6680; Wang, Yufeng/0000-0002-9959-4149	National Basic Research Program of China (973 Program) [2012CB721005]; National Natural Science Foundation of China [30870033]; Education Bureau of Zhejiang Province [Y201016960]; China Scholarship Council; China Postdoctoral Science Foundation [2013M531117]; National Institutes of Health [GM100806, AI080579, G12MD007591]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI080579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM100806, SC1GM081068] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Bureau of Zhejiang Province; China Scholarship Council(China Scholarship Council); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from National Basic Research Program of China (973 Program, 2012CB721005) and National Natural Science Foundation of China (30870033) to YQL, and a grant from the Education Bureau of Zhejiang Province (Y201016960) to YDL. ZZ was supported by a government scholarship from China Scholarship Council and a general financial grant from China Postdoctoral Science Foundation (2013M531117). YW was supported by grants from National Institutes of Health (GM100806, AI080579, and G12MD007591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne J, 2014, BBA-MOL CELL RES, V1843, P1750, DOI 10.1016/j.bbamcr.2013.12.023; Anne J, 2012, J BIOTECHNOL, V158, P159, DOI 10.1016/j.jbiotec.2011.06.028; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bolhuis A, 1998, J BIOL CHEM, V273, P21217, DOI 10.1074/jbc.273.33.21217; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; Chatzi KE, 2013, BIOCHEM J, V449, P25, DOI 10.1042/BJ20121227; Driessen AJM, 1998, CURR OPIN MICROBIOL, V1, P216, DOI 10.1016/S1369-5274(98)80014-3; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Eichler J, 2003, MOL PHYLOGENET EVOL, V27, P504, DOI 10.1016/S1055-7903(03)00015-0; GARDEL C, 1990, EMBO J, V9, P4205, DOI 10.1002/j.1460-2075.1990.tb07645.x; Geukens N, 2006, MICROBIOL-SGM, V152, P1441, DOI 10.1099/mic.0.28734-0; Green MR, 2012, MOL CLONING LAB MANU; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hennerdal A, 2010, PROTEIN SCI, V19, P2305, DOI 10.1002/pro.510; Hopwood DA, 2006, ANNU REV GENET, V40, P1, DOI 10.1146/annurev.genet.40.110405.090639; Hsieh YH, 2013, BIOCHEM BIOPH RES CO, V431, P388, DOI 10.1016/j.bbrc.2013.01.042; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lammertyn E, 1998, APPL MICROBIOL BIOT, V49, P424, DOI 10.1007/s002530051193; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li YD, 2009, PROTEIN PEPTIDE LETT, V16, P706, DOI 10.2174/092986609788490096; Mao XM, 2009, J BACTERIOL, V191, P6473, DOI 10.1128/JB.00875-09; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Morosoli R, 1997, FEMS MICROBIOL LETT, V146, P167, DOI 10.1016/S0378-1097(96)00411-9; Morosoli R, 1999, FEMS MICROBIOL LETT, V179, P437, DOI 10.1016/S0378-1097(99)00448-6; Mulder KCL, 2013, PROTEIN EXPRES PURIF, V89, P92, DOI 10.1016/j.pep.2013.02.008; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nouwen N, 2005, J BACTERIOL, V187, P6852, DOI 10.1128/JB.187.19.6852-6855.2005; Nouwen N, 2005, J BACTERIOL, V187, P5857, DOI 10.1128/JB.187.16.5857-5860.2005; Page N, 1996, APPL ENVIRON MICROB, V62, P109; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; POGLIANO KJ, 1993, GENETICS, V133, P763; Quiblier C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-72; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Sun JH, 1999, MICROBIOL-UK, V145, P2221, DOI 10.1099/00221287-145-9-2221; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Vrancken K, 2009, FUTURE MICROBIOL, V4, P181, DOI 10.2217/17460913.4.2.181; Widdick DA, 2008, J MOL BIOL, V375, P595, DOI 10.1016/j.jmb.2007.11.002; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Yang R, 1998, Chin J Biotechnol, V14, P1; Yin XH, 1998, GENE, V215, P171, DOI 10.1016/S0378-1119(98)00265-0; Zhou Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S8; Zhou Z, 2011, CURR GENOMICS, V12, P404, DOI 10.2174/138920211797248556	55	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105237	10.1371/journal.pone.0105237	http://dx.doi.org/10.1371/journal.pone.0105237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140821	Green Submitted, gold, Green Published			2022-12-25	WOS:000342687200066
J	Kumar, P; Smith, T; Rahman, K; Mells, JE; Thorn, NE; Saxena, NK; Anania, FA				Kumar, Pradeep; Smith, Tekla; Rahman, Khalidur; Mells, Jamie E.; Thorn, Natalie E.; Saxena, Neeraj K.; Anania, Frank A.			Adiponectin modulates focal adhesion disassembly in activated hepatic stellate cells: implication for reversing hepatic fibrosis	FASEB JOURNAL			English	Article						FAK; Shp2; vinculin; APPL1; myofibroblasts	TYROSINE-PHOSPHATASE SHP2; LIVER FIBROSIS; KUPFFER CELLS; T-CADHERIN; LEPTIN; MECHANISMS; MIGRATION; RATS; PHOSPHORYLATION; DIFFERENTIATION	Previous evidence indicates that adiponectin possesses antifibrogenic activity in inhibiting liver fibrosis. Therapeutic strategies, however, are limited by adiponectin quaternary structure and effective concentrations in circulation. Here we postulate a novel molecular mechanism, whereby adiponectin targets focal adhesion kinase (FAK) activity and disrupts key features of the fibrogenic response. Adiponectin-null (Ad(-/-)) mice and wild-type littermates were exposed to either saline or carbon tetrachloride (CCl4) for 6 wk. CCl4-gavaged mice were also injected with attenuated adenoviral adiponectin (Ad-Adn) or Ad-LacZ for 2 wk. Hepatic stellate cells (HSCs) were treated with or without adiponectin to elucidate signal transduction mechanisms. In vivo delivery of Ad-Adn markedly attenuates CCl4-induced expression of key integrin proteins and markers of HSC activation: alpha v, beta 3, beta 1, alpha 2(I) collagen, and alpha-smooth muscle actin. Confocal experiments of liver tissues demonstrated that adiponectin delivery also suppressed vinculin and p-FAK activity in activated HSCs. In vitro, adiponectin induced dephosphorylation of FAK, mediated by a physical association with activated tyrosine phosphatase, Shp2. Conversely, Shp2 knockdown by siRNA significantly attenuated adiponectin-induced FAK deactivation, and expression of TIMP1 and alpha 2(I) collagen was abolished in the presence of adiponectin and si-FAK. Finally, we documented that either adiponectin or the synthetic peptide with adiponectin properties, ADP355, suppressed p-FAK in synthetic matrices with stiffness measurements of 9 and 15 kPa, assessed by immunofluorescent imaging and quantitation. The in vivo and in vitro data presented indicate that disassembly of focal adhesion complexes in HSCs is pivotal for hepatic fibrosis therapy, now that small adiponectin-like peptides are available.-Kumar, P., Smith, T., Rahman, K., Mells, J. E., Thorn, N. E., Saxena, N. K., Anania, F. A. Adiponectin modulates focal adhesion disassembly in activated hepatic stellate cells: implication for reversing hepatic fibrosis.	[Kumar, Pradeep; Smith, Tekla; Rahman, Khalidur; Mells, Jamie E.; Thorn, Natalie E.; Anania, Frank A.] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Saxena, Neeraj K.] Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA	Emory University; University System of Maryland; University of Maryland Baltimore	Anania, FA (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, 615 Michael St,Ste 201, Atlanta, GA 30322 USA.	fanania@emory.edu	Raeman, Reben/AAF-7282-2021	Raeman, Reben/0000-0002-3914-1797	U.S. Public Health Service [DK062092]; U.S. Department of Veterans Affairs [I01BX001746]; Emory University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062092, R01DK062092] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001746] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Emory University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Rebecca Wells and her laboratory staff (University of Pennsylvania, Philadelphia, PA, USA) for intellectual input with respect to experimental outcome and their assistance in helping with the glass coverslip experiments. This work was supported by grants from the U.S. Public Health Service (DK062092), the U.S. Department of Veterans Affairs (I01BX001746), and Emory University, all awarded to F.A.A.	Asada K, 2007, INT J MOL MED, V20, P725; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Christou GA, 2014, J ENDOCRINOL, V221, pR49, DOI 10.1530/JOE-13-0578; Dadson K, 2014, J CELL BIOCHEM, V115, P785, DOI 10.1002/jcb.24722; Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Ding XK, 2005, AM J PATHOL, V166, P1655, DOI 10.1016/S0002-9440(10)62476-5; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; FRIEDMAN SL, 1987, ANAL BIOCHEM, V161, P207, DOI 10.1016/0003-2697(87)90673-7; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Handy JA, 2011, BIOCHEM J, V440, P385, DOI 10.1042/BJ20102148; Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Huang YS, 2012, BRAIN DEV-JPN, V34, P674, DOI 10.1016/j.braindev.2011.10.011; Kitade M, 2006, HEPATOLOGY, V44, P983, DOI 10.1002/hep.21338; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Shuangwei, 2012, Front Med, V6, P275, DOI 10.1007/s11684-012-0216-4; Liu ML, 2012, J BIOL CHEM, V287, P26087, DOI 10.1074/jbc.M112.372292; Machado MV, 2014, MAYO CLIN PROC, V89, P120, DOI 10.1016/j.mayocp.2013.10.009; Mair M, 2011, FRONT BIOSCI-LANDMRK, V16, P2794, DOI 10.2741/3886; Nerstedt A, 2013, MOL CELL ENDOCRINOL, V375, P68, DOI 10.1016/j.mce.2013.05.013; Nigro E, 2013, INT J BIOCHEM CELL B, V45, P1145, DOI 10.1016/j.biocel.2013.03.003; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Otvos L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-90; Parsons CJ, 2004, HEPATOLOGY, V40, P1106, DOI 10.1002/hep.20425; Qamar A, 2006, DIGEST DIS SCI, V51, P1697, DOI 10.1007/s10620-006-9244-8; Rafiq K, 2006, J BIOL CHEM, V281, P19781, DOI 10.1074/jbc.M513040200; Rosenbloom J, 2013, BBA-MOL BASIS DIS, V1832, P1088, DOI 10.1016/j.bbadis.2012.12.007; Rovida E, 2008, J HEPATOL, V48, P107, DOI 10.1016/j.jhep.2007.08.010; Sam F, 2010, ENDOCRINOLOGY, V151, P322, DOI 10.1210/en.2009-0806; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Shen C, 2012, FRONT BIOSCI-LANDMRK, V17, P2356, DOI 10.2741/4057; Van Rossen E, 2009, HISTOCHEM CELL BIOL, V131, P313, DOI 10.1007/s00418-008-0544-2; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011	37	29	29	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5172	5183		10.1096/fj.14-253229	http://dx.doi.org/10.1096/fj.14-253229			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25154876	Green Published			2022-12-25	WOS:000345894500013
J	Suehiro, J; Kanki, Y; Makihara, C; Schadler, K; Miura, M; Manabe, Y; Aburatani, H; Kodama, T; Minami, T				Suehiro, Jun-ichi; Kanki, Yasuharu; Makihara, Chihiro; Schadler, Keri; Miura, Mai; Manabe, Yuuka; Aburatani, Hiroyuki; Kodama, Tatsuhiko; Minami, Takashi			Genome-wide Approaches Reveal Functional Vascular Endothelial Growth Factor (VEGF)-inducible Nuclear Factor of Activated T Cells (NFAT) c1 Binding to Angiogenesis-related Genes in the Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE-1 PROMOTER; SYNDROME CRITICAL REGION-1; CHEMOKINE RECEPTOR CXCR4; TUMOR-GROWTH; THROMBIN; CALCINEURIN; TRANSCRIPTION; EXPRESSION; PATHWAY; BREAST	VEGF is a key regulator of endothelial cell migration, proliferation, and inflammation, which leads to activation of several signaling cascades, including the calcineurin-nuclear factor of activated T cells (NFAT) pathway. NFAT is not only important for immune responses but also for cardiovascular development and the pathogenesis of Down syndrome. By using Down syndrome model mice and clinical patient samples, we showed recently that the VEGF-calcineurin-NFAT signaling axis regulates tumor angiogenesis and tumor metastasis. However, the connection between genome-wide views of NFAT-mediated gene regulation and downstream gene function in the endothelium has not been studied extensively. Here we performed comprehensive mapping of genome-wide NFATc1 binding in VEGF-stimulated primary cultured endothelial cells and elucidated the functional consequences of VEGF-NFATc1-mediated phenotypic changes. A comparison of the NFATc1 ChIP sequence profile and epigenetic histone marks revealed that predominant NFATc1-occupied peaks overlapped with promoter-associated histone marks. Moreover, we identified two novel NFATc1 regulated genes, CXCR7 and RND1. CXCR7 knockdown abrogated SDF-1- and VEGF-mediated cell migration and tube formation. siRNA treatment of RND1 impaired vascular barrier function, caused RhoA hyperactivation, and further stimulated VEGF-mediated vascular outgrowth from aortic rings. Taken together, these findings suggest that dynamic NFATc1 binding to target genes is critical for VEGF-mediated endothelial cell activation. CXCR7 and RND1 are NFATc1 target genes with multiple functions, including regulation of cell migration, tube formation, and barrier formation in endothelial cells.	[Suehiro, Jun-ichi; Kanki, Yasuharu; Makihara, Chihiro; Schadler, Keri; Miura, Mai; Manabe, Yuuka; Minami, Takashi] Univ Tokyo, Res Ctr Adv Sci & Technol, Div Vasc Biol, Tokyo 1538904, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo 1538904, Japan; [Kanki, Yasuharu; Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan; [Schadler, Keri] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Tokyo; University of Tokyo; University of Tokyo; University of Pennsylvania; Pennsylvania Medicine	Minami, T (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Div Vasc Biol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	minami@med.rcast.u-tokyo.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology in Japan; MEXT in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Leading-edge Research Promotion Fund from the Japan Society for the Promotion of Science (to T. M.) and by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (to T. M.). This work was also supported by a project for developing innovation systems of MEXT in Japan (to T. M.).	Amerongen GPV, 2009, AM J PHYSIOL-HEART C, V296, pH903, DOI 10.1152/ajpheart.00125.2009; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Ghosh K, 2008, P NATL ACAD SCI USA, V105, P11305, DOI 10.1073/pnas.0800835105; Hadri L, 2006, BIOCHEM J, V394, P27, DOI 10.1042/BJ20051387; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Lee BC, 2004, MOL CANCER RES, V2, P327; Luo C, 2006, J BIOL CHEM, V281, P30081, DOI 10.1074/jbc.M605837200; Markowetz F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001034; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Minami T, 2014, J BIOCHEM, V155, P217, DOI 10.1093/jb/mvu006; Minami T, 2006, J BIOL CHEM, V281, P20503, DOI 10.1074/jbc.M513112200; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Oinuma I, 2012, MOL BIOL CELL, V23, P1593, DOI 10.1091/mbc.E11-11-0900; Phoon CKL, 2004, CIRC RES, V95, P92, DOI 10.1161/01.RES.0000133681.99617.28; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Song HH, 2009, J BIOL CHEM, V284, P29109, DOI 10.1074/jbc.M109.041145; Suehiro J, 2010, BLOOD, V115, P2520, DOI 10.1182/blood-2009-07-233478; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tozawa H, 2011, MOL CELL BIOL, V31, P2196, DOI 10.1128/MCB.01430-10; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911	32	50	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29044	29059		10.1074/jbc.M114.555235	http://dx.doi.org/10.1074/jbc.M114.555235			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25157100	hybrid, Green Published			2022-12-25	WOS:000344141000023
J	Otero, JH; Lizak, B; Feige, MJ; Hendershot, LM				Otero, Joel H.; Lizak, Beata; Feige, Matthias J.; Hendershot, Linda M.			Dissection of Structural and Functional Requirements That Underlie the Interaction of ERdj3 Protein with Substrates in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton Heat Shock Protein (Hsp70); Chaperone DnaJ (DnaJ); Chaperone DnaK (DnaK); Endoplasmic Reticulum (ER); Endoplasmic Reticulum-associated Protein Degradation (ERAD); Protein Folding	ESCHERICHIA-COLI DNAJ; PEPTIDE-BINDING FRAGMENT; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; YEAST HSP40; HSP70 CHAPERONES; PLASMODIUM-FALCIPARUM; UNFOLDED PROTEINS; COCHAPERONE DNAJ	Background: ERdj3 is a dimeric type I DnaJ co-chaperone for BiP, the ER Hsp70. Results: Mutational analyses revealed the requirements for ERdj3 substrate binding and release in cells. Conclusion: ERdj3 does not rebind substrates after release, which is linked to substrate half-life. Significance: This study provides mechanistic insights into how ERdj3 aids BiP in deciding the fate of nascent ER proteins. ERdj3, a mammalian endoplasmic reticulum (ER) Hsp40/DnaJ family member, binds unfolded proteins, transfers them to BiP, and concomitantly stimulates BiP ATPase activity. However, the requirements for ERdj3 binding to and release from substrates in cells are not well understood. We found that ERdj3 homodimers that cannot stimulate the ATPase activity of BiP (QPD mutants) bound to unfolded ER proteins under steady state conditions in much greater amounts than wild-type ERdj3. This was due to reduced release from these substrates as opposed to enhanced binding, although in both cases dimerization was strictly required for substrate binding. Conversely, heterodimers consisting of one wild-type and one mutant ERdj3 subunit bound substrates at levels comparable with wild-type ERdj3 homodimers, demonstrating that release requires only one protomer to be functional in stimulating BiP ATPase activity. Co-expressing wild-type ERdj3 and a QPD mutant, which each exclusively formed homodimers, revealed that the release rate of wild-type ERdj3 varied according to the relative half-lives of substrates, suggesting that ERdj3 release is an important step in degradation of unfolded client proteins in the ER. Furthermore, pulse-chase experiments revealed that the binding of QPD mutant homodimers remained constant as opposed to increasing, suggesting that ERdj3 does not normally undergo reiterative binding cycles with substrates.	[Otero, Joel H.; Lizak, Beata; Feige, Matthias J.; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Hendershot, LM (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Feige, Matthias/0000-0001-5435-4312	National Institutes of Health [R01 GM54068]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; Leopoldina - National Academy of Sciences [LPDS 2009-32]; St. Jude Children's Research Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Leopoldina - National Academy of Sciences; St. Jude Children's Research Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM54068 (to L. M. H.) and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital.; Funded by the Leopoldina - National Academy of Sciences, Grant LPDS 2009-32, and by the Paul-Barrett endowed fellowship of St. Jude Children's Research Hospital.	Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Barends TRM, 2013, ACTA CRYSTALLOGR D, V69, P1540, DOI 10.1107/S0907444913010640; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Cuellar J, 2013, J BIOL CHEM, V288, P15065, DOI 10.1074/jbc.M112.430595; CYR DM, 1992, J BIOL CHEM, V267, P20927; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; GAUT JR, 1993, J BIOL CHEM, V268, P7248; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li JZ, 2006, BIOCHEM J, V398, P353, DOI 10.1042/BJ20060618; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Marcinowski M, 2013, J MOL BIOL, V425, P466, DOI 10.1016/j.jmb.2012.11.030; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Marcus NY, 2007, ARCH BIOCHEM BIOPHYS, V468, P147, DOI 10.1016/j.abb.2007.10.001; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Michels AA, 1999, J BIOL CHEM, V274, P36757, DOI 10.1074/jbc.274.51.36757; Morahan BJ, 2011, EUKARYOT CELL, V10, P1492, DOI 10.1128/EC.05155-11; Nollen EAA, 2000, MOL CELL BIOL, V20, P1083, DOI 10.1128/MCB.20.3.1083-1088.2000; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Qian XG, 2002, BIOCHEM J, V361, P27, DOI 10.1042/0264-6021:3610027; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vanhove M, 2001, IMMUNITY, V15, P105, DOI 10.1016/S1074-7613(01)00163-7; Vembar SS, 2009, J BIOL CHEM, V284, P32462, DOI 10.1074/jbc.M109.000729; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200	50	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27504	27512		10.1074/jbc.M114.587147	http://dx.doi.org/10.1074/jbc.M114.587147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143379	hybrid, Green Published			2022-12-25	WOS:000342852800013
J	Choi, H; Chakraborty, S; Liu, RH; Gellman, SH; Weisshaar, JC				Choi, Heejun; Chakraborty, Saswata; Liu, Runhui; Gellman, Samuel H.; Weisshaar, James C.			Medium Effects on Minimum Inhibitory Concentrations of Nylon-3 Polymers against E-coli	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE ACTION; REAL-TIME ATTACK; ANTIBACTERIAL; MECHANISMS; COPOLYMERS; DESIGN; MIMICS	Minimum inhibitory concentrations (MICs) against E. coli were measured for three nylon-3 polymers using Luria-Bertani broth (LB), brain-heart infusion broth (BHI), and a chemically defined complete medium (EZRDM). The polymers differ in the ratio of hydrophobic to cationic subunits. The cationic homopolymer is inert against E. coli in BHI and LB, but becomes highly potent in EZRDM. A mixed hydrophobic/cationic polymer with a hydrophobic t-butylbenzoyl group at its N-terminus is effective in BHI, but becomes more effective in EZRDM. Supplementation of EZRDM with the tryptic digest of casein (often found in LB) recapitulates the LB and BHI behavior. Additional evidence suggests that polyanionic peptides present in LB and BHI may form electrostatic complexes with cationic polymers, decreasing activity by diminishing binding to the anionic lipopolysaccharide layer of E. coli. In contrast, two natural antimicrobial peptides show no medium effects. Thus, the use of a chemically defined medium helps to reveal factors that influence antimicrobial potency of cationic polymers and functional differences between these polymers and evolved antimicrobial peptides.	[Choi, Heejun; Chakraborty, Saswata; Liu, Runhui; Gellman, Samuel H.; Weisshaar, James C.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Gellman, Samuel H.; Weisshaar, James C.] Univ Wisconsin, Mol Biophys Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gellman, SH (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	gellman@chem.wisc.edu; weisshaar@chem.wisc.edu		Choi, Heejun/0000-0002-1337-3813	National Institute of General Medical Sciences of the National Institutes of Health [R01GM094510, R01GM093265]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094510, R01GM093265] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health, Grant # R01GM094510 (JCW as PI) and R01GM093265 (JCW and SHG as co-PIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BC, 2007, BIOMACROMOLECULES, V8, P2995, DOI 10.1021/bm7004627; Bakshi S, 2011, BIOPHYS J, V101, P2535, DOI 10.1016/j.bpj.2011.10.013; Barns KJ, 2013, BBA-BIOMEMBRANES, V1828, P1511, DOI 10.1016/j.bbamem.2013.02.011; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bryan L., 1984, ANTIMICROBIAL DRUG R; Chakraborty S, 2013, ACS MACRO LETT, V2, P753, DOI 10.1021/mz400239r; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Godballe T, 2011, CHEM BIOL DRUG DES, V77, P107, DOI 10.1111/j.1747-0285.2010.01067.x; Goodson B, 1999, ANTIMICROB AGENTS CH, V43, P1429, DOI 10.1128/AAC.43.6.1429; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hiraki J, 2003, REGUL TOXICOL PHARM, V37, P328, DOI 10.1016/S0273-2300(03)00029-1; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; Kuroda K, 2013, WIRES NANOMED NANOBI, V5, P49, DOI 10.1002/wnan.1199; Lewenza S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00021; Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004; Mowery BP, 2009, J AM CHEM SOC, V131, P9735, DOI 10.1021/ja901613g; Munk JK, 2013, J PEPT SCI, V19, P669, DOI 10.1002/psc.2548; Patch JA, 2003, J AM CHEM SOC, V125, P12092, DOI 10.1021/ja037320d; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Rangarajan N, 2013, BIOCHEMISTRY-US, V52, P6584, DOI 10.1021/bi400785j; Sambhy V, 2008, ANGEW CHEM INT EDIT, V47, P1250, DOI 10.1002/anie.200702287; Schwab U, 1999, ANTIMICROB AGENTS CH, V43, P1435, DOI 10.1128/AAC.43.6.1435; Sellenet PH, 2007, BIOMACROMOLECULES, V8, P19, DOI 10.1021/bm0605513; SHIMA S, 1984, J ANTIBIOT, V37, P1449, DOI 10.7164/antibiotics.37.1449; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; Takahashi H, 2013, MACROMOL BIOSCI, V13, P1285, DOI 10.1002/mabi.201300126; Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wesolowski D, 2013, P NATL ACAD SCI USA, V110, P8686, DOI 10.1073/pnas.1306911110; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306; Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao X., 2013, PLOS ONE, V8	38	31	31	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104500	10.1371/journal.pone.0104500	http://dx.doi.org/10.1371/journal.pone.0104500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153714	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200020
J	Latini, A; Tomellini, M; Lazzarini, L; Bertoni, G; Gazzoli, D; Bossa, L; Gozzi, D				Latini, Alessandro; Tomellini, Massimo; Lazzarini, Laura; Bertoni, Giovanni; Gazzoli, Delia; Bossa, Luigi; Gozzi, Daniele			High Temperature Stability of Onion-Like Carbon vs Highly Oriented Pyrolytic Graphite	PLOS ONE			English	Article							TRANSFORMATIONS; THERMODYNAMICS	The thermodynamic stability of onion-like carbon (OLC) nanostructures with respect to highly oriented pyrolytic graphite (HOPG) was determined in the interval 765-1030 K by the electromotive force (emf) measurements of solid electrolyte galvanic cell: (Low) Pt|Cr3C2,CrF2,OLC|CaF(2)s.c.|Cr3C2,CrF2,HOPG|Pt (High). The free energy change of transformation HOPG = OLC was found positive below 920.6 K crossing the zero value at this temperature. Its trend with temperature was well described by a 3rd degree polynomial. The unexpected too high values of (partial derivative Delta H-r(T)/partial derivative T)(P) = Delta C-p(T) jointly to the HR-TEM, STEM and EELS evidences that showed OLC completely embedded in rigid cages made of a Cr3C2/CrF2 matrix, suggested that carbon in the electrodes experienced different internal pressures. This was confirmed by the evaluation under constant volume of dP/dT by the alpha/kappa ratio for OLC (0.5 MPa K-1) and HOPG (8 Pa K-1) where alpha and kappa are the isobaric thermal expansion and isothermal compressibility coefficients, respectively. The temperature dependency of the pressure was derived and utilized to calculate the enthalpy and entropy changes as function of temperature and pressure. The highest value of the internal pressure experienced by OLC was calculated to be about 7 GPa at the highest temperature. At 920.6 K, Delta H-r and Delta S-r values are 95.8 kJ mol(-1) and 104.1 JK(-1) mol(-1), respectively. The surface contributions to the energetic of the system were evaluated and they were found negligible compared with the bulk terms. As a consequence of the high internal pressure, the values of the enthalpy and entropy changes were mainly attributed to the formation of carbon defects in OLC considered as multishell fullerenes. The change of the carbon defect fraction is reported as a function of temperature.	[Latini, Alessandro; Gazzoli, Delia; Bossa, Luigi; Gozzi, Daniele] Univ Roma La Sapienza, Dipartimento Chim, I-00185 Rome, Italy; [Tomellini, Massimo] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Rome, Italy; [Lazzarini, Laura; Bertoni, Giovanni] CNR, IMEM, I-43100 Parma, Italy	Sapienza University Rome; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Materiali per l'Elettronica ed il Magnetismo (IMEM-CNR)	Gozzi, D (corresponding author), Univ Roma La Sapienza, Dipartimento Chim, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	daniele.gozzi@uniroma1.it	Gazzoli, Delia/AAX-7403-2020; Gozzi, Daniele/M-6356-2014; lazzarini, Laura/AAE-7796-2021; Bertoni, Giovanni/J-4710-2012; lazzarini, laura/B-7009-2015	Gazzoli, Delia/0000-0001-9850-1855; Gozzi, Daniele/0000-0002-4190-2022; Bertoni, Giovanni/0000-0001-6424-9102; lazzarini, laura/0000-0001-5346-4026; Latini, Alessandro/0000-0002-3205-4826	PRIN Project [2009N4BJ4J]; "Acquisizione di medie e grandi attrezzature scientifiche" Universita di Roma La Sapienza [C26G10KKK5]	PRIN Project(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); "Acquisizione di medie e grandi attrezzature scientifiche" Universita di Roma La Sapienza	This work was partially financed through the PRIN 2009 Project no. 2009N4BJ4J and "Acquisizione di medie e grandi attrezzature scientifiche 2010" Universita di Roma La Sapienza, no. C26G10KKK5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GLUSHKO THERMOCENTER; Banhart F, 1997, CHEM PHYS LETT, V269, P349, DOI 10.1016/S0009-2614(97)00269-8; Banhart F, 1996, NATURE, V382, P433, DOI 10.1038/382433a0; Barnard AS, 2006, DIAM RELAT MATER, V15, P285, DOI 10.1016/j.diamond.2005.05.007; BERNHOLC J, 1994, COMP MATER SCI, V2, P547, DOI 10.1016/0927-0256(94)90086-8; Chao J, 2008, APPL PHYS LETT, V92; Colonna F, 2011, CARBON, V49, P364, DOI 10.1016/j.carbon.2010.09.029; Dubitsky GA, 2011, RUSS CHEM B+, V60, P413, DOI 10.1007/s11172-011-0065-3; Girifalco LA, 2000, PHYS REV B, V62, P13104, DOI 10.1103/PhysRevB.62.13104; GIRIFALCO LA, 1995, PHYS REV B, V52, P9910, DOI 10.1103/PhysRevB.52.9910; Gozzi D, 2007, J AM CHEM SOC, V129, P10269, DOI 10.1021/ja072120d; Gozzi D, 2009, J AM CHEM SOC, V131, P12474, DOI 10.1021/ja904294z; Gozzi D, 2009, J PHYS CHEM C, V113, P45, DOI 10.1021/jp806102f; Jiang Q, 2006, CARBON, V44, P79, DOI 10.1016/j.carbon.2005.07.014; Klotz IM, 2008, CHEM THERMODYN, P200; KUZNETSOV VL, 1995, MATER RES SOC SYMP P, V359, P105, DOI 10.1557/PROC-359-105; Latini A, 2011, J PHYS CHEM C, V115, P11023, DOI 10.1021/jp203149v; Lee RKF, 2012, J MATH CHEM, V50, P1289, DOI 10.1007/s10910-011-9970-9; Mutaftschiev B., 2001, ATOMISTIC NATURE CRY; Sano N, 2002, J APPL PHYS, V92, P2783, DOI 10.1063/1.1498884; Scabarozi TH, 2009, J APPL PHYS, V105, DOI 10.1063/1.3021465; Shenderova OA, 2002, CRIT REV SOLID STATE, V27, P227, DOI 10.1080/10408430208500497; SHUTTLEWORTH R, 1950, P PHYS SOC LOND A, V63, P444, DOI 10.1088/0370-1298/63/5/302; Sun L, 2006, APPL PHYS LETT, V88; Tang AC, 1995, PHYS REV B, V52, P17435, DOI 10.1103/PhysRevB.52.17435; TOMANEK D, 1993, PHYS REV B, V48, P15461, DOI 10.1103/PhysRevB.48.15461; Welz S, 2006, J MATER PROCESS TECH, V179, P11, DOI 10.1016/j.jmatprotec.2006.03.103; Zaiser M, 1997, PHYS REV LETT, V79, P3680, DOI 10.1103/PhysRevLett.79.3680	28	6	7	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105788	10.1371/journal.pone.0105788	http://dx.doi.org/10.1371/journal.pone.0105788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153181	Green Submitted, gold, Green Published			2022-12-25	WOS:000340952200081
J	Li, SG; Hu, T; Beran, MA; Li, S				Li, Shengai; Hu, Tracy; Beran, Maria A.; Li, Sheng			Habituation to Experimentally Induced Electrical Pain during Voluntary-Breathing Controlled Electrical Stimulation (BreEStim)	PLOS ONE			English	Article							SPINAL-CORD-INJURY; PRIMARY SOMATOSENSORY CORTEX; CEREBRAL-BLOOD-FLOW; CINGULATE CORTEX; VOLITIONAL INSPIRATION; PERIAQUEDUCTAL GRAY; NERVE-STIMULATION; BRAIN ACTIVATION; FUNCTIONAL MRI; INSULAR CORTEX	Objective: Painful peripheral electrical stimulation to acupuncture points was found to cause sensitization if delivered randomly (EStim), but induced habituation if triggered by voluntary breathing (BreEStim). The objective was to systematically compare the effectiveness of BreEStim and EStim and to investigate the possible mechanisms mediating the habituation effect of BreEStim. Methods: Eleven pain-free, healthy subjects (6 males, 5 females) participated in the study. Each subject received the BreEStim and EStim treatments in a random order at least three days apart. Both treatments consisted of 120 painful but tolerable stimuli to the ulnar nerve at the elbow on the dominant arm. BreEStim was triggered by voluntary breathing while EStim was delivered randomly. Electrical sensation threshold (EST) and electrical pain threshold (EPT) were measured from the thenar and hypothenar eminences on both hands at pre-intervention and 10-minutes post-intervention. Results: There was no difference in the pre-intervention baseline measurement of EST and EPT between BreEStim and EStim. BreEStim increased EPT in all tested sites on both hands, while EStim increased EPT in the dominant hypothenar eminence distal to the stimulating site and had no effect on EPT in other sites. There was no difference in the intensity of electrical stimulation between EStim and BreEStim. Conclusion: Our findings support the important role human voluntary breathing plays in the systemic habituation effect of BreEStim to peripheral painful electrical stimulation.	[Li, Shengai; Hu, Tracy; Beran, Maria A.; Li, Sheng] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Li, Shengai; Hu, Tracy; Beran, Maria A.; Li, Sheng] TIRR Mem Hermann Res Ctr, Neurorehabil Res Lab, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Li, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	sheng.li@uth.tmc.edu	Li, Sheng/ABC-5392-2021		NIH grant [NIH/NINDS R01NS060774]; Mission Connect, a program of TIRR Foundation [013-109]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060774] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mission Connect, a program of TIRR Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by an NIH grant (NIH/NINDS R01NS060774) and a research grant (013-109) from Mission Connect, a program of TIRR Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggio PS, 2008, EUR J NEUROL, V15, P1124, DOI 10.1111/j.1468-1331.2008.02270.x; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; Budh CN, 2005, SPINAL CORD, V43, P85, DOI 10.1038/sj.sc.3101680; Budh CN, 2004, COMPLEMENT THER MED, V12, P189, DOI 10.1016/j.ctim.2004.10.003; COLEBATCH JG, 1991, J PHYSIOL-LONDON, V443, P91, DOI 10.1113/jphysiol.1991.sp018824; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; Evans KC, 2009, NEUROIMAGE, V47, P961, DOI 10.1016/j.neuroimage.2009.05.025; Evans KC, 1999, J PHYSIOL-LONDON, V520, P383, DOI 10.1111/j.1469-7793.1999.00383.x; Fink GR, 1995, J PHYSIOL-LONDON, V489, P663, DOI 10.1113/jphysiol.1995.sp021081; Finnerup NB, 2001, PAIN CLIN UPDATES, V9, P1; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Freund W, 2011, CLIN J PAIN, V27, P796, DOI 10.1097/AJP.0b013e31821d9063; Gaytan SP, 1998, BRAIN RES BULL, V47, P625, DOI 10.1016/S0361-9230(98)00125-7; Green AL, 2007, J PHYSIOL-LONDON, V578, P605, DOI 10.1113/jphysiol.2006.122549; Guz A, 1997, RESP PHYSIOL, V109, P197, DOI 10.1016/S0034-5687(97)00050-9; Hahn A, 2013, NEUROIMAGE, V82, P336, DOI 10.1016/j.neuroimage.2013.06.010; Hanamori T, 1998, BRAIN RES, V785, P97, DOI 10.1016/S0006-8993(97)01392-9; Haouzi P, 2006, RESP PHYSIOL NEUROBI, V152, P169, DOI 10.1016/j.resp.2005.08.004; Ikeda ER, 2009, J STRENGTH COND RES, V23, P127, DOI 10.1519/JSC.0b013e31818eb256; Jensen MP, 2007, NEUROLOGY, V68, P1178, DOI 10.1212/01.wnl.0000259085.61898.9e; Kastrup A, 2008, NEUROIMAGE, V41, P1364, DOI 10.1016/j.neuroimage.2008.03.049; Kotze A, 2008, ANAEST INTENS CARE M, V9, P29, DOI 10.1016/j.mpaic.2007.10.008; LaBuda CJ, 2005, NEUROSCIENCE, V136, P311, DOI 10.1016/j.neuroscience.2005.07.010; LaGraize SC, 2006, EXP NEUROL, V197, P22, DOI 10.1016/j.expneurol.2005.05.008; Li S, 2007, NEUROSCI LETT, V412, P243, DOI 10.1016/j.neulet.2006.11.013; Li S, 2006, MUSCLE NERVE, V34, P651, DOI 10.1002/mus.20592; Li S, 2013, JOVE-J VIS EXP, DOI 10.3791/50077; Li S, 2012, MOTOR CONTROL, V16, P493, DOI 10.1123/mcj.16.4.493; Li Sheng, 2012, J Pain Res, V5, P71, DOI 10.2147/JPR.S31036; Li S, 2011, J NEUROPHYSIOL, V105, P512, DOI 10.1152/jn.00946.2010; Li SG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070282, 10.1371/journal.pone.0070461]; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Macey KE, 2004, J APPL PHYSIOL, V97, P1897, DOI 10.1152/japplphysiol.00359.2004; Macey PM, 2003, RESP PHYSIOL NEUROBI, V138, P275, DOI 10.1016/j.resp.2003.09.002; MASKILL D, 1991, J PHYSIOL-LONDON, V443, P105, DOI 10.1113/jphysiol.1991.sp018825; Mazzone SB, 2007, AM J RESP CRIT CARE, V176, P327, DOI 10.1164/rccm.200612-1856OC; Murphy D, 2001, SPINAL CORD, V39, P44, DOI 10.1038/sj.sc.3101094; Nickel FT, 2014, EUR J PAIN, V18, P56, DOI 10.1002/j.1532-2149.2013.00339.x; Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011; Plow EB, 2012, J PAIN, V13, P411, DOI 10.1016/j.jpain.2012.02.001; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; RAMSAY SC, 1993, J PHYSIOL-LONDON, V461, P85, DOI 10.1113/jphysiol.1993.sp019503; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; Sluka KA, 2003, J PAIN, V4, P109, DOI 10.1054/jpai.2003.434; Smejkal V, 1999, PHYSIOL RES, V48, P21; Smejkal V, 2000, PHYSIOL RES, V49, P659; Stehberg J, 2009, EUR J NEUROSCI, V29, P964, DOI 10.1111/j.1460-9568.2009.06634.x; Stormer S, 1997, SPINAL CORD, V35, P446, DOI 10.1038/sj.sc.3100411; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; von Leupoidt A, 2009, AM J RESP CRIT CARE, V180, P232, DOI 10.1164/rccm.200902-0300OC; Zautra AJ, 2010, PAIN, V149, P12, DOI 10.1016/j.pain.2009.10.001; Zeidan F, 2011, J NEUROSCI, V31, P5540, DOI 10.1523/JNEUROSCI.5791-10.2011	53	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104729	10.1371/journal.pone.0104729	http://dx.doi.org/10.1371/journal.pone.0104729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153077	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200023
J	Zhang, HW; Gao, L; Zhang, JL; Li, WH; Yang, M; Zhang, H; Gao, CH; He, ZG				Zhang, Haiwei; Gao, Long; Zhang, Jiaoling; Li, Weihui; Yang, Min; Zhang, Hua; Gao, Chunhui; He, Zheng-Guo			A Novel marRAB Operon Contributes to the Rifampicin Resistance in Mycobacterium smegmatis	PLOS ONE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; DRUG-RESISTANCE; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; REGULATOR; REPRESSOR; EFFLUX; TUBERCULOSIS; EXPRESSION	The multiple-antibiotic resistance regulator (MarR) plays an important role in modulating bacterial antibiotic resistance. However, the regulatory model of the marRAB operon in mycobacteria remains to be characterized. Here we report that a MarR, encoded by Ms6508, and its marRAB operon specifically contribute to rifampicin (RIF) resistance in Mycobacterium smegmatis. We show that the MarR recognizes a conserved 21-bp palindromic motif and negatively regulates the expression of two ABC transporters in the operon, encoded by Ms6509-6510. Unlike other known drug efflux pumps, overexpression of these two ABC transporters unexpectedly increased RIF sensitivity and deletion of these two genes increased mycobacterial resistance to the antibiotic. No change can be detected for the sensitivity of recombinant mycobacterial strains to three other anti-TB drugs. Furthermore, HPLC experiments suggested that Ms6509-Ms6510 could pump RIF into the mycobacterial cells. These findings indicated that the mycobacterial MarR functions as a repressor and constitutively inhibits the expression of the marRAB operon, which specifically contributes to RIF resistance in M. smegmatis. Therefore, our data suggest a new regulatory mechanism of RIF resistance and also provide the new insight into the regulatory model of a marRAB operon in mycobacteria.	[Zhang, Haiwei; Gao, Long; Zhang, Jiaoling; Li, Weihui; Yang, Min; Zhang, Hua; Gao, Chunhui; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014; Gao, Chun-Hui/B-3667-2016; Gao, Chun-Hui/B-4111-2008	Gao, Chun-Hui/0000-0002-1445-7939; Gao, Chun-Hui/0000-0002-1445-7939; Yang, Min/0000-0003-2924-5717	973 Program [2012CB518800]; National Natural Science Foundation of China [31025002, 31121004]; Hubei Chutian Scholar Program; Chang Jiang Scholars Program	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Chutian Scholar Program; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by 973 Program (2012CB518800), the National Natural Science Foundation of China (31025002 and 31121004), Hubei Chutian Scholar Program and Chang Jiang Scholars Program (to Z-G He). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Li XZ, 1999, CAN J MICROBIOL, V45, P18, DOI 10.1139/cjm-45-1-18; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Nikaido H, 2001, SEMIN CELL DEV BIOL, V12, P215, DOI 10.1006/scdb.2000.0247; Panchagnula R, 1999, J PHARMACEUT BIOMED, V18, P1013, DOI 10.1016/S0731-7085(98)00112-5; Quan SW, 1997, ANTIMICROB AGENTS CH, V41, P2456, DOI 10.1128/AAC.41.11.2456; Radhakrishnan A, 2014, J BIOL CHEM, V289, P16526, DOI 10.1074/jbc.M113.538959; Rodrigues L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-35; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; SEOANE AS, 1995, J BACTERIOL, V177, P3414, DOI 10.1128/jb.177.12.3414-3419.1995; Srikumar R, 2000, J BACTERIOL, V182, P1410, DOI 10.1128/JB.182.5.1410-1414.2000; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672	30	7	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106016	10.1371/journal.pone.0106016	http://dx.doi.org/10.1371/journal.pone.0106016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153492	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200106
J	Decaro, N; Martella, V; Desario, C; Lanave, G; Circella, E; Cavalli, A; Elia, G; Camero, M; Buonavoglia, C				Decaro, Nicola; Martella, Vito; Desario, Costantina; Lanave, Gianvito; Circella, Elena; Cavalli, Alessandra; Elia, Gabriella; Camero, Michele; Buonavoglia, Canio			Genomic Characterization of a Circovirus Associated with Fatal Hemorrhagic Enteritis in Dog, Italy	PLOS ONE			English	Article							CANINE PARVOVIRUS TYPE-2; TIME PCR ASSAY; PORCINE CIRCOVIRUS; DIARRHEIC DOGS; QUANTITATION; SEQUENCE; VIRUS; FECES; RNA; KOBUVIRUSES	Dog circovirus (DogCV) was identified in an outbreak of enteritis in pups in Italy. The disease was observed in 6 young dachshunds pups of a litter from a breeding kennel and caused the death of 2 dogs. Upon full-genome analysis, the virus detected in one of the dead pups (strain Bari/411-13) was closely related to DogCVs that have been recently isolated in the USA. The present study, if corroborated by further reports, could represent a useful contribution to the knowledge of the pathogenic potential of DogCV and its association with enteritis in dogs.	[Decaro, Nicola; Martella, Vito; Desario, Costantina; Lanave, Gianvito; Circella, Elena; Cavalli, Alessandra; Elia, Gabriella; Camero, Michele; Buonavoglia, Canio] Univ Bari, Dept Vet Med, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Decaro, N (corresponding author), Univ Bari, Dept Vet Med, Bari, Italy.	nicola.decaro@uniba.it	Decaro, Nicola/K-2560-2018; Decaro, Nicola/AAB-8820-2019; Martella, Vito/K-3146-2016; Lanave, Gianvito/J-2375-2018; Decaro, Nicola/ABB-1426-2021; Elia, Gabriella/K-5286-2018	Decaro, Nicola/0000-0001-6348-7969; Martella, Vito/0000-0002-5740-6947; Lanave, Gianvito/0000-0003-4614-677X; Elia, Gabriella/0000-0001-7469-2175; Camero, Michele/0000-0003-0026-8325	Italian Ministry of Health, Ricerca corrente [IZS VE 21/09 RC]	Italian Ministry of Health, Ricerca corrente(Ministry of Health, Italy)	This work was supported by grants from the Italian Ministry of Health, Ricerca corrente 2009, project IZS VE 21/09 RC "Definizione di una procedura validata per la selezione di cani per programmi di Interventi Assistiti dagli Animali (IAA)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINN L N, 1970, Infection and Immunity, V1, P503; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Decaro N, 2005, J VIROL METHODS, V130, P72, DOI 10.1016/j.jviromet.2005.06.005; Decaro N, 2005, VET MICROBIOL, V105, P19, DOI 10.1016/j.vetmic.2004.09.018; Decaro N, 2004, J VIROL METHODS, V119, P145, DOI 10.1016/j.jviromet.2004.03.012; Decaro N, 2002, MICROBIOLOGICA, V25, P291; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; Decaro N, 2008, VET CLIN N AM-SMALL, V38, P799, DOI 10.1016/j.cvsm.2008.02.006; Decaro N, 2006, J VIROL METHODS, V133, P92, DOI 10.1016/j.jviromet.2005.10.026; Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007; Decaro N, 2010, J VIROL METHODS, V169, P176, DOI 10.1016/j.jviromet.2010.07.021; Di Martino B, 2013, VET MICROBIOL, V166, P246, DOI 10.1016/j.vetmic.2013.05.007; Elia G, 2006, J VIROL METHODS, V136, P171, DOI 10.1016/j.jviromet.2006.05.004; EUGSTER AK, 1979, VET MED SM ANIM CLIN, V74, P817; Gouvea V, 1999, J CLIN MICROBIOL, V32, P1338; Hu RL, 2001, VET RES COMMUN, V25, P77, DOI 10.1023/A:1006417203856; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; Kapoor A, 2012, J VIROL, V86, P7018, DOI 10.1128/JVI.00791-12; KOKUBU T, 1993, J VET MED SCI, V55, P453, DOI 10.1292/jvms.55.453; Leary TP, 2002, J CLIN MICROBIOL, V40, P1368, DOI 10.1128/JCM.40.4.1368-1375.2002; Li LL, 2013, EMERG INFECT DIS, V19, P534, DOI 10.3201/eid1904.121390; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Martella V, 2012, J CLIN MICROBIOL, V50, P1066, DOI 10.1128/JCM.05018-11; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Martella V, 2008, VET CLIN N AM-SMALL, V38, P787, DOI 10.1016/j.cvsm.2008.02.007; MOCHIZUKI M, 1993, VET REC, V132, P221, DOI 10.1136/vr.132.9.221; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Reuter G, 2009, ARCH VIROL, V154, P101, DOI 10.1007/s00705-008-0288-2; Segales J, 2013, VET MICROBIOL, V165, P13, DOI 10.1016/j.vetmic.2012.12.033; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TISCHER I, 1987, ARCH VIROL, V96, P39, DOI 10.1007/BF01310989; van den Brand JMA, 2012, J VIROL, V86, P2360, DOI 10.1128/JVI.06373-11	34	62	70	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105909	10.1371/journal.pone.0105909	http://dx.doi.org/10.1371/journal.pone.0105909			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147946	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600096
J	Fang, M; Fu, WX; Jiang, D; Zhang, Q; Sun, DX; Ding, XD; Liu, JF				Fang, Ming; Fu, Weixuan; Jiang, Dan; Zhang, Qin; Sun, Dongxiao; Ding, Xiangdong; Liu, Jianfeng			A Multiple-SNP Approach for Genome-Wide Association Study of Milk Production Traits in Chinese Holstein Cattle	PLOS ONE			English	Article							BAYESIAN LASSO; ALGORITHM; PREDICTION; REGRESSION	The multiple-SNP analysis has been studied by many researchers, in which the effects of multiple SNPs are simultaneously estimated and tested in a multiple linear regression. The multiple-SNP association analysis usually has higher power and lower false-positive rate for detecting causative SNP(s) than single marker analysis (SMA). Several methods have been proposed to simultaneously estimate and test multiple SNP effects. In this research, a fast method called MEML (Mixed model based Expectation-Maximization Lasso algorithm) was developed for simultaneously estimate of multiple SNP effects. An improved Lasso prior was assigned to SNP effects which were estimated by searching the maximum joint posterior mode. The residual polygenic effect was included in the model to absorb many tiny SNP effects, which is treated as missing data in our EM algorithm. A series of simulation experiments were conducted to validate the proposed method, and the results showed that compared with SMMA, the new method can dramatically decrease the false-positive rate. The new method was also applied to the 50k SNP-panel dataset for genome-wide association study of milk production traits in Chinese Holstein cattle. Totally, 39 significant SNPs and their nearby 25 genes were found. The number of significant SNPs is remarkably fewer than that by SMMA which found 105 significant SNPs. Among 39 significant SNPs, 8 were also found by SMMA and several well-known QTLs or genes were confirmed again; furthermore, we also got some positional candidate gene with potential function of effecting milk production traits. These novel findings in our research should be valuable for further investigation.	[Fang, Ming; Fu, Weixuan; Zhang, Qin; Sun, Dongxiao; Ding, Xiangdong; Liu, Jianfeng] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Beijing 100094, Peoples R China; [Fang, Ming; Jiang, Dan] Heilongjiang Bayi Agr Univ, Life Sci Coll, Daqing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Heilongjiang Bayi Agricultural University	Fang, M (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Beijing 100094, Peoples R China.	fangming618@126.com; qzhang@cau.edu.cn; sundx@cau.edu.cn			National Natural Science Foundation of China [31001001]; Program for New Century Excellent Talents In Heilongjiang Provincial University [1253-NCET-001]; National Science and Technology Programs of China [2011BAD28B02, 2012BAD12B01, 2013AA102504]; Beijing Dairy Industry Innovation Team; Beijing Research and Technology program [D121100003312001]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents In Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET)); National Science and Technology Programs of China; Beijing Dairy Industry Innovation Team; Beijing Research and Technology program; Program for Changjiang Scholar and Innovation Research Team in University	This work was supported by the the National Natural Science Foundation of China (Grant No. 31001001), Program for New Century Excellent Talents In Heilongjiang Provincial University (Grant No. 1253-NCET-001), National Science and Technology Programs of China (2011BAD28B02, 2012BAD12B01, 2013AA102504), Beijing Dairy Industry Innovation Team, Beijing Research and Technology program (D121100003312001) and Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Duan Q, 2012, ANIM GENET, V43, P115, DOI 10.1111/j.1365-2052.2011.02224.x; Fang M, 2012, THEOR APPL GENET, V124, P1315, DOI 10.1007/s00122-012-1789-7; Golik M, 2011, J DAIRY SCI, V94, P2092, DOI 10.3168/jds.2010-3655; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Li JH, 2011, BIOINFORMATICS, V27, P516, DOI 10.1093/bioinformatics/btq688; Logsdon BA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-53; Lu BZ, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1924448; Lund M. S., 2009, BMC P S1, V3, pS1, DOI DOI 10.1186/1753-6561-3-S1-S1; Meuwissen THE, 2001, GENETICS, V157, P1819; Mutshinda CM, 2010, GENETICS, V186, P1067, DOI 10.1534/genetics.110.119586; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Xu S, 2010, HEREDITY, V105, P483, DOI 10.1038/hdy.2009.180; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	17	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e99544	10.1371/journal.pone.0099544	http://dx.doi.org/10.1371/journal.pone.0099544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148050	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600001
J	Jung, GS; Jeon, JH; Jung, YA; Choi, YK; Kim, HS; Kim, JG; Park, KG; Kim, MK; Lee, IK				Jung, Gwon-Soo; Jeon, Jae-Han; Jung, Yun-A; Choi, Yeon-Kyung; Kim, Hye-Soon; Kim, Jung-Guk; Park, Keun-Gyu; Kim, Mi-Kyung; Lee, In-Kyu			Clusterin/Apolipoprotein J Attenuates Angiotensin II-Induced Renal Fibrosis	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR-BETA; TUBULOINTERSTITIAL FIBROSIS; KIDNEY-DISEASE; TGF-BETA; DIABETIC-NEPHROPATHY; URETERAL OBSTRUCTION; DELAYED TREATMENT; OXIDATIVE STRESS; UP-REGULATION	The blockade of angiotensin II (Ang II) is a major therapeutic strategy for diabetic nephropathy. The main roles of Ang II in renal disease are mediated via the Ang type 1 receptor (AT1R). Upregulation of clusterin/apolipoprotein J has been reported in nephropathy models, suggesting it has a protective role in nephropathogenesis. Here, we studied how clusterin acts against Ang II-induced renal fibrosis. Levels of AT1R and fibrotic markers in clusterin-/- mice and Ang II infused rats transfected with an adenovirus encoding clusterin were evaluated by immunoblot analysis, real time RT-PCR, and immunohistochemical staining. The effect of clusterin on renal fibrosis was evaluated in NRK-52E cells, a cultured renal tubular epithelial cell line, using immunoblot analysis and real time RT-PCR. Nuclear localization of NF-kappa B was evaluated using immunofluorecence and co-immunoprecipitation. Renal fibrosis and expression of AT1R was higher in the kidneys of clusterin-/- mice than in those of wild-type mice. Furthermore, loss of clusterin accelerated Ang II-stimulated renal fibrosis and AT1R expression. Overexpression of clusterin in proximal tubular epithelial cells decreased the levels of Ang II-stimulated fibrotic markers and AT1R. Moreover, intrarenal delivery of clusterin attenuated Ang II-mediated expression of fibrotic markers and AT1R in rats. Fluorescence microscopy and co-immunoprecipitation in conjunction with western blot revealed that clusterin inhibited Ang II-stimulated nuclear localization of p-NF-kappa B via a direct physical interaction and subsequently decreased the AT1R level in proximal tubular epithelial cells. These data suggest that clusterin attenuates Ang II-induced renal fibrosis by inhibition of NF-kappa B activation and subsequent downregulation of AT1R. This study raises the possibility that clusterin could be used as a therapeutic target for Ang II-induced renal diseases.	[Jung, Gwon-Soo; Jeon, Jae-Han; Choi, Yeon-Kyung; Kim, Jung-Guk; Park, Keun-Gyu; Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Taegu, South Korea; [Jung, Yun-A; Kim, Hye-Soon; Kim, Mi-Kyung] Keimyung Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Taegu, South Korea	Kyungpook National University; Keimyung University	Kim, MK (corresponding author), Keimyung Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Taegu, South Korea.	mdkmk@dsmc.or.kr; leei@knu.ac.kr	Lee, In-Kyu/AAR-6374-2021		National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2010-0019514, 2012R1A2A2A01043867, NRF-2012R1A1A1010047, NRF-2013R1A1A3007064]; Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea [A111345]; Korean Diabetes Association Grant; Korea Science and Engineering Foundation (KOSEF) - Korea government (MEST) [2006-2005412]	National Research Foundation of Korea (NRF) - Ministry of Education; Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea; Korean Diabetes Association Grant; Korea Science and Engineering Foundation (KOSEF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorea Science and Engineering FoundationKorean Government)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2010-0019514, 2012R1A2A2A01043867, NRF-2012R1A1A1010047, NRF-2013R1A1A3007064), a grant from the Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea (A111345), the Korean Diabetes Association Grant (2011) and by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (NO. 2006-2005412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; Brewster UC, 2004, AM J MED, V116, P263, DOI 10.1016/j.amjmed.2003.09.034; Calero M, 2005, SUB CELL BIOCHEM, V38, P273; Chuang LY, 2001, NEPHROLOGY, V6, P165, DOI 10.1046/j.1440-1797.2001.00043.x; Chung ACK, 2010, J AM SOC NEPHROL, V21, P249, DOI 10.1681/ASN.2009010018; Cooper ME, 2001, DIABETOLOGIA, V44, P1957, DOI 10.1007/s001250100000; Cowling RT, 2002, J BIOL CHEM, V277, P5719, DOI 10.1074/jbc.M107515200; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Gilmore TD, 1996, ONCOGENE, V13, P1367; Griffin KA, 2006, CLIN J AM SOC NEPHRO, V1, P1054, DOI 10.2215/CJN.02231205; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hwang M, 2006, EXP MOL PATHOL, V81, P48, DOI 10.1016/j.yexmp.2005.11.005; Ishidoya S, 1996, KIDNEY INT, V49, P1110, DOI 10.1038/ki.1996.161; ISHIDOYA S, 1995, KIDNEY INT, V47, P1285, DOI 10.1038/ki.1995.183; Jung GS, 2012, J AM SOC NEPHROL, V23, P73, DOI 10.1681/ASN.2011010048; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; Lan HY, 2012, SEMIN NEPHROL, V32, P236, DOI 10.1016/j.semnephrol.2012.04.002; Lavoz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040490; Lee FTH, 2004, J AM SOC NEPHROL, V15, P2139, DOI 10.1097/01.ASN.0000135055.61833.A8; LEE SK, 1993, NEPHROL DIAL TRANSPL, V8, P1338; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010; Okada H, 2004, BIOCHEM BIOPH RES CO, V314, P403, DOI 10.1016/j.bbrc.2003.12.105; Peters H, 1998, KIDNEY INT, V54, P1570, DOI 10.1046/j.1523-1755.1998.00164.x; Pucci S, 2004, ONCOGENE, V23, P2298, DOI 10.1038/sj.onc.1207404; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Ruiz-Ortega M, 2002, KIDNEY INT, V62, pS12, DOI 10.1046/j.1523-1755.62.s82.4.x; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; Ruiz-Ortega M, 2000, CIRC RES, V86, P1266, DOI 10.1161/01.RES.86.12.1266; RuizOrtega M, 1997, KIDNEY INT, V52, P1497, DOI 10.1038/ki.1997.480; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Vaziri ND, 2007, J PHARMACOL EXP THER, V323, P85, DOI 10.1124/jpet.107.123638; Wolf G, 2000, NEPHROL DIAL TRANSPL, V15, P61, DOI 10.1093/ndt/15.suppl_6.61; Wolf G, 1998, MINER ELECTROL METAB, V24, P174, DOI 10.1159/000057367; WOLF G, 1993, J AM SOC NEPHROL, V3, P1531; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Yamada K, 2001, KIDNEY INT, V59, P137, DOI 10.1046/j.1523-1755.2001.00474.x; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Zhou XY, 2005, CURR OPIN CARDIOL, V20, P290	44	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105635	10.1371/journal.pone.0105635	http://dx.doi.org/10.1371/journal.pone.0105635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148511	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600064
J	Luo, HX; Wu, Q; Ye, XY; Xiong, Y; Zhu, JY; Xu, JY; Diao, YR; Zhang, D; Wang, MS; Qiu, JH; Miao, JT; Zhang, W; Wan, J				Luo, Hongxue; Wu, Qi; Ye, Xiaoyang; Xiong, Yi; Zhu, Jinyong; Xu, Junyu; Diao, Yarui; Zhang, Duo; Wang, Maosheng; Qiu, Jinhua; Miao, Jianting; Zhang, Wei; Wan, Jun			Genome-Wide Analysis of miRNA Signature in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							SIGNALING ALTERATION; MICRORNA TARGETS; MTOR; EXPRESSION; GENES; NEURODEGENERATION; DEPOSITION; SEQUENCES; PATHOLOGY; PATHWAYS	Alzheimer's disease (AD) is the most common cause of dementia. One of the pathological hallmarks of AD is amyloid beta (A beta) deposition. MicroRNAs (miRNAs) are small non-coding RNAs whose expression levels change significantly during neuronal pathogenesis and may be used as diagnostic markers. Some miRNAs are important in AD development by targeting genes responsible for A beta metabolism. However, a systematic assessment of the miRNA expression profile induced by A beta-mediated neuronal pathogenesis is still lacking. In the present study, we examined miRNA expression profile by using the APPswe/PS1 Delta E9 mouse model of AD. Two sibling pairs of mice were examined, showing 30 and 24 miRNAs with significantly altered expression levels from each paired control, respectively. Nine known miRNAs were common in both groups. Prediction of putative target genes and functional annotation implied that these altered miRNAs affect many target genes mainly involved in PI3K/Akt signaling pathway. This study provides a general profile of miRNAs regulated by A beta-associated signal pathways, which is helpful to understand the mechanism of A beta-induced neuronal dysfunction in AD development.	[Luo, Hongxue; Wu, Qi; Ye, Xiaoyang; Xiong, Yi; Zhu, Jinyong; Xu, Junyu; Zhang, Wei; Wan, Jun] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Shenzhen Key Lab Neuronal Struct Biol, Biomed Res Inst,Med Ctr, Shenzhen, Guangdong, Peoples R China; [Diao, Yarui] Ludwig Inst Canc Res, La Jolla, CA USA; [Zhang, Duo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Wang, Maosheng; Qiu, Jinhua] GaoZhou Peoples Hosp, Gao Zhou, Guangdong, Peoples R China; [Miao, Jianting] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Shanxi Province, Peoples R China; [Wan, Jun] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Ludwig Institute for Cancer Research; University of California System; University of California Los Angeles; Air Force Military Medical University; Hong Kong University of Science & Technology	Zhang, W (corresponding author), Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Shenzhen Key Lab Neuronal Struct Biol, Biomed Res Inst,Med Ctr, Shenzhen, Guangdong, Peoples R China.	zhangweispace@gmail.com; wanj@ust.hk	Ye, Xiaoyang/ABF-1682-2020	Wan, Jun/0000-0001-7308-0150	National Natural Scientific Foundation of China [81000465, 81171017]; Innovation Science and Technology Commission of Shenzhen Municipality for Basic Research Grant [JC201005260206A, JCYJ20120616153316095]; Peacock Plan Research Grant [KQC201105300001A]; Distinguished Young Scholars Grant [JC201005260218A]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Science and Technology Commission of Shenzhen Municipality for Basic Research Grant; Peacock Plan Research Grant; Distinguished Young Scholars Grant	This work was supported by the National Natural Scientific Foundation of China (Grant No. 81000465 and 81171017); and by Innovation Science and Technology Commission of Shenzhen Municipality for Basic Research Grants (Grant No. JC201005260206A, JCYJ20120616153316095), Peacock Plan Research Grant (Grant No. KQC201105300001A), Distinguished Young Scholars Grant (JC201005260218A). The funders had no contribution in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Chano T, 2007, BRAIN RES, V1168, P97, DOI 10.1016/j.brainres.2007.06.075; Chen TJ, 2009, J NEUROSCI RES, V87, P2297, DOI 10.1002/jnr.22057; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Guo XB, 2010, BIOCHEM BIOPH RES CO, V398, P1, DOI 10.1016/j.bbrc.2010.05.082; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2007, SCIENCE, V317, P1179, DOI 10.1126/science.1148530; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li X, 2005, FEBS J, V272, P4211, DOI 10.1111/j.1742-4658.2005.04833.x; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Oddo Salvatore, 2012, Front Biosci (Schol Ed), V4, P941; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Phillips M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019567; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Satoh J, 2009, DIS MARKERS, V27, P239, DOI [10.1155/2009/618619, 10.3233/DMA-2009-0670]; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wu XF, 2010, BIOCHEM BIOPH RES CO, V393, P514, DOI 10.1016/j.bbrc.2010.02.038; Zanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003; Zhang Chun-zhi, 2009, Zhonghua Zhong Liu Za Zhi, V31, P721; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054111	48	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e101725	10.1371/journal.pone.0101725	http://dx.doi.org/10.1371/journal.pone.0101725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148207	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600002
J	Barth, MB; Moritz, RFA; Kraus, FB				Barth, Matthias Benjamin; Moritz, Robin Frederik Alexander; Kraus, Frank Bernhard			The Evolution of Extreme Polyandry in Social Insects: Insights from Army Ants	PLOS ONE			English	Article							GENETIC DIVERSITY; PATERNITY SKEW; MICROSATELLITE MARKERS; SPERM COMPETITION; MULTIPLE QUEENS; HYMENOPTERA; PATTERNS; BEHAVIOR; DNA; STATISTICS	The unique nomadic life-history pattern of army ants (army ant adaptive syndrome), including obligate colony fission and strongly male-biased sex-ratios, makes army ants prone to heavily reduced effective population sizes (N-e). Excessive multiple mating by queens (polyandry) has been suggested to compensate these negative effects by increasing genetic variance in colonies and populations. However, the combined effects and evolutionary consequences of polyandry and army ant life history on genetic colony and population structure have only been studied in a few selected species. Here we provide new genetic data on paternity frequencies, colony structure and paternity skew for the five Neotropical army ants Eciton mexicanum, E. vagans, Labidus coecus, L. praedator and Nomamyrmex esenbeckii; and compare those data among a total of nine army ant species (including literature data). The number of effective matings per queen ranged from about 6 up to 25 in our tested species, and we show that such extreme polyandry is in two ways highly adaptive. First, given the detected low intracolonial relatedness and population differentiation extreme polyandry may counteract inbreeding and low N-e. Second, as indicated by a negative correlation of paternity frequency and paternity skew, queens maximize intracolonial genotypic variance by increasingly equalizing paternity shares with higher numbers of sires. Thus, extreme polyandry is not only an integral part of the army ant syndrome, but generally adaptive in social insects by improving genetic variance, even at the high end spectrum of mating frequencies.	[Barth, Matthias Benjamin; Moritz, Robin Frederik Alexander; Kraus, Frank Bernhard] Univ Halle Wittenberg, Dept Zool, Inst Biol, D-06108 Halle, Saale, Germany; [Barth, Matthias Benjamin] Senckenberg Nat Hist Collect Dresden, Museum Zool, DNA Lab, Dresden, Germany; [Moritz, Robin Frederik Alexander] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Kraus, Frank Bernhard] Univ Hosp Halle, Dept Lab Med, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Pretoria; Martin Luther University Halle Wittenberg	Barth, MB (corresponding author), Univ Halle Wittenberg, Dept Zool, Inst Biol, D-06108 Halle, Saale, Germany.	benjamin.barth@zoologie.uni-halle.de	Kraus, Bernhard/B-8172-2011; Moritz, Robin FA/K-6053-2012	Kraus, Bernhard/0000-0003-4354-9952; Moritz, Robin FA/0000-0003-0791-887X; Barth, Benjamin/0000-0003-3459-2174	Saxony Anhalt; Mexican-European grant MUTUAL [FONCICYT 94293]	Saxony Anhalt; Mexican-European grant MUTUAL	This work was supported by the Graduate Scholarship of Saxony Anhalt (http://www.uni-halle.de/forschung/service/wissenschaftlicher_nachwuchs/gradfoerd_lsa/#anchor1071166), Mexican-European grant MUTUAL (FONCICYT 94293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist Goran, 2005, pUnpaginated; Barth MB, 2013, POPUL ECOL, V55, P523, DOI 10.1007/s10144-013-0383-4; Berghoff SM, 2008, J EVOLUTION BIOL, V21, P1125, DOI 10.1111/j.1420-9101.2008.01531.x; Boomsma Jacobus J., 2009, P3; Boomsma JJ, 1996, PHILOS T R SOC B, V351, P947, DOI 10.1098/rstb.1996.0087; Boomsma JJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P85, DOI 10.1007/s002650050415; Brady SG, 2003, P NATL ACAD SCI USA, V100, P6575, DOI 10.1073/pnas.1137809100; BULMER MG, 1983, J THEOR BIOL, V100, P329, DOI 10.1016/0022-5193(83)90356-9; Chapman RE, 2001, ECOL LETT, V4, P650, DOI 10.1046/j.1461-0248.2001.00253.x; COLE BJ, 1983, BEHAV ECOL SOCIOBIOL, V12, P191, DOI 10.1007/BF00290771; Crozier RH, 2001, ANN ZOOL FENN, V38, P267; den Boer SPA, 2010, SCIENCE, V327, P1506, DOI 10.1126/science.1184709; Denny AJ, 2004, MOL ECOL NOTES, V4, P234, DOI 10.1111/j.1471-8286.2004.00627.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Evison SEF, 2011, NATURWISSENSCHAFTEN, V98, P643, DOI 10.1007/s00114-011-0810-3; Franck P, 2002, ANIM BEHAV, V64, P503, DOI 10.1006/anbe.2002.3078; Franks N. R., 1983, Tropical rain forest; ecology and management, P151; FRANKS NR, 1985, FORTS ZOOL, V31, P91; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fuchs S, 1999, BEHAV ECOL SOCIOBIOL, V45, P269, DOI 10.1007/s002650050561; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goulson Dave, 2009, Glasgow Naturalist, V25, P31; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hartl D., 2007, PRINCIPLES POPULATIO; Holman L, 2011, MOL ECOL, V20, P5092, DOI 10.1111/j.1365-294X.2011.05338.x; Hughes WOH, 2008, J EVOLUTION BIOL, V21, P1090, DOI 10.1111/j.1420-9101.2008.01532.x; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Jaffe R, 2014, SOCIOBIOLOGY, V61, P1; Jaffe R, 2007, BIOL LETTERS, V3, P513, DOI 10.1098/rsbl.2007.0257; Jaffe R, 2014, NATURWISSENSCHAFTEN, V101, P261, DOI 10.1007/s00114-014-1149-3; Jaffe R, 2012, EVOLUTION, V66, P3778, DOI 10.1111/j.1558-5646.2012.01721.x; Jaffe R, 2009, POPUL ECOL, V51, P227, DOI 10.1007/s10144-008-0133-1; Kaspari M, 2003, EVOL ECOL RES, V5, P933; Kaspari M, 2011, J ANIM ECOL, V80, P818, DOI 10.1111/j.1365-2656.2011.01826.x; KELLER L, 1994, EVOLUTION, V48, P694, DOI [10.2307/2410479, 10.1111/j.1558-5646.1994.tb01354.x]; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kraus FB, 2011, BEHAV GENET, V41, P323, DOI 10.1007/s10519-010-9382-9; Kraus FB, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P413, DOI 10.1007/978-3-642-02624-9_14; Kraus FB, 2005, INSECT SOC, V52, P1, DOI 10.1007/s00040-004-0766-9; Kraus FB, 2004, BEHAV ECOL SOCIOBIOL, V55, P494, DOI 10.1007/s00265-003-0706-0; Kronauer DJC, 2007, CURR BIOL, V17, pR753, DOI 10.1016/j.cub.2007.06.057; Kronauer DJC, 2007, EVOLUTION, V61, P413, DOI 10.1111/j.1558-5646.2007.00040.x; Kronauer DJC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-20; Kronauer DJC, 2011, MOL ECOL, V20, P420, DOI 10.1111/j.1365-294X.2010.04945.x; Kronauer DJC, 2009, MYRMECOL NEWS, V12, P51; Kronauer DJC, 2004, MOL ECOL NOTES, V4, P289, DOI 10.1111/j.1471-8286.2004.00645.x; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Moilanen A, 2004, MOL ECOL NOTES, V4, P795, DOI 10.1111/j.1471-8286.2004.00779.x; MORITZ RFA, 1995, BEHAV ECOL SOCIOBIOL, V37, P357, DOI 10.1007/BF00174141; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2003, MOL ECOL, V12, P3157, DOI 10.1046/j.1365-294X.2003.01994.x; Nonacs P, 2007, J EVOLUTION BIOL, V20, P2253, DOI 10.1111/j.1420-9101.2007.01418.x; Nonacs P, 2003, ANIM BEHAV, V65, P615, DOI 10.1006/anbe.2003.2096; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; OHTA T, 1971, GENET RES, V18, P277, DOI 10.1017/S0016672300012684; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Packer L, 2001, CONSERV ECOL, V5; PAGE RE, 1989, NATURE, V338, P576, DOI 10.1038/338576a0; PAGE RE, 1982, AM NAT, V119, P263, DOI 10.1086/283907; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; PAMILO P, 1993, HEREDITY, V70, P472, DOI 10.1038/hdy.1993.69; Pamilo P, 1996, OIKOS, V75, P533, DOI 10.2307/3545895; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pearcy M, 2009, INSECT SOC, V56, P94, DOI 10.1007/s00040-008-1043-0; Powell S, 2004, INSECT SOC, V51, P342, DOI 10.1007/s00040-004-0752-2; Powell S, 2006, FUNCT ECOL, V20, P1105, DOI 10.1111/j.1365-2435.2006.01184.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; RETTENMEYER C W, 1978, Journal of the Kansas Entomological Society, V51, P581; RETTENMEYER CARL W., 1963, UNIV KANSAS SCI BULL, V44, P281; Schluns H, 2005, APIDOLOGIE, V36, P201, DOI 10.1051/apido:2005006; Schmid-Hempel P., 1998, Parasites in social insects.; Schneirla T. C., 1971, ARMY ANTS STUDY SOCI; Seppa Perttu, 2008, Myrmecological News, V11, P161; Simmons L. W., 2001, MG BEH ECOL; Starr C.K., 1984, P427; StatSoft Inc, 2008, STATISTICA DAT AN SO; Sundstrom L, 2000, P ROY SOC B-BIOL SCI, V267, P1439, DOI 10.1098/rspb.2000.1161; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Watkins JF., 1976, IDENTIFICATION DISTR; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zayed A, 2004, HEREDITY, V93, P627, DOI 10.1038/sj.hdy.6800588	87	15	16	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105621	10.1371/journal.pone.0105621	http://dx.doi.org/10.1371/journal.pone.0105621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144731	Green Submitted, gold, Green Published			2022-12-25	WOS:000341106100099
J	Kashi, VP; Ortega, SB; Karandikar, NJ				Kashi, Venkatesh P.; Ortega, Sterling B.; Karandikar, Nitin J.			Neuroantigen-Specific Autoregulatory CD8+T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function	PLOS ONE			English	Article							CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS LESIONS; CUTTING EDGE; CEREBROSPINAL-FLUID; CROSS-PRESENTATION; CLONAL EXPANSIONS; IMMUNE-RESPONSES; B-CELLS	Experimental autoimmune encephalomyelitis (EAE) is a well-established murine model of multiple sclerosis, an immune-mediated demyelinating disorder of the central nervous system (CNS). We have previously shown that CNS-specific CD8+ T cells (CNS-CD8+) ameliorate EAE, at least in part through modulation of CNS-specific CD4+ T cell responses. In this study, we show that CNS-CD8+ also modulate the function of CD11c+ dendritic cells (DC), but not other APCs such as CD11b+ monocytes or B220+ B cells. DC from mice receiving either myelin oligodendrocyte glycoprotein-specific CD8+ (MOG-CD8+) or proteolipid protein-specific CD8+ (PLP-CD8+) T cells were rendered inefficient in priming T cell responses from naive CD4+ T cells (OT-II) or supporting recall responses from CNS-specific CD4+ T cells. CNS-CD8+ did not alter DC subset distribution or MHC class II and CD86 expression, suggesting that DC maturation was not affected. However, the cytokine profile of DC from CNS-CD8+ recipients showed lower IL-12 and higher IL-10 production. These functions were not modulated in the absence of immunization with CD8-cognate antigen, suggesting an antigen-specific mechanism likely requiring CNS-CD8-DC interaction. Interestingly, blockade of IL-10 in vitro rescued CD4+ proliferation and in vivo expression of IL-10 was necessary for the suppression of EAE by MOG-CD8+. These studies demonstrate a complex interplay between CNS-specific CD8+ T cells, DC and pathogenic CD4+ T cells, with important implications for therapeutic interventions in this disease.	[Kashi, Venkatesh P.; Ortega, Sterling B.; Karandikar, Nitin J.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Karandikar, NJ (corresponding author), Univ Iowa Hlth Care, Dept Pathol, Iowa City, IA 52242 USA.	nitin-karandikar@uiowa.edu		Karandikar, Nitin/0000-0002-6867-6950; Ortega, Sterling/0000-0003-3542-9555	National Institutes of Health (NIH) [K24 AI079272, NIH R01 AI092106]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092106, K24AI079272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS051837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) K24 AI079272 and NIH R01 AI092106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Anderson AC, 2012, J IMMUNOL, V188, P2084, DOI 10.4049/jimmunol.1102186; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Bailey-Bucktrout SL, 2008, J IMMUNOL, V180, P6457, DOI 10.4049/jimmunol.180.10.6457; Baughman EJ, 2011, J AUTOIMMUN, V36, P115, DOI 10.1016/j.jaut.2010.12.003; Bettini M, 2009, J NEUROIMMUNOL, V213, P60, DOI 10.1016/j.jneuroim.2009.05.017; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Demangel C, 2002, EUR J IMMUNOL, V32, P994, DOI 10.1002/1521-4141(200204)32:4<994::AID-IMMU994>3.3.CO;2-Y; Deshpande P, 2007, J IMMUNOL, V178, P6695, DOI 10.4049/jimmunol.178.11.6695; Ford ML, 2005, EUR J IMMUNOL, V35, P76, DOI 10.1002/eji.200425660; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; Gonzalez P, 2009, J NEUROPATH EXP NEUR, V68, P391, DOI 10.1097/NEN.0b013e31819dca30; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Huber M, 2013, J CLIN INVEST, V123, P247, DOI 10.1172/JCI63681; Huseby ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00064; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Jacobsen M, 2002, BRAIN, V125, P538, DOI 10.1093/brain/awf059; Ji QY, 2007, ANN NY ACAD SCI, V1103, P157, DOI 10.1196/annals.1394.017; Ji QY, 2013, NAT IMMUNOL, V14, P254, DOI 10.1038/ni.2513; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Jurewicz A, 1998, J IMMUNOL, V160, P3056; Kala M, 2010, EXP NEUROL, V221, P136, DOI 10.1016/j.expneurol.2009.10.015; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Lee YH, 2008, J IMMUNOL, V180, P825, DOI 10.4049/jimmunol.180.2.825; Leech MD, 2013, J IMMUNOL, V190, P881, DOI 10.4049/jimmunol.1202925; Lewis KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007401; Linker RA, 2005, NEUROBIOL DIS, V19, P218, DOI 10.1016/j.nbd.2004.12.017; Mangalam AK, 2012, J AUTOIMMUN, V38, P344, DOI 10.1016/j.jaut.2012.02.004; Mars LT, 2007, J IMMUNOL, V179, P5090, DOI 10.4049/jimmunol.179.8.5090; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Miller SD, 2007, ANN NY ACAD SCI, V1103, P179, DOI 10.1196/annals.1394.023; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Na SY, 2008, BRAIN, V131, P2353, DOI 10.1093/brain/awn148; Najafian N, 2003, J CLIN INVEST, V112, P1037, DOI 10.1172/JCI200317935; Ortega SB, 2013, J IMMUNOL, V191, P117, DOI 10.4049/jimmunol.1300452; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saxena A, 2008, J IMMUNOL, V181, P1617, DOI 10.4049/jimmunol.181.3.1617; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Segura E, 2013, J EXP MED, V210, P1035, DOI 10.1084/jem.20121103; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Sinha S, 2014, IMMUNOL RES; Skulina C, 2004, P NATL ACAD SCI USA, V101, P2428, DOI 10.1073/pnas.0308689100; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; WOODROOFE MN, 1986, J NEUROL SCI, V74, P135, DOI 10.1016/0022-510X(86)90100-0; Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025; York NR, 2010, J AUTOIMMUN, V35, P33, DOI 10.1016/j.jaut.2010.01.003; Zhou H, 2014, EUR J IMMUNOL; Zozulya AL, 2008, HUM IMMUNOL, V69, P797, DOI 10.1016/j.humimm.2008.07.014	58	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105763	10.1371/journal.pone.0105763	http://dx.doi.org/10.1371/journal.pone.0105763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144738	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100119
J	Schafer, JL; Just, MG				Schafer, Jennifer L.; Just, Michael G.			Size Dependency of Post-Disturbance Recovery of Multi-Stemmed Resprouting Trees	PLOS ONE			English	Article							LONGLEAF PINE SAVANNAS; SOUTHEASTERN UNITED-STATES; SHRUB ERICA-AUSTRALIS; HEIGHT GROWTH; GRASSLAND COMMUNITIES; WOODY-PLANTS; QUERCUS-ILEX; FIRE REGIMES; VEGETATION; PERSISTENCE	In frequently burned ecosystems, many plants persist by repeated resprouting from basal or belowground buds. This strategy requires that plants reach a balance between biomass loss and recovery, which depends on the shape of the relationship between pre- and post-fire size. Previous analyses of this relationship, however, have focused on the size of the largest stem, which ignores the importance of the multi-stem growth habit that is common in pyrogenic ecosystems. We hypothesized that the presence of multiple stems causes a substantial shift in the relationship between pre- and post-fire size and in the relationship between pre-fire size and size recovery. We measured the height and basal diameter, then calculated volume and biomass, of all stems of six tree species before and nine months after complete removal of aboveground biomass via coppicing. The number of resprouts was correlated with the original number of stems for four species. For all species, the relationship between pre-coppicing and resprout size fit a positive curvilinear function, and the shape of this curve did not differ for maximum and total stem size. Smaller individuals recovered a larger proportion of their pre-coppicing size than larger individuals, but the shape of the size recovery curves were the same regardless of whether the analysis was performed with all stems or only the largest stem. Our results indicate that measuring only the largest stem of multi-stemmed individuals is sufficient to assess the ability of individuals to recover after complete loss of aboveground biomass and persist under frequent burning.	[Schafer, Jennifer L.; Just, Michael G.] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Schafer, JL (corresponding author), William Jewell Coll, Dept Biol, Liberty, MO 64068 USA.	schaferj@william.jewell.edu	Just, Michael G/N-1279-2013	Just, Michael G/0000-0003-2493-9269	US Army Engineer Research and Development Center [W9132T-11-2-0007]; North Carolina State University [W9132T-11-2-0007]	US Army Engineer Research and Development Center(United States Department of DefenseUnited States Army); North Carolina State University	This research was supported by a cooperative agreement between the US Army Engineer Research and Development Center and North Carolina State University (W9132T-11-2-0007 to W. Hoffmann). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Bonfil C, 2004, J VEG SCI, V15, P423, DOI 10.1658/1100-9233(2004)015[0423:TRODIT]2.0.CO;2; BOWEN BJ, 1993, ANN BOT-LONDON, V72, P7, DOI 10.1006/anbo.1993.1075; Canadell J, 1998, FUNCT ECOL, V12, P31, DOI 10.1046/j.1365-2435.1998.00154.x; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Cruz A, 2003, NEW PHYTOL, V157, P251, DOI 10.1046/j.1469-8137.2003.00668.x; Cruz A, 2002, J VEG SCI, V13, P641, DOI 10.1111/j.1654-1103.2002.tb02092.x; Dacy EC, 2009, RANGELAND ECOL MANAG, V62, P179, DOI 10.2111/08-125.1; DAVIES SJ, 1991, AUST J BOT, V39, P459, DOI 10.1071/BT9910459; Drewa PB, 2006, APPL VEG SCI, V9, P27, DOI 10.1111/j.1654-109X.2006.tb00653.x; Drewa PB, 2002, ECOLOGY, V83, P755, DOI 10.1890/0012-9658(2002)083[0755:FEOROS]2.0.CO;2; El Omari B, 2003, PLANT SOIL, V252, P349, DOI 10.1023/A:1024792206369; Falster DS, 2005, OIKOS, V111, P57, DOI 10.1111/j.0030-1299.2005.13383.x; Fang XW, 2013, TREE PHYSIOL, V33, P275, DOI 10.1093/treephys/tpt006; Fill JM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00044.1; Fowler C, 2007, HUM ECOL REV, V14, P165; Frost CC, 1995, FIRE WETLANDS MANAGE, V19, P39; Goorman R, 2011, PLANT ECOL, V212, P2023, DOI 10.1007/s11258-011-9967-2; Grady JM, 2012, ECOLOGY, V93, P2052, DOI 10.1890/12-0354.1; Hermann JM, 2012, PLANT ECOL, V213, P1757, DOI 10.1007/s11258-012-0131-4; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Hmielowski TL, 2014, PLANT ECOL, V215, P1221, DOI 10.1007/s11258-014-0380-5; Hoffmann W.A., 2002, CERRADOS BRAZIL ECOL, P159, DOI DOI 10.7312/OLIV12042-008; Hoffmann WA, 2003, FOREST ECOL MANAG, V180, P273, DOI 10.1016/S0378-1127(02)00566-2; Kabeya D, 2005, ANN BOT-LONDON, V96, P479, DOI 10.1093/aob/mci200; Kennedy LM, 2008, BIOTROPICA, V40, P412, DOI 10.1111/j.1744-7429.2007.00394.x; KING DA, 1986, ECOLOGY, V67, P980, DOI 10.2307/1939821; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; Konstantinidis P, 2006, FOREST ECOL MANAG, V225, P359, DOI 10.1016/j.foreco.2006.01.011; Kozovits AR, 2005, NEW PHYTOL, V167, P181, DOI 10.1111/j.1469-8137.2005.01391.x; Krall JS, 2014, BIOL INVASIONS, V16, P1055, DOI 10.1007/s10530-013-0557-1; Lashley MA, 2014, ECOL INDIC, V38, P212, DOI 10.1016/j.ecolind.2013.11.006; LLORET F, 1993, J VEG SCI, V4, P367, DOI 10.2307/3235595; Maguire AJ, 2011, FIRE ECOL, V7, P12, DOI 10.4996/fireecology.0703012; MALANSON GP, 1988, J ECOL, V76, P351, DOI 10.2307/2260598; Masaka K, 2000, ANN BOT-LONDON, V85, P137, DOI 10.1006/anbo.1999.1007; Moreira B, 2012, OIKOS, V121, P1577, DOI 10.1111/j.1600-0706.2011.20258.x; MORENO JM, 1991, OECOLOGIA, V85, P429, DOI 10.1007/BF00320621; Niklas KJ, 2007, TREE PHYSIOL, V27, P433, DOI 10.1093/treephys/27.3.433; Niklas KJ, 2006, ANN BOT-LONDON, V97, P155, DOI 10.1093/aob/mcj021; Niklas KJ, 2005, AM J BOT, V92, P1256, DOI 10.3732/ajb.92.8.1256; Noble JC, 2001, AUST J BOT, V49, P31, DOI 10.1071/BT00046; Olano JM, 2006, NEW PHYTOL, V170, P99, DOI 10.1111/j.1469-8137.2005.01634.x; OLSON MS, 1995, VEGETATIO, V119, P101, DOI 10.1007/BF00045593; Paula S, 2009, BOTANY, V87, P253, DOI 10.1139/B08-134; Robertson KM, 2014, OECOLOGIA, V174, P765, DOI 10.1007/s00442-013-2823-4; Robertson KM, 2009, SOUTH J APPL FOR, V33, P121, DOI 10.1093/sjaf/33.3.121; Schafale MP, 1990, CLASSIFICATION NATUR, P321; Schafer JL, 2014, AM MIDL NAT IN PRESS; Schafer JL, 2010, THESIS U FLORIDA GAI, P257; Schutz AEN, 2009, OECOLOGIA, V160, P235, DOI 10.1007/s00442-009-1293-1; Sorrie BA, 2006, CASTANEA, V71, P129, DOI 10.2179/05-02.1; Stambaugh MC, 2011, J VEG SCI, V22, P1094, DOI 10.1111/j.1654-1103.2011.01322.x; *USDA, 2007, SOIL SURV GEOGR SSUR; Vesk PA, 2004, J ECOL, V92, P310, DOI 10.1111/j.0022-0477.2004.00871.x; WALDROP TA, 1992, FOREST ECOL MANAG, V47, P195, DOI 10.1016/0378-1127(92)90274-D	57	16	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105600	10.1371/journal.pone.0105600	http://dx.doi.org/10.1371/journal.pone.0105600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144236	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100092
J	Feng, L; Li, P; Wang, XH; Hu, Z; Ma, Y; Tang, WM; Ben, YL; Mahapatra, T; Cao, XL; Mahapatra, S; Ling, M; Gou, AS; Wang, YM; Xiao, JQ; Hou, M; Wang, XL; Lin, B; Wang, FX				Feng, Lei; Li, Ping; Wang, Xihua; Hu, Zhi; Ma, Ying; Tang, Weiming; Ben, Yanli; Mahapatra, Tanmay; Cao, Xiaolin; Mahapatra, Sanchita; Ling, Min; Gou, Anshuan; Wang, Yanmei; Xiao, Jiangqin; Hou, Ming; Wang, Xiuli; Lin, Bo; Wang, Faxing			Distribution and Determinants of Non Communicable Diseases among Elderly Uyghur Ethnic Group in Xinjiang, China	PLOS ONE			English	Article							PRESSURE-RELATED DISEASE; NONCOMMUNICABLE DISEASES; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; HEALTH; PREVALENCE; METAANALYSIS; PREVENTION; REGRESSION	Background: Non-communicable diseases (NCDs) are showing an increasing trend globally as well as in China. Elderly population are more prone to these NCDs. Situation in China is worse owing to the higher proportion of geriatric population. Burden of NCDs and the role of their socio-demographic and behavioral predictors among these elderly and more so among the ethnic minority groups among them, need to be investigated specifically, owing to their distinct genetic background, lifestyles and behavior. Methods: A cross-sectional study was conducted among 1329 randomly selected persons of Uyghur ethnicity, aged 60 years or more in Xinjiang, the largest administrative division in China to measure the burden of NCDs, understand the distribution of socio-demographic, behavioral and life event-related potential correlates of them and to estimate the association of the NCDs with these correlates. Results: Among these participants 54.2% were female, 86.8% were married and more than half had only attended elementary school or less. 41.46% was suffering from at least one NCD. 20.22% had one NCD, 12.11% had two and 8.58% had three or more. 27.3% had hypertension, 4.06% had diabetes, 6.02% had hyperlipidemia, 7.37% had angina, 14.52% had cardiovascular diseases, 11.59% had any kind of cancers and 9.78% had chronic obstructive pulmonary diseases. Rural residents (OR = 1.45, 95% CI: 1.17-1.80, AOR = 2.00, 95% CI: 1.53-2.61) and current smokers had higher odds of having more NCDs (AOR = 1.53, 95% CI: 1.00-2.34). Additionally not being satisfied with current life, not being able to take care of self in daily life, currently not being involved in farm work, less intake of fresh vegetables, fruits and garlic, too less or too much salt intake, not having hobbies were found to be positively associated with having more NCDs. Conclusion: Implementation of effective intervention strategies to promote healthy life styles among the Uyghur elderly population of China seems urgent.	[Feng, Lei; Hu, Zhi; Ma, Ying] Anhui Med Univ, Sch Hlth Serv Adm, Dept Hlth Serv management, Hefei, Anhui, Peoples R China; [Feng, Lei; Li, Ping; Wang, Xihua; Ben, Yanli; Cao, Xiaolin; Ling, Min; Gou, Anshuan; Wang, Yanmei; Xiao, Jiangqin; Hou, Ming; Wang, Xiuli; Lin, Bo; Wang, Faxing] Peoples Hosp Xinjiang Uighur Autonomous Reg, Dept Med, Urumqi, Xinjiang, Peoples R China; [Tang, Weiming] Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China; [Tang, Weiming] Guangdong Ctr Skin Dis & STI Control, Dept STI Control, Guangzhou, Guangdong, Peoples R China; [Mahapatra, Tanmay; Mahapatra, Sanchita] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA	Anhui Medical University; University of California System; University of California Los Angeles	Wang, FX (corresponding author), Peoples Hosp Xinjiang Uighur Autonomous Reg, Dept Med, Urumqi, Xinjiang, Peoples R China.	wfx116@126.com		Tang, Weiming/0000-0002-9026-707X	Natural Science Fund Regional Fund of China [8126212]; Science and Technology Project of Xinjiang Autonomous Region [201242178]; National Institutes of Health (NIH) program [1D43TW009532-01]; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER	Natural Science Fund Regional Fund of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Xinjiang Autonomous Region; National Institutes of Health (NIH) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Natural Science Fund Regional Fund of China (8126212) and Science and Technology Project of Xinjiang Autonomous Region (201242178) and National Institutes of Health (NIH) program (1D43TW009532-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn T, 2012, LANCET, V379, P2227, DOI 10.1016/S0140-6736(12)60963-5; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Barouki Robert, 2012, Environ Health, V11, P42, DOI 10.1186/1476-069X-11-42; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bender R, 1997, J ROY COLL PHYS LOND, V31, P546; Cai W, 2014, SCI WORLD J, DOI 10.1155/2014/393628; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Chapman IM, 2013, EFFECT AGING SENSITI; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Cong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090262; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; DOWSE GK, 1995, BRIT MED J, V311, P1255, DOI 10.1136/bmj.311.7015.1255; Gavrilov LA, 2003, ENCY POPULATION, V1, P32; HARENBERG J, 1988, ATHEROSCLEROSIS, V74, P247, DOI 10.1016/0021-9150(88)90244-4; Institute S, 1996, SAS SYST WIND; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin Z-Y, 2013, CANC PREVENTION RES; Lauritsen J, 2003, COMPREHENSIVE TOOL V; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Li LL, 2008, CARDIOVASC TOXICOL, V8, P87, DOI 10.1007/s12012-008-9017-z; Li NF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-499; MacMahon S, 2008, AM J HYPERTENS, V21, P843, DOI 10.1038/ajh.2008.223; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Qin J, 2010, CHINESE J PUBLIC HLT, V7, P055; SILAGY CAS, 1994, J HYPERTENS, V12, P463; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Tang SL, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-7; The World Bank, 2011, HLTH HARM LIF CHIN S; USCDC, 2011, PROBL NONC DIS CDCS; Varagic J, 2001, CURR OPIN CARDIOL, V16, P336, DOI 10.1097/00001573-200111000-00004; Wu Y, 2011, SICK SOC RESPONDING, P241; Wu ZS, 2001, CIRCULATION, V103, P462; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423	37	13	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105536	10.1371/journal.pone.0105536	http://dx.doi.org/10.1371/journal.pone.0105536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141133	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200095
J	Furuhagen, S; Fuchs, A; Belleza, EL; Breitholtz, M; Gorokhova, E				Furuhagen, Sara; Fuchs, Anne; Belleza, Elin Lundstrom; Breitholtz, Magnus; Gorokhova, Elena			Are Pharmaceuticals with Evolutionary Conserved Molecular Drug Targets More Potent to Cause Toxic Effects in Non-Target Organisms?	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; TANDEM MASS-SPECTROMETRY; DAPHNIA-MAGNA; MESSENGER-RNA; RNA/DNA RATIOS; IN-VITRO; FISH; ECOTOXICOLOGY; REPRODUCTION; CALMODULIN	The ubiquitous use of pharmaceuticals has resulted in a continuous discharge into wastewater and pharmaceuticals and their metabolites are found in the environment. Due to their design towards specific drug targets, pharmaceuticals may be therapeutically active already at low environmental concentrations. Several human drug targets are evolutionary conserved in aquatic organisms, raising concerns about effects of these pharmaceuticals in non-target organisms. In this study, we hypothesized that the toxicity of a pharmaceutical towards a non-target invertebrate depends on the presence of the human drug target orthologs in this species. This was tested by assessing toxicity of pharmaceuticals with (miconazole and promethazine) and without (levonorgestrel) identified drug target orthologs in the cladoceran Daphnia magna. The toxicity was evaluated using general toxicity endpoints at individual (immobility, reproduction and development), biochemical (RNA and DNA content) and molecular (gene expression) levels. The results provide evidence for higher toxicity of miconazole and promethazine, i.e. the drugs with identified drug target orthologs. At the individual level, miconazole had the lowest effect concentrations for immobility and reproduction (0.3 and 0.022 mg L-1, respectively) followed by promethazine (1.6 and 0.18 mg L-1, respectively). At the biochemical level, individual RNA content was affected by miconazole and promethazine already at 0.0023 and 0.059 mg L-1, respectively. At the molecular level, gene expression for cuticle protein was significantly suppressed by exposure to both miconazole and promethazine; moreover, daphnids exposed to miconazole had significantly lower vitellogenin expression. Levonorgestrel did not have any effects on any endpoints in the concentrations tested. These results highlight the importance of considering drug target conservation in environmental risk assessments of pharmaceuticals.	[Furuhagen, Sara; Fuchs, Anne; Belleza, Elin Lundstrom; Breitholtz, Magnus; Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University	Furuhagen, S (corresponding author), Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden.	sara.furuhagen@itm.su.se	Gorokhova, Elena/E-7105-2018	Gorokhova, Elena/0000-0002-4192-6956	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Stockholm University's strategic marine environmental research program 'Baltic Ecosystem Adaptive Management'; Swedish foundation for strategic environmental research (MISTRA; MistraPharma)	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Stockholm University's strategic marine environmental research program 'Baltic Ecosystem Adaptive Management'; Swedish foundation for strategic environmental research (MISTRA; MistraPharma)	This study was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Stockholm University's strategic marine environmental research program 'Baltic Ecosystem Adaptive Management' and the Swedish foundation for strategic environmental research (MISTRA; MistraPharma). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers J, 2008, ENVIRON SCI POLLUT R, V15, P565, DOI 10.1007/s11356-008-0043-y; Ahlers J, 2006, ENVIRON TOXICOL CHEM, V25, P2937, DOI 10.1897/05-701R.1; Alam MS, 2008, J PHYS CHEM B, V112, P12962, DOI 10.1021/jp804238k; ALLEN Y, 1995, ENVIRON TOXICOL CHEM, V14, P1625, DOI 10.1002/etc.5620140923; Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; [Anonymous], OECD 202 GUID TEST C; Barata C, 2008, SCI TOTAL ENVIRON, V405, P78, DOI 10.1016/j.scitotenv.2008.06.028; Breitholtz M, 2001, MAR POLLUT BULL, V42, P879, DOI 10.1016/S0025-326X(01)00046-7; Breitholtz M., 2013, ENDOCRINE DISRUPTERS, P116, DOI [10.1002/9781118355961.ch5, DOI 10.1002/9781118355961.CH5]; Buckley BA, 2004, MAR ECOL PROG SER, V282, P143, DOI 10.3354/meps282143; Caldwell DJ, 2008, ENVIRON SCI TECHNOL, V42, P7046, DOI 10.1021/es800633q; Campos B, 2012, ENVIRON SCI TECHNOL, V46, P2943, DOI 10.1021/es203157f; Christen V, 2010, AQUAT TOXICOL, V96, P167, DOI 10.1016/j.aquatox.2009.11.021; Escher BI, 2005, ENVIRON SCI TECHNOL, V39, P3090, DOI 10.1021/es048590e; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; GAUSING K, 1977, J MOL BIOL, V115, P335, DOI 10.1016/0022-2836(77)90158-9; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173; Hannas BR, 2011, AQUAT TOXICOL, V101, P351, DOI 10.1016/j.aquatox.2010.11.006; HEGEMANN L, 1993, J INVEST DERMATOL, V100, P343, DOI 10.1111/1523-1747.ep12470043; HENSHAW EC, 1971, J BIOL CHEM, V246, P436; Ibiam U, 2005, ENVIRON TOXICOL CHEM, V24, P1155, DOI 10.1897/04-262R.1; Ioele G, 2012, CURR PHARM ANAL, V8, P196, DOI 10.2174/1573412911208020196; Jukosky JA, 2008, B ENVIRON CONTAM TOX, V81, P230, DOI 10.1007/s00128-008-9462-1; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kim J, 2011, ECOTOXICOLOGY, V20, P1741, DOI 10.1007/s10646-011-0707-0; Kvarnryd M, 2011, AQUAT TOXICOL, V103, P18, DOI 10.1016/j.aquatox.2011.02.003; Larsson DGJ, 1999, AQUAT TOXICOL, V45, P91, DOI 10.1016/S0166-445X(98)00112-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTSON MP, 1986, MOL CELL ENDOCRINOL, V48, P135, DOI 10.1016/0303-7207(86)90036-5; Neumann NF, 2002, BIOTECHNOL ADV, V20, P391, DOI 10.1016/S0734-9750(02)00025-3; OECD, 2012, OECD 211 GUID TEST C; Pacheco LF, 2003, J COLLOID INTERF SCI, V258, P146, DOI 10.1016/S0021-9797(02)00103-0; Pereira JL, 2008, ANN LIMNOL-INT J LIM, V44, P169, DOI 10.1051/limn:2008001; Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a; Roberts PH, 2006, J CHROMATOGR A, V1134, P143, DOI 10.1016/j.chroma.2006.08.093; Seiler JP, 2002, TOXICOL LETT, V131, P105, DOI 10.1016/S0378-4274(02)00045-0; Soetaert A, 2006, COMP BIOCHEM PHYS C, V142, P66, DOI 10.1016/j.cbpc.2005.10.009; Soetaert A, 2007, CHEMOSPHERE, V67, P60, DOI 10.1016/j.chemosphere.2006.09.076; Sumpter JP, 1995, TOXICOL LETT, V82-3, P737, DOI 10.1016/0378-4274(95)03517-6; Thomson SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-500; TUCCIARONE LM, 1982, MOL CELL BIOCHEM, V45, P159; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; VAN WEZEL A, 1995, CRIT REV TOXICOL, V25, P255, DOI 10.3109/10408449509089890; Vandenbrouck T, 2009, AQUAT TOXICOL, V92, P18, DOI 10.1016/j.aquatox.2008.12.012; Varshney R, 1996, RADIAT PHYS CHEM, V47, P595, DOI 10.1016/0969-806X(95)00056-4; Vena GA, 2008, CURR PHARM DESIGN, V14, P2902, DOI 10.2174/138161208786369777; Versonnen BJ, 2003, ENVIRON TOXICOL CHEM, V22, P329, DOI [10.1002/etc.5620220213, 10.1897/1551-5028(2003)022&lt;0329:IVAIVE&gt;2.0.CO;2]; Vulliet E, 2008, J CHROMATOGR A, V1210, P84, DOI 10.1016/j.chroma.2008.09.034; Walker SD, 2013, CHEMOSPHERE, V93, P2568, DOI 10.1016/j.chemosphere.2013.09.074; Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1	54	30	30	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105028	10.1371/journal.pone.0105028	http://dx.doi.org/10.1371/journal.pone.0105028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140792	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200047
J	Fernandez, S; Risolino, M; Mandia, N; Talotta, F; Soini, Y; Incoronato, M; Condorelli, G; Banfi, S; Verde, P				Fernandez, S.; Risolino, M.; Mandia, N.; Talotta, F.; Soini, Y.; Incoronato, M.; Condorelli, G.; Banfi, S.; Verde, P.			miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer	ONCOGENE			English	Article							MESSENGER-RNA; EXPRESSION; MICRORNA; MIR-222; MIRNA; OVEREXPRESSION; DEGRADATION; PROGRESSION; FAMILY; SKP2	MicroRNAs (miRNAs) control cell cycle progression by targeting the transcripts encoding for cyclins, CDKs and CDK inhibitors, such as p27(KIP1) (p27).p27 expression is controlled by multiple transcriptional and posttranscriptional mechanisms, including translational inhibition by miR-221/222 and posttranslational regulation by the SCFSKP2 complex. The oncosuppressor activity of miR-340 has been recently characterized in breast, colorectal and osteosarcoma tumor cells. However, the mechanisms underlying miR-340-induced cell growth arrest have not been elucidated. Here, we describe miR-340 as a novel tumor suppressor in non-small cell lung cancer (NSCLC). Starting from the observation that the growth-inhibitory and proapoptotic effects of miR-340 correlate with the accumulation of p27 in lung adenocarcinoma and glioblastoma cells, we have analyzed the functional relationship between miR-340 and p27 expression. miR-340 targets three key negative regulators of p27. The miR-340-mediated inhibition of both Pumilio family RNA-binding proteins (PUM1 and PUM2), required for the miR-221/222 interaction with the p27 3'-UTR, antagonizes the miRNA-dependent downregulation of p27. At the same time, miR-340 induces the stabilization of p27 by targeting SKP2, the key posttranslational regulator of p27. Therefore, miR-340 controls p27 at both translational and posttranslational levels. Accordingly, the inhibition of either PUM1 or SKP2 partially recapitulates the miR-340 effect on cell proliferation and apoptosis. In addition to the effect on tumor cell proliferation, miR-340 also inhibits intercellular adhesion and motility in lung cancer cells. These changes correlate with the miR-340-mediated inhibition of previously validated (MET and ROCK1) and potentially novel (RHOA and CDH1) miR-340 target transcripts. Finally, we show that in a small cohort of NSCLC patients (n = 23), representative of all four stages of lung cancer, miR-340 expression inversely correlates with clinical staging, thus suggesting that miR-340 downregulation contributes to the disease progression.	[Fernandez, S.; Risolino, M.; Mandia, N.; Talotta, F.; Verde, P.] CNR, Inst Genet & Biophys, I-80123 Naples, Italy; [Soini, Y.] Univ Eastern Finland, Canc Ctr Eastern Finland, Sch Med, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Incoronato, M.] IRCCS SDN, Naples, Italy; [Condorelli, G.] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Banfi, S.] Telethon Inst Genet & Med TIGEM, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Eastern Finland; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Verde, P (corresponding author), CNR, Inst Genet & Biophys, Via P Castellino 111, I-80123 Naples, Italy.	pasquale.verde@igb.cnr.it	Condorelli, Gerolama/AAC-3472-2022; Banfi, Sandro/K-3963-2018; Incoronato, Mariarosaria/AAA-7541-2021; Incoronato, Mariarosaria/K-8727-2016	Condorelli, Gerolama/0000-0003-0177-8829; Banfi, Sandro/0000-0002-6541-8833; Incoronato, Mariarosaria/0000-0001-7019-0581; Incoronato, Mariarosaria/0000-0001-7019-0581	AIRC (Associazione Italiana per la Ricerca sul Cancro) [10489]; AICR (Association for International Cancer Research, UK) [08-182]; MERIT Grant (MIUR) [RBNE08YFN3]; AIRC [14046]; Fondazione Berlucchi; Fondazione Telethon Funding Source: Custom	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); AICR (Association for International Cancer Research, UK); MERIT Grant (MIUR); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Berlucchi; Fondazione Telethon(Fondazione Telethon)	We thank Reuven Agami, Judy Lieberman and Vladimir Spiegelman for expression vectors. We also thank the IGB FACS and Microscopy facilities. This work was supported by the AIRC (Associazione Italiana per la Ricerca sul Cancro) Grant-10489, AICR (Association for International Cancer Research, UK) Grant-08-182 and MERIT Grant-RBNE08YFN3 (MIUR) to Pasquale Verde. Gerolama Condorelli was supported by grants from AIRC (Grant-14046) and Fondazione Berlucchi.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Cai HQ, 2014, INT J MOL SCI, V15, P560, DOI 10.3390/ijms15010560; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Das S, 2013, ONCOGENE, V32, P2927, DOI 10.1038/onc.2012.311; Dong H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-163; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Hashimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062589; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019718; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; le Sage C, 2007, CELL CYCLE, V6, P2742, DOI 10.4161/cc.6.22.4900; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nassirpour R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062170; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sun Y, 2012, ONCOL REP, V28, P1346, DOI 10.3892/or.2012.1958; Takanami I, 2005, ONCOL REP, V13, P727; Talotta F, 2010, ONCOGENE, V29, P4732, DOI 10.1038/onc.2010.211; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; Wu ZS, 2011, CANCER-AM CANCER SOC, V117, P2842, DOI 10.1002/cncr.25860; Zhang C, 2010, INT J ONCOL, V37, P1; Zhou X, 2013, BIOCHEM BIOPH RES CO, V437, P653, DOI 10.1016/j.bbrc.2013.07.033	41	141	148	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2015	34	25					3240	3250		10.1038/onc.2014.267	http://dx.doi.org/10.1038/onc.2014.267			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK9XH	25151966	Green Accepted			2022-12-25	WOS:000356592300003
J	Liu, L; Trent, CM; Fang, X; Son, NH; Jiang, HF; Blaner, WS; Hu, YY; Yin, YX; Farese, RV; Homma, S; Turnbull, AV; Eriksson, JW; Hu, SL; Ginsberg, HN; Huang, LS; Goldberg, IJ				Liu, Li; Trent, Chad M.; Fang, Xiang; Son, Ni-Huiping; Jiang, HongFeng; Blaner, William S.; Hu, Yunying; Yin, Yu-Xin; Farese, Robert V., Jr.; Homma, Shunichi; Turnbull, Andrew V.; Eriksson, Jan W.; Hu, Shi-Lian; Ginsberg, Henry N.; Huang, Li-Shin; Goldberg, Ira J.			Cardiomyocyte-specific Loss of Diacylglycerol Acyltransferase 1 (DGAT1) Reproduces the Abnormalities in Lipids Found in Severe Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Animal Model; Cardiac Metabolism; Ceramide; Diacylglycerol; Heart Failure; Lipid; Lipotoxicity; Metabolism; Signal Transduction	KINASE-C-ALPHA; INSULIN-RESISTANCE; SKELETAL-MUSCLE; IN-VIVO; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SYNTHESIS; OBESITY RESISTANCE; HEPATIC STEATOSIS; SYNTHESIS ENZYME; MICE	Background: Total body DGAT1 mice have no cardiac phenotype. Results: Cardiomyocyte DGAT1 knock-out mice have increased mortality and accumulation of potentially toxic lipids, which were corrected by intestinal DGAT1 deletion and GLP-1 receptor agonists. Conclusion: Cardiomyocyte DGAT1 deletion produces heart dysfunction and lipid abnormalities. Significance: Lipotoxicity in the heart can be alleviated by changes in intestinal metabolism. Diacylglycerol acyltransferase 1 (DGAT1) catalyzes the final step in triglyceride synthesis, the conversion of diacylglycerol (DAG) to triglyceride. Dgat1(-/-) mice exhibit a number of beneficial metabolic effects including reduced obesity and improved insulin sensitivity and no known cardiac dysfunction. In contrast, failing human hearts have severely reduced DGAT1 expression associated with accumulation of DAGs and ceramides. To test whether DGAT1 loss alone affects heart function, we created cardiomyocyte-specific DGAT1 knock-out (hDgat1(-/-)) mice. hDgat1(-/-) mouse hearts had 95% increased DAG and 85% increased ceramides compared with floxed controls. 50% of these mice died by 9 months of age. The heart failure marker brain natriuretic peptide increased 5-fold in hDgat1(-/-) hearts, and fractional shortening (FS) was reduced. This was associated with increased expression of peroxisome proliferator-activated receptor and cluster of differentiation 36. We crossed hDgat1(-/-) mice with previously described enterocyte-specific Dgat1 knock-out mice (hiDgat1(-/-)). This corrected the early mortality, improved FS, and reduced cardiac ceramide and DAG content. Treatment of hDgat1(-/-) mice with the glucagon-like peptide 1 receptor agonist exenatide also improved FS and reduced heart DAG and ceramide content. Increased fatty acid uptake into hDgat1(-/-) hearts was normalized by exenatide. Reduced activation of protein kinase C (PKC), which is increased by DAG and ceramides, paralleled the reductions in these lipids. Our mouse studies show that loss of DGAT1 reproduces the lipid abnormalities seen in severe human heart failure.	[Liu, Li; Trent, Chad M.; Fang, Xiang; Son, Ni-Huiping; Jiang, HongFeng; Blaner, William S.; Hu, Yunying; Ginsberg, Henry N.; Huang, Li-Shin; Goldberg, Ira J.] Columbia Univ Coll Phys & Surg, Div Prevent Med & Nutr, New York, NY 10032 USA; [Homma, Shunichi; Goldberg, Ira J.] Columbia Univ Coll Phys & Surg, Div Cardiol, New York, NY 10032 USA; [Liu, Li; Yin, Yu-Xin] Peking Univ, Inst Syst Biomed, Hlth Sci Ctr, Beijing 100083, Peoples R China; [Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Fang, Xiang; Hu, Shi-Lian] Anhui Med Univ, Affiliated Prov Hosp, Dept Geriatr, Hefei 230001, Peoples R China; [Turnbull, Andrew V.; Eriksson, Jan W.] Astra Zeneca Co, S-43150 Molndal, Sweden; [Eriksson, Jan W.] Uppsala Univ, Dept Med Sci, S-75105 Uppsala, Sweden; [Goldberg, Ira J.] NYU, Langone Sch Med, Div Endocrinol Diabet & Metab, New York, NY 10016 USA	Columbia University; Columbia University; Peking University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Anhui Medical University; Uppsala University; New York University; NYU Langone Medical Center	Goldberg, IJ (corresponding author), NYU, Langone Med Center, Div Endocrinol Diabet & Metab, 522 First Ave,Smilow 9B, New York, NY 10016 USA.	Ira.Goldberg@nyumc.org	jiang, hongfeng/I-6188-2013; Eriksson, Jan/AAB-5820-2021		National Institutes of Health from the NHLBI [HL45095, HL73029]; National Center for Advancing Translational Sciences [UL1 TR000040]; Heritage Affiliate of the American Heart Association; Department of Human Resources and Social Security of Anhui Province; Anhui Provincial Hospital; China National Major Scientific Program (973 Project) [2010CB912202]; National Natural Science Foundation of China [30930021]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045095, R01HL073029, R37HL045095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019413] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Heritage Affiliate of the American Heart Association(American Heart Association); Department of Human Resources and Social Security of Anhui Province; Anhui Provincial Hospital; China National Major Scientific Program (973 Project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL45095 and HL73029 (to I. J. G.) from the NHLBI and Grant UL1 TR000040 from the National Center for Advancing Translational Sciences.; Supported by a predoctoral fellowship from the Heritage Affiliate of the American Heart Association.; Supported by funds from Department of Human Resources and Social Security of Anhui Province and Anhui Provincial Hospital.; Supported by the China National Major Scientific Program (973 Project 2010CB912202) and National Natural Science Foundation of China (Key Project 30930021).	Ables GP, 2012, J LIPID RES, V53, P2364, DOI 10.1194/jlr.M029041; Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Axelsen LN, 2012, BRIT J PHARMACOL, V165, P2736, DOI 10.1111/j.1476-5381.2011.01714.x; Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; Birch AM, 2009, J MED CHEM, V52, P1558, DOI 10.1021/jm801507v; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen HC, 2003, J CLIN INVEST, V111, P1715, DOI [10.1172/JCI15859, 10.1172/JCI200315859]; Chen HC, 2003, AM J PHYSIOL-ENDOC M, V284, pE213, DOI 10.1152/ajpendo.00248.2002; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chokshi A, 2012, CIRCULATION, V125, P2844, DOI 10.1161/CIRCULATIONAHA.111.060889; Denison H, 2013, DIABETES OBES METAB, V15, P136, DOI 10.1111/dom.12002; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Drosatos K, 2011, AM J PHYSIOL-ENDOC M, V300, pE489, DOI 10.1152/ajpendo.00569.2010; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Hahn HS, 2003, CIRC RES, V93, P1111, DOI 10.1161/01.RES.0000105087.79373.17; Idris Iskandar, 2006, Diab Vasc Dis Res, V3, P172, DOI 10.3132/dvdr.2006.026; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; King AJ, 2010, EUR J PHARMACOL, V637, P155, DOI 10.1016/j.ejphar.2010.03.056; Lee B, 2010, J LIPID RES, V51, P1770, DOI 10.1194/jlr.M002311; Lin HV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054480; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu L, 2012, J LIPID RES, V53, P1482, DOI 10.1194/jlr.M024208; Liu L, 2011, J LIPID RES, V52, P732, DOI 10.1194/jlr.M011395; Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Morrow JP, 2011, CIRCULATION, V124, P2812, DOI 10.1161/CIRCULATIONAHA.111.056309; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Noyan-Ashraf MH, 2013, CIRCULATION, V127, P74, DOI 10.1161/CIRCULATIONAHA.112.091215; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Pineau L, 2010, FEMS YEAST RES, V10, P1035, DOI 10.1111/j.1567-1364.2010.00674.x; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; Rotolo J, 2012, J CLIN INVEST, V122, P1786, DOI 10.1172/JCI59920; Schmitz-Peiffer C, 2000, CELL SIGNAL, V12, P583, DOI 10.1016/S0898-6568(00)00110-8; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Streeper RS, 2012, AGING-US, V4, P13, DOI 10.18632/aging.100424; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Ussher JR, 2014, MOL METAB, V3, P507, DOI 10.1016/j.molmet.2014.04.009; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Vamecq J, 2012, CURR DRUG METAB, V13, P1388, DOI 10.2174/138920012803762792; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Yamamoto T, 2010, EUR J PHARMACOL, V640, P243, DOI 10.1016/j.ejphar.2010.04.050; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	52	47	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29881	29891		10.1074/jbc.M114.601864	http://dx.doi.org/10.1074/jbc.M114.601864			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25157099	Green Published, hybrid			2022-12-25	WOS:000344370800032
J	Costa, KM; Maciel, IS; Kist, LW; Campos, MM; Bogo, MR				Costa, Kesiane M.; Maciel, Izaque S.; Kist, Luiza W.; Campos, Maria M.; Bogo, Mauricio R.			Pharmacological Inhibition of CXCR2 Chemokine Receptors Modulates Paraquat-Induced Intoxication in Rats	PLOS ONE			English	Article							PARKINSONS-DISEASE; NITRIC-OXIDE; HEMORRHAGIC CYSTITIS; LIPID-PEROXIDATION; MOUSE-BRAIN; CELL-DEATH; ADULT RATS; IN-VIVO; EXPRESSION; MODEL	Paraquat (PQ) is an agrochemical agent commonly used worldwide, which is allied to potential risks of intoxication. This herbicide induces the formation of reactive oxygen species (ROS) that ends up compromising various organs, particularly the lungs and the brain. This study evaluated the deleterious effects of paraquat on the central nervous system (CNS) and peripherally, with special attempts to assess the putative protective effects of the selective CXCR2 receptor antagonist SB225002 on these parameters. PQ-toxicity was induced in male Wistar rats, in a total dose of 50 mg/kg, and control animals received saline solution at the same schedule of administration. Separate groups of animals were treated with the selective CXCR2 antagonist SB225002 (1 or 3 mg/kg), administered 30 min before each paraquat injection. The major changes found in paraquat-treated animals were: decreased body weight and hypothermia, nociception behavior, impairment of locomotor and gait capabilities, enhanced TNF-alpha and IL-1 beta expression in the striatum, and cell migration to the lungs and blood. Some of these parameters were reversed when the antagonist SB225002 was administered, including recovery of physiological parameters, decreased nociception, improvement of gait abnormalities, modulation of striatal TNF-alpha and IL-1 beta expression, and decrease of neutrophil migration to the lungs and blood. Taken together, our results demonstrate that damage to the central and peripheral systems elicited by paraquat can be prevented by the pharmacological inhibition of CXCR2 chemokine receptors. The experimental evidence presented herein extends the comprehension on the toxicodynamic aspects of paraquat, and opens new avenues to treat intoxication induced by this herbicide.	[Costa, Kesiane M.; Maciel, Izaque S.; Kist, Luiza W.; Campos, Maria M.; Bogo, Mauricio R.] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Med & Hlth Sci, Porto Alegre, RS, Brazil; [Kist, Luiza W.; Bogo, Mauricio R.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biosci, Lab Genom & Mol Biol, Porto Alegre, RS, Brazil; [Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Inst Pharmacol & Toxicol, Porto Alegre, RS, Brazil; [Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Fac Dent, Porto Alegre, RS, Brazil; [Bogo, Mauricio R.] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Cellular & Mol Biol, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Bogo, MR (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Med & Hlth Sci, Porto Alegre, RS, Brazil.	mbogo@pucrs.br	de Sousa Maciel, Izaque/AAD-9693-2020; Maciel, Izaque/I-1038-2014; Kist, Luiza Wilges/J-3786-2013; Campos, Maria Martha M/J-8829-2015; Bogo, Mauricio R/D-7537-2013	de Sousa Maciel, Izaque/0000-0001-6597-5288; Kist, Luiza Wilges/0000-0001-6358-9367; Campos, Maria Martha M/0000-0002-1153-3633; Bogo, Mauricio R/0000-0002-5728-9576; Campos, Maria/0000-0001-7738-9892	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); DECIT/SCTIEMS through CNPq; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [Proc. FAPERGS 10/0036-5 - PRONEX]; FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS'' (PUCRSINFRA) [01.11.0014-00]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DECIT/SCTIEMS through CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS'' (PUCRSINFRA)	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), DECIT/SCTIEMS through CNPq and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) (Proc. FAPERGS 10/0036-5 - PRONEX), and FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS'' (PUCRSINFRA) # 01.11.0014-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073562; Bacon KB, 2000, J NEUROIMMUNOL, V104, P92, DOI 10.1016/S0165-5728(99)00266-0; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Carvalho MM, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-14; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chanyachukul T, 2004, TOXICOL LETT, V150, P259, DOI 10.1016/j.toxlet.2004.02.007; Cho JH, 2005, VASC PHARMACOL, V42, P171, DOI 10.1016/j.vph.2005.01.001; Choi WS, 2010, J NEUROPATH EXP NEUR, V69, P511, DOI 10.1097/NEN.0b013e3181db8100; Cicchetti F, 2005, NEUROBIOL DIS, V20, P360, DOI 10.1016/j.nbd.2005.03.018; Corasaniti MT, 1998, PHARMACOL TOXICOL, V83, P1, DOI 10.1111/j.1600-0773.1998.tb01434.x; Czerniczyniec A, 2011, FREE RADICAL BIO MED, V51, P1428, DOI 10.1016/j.freeradbiomed.2011.06.034; Day BJ, 1999, P NATL ACAD SCI USA, V96, P12760, DOI 10.1073/pnas.96.22.12760; DELLON ES, 1991, PLAST RECONSTR SURG, V88, P686, DOI 10.1097/00006534-199110000-00020; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Dinis-Oliveira RJ, 2006, TOXICOLOGY, V227, P73, DOI 10.1016/j.tox.2006.07.025; Dinis-Oliveira RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007149; Dornelles FN, 2014, BRIT J PHARMACOL, V171, P452, DOI 10.1111/bph.12467; Fareed M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069755; Gupta SP, 2010, NEUROCHEM RES, V35, P1206, DOI 10.1007/s11064-010-0176-5; Hanafy S, 2012, J PHARM PHARM SCI, V15, P361, DOI 10.18433/J30300; Hayashi A, 2013, NEUROMOL MED, V15, P238, DOI 10.1007/s12017-012-8214-x; HOLLAND HC, 1968, ACTA PSYCHOL, V28, P293, DOI 10.1016/0001-6918(68)90020-6; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Hsieh YW, 2013, PEDIATR EMERG CARE, V29, P487, DOI 10.1097/PEC.0b013e31828a347e; Kang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078160; Kang MJ, 2010, TOXICOL LETT, V195, P127, DOI 10.1016/j.toxlet.2010.03.011; Kireev RA, 2012, J SURG RES, V178, P922, DOI 10.1016/j.jss.2012.04.060; KORNBRUST DJ, 1980, TOXICOL APPL PHARM, V53, P323, DOI 10.1016/0041-008X(80)90433-0; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Litteljohn D, 2008, EUR J NEUROSCI, V28, P707, DOI 10.1111/j.1460-9568.2008.06371.x; Mainwaring G, 2006, TOXICOLOGY, V225, P157, DOI 10.1016/j.tox.2006.05.017; Manjavachi MN, 2010, EUR J PAIN, V14, P23, DOI 10.1016/j.ejpain.2009.01.007; Martins JP, 2012, BRIT J PHARMACOL, V165, P183, DOI 10.1111/j.1476-5381.2011.01535.x; Mitra S, 2006, BBA-MOL BASIS DIS, V1762, P732, DOI 10.1016/j.bbadis.2006.06.011; Mitra S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-163; Moretto A, 2013, TOXICOLOGY, V307, P24, DOI 10.1016/j.tox.2012.11.021; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nasser MW, 2007, J BIOL CHEM, V282, P6906, DOI 10.1074/jbc.M610289200; Nguyen D, 2001, DEV BRAIN RES, V128, P77, DOI 10.1016/S0165-3806(01)00128-6; Paolillo N, 2011, INT J IMMUNOPATH PH, V24, P861, DOI 10.1177/039463201102400405; Pereira VM, 2012, NEUROTOXICOLOGY, V33, P469, DOI 10.1016/j.neuro.2012.03.005; Pilny Anthony A., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P523, DOI 10.1016/j.cvex.2008.04.001; Popivanova BK, 2003, BRAIN RES, V970, P195, DOI 10.1016/S0006-8993(03)02343-6; Prasad K, 2009, EXP NEUROL, V215, P358, DOI 10.1016/j.expneurol.2008.11.003; Richter F, 2008, BRAIN RES, V1188, P148, DOI 10.1016/j.brainres.2007.09.083; ROSE MS, 1976, BIOCHEM PHARMACOL, V25, P419, DOI 10.1016/0006-2952(76)90344-0; Santos AA, 2010, N-S ARCH PHARMACOL, V382, P399, DOI 10.1007/s00210-010-0555-0; Satomi Yoshihide, 2004, J Toxicol Sci, V29, P91, DOI 10.2131/jts.29.91; Singh LP, 2012, EXP NEUROL, V238, P79, DOI 10.1016/j.expneurol.2012.08.009; Smith P, 1975, J Clin Pathol Suppl (R Coll Pathol), V9, P81, DOI 10.1136/jcp.28.Suppl_9.81; Souza DG, 2000, EUR J PHARMACOL, V403, P121, DOI 10.1016/S0014-2999(00)00574-4; Thrash Bessy, 2007, Proc West Pharmacol Soc, V50, P31; Tomita M, 2007, TOXICOLOGY, V231, P200, DOI 10.1016/j.tox.2006.12.005; Vaculin S, 2010, NEUROSCI LETT, V477, P82, DOI 10.1016/j.neulet.2010.04.037; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Venkatesan N, 1999, LIFE SCI, V66, pPL21, DOI 10.1016/S0024-3205(99)00576-7; WALLACE JE, 1980, J GERONTOL, V35, P364, DOI 10.1093/geronj/35.3.364; Wantuch C, 2007, NEUROSCI LETT, V421, P250, DOI 10.1016/j.neulet.2007.05.043; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Zhang ZJ, 2013, PAIN, V154, P2185, DOI 10.1016/j.pain.2013.07.002; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	64	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105740	10.1371/journal.pone.0105740	http://dx.doi.org/10.1371/journal.pone.0105740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153082	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200079
J	Knipping, K; Simons, PJ; Buelens-Sleumer, LS; Cox, L; den Hartog, M; de Jong, N; Teshima, R; Garssen, J; Boon, L; Knippels, LMJ				Knipping, Karen; Simons, Peter J.; Buelens-Sleumer, Laura S.; Cox, Linda; den Hartog, Marcel; de Jong, Niels; Teshima, Reiko; Garssen, Johan; Boon, Louis; Knippels, Leon M. J.			Development of beta-Lactoglobulin-Specific Chimeric Human IgE kappa Monoclonal Antibodies for In Vitro Safety Assessment of Whey Hydrolysates	PLOS ONE			English	Article							COWS MILK ALLERGY; INFANT FORMULAS; SERUM IGE; CELL DEGRANULATION; BINDING EPITOPES; CROSS-LINKING; MAST-CELLS; PREVENTION; FOOD; ALLERGENICITY	Background: Cow's milk-derived whey hydrolysates are nutritional substitutes for allergic infants. Safety or residual allergenicity assessment of these whey hydrolysates is crucial. Currently, rat basophilic leukemia RBL-2H3 cells expressing the human IgE receptor alpha-chain (huFc epsilon RI alpha-RBL-2H3), sensitized with serum IgE from cow's milk allergic children, are being employed to assess in vitro residual allergenicity of these whey hydrolysates. However, limited availability and inter-lot variation of these allergic sera impede standardization of whey hydrolysate safety testing in degranulation assays. Objective: An oligoclonal pool of chimeric human (chu)IgE antibodies against bovine beta-lactoglobulin (a major allergen in whey) was generated to increase sensitivity, specificity, and reproducibility of existing degranulation assays. Methods: Mice were immunized with bovine beta-lactoglobulin, and subsequently the variable domains of dissimilar anti-blactoglobulin mouse IgG antibodies were cloned and sequenced. Six chimeric antibodies were generated comprising mouse variable domains and human constant IgE/kappa domains. Results: After sensitization with this pool of anti-beta-lactoglobulin chuIgEs, huFc epsilon RI alpha-expressing RBL-2H3 cells demonstrated degranulation upon cross-linking with whey, native 18 kDa beta-lactoglobulin, and 5-10 kDa whey hydrolysates, whereas a 3 kDa whey hydrolysate and cow's milk powder (mainly casein) showed no degranulation. In parallel, allergic serum IgEs were less sensitive. In addition, our pool anti-beta-lactoglobulin chuIgEs recognized multiple allergenic immunodominant regions on beta-lactoglobulin, which were also recognized by serum IgEs from cow's milk allergic children. Conclusion: Usage of our 'unlimited' source and well-defined pool of beta-lactoglobulin-specific recombinant chuIgEs to sensitize huFc epsilon RI alpha on RBL-2H3 cells showed to be a relevant and sensitive alternative for serum IgEs from cow's milk allergic patients to assess safety of whey-based non-allergic hydrolyzed formula.	[Knipping, Karen; Buelens-Sleumer, Laura S.; Garssen, Johan; Knippels, Leon M. J.] Nutricia Res BV, Utrecht, Netherlands; [Knipping, Karen; Garssen, Johan; Knippels, Leon M. J.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Simons, Peter J.; Cox, Linda; den Hartog, Marcel; de Jong, Niels; Boon, Louis] Bioceros Holding BV, Utrecht, Netherlands; [Teshima, Reiko] Natl Inst Hlth Sci, Div Foods, Tokyo, Japan	Danone Nutricia; Utrecht University; Bioceros B.V.; National Institute of Health Sciences - Japan	Knipping, K (corresponding author), Nutricia Res BV, Utrecht, Netherlands.	karen.knipping@danone.com; p.simons@bioceros.com	garssen, johan/I-7159-2016; Boon, Laurence/HCI-3629-2022	Boon, Louis/0000-0002-0937-9171	Agentschap NL within the SLIM (SneLler van Innovatie naar Mens) project [PID 101063]	Agentschap NL within the SLIM (SneLler van Innovatie naar Mens) project	This study is financially supported by Agentschap NL within the SLIM (SneLler van Innovatie naar Mens) project in frame of 'Pieken in de Delta' (PID 101063) to improve fast implementation of alternatives for animal testing. Funding received by KK, PS, LBS, LC, MdH, NdJ, JG, LB and LK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan YH, 2002, J PAEDIATR CHILD H, V38, P84, DOI 10.1046/j.1440-1754.2002.00725.x; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Cocco RR, 2007, CLIN EXP ALLERGY, V37, P831, DOI 10.1111/j.1365-2222.2007.02712.x; Dibbern DA, 2003, J IMMUNOL METHODS, V274, P37, DOI 10.1016/S0022-1759(02)00369-1; Fritsche R, 2003, TOXICOL LETT, V140, P303, DOI 10.1016/S0378-4274(03)00026-2; Halken S, 2000, PEDIATR ALLERGY IMMU, V11, P149, DOI 10.1034/j.1399-3038.2000.00081.x; Hays T, 2005, ARCH PEDIAT ADOL MED, V159, P810, DOI 10.1001/archpedi.159.9.810; Howard G., 2006, MAKING USING ANTIBOD; HUDSON MJ, 1995, EUR J CLIN NUTR, V49, pS64; Jarvinen KM, 2001, INT ARCH ALLERGY IMM, V126, P111, DOI 10.1159/000049501; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Knipping K, 2014, ACTA PAEDIATR, V103, P766, DOI 10.1111/apa.12651; Knipping K, 2012, INT ARCH ALLERGY IMM, V159, P263, DOI 10.1159/000338007; Knol EF, 2006, MOL NUTR FOOD RES, V50, P620, DOI 10.1002/mnfr.200500272; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Ladics GS, 2008, REGUL TOXICOL PHARM, V51, P288, DOI 10.1016/j.yrtph.2008.04.012; LINKOLOPPONEN S, 1985, ANAL BIOCHEM, V148, P50, DOI 10.1016/0003-2697(85)90626-8; Marchand F, 2003, ALLERGY, V58, P1037, DOI 10.1034/j.1398-9995.2003.00251.x; Meza-Nieto MA, 2007, J DAIRY SCI, V90, P582, DOI 10.3168/jds.S0022-0302(07)71541-2; Monaci L, 2006, EUR FOOD RES TECHNOL, V223, P149, DOI 10.1007/s00217-005-0178-8; Nakamura R, 2010, ALLERGY, V65, P1266, DOI 10.1111/j.1398-9995.2010.02363.x; Nakamura R, 2012, ALLERGOL INT, V61, P431, DOI 10.2332/allergolint.11-OA-0407; Rouvinen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009037; Takagi K, 2003, BIOL PHARM BULL, V26, P252, DOI 10.1248/bpb.26.252; van Esch BCAM, 2013, TOXICOL LETT, V220, P95, DOI 10.1016/j.toxlet.2013.04.008; van Esch BCAM, 2011, TOXICOL LETT, V201, P264, DOI 10.1016/j.toxlet.2011.01.010; von Berg A, 2003, J ALLERGY CLIN IMMUN, V111, P533, DOI 10.1067/mai.2003.101; Wada Naruhito, 1997, Allergology International, V46, P173, DOI 10.2332/allergolint.46.173; ZEIGER RS, 1995, J ALLERGY CLIN IMMUN, V95, P1179, DOI 10.1016/S0091-6749(95)70074-9	29	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106025	10.1371/journal.pone.0106025	http://dx.doi.org/10.1371/journal.pone.0106025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153680	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200107
J	Kong, XZ; Zhen, ZL; Li, XT; Lu, HH; Wang, RS; Liu, L; He, Y; Zang, YF; Liu, J				Kong, Xiang-zhen; Zhen, Zonglei; Li, Xueting; Lu, Huan-hua; Wang, Ruosi; Liu, Ling; He, Yong; Zang, Yufeng; Liu, Jia			Individual Differences in Impulsivity Predict Head Motion during Magnetic Resonance Imaging	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; FUNCTIONAL CONNECTIVITY MRI; FRONTAL-CORTEX; FMRI; CHILDREN; BEHAVIOR; ADHD; DYSFUNCTION; ACTIVATION; NETWORK	Magnetic resonance imaging (MRI) provides valuable data for understanding the human mind and brain disorders, but in-scanner head motion introduces systematic and spurious biases. For example, differences in MRI measures (e.g., network strength, white matter integrity) between patient and control groups may be due to the differences in their head motion. To determine whether head motion is an important variable in itself, or just simply a confounding variable, we explored individual differences in psychological traits that may predispose some people to move more than others during an MRI scan. In the first two studies, we demonstrated in both children (N = 245) and adults (N = 581) that head motion, estimated from resting-state functional MRI and diffusion tensor imaging, was reliably correlated with impulsivity scores. Further, the difference in head motion between children with attention deficit hyperactivity disorder (ADHD) and typically developing children was largely due to differences in impulsivity. Finally, in the third study, we confirmed the observation that the regression approach, which aims to deal with motion issues by regressing out motion in the group analysis, would underestimate the effect of interest. Taken together, the present findings provide empirical evidence that links in-scanner head motion to psychological traits.	[Kong, Xiang-zhen; Zhen, Zonglei; Li, Xueting; Lu, Huan-hua; Wang, Ruosi; Liu, Ling; He, Yong] Beijing Normal Univ, McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Kong, Xiang-zhen; Zhen, Zonglei; Li, Xueting; Lu, Huan-hua; Wang, Ruosi; Liu, Ling; He, Yong] Beijing Normal Univ, McGovern Inst Brain Res, IDG, Beijing 100875, Peoples R China; [Liu, Jia] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Kong, Xiang-zhen; Zhen, Zonglei; Li, Xueting; Lu, Huan-hua; Liu, Ling; He, Yong; Liu, Jia] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Zang, Yufeng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University; Hangzhou Normal University	Liu, J (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn	Wang, Ruosi/AAB-4624-2022; He, Yong/Q-5756-2018; ZANG, Yu-Feng/J-1558-2012; He, Yong/C-2161-2009; Zhen, Zonglei/GPG-1239-2022	Wang, Ruosi/0000-0002-0341-5020; ZANG, Yu-Feng/0000-0003-1833-8010; Liu, Jia/0000-0003-0383-0934; He, Yong/0000-0002-7039-2850; Kong, Xiangzhen/0000-0002-0805-1350	National Natural Science Foundation of China [31230031, 91132703, 31221003, 30800295]; National Basic Research Program of China [2010CB833903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (31230031, 91132703, 31221003 and 30800295) and the National Basic Research Program of China (2010CB833903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cho SS, 2013, BRAIN TOPOGR, V26, P479, DOI 10.1007/s10548-012-0270-x; Deen Ben, 2012, Nature, V491, pS20; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; Dvorak RD, 2013, AGGRESSIVE BEHAV, V39, P222, DOI 10.1002/ab.21474; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaiser MD, 2010, P NATL ACAD SCI USA, V107, P21223, DOI 10.1073/pnas.1010412107; Kong XZ, 2014, PEERJ, V2, DOI 10.7717/peerj.366; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Lucantonio F, 2012, NAT NEUROSCI, V15, P358, DOI 10.1038/nn.3014; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Murphy K, 2013, RESTING STATE FMRI C; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PAULSEN K, 1980, J ABNORM CHILD PSYCH, V8, P269, DOI 10.1007/BF00919070; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reynolds B, 2008, EXP CLIN PSYCHOPHARM, V16, P124, DOI 10.1037/1064-1297.16.2.124; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Tijssen RHN, 2009, HUM BRAIN MAPP, V30, P2641, DOI 10.1002/hbm.20695; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Worsley K.J., 2001, FUNCTIONAL MRI INTRO, P25; Wylie GR, 2014, HUM BRAIN MAPP, V35, P1, DOI 10.1002/hbm.22150; Yan CG, 2013, NEUROIMAGE; Yendiki A, 2013, NEUROIMAGE; Yoo SS, 2005, NEUROSCI RES, V53, P84, DOI 10.1016/j.neures.2005.06.004; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng L-L, 2014, P NATL ACAD SCI US; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	41	63	63	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104989	10.1371/journal.pone.0104989	http://dx.doi.org/10.1371/journal.pone.0104989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148416	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600028
J	Tahara, T; Shibata, T; Okubo, M; Sumi, K; Ishizuka, T; Nakamura, M; Nagasaka, M; Nakagawa, Y; Ohmiya, N; Arisawa, T; Hirata, I				Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Sumi, Kazuya; Ishizuka, Takamitsu; Nakamura, Masakatsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki; Arisawa, Tomiyasu; Hirata, Ichiro			Change in DNA Methylation Patterns of SLC6A4 Gene in the Gastric Mucosa in Functional Dyspepsia	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; SEROTONIN TRANSPORTER GENE; PSYCHOSOCIAL FACTORS; POLYMORPHISM; POPULATION; GENOTYPE	Background: The neurochemical serotonin (5-HT) is an important signaling molecule in the gastrointestinal motor and sensory functions. A key regulator of 5-HT levels is the transmembrane serotonin transporter (5-HTT; SLC6A4) that governs the reuptake of 5-HT. Recent studies have indicated 5-HTT expression may be regulated by epigenetic mechanisms. We investigated DNA methylation status of SLC6A4 gene in the gastric mucosa from functional dyspepsia (FD) because of their potential role in dyspeptic symptoms. Methods: Endoscopic gastric biopsies were obtained from 78 subjects with no upper abdominal symptoms and 79 patients with FD. Bisulfite Pyrosequencing was carried out to determine the methylation status of promoter CpG islands (PCGIs), promoter non-CpG islands (PNCGIs) and gene body non-CpG islands (NPNCGIs) in the SLC6A4 gene. Gene expression was examined by real-time PCR. Results: In overall, methylation level of PCGIs was significantly lower in FD compared to control subjects (p = 0.04). On the other hand, methylation level of NPNCGIs was significantly higher in FD compared to control subjects (p = 0.03). Lower methylation level in PNCGIs was highlighted in the patients with PDS (p = 0.01), while higher methylation level in NPNCGIs was more prominent in the patients with EPS (p = 0.017). Methylation levels of PCGIs and PNCGIs were inversely correlated, while methylation levels of NPNCGIs was positively correlated with SLC6A4 mRNA levels in FD patients. Conclusions: Our data suggest that change in DNA methylation pattern of SLC6A4 in the gastric mucosa may have a role for developing FD. A role of epigenetics for developing FD needs to be further evaluated.	[Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Sumi, Kazuya; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki; Hirata, Ichiro] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi 47011, Japan; [Nakamura, Masakatsu; Arisawa, Tomiyasu] Kanazawa Med Univ, Dept Gastroenterol, Uchinada, Ishikawa 92002, Japan	Fujita Health University; Kanazawa Medical University	Tahara, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi 47011, Japan.	tomomiccyu@yahoo.co.jp	Sumi, Kazuya/AFN-4425-2022	Sumi, Kazuya/0000-0002-5484-8504				Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Coffin B, 1991, GASTROENTEROLOGY; DROSSMAN DA, 1988, GASTROENTEROLOGY, V95, P701, DOI 10.1016/S0016-5085(88)80017-9; DROSSMAN DA, 1990, GASTROEN CLIN BIOL, V14, pC49; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; Holtmann G, 2004, GASTROENTEROLOGY, V126, P971, DOI 10.1053/j.gastro.2004.01.006; Holtmann G, 1998, GUT, V42, P501, DOI 10.1136/gut.42.4.501; Locke GR, 1998, BAILLIERE CLIN GASTR, V12, P435; Pata C, 2002, AM J GASTROENTEROL, V97, P1780; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Philibert RA, 2008, AM J MED GENET B, V147B, P543, DOI 10.1002/ajmg.b.30657; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Stanghellini V, 1996, GASTROENTEROLOGY, V110, P1036, DOI 10.1053/gast.1996.v110.pm8612991; Tack J, 1998, GASTROENTEROLOGY, V115, P1346, DOI 10.1016/S0016-5085(98)70012-5; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Tahara T, 2012, EXPERT REV MOL DIAGN, V12, P489, DOI [10.1586/erm.12.38, 10.1586/ERM.12.38]; TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P1259; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Toyoshima F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-88; Turker MS, 1999, SEMIN CANCER BIOL, V9, P329, DOI 10.1006/scbi.1999.0133; Yeo A, 2004, GUT, V53, P1452, DOI 10.1136/gut.2003.035451	22	6	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105565	10.1371/journal.pone.0105565	http://dx.doi.org/10.1371/journal.pone.0105565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148529	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600059
J	Akinyemiju, TF; McDonald, JA; Tsui, J; Greenlee, H				Akinyemiju, Tomi F.; McDonald, Jasmine A.; Tsui, Jennifer; Greenlee, Heather			Adherence to Cancer Prevention Guidelines in 18 African Countries	PLOS ONE			English	Article							RESEARCH FUND/AMERICAN INSTITUTE; LIFE-STYLE FACTORS; RISK-FACTORS; PROSTATE-CANCER; SOCIOECONOMIC-STATUS; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; HEALTH; MORTALITY; WORLD	Background: Cancer rates in Africa are projected to double by 2030 due to aging and increased exposure to cancer risk factors, including modifiable risk factors. We assessed adherence to 5 modifiable cancer risk factors across 18 African countries. Methods: Data on adults 18 years and older were obtained from the 2002-2004 World Health Survey. Adherence to current World Cancer Research Fund guidelines on smoking, alcohol, body weight, physical activity, and nutrition was assessed. Adherence scores ranged from 0 (no guideline met) to 5 (all guidelines met). Determinants of adherence were assessed using multivariable linear regression adjusted for individual and country level characteristics. Results: Across all countries, adherence to the guidelines among adults was high for smoking (72%-99%) and alcohol (85%-100%), but low for body weight (1.8%-78%), physical activity (3.4%-84%) and nutrition (1.4%-61%). Overall adherence score ranged from 2.32 in Mali to 3.72 in Comoros. In multivariable models, residing in low versus high SES households was associated with reduced adherence by 0.24 and 0.21 points for men and women respectively after adjusting for age, gender, education, and marital status (p<0.001). Every % increase in GDP spent on health was associated with increased adherence by 0.03 in men and 0.09 in women (p<0.001). Conclusions: The wide variation in adherence to cancer prevention guidelines observed across countries and between population sub-groups suggests the need for targeted public health efforts to improve behaviors related to body weight, physical activity and nutrition.	[Akinyemiju, Tomi F.; McDonald, Jasmine A.; Tsui, Jennifer; Greenlee, Heather] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Greenlee, Heather] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University	Akinyemiju, TF (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	ofa2107@columbia.edu	McDonald, Jasmine/L-4249-2019; Tsui, Jennifer/ABE-3743-2020	McDonald, Jasmine/0000-0002-8270-8074; 	National Cancer Institute [2-R25-CA-09529, 5T32CA09529, K23CA141052]; NATIONAL CANCER INSTITUTE [K23CA141052, T32CA009529] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was financially supported by the National Cancer Institute's R25 Cancer Training Grant 2-R25-CA-09529 (TA and JT), 5T32CA09529 (JAM), and K23CA141052 (HG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji J, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P11; Akinyemiju TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048834; American Cancer Society, 2011, CANC FACTS FIG 2011; Arab L, 2013, NUTR CANCER, V65, P633, DOI 10.1080/01635581.2013.789540; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Blakely T, 2005, B WORLD HEALTH ORGAN, V83, P118; Catsburg C, 2014, INT J CANC; Centers for Disease Control and Prevention, 2009, BEH RISK FACT SURV S; Farag M, 2013, INT J HEALTH CARE FI, V13, P33, DOI 10.1007/s10754-012-9120-3; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; Hastert TA, 2013, CANC EPIDEMIOL BIOMA; Hastert TA, 2014, CANCER CAUSE CONTROL, V25, P541, DOI 10.1007/s10552-014-0358-6; Health and Social Science Information Center, 2011, HLTH SURV ENGL 2011; Inoue-Choi M, 2013, J CLIN ONCOL, V31, P1758, DOI 10.1200/JCO.2012.45.4462; Inoue-Choi M, 2013, CANCER EPIDEM BIOMAR, V22, P792, DOI 10.1158/1055-9965.EPI-13-0054; International Agency for Research on Cancer, 2013, GLOBOCAN CANC STAT; International Agency for Research on Cancer, 2008, WORLD CANC REPORT 20; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Manthalu G, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-6; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Nelson NJ, 2012, J NATL CANCER I, V104, P574, DOI 10.1093/jnci/djs213; Nilsen TIL, 2000, BRIT J CANCER, V82, P1358; Putnam SD, 2000, ANN EPIDEMIOL, V10, P361, DOI 10.1016/S1047-2797(00)00057-0; Rasool S, 2013, TUMOUR BIOL; Romaguera D, 2012, AM J CLIN NUTR, V96, P150, DOI 10.3945/ajcn.111.031674; Rosato V, 2013, EUR J CANC PREV; Swift R, 2011, HEALTH ECON, V20, P306, DOI 10.1002/hec.1590; Tehranifar P, 2009, CANCER EPIDEM BIOMAR, V18, P2701, DOI 10.1158/1055-9965.EPI-09-0305; The World Bank, 2013, INDICATORS; Thomson CA, 2014, CANCER PREV RES, V7, P42, DOI 10.1158/1940-6207.CAPR-13-0258; Vergnaud AC, 2013, AM J CLIN NUTR, V97, P1107, DOI 10.3945/ajcn.112.049569; Vossenaar M, 2010, NUTRITION, V26, P40, DOI 10.1016/j.nut.2009.04.007; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2013, WHO WORLD HLTH SURV; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105209	10.1371/journal.pone.0105209	http://dx.doi.org/10.1371/journal.pone.0105209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144291	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100043
J	Gilabert, M; Launay, S; Ginestier, C; Bertucci, F; Audebert, S; Pophillat, M; Toiron, Y; Baudelet, E; Finetti, P; Noguchi, T; Sobol, H; Birnbaum, D; Borg, JP; Charafe-Jauffret, E; Goncalves, A				Gilabert, Marine; Launay, Simon; Ginestier, Christophe; Bertucci, Francois; Audebert, Stephane; Pophillat, Mathieu; Toiron, Yves; Baudelet, Emilie; Finetti, Pascal; Noguchi, Tetsuro; Sobol, Hagay; Birnbaum, Daniel; Borg, Jean-Paul; Charafe-Jauffret, Emmanuelle; Goncalves, Anthony			Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib	PLOS ONE			English	Article							DRUG-RESISTANCE; TUMORS; EXPRESSION; CARCINOMA; GRADE	Background: Breast cancer stem cells (BCSCs) have been recognized as playing a major role in various aspects of breast cancer biology. To identify specific biomarkers of BCSCs, we have performed comparative proteomics of BCSC-enriched and mature cancer cell populations from the human breast cancer cell line (BCL), BrCA-MZ-01. Methods: ALDEFLUOR assay was used to sort BCSC-enriched (ALDH+) and mature cancer (ALDH-) cell populations. Total proteins were extracted from both fractions and subjected to 2-Dimensional Difference In-Gel Electrophoresis (2-D DIGE). Differentially-expressed spots were excised and proteins were gel-extracted, digested and identified using MALDI-TOF MS. Results: 2-D DIGE identified poly(ADP-ribose) polymerase 1 (PARP1) as overexpressed in ALDH+ cells from BrCA-MZ-01. This observation was confirmed by western blot and extended to four additional human BCLs. ALDH+ cells from BRCA1-mutated HCC1937, which had the highest level of PARP1 overexpression, displayed resistance to olaparib, a specific PARP1 inhibitor. Conclusion: An unbiased proteomic approach identified PARP1 as upregulated in ALDH+, BCSC-enriched cells from various human BCLs, which may contribute to clinical resistance to PARP inhibitors.	[Gilabert, Marine; Audebert, Stephane; Pophillat, Mathieu; Toiron, Yves; Baudelet, Emilie; Borg, Jean-Paul; Goncalves, Anthony] Inst Paoli Calmettes, Dept Mol Pharmacol, Marseille, France; [Gilabert, Marine; Launay, Simon; Bertucci, Francois; Goncalves, Anthony] Inst Paoli Calmettes, Dept Med Oncol, Marseille, France; [Charafe-Jauffret, Emmanuelle] Inst Paoli Calmettes, Dept Biopathol, Marseille, France; [Launay, Simon; Ginestier, Christophe; Bertucci, Francois; Finetti, Pascal; Birnbaum, Daniel; Charafe-Jauffret, Emmanuelle] Inst Paoli Calmettes, Dept Mol Oncol, Marseille, France; [Noguchi, Tetsuro; Sobol, Hagay] Inst Paoli Calmettes, Dept Canc Genet, Marseille, France; [Gilabert, Marine; Bertucci, Francois; Sobol, Hagay; Borg, Jean-Paul; Charafe-Jauffret, Emmanuelle; Goncalves, Anthony] Aix Marseille Univ, Marseille, France; [Gilabert, Marine; Ginestier, Christophe; Bertucci, Francois; Audebert, Stephane; Pophillat, Mathieu; Toiron, Yves; Baudelet, Emilie; Finetti, Pascal; Birnbaum, Daniel; Borg, Jean-Paul; Charafe-Jauffret, Emmanuelle; Goncalves, Anthony] CNRS, INSERM, Ctr Rech Cancerol Marseille, U1068,U7258, Marseille, France	UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Goncalves, A (corresponding author), Inst Paoli Calmettes, Dept Mol Pharmacol, Marseille, France.	goncalvesa@ipc.unicancer.fr	Ginestier, Christophe/M-8828-2017; Borg, Jean-Paul/AAX-8096-2020; Charafe-Jauffret, emmanuelle/P-6009-2017; Finetti, Pascal/O-8669-2017	Ginestier, Christophe/0000-0002-7477-3837; Borg, Jean-Paul/0000-0001-8418-3382; Charafe-Jauffret, emmanuelle/0000-0002-0286-1299; Finetti, Pascal/0000-0002-2674-3123; Bertucci, Francois/0000-0002-0157-0959; Audebert, Stephane/0000-0002-9409-2588	SIRIC program [INCa-DGOS-Inserm 6038]; Sanofi-Aventis; Association pour la Recherche sur le Cancer (ARC); Fondation pour la Recherche Medicale (FRM)	SIRIC program; Sanofi-Aventis(Sanofi-Aventis); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by SIRIC program (INCa-DGOS-Inserm 6038) and Sanofi-Aventis. MG was supported by a grant from "Association pour la Recherche sur le Cancer (ARC)''. SL was supported by a grant from "Fondation pour la Recherche Medicale (FRM)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goncalves A, 2008, MOL CELL PROTEOMICS, V7, P1420, DOI 10.1074/mcp.M700487-MCP200; Goncalves A, 2011, BREAST CANCER RES TR, V127, P273, DOI 10.1007/s10549-010-1199-y; Guo W, 1999, CLIN CANCER RES, V5, P621; Hassanein M, 2013, PATHOBIOLOGY, V80, P219, DOI 10.1159/000339432; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kelly RJ, 2012, ONCOLOGIST, V17, P512, DOI 10.1634/theoncologist.2012-0080; Mobus VJ, 1998, INT J CANCER, V77, P415, DOI 10.1002/(SICI)1097-0215(19980729)77:3<415::AID-IJC18>3.0.CO;2-6; O'Shaughnessy J, 2011, J CLIN ONCOL S, V29; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; von Minckwitz G, 2011, J CLIN ONCOL, V29, P2150, DOI 10.1200/JCO.2010.31.9079; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153	23	40	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104302	10.1371/journal.pone.0104302	http://dx.doi.org/10.1371/journal.pone.0104302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144364	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100014
J	Kremb, S; Helfer, M; Kraus, B; Wolff, H; Wild, C; Schneider, M; Voolstra, CR; Brack-Werner, R				Kremb, Stephan; Helfer, Markus; Kraus, Birgit; Wolff, Horst; Wild, Christian; Schneider, Martha; Voolstra, Christian R.; Brack-Werner, Ruth			Aqueous Extracts of the Marine Brown Alga Lobophora variegata Inhibit HIV-1 Infection at the Level of Virus Entry into Cells	PLOS ONE			English	Article							POLYSACCHARIDES; REPLICATION; GRIFFITHSIN	In recent years, marine algae have emerged as a rich and promising source of molecules with potent activities against various human pathogens. The widely distributed brown alga Lobophora variegata that is often associated with tropical coral reefs exerts strong antibacterial and antiprotozoal effects, but so far has not been associated with specific anti-viral activities. This study investigated potential HIV-1 inhibitory activity of L. variegata collected from different geographical regions, using a cell-based full replication HIV-1 reporter assay. Aqueous L. variegata extracts showed strong inhibitory effects on several HIV-1 strains, including drug-resistant and primary HIV-1 isolates, and protected even primary cells (PBMC) from HIV-1-infection. Anti-viral potency was related to ecological factors and showed clear differences depending on light exposition or epiphyte growth. Assays addressing early events of the HIV-1 replication cycle indicated that L. variegata extracts inhibited entry of HIV-1 into cells at a pre-fusion step possibly by impeding mobility of virus particles. Further characterization of the aqueous extract demonstrated that even high doses had only moderate effects on viability of cultured and primary cells (PBMCs). Imaging-based techniques revealed extract effects on the plasma membrane and actin filaments as well as induction of apoptosis at concentrations exceeding EC50 of anti-HIV-1 activity by more than 400 fold. In summary, we show for the first time that L. variegata extracts inhibit HIV-1 entry, thereby suggesting this alga as promising source for the development of novel HIV-1 inhibitors.	[Kremb, Stephan; Voolstra, Christian R.] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Kremb, Stephan; Helfer, Markus; Schneider, Martha; Brack-Werner, Ruth] Helmholtz Zentrum Muenchen, Inst Virol, Neuherberg, Germany; [Kraus, Birgit] Univ Regensburg, Inst Pharm, D-93053 Regensburg, Germany; [Wolff, Horst] Carl Zeiss Microscopy GmbH, Gottingen, Germany; [Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany; [Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	King Abdullah University of Science & Technology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; Carl Zeiss AG; Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen	Kremb, S (corresponding author), KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia.	StephanGeorg.Kremb@kaust.edu.sa	Brack-Werner, Ruth/M-4615-2014; Kraus, Birgit/AAM-2985-2020; Voolstra, Christian R/H-7158-2014	Brack-Werner, Ruth/0000-0002-8651-9318; Voolstra, Christian R/0000-0003-4555-3795	Helmholtz Zentrum Munich; King Abdullah University of Science and Technology	Helmholtz Zentrum Munich; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This study was jointly funded by the Helmholtz Zentrum Munich (www.helmholtz-muenchen.de) and the King Abdullah University of Science and Technology (www.kaust.edu.sa). The research vessel "Aldebaran'' was provided by "ALDEBARAN Marine Research and Broadcast'' (aldebaran.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre KB, 2011, J VIROL, V85, P9039, DOI 10.1128/JVI.02675-10; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Cantillo-Ciau Z, 2010, MAR DRUGS, V8, P1292, DOI 10.3390/md8041292; Chung HY, 2003, J AGR FOOD CHEM, V51, P2619, DOI 10.1021/jf026082n; Cirne-Santos CC, 2006, PLANTA MED, V72, P295, DOI 10.1055/s-2005-916209; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Freile-Pelegrin Y, 2008, FITOTERAPIA, V79, P374, DOI 10.1016/j.fitote.2008.02.006; Helfer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087487; Huskens D, 2012, MAR DRUGS, V10, P1476, DOI 10.3390/md10071476; Jiang ZD, 1999, BIOORG MED CHEM LETT, V9, P2003, DOI 10.1016/S0960-894X(99)00337-6; Kabamba-Mukadi B, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-15; Karsten U, 2009, BOT MAR, V52, P639, DOI 10.1515/BOT.2009.077; Koppensteiner H, 2012, J VIROL, V86, P2826, DOI 10.1128/JVI.05915-11; Kouokam JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022635; Kremb S, 2010, ANTIMICROB AGENTS CH, V54, P5257, DOI 10.1128/AAC.00515-10; Kubanek J, 2003, P NATL ACAD SCI USA, V100, P6916, DOI 10.1073/pnas.1131855100; Medeiros VP, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1018, DOI 10.1134/S0006297908090095; Moo-Puc R, 2008, J ETHNOPHARMACOL, V120, P92, DOI 10.1016/j.jep.2008.07.035; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Morrow KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044859; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Paiva AAD, 2011, INT IMMUNOPHARMACOL, V11, P1241, DOI 10.1016/j.intimp.2011.04.003; Siqueira RCL, 2011, PHARM BIOL, V49, P167, DOI 10.3109/13880209.2010.505605; Suarez A.M., 2005, REV INVEST MAR, V26, P93; Teas J, 2004, MED HYPOTHESES, V62, P507, DOI 10.1016/j.mehy.2003.10.005; Teas J, 2012, J APPL PHYCOL, V24, P575, DOI 10.1007/s10811-011-9766-0; Trinchero J, 2009, PHYTOTHER RES, V23, P707, DOI 10.1002/ptr.2723; Wiencke C, 2012, ECOLOGICAL STUDIES, V219; Witvrouw M, 1997, GEN PHARMACOL-VASC S, V29, P497, DOI 10.1016/S0306-3623(96)00563-0; Wolkerstorfer A, 2009, ANTIVIR RES, V83, P171, DOI 10.1016/j.antiviral.2009.04.012	30	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103895	10.1371/journal.pone.0103895	http://dx.doi.org/10.1371/journal.pone.0103895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144758	Green Published, gold			2022-12-25	WOS:000341106100010
J	Martins, AES; Lucena-Silva, N; Garcia, RG; Welkovic, S; Barbosa, A; Menezes, MLB; Tenorio, T; Maruza, M; Ximenes, RAA				Silva Martins, Albert Eduardo; Lucena-Silva, Norma; Garcia, Renan Gomes; Welkovic, Stefan; Barbosa, Aureliana; Bezerra Menezes, Maria Luiza; Tenorio, Terezinha; Maruza, Magda; Ximenes, Ricardo A. A.			Prognostic Evaluation of DNA Index in HIV-HPV Co-Infected Women Cervical Samples Attending in Reference Centers for HIV-AIDS in Recife	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA; POSITIVE WOMEN; FLOW-CYTOMETRY; PREVALENCE; PLOIDY; RISK; PROGRESSION; ANEUPLOIDY; DYSPLASIA	Introduction: Persistence of cervical infection caused by human papillomavirus (HPV) types with high oncogenic risk may lead to cervical intraepithelial neoplasia (CIN). The aim of the present study was to evaluate whether, in HIV-positive women, the presence of aneuploidy in cervical cell samples is associated with presence and evolution of CIN. Methods: The present study had two stages. In the first stage, comprising a cross-sectional study, the association between the presence of aneuploidy seen via flow cytometry and sociodemographic characteristics, habits and characteristics relating to HPV and HIV infection was analyzed. In the second stage, comprising a cohort study, it was investigated whether aneuploidy was predictive of CIN evolution. Results: No association was observed between the presence of aneuploidy and HPV infection, or between its presence and alterations seen in oncotic cytological analysis. On the other hand, aneuploidy was associated with the presence of CIN (p = 0.030) in histological analysis and with nonuse of antiretroviral therapy (p = 0.001). Most of the HIV-positive women (234/272) presented normal CD4+ T lymphocyte counts (greater than 350 cells/mm(3)) and showed a greater aneuploidy regression rate (77.5%) than a progression rate (23.9%) over a follow-up of up to two years. Conclusion: Although there was an association between the presence of cervical tissue lesions and the DNA index, the latter was not predictive of progression of the cervical lesion. This suggests that progression of the cervical lesion to cancer in HIV-positive women may also be changed through improvement of the immunological state enabled by using antiretroviral therapy.	[Silva Martins, Albert Eduardo; Lucena-Silva, Norma; Garcia, Renan Gomes] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Imunogenet, Recife, PE, Brazil; [Silva Martins, Albert Eduardo; Lucena-Silva, Norma] Hosp IMIP, Dept Oncol Pediat, Lab Biol Mol, Recife, PE, Brazil; [Welkovic, Stefan; Barbosa, Aureliana; Bezerra Menezes, Maria Luiza] Univ Pernambuco, Dept Materno Infantil, Recife, PE, Brazil; [Welkovic, Stefan; Barbosa, Aureliana; Bezerra Menezes, Maria Luiza] Univ Pernambuco, Ctr Integrado Saude Amaury Medeiro CISAM UPE, Recife, PE, Brazil; [Tenorio, Terezinha] Univ Fed Pernambuco, Dept Materno Infantil, Recife, PE, Brazil; [Maruza, Magda] Hosp Correia Picanco, Secretaria Saude Pernambuco, Recife, PE, Brazil; [Ximenes, Ricardo A. A.] Univ Fed Pernambuco UFPE, Dept Trop Med, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Martins, AES (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Imunogenet, Recife, PE, Brazil.	aesmartins@hotmail.com	Lucena-Silva, Norma/AAH-9437-2019	Garcia Gomes, Renan/0000-0003-4950-7614	Program for Technological Development in Tools for Health-PDTISFIOCRUZ; FACEPE [APQ-IBPG-1802-4]; CNPq [150572/2011-5]; Brazilian Health Ministry [322/2005]	Program for Technological Development in Tools for Health-PDTISFIOCRUZ; FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Health Ministry	The Program for Technological Development in Tools for Health-PDTISFIOCRUZ gave financial support for gene sequencing. A. E. S. M was a Ph.D. student supported by FACEPE (APQ-IBPG-1802-4). N.L.S. is the recipient of a postdoctoral fellowship from CNPq (grant # 150572/2011-5). This work was supported by Brazilian Health Ministry (Grant #322/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165; Brandao VDRAB, 2009, MEM I OSWALDO CRUZ, V104, P755, DOI 10.1590/S0074-02762009000500016; Anton M, 1997, CANCER DETECT PREV, V21, P242; Bollmann R, 2005, CANCER, V105, P1; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Chhavi, 2010, BIOSCI TRENDS, V4, P103; Dabic MM, 2008, ACTA OBSTET GYN SCAN, V87, P366, DOI 10.1080/00016340801936560; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doeberitz MV, 2009, ARCH MED RES, V40, P435, DOI 10.1016/j.arcmed.2009.06.002; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; El-Sayed SS, 2004, CAN J GASTROENTEROL, V18, P87, DOI 10.1155/2004/638136; Entiauspe LG, 2010, REV SOC BRAS MED TRO, V43, P260, DOI 10.1590/S0037-86822010000300009; Firnhaber C, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17382; Garbuglia AR, 2012, J CLIN VIROL, V54, P141, DOI 10.1016/j.jcv.2012.02.013; Garnett TO, 2006, ARCH VIROL, V151, P2321, DOI 10.1007/s00705-006-0821-0; Gillet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045201; Heilmann Volker, 2002, Curr Womens Health Rep, V2, P27; Klaes R, 1999, CANCER RES, V59, P6132; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI [10.1586/eri.11.21, 10.1586/ERI.11.21]; LOOK AT, 1985, BLOOD, V65, P1079; MacLeod IJ, 2011, J MED VIROL, V83, P1689, DOI 10.1002/jmv.22178; Mangili G, 2008, ANN ONCOL, V19, P1278, DOI 10.1093/annonc/mdn041; Massad LS, 2001, GYNECOL ONCOL, V82, P516, DOI 10.1006/gyno.2001.6323; Melsheimer P, 2004, CLIN CANCER RES, V10, P3059, DOI 10.1158/1078-0432.CCR-03-0565; Melsheimer P, 2001, CYTOMETRY, V46, P166, DOI 10.1002/cyto.1101; Naucler P, 2011, J GEN VIROL, V92, P2784, DOI 10.1099/vir.0.034298-0; Palefsky J, 2006, Adv Dent Res, V19, P99; Schneider ML, 1998, ATLAS DIAGNOSTICO DI; Sharma Surendra K, 2011, Indian J Med Res, V134, P866, DOI 10.4103/0971-5916.92632; Singh M, 2008, J CANCER EPIDEMIOL, V2008, DOI 10.1155/2008/298495; Sociedade Brasileira de Patologia do Trato Genital Inferior e Colposcopia (SBPTGIC), 2003, B INF DIR SBPTGIC, V5, P5; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104801	10.1371/journal.pone.0104801	http://dx.doi.org/10.1371/journal.pone.0104801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144309	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100023
J	Castro, SA; Escobedo, VM; Aranda, J; Carvallo, GO				Castro, Sergio A.; Escobedo, Victor M.; Aranda, Jorge; Carvallo, Gaston O.			Evaluating Darwin's Naturalization Hypothesis in Experimental Plant Assemblages: Phylogenetic Relationships Do Not Determine Colonization Success	PLOS ONE			English	Article							INVASIONS; BIOGEOGRAPHY; COMMUNITIES; CONUNDRUM; INVADERS; ECOLOGY; BIOLOGY	Darwin's naturalization hypothesis (DNH) proposes that colonization is less likely when the colonizing species is related to members of the invaded community, because evolutionary closeness intensifies competition among species that share similar resources. Studies that have evaluated DNH from correlational evidence have yielded controversial results with respect to its occurrence and generality. In the present study we carried out a set of manipulative experiments in which we controlled the phylogenetic relatedness of one colonizing species (Lactuca sativa) with five assemblages of plants (the recipient communities), and evaluated the colonizing success using five indicators (germination, growth, flowering, survival, and recruitment). The evolutionary relatedness was calculated as the mean phylogenetic distance between Lactuca and the members of each assemblage (MPD) and by the mean phylogenetic distance to the nearest neighbor (MNND). The results showed that the colonization success of Lactuca was not affected by MPD or MNND values, findings that do not support DNH. These results disagree with experimental studies made with communities of microorganisms, which show an inverse relation between colonization success and phylogenetic distances. We suggest that these discrepancies may be due to the high phylogenetic distance used, since in our experiments the colonizing species (Lactuca) was a distant relative of the assemblage members, while in the other studies the colonizing taxa have been related at the congeneric and conspecific levels. We suggest that under field conditions the phylogenetic distance is a weak predictor of competition, and it has a limited role in determining colonization success, contrary to prediction of the DNH. More experimental studies are needed to establish the importance of phylogenetic distance between colonizing species and invaded community on colonization success.	[Castro, Sergio A.; Escobedo, Victor M.; Aranda, Jorge] Univ Santiago Chile, Lab Ecol & Biodiversidad, Dept Biol, Santiago, Chile; [Castro, Sergio A.; Escobedo, Victor M.; Aranda, Jorge] Univ Santiago Chile, Ctr Dev Nanosci & Nanotechnol CEDENNA, Santiago, Chile; [Carvallo, Gaston O.] Pontificia Univ Catolica Valparaiso, Inst Biol, Fac Ciencias, Valparaiso, Chile	Universidad de Santiago de Chile; Universidad de Santiago de Chile; Pontificia Universidad Catolica de Valparaiso	Castro, SA (corresponding author), Univ Santiago Chile, Lab Ecol & Biodiversidad, Dept Biol, Santiago, Chile.	sergio.castro@usach.cl	Escobedo, Víctor Manuel/AAV-9690-2021	Escobedo, Victor/0000-0003-2673-3803	Fondecyt [11085013, PD 3130399]; Linea 6 of CEDENNA	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Linea 6 of CEDENNA	This research has been financially supported by Fondecyt 11085013, Fondecyt PD 3130399, and Linea 6 of CEDENNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burns JH, 2011, P NATL ACAD SCI USA, V108, P5302, DOI 10.1073/pnas.1013003108; Cahill JF, 2008, PERSPECT PLANT ECOL, V10, P41, DOI 10.1016/j.ppees.2007.10.001; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Daehler CC, 2001, AM NAT, V158, P324, DOI 10.1086/321316; Darwin C., 1859, ORIGIN SPECIES MEANS, DOI [10.5962/bhl.title.82303, DOI 10.5962/BHL.TITLE.82303]; Davis M. A., 2009, INVASION BIOL; Diez JM, 2008, ECOL LETT, V11, P674, DOI 10.1111/j.1461-0248.2008.01178.x; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; Downie SR, 2000, AM J BOT, V87, P273, DOI 10.2307/2656915; Duncan RP, 2002, NATURE, V417, P608, DOI 10.1038/417608a; Escobedo VM, 2011, REV CHIL HIST NAT, V84, P543, DOI 10.4067/S0716-078X2011000400007; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Gerhold P, 2011, AM NAT, V177, P668, DOI 10.1086/659059; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hill SB, 2009, OECOLOGIA, V161, P581, DOI 10.1007/s00442-009-1403-0; Jiang L, 2010, AM NAT, V175, P415, DOI 10.1086/650720; Jones EI, 2013, P NATL ACAD SCI USA, V110, P20627, DOI 10.1073/pnas.1310247110; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lambdon PW, 2006, J BIOGEOGR, V33, P1116, DOI 10.1111/j.1365-2699.2006.01486.x; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Lockwood JL, 2007, INVASION ECOLOGY; MacDougall AS, 2009, J ECOL, V97, P609, DOI 10.1111/j.1365-2745.2009.01514.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Park DS, 2013, P NATL ACAD SCI USA, V110, P17915, DOI 10.1073/pnas.1309948110; Pearson DE, 2012, BIOL INVASIONS, V14, P901, DOI 10.1007/s10530-011-0126-4; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Proches S, 2008, GLOBAL ECOL BIOGEOGR, V17, P5, DOI 10.1111/j.1466-8238.2007.00333.x; Pysek P, 2006, J BIOGEOGR, V33, P2040, DOI 10.1111/j.1365-2699.2006.01578.x; Ricciardi A, 2004, ECOL LETT, V7, P781, DOI 10.1111/j.1461-0248.2004.00642.x; Ricciardi A, 2006, BIOL INVASIONS, V8, P1403, DOI 10.1007/s10530-006-0005-6; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schaefer H, 2011, ECOL LETT, V14, P389, DOI 10.1111/j.1461-0248.2011.01600.x; SHIGESADA N, 2001, BIOL INVASIONS THEOR; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Strong D.R., 1984, INSECTS PLANTS COMMU; Thuiller W, 2010, DIVERS DISTRIB, V16, P461, DOI 10.1111/j.1472-4642.2010.00645.x; Tingley R, 2011, AM NAT, V177, P382, DOI 10.1086/658342; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Williamson M., 1996, BIOL INVASIONS	48	9	11	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105535	10.1371/journal.pone.0105535	http://dx.doi.org/10.1371/journal.pone.0105535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141013	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200094
J	Moreira, X; Abdala-Roberts, L; Parra-Tabla, V; Mooney, KA				Moreira, Xoaquin; Abdala-Roberts, Luis; Parra-Tabla, Victor; Mooney, Kailen A.			Positive Effects of Plant Genotypic and Species Diversity on Anti-Herbivore Defenses in a Tropical Tree Species	PLOS ONE			English	Article							GENETIC DIVERSITY; ASSOCIATIONAL RESISTANCE; TRADE-OFFS; MAHOGANY; COMMUNITY; DAMAGE; COMPLEMENTARITY; POPULATIONS; SEEDLINGS; RICHNESS	Despite increasing evidence that plant intra-and inter-specific diversity increases primary productivity, and that such effect may in turn cascade up to influence herbivores, there is little information about plant diversity effects on plant anti-herbivore defenses, the relative importance of different sources of plant diversity, and the mechanisms for such effects. For example, increased plant growth at high diversity may lead to reduced investment in defenses via growth-defense trade-offs. Alternatively, positive effects of plant diversity on plant growth may lead to increased herbivore abundance which in turn leads to a greater investment in plant defenses. The magnitude of trait variation underlying diversity effects is usually greater among species than among genotypes within a given species, so plant species diversity effects on resource use by producers as well as on higher trophic levels should be stronger than genotypic diversity effects. Here we compared the relative importance of plant genotypic and species diversity on anti-herbivore defenses and whether such effects are mediated indirectly via diversity effects on plant growth and/or herbivore damage. To this end, we performed a large-scale field experiment where we manipulated genotypic diversity of big-leaf mahogany (Swietenia macrophylla) and tree species diversity, and measured effects on mahogany growth, damage by the stem-boring specialist caterpillar Hypsipyla grandella, and defensive traits (polyphenolics and condensed tannins in stem and leaves). We found that both forms of plant diversity had positive effects on stem (but not leaf) defenses. However, neither source of diversity influenced mahogany growth, and diversity effects on defenses were not mediated by either growth-defense trade-offs or changes in stem-borer damage. Although the mechanism(s) of diversity effects on plant defenses are yet to be determined, our study is one of the few to test for and show producer diversity effects on plant chemical defenses.	[Moreira, Xoaquin; Abdala-Roberts, Luis; Mooney, Kailen A.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Parra-Tabla, Victor] Univ Autonoma Yucatan, Dept Ecol Trop, Merida, Yucatan, Mexico	University of California System; University of California Irvine; Universidad Autonoma de Yucatan	Moreira, X (corresponding author), Univ Neuchatel, Inst Biol, Lab Evolut Entomol, CH-2000 Neuchatel, Switzerland.	xmoreira1@gmail.com	Moreira, Xoaquín/J-9427-2018; Parra-Tabla, Victor/H-7320-2015	Moreira, Xoaquín/0000-0003-0166-838X; 	UC MEXUS-CONACyT [UCM-101443, UCM-55592]; CONACyT [128856]; Postdoctoral Fulbright/Spanish Ministry of Education grant program; GAANN fellowship; UC MEXUS-CONACyT scholarship	UC MEXUS-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Postdoctoral Fulbright/Spanish Ministry of Education grant program; GAANN fellowship(US Department of Education); UC MEXUS-CONACyT scholarship	This research was supported by a UC MEXUS-CONACyT grant for UC postdocs to XM (UCM-101443), a CONACyT grant to VPT (128856) and a UC MEXUS-CONACyT collaborative grant to all the authors (UCM-55592). XM received financial support from Postdoctoral Fulbright/Spanish Ministry of Education grant program. LAR was funded by a GAANN fellowship and a UC MEXUS-CONACyT scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Roberts L, 2014, BIOTROPICA IN PRESS; [Anonymous], 2005, ARBOLES TROPICALES M; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Castagneyrol B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044247; CICY (Centro de Investigacion Cientifica de Yucatan A.C.), 2020, FLOR DIG PEN YUC; Close D, 2003, ECOLOGY, V84, P2952, DOI 10.1890/02-0531; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Crawford KM, 2013, ECOLOGY, V94, P1025, DOI 10.1890/12-1468.1; Crawford KM, 2012, J ECOL, V100, P1512, DOI 10.1111/j.1365-2745.2012.02016.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Fridley JD, 2010, ECOLOGY, V91, P2272, DOI 10.1890/09-1240.1; Gillies ACM, 1999, HEREDITY, V83, P722, DOI 10.1038/sj.hdy.6886260; Grijpma P, 1973, IICA MISCELLANEOUS P, V1, P3; Grogan J, 2003, ECOL STU AN, V159, P193; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hamback PA, 2000, ECOLOGY, V81, P1784, DOI 10.1890/0012-9658(2000)081[1784:ARIDTP]2.0.CO;2; Heil M, 2002, NATURWISSENSCHAFTEN, V89, P519, DOI 10.1007/s00114-002-0366-3; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Karban R, 2014, ECOL LETT, V17, P44, DOI 10.1111/ele.12205; Kareiva P., 1983, P259; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Lang AC, 2014, J APPL ECOL, V51, P224, DOI 10.1111/1365-2664.12157; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loveless MD, 2003, ECOL STU AN, V159, P9; Mayhew JE, 1998, SILVICULTURA MAHOGAN; McArt SH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0639; Mcart SH, 2012, OECOLOGIA, V168, P1013, DOI 10.1007/s00442-011-2150-6; Mooney KA, 2010, SCIENCE, V327, P1642, DOI 10.1126/science.1184814; Moreira X, 2014, ECOL LETT, V17, P537, DOI 10.1111/ele.12253; Moreira X, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0133; Moreira X, 2012, P ROY SOC B-BIOL SCI, V279, P4464, DOI 10.1098/rspb.2012.0893; Moreira X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034006; Mraja A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028055; Nair KSS, 2007, TROPICAL FOREST INSECT PESTS: ECOLOGY, IMPACT, AND MANAGEMENT, P1, DOI 10.1017/CBO9780511542695; Newton A. C., 1999, Agricultural and Forest Entomology, V1, P11; Norghauer JM, 2008, J ECOL, V96, P103, DOI 10.1111/j.1365-2745.2007.01325.x; Norghauer JM, 2010, OECOLOGIA, V162, P405, DOI 10.1007/s00442-009-1476-9; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Otway SJ, 2005, J ANIM ECOL, V74, P234, DOI 10.1111/j.1365-2656.2005.00913.x; Parker JD, 2010, ECOL LETT, V13, P553, DOI 10.1111/j.1461-0248.2010.01452.x; Perez-Flores J., 2012, American Journal of Plant Sciences, V3, P988, DOI 10.4236/ajps.2012.37117; PORTER L J, 1986, Phytochemistry (Oxford), V25, P223; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roscher C, 2011, PLANT BIOLOGY, V13, P134, DOI 10.1111/j.1438-8677.2010.00338.x; Salminen JP, 2011, FUNCT ECOL, V25, P325, DOI 10.1111/j.1365-2435.2010.01826.x; Sampedro L, 2011, J ECOL, V99, P818, DOI 10.1111/j.1365-2745.2011.01814.x; Scherber C, 2006, OECOLOGIA, V147, P489, DOI 10.1007/s00442-005-0281-3; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Taveras R, 2004, AGR FOREST ENTOMOL, V6, P89, DOI 10.1111/j.1461-9555.2004.00205.x; Tilman D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P21; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Van Der Putten WH, 2003, ECOLOGY, V84, P2269, DOI 10.1890/02-0284; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7	59	51	52	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105438	10.1371/journal.pone.0105438	http://dx.doi.org/10.1371/journal.pone.0105438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141305	Green Published, gold			2022-12-25	WOS:000342687200089
J	Ramer, SJ; Cohen, ED; Chang, CCH; Unruh, ML; Barnato, AE				Ramer, Sarah J.; Cohen, Elan D.; Chang, Chung-Chou H.; Unruh, Mark L.; Barnato, Amber E.			Survival after Acute Hemodialysis in Pennsylvania, 2005-2007: A Retrospective Cohort Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; QUALITY-OF-LIFE; REPLACEMENT THERAPY; INTENSIVE-CARE; MORTALITY; DIALYSIS; NONRECOVERY; VALIDATION	Background: Little is known about acute hemodialysis in the US. Here we describe predictors of receipt of acute hemodialysis in one state and estimate the marginal impact of acute hemodialysis on survival after accounting for confounding due to illness severity. Materials and Methods: This is a retrospective cohort study of acute-care hospitalizations in Pennsylvania from October 2005 to December 2007 using data from the Pennsylvania Health Care Cost Containment Council. Exposure variable is acute hemodialysis; dependent variable is survival following acute hemodialysis. We used multivariable logistic regression to determine propensity to receive acute hemodialysis and then, for a Cox proportional hazards model, matched acute hemodialysis and non-acute hemodialysis patients 1:5 on this propensity. Results: In 2,131,248 admissions of adults without end-stage renal disease, there were 6,657 instances of acute hemodialysis. In analyses adjusted for predicted probability of death upon admission plus other covariates and stratified on age, being male, black, and insured were independent predictors of receipt of acute hemodialysis. One-year post-admission mortality was 43% for those receiving acute hemodialysis, compared to 13% among those not receiving acute hemodialysis. After matching on propensity to receive acute hemodialysis and adjusting for predicted probability of death upon admission, patients who received acute hemodialysis had a higher risk of death than patients who did not over at least 1 year of follow-up (hazard ratio 1.82, 95% confidence interval 1.68-1.97). Conclusions: In a populous US state, receipt of acute hemodialysis varied by age, sex, race, and insurance status even after adjustment for illness severity. In a comparison of patients with similar propensity to receive acute hemodialysis, those who did receive it were less likely to survive than those who did not. These findings raise questions about reasons for lack of benefit.	[Ramer, Sarah J.] Rutgers State Univ, Newark, NJ 07102 USA; [Cohen, Elan D.; Chang, Chung-Chou H.; Barnato, Amber E.] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; [Chang, Chung-Chou H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Unruh, Mark L.] Univ New Mexico, Sch Med, Dept Internal Med, Div Nephrol, Albuquerque, NM 87131 USA; [Barnato, Amber E.] Univ Pittsburgh, Sch Med, Dept Clin & Translat Sci, Pittsburgh, PA USA; [Barnato, Amber E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Barnato, Amber E.] Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab Clin Res Invest & Syst Modeling Acute, Pittsburgh, PA USA	Rutgers State University Newark; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ramer, SJ (corresponding author), Rutgers State Univ, Newark, NJ 07102 USA.	sramer@post.harvard.edu		Ramer, Sarah/0000-0001-8584-1148	Doris Duke Clinical Research Fellowship for Medical Students; National Institutes of Health [R01AG035112]; NATIONAL INSTITUTE ON AGING [R01AG035112] Funding Source: NIH RePORTER	Doris Duke Clinical Research Fellowship for Medical Students; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Doris Duke Clinical Research Fellowship for Medical Students to SR (http://www.ddcf.org/) and by National Institutes of Health grant R01AG035112 to AB (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Barnato AE, 2009, MED CARE, V47, P1098, DOI 10.1097/MLR.0b013e3181993191; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clec'h C, 2012, CRIT CARE, V16, DOI 10.1186/cc11905; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ehlenbach WJ, 2009, NEW ENGL J MED, V361, P22, DOI 10.1056/NEJMoa0810245; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elseviers MM, 2010, CRIT CARE, V14, DOI 10.1186/cc9355; Fowler RA, 2007, CAN MED ASSOC J, V177, P1513, DOI 10.1503/cmaj.071112; Gopal I, 1997, INTENS CARE MED, V23, P766, DOI 10.1007/s001340050407; Hamel MB, 1997, ANN INTERN MED, V127, P195, DOI 10.7326/0003-4819-127-3-199708010-00003; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Johansen KL, 2010, CLIN J AM SOC NEPHRO, V5, P1366, DOI 10.2215/CJN.02570310; Lyon SM, 2011, AM J RESP CRIT CARE, V184, P809, DOI 10.1164/rccm.201101-0089OC; Mehta RL, 2002, JAMA-J AM MED ASSOC, V288, P2547, DOI 10.1001/jama.288.20.2547; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Mehta RL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014692.19351.52; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pietropaoli AP, 2010, GENDER MED, V7, P422, DOI 10.1016/j.genm.2010.09.005; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Rauf Anis Abdul, 2008, J Intensive Care Med, V23, P195, DOI 10.1177/0885066608315743; Valentin A, 2003, CRIT CARE MED, V31, P1901, DOI 10.1097/01.CCM.0000069347.78151.50; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wilson FP, 2014, CLIN J AM SOC NEPHRO, V9, P673, DOI 10.2215/CJN.07630713; Wilson FP, 2013, CLIN J AM SOC NEPHRO, V8, P1863, DOI 10.2215/CJN.03540413; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668	28	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105083	10.1371/journal.pone.0105083	http://dx.doi.org/10.1371/journal.pone.0105083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141028	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000342687200050
J	Flaquer, A; Baumbach, C; Kriebel, J; Meitinger, T; Peters, A; Waldenberger, M; Grallert, H; Strauch, K				Flaquer, Antonia; Baumbach, Clemens; Kriebel, Jennifer; Meitinger, Thomas; Peters, Annette; Waldenberger, Melanie; Grallert, Harald; Strauch, Konstantin			Mitochondrial Genetic Variants Identified to Be Associated with BMI in Adults	PLOS ONE			English	Article							BODY-MASS INDEX; OXIDATIVE STRESS; COMMON VARIANTS; GENOME; METAANALYSIS; LOCI; POLYMORPHISMS; OXIDASE; OBESITY; IMPACT	It has been suggested that mitochondrial dysfunction plays a role in metabolic disorders including obesity, diabetes, and hypertension. The fact that mitochondrial defects can be accumulated over time as a normal part of aging may explain why some individuals can eat all sorts of foods and remain at normal weight while they are young. However, around the fourth decade of life there is a trend towards "middle-age spread'' with weight gain and the body's decreasing ability to metabolize calories efficiently. To test the hypothesis that mitochondrial variants are associated with BMI in adults, we analyzed a total number of 984 mitochondrial single nucleotide polymorphisms (mtSNPs) in a sample of 6,528 individuals participating in the KORA studies. To assess mtSNP association while taking heteroplasmy into account we used the raw signal intensity values measured on the microarray and applied linear regression. Significant results were obtained for 2 mtSNPs located in the Cytochrome c oxidase subunit genes (MT-CO1: P-adjusted = 0.0140 and MT-CO3: P-adjusted = 0.0286) and 3 mtSNPs located in the NADH dehydrogenase subunit genes (MT-ND1, MT-ND2 and MT-ND4L: P-adjusted = 0.0286). Polymorphisms located in the MT-CO3 and MT-ND4L genes have not been associated with BMI or related phenotypes in the past. Our results highlight the importance of the mitochondrial genome among the factors that contribute to the risk of high BMI. Focusing on mitochondrial variants may lead to further insights regarding effects of existing medications, or even to the development of innovative treatments.	[Flaquer, Antonia; Baumbach, Clemens; Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Neuherberg, Germany; [Flaquer, Antonia; Baumbach, Clemens; Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Kriebel, Jennifer; Peters, Annette; Waldenberger, Melanie; Grallert, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Peters, Annette; Waldenberger, Melanie; Grallert, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Flaquer, A (corresponding author), Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Neuherberg, Germany.	antonia.flaquer@lmu.de	Grallert, Harald/B-3424-2013; Waldenberger, Melanie/B-5355-2014; Kriebel, Jennifer/N-4782-2017; Peters, Annette/A-6117-2011; Meitinger, Thomas/O-1318-2015	Waldenberger, Melanie/0000-0003-0583-5093; Kriebel, Jennifer/0000-0003-4270-018X; Peters, Annette/0000-0001-6645-0985; Meitinger, Thomas/0000-0002-8838-8403	Helmholtz Zentrum Munchen - German Research Center for Environmental Health; State of Bavaria; KORA research within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); State of Bavaria; KORA research within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health which is founded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; BRADY LJ, 1985, BIOCHEM J, V231, P439, DOI 10.1042/bj2310439; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6; Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Flaquer A, 2014, MITOCHONDRION, V14, P49, DOI 10.1016/j.mito.2013.11.002; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hipkiss AR, 2010, ADV CLIN CHEM, V50, P123, DOI 10.1016/S0065-2423(10)50007-6; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Johannsen DL, 2012, J CLIN ENDOCR METAB, V97, P242, DOI 10.1210/jc.2011-1798; KATYARE SS, 1978, ARCH BIOCHEM BIOPHYS, V188, P15, DOI 10.1016/0003-9861(78)90349-1; Knoll N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094882; Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee SH, 2012, LIVEST SCI, V146, P160, DOI 10.1016/j.livsci.2012.03.003; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liu CY, 2012, HYPERTENSION, V60, P949, DOI 10.1161/HYPERTENSIONAHA.112.196519; Macgregor S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl136; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Nardelli C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/631082; Nube M, 1998, EUR J CLIN NUTR, V52, P136, DOI 10.1038/sj.ejcn.1600528; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Peterson Courtney M, 2012, J Aging Res, V2012, P194821, DOI 10.1155/2012/194821; Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x; R Core Team, 2021, R LANG ENV STAT COMP; RAGAN CI, 1987, CURR TOP BIOENERG, V15, P1; Rahkonen O, 1998, J PUBLIC HEALTH POL, V19, P88, DOI 10.2307/3343091; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Sankhla M, 2012, CLIN LAB, V58, P385; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Smyth GK, 2010, P ADJUST PART R PACK; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Welon Z, 2002, AM J HUM BIOL, V14, P693, DOI 10.1002/ajhb.10079; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; World Health Organization, 2010, INT STAT CLASS DIS H; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a; Yang HC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-196; Yang TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021595	51	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105116	10.1371/journal.pone.0105116	http://dx.doi.org/10.1371/journal.pone.0105116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153900	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200038
J	Sui, ZW; Wen, B; Gao, ZM; Chen, QJ				Sui, Zhiwei; Wen, Bo; Gao, Zhimin; Chen, Quanjiao			Fusion-Related Host Proteins Are Actively Regulated by NA during Influenza Infection as Revealed by Quantitative Proteomics Analysis	PLOS ONE			English	Article							LAMININ RECEPTOR; DIFFERENTIAL EXPRESSION; VIRUS-INFECTION; CELLS; ENZYMES; LIFE	Three recombinant influenza A viruses with different neuraminidases (NAs) in the background of A/PR/8/34 (PR8), named rPR8-H5N1NA, rPR8-H9N2NA, and rPR8-H1N1NA, derived from H5N1, H9N2, H1N1 (swine) viruses, respectively, were constructed. We performed a quantitative proteomics analysis to investigate differential protein expression in Madin-Darby canine kidney (MDCK) cells infected with recombinant and wild-type influenza viruses to determine whether NA replacement would alter host cell gene expression. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-TOF MS) and two-dimensional gel electrophoresis (2-DE), we identified 12 up-regulated and 49 down-regulated protein spots, including cytoskeletal proteins, molecular biosynthesis proteins, ubiquitin-proteasome pathway proteins, and heat shock proteins. The most significant changes in infected cells were observed for molecular biosynthesis proteins. We found more differentially expressed protein spots in cells infected with rPR8-H5N1NA or rPR8-H9N2NA viruses than cells infected with wild-type virus. Many of those proteins are postulated to be involved in cell-cell fusion, but the full mechanism remains to be explored. Meanwhile, our data demonstrate that the wild-type virus has evolutionary advantages over recombinant viruses.	[Gao, Zhimin; Chen, Quanjiao] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Sui, Zhiwei] Natl Inst Metrol, Beijing, Peoples R China; [Wen, Bo] BGI Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; National Institute of Metrology China; Beijing Genomics Institute (BGI)	Chen, QJ (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	chenqj@wh.iov.cn	Wen, Bo/I-1259-2019	Wen, Bo/0000-0003-2261-3150	National Natural Science Foundation of China [31070141, 31100132]; National Science and Technology Support Program [2013BAK12B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program	This work was supported by grants from National Natural Science Foundation of China (31070141, 31100132) and National Science and Technology Support Program (NO. 2013BAK12B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Baas T, 2006, J VIROL, V80, P10813, DOI 10.1128/JVI.00851-06; Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Chen QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054334; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Jamieson KV, 2011, J MOL BIOL, V405, P24, DOI 10.1016/j.jmb.2010.10.028; Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Osaki H, 2013, LEUKEMIA, V27, P1461, DOI 10.1038/leu.2013.42; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zou W, 2010, J PROTEOME RES, V9, P3789, DOI 10.1021/pr100080x	18	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105947	10.1371/journal.pone.0105947	http://dx.doi.org/10.1371/journal.pone.0105947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153908	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200094
J	Brantley, ST; Bissett, SN; Young, DR; Wolner, CWV; Moore, LJ				Brantley, Steven T.; Bissett, Spencer N.; Young, Donald R.; Wolner, Catherine W. V.; Moore, Laura J.			Barrier Island Morphology and Sediment Characteristics Affect the Recovery of Dune Building Grasses following Storm-Induced Overwash	PLOS ONE			English	Article							COASTAL; PLANT; ZONATION; STABILITY; SALINITY; DYNAMICS; BIOMASS; BURIAL; SCALE; SAND	Barrier islands are complex and dynamic systems that provide critical ecosystem services to coastal populations. Stability of these systems is threatened by rising sea level and the potential for coastal storms to increase in frequency and intensity. Recovery of dune-building grasses following storms is an important process that promotes topographic heterogeneity and long-term stability of barrier islands, yet factors that drive dune recovery are poorly understood. We examined vegetation recovery in overwash zones on two geomorphically distinct (undisturbed vs. frequently overwashed) barrier islands on the Virginia coast, USA. We hypothesized that vegetation recovery in overwash zones would be driven primarily by environmental characteristics, especially elevation and beach width. We sampled species composition and environmental characteristics along a continuum of disturbance from active overwash zones to relict overwash zones and in adjacent undisturbed environments. We compared species assemblages along the disturbance chronosequence and between islands and we analyzed species composition data and environmental measurements with Canonical Correspondence Analysis to link community composition with environmental characteristics. Recovering and geomorphically stable dunes were dominated by Ammophila breviligulata Fernaud (Poaceae) on both islands while active overwash zones were dominated by Spartina patens (Aiton) Muhl. (Poaceae) on the frequently disturbed island and bare sand on the less disturbed island. Species composition was associated with environmental characteristics only on the frequently disturbed island (p = 0.005) where A. breviligulata was associated with higher elevation and greater beach width. Spartina patens, the second most abundant species, was associated with larger sediment grain size and greater sediment size distribution. On the less frequently disturbed island, time since disturbance was the only factor that affected community composition. Thus, factors driving the abundance of dune-building grasses and subsequent recovery of dunes varied between the two geomorphically distinct islands.	[Brantley, Steven T.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55455 USA; [Bissett, Spencer N.; Young, Donald R.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Wolner, Catherine W. V.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Moore, Laura J.] Univ N Carolina, Dept Geol Sci, Chapel Hill, NC USA	University of Minnesota System; University of Minnesota Twin Cities; Virginia Commonwealth University; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Brantley, ST (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55455 USA.	sbrantle@umn.edu		Brantley, Steven/0000-0002-1780-3366	United States Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute for Climatic Change Research at Tulane University [DE-FC02-06ER64298]; Geological Society of America; Virginia Coast Reserve Long-Term Ecological Research (VCR-LTER) [DEB-0080381]; Direct For Biological Sciences [1237733] Funding Source: National Science Foundation	United States Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute for Climatic Change Research at Tulane University; Geological Society of America; Virginia Coast Reserve Long-Term Ecological Research (VCR-LTER); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the United States Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute for Climatic Change Research at Tulane University (http://www.tulane.edu/similar to NICCR/) grant number DE-FC02-06ER64298 to LJM and DRY. The Geological Society of America and the Virginia Coast Reserve Long-Term Ecological Research (VCR-LTER) program provided additional support through grant number DEB-0080381 to LJM and DRY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTNESS MD, 1991, ECOLOGY, V72, P125, DOI 10.2307/1938908; BOYCE SG, 1954, ECOL MONOGR, V24, P29, DOI 10.2307/1943510; Cahoon DR, 2006, ESTUAR COAST, V29, P889, DOI 10.1007/BF02798648; CLARK JS, 1990, REV AQUAT SCI, V2, P509; da Silva GM, 2008, EARTH SURF PROC LAND, V33, P1557, DOI 10.1002/esp.1633; Day FP, 2001, J TORREY BOT SOC, V128, P197, DOI 10.2307/3088711; Dilustro JJ, 1997, AM MIDL NAT, V137, P27, DOI 10.2307/2426752; Duncan W. H., 1987, SEASIDE PLANTS GULF; EHRENFELD JG, 1990, REV AQUAT SCI, V2, P437; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Emanuel KA, 2013, P NATL ACAD SCI USA, V110, P12219, DOI 10.1073/pnas.1301293110; FAHRIG L, 1993, J COASTAL RES, V9, P403; Feagin RA, 2010, J COASTAL RES, V26, P987, DOI 10.2112/09-1185.1; Fenu G, 2013, FOLIA GEOBOT, V48, P493, DOI 10.1007/s12224-012-9141-1; Godfrey P. J., 1979, BARRIER ISLANDS, P99; Gornish ES, 2010, GLOBAL CHANGE BIOL, V16, P2668, DOI 10.1111/j.1365-2486.2009.02144.x; Houle G, 2008, ECOSCIENCE, V15, P113, DOI 10.2980/1195-6860(2008)15[113:PSRAID]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; LEATHERMAN SP, 1987, SEDIMENT GEOL, V52, P183, DOI 10.1016/0037-0738(87)90061-3; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; MAUN MA, 1984, J ECOL, V72, P827, DOI 10.2307/2259534; MAUN MA, 1994, VEGETATIO, V111, P59; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Miller TE, 2010, PLANT ECOL, V206, P97, DOI 10.1007/s11258-009-9626-z; Molina JA, 2003, PHYTOCOENOLOGIA, V33, P475, DOI 10.1127/0340-269X/2003/0033-0475; Morton RA, 2005, J COASTAL RES, V21, P704, DOI 10.2112/04-0230.1; Oosting HJ, 1942, ECOLOGY, V23, P131, DOI 10.2307/1931081; Oster DJ, 2012, THESIS U VIRGINIA; PENNINGS SC, 1992, ECOLOGY, V73, P681, DOI 10.2307/1940774; Radford AE, 1968, MANUAL VASCULAR FLOR; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Sallenger AH, 2000, J COASTAL RES, V16, P890; Seabloom EW, 2013, GLOBAL CHANGE BIOL, V19, P824, DOI 10.1111/gcb.12078; Snyder RA, 2002, J COASTAL RES, V18, P530; Stallins JA, 2005, ECOL COMPLEX, V2, P410, DOI 10.1016/j.ecocom.2005.04.011; Stallins JA, 2003, ANN ASSOC AM GEOGR, V93, P13, DOI 10.1111/1467-8306.93102; Uva RH., 1997, WEEDS NE, P408; VANDERVALK AG, 1974, CAN J BOT, V52, P1057, DOI 10.1139/b74-135; Wilson JB, 1999, ECOL LETT, V2, P233; Wolner CWV, 2013, GEOMORPHOLOGY, V199, P115, DOI 10.1016/j.geomorph.2013.03.035; WONG P. P, 2007, CLIMATE CHANGE, P315, DOI DOI 10.1017/CB09781107415379; Young DR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00186.1; YOUNG DR, 1995, AM J BOT, V82, P638, DOI 10.2307/2445422; YOUNG DR, 1994, CAN J BOT, V72, P1365, DOI 10.1139/b94-167	45	36	36	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104747	10.1371/journal.pone.0104747	http://dx.doi.org/10.1371/journal.pone.0104747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148028	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600019
J	Budde, H; Kolb, S; Tejedor, LS; Wulf, G; Reichardt, HM; Riggert, J; Legler, TJ				Budde, Holger; Kolb, Susanne; Tejedor, Laura Salinas; Wulf, Gerald; Reichardt, Holger M.; Riggert, Joachim; Legler, Tobias J.			Modified Extracorporeal Photopheresis with Cells from a Healthy Donor for Acute Graft-versus-Host Disease in a Mouse Model	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; PERIPHERAL-BLOOD; APOPTOTIC CELLS; PHOTOCHEMOTHERAPY; DEATH; MECHANISMS; INDUCTION; IMMUNITY; FOCUS	Background: Graft-versus-host disease (GvHD) is a major challenge after hematopoietic stem cell transplantation but treatment options for patients are still limited. In many cases first-line treatment with glucocorticoids is not successful. Among second-line therapies the extracorporeal photopheresis (ECP) is frequently performed, due to induction of selective tolerance instead of general immunosuppression. However, for some patients with severe acute GvHD the leukapheresis step of the ECP procedure is physically exhausting and limits the number of ECP cycles. Methods: We hypothesized that leukocytes from healthy cell donors could be used as a replacement for ECP leukocytes gained from the GvHD patient. For this purpose we used a well established mouse model of acute GvHD. The ECP therapy was based on cells with the genetic background of the initial donor of the stem cell transplantation. As a precondition we developed a protocol representing conventional ECP in mice equivalent to clinical used ECP setup. Results: We could demonstrate that conventional, clinically derived ECP setup is able to alleviate acute GvHD. By using leukocytes obtained from healthy mice with the bone marrow donor's genetic background we could not observe a statistically significant therapeutic effect. Conclusions: Conventional human ECP setup is effective in the mouse model of severe acute GvHD. In addition we could not prove that ECP cells from healthy mice with bone marrow donor's genetic background are as effective as ECP cells derived from GvHD mice. Based on our findings, new questions arise for further studies, in which the cellular characteristics for ECP mediated immune tolerance are a matter of investigation.	[Budde, Holger; Kolb, Susanne; Tejedor, Laura Salinas; Riggert, Joachim; Legler, Tobias J.] Univ Med Ctr Gottingen, Dept Transfus Med, Gottingen, Germany; [Wulf, Gerald] Univ Med Ctr Gottingen, Dept Hematol & Oncol, Gottingen, Germany; [Reichardt, Holger M.] Univ Med Ctr Gottingen, Inst Cellular & Mol Immunol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Budde, H (corresponding author), Univ Med Ctr Gottingen, Dept Transfus Med, Gottingen, Germany.	holger.budde@med.uni-goettingen.de	Reichardt, Holger/AAF-3048-2020	Reichardt, Holger/0000-0003-4647-057X	Deutsche Jose Carreras Leukamie Stiftung e.V [DJCLS R 12/34]	Deutsche Jose Carreras Leukamie Stiftung e.V	This work was supported by grants from the Deutsche Jose Carreras Leukamie Stiftung e.V. to H.B. (grant number: DJCLS R 12/34, http://www.carreras-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; Bladon J, 2006, J DERMATOL SCI, V43, P85, DOI 10.1016/j.jdermsci.2006.05.004; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Capitini CM, 2011, BIOL BLOOD MARROW TR, V17, P790, DOI 10.1016/j.bbmt.2010.12.712; Devine SM, 2011, BIOL BLOOD MARROW TR, V17, P1343, DOI 10.1016/j.bbmt.2011.02.002; Edelson RL, 2014, TRANSFUS APHER SCI, V50, P322, DOI 10.1016/j.transci.2013.07.031; GASPARRO FP, 1989, YALE J BIOL MED, V62, P579; Gatza E, 2008, BLOOD, V112, P1515, DOI 10.1182/blood-2007-11-125542; Greinix HT, 2006, BONE MARROW TRANSPL, V38, P265, DOI 10.1038/sj.bmt.1705440; Greinix HT, 2010, BIOL BLOOD MARROW TR, V16, P1747, DOI 10.1016/j.bbmt.2010.06.012; Greinix HT, 2000, BLOOD, V96, P2426; Hart JW, 2013, THER ADV HEMATOL, V4, P320, DOI 10.1177/2040620713490316; Heshmati F, 2003, TRANSFUS APHER SCI, V29, P61, DOI 10.1016/S1473-0502(03)00103-4; KORNGOLD R, 1978, J EXP MED, V148, P1687; Li HW, 2012, NAT REV IMMUNOL, V12, P403, DOI 10.1038/nri3226; Maeda A, 2008, J IMMUNOL, V181, P5956, DOI 10.4049/jimmunol.181.9.5956; Marshall SR, 2006, NAT CLIN PRACT ONCOL, V3, P302, DOI 10.1038/ncponc0511; Merlin E, 2010, BONE MARROW TRANSPL, V45, P963, DOI 10.1038/bmt.2009.271; Pasquini Marcelo C, 2010, Clin Transpl, P87; Perfetti P, 2008, BONE MARROW TRANSPL, V42, P609, DOI 10.1038/bmt.2008.221; Reddy P, 2009, MOUSE MODELS GRAFT V, DOI [10.3824/stem-book.1.36.1, DOI 10.3824/STEM-BOOK.1.36.1.]; Reddy P, 2008, BIOL BLOOD MARROW TR, V14, P129, DOI 10.1016/j.bbmt.2007.10.021; Schroeder MA, 2011, DIS MODEL MECH, V4, P318, DOI 10.1242/dmm.006668; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Suchin KR, 1999, J AM ACAD DERMATOL, V41, P980, DOI 10.1016/S0190-9622(99)70257-4; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Tischner D, 2011, J IMMUNOL, V187, P4509, DOI 10.4049/jimmunol.1100911; Wolf CE, 2005, VOX SANG, V88, P249, DOI 10.1111/j.1423-0410.2005.00562.x; Wolf D, 2012, BLOOD, V119, P16, DOI 10.1182/blood-2011-08-339465; Wolff D, 2009, CURR PHARM DESIGN, V15, P1974, DOI 10.2174/138161209788453158; Xia CQ, 2009, CURR OPIN ORGAN TRAN, V14, P338, DOI 10.1097/MOT.0b013e32832ce943	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105896	10.1371/journal.pone.0105896	http://dx.doi.org/10.1371/journal.pone.0105896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148404	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600094
J	Daume, M; Plagens, A; Randau, L				Daume, Michael; Plagens, Andre; Randau, Lennart			DNA Binding Properties of the Small Cascade Subunit Csa5	PLOS ONE			English	Article							ADAPTIVE BACTERIAL IMMUNITY; IN-VITRO RECONSTITUTION; CRISPR-CAS SYSTEMS; ESCHERICHIA-COLI; RNA; COMPLEX; INTERFERENCE; DEGRADATION; PROKARYOTES; DEFENSE	CRISPR-Cas systems provide immunity against viral attacks in archaeal and bacterial cells. Type I systems employ a Cas protein complex termed Cascade, which utilizes small CRISPR RNAs to detect and degrade the exogenic DNA. A small sequence motif, the PAM, marks the foreign substrates. Previously, a recombinant type I-A Cascade complex from the archaeon Thermoproteus tenax was shown to target and degrade DNA in vitro, dependent on a native PAM sequence. Here, we present the biochemical analysis of the small subunit, Csa5, of this Cascade complex. T. tenax Csa5 preferentially bound ssDNA and mutants that showed decreased ssDNA-binding and reduced Cascade-mediated DNA cleavage were identified. Csa5 oligomerization prevented DNA binding. Specific recognition of the PAM sequence was not observed. Phylogenetic analyses identified Csa5 as a universal member of type I-A systems and revealed three distinct groups. A potential role of Csa5 in R-loop stabilization is discussed.	[Daume, Michael; Plagens, Andre; Randau, Lennart] Max Planck Inst Terr Microbiol, Prokaryot Small RNA Biol, D-35043 Marburg, Germany	Max Planck Society	Randau, L (corresponding author), Max Planck Inst Terr Microbiol, Prokaryot Small RNA Biol, D-35043 Marburg, Germany.	lennart.randau@mpi-marburg.mpg.de		Randau, Lennart/0000-0002-2780-2076	Deutsche Forschungsgemeinschaft (DFG) [FOR1680]; Max-Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG (dfg. de), FOR1680) and the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kiro R, 2013, BIOCHEM SOC T, V41, P1412, DOI 10.1042/BST20130109; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nam KH, 2012, FEBS LETT, V586, P3956, DOI 10.1016/j.febslet.2012.09.041; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Pande VS, 1998, P NATL ACAD SCI USA, V95, P1490, DOI 10.1073/pnas.95.4.1490; Plagens A, 2014, NUCLEIC ACIDS RES, V42, P5125, DOI 10.1093/nar/gku120; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Reeks J, 2013, RNA BIOL, V10, P762, DOI 10.4161/rna.23854; Richter C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049549; Richter H, 2012, NUCLEIC ACIDS RES, V40, P9887, DOI 10.1093/nar/gks737; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	37	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105716	10.1371/journal.pone.0105716	http://dx.doi.org/10.1371/journal.pone.0105716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148031	Green Submitted, gold, Green Published			2022-12-25	WOS:000341230600073
J	Pacheco-Arjona, JR; Ramirez-Prado, JH				Ramon Pacheco-Arjona, Jose; Humberto Ramirez-Prado, Jorge			Large-Scale Phylogenetic Classification of Fungal Chitin Synthases and Identification of a Putative Cell-Wall Metabolism Gene Cluster in Aspergillus Genomes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SACCHAROMYCES-CEREVISIAE; PROTEIN EVOLUTION; PROBE LEVEL; CLASS-VII; YEAST; CONSERVATION; KINESIN-1; FUMIGATUS; COOPERATE	The cell wall is a protective and versatile structure distributed in all fungi. The component responsible for its rigidity is chitin, a product of chitin synthase (Chsp) enzymes. There are seven classes of chitin synthase genes (CHS) and the amount and type encoded in fungal genomes varies considerably from one species to another. Previous Chsp sequence analyses focused on their study as individual units, regardless of genomic context. The identification of blocks of conserved genes between genomes can provide important clues about the interactions and localization of chitin synthases. On the present study, we carried out an in silico search of all putative Chsp encoded in 54 full fungal genomes, encompassing 21 orders from five phyla. Phylogenetic studies of these Chsp were able to confidently classify 347 out of the 369 Chsp identified (94%). Patterns in the distribution of Chsp related to taxonomy were identified, the most prominent being related to the type of fungal growth. More importantly, a synteny analysis for genomic blocks centered on class IV Chsp (the most abundant and widely distributed Chsp class) identified a putative cell wall metabolism gene cluster in members of the genus Aspergillus, the first such association reported for any fungal genome.	[Ramon Pacheco-Arjona, Jose; Humberto Ramirez-Prado, Jorge] Ctr Invest Cient Yucatan, Unidad Biotecnol, AC, Merida, Yucatan, Mexico	Centro de Investigacion Cientifica de Yucatan	Ramirez-Prado, JH (corresponding author), Ctr Invest Cient Yucatan, Unidad Biotecnol, AC, Merida, Yucatan, Mexico.	jhramirez@cicy.mx	Pacheco-Arjona, Ramon/F-3635-2019; Ramirez-Prado, Jorge H/A-3012-2011	Pacheco-Arjona, Ramon/0000-0001-9067-5316; Ramirez-Prado, Jorge H/0000-0003-2780-5223	Mexico National Science and Technology Council CONACYT [CB-2008 107114]; CONACYT Ph. D. scholarship	Mexico National Science and Technology Council CONACYT; CONACYT Ph. D. scholarship	This work was supported by funds from Mexico National Science and Technology Council CONACYT grant CB-2008 107114 to JHR-P as well as a CONACYT Ph. D. scholarship to JRP-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Brown SS, 1997, CURR OPIN CELL BIOL, V9, P44, DOI 10.1016/S0955-0674(97)80150-0; Chen NS, 2006, GENOME RES, V16, P606, DOI 10.1101/gr.4515306; Choquer M, 2004, EUR J BIOCHEM, V271, P2153, DOI 10.1111/j.1432-1033.2004.04135.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Goodson HV, 1996, J CELL BIOL, V133, P1277, DOI 10.1083/jcb.133.6.1277; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hane JK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r45; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Jacob F, 1960, CR HEBD ACAD SCI, V250; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jukes TH, 1969, EVOLUTION PROTEIN MO; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Mahabhashyam Brudno, 2005, GENOME RES, V15, P330; Mandel MA, 2006, FUNGAL GENET BIOL, V43, P775, DOI 10.1016/j.fgb.2006.05.005; McGary KL, 2013, P NATL ACAD SCI USA, V110, P11481, DOI 10.1073/pnas.1304461110; Mellado E, 1996, FEMS MICROBIOL LETT, V143, P69, DOI 10.1111/j.1574-6968.1996.tb08463.x; NAGAHASHI S, 1995, J BIOL CHEM, V270, P13961, DOI 10.1074/jbc.270.23.13961; Nei M., 2000, MOL EVOLUTION PHYLOG; Nino-Vega GA, 2004, MED MYCOL, V42, P51, DOI 10.1080/1369378031000153811; Odenbach D, 2009, MOL PLANT PATHOL, V10, P81, DOI 10.1111/j.1364-3703.2008.00515.x; Osmond BC, 1999, P NATL ACAD SCI USA, V96, P11206, DOI 10.1073/pnas.96.20.11206; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruiz-Herrera Jose, 2002, FEMS Yeast Research, V1, P247, DOI 10.1016/S1567-1356(01)00049-6; Ruiz-Herrera J, 2010, FEMS YEAST RES, V10, P225, DOI 10.1111/j.1567-1364.2009.00589.x; Santiago-Sotelo P, 2012, BIOTECHNIQUES, V53, P299, DOI [10.2144/0000113953, 10.2144/000113953]; Schuchardt I, 2005, MOL BIOL CELL, V16, P5191, DOI 10.1091/mbc.E05-04-0272; Schuster M, 2012, EMBO J, V31, P214, DOI 10.1038/emboj.2011.361; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Tamura K, 2011, MEGA5 MOL EVOLUTIONA; Teparic R, 2004, MICROBIOL-SGM, V150, P3145, DOI 10.1099/mic.0.27296-0; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Trilla JA, 1997, YEAST, V13, P795, DOI 10.1002/(SICI)1097-0061(199707)13:9<795::AID-YEA139>3.3.CO;2-C; Wang H., 2009, BMC EVOLUTIONARY BIO, P9; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	50	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104920	10.1371/journal.pone.0104920	http://dx.doi.org/10.1371/journal.pone.0104920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148134	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600026
J	Zhou, JL; Zhong, RQ; Ye, ZH				Zhou, Jianli; Zhong, Ruiqin; Ye, Zheng-Hua			Arabidopsis NAC Domain Proteins, VND1 to VND5, Are Transcriptional Regulators of Secondary Wall Biosynthesis in Vessels	PLOS ONE			English	Article							CELL-WALL; WOOD FORMATION; DIRECT TARGET; POPLAR; GENES; SND1; MYB46; XYLEM; RICE; NST1	One of the most prominent features of xylem conducting cells is the deposition of secondary walls. In Arabidopsis, secondary wall biosynthesis in the xylem conducting cells, vessels, has been shown to be regulated by two VASCULAR-RELATED NAC-DOMAIN (VND) genes, VND6 and VND7. In this report, we have investigated the roles of five additional Arabidopsis VND genes, VND1 to VND5, in regulating secondary wall biosynthesis in vessels. The VND1 to VND5 genes were shown to be specifically expressed in vessels but not in interfascicular fibers in stems. The expression of VND4 and VND5 was also seen specifically in vessels in the secondary xylem of the root-hypocotyl region. When overexpressed, VND1 to VND5 were able to activate the expression of secondary wall-associated transcription factors and genes involved in secondary wall biosynthesis and programmed cell death. As a result, many normally parenchymatous cells in leaves and stems acquired thickened secondary walls in the VND1 to VND5 overexpressors. In contrast, dominant repression of VND3 function resulted in reduced secondary wall thickening in vessels and a collapsed vessel phenotype. In addition, VND1 to VND5 were shown to be capable of rescuing the secondary wall defects in the fibers of the snd1 nst1 double mutant when expressed under the SND1 promoter. Furthermore, transactivation analysis revealed that VND1 to VND5 could activate expression of the GUS reporter gene driven by the secondary wall NAC binding element (SNBE). Together, these results demonstrate that VND1 to VND5 possess functions similar to that of the SND1 secondary wall NAC and are transcriptional regulators of secondary wall biosynthesis in vessels.	[Zhou, Jianli; Zhong, Ruiqin; Ye, Zheng-Hua] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Ye, ZH (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	zhye@plantbio.uga.edu			United States Department of Agriculture National Institute of Food and Agriculture [2010-65116-20468]; National Science Foundation [ISO-1051900]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the United States Department of Agriculture National Institute of Food and Agriculture (AFRI Plant Biology program (#2010-65116-20468)) and the National Science Foundation (ISO-1051900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avci U, 2008, PLANT J, V56, P303, DOI 10.1111/j.1365-313X.2008.03592.x; Bomal C, 2008, J EXP BOT, V59, P3925, DOI 10.1093/jxb/ern234; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Burk DH, 2006, J INTEGR PLANT BIOL, V48, P85, DOI 10.1111/j.1744-7909.2006.00202.x; Gampala SSL, 2001, J BIOL CHEM, V276, P9855, DOI 10.1074/jbc.M009168200; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Handakumbura PP, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00074; Hiratsu K, 2004, BIOCHEM BIOPH RES CO, V321, P172, DOI 10.1016/j.bbrc.2004.06.115; HUGHES J, 1975, STAIN TECHNOL, V50, P319, DOI 10.3109/10520297509117082; Ko JH, 2009, PLANT J, V60, P649, DOI 10.1111/j.1365-313X.2009.03989.x; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1659, DOI 10.1093/pcp/pcm155; Lee C, 2010, PLANT PHYSIOL, V153, P526, DOI 10.1104/pp.110.155309; Mauseth J., 1988, PLANT ANATOMY; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Taylor NG, 2004, CELLULOSE, V11, P329, DOI 10.1023/B:CELL.0000046405.11326.a8; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Yamaguchi M, 2011, PLANT J, V66, P579, DOI 10.1111/j.1365-313x.2011.04514.x; Ye ZH, 2002, INT REV CYTOL, V220, P225; Yoshida K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00383; Zhang J, 2014, CURR OPIN PLANT BIOL, V17, P56, DOI 10.1016/j.pbi.2013.11.003; Zhao QA, 2010, PLANT J, V63, P100, DOI 10.1111/j.1365-313X.2010.04223.x; Zhong RQ, 1997, PLANT CELL, V9, P2159, DOI 10.1105/tpc.9.12.2159; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069219; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007; Zhong RQ, 2010, PLANT PHYSIOL, V152, P1044, DOI 10.1104/pp.109.148270; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	46	47	61	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105726	10.1371/journal.pone.0105726	http://dx.doi.org/10.1371/journal.pone.0105726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148240	gold, Green Submitted, Green Published			2022-12-25	WOS:000341230600075
J	Chen, DP; Wang, Y; Zhou, XY; Wang, YL; Xu, JR				Chen, Daipeng; Wang, Yang; Zhou, Xiaoying; Wang, Yulin; Xu, Jin-Rong			The Sch9 Kinase Regulates Conidium Size, Stress Responses, and Pathogenesis in Fusarium graminearum	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE SCH9; MAGNAPORTHE-GRISEA; GIBBERELLA-ZEAE; FISSION YEAST; CELL-GROWTH; HEAD-BLIGHT; MAP KINASE; GENE; VIRULENCE; WHEAT	Fusarium head blight caused by Fusarium graminearum is an important disease of wheat and barley worldwide. In a previous study on functional characterization of the F. graminearum kinome, one protein kinase gene important for virulence is orthologous to SCH9 that is functionally related to the cAMP-PKA and TOR pathways in the budding yeast. In this study, we further characterized the functions of FgSCH9 in F. graminearum and its ortholog in Magnaporthe oryzae. The Delta Fgsch9 mutant was slightly reduced in growth rate but significantly reduced in conidiation, DON production, and virulence on wheat heads and corn silks. It had increased tolerance to elevated temperatures but became hypersensitive to oxidative, hyperosmotic, cell wall, and membrane stresses. The Delta Fgsch9 deletion also had conidium morphology defects and produced smaller conidia. These results suggest that FgSCH9 is important for stress responses, DON production, conidiogenesis, and pathogenesis in F. graminearum. In the rice blast fungus Magnaporthe oryzae, the Delta Mosch9 mutant also was defective in conidiogenesis and pathogenesis. Interestingly, it also produced smaller conidia and appressoria. Taken together, our data indicate that the SCH9 kinase gene may have a conserved role in regulating conidium size and plant infection in phytopathogenic ascomycetes.	[Chen, Daipeng; Wang, Yang; Wang, Yulin; Xu, Jin-Rong] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Zhou, Xiaoying; Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xu, JR (corresponding author), Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	jinrong@purdue.edu			National Major Project of Breeding for New Transgenic Organisms [2012ZX08009003]; National Basic Research Program of China [2012CB114002, 2013CB127703]	National Major Project of Breeding for New Transgenic Organisms; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Major Project of Breeding for New Transgenic Organisms (2012ZX08009003) and the National Basic Research Program of China (2012CB114002; 2013CB127703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Boddu J, 2006, MOL PLANT MICROBE IN, V19, P407, DOI 10.1094/MPMI-19-0407; Bormann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091135; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Desjardins AE, 2003, ANNU REV PHYTOPATHOL, V41, P177, DOI 10.1146/annurev.phyto.41.011703.115501; Ding SL, 2009, EUKARYOT CELL, V8, P867, DOI 10.1128/EC.00048-09; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fujita M, 1998, CURR GENET, V33, P248, DOI 10.1007/s002940050333; Gale LR, 2002, PHYTOPATHOLOGY, V92, P1315, DOI 10.1094/PHYTO.2002.92.12.1315; Geyskens I, 2000, NATO SCI S A LIF SCI, V316, P117; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Harris LJ, 1999, PLANT DIS, V83, P954, DOI 10.1094/PDIS.1999.83.10.954; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Hu S, 2014, MOL PLANT M IN PRESS, V27; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; JIN M, 1995, GENETICS, V140, P457; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Li GT, 2012, CURR OPIN MICROBIOL, V15, P678, DOI 10.1016/j.mib.2012.09.004; Liu W, 2010, FEMS YEAST RES, V10, P462, DOI 10.1111/j.1567-1364.2010.00617.x; Liu X, 2014, MICROBIOL-SGM, V160, P692, DOI 10.1099/mic.0.075333-0; Menke J, 2012, MOL PLANT MICROBE IN, V25, P1408, DOI 10.1094/MPMI-04-12-0081-R; Min K, 2012, FEMS MICROBIOL LETT, V334, P66, DOI 10.1111/j.1574-6968.2012.02620.x; Motoyama T, 2008, CURR GENET, V54, P185, DOI 10.1007/s00294-008-0211-0; Park G, 2006, PLANT CELL, V18, P2822, DOI 10.1105/tpc.105.038422; Pascual-Ahuir A, 2007, EMBO J, V26, P3098, DOI 10.1038/sj.emboj.7601756; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Seong K, 2006, FUNGAL GENET BIOL, V43, P34, DOI 10.1016/j.fgb.2005.10.002; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Swinnen E, 2014, FEMS YEAST RES, V14, P17, DOI 10.1111/1567-1364.12097; Nguyen TV, 2012, MOL PLANT MICROBE IN, V25, P1142, DOI 10.1094/MPMI-02-12-0047-R; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Voigt CA, 2005, PLANT J, V42, P364, DOI 10.1111/j.1365-313X.2005.02377.x; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wang GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038324; Wang P, 2004, CURR GENET, V46, P247, DOI 10.1007/s00294-004-0529-1; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Yu F, 2014, NEW PHYTOLO IN PRESS; Zhang AL, 2011, FEBS LETT, V585, P3026, DOI 10.1016/j.febslet.2011.08.023; Zhang XW, 2012, PLANT CELL, V24, P5159, DOI 10.1105/tpc.112.105957; Zhao X., 2004, FUNGAL GENETICS REPO, V51, P17; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116; Zhao XH, 2007, MOL MICROBIOL, V63, P881, DOI 10.1111/j.1365-2958.2006.05548.x; Zheng DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049495; Zheng Q, 2013, PLOS ONE, V8; Zheng Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066980; Zhou XY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002911; Zhou XY, 2011, MOL MICROBIOL, V80, P33, DOI 10.1111/j.1365-2958.2011.07556.x; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	63	30	31	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105811	10.1371/journal.pone.0105811	http://dx.doi.org/10.1371/journal.pone.0105811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144230	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100122
J	Korir, JC; Nyakoe, NK; Awinda, G; Waitumbi, JN				Korir, Jackson C.; Nyakoe, Nancy K.; Awinda, George; Waitumbi, John N.			Complement Activation by Merozoite Antigens of Plasmodium falciparum	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; IMMUNE-COMPLEXES; INFECTED ERYTHROCYTES; MALARIA PARASITES; CEREBRAL MALARIA; CHILDREN; PROTEINS; POLYMORPHISMS; COMPONENT; INVASION	Background: Complement (C) is a crucial part of the innate immune system and becomes over activated during malaria, resulting in depletion of C components, especially those for lectin pathway (LP), thereby compromising the host's innate defense. In this study, involvement of P. falciparum antigens in C activation was investigated. Methods: A highly synchronous culture of the Dd2 clone of P. falciparum was established in a serum free medium. Supernatants harvested from rings, trophozoites and schizonts at various parasite densities were tested for ability to activate C by quantifying amount of C3b deposited on erythrocytes (E). Uninfected sham culture was used as control. Remnants of each C pathway were determined using Wieslab complement System Screenkit (Euro-diagnostica, Sweden). To identify MBL binding antigens of LP, culture supernatants were added to MBL sepharose columns and trapped antigens eluted with increasing concentrations of EDTA (10 mM, 50 mM and 100 mM) and then desalted before being tested for ability to activate C. The EDTA eluate with highest activity was run on a polyacrylamide gel and silver stained proteins analyzed by mass spectroscopy. Results: Antigens released by P. falciparum growing in culture activated C leading to C3b deposition on E. Maximal activation at 7% parasitemia was associated with schizont stage (36.7%) compared to 22% for rings, 21% for trophozoites and 3% for sham culture. All the three pathways of C were activated, with highest activation being for the alternative pathway (only 6% of C activation potential remained), 65% for classiical and 43% for the LP. Seven MBL binding merozoite proteins were identified by mass spectrometry in the 50 mM EDTA eluate. Conclusions: MBL binding merozoite adhesins with ability to activate C pathway were identified. The survival advantage for such pronounced C activation is unclear, but opsonisation could facilitate recognition and invasion of E.	[Korir, Jackson C.] Masinde Muliro Univ Sci & Technol, Kakamega, Kenya; [Nyakoe, Nancy K.; Awinda, George; Waitumbi, John N.] Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya	Kenya Medical Research Institute	Waitumbi, JN (corresponding author), Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya.	John.Waitumbi@usamru-k.org	Korir, Jackson Cheruiyot/AAG-7764-2021	Korir, Jackson Cheruiyot/0000-0003-3264-3054	D43 Training Grant, Forgaty International Training Center, of NIH	D43 Training Grant, Forgaty International Training Center, of NIH	This work was supported by D43 Training Grant, Forgaty International Training Center, of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM C, 1981, INFECT IMMUN, V31, P530, DOI 10.1128/IAI.31.2.530-535.1981; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Brunner J, 2012, RHEUMATOL INT, V32, P1815, DOI 10.1007/s00296-011-1973-0; Garred P, 2003, J INFECT DIS, V188, P1394, DOI 10.1086/379044; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 2003, INFECT IMMUN, V71, P5245, DOI 10.1128/IAI.71.9.5245-5253.2003; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; GREENWOOD BM, 1974, CLIN EXP IMMUNOL, V18, P267; Gunalan K, 2011, INFECT IMMUN, V79, P3421, DOI 10.1128/IAI.00201-11; KACA W, 1995, BBA-GEN SUBJECTS, V1245, P49, DOI 10.1016/0304-4165(95)00077-O; Kilpatrick DC, 1997, TRANSFUSION MED, V7, P289, DOI 10.1046/j.1365-3148.1997.d01-40.x; Klabunde J, 2002, PARASITOL RES, V88, P113, DOI 10.1007/s00436-001-0518-y; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Luty AJF, 1998, J INFECT DIS, V178, P1221, DOI 10.1086/515690; Mibei EK, 2008, PARASITE IMMUNOL, V30, P334, DOI 10.1111/j.1365-3024.2008.01030.x; Mibei EK, 2005, AM J TROP MED HYG, V72, P593, DOI 10.4269/ajtmh.2005.72.593; NEVA FA, 1974, J CLIN INVEST, V54, P451, DOI 10.1172/JCI107781; Nyakoe NK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-7; Ocarnpo M, 2004, PARASITOL INT, V53, P77, DOI 10.1016/j.parint.2003.11.004; Pawluczkowycz AW, 2007, J IMMUNOL, V179, P5543, DOI 10.4049/jimmunol.179.8.5543; Plank C, 1996, HUM GENE THER, V7, P1437, DOI 10.1089/hum.1996.7.12-1437; Roestenberg M, 2007, T ROY SOC TROP MED H, V101, P643, DOI 10.1016/j.trstmh.2007.02.023; Sahar T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017102; Salvesen B, 2009, MOL IMMUNOL, V46, P1620, DOI 10.1016/j.molimm.2009.02.028; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P355, DOI 10.1128/CMR.15.3.355-364.2002; STANLEY HA, 1984, MOL IMMUNOL, V21, P145, DOI 10.1016/0161-5890(84)90129-9; TAYLOR RP, 1991, CLIN IMMUNOL IMMUNOP, V61, P143, DOI 10.1016/S0090-1229(05)80020-0; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 2009, CELL MICROBIOL, V11, P1671, DOI 10.1111/j.1462-5822.2009.01358.x; Wenisch C, 1997, CLIN IMMUNOL IMMUNOP, V85, P166, DOI 10.1006/clin.1997.4417	33	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105093	10.1371/journal.pone.0105093	http://dx.doi.org/10.1371/journal.pone.0105093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144772	gold, Green Submitted, Green Published			2022-12-25	WOS:000341106100040
J	Krock, BL; Perkins, BD				Krock, Bryan L.; Perkins, Brian D.			The Par-PrkC Polarity Complex Is Required for Cilia Growth in Zebrafish Photoreceptors	PLOS ONE			English	Article							RETROGRADE INTRAFLAGELLAR TRANSPORT; SENSORY OUTER SEGMENT; VERTEBRATE PHOTORECEPTORS; EPITHELIAL POLARITY; CELL POLARITY; KINESIN-II; REVEALS MULTIPLE; KUPFFERS VESICLE; CRUMBS COMPLEX; MOSAIC EYES	Specification and development of the apical membrane in epithelial cells requires the function of polarity proteins, including Pard3 and an atypical protein kinase C (PrkC). Many epithelial cells possess microtubule-based organelles, known as cilia, that project from their apical surface and the membrane surrounding the cilium is contiguous with the apical cell membrane. Although cilia formation in cultured cells required Pard3, the in vivo requirement for Pard3 in cilia development remains unknown. The vertebrate photoreceptor outer segment represents a highly specialized cilia structure in which to identify factors necessary for apical and ciliary membrane formation. Pard3 and PrkC localized to distinct domains within vertebrate photoreceptors. Using partial morpholino knockdown, photo-morpholinos, and pharmacological approaches, the function of Pard3 and PrkC were found to be required for the formation of both the apical and ciliary membrane of vertebrate photoreceptors. Inhibition of Pard3 or PrkC activity significantly reduced the size of photoreceptor outer segments and resulted in mislocalization of rhodopsin. Suppression of Pard3 or PrkC also led to a reduction in cilia size and cilia number in Kupffer's Vesicle, which resulted in left-right asymmetry defects. Thus, the Par-PrkC complex functions in cilia formation in vivo and this likely reflects a general role in specifying non-ciliary and ciliary compartments of the apical domain.	[Krock, Bryan L.; Perkins, Brian D.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Perkins, Brian D.] Cleveland Clin Fdn, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44195 USA	Texas A&M University System; Texas A&M University College Station; Cleveland Clinic Foundation	Perkins, BD (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	perkinb2@ccf.org		Perkins, Brian/0000-0002-9348-6542	National Institutes of Health [EY017037]; Doris and Jules Stein Professorship from the Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY017037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris and Jules Stein Professorship from the Research to Prevent Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by a grant from the National Institutes of Health (EY017037) and from a Doris and Jules Stein Professorship from the Research to Prevent Blindness to BDP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Bloodgood RA, 2010, J CELL SCI, V123, P505, DOI 10.1242/jcs.066308; BOISVIEUXULRICH E, 1989, BIOL CELL, V67, P67, DOI 10.1111/j.1768-322X.1989.tb03011.x; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Cui S, 2007, MOL CELL NEUROSCI, V34, P431, DOI 10.1016/j.mcn.2006.11.016; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Fadool JM, 1999, INVEST OPHTH VIS SCI, V40, P1251; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Hong E, 2010, DEV BIOL, V341, P335, DOI 10.1016/j.ydbio.2010.01.034; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hsu YC, 2006, DEVELOPMENT, V133, P4849, DOI 10.1242/dev.02685; Hsu YC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-60; Hu QC, 2011, CYTOSKELETON, V68, P313, DOI 10.1002/cm.20514; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Insinna C, 2008, DEV DYNAM, V237, P1982, DOI 10.1002/dvdy.21554; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jacobson SG, 2003, HUM MOL GENET, V12, P1073, DOI 10.1093/hmg/ddg117; Jensen AM, 2001, DEVELOPMENT, V128, P95; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohjima M, 2002, BIOCHEM BIOPH RES CO, V299, P641, DOI 10.1016/S0006-291X(02)02698-0; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Krahn MP, 2010, J CELL BIOL, V190, P751, DOI 10.1083/jcb.201006029; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; Krock BL, 2009, INVEST OPHTH VIS SCI, V50, P5463, DOI 10.1167/iovs.09-3828; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; Lunt S, 2009, DEV DYN IN PRESS; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; NAGLE BW, 1986, INVEST OPHTH VIS SCI, V27, P689; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Pocha SM, 2011, J CELL BIOL, V195, P827, DOI 10.1083/jcb.201105144; Pruliere G, 2011, MOL BIOL CELL, V22, P2042, DOI 10.1091/mbc.E10-10-0844; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; Standaert ML, 1999, J BIOL CHEM, V274, P14074, DOI 10.1074/jbc.274.20.14074; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Tallafuss A, 2012, DEVELOPMENT, V139, P1691, DOI 10.1242/dev.072702; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; Wei XY, 2002, NAT GENET, V31, P150, DOI 10.1038/ng883; Westerfield M, 1995, ZEBRAFISH BOOK	70	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104661	10.1371/journal.pone.0104661	http://dx.doi.org/10.1371/journal.pone.0104661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144710	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100018
J	Lee, Y; Song, YS; Fang, CH; So, BI; Park, JY; Joo, HW; Park, IH; Shen, GY; Shin, JH; Kim, H; Ahn, YH; Kim, KS				Lee, Yonggu; Song, Yi-Sun; Fang, Cheng-Hu; So, Byung-Im; Park, Jun-Young; Joo, Hyun-Woo; Park, In-Hwa; Shen, Guang-Yin; Shin, Jeong-Hun; Kim, Hyuck; Ahn, You-Heon; Kim, Kyung-Soo			Anti-Obesity Effects of Granulocyte-Colony Stimulating Factor in Otsuka-Long-Evans-Tokushima Fatty Rats	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; UNCOUPLING PROTEIN-1 UCP1; TYPE-2 DIABETES-MELLITUS; TUMOR-NECROSIS-FACTOR; BROWN ADIPOSE-TISSUE; FACTOR G-CSF; BODY-WEIGHT; FOOD-INTAKE; ENERGY-EXPENDITURE; INSULIN-RESISTANCE	Granulocyte-colony stimulating factor (G-CSF) has molecular structures and intracellular signaling pathways that are similar to those of leptin and ciliary neurotropic factor (CNTF). It also has immune-modulatory properties. Given that leptin and CNTF play important roles in energy homeostasis and that obesity is an inflammatory condition in adipose tissue, we hypothesized that G-CSF could also play a role in energy homeostasis. We treated 12 38-week-old male Otsuka-Long-Evans-Tokushima fatty rats (OLETF, diabetic) and 12 age-matched male Long-Evans-Tokushima rats (LETO, healthy) with 200 mu g/day G-CSF or saline for 5 consecutive days. Body weight reduction was greater in G-CSF-treated OLETF (G-CSF/OLETF) than saline-treated OLETF (saline/OLETF) following 8 weeks of treatment (-6.9 +/- 1.6% vs. -3.1 +/- 2.2%, p<0.05). G-CSF treatment had no effect on body weight in LETO or on food intake in either OLETF or LETO. Body fat in G-CSF/OLETF was more reduced than in saline/OLETF (-32.2 +/- 3.1% vs. -20.8 +/- 6.2%, p<0.05). Energy expenditure was higher in G-CSF/OLETF from 4 weeks after the treatments than in saline/OLETF. Serum levels of cholesterol, triglyceride, interleukin-6 and tumor necrosis factor-a were lower in G-CSF/OLETF than in saline/OLETF. Uncoupling protein-1 (UCP-1) expression in brown adipose tissue (BAT) was higher in G-CSF/OLETF than in saline/OLETF, but was unaffected in LETO. Immunofluorescence staining and PCR results revealed that G-CSF receptors were expressed in BAT. In vitro experiments using brown adipocyte primary culture revealed that G-CSF enhanced UCP-1 expression from mature brown adipocytes via p38 mitogen-activated protein kinase pathway. In conclusion, G-CSF treatment reduced body weight and increased energy expenditure in a diabetic model, and enhanced UCP-1 expression and decreased inflammatory cytokine levels may be associated with the effects of G-CSF treatment.	[Lee, Yonggu; Shin, Jeong-Hun; Kim, Kyung-Soo] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 133791, South Korea; [Song, Yi-Sun; So, Byung-Im; Park, Jun-Young; Joo, Hyun-Woo; Park, In-Hwa; Shen, Guang-Yin; Kim, Kyung-Soo] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Fang, Cheng-Hu] Yanbian Univ, Div Cardiol, Yanji, Peoples R China; [Kim, Hyuck] Hanyang Univ Hosp, Dept Thorac Surg, Seoul, South Korea; [Ahn, You-Heon] Hanyang Univ Hosp, Dept Endocrinol, Seoul, South Korea; [Lee, Yonggu] Sung Ae Hosp, Dept Cardiol, Seoul, South Korea	Hanyang University; Hanyang University; Yanbian University; Hanyang University; Hanyang University Hospital; Hanyang University; Hanyang University Hospital	Kim, KS (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 133791, South Korea.	kskim@hanyang.ac.kr	Shin, Jeong Hun/O-1273-2019; Lee, Yonggu/Q-3832-2018	Shin, Jeong Hun/0000-0002-6718-9763; Lee, Yonggu/0000-0002-3757-3692				Beretta E, 2002, PEPTIDES, V23, P975, DOI 10.1016/S0196-9781(02)00021-9; Bi S, 2007, AM J PHYSIOL-REG I, V293, pR55, DOI 10.1152/ajpregu.00002.2007; Bluher S, 2004, DIABETES, V53, P2787, DOI 10.2337/diabetes.53.11.2787; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Brondani LD, 2012, ARQ BRAS ENDOCRINOL, V56, P215, DOI 10.1590/S0004-27302012000400001; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Choi HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072340; Couvreur O, 2012, AM J PHYSIOL-ENDOC M, V302, pE458, DOI 10.1152/ajpendo.00388.2011; Crowe S, 2008, ENDOCRINOLOGY, V149, P2546, DOI 10.1210/en.2007-1447; Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Hidaka S, 2002, FASEB J, V16, P509, DOI 10.1096/fj.01-0164com; Hong EG, 2002, J KOREAN MED SCI, V17, P34, DOI 10.3346/jkms.2002.17.1.34; Huising MO, 2006, J ENDOCRINOL, V189, P1, DOI 10.1677/joe.1.06591; Hwa JJ, 1997, AM J PHYSIOL-REG I, V272, pR1204, DOI 10.1152/ajpregu.1997.272.4.R1204; Janoschek R, 2006, P NATL ACAD SCI USA, V103, P10707, DOI 10.1073/pnas.0600425103; Jia JJ, 2010, MOL BIOL REP, V37, P1513, DOI 10.1007/s11033-009-9550-2; Jung H, 2009, BIOCHEM BIOPH RES CO, V383, P252, DOI 10.1016/j.bbrc.2009.04.001; Kanemoto N, 1998, MAMM GENOME, V9, P419, DOI 10.1007/s003359900789; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Knapp S, 2004, J INFECT DIS, V189, P1506, DOI 10.1086/382962; Lim YH, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-92; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Marino VJ, 2008, J CELL BIOCHEM, V103, P1512, DOI 10.1002/jcb.21542; Markelic M, 2011, EUR J HISTOCHEM, V55, P187, DOI 10.4081/ejh.2011.e34; Moran TH, 2006, PHILOS T R SOC B, V361, P1211, DOI 10.1098/rstb.2006.1857; Moschen AR, 2010, GUT, V59, P1259, DOI 10.1136/gut.2010.214577; Nishiki S, 2004, AM J PHYSIOL-CELL PH, V286, pC1302, DOI 10.1152/ajpcell.00387.2003; Ott V, 2002, J ENDOCRINOL, V173, pR1, DOI 10.1677/joe.0.173R001; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Porras A, 1997, FEBS LETT, V416, P324, DOI 10.1016/S0014-5793(97)01204-0; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Scarpace PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE226, DOI 10.1152/ajpendo.1997.273.1.E226; Schroeder M, 2009, AM J PHYSIOL-REG I, V297, pR1749, DOI 10.1152/ajpregu.00461.2009; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; So BI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077048; Song YS, 2013, ANN HEPATOL, V12, P115, DOI 10.1016/S1665-2681(19)31393-6; STORLIEN LH, 1986, AM J PHYSIOL, V251, pE576, DOI 10.1152/ajpendo.1986.251.5.E576; Suzuki H, 2013, J GASTROENTEROL, V48, P574, DOI 10.1007/s00535-013-0787-0; TANAKA H, 1991, DRUG METAB DISPOS, V19, P200; Valladares A, 2001, FEBS LETT, V493, P6, DOI 10.1016/S0014-5793(01)02264-5; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; White UA, 2011, CURR PHARM DESIGN, V17, P340	49	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105603	10.1371/journal.pone.0105603	http://dx.doi.org/10.1371/journal.pone.0105603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144367	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100094
J	Saletti, PG; Maior, RS; Hori, E; de Almeida, RM; Nishijo, H; Tomaz, C				Saletti, Patricia G.; Maior, Rafael S.; Hori, Etsuro; de Almeida, Ricardo Miyasaka; Nishijo, Hisao; Tomaz, Carlos			Whole-Body Prepulse Inhibition Protocol to Test Sensorymotor Gating Mechanisms in Monkeys	PLOS ONE			English	Article							PRIMATE SUPERIOR COLLICULUS; FEAR-POTENTIATED STARTLE; SACCADIC EYE-MOVEMENTS; SENSORIMOTOR INTEGRATION; THREAT RESPONSIVENESS; INFERIOR COLLICULUS; RHESUS-MONKEYS; HABITUATION; DEFICITS; SCHIZOPHRENIA	Prepulse inhibition (PPI) is the decrease of startle reflex amplitude when a slight stimulus is previously generated. This paradigm may provide valuable information about sensorimotor gating functionality. Here we aimed at determining the inhibited and uninhibited startle response of capuchin monkeys (Sapajus spp.), and to evaluate the role of the superior colliculus in PPI. Capuchin monkeys were tested in a whole-body protocol, to determine the best startle amplitude and interstimuli interval. Additionally we tested two subjects with bilateral superior colliculus damage in this protocol. Results show that 115 dB auditory pulse has induced the best startle response. In contrast to reports in other species, no habituation to the auditory stimuli was observed here in capuchins. Also, startle reflex inhibition was optimal after 120 msec interstimuli interval. Finally, there was a downward tendency of percentage inhibition in superior colliculus-lesioned monkeys. Our data provides the possibility of further studies with whole-body protocol in capuchin monkeys and reinforces the importance of the superior colliculus in PPI.	[Saletti, Patricia G.; Maior, Rafael S.; Tomaz, Carlos] Univ Brasilia, Ctr Primate, Brasilia, DF, Brazil; [Saletti, Patricia G.; Maior, Rafael S.; Tomaz, Carlos] Univ Brasilia, Dept Physiol Sci, Inst Biol, Lab Neurosci & Behav, Brasilia, DF, Brazil; [Hori, Etsuro; Nishijo, Hisao] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [de Almeida, Ricardo Miyasaka] Univ Brasilia, Fac Agron & Vet Med, Large Anim Teaching Hosp, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; University of Toyama; Universidade de Brasilia	Tomaz, C (corresponding author), Univ Brasilia, Ctr Primate, Brasilia, DF, Brazil.	ctomaz@unb.br	Tomaz, Carlos A B/F-8626-2012; Tomaz, Carlos/AAU-1524-2020; de Almeida, Ricardo Miyasaka/F-5437-2010; Maior, Rafael S./F-3994-2012	Tomaz, Carlos/0000-0001-7341-0922; de Almeida, Ricardo Miyasaka/0000-0002-2858-3637; Maior, Rafael S./0000-0001-7219-8675	JSPS Asian Core Program; Ministry of Education, Science, Sports, and Culture [25290005]; Research Support Foundation, FAP-DF, Brazil [2010/00154-0]; CAPES; CNPq	JSPS Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Support Foundation, FAP-DF, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported in part by the JSPS Asian Core Program and the Ministry of Education, Science, Sports, and Culture, Grant-in-Aid for Scientific Research (B) (25290005); and Research Support Foundation, FAP-DF, Brazil (2010/00154-0). PGS was recipient of a doctoral fellowship from CAPES and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballmaier M, 2007, NEUROPSYCHOPHARMACOL, V32, P2098, DOI 10.1038/sj.npp.1301344; Bell AH, 2005, J NEUROPHYSIOL, V93, P3659, DOI 10.1152/jn.01214.2004; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Brandao ML, 2003, EUR J PHARMACOL, V463, P225, DOI 10.1016/S0014-2999(03)01284-6; Coimbra NC, 2006, EXP NEUROL, V197, P93, DOI 10.1016/j.expneurol.2005.08.022; CYNADER M, 1972, J NEUROPHYSIOL, V35, P187, DOI 10.1152/jn.1972.35.2.187; Doubell TP, 2003, J NEUROSCI, V23, P6596; Feifel D, 1999, J PHARMACOL EXP THER, V288, P710; Fendt M, 1999, BRAIN RES, V833, P81, DOI 10.1016/S0006-8993(99)01525-5; FENDT M, 1994, NEUROREPORT, V5, P1725, DOI 10.1097/00001756-199409080-00009; Gacsalyi I, 2013, NEUROPHARMACOLOGY, V64, P254, DOI 10.1016/j.neuropharm.2012.07.017; GEYER MA, 1987, SCHIZOPHRENIA BULL, V13, P643, DOI 10.1093/schbul/13.4.643; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Harting JK, 2000, BRAIN RES, V881, P244, DOI 10.1016/S0006-8993(00)02849-3; HOFFMAN HS, 1980, PSYCHOL REV, V87, P175, DOI 10.1037/0033-295X.87.2.175; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Isa T, 2002, CURR OPIN NEUROBIOL, V12, P668, DOI 10.1016/S0959-4388(02)00387-2; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Lane ST, 2013, INT J PSYCHOPHYSIOL, V88, P55, DOI 10.1016/j.ijpsycho.2013.01.010; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Li L, 1998, PHYSIOL BEHAV, V65, P133, DOI 10.1016/S0031-9384(98)00143-7; Linn GS, 2003, PSYCHOPHARMACOLOGY, V169, P234, DOI 10.1007/s00213-003-1533-8; Linn GS, 2001, NEUROREPORT, V12, P117, DOI 10.1097/00001756-200101220-00031; Maior RS, 2012, REV NEUROSCIENCE, V23, P697, DOI 10.1515/revneuro-2012-0055; Maior RS, 2011, NEUROSCI LETT, V504, P257, DOI 10.1016/j.neulet.2011.09.042; Manocha S. L., 1968, STEREOTAXIC ATLAS BR; Maravita A, 2008, NEUROREPORT, V19, P271, DOI 10.1097/WNR.0b013e3282f4f04e; Northmore OPM, 1988, EXP BRAIN RES, V73, P595; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; RIGDON GC, 1991, DRUG DEVELOP RES, V23, P91, DOI 10.1002/ddr.430230110; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; Stein BE, 1976, J NEUROPHYSIOL, V39, P410; SWERDLOW NR, 1993, PHARMACOL BIOCHEM BE, V44, P741, DOI 10.1016/0091-3057(93)90193-W; Thompson RF, 2009, NEUROBIOL LEARN MEM, V92, P127, DOI 10.1016/j.nlm.2008.07.011; Williams LE, 2013, SCHIZOPHR RES, V151, P124, DOI 10.1016/j.schres.2013.10.017; Winslow JT, 2007, BIOL PSYCHIAT, V61, P389, DOI 10.1016/j.biopsych.2006.03.012; Winslow JT, 2002, BIOL PSYCHIAT, V51, P859, DOI 10.1016/S0006-3223(02)01345-8; Yeomans JS, 2006, NEUROSCIENCE, V142, P921, DOI 10.1016/j.neuroscience.2006.06.025	44	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105551	10.1371/journal.pone.0105551	http://dx.doi.org/10.1371/journal.pone.0105551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144368	gold, Green Submitted, Green Published			2022-12-25	WOS:000341106100084
J	Soderstjerna, E; Bauer, P; Cedervall, T; Abdshill, H; Johansson, F; Johansson, UE				Soderstjerna, Erika; Bauer, Patrik; Cedervall, Tommy; Abdshill, Hodan; Johansson, Fredrik; Johansson, Ulrica Englund			Silver and Gold Nanoparticles Exposure to In Vitro Cultured Retina - Studies on Nanoparticle Internalization, Apoptosis, Oxidative Stress, Glial- and Microglial Activity	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; ORGANOTYPIC CULTURES; MOUSE RETINA; CELLS; DEGENERATION; RATS; VIVO; NEURONS; SYSTEM; TRANSLOCATION	The complex network of neuronal cells in the retina makes it a potential target of neuronal toxicity - a risk factor for visual loss. With growing use of nanoparticles (NPs) in commercial and medical applications, including ophthalmology, there is a need for reliable models for early prediction of NP toxicity in the eye and retina. Metal NPs, such as gold and silver, gain much of attention in the ophthalmology community due to their potential to cross the barriers of the eye. Here, NP uptake and signs of toxicity were investigated after exposure to 20 and 80 nm Ag- and AuNPs, using an in vitro tissue culture model of the mouse retina. The model offers long-term preservation of retinal cell types, numbers and morphology and is a controlled system for delivery of NPs, using serum-free defined culture medium. AgNO3-treatment was used as control for toxicity caused by silver ions. These end-points were studied; gross morphological organization, glial activity, microglial activity, level of apoptosis and oxidative stress, which are all well described as signs of insult to neural tissue. TEM analysis demonstrated cellular- and nuclear uptake of all NP types in all neuronal layers of the retina. Htx-eosin staining showed morphological disruption of the normal complex layered retinal structure, vacuole formation and pyknotic cells after exposure to all Ag- and AuNPs. Significantly higher numbers of apoptotic cells as well as an increased number of oxidative stressed cells demonstrated NP-related neuronal toxicity. NPs also caused increased glial staining and microglial cell activation, typical hallmarks of neural tissue insult. This study demonstrates that low concentrations of 20 and 80 nm sized Ag- and AuNPs have adverse effects on the retina, using an organotypic retina culture model. Our results motivate careful assessment of candidate NP, metallic or-non-metallic, to be used in neural systems for therapeutic approaches.	[Soderstjerna, Erika; Abdshill, Hodan; Johansson, Ulrica Englund] Lund Univ, Dept Ophthalmol, Inst Clin Sci, Lund, Sweden; [Bauer, Patrik; Johansson, Fredrik] Lund Univ, Dept Biol, Sect Funct Zool, Lund, Sweden; [Cedervall, Tommy] Lund Univ, Lund, Sweden	Lund University; Lund University; Lund University	Johansson, UE (corresponding author), Lund Univ, Dept Ophthalmol, Inst Clin Sci, Lund, Sweden.	ulrica.englund_johansson@med.lu.se	Johansson, Fredrik/M-4554-2014; Cedervall, Tommy/AAT-9766-2021	Johansson, Fredrik/0000-0002-7813-8822; Cedervall, Tommy/0000-0003-2255-8446	Crafoord Foundation; VELUX stiftung; Clas Groschinskys Foundation; Kronprinsessan Margaretas Arbetsnamnd for synskadade (KMA); Magnus Bergvall Foundation; Greta and Johans Kock Foundation; Signhild Engqvist Foundation; Royal Physiographic Society in Lund; Nanometer Consortium at Lund University	Crafoord Foundation; VELUX stiftung; Clas Groschinskys Foundation; Kronprinsessan Margaretas Arbetsnamnd for synskadade (KMA); Magnus Bergvall Foundation; Greta and Johans Kock Foundation; Signhild Engqvist Foundation; Royal Physiographic Society in Lund; Nanometer Consortium at Lund University	This work was supported by grants from the Crafoord Foundation, VELUX stiftung, Clas Groschinskys Foundation, Kronprinsessan Margaretas Arbetsnamnd for synskadade (KMA), Magnus Bergvall Foundation, Greta and Johans Kock Foundation, Signhild Engqvist Foundation, The Royal Physiographic Society in Lund and the Nanometer Consortium at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Bassett EA, 2012, TRENDS NEUROSCI, V35, P565, DOI 10.1016/j.tins.2012.05.004; Bhatt L, 2010, MOL VIS, V16, P283; Bull ND, 2011, INVEST OPHTH VIS SCI, V52, P3309, DOI 10.1167/iovs.10-6873; Buyukhatipoglu K, 2011, J BIOMED MATER RES A, V96A, P186, DOI 10.1002/jbm.a.32972; Caffe AR, 2001, J CHEM NEUROANAT, V22, P263; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Chen JM, 2006, TOXICOLOGY, V222, P195, DOI 10.1016/j.tox.2006.02.016; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cortese-Krott MM, 2009, FREE RADICAL BIO MED, V47, P1570, DOI 10.1016/j.freeradbiomed.2009.08.023; Diebold Y, 2010, PROG RETIN EYE RES, V29, P596, DOI 10.1016/j.preteyeres.2010.08.002; Drexler B, 2010, CURR MED CHEM, V17, P4538, DOI 10.2174/092986710794183042; Dziendzikowska K, 2012, J APPL TOXICOL, V32, P920, DOI 10.1002/jat.2758; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Englund-Johansson U, 2010, EXP EYE RES, V90, P292, DOI 10.1016/j.exer.2009.11.005; Farjo KM, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-21; GAHWILER BH, 1988, TRENDS NEUROSCI, V11, P484, DOI 10.1016/0166-2236(88)90007-0; Gramowski A, 2010, ENVIRON HEALTH PERSP, V118, P1363, DOI 10.1289/ehp.0901661; Grottone GT, 2013, CURR EYE RES; GUERIN CJ, 1990, INVEST OPHTH VIS SCI, V31, P1474; Guo DD, 2013, J NANOSCI NANOTECHNO, V13, P3769, DOI 10.1166/jnn.2013.7169; Gurunathan S, 2009, BIOMATERIALS, V30, P6341, DOI 10.1016/j.biomaterials.2009.08.008; Haase A, 2012, TOXICOL SCI, V126, P457, DOI 10.1093/toxsci/kfs003; Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001; Hakansson Gisela, 2010, J Ocul Biol Dis Infor, V3, P20, DOI 10.1007/s12177-010-9050-6; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Hussain SM, 2006, TOXICOL SCI, V92, P456, DOI 10.1093/toxsci/kfl020; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; Ji JH, 2007, INHAL TOXICOL, V19, P857, DOI 10.1080/08958370701432108; Jo DH, 2014, NANOMEDICINE; Jo SH, 2011, INT J MOL SCI, V12, P1359, DOI 10.3390/ijms12021359; Kalishwaralal K, 2010, J CONTROL RELEASE, V145, P76, DOI 10.1016/j.jconrel.2010.03.022; Karthikeyan B, 2010, EXP EYE RES, V91, P769, DOI 10.1016/j.exer.2010.09.003; Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c; Kim JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/50/505101; Kim JH, 2011, BIOMATERIALS, V32, P1865, DOI 10.1016/j.biomaterials.2010.11.030; Kim S, 2013, J APPL TOXICOL, V33, P78, DOI 10.1002/jat.2792; Kompella UB, 2010, THER DELIV, V1, P435, DOI 10.4155/TDE.10.40; Kreyling WG, 2006, J AEROSOL MED, V19, P74, DOI 10.1089/jam.2006.19.74; Kreyling Wolfgang G, 2009, Inhal Toxicol, V21 Suppl 1, P55, DOI 10.1080/08958370902942517; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lavik E, 2011, EYE, V25, P578, DOI 10.1038/eye.2011.82; Li F, 2012, KENYON REV, V34, P6; Liu ZW, 2011, ENVIRON TOXICOL, V26, P552, DOI 10.1002/tox.20586; Liu ZW, 2009, TOXICOLOGY, V264, P179, DOI 10.1016/j.tox.2009.08.005; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; Mertsch K, 2001, J COMP NEUROL, V431, P217; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; Ning T, 2004, VISION RES, V44, P3307, DOI 10.1016/j.visres.2004.07.041; Oberdorster G, 2009, J NANOSCI NANOTECHNO, V9, P4996, DOI 10.1166/jnn.2009.GR02; Ogilvie JM, 1999, J NEUROSCI METH, V87, P57; Olson JL, 2013, J NANOMATER MOL NANO, V2, DOI [10.4172/2324-8777.1000111, DOI 10.4172/2324-8777.1000111]; Panariti A, 2012, NANOTECHNOL SCI APPL, V5, P87, DOI 10.2147/NSA.S25515; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Prediger RDS, 2012, NEUROTOX RES, V21, P90, DOI 10.1007/s12640-011-9281-8; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ramirez-Lee MA, 2013, TOXICOL LETT; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ryu JK, 2002, GLIA, V38, P15, DOI 10.1002/glia.10047; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; Schleh C, 2012, NANOTOXICOLOGY, V6, P36, DOI 10.3109/17435390.2011.552811; Sintubin L, 2012, BIOTECHNOL BIOENG, V109, P2422, DOI 10.1002/bit.24570; Soderstjerna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058211; Soenen SJ, 2012, ACS NANO, V6, P5767, DOI 10.1021/nn301714n; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Suen WLL, 2013, J CONTROL RELEASE, V167, P21, DOI 10.1016/j.jconrel.2013.01.004; Tsai GY, 2009, CLIN EXP OPHTHALMOL, V37, P223, DOI 10.1111/j.1442-9071.2009.02000.x; Wang JY, 2009, NEUROTOXICOLOGY, V30, P926, DOI 10.1016/j.neuro.2009.09.005; Wang SW, 2002, METHODS, V28, P448, DOI 10.1016/S1046-2023(02)00264-5; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Xue Y, 2012, TOXICOL LETT, V214, P91, DOI 10.1016/j.toxlet.2012.08.009; Zou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028720	77	68	71	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105359	10.1371/journal.pone.0105359	http://dx.doi.org/10.1371/journal.pone.0105359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144684	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100058
J	Wang, HG; van Eeuwijk, FA				Wang, Huange; van Eeuwijk, Fred A.			A New Method to Infer Causal Phenotype Networks Using QTL and Phenotypic Information	PLOS ONE			English	Article							MULTI-TRAIT; ACCUMULATION; MODELS; LOCI	In the context of genetics and breeding research on multiple phenotypic traits, reconstructing the directional or causal structure between phenotypic traits is a prerequisite for quantifying the effects of genetic interventions on the traits. Current approaches mainly exploit the genetic effects at quantitative trait loci (QTLs) to learn about causal relationships among phenotypic traits. A requirement for using these approaches is that at least one unique QTL has been identified for each trait studied. However, in practice, especially for molecular phenotypes such as metabolites, this prerequisite is often not met due to limited sample sizes, high noise levels and small QTL effects. Here, we present a novel heuristic search algorithm called the QTL+phenotype supervised orientation (QPSO) algorithm to infer causal directions for edges in undirected phenotype networks. The two main advantages of this algorithm are: first, it does not require QTLs for each and every trait; second, it takes into account associated phenotypic interactions in addition to detected QTLs when orienting undirected edges between traits. We evaluate and compare the performance of QPSO with another state-of-the-art approach, the QTL-directed dependency graph (QDG) algorithm. Simulation results show that our method has broader applicability and leads to more accurate overall orientations. We also illustrate our method with a real-life example involving 24 metabolites and a few major QTLs measured on an association panel of 93 tomato cultivars. Matlab source code implementing the proposed algorithm is freely available upon request.	[Wang, Huange; van Eeuwijk, Fred A.] Wageningen Univ, Dept Plant Sci, NL-6700 AP Wageningen, Netherlands; [van Eeuwijk, Fred A.] Ctr BioSyst Genom, Wageningen, Netherlands; [van Eeuwijk, Fred A.] Netherlands Metabol Ctr, Leiden, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	Wang, HG (corresponding author), Wageningen Univ, Dept Plant Sci, NL-6700 AP Wageningen, Netherlands.	hw428@cam.ac.uk			Centre for BioSystems Genomics (CBSG); Netherlands Metabolomics Centre (NMC), The Netherlands Genomics Initiative/The Netherlands Organization for Scientific Research; CBSG	Centre for BioSystems Genomics (CBSG); Netherlands Metabolomics Centre (NMC), The Netherlands Genomics Initiative/The Netherlands Organization for Scientific Research; CBSG	This work was supported by the Centre for BioSystems Genomics (CBSG) and the Netherlands Metabolomics Centre (NMC), which are part of The Netherlands Genomics Initiative/The Netherlands Organization for Scientific Research. CBSG financed the collection of the tomato volatile data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimi NA, 2013, THEOR APPL GENET, V126, P2597, DOI 10.1007/s00122-013-2160-3; Aten JE, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-34; Baldermann S, 2010, J EXP BOT, V61, P2967, DOI 10.1093/jxb/erq123; Blair RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002458; Calus MPL, 2011, GENETICS SELECTION E, V43; Chickering DM, 1996, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P150; Gagneur J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-406; Gao HY, 2008, J INTEGR PLANT BIOL, V50, P991, DOI 10.1111/j.1744-7909.2008.00685.x; Gavai AK, 2009, METABOLOMICS, V5, P419, DOI 10.1007/s11306-009-0166-2; Hill CB, 2013, PLANT PHYSIOL, V162, P1266, DOI 10.1104/pp.113.217851; Hodges AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009513; Iyer SP, 2013, NEUROIMAGE, V75, P165, DOI 10.1016/j.neuroimage.2013.02.054; Jansen RC, 2009, CURR OPIN PLANT BIOL, V12, P241, DOI 10.1016/j.pbi.2009.01.003; JIANG CJ, 1995, GENETICS, V140, P1111; Joosen RVL, 2013, PLANT PHYSIOL, V162, P553, DOI 10.1104/pp.113.216176; Krumsiek J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-21; Li RH, 2006, PLOS GENET, V2, P1046, DOI 10.1371/journal.pgen.0020114; Li Y, 2010, TRENDS GENET, V26, P493, DOI 10.1016/j.tig.2010.09.002; Logsdon BA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001014; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Mahdi R, 2013, J MACH LEARN RES, V14, P1563; Malosetti M, 2008, EUPHYTICA, V161, P241, DOI 10.1007/s10681-007-9594-0; Mathieu S, 2009, J EXP BOT, V60, P325, DOI 10.1093/jxb/ern294; Neto EC, 2008, GENETICS, V179, P1089, DOI 10.1534/genetics.107.085167; Neto EC, 2010, ANN APPL STAT, V4, P320, DOI 10.1214/09-AOAS288; Rambla J. L, 2014, J EXPT BOT; Roessner-Tunali U, 2003, PLANT PHYSIOL, V133, P84, DOI 10.1104/pp.103.023572; Rosa GJM, 2011, GENETICS SELECTION E, V43; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shenoy P. P, 2006, INFERENCE HYBRID BAY, P428; Spirtes P., 2000, CAUSATION PREDICTION; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Ursem R, 2008, EUPHYTICA, V161, P181, DOI 10.1007/s10681-008-9672-y; Valente BD, 2013, GENETICS, V194, P561, DOI 10.1534/genetics.113.151209; Verma T, 1990, EQUIVALENCE SYNTHESI, P220; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391	37	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103997	10.1371/journal.pone.0103997	http://dx.doi.org/10.1371/journal.pone.0103997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144184	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100011
J	Yu, H; Zeng, JP; Liang, XM; Wang, WF; Zhou, YB; Sun, YD; Liu, SL; Li, WJ; Chen, CY; Jia, JH				Yu, Han; Zeng, Jiping; Liang, Xiuming; Wang, Wenfu; Zhou, Yabin; Sun, Yundong; Liu, Shili; Li, Wenjuan; Chen, Chunyan; Jia, Jihui			Helicobacter pylori Promotes Epithelial-Mesenchymal Transition in Gastric Cancer by Downregulating Programmed Cell Death Protein 4 (PDCD4)	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PDCD4; E-CADHERIN; EXPRESSION; CAGA; GENE; TUMORIGENESIS; TRANSCRIPTION; MICRORNA-21; PROGRESSION; METASTASIS	Helicobacter pylori, a Gram-negative, microaerophilic bacterium found in the stomach, is assumed to be associated with carcinogenesis, invasion and metastasis in digestive diseases. Cytotoxin-associated gene A (CagA) is an oncogenic protein of H. pylori that is encoded by a Cag pathogenicity island related to the development of gastric cancer. The epithelial-mesenchymal transition (EMT) is the main biological event in invasion or metastasis of epithelial cells. H. pylori may promote EMT in human gastric cancer cell lines, but the specific mechanisms are still obscure. We explored the underlying molecular mechanism of EMT induced by H. pylori CagA in gastric cancer. In our article, we detected gastric cancer specimens and adjacent non-cancerous specimens by immunohistochemistry and found increased expression of the EMT-related regulatory protein TWIST1 and the mesenchymal marker vimentin in cancer tissues, while programmed cell death factor 4 (PDCD4) and the epithelial marker E-cadherin expression decreased in cancer specimens. These changes were associated with degree of tissue malignancy. In addition, PDCD4 and TWIST1 levels were related. In gastric cancer cells cocultured with CagA expression plasmid, CagA activated TWIST1 and vimentin expression, and inhibited E-cadherin expression by downregulating PDCD4. CagA also promoted mobility of gastric cancer cells by regulating PDCD4. Thus, H. pylori CagA induced EMT in gastric cancer cells, which reveals a new signaling pathway of EMT in gastric cancer cell lines.	[Yu, Han; Zeng, Jiping; Liang, Xiuming; Wang, Wenfu; Zhou, Yabin; Sun, Yundong; Liu, Shili; Li, Wenjuan; Chen, Chunyan; Jia, Jihui] Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan 250100, Peoples R China; [Zeng, Jiping] Shandong Univ, Sch Med, Dept Biochem, Jinan 250100, Peoples R China	Shandong University; Shandong University	Jia, JH (corresponding author), Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan 250100, Peoples R China.	jiajihui@sdu.edu.cn			National Basic Research Program of China (973 Program) [2012CB911202]; National Natural Science Foundation of China [81171536, 81371781, 81272654, 81372680, 81170514]; Medical Science and Technology Development Program of Shandong [2013WS0209]; Independent Innovation Foundation of Shandong University [2012TS106]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology Development Program of Shandong; Independent Innovation Foundation of Shandong University	This work was supported by the National Basic Research Program of China (no. 973 Program 2012CB911202), the National Natural Science Foundation of China (nos: 81171536, 81371781, 81272654, 81372680 and 81170514), the Medical Science and Technology Development Program of Shandong (no. 2013WS0209) and the Independent Innovation Foundation of Shandong University (no. 2012TS106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Azzoni L, 1998, J IMMUNOL, V161, P3493; Buti L, 2011, P NATL ACAD SCI USA, V108, P9238, DOI 10.1073/pnas.1106200108; Chan AOO, 2006, WORLD J GASTROENTERO, V12, P199, DOI 10.3748/wjg.v12.i2.199; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; KUIPERS EJ, 1995, ALIMENT PHARM THERAP, V9, P59; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Li J, 2010, BMC EVOL BIOL, V10, DOI [10.1186/1471-2148-10-68, 10.1186/1471-2407-10-354]; Liu YC, 2005, WORLD J GASTROENTERO, V11, P5174; Ma G, 2013, TUMOR BIOL, V34, P3879, DOI 10.1007/s13277-013-0975-9; Motoyama K, 2010, INT J ONCOL, V36, P1089, DOI 10.3892/ijo_00000590; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Natalwala A, 2008, WORLD J GASTROENTERO, V14, P3792, DOI 10.3748/wjg.14.3792; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pinzani M, 2011, J HEPATOL, V55, P459, DOI 10.1016/j.jhep.2011.02.001; Resende C, 2011, HELICOBACTER, V16, P38, DOI 10.1111/j.1523-5378.2011.00879.x; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Sohn SH, 2011, ENVIRON TOXICOL PHAR, V32, P382, DOI 10.1016/j.etap.2011.08.006; Talbot Lindsay J, 2012, Int J Biochem Mol Biol, V3, P117; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vikhreva P N, 2010, Mol Gen Mikrobiol Virusol, P3; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang Q, 2013, EUR J CANCER, V49, P1761, DOI 10.1016/j.ejca.2012.12.014; Watanabe T, 2014, INT J CANCER, V134, P2373, DOI 10.1002/ijc.28582; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yao Q, 2011, INT J CANCER, V128, P1783, DOI 10.1002/ijc.25506; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794	42	38	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105306	10.1371/journal.pone.0105306	http://dx.doi.org/10.1371/journal.pone.0105306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144746	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100050
J	Li, L; Wang, BT; Feng, S; Li, JN; Wu, CM; Wang, Y; Ruan, XC; Zeng, MH				Li, Lin; Wang, Binting; Feng, Shuai; Li, Jinnian; Wu, Congming; Wang, Ying; Ruan, Xiangchun; Zeng, Minghua			Prevalence and Characteristics of Extended-Spectrum beta-Lactamase and Plasmid-Mediated Fluoroquinolone Resistance Genes in Escherichia coli Isolated from Chickens in Anhui Province, China	PLOS ONE			English	Article							QUINOLONE RESISTANCE; ANTIMICROBIAL RESISTANCE; CTX-M; ENTEROBACTERIACEAE; COMMUNITY; ANIMALS; ESBLS; EPIDEMIOLOGY; EMERGENCE; THREAT	The aim of this study was to characterize the prevalence of extended-spectrum beta-lactamase (ESBL) genes and plasmidmediated fluoroquinolone resistance (PMQR) determinants in 202 Escherichia coli isolates from chickens in Anhui Province, China, and to determine whether ESBL and PMQR genes co-localized in the isolates. Antimicrobial susceptibility for 12 antimicrobials was determined by broth microdilution. Polymerase chain reactions (PCRs), DNA sequencing, and pulsed field gel electrophoresis (PFGE) were employed to characterize the molecular basis for beta-lactam and fluoroquinolone resistance. High rates of antimicrobial resistance were observed, 147 out of the 202 (72.8%) isolates were resistant to at least 6 antimicrobial agents and 28 (13.9%) of the isolates were resistant to at least 10 antimicrobials. The prevalence of bla(CTX-M), bla(TEM-1) and bla(TEM-206) genes was 19.8%, 24.3% and 11.9%, respectively. Seventy-five out of the 202 (37.1%) isolates possessed a plasmid-mediated quinolone resistance determinant in the form of qnrS (n = 21); this determinant occurred occasionally in combination with aac(6')-1b-cr (n = 65). Coexistence of ESBL and/or PMQR genes was identified in 31 of the isolates. Two E. coli isolates carried bla(TEM-1), bla(CTX-M) and qnrS, while two others carried bla(CTX-M), qnrS and aac(6')-1b-cr. In addition, bla(TEM-1), qnrS and aac(6')-1b-cr were co-located in two other E. coli isolates. PFGE analysis showed that these isolates were not clonally related and were genetically diverse. To the best of our knowledge, this study is the first to describe detection of TEM-206-producing E. coli in farmed chickens, and the presence of bla(TEM-206), qnrS and aac(6')-1b-cr in one of the isolates.	[Li, Lin; Wang, Binting; Feng, Shuai; Wang, Ying; Ruan, Xiangchun; Zeng, Minghua] Anhui Agr Univ, Coll Anim Sci & Technol, Pharmacol & Toxicol Lab, Hefei, Peoples R China; [Li, Jinnian] Anhui Agr Univ, Coll Anim Sci & Technol, Microbiol & Immunol Lab, Hefei, Peoples R China; [Wu, Congming] China Agr Univ, Coll Vet Med, Beijing Key Lab Detect Technol Anim Derived Food, Beijing 100094, Peoples R China	Anhui Agricultural University; Anhui Agricultural University; China Agricultural University	Zeng, MH (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Pharmacol & Toxicol Lab, Hefei, Peoples R China.	zmhzmh@ahau.edu.cn	li, lijinnian/HDO-3498-2022; Zeng, Ming/GXF-3628-2022	Zeng, Ming/0000-0003-2836-9240	Anhui University Provincial Natural Science Research Project [KJ2012A111]; National Natural Science Foundation of China [31201957]; Annual disciplinary and academic degree construction projects [XKXWD2013006]; Special Fund for Agro-Scientific Research in the Public Interest [201203040]	Anhui University Provincial Natural Science Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Annual disciplinary and academic degree construction projects; Special Fund for Agro-Scientific Research in the Public Interest	This work was supported by grants from the Anhui University Provincial Natural Science Research Project (KJ2012A111), National Natural Science Foundation of China (31201957), Annual disciplinary and academic degree construction projects in 2013 (XKXWD2013006), and Special Fund for Agro-Scientific Research in the Public Interest (201203040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin C, 2009, J ANTIMICROB CHEMOTH, V63, P1205, DOI 10.1093/jac/dkp108; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; CLSI, 2018, PERFORMANCE STANDARD; Dai L, 2008, FEMS MICROBIOL LETT, V286, P178, DOI 10.1111/j.1574-6968.2008.01272.x; Drugdova Z, 2013, BIOLOGIA, V68, P11, DOI 10.2478/s11756-012-0142-6; Fortini D, 2011, J ANTIMICROB CHEMOTH, V66, P1269, DOI 10.1093/jac/dkr085; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Li L, 2010, VET MICROBIOL, V144, P505, DOI 10.1016/j.vetmic.2010.02.005; Liu JH, 2007, INT J ANTIMICROB AG, V29, P576, DOI 10.1016/j.ijantimicag.2006.12.015; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Luo YP, 2011, INT J ANTIMICROB AG, V37, P352, DOI 10.1016/j.ijantimicag.2010.12.018; Mustak HK, 2012, ANKARA UNIV VET FAK, V59, P255, DOI 10.1501/Vetfak_0000002535; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rodriguez-Bano J, 2004, J CLIN MICROBIOL, V42, P1089, DOI 10.1128/JCM.42.3.1089-1094.2004; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Wang Y, 2012, VET MICROBIOL, V159, P53, DOI 10.1016/j.vetmic.2012.03.009; Xia LN, 2010, FOODBORNE PATHOG DIS, V7, P207, DOI 10.1089/fpd.2009.0378; Yang T, 2014, VET MICROBIOL, V170, P89, DOI 10.1016/j.vetmic.2014.01.019; Yuan L, 2009, J MED MICROBIOL, V58, P1449, DOI 10.1099/jmm.0.012229-0; Yue L, 2008, VET MICROBIOL, V132, P414, DOI 10.1016/j.vetmic.2008.05.009; Zhou TL, 2011, JPN J INFECT DIS, V64, P55	25	21	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104356	10.1371/journal.pone.0104356	http://dx.doi.org/10.1371/journal.pone.0104356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141348	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200017
J	Li, MW; Oishi, K; He, XH; Qin, YY; Gao, F; Mori, S				Li, Muwei; Oishi, Kenichi; He, Xiaohai; Qin, Yuanyuan; Gao, Fei; Mori, Susumu		Alzheimer's Dis Neuroimaging	An Efficient Approach for Differentiating Alzheimer's Disease from Normal Elderly Based on Multicenter MRI Using Gray-Level Invariant Features	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MULTITASK FEATURE-SELECTION; VOXEL-BASED MORPHOMETRY; VENTRICULAR ENLARGEMENT; IMAGE-ANALYSIS; CLASSIFICATION; BRAIN; DIAGNOSIS; DEMENTIA; PATTERNS	Machine learning techniques, along with imaging markers extracted from structural magnetic resonance images, have been shown to increase the accuracy to differentiate patients with Alzheimer's disease ( AD) from normal elderly controls. Several forms of anatomical features, such as cortical volume, shape, and thickness, have demonstrated discriminative capability. These approaches rely on accurate non-linear image transformation, which could invite several nuisance factors, such as dependency on transformation parameters and the degree of anatomical abnormality, and an unpredictable influence of residual registration errors. In this study, we tested a simple method to extract disease-related anatomical features, which is suitable for initial stratification of the heterogeneous patient populations often encountered in clinical data. The method employed gray-level invariant features, which were extracted from linearly transformed images, to characterize AD-specific anatomical features. The intensity information from a disease-specific spatial masking, which was linearly registered to each patient, was used to capture the anatomical features. We implemented a two-step feature selection for anatomic recognition. First, a statistic-based feature selection was implemented to extract AD-related anatomical features while excluding non-significant features. Then, seven knowledge-based ROIs were used to capture the local discriminative powers of selected voxels within areas that were sensitive to AD or mild cognitive impairment (MCI). The discriminative capability of the proposed feature was measured by its performance in differentiating AD or MCI from normal elderly controls (NC) using a support vector machine. The statistic-based feature selection, together with the knowledge-based masks, provided a promising solution for capturing anatomical features of the brain efficiently. For the analysis of clinical populations, which are inherently heterogeneous, this approach could stratify the large amount of data rapidly and could be combined with more detailed subsequent analyses based on non-linear transformation.	[Li, Muwei; He, Xiaohai] Sichuan Univ, Coll Elect & Informat Engn, Chengdu 610064, Peoples R China; [Oishi, Kenichi; Mori, Susumu] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Qin, Yuanyuan] Huazhong Univ Sci & Technol, Dept Radiol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Gao, Fei] Shandong Univ, Shandong Med Imaging Res Inst, Jinan 250100, Peoples R China	Sichuan University; Johns Hopkins University; Huazhong University of Science & Technology; Shandong University	He, XH (corresponding author), Sichuan Univ, Coll Elect & Informat Engn, Chengdu 610064, Peoples R China.	hxh@scu.edu.cn; susumu@mri.jhu.edu	qin, yuanyuan/G-4351-2010; Oishi, Kenichi/H-1371-2013	qin, yuanyuan/0000-0002-0673-3200; Oishi, Kenichi/0000-0002-1200-8611	Natural Science Foundations of China [81173356]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Natural Science Foundations of China (No. 81173356, http://www.nsfc.gov.cn/publish/portal1/). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to Rev December 5, 2013 support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Apostolova LG, 2012, ALZ DIS ASSOC DIS, V26, P17, DOI 10.1097/WAD.0b013e3182163b62; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; Cardillo G., 2008, ROC CURVE COMPUTE RE; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CLAUS JJ, 1994, NEUROLOGY, V44, P454, DOI 10.1212/WNL.44.3_Part_1.454; Cocosco C. A., 1997, NEUROIMAGE, V5, pS425, DOI DOI 10.1016/S1053-8119(97)80018-3; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; Convit A, 1997, NEUROBIOL AGING, V18, P131, DOI 10.1016/S0197-4580(97)00001-8; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fan Y, 2005, LECT NOTES COMPUT SC, V3749, P1; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; Guoying Z, 2007, EXPT FACIAL EXPRESSI, V2007, P1091; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Higdon R, 2004, STAT MED, V23, P315, DOI 10.1002/sim.1719; Hinrichs C, 2009, NEUROIMAGE, V48, P138, DOI 10.1016/j.neuroimage.2009.05.056; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jie B, 2013, LECT NOTES COMPUT SC, V8149, P275, DOI 10.1007/978-3-642-40811-3_35; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Liu F, 2013, LECT NOTES COMPUT SC, V8150, P311, DOI 10.1007/978-3-642-40763-5_39; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu MH, 2014, HUM BRAIN MAPP, V35, P1305, DOI 10.1002/hbm.22254; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Miller MI, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00031; Mori S, 2013, ANNU REV BIOMED ENG, V15, P71, DOI 10.1146/annurev-bioeng-071812-152335; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Ohnishi T, 2001, AM J NEURORADIOL, V22, P1680; Oishi K, 2011, J ALZHEIMERS DIS, V26, P287, DOI 10.3233/JAD-2011-0007; Oishi Kenichi, 2011, Front Neurol, V2, P54, DOI 10.3389/fneur.2011.00054; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Plant C, 2010, NEUROIMAGE, V50, P162, DOI 10.1016/j.neuroimage.2009.11.046; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Qin YY, 2013, NEUROIMAGE-CLIN, V3, P202, DOI 10.1016/j.nicl.2013.08.006; Qiu A, 2008, NEUROIMAGE, V40, P68, DOI 10.1016/j.neuroimage.2007.11.041; Qiu AQ, 2009, NEUROIMAGE, V45, P656, DOI 10.1016/j.neuroimage.2009.01.013; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Salat DH, 2011, NEUROIMAGE, V54, P1795, DOI 10.1016/j.neuroimage.2010.10.034; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Suk H.-I., 2013, BRAIN STRUCT FUNCT, P1; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; Wang LQ, 1998, MAGNET RESON MED, V39, P322, DOI 10.1002/mrm.1910390222; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wee CY, 2013, HUM BRAIN MAPP, V34, P3411, DOI 10.1002/hbm.22156; Westman E, 2013, BRAIN TOPOGR, V26, P9, DOI 10.1007/s10548-012-0246-x; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zhang TH, 2013, NEUROIMAGE, V79, P94, DOI 10.1016/j.neuroimage.2013.04.063; Zhao GY, 2007, IEEE T PATTERN ANAL, V29, P915, DOI 10.1109/TPAMI.2007.1110; Zhao GY, 2012, IEEE T IMAGE PROCESS, V21, P1465, DOI 10.1109/TIP.2011.2175739; ZWEIG MH, 1993, CLIN CHEM, V39, P561	73	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105563	10.1371/journal.pone.0105563	http://dx.doi.org/10.1371/journal.pone.0105563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140532	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200099
J	Qu, H; Wang, H; Deng, M; Wei, HL; Deng, HC				Qu, Hua; Wang, Hang; Deng, Min; Wei, Huili; Deng, Huacong			Associations between Longer Habitual Day Napping and Non-Alcoholic Fatty Liver Disease in an Elderly Chinese Population	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; HEPATIC STEATOSIS; RISK; PERFORMANCE; COHORT; STEATOHEPATITIS; AFTERNOON; EPIDEMIC; SIESTA; ADULTS	Context: Both longer habitual day napping and Non-Alcoholic Fatty Liver Disease (NAFLD) are associated with diabetes and inflammation, but the association between day napping and NAFLD remains unexplored. Objective: To investigate the association between the duration of habitual day napping and NAFLD in an elderly Chinese population and to gain insight into the role of inflammatory cytokines in this association. Design and Setting: We conducted a series of cross-sectional studies of the community population in Chongqing, China, from 2011 to 2012. Participants: Among 6998 participants aged 40 to 75 years, 6438 eligible participants were included in the first study and analyzed to observe the association between day napping duration and NAFLD. In a separate study, 80 non-nappers and 90 nappers were selected to identify the role of inflammatory cytokines in this association. Logistic regression models were used to examine the odds ratios (ORs) of day nap duration with NAFLD. Results: Day nappers had a significantly higher prevalence of NAFLD (P < 0.001). Longer day napping duration was associated in a dose-dependent manner with NAFLD (P trend < 0.001). After adjustment for potential confounders, the ORs were 1.67 (95% CI 1.13-2.46) for those reporting 0.5-1 h and 1.49 (95% CI 1.01-2.19) for those reporting >1 h of day napping compared with individuals who did not take day naps (all P < 0.05). Longer-duration day nappers had higher levels of IL-6 and progranulin (PGRN) but lower levels of Secreted frizzled-related protein-5 (SFRP5, all P trend < 0.001). After adjusting for IL-6, PGRN, and SFRP5, the association between day napping duration and NAFLD disappeared (all P > 0.05). Conclusion: Longer day napping duration is associated with a higher prevalence of NAFLD, and inflammatory cytokines may be an essential link between day napping and NAFLD.	[Qu, Hua; Wang, Hang; Deng, Min; Wei, Huili; Deng, Huacong] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China	Chongqing Medical University	Deng, HC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China.	deng_huacong@126.com		Qu, Hua/0000-0002-4895-5979	National Natural Science Foundation of China [81070639, 81270911, 30771038, 30570744]; Chinese Society of Endocrinology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Society of Endocrinology	This study is supported by the grants from the Chinese Society of Endocrinology and the National Natural Science Foundation of China (81070639, 81270911, 30771038, and 30570744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves ED, 2013, SLEEP BREATH, V17, P505, DOI 10.1007/s11325-012-0729-8; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bursztyn M, 1999, ARCH INTERN MED, V159, P1582, DOI 10.1001/archinte.159.14.1582; Campos H, 2000, INT J EPIDEMIOL, V29, P429, DOI 10.1093/ije/29.3.429; Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dhand R, 2006, CURR OPIN PULM MED, V12, P379; Fang WM, 2013, SLEEP MED, V14, P950, DOI 10.1016/j.sleep.2013.04.015; Fruci B, 2013, INT J MOL SCI, V14, P22933, DOI 10.3390/ijms141122933; Hayashi M, 1999, CLIN NEUROPHYSIOL, V110, P272, DOI 10.1016/S1388-2457(98)00003-0; Hernandez-Alejandro R, 2012, WORLD J GASTROENTERO, V18, P4145, DOI 10.3748/wjg.v18.i31.4145; Hu XN, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-123; Lam KBH, 2010, SLEEP, V33, P402; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Okun ML, 2004, BRAIN BEHAV IMMUN, V18, P326, DOI 10.1016/j.bbi.2003.11.002; Parola M, 2011, ANTIOXID REDOX SIGN, V15, P461, DOI 10.1089/ars.2010.3848; Ray K, 2013, NAT REV GASTRO HEPAT, V10, P621, DOI [10.1038/nrgastro.2013.184, 10.1038/nrgastro.2013.197]; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Ruckert IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022932; Salt William B 2nd, 2004, J Insur Med, V36, P27; Santhi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079688; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; Takahashi M, 2000, SLEEP, V23, P813; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Tsaoussoglou M, 2010, J CLIN ENDOCR METAB, V95, P143, DOI 10.1210/jc.2009-0435; Vgontzas AN, 2007, AM J PHYSIOL-ENDOC M, V292, pE253, DOI 10.1152/ajpendo.00651.2005; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Xu Q, 2010, DIABETES CARE, V33, P78, DOI 10.2337/dc09-1143; Zelber-Sagi S, 2013, WORLD J GASTROENTERO, V19, P57, DOI 10.3748/wjg.v19.i1.57	34	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105583	10.1371/journal.pone.0105583	http://dx.doi.org/10.1371/journal.pone.0105583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140521	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200108
J	Schurch, R; Gruter, C				Schuerch, Roger; Grueter, Christoph			Dancing Bees Improve Colony Foraging Success as Long-Term Benefits Outweigh Short-Term Costs	PLOS ONE			English	Article							SOCIAL-LEARNING STRATEGIES; COLLECTIVE DECISION-MAKING; HONEY-BEES; APIS-MELLIFERA; WAGGLE DANCE; INFORMATION; COMMUNICATION; FORAGERS; INSIGHTS; BEHAVIOR	Waggle dancing bees provide nestmates with spatial information about high quality resources. Surprisingly, attempts to quantify the benefits of this encoded spatial information have failed to find positive effects on colony foraging success under many ecological circumstances. Experimental designs have often involved measuring the foraging success of colonies that were repeatedly switched between oriented dances versus disoriented dances (i.e. communicating vectors versus not communicating vectors). However, if recruited bees continue to visit profitable food sources for more than one day, this procedure would lead to confounded results because of the long-term effects of successful recruitment events. Using agent-based simulations, we found that spatial information was beneficial in almost all ecological situations. Contrary to common belief, the benefits of recruitment increased with environmental stability because benefits can accumulate over time to outweigh the short-term costs of recruitment. Furthermore, we found that in simulations mimicking previous experiments, the benefits of communication were considerably underestimated (at low food density) or not detected at all (at medium and high densities). Our results suggest that the benefits of waggle dance communication are currently underestimated and that different experimental designs, which account for potential long-term benefits, are needed to measure empirically how spatial information affects colony foraging success.	[Schuerch, Roger] Univ Sussex, Sch Life Sci, Lab Apiculture & Social Insects, Falmer, England; [Grueter, Christoph] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil	University of Sussex; Universidade de Sao Paulo	Schurch, R (corresponding author), Univ Sussex, Sch Life Sci, Lab Apiculture & Social Insects, Falmer, England.	R.Schuerch@sussex.ac.uk	Schurch, Roger/J-8744-2019	Schurch, Roger/0000-0001-9075-8912; Gruter, Christoph/0000-0001-5553-5465	Swiss National Science Foundation [PA00P3_139731]; Brazilian National Council for Scientific and Technological Development (CNPq) [400664/2012-7]; Ambizione fellowship from the Swiss National Science Foundation [PZ00P3_142628/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ambizione fellowship from the Swiss National Science Foundation	RS was funded by the Swiss National Science Foundation (Grant PA00P3_139731). CG was funded by a Science without Borders fellowship from the Brazilian National Council for Scientific and Technological Development (CNPq, Process-number: 400664/2012-7) and an Ambizione fellowship from the Swiss National Science Foundation (PZ00P3_142628/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Toufailia H, 2013, ETHOLOGY, V119, P1096, DOI 10.1111/eth.12170; Anderson C, 1999, AM NAT, V154, P521, DOI 10.1086/303255; Anderson C, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P31; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; Beekman M, 2005, J COMP PHYSIOL A, V191, P1107, DOI 10.1007/s00359-005-0034-0; Beekman M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1259, DOI 10.1007/s00265-008-0554-z; Beekman M, 2008, BEHAV ECOL, V19, P255, DOI 10.1093/beheco/arm117; Beekman M, 2007, BEHAV ECOL SOCIOBIOL, V61, P985, DOI 10.1007/s00265-006-0331-9; BELING INGEBORG, 1929, ZEITSCHR VERGLEICH PHYSIOL, V9, P259, DOI 10.1007/BF00340159; Biesmeijer J, 2005, BEHAV ECOL SOCIOBIOL, V59, P133, DOI 10.1007/s00265-005-0019-6; BOCH R, 1956, Z VERGL PHYSIOL, V38, P136, DOI 10.1007/BF00338624; BOGDANY FJ, 1978, BEHAV ECOL SOCIOBIOL, V3, P323, DOI 10.1007/BF00303198; Butler CG, 1943, J EXP BIOL, V20, P65; Collett M, 2009, CURR BIOL, V19, pR1103, DOI 10.1016/j.cub.2009.10.004; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; Couvillon MJ, 2012, INSECT SOC, V59, P297, DOI 10.1007/s00040-012-0224-z; Couvillon MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093495; De Marco RJ, 2003, J COMP PHYSIOL A, V189, P125, DOI 10.1007/s00359-002-0382-y; Dechaume-Moncharmont FX, 2005, P ROY SOC B-BIOL SCI, V272, P1689, DOI 10.1098/rspb.2005.3137; Donaldson-Matasci MC, 2013, ANIM BEHAV, V85, P585, DOI 10.1016/j.anbehav.2012.12.020; Donaldson-Matasci MC, 2012, BEHAV ECOL SOCIOBIOL, V66, P583, DOI 10.1007/s00265-011-1306-z; Dornhaus A, 2004, BEHAV ECOL SOCIOBIOL, V55, P395, DOI 10.1007/s00265-003-0726-9; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Dornhaus A, 2006, BEHAV ECOL, V17, P336, DOI 10.1093/beheco/arj036; ESCH H, 1970, Z VERGL PHYSIOL, V68, P175, DOI 10.1007/BF00297693; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Farina WM., 2012, C GALIZIA, DOI [10.1007/978-94-007-2099-2_8, DOI 10.1007/978-94-007-2099-2_8]; Frisch K. v., 1946, OESTERREICH ZOOL ZEITSCHR [ VIENNA], V1, P1; GENTRY A H, 1974, Biotropica, V6, P64, DOI 10.2307/2989698; Gilley DC, 2012, APIDOLOGIE, V43, P85, DOI 10.1007/s13592-011-0080-2; GOULD JL, 1970, SCIENCE, V169, P544, DOI 10.1126/science.169.3945.544; GOULD JL, 1976, Q REV BIOL, V51, P211, DOI 10.1086/409309; Granovskiy B, 2012, BEHAV ECOL, V23, P588, DOI 10.1093/beheco/ars002; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gruter C, 2008, P R SOC B, V275, P1321, DOI 10.1098/rspb.2008.0186; Gruter C, 2014, TRENDS ECOL EVOL, V29, P177, DOI 10.1016/j.tree.2014.01.004; Gruter C, 2013, ANIM BEHAV, V85, P1443, DOI 10.1016/j.anbehav.2013.03.041; Gruter C, 2011, ANIM BEHAV, V81, P949, DOI 10.1016/j.anbehav.2011.01.014; Gruter C, 2010, CURR BIOL, V20, pR683, DOI 10.1016/j.cub.2010.06.052; Gruter C, 2009, TRENDS ECOL EVOL, V24, P242, DOI 10.1016/j.tree.2008.12.007; Holldobler B., 2009, SUPERORGANISM; Jarau S, 2009, CONTEMP TOP ENTOMOL, P1, DOI 10.1201/9781420075618; JOHNSON DL, 1967, ANIM BEHAV, V15, P487, DOI 10.1016/0003-3472(67)90048-6; Kleber E., 1935, Zeitschrift fuer Vergleichende Physiologie Berlin, V22, P221, DOI 10.1007/BF00586500; Liang ZZS, 2012, SCIENCE, V335, P1225, DOI 10.1126/science.1213962; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; LINDAUER M, 1949, Z VERGL PHYSIOL, V31, P348, DOI 10.1007/BF00297951; MAUTZ D, 1971, Z VERGL PHYSIOL, V72, P197, DOI 10.1007/BF00297822; Menzel R, 2011, CURR BIOL, V21, P645, DOI 10.1016/j.cub.2011.02.039; Moore D, 2001, J INSECT PHYSIOL, V47, P843, DOI 10.1016/S0022-1910(01)00057-9; Moore D, 2011, J COMP PHYSIOL A, V197, P641, DOI 10.1007/s00359-011-0624-y; Moore D, 2009, J COMP PHYSIOL A, V195, P741, DOI 10.1007/s00359-009-0450-7; Naeger NL, 2011, J EXP BIOL, V214, P979, DOI 10.1242/jeb.053421; NUNEZ JA, 1966, Z VERGL PHYSIOL, V53, P142; Okada R, 2012, ACTA BIOL HUNG, V63, P75, DOI 10.1556/ABiol.63.2012.Suppl.2.8; Park WO, 1926, J ECON ENTOMOL, V19, P656, DOI 10.1093/jee/19.4.656; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; R Core Team, 2021, R LANG ENV STAT COMP; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Rendell L, 2011, PHILOS T R SOC B, V366, P1118, DOI 10.1098/rstb.2010.0376; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Reynolds AM, 2009, BEHAV ECOL SOCIOBIOL, V64, P115, DOI 10.1007/s00265-009-0826-2; RIBBANDS CR, 1949, J ANIM ECOL, V18, P47, DOI 10.2307/1581; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1988, BEHAV ECOL SOCIOBIOL, V22, P229, DOI 10.1007/BF00299837; SEELEY TD, 1986, BEHAV ECOL SOCIOBIOL, V19, P343, DOI 10.1007/BF00295707; SEELEY TD, 1983, AM SCI, V71, P264; SEELEY TD, 1992, BEHAV ECOL SOCIOBIOL, V30, P59, DOI 10.1007/BF00168595; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Seeley TD, 2012, HONEYBEE NEUROBIOLOG, P77; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Tanner DA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1891, DOI 10.1007/s00265-008-0619-z; Tautz J, 1996, J EXP BIOL, V199, P1375; TOWNE W F, 1988, Journal of Insect Behavior, V1, P129, DOI 10.1007/BF01052234; Van Nest BN, 2012, BEHAV ECOL, V23, P649, DOI 10.1093/beheco/ars010; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vogel S., 1983, Encyclopedia of plant physiology, New Series, Volume 12C. Physiological plant ecology III, P559; von Frisch K, 1923, SODERABDRUCK ZOOLOGI, P1186; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wenner AM., 1990, ANATOMY CONTROVERSY, DOI [10.7312/wenn90330, DOI 10.7312/WENN90330]; Wilms W, 1996, STUD NEOTROP FAUNA E, V31, P137, DOI 10.1076/snfe.31.3.137.13336; Wilson E.O., 1971, INSECT SOC; Wray MK, 2012, BEHAV ECOL, V23, P125, DOI 10.1093/beheco/arr165	87	31	31	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104660	10.1371/journal.pone.0104660	http://dx.doi.org/10.1371/journal.pone.0104660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141306	Green Submitted, gold, Green Published			2022-12-25	WOS:000342687200026
J	Yu, CY; Su, S; Xu, YC; Zhao, YQ; Yan, A; Huang, LL; Ali, I; Gan, YB				Yu, Chunyan; Su, Sha; Xu, Yichun; Zhao, Yongqin; Yan, An; Huang, Linli; Ali, Imran; Gan, Yinbo			The Effects of Fluctuations in the Nutrient Supply on the Expression of Five Members of the AGL17 Clade of MADS-Box Genes in Rice	PLOS ONE			English	Article							PHOSPHATE-STARVATION RESPONSES; AFFINITY NITRATE TRANSPORT; ARABIDOPSIS-THALIANA; ROOT ARCHITECTURE; ORYZA-SATIVA; NUTRITIONAL REGULATION; TRANSCRIPTION FACTOR; PLANTS; NITROGEN; METABOLISM	The ANR1 MADS-box gene in Arabidopsis is a key gene involved in regulating lateral root development in response to the external nitrate supply. There are five ANR1-like genes in Oryza sativa, OsMADS23, OsMADS25, OsMADS27, OsMADS57 and OsMADS61, all of which belong to the AGL17 clade. Here we have investigated the responsiveness of these genes to fluctuations in nitrogen (N), phosphorus (P) and sulfur (S) mineral nutrient supply. The MADS-box genes have been shown to have a range of responses to the nutrient supply. The expression of OsMADS61 was transiently induced by N deprivation but was not affected by re-supply with various N sources. The expression of OsMADS25 and OsMADS27 was induced by re-supplying with NO3- and NH4NO3, but downregulated by NH4+. The expression of OsMADS57 was significantly downregulated by N starvation and upregulated by 3 h NO3- re-supply. OsMADS23 was the only gene that showed no response to either N starvation nor NO3- re-supply. OsMADS57 was the only gene not regulated by P fluctuation whereas the expression of OsMADS23, OsMADS25 and OsMADS27 was downregulated by P starvation and P re-supply. In contrast, all five ANR1-related genes were significantly upregulated by S starvation. Our results also indicated that there were interactions among nitrate, sulphate and phosphate transporters in rice.	[Yu, Chunyan; Su, Sha; Xu, Yichun; Zhao, Yongqin; Yan, An; Huang, Linli; Ali, Imran; Gan, Yinbo] Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Gan, YB (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou 310003, Zhejiang, Peoples R China.	ygan@zju.edu.cn	Gan, Yinbo/N-1480-2015		International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China [2010DFA34430]; International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province [2013C34G2010017]; National Natural Science Foundation of China [31370215, 31228002]; Zhejiang Provincial Natural Science Foundation of China [Z3110004]	International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China; International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The research was supported by the International Scientific and Technological Cooperation Project of the Ministry of Science and Technology of China (grant number 2010DFA34430), International Scientific and Technological Cooperation Project of Science and Technology Department of Zhejiang Province (grant number 2013C34G2010017), National Natural Science Foundation of China (Grant No. 31370215; 31228002), and Zhejiang Provincial Natural Science Foundation of China (Grant No. Z3110004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; An LJ, 2012, PLANT J, V72, P474, DOI 10.1111/j.1365-313X.2012.05094.x; Araki R, 2006, BREEDING SCI, V56, P295, DOI 10.1270/jsbbs.56.295; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Aziz T., 2014, PLANT SIGNALING UNDE, P133, DOI DOI 10.1007/978-81-322-1542-4_7; Bao SJ, 2011, BOTANY, V89, P647, DOI [10.1139/B11-053, 10.1139/b11-053]; Bates TR, 1996, PLANT CELL ENVIRON, V19, P529, DOI 10.1111/j.1365-3040.1996.tb00386.x; Burgeff C, 2002, PLANTA, V214, P365, DOI 10.1007/s004250100637; Cai C, 2008, J INTEGR PLANT BIOL, V50, P443, DOI 10.1111/j.1744-7909.2008.00642.x; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; CRAWFORD NM, 2002, ARABIDOPSIS BOOK; Dai XY, 2012, PLANT PHYSIOL, V159, P169, DOI 10.1104/pp.112.194217; Fan XR, 2005, SCI CHINA SER C, V48, P897, DOI 10.1360/062005-281; Feng HM, 2011, J EXP BOT, V62, P2319, DOI 10.1093/jxb/erq403; Filleur S, 2005, BIOCHEM SOC T, V33, P283, DOI 10.1042/BST0330283; Forde BG, 1999, ADV BOT RES, V30, P1; Forde BG, 2014, J EXP BOT, V65, P779, DOI 10.1093/jxb/ert335; Gan YB, 2005, PLANTA, V222, P730, DOI 10.1007/s00425-005-0020-3; Gan YB, 2011, AGR SCI CHINA, V10, P335, DOI 10.1016/S1671-2927(11)60012-6; Gan YB, 2012, PLANT CELL PHYSIOL, V53, P1003, DOI 10.1093/pcp/pcs050; Gan YB, 2010, BOTANY, V88, P1023, DOI 10.1139/B10-075; Hou XL, 2005, PLANT CELL ENVIRON, V28, P353, DOI 10.1111/j.1365-3040.2005.01272.x; Ide Y, 2011, J EXP BOT, V62, P1483, DOI 10.1093/jxb/erq345; Krouk G, 2011, TRENDS PLANT SCI, V16, P178, DOI 10.1016/j.tplants.2011.02.004; Kumar S, 2011, FUNCT INTEGR GENOMIC, V11, P259, DOI 10.1007/s10142-010-0207-y; Lee S, 2003, PLANT CELL PHYSIOL, V44, P1403, DOI 10.1093/pcp/pcg156; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; Linkohr BI, 2002, PLANT J, V29, P751, DOI 10.1046/j.1365-313X.2002.01251.x; Marschner H., 1988, PLANT CELL ENVIRON, V11, P147, DOI [10.1111/1365-3040.ep11604921, DOI 10.1111/1365-3040.EP11604921]; Meng YJ, 2013, NEW PHYTOL, V197, P441, DOI 10.1111/nph.12018; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Prosser IM, 2001, J EXP BOT, V52, P113, DOI 10.1093/jexbot/52.354.113; Puig J, 2013, GENE EXPR PATTERNS, V13, P160, DOI 10.1016/j.gep.2013.02.004; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; Rouached H, 2011, PLANT J, V65, P557, DOI 10.1111/j.1365-313X.2010.04442.x; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Tabe LM, 2002, PLANT PHYSIOL, V128, P1137, DOI 10.1104/pp.010935; Takehisa H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24409; Ticconi CA, 2001, PLANT PHYSIOL, V127, P963, DOI 10.1104/pp.010396; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003; Walch-Liu P, 2006, ANN BOT-LONDON, V97, P875, DOI 10.1093/aob/mcj601; Walch-Liu P, 2006, PLANT CELL PHYSIOL, V47, P1045, DOI 10.1093/pcp/pcj075; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang XB, 2002, GENE, V297, P93, DOI 10.1016/S0378-1119(02)00870-3; Wu P., 2013, GENETICS GENOMICS RI, P217; Yan YS, 2014, PLANT J, V78, P44, DOI 10.1111/tpj.12446; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhou ZJ, 2011, PLANT PHYSIOL, V157, P673, DOI 10.1104/pp.111.180281	55	15	17	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105597	10.1371/journal.pone.0105597	http://dx.doi.org/10.1371/journal.pone.0105597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140876	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200111
J	Liu, CK; Tan, XY; Luo, JC; Liu, HW; Hu, M; Yue, W				Liu, ChangKui; Tan, XinYing; Luo, JinChao; Liu, HuaWei; Hu, Min; Yue, Wen			Reconstruction of Beagle Hemi-Mandibular Defects with Allogenic Mandibular Scaffolds and Autologous Mesenchymal Stem Cells	PLOS ONE			English	Article							SIMULTANEOUS IMPLANT PLACEMENT; RETRIEVED HUMAN ALLOGRAFTS; TISSUE-ENGINEERED BONE; FIBRIN GLUE; OSTEOGENESIS; GRAFT	Objective: Massive bone allografts are frequently used in orthopedic reconstructive surgery, but carry a high failure rate of approximately 25%. We tested whether treatment of graft with mesenchymal stem cells (MSCs) can increase the integration of massive allografts (hemi-mandible) in a large animal model. Methods: Thirty beagle dogs received surgical left-sided hemi-mandibular defects, and then divided into two equal groups. Bony defects of the control group were reconstructed using allografts only. Those of the experimental group were reconstructed using allogenic mandibular scaffold-loaded autologous MSCs. Beagles from each group were killed at4 (n = 4), 12 (n = 4), 24 (n = 4) or 48 weeks (n = 3) postoperatively. CT and micro-CT scans, histological analyses and the bone mineral density (BMD) of transplants were used to evaluate defect reconstruction outcomes. Results: Gross and CT examinations showed that the autologous bone grafts had healed in both groups. At 48 weeks, the allogenic mandibular scaffolds of the experimental group had been completely replaced by new bone, which has a smaller surface area to that of the original allogenic scaffold, whereas the scaffold in control dogs remained the same size as the original allogenic scaffold throughout. At 12 weeks, the BMD of the experimental group was significantly higher than the control group (p<0.05), and all micro-architectural parameters were significantly different between groups (p<0.05). Histological analyses showed almost all transplanted allogeneic bone was replaced by new bone, principally fibrous ossification, in the experimental group, which differed from the control group where little new bone formed. Conclusions: Our study demonstrated the feasibility of MSC-loaded allogenic mandibular scaffolds for the reconstruction of hemi-mandibular defects. Further studies are needed to test whether these results can be surpassed by the use of allogenic mandibular scaffolds loaded with a combination of MSCs and osteoinductive growth factors.	[Liu, ChangKui; Tan, XinYing; Luo, JinChao; Liu, HuaWei; Hu, Min] Gen Hosp PLA, Dept Stomatol, Beijing, Peoples R China; [Yue, Wen] Beijing Inst Transfus Med, Dept Stem Cell, Beijing, Peoples R China; [Yue, Wen] Beijing Inst Transfus Med, Regenerat Med Lab, Beijing, Peoples R China; [Liu, ChangKui] 451th Hosp Peoples Librat Army, Dept Stomatol, Xian, Peoples R China	Chinese People's Liberation Army General Hospital	Hu, M (corresponding author), Gen Hosp PLA, Dept Stomatol, Beijing, Peoples R China.	humin48@vip.163.com; wenyue26@yahoo.com			Beijing Municipal Commission of Science and Technology [D131100003013001]; Beijing Natural Science Foundation of China [7112124]	Beijing Municipal Commission of Science and Technology; Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work was Supported by the Beijing Municipal Commission of Science and Technology (D131100003013001) and Beijing Natural Science Foundation of China (7112124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Caldroa P, 1995, Chir Organi Mov, V80, P191; Chen FL, 2002, J ORAL MAXIL SURG, V60, P1155, DOI 10.1053/joms.2002.34991; Donati D, 2000, CLIN ORTHOP RELAT R, P186; Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971, DOI 10.2106/00004623-200107000-00001; ENNEKING WF, 1991, J BONE JOINT SURG AM, V73A, P1123, DOI 10.2106/00004623-199173080-00002; Goh BT, 2008, INT J ORAL MAX SURG, V37, P597, DOI 10.1016/j.ijom.2008.03.002; Hasegawa N, 2006, J PERIODONTOL, V77, P1003, DOI 10.1902/jop.2006.050341; Isogai N, 2000, PLAST RECONSTR SURG, V105, P953, DOI 10.1097/00006534-200003000-00019; Ito K, 2006, CLIN ORAL IMPLAN RES, V17, P579, DOI 10.1111/j.1600-0501.2006.01246.x; Lee LT, 2008, J CHIN MED ASSOC, V71, P66, DOI 10.1016/S1726-4901(08)70077-7; Marshall R, 1979, P NATL ACAD SCI USA, VSci76, P1828; Street J, 2000, CLIN ORTHOP RELAT R, P224, DOI 10.1097/00003086-200009000-00033; Ueda M, 2005, INT J PERIODONT REST, V25, P129; URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828	15	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105733	10.1371/journal.pone.0105733	http://dx.doi.org/10.1371/journal.pone.0105733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153673	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200075
J	Cuneo, NR; Gandolfo, MA; Zamaloa, MC; Hermsen, E				Cuneo, N. Ruben; Gandolfo, Maria A.; Zamaloa, Maria C.; Hermsen, Elizabeth			Late Cretaceous Aquatic Plant World in Patagonia, Argentina	PLOS ONE			English	Article							COLONIA FORMATION; HETEROSPOROUS FERN; SP-NOV.; FOSSIL; EVOLUTION; SPORES; SOUTH; NELUMBONACEAE; MARSILEACEAE; VEGETATION	In this contribution, we describe latest Cretaceous aquatic plant communities from the La Colonia Formation, Patagonia, Argentina, based on their taxonomic components and paleoecological attributes. The La Colonia Formation is a geological unit deposited during a Maastrichtian-Danian transgressive episode of the South Atlantic Ocean. This event resulted in the deposition of a series of fine-grained sediments associated with lagoon systems occurring along irregular coastal plains in northern Patagonia. These deposits preserved a diverse biota, including aquatic and terrestrial plants and animals. The aquatic macrophytes can be broadly divided into two groups: free-floating and rooted, the latter with emergent or floating leaves. Free-floating macrophytes include ferns in Salviniaceae (Azolla and Paleoazolla) and a monocot (Araceae). Floating microphytes include green algae (Botryoccocus, Pediastrum and Zygnemataceae). Among the rooted components, marsileaceous water ferns (including Regnellidium and an extinct form) and the eudicot angiosperm Nelumbo (Nelumbonaceae) are the dominant groups. Terrestrial plants occurring in the vegetation surrounding the lagoons include monocots (palms and Typhaceae), ferns with affinities to Dicksoniaceae, conifers, and dicots. A reconstruction of the aquatic plant paleocommuniy is provided based on the distribution of the fossils along a freshwater horizon within the La Colonia Formation. This contribution constitutes the first reconstruction of a Cretaceous aquatic habitat for southern South America.	[Cuneo, N. Ruben] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Gandolfo, Maria A.] Cornell Univ, Sch Integrat Plant Sci, LH Bailey Hortorium Plant Biol Sect, Ithaca, NY USA; [Zamaloa, Maria C.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Hermsen, Elizabeth] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Cornell University; University of Buenos Aires; University System of Ohio; Ohio University	Cuneo, NR (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina.	rcuneo@mef.org.ar		Hermsen, Elizabeth/0000-0003-2666-4385	Philosophical Society Franklin Award; United States National Science Foundation [DEB-0918932]; National Science Foundation [DEB-0919071]; CONICET [12410]; Agencia Nacional Promicion Ciencia y Tecnologia PICT [1696]; Direct For Biological Sciences [0919071] Funding Source: National Science Foundation; Division Of Environmental Biology [0830020] Funding Source: National Science Foundation	Philosophical Society Franklin Award; United States National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional Promicion Ciencia y Tecnologia PICT; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding provided by Philosophical Society Franklin Award and United States National Science Foundation DEB-0918932 to MAG; National Science Foundation DEB-0919071 and CONICET 12410 to NRC; Agencia Nacional Promicion Ciencia y Tecnologia PICT 1696 to MCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino Adriana Maria, 2000, Geodiversitas, V22, P247; Alonso Paz E, 2002, MUSEOS NACL HIST NAT, V125, P1; Archangelsky A, 1999, AM J BOT, V86, P1200, DOI 10.2307/2656984; Ardolino A., 1987, 10 C GEOL ARG TUC AC CONGRESO GEOLOGICO A, V3, P193; Ardolino AA, 1996, DIRECCION NACL SERVI; Barreda VD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052455; BATTEN D J, 1988, Cretaceous Research, V9, P337, DOI 10.1016/0195-6671(88)90007-9; Batten D.J., 1996, PALYNOLOGY PRINCIPLE, V1, P191; BATTEN D.J., 1996, PALYNOLOGY PRINCIPLE, V1, P205; Batten DJ, 1990, AM ASS STRAT PALYN C, V24; Benson RBJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031838; Blanc-Louvel C., 1984, ILERDA, V45, P83; Bonaparte JF, 1985, NAT GEOG RES, V1, P263; BOYD R, 1992, SEDIMENT GEOL, V80, P139, DOI 10.1016/0037-0738(92)90037-R; Cambon G, 1997, GRANA, V36, P105, DOI 10.1080/00173139709362596; Cattaneo A, 2003, EARTH-SCI REV, V62, P187, DOI 10.1016/S0012-8252(02)00134-4; Chambers PA, 2008, HYDROBIOLOGIA, V595, P9, DOI 10.1007/s10750-007-9154-6; Coiffard C, 2013, TAXON, V62, P141, DOI 10.1002/tax.621012; COLLINSON ME, 1988, PALAEOGEOGR PALAEOCL, V62, P317, DOI 10.1016/0031-0182(88)90060-0; Collinson ME, 2001, POLLEN SPORES SYST A, V44, P119; Cook C.D.K., 1990, AQUATIC PLANT BOOK; Cook CD., 1996, AQUATIC PLANT BOOK; CROW GE, 1993, AQUAT BOT, V44, P229, DOI 10.1016/0304-3770(93)90072-5; Cruickshank Arthur R. I., 1997, Annals of the South African Museum, V105, P207; Cuneo NR, 2013, INT J PLANT SCI, V174, P340, DOI 10.1086/668811; DALRYMPLE RW, 1992, J SEDIMENT PETROL, V62, P1130, DOI 10.1306/D4267A69-2B26-11D7-8648000102C1865D; DETTMANN ME, 1992, CRETACEOUS RES, V13, P207, DOI 10.1016/0195-6671(92)90001-7; Dransfield J, 2008, GENERA PALMARUM EVOL; Estrada-Ruiz E, 2011, SYST BOT, V36, P337, DOI 10.1600/036364411X569525; FINLAYSON M, 1985, AUST J BOT, V33, P101, DOI 10.1071/BT9850101; Fiori CCL, 2009, AM FERN J, V99, P207, DOI 10.1640/0002-8444-99.3.207; FLYNN KM, 1995, OECOLOGIA, V103, P63, DOI 10.1007/BF00328426; Franzese J, 2003, J S AM EARTH SCI, V16, P81, DOI 10.1016/S0895-9811(03)00020-8; Gallego J, REV PALAEOB IN PRESS; Gandolfo MA, 2004, P NATL ACAD SCI USA, V101, P8056, DOI 10.1073/pnas.0402473101; Gandolfo MA, 2005, REV PALAEOBOT PALYNO, V133, P169, DOI 10.1016/j.revpalbo.2004.09.007; Gandolfo MA, 2014, BOL SOC GEOL MEX, V66, P11, DOI 10.18268/BSGM2014v66n1a2; Gandolfo MA, 2009, INT J PLANT SCI, V170, P419, DOI 10.1086/595290; Gasparini Z, 2001, J S AM EARTH SCI, V14, P51, DOI 10.1016/S0895-9811(01)00012-8; Gasparini Zulma, 2000, Revista Espanola de Paleontologia, V15, P23; Golovneva Lena B., 2000, Acta Palaeobotanica, V40, P139; GRACE JB, 1986, CAN J PLANT SCI, V66, P361, DOI 10.4141/cjps86-051; Gupta KM, 1962, BOT MONOGR, V2, P1; Hayes M.O., 1979, BARIER ISLANDS MEXIC; Hermsen EJ, 2014, PLANT SYST EVOL, V300, P369, DOI 10.1007/s00606-013-0886-7; Heusser CJ, 1996, ARCTIC ALPINE RES, V28, P148, DOI 10.2307/1551754; Hofmann CC, 2002, REV PALAEOBOT PALYNO, V119, P191, DOI 10.1016/S0034-6667(01)00141-5; HORNE JC, 1978, AAPG BULL, V62, P2379; Iglesias A, 2011, BIOL J LINN SOC, V103, P409, DOI 10.1111/j.1095-8312.2011.01657.x; Janauer Georg A., 2001, Journal of Limnology, V60, P33; JOHNSON D. M., 1986, SYSTEMATIC BOT MONOG, V11, P1, DOI DOI 10.2307/25027626; Kielan-Jaworowska Z, 2007, ACTA PALAEONTOL POL, V52, P257; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; Kovach W.L., 1989, PALYNOLOGY, V13, P247277, DOI [10.1080/01916122.1989.9989362, DOI 10.1080/01916122.1989.9989362]; Kramer K.U., 1990, FAMILIES GENERA VASC, P180; Kramer K. U., 1990, FAMILIES GENERA VASC, V1; Krassilov V.A., 1995, PALEONTOL J+, V29, P119; Krassilov VA, 2010, B GEOSCI, V85, P95, DOI 10.3140/bull.geosci.1150; Kvacek J, 2004, REV PALAEOBOT PALYNO, V128, P323, DOI 10.1016/S0034-6667(03)00154-4; KVACEK Z, 1995, AQUAT BOT, V50, P49, DOI 10.1016/0304-3770(94)00442-O; Lacoul P, 2006, ENVIRON REV, V14, P89, DOI 10.1139/a06-001; Lawver DR, 2011, ANN CARNEGIE MUS, V80, P35, DOI 10.2992/007.080.0104; Li Y, 2014, PALAEOGEOGR PALAEOCL, V399, P284, DOI 10.1016/j.palaeo.2014.01.022; Lupia R, 2000, INT J PLANT SCI, V161, P975, DOI 10.1086/317567; MAHABALE TS, 1968, REV PALAEOBOT PALYNO, V7, P285, DOI 10.1016/0034-6667(68)90034-1; MAI DH, 1985, FLORA, V176, P449, DOI 10.1016/S0367-2530(17)30141-X; Malumian N, 2011, BIOL J LINN SOC, V103, P269, DOI 10.1111/j.1095-8312.2011.01649.x; Martin-Closas C., 2003, Geologica Acta, V1, P315; McIver EE, 1993, PALAEONTOGR CAN, V10, P101; Metzgar JS, 2007, INT J PLANT SCI, V168, P1045, DOI 10.1086/519007; Mohr BAR, 2000, INT J PLANT SCI, V161, pS155, DOI 10.1086/317580; Nanez Carolina, 2008, Revista Espanola de Paleontologia, V23, P273; O'Gorman JP, 2013, ALCHERINGA, V37, P259, DOI 10.1080/03115518.2013.745250; O'Gorman JP, 2013, ALCHERINGA, V37, P163, DOI 10.1080/03115518.2013.736788; Pascual Rosendo, 2000, Geodiversitas, V22, P395; PUNT W, 1975, REV PALAEOBOT PALYNO, V19, pNE75, DOI 10.1016/0034-6667(75)90060-3; Rai AK, 2000, SYMBIOSIS, V29, P249; Rai V, 1999, PLANT SOIL, V206, P79, DOI 10.1023/A:1004340005693; Reading H.G., 1996, SEDIMENTARY ENV PROC, V3rd edn, P154; Reinson G E, 1992, FACIES MODELS RESPON, P179; ROTHWELL GW, 1994, AM J BOT, V81, P479, DOI 10.2307/2445498; Rougier GW, 2009, ACTA PALAEONTOL POL, V54, P195, DOI 10.4202/app.2006.0026; SANDERS JE, 1975, GEOL SOC AM BULL, V86, P65, DOI 10.1130/0016-7606(1975)86<65:EOSRAI>2.0.CO;2; Saulich A.H., 2007, SEASONAL DEV AQUATIC; SAUNDERS RMK, 1993, PLANT SYST EVOL, V184, P175, DOI 10.1007/BF00937434; Scasso RA, 2012, CRETACEOUS RES, V36, P37, DOI 10.1016/j.cretres.2012.02.002; Schneider H, 2002, INT J PLANT SCI, V163, P485, DOI 10.1086/340736; Schneller J.J., 1990, FAMILIES GENERA VASC, P57; SCHULTZ ALARICH R., 1949, LILLOA, V17, P139; Schuyler AE, 1984, BARTONIA, V50, P8; Scremin-Dias E, 2003, TROPICAL BIOL CONSER, V1; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; STAMP L. D., 1921, GEOLOGICAL MAGAZINE, V58, P108; Sterli J, 2011, PALAEONTOLOGY, V54, P63, DOI 10.1111/j.1475-4983.2010.01002.x; Stockey RA, 1997, AM J BOT, V84, P355, DOI 10.2307/2446009; Stockey RA, 2007, AM J BOT, V94, P609, DOI 10.3732/ajb.94.4.609; SWIFT DJP, 1968, J GEOL, V76, P444, DOI 10.1086/627342; THIERET JW, 1982, J ARNOLD ARBORETUM, V63, P341; Thieret JW, 1996, HARVARD PAPERS BOT, V8, P27; Thomaz SM, 2008, TROPICAL BIOL CONSER, V4; Tryon A.F., 2012, SPORES PTERIDOPHYTA; Tryon R. M., 1982, FERNS ALLIED PLANTS; Vajda V, 2013, CRETACEOUS RES, V46, P114, DOI 10.1016/j.cretres.2013.08.010; VAN GEEL B., 1996, PALYNOLOGY PRINCIPLE, V1; Guler MV, 2014, AMEGHINIANA, V51, P141, DOI 10.5710/AMGH.15.02.2014.949; Volkheimer W., 2007, REV ESPA NOLA MICROP, V39, P117; Wang H, 2006, INT J PLANT SCI, V167, P385, DOI 10.1086/499502; Wang Xin, 2012, Palaeoworld, V21, P193, DOI 10.1016/j.palwor.2012.10.002; Williamson PS., 1993, FAMILIES GENERA VASC, VII, P470; Yamada T, 2002, INT J PLANT SCI, V163, P715, DOI 10.1086/342036; Zamaloa Maria Del Carmen, 1996, Ameghiniana, V33, P179; Zamaloa MD, 2005, J PALEOLIMNOL, V34, P433, DOI 10.1007/s10933-005-5804-8; Zippi Pierre A., 1998, Micropaleontology (New York), V44, P1, DOI 10.2307/1485998	113	27	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104749	10.1371/journal.pone.0104749	http://dx.doi.org/10.1371/journal.pone.0104749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148081	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600020
J	Dugue, GP; Lorincz, ML; Lottem, E; Audero, E; Matias, S; Correia, PA; Lena, C; Mainen, ZF				Dugue, Guillaume P.; Loerincz, Magor L.; Lottem, Eran; Audero, Enrica; Matias, Sara; Correia, Patricia A.; Lena, Clement; Mainen, Zachary F.			Optogenetic Recruitment of Dorsal Raphe Serotonergic Neurons Acutely Decreases Mechanosensory Responsivity in Behaving Mice	PLOS ONE			English	Article							NOCICEPTIVE RESPONSES; MECHANICAL ALLODYNIA; LATERAL GENICULATE; NEUROPATHIC PAIN; NUCLEUS; MODULATION; GLUTAMATE; RAT; RECEPTORS; MODELS	The inhibition of sensory responsivity is considered a core serotonin function, yet this hypothesis lacks direct support due to methodological obstacles. We adapted an optogenetic approach to induce acute, robust and specific firing of dorsal raphe serotonergic neurons. In vitro, the responsiveness of individual dorsal raphe serotonergic neurons to trains of light pulses varied with frequency and intensity as well as between cells, and the photostimulation protocol was therefore adjusted to maximize their overall output rate. In vivo, the photoactivation of dorsal raphe serotonergic neurons gave rise to a prominent light-evoked field response that displayed some sensitivity to a 5-HT1A agonist, consistent with autoreceptor inhibition of raphe neurons. In behaving mice, the photostimulation of dorsal raphe serotonergic neurons produced a rapid and reversible decrease in the animals' responses to plantar stimulation, providing a new level of evidence that serotonin gates sensory-driven responses.	[Dugue, Guillaume P.; Loerincz, Magor L.; Lottem, Eran; Audero, Enrica; Matias, Sara; Correia, Patricia A.; Mainen, Zachary F.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Dugue, Guillaume P.; Lena, Clement] CNRS, INSERM, Inst Biol Ecole Normale Super, UMR8197,U1024, Paris, France; [Loerincz, Magor L.] Univ Szeged, Dept Physiol, MTA SZTE Res Grp Cort Microcircuits, Szeged, Hungary	Fundacao Champalimaud; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Szeged University	Dugue, GP (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.	gdugue@biologie.ens.fr; zmainen@neuro.fchampalimaud.org	Lőrincz, Magor L/C-7746-2012; Matias, Sara/GSE-3006-2022; Léna, Clément/T-8458-2018; Léna, Clément/P-6929-2019; , clement/ADN-8076-2022; Léna, Clément/ABE-4862-2021	Lőrincz, Magor L/0000-0001-5240-1904; Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Correia, Patricia/0000-0002-2136-4757; Matias, Sara/0000-0002-7432-6754; Mainen, Zachary/0000-0001-7913-9109	European Research Council [250334]; Intra-European Marie Curie postdoctoral fellowship [220098]; Human Frontier Science Programme postdoctoral fellowship [LT001009/2010L, LT000881/2011L]; Agence Nationale pour la Recherche grant [11-BSV4-028]	European Research Council(European Research Council (ERC)European Commission); Intra-European Marie Curie postdoctoral fellowship; Human Frontier Science Programme postdoctoral fellowship; Agence Nationale pour la Recherche grant(French National Research Agency (ANR))	This work was supported by an European Research Council grant to ZM (No 250334), an Intra-European Marie Curie postdoctoral fellowship to GD (No 220098), a Human Frontier Science Programme postdoctoral fellowship to MLL (No LT001009/2010L), a Human Frontier Science Programme postdoctoral fellowship to EL (No LT000881/2011L) and an Agence Nationale pour la Recherche grant to CL (Sensocode 11-BSV4-028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JK, 2004, ANN NY ACAD SCI, V1018, P46, DOI 10.1196/annals.1296.005; ANDERSEN E, 1982, INT J NEUROSCI, V17, P151, DOI 10.3109/00207458208985917; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Bromberg-Martin ES, 2010, J NEUROSCI, V30, P6262, DOI 10.1523/JNEUROSCI.0015-10.2010; Challis C, 2013, J NEUROSCI, V33, P13978, DOI 10.1523/JNEUROSCI.2383-13.2013; Chen CF, 2003, J NEUROSCI, V23, P3130; Choi IS, 2012, BRIT J PHARMACOL, V167, P356, DOI 10.1111/j.1476-5381.2012.01964.x; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; DAVIS M, 1980, SCIENCE, V209, P521, DOI 10.1126/science.7394520; FARDIN V, 1984, BRAIN RES, V306, P105, DOI 10.1016/0006-8993(84)90360-3; FORNAL CA, 1994, J PHARMACOL EXP THER, V270, P1345; Fornal CA, 1996, BRAIN RES, V716, P123, DOI 10.1016/0006-8993(96)00006-6; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gras C, 2002, J NEUROSCI, V22, P5442; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; Ikeda T, 2009, NEUROSCI RES, V63, P42, DOI 10.1016/j.neures.2008.10.002; Ito H, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-59; IWAYAMA K, 1989, Neurological Research, V11, P105; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Katsuyama S, 2013, BIOMED RES-TOKYO, V34, P105, DOI 10.2220/biomedres.34.105; KAYAMA Y, 1989, BRAIN RES, V489, P1, DOI 10.1016/0006-8993(89)90002-4; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Miyazaki K, 2011, J NEUROSCI, V31, P469, DOI 10.1523/JNEUROSCI.3714-10.2011; Ohmura Y, 2014, INT J NEUROPSYCHOPH, P1; Petzold GC, 2009, NAT NEUROSCI, V12, P784, DOI 10.1038/nn.2335; QIAO JT, 1988, PAIN, V34, P65, DOI 10.1016/0304-3959(88)90183-2; REYESVAZQUEZ C, 1989, BRAIN RES BULL, V23, P405, DOI 10.1016/0361-9230(89)90181-0; Riad M, 2001, J NEUROSCI, V21, P8378, DOI 10.1523/JNEUROSCI.21-21-08378.2001; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Rothermel M, 2013, J NEUROSCI, V33, P15195, DOI 10.1523/JNEUROSCI.1618-13.2013; Trudeau LE, 2004, J PSYCHIATR NEUROSCI, V29, P296; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; WALLETSCHEK H, 1982, PHYSIOL BEHAV, V28, P697, DOI 10.1016/0031-9384(82)90054-3; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; WATERHOUSE BD, 1990, BRAIN RES, V514, P276, DOI 10.1016/0006-8993(90)91422-D; Xu WJ, 2013, NEUROSCIENCE, V238, P252, DOI 10.1016/j.neuroscience.2013.02.036; Yokogawa T, 2012, J NEUROSCI, V32, P15205, DOI 10.1523/JNEUROSCI.1019-12.2012; YOSHIDA M, 1984, BRAIN RES, V290, P95, DOI 10.1016/0006-8993(84)90739-X	41	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105941	10.1371/journal.pone.0105941	http://dx.doi.org/10.1371/journal.pone.0105941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148042	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600097
J	Liu, ZX; Zhao, ZW				Liu, Zhenxing; Zhao, Zhangwu			Effects of Light Interruption on Sleep and Viability of Drosophila melanogaster	PLOS ONE			English	Article							DIFFERENTIAL ROLES; CIRCADIAN CLOCK; CRYPTOCHROME; PHOTORECEPTOR; DISORDERS; GENETICS; MUTATION; CRY	Light is a very important regulator of the daily sleep rhythm. Here, we investigate the influence of nocturnal light stimulation on Drosophila sleep. Results showed that total daytime sleep was reduced due to a decrease in daytime sleep episode duration caused by discontinuous light stimulation, but sleep was not strongly impacted at nighttime although the discontinuous light stimulation occurred during the scotophase. During a subsequent recovery period without light interruption, the sleep quality of nighttime sleep was improved and of daytime sleep reduced, indicating flies have a persistent response to nocturnal light stimulation. Further studies showed that the discontinuous light stimulation damped the daily rhythm of a circadian light-sensitive protein cryptochrome both at the mRNA and protein levels, which subsequently caused disappearance of circadian rhythm of the core oscillator timeless and decrease of TIMLESS protein at nighttime. These data indicate that the nocturnal light interruption plays an important role in sleep through core proteins CRYTOCHROME and TIMLESS, Moreover, interruption of sleep further impacted reproduction and viability.	[Liu, Zhenxing; Zhao, Zhangwu] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China	China Agricultural University	Zhao, ZW (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	zhaozw@cau.edu.cn	Liu, Zhenxing/HCH-6877-2022; Liu, Zhenxing/U-2062-2019; liu, zhenxing/GWC-9542-2022	liu, zhenxing/0000-0001-8236-1931	National Basic Research Program from Ministry of Science and Technology of the People's Republic of China ("973" Program) [2012CB114100]; National Natural Science Foundation of China [31272371]	National Basic Research Program from Ministry of Science and Technology of the People's Republic of China ("973" Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program from Ministry of Science and Technology of the People's Republic of China ("973" Program Grant number 2012CB114100) and the National Natural Science Foundation of China (Grant number 31272371) to Z. Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; ANGUS J, 1974, BEHAV GENET, V4, P317, DOI 10.1007/BF01066153; Antoch MP, 2008, CELL CYCLE, V7, P1197, DOI 10.4161/cc.7.9.5886; Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Benguria A, 1996, J BIOTECHNOL, V47, P191, DOI 10.1016/0168-1656(96)01407-1; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Busza J, 2004, AIDS CARE, V16, P507, DOI 10.1080/09540120410001683457; Catterson JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012062; Caylak E, 2009, AM J MED GENET A, V149A, P2612, DOI 10.1002/ajmg.a.33087; Cermakian N, 2003, BRAIN RES REV, V42, P204, DOI 10.1016/S0165-0173(03)00171-1; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Froy O, 2002, CURR BIOL, V12, P147, DOI 10.1016/S0960-9822(01)00656-X; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Helfand SL, 2003, ANNU REV GENET, V37, P329, DOI 10.1146/annurev.genet.37.040103.095211; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Ikeda A, 2001, HUM MOL GENET, V10, P1325, DOI 10.1093/hmg/10.12.1325; Klarsfeld A, 1998, J BIOL RHYTHM, V13, P471, DOI 10.1177/074873098129000309; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kumar S, 2012, GENE DEV, V26, P1224, DOI 10.1101/gad.186338.111; LEBOURG E, 1992, GERONTOLOGY, V38, P65; Nishinokubi Izumi, 2006, J Circadian Rhythms, V4, P4, DOI 10.1186/1740-3391-4-4; Rakshit K, 2013, AGING CELL, V12, P752, DOI 10.1111/acel.12100; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Sakai T, 2006, J NEUROBIOL, V66, P821, DOI 10.1002/neu.20262; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sloane PD, 2007, J AM GERIATR SOC, V55, P1524, DOI 10.1111/j.1532-5415.2007.01358.x; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Swanson LM, 2011, J SLEEP RES, V20, P487, DOI 10.1111/j.1365-2869.2010.00890.x; Torres G, 1998, SYNAPSE, V29, P148, DOI 10.1002/(SICI)1098-2396(199806)29:2<148::AID-SYN6>3.0.CO;2-7; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323	39	11	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105678	10.1371/journal.pone.0105678	http://dx.doi.org/10.1371/journal.pone.0105678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148297	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600069
J	Towns, AM; Eyi, SM; van Andel, T				Towns, Alexandra M.; Eyi, Sandra Mengue; van Andel, Tinde			Traditional Medicine and Childcare in Western Africa: Mothers' Knowledge, Folk Illnesses, and Patterns of Healthcare-Seeking Behavior	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; SUB-SAHARAN AFRICA; MORTALITY; MALARIA; MANAGEMENT; DIARRHEA	Background: In spite of the strong role of traditional medicine in childcare in the pluralistic healthcare system in Western Africa, little information is known on mothers' domestic plant knowledge. Identifying local perspectives and treatments of children's illnesses, including folk illnesses, is essential to having a comprehensive understanding of how mothers make healthcare treatment decisions. We aimed to identify which infant illnesses Beninese and Gabonese mothers knew to treat with medicinal plants and for which illnesses they sought biomedical care or traditional healers. Methods: We conducted 81 questionnaires with mothers in Benin and Gabon and made 800 botanical specimens of cited medicinal plants. We calculated the number of species cited per illness and the proportion of participants knowledgeable on at least one herbal remedy per illness. Using qualitative data, we described folk illnesses in each country and summarized responses on preferences for each of the three healthcare options. Results: Participants from both countries were most knowledgeable on plants to treat respiratory illnesses, malaria, diarrhea, and intestinal ailments. Mothers also frequently mentioned the use of plants to encourage children to walk early, monitor the closure of fontanels, and apply herbal enemas. Major folk illnesses were atita and ka in Benin and la rate and fesses rouges in Gabon. Traditional healers were reported to have specialized knowledge of cultural bound illnesses. Malaria was frequently cited as an illness for which mothers would directly seek biomedical treatment. Conclusion: Mothers largely saw the three systems as complementary, seamlessly switching between different healing options until a remedy was found. Folk illnesses were found to give insight into local treatments and may reveal important neglected diseases. Due to high reported levels of knowledge on treating top statistical causes of infant mortality and folk illnesses, mothers' medicinal plant knowledge should be included in the analysis of healthcare-seeking behavior for childcare.	[Towns, Alexandra M.; van Andel, Tinde] Leiden Univ, Naturalis Biodivers Ctr, Leiden, Netherlands; [Eyi, Sandra Mengue] Ctr Natl Rech Sci & Technol, Libreville, Gabon	Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center	Towns, AM (corresponding author), Leiden Univ, Naturalis Biodivers Ctr, Leiden, Netherlands.	alexandra.towns@naturalis.nl		Towns, Alexandra/0000-0002-1886-9447	Netherlands Organization for Scientific Research (NWO) [864.09.00]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was funded by the Netherlands Organization for Scientific Research (NWO), Vidi grant nr. 864.09.00 (http://www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi SS, 2013, ACTA TROP, V127, P46, DOI 10.1016/j.actatropica.2013.03.010; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bland RM, 2004, TROP MED INT HEALTH, V9, P118, DOI 10.1046/j.1365-3156.2003.01148.x; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; DEZOYSA I, 1984, SOC SCI MED, V19, P727, DOI 10.1016/0277-9536(84)90245-4; Etkin NL, 1998, CONTEXT MED DEV COUN, P299; Friend-du Preez N, 2013, SOC SCI MED, V92, P43, DOI 10.1016/j.socscimed.2013.05.014; Geissler PW, 2002, J ETHNOPHARMACOL, V83, P39, DOI 10.1016/S0378-8741(02)00191-5; Gottlieb A, 2004, AFTERLIFE IS WE COME, P1; GREEN EC, 1985, SOC SCI MED, V20, P277, DOI 10.1016/0277-9536(85)90242-4; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Helman CG, 2007, CULTURE HLTH ILLNESS, P266; Kay M A, 1993, Med Anthropol, V15, P137; Kiesler J, 2003, AM FAM PHYSICIAN, V67, P2547; Langwick SA, 2008, AM ETHNOL, V35, P428, DOI 10.1111/j.1548-1425.2008.00044.x; Makani J, 2007, ANN TROP MED PARASIT, V101, P3, DOI 10.1179/136485907X154638; Martin, 2004, ETHNOBOTANY METHODS; Mathez-Stiefel SL, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-26; McDade TW, 2007, P NATL ACAD SCI USA, V104, P6134, DOI 10.1073/pnas.0609123104; Meier ER, 2012, DRUGS, V72, P895, DOI 10.2165/11632890-000000000-00000; Miller EM, 2011, SOC SCI MED, V73, P1266, DOI 10.1016/j.socscimed.2011.07.009; Mogensen HO, 2000, CULT MED PSYCHIAT, V24, P331, DOI 10.1023/A:1005615619241; Montgomery CM, 2006, TROP MED INT HEALTH, V11, P1661, DOI 10.1111/j.1365-3156.2006.01719.x; Nsungwa-Sabiiti J, 2004, TROP MED INT HEALTH, V9, P1191, DOI 10.1111/j.1365-3156.2004.01319.x; Nyamongo IK, 2002, SOC SCI MED, V54, P377, DOI 10.1016/S0277-9536(01)00036-3; Pearce TO, 1993, KNOWLEDGE POWER PRAC, P150; Pfeiffer Jeanine M., 2005, Journal of Ethnobiology, V25, P240, DOI 10.2993/0278-0771(2005)25[240:ACAEVI]2.0.CO;2; Quinlan MB, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-9; Reyes-Garcia V, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-32; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Ryan GW, 1998, SOC SCI MED, V46, P209, DOI 10.1016/S0277-9536(97)00151-2; Straus L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-556; Tanner S, 2011, SOC SCI MED, V72, P701, DOI 10.1016/j.socscimed.2010.12.012; Towns AM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-113; Vandebroek I, 2013, J ETHNOPHARMACOL, V148, P746, DOI 10.1016/j.jep.2013.05.039; vanderGeest S, 1997, TROP MED INT HEALTH, V2, P903, DOI 10.1046/j.1365-3156.1997.d01-410.x; World Health Organization, TRAD MED	38	25	25	0	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105972	10.1371/journal.pone.0105972	http://dx.doi.org/10.1371/journal.pone.0105972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LL	25147924	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600102
J	Aoki, M; Ehara, M; Saito, Y; Yoshioka, H; Miyazaki, M; Saito, Y; Miyashita, A; Kawakami, S; Yamaguchi, T; Ohashi, A; Nunoura, T; Takai, K; Imachi, H				Aoki, Masataka; Ehara, Masayuki; Saito, Yumi; Yoshioka, Hideyoshi; Miyazaki, Masayuki; Saito, Yayoi; Miyashita, Ai; Kawakami, Shuji; Yamaguchi, Takashi; Ohashi, Akiyoshi; Nunoura, Takuro; Takai, Ken; Imachi, Hiroyuki			A Long-Term Cultivation of an Anaerobic Methane-Oxidizing Microbial Community from Deep-Sea Methane-Seep Sediment Using a Continuous-Flow Bioreactor	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; IN-SITU HYBRIDIZATION; SULFATE-REDUCING BACTERIA; MARINE SUBSURFACE SEDIMENTS; HANGING SPONGE-CUBES; METHANOTROPHIC ARCHAEA; MESSENGER-RNA; UASB REACTOR; MUD VOLCANO; SP NOV.	Anaerobic oxidation of methane (AOM) in marine sediments is an important global methane sink, but the physiological characteristics of AOM-associated microorganisms remain poorly understood. Here we report the cultivation of an AOM microbial community from deep-sea methane-seep sediment using a continuous-flow bioreactor with polyurethane sponges, called the down-flow hanging sponge (DHS) bioreactor. We anaerobically incubated deep-sea methane-seep sediment collected from the Nankai Trough, Japan, for 2,013 days in the bioreactor at 10 degrees C. Following incubation, an active AOM activity was confirmed by a tracer experiment using C-13-labeled methane. Phylogenetic analyses demonstrated that phylogenetically diverse Archaea and Bacteria grew in the bioreactor. After 2,013 days of incubation, the predominant archaeal components were anaerobic methanotroph (ANME)-2a, Deep-Sea Archaeal Group, and Marine Benthic Group-D, and Gammaproteobacteria was the dominant bacterial lineage. Fluorescence in situ hybridization analysis showed that ANME-1 and -2a, and most ANME-2c cells occurred without close physical interaction with potential bacterial partners. Our data demonstrate that the DHS bioreactor system is a useful system for cultivating fastidious methane-seep-associated sedimentary microorganisms.	[Aoki, Masataka; Saito, Yumi; Miyazaki, Masayuki; Saito, Yayoi; Takai, Ken; Imachi, Hiroyuki] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Subsurface Geobiol Anal & Res D SUGAR, Yokosuka, Kanagawa, Japan; [Aoki, Masataka; Ehara, Masayuki; Saito, Yayoi; Miyashita, Ai; Kawakami, Shuji; Yamaguchi, Takashi] Nagaoka Univ Technol, Dept Environm Syst Engn, Nagaoka, Niigata 94021, Japan; [Yoshioka, Hideyoshi] Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Tsukuba, Ibaraki, Japan; [Kawakami, Shuji] Anan Natl Coll Technol, Dept Construct Syst Engn, Anan, Tokushima, Japan; [Ohashi, Akiyoshi] Hiroshima Univ, Dept Social & Environm Engn, Hiroshima, Japan; [Nunoura, Takuro] JAMSTEC, Res & Dev Ctr Marine Biosci, Yokosuka, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Nagaoka University of Technology; National Institute of Advanced Industrial Science & Technology (AIST); Hiroshima University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Imachi, H (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Subsurface Geobiol Anal & Res D SUGAR, Yokosuka, Kanagawa, Japan.	imachi@jamstec.go.jp	Imachi, Hiroyuki/D-3298-2009; Ohashi, Akiyoshi/H-4744-2011; Nunoura, Takuro/AAL-6266-2020	Imachi, Hiroyuki/0000-0001-6588-5055; Ohashi, Akiyoshi/0000-0003-2213-3915; Nunoura, Takuro/0000-0003-2323-0880; AOKI, MASATAKA/0000-0002-9352-2072	Japan Society for the Promotion of Science (JSPS) KAKENHI [24687011, 13J08869]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23241029] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 24687011 and 13J08869, and by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal LK, 1997, WATER SCI TECHNOL, V36, P433, DOI 10.1016/S0273-1223(97)00552-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araki N, 1999, WATER SCI TECHNOL, V39, P23, DOI 10.1016/S0273-1223(99)00146-8; Bertram S, 2013, ENVIRON MICROBIOL, V15, P2384, DOI 10.1111/1462-2920.12112; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bowman J.P., 2005, BERGEYS MANUAL SYSTE, V2, P248, DOI DOI 10.1007/0-387-28022-7_7; Deusner C, 2010, BIOTECHNOL BIOENG, V105, P524, DOI 10.1002/bit.22553; Durbin AM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00168; Fry JC, 2008, FEMS MICROBIOL ECOL, V66, P181, DOI 10.1111/j.1574-6941.2008.00566.x; Girguis PR, 2005, APPL ENVIRON MICROB, V71, P3725, DOI 10.1128/AEM.71.7.3725-3733.2005; Girguis PR, 2003, APPL ENVIRON MICROB, V69, P5472, DOI 10.1128/AEM.69.9.5472-5482.2003; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Green-Saxena A, 2014, ISME J, V8, P150, DOI 10.1038/ismej.2013.147; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Harrison BK, 2009, APPL ENVIRON MICROB, V75, P1487, DOI 10.1128/AEM.01812-08; Heijs SK, 2007, MICROB ECOL, V53, P384, DOI 10.1007/s00248-006-9172-3; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holler T, 2011, P NATL ACAD SCI USA, V108, pE1484, DOI 10.1073/pnas.1106032108; Holler T, 2011, ISME J, V5, P1946, DOI 10.1038/ismej.2011.77; Imachi H, 2006, APPL ENVIRON MICROB, V72, P2080, DOI 10.1128/AEM.72.3.2080-2091.2006; Imachi H, 2008, INT J SYST EVOL MICR, V58, P2258, DOI 10.1099/ijs.0.65727-0; Imachi H, 2011, ISME J, V5, P1913, DOI 10.1038/ismej.2011.64; Imachi H, 2009, INT J SYST EVOL MICR, V59, P800, DOI 10.1099/ijs.0.003731-0; Inagaki F, 2004, APPL ENVIRON MICROB, V70, P7445, DOI 10.1128/AEM.70.12.7445-7455.2004; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Jagersma GC, 2009, ENVIRON MICROBIOL, V11, P3223, DOI 10.1111/j.1462-2920.2009.02036.x; Jorgensen SL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00299; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; Kalyuzhnaya MG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3785; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Kleindienst S, 2012, ENVIRON MICROBIOL, V14, P2689, DOI 10.1111/j.1462-2920.2012.02832.x; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kruger M, 2008, ENVIRON MICROBIOL, V10, P1934, DOI 10.1111/j.1462-2920.2008.01607.x; Kubota K, 2006, J MICROBIOL METH, V66, P521, DOI 10.1016/j.mimet.2006.02.002; Li LN, 1999, BIODIVERS CONSERV, V8, P659, DOI 10.1023/A:1008848203739; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Machdar I, 2000, WATER SCI TECHNOL, V42, P83, DOI 10.2166/wst.2000.0362; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Meulepas RJW, 2010, FEMS MICROBIOL ECOL, V72, P261, DOI 10.1111/j.1574-6941.2010.00849.x; Meulepas RJW, 2009, BIOTECHNOL BIOENG, V104, P458, DOI 10.1002/bit.22412; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Miyashita A, 2009, FEMS MICROBIOL LETT, V297, P31, DOI 10.1111/j.1574-6968.2009.01648.x; MOENCH T T, 1983, Journal of Microbiological Methods, V1, P199, DOI 10.1016/0167-7012(83)90024-6; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Nunoura T, 2006, FEMS MICROBIOL ECOL, V57, P149, DOI 10.1111/j.1574-6941.2006.00101.x; Nunoura T, 2012, MICROBES ENVIRON, V27, P382, DOI 10.1264/jsme2.ME12032; Onodera T, 2013, BIORESOURCE TECHNOL, V136, P169, DOI 10.1016/j.biortech.2013.02.096; Orcutt BN, 2010, DEEP-SEA RES PT II, V57, P2008, DOI 10.1016/j.dsr2.2010.05.014; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Pachiadaki MG, 2010, FEMS MICROBIOL ECOL, V72, P429, DOI 10.1111/j.1574-6941.2010.00857.x; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Rossel PE, 2011, GEOCHIM COSMOCHIM AC, V75, P164, DOI 10.1016/j.gca.2010.09.031; Schramm A, 2002, ENVIRON MICROBIOL, V4, P713, DOI 10.1046/j.1462-2920.2002.00364.x; Schreiber L, 2010, ENVIRON MICROBIOL, V12, P2327, DOI 10.1111/j.1462-2920.2010.02275.x; Sekiguchi Y, 2005, WATER SCI TECHNOL, V52, P107, DOI 10.2166/wst.2005.0505; Sekiguchi Y, 1999, APPL ENVIRON MICROB, V65, P1280; Sorensen KB, 2006, APPL ENVIRON MICROB, V72, P4596, DOI 10.1128/AEM.00562-06; Sowers KR, 2001, BERGEYS MANUAL SYSTE, P276; Steeb P, 2014, LIMNOL OCEANOGR-METH, V12, P25, DOI 10.4319/lom.2014.12.25; Stokke R, 2012, ENVIRON MICROBIOL, V14, P1333, DOI 10.1111/j.1462-2920.2012.02716.x; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Uemura S., 2010, ENV ANAEROBIC TECHNO, P91; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Vigneron A, 2013, ISME J, V7, P1595, DOI 10.1038/ismej.2013.18; Wang FP, 2014, ISME J, V8, P1069, DOI 10.1038/ismej.2013.212; Wegener G, 2009, BIOGEOSCIENCES, V6, P867, DOI 10.5194/bg-6-867-2009; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; YAMAMOTO S, 1976, J CHEM ENG DATA, V21, P78, DOI 10.1021/je60068a029; Yanagawa K, 2011, GEOMICROBIOL J, V28, P118, DOI 10.1080/01490451003709334; Yoshioka H, 2010, GEOBIOLOGY, V8, P223, DOI 10.1111/j.1472-4669.2009.00231.x; Zhang Y, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-137; Zhang Y, 2010, BIORESOURCE TECHNOL, V101, P3132, DOI 10.1016/j.biortech.2009.11.103	82	15	15	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105356	10.1371/journal.pone.0105356	http://dx.doi.org/10.1371/journal.pone.0105356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141130	Green Submitted, gold, Green Published			2022-12-25	WOS:000342687200077
J	Kinaston, R; Bedford, S; Richards, M; Hawkins, S; Gray, A; Jaouen, K; Valentin, F; Buckley, H				Kinaston, Rebecca; Bedford, Stuart; Richards, Michael; Hawkins, Stuart; Gray, Andrew; Jaouen, Klervia; Valentin, Frederique; Buckley, Hallie			Diet and Human Mobility from the Lapita to the Early Historic Period on Uripiv Island, Northeast Malakula, Vanuatu	PLOS ONE			English	Article							NITROGEN-ISOTOPE RATIOS; STABLE-ISOTOPE; BONE-COLLAGEN; TERRESTRIAL COMPONENTS; CARBON-ISOTOPE; WATOM ISLAND; TEOUMA EFATE; NEW-HEBRIDES; CORAL-REEF; STRONTIUM	Vanuatu was first settled ca. 3000 years ago by populations associated with the Lapita culture. Models of diet, subsistence practices, and human interaction for the Lapita and subsequent occupation periods have been developed mainly using the available archaeological and paleoenvironmental data. We test these models using stable (carbon, nitrogen, and sulfur) and radiogenic (strontium) isotopes to assess the diet and childhood residency of past communities that lived on the small (<1 km(2)) island of Uripiv, located off the northeast coast of Malakula, Vanuatu. The burials are from the initial Lapita occupation of the island (ca. 2800-2600 BP), the subsequent later Lapita (LL, ca. 2600-2500 BP) and post-Lapita (PL, ca. 2500-2000 BP) occupations, in addition to a late prehistoric/historic (LPH, ca. 300-150 BP) occupation period. The human stable isotope results indicate a progressively more terrestrial diet over time, which supports the archaeological model of an intensification of horticultural and arboricultural systems as local resources were depleted, populations grew, and cultural situations changed. Pig diets were similar and included marine foods during the Lapita and PL periods but were highly terrestrial during the LPH period. This dietary pattern indicates that there was little variation in animal husbandry methods during the first 800 years of prehistory; however, there was a subsequent change as animal diets became more controlled in the LPH period. After comparison with the local bioavailable Sr-87/Sr-86 baseline, all of the Lapita and LPH individuals appeared to be 'local', but three of the PL individuals were identified as "non-local.'' We suggest that these "non-locals'' moved to the island after infancy or childhood from one of the larger islands, supporting the model of a high level of regional interaction during the post-Lapita period.	[Kinaston, Rebecca; Buckley, Hallie] Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Bedford, Stuart] Australian Natl Univ, Dept Archaeol & Nat Hist, Coll Asia & Pacific, Canberra, ACT, Australia; [Richards, Michael] Univ British Columbia, Dept Anthropol, Vancouver, BC V5Z 1M9, Canada; [Richards, Michael; Jaouen, Klervia] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Hawkins, Stuart] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Gray, Andrew] Univ Otago, Otago Sch Med Sci, Dept Prevent & Social Med, Dunedin, New Zealand; [Valentin, Frederique] Maison Archeol & Ethnol, CNRS, Nanterre, France	University of Otago; Australian National University; University of British Columbia; Max Planck Society; Australian National University; University of Otago; Centre National de la Recherche Scientifique (CNRS)	Kinaston, R (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand.	rebecca.kinaston@gmail.com	Buckley, Hallie/Q-5458-2019; Richards, Michael/O-3717-2016; Gray, Andrew Robert/L-9161-2015	Richards, Michael/0000-0001-5274-8887; Gray, Andrew Robert/0000-0003-4299-2194; Bedford, Stuart/0000-0001-6476-5617	Australian Research Council (ARC) Discovery Grant [DP0556874]; New Zealand Marsden Grant [09-UOO-106]; Centre national de la recherche scientifique (CNRS) equipe Ethnologie prehistorique grant [NRS UMR 7041]; Department of Human Evolution, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany; Natural Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research Council (SSHRC)	Australian Research Council (ARC) Discovery Grant(Australian Research Council); New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); Centre national de la recherche scientifique (CNRS) equipe Ethnologie prehistorique grant; Department of Human Evolution, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC))	The excavation of the Uripiv site, dating of the archaeological material, and the stable isotope analysis was primarily funded by an Australian Research Council (ARC) Discovery Grant (DP0556874, www.arc.gov.au) and a New Zealand Marsden Grant (09-UOO-106, www.royalsociety.org.nz/programmes/funds/marsden/). Further human bone dates were paid for by a Centre national de la recherche scientifique (CNRS) equipe Ethnologie prehistorique grant (NRS UMR 7041, www.cnrs.fr). Strontium isotope analysis was funded by the Department of Human Evolution, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany (http://www.eva.mpg.de/evolution/), the Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca), and the Social Sciences and Humanities Research Council (SSHRC, http://www.sshrc-crsh.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MS, 2009, PAC SCI, V63, P477, DOI 10.2984/049.063.0403; Ambrose S.H., 1993, PREHISTORIC HUMAN BO, P1, DOI 10.1007/978-3-662-02894-0_1; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Andersen AJ, 2001, ARCHAEOLOGY LAPITA D; Anderson A, 2002, WORLD ARCHAEOL, V33, P375, DOI 10.1080/00438240120107431; [Anonymous], 1989, CARNEGIE I WASH YR B; Athfield NB, 2008, J ROY SOC NEW ZEAL, V38, P1, DOI 10.1080/03014220809510543; Barrau J., 1973, Man and his foods., P87; Barrau J, 1958, SUBSISTENCE AGR MELA; Bashan Y, 2002, TREES-STRUCT FUNCT, V16, P159, DOI 10.1007/s00468-001-0152-4; Bedford S., 2010, LAPITA ANCETRES OCEA, P122; Bedford S., 2008, ASIAN PERSPECT, V47, P95, DOI DOI 10.1353/ASI.2008.0003; Bedford S., 2003, PACIFIC ARCHAEOLOGY, P147; Bedford S., 2009, NZ ARCHAEOLOGICAL AS, V28, P215; Bedford S, 2011, J PAC ARCHAEOL, V2, P26; Bentley RA, 2007, AM ANTIQUITY, V72, P645, DOI 10.2307/25470438; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Briqueu L, 1994, P OCEAN DRILLING PRO, V134, P393; Budd P, 2000, APPL GEOCHEM, V15, P687, DOI 10.1016/S0883-2927(99)00069-4; Budd P, 2004, ANTIQUITY, V78, P127, DOI 10.1017/S0003598X0009298X; Budd Paul, 2000, EUR J ARCHAEOL, V3, P370, DOI DOI 10.1177/146195710000300304; Budda P, 1999, COLLOQ SEMI, P301; Buikstra J. E., 1994, STANDARDS DATA COLLE; Burley DV., 2001, ARCHAEOL OCEAN, V36, P89, DOI [10.1002/j.1834-4453.2001.tb00481.x, DOI 10.1002/J.1834-4453.2001.TB00481.X]; Clark G., 2010, LAPITA ANCETRES OCEA, P212; Clark G, 2013, ARCHAEOL OCEAN, V48, P141, DOI 10.1002/arco.5012; COMAR CL, 1957, SCIENCE, V126, P485, DOI 10.1126/science.126.3272.485; Comar CL, 1957, P SOC EXPT BIOL MED, V88; Craig OE, 2010, J ARCHAEOL SCI, V37, P2504, DOI 10.1016/j.jas.2010.05.010; Davidson J, 2001, ARCHAEOLOGY LAPITA D, V17, P115; Deacon A. Bernard, 1934, MALEKULA VANISHING P; Deniel C, 2001, ANAL CHIM ACTA, V426, P95, DOI 10.1016/S0003-2670(00)01185-5; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Dickinson WR, 2013, J PAC ARCHAEOL, V4, P1; Dickinson WR, 2001, GEOARCHAEOLOGY, V16, P275, DOI 10.1002/1520-6548(200103)16:3<275::AID-GEA1005>3.0.CO;2-E; Donohue M, 2008, OCEAN LINGUIST, V47, P433; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Evans J, 2010, PARLIAMENT AFF, V63, P1, DOI 10.1093/pa/gsp042; Fell TP, 1998, RADIAT PROT DOSIM, V79, P311, DOI 10.1093/oxfordjournals.rpd.a032417; Field JS, 2009, J ARCHAEOL SCI, V36, P1547, DOI 10.1016/j.jas.2009.03.016; Froehle AW, 2010, J ARCHAEOL SCI, V37, P2662, DOI 10.1016/j.jas.2010.06.003; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P45, DOI 10.1002/ajpa.20244; Galipaud J, 2014, ARCHAEOL OCEAN; Galipaud JC, 2007, TERRA AUSTRALIS, V26, P151; Green R.C, 1982, NZ J ARCHAEOLOGY, V4, P7; Hamilton AM, 2010, PAC SCI, V64, P149, DOI 10.2984/64.2.149; Hartman G, 2014, GEOCHIM COSMOCHIM AC, V126, P250, DOI 10.1016/j.gca.2013.11.015; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Hide R., 2003, ACIAR MONOGRAPH, V108; Horrocks M, 2014, J ROY SOC NEW ZEAL, V44, P17, DOI 10.1080/03036758.2013.842177; Horrocks M, 2009, J ARCHAEOL SCI, V36, P2048, DOI 10.1016/j.jas.2009.05.024; Horrocks Mark, 2005, Archaeology in Oceania, V40, P67; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; JOHNSON CM, 1990, CONTRIB MINERAL PETR, V104, P99, DOI 10.1007/BF00310649; Jones S, 2009, FOOD GENDER FIJI; Jones S, 2009, J ARCHAEOL SCI, V36, P2742, DOI 10.1016/j.jas.2009.08.014; Katzenberg MA, 2012, BLACKW COMPANION ANT, P97; Katzenberg MA., 2008, BIOL ANTHR HUMAN SKE, P413, DOI 10.1002/9780470245842; KEEGAN WF, 1988, AM ANTIQUITY, V53, P320, DOI 10.2307/281022; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Kennett D, 2006, ORIG HUM BEHAV, V1, P265; Kinaston RL, 2009, J ARCHAEOL SCI, V36, P2780, DOI 10.1016/j.jas.2009.09.004; Kinaston R.L., 2013, PACIFIC ARCHAEOLOGY, P91; Kinaston R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090376; Kinaston RL, 2013, AM J PHYS ANTHROPOL, V151, P589, DOI 10.1002/ajpa.22314; Kinaston RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064580; KIRCH PV, 1997, LAPITA PEOPLES ANCES; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Layard J., 1942, STONE MEN MALEKULA; Leach B, 2003, NZ J ARCHAEOL, V23, P31; Littleton, 2008, FORENSIC APPROACHES, P155; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; MacCall G.J.H., 1970, B VOLCANOL, V34, P681, DOI DOI 10.1007/BF02596698; MARSHALL AG, 1976, BIOL J LINN SOC, V8, P319, DOI 10.1111/j.1095-8312.1976.tb00253.x; MEDWAY, 1975, PHILOS T R SOC B, V272, P423, DOI 10.1098/rstb.1975.0096; Montgomery J., 2002, LEAD STRONTIUM ISOTO; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Muldner G, 2007, AM J PHYS ANTHROPOL, V133, P682, DOI 10.1002/ajpa.20561; Mueller-Dombois D, 1998, VEGETATION TROPICAL; Nehlich O, 2011, GEOCHIM COSMOCHIM AC, V75, P4963, DOI 10.1016/j.gca.2011.06.009; Nehlich O, 2009, ARCHAEOL ANTHROP SCI, V1, P59, DOI 10.1007/s12520-009-0003-6; Nehlich O, 2009, J ARCHAEOL SCI, V36, P1791, DOI 10.1016/j.jas.2009.04.008; Nojima Y, 2008, COOKING STONES VANUA; O'Connell TC, 2012, AM J PHYS ANTHROPOL, V149, P426, DOI 10.1002/ajpa.22140; Oelze VM, 2012, AM J PHYS ANTHROPOL, V148, P406, DOI 10.1002/ajpa.22063; Oliver D, 1989, OCEANIA NATIVE CULTU; Oomen H, 1958, 118 S PAC COMM; PARKINSON R, 1999, 30 YEARS S SEAS; Pawley A, 2010, MIGRATION HIST WORLD, P77; Petchey F, 2005, RADIOCARBON, V47, P181, DOI 10.1017/S0033822200019688; Petchey F, 2011, J ARCHAEOL SCI, V38, P29, DOI 10.1016/j.jas.2010.07.029; Pollock N., 1992, THESE ROOTS REMAIN F; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Quantin P, 1972, NOUVELLES HEBRIDES A; Raos AM, 2004, J VOLCANOL GEOTH RES, V134, P35, DOI 10.1016/j.jvolgeores.2003.12.004; Richards MP, 2009, ARCHAEOL OCEAN, V44, P29, DOI 10.1002/j.1834-4453.2009.tb00042.x; Richards MP, 2003, INT J OSTEOARCHAEOL, V13, P37, DOI 10.1002/oa.654; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; Richards MP, 2001, EARTH PLANET SC LETT, V191, P185, DOI 10.1016/S0012-821X(01)00427-7; Sand C, 2010, LAPITA OCEANIC ANCES, P271; Scheuer L., 2000, DEV JUVENILE OSTEOLO; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; Shaw B, 2011, J ANTHROPOL ARCHAEOL, V30, P344, DOI 10.1016/j.jaa.2011.05.004; Shaw B, 2010, J ARCHAEOL SCI, V37, P605, DOI 10.1016/j.jas.2009.10.025; Shaw BJ, 2009, J ARCHAEOL SCI, V36, P1079, DOI 10.1016/j.jas.2008.12.010; Sheppard PJ, 2011, CURR ANTHROPOL, V52, P799, DOI 10.1086/662201; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Spriggs M., 1997, ISLAND MELANESIANS P; Steadman DW, 1999, COLLOQ SEMI, P375; Summerhayes G, 2001, ARCHAEOLOGY LAPITA D, V17, P25; Szabo K, 2000, ARCHAEOLOGY LAPITA D, P159; Szabo K, 2011, QUATERN INT, V239, P8, DOI 10.1016/j.quaint.2011.02.033; TAYLOR FW, 1980, J GEOPHYS RES, V85, P5367, DOI 10.1029/JB085iB10p05367; TERAKADO Y, 1988, CONTRIB MINERAL PETR, V99, P1, DOI 10.1007/BF00399360; THOMAS WL, 1963, MANS PLACE ISLAND EC, P7; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; Trickett MA, 2003, APPL GEOCHEM, V18, P653, DOI 10.1016/S0883-2927(02)00181-6; Valentin F, 2006, J ARCHAEOL SCI, V33, P1396, DOI 10.1016/j.jas.2006.01.012; Valentin F, 2010, J ARCHAEOL SCI, V37, P1820, DOI 10.1016/j.jas.2010.01.039; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Walter A, 1993, NOTES TECHNIQUES ORS; WASSERMAN RH, 1957, AM J PHYSIOL, V189, P91, DOI 10.1152/ajplegacy.1957.189.1.91; Waters-Rist AL, 2010, INT J OSTEOARCHAEOL, V20, P172, DOI 10.1002/oa.1017; Weightman B, 1989, AGR VANUATU HIST PER; Wirrmann D, 2011, QUATERNARY SCI REV, V30, P3908, DOI 10.1016/j.quascirev.2011.10.003; YAMAMURO M, 1995, LIMNOL OCEANOGR, V40, P617, DOI 10.4319/lo.1995.40.3.0617; YEN DE, 1974, ECON BOT, V28, P247, DOI 10.1007/BF02861424; Yen DE, 1996, ACIAR PROC, P36	134	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104071	10.1371/journal.pone.0104071	http://dx.doi.org/10.1371/journal.pone.0104071			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AQ3JB	25140807	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200011
J	Oh, HY; Seo, SS; Kim, MK; Lee, DO; Chung, YK; Lim, MC; Kim, JY; Lee, CW; Park, SY				Oh, Hea Young; Seo, Sang-Soo; Kim, Mi Kyung; Lee, Dong Ock; Chung, Youn Kyung; Lim, Myong Cheol; Kim, Joo-Young; Lee, Chan Wha; Park, Sang-Yoon			Synergistic Effect of Viral Load and Alcohol Consumption on the Risk of Persistent High-Risk Human Papillomavirus Infection	PLOS ONE			English	Article							CERVICAL-CANCER; CIGARETTE-SMOKING; NATURAL-HISTORY; WOMEN; TYPE-16; PREVALENCE; CLEARANCE; POPULATION; EXPRESSION; HPV-16	Purpose: This prospective study aimed to examine the combined effect of viral load and alcohol consumption on the risk of persistent high-risk (HR) human papillomavirus (HPV) infection. Methods: Among women undergoing health screening between 2002 and 2011 at the National Cancer Center, 284 and 122 women with HR-HPV infection and cytological findings of low-grade squamous intraepithelial or lower-grade lesions were followed up for 1 and 2 years, respectively. Multivariate logistic regression analysis was performed, and the relative excess risk due to interaction (RERI) and synergy index (S) were calculated. Results: Among drinkers, the risks of 1-year (odds ratio [OR] 4.09, 95% confidence interval [CI] 2.05-8.18) and 2-year persistence (OR 8.08, CI 2.36-27.6) were significantly higher for high HPV loads than for low HPV loads; this association was not seen for non-drinkers. The risks for 1-year (OR 4.14, CI 1.89-9.05) and 2-year persistence (OR 6.61, CI 2.09-20.9) were significantly higher in subjects with a high HPV load who were also drinkers than in those who were non-drinkers. A high HPV load together with a longer drinking duration or higher alcohol consumption was associated with increased risks of 1-year (OR 3.07, CI 1.40-6.75 or OR 2.05, CI 0.87-4.83) and 2-year persistence (OR 6.40, CI 1.72-23.8 or OR 4.14, CI 1.18-14.6). The synergistic effect of alcohol consumption and HR-HPV load was stronger on the risk of 2-year persistence (RERI = 3.26, S = 2.38) than on the risk of 1-year persistence (RERI = 1.21, S = 1.63). Conclusions: The synergistic effect of HR-HPV load and alcohol consumption was associated with the risk of HR-HPV persistence and was stronger for longer-term HR-HPV infection. Limiting alcohol consumption might be an important measure to prevent the development of cervical cancer in women with a high HR-HPV load.	[Oh, Hea Young; Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol & Prevent, Goyang Si, Gyeonggi Do, South Korea; [Seo, Sang-Soo; Lee, Dong Ock; Lim, Myong Cheol; Kim, Joo-Young; Park, Sang-Yoon] Natl Canc Ctr, Ctr Uterine Canc, Goyang Si, Gyeonggi Do, South Korea; [Chung, Youn Kyung; Lee, Chan Wha] Natl Canc Ctr, Ctr Canc Prevent & Detect, Goyang Si, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, MK (corresponding author), Natl Canc Ctr, Div Canc Epidemiol & Prevent, Goyang Si, Gyeonggi Do, South Korea.	alrud@ncc.re.kr			National Cancer Center Korea [1110320, 1310361, 0910221]	National Cancer Center Korea	This research was supported by grants from the National Cancer Center Korea (1110320, 1310361, 0910221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Bae J, 2009, GYNECOL ONCOL, V115, P75, DOI 10.1016/j.ygyno.2009.06.016; Briolat J, 2007, INT J CANCER, V121, P2198, DOI 10.1002/ijc.22959; Broccolo F, 2009, J MED VIROL, V81, P278, DOI 10.1002/jmv.21395; Carcopino X, 2006, J MED VIROL, V78, P1131, DOI 10.1002/jmv.20673; Carcopino X, 2011, J MED VIROL, V83, P637, DOI 10.1002/jmv.22022; Castle PE, 2005, CANCER EPIDEM BIOMAR, V14, P1311, DOI 10.1158/1055-9965.EPI-04-0799; de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047; De Marco F, 2013, VIRUSES-BASEL, V5, P708, DOI 10.3390/v5020708; Del Nonno F, 2011, MODERN PATHOL, V24, P855, DOI 10.1038/modpathol.2011.40; FERNANDEZ C, 1995, BRIT J CANCER, V72, P1194, DOI 10.1038/bjc.1995.485; Fontaine J, 2008, J CLIN VIROL, V43, P307, DOI 10.1016/j.jcv.2008.07.013; Gage JC, 2010, CANCER EPIDEM BIOMAR, V19, P1668, DOI 10.1158/1055-9965.EPI-09-1286; Goodman MT, 2008, CANCER RES, V68, P8813, DOI 10.1158/0008-5472.CAN-08-1380; GROOTENHUIS PA, 1995, J CLIN EPIDEMIOL, V48, P859, DOI 10.1016/0895-4356(95)00013-T; Gunnell AS, 2006, CANCER EPIDEM BIOMAR, V15, P2141, DOI 10.1158/1055-9965.EPI-06-0399; Hibma Merilyn H, 2012, Open Virol J, V6, P241, DOI 10.2174/1874357901206010241; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; International Collaboration of Epidemiological Studies of Cervical Cancer, 2006, Int J Cancer, V118, P1481, DOI 10.1002/ijc.21493; Kang WD, 2011, GYNECOL ONCOL, V121, P546, DOI 10.1016/j.ygyno.2011.01.015; Kim JW, 2012, J INT MED RES, V40, P486, DOI 10.1177/147323001204000210; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Lee SA, 2003, CANCER LETT, V198, P187, DOI 10.1016/S0304-3835(03)00312-4; Marks MA, 2012, J CLIN MICROBIOL, V50, P300, DOI 10.1128/JCM.05979-11; Min KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072142; Nielsen A, 2010, J MED VIROL, V82, P616, DOI 10.1002/jmv.21750; Oh JK, 2009, EUR J CANCER PREV, V18, P56, DOI 10.1097/CEJ.0b013e328305a0a6; Park Young-Joo, 2003, Taehan Kanho Hakhoe Chi, V33, P457; Perluigi M, 2009, J CELL MOL MED, V13, P1809, DOI 10.1111/j.1582-4934.2008.00465.x; Piyathilake CJ, 2010, INT J WOMENS HEALTH, V2, P7; Ryu A, 2010, J GYNECOL ONCOL, V21, P87, DOI 10.3802/jgo.2010.21.2.87; Sammarco ML, 2013, EUR J OBSTET GYN R B, V168, P222, DOI 10.1016/j.ejogrb.2013.01.012; Sanjoaquin MA, 2005, INT J CANCER, V113, P825, DOI 10.1002/ijc.20648; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schmeink CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027937; Siegel EM, 2012, INT J CANCER, V131, P219, DOI 10.1002/ijc.26363; Xi LF, 2011, J INFECT DIS, V203, P1425, DOI 10.1093/infdis/jir049; Xi LF, 2009, CANCER EPIDEM BIOMAR, V18, P3490, DOI 10.1158/1055-9965.EPI-09-0763; Xu YC, 2009, INT J CLIN EXP PATHO, V2, P169; Yoon H, 2001, KOREAN J UROL, V42, P13	41	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104374	10.1371/journal.pone.0104374	http://dx.doi.org/10.1371/journal.pone.0104374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140695	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200019
J	Park, E; Song, CH; Park, JI; Ahn, RS; Choi, HS; Ko, C; Lee, K				Park, Eunsook; Song, Chin-Hee; Park, Jae-Il; Ahn, Ryun-Sup; Choi, Hueng-Sik; Ko, CheMyong; Lee, Keesook			Transforming Growth Factor-beta 1 Signaling Represses Testicular Steroidogenesis through Cross-Talk with Orphan Nuclear Receptor Nur77	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LEYDIG-CELL STEROIDOGENESIS; P450C17 GENE-TRANSCRIPTION; STAR TRANSCRIPTION; PRIMARY CULTURE; FACTOR-I; NGFI-B; EXPRESSION; SMAD3; PROMOTER	Transforming growth factor-beta 1 (TGF-beta 1) has been reported to inhibit luteinizing hormone (LH) mediated-steroidogenesis in testicular Leydig cells. However, the mechanism by which TGF-beta 1 controls the steroidogenesis in Leydig cells is not well understood. Here, we investigated the possibility that TGF-beta 1 represses steroidogenesis through cross-talk with the orphan nuclear receptor Nur77. Nur77, which is induced by LH/cAMP signaling, is one of major transcription factors that regulate the expression of steroidogenic genes in Leydig cells. TGF-beta 1 signaling inhibited cAMP-induced testosterone production and the expression of steroidogenic genes such as P450c17, StAR and 3 beta-HSD in mouse Leydig cells. Further, TGF-beta 1/ALK5 signaling repressed cAMP-induced and Nur77-activated promoter activity of steroidogenic genes. In addition, TGF-beta 1/ALK5-activated Smad3 repressed Nur77 transactivation of steroidogenic gene promoters by interfering with Nur77 binding to DNA. In primary Leydig cells isolated from Tgfbr2(flox/flox) Cyp17iCre mice, TGF-beta 1-mediated repression of cAMP-induced steroidogenic gene expression was significantly less than that in primary Leydig cells from Tgfbr2flox/flox mice. Taken together, these results suggest that TGF-beta 1/ALK5/Smad3 signaling represses the expression of steroidogenic genes via the suppression of Nur77 transactivation in testicular Leydig cells. These findings may provide a molecular mechanism involved in the TGF-beta 1-mediated repression of testicular steroidogenesis.	[Park, Eunsook; Song, Chin-Hee; Choi, Hueng-Sik; Lee, Keesook] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea; [Park, Jae-Il] Chonnam Natl Univ, Gwangju Ctr, Korea Basic Sci Inst, Kwangju, South Korea; [Ahn, Ryun-Sup] CHA Med Univ, Grad Sch Integrat Med, Seoul, South Korea; [Ko, CheMyong] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL 61801 USA	Chonnam National University; Chonnam National University; Korea Basic Science Institute (KBSI); University of Illinois System; University of Illinois Urbana-Champaign	Lee, K (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea.	klee@chonnam.ac.kr	Ko, CheMyong Jay/A-7475-2019; Ahn, Ryun S./D-1218-2011	Ko, CheMyong Jay/0000-0002-0963-3731; 	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A2A2A01008388]; STFC [ST/F501761/1, ST/J001511/1] Funding Source: UKRI	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012R1A2A2A01008388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVALLET O, 1994, ENDOCRINOLOGY, V134, P2079, DOI 10.1210/en.134.5.2079; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Derebecka-Holysz N, 2008, MOL CELL BIOCHEM, V307, P65, DOI 10.1007/s11010-007-9585-4; Gnessi L, 1997, ENDOCR REV, V18, P541, DOI 10.1210/er.18.4.541; Gonzalez CR, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-148; Gonzalez CR, 2010, J REPROD DEVELOP, V56, P389, DOI 10.1262/jrd.09-166N; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; Hayes SA, 2001, CANCER RES, V61, P2112; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Ingman WV, 2007, ENDOCRINOLOGY, V148, P4032, DOI 10.1210/en.2006-1759; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim W, 2008, MOL BIOL CELL, V19, P2135, DOI 10.1091/mbc.E07-10-0991; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Le Roy C, 1999, J STEROID BIOCHEM, V69, P379, DOI 10.1016/S0960-0760(99)00075-8; Lee SY, 2012, MOL CELL ENDOCRINOL, V362, P91, DOI 10.1016/j.mce.2012.05.015; Lee SY, 2009, FREE RADICAL BIO MED, V47, P1591, DOI 10.1016/j.freeradbiomed.2009.09.004; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; LIN T, 1987, BIOCHEM BIOPH RES CO, V146, P387, DOI 10.1016/0006-291X(87)90541-9; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Martin LJ, 2005, ENDOCRINOLOGY, V146, P861, DOI 10.1210/en.2004-0859; Martin LJ, 2008, MOL ENDOCRINOL, V22, P2021, DOI 10.1210/me.2007-0370; Martin LJ, 2010, BIOL REPROD, V83, P3, DOI 10.1095/biolreprod.110.083824; Martin LJ, 2009, J MOL ENDOCRINOL, V42, P119, DOI 10.1677/JME-08-0095; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mellon SH, 1998, ENDOCR RES, V24, P505, DOI 10.3109/07435809809032639; MORERA AM, 1988, J STEROID BIOCHEM, V30, P443, DOI 10.1016/0022-4731(88)90139-2; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Ozguden-Akkoc CG, 2012, BIOTECH HISTOCHEM, V87, P154, DOI 10.3109/10520295.2011.592150; PAYNE AH, 1995, BIOL REPROD, V52, P217, DOI 10.1095/biolreprod52.2.217; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Qamar I, 2010, J BIOL CHEM, V285, P22360, DOI 10.1074/jbc.M109.059949; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Steinmetz ACU, 2001, ANNU REV BIOPH BIOM, V30, P329, DOI 10.1146/annurev.biophys.30.1.329; Stocco CO, 2002, J BIOL CHEM, V277, P3293, DOI 10.1074/jbc.M110936200; Suh JH, 2006, J BIOL CHEM, V281, P39169, DOI 10.1074/jbc.M605947200; TEERDS KJ, 1993, BIOL REPROD, V48, P40, DOI 10.1095/biolreprod48.1.40; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861; Yang L, 2008, CANCER RES, V68, P9107, DOI 10.1158/0008-5472.CAN-08-2556; Yazawa T, 2009, ENDOCRINOLOGY, V150, P3885, DOI 10.1210/en.2008-1310; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891	51	14	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104812	10.1371/journal.pone.0104812	http://dx.doi.org/10.1371/journal.pone.0104812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140527	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200036
J	Schroeter, ER; Egerton, VM; Ibiricu, LM; Lacovara, KJ				Schroeter, Elena R.; Egerton, Victoria M.; Ibiricu, Lucio M.; Lacovara, Kenneth J.			Lamniform Shark Teeth from the Late Cretaceous of Southernmost South America (Santa Cruz Province, Argentina)	PLOS ONE			English	Article							CARCHARHINUS-LEUCAS; GEARLE SILTSTONE; ASSEMBLAGE; TAXONOMY; DINOSAUR; BASIN	Here we report multiple lamniform shark teeth recovered from fluvial sediments in the (Campanian-Maastrichtian) Cerro Fortaleza Formation, Santa Cruz Province, Argentina. This small tooth assemblage is compared to various lamniform sharks possessing similar dental morphologies, including Archaeolamna, Cretalamna, Dwardius, Dallasiella, and Cretodus. Although the teeth share numerous morphological features with the genus Archaeolamna, including a developed neck that maintains a relatively consistent width along the base of the crown, the small sample size and incomplete nature of these specimens precludes definitive taxonomic assignment. Regardless, the discovery of selachian teeth unique from those previously described for the region broadens the known diversity of Late Cretaceous South American sharks. Additionally, the discovery of the teeth in fluvial sandstone may indicate a euryhaline paleobiology in the lamniform taxon or taxa represented by this tooth assemblage.	[Schroeter, Elena R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Egerton, Victoria M.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Ibiricu, Lucio M.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Lab Paleontol, Puerto Madryn, Chubut, Argentina; [Lacovara, Kenneth J.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Drexel University; University of Manchester; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Drexel University	Lacovara, KJ (corresponding author), Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA.	lacovara@drexel.edu		Schroeter, Elena/0000-0003-4314-2976; Egerton, Victoria/0000-0002-0739-6533	Betz Fund for Environmental Science, Drexel University; National Science Foundation [DGE 1002809]	Betz Fund for Environmental Science, Drexel University; National Science Foundation(National Science Foundation (NSF))	This work was funded by the Betz Fund for Environmental Science, Drexel University, and a National Science Foundation Graduate Research Fellowship award (DGE 1002809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1972, GEOLOGIA REGIONAL AR; Arbe H.A., 2002, GEOLOG A RECURSOS NA, P103; Arbe H.A., 1984, ACT 9 C GEOL ARG, P124; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Beavan NR, 1999, J PALEONTOL, V73, P494, DOI 10.1017/S0022336000028006; Becker MA, 2000, LETHAIA, V33, P103; Biddle J.P., 1993, Service Geologique de Belgique Professional Paper, V264, P191; Bogan Sergio, 2010, Pap. Avulsos Zool. (São Paulo), V50, P175, DOI 10.1590/S0031-10492010001200001; Cappetta H., 1975, Palaeontographica Abt A, V151, P1; Cappetta H., 1987, CHONDRICHTHYES; CASE G R, 1987, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V197, P1; Case G.R., 1978, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V160, P176; Cook TD, 2011, J VERTEBR PALEONTOL, V31, P8, DOI 10.1080/02724634.2011.539968; Cook TD, 2008, CAN J EARTH SCI, V45, P1185, DOI 10.1139/E08-064; Cumbaa Stephen L., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P139; DAVis J. W., 1890, SCI T ROYAL DUBLIN S, V4, P363; Egerton VM, 2013, GONDWANA RES, V23, P268, DOI 10.1016/j.gr.2012.08.010; Ezcurra MD, 2010, ZOOTAXA, P1; Feruglio E., 1938, Physis Buenos Aires, V12, P293; Feruglio E, 1944, B ACAD NACL CIENCIAS, V37, P3; Herman J., 1977, MEMOIRES SERVIR LESP, V15, P1; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Kennedy WJ, 2008, BULL INST R SC N B-S, V78, P117; Kent B. W., 1994, FOSSIL SHARKS CHESAP; Kraemer P.E., 1997, Revista de la Asociacion Geologica Argentina, V52, P333; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Macellari C., 1989, J S AM EARTH SCI, V2, P223, DOI [DOI 10.1016/0895-9811(89)90031-X, 10.1016/0895-9811(89)90031-X]; Marenssi SA, 2003, Rev. Asoc. Geol. Argent., V58, P403; Novas FE, 2002, ACT 15 C GEOL ARG, V315, P1; O'Gorman JP, 2010, AMEGHINIANA, V47, P447, DOI 10.5710/AMGH.v47i4.3; Riccardi A., 1980, S GEOLOGIA REGIONAL, V2, P1173; Schwimmer DR, 2002, J VERTEBR PALEONTOL, V22, P704, DOI 10.1671/0272-4634(2002)022[0704:RTAAGR]2.0.CO;2; Shimada K, 2002, J MORPHOL, V251, P38, DOI 10.1002/jmor.1073; Shimada K., 2008, FORT HAYS STUDIES, V2, P89; Shimada K, 2007, J VERTEBR PALEONTOL, V27, P584, DOI 10.1671/0272-4634(2007)27[584:SADAOL]2.0.CO;2; SIVERSON M, 1992, PALAEONTOLOGY, V35, P519; Siverson M, 1996, PALAEONTOLOGY, V39, P813; Siverson M, 1999, T ROY SOC EDIN-EARTH, V90, P49, DOI 10.1017/S0263593300002509; Siverson M, 1997, J VERTEBR PALEONTOL, V17, P453, DOI 10.1080/02724634.1997.10010995; Siverson M, ACTA PALAEO IN PRESS; THORSON TB, 1973, PHYSIOL ZOOL, V46, P29, DOI 10.1086/physzool.46.1.30152514; Underwood CJ, 2010, PALAEONTOLOGY, V53, P903, DOI 10.1111/j.1475-4983.2010.00969.x; Varela AN, 2012, SEDIMENT GEOL, V271, P67, DOI 10.1016/j.sedgeo.2012.06.006; Vullo R, 2004, CR PALEVOL, V4, P95; Welton B.J., 1993, COLLECTORS GUIDE FOS; Woodward A. S., 1894, Proceedings of the Geologists' Association, Vxiii, P190; Wosnick N, 2013, COMP BIOCHEM PHYS A, V166, P36, DOI 10.1016/j.cbpa.2013.05.002; [No title captured]	48	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104800	10.1371/journal.pone.0104800	http://dx.doi.org/10.1371/journal.pone.0104800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141301	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200035
J	Liu, CC; Kanekiyo, T; Roth, B; Bu, GJ				Liu, Chia-Chen; Kanekiyo, Takahisa; Roth, Barbara; Bu, Guojun			Tyrosine-based Signal Mediates LRP6 Receptor Endocytosis and Desensitization of Wnt/beta-Catenin Pathway Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						LRP6; Phosphorylation; Lipid Raft; Endocytosis; -Catenin; Wnt	DENSITY-LIPOPROTEIN RECEPTOR; EPIDERMAL-GROWTH-FACTOR; BETA-CATENIN; INTERNALIZATION; CLATHRIN; PROTEIN; DISEASE; CELL; TRANSDUCTION; TRAFFICKING	Background: LRP6 is an essential co-receptor for Wnt/-catenin signaling, which controls various biological pathways. Results: LRP6 tyrosine mutant exhibited longer half-life and increased lipid raft distribution, phosphorylation, and signaling. Conclusion: Clathrin-mediated endocytosis of LRP6 mediates its degradation, whereas caveolae-dependent pathway promotes Wnt/-catenin signaling. Significance: Understanding the molecular mechanisms underlying LRP6 endocytosis and Wnt/-catenin signaling will help the development of therapeutic methods targeting this pathway. Wnt/-catenin signaling orchestrates a number of critical events including cell growth, differentiation, and cell survival during development. Misregulation of this pathway leads to various human diseases, specifically cancers. Endocytosis and phosphorylation of the LDL receptor-related protein 6 (LRP6), an essential co-receptor for Wnt/-catenin signaling, play a vital role in mediating Wnt/-catenin signal transduction. However, its regulatory mechanism is not fully understood. In this study, we define the mechanisms by which LRP6 endocytic trafficking regulates Wnt/-catenin signaling activation. We show that LRP6 mutant with defective tyrosine-based signal in its cytoplasmic tail has an increased cell surface distribution and decreased endocytosis rate. These changes in LRP6 endocytosis coincide with an increased distribution to caveolae, increased phosphorylation, and enhanced Wnt/-catenin signaling. We further demonstrate that treatment of Wnt3a ligands or blocking the clathrin-mediated endocytosis of LRP6 leads to a redistribution of wild-type receptor to lipid rafts. The LRP6 tyrosine mutant also exhibited an increase in signaling activation in response to Wnt3a stimulation when compared with wild-type LRP6, and this activation is suppressed when caveolae-mediated endocytosis is blocked. Our results reveal molecular mechanisms by which LRP6 endocytosis routes regulate its phosphorylation and the strength of Wnt/-catenin signaling, and have implications on how this pathway can be modulated in human diseases.	[Liu, Chia-Chen; Bu, Guojun] Xiamen Univ, Inst Neurosci, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China; [Liu, Chia-Chen; Kanekiyo, Takahisa; Roth, Barbara; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Xiamen University; Mayo Clinic	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu			National Institutes of Health [R01 AG035355, P01 AG030128]; Alex's Lemonade Stand Foundation Young Investigator Award; NATIONAL INSTITUTE ON AGING [R01AG035355, R01AG027924, P01AG030128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation Young Investigator Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG035355 and P01 AG030128 (to G. B.) and Alex's Lemonade Stand Foundation Young Investigator Award (to T. K.).	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Choi SC, 2008, DEV CELL, V15, P49, DOI 10.1016/j.devcel.2008.05.004; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gong Q, 2008, J CELL MOL MED, V12, P126, DOI 10.1111/j.1582-4934.2007.00148.x; HANOVER JA, 1984, CELL, V39, P283, DOI 10.1016/0092-8674(84)90006-0; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jiang Y, 2012, EMBO J, V31, P2336, DOI 10.1038/emboj.2012.83; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; PAPKOFF J, 1987, MOL CELL BIOL, V7, P3978, DOI 10.1128/MCB.7.11.3978; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	42	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27562	27570		10.1074/jbc.M113.533927	http://dx.doi.org/10.1074/jbc.M113.533927			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143377	hybrid, Green Published			2022-12-25	WOS:000342852800018
J	Chung, RY; Kim, JH; Yip, BH; Wong, SYS; Wong, MCS; Chung, VCH; Griffiths, SM				Chung, Roger Y.; Kim, Jean H.; Yip, Benjamin H.; Wong, Samuel Y. S.; Wong, Martin C. S.; Chung, Vincent C. H.; Griffiths, Sian M.			Alcohol Tax Policy and Related Mortality. An Age-Period-Cohort Analysis of a Rapidly Developed Chinese Population, 1981-2010	PLOS ONE			English	Article							DRINKING BEHAVIOR; CONSUMPTION; PATTERNS; TRENDS; RISK; ADULTS; ONSET	To delineate the temporal dynamics between alcohol tax policy changes and related health outcomes, this study examined the age, period and cohort effects on alcohol-related mortality in relation to changes in government alcohol policies. We used the age-period-cohort modeling to analyze retrospective mortality data over 30 years from 1981 to 2010 in a rapidly developed Chinese population, Hong Kong. Alcohol-related mortality from 1) chronic causes, 2) acute causes, 3) all (chronic+acute) causes and 4) causes 100% attributable to alcohol, as defined according to the Alcohol-Related Disease Impact (ARDI) criteria developed by the US Centers for Disease Control and Prevention, were examined. The findings illustrated the possible effects of alcohol policy changes on adult alcohol-related mortality. The age-standardized mortality trends were generally in decline, with fluctuations that coincided with the timing of the alcohol policy changes. The age-period-cohort analyses demonstrated possible temporal dynamics between alcohol policy changes and alcohol-related mortality through the period effects, and also generational impact of alcohol policy changes through the cohort effects. Based on the illustrated association between the dramatic increase of alcohol imports in the mid-1980s and the increased alcohol-related mortality risk of the generations coming of age of majority at that time, attention should be paid to generations coming of drinking age during the 2007-2008 duty reduction.	[Chung, Roger Y.; Kim, Jean H.; Yip, Benjamin H.; Wong, Samuel Y. S.; Wong, Martin C. S.; Chung, Vincent C. H.; Griffiths, Sian M.] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Yip, BH (corresponding author), Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	benyip@cuhk.edu.hk	Yip, Benjamin/AAC-7845-2019; WONG, Samuel Yeung Shan/D-7311-2013; Wong, Martin/L-4568-2014; Chung, Vincent CH/K-2447-2013; Chung, Roger Y. N./B-7288-2016	Yip, Benjamin/0000-0002-4749-7611; WONG, Samuel Yeung Shan/0000-0003-0934-6385; Wong, Martin/0000-0001-7706-9370; Chung, Vincent CH/0000-0002-5947-4492; /0000-0002-5799-5913				AHMAD O, 2001, 31 GPE WHO; Aristei D, 2008, EMPIR ECON, V35, P29, DOI 10.1007/s00181-007-0142-5; CASE R A, 1956, Br J Prev Soc Med, V10, P172; CASE R A, 1956, Br J Prev Soc Med, V10, P159; CHI I, 1988, J STUD ALCOHOL, V49, P21, DOI 10.15288/jsa.1988.49.21; CHI I, 1989, J STUD ALCOHOL, V50, P15, DOI 10.15288/jsa.1989.50.15; CHOU SP, 1992, BRIT J ADDICT, V87, P1199; Chung RY, 2012, EPIDEMIOL INFECT, V140, P1904, DOI 10.1017/S0950268811002469; Chung RY, 2010, AM J EPIDEMIOL, V171, P345, DOI 10.1093/aje/kwp378; Chung VCH, 2013, ALCOHOL ALCOHOLISM, V48, P720, DOI 10.1093/alcalc/agt065; COLLINS JJ, 1982, DEMOGRAPHY, V19, P409, DOI 10.2307/2060979; Corrao G, 1997, INT J EPIDEMIOL, V26, P100, DOI 10.1093/ije/26.1.100; Department of Health, 2011, ACT PLAN RED ALC REL; Donnan SPB, 1988, HONG KONG MED J, V41, P16; Duff Cameron, 2011, J Ethn Subst Abuse, V10, P2, DOI 10.1080/15332640.2011.547791; Fienberg S.E., 1985, COHORT ANAL SOCIAL R, DOI DOI 10.1007/978-1-4613-8536-3; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Hong Kong Government Financial Secretary, 2008, HONG KONG BUDG REP 2; Hong Kong Government Financial Secretary, 2001, HONG KONG BUDG REP 2; Hong Kong Government Financial Secretary, 2007, HONG KONG BUDG REP 2; Hong Kong Transport Department, FIGUREA1 TREND ROAD; Kerr WC, 2004, ADDICTION, V99, P1111, DOI 10.1111/j.1360-0443.2004.00820.x; Kerr WC, 2013, ADDICTION, V108, P1038, DOI 10.1111/j.1360-0443.2012.04055.x; Kim JH, 2008, ALCOHOL ALCOHOLISM, V43, P360, DOI 10.1093/alcalc/agm181; Kim JH, 2010, ACCIDENT ANAL PREV, V42, P994, DOI 10.1016/j.aap.2009.12.001; Kohn C, 2014, TRAFFIC INJ PREV, V15, P119, DOI 10.1080/15389588.2013.803221; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Levenson MR, 1998, J STUD ALCOHOL, V59, P712, DOI 10.15288/jsa.1998.59.712; Mannheim K., 1952, ESSAYS SOCIOL KNOW; Mason W., 1985, COHORT ANAL SOCIAL R, P1, DOI DOI 10.1007/978-1-4613-8536-3; Moore AA, 2005, AM J PUBLIC HEALTH, V95, P458, DOI 10.2105/AJPH.2003.019471; Pitkanen T, 2005, ADDICTION, V100, P652, DOI 10.1111/j.1360-0443.2005.01053.x; Pun VC, 2013, J EPIDEMIOL COMMUN H, V67, P514, DOI 10.1136/jech-2012-201859; Ramstedt M, 2001, ADDICTION, V96, pS19; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rosen M, 2006, ADDICTION, V101, P835, DOI 10.1111/j.1360-0443.2006.01421.x; Shahpar C, 1999, AM J EPIDEMIOL, V150, P1213; Siliquini R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-526; Tarone RE, 1996, AM J EPIDEMIOL, V143, P85; Treasury Branch Financial Services and the Treasury Bureau Government of the Hong Kong Special Administrative Region, 2004, DUT ALC BEV CONS DOC; Tse G. M. K., 2000, Hong Kong Medical Journal, V6, P190; US Centers for Disease Control and Prevention, ALC PUBL HLTH ALC RE; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Wong IOL, 2010, J EPIDEMIOL COMMUN H, V64, P596, DOI 10.1136/jech.2008.080788; Young B, 1996, HK J PAEDIAT NEW SER, V1, P207	45	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e99906	10.1371/journal.pone.0099906	http://dx.doi.org/10.1371/journal.pone.0099906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153324	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200002
J	Daigle, RM; Metaxas, A; deYoung, B				Daigle, Remi M.; Metaxas, Anna; deYoung, Brad			Fine-Scale Distribution and Spatial Variability of Benthic Invertebrate Larvae in an Open Coastal Embayment in Nova Scotia, Canada	PLOS ONE			English	Article							SUPPLY-SIDE ECOLOGY; VERTICAL-DISTRIBUTION; PLACOPECTEN-MAGELLANICUS; THERMAL STRATIFICATION; TRANSPORT; DISPERSAL; BEHAVIOR; PATTERNS; AUTOCORRELATION; PHYTOPLANKTON	This study quantified the fine-scale (0.5 km) of variability in the horizontal distributions of benthic invertebrate larvae and related this variability to that in physical and biological variables, such as density, temperature, salinity, fluorescence and current velocity. Larvae were sampled in contiguous 500-m transects along two perpendicular 10-km transects with a 200-mu m plankton ring net (0.75-m diameter) in St. George's Bay, Nova Scotia, Canada, in Aug 2009. Temperature, conductivity, pressure and fluorescence were measured with a CTD cast at each station, and currents were measured with an Acoustic Doppler Current Profiler moored at the intersection of the 2 transects. Gastropod, bivalve and, to a lesser extent, bryozoan larvae had very similar spatial distributions, but the distribution of decapod larvae had a different pattern. These findings suggest that taxonomic groups with functionally similar larvae have similar dispersive properties such as distribution and spatial variability, while the opposite is true for groups with functionally dissimilar larvae. The spatial variability in larval distributions was anisotropic and matched the temporal/spatial variability in the current velocity. We postulate that in a system with no strong oceanographic features, the scale of spatially coherent physical forcing (e.g. tidal periodicity) can regulate the formation or maintenance of larval patches; however, swimming ability may modulate it.	[Daigle, Remi M.; Metaxas, Anna] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [deYoung, Brad] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada	Dalhousie University; Memorial University Newfoundland	Daigle, RM (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada.	daigleremi@gmail.com	Daigle, Remi M/H-3160-2019	Daigle, Remi M/0000-0001-8832-4189	NSERC (Natural Sciences and Engineering Research Council of Canada) [222932, 200291]; Strategic Network - Canadian Healthy Oceans Network (CHONe) [290606]; NSERC; Dalhousie University	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Strategic Network - Canadian Healthy Oceans Network (CHONe); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie University	Funding for this study was provided by NSERC (Natural Sciences and Engineering Research Council of Canada) grants to A.M. and B.deY.: Discovery (A.M.: 222932, B.deY.: 200291) and the Strategic Network (290606) - Canadian Healthy Oceans Network (CHONe). Funding to R.D. was through a NSERC CGS M and PGS D, as well as Graduate Scholarships and President Awards from Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler MJ, 2011, MAR ECOL PROG SER, V422, P223, DOI 10.3354/meps08878; CHIA FS, 1984, CAN J ZOOL, V62, P1205, DOI 10.1139/z84-176; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Daigle RM, 2014, MAR ECOL PROG SER, V503, P139, DOI 10.3354/meps10734; Daigle RM, 2012, J EXP MAR BIOL ECOL, V438, P14, DOI 10.1016/j.jembe.2012.09.004; Daigle RM, 2011, J EXP MAR BIOL ECOL, V409, P89, DOI 10.1016/j.jembe.2011.08.008; DiBacco C, 2001, MAR ECOL PROG SER, V217, P191, DOI 10.3354/meps217191; DiBacco C, 2011, MAR ECOL PROG SER, V433, P131, DOI 10.3354/meps09186; Epstein AW, 2001, DEEP-SEA RES PT II, V48, P395, DOI 10.1016/S0967-0645(00)00086-2; Folt CL, 1999, TRENDS ECOL EVOL, V14, P300, DOI 10.1016/S0169-5347(99)01616-X; Forward RB, 2003, B MAR SCI, V72, P347; Fuchs HL, 2007, LIMNOL OCEANOGR, V52, P1156, DOI 10.4319/lo.2007.52.3.1156; Fujimura AG, 2014, LIMNOL OCEANOGR, V59, P1434, DOI 10.4319/lo.2014.59.4.1434; Gallager SM, 1996, MAR BIOL, V124, P679, DOI 10.1007/BF00351049; GROSBERG RK, 1992, TRENDS ECOL EVOL, V7, P130, DOI 10.1016/0169-5347(92)90148-5; Higgins FA, 2012, J THERM BIOL, V37, P83, DOI 10.1016/j.jtherbio.2011.11.004; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; JILLETT J B, 1976, New Zealand Journal of Marine and Freshwater Research, V10, P543; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lloyd MJ, 2012, MAR ECOL PROG SER, V469, P37, DOI 10.3354/meps09983; MACKAS DL, 1984, LIMNOL OCEANOGR, V29, P451, DOI 10.4319/lo.1984.29.3.0451; Manuel JL, 1997, J PLANKTON RES, V19, P1929, DOI 10.1093/plankt/19.12.1929; Martin AP, 2003, PROG OCEANOGR, V57, P125, DOI 10.1016/S0079-6611(03)00085-5; Menge BA, 2009, ECOL MONOGR, V79, P379, DOI 10.1890/08-2086.1; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Miller SH, 2013, MAR ECOL PROG SER, V476, P301, DOI 10.3354/meps10150; Oksanen J., 2008, COMMUNITY ECOLOGY PA, V190, P254, DOI 10.4135/9781412971874.n145; Okubo A, 1977, SPATIAL PATTERN PLAN, P21; OKUBO A, 2001, DIFFUSION ECOLOGICAL; OLSON RR, 1985, ECOLOGY, V66, P30, DOI 10.2307/1941304; OMORI M, 1982, MAR BIOL, V72, P193, DOI 10.1007/BF00396920; PINEDA J, 1991, SCIENCE, V253, P548, DOI 10.1126/science.253.5019.548; Poulin E, 2002, LIMNOL OCEANOGR, V47, P1248, DOI 10.4319/lo.2002.47.4.1248; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ryland JS, 1977, BIOL BRYOZOANS, P441; SHANKS AL, 1995, J EXP MAR BIOL ECOL, V186, P1, DOI 10.1016/0022-0981(94)00144-3; Shanks AL, 2005, MAR ECOL PROG SER, V302, P1, DOI 10.3354/meps302001; Shanks AL, 2002, J PLANKTON RES, V24, P391, DOI 10.1093/plankt/24.4.391; Shanks AL, 2000, LIMNOL OCEANOGR; Shanks AL, 2009, BIOL BULL-US, V216, P373; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Steele JH, 1976, ECOLOGY SEAS; Tamaki A, 2010, ESTUAR COAST SHELF S, V86, P125, DOI 10.1016/j.ecss.2009.11.005; Tapia FJ, 2007, MAR ECOL PROG SER, V342, P177, DOI 10.3354/meps342177; Team RC, 2012, R LANG ENV STAT COMP; TREMBLAY MJ, 1990, MAR ECOL PROG SER, V61, P1, DOI 10.3354/meps061001; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Vazquez E, 2007, MAR ECOL PROG SER, V338, P119, DOI 10.3354/meps338119; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Young Craig M., 1995, P249; Zar JH, 1999, BIOSTATISTICAL ANAL	52	3	3	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106178	10.1371/journal.pone.0106178	http://dx.doi.org/10.1371/journal.pone.0106178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153075	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200119
J	Morgado, L; Lourenco, S; Londer, YY; Schiffer, M; Pokkuluri, PR; Salgueiro, CA				Morgado, Leonor; Lourenco, Silvia; Londer, Yuri Y.; Schiffer, Marianne; Pokkuluri, P. Raj; Salgueiro, Carlos A.			Dissecting the Functional Role of Key Residues in Triheme Cytochrome PpcA: A Path to Rational Design of G-sulfurreducens Strains with Enhanced Electron Transfer Capabilities	PLOS ONE			English	Article							C-TYPE CYTOCHROME; GEOBACTER-SULFURREDUCENS; THERMODYNAMIC CHARACTERIZATION; C(7); FAMILY; PHYSIOLOGY; REDUCTION; PROTEINS; PROTEOME; CENTERS	PpcA is the most abundant member of a family of five triheme cytochromes c(7) in the bacterium Geobacter sulfurreducens (Gs) and is the most likely carrier of electrons destined for outer surface during respiration on solid metal oxides, a process that requires extracellular electron transfer. This cytochrome has the highest content of lysine residues (24%) among the family, and it was suggested to be involved in e(-)/H+ energy transduction processes. In the present work, we investigated the functional role of lysine residues strategically located in the vicinity of each heme group. Each lysine was replaced by glutamine or glutamic acid to evaluate the effects of a neutral or negatively charged residue in each position. The results showed that replacing Lys(9) (located near heme IV), Lys(18) (near heme I) or Lys(22) (between hemes I and III) has essentially no effect on the redox properties of the heme groups and are probably involved in redox partner recognition. On the other hand, Lys(43) (near heme IV), Lys(52) (between hemes III and IV) and Lys(60) (near heme III) are crucial in the regulation of the functional mechanism of PpcA, namely in the selection of microstates that allow the protein to establish preferential e(-)/H+ transfer pathways. The results showed that the preferred e(-)/H+ transfer pathways are only established when heme III is the last heme to oxidize, a feature reinforced by a higher difference between its reduction potential and that of its predecessor in the order of oxidation. We also showed that K43 and K52 mutants keep the mechanistic features of PpcA by establishing preferential e(-)/H+ transfer pathways at lower reduction potential values than the wild-type protein, a property that can enable rational design of Gs strains with optimized extracellular electron transfer capabilities.	[Morgado, Leonor; Lourenco, Silvia; Salgueiro, Carlos A.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Requimte,CQFB, Caparica, Portugal; [Londer, Yuri Y.; Schiffer, Marianne; Pokkuluri, P. Raj] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	Universidade Nova de Lisboa; United States Department of Energy (DOE); Argonne National Laboratory	Salgueiro, CA (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Requimte,CQFB, Caparica, Portugal.	csalgueiro@fct.unl.pt	Salgueiro, Carlos/A-4522-2013; Morgado, Leonor/D-7387-2013	Salgueiro, Carlos/0000-0003-1136-809X; Morgado, Leonor/0000-0002-3760-5180	Fundacao para a Cieancia e a Tecnologia (FCT), Portugal [PEst-C/EQB/LA0006/2013]; Fundacao para a Cieancia e a Tecnologia [RECI/BBB-BQB/0230/2012]; division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy program [DE-AC02-06CH11357];  [PTDC/BBB-BEP/0753/2012]	Fundacao para a Cieancia e a Tecnologia (FCT), Portugal; Fundacao para a Cieancia e a Tecnologia; division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy program; 	This work was supported by project grant PTDC/BBB-BEP/0753/2012 (to CAS) and the strategic grant PEst-C/EQB/LA0006/2013 (to REQUIMTE Laboratorio Associado) from Fundacao para a Cieancia e a Tecnologia (FCT), Portugal. The NMR spectrometers are part of The National NMR Facility, supported by Fundacao para a Cieancia e a Tecnologia (RECI/BBB-BQB/0230/2012). PRP is partially supported by the division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy program under contract no. DE-AC02-06CH11357 (URL:http://www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-109; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Dantas JM, 2012, J BIOL INORG CHEM, V17, P11, DOI 10.1007/s00775-011-0821-8; Ding YHR, 2006, BBA-PROTEINS PROTEOM, V1764, P1198, DOI 10.1016/j.bbapap.2006.04.017; Ding YHR, 2008, BBA-PROTEINS PROTEOM, V1784, P1935, DOI 10.1016/j.bbapap.2008.06.011; Goddard T., 2007, SPARKY 3 114; Lloyd JR, 2003, BIOCHEM J, V369, P153, DOI 10.1042/BJ20020597; Londer YY, 2002, BBA-BIOENERGETICS, V1554, P202, DOI 10.1016/S0005-2728(02)00244-X; Louro RO, 2004, FEBS LETT, V576, P77, DOI 10.1016/j.febslet.2004.08.066; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Morgado L, 2008, BBA-BIOENERGETICS, V1777, P1157, DOI 10.1016/j.bbabio.2008.04.043; Morgado L, 2007, BIOCHEM BIOPH RES CO, V360, P194, DOI 10.1016/j.bbrc.2007.06.026; Morgado L, 2013, BIOSCIENCE REP, V33, P11, DOI 10.1042/BSR20120086; Morgado L, 2012, BIOINORG CHEM APPL, V2012, DOI 10.1155/2012/298739; Morgado L, 2012, BIOCHEM J, V441, P179, DOI 10.1042/BJ20111103; Morgado L, 2011, BIOMOL NMR ASSIGN, V5, P113, DOI 10.1007/s12104-010-9280-3; Morgado L, 2010, BIOPHYS J, V99, P293, DOI 10.1016/j.bpj.2010.04.017; Moss G P, 1988, Eur J Biochem, V178, P277, DOI 10.1111/j.1432-1033.1988.tb14453.x; Pessanha M, 2004, BIOCHEMISTRY-US, V43, P9909, DOI 10.1021/bi0492859; Pessanha M, 2006, BIOCHEMISTRY-US, V45, P13910, DOI 10.1021/bi061394v; Pokkuluri PR, 2010, BBA-BIOENERGETICS, V1797, P222, DOI 10.1016/j.bbabio.2009.10.007; Pokkuluri PR, 2004, BIOCHEMISTRY-US, V43, P849, DOI 10.1021/bi0301439; SALGUEIRO CA, 1992, FEBS LETT, V314, P155, DOI 10.1016/0014-5793(92)80963-H; SANTOS H, 1984, EUR J BIOCHEM, V141, P283, DOI 10.1111/j.1432-1033.1984.tb08190.x; Shelobolina ES, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-16; Speers AM, 2012, APPL ENVIRON MICROB, V78, P437, DOI 10.1128/AEM.06782-11; Turner DL, 1996, EUR J BIOCHEM, V241, P723, DOI 10.1111/j.1432-1033.1996.00723.x; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105566	10.1371/journal.pone.0105566	http://dx.doi.org/10.1371/journal.pone.0105566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153891	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200061
J	Stormo, C; Kringen, MK; Lyle, R; Olstad, OK; Sachse, D; Berg, JP; Piehler, AP				Stormo, Camilla; Kringen, Marianne K.; Lyle, Robert; Olstad, Ole Kristoffer; Sachse, Daniel; Berg, Jens P.; Piehler, Armin P.			RNA-Sequencing Analysis of HepG2 Cells Treated with Atorvastatin	PLOS ONE			English	Article							RANDOMIZED CONTROLLED TRIAL; STATIN-INDUCED MYOPATHY; GENE-EXPRESSION; DIFFERENTIAL GENE; C2C12 MYOTUBES; SEQ; CHOLESTEROL; SIMVASTATIN; MICROARRAY; QUANTIFICATION	The cholesterol-lowering drug atorvastatin is among the most prescribed drug in the world. Alternative splicing in a number of genes has been reported to be associated with variable statin response. RNA-seq has proven to be a powerful technique for genome-wide splice variant analysis. In the present study, we sought to investigate atorvastatin responsive splice variants in HepG2 cells using RNA-seq analysis to identify novel candidate genes implicated in cholesterol homeostasis and in the statin response. HepG2 cells were treated with 10 mu M atorvastatin for 24 hours. RNA-seq and exon array analyses were performed. The validation of selected genes was performed using Taqman gene expression assays. RNA-seq analysis identified 121 genes and 98 specific splice variants, of which four were minor splice variants to be differentially expressed, 11 were genes with potential changes in their splicing patterns (SYCP3, ZNF195, ZNF674, MYD88, WHSC1, KIF16B, ZNF92, AGER, FCHO1, SLC6A12 and AKAP9), and one was a gene (RAP1GAP) with differential promoter usage. The IL21R transcript was detected to be differentially expressed via RNA-seq and RT-qPCR, but not in the exon array. In conclusion, several novel candidate genes that are affected by atorvastatin treatment were identified in this study. Further studies are needed to determine the biological significance of the atorvastatin responsive splice variants that have been uniquely identified using RNA-seq.	[Stormo, Camilla; Olstad, Ole Kristoffer; Berg, Jens P.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Kringen, Marianne K.] Oslo Univ Hosp, Dept Pharmacol, Oslo, Norway; [Lyle, Robert] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Lyle, Robert] Univ Oslo, Oslo, Norway; [Sachse, Daniel; Berg, Jens P.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Piehler, Armin P.] Furst Med Lab, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Stormo, C (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.	camilla.stormo@medisin.uio.no	Berg, Jens P/G-1455-2012	Berg, Jens P/0000-0003-0157-5888; Sachse, Daniel/0000-0002-3121-1236	Division of Diagnostics and Intervention, Oslo University Hospital, Norway; Blix Family Foundation; Sigrid Wolmar Fund for Heart and Lung Diseases; Research Council of Norway; Southeastern Regional Health Authorities	Division of Diagnostics and Intervention, Oslo University Hospital, Norway; Blix Family Foundation; Sigrid Wolmar Fund for Heart and Lung Diseases; Research Council of Norway(Research Council of Norway); Southeastern Regional Health Authorities	This work was funded by the Division of Diagnostics and Intervention, Oslo University Hospital, Norway and by grants from The Blix Family Foundation and Sigrid Wolmar Fund for Heart and Lung Diseases. The sequencing service was provided by the Norwegian Sequencing Centre (www.sequencing.uio.no) a national technology platform supported by the Research Council of Norway and the Southeastern Regional Health Authorities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerma M, 2008, BLOOD COAGUL FIBRIN, V19, P709, DOI 10.1097/MBC.0b013e32830b2891; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gao Y, 2012, INT J MOL MED, V30, P765, DOI 10.3892/ijmm.2012.1054; Gelissen IC, 2012, PHARMACOGENOMICS, V13, P1223, DOI [10.2217/PGS.12.107, 10.2217/pgs.12.107]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerber R, 2004, ANAL BIOCHEM, V329, P28, DOI 10.1016/j.ab.2004.03.023; Kohro T, 2009, J ATHEROSCLER THROMB, V16, P30, DOI 10.5551/jat.E812; Kulseth MA, 2010, J HUM GENET, V55, P676, DOI 10.1038/jhg.2010.87; Leszczynska A, 2011, ACTA BIOCHIM POL, V58, P635; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Maeda A, 2010, ATHEROSCLEROSIS, V208, P112, DOI 10.1016/j.atherosclerosis.2009.07.033; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Medina MW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003058; Medina MW, 2008, CIRCULATION, V118, P355, DOI 10.1161/CIRCULATIONAHA.108.773267; Medina MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019420; Morikawa S, 2005, J ATHEROSCLER THROMB, V12, P121, DOI 10.5551/jat.12.121; Morikawa Shigeru, 2004, J Atheroscler Thromb, V11, P62; Mullen PJ, 2010, BIOCHEM PHARMACOL, V79, P1200, DOI 10.1016/j.bcp.2009.12.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollack JR, 2009, METHODS MOL BIOL, V556, P1, DOI 10.1007/978-1-60327-192-9_1; R Core Team, 2012, R LANG ENV STAT COMP; Raghavachari N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-28; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Skottheim IB, 2008, EUR J PHARM SCI, V33, P317, DOI 10.1016/j.ejps.2007.12.009; Stormo C, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-29; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2011, BIOMED PHARMACOTHER, V65, P118, DOI 10.1016/j.biopha.2010.12.005; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yu JG, 2009, J ATHEROSCLER THROMB, V16, P21, DOI 10.5551/jat.E551; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124	41	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105836	10.1371/journal.pone.0105836	http://dx.doi.org/10.1371/journal.pone.0105836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153832	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200085
J	Wei, P; Xu, LD; Li, CD; Sun, FD; Chen, L; Tan, TW; Luo, SZ				Wei, Peng; Xu, Lida; Li, Cheng-Dong; Sun, Fu-De; Chen, Long; Tan, Tianwei; Luo, Shi-Zhong			Molecular Dynamic Simulation of the Self-Assembly of DAP12-NKG2C Activating Immunoreceptor Complex	PLOS ONE			English	Article							HELIX-HELIX INTERACTIONS; COARSE-GRAINED MODEL; FORCE-FIELD; MEMBRANE-PROTEINS; IMMUNE RECEPTORS; CELL RECEPTORS; DAP12; ASSOCIATION; NKG2-C; DOMAIN	The DAP12-NKG2C activating immunoreceptor complex is one of the multisubunit transmembrane protein complexes in which ligand-binding receptor chains assemble with dimeric signal-transducing modules through non-covalent associations in their transmembrane (TM) domains. In this work, both coarse grained and atomistic molecular dynamic simulation methods were applied to investigate the self-assembly dynamics of the transmembrane domains of the DAP12-NKG2C activating immunoreceptor complex. Through simulating the dynamics of DAP12-NKG2C TM heterotrimer and point mutations, we demonstrated that a five-polar-residue motif including: 2 Asps and 2 Thrs in DAP12 dimer, as well as 1 Lys in NKG2C TM plays an important role in the assembly structure of the DAP12-NKG2C TM heterotrimer. Furthermore, we provided clear evidences to exclude the possibility that another NKG2C could stably associate with the DAP12-NKG2C heterotrimer. Based on the simulation results, we proposed a revised model for the self-assembly of DAP12-NKG2C activating immunoreceptor complex, along with a plausible explanation for the association of only one NKG2C with a DAP12 dimer.	[Wei, Peng; Xu, Lida; Li, Cheng-Dong; Sun, Fu-De; Chen, Long; Tan, Tianwei; Luo, Shi-Zhong] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China	Beijing University of Chemical Technology	Luo, SZ (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China.	luosz@mail.buct.edu.cn	Chen, Long/AAM-9688-2021; xu, li/GNH-3667-2022		National Basic Research Program of China (973 program) [2013CB910700]; National Natural Science Foundation of China [21002007, 21372026]; Beijing NOVA Programme [Z131102000413010]; CHEMCLOUDCOMPUTING	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing NOVA Programme(Beijing Municipal Science & Technology Commission); CHEMCLOUDCOMPUTING	This work was supported by the National Basic Research Program of China (973 program) (2013CB910700), the National Natural Science Foundation of China (Nos. 21002007, and 21372026), and Beijing NOVA Programme (Z131102000413010). This work is partly supported by CHEMCLOUDCOMPUTING. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Braun R, 2004, BIOPHYS J, V87, P754, DOI 10.1529/biophysj.104.040279; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Cantoni C, 1998, EUR J IMMUNOL, V28, P327, DOI 10.1002/(SICI)1521-4141(199801)28:01<327::AID-IMMU327>3.0.CO;2-O; Cheng X, 2012, BIOPHYS J, V102, pL27, DOI 10.1016/j.bpj.2012.03.002; Chng CP, 2011, PROTEINS, V79, P2203, DOI 10.1002/prot.23044; Cuthbertson JM, 2006, BIOCHEMISTRY-US, V45, P14298, DOI 10.1021/bi0610911; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Drolle E, 2013, BBA-BIOMEMBRANES, V1828, P2247, DOI 10.1016/j.bbamem.2013.05.015; Feng JW, 2006, PLOS BIOL, V4, P768, DOI 10.1371/journal.pbio.0040142; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holdbrook DA, 2013, BBA-BIOMEMBRANES, V1828, P715, DOI 10.1016/j.bbamem.2012.09.002; Houchins JP, 1997, J IMMUNOL, V158, P3603; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lazetic S, 1996, J IMMUNOL, V157, P4741; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2010, PHYS CHEM CHEM PHYS, V12, P2254, DOI 10.1039/b915293h; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nielsen SO, 2004, J PHYS-CONDENS MAT, V16, pR481, DOI 10.1088/0953-8984/16/15/R03; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Psachoulia E, 2008, BIOCHEMISTRY-US, V47, P10503, DOI 10.1021/bi800678t; Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sharma S, 2013, J AM CHEM SOC, V135, P2188, DOI 10.1021/ja308413e; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Sun H, 2013, J PHYS CHEM B, V117, P4789, DOI 10.1021/jp312375g; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Wee CL, 2010, BIOPHYS J, V98, P1558, DOI 10.1016/j.bpj.2009.12.4321; Wei P, 2013, BIOPHYS J, V104, P1435, DOI 10.1016/j.bpj.2013.01.054	40	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105560	10.1371/journal.pone.0105560	http://dx.doi.org/10.1371/journal.pone.0105560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148259	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600057
J	Bevivino, A; Paganin, P; Bacci, G; Florio, A; Pellicer, MS; Papaleo, MC; Mengoni, A; Ledda, L; Fani, R; Benedetti, A; Dalmastri, C				Bevivino, Annamaria; Paganin, Patrizia; Bacci, Giovanni; Florio, Alessandro; Pellicer, Maite Sampedro; Papaleo, Maria Cristiana; Mengoni, Alessio; Ledda, Luigi; Fani, Renato; Benedetti, Anna; Dalmastri, Claudia			Soil Bacterial Community Response to Differences in Agricultural Management along with Seasonal Changes in a Mediterranean Region	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; MICROBIAL BIOMASS; ORGANIC-CARBON; LAND-USE; BIODIVERSITY HOTSPOTS; DIVERSITY; RATIOS; IDENTIFICATION; RHIZOSPHERE	Land-use change is considered likely to be one of main drivers of biodiversity changes in grassland ecosystems. To gain insight into the impact of land use on the underlying soil bacterial communities, we aimed at determining the effects of agricultural management, along with seasonal variations, on soil bacterial community in a Mediterranean ecosystem where different land-use and plant cover types led to the creation of a soil and vegetation gradient. A set of soils subjected to different anthropogenic impact in a typical Mediterranean landscape, dominated by Quercus suber L., was examined in spring and autumn: a natural cork-oak forest, a pasture, a managed meadow, and two vineyards (ploughed and grass covered). Land uses affected the chemical and structural composition of the most stabilised fractions of soil organic matter and reduced soil C stocks and labile organic matter at both sampling season. A significant effect of land uses on bacterial community structure as well as an interaction effect between land uses and season was revealed by the EP index. Cluster analysis of culture-dependent DGGE patterns showed a different seasonal distribution of soil bacterial populations with subgroups associated to different land uses, in agreement with culture-independent T-RFLP results. Soils subjected to low human inputs (cork-oak forest and pasture) showed a more stable bacterial community than those with high human input (vineyards and managed meadow). Phylogenetic analysis revealed the predominance of Proteobacteria, Actinobacteria, Bacteroidetes, and Firmicutes phyla with differences in class composition across the site, suggesting that the microbial composition changes in response to land uses. Taken altogether, our data suggest that soil bacterial communities were seasonally distinct and exhibited compositional shifts that tracked with changes in land use and soil management. These findings may contribute to future searches for bacterial bio-indicators of soil health and sustainable productivity.	[Bevivino, Annamaria; Paganin, Patrizia; Pellicer, Maite Sampedro; Dalmastri, Claudia] ENEA Italian Natl Agcy New Technol Energy & Susta, Casaccia Res Ctr, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy; [Bacci, Giovanni; Florio, Alessandro; Benedetti, Anna] Consiglio Ric & Sperimentaz Agr, Res Ctr Soil Plant Syst, Rome, Italy; [Bacci, Giovanni; Papaleo, Maria Cristiana; Mengoni, Alessio; Fani, Renato] Univ Florence, Dept Biol, Lab Microbial & Mol Evolut, Florence, Italy; [Ledda, Luigi] Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Florence; University of Sassari	Bevivino, A (corresponding author), ENEA Italian Natl Agcy New Technol Energy & Susta, Casaccia Res Ctr, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy.	annamaria.bevivino@enea.it	Ledda, Luigi/AAY-6332-2021; florio, alessandro/I-6066-2019; MARTINEZ, ANTONIO PELLICER/C-4832-2015; Mengoni, Alessio/G-5336-2013; Bevivino, Annamaria/F-4060-2015; Paganin, Patrizia/AAB-9735-2022; Dalmastri, Claudia/AAD-1627-2021; Ledda, Luigi/E-2649-2012	Mengoni, Alessio/0000-0002-1265-8251; Paganin, Patrizia/0000-0002-8993-6651; Ledda, Luigi/0000-0001-5337-5701; Bevivino, Annamaria/0000-0003-4277-7048; Bacci, Giovanni/0000-0003-4406-7816; Florio, Alessandro/0000-0001-6814-8675	MIUR; MIUR (Research Department of Italian Government) [191]	MIUR(Ministry of Education, Universities and Research (MIUR)); MIUR (Research Department of Italian Government)(Ministry of Education, Universities and Research (MIUR))	This research was funded by MIUR (Integrated Special Fund for Research - FISR) in the frame of the Italian National Project SOILSINK "Climate change and agro-forestry systems, impacts on soil carbon sink and microbial diversity'', and partially supported by MIUR (Research Department of Italian Government) in the framework of the Agreement Program ENEA-CNR (Articolo 2, comma 44, Legge 23.12.2009 n. 191 - Legge Finanziaria 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; ANDERSON TH, 1993, SOIL BIOL BIOCHEM, V25, P393, DOI 10.1016/0038-0717(93)90140-7; [Anonymous], 1999, BIOL WILDLIFE MEDITE; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1, DOI [10.1002/mrd.1080010210, DOI 10.1002/MRD.1080010210]; Bacchetta G., 2004, Fitosociologia (Pavia), V41, P29; Bachetta G., 2009, Fitosociologia (Pavia), V46, P3; BADALUCCO L, 1992, BIOL FERT SOILS, V14, P76, DOI 10.1007/BF00336254; Bagella S., 2011, FITOSOCIOLOGIA, V48, P47; Benedetti A, 2005, SOIL QUALITY, P63; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; CIAVATTA C, 1990, J CHROMATOGR, V509, P141, DOI 10.1016/S0021-9673(01)93248-0; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Council of the European Communities, 1992, OFFICIAL J EUROPEAN, V35, P7, DOI DOI 10.1017/CB09780511610851.039; Council of the European Communities, 2001, OFF J EUR COMMUNIT L, V250, P1; Cremonesi L, 1997, BIOTECHNIQUES, V22, P326, DOI 10.2144/97222rr01; DELEIJ FAAM, 1994, MICROB ECOL, V27, P81, DOI 10.1007/BF00170116; DiCello F, 1997, RES MICROBIOL, V148, P237, DOI 10.1016/S0923-2508(97)85244-8; Dilly O, 1998, BIOL FERT SOILS, V27, P374, DOI 10.1007/s003740050446; Doran JW, 1998, SOIL TILL RES, V49, P3, DOI 10.1016/S0167-1987(98)00150-0; Duineveld BM, 2001, APPL ENVIRON MICROB, V67, P172, DOI 10.1128/AEM.67.1.172-178.2001; Edenborn SL, 2007, SOIL BIOL BIOCHEM, V39, P1570, DOI 10.1016/j.soilbio.2007.01.007; El Fantroussi S, 1999, APPL ENVIRON MICROB, V65, P982; Ellis RJ, 2003, APPL ENVIRON MICROB, V69, P3223, DOI 10.1128/AEM.69.6.3223-3230.2003; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Francaviglia R, 2014, AGR ECOSYST ENVIRON, V183, P86, DOI 10.1016/j.agee.2013.10.026; Francaviglia R, 2012, AGR SYST, V112, P48, DOI 10.1016/j.agsy.2012.07.001; Franzluebbers AJ, 2000, SOIL BIOL BIOCHEM, V32, P469, DOI 10.1016/S0038-0717(99)00176-5; Garland J., 1999, P 8 INT S MICROBIAL, P1; Girvan MS, 2005, ENVIRON MICROBIOL, V7, P301, DOI 10.1111/j.1462-2920.2005.00695.x; Goncalves P, 2012, AGROFOREST SYST, V85, P383, DOI 10.1007/s10457-011-9439-7; GRIFONI A, 1995, FEMS MICROBIOL LETT, V127, P85, DOI 10.1111/j.1574-6968.1995.tb07454.x; Haider K., 1992, SOIL BIOCH, V7, P55; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Lagomarsino A, 2011, BIOL FERT SOILS, V47, P283, DOI 10.1007/s00374-010-0530-4; Lai R, 2014, TURK J AGRIC FOR, V38, P62, DOI 10.3906/tar-1303-82; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Mengoni A, 2005, MICROB ECOL, V50, P375, DOI 10.1007/s00248-004-0222-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Oades JM, 1995, DAHL WS ENV, V16, P293; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Pastorelli R, 2011, APPL SOIL ECOL, V49, P46, DOI 10.1016/j.apsoil.2011.07.002; Pinzari F, 1999, J MICROBIOL METH, V36, P21, DOI 10.1016/S0167-7012(99)00007-X; Puddu G, 2012, AGROFOREST SYST, V85, P319, DOI 10.1007/s10457-011-9443-y; Riffaldi R, 1996, BIOL FERT SOILS, V22, P293, DOI 10.1007/BF00334572; Salis L., 2010, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P181; Seddaiu G, 2013, AGR ECOSYST ENVIRON, V167, P1, DOI 10.1016/j.agee.2013.01.002; SEQUI P, 1986, AGROCHIMICA, V30, P175; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Shannon CE., 1949, MATH THEORY COMMUNIC; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Soil Survey Staff, 2006, KEYS SOIL TAXONOMY, V10; Soltani A. A., 2010, Journal of Agricultural Science (Toronto), V2, P106; Springer U KJ, J PLANT NUTR SOIL SC, V64, P1; Stevenson F. J., 1999, Cycles of soil: carbon, nitrogen, phosphorus, sulfur, micronutrients., ppp; STOTZKY G., 1962, Plant and Soil, V16, P1, DOI 10.1007/BF01378154; Tiedje JM, 1999, APPL SOIL ECOL, V13, P109, DOI 10.1016/S0929-1393(99)00026-8; Trabelsi D, 2009, ANN MICROBIOL, V59, P25, DOI 10.1007/BF03175594; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Weon HY, 2008, INT J SYST EVOL MICR, V58, P470, DOI 10.1099/ijs.0.65295-0; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	70	69	73	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105515	10.1371/journal.pone.0105515	http://dx.doi.org/10.1371/journal.pone.0105515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144665	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100077
J	Cai, HY; Jiang, HL; Krumholz, LR; Yang, Z				Cai, Haiyuan; Jiang, Helong; Krumholz, Lee R.; Yang, Zhen			Bacterial Community Composition of Size-Fractioned Aggregates within the Phycosphere of Cyanobacterial Blooms in a Eutrophic Freshwater Lake	PLOS ONE			English	Article							MICROCYSTIS-AERUGINOSA; HETEROTROPHIC BACTERIA; LEGIONELLA-PNEUMOPHILA; MICROBIAL COMMUNITY; TAIHU LAKE; SP-NOV.; DIVERSITY; DYNAMICS; GENUS; RECLASSIFICATION	Bacterial community composition of different sized aggregates within the Microcystis cyanobacterial phycosphere were determined during summer and fall in Lake Taihu, a eutrophic lake in eastern China. Bloom samples taken in August and September represent healthy bloom biomass, whereas samples from October represent decomposing bloom biomass. To improve our understanding of the complex interior structure in the phycosphere, bloom samples were separated into large (>100 mu m), medium (10-100 mu m) and small (0.2-10 mu m) size aggregates. Species richness and library coverage indicated that pyrosequencing recovered a large bacterial diversity. The community of each size aggregate was highly organized, indicating highly specific conditions within the Microcystis phycosphere. While the communities of medium and small-size aggregates clustered together in August and September samples, large-and medium-size aggregate communities in the October sample were grouped together and distinct from small-size aggregate community. Pronounced changes in the absolute and relative percentages of the dominant genus from the two most important phyla Proteobacteria and Bacteroidetes were observed among the various size aggregates. Bacterial species on large and small-size aggregates likely have the ability to degrade high and low molecular weight compounds, respectively. Thus, there exists a spatial differentiation of bacterial taxa within the phycosphere, possibly operating in sequence and synergy to catalyze the turnover of complex organic matters.	[Cai, Haiyuan; Jiang, Helong; Yang, Zhen] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Krumholz, Lee R.] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; University of Oklahoma System; University of Oklahoma - Norman	Jiang, HL (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	hljiang@niglas.ac.cn	Cai, Haiyuan/ABJ-7799-2022; Jiang, Helong/H-2709-2015	Jiang, He-Long/0000-0001-5528-423X; Cai, Haiyuan/0000-0003-4105-2790	National Natural Science Foundation of China [31100021, 51079139]; Innovation program of the Chinese Academy of Science [KZCX2-EW-314]; Natural Science Foundation of Jiangsu Province of China [Bk2011875]; 135 project of Nanjing Institute of Geography and Limnology, CAS [NIGLAS2012135008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation program of the Chinese Academy of Science(Knowledge Innovation Program of the Chinese Academy of Sciences); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); 135 project of Nanjing Institute of Geography and Limnology, CAS	National Natural Science Foundation of China (31100021 and 51079139), Innovation program of the Chinese Academy of Science (KZCX2-EW-314), Natural Science Foundation of Jiangsu Province of China (Bk2011875), and the 135 project of Nanjing Institute of Geography and Limnology, CAS (No. NIGLAS2012135008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach LA, 2001, INT J SYST EVOL MICR, V51, P527, DOI 10.1099/00207713-51-2-527; Asai R, 2001, ANAL LETT, V34, P2521, DOI 10.1081/AL-100107533; BERENDT RF, 1981, INFECT IMMUN, V32, P690, DOI 10.1128/IAI.32.2.690-692.1981; Berg KA, 2011, J WATER HEALTH, V9, P670, DOI 10.2166/wh.2011.206; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; Brune A, 2002, INT J SYST EVOL MICR, V52, P441, DOI 10.1099/00207713-52-2-441; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Cai HY, 2010, APPL ENVIRON MICROB, V76, P2955, DOI 10.1128/AEM.02868-09; CAIOLA MG, 1984, J PHYCOL, V20, P471, DOI 10.1111/j.0022-3646.1984.00471.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carey CC, 2012, WATER RES, V46, P1394, DOI 10.1016/j.watres.2011.12.016; Chin KJ, 2002, APPL ENVIRON MICROB, V68, P2089, DOI 10.1128/AEM.68.4.2089-2092.2002; Coman C, 2011, ANTON LEEUW INT J G, V99, P271, DOI 10.1007/s10482-010-9486-5; Davidov Y, 2004, INT J SYST EVOL MICR, V54, P1439, DOI 10.1099/ijs.0.02978-0; Detkova E N, 2009, Mikrobiologiia, V78, P310; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Eiler A, 2006, FRESHWATER BIOL, V51, P298, DOI 10.1111/j.1365-2427.2005.01493.x; Gallego V, 2005, INT J SYST EVOL MICR, V55, P281, DOI 10.1099/ijs.0.63319-0; GOVORUKHINA NI, 1991, INT J SYST BACTERIOL, V41, P158, DOI 10.1099/00207713-41-1-158; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Havens KE, 2007, CYANOBACTERIAL HARMF, V619, P675; Holt J., 1994, BERGEYS MANUAL DETER; Jasti S, 2005, APPL ENVIRON MICROB, V71, P3483, DOI 10.1128/AEM.71.7.3483-3494.2005; JENKINS O, 1987, INT J SYST BACTERIOL, V37, P446, DOI 10.1099/00207713-37-4-446; Jin X., 1990, STANDARD METHODS OBS; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Li HB, 2011, WATER RES, V45, P1702, DOI 10.1016/j.watres.2010.11.011; Madigan M.T., 2006, BROCK BIOL MICROORGA; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nelson CE, 2012, ENVIRON MICROBIOL, V14, P1500, DOI 10.1111/j.1462-2920.2012.02738.x; Oliver R. L., 2000, ECOLOGY CYANOBACTERI, P149, DOI [10.1007/0-306-46855-7_6, DOI 10.1007/0-306-46855-7_6]; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; Pope PB, 2008, FEMS MICROBIOL ECOL, V64, P9, DOI 10.1111/j.1574-6941.2008.00448.x; Qu FS, 2012, WATER RES, V46, P1490, DOI 10.1016/j.watres.2011.11.051; Riemann L, 2001, MICROB ECOL, V42, P274, DOI 10.1007/s00248-001-0018-8; Salcher MM, 2011, ISME J, V5, P1242, DOI 10.1038/ismej.2011.8; Sapp M, 2007, MICROB ECOL, V53, P683, DOI 10.1007/s00248-006-9162-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen H, 2011, FRESHWATER BIOL, V56, P1065, DOI 10.1111/j.1365-2427.2010.02551.x; Shi LM, 2012, ENV MICROBIOL REP, V4, P669, DOI 10.1111/1758-2229.12001; TISON DL, 1980, APPL ENVIRON MICROB, V39, P456, DOI 10.1128/AEM.39.2.456-459.1980; Turner AM, 2010, ECOL APPL, V20, P2089, DOI 10.1890/10-0208.1; Wang HJ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006864; Wang XY, 2013, WATER RES, V47, P5659, DOI 10.1016/j.watres.2013.06.040; Wiegand C, 2005, TOXICOL APPL PHARM, V203, P201, DOI 10.1016/j.taap.2004.11.002; Worm J, 1998, AQUAT MICROB ECOL, V14, P19, DOI 10.3354/ame014019; Wu QL, 2007, ENVIRON MICROBIOL, V9, P2765, DOI 10.1111/j.1462-2920.2007.01388.x; Xing P, 2011, ISME J, V5, P792, DOI 10.1038/ismej.2010.176; Xu HC, 2013, WATER RES, V47, P2005, DOI 10.1016/j.watres.2013.01.019	53	44	50	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e102879	10.1371/journal.pone.0102879	http://dx.doi.org/10.1371/journal.pone.0102879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144467	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100005
J	Lindenberg, KS; Weydt, P; Muller, HP; Bornstedt, A; Ludolph, AC; Landwehrmeyer, GB; Rottbauer, W; Kassubek, J; Rasche, V				Lindenberg, Katrin S.; Weydt, Patrick; Mueller, Hans-Peter; Bornstedt, Axel; Ludolph, Albert C.; Landwehrmeyer, G. Bernhard; Rottbauer, Wolfgang; Kassubek, Jan; Rasche, Volker			Two-Point Magnitude MRI for Rapid Mapping of Brown Adipose Tissue and Its Application to the R6/2 Mouse Model of Huntington Disease	PLOS ONE			English	Article							TRANSGENIC MOUSE; ADULT HUMANS; WATER; FAT; MICE; PROTON; NMR; IDENTIFICATION; PGC-1-ALPHA	The recent discovery of active brown fat in human adults has led to renewed interest in the role of this key metabolic tissue. This is particularly true for neurodegenerative conditions like Huntington disease (HD), an adult-onset heritable disorder with a prominent energy deficit phenotype. Current methods for imaging brown adipose tissue (BAT) are in limited use because they are equipment-wise demanding and often prohibitively expensive. This prompted us to explore how a standard MRI set-up can be modified to visualize BAT in situ by taking advantage of its characteristic fat/water content ratio to differentiate it from surrounding white fat. We present a modified MRI protocol for use on an 11.7 T small animal MRI scanner to visualize and quantify BAT in wild-type and disease model laboratory mice. In this application study using the R6/2 transgenic mouse model of HD we demonstrate a significantly reduced BAT volume in HD mice vs. matched controls (n = 5 per group). This finding provides a plausible structural explanation for the previously described temperature phenotype of HD mice and underscores the significance of peripheral tissue pathology for the HD phenotype. On a more general level, the results demonstrate the feasibility of MR-based BAT imaging in rodents and open the path towards transferring this imaging approach to human patients. Future studies are needed to determine if this method can be used to track disease progression in HD and other disease entities associated with BAT abnormalities, including metabolic conditions such as obesity, cachexia, and diabetes.	[Lindenberg, Katrin S.; Weydt, Patrick; Mueller, Hans-Peter; Ludolph, Albert C.; Landwehrmeyer, G. Bernhard; Kassubek, Jan] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Bornstedt, Axel; Rottbauer, Wolfgang; Rasche, Volker] Univ Ulm, Dept Internal Med 2, D-89069 Ulm, Germany; [Rasche, Volker] Univ Ulm, Core Facil Small Anim Imaging, D-89069 Ulm, Germany	Ulm University; Ulm University; Ulm University	Rasche, V (corresponding author), Univ Ulm, Dept Internal Med 2, Robert Koch Str 8, D-89069 Ulm, Germany.	volker.rasche@uni-ulm.de	Rasche, Volker/P-6523-2016; Kassubek, Jan/GPX-0910-2022; Weydt, Patrick/F-5114-2015; Kassubek, Jan/F-2774-2015; Landwehrmeyer, Georg Bernhard/AHB-4443-2022; Kassubek, Jan/O-1740-2019	Rasche, Volker/0000-0001-8844-3583; Kassubek, Jan/0000-0002-7106-9270; Weydt, Patrick/0000-0003-2344-5662; Kassubek, Jan/0000-0002-7106-9270; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Kassubek, Jan/0000-0002-7106-9270	European Huntington's Disease Network (EHDN) [414]	European Huntington's Disease Network (EHDN)	Funding provided by European Huntington's Disease Network (EHDN) seed fund 414, http://www.eurohd.net/html/network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauwens M, 2014, EUR J NUCL MED MOL I, V41, P776, DOI 10.1007/s00259-013-2611-8; Bley TA, 2010, J MAGN RESON IMAGING, V31, P4, DOI 10.1002/jmri.21895; Branca RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074206; Branca RT, 2011, MAGN RESON MED, V65, P313, DOI 10.1002/mrm.22622; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chen YI, 2012, OBESITY, V20, P1519, DOI 10.1038/oby.2012.22; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Fain JN, 2001, HUM MOL GENET, V10, P145, DOI 10.1093/hmg/10.2.145; GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504; Hamilton G, 2011, J MAGN RESON IMAGING, V34, P468, DOI 10.1002/jmri.22623; Ho DJ, 2010, EXP NEUROL, V225, P74, DOI 10.1016/j.expneurol.2010.05.006; Hu HH, 2013, NMR BIOMED, V26, P1609, DOI 10.1002/nbm.3025; Hu HCH, 2013, J MAGN RESON IMAGING, V38, P885, DOI 10.1002/jmri.24053; Hu HH, 2010, J MAGN RESON IMAGING, V31, P1195, DOI 10.1002/jmri.22162; Hu HH, 2012, MAGN RESON MED, V68, P378, DOI 10.1002/mrm.24369; Jahnke W, 2004, CELL MOL LIFE SCI, V61, P580, DOI 10.1007/s00018-003-3382-3; Johri A, 2012, HUM MOL GENET, V21, P1124, DOI 10.1093/hmg/ddr541; Khanna A, 2012, MAGN RESON MED, V68, P1285, DOI 10.1002/mrm.24118; Lee P, 2013, ENDOCR REV, V34, P413, DOI 10.1210/er.2012-1081; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lindauer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067783; Lunati E, 1999, J LIPID RES, V40, P1395; Ma JF, 2008, J MAGN RESON IMAGING, V28, P543, DOI 10.1002/jmri.21492; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marion D, 2013, MOL CELL PROTEOMICS, V12, P3006, DOI 10.1074/mcp.O113.030239; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Rasmussen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077907; Rona-Voros K, 2010, CURR DRUG TARGETS, V11, P1262, DOI 10.2174/1389450111007011262; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wijers SLJ, 2010, OBESITY, V18, P1092, DOI 10.1038/oby.2010.74; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	42	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105556	10.1371/journal.pone.0105556	http://dx.doi.org/10.1371/journal.pone.0105556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144457	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100085
J	Yao, LB; Li, CH; Ge, XL; Wang, HD; Xu, KS; Zhang, AQ; Dong, JH				Yao, Libin; Li, Chonghui; Ge, Xinlan; Wang, Hongdong; Xu, Kesen; Zhang, Aiqun; Dong, Jiahong			Establishment of a Rat Model of Portal Vein Ligation Combined with In Situ Splitting	PLOS ONE			English	Article							POSTOPERATIVE LIVER-FAILURE; MAJOR HEPATECTOMY; HEPATOCELLULAR-CARCINOMA; HEPATIC RESECTION; ALPPS APPROACH; EMBOLIZATION; REGENERATION; RESECTABILITY; HYPERTROPHY; INCREASE	Background: Portal vein ligation (PVL) combined with in situ splitting (ISS) has been shown to induce remarkable liver regeneration in patients. The purpose of this study was to establish a model of PVL+ISS in rats for exploring the possible mechanisms of liver regeneration using these techniques. Materials and Methods: Rats were randomly assigned to three experimental groups: selective PVL, selective PVL+ISS and sham operation. The hepatic regeneration rate (HRR), Ki-67, liver biochemical determinations and histopathology were assessed at 24, 48, and 72 h and 7 days after the operation. The microcirculation of the median lobes before and after ISS was examined by laser speckle contrast imaging. Meanwhile, cytokines such as TNF-alpha, IL-6, HGF and HSP70 in regenerating liver lobes at 24 h was investigated by RT-PCR and ELISA. Results: The HRR of PVL+ISS was much higher than that of the PVL at 72 h and 7 days after surgery (p<0.01). The expression of Ki-67 in hepatocytes in the regenerating liver lobe was stronger in the PVL+ISS group than in the PVL group at 48 and 72 h (p<0.01). There was a significant reduction in microcirculation blood perfusion of the left median lobe before and after ISS. Liver biochemical determinations and histopathology demonstrated more severe hepatocyte injury in the PVL+ISS group. Both the mRNA levels of TNF-alpha and IL-6 and the protein levels of TNF-alpha, IL-6 and HGF in regenerating liver lobes were higher in the PVL+ISS than the PVL alone. Conclusions: The higher HRR in the PVL+ISS compared with the PVL confirmed that we had successfully established a PVL+ISS model in rats. The possible mechanisms included the reduced microcirculation blood perfusion of the left median lobe and up-regulation of cytokines in the regenerating lobes after ISS.	[Yao, Libin; Wang, Hongdong; Xu, Kesen; Dong, Jiahong] Shandong Univ, Qilu Hosp, Dept Hepatobiliary Surg, Jinan 250100, Shandong, Peoples R China; [Li, Chonghui; Ge, Xinlan; Zhang, Aiqun; Dong, Jiahong] Chinese Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Beijing, Peoples R China	Shandong University; Chinese People's Liberation Army General Hospital	Dong, JH (corresponding author), Shandong Univ, Qilu Hosp, Dept Hepatobiliary Surg, Jinan 250100, Shandong, Peoples R China.	dongjh301@163.com		Yao, Libin/0000-0001-8274-2857	National Key Technology R&D Program of China [2012BAI06B01]; National Natural Science Foundation of China [81271738]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Technology R&D Program of China (2012BAI06B01) and the Project of the National Natural Science Foundation of China (81271738). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2010, J SURG ONCOL, V102, P960, DOI 10.1002/jso.21654; Abulkhir A, 2008, ANN SURG, V247, P49, DOI 10.1097/SLA.0b013e31815f6e5b; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; de Santibanes E, 2012, ANN SURG, V255, P415, DOI 10.1097/SLA.0b013e318248577d; Fujiyoshi M, 2011, J HEPATO-BIL-PAN SCI, V18, P13, DOI 10.1007/s00534-010-0304-2; Jaeck D, 2004, ANN SURG, V240, P1037, DOI 10.1097/01.sla.0000145965.86383.89; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kishi Y, 2009, T M AM SURG ASS, V127, P171; Liu H, 2009, AM J SURG, V197, P686, DOI [10.1016/j.amjsurg.2008.04.006, 10.1016/j.amjsurg.2008.04.022]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado MA, 2013, ANN SURG ONCOL, V20, P1491, DOI 10.1245/s10434-013-2920-y; MAKUUCHI M, 1990, SURGERY, V107, P521; McGuire PG, 2010, J SURG RES, V164, pE201, DOI 10.1016/j.jss.2010.07.059; Neumann UP, 2013, BRIT J SURG, V100, P310, DOI 10.1002/bjs.9050; Pahlavan PS, 2006, J SURG RES, V134, P238, DOI 10.1016/j.jss.2005.12.011; Ribero D, 2007, BRIT J SURG, V94, P1386, DOI 10.1002/bjs.5836; Ribero D, 2008, ANN SURG ONCOL, V15, P986, DOI 10.1245/s10434-007-9731-y; Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5; Seyama Y, 2007, WORLD J GASTROENTERO, V13, P1505, DOI 10.3748/wjg.v13.i10.1505; Shirabe K, 1999, J AM COLL SURGEONS, V188, P304, DOI 10.1016/S1072-7515(98)00301-9; Sturesson C, 2013, MICROVASC RES, V87, P34, DOI 10.1016/j.mvr.2013.01.004; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tschuor C, 2013, EJSO-EUR J SURG ONC, V39, P1230, DOI 10.1016/j.ejso.2013.08.009; Vetelainen R, 2006, J VASC INTERV RADIOL, V17, P1181, DOI 10.1097/01.RVI.0000228460.48294.2E	24	29	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105511	10.1371/journal.pone.0105511	http://dx.doi.org/10.1371/journal.pone.0105511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144490	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100075
J	Coty, D; Aria, C; Garrouste, R; Wils, P; Legendre, F; Nel, A				Coty, David; Aria, Cedric; Garrouste, Romain; Wils, Patricia; Legendre, Frederic; Nel, Andre			The First Ant-Termite Syninclusion in Amber with CT-Scan Analysis of Taphonomy	PLOS ONE			English	Article							HYMENOPTERA; FORMICIDAE; PREDATION; CHIAPAS; INCLUSIONS; SIMOJOVEL; ISOPTERA; RECORD; WORLD; NESTS	We describe here a co-occurrence (i.e. a syninclusion) of ants and termites in a piece of Mexican amber (Totolapa deposit, Chiapas), whose importance is two-fold. First, this finding suggests at least a middle Miocene antiquity for the modern, though poorly documented, relationship between Azteca ants and Nasutitermes termites. Second, the presence of a Neivamyrmex army ant documents an in situ raiding behaviour of the same age and within the same community, confirmed by the fact that the army ant is holding one of the termite worker between its mandibles and by the presence of a termite with bitten abdomen. In addition, we present how CT-scan imaging can be an efficient tool to describe the topology of resin flows within amber pieces, and to point out the different states of preservation of the embedded insects. This can help achieving a better understanding of taphonomical processes, and tests ethological and ecological hypotheses in such complex syninclusions.	[Coty, David; Garrouste, Romain; Legendre, Frederic; Nel, Andre] UPMC, Museum Natl Hist Nat, Inst Systemat, ISYEB,CNRS,EPHE,UMR 7205, Paris, France; [Aria, Cedric] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada; [Aria, Cedric] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Wils, Patricia] Museum Natl Hist Nat, CNRS, UMS 2700, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Royal Ontario Museum; University of Toronto; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Coty, D (corresponding author), UPMC, Museum Natl Hist Nat, Inst Systemat, ISYEB,CNRS,EPHE,UMR 7205, Paris, France.	coty.david@gmail.com	Legendre, Frederic/B-5101-2013; Aria, Cédric/J-4449-2019; GARROUSTE, Romain/AAK-3692-2021	Legendre, Frederic/0000-0001-5900-8048; Aria, Cédric/0000-0002-0567-1730; GARROUSTE, Romain/0000-0002-0880-5781	French ISYEB; UPMC; EPHE; Spanish Ministry of Economy and Competitiveness [CGL2011-23948/BTE];  [UMR 7205 CNRS]	French ISYEB; UPMC; EPHE; Spanish Ministry of Economy and Competitiveness(Spanish Government); 	This study is supported by the French ISYEB, UMR 7205 CNRS, UPMC and EPHE, and the Spanish Ministry of Economy and Competitiveness project CGL2011-23948/BTE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P.A., 1991, Topics in Geobiology, V9, P25; Allison P.A., 1991, P120; Bignell DE, 2010, BIOL TERMITES MODERN, P576; Bolton Barry, 1994, P1; Boucot A.J., 2010, FOSSIL BEHAV COMPEND, P391; Brady SG, 2003, P NATL ACAD SCI USA, V100, P6575, DOI 10.1073/pnas.1137809100; Castaneda-Posadas C, 2007, AM J BOT, V94, P1821, DOI 10.3732/ajb.94.11.1821; CORNELIUS ML, 1995, SOCIOBIOLOGY, V26, P291; Perrilliat MD, 2010, J S AM EARTH SCI, V30, P111, DOI 10.1016/j.jsames.2010.04.005; Deligne J., 1981, P1; Duran-Ruiz C, 2013, CAN J EARTH SCI, V50, P495, DOI 10.1139/cjes-2012-0166; Ferrusquia-Villafranca I, 2006, J VERTEBR PALEONTOL, V26, P989, DOI 10.1671/0272-4634(2006)26[989:TFPMRO]2.0.CO;2; Frost SH, 1974, CENOZOIC REEF BIOFAC, P1; Goncalves TT, 2005, SOCIOBIOLOGY, V46, P1; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA, P302; GRAY B, 1974, INSECT SOC, V21, P289, DOI 10.1007/BF02226920; Grimaldi D, 2000, ULTR, P77; Grimaldi David, 2005, pi; Henderickx H, 2006, ZOOTAXA, P41, DOI 10.11646/zootaxa.1305.1.4; HENWOOD A, 1992, Palaios, V7, P203, DOI 10.2307/3514931; Henwood A, 1992, THESIS U CAMBRIDGE, P166; HIGASHI S, 1989, OECOLOGIA, V80, P145, DOI 10.1007/BF00380142; Holldobler B., 1990, pi; Howse P.E., 1984, P151; JAFFE K, 1995, ANN ENTOMOL SOC AM, V88, P328, DOI 10.1093/aesa/88.3.328; Jolivet P, 1986, FOURMIS PLANTES EXEM, P255; Kaspari M, 2001, GLOBAL ECOL BIOGEOGR, V10, P229, DOI 10.1046/j.1466-822X.2001.00214.x; Koteja J, 1989, WROSTEK, V8, P7; Kraemer MMS, 2007, PALAEONTOGR ABT A, V282, P1; Krishna K, 2013, B AM MUS NAT HIST, V377, P2704; Krishna Kumar, 2013, Bulletin of the American Museum of Natural History, V377, P1; Krishna Kumar, 1996, American Museum Novitates, V3176, P1; Krishna K, 2009, AM MUS NOVIT, P1, DOI 10.1206/633.1; Lak M, 2008, MICROSC MICROANAL, V14, P251, DOI 10.1017/S1431927608080264; LAMBERT JB, 1989, ADV CHEM SER, P381; LaPolla JS, 2013, ANNU REV ENTOMOL, V58, P609, DOI 10.1146/annurev-ento-120710-100600; LaPolla JS, 2002, INSECT SOC, V49, P251, DOI 10.1007/s00040-002-8310-2; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; Le Breton J, 2007, J APPL ENTOMOL, V131, P740, DOI 10.1111/j.1439-0418.2007.01221.x; Leponce M, 1999, INSECT SOC, V46, P126, DOI 10.1007/s000400050122; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; MARTIUS C, 1994, PEDOBIOLOGIA, V38, P407; Mierzejewski P, 1978, PRACE MUZEUM ZEIMI, V28, P81; Nel Andre, 1997, Memoires du Museum National d'Histoire Naturelle, V173, P305; Penney D, 2007, ZOOTAXA, P47; Penney D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047651; Perkovsky EE, 2012, PALEONTOL J+, V46, P293, DOI 10.1134/S0031030112030136; Perrichot V, 2008, NATURWISSENSCHAFTEN, V95, P85, DOI 10.1007/s00114-007-0301-8; Poinar G, 2002, BOT J LINN SOC, V139, P125, DOI 10.1046/j.1095-8339.2002.00053.x; Poinar Jr. G.O., 1999, AMBER FOREST; Quinet Y, 2005, J INSECT BEHAV, V18, P1, DOI 10.1007/s10905-005-9343-y; RETTENMEYER CARL W., 1963, UNIV KANSAS SCI BULL, V44, P281; Santos PP, 2010, REV BRAS ENTOMOL, V54, P450, DOI 10.1590/S0085-56262010000300016; SCHNEIRLA T C, 1971, P349; Sennepin A, 1998, ACT COLLOQ INSECT S, V12, P181; Soriano C, 2010, CR PALEVOL, V9, P361, DOI 10.1016/j.crpv.2010.07.014; Souza JLP, 2008, SOCIOBIOLOGY, V52, P399; Sutton M. D., 2014, TECHNIQUES VIRTUAL P; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; Vega Francisco J., 2009, Bulletin of the Mizunami Fossil Museum, V35, P51; Weitschat W, 1998, ATLAS PFLANZEN TIERE, P256; WHEELER WILLIAM MORTON, 1936, PROC AMER ACAD ARTS AND SCI, V71, P159, DOI 10.2307/20023221; Wheeler WM, 1910, COLUMBIA U BIOL SERI, V9, p[xxvi, 663]; WILSON E O, 1985, Psyche (Cambridge), V92, P11, DOI 10.1155/1985/63693; WILSON E.O., 1971, INSECT SOC, P562	66	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104410	10.1371/journal.pone.0104410	http://dx.doi.org/10.1371/journal.pone.0104410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140873	gold, Green Submitted, Green Published			2022-12-25	WOS:000342687200021
J	de Wouters, T; Ledue, F; Nepelska, M; Dore, J; Blottiere, HM; Lapaque, N				de Wouters, Tomas; Ledue, Florence; Nepelska, Malgorzata; Dore, Joel; Blottiere, Herve M.; Lapaque, Nicolas			A Robust and Adaptable High Throughput Screening Method to Study Host-Microbiota Interactions in the Human Intestine	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; METAGENOMICS	The intestinal microbiota has many beneficial roles for its host. However, the precise mechanisms developed by the microbiota to influence the host intestinal cell responses are only partially known. The complexity of the ecosystem and our inability to culture most of these micro-organisms have led to the development of molecular approaches such as functional metagenomics, i.e. the heterologous expression of a metagenome in order to identify functions. This elegant strategy coupled to high throughput screening allowed to identify novel enzymes from different ecosystems where culture methods have not yet been adapted to isolate the candidate microorganisms. We have proposed to use this functional metagenomic approach in order to model the microbiota's interaction with the host by combining this heterologous expression with intestinal reporter cell lines. The addition of the cellular component to this functional metagenomic approach introduced a second important source of variability resulting in a novel challenge for high throughput screening. First attempts of high throughput screening with various reporter cell-lines showed a high distribution of the response and consequent difficulties to reproduce the response, impairing an easy and clear identification of confirmed hits. In this study, we developed a robust and reproducible methodology to combine these two biological systems for high throughput application. We optimized experimental setups and completed them by appropriate statistical analysis tools allowing the use this innovative approach in a high throughput manner and on a broad range of reporter assays. We herewith present a methodology allowing a high throughput screening combining two biological systems. Therefore ideal conditions for homogeneity, sensitivity and reproducibility of both metagenomic clones as well as reporter cell lines have been identified and validated. We believe that this innovative method will allow the identification of new bioactive microbial molecules and, subsequently, will promote understanding of host-microbiota interactions.	[de Wouters, Tomas; Ledue, Florence; Nepelska, Malgorzata; Dore, Joel; Blottiere, Herve M.; Lapaque, Nicolas] INRA, UMR MICALIS 1319, Jouy En Josas, France; [de Wouters, Tomas; Ledue, Florence; Nepelska, Malgorzata; Dore, Joel; Blottiere, Herve M.; Lapaque, Nicolas] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Dore, Joel; Blottiere, Herve M.] INRA, US MetaGenoPoliS 1367, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Blottiere, HM (corresponding author), INRA, UMR MICALIS 1319, Jouy En Josas, France.	herve.blottiere@jouy.inra.fr; nicolas.lapaque@jouy.inra.fr	BLOTTIERE, Hervé M/C-6120-2011; Dore, Joel/ABA-8921-2020; Lapaque, Nicolas/AAB-4530-2021	BLOTTIERE, Hervé M/0000-0002-8390-0607; Lapaque, Nicolas/0000-0003-0824-0108	European Marie-Curie Initial Training Network Cross-Talk [215553]; ANR blanc MicroObes; ANR blanc FunMetaGen; EU MetaHit (Metagenomics of the Human Intestinal Tract) project [HEALTH-F4-2007-201052]	European Marie-Curie Initial Training Network Cross-Talk; ANR blanc MicroObes(French National Research Agency (ANR)); ANR blanc FunMetaGen(French National Research Agency (ANR)); EU MetaHit (Metagenomics of the Human Intestinal Tract) project	TDW, MN and HMB are members of the European Marie-Curie Initial Training Network Cross-Talk (grant agreement#215553). TDW was supported by the ANR blanc MicroObes. This work was supported by the ANR blanc FunMetaGen, by the EU MetaHit (Metagenomics of the Human Intestinal Tract) project HEALTH-F4-2007-201052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blottiere HM, 2013, CURR OPIN MICROBIOL, V16, P232, DOI 10.1016/j.mib.2013.06.006; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Cecchini DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072766; Esser P, 2010, THERMOSCIENTIFIC NUN; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Geuking MB, 2014, GUT MICROBES, V5; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Gloux K, 2007, APPL ENVIRON MICROB, V73, P3734, DOI 10.1128/AEM.02204-06; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Korecka A, 2013, AM J PHYSIOL-GASTR L, V304, pG1025, DOI 10.1152/ajpgi.00293.2012; Lakhdari O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013092; Lepage P, 2012, GUT; Lundholt BK, 2003, J BIOMOL SCREEN, V8, P566, DOI 10.1177/1087057103256465; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Makarenkov V, 2007, BIOINFORMATICS, V23, P1648, DOI 10.1093/bioinformatics/btm145; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Tukey JW, 1977, EXPLORATORY DATA ANA	26	11	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105598	10.1371/journal.pone.0105598	http://dx.doi.org/10.1371/journal.pone.0105598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141006	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200112
J	Feng, L; Wang, JM; Cao, BR; Zhang, Y; Wu, B; Di, XB; Jiang, W; An, N; Lu, D; Gao, SH; Zhao, YD; Chen, ZL; Mao, YS; Gao, YN; Zhou, DS; Jen, J; Liu, XH; Zhang, YP; Li, X; Zhang, KT; He, J; Cheng, SJ				Feng, Lin; Wang, Jiamei; Cao, Bangrong; Zhang, Yi; Wu, Bo; Di, Xuebing; Jiang, Wei; An, Ning; Lu, Dan; Gao, Suhong; Zhao, Yuda; Chen, Zhaoli; Mao, Yousheng; Gao, Yanning; Zhou, Deshan; Jen, Jin; Liu, Xiaohong; Zhang, Yunping; Li, Xia; Zhang, Kaitai; He, Jie; Cheng, Shujun			Gene Expression Profiling in Human Lung Development: An Abundant Resource for Lung Adenocarcinoma Prognosis	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; COLORECTAL-CANCER; PREDICT SURVIVAL; EMBRYONIC COLON; SIGNATURE; MOUSE; VALIDATION; PROLIFERATION; PERSPECTIVE	A tumor can be viewed as a special "organ" that undergoes aberrant and poorly regulated organogenesis. Progress in cancer prognosis and therapy might be facilitated by re-examining distinctive processes that operate during normal development, to elucidate the intrinsic features of cancer that are significantly obscured by its heterogeneity. The global gene expression signatures of 44 human lung tissues at four development stages from Asian descent and 69 lung adenocarcinoma (ADC) tissue samples from ethnic Chinese patients were profiled using microarrays. All of the genes were classified into 27 distinct groups based on their expression patterns (named as PTN1 to PTN27) during the developmental process. In lung ADC, genes whose expression levels decreased steadily during lung development (genes in PTN1) generally had their expression reactivated, while those with uniformly increasing expression levels (genes in PTN27) had their expression suppressed. The genes in PTN1 contain many n-gene signatures that are of prognostic value for lung ADC. The prognostic relevance of a 12-gene demonstrator for patient survival was characterized in five cohorts of healthy and ADC patients [ADC_CICAMS (n = 69, p = 0.007), ADC_PNAS (n = 125, p = 0.0063), ADC_GSE13213 (n = 117, p = 0.0027), ADC_GSE8894 (n = 62, p = 0.01), and ADC_NCI (n = 282, p = 0.045)] and in four groups of stage I patients [ADC_CICAMS (n = 22, p = 0.017), ADC_PNAS (n = 76, p = 0.018), ADC_GSE13213 (n = 79, p = 0.02), and ADC_qPCR (n = 62, p = 0.006)]. In conclusion, by comparison of gene expression profiles during human lung developmental process and lung ADC progression, we revealed that the genes with a uniformly decreasing expression pattern during lung development are of enormous prognostic value for lung ADC.	[Feng, Lin; Cao, Bangrong; Di, Xuebing; An, Ning; Lu, Dan; Gao, Yanning; Zhang, Kaitai; Cheng, Shujun] Peking Union Med Coll, Canc Hosp & Inst, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Feng, Lin; Cao, Bangrong; Di, Xuebing; An, Ning; Lu, Dan; Zhao, Yuda; Chen, Zhaoli; Mao, Yousheng; Gao, Yanning; Zhang, Kaitai; He, Jie; Cheng, Shujun] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wang, Jiamei; Gao, Suhong; Liu, Xiaohong; Zhang, Yunping] Maternal & Child Hlth Care Hosp Haidian, Dept Obstet & Gynaecol, Beijing, Peoples R China; [Zhang, Yi] Capital Med Univ, Xuanwu Hosp, Dept Thorac Surg, Beijing, Peoples R China; [Wu, Bo; Zhou, Deshan] Capital Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Beijing, Peoples R China; [Jiang, Wei; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Zhao, Yuda; Chen, Zhaoli; Mao, Yousheng; He, Jie] Peking Union Med Coll, Canc Hosp & Inst, Dept Thorac Surg, Beijing 100021, Peoples R China; [Jen, Jin] Mayo Clin, Med Genome Facil, Rochester, MN USA; [Jen, Jin] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University; Capital Medical University; Harbin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Mayo Clinic; Mayo Clinic	Zhang, KT (corresponding author), Peking Union Med Coll, Canc Hosp & Inst, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	zhangkt@cicams.ac.cn; prof.hejie@263.net; chengshj@263.net.cn	, 曹邦荣/AAN-3604-2020; Mao, Yousheng/T-7200-2018	Cao, Bangrong/0000-0002-3865-3563; Mao, Yousheng/0000-0003-1120-241X	National High Technology Research and Development Program of China [2012AA02A502, 2014AA020602]; Capital Citizen Health Project [Z111107067311018]; National Natural Science Foundation of China [81201592]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Capital Citizen Health Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China (2012AA02A502 and 2014AA020602) received by YG and SC, respectively; and the Capital Citizen Health Project (Z111107067311018) received by SC; and the National Natural Science Foundation of China (81201592) received by LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, GLOB CANC FACTS FIG; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Frangogiannis NG, 2012, TRANSL RES, V159, P197, DOI 10.1016/j.trsl.2012.01.023; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; He K, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-41; Hu M, 2005, CANCER RES, V65, P8715, DOI 10.1158/0008-5472.CAN-05-0700; Iwamoto T, 2010, GENOME MED, V2, DOI 10.1186/gm202; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kim SY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-147; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Liu HY, 2006, PLOS MED, V3, P1090, DOI 10.1371/journal.pmed.0030232; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Monzo M, 2008, CELL RES, V18, P823, DOI 10.1038/cr.2008.81; Mosley JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-11; Naxerova K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r108; Peacock CD, 2008, J CLIN ONCOL, V26, P2883, DOI 10.1200/JCO.2007.15.2702; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Silvia S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-200; Starmans MHW, 2008, BRIT J CANCER, V99, P1884, DOI 10.1038/sj.bjc.6604746; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Yi H, 2010, FASEB J, V24, P3341, DOI 10.1096/fj.10-158782	39	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105639	10.1371/journal.pone.0105639	http://dx.doi.org/10.1371/journal.pone.0105639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141350	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200116
J	Hutchins, ED; Markov, GJ; Eckalbar, WL; George, RM; King, JM; Tokuyama, MA; Geiger, LA; Emmert, N; Ammar, MJ; Allen, AN; Siniard, AL; Corneveaux, JJ; Fisher, RE; Wade, J; DeNardo, DF; Rawls, JA; Huentelman, MJ; Wilson-Rawls, J; Kusumi, K				Hutchins, Elizabeth D.; Markov, Glenn J.; Eckalbar, Walter L.; George, Rajani M.; King, Jesse M.; Tokuyama, Minami A.; Geiger, Lauren A.; Emmert, Nataliya; Ammar, Michael J.; Allen, April N.; Siniard, Ashley L.; Corneveaux, Jason J.; Fisher, Rebecca E.; Wade, Juli; DeNardo, Dale F.; Rawls, J. Alan; Huentelman, Matthew J.; Wilson-Rawls, Jeanne; Kusumi, Kenro			Transcriptomic Analysis of Tail Regeneration in the Lizard Anolis carolinensis Reveals Activation of Conserved Vertebrate Developmental and Repair Mechanisms	PLOS ONE			English	Article							SKELETAL-MUSCLE REGENERATION; LOCALIZED GROWTH ZONES; SATELLITE CELLS; GREEN ANOLE; EXPRESSION ANALYSIS; LIMB REGENERATION; SPINAL-CORD; STEM-CELLS; GENE; BIOINFORMATICS	Lizards, which are amniote vertebrates like humans, are able to lose and regenerate a functional tail. Understanding the molecular basis of this process would advance regenerative approaches in amniotes, including humans. We have carried out the first transcriptomic analysis of tail regeneration in a lizard, the green anole Anolis carolinensis, which revealed 326 differentially expressed genes activating multiple developmental and repair mechanisms. Specifically, genes involved in wound response, hormonal regulation, musculoskeletal development, and the Wnt and MAPK/FGF pathways were differentially expressed along the regenerating tail axis. Furthermore, we identified 2 microRNA precursor families, 22 unclassified non-coding RNAs, and 3 novel protein-coding genes significantly enriched in the regenerating tail. However, high levels of progenitor/stem cell markers were not observed in any region of the regenerating tail. Furthermore, we observed multiple tissue-type specific clusters of proliferating cells along the regenerating tail, not localized to the tail tip. These findings predict a different mechanism of regeneration in the lizard than the blastema model described in the salamander and the zebrafish, which are anamniote vertebrates. Thus, lizard tail regrowth involves the activation of conserved developmental and wound response pathways, which are potential targets for regenerative medical therapies.	[Hutchins, Elizabeth D.; Markov, Glenn J.; Eckalbar, Walter L.; George, Rajani M.; King, Jesse M.; Tokuyama, Minami A.; Geiger, Lauren A.; Emmert, Nataliya; Ammar, Michael J.; Fisher, Rebecca E.; DeNardo, Dale F.; Rawls, J. Alan; Wilson-Rawls, Jeanne; Kusumi, Kenro] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Allen, April N.; Siniard, Ashley L.; Corneveaux, Jason J.; Huentelman, Matthew J.; Kusumi, Kenro] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Fisher, Rebecca E.] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ USA; [Wade, Juli] Michigan State Univ, Program Neurosci, Dept Psychol, E Lansing, MI 48824 USA; [Wade, Juli] Michigan State Univ, Program Neurosci, Dept Zool, E Lansing, MI 48824 USA	Arizona State University; Arizona State University-Tempe; Translational Genomics Research Institute; University of Arizona; Michigan State University; Michigan State University	Kusumi, K (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Kenro.Kusumi@asu.edu	George, Rajani Mary/AAM-7256-2020; Kusumi, Kenro/J-2626-2012	George, Rajani Mary/0000-0002-9153-5523; Wilson-Rawls, Jeanne/0000-0002-3704-6956; Kusumi, Kenro/0000-0002-1458-4540; Hutchins, Elizabeth/0000-0003-2543-0798	National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) [R21 RR031305]; National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the National Institutes of Health [R21 AR064935]; Arizona Biomedical Research Commission [1113]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR031305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR064935] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP); National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arizona Biomedical Research Commission; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funding from the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) grant R21 RR031305 (KK, JW-R); National Institute of Arthritis, Musculoskeletal, and Skin Diseases grant R21 AR064935 of the National Institutes of Health (KK); and funding from the Arizona Biomedical Research Commission grant 1113 (KK, REF). Computational analysis was supported by allocations from the Arizona State University Advanced Computing Center (A2C2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; ALIBARDI L, 2010, ADV ANAT EMBRYOL CEL, V207, P1; Allen RE, 1997, METHOD CELL BIOL, V52, P155, DOI 10.1016/S0091-679X(08)60378-7; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anderson DM, 2012, J BIOL CHEM, V287, P35351, DOI 10.1074/jbc.M112.399386; Anderson DM, 2009, DEV DYNAM, V238, P572, DOI 10.1002/dvdy.21873; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; BOOTHBY M, 1981, J BIOL CHEM, V256, P5121; Brown DD, 2005, P NATL ACAD SCI USA, V102, P12455, DOI 10.1073/pnas.0505989102; BUCKBINDER L, 1993, P NATL ACAD SCI USA, V90, P3820, DOI 10.1073/pnas.90.9.3820; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Cairns DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039642; Chen Y, 2006, DEVELOPMENT, V133, P2303, DOI 10.1242/dev.02397; Chodankar R, 2003, J INVEST DERMATOL, V120, P20, DOI 10.1046/j.1523-1747.2003.12008.x; COX PG, 1969, J EXP ZOOL, V171, P127, DOI 10.1002/jez.1401710202; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; DUFFY MT, 1990, J COMP NEUROL, V293, P208, DOI 10.1002/cne.902930205; Eckalbar WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-49; Eckalbar WL, 2012, DEV BIOL, V363, P308, DOI 10.1016/j.ydbio.2011.11.021; Eckalbar WL, 2010, DEV BIOL, V344, P528, DOI 10.1016/j.ydbio.2010.05.385; Fan CM, 2012, WIRES DEV BIOL, V1, P315, DOI 10.1002/wdev.30; FELDMAN JL, 1991, DEV BIOL, V143, P320, DOI 10.1016/0012-1606(91)90083-F; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Fisher RE, 2012, ANAT REC, V295, P1609, DOI 10.1002/ar.22537; Furlow JD, 2006, TRENDS ENDOCRIN MET, V17, P38, DOI 10.1016/j.tem.2006.01.007; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; George RM, 2013, P NATL ACAD SCI USA, V110, P18549, DOI 10.1073/pnas.1311628110; Goldie RG, 1999, CLIN EXP PHARMACOL P, V26, P145, DOI 10.1046/j.1440-1681.1999.03014.x; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUGHES A, 1959, J EMBRYOL EXP MORPH, V7, P281; Hui SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084212; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Koshiba-Takeuchi K, 2009, NATURE, V461, P95, DOI 10.1038/nature08324; Kusumi K, 2013, CURR OPIN GENET DEV, V23, P491, DOI 10.1016/j.gde.2013.02.011; Kusumi K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-554; Lee WS, 1998, CIRC RES, V82, P845; Lees SJ, 2006, AM J PHYSIOL-CELL PH, V290, pC609, DOI 10.1152/ajpcell.00408.2005; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Lovern MB, 2003, J EXP ZOOL PART A, V295A, P206, DOI 10.1002/jez.a.10225; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; McCusker C, 2011, GERONTOLOGY, V57, P565, DOI 10.1159/000323761; Mescher AL, 1996, INT J DEV BIOL, V40, P785; Montuelle SJ, 2008, J EXP ZOOL PART A, V309A, P563, DOI 10.1002/jez.484; Nacu E, 2013, DEVELOPMENT, V140, P513, DOI 10.1242/dev.081752; Panaite PA, 2010, J NEUROSCI RES, V88, P1751, DOI 10.1002/jnr.22344; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Pownall M. E., 2010, C SER DEV BIOL, V1, P1, DOI DOI 10.4199/C00011ED1V01Y201004DEB002; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Ritzman TB, 2012, ANAT REC, V295, P1596, DOI 10.1002/ar.22524; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; Santos-Ruiz L, 2002, DEV DYNAM, V223, P262, DOI 10.1002/dvdy.10055; Shen YJ, 2008, NUCLEIC ACIDS RES, V36, P3150, DOI 10.1093/nar/gkn158; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; SIMPSON SB, 1994, PROG BRAIN RES, V103, P229; Simpson SB, 1965, REGENERATION ANIMALS, P431; Suksaweang S, 2004, DEV BIOL, V266, P109, DOI 10.1016/j.ydbio.2003.10.010; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takahashi Y, 2007, DEV DYNAM, V236, P1484, DOI 10.1002/dvdy.21178; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Tatsumi R, 2006, INT J BIOCHEM CELL B, V38, P1678, DOI 10.1016/j.biocel.2006.04.003; Tollis M, 2014, GENETICA, V142, P59, DOI 10.1007/s10709-013-9754-1; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wade J, 2012, GEN COMP ENDOCR, V176, P456, DOI 10.1016/j.ygcen.2011.12.011; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Wordley C, 2011, MOL ECOL RESOUR, V11, P126, DOI 10.1111/j.1755-0998.2010.02863.x; Wu CH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-434; YABLONKAREUVENI Z, 1987, DEV BIOL, V119, P252, DOI 10.1016/0012-1606(87)90226-0; Yue R, 2012, DEV CELL, V22, P1092, DOI 10.1016/j.devcel.2012.01.025	93	95	98	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105004	10.1371/journal.pone.0105004	http://dx.doi.org/10.1371/journal.pone.0105004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140675	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200046
J	Kim, JY; Jung, WH; Koo, JS				Kim, Ji-Ye; Jung, Woo Hee; Koo, Ja Seung			Expression of Autophagy-Related Proteins According to Androgen Receptor and HER-2 Status in Estrogen Receptor-Negative Breast Cancer	PLOS ONE			English	Article							LIGHT-CHAIN 3A; PROSTATE-CANCER; THIOREDOXIN SYSTEM; PROGNOSTIC-FACTORS; MOLECULAR SUBTYPE; OXIDATIVE STRESS; TUMOR-STROMA; BECLIN-1; PATTERNS; INDUCTION	Purpose: The purpose of this study was to investigate the expression of autophagy-related proteins in relation to androgen receptor (AR) status in estrogen receptor (ER)-negative breast cancers. Methods: We extracted 334 ER-negative breast cancer samples to construct tissue microarrays (TMAs), which were immunohistochemically stained for autophagy-related proteins (beclin-1, LC3A, LC3B, p62) and for AR and HER-2. Results: There were 127 AR-positive cases and 207 AR-negative cases, and 140 HER-2-positive cases and 194 HER-2 negative cases. The AR-negative group was associated with tumoral LC3A expression (P < 0.001), while the AR-positive group was associated with tumoral BNIP3 expression (P < 0.001). Tumoral LC3A was most highly expressed in the AR-negative and HER-2 negative group, while stromal LC3A showed the highest expression in the AR-negative and HER-2-positive group. Tumoral BNIP3 and stromal BNIP3 were highest in the AR-positive and HER-2-negative group. In the AR-positive and HER-2-negative group, stromal p62 positivity was an independent factor that was statistically significant in its association with shorter disease-free survival (DFS) (Hazard ratio: 10.21, 95% CI: 1.130-92.31, P = 0.039). Shorter DFS was associated with tumoral LC3A positivity (Hazard ratio: 10.28, 95% CI: 2.068-51.19, P = 0.004) in the AR-negative and HER-2-positive group. Conclusion: In ER-negative breast cancers, AR status was associated with expression of different types of autophagy-related proteins. Tumoral LC3A was most highly expressed in AR-negative breast cancers, while tumor BNIP3 was highest in AR-positive breast cancers.	[Kim, Ji-Ye; Jung, Woo Hee; Koo, Ja Seung] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Severance Hosp,Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System	Koo, JS (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Severance Hosp,Dept Pathol, Seoul, South Korea.	kjs1976@yuhs.ac		Migliaccio, Antimo/0000-0002-4197-2055; koo, ja seung/0000-0003-4546-4709	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A1002886]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2012R1A1A1002886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P419, DOI 10.1016/j.semcancer.2006.10.001; Banneau G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2626; Barth RJ, 1999, BREAST CANCER RES TR, V57, P291, DOI 10.1023/A:1006260225618; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bennett HL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.50; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Chen YS, 2009, PATHOL ONCOL RES, V15, P487, DOI 10.1007/s12253-008-9143-8; Choi J, 2013, HISTOPATHOLOGY, V62, P275, DOI 10.1111/his.12002; Choi J, 2013, PATHOBIOLOGY, V80, P41, DOI 10.1159/000339513; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Fukuhara T, 2006, HYBRIDOMA, V25, P51, DOI 10.1089/hyb.2006.25.51; Giatromanolaki A, 2010, J CLIN PATHOL, V63, P867, DOI 10.1136/jcp.2010.079525; Giatromanolaki AN, 2011, MODERN PATHOL, V24, P1036, DOI 10.1038/modpathol.2011.63; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Jiang Q, 2012, J UROLOGY, V188, P1361, DOI 10.1016/j.juro.2012.06.004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karpathiou G, 2011, CHEST, V140, P127, DOI 10.1378/chest.10-1831; Koo JS, 2011, TUMOR BIOL, V32, P787, DOI 10.1007/s13277-011-0181-6; KuenenBoumeester V, 1996, EUR J CANCER, V32A, P1560, DOI 10.1016/0959-8049(96)00112-8; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Miracco C, 2007, INT J ONCOL, V30, P429; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Pirtoli L, 2009, AUTOPHAGY, V5, P930, DOI 10.4161/auto.5.7.9227; Riva C, 2005, VIRCHOWS ARCH, V447, P695, DOI 10.1007/s00428-005-0003-6; Roy S, 2010, SEMIN IMMUNOPATHOL, V32, P383, DOI 10.1007/s00281-010-0213-0; Shaida N, 2008, PROSTATE, V68, P336, DOI 10.1002/pros.20707; Shi Y, 2013, MOL ENDOCRINOL, V27, P280, DOI 10.1210/me.2012-1260; Sivridis E, 2011, MELANOMA RES, V21, P188, DOI 10.1097/CMR.0b013e328346612c; Sivridis E, 2010, AM J PATHOL, V176, P2477, DOI 10.2353/ajpath.2010.090049; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spowart JE, 2012, J PATHOL; Tavassoli FA, 2003, IARC WHO CLASSIFICAT; Wan XB, 2010, AUTOPHAGY, V6, P395, DOI 10.4161/auto.6.3.11303; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WILLIAMS ARW, 1990, J PATHOL, V160, P287, DOI 10.1002/path.1711600404; Witkiewicz AK, 2012, CELL CYCLE, V11, P1108, DOI 10.4161/cc.11.6.19530; Witkiewicz AK, 2009, CANCER BIOL THER, V8, P1071, DOI 10.4161/cbt.8.11.8874; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Won KY, 2010, HUM PATHOL, V41, P107, DOI 10.1016/j.humpath.2009.07.006; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	54	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105666	10.1371/journal.pone.0105666	http://dx.doi.org/10.1371/journal.pone.0105666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140630	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200118
J	Kozomara, A; Hunt, S; Ninova, M; Griffiths-Jones, S; Ronshaugen, M				Kozomara, Ana; Hunt, Suzanne; Ninova, Maria; Griffiths-Jones, Sam; Ronshaugen, Matthew			Target Repression Induced by Endogenous microRNAs: Large Differences, Small Effects	PLOS ONE			English	Article							SMALL RNAS; RECOGNITION; EXPRESSION; SIRNAS; MIRNAS; ENCODES; TISSUE; ROLES	MicroRNAs are small RNAs that regulate protein levels. It is commonly assumed that the expression level of a microRNA is directly correlated with its repressive activity - that is, highly expressed microRNAs will repress their target mRNAs more. Here we investigate the quantitative relationship between endogenous microRNA expression and repression for 32 mature microRNAs in Drosophila melanogaster S2 cells. In general, we find that more abundant microRNAs repress their targets to a greater degree. However, the relationship between expression and repression is nonlinear, such that a 10-fold greater microRNA concentration produces only a 10% increase in target repression. The expression/repression relationship is the same for both dominant guide microRNAs and minor mature products (so-called passenger strands/microRNA* sequences). However, we find examples of microRNAs whose cellular concentrations differ by several orders of magnitude, yet induce similar repression of target mRNAs. Likewise, microRNAs with similar expression can have very different repressive abilities. We show that the association of microRNAs with Argonaute proteins does not explain this variation in repression. The observed relationship is consistent with the limiting step in target repression being the association of the microRNA/RISC complex with the target site. These findings argue that modest changes in cellular microRNA concentration will have minor effects on repression of targets.	[Kozomara, Ana; Hunt, Suzanne; Ninova, Maria; Griffiths-Jones, Sam; Ronshaugen, Matthew] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Griffiths-Jones, S (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	sam.griffiths-jones@manchester.ac.uk; matthew.ronshaugen@manchester.ac.uk	Ninova, Maria/AAG-9476-2021; Griffiths-Jones, Sam/H-2998-2014	Ninova, Maria/0000-0001-5051-5502; Griffiths-Jones, Sam/0000-0001-6043-807X; Ronshaugen, Matthew/0000-0001-5326-5924	Biotechnology and Biological Sciences Research Council [BB/G022623/1, BB/H017801/1]; Wellcome Trust; BBSRC [BB/G022623/1, BB/H017801/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council [BB/G022623/1 to AK, SGJ; BB/H017801/1 SH, MR] http://bbsrc.ac.uk/home/home.aspx Wellcome Trust (PhD studentship to MN] http://www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; HE L, 2004, NAT REV GENET, V5, P522; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kadri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029217; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC., 2001, SCIENCE, V294, P858, DOI [DOI 10.1126/SCIENCE.1065062, 10.1126/science.1065062, DOI 10.1126/science.1065062]; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Marco A, 2012, BIOINFORMATICS, V28, P318, DOI 10.1093/bioinformatics/btr686; Marco A, 2010, GENOME BIOL EVOL, V2, P686, DOI 10.1093/gbe/evq053; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051	59	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104286	10.1371/journal.pone.0104286	http://dx.doi.org/10.1371/journal.pone.0104286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141277	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200016
J	Srimani, JK; Yao, G; Neu, J; Tanouchi, Y; Lee, TJ; You, LC				Srimani, Jaydeep K.; Yao, Guang; Neu, John; Tanouchi, Yu; Lee, Tae Jun; You, Lingchong			Linear Population Allocation by Bistable Switches in Response to Transient Stimulation	PLOS ONE			English	Article							GENE-EXPRESSION; SIGNAL-TRANSDUCTION; FEEDBACK; SYSTEMS; PROTEIN; MODULATE; DENSITY; GROWTH; MODEL; ACTS	Many cellular decision processes, including proliferation, differentiation, and phenotypic switching, are controlled by bistable signaling networks. In response to transient or intermediate input signals, these networks allocate a population fraction to each of two distinct states (e.g. OFF and ON). While extensive studies have been carried out to analyze various bistable networks, they are primarily focused on responses of bistable networks to sustained input signals. In this work, we investigate the response characteristics of bistable networks to transient signals, using both theoretical analysis and numerical simulation. We find that bistable systems exhibit a common property: for input signals with short durations, the fraction of switching cells increases linearly with the signal duration, allowing the population to integrate transient signals to tune its response. We propose that this allocation algorithm can be an optimal response strategy for certain cellular decisions in which excessive switching results in lower population fitness.	[Srimani, Jaydeep K.; Neu, John; Tanouchi, Yu; Lee, Tae Jun; You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Yao, Guang] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	Duke University; University of Arizona	You, LC (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	you@duke.edu		, Guang/0000-0003-0167-777X	National Science Foundation [CBET-0953202]; National Institutes of Health [1R01GM098642]; North Carolina Biotech Center [2012-MRG-1102]; DuPont Young Professorship; David and Lucile Packard Fellowship; American Cancer Society [IRG7400l34]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106107, R01GM098642] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Biotech Center; DuPont Young Professorship; David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Science Foundation (LY, CBET-0953202); National Institutes of Health (LY, 1R01GM098642); North Carolina Biotech Center (LY, 2012-MRG-1102); DuPont Young Professorship (LY); David and Lucile Packard Fellowship (LY); American Cancer Society (GY, IRG7400l34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Arvanitis DN, 2010, MOL CELL BIOL, V30, P2508, DOI 10.1128/MCB.01620-09; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Choi MH, 1998, PHYS REV E, V57, P6335, DOI 10.1103/PhysRevE.57.6335; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; CONTOIS DE, 1959, J GEN MICROBIOL, V21, P40, DOI 10.1099/00221287-21-1-40; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913; Diaz, 2011, FRONTIERS MICROBIOLO; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Galan Jorge E., 1999, Science (Washington D C), V284, P1322, DOI 10.1126/science.284.5418.1322; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Greber D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn443; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; JUNG P, 1989, Z PHYS B CON MAT, V76, P521, DOI 10.1007/BF01307904; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Lee TJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000488; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Menke NB, 2010, WOUND REPAIR REGEN, V18, P105, DOI 10.1111/j.1524-475X.2009.00549.x; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Munsky B, 2010, IET SYST BIOL, V4, P356, DOI 10.1049/iet-syb.2010.0013; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; NEVINS JR, 1992, SCIENCE, V258, P424; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Pace V, 2010, CELL STRESS CHAPERON, V15, P13, DOI 10.1007/s12192-009-0118-9; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Saini S, 2010, PLOS PATHOG, V6, DOI [10.1371/annotation/df7e26bc-4c62-43b4-865f-a39274d98ab3, 10.1371/journal.ppat.1001025]; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tanouchi Y, 2012, MOL SYSTEMS BIOL, V8, P1; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; Wong JV, 2011, MOL CELL, V41, P275, DOI 10.1016/j.molcel.2011.01.014; Xu SW, 2012, RHEUMATOLOGY, V51, P2146, DOI 10.1093/rheumatology/kes234; Yao G, 2011, MOL SYSTEMS BIOL, V7, P1; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zeng Q, 2012, MOL PLANT MICROBE IN, V25, P37, DOI 10.1094/MPMI-05-11-0105; ZHOU T, 1990, PHYS REV A, V42, P3161, DOI 10.1103/PhysRevA.42.3161	51	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105408	10.1371/journal.pone.0105408	http://dx.doi.org/10.1371/journal.pone.0105408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141235	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200088
J	Blin, S; Chatelain, FC; Feliciangeli, S; Kang, D; Lesage, F; Bichet, D				Blin, Sandy; Chatelain, Franck C.; Feliciangeli, Sylvain; Kang, Dawon; Lesage, Florian; Bichet, Delphine			Tandem Pore Domain Halothane-inhibited K+ Channel Subunits THIK1 and THIK2 Assemble and Form Active Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNELS; DEAFNESS ASSOCIATED CHANGES; PLASMA-MEMBRANE; FUNCTIONAL EXPRESSION; SUMOYLATION SILENCES; STOICHIOMETRY; NEURONS; BRAIN; CONDUCTANCE; ASSOCIATION	Despite a high level of sequence homology, tandem pore domain halothane-inhibited K+ channel 1 (THIK1) produces background K+ currents, whereas THIK2 is silent. This lack of activity is due to a unique combination of intracellular retention and weak basal activity in the plasma membrane. Here, we designed THIK subunits containing dominant negative mutations (THIK1(DN) and THIK2(DN)). THIK2(DN) mutant inhibits THIK1 currents, whereas THIK1(DN) inhibits an activated form of THIK2 (THIK2-A155P-I158D). In situ proximity ligation assays and Forster/fluorescence resonance energy transfer (FRET) experiments support a physical association between THIK1 and THIK2. Next, we expressed covalent tandems of THIK proteins to obtain expression of pure heterodimers. Td-THIK1-THIK2 (where Td indicates tandem) produces K+ currents of amplitude similar to Td-THIK1-THIK1 but with a noticeable difference in the current kinetics. Unlike Td-THIK2-THIK2 that is mainly detected in the endoplasmic reticulum, Td-THIK1-THIK2 distributes at the plasma membrane, indicating that THIK1 can mask the endoplasmic reticulum retention/retrieval motif of THIK2. Kinetics and unitary conductance of Td-THIK1-THIK2 are intermediate between THIK1 and THIK2. Altogether, these results show that THIK1 and THIK2 form active heteromeric channels, further expanding the known repertoire of K+ channels.	[Blin, Sandy; Chatelain, Franck C.; Feliciangeli, Sylvain; Lesage, Florian; Bichet, Delphine] CNRS, Inst Pharmacol Mol & Cellulaire, LabEx ICST, F-06560 Valbonne, France; [Blin, Sandy; Chatelain, Franck C.; Feliciangeli, Sylvain; Lesage, Florian; Bichet, Delphine] Univ Nice Sophia Antipolis, F-06560 Valbonne, France; [Kang, Dawon] Gyeongsang Natl Univ, Sch Med, Dept Physiol, Jinju 660751, South Korea; [Kang, Dawon] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju 660751, South Korea	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Gyeongsang National University; Gyeongsang National University	Lesage, F (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, LabEx ICST, 660 Route Lucioles, F-06560 Valbonne, France.	lesage@ipmc.cnrs.fr	Lesage, Florian/D-5097-2011; Feliciangeli, Sylvain/Q-1292-2016; Lesage, Florian/P-9780-2019	Lesage, Florian/0000-0002-4406-7106; Feliciangeli, Sylvain/0000-0003-3358-3719; Lesage, Florian/0000-0002-4406-7106; Bichet, Delphine/0000-0002-9601-089X; CHATELAIN, Franck C./0000-0002-8426-8893	Fondation pour la Recherche Medicale (Equipe labellisee FRM); Agence Nationale de la Recherche (Laboratory of Excellence "Ion Channel Science and Therapeutics") [ANR-11-LABX-0015-01]	Fondation pour la Recherche Medicale (Equipe labellisee FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (Laboratory of Excellence "Ion Channel Science and Therapeutics")(French National Research Agency (ANR))	This work was supported by the Fondation pour la Recherche Medicale (Equipe labellisee FRM 2011) and by the Agence Nationale de la Recherche (Laboratory of Excellence "Ion Channel Science and Therapeutics" Grant ANR-11-LABX-0015-01).	Aller MI, 2008, NEUROSCIENCE, V151, P1154, DOI 10.1016/j.neuroscience.2007.12.011; Ashmole I, 2001, PFLUG ARCH EUR J PHY, V442, P828, DOI 10.1007/s004240100620; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Chatelain FC, 2013, J BIOL CHEM, V288, P35081, DOI 10.1074/jbc.M113.503318; Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cui YL, 2007, NEUROSCIENCE, V149, P421, DOI 10.1016/j.neuroscience.2007.05.054; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2007, CELL, V130, P563, DOI 10.1016/j.cell.2007.06.012; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Holt AG, 2006, HEARING RES, V216, P146, DOI 10.1016/j.heares.2006.03.009; Hwang EM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4227; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Kang D, 2014, PFLUG ARCH EUR J PHY, V466, P1289, DOI 10.1007/s00424-013-1358-1; Karpova Tatiana, 2006, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1207s35; Kim D, 2001, BIOCHEM BIOPH RES CO, V284, P923, DOI 10.1006/bbrc.2001.5064; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Liao YJ, 1996, J NEUROSCI, V16, P7137; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Plant LD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003431; Rajan S, 2001, J BIOL CHEM, V276, P7302, DOI 10.1074/jbc.M008985200; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Renigunta V, 2014, PFLUG ARCH EUR J PHY, V466, P1735, DOI 10.1007/s00424-013-1404-z; Salinas M, 1999, J BIOL CHEM, V274, P11751, DOI 10.1074/jbc.274.17.11751; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Theilig F, 2008, CELL PHYSIOL BIOCHEM, V21, P63, DOI 10.1159/000113748; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419; Yeom M, 2005, BIOCHEM BIOPH RES CO, V326, P321, DOI 10.1016/j.bbrc.2004.11.034; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	49	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28202	28212		10.1074/jbc.M114.600437	http://dx.doi.org/10.1074/jbc.M114.600437			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148687	Green Published, hybrid			2022-12-25	WOS:000343765400017
J	Mas, C; Norwood, SJ; Bugarcic, A; Kinna, G; Leneva, N; Kovtun, O; Ghai, R; Yanez, LEO; Davis, JL; Teasdale, RD; Collins, BM				Mas, Caroline; Norwood, Suzanne J.; Bugarcic, Andrea; Kinna, Genevieve; Leneva, Natalya; Kovtun, Oleksiy; Ghai, Rajesh; Yanez, Lorena E. Ona; Davis, Jasmine L.; Teasdale, Rohan D.; Collins, Brett M.			Structural Basis for Different Phosphoinositide Specificities of the PX Domains of Sorting Nexins Regulating G-protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOX-HOMOLOGY DOMAIN; MITOCHONDRIAL INHERITANCE; CRYSTAL-STRUCTURE; RGS; ENDOCYTOSIS; NUCLEAR; BINDING; SYSTEM	Sorting nexins (SNXs) or phox homology (PX) domain containing proteins are central regulators of cell trafficking and signaling. A subfamily of PX domain proteins possesses two unique PX-associated domains, as well as a regulator of G protein-coupled receptor signaling (RGS) domain that attenuates G alpha(s)-coupled G protein-coupled receptor signaling. Here we delineate the structural organization of these RGS-PX proteins, revealing a protein family with a modular architecture that is conserved in all eukaryotes. The one exception to this is mammalian SNX19, which lacks the typical RGS structure but preserves all other domains. The PX domain is a sensor of membrane phosphoinositide lipids and we find that specific sequence alterations in the PX domains of the mammalian RGS-PX proteins, SNX13, SNX14, SNX19, and SNX25, confer differential phosphoinositide binding preferences. Although SNX13 and SNX19 PX domains bind the early endosomal lipid phosphatidylinositol 3-phosphate, SNX14 shows no membrane binding at all. Crystal structures of the SNX19 and SNX14 PX domains reveal key differences, with alterations in SNX14 leading to closure of the binding pocket to prevent phosphoinositide association. Our findings suggest a role for alternative membrane interactions in spatial control of RGS-PX proteins in cell signaling and trafficking.	[Mas, Caroline; Norwood, Suzanne J.; Bugarcic, Andrea; Kinna, Genevieve; Leneva, Natalya; Kovtun, Oleksiy; Ghai, Rajesh; Yanez, Lorena E. Ona; Davis, Jasmine L.; Teasdale, Rohan D.; Collins, Brett M.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Collins, BM (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	b.collins@imb.uq.edu.au	Collins, Brett/J-1563-2014; Bugarcic, Andrea/AAN-8952-2021; Kovtun, Oleksiy/AAE-5397-2019; Bugarcic, Andrea/D-7986-2013; Teasdale, Rohan/AAD-6698-2019; Teasdale, Rohan D/B-2538-2009; Kovtun, Oleksiy/F-7443-2015; Ghai, Rajesh/D-5903-2012	Collins, Brett/0000-0002-6070-3774; Kovtun, Oleksiy/0000-0001-6374-7863; Teasdale, Rohan/0000-0001-7455-5269; Teasdale, Rohan D/0000-0001-7455-5269; Kovtun, Oleksiy/0000-0001-6374-7863; Ghai, Rajesh/0000-0002-0919-0934; Mas, Caroline/0000-0002-7733-6982; Ona Yanez, Lorena E./0000-0001-5958-9057; Leneva, Natalya/0000-0001-8102-9769; Bugarcic, Andrea/0000-0003-2525-2450	ACRF	ACRF	We acknowledge support from the staff and facilities of the University of Queensland Remote Operation Crystallization and x-ray (UQ ROCX) facility and the Australian Synchrotron. We thank Patricia Walden and Jenny Martin for assistance with x-ray diffraction data collection. Microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology established with the support of ACRF.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bin Z, 2004, MOL BIOL CELL, V15, P5538, DOI 10.1091/mbc.E04-06-0446; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Carroll P, 2001, DEV DYNAM, V221, P431, DOI 10.1002/dvdy.1163; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du YS, 2013, BRAIN RES, V1509, P79, DOI 10.1016/j.brainres.2013.03.005; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fisk HA, 1997, J CELL BIOL, V138, P485, DOI 10.1083/jcb.138.3.485; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hao XB, 2011, CELL SIGNAL, V23, P935, DOI 10.1016/j.cellsig.2011.01.022; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098383; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Jean-Baptiste G, 2006, CELL MOL LIFE SCI, V63, P1969, DOI 10.1007/s00018-006-6066-y; Kan A, 2009, ARTHRITIS RHEUM-US, V60, P3314, DOI 10.1002/art.24878; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Koharudin LMI, 2009, J BIOL CHEM, V284, P23697, DOI 10.1074/jbc.M109.008995; Krauss M, 2007, FEBS LETT, V581, P2105, DOI 10.1016/j.febslet.2007.01.089; MCCONNELL SJ, 1992, J CELL BIOL, V118, P385, DOI 10.1083/jcb.118.2.385; MCCONNELL SJ, 1993, SCIENCE, V260, P687, DOI 10.1126/science.8480179; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Suh JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002152; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Xing Y, 2004, J BIOL CHEM, V279, P30662, DOI 10.1074/jbc.M404107200; Xu JX, 2013, J BIOL CHEM, V288, P16598, DOI 10.1074/jbc.M112.449306; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757; Zheng B, 2006, P NATL ACAD SCI USA, V103, P16776, DOI 10.1073/pnas.0607974103; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200	50	36	39	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28554	28568		10.1074/jbc.M114.595959	http://dx.doi.org/10.1074/jbc.M114.595959			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148684	hybrid, Green Published			2022-12-25	WOS:000343765400045
J	Li, T; Pantazes, RJ; Maranas, CD				Li, Tong; Pantazes, Robert J.; Maranas, Costas D.			OptMAVEn - A New Framework for the de novo Design of Antibody Variable Region Models Targeting Specific Antigen Epitopes	PLOS ONE			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; COMPUTATIONAL PROTEIN DESIGN; RECEPTOR-BINDING SITE; NEUTRALIZING ANTIBODIES; AFFINITY MATURATION; STRUCTURAL BASIS; HIV-1 VACCINE; MOLECULES; SEQUENCE; DOCKING	Antibody-based therapeutics provides novel and efficacious treatments for a number of diseases. Traditional experimental approaches for designing therapeutic antibodies rely on raising antibodies against a target antigen in an immunized animal or directed evolution of antibodies with low affinity for the desired antigen. However, these methods remain time consuming, cannot target a specific epitope and do not lead to broad design principles informing other studies. Computational design methods can overcome some of these limitations by using biophysics models to rationally select antibody parts that maximize affinity for a target antigen epitope. This has been addressed to some extend by OptCDR for the design of complementary determining regions. Here, we extend this earlier contribution by addressing the de novo design of a model of the entire antibody variable region against a given antigen epitope while safeguarding for immunogenicity (Optimal Method for Antibody Variable region Engineering, OptMAVEn). OptMAVEn simulates in silico the in vivo steps of antibody generation and evolution, and is capable of capturing the critical structural features responsible for affinity maturation of antibodies. In addition, a humanization procedure was developed and incorporated into OptMAVEn to minimize the potential immunogenicity of the designed antibody models. As case studies, OptMAVEn was applied to design models of neutralizing antibodies targeting influenza hemagglutinin and HIV gp120. For both HA and gp120, novel computational antibody models with numerous interactions with their target epitopes were generated. The observed rates of mutations and types of amino acid changes during in silico affinity maturation are consistent with what has been observed during in vivo affinity maturation. The results demonstrate that OptMAVEn can efficiently generate diverse computational antibody models with both optimized binding affinity to antigens and reduced immunogenicity.	[Li, Tong; Pantazes, Robert J.; Maranas, Costas D.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Maranas, CD (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	costas@psu.edu	Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398; Pantazes, Robert/0000-0002-0994-007X	National Science Foundation [CBET-1133040]; Div Of Chem, Bioeng, Env, & Transp Sys [1133040] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation CBET-1133040 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinandan KR, 2007, J MOL BIOL, V369, P852, DOI 10.1016/j.jmb.2007.02.100; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; BOULIANNE GL, 1984, NATURE, V312, P643, DOI 10.1038/312643a0; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Burkovitz A, 2014, FEBS J, V281, P306, DOI 10.1111/febs.12597; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Ehrenmann Francois, 2011, Cold Spring Harb Protoc, V2011, P726, DOI 10.1101/pdb.prot5635; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gao SH, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-55; Hoess RH, 2001, CHEM REV, V101, P3205, DOI 10.1021/cr000056b; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; ILOG, 2013, ILOG CPLEX 12 4 US M; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jaramillo A, 2005, BIOPHYS J, V88, P156, DOI 10.1529/biophysj.104.042044; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; JESPERS LS, 1994, BIO-TECHNOL, V12, P899, DOI 10.1038/nbt0994-899; Krawczyk K, 2013, PROTEIN ENG DES SEL, V26, P621, DOI 10.1093/protein/gzt043; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lazar GA, 2007, MOL IMMUNOL, V44, P1986, DOI 10.1016/j.molimm.2006.09.029; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P633, DOI 10.1101/pdb.ip85; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P643, DOI 10.1101/pdb.ip86; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; Li T, 2013, PROTEIN PEPT LETT; Li T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092870; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Livesay DR, 2004, PROTEIN ENG DES SEL, V17, P463, DOI 10.1093/protein/gzh058; Miller BR, 2010, PROTEIN ENG DES SEL, V23, P549, DOI 10.1093/protein/gzq028; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Pantazes RJ, 2010, PROTEIN ENG DES SEL, V23, P849, DOI 10.1093/protein/gzq061; Pantazes RJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-168; Parker AS, 2013, J COMPUT BIOL, V20, P152, DOI 10.1089/cmb.2012.0251; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Saraf MC, 2006, BIOPHYS J, V90, P4167, DOI 10.1529/biophysj.105.079277; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Schneider G, 2013, NOVO MOL DESIGN, P480; Sciretti D, 2009, PROTEINS, V74, P176, DOI 10.1002/prot.22145; Sellers BD, 2010, PROTEINS, V78, P2490, DOI 10.1002/prot.22757; Simonelli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055561; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Willis JR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003045; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Yu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033340; Zhang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080636; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	66	42	52	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105954	10.1371/journal.pone.0105954	http://dx.doi.org/10.1371/journal.pone.0105954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153121	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200096
J	Tseng, P; Pushkarsky, I; Di Carlo, D				Tseng, Peter; Pushkarsky, Ivan; Di Carlo, Dino			Metallization and Biopatterning on Ultra-Flexible Substrates via Dextran Sacrificial Layers	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; THIN-FILMS; POLY(DIMETHYLSILOXANE); CELLS; ELECTRONICS; SURFACE; FORCES; FABRICATION; SILICON; ARRAYS	Micro-patterning tools adopted from the semiconductor industry have mostly been optimized to pattern features onto rigid silicon and glass substrates, however, recently the need to pattern on soft substrates has been identified in simulating cellular environments or developing flexible biosensors. We present a simple method of introducing a variety of patterned materials and structures into ultra-flexible polydimethylsiloxane (PDMS) layers (elastic moduli down to 3 kPa) utilizing water-soluble dextran sacrificial thin films. Dextran films provided a stable template for photolithography, metal deposition, particle adsorption, and protein stamping. These materials and structures (including dextran itself) were then readily transferrable to an elastomer surface following PDMS (10 to 70: 1 base to crosslinker ratios) curing over the patterned dextran layer and after sacrificial etch of the dextran in water. We demonstrate that this simple and straightforward approach can controllably manipulate surface wetting and protein adsorption characteristics of PDMS, covalently link protein patterns for stable cell patterning, generate composite structures of epoxy or particles for study of cell mechanical response, and stably integrate certain metals with use of vinyl molecular adhesives. This method is compatible over the complete moduli range of PDMS, and potentially generalizable over a host of additional micro- and nano-structures and materials.	[Tseng, Peter; Pushkarsky, Ivan; Di Carlo, Dino] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Di Carlo, D (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	dicarlo@ucla.edu		Tseng, Peter/0000-0001-6598-1661	NIH New Innovator Award [1DP2OD007113]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007113] Funding Source: NIH RePORTER	NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work received support from a NIH New Innovator Award (#1DP2OD007113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrega T, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/5/055025; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Befahy S, 2010, LANGMUIR, V26, P3372, DOI 10.1021/la903154y; Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Farrell M, 2010, COLLOID SURFACE B, V81, P468, DOI 10.1016/j.colsurfb.2010.07.059; Gou HL, 2010, ACS APPL MATER INTER, V2, P1324, DOI 10.1021/am100196z; Gray DS, 2004, ADV MATER, V16, P393, DOI 10.1002/adma.200306107; Guo L, 2010, SMALL, V6, P2847, DOI 10.1002/smll.201001456; Gutierrez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023807; Heyries KA, 2007, LANGMUIR, V23, P4523, DOI 10.1021/la070018o; Horsfall AB, 2004, IEEE T DEVICE MAT RE, V4, P482, DOI 10.1109/TDMR.2004.829389; Hung PJ, 2004, APPL PHYS LETT, V85, P6051, DOI 10.1063/1.1835553; Iwadate Y, 2008, J CELL SCI, V121, P1314, DOI 10.1242/jcs.021576; Iwadate Y, 2008, BIOTECHNIQUES, V44, P739, DOI 10.2144/000112752; Karlsson JM, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/8/085009; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Kim DH, 2008, ADV MATER, V20, P4887, DOI 10.1002/adma.200801788; Kishi K, 2000, J POLYM SCI POL CHEM, V38, P804; Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+; Lee KS, 2009, LAB CHIP, V9, P1618, DOI 10.1039/b820924c; Lee KJ, 2005, ADV FUNCT MATER, V15, P557, DOI 10.1002/adfm.200400189; Lim KS, 2006, LAB CHIP, V6, P578, DOI 10.1039/b514755g; Linder V, 2005, SMALL, V1, P730, DOI 10.1002/smll.200400159; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/nmat2834, 10.1038/NMAT2834]; Moon MW, 2007, P NATL ACAD SCI USA, V104, P1130, DOI 10.1073/pnas.0610654104; Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o; Park JY, 2010, SOFT MATTER, V6, P677, DOI 10.1039/b916603c; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Tseng P, 2014, ADV MATER, V26, P1242, DOI 10.1002/adma.201304607; Tseng P, 2012, NAT METHODS, V9, P1113, DOI [10.1038/NMETH.2210, 10.1038/nmeth.2210]; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yoon J, 2008, NAT MATER, V7, P907, DOI 10.1038/nmat2287; Yu HY, 2012, ACTA BIOMATER, V8, P1267, DOI 10.1016/j.actbio.2011.09.006; Yu L, 2009, LAB CHIP, V9, P1243, DOI 10.1039/b816018j	39	22	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106091	10.1371/journal.pone.0106091	http://dx.doi.org/10.1371/journal.pone.0106091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153326	Green Submitted, gold, Green Published			2022-12-25	WOS:000340952200114
J	Wes, PD; Easton, A; Corradi, J; Barten, DM; Devidze, N; DeCarr, LB; Truong, A; He, AQ; Barrezueta, NX; Polson, C; Bourin, C; Flynn, ME; Keenan, S; Lidge, R; Meredith, J; Natale, J; Sankaranarayanan, S; Cadelina, GW; Albright, CF; Cacace, AM				Wes, Paul D.; Easton, Amy; Corradi, John; Barten, Donna M.; Devidze, Nino; DeCarr, Lynn B.; Amy Truong; He, Aiqing; Barrezueta, Nestor X.; Polson, Craig; Bourin, Clotilde; Flynn, Marianne E.; Keenan, Stefanie; Lidge, Regina; Meredith, Jere; Natale, Joanne; Sankaranarayanan, Sethu; Cadelina, Greg W.; Albright, Charlie F.; Cacace, Angela M.			Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RTG4510 MOUSE MODEL; FRONTOTEMPORAL DEMENTIA; IDENTIFIES VARIANTS; INDUCED DEFICITS; IMPROVES MEMORY; TAUOPATHY; MICE; DOXYCYCLINE; CLU	Filamentous inclusions of the microtubule-associated protein, tau, define a variety of neurodegenerative diseases known as tauopathies, including Alzheimer's disease (AD). To better understand the role of tau-mediated effects on pathophysiology and global central nervous system function, we extensively characterized gene expression, pathology and behavior of the rTg4510 mouse model, which overexpresses a mutant form of human tau that causes Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). We found that the most predominantly altered gene expression pathways in rTg4510 mice were in inflammatory processes. These results closely matched the causal immune function and microglial gene-regulatory network recently identified in AD. We identified additional gene expression changes by laser microdissecting specific regions of the hippocampus, which highlighted alterations in neuronal network activity. Expression of inflammatory genes and markers of neuronal activity changed as a function of age in rTg4510 mice and coincided with behavioral deficits. Inflammatory changes were tau-dependent, as they were reversed by suppression of the tau transgene. Our results suggest that the alterations in microglial phenotypes that appear to contribute to the pathogenesis of Alzheimer's disease may be driven by tau dysfunction, in addition to the direct effects of beta-amyloid.	[Wes, Paul D.; Easton, Amy; Barten, Donna M.; Devidze, Nino; DeCarr, Lynn B.; Barrezueta, Nestor X.; Polson, Craig; Bourin, Clotilde; Flynn, Marianne E.; Keenan, Stefanie; Lidge, Regina; Meredith, Jere; Natale, Joanne; Sankaranarayanan, Sethu; Cadelina, Greg W.; Albright, Charlie F.; Cacace, Angela M.] Bristol Myers Squibb Co, Dept Neurosci, Wallingford, CT 06492 USA; [Corradi, John; Amy Truong; He, Aiqing] Bristol Myers Squibb Co, Dept Appl Genom, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb	Cacace, AM (corresponding author), Bristol Myers Squibb Co, Dept Neurosci, 5 Res Pkwy, Wallingford, CT 06492 USA.	angela.cacace@bms.com		Corradi, John/0000-0003-3456-4974	Bristol-Myers Squibb internal RD budget	Bristol-Myers Squibb internal RD budget	The Bristol-Myers Squibb internal R&D budget provided all sources of funding. The funders had no rolein the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badrakalimuthu V.R., 2012, ADV PSYCHIAT TREATME, V18, P119, DOI DOI 10.1192/APT.BP.110.008458; Bailey RM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-8; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brouwers N, 2011, MOL PSYCHIAT; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Crimins JL, 2011, ACTA NEUROPATHOL, V122, P551, DOI 10.1007/s00401-011-0877-0; Dodart JC, 1997, NEUROREPORT, V8, P1173, DOI 10.1097/00001756-199703240-00023; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Duncan RS, 2005, EXP BIOL MED, V230, P527, DOI 10.1177/153537020523000803; Dunlop DD, 2000, STAT DATA ANAL ELEME; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Forabosco P, 2013, NEUROBIOL AGING, V34, P2699, DOI 10.1016/j.neurobiolaging.2013.05.001; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Gandy S, 2013, NEURON, V78, P575, DOI 10.1016/j.neuron.2013.05.007; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Han HJ, 2012, J NEUROSCI, V32, P10574, DOI 10.1523/JNEUROSCI.0893-12.2012; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kopeikina KJ, 2013, J COMP NEUROL, V521, P1334, DOI 10.1002/cne.23234; Krakauer T, 2003, ANTIMICROB AGENTS CH, V47, P3630, DOI 10.1128/AAC.47.11.3630-3633.2003; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2011, CURR OPIN GENET DEV, V21, P295, DOI 10.1016/j.gde.2011.02.002; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P345, DOI 10.1016/j.neubiorev.2010.02.004; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee VMY, 2005, BBA-MOL BASIS DIS, V1739, P251, DOI 10.1016/j.bbadis.2004.06.014; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu W, 2004, NEUROLOGY, V62, P742, DOI 10.1212/01.WNL.0000113729.77161.C9; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; McKinney BC, 2008, GENES BRAIN BEHAV, V7, P203, DOI 10.1111/j.1601-183X.2007.00339.x; Milano S, 1997, ANTIMICROB AGENTS CH, V41, P117, DOI 10.1128/AAC.41.1.117; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Myers AJ, 2013, J ALZHEIMERS DIS, V33, pS15, DOI 10.3233/JAD-2012-129013; Nash KR, 2013, NEUROBIOL AGING, V34, P1540, DOI 10.1016/j.neurobiolaging.2012.12.011; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sahara N, 2013, J ALZHEIMERS DIS, V33, P249, DOI 10.3233/JAD-2012-121093; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selenica ML, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt241; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Solomon A, 2000, INVEST OPHTH VIS SCI, V41, P2544; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Teri L, 1999, J GERONTOL A-BIOL, V54, pM348, DOI 10.1093/gerona/54.7.M348; Yi CJ, 2011, NEUROCHEM RES, V36, P1984, DOI 10.1007/s11064-011-0522-2; Yue M, 2011, NEUROBIOL AGING, V32, P590, DOI 10.1016/j.neurobiolaging.2009.04.006; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	63	76	76	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106050	10.1371/journal.pone.0106050	http://dx.doi.org/10.1371/journal.pone.0106050			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153994	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200110
J	Biswas, MK; Xu, Q; Mayer, C; Deng, XX				Biswas, Manosh Kumar; Xu, Qiang; Mayer, Christoph; Deng, Xiuxin			Genome Wide Characterization of Short Tandem Repeat Markers in Sweet Orange (Citrus sinensis)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; BAC-END SEQUENCES; SSR MARKERS; MICROSATELLITE MARKERS; TRANSFERABILITY; DNA; INSTABILITY; LENGTH; PLANTS; DIVERSITY	Sweet orange (Citrus sinensis) is one of the major cultivated and most-consumed citrus species. With the goal of enhancing the genomic resources in citrus, we surveyed, developed and characterized microsatellite markers in the approximate to 347 Mb sequence assembly of the sweet orange genome. A total of 50,846 SSRs were identified with a frequency of 146.4 SSRs/Mbp. Dinucleotide repeats are the most frequent repeat class and the highest density of SSRs was found in chromosome 4. SSRs are non-randomly distributed in the genome and most of the SSRs (62.02%) are located in the intergenic regions. We found that AT-rich SSRs are more frequent than GC-rich SSRs. A total number of 21,248 SSR primers were successfully developed, which represents 89 SSR markers per Mb of the genome. A subset of 950 developed SSR primer pairs were synthesized and tested by wet lab experiments on a set of 16 citrus accessions. In total we identified 534 (56.21%) polymorphic SSR markers that will be useful in citrus improvement. The number of amplified alleles ranges from 2 to 12 with an average of 4 alleles per marker and an average PIC value of 0.75. The newly developed sweet orange primer sequences, their in silico PCR products, exact position in the genome assembly and putative function are made publicly available. We present the largest number of SSR markers ever developed for a citrus species. Almost two thirds of the markers are transferable to 16 citrus relatives and may be used for constructing a high density linkage map. In addition, they are valuable for marker-assisted selection studies, population structure analyses and comparative genomic studies of C. sinensis with other citrus related species. Altogether, these markers provide a significant contribution to the citrus research community.	[Biswas, Manosh Kumar; Xu, Qiang; Deng, Xiuxin] Huazhong Agr Univ, Minist Educ MOE, Key Lab Hort Plant Biol, Wuhan, Hubei, Peoples R China; [Mayer, Christoph] Forschungs Museum Alexander Koenig, Bonn, Germany	Huazhong Agricultural University; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Deng, XX (corresponding author), Huazhong Agr Univ, Minist Educ MOE, Key Lab Hort Plant Biol, Wuhan, Hubei, Peoples R China.	xxdeng@mail.hzau.edu.cn	Mayer, Christoph/AAD-6696-2019	Mayer, Christoph/0000-0001-5104-6621; Xiuxin, Deng/0000-0003-4490-4514	Ministry of Science & Technology of China [2011CB100600]; National Natural Science Foundation of China [31330066]	Ministry of Science & Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the Ministry of Science & Technology of China (No. 2011CB100600) and the National Natural Science Foundation of China (No. 31330066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Biswas MK, 2012, MOL BIOL REP, V39, P5373, DOI 10.1007/s11033-011-1338-5; Biswas MK, 2011, SCI HORTIC-AMSTERDAM, V129, P798, DOI 10.1016/j.scienta.2011.06.015; Biswas MK, 2010, SCI HORTIC-AMSTERDAM, V124, P254, DOI 10.1016/j.scienta.2009.12.013; Bohra A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-56; Cardle L, 2000, GENETICS, V156, P847; Cavagnaro PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-386; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Cheng YunJiang, 2003, Plant Molecular Biology Reporter, V21, p177a, DOI 10.1007/BF02774246; da Maia LC, 2009, GENET MOL BIOL, V32, P822, DOI 10.1590/S1415-47572009005000091; Duval A, 2002, ANN GENET-PARIS, V45, P71, DOI 10.1016/S0003-3995(02)01115-2; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Hong CP, 2007, MOL CELLS, V23, P349; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; Kuntal H, 2012, BIOINFORMATION, V8, P255, DOI 10.6026/97320630008255; Labbe J, 2011, CURR GENET, V57, P75, DOI 10.1007/s00294-010-0328-9; Li Bin, 2004, Genomics Proteomics & Bioinformatics, V2, P24; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Mayer C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; Murat C, 2011, FUNGAL GENET BIOL, V48, P592, DOI 10.1016/j.fgb.2010.10.007; Ollitrault F, 2010, AM J BOT, V97, pE124, DOI 10.3732/ajb.1000280; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Ruiz C, 2000, EUPHYTICA, V112, P89, DOI 10.1023/A:1003992719598; Shama S, 1996, EUR J BIOCHEM, V236, P383, DOI 10.1111/j.1432-1033.1996.00383.x; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Vassileva V, 2002, CANCER RES, V62, P4095; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weng Y, 2007, INSECT MOL BIOL, V16, P613, DOI 10.1111/j.1365-2583.2007.00757.x; Wierdl M, 1997, GENETICS, V146, P769; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]; Zhang LY, 2005, THEOR APPL GENET, V111, P677, DOI 10.1007/s00122-005-2041-5; Zhao H, 2011, J INTEGR PLANT BIOL, V53, P232, DOI 10.1111/j.1744-7909.2010.01026.x	40	36	40	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104182	10.1371/journal.pone.0104182	http://dx.doi.org/10.1371/journal.pone.0104182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148383	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600010
J	Lan, AP; Zhang, J; Xiao, ZC; Peng, XG; Qi, YF; Du, J				Lan, Aiping; Zhang, Jing; Xiao, Zhicheng; Peng, Xiaogang; Qi, Yongfen; Du, Jie			Akt2 Is Involved in Loss of Epithelial Cells and Renal Fibrosis following Unilateral Ureteral Obstruction	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; INTERSTITIAL FIBROSIS; MECHANISMS; PROGRESSION; ORIGIN	Obstructive nephropathy is an aggressive form of chronic kidney disease (CKD), which is characterized by an epithelial-to-mesenchymal transition (EMT) and interstitial fibrosis. However, the molecular mechanisms of EMT and fibrosis are complex and not fully understood. In this study, we investigated the contribution of Akt2 to experimental renal EMT and fibrosis using the well-established model of unilateral ureteral obstruction (UUO). We found that Akt2 and phosphor (p)-Akt protein levels were increased in the obstructed kidneys. UUO induced activation of transforming growth factor-beta 1 (TGF-beta 1) signaling. Importantly, knockout of Akt2 suppressed UUO-induced EMT, kidney fibrosis, increased GSK3 beta activity, and decreased expression of Snail and beta-catenin. Inhibition of GSK3 beta with LiCl (the inhibitor of GSK3 beta) increased the expression of Snail and beta-catenin in cultured kidney epithelial cells. Our findings suggest that Akt2 partially contributes to interstitial fibrosis following UUO and that inhibition of this signaling pathway may provide a novel approach of prevent progression of renal fibrosis.	[Lan, Aiping; Zhang, Jing; Xiao, Zhicheng; Peng, Xiaogang; Qi, Yongfen; Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Inst Heart Lung & Blood Vessel Dis,Minist Educ, Beijing, Peoples R China	Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Inst Heart Lung & Blood Vessel Dis,Minist Educ, Beijing, Peoples R China.	jdu@bcm.edu	lan, A/HHZ-6588-2022		National Science Foundation of China Grant EMT [31090363]; Chinese Ministry of Science and Technology [2009CB522205]	National Science Foundation of China Grant EMT; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This study was supported by National Science Foundation of China Grant EMT grant 31090363, and Chinese Ministry of Science and Technology Grants 2009CB522205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Carew RM, 2010, AM J PHYSIOL-RENAL, V298, P1263; Cheng JZ, 2010, KIDNEY INT, V78, P668, DOI 10.1038/ki.2010.214; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Duffield JS, 2011, KIDNEY INT, V79, P494, DOI 10.1038/ki.2010.338; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mishra Prajna, 2010, J Mol Signal, V5, P9, DOI 10.1186/1750-2187-5-9; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Villagrasa P, 2012, ONCOGENE, V31, P4022, DOI 10.1038/onc.2011.562; White BD, 2007, CURR BIOL, V17, pR923, DOI 10.1016/j.cub.2007.08.062	25	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105451	10.1371/journal.pone.0105451	http://dx.doi.org/10.1371/journal.pone.0105451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148525	gold, Green Submitted, Green Published			2022-12-25	WOS:000341230600047
J	Nibouche, S; Fartek, B; Mississipi, S; Delatte, H; Reynaud, B; Costet, L				Nibouche, Samuel; Fartek, Benjamin; Mississipi, Stelly; Delatte, Helene; Reynaud, Bernard; Costet, Laurent			Low Genetic Diversity in Melanaphis sacchari Aphid Populations at the Worldwide Scale	PLOS ONE			English	Article							YELLOW-LEAF-VIRUS; INSECTA HEMIPTERA APHIDIDAE; SEXUAL REPRODUCTION; SITOBION-AVENAE; COTTON APHID; SUGARCANE; MITOCHONDRIAL; RESISTANCE; PLANT; SUPERCLONES	Numerous studies have examined the genetic diversity and genetic structure of invading species, with contrasting results concerning the relative roles of genetic diversity and phenotypic plasticity in the success of introduced populations. Increasing evidence shows that asexual lineages of aphids are able to occupy a wide geographical and ecological range of habitats despite low genetic diversity. The anholocyclic aphid Melanaphis sacchari is a pest of sugarcane and sorghum which originated in the old world, was introduced into the Americas, and is now distributed worldwide. Our purpose was to assess the genetic diversity and structuring of populations of this species according to host and locality. We used 10 microsatellite markers to genotype 1333 individuals (57 samples, 42 localities, 15 countries) collected mainly on sugarcane or sorghum. Five multilocus lineages (MLL) were defined, grouping multilocus genotypes (MLG) differing by only a few mutations or scoring errors. Analysis of a 658 bp sequence of mitochondrial COI gene on 96 individuals revealed five haplotypes, with a mean divergence of only 0.19 %. The distribution of MLL appeared to be strongly influenced by geography but not by host plant. Each of the five MLL grouped individuals from (A) Africa, (B) Australia, (C) South America, the Caribbean and the Indian Ocean including East Africa, (D) USA, and (E) China. The MLL A and C, with a wide geographic distribution, matched the definition of superclone. Among aphids, M. sacchari has one of the lowest known rates of genetic diversity for such a wide geographical distribution.	[Nibouche, Samuel; Fartek, Benjamin; Mississipi, Stelly; Delatte, Helene; Reynaud, Bernard; Costet, Laurent] Cirad, UMR PVBMT, Saint Pierre, La Reunion, France; [Fartek, Benjamin] Univ La Reunion, UMR PVBMT, Saint Pierre, La Reunion, France	CIRAD; University of La Reunion	Nibouche, S (corresponding author), Cirad, UMR PVBMT, Saint Pierre, La Reunion, France.	samuel.nibouche@cirad.fr	Costet, Laurent/AAQ-1579-2020; Costet, Laurent/C-2281-2011; Nibouche, Samuel/C-1964-2008	Costet, Laurent/0000-0003-3199-2885; Nibouche, Samuel/0000-0003-2675-1382	CIRAD; Conseil Regional de La Reunion; European Union: European regional development fund (ERDF)	CIRAD; Conseil Regional de La Reunion; European Union: European regional development fund (ERDF)	This work was funded by CIRAD, by the Conseil Regional de La Reunion and by the European Union: European regional development fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar W, 2011, ANN ENTOMOL SOC AM, V104, P699, DOI 10.1603/AN11020; Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; Andris M, 2010, MOL ECOL RESOUR, V10, P1106, DOI 10.1111/j.1755-0998.2010.02916.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Biomatters, 2012, GEN VERS 5 6 6; Blackman R.L., 2000, APHIDS WORLD CROPS I; Blackman RL, 2006, APHIDS WORLDS HERBAC; Blackman RL, 1990, WORLD PERSPECTIVES B, P197; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; CAILLAUD CM, 1995, B ENTOMOL RES, V85, P189, DOI 10.1017/S000748530003426X; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Chen YZ, 2013, PEST MANAG SCI, V69, P938, DOI 10.1002/ps.3455; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dogimont C, 2010, CR BIOL, V333, P566, DOI 10.1016/j.crvi.2010.04.003; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Fartek B, 2012, ENTOMOL EXP APPL, V144, P270, DOI 10.1111/j.1570-7458.2012.01286.x; Figueroa CC, 2005, HEREDITY, V95, P24, DOI 10.1038/sj.hdy.6800662; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Foottit RG, 2012, PAC SCI, V66, P1, DOI 10.2984/66.1.1; Goncalves MC, 2012, FUNCT PLANT SCI BIOT, V6, P108; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; HALL DG, 1988, FLA ENTOMOL, V71, P138, DOI 10.2307/3495361; Hall DG, 1987, J AM SOC SUGAR CANE, V7, P26; Harrison JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017524; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kim H, 2008, MOL CELLS, V25, P510; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Lehrer AT, 2009, J GEN PLANT PATHOL, V75, P288, DOI 10.1007/s10327-009-0172-2; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Lombaert E, 2009, ENTOMOL EXP APPL, V133, P46, DOI 10.1111/j.1570-7458.2009.00904.x; Loxdale HD, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P535, DOI 10.1007/978-90-481-2770-2_25; Loxdale HD, 2008, MITT DEUT GES ALLGEM, V16, P437; Mead FW, 1978, COOPERATIVE PLANT PE; Mondor EB, 2007, BIOL INVASIONS, V9, P87, DOI 10.1007/s10530-006-9010-z; Nei M, 2000, MOL EVOLUTION PHYLOG; Piffaretti J, 2013, MOL ECOL, V22, P3916, DOI 10.1111/mec.12371; Rassaby L, 2003, EUR J PLANT PATHOL, V109, P459, DOI 10.1023/A:1024211823306; Raymond M, 2004, GENEPOP WEB V 3 4; Razmjou J, 2010, ENTOMOL EXP APPL, V134, P191, DOI 10.1111/j.1570-7458.2009.00951.x; Rebijith KB, 2013, B ENTOMOL RES, V103, P601, DOI 10.1017/S0007485313000278; Remaudiere Georges, 1997, P1; Rott P., 2008, Sugar Cane International, V26, P18; Schenck S, 2000, PLANT DIS, V84, P1085, DOI 10.1094/PDIS.2000.84.10.1085; Singh BU, 2004, CROP PROT, V23, P739, DOI 10.1016/j.cropro.2004.01.004; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Thomas S, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-47; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vorburger C, 2003, MOL ECOL, V12, P3493, DOI 10.1046/j.1365-294X.2003.01998.x; Vrijenhoek RC, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P99, DOI 10.1007/978-90-481-2770-2_6; Wang FM, 2013, MOL BREEDING, V31, P777, DOI 10.1007/s11032-012-9832-6; Ward SM, 2008, INVAS PLANT SCI MANA, V1, P98, DOI 10.1614/IPSM-07-022.1; White WH, 2001, FLA ENTOMOL, V84, P435, DOI 10.2307/3496505; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; Zimmerman EC, 1948, INSECTS HAWAII	61	41	42	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106067	10.1371/journal.pone.0106067	http://dx.doi.org/10.1371/journal.pone.0106067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148510	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600112
J	Gambarotta, G; Ronchi, G; Friard, O; Galletta, P; Perroteau, I; Geuna, S				Gambarotta, Giovanna; Ronchi, Giulia; Friard, Olivier; Galletta, Pantaleo; Perroteau, Isabelle; Geuna, Stefano			Identification and Validation of Suitable Housekeeping Genes for Normalizing Quantitative Real-Time PCR Assays in Injured Peripheral Nerves	PLOS ONE			English	Article							WALLERIAN DEGENERATION; SCHWANN-CELLS	Injury to the peripheral nerve induces dramatic changes in terms of cellular composition that are reflected on RNA quality and quantity, making messenger RNA expression analysis very complex. Several commonly used housekeeping genes are regulated following peripheral nerve injury and are thus not suitable for quantitative real-time PCR normalization; moreover, the presence of pseudogenes in some of them impairs their use. To deal with this problem, we have developed a new method to identify new stable housekeeping genes based on publicly available microarray data on normal and injured nerves. Four new candidate stable genes were identified and validated by quantitative real-time PCR analysis on nerves during the different phases after nerve injury: nerve degeneration, regeneration and remyelination. The stability measure of these genes was calculated with both NormFinder and geNorm algorithms and compared with six commonly used housekeeping genes. This procedure allowed us to identify two new and highly stable genes that can be employed for normalizing injured peripheral nerve data: ANKRD27 and RICTOR. Besides providing a tool for peripheral nerve research, our study also describes a simple and cheap procedure that can be used to identify suitable housekeeping genes in other tissues and organs.	[Gambarotta, Giovanna; Ronchi, Giulia; Galletta, Pantaleo; Perroteau, Isabelle; Geuna, Stefano] Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy; [Gambarotta, Giovanna; Perroteau, Isabelle; Geuna, Stefano] Univ Turin, NIT, Orbassano, Italy; [Ronchi, Giulia; Geuna, Stefano] Univ Turin, Neurosci Inst Cavalieri Ottolenghi Fdn NICO, Orbassano, Italy; [Friard, Olivier] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	University of Turin; University of Turin; University of Turin; University of Turin	Gambarotta, G (corresponding author), Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy.	giovanna.gambarotta@unito.it	Ronchi, Giulia/J-4785-2018; Gambarotta, Giovanna/I-8473-2012; Friard, Olivier/ABG-2435-2021	Ronchi, Giulia/0000-0002-4795-7024; Gambarotta, Giovanna/0000-0002-8380-5925; Friard, Olivier/0000-0002-0374-9872; Geuna, Stefano/0000-0002-6962-831X; Perroteau, Isabelle/0000-0001-9797-2276	European Community [278612]; MIUR; Compagnia di San Paolo	European Community(European Commission); MIUR(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo(Compagnia di San Paolo)	The research leading to this paper has received funding from the European Community's Seventh Framework Programme (FP7-HEALTH-2011) under grant agreement no. 278612 (BIOHYBRID), from MIUR and from Compagnia di San Paolo (MOVAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barrette B, 2010, BRAIN BEHAV IMMUN, V24, P1254, DOI 10.1016/j.bbi.2010.07.249; BRADLEY W G, 1970, Experimental Neurology, V26, P275, DOI 10.1016/0014-4886(70)90125-1; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Geuna S, 2009, INT REV NEUROBIOL, V87, P27, DOI 10.1016/S0074-7742(09)87003-7; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; LUBINSKA L, 1982, BRAIN RES, V233, P227, DOI 10.1016/0006-8993(82)91199-4; Ren SW, 2010, MOL VIS, V16, P1076; Ronchi G, 2009, J NEUROSCI METH, V179, P51, DOI 10.1016/j.jneumeth.2009.01.011; SCHLAEPFER WW, 1977, BRAIN RES, V136, P1, DOI 10.1016/0006-8993(77)90126-3; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VIAL JD, 1958, J BIOPHYS BIOCHEM CY, V4, P551, DOI 10.1083/jcb.4.5.551	17	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105601	10.1371/journal.pone.0105601	http://dx.doi.org/10.1371/journal.pone.0105601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144298	Green Submitted, gold, Green Published			2022-12-25	WOS:000341106100093
J	de Pablo, JFL; Badal, E; Garcia, CF; Martinez-Orti, A; Serra, AS				Fernandez-Lopez de Pablo, Javier; Badal, Ernestina; Ferrer Garcia, Carlos; Martinez-Orti, Alberto; Sanchis Serra, Alfred			Land Snails as a Diet Diversification Proxy during the Early Upper Palaeolithic in Europe	PLOS ONE			English	Article							MOLLUSK EXPLOITATION; MUMBA ROCKSHELTER; HAUA FTEAH; CONSUMPTION; MIDDLE; POPULATION; GASTROPODS; VARIABILITY; TRANSITION; CYRENAICA	Despite the ubiquity of terrestrial gastropods in the Late Pleistocene and Holocene archaeological record, it is still unknown when and how this type of invertebrate resource was incorporated into human diets. In this paper, we report the oldest evidence of land snail exploitation as a food resource in Europe dated to 31.3-26.9 ka yr cal BP from the recently discovered site of Cova de la Barriada (eastern Iberian Peninsula). Mono-specific accumulations of large Iberus alonensis land snails (Ferussac 1821) were found in three different archaeological levels in association with combustion structures, along with lithic and faunal assemblages. Using a new analytical protocol based on taphonomic, microX-Ray Diffractometer (DXR) and biometric analyses, we investigated the patterns of selection, consumption and accumulation of land snails at the site. The results display a strong mono-specific gathering of adult individuals, most of them older than 55 weeks, which were roasted in ambers of pine and juniper under 375 degrees C. This case study uncovers new patterns of invertebrate exploitation during the Gravettian in southwestern Europe without known precedents in the Middle Palaeolithic nor the Aurignacian. In the Mediterranean context, such an early occurrence contrasts with the neighbouring areas of Morocco, France, Italy and the Balkans, where the systematic nutritional use of land snails appears approximately 10,000 years later during the Iberomaurisian and the Late Epigravettian. The appearance of this new subsistence activity in the eastern and southern regions of Spain was coeval to other demographically driven transformations in the archaeological record, suggesting different chronological patterns of resource intensification and diet broadening along the Upper Palaeolithic in the Mediterranean basin.	[Fernandez-Lopez de Pablo, Javier] Inst Catala Paleoecol Humana & Evolucio Social, Tarragona, Spain; [Fernandez-Lopez de Pablo, Javier] URV, Area Prehist, Tarragona, Spain; [Badal, Ernestina] Univ Valencia, Fac Geog & Hist, Dept Prehist & Arqueol, Valencia, Spain; [Ferrer Garcia, Carlos; Sanchis Serra, Alfred] SIP, Museu Prehist Valencia, Valencia, Spain; [Martinez-Orti, Alberto] Museu Valencia Hist Nat & Biotaxa, Valencia, Spain	ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; University of Valencia	de Pablo, JFL (corresponding author), Inst Catala Paleoecol Humana & Evolucio Social, Zona Educ 4 Campus Sescelades,Edifici W3, Tarragona, Spain.	jfernandez@iphes.cat	Fernández-López de Pablo, Javier/GXG-1170-2022; de Pablo, Javier Fernández-López/G-6590-2016; Ferrer García, Carlos/ABC-7677-2021; Badal Garcia, Ernestina/K-9462-2014	Fernández-López de Pablo, Javier/0000-0002-6953-7004; Ferrer García, Carlos/0000-0003-0588-5488; Martinez-Orti, Alberto/0000-0001-6816-1140; Badal Garcia, Ernestina/0000-0002-8296-1870	Fundacion Adendia; MINECO Spanish Ministry [RYC-2011-09363, HAR2012-32703, 2012CGL-34717]; Consolidated Research Groug "Group d'analisis de processos socioecologics, canvis culturals i dinamiques de Poblacio a la Prehistoria" [SGR-2014-900]	Fundacion Adendia; MINECO Spanish Ministry(Spanish Government); Consolidated Research Groug "Group d'analisis de processos socioecologics, canvis culturals i dinamiques de Poblacio a la Prehistoria"	The fieldwork research and the radiocarbon analyses were supported by private funds provided by the Fundacion Adendia in the framework of the research project named "El Poblamiento inicial de Benidorm y la Marina Baixa (Alicante)". JFL is supported by a Ramon y Cajal program postdoctoral research grant (Ref. RYC-2011-09363) of the MINECO Spanish Ministry and the Consolidated Research Groug (Ref. SGR-2014-900) "Group d'analisis de processos socioecologics, canvis culturals i dinamiques de Poblacio a la Prehistoria". The MINECO Spanish Ministry also funded the research projects "Paleolitico Medio final y Paleolitico Superior inicial en la region central mediterranea iberica (Valencia y Murcia)" (Ref. HAR2012-32703) and "Paleoflora iberica en un contexto de complejidad: interacciones fisiograficas, ecologicas y evolutivas" (Ref. 2012CGL-34717) that supported the post-excavation palaeobotanical analyses and the cost of a radiocarbon determination. The funders had no role in the study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Allen John A., 2004, P1, DOI 10.1079/9780851993195.0001; Amara A., 2011, ACT C INT PREH MAGHR, VI; [Anonymous], 2001, NEANDERTALES CROMA O; Aura JE., 2013, PENSANDO GRAVETIENSE, P104; Barker G, 2012, LIBYAN STUDIES, V43, P115, DOI [DOI 10.1017/S026371890000008X, DOI 10.1017/S026371890000008X)]; Barton CM, 2013, QUATERN INT, V318, P53, DOI 10.1016/j.quaint.2013.05.007; Bicho N, 2007, J ARCHAEOL METHOD TH, V14, P81, DOI 10.1007/s10816-007-9025-5; Blasco R, 2008, J ARCHAEOL SCI, V35, P2839, DOI 10.1016/j.jas.2008.05.013; Blasco R, 2012, CR PALEVOL, V11, P265, DOI 10.1016/j.crpv.2012.01.003; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; Brown K, 2011, INTERD CONTRIB ARCH, P247, DOI 10.1007/978-1-4419-8219-3_10; Cacho I, 2001, PALEOCEANOGRAPHY, V16, P40, DOI 10.1029/2000PA000502; Claassen C., 1998, CAMBRIDGE MANUALS AR; Colonese AC, 2011, QUATERN INT, V244, P76, DOI 10.1016/j.quaint.2011.04.035; Colonese AC, 2011, QUATERN INT, V239, P86, DOI 10.1016/j.quaint.2010.09.001; Colonese AC, 2010, P 5 CONV NAZ ARCH RO, P93; Colonese AC, 2005, RIV SCI PREISTORI S1, V1, P271; Cortes-Sanchez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024026; Cullity B. D., 1978, ELEMENTS XRAY DIFFRA; Diez-Martin F, 2009, J AFR ARCHAEOL, V7, P147, DOI 10.3213/1612-1651-10136; Douka K, 2014, J HUM EVOL, V66, P39, DOI 10.1016/j.jhevol.2013.10.001; Durante S., 1972, Quaternaria, V16, P255; Estrada A, 2009, MONOGRAFIES SERP U B, V7, P83; Fa JE, 2013, J HUM EVOL, V64, P233, DOI 10.1016/j.jhevol.2013.01.002; Faus FV, 1988, SERIES ESTUDIOS BIOL, V10, P19; de Pablo JFL, 2011, QUATERN INT, V244, P45, DOI 10.1016/j.quaint.2011.05.031; Gamble C, 2005, CAMB ARCHAEOL J, V15, P193, DOI 10.1017/S0959774305000107; Girod A, 2011, QUATERN INT, V244, P105, DOI 10.1016/j.quaint.2011.04.025; Gliganic LA, 2012, J HUM EVOL, V62, P533, DOI 10.1016/j.jhevol.2012.02.004; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Hey RW, 1967, HAUA FTEAH CYRENAICA, P358; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; Hunt CO, 2011, QUATERN INT, V244, P15, DOI 10.1016/j.quaint.2011.04.045; Jimenez-Espejo FJ, 2007, QUATERNARY SCI REV, V26, P836, DOI 10.1016/j.quascirev.2006.12.013; Jorda JF, 2011, QUATERN INT, V244, P27, DOI 10.1016/j.quaint.2011.04.038; JordaPardo J. F., 2011, Boletin de la Real Sociedad Espanola de Historia Natural, Seccion Geologica, V105, P137; KLEIN RG, 1986, J ARCHAEOL SCI, V13, P515, DOI 10.1016/0305-4403(86)90038-5; Kuhn S.L., 2010, EURASIAN PREHISTORY, V7, P37; Kuhn SL, 2009, J HUM EVOL, V56, P87, DOI 10.1016/j.jhevol.2008.07.014; Lloveras L, 2011, QUATERN INT, V244, P37, DOI 10.1016/j.quaint.2011.04.036; Lubell D., 2004, PETITS ANIMAUX SOC H, P77; Lubell D, 2011, QUATERN INT, V244, P1, DOI 10.1016/j.quaint.2011.06.042; Martinez M, 1997, MON MEDITERRANI DESP, P345; Martinez-Orti A, 1999, MALACOLOGIC, P1; Martinez-Orti A, 1999, MOLUSCOS TERRESTRES; MARTINEZ-ORTI Alberto, 2003, MOLUSCOS CONTINENTAL; Martini F., 2009, MEDITERR REV GEOGRAP, V112, P89, DOI DOI 10.4000/MEDITERRANEE.3211; MEADS MJ, 1984, NEW ZEAL J ZOOL, V11, P277, DOI 10.1080/03014223.1984.10428241; MEHLMAN MJ, 1979, WORLD ARCHAEOL, V11, P80, DOI 10.1080/00438243.1979.9979751; MELLARS P, 1989, ANTIQUITY, V63, P761, DOI 10.1017/S0003598X00076894; Miracle P., 2001, DOCUMENTA PRAEHISTOR, V26, P177, DOI DOI 10.4312/DP.28.10; Moreno-Rueda G, 2009, EVOL ECOL, V23, P463, DOI 10.1007/s10682-008-9245-5; Mussi M, 1995, PREHISTOIRE EUROPEEN, V7, P169; Parker JE, 2010, CRYSTENGCOMM, V12, P1590, DOI 10.1039/b921487a; R Core Team, 2021, R LANG ENV STAT COMP; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rey J, 1996, CUADERNOS GEOGRAFIA, V60, P243; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Rizner M, 2009, MESOLITHIC HORIZONS, P527; Rodriguez-Hidalgo AJ, 2013, INT J OSTEOARCHAEOL, V23, P34, DOI 10.1002/oa.1238; Rodriguez-Perochena I, 2006, THESIS U COMPLUTENSE; Rosin ZM, 2011, J BIOSCIENCES, V36, P691, DOI 10.1007/s12038-011-9077-2; Sanchis Serra A, 2012, TRABAJOS VARIOS SIP, V115; Serra AS, 2011, ARCHAEOFAUNA, V20, P47; Serra AS, 2008, COMPLUTUM, V19, P25; Schmidt I, 2012, QUATERN INT, V274, P179, DOI 10.1016/j.quaint.2012.01.018; Starkovich B, 2010, EURASIAN PREHISTORY, V7, P107; Stiner MC, 2011, J HUM EVOL, V60, P618, DOI 10.1016/j.jhevol.2010.12.005; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; Stiner MC, 1999, ANTIQUITY, V73, P735, DOI 10.1017/S0003598X00065492; Stiner MC, 2006, CURR ANTHROPOL, V47, P953; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Tayor VK, 2011, QUATERN INT, V244, P5, DOI 10.1016/j.quaint.2011.04.041; Tixier J., 1970, B MUS BEYROUTH, V23, P173; Vilaseca S, 1991, TRABAJOS PREHIST, V28, P63; Villaverde V, 2013, PENSANDO GRAVETIENSE, P34; Villaverde V, 2010, PALEOLITICO SUPERIOR, P85; Villaverde V., 1994, ARTE PALEOLITICO COV; Weninger B, 2008, J HUM EVOL, V55, P772, DOI 10.1016/j.jhevol.2008.08.017; Wenk H.R., 2016, PREFERRED ORIENTATIO; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107; Zugasti FIG, 2011, ENVIRON ARCHAEOL, V16, P36, DOI 10.1179/146141010X12640787648306	86	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104898	10.1371/journal.pone.0104898	http://dx.doi.org/10.1371/journal.pone.0104898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141047	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200041
J	Huang, SY; Feng, CW; Hung, HC; Chakraborty, C; Chen, CH; Chen, WF; Jean, YH; Wang, HMD; Sung, CS; Sun, YM; Wu, CY; Liu, WT; Hsiao, CD; Wen, ZH				Huang, Shi-Ying; Feng, Chien-Wei; Hung, Han-Chun; Chakraborty, Chiranjib; Chen, Chun-Hong; Chen, Wu-Fu; Jean, Yen-Hsuan; Wang, Hui-Min David; Sung, Chun-Sung; Sun, Yu-Min; Wu, Chang-Yi; Liu, Wangta; Hsiao, Chung-Der; Wen, Zhi-Hong			A Novel Zebrafish Model to Provide Mechanistic Insights into the Inflammatory Events in Carrageenan-Induced Abdominal Edema	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CARP CYPRINUS-CARPIO; INDUCED PAW EDEMA; IN-VIVO; NOCICEPTIVE RESPONSES; KAPPA-CARRAGEENAN; IMMUNE-RESPONSE; ANIMAL-MODELS; MOUSE PAW; RAT MODEL	A suitable small animal model may help in the screening and evaluation of new drugs, especially those from natural products, which can be administered at lower dosages, fulfilling an urgent worldwide need. In this study, we explore whether zebrafish could be a model organism for carrageenan-induced abdominal edema. The research results showed that intraperitoneal (i.p.) administration of 1.5% lambda-carrageenan in a volume of 20 mL significantly increased abdominal edema in adult zebrafish. Levels of the proinflammatory proteins tumor necrosis factor-alpha (TNF-alpha) and inducible nitric oxide synthase (iNOS) were increased in carrageenan-injected adult zebrafish during the development of abdominal edema. An associated enhancement was also observed in the leukocyte marker, myeloperoxidase (MPO). To support these results, we further observed that i.p. methylprednisolone (MP; 1 mg), a positive control, significantly inhibited carrageenan-induced inflammation 24 h after carrageenan administration. Furthermore, i.p. pretreatment with either an anti-TNF-alpha antibody (1:5 dilution in a volume of 20 mu L) or the iNOS-selective inhibitor aminoguanidine (AG; 1 mg) inhibited carrageenan-induced abdominal edema in adult zebrafish. This new animal model is uncomplicated, easy to develop, and involves a straightforward inducement of inflammatory edema for the evaluation of small volumes of drugs or test compounds.	[Huang, Shi-Ying; Chakraborty, Chiranjib; Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Huang, Shi-Ying] Natl Sun Yat Sen Univ, Ctr Neurosci, Kaohsiung 80424, Taiwan; [Huang, Shi-Ying] Natl Kaohsiung Marine Univ, Dept & Grad Inst Aquaculture, Kaohsiung, Taiwan; [Feng, Chien-Wei; Hung, Han-Chun; Chen, Chun-Hong; Sun, Yu-Min; Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Feng, Chien-Wei; Hung, Han-Chun; Chen, Chun-Hong; Sun, Yu-Min; Wen, Zhi-Hong] Acad Sinica, Kaohsiung, Taiwan; [Chen, Wu-Fu] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Chen, Wu-Fu] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Jean, Yen-Hsuan] Ping Tung Christian Hosp, Dept Orthopaed Surg, Pingtung, Taiwan; [Wang, Hui-Min David] Kaohsiung Med Univ, Dept Fragrance & Cosmet Sci, Kaohsiung, Taiwan; [Wang, Hui-Min David] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Sung, Chun-Sung] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Sung, Chun-Sung] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wu, Chang-Yi] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Liu, Wangta] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Liu, Wangta] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan	National Sun Yat Sen University; National Sun Yat Sen University; National Kaohsiung University of Science & Technology; National Sun Yat Sen University; Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; Chung Yuan Christian University; Chung Yuan Christian University	Wen, ZH (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan.	wzh@mail.nsysu.edu.tw	Chakraborty, Chiranjib/J-4847-2013; Hsiao, Chung-Der/W-4535-2019; Wen, Zhi-Hong/AAG-8034-2019	Chakraborty, Chiranjib/0000-0002-3958-239X; Hsiao, Chung-Der/0000-0002-6398-8672; Huang, Shi-Ying/0000-0002-0370-1553; Wang, Hui-Min/0000-0002-4692-4917; /0000-0002-8170-5162	National Science Council, Taiwan [NSC100-2325-B-110-001, NSC99-2313-B110-003-MY03]; NSYSU-KMU Joint research project [NSYSUKMU P013]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NSYSU-KMU Joint research project	This work was supported, in part, by grants from the National Science Council, Taiwan (NSC100-2325-B-110-001 and NSC99-2313-B110-003-MY03) and the NSYSU-KMU Joint research project (NSYSUKMU P013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhouse N, 2002, PHYTOTHER RES, V16, P562, DOI 10.1002/ptr.997; Backhouse N, 1996, INT J PHARMACOGN, V34, P53, DOI 10.1076/phbi.34.1.53.13176; BACKHOUSE N, 1994, AGENTS ACTIONS, V42, P114, DOI 10.1007/BF01983475; Brown SB, 2007, J LEUKOCYTE BIOL, V82, P79, DOI 10.1189/jlb.0107030; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Chan Chi-Chung, 2003, Methods Mol Biol, V225, P321; CHEN YL, 1994, EUR J PHARMACOL, V271, P319; Cheng AC, 2007, FISH SHELLFISH IMMUN, V22, P197, DOI 10.1016/j.fsi.2006.04.009; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Coruzzi G, 2007, EUR J PHARMACOL, V563, P240, DOI 10.1016/j.ejphar.2007.02.026; d'Alencon CA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-151; Delporte C, 2002, Z NATURFORSCH C, V57, P100; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Fleming A, 2010, INFLAMM BOWEL DIS, V16, P1162, DOI 10.1002/ibd.21200; Fujiki K, 1997, J FAC AGR KYUSHU U, V42, P113; Fujiki K, 1997, FISHERIES SCI, V63, P934, DOI 10.2331/fishsci.63.934; Gill N, 2013, INDIAN J PHARMACOL, V45, P278, DOI 10.4103/0253-7613.111944; Huang SY, 2012, MAR DRUGS, V10, P1899, DOI 10.3390/md10091899; Jean YH, 2008, EUR J PHARMACOL, V578, P323, DOI 10.1016/j.ejphar.2007.08.048; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; LEVY L, 1969, LIFE SCI PT 1 PHYSI, V8, P601, DOI 10.1016/0024-3205(69)90021-6; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lisu CH, 2007, CURR NEUROVASC RES, V4, P111, DOI 10.2174/156720207780637234; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Loynes CA, 2010, J LEUKOCYTE BIOL, V87, P203, DOI 10.1189/jlb.0409255; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; McDaniel JC, 2011, WOUND REPAIR REGEN, V19, P189, DOI 10.1111/j.1524-475X.2010.00659.x; Moor AN, 2009, WOUND REPAIR REGEN, V17, P832, DOI 10.1111/j.1524-475X.2009.00547.x; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Nishikori T, 2002, EUR J PHARMACOL, V451, P327, DOI 10.1016/S0014-2999(02)02238-0; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Oehlers SH, 2013, ZEBRAFISH, V10, P184, DOI 10.1089/zeb.2012.0824; Oehlers SH, 2011, DEV DYNAM, V240, P288, DOI 10.1002/dvdy.22519; Palic D, 2007, J IMMUNOL METHODS, V319, P87, DOI 10.1016/j.jim.2006.11.003; Panusa A, 2011, J PHARM SCI-US, V100, P4580, DOI 10.1002/jps.22722; Park KH, 2011, FISH SHELLFISH IMMUN, V31, P904, DOI 10.1016/j.fsi.2011.08.006; Pase L, 2012, METHOD ENZYMOL, V506, P135, DOI 10.1016/B978-0-12-391856-7.00032-9; Phelps HA, 2007, INFECT IMMUN, V75, P4541, DOI 10.1128/IAI.00518-07; Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650; Renkin Eugene M., 1994, Microcirculation (New York), V1, P157, DOI 10.3109/10739689409148270; Renshaw SA, 2006, EUR RESPIR REV, V15, P168, DOI 10.1183/09059180.00010108; Renshaw SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-148; Rocha ACC, 2006, BRIT J PHARMACOL, V148, P688, DOI 10.1038/sj.bjp.0706775; Rowland M, 1995, CLIN PHARMACOKINET, P469; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Sekiguchi F, 2004, NEUROSCI LETT, V365, P111, DOI 10.1016/j.neulet.2004.04.069; Shin DH, 2000, NEUROSCI LETT, V292, P220, DOI 10.1016/S0304-3940(00)01407-5; Small DL, 2000, BRIT MED BULL, V56, P307, DOI 10.1258/0007142001903238; TIMUR M, 1977, J COMP PATHOL, V87, P89, DOI 10.1016/0021-9975(77)90083-4; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tomassoni D, 2013, INT J MOL SCI, V14, P4580, DOI 10.3390/ijms14034580; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Xu QH, 2011, J NEUROSCI, V31, P2113, DOI 10.1523/JNEUROSCI.2139-10.2011	57	31	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104414	10.1371/journal.pone.0104414	http://dx.doi.org/10.1371/journal.pone.0104414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141004	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200022
J	Panzarini, E; Inguscio, V; Fimia, GM; Dini, L				Panzarini, Elisa; Inguscio, Valentina; Fimia, Gian Maria; Dini, Luciana			Rose Bengal Acetate PhotoDynamic Therapy (RBAc-PDT) Induces Exposure and Release of Damage-Associated Molecular Patterns (DAMPs) in Human HeLa Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; APOPTOTIC CELLS; CANCER-THERAPY; TUMOR-CELLS; CALRETICULIN EXPOSURE; SURFACE EXPRESSION; IN-VITRO; DEATH; HSP70; IMMUNOGENICITY	The new concept of Immunogenic Cell Death (ICD), associated with Damage Associated Molecular Patterns (DAMPs) exposure and/or release, is recently becoming very appealing in cancer treatment. In this context, PhotoDynamic Therapy (PDT) can give rise to ICD and to immune response upon dead cells removal. The list of PhotoSensitizers (PSs) able to induce ICD is still short and includes Photofrin, Hypericin, Foscan and 5-ALA. The goal of the present work was to investigate if Rose Bengal Acetate (RBAc), a powerful PS able to trigger apoptosis and autophagy, enables photosensitized HeLa cells to expose and/or release pivotal DAMPs, i.e. ATP, HSP70, HSP90, HMGB1, and calreticulin (CRT), that characterize ICD. We found that apoptotic HeLa cells after RBAc-PDT exposed and released, early after the treatment, high amount of ATP, HSP70, HSP90 and CRT; the latter was distributed on the cell surface as uneven patches and co-exposed with ERp57. Conversely, autophagic HeLa cells after RBAc-PDT exposed and released HSP70, HSP90 but not CRT and ATP. Exposure and release of HSP70 and HSP90 were always higher on apoptotic than on autophagic cells. HMGB1 was released concomitantly to secondary necrosis (24 h after RBAc-PDT). Phagocytosis assay suggests that CRT is involved in removal of RBAc-PDT generated apoptotic HeLa cells. Altogether, our data suggest that RBAc has all the prerequisites (i.e. exposure and/or release of ATP, CRT, HSP70 and HSP90), that must be verified in future vaccination experiments, to be considered a good PS candidate to ignite ICD. We also showed tha CRT is involved in the clearance of RBAc photokilled HeLa cells. Interestingly, RBAc-PDT is the first cancer PDT protocol able to induce the translocation of HSP90 and plasma membrane co-exposure of CRT with ERp57.	[Panzarini, Elisa; Inguscio, Valentina; Fimia, Gian Maria; Dini, Luciana] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lecce, Italy; [Fimia, Gian Maria] Natl Inst Infect Dis IRCCS L Spallanzani, Rome, Italy	University of Salento; IRCCS Lazzaro Spallanzani	Dini, L (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lecce, Italy.	luciana.dini@unisalento.it	Fimia, Gian Maria/K-3232-2016	Fimia, Gian Maria/0000-0003-4438-3325; Panzarini, Elisa/0000-0003-4219-4272				Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; D'Eliseo D, 2013, CELL STRESS CHAPERON, V18, P801, DOI 10.1007/s12192-013-0422-2; Davies AM, 2007, CLIN CANCER RES, V13, p4647S, DOI 10.1158/1078-0432.CCR-07-0334; Dini L, 2010, CANCER BIOL THER, V10, P1048, DOI 10.4161/cbt.10.10.13371; Dudek AM, 2013, CYTOKINE GROWTH F R, V24, P319, DOI 10.1016/j.cytogfr.2013.01.005; Etminan N, 2011, BRIT J CANCER, V105, P961, DOI 10.1038/bjc.2011.327; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Fucikova J, 2011, CANCER RES, V71, P4821, DOI 10.1158/0008-5472.CAN-11-0950; Galluzzi L, 2012, EMBO J, V31, P1055, DOI 10.1038/emboj.2012.2; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2012, CANCER IMMUNOL IMMUN, V61, P215, DOI 10.1007/s00262-011-1184-2; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Korbelik M, 2005, CANCER RES, V65, P1018; Korbelik M, 2011, CANCER IMMUNOL IMMUN, V60, P1431, DOI 10.1007/s00262-011-1047-x; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Luheshi NM, 2012, EUR J IMMUNOL, V42, P716, DOI 10.1002/eji.201142079; Mitra S, 2011, LASER SURG MED, V43, P632, DOI 10.1002/lsm.21108; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Panzarini E, 2006, J PHOTOCH PHOTOBIO B, V83, P39, DOI 10.1016/j.jphotobiol.2005.11.014; Panzarini E, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.51; Panzarini E, 2013, EXP BIOL MED, V238, P765, DOI 10.1177/1535370213494552; Panzarini E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/482160; Panzarini E, 2011, INT J PHOTOENERGY, V2011, DOI 10.1155/2011/713726; Panzarini E, 2009, ANN NY ACAD SCI, V1171, P617, DOI 10.1111/j.1749-6632.2009.04908.x; Plaetzer K, 2009, LASER MED SCI, V24, P259, DOI 10.1007/s10103-008-0539-1; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Srikrishna G, 2009, NEOPLASIA, V11, P615, DOI 10.1593/neo.09284; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P179, DOI 10.4161/onci.1.2.19026; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Zhou F, 2008, CANCER LETT, V264, P135, DOI 10.1016/j.canlet.2008.01.040; Zhou FF, 2009, INT J CANCER, V125, P1380, DOI 10.1002/ijc.24520	45	82	83	7	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105778	10.1371/journal.pone.0105778	http://dx.doi.org/10.1371/journal.pone.0105778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140900	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200121
J	Cao, HH; Zheng, CP; Wang, SH; Wu, JY; Shen, JH; Xu, XE; Fu, JH; Wu, ZY; Li, EM; Xu, LY				Cao, Hui-Hui; Zheng, Chun-Peng; Wang, Shao-Hong; Wu, Jian-Yi; Shen, Jin-Hui; Xu, Xiu-E; Fu, Jun-Hui; Wu, Zhi-Yong; Li, En-Min; Xu, Li-Yan			A Molecular Prognostic Model Predicts Esophageal Squamous Cell Carcinoma Prognosis	PLOS ONE			English	Article							EXPRESSION SIGNATURE; FASCIN; OVEREXPRESSION; PROGRESSION; BIOMARKERS; CETUXIMAB; SURVIVAL; GROWTH; RISK; EGFR	Background: Esophageal squamous cell carcinoma (ESCC) has the highest mortality rates in China. The 5-year survival rate of ESCC remains dismal despite improvements in treatments such as surgical resection and adjuvant chemoradiation, and current clinical staging approaches are limited in their ability to effectively stratify patients for treatment options. The aim of the present study, therefore, was to develop an immunohistochemistry-based prognostic model to improve clinical risk assessment for patients with ESCC. Methods: We developed a molecular prognostic model based on the combined expression of axis of epidermal growth factor receptor (EGFR), phosphorylated Specificity protein 1 (p-Sp1), and Fascin proteins. The presence of this prognostic model and associated clinical outcomes were analyzed for 130 formalin-fixed, paraffin-embedded esophageal curative resection specimens (generation dataset) and validated using an independent cohort of 185 specimens (validation dataset). Results: The expression of these three genes at the protein level was used to build a molecular prognostic model that was highly predictive of ESCC survival in both generation and validation datasets (P = 0.001). Regression analysis showed that this molecular prognostic model was strongly and independently predictive of overall survival (hazard ratio = 2.358 [95% CI, 1.391-3.996], P = 0.001 in generation dataset; hazard ratio = 1.990 [95% CI, 1.256-3.154], P = 0.003 in validation dataset). Furthermore, the predictive ability of these 3 biomarkers in combination was more robust than that of each individual biomarker. Conclusions: This technically simple immunohistochemistry-based molecular model accurately predicts ESCC patient survival and thus could serve as a complement to current clinical risk stratification approaches.	[Cao, Hui-Hui; Wu, Jian-Yi; Xu, Xiu-E; Li, En-Min; Xu, Li-Yan] Shantou Univ, Coll Med, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou, Guangdong, Peoples R China; [Cao, Hui-Hui; Xu, Xiu-E; Xu, Li-Yan] Shantou Univ Med Coll, Inst Oncol Pathol, Shantou, Guangdong, Peoples R China; [Wu, Jian-Yi; Li, En-Min] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Shantou, Guangdong, Peoples R China; [Zheng, Chun-Peng; Shen, Jin-Hui; Fu, Jun-Hui; Wu, Zhi-Yong] Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Dept Surg Oncol, Shantou, Guangdong, Peoples R China; [Wang, Shao-Hong] Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Dept Pathol, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Sun Yat Sen University; Sun Yat Sen University	Li, EM (corresponding author), Shantou Univ, Coll Med, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou, Guangdong, Peoples R China.	nmli@stu.edu.cn; lyxu@stu.edu.cn	xu, li/GNH-3667-2022		National Research Program (973 Program) [2012CB526600]; National High Technology Research and Development Program of China [2012AA02A503, 2012AA02A209]; Natural Science Foundation of China-GuangDong Joint Fund [U0932001, U1301227]	National Research Program (973 Program); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of China-GuangDong Joint Fund	This work was supported by grants from the National Research Program (973 Program No. 2012CB526600), the National High Technology Research and Development Program of China (No. 2012AA02A503 and No. 2012AA02A209), and the Natural Science Foundation of China-GuangDong Joint Fund (No. U0932001 and No. U1301227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ONCOLOGY WILLISTON P, V21; Benowitz S, 2008, J NATL CANCER I, V100, P916, DOI 10.1093/jnci/djn228; Bilous M, 2003, MODERN PATHOL, V16, P173, DOI 10.1097/01.MP.0000052102.90815.82; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chen YS, 2012, CANCER SCI, V103, P1979, DOI 10.1111/j.1349-7006.2012.02393.x; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Garcia I, 2012, CLIN CANCER RES, V18, P2012, DOI 10.1158/1078-0432.CCR-11-2483; Gonzaga IM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-569; Gou HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062175; Grothey A, 2000, BRIT J CANCER, V83, P870, DOI 10.1054/bjoc.2000.1395; Hashimoto Y, 2005, CLIN CANCER RES, V11, P2597, DOI 10.1158/1078-0432.CCR-04-1378; Heinemann V, 2009, CANCER TREAT REV, V35, P262, DOI 10.1016/j.ctrv.2008.11.005; Hoffman AC, 2009, CLIN CANCER RES, V15, P5191, DOI 10.1158/1078-0432.CCR-08-2534; Kadara H, 2011, CLIN CANCER RES, V17, P1490, DOI 10.1158/1078-0432.CCR-10-2703; Krikelis D, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-1; Li LW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-52; Lu XF, 2010, CELL MOL LIFE SCI, V67, P3313, DOI 10.1007/s00018-010-0382-y; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sun LL, 2013, ACTA HISTOCHEM, V115, P56, DOI 10.1016/j.acthis.2012.04.001; Sveen A, 2012, CLIN CANCER RES, V18, P6001, DOI 10.1158/1078-0432.CCR-11-3302; Tan VY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-52; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Xu QX, 2012, J HISTOCHEM CYTOCHEM, V60, P457, DOI 10.1369/0022155412443542; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Zhang H, 2006, J CLIN PATHOL, V59, P958, DOI 10.1136/jcp.2005.032730; ZHAO Q, 2010, HEALTH TECHNOL ASSES, V14, P979, DOI DOI 10.1369/JHC.2010.955765; Zhu H, 2013, AM J CANCER RES, V3, P230	32	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106007	10.1371/journal.pone.0106007	http://dx.doi.org/10.1371/journal.pone.0106007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153136	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200104
J	Haack, N; Dublin, P; Rose, CR				Haack, Nicole; Dublin, Pavel; Rose, Christine R.			Dysbalance of Astrocyte Calcium under Hyperammonemic Conditions	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACUTE LIVER-FAILURE; ACUTE AMMONIA INTOXICATION; CULTURED RAT ASTROCYTES; HEPATIC-ENCEPHALOPATHY; BRAIN EDEMA; GLIAL-CELLS; IN-VIVO; HIPPOCAMPAL ASTROCYTES; PORTACAVAL ANASTOMOSIS	Increased brain ammonium (NH4+/NH3) plays a central role in the manifestation of hepatic encephalopathy (HE), a complex syndrome associated with neurological and psychiatric alterations, which is primarily a disorder of astrocytes. Here, we analysed the influence of NH4+/NH3 on the calcium concentration of astrocytes in situ and studied the underlying mechanisms of NH4+/NH3-evoked calcium changes, employing fluorescence imaging with Fura-2 in acute tissue slices derived from different regions of the mouse brain. In the hippocampal stratum radiatum, perfusion with 5 mM NH4+/NH3 for 30 minutes caused a transient calcium increase in about 40% of astrocytes lasting about 10 minutes. Furthermore, the vast majority of astrocytes (similar to 90%) experienced a persistent calcium increase by similar to 50 nM. This persistent increase was already evoked at concentrations of 1-2 mM NH4+/NH3, developed within 10-20 minutes and was maintained as long as the NH4+/NH3 was present. Qualitatively similar changes were observed in astrocytes of different neocortical regions as well as in cerebellar Bergmann glia. Inhibition of glutamine synthetase resulted in significantly larger calcium increases in response to NH4+/NH3, indicating that glutamine accumulation was not a primary cause. Calcium increases were not mimicked by changes in intracellular pH. Pharmacological inhibition of voltage-gated sodium channels, sodium-potassium-chloride-cotransporters (NKCC), the reverse mode of sodium/calcium exchange (NCX), AMPA-or mGluR5-receptors did not dampen NH4+/NH3-induced calcium increases. They were, however, significantly reduced by inhibition of NMDA receptors and depletion of intracellular calcium stores. Taken together, our measurements show that sustained exposure to NH4+/NH3 causes a sustained increase in intracellular calcium in astrocytes in situ, which is partly dependent on NMDA receptor activation and on release of calcium from intracellular stores. Our study furthermore suggests that dysbalance of astrocyte calcium homeostasis under hyperammonemic conditions is a widespread phenomenon, which might contribute to the disturbance of neurotransmission during HE.	[Haack, Nicole; Dublin, Pavel; Rose, Christine R.] Univ Dusseldorf, Inst Neurobiol, Fac Math & Nat Sci, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Rose, CR (corresponding author), Univ Dusseldorf, Inst Neurobiol, Fac Math & Nat Sci, Dusseldorf, Germany.	rose@uni-duesseldorf.de			DFG (German Research Foundation) [575]	DFG (German Research Foundation)(German Research Foundation (DFG))	The study was supported by a grant of the DFG (German Research Foundation) to CRR (Collaborative Research Center 575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Albrecht J, 2010, BIOCHEM PHARMACOL, V80, P1303, DOI 10.1016/j.bcp.2010.07.024; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Beck A, 2004, CELL CALCIUM, V35, P47, DOI 10.1016/S0143-4160(03)00171-4; Bender AS, 1998, J NEUROSCI RES, V54, P673, DOI 10.1002/(SICI)1097-4547(19981201)54:5<673::AID-JNR12>3.3.CO;2-G; Bezzi P, 2001, Prog Brain Res, V132, P255; BLEI AT, 1994, HEPATOLOGY, V19, P1437, DOI 10.1002/hep.1840190619; Butterworth RF, 2010, NEUROCHEM INT, V57, P383, DOI 10.1016/j.neuint.2010.03.012; Cauli O, 2009, METAB BRAIN DIS, V24, P69, DOI 10.1007/s11011-008-9115-4; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Chepkova AN, 2006, NEUROBIOL DIS, V23, P512, DOI 10.1016/j.nbd.2006.04.006; Dadsetan S, 2013, J CEREBR BLOOD F MET, V33, P1235, DOI 10.1038/jcbfm.2013.73; DEKNEGT RJ, 1994, J HEPATOL, V20, P19, DOI 10.1016/S0168-8278(05)80462-3; Desjardins P, 2012, NEUROCHEM INT, V60, P690, DOI 10.1016/j.neuint.2012.02.001; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; GANZ R, 1989, METAB BRAIN DIS, V4, P213, DOI 10.1007/BF01000297; Gorg B, 2013, ARCH BIOCHEM BIOPHYS, V536, P158, DOI 10.1016/j.abb.2013.03.010; Gorg B, 2010, GLIA, V58, P691, DOI 10.1002/glia.20955; Golovina VA, 1996, GLIA, V16, P296; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hermenegildo C, 2000, HEPATOLOGY, V31, P709, DOI 10.1002/hep.510310322; HINDFELT B, 1977, J CLIN INVEST, V59, P386, DOI 10.1172/JCI108651; INESI G, 1994, J MEMBRANE BIOL, V141, P1; Jayakumar AR, 2009, J NEUROCHEM, V109, P252, DOI 10.1111/j.1471-4159.2009.05842.x; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Kafitz KW, 2008, J NEUROSCI METH, V169, P84, DOI 10.1016/j.jneumeth.2007.11.022; Kang J, 2010, NEUROSCIENCE, V169, P1601, DOI 10.1016/j.neuroscience.2010.06.020; Kelly T, 2010, J NEUROCHEM, V115, P1123, DOI 10.1111/j.1471-4159.2010.07009.x; Kelly T, 2009, GLIA, V57, P921, DOI 10.1002/glia.20817; Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003; KOSENKO E, 1993, BIOCHIM BIOPHYS ACTA, V1180, P321, DOI 10.1016/0925-4439(93)90057-8; Lalo U, 2011, BBA-MOL CELL RES, V1813, P992, DOI 10.1016/j.bbamcr.2010.09.007; Latour I, 2001, HIPPOCAMPUS, V11, P132, DOI 10.1002/hipo.1031; LAVOIE J, 1987, J NEUROCHEM, V49, P692, DOI 10.1111/j.1471-4159.1987.tb00949.x; Lemberg A, 2009, ANN HEPATOL, V8, P95, DOI 10.1016/S1665-2681(19)31785-5; Llansola M, 2007, METAB BRAIN DIS, V22, P321, DOI 10.1007/s11011-007-9067-0; MANS AM, 1979, J NEUROCHEM, V32, P285, DOI 10.1111/j.1471-4159.1979.tb00350.x; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Matthias K, 2003, J NEUROSCI, V23, P1750; Meier SD, 2008, GLIA, V56, P1127, DOI 10.1002/glia.20684; Michalak A, 1996, HEPATOLOGY, V24, P908, DOI 10.1002/hep.510240425; Monfort P, 2007, EUR J NEUROSCI, V25, P2103, DOI 10.1111/j.1460-9568.2007.05444.x; Munoz MD, 2000, NEUROCHEM RES, V25, P437, DOI 10.1023/A:1007547622844; Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883, DOI 10.1152/ajpcell.1998.274.4.C883; Nedergaard M, 2010, CELL CALCIUM, V47, P101, DOI 10.1016/j.ceca.2009.12.011; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohara K, 2009, NEUROSCI LETT, V462, P109, DOI 10.1016/j.neulet.2009.06.090; Palomero-Gallagher N, 2013, ARCH BIOCHEM BIOPHYS, V536, P109, DOI 10.1016/j.abb.2013.02.010; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Rao KVR, 2012, NEUROCHEM INT, V61, P575, DOI 10.1016/j.neuint.2012.01.012; Rao KVR, 2001, METAB BRAIN DIS, V16, P67, DOI 10.1023/A:1011666612822; Rodrigo R, 2009, NEUROCHEM INT, V55, P113, DOI 10.1016/j.neuint.2009.01.007; Rose C, 2006, J NEUROCHEM, V97, P11, DOI 10.1111/j.1471-4159.2006.03796.x; Rose C, 2005, J BIOL CHEM, V280, P20937, DOI 10.1074/jbc.M412448200; Rose CR, 2013, GLIA, V61, P1191, DOI 10.1002/glia.22492; Schliess F, 2002, FASEB J, V16, P739, DOI 10.1096/fj.01-0862fje; Sergeeva OA, 2013, ARCH BIOCHEM BIOPHYS, V536, P122, DOI 10.1016/j.abb.2013.04.005; Stephan J, 2012, GLIA, V60, P965, DOI 10.1002/glia.22328; SWAIN M, 1992, HEPATOLOGY, V15, P449, DOI 10.1002/hep.1840150316; SWAIN MS, 1991, AM J PHYSIOL, V261, pR1491, DOI 10.1152/ajpregu.1991.261.6.R1491; THOMAS RC, 1984, J PHYSIOL-LONDON, V354, P3; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; TRABER PG, 1987, HEPATOLOGY, V7, P1272, DOI 10.1002/hep.1840070616; Vaquero J, 2007, NEUROL RES, V29, P683, DOI 10.1179/016164107X240099; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; WATANABE A, 1984, BIOCHEM MED METAB B, V32, P225, DOI 10.1016/0006-2944(84)90076-0; Wen SP, 2013, ARCH BIOCHEM BIOPHYS, V536, P183, DOI 10.1016/j.abb.2013.04.008; WillardMack CL, 1996, NEUROSCIENCE, V71, P589, DOI 10.1016/0306-4522(95)00462-9	74	29	29	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105832	10.1371/journal.pone.0105832	http://dx.doi.org/10.1371/journal.pone.0105832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153709	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200084
J	Ji, WJ; Shi, Z; Huang, JY; Li, S				Ji Wenjun; Shi Zhou; Huang Jingyi; Li Shuo			In Situ Measurement of Some Soil Properties in Paddy Soil Using Visible and Near-Infrared Spectroscopy	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE; CHEMICAL-PROPERTIES; CLAY CONTENT; ONLINE; PHOSPHORUS; PREDICTION; NITROGEN; SPECTRA; MODEL	In situ measurements with visible and near-infrared spectroscopy (vis-NIR) provide an efficient way for acquiring soil information of paddy soils in the short time gap between the harvest and following rotation. The aim of this study was to evaluate its feasibility to predict a series of soil properties including organic matter (OM), organic carbon (OC), total nitrogen (TN), available nitrogen (AN), available phosphorus (AP), available potassium (AK) and pH of paddy soils in Zhejiang province, China. Firstly, the linear partial least squares regression (PLSR) was performed on the in situ spectra and the predictions were compared to those with laboratory-based recorded spectra. Then, the non-linear least-square support vector machine (LS-SVM) algorithm was carried out aiming to extract more useful information from the in situ spectra and improve predictions. Results show that in terms of OC, OM, TN, AN and pH, (i) the predictions were worse using in situ spectra compared to laboratory-based spectra with PLSR algorithm (ii) the prediction accuracy using LS-SVM (R-2>0.75, RPD>1.90) was obviously improved with in situ vis-NIR spectra compared to PLSR algorithm, and comparable or even better than results generated using laboratory-based spectra with PLSR; (iii) in terms of AP and AK, poor predictions were obtained with in situ spectra (R-2<0.5, RPD<1.50) either using PLSR or LS-SVM. The results highlight the use of LS-SVM for in situ vis-NIR spectroscopic estimation of soil properties of paddy soils.	[Ji Wenjun; Shi Zhou; Li Shuo] Zhejiang Univ, Inst Agr Remote Sensing & Informat Technol, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Huang Jingyi] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2033, Australia; [Shi Zhou] Zhejiang Univ, Zhejiang Prov Key Lab Subtrop Soil & Plant Nutr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; University of New South Wales Sydney; Zhejiang University	Shi, Z (corresponding author), Zhejiang Univ, Inst Agr Remote Sensing & Informat Technol, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	shizhou@zju.edu.cn	Huang, Jingyi/ABI-5860-2020; shi, Zhou/A-2283-2015; Huang, Jingyi/B-5541-2015; shi, Zhou/M-7845-2019	Huang, Jingyi/0000-0002-1209-9699; shi, Zhou/0000-0003-3914-5402; Huang, Jingyi/0000-0002-1209-9699; shi, Zhou/0000-0003-3914-5402	National High Technology Research and Development Program of China [2013AA102301]; National Natural Science Foundation of China [41271234]; Zhejiang Provincial Science and Technology Project of China [2011C13010]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Science and Technology Project of China	This research was supported by National High Technology Research and Development Program of China (No. 2013AA102301); National Natural Science Foundation of China (No. 41271234); Zhejiang Provincial Science and Technology Project of China (No. 2011C13010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAO SD, 1981, SOIL AGR CHEM ANAL; Bogrekci I, 2005, BIOSYST ENG, V92, P527, DOI 10.1016/j.biosystemseng.2005.09.001; Bogrekci I, 2005, BIOSYST ENG, V91, P305, DOI 10.1016/j.biosystemseng.2005.04.015; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; Christy CD, 2008, COMPUT ELECTRON AGR, V61, P10, DOI 10.1016/j.compag.2007.02.010; Clark R.N., 1999, REMOTE SENSING EARTH, P3, DOI DOI 10.1111/J.1945-5100.2004.TB00079.X; Cogdill RP, 2004, J NEAR INFRARED SPEC, V12, P93, DOI 10.1255/jnirs.412; Cohen MJ, 2005, J ENVIRON QUAL, V34, P1422, DOI 10.2134/jeq2004.0353; Fystro G, 2002, PLANT SOIL, V246, P139, DOI 10.1023/A:1020612319014; Gebbers R, 2010, SCIENCE, V327, P828, DOI 10.1126/science.1183899; Gholizade A, 2013, J FOOD AGRIC ENVIRON, V11, P859; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo Y, 2012, SPECTROSC SPECT ANAL, V33, P1135; Ji W, 2012, SPECTROSC SPECT ANAL, V32, P2392; Kim YJ, 2013, J KOREAN SOC APPL BI, V56, P559, DOI 10.1007/s13765-013-3067-z; Kleinebecker T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070517; Kuang BY, 2013, SOIL TILL RES, V128, P125, DOI 10.1016/j.still.2012.11.006; Kuang B, 2012, ADV AGRON, V114, P155, DOI 10.1016/B978-0-12-394275-3.00003-1; Kusumo BH, 2010, EUR J SOIL SCI, V61, P1, DOI 10.1111/j.1365-2389.2009.01199.x; Li BB, 2002, CHEMOMETR INTELL LAB, V64, P79, DOI 10.1016/S0169-7439(02)00051-5; Li Q. K., 1992, PADDY SOILS CHINA; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lobell DB, 2002, SOIL SCI SOC AM J, V66, P722, DOI 10.2136/sssaj2002.0722; Morgan, 1996, SOIL EROSION CONSERV, P320; Mouazen AM, 2007, SOIL TILL RES, V93, P13, DOI 10.1016/j.still.2006.03.009; Mouazen AM, 2009, SOIL TILL RES, V103, P144, DOI 10.1016/j.still.2008.10.006; Nas T., 2004, USER FRIENDLY GUIDE; R Development Core Team, 2012, R LANG ENV STAT COMP; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Rossel RAV, 2009, GEODERMA, V150, P253, DOI 10.1016/j.geoderma.2009.01.025; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Saeys W, 2005, BIOSYST ENG, V91, P393, DOI 10.1016/j.biosystemseng.2005.05.001; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shao YN, 2011, SOIL RES, V49, P166, DOI 10.1071/SR10098; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; SHERMAN DM, 1985, AM MINERAL, V70, P1262; Soil Science Society of China, 2000, SOIL AGR CHEM ANAL; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Tekin Y, 2013, SENSORS-BASEL, V13, P10177, DOI 10.3390/s130810177; Udelhoven T, 2003, PLANT SOIL, V251, P319, DOI 10.1023/A:1023008322682; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Waiser TH, 2007, SOIL SCI SOC AM J, V71, P389, DOI 10.2136/sssaj2006.0211; Weyer L., 2002, HDB VIBRATIONAL SPEC, V3, P1817; Williams P., 2003, NEAR INFRARED TECHNO; WOLD S, 1983, LECT NOTES MATH, V973, P286	45	62	66	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105708	10.1371/journal.pone.0105708	http://dx.doi.org/10.1371/journal.pone.0105708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153132	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200072
J	Jonsson, S; Lundberg, AK; Jonasson, L				Jonsson, Simon; Lundberg, Anna K.; Jonasson, Lena			Overexpression of MMP-9 and Its Inhibitors in Blood Mononuclear Cells after Myocardial Infarction - Is It Associated with Depressive Symptomatology?	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; AGED NORMAL POPULATION; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; METALLOPROTEINASE EXPRESSION; ATHEROSCLEROTIC PLAQUE; MAJOR DEPRESSION; WHITEHALL-II; MATRIX-METALLOPROTEINASE-9; INFLAMMATION	Background: Matrix metalloproteinase (MMP)-9 may play a central role in the development and progression of atherosclerosis. Emerging evidence also indicates an association between MMP-9 and depressive symptomatology. Here, we investigated whether expression of MMP-9 and its inhibitors in blood mononuclear cells and plasma were related to depressive symptoms in patients with a recent myocardial infarction (MI). Methods and Results: Blood sampling was performed between 6 and 18 months after MI in 57 patients. Forty-one clinically healthy subjects were included as controls. Gene expression of MMP-9 and its main tissue inhibitors TIMP-1 and -2 were analyzed in freshly isolated or cultured blood mononuclear cells. Corresponding protein levels were assessed in cell supernatants and plasma. In post-MI patients, mRNA levels of MMP-9 and TIMP-1 and -2 were significantly higher than in controls while protein levels in cell supernatants and plasma did not differ between groups. The Center for Epidemiological Studies - Depression (CES-D) scale was used to assess depressive symptomatology. Repeated assessments during the first 18 months after MI showed significantly higher CES-D scores in patients compared with controls. However, there were no relationships between depressive mood and any of the measurements of MMP-9 or TIMPs. Conclusion: Our findings indicate that overexpression of MMP-9 and TIMPs in blood mononuclear cells and elevated depressive symptoms represent two unrelated phenomena after MI.	[Jonsson, Simon; Lundberg, Anna K.; Jonasson, Lena] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden	Linkoping University	Jonasson, L (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden.	lena.jonasson@liu.se			Swedish Research Council [521-2011-3847]; Swedish Heart-Lung Foundation [20120608]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This study was supported by Swedish Research Council, grant number 521-2011-3847, (www.vr.se) and the Swedish Heart-Lung Foundation, grant number 20120608, (www.hjart-lungfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham M, 2005, J NEUROIMMUNOL, V163, P157, DOI 10.1016/j.jneuroim.2005.02.001; Avolio C, 2005, MULT SCLER, V11, P441, DOI 10.1191/1352458505ms1193oa; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brunner S, 2010, AM J CARDIOL, V105, P429, DOI 10.1016/j.amjcard.2009.10.013; Chen F, 2005, INT J MOL MED, V15, P57; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; Davidson KW, 2009, AM J CARDIOL, V103, P755, DOI 10.1016/j.amjcard.2008.11.035; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Duivis HE, 2011, AM J PSYCHIAT, V168, P913, DOI 10.1176/appi.ajp.2011.10081163; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; Garvin P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001774; Garvin P, 2009, PSYCHOSOM MED, V71, P292, DOI 10.1097/PSY.0b013e3181960e7f; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; HOWARD EW, 1991, J BIOL CHEM, V266, P13070; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340; Kouwenhoven M, 2001, J AUTOIMMUN, V16, P463, DOI 10.1006/jaut.2001.0505; Lane D, 2002, BRIT J HEALTH PSYCH, V7, P11, DOI 10.1348/135910702169321; Lesperance F, 1996, PSYCHOSOM MED, V58, P99, DOI 10.1097/00006842-199603000-00001; Lichtinghagen R, 2000, CLIN CHEM, V46, P183; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lundgren O, 2014, INT J BEHAV MED; Lutgendorf SK, 2008, CLIN CANCER RES, V14, P6839, DOI 10.1158/1078-0432.CCR-08-0230; Matache C, 2003, J AUTOIMMUN, V20, P323, DOI 10.1016/S0896-8411(03)00037-4; Matthews KA, 2004, CIRCULATION, V109, P66, DOI 10.1161/01.CIR.0000105766.33142.13; Mayou RA, 2000, PSYCHOSOM MED, V62, P212, DOI 10.1097/00006842-200003000-00011; Michal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072014; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Nabi H, 2010, PSYCHOL MED, V40, P405, DOI 10.1017/S0033291709990432; Nabi H, 2008, ARTERIOSCL THROM VAS, V28, P1398, DOI 10.1161/ATVBAHA.108.167239; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rybakowski JK, 2013, J AFFECT DISORDERS, V146, P286, DOI 10.1016/j.jad.2012.07.019; Sternberg Z, 2013, ATHEROSCLEROSIS, V229, P338, DOI 10.1016/j.atherosclerosis.2013.04.035; Suarez EC, 2004, PSYCHONEUROENDOCRINO, V29, P1119, DOI 10.1016/j.psyneuen.2004.01.002; Suarez EC, 2003, PSYCHOSOM MED, V65, P362, DOI 10.1097/01.PSY.0000035719.79068.2B; Thygesen K, 2007, EUR HEART J, V28, P2525; Tindle HA, 2009, CIRCULATION, V120, P656, DOI 10.1161/CIRCULATIONAHA.108.827642; Zouridakis E, 2004, CIRCULATION, V110, P1747, DOI 10.1161/01.CIR.0000142664.18739.92	43	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105572	10.1371/journal.pone.0105572	http://dx.doi.org/10.1371/journal.pone.0105572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153995	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200062
J	Rodriguez, SB; Leyh, TS				Rodriguez, Sofia B.; Leyh, Thomas S.			An Enzymatic Platform for the Synthesis of Isoprenoid Precursors	PLOS ONE			English	Article							ESCHERICHIA-COLI; COENZYME-A; DIRECTED EVOLUTION; KINETIC MECHANISM; PATHWAY; BIOSYNTHESIS; ARTEMISININ; OPTIMIZATION; SYNTHASE; ENZYMES	The isoprenoid family of compounds is estimated to contain similar to 65,000 unique structures including medicines, fragrances, and biofuels. Due to their structural complexity, many isoprenoids can only be obtained by extraction from natural sources, an inherently risky and costly process. Consequently, the biotechnology industry is attempting to genetically engineer microorganisms that can produce isoprenoid-based drugs and fuels on a commercial scale. Isoprenoid backbones are constructed from two, five-carbon building blocks, isopentenyl 5-pyrophosphate and dimethylallyl 5-pyrophosphate, which are end-products of either the mevalonate or non-mevalonate pathways. By linking the HMG-CoA reductase pathway (which produces mevalonate) to the mevalonate pathway, these building block can be synthesized enzymatically from acetate, ATP, NAD(P)H and CoA. Here, the enzymes in these pathways are used to produce pathway intermediates and end-products in single-pot reactions and in remarkably high yield, similar to 85%. A strategy for the regio-specific incorporation of isotopes into isoprenoid backbones is developed and used to synthesize a series of isotopomers of diphosphomevalonate, the immediate end-product of the mevalonate pathway. The enzymatic system is shown to be robust and capable of producing quantities of product in aqueous solutions that meet or exceed the highest levels achieved using genetically engineered organisms in high-density fermentation.	[Rodriguez, Sofia B.; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	tom.leyh@einstein.yu.edu			NIH [GM54469, AI068989, GM106158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106158, R01GM054469] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH GM54469, NIH AI068989, NIH GM106158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P16461, DOI 10.1021/bi048075t; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Arsenault PR, 2008, CURR MED CHEM, V15, P2886, DOI 10.2174/092986708786242813; Brown GD, 2010, MOLECULES, V15, P7603, DOI 10.3390/molecules15117603; BURBAUM JJ, 1989, BIOCHEMISTRY-US, V28, P9293, DOI 10.1021/bi00450a009; Caputi Lorenzo, 2011, Recent Pat Food Nutr Agric, V3, P9; CEDERSTAV AK, 1994, J AM CHEM SOC, V116, P4073, DOI 10.1021/ja00088a051; Cheng Q, 2007, NAT CHEM BIOL, V3, P557, DOI 10.1038/nchembio.2007.22; Clinkenbeard K D, 1975, Methods Enzymol, V35, P167, DOI 10.1016/0076-6879(75)35152-5; CORNFORTH JW, 1974, EUR J BIOCHEM, V42, P591, DOI 10.1111/j.1432-1033.1974.tb03374.x; CORNFORTH RH, 1960, NATURE, V185, P923, DOI 10.1038/185923a0; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Farhi M, 2011, NAT BIOTECHNOL, V29, P1072, DOI 10.1038/nbt.2054; Fokt I, 2013, CARBOHYD RES, V368, P111, DOI 10.1016/j.carres.2012.11.021; Fox JL, 2011, NAT BIOTECHNOL, V29, P1062, DOI 10.1038/nbt1211-1062; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; Gorenstein DG, 1984, PHOSPHORUS 31 NMR PR; Hale V, 2007, AM J TROP MED HYG, V77, P198, DOI 10.4269/ajtmh.2007.77.198; Hedl M, 2002, J BACTERIOL, V184, P2116, DOI 10.1128/JB.184.8.2116-2122.2002; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Hsu E, 2006, T ROY SOC TROP MED H, V100, P505, DOI 10.1016/j.trstmh.2005.09.020; Huang KT, 2006, CARBOHYD RES, V341, P2151, DOI 10.1016/j.carres.2006.04.047; Huang YQ, 2011, ANALYST, V136, P1515, DOI 10.1039/c0an00736f; Kajiwara Y, 2006, J AM CHEM SOC, V128, P9971, DOI 10.1021/ja062940a; Klinman JP, 2014, FEBS J, V281, P489, DOI 10.1111/febs.12477; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; Krutsakorn B, 2013, METAB ENG, V20, P84, DOI 10.1016/j.ymben.2013.09.006; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Lacaze C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-142; Lefurgy ST, 2010, J BIOL CHEM, V285, P20654, DOI 10.1074/jbc.M109.098350; Levy GC., 1972, CARBON 13 NUCL MAGNE; Martin del Campo JS, 2013, ANGEW CHEM INT EDIT, V52, P4587, DOI 10.1002/anie.201300766; Melnick JS, 2003, BIOORG MED CHEM LETT, V13, P4139, DOI 10.1016/j.bmcl.2003.07.026; MIDDLETON B, 1974, BIOCHEM J, V139, P109, DOI 10.1042/bj1390109; MIZIORKO HM, 1977, J BIOL CHEM, V252, P1414; Miziorko HM, 2011, ARCH BIOCH BIOPHYS; Neuhoff V. SR, 1885, ELECTROPHORESIS, V6:, P427; NODA L, 1958, J BIOL CHEM, V232, P237; Noda L, 1962, ENZYMES, P139; Ohdan K, 2007, J BIOTECHNOL, V127, P496, DOI 10.1016/j.jbiotec.2006.07.023; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Osbourn A, 2011, NAT PROD REP, V28, P1261, DOI 10.1039/c1np00015b; OZER N, 1985, BIOCHEM MED METAB B, V33, P367, DOI 10.1016/0006-2944(85)90012-2; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; Pilloff DE, 2003, J BIOL CHEM, V278, P50435, DOI 10.1074/jbc.M306897200; Pohjanjoki P, 1998, BIOCHEMISTRY-US, V37, P1754, DOI 10.1021/bi971771r; Popjak G., 1970, ENZYMES, P115; Puri M, 2011, BIOTECHNOL ADV, V29, P781, DOI 10.1016/j.biotechadv.2011.06.006; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Romanowski MJ, 2002, PROTEINS, V47, P568, DOI 10.1002/prot.10118; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schultheisz HL, 2008, ACS CHEM BIOL, V3, P499, DOI 10.1021/cb800066p; Sen S, 2007, APPL BIOCHEM BIOTECH, V143, P212, DOI 10.1007/s12010-007-8003-4; SHAPIRO AL, 1967, BIOCHEM BIOPH RES CO, V28, P815, DOI 10.1016/0006-291X(67)90391-9; Sugiyama M, 2007, J AM CHEM SOC, V129, P14811, DOI 10.1021/ja073911i; Sutherlin A, 2004, BIOTECHNOL BIOENG, V87, P546, DOI 10.1002/bit.20157; Sutherlin A, 2002, J BACTERIOL, V184, P4065, DOI 10.1128/JB.184.15.4065-4070.2002; Thulasiram HV, 2008, J AM CHEM SOC, V130, P1966, DOI 10.1021/ja0771282; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; van den Heuvel RHH, 2001, J AGR FOOD CHEM, V49, P2954, DOI 10.1021/jf010093j; Wang C, 2010, BIOTECHNOL BIOENG, V107, P421, DOI 10.1002/bit.22831; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wouters J, 2003, J BIOL CHEM, V278, P11903, DOI 10.1074/jbc.M212823200; Wu Tao, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P1040; Xiao YS, 2013, ANAL CHEM, V85, P7478, DOI 10.1021/ac401415z; Yamaguchi S, 2007, APPL ENVIRON MICROB, V73, P5370, DOI 10.1128/AEM.00807-07; You C, 2013, P NATL ACAD SCI USA, V110, P7182, DOI 10.1073/pnas.1302420110; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Zhao LS, 2013, ANNU REV BIOCHEM, V82, P497, DOI 10.1146/annurev-biochem-052010-100934; Zhu ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4026; Zyryanov AB, 2002, BIOCHEM J, V367, P901, DOI 10.1042/BJ20020880	80	8	8	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105594	10.1371/journal.pone.0105594	http://dx.doi.org/10.1371/journal.pone.0105594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153179	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200065
J	Van der Hiele, K; Middelkoop, HAM; Ruimschotel, R; Kamminga, NGA; Visser, LH				Van der Hiele, Karin; Middelkoop, Huub A. M.; Ruimschotel, Rob; Kamminga, Noelle G. A.; Visser, Leo H.			A Pilot Study on Factors Involved with Work Participation in the Early Stages of Multiple Sclerosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; EMPLOYMENT STATUS; COGNITIVE FUNCTION; DEPRESSION SCALE; HOSPITAL ANXIETY; IMPACT; DISABILITY; FATIGUE; HEALTH; INDIVIDUALS	Background: Up to 30% of recently diagnosed MS patients lose their jobs in the first four years after diagnosis. Taking into account the personal and socio-economic importance of sustaining employment, it is of the utmost importance to examine factors involved with work participation. Objective: To investigate differences in self-reported functioning in recently diagnosed MS patients with and without a paid job. Methods: Self-reports of physical and cognitive functioning, depression, anxiety and fatigue were gathered from 44 relapsing-remitting MS patients diagnosed within 3 years. Results: Patients with a paid job (57%) reported better physical functioning (p<0.001), better memory functioning (p = 0.01) and a lower physical impact of fatigue (p = 0.018) than patients without a paid job. Physical functioning was the main predictor of employment status in a logistic regression model. In those with a paid job better memory functioning (r = 0.54, p = 0.005) and a lower social impact of fatigue (r = -0.46, p = 0.029) correlated with an increased number of working hours. Conclusion: Better physical functioning is the primary factor involved with increased work participation in early MS. Better self-reported memory functioning and less social fatigue were associated with increased working hours. These findings highlight the importance of battling these symptoms in the early stages of MS.	[Van der Hiele, Karin] Natl Multiple Sclerosis Fdn, Maassluis, Netherlands; [Van der Hiele, Karin; Middelkoop, Huub A. M.] Leiden Univ, Dept Psychol, Sect Hlth Med & Neuropsychol, Leiden, Netherlands; [Ruimschotel, Rob] Med Psychiat Ctr PsyToBe, Rotterdam, Netherlands; [Middelkoop, Huub A. M.; Kamminga, Noelle G. A.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Visser, Leo H.] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [Visser, Leo H.] Univ Humanist Studies, Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Van der Hiele, K (corresponding author), Natl Multiple Sclerosis Fdn, Maassluis, Netherlands.	hiele@fsw.leidenuniv.nl		van der Hiele, Karin/0000-0002-1567-0627	National Multiple Sclerosis Foundation, The Netherlands	National Multiple Sclerosis Foundation, The Netherlands	This research was financially supported by the National Multiple Sclerosis Foundation, The Netherlands. The first author, KH, was employed by the National Multiple Sclerosis Foundation and had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Volunteers working for the National Multiple Sclerosis Foundation helped with data collection by sending out questionnaires.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Arrindell WA, 2004, KLACHTENLIJST SCL 90; Bakshi R, 2003, MULT SCLER J, V9, P219, DOI 10.1191/1352458503ms904oa; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; de Groot V, 2006, BRAIN, V129, P2648, DOI 10.1093/brain/awl223; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Gommer A, 2010, VOLKSGEZONDHEID TOEK; Honarmand K, 2011, J NEUROL, V258, P244, DOI 10.1007/s00415-010-5736-8; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Ingram G, 2010, MULT SCLER J, V16, P472, DOI 10.1177/1352458509358902; Janssen B, 2011, EMANCIPATIEMONITOR 2, P72; Janssens ACJW, 2003, ACTA NEUROL SCAND, V108, P389, DOI 10.1034/j.1600-0404.2003.00166.x; Jonsson A, 2006, J NEUROL SCI, V245, P77, DOI 10.1016/j.jns.2005.09.016; Julian LJ, 2008, J NEUROL, V255, P1354, DOI 10.1007/s00415-008-0910-y; Klevan G, 2014, ACTA NEUROL SCAND, V129, P21, DOI 10.1111/ane.12142; Krabbendam L., 1997, BADS BEHAV ASSESSMEN; Krause I, 2013, MULT SCLER J, V19, P1792, DOI 10.1177/1352458513485655; Krokavcova M, 2010, DISABIL REHABIL, V32, P1742, DOI 10.3109/09638281003734334; Lankhorst GJ, 1996, J NEUROL, V243, P469, DOI 10.1007/BF00900502; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Morrow SA, 2010, CLIN NEUROPSYCHOL, V24, P1131, DOI 10.1080/13854046.2010.511272; Patti F, 2007, MULT SCLER J, V13, P783, DOI 10.1177/1352458506073511; Pompeii LA, 2005, J OCCUP REHABIL, V15, P69, DOI 10.1007/s10926-005-0875-y; Rijken M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-803; Roessler Richard T, 2003, Work, V21, P17; Ruet A, 2013, J NEUROL, V260, P776, DOI 10.1007/s00415-012-6705-1; Schiavolin S, 2013, INT J REHABIL RES, V36, P105, DOI 10.1097/MRR.0b013e32835c79ea; Schulz D, 2006, J NEUROL, V253, P1002, DOI 10.1007/s00415-006-0145-8; Simmons RD, 2010, J NEUROL, V257, P926, DOI 10.1007/s00415-009-5441-7; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; Sweetland J, 2012, DISABIL REHABIL, V34, P2031, DOI 10.3109/09638288.2012.669019; van der Hiele K, 2012, EUR J NEUROL, V19, P562, DOI 10.1111/j.1468-1331.2011.03538.x; van der Hiele K, 2012, J NEUROL SCI, V320, P85, DOI 10.1016/j.jns.2012.06.023; Visser LH, 2014, NEURODEGENER DIS MAN, V4, P109, DOI [10.2217/nmt.14.15, 10.2217/NMT.14.15]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105673	10.1371/journal.pone.0105673	http://dx.doi.org/10.1371/journal.pone.0105673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153710	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200068
J	Cabello, M; Mendoza, Y; Bello, G				Cabello, Marina; Mendoza, Yaxelis; Bello, Gonzalo			Spatiotemporal Dynamics of Dissemination of Non-Pandemic HIV-1 Subtype B Clades in the Caribbean Region	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL DRUG-RESISTANCE; DIAGNOSED CUBAN PATIENTS; HIGH GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; PUERTO-RICO; EVOLUTIONARY HISTORY; POPULATION-DYNAMICS; MAXIMUM-LIKELIHOOD; RECOMBINANT FORMS	The Human immunodeficiency virus type-1 (HIV-1) epidemic in the Caribbean region is mostly driven by subtype B; but information about the pattern of viral spread in this geographic region is scarce and different studies point to quite divergent models of viral dissemination. In this study, we reconstructed the spatiotemporal and population dynamics of the HIV-1 subtype B epidemic in the Caribbean. A total of 1,806 HIV-1 subtype B pol sequences collected from 17 different Caribbean islands between 1996 and 2011 were analyzed together with sequences from the United States (n = 525) and France (n = 340) included as control. Maximum Likelihood phylogenetic analyses revealed that HIV-1 subtype B infections in the Caribbean are driven by dissemination of the pandemic clade (B-PANDEMIC) responsible for most subtype B infections across the world, and older non-pandemic lineages (B-CAR) characteristics of the Caribbean region. The non-pandemic B-CAR strains account for >40% of HIV-1 infections in most Caribbean islands; with exception of Cuba and Puerto Rico. Bayesian phylogeographic analyses indicate that B-CAR strains probably arose in the island of Hispaniola (Haiti/Dominican Republic) around the middle 1960s and were later disseminated to Trinidad and Tobago and to Jamaica between the late 1960s and the early 1970s. In the following years, the B-CAR strains were also disseminated from Hispaniola and Trinidad and Tobago to other Lesser Antilles islands at multiple times. The B-CAR clades circulating in Hispaniola, Jamaica and Trinidad and Tobago appear to have experienced an initial phase of exponential growth, with mean estimated growth rates of 0.35-0.45 year(-1), followed by a more recent stabilization since the middle 1990s. These results demonstrate that non-pandemic subtype B lineages have been widely disseminated through the Caribbean since the late 1960s and account for an important fraction of current HIV-1 infections in the region.	[Cabello, Marina; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil; [Mendoza, Yaxelis] Gorgas Mem Inst Hlth Studies, Dept Genom & Proteom, Panama City, Panama; [Mendoza, Yaxelis] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur City, Andhra Pradesh, India; [Mendoza, Yaxelis] Univ Panama, Dept Genet & Mol Biol, Panama City, Panama; [Mendoza, Yaxelis] INDICASAT AIP, INDICASAT AIP,City Knowledge,Clayton, Panama City, Panama	Fundacao Oswaldo Cruz; Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Universidad de Panama; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP)	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	gbellobr@gmail.com	Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793	FAPERJ [E-26/111.758/2012, 472896/2012-1]; Instituto Oswaldo Cruz - FIOCRUZ; CNPq [472896/2012-1]	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Oswaldo Cruz - FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Public Health Service grants E-26/111.758/2012 from the FAPERJ and 472896/2012-1 from the CNPq. MC was funded by a fellowship from Instituto Oswaldo Cruz -FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; BARTHOLOMEW C, 1987, JAMA-J AM MED ASSOC, V257, P2604, DOI 10.1001/jama.257.19.2604; BARTHOLOMEW C, 1983, W INDIAN MED J, V32, P177; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Passaes CPB, 2009, INFECT GENET EVOL, V9, P474, DOI 10.1016/j.meegid.2009.01.008; Chen J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026827, 10.1371/journal.pone.0025286]; Cleghorn FR, 2000, P NATL ACAD SCI USA, V97, P10532, DOI 10.1073/pnas.97.19.10532; Cohen J, 2006, SCIENCE, V313, P473, DOI 10.1126/science.313.5786.473; Veras NMC, 2011, AIDS RES HUM RETROV, V27, P1173, DOI [10.1089/aid.2010.0333, 10.1089/AID.2010.0333]; Collins-Fairclough AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019995; Cuevas MT, 2002, AIDS, V16, P1643, DOI 10.1097/00002030-200208160-00010; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Arazoza H, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-130; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074072; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448; Delatorre E, 2013, AIDS, V27, P1313, DOI 10.1097/QAD.0b013e32835f1df4; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Deren S, 2003, AM J PUBLIC HEALTH, V93, P812, DOI 10.2105/AJPH.93.5.812; Deren S, 2007, J URBAN HEALTH, V84, P243, DOI 10.1007/s11524-006-9151-5; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Figueras MA, 2001, LAT AM STUD ASS LASA; Figueroa JP, 2008, W INDIAN MED J, V57, P195; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gittens MV, 2003, AIDS RES HUM RETROV, V19, P313, DOI 10.1089/088922203764969519; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton CLC, 2012, AIDS RES HUM RETROV, V28, P923, DOI [10.1089/aid.2011.0312, 10.1089/AID.2011.0312]; Heslop OD, 2009, W INDIAN MED J, V58, P195; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489; KOENIG RE, 1987, JAMA-J AM MED ASSOC, V257, P631, DOI 10.1001/jama.257.5.631; Kouri V, 2012, J CLIN VIROL, V55, P348, DOI 10.1016/j.jcv.2012.08.019; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Machado LY, 2013, AIDS RES HUM RETROV, V29, P411, DOI [10.1089/AID.2012.0183, 10.1089/aid.2012.0183]; Machado LY, 2012, AIDS RES HUM RETROV, V28, P956, DOI [10.1089/aid.2011.0295, 10.1089/AID.2011.0295]; Mendoza Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095360; Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8; Murillo W, 2013, J VIROL, V87, P7463, DOI 10.1128/JVI.01602-12; MURPHY EL, 1988, J ACQ IMMUN DEF SYND, V1, P143; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; Narain J P, 1989, Bull Pan Am Health Organ, V23, P42; Noel RJ, 2003, CELL MOL BIOL, V49, P1193; Pagan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069218; PAPE JW, 1983, NEW ENGL J MED, V309, P945, DOI 10.1056/NEJM198310203091603; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Perez L, 2013, INFECT GENET EVOL, V16, P144, DOI 10.1016/j.meegid.2013.02.002; Perez L, 2006, AIDS RES HUM RETROV, V22, P724, DOI 10.1089/aid.2006.22.724; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2014, FIGTREE V14 TREE FIG; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Rojas Patria, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P306, DOI 10.1177/1545109710397770; Roye ME, 2011, AIDS RES HUM RETROV, V27, P91, DOI 10.1089/aid.2010.0106; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Sepulveda-Torres Ldel C, 2012, AIDS RES TREAT, V2012; Suchard M., 2007, TRACER V1 6; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217; UNAIDS, 2013, REP GLOB AIDS EP; Vaughan HE, 2003, AIDS RES HUM RETROV, V19, P929, DOI 10.1089/088922203322493120; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	75	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106045	10.1371/journal.pone.0106045	http://dx.doi.org/10.1371/journal.pone.0106045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148215	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600110
J	Leonhardt, SD; Kaltenpoth, M				Leonhardt, Sara D.; Kaltenpoth, Martin			Microbial Communities of Three Sympatric Australian Stingless Bee Species	PLOS ONE			English	Article							APIS-MELLIFERA; HONEY-BEES; CROP POLLINATION; GUT MICROBIOTA; ACID BACTERIA; BUMBLE-BEES; DIVERSITY; POLLEN; IDENTIFICATION; SYMBIONTS	Bacterial symbionts of insects have received increasing attention due to their prominent role in nutrient acquisition and defense. In social bees, symbiotic bacteria can maintain colony homeostasis and fitness, and the loss or alteration of the bacterial community may be associated with the ongoing bee decline observed worldwide. However, analyses of microbiota associated with bees have been largely confined to the social honeybees (Apis mellifera) and bumblebees (Bombus spec.), revealing - among other taxa - host-specific lactic acid bacteria (LAB, genus Lactobacillus) that are not found in solitary bees. Here, we characterized the microbiota of three Australian stingless bee species (Apidae: Meliponini) of two phylogenetically distant genera (Tetragonula and Austroplebeia). Besides common plant bacteria, we find LAB in all three species, showing that LAB are shared by honeybees, bumblebees and stingless bees across geographical regions. However, while LAB of the honeybee-associated Firm4-5 clusters were present in Tetragonula, they were lacking in Austroplebeia. Instead, we found a novel clade of likely host-specific LAB in all three Australian stingless bee species which forms a sister clade to a large cluster of Halictidae-associated lactobacilli. Our findings indicate both a phylogenetic and geographical signal of host-specific LAB in stingless bees and highlight stingless bees as an interesting group to investigate the evolutionary history of the bee-LAB association.	[Leonhardt, Sara D.] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany; [Kaltenpoth, Martin] Max Planck Inst Chem Ecol, Insect Symbiosis Res Grp, Jena, Germany	University of Wurzburg; Max Planck Society	Leonhardt, SD (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany.	sara.leonhardt@uni-wuerzburg.de; mkaltenpoth@ice.mpg.de	Kaltenpoth, Martin/M-8475-2014; Leonhardt, Sara/AAI-6901-2020	Kaltenpoth, Martin/0000-0001-9450-0345; Leonhardt, Sara/0000-0002-8154-9569	German Science Foundation [LE2750/1-1, KA2846/2-1]; Max Planck Society	German Science Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	The authors gratefully acknowledge funding from the German Science Foundation (LE2750/1-1 to SDL, and KA2846/2-1 to MK; www.dfg.de) and the Max Planck Society (MK; www.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Banaszak J., 1995, CHANGES FAUNA WILD B; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Dollin A, 2009, TRIGONA CARBONARIA S; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Genin S, 2004, ANNU REV PHYTOPATHOL, V42, P107, DOI 10.1146/annurev.phyto.42.011204.104301; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; GILLIAM M, 1988, J INVERTEBR PATHOL, V52, P314, DOI 10.1016/0022-2011(88)90141-3; GOULSON D, 2003, BUMBLEBEES THEIR BEH; HEINRICH B, 1976, ECOL MONOGR, V46, P105, DOI 10.2307/1942246; HEINRICH B, 1977, BEHAV ECOL SOCIOBIOL, V2, P247, DOI 10.1007/BF00299738; HEITHAUS ER, 1979, ECOLOGY, V60, P190, DOI 10.2307/1936480; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Junker RR, 2011, PLANT BIOLOGY, V13, P918, DOI 10.1111/j.1438-8677.2011.00454.x; Keller A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078296; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2008, EC SOC AM ANN M; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Leonhardt SD, 2014, APIDOLOGIE, V45, P514, DOI 10.1007/s13592-013-0266-x; Leonhardt SD, 2011, AUSTRAL ECOL, V36, P537, DOI 10.1111/j.1442-9993.2010.02184.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loncaric I, 2009, APIDOLOGIE, V40, P40, DOI 10.1051/apido/2008062; Lyapunov YE, 2008, MICROBIOLOGY+, V77, P373, DOI 10.1134/S0026261708030181; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; McFrederick SQ, 2013, APPL ENVIRON MICROB; MERGAERT J, 1984, J GEN MICROBIOL, V130, P1893; Michener C.D., 2007, BEES WORLD, Vsecond; MILBORROW BV, 1987, AUST J BIOL SCI, V40, P15; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Olofsson TC, 2009, J APICULT RES, V48, P233, DOI 10.3896/IBRA.1.48.4.02; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Promnuan Y, 2009, WORLD J MICROB BIOT, V25, P1685, DOI 10.1007/s11274-009-0051-1; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rasmussen C, 2007, SYST ENTOMOL, V32, P26, DOI 10.1111/j.1365-3113.2006.00362.x; Rasmussen C, 2010, BIOL J LINN SOC, V99, P206, DOI 10.1111/j.1095-8312.2009.01341.x; Ryan MP, 2014, EUR J CLIN MICROBIOL, V33, P291, DOI 10.1007/s10096-013-1975-9; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Sun Y, 2011, METHODS MOL BIOL, V733, P129, DOI 10.1007/978-1-61779-089-8_9; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Walker K, 2010, AUSTROPLEBEIA AUSTRA; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1	62	34	34	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105718	10.1371/journal.pone.0105718	http://dx.doi.org/10.1371/journal.pone.0105718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148082	Green Published, gold			2022-12-25	WOS:000341230600074
J	Li, XQ; Choi, WW; Yan, R; Yu, HY; Krasnoperov, V; Kumar, SR; Schuckman, A; Klumpp, DJ; Pan, CX; Quinn, D; Gill, IS; Gill, PS; Liu, R				Li, Xiuqing; Choi, Wesley W.; Yan, Rui; Yu, Haiyang; Krasnoperov, Valery; Kumar, S. Ram; Schuckman, Anne; Klumpp, David J.; Pan, Chong-Xian; Quinn, David; Gill, Inderbir S.; Gill, Parkash S.; Liu, Ren			The Differential Expression of EphB2 and EphB4 Receptor Kinases in Normal Bladder and in Transitional Cell Carcinoma of the Bladder	PLOS ONE			English	Article							COLORECTAL-CANCER PROGRESSION; TYROSINE KINASE; PROSTATE-CANCER; TUMOR ANGIOGENESIS; EPHRIN-B2; SURVIVAL; GROWTH; DISEASE; SIGNALS; TARGET	Effective treatment of transitional cell carcinoma (TCC) of the bladder requires early diagnosis. Identifying novel molecular markers in TCC would guide the development of diagnostic and therapeutic targets. Ephrins mediate signals via tyrosine kinase activity that modulates diverse physiologic and developmental processes, and ephrins are increasingly implicated in carcinogenesis. The aim of our study was to examine the differential regulation of EphB4 and EphB2 in normal bladder and in TCC of the bladder in 40 patients undergoing radical cystectomy for curative intent. Immunostaining and Western blotting revealed that normal urothelium expresses EphB2 (20 of 24 cases, 83% of the time) not EphB4 (0 of 24 cases, 0%). In sharp contrast, TCC specimens show loss of EphB2 expression (0 of 34 cases, 0%) and gain of EphB4 expression (32 of 34, 94%). Furthermore, EphB4 signal strength statistically correlated with higher tumor stage, and trended toward the presence of carcinoma in situ (CIS). These results are confirmed by analysis of normal urothelial and tumor cell lines. EphB2 is not a survival factor in normal urothelium, while EphB4 is a survival factor in TCC. Treatment of bladder tumor xenograft with an EphB4 inhibitor sEphB4-HSA leads to 62% tumor regression and complete remission when combined with Bevacizumab. Furthermore, tissue analysis revealed that sEphB4-HSA led to increased apoptosis, decreased proliferation, and reduced vessel density, implicating direct tumor cell targeting as well as anti-angiogenesis effect. In summary loss of EphB2 and gain of EphB4 expression represents an inflection point in the development, growth and possibly progression of TCC. Therapeutic compounds targeting EphB4 have potential for diagnosing and treating TCC.	[Li, Xiuqing; Yan, Rui; Yu, Haiyang; Quinn, David; Gill, Parkash S.; Liu, Ren] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Choi, Wesley W.; Gill, Inderbir S.] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90033 USA; [Yu, Haiyang] Cent S Univ, Natl Hepatobiliary & Enter Surg Res Ctr, Dept Surg, Changsha, Hunan, Peoples R China; [Krasnoperov, Valery] VasGene Therapeut Inc, Los Angeles, CA USA; [Kumar, S. Ram; Schuckman, Anne] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Quinn, David] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Pan, Chong-Xian] Univ Calif Davis Comprehens Canc, Dept Internal Med, Sacramento, CA USA	University of Southern California; University of Southern California; Central South University; University of Southern California; Northwestern University; Feinberg School of Medicine	Gill, PS (corresponding author), Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA.	parkashg@usc.edu; renliu@usc.edu	Quinn, David/N-3730-2019; Quinn, David I/F-4343-2015	Quinn, David/0000-0002-1411-0417; Quinn, David I/0000-0002-1411-0417	Ezralow Family; Veterans Affairs [I01BX001784] Funding Source: NIH RePORTER	Ezralow Family; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Ezralow Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Chen MC, 2006, AM J PHYSIOL-RENAL, V291, pF741, DOI 10.1152/ajprenal.00081.2006; Djokovic D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-641; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Ferguson BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067668; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Hasina R, 2013, CANCER RES, V73, P184, DOI 10.1158/0008-5472.CAN-12-0915; Kertesz N, 2006, BLOOD, V107, P2330, DOI 10.1182/blood-2005-04-1655; Kittles RA, 2006, J MED GENET, V43, P507, DOI 10.1136/jmg.2005.035790; Kumar SR, 2007, BRIT J CANCER, V96, P1083, DOI 10.1038/sj.bjc.6603642; Kumar SR, 2006, AM J PATHOL, V169, P279, DOI 10.2353/ajpath.2006.050889; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Lee YC, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-119; Liu R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-269; Masood R, 2006, INT J CANCER, V119, P1236, DOI 10.1002/ijc.21926; MESSING EM, 2002, CAMPBELLS UROLOGY; Mitra AP, 2006, J CLIN ONCOL, V24, P5552, DOI 10.1200/JCO.2006.08.2073; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Scehnet JS, 2009, BLOOD, V113, P254, DOI 10.1182/blood-2008-02-140020; Sinha UK, 2006, ARCH OTOLARYNGOL, V132, P1053, DOI 10.1001/archotol.132.10.1053; Spannuth WA, 2010, MOL CANCER THER, V9, P2377, DOI 10.1158/1535-7163.MCT-10-0200; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Tickle C, 1999, CURR OPIN GENET DEV, V9, P455, DOI 10.1016/S0959-437X(99)80069-0; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wu QH, 2004, PATHOL ONCOL RES, V10, P26, DOI 10.1007/BF02893405; Xia G, 2006, ONCOGENE, V25, P769, DOI 10.1038/sj.onc.1209108; Xia GB, 2005, CANCER RES, V65, P4623, DOI 10.1158/0008-5472.CAN-04-2667; Xia GB, 2006, J UROLOGY, V175, P1245, DOI 10.1016/S0022-5347(05)00736-6	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105326	10.1371/journal.pone.0105326	http://dx.doi.org/10.1371/journal.pone.0105326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148033	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600043
J	Pightling, AW; Petronella, N; Pagotto, F				Pightling, Arthur W.; Petronella, Nicholas; Pagotto, Franco			Choice of Reference Sequence and Assembler for Alignment of Listeria monocytogenes Short-Read Sequence Data Greatly Influences Rates of Error in SNP Analyses	PLOS ONE			English	Article							DISCOVERY; FRAMEWORK; GENOTYPE; BLOCKS	The wide availability of whole-genome sequencing (WGS) and an abundance of open-source software have made detection of single-nucleotide polymorphisms (SNPs) in bacterial genomes an increasingly accessible and effective tool for comparative analyses. Thus, ensuring that real nucleotide differences between genomes (i.e., true SNPs) are detected at high rates and that the influences of errors (such as false positive SNPs, ambiguously called sites, and gaps) are mitigated is of utmost importance. The choices researchers make regarding the generation and analysis of WGS data can greatly influence the accuracy of short-read sequence alignments and, therefore, the efficacy of such experiments. We studied the effects of some of these choices, including: i) depth of sequencing coverage, ii) choice of reference-guided short-read sequence assembler, iii) choice of reference genome, and iv) whether to perform read-quality filtering and trimming, on our ability to detect true SNPs and on the frequencies of errors. We performed benchmarking experiments, during which we assembled simulated and real Listeria monocytogenes strain 08-5578 short-read sequence datasets of varying quality with four commonly used assemblers (BWA, MOSAIK, Novoalign, and SMALT), using reference genomes of varying genetic distances, and with or without read pre-processing (i.e., quality filtering and trimming). We found that assemblies of at least 50-fold coverage provided the most accurate results. In addition, MOSAIK yielded the fewest errors when reads were aligned to a nearly identical reference genome, while using SMALT to align reads against a reference sequence that is similar to 0.82% distant from 08-5578 at the nucleotide level resulted in the detection of the greatest numbers of true SNPs and the fewest errors. Finally, we show that whether read pre-processing improves SNP detection depends upon the choice of reference sequence and assembler. In total, this study demonstrates that researchers should test a variety of conditions to achieve optimal results.	[Pightling, Arthur W.; Pagotto, Franco] Hlth Canada, Listeriosis Reference Serv Canada, Hlth Prod & Food Branch, Div Res,Food Directorate,Bur Microbial Hazards, Ottawa, ON K1A 0L2, Canada; [Petronella, Nicholas] Hlth Canada, Hlth Prod & Food Branch, Bur Food Surveillance & Sci Integrat, Biostat & Modelling Div,Food Directorate, Ottawa, ON K1A 0L2, Canada	Health Canada; Health Canada	Pagotto, F (corresponding author), Hlth Canada, Listeriosis Reference Serv Canada, Hlth Prod & Food Branch, Div Res,Food Directorate,Bur Microbial Hazards, Ottawa, ON K1A 0L2, Canada.	Franco.Pagotto@hc-sc.gc.ca	PIGHTLING, ARTHUR/AAD-6621-2020		Genomics R&D Initiative (GRDI) grant [4500834]; Natural Sciences and Engineering Research Council (NSERC)	Genomics R&D Initiative (GRDI) grant; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by Genomics R&D Initiative (GRDI) grant #4500834, awarded to FP. AWP was supported by a Natural Sciences and Engineering Research Council (NSERC) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Brockhurst MA, 2011, MOL ECOL, V20, P972, DOI 10.1111/j.1365-294X.2010.04835.x; Burrows M., 1994, BLOCK SORTING LOSSLE; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Courvalin P, 2005, EMERG INFECT DIS, V11, P1503, DOI 10.3201/eid1110.051014; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Dettman JR, 2012, MOL ECOL, V21, P2058, DOI 10.1111/j.1365-294X.2012.05484.x; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Farrer RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01512; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Holch A, 2013, APPL ENVIRON MICROB, V79, P2944, DOI 10.1128/AEM.03715-12; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Knabel SJ, 2012, J CLIN MICROBIOL, V50, P1748, DOI 10.1128/JCM.06185-11; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; Landan G, 2009, GENE, V441, P141, DOI 10.1016/j.gene.2008.05.016; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S8; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moorhead SM, 2003, J MICROBIOL METH, V55, P425, DOI 10.1016/S0167-7012(03)00188-X; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; SMITH TF, 1981, J MOL EVOL, V18, P38, DOI 10.1007/BF01733210; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Williams Larissa M, 2010, BMC Genet, V11, P32, DOI 10.1186/1471-2156-11-32; Wilson DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002874	38	55	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104579	10.1371/journal.pone.0104579	http://dx.doi.org/10.1371/journal.pone.0104579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144537	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100016
J	Stalmach, A; Johnsson, H; McInnes, IB; Husi, H; Klein, J; Dakna, M; Mullen, W; Mischak, H; Porter, D				Stalmach, Angelique; Johnsson, Hanna; McInnes, Iain B.; Husi, Holger; Klein, Julie; Dakna, Mohammed; Mullen, William; Mischak, Harald; Porter, Duncan			Identification of Urinary Peptide Biomarkers Associated with Rheumatoid Arthritis	PLOS ONE			English	Article							PROTEOME ANALYSIS; DIAGNOSIS; TOOL; PROGRESSION; VALIDATION; KALLIKREIN; CRITERIA; MMP-1	Early diagnosis and treatment of rheumatoid arthritis are associated with improved outcomes but current diagnostic tools such as rheumatoid factor or anti-citrullinated protein antibodies have shown limited sensitivity. In this pilot study we set out to establish a panel of urinary biomarkers associated with rheumatoid arthritis using capillary electrophoresis coupled to mass spectrometry. We compared the urinary proteome of 33 participants of the Scottish Early Rheumatoid Arthritis inception cohort study with 30 healthy controls and identified 292 potential rheumatoid arthritis-specific peptides. Amongst them, 39 were used to create a classifier model using support vector machine algorithms. Specific peptidic fragments were differentially excreted between groups; fragments of protein S100-A9 and gelsolin were less abundant in rheumatoid arthritis while fragments of uromodulin, complement C3 and fibrinogen were all increasingly excreted. The model generated was subsequently tested in an independent test-set of 31 samples. The classifier demonstrated a sensitivity of 88% and a specificity of 93% in diagnosing the condition, with an area under the receiver operating characteristic curve of 0.93 (p<0.0001). These preliminary results suggest that urinary biomarkers could be useful in the early diagnosis of rheumatoid arthritis. Further studies are currently being undertaken in larger cohorts of patients with rheumatoid arthritis and other athridities to assess the potential of the urinary peptide based classifier in the early detection of rheumatoid arthritis.	[Stalmach, Angelique; Husi, Holger; Mullen, William; Mischak, Harald] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Johnsson, Hanna] Western Gen Infirm, Edinburgh, Midlothian, Scotland; [McInnes, Iain B.; Porter, Duncan] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Klein, Julie; Dakna, Mohammed; Mischak, Harald] Mosaiques Diagnost GmbH, Hannover, Germany	University of Glasgow; University of Glasgow; Mosaiques Diagnostics GmbH (MOS)	Stalmach, A (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	Angelique.Stalmach@glasgow.ac.uk	Mullen, William/GWC-8078-2022; Stalmach, Angelique/B-3250-2009; Klein, Julie/M-7088-2017; Klein, Julie/ABE-2622-2020	Stalmach, Angelique/0000-0003-4491-654X; Klein, Julie/0000-0002-3279-0559; Klein, Julie/0000-0002-3279-0559; Porter, Duncan/0000-0001-8481-5204; Mullen, William/0000-0002-5685-1563; McInnes, Iain/0000-0002-6462-4280; Johnsson, Hanna/0000-0003-1916-6222; Mischak, Harald/0000-0003-0323-0306	Chief Scientist's Office, Scottish Government; Pfizer	Chief Scientist's Office, Scottish Government; Pfizer(Pfizer)	The Scottish Early Rheumatoid Arthritis (SERA) inception cohort and biobank is funded by the Chief Scientist's Office, Scottish Government and Pfizer; neither funder was involved in this study design, execution, analysis, decision to publish or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cader MZ, 2011, ANN RHEUM DIS, V70, P949, DOI 10.1136/ard.2010.143560; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Cassim B, 2009, RHEUMATOLOGY, V48, P490, DOI 10.1093/rheumatology/kep016; Chandra PE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3383; Dakna M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-594; Dawson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035879; De Franceschi L, 2011, PROTEOM CLIN APPL, V5, P78, DOI 10.1002/prca.201000069; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Eissa A, 2013, CLIN CHEM LAB MED, V51, P317, DOI 10.1515/cclm-2012-0251; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Green MJ, 2003, RHEUMATOLOGY, V42, P83, DOI 10.1093/rheumatology/keg037; Isordia-Salas I, 2004, ARCH MED RES, V35, P369, DOI 10.1016/j.arcmed.2004.05.004; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Judex MO, 2005, AM J PATHOL, V166, P645, DOI 10.1016/S0002-9440(10)62285-7; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Klein J, 2013, PROTEOMICS, V13, P1077, DOI 10.1002/pmic.201200493; Kriegsmann M, 2012, SCAND J RHEUMATOL, V41, P305, DOI 10.3109/03009742.2011.647925; Metzger J, 2010, KIDNEY INT, V78, P1252, DOI 10.1038/ki.2010.322; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Mischak H, 2010, NEPHROL DIAL TRANSPL, V25, P2843, DOI 10.1093/ndt/gfq363; Mischak H, 2010, PROTEOM CLIN APPL, V4, P464, DOI 10.1002/prca.200900189; Mullan RH, 2007, ARTHRITIS RHEUM, V56, P2919, DOI 10.1002/art.22843; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P283, DOI 10.1002/art.10092; Osborn TM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2520; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; RAHMAN MM, 1995, BRIT J RHEUMATOL, V34, P88; RAHMAN MM, 1995, ANN RHEUM DIS, V54, P345, DOI 10.1136/ard.54.5.345; Scarisbrick IA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018376; Schiffer E, 2012, INT J UROL, V19, P118, DOI 10.1111/j.1442-2042.2011.02901.x; Symmons DPM, 1998, J RHEUMATOL, V25, P1072; TRABANDT A, 1991, ARTHRITIS RHEUM, V34, P1444; Verstappen SMM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1882; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Whiting PF, 2010, ANN INTERN MED, V152, P456, DOI 10.7326/0003-4819-152-7-201004060-00010; Wild N, 2008, BIOMARKERS, V13, P88, DOI 10.1080/13547500701669410 ; Williams RJ, 1997, BRIT J RHEUMATOL, V36, P420; Wittke S, 2003, J CHROMATOGR A, V1013, P173, DOI 10.1016/S0021-9673(03)00713-1; Zhao XY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2478	44	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104625	10.1371/journal.pone.0104625	http://dx.doi.org/10.1371/journal.pone.0104625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144639	Green Published, gold, Green Accepted			2022-12-25	WOS:000341106100017
J	Xiao, JQ; Cerminara, NL; Kotsurovskyy, Y; Aoki, H; Burroughs, A; Wise, AK; Luo, YJ; Marshall, SP; Sugihara, I; Apps, R; Lang, EJ				Xiao, Jianqiang; Cerminara, Nadia L.; Kotsurovskyy, Yuriy; Aoki, Hanako; Burroughs, Amelia; Wise, Andrew K.; Luo, Yuanjun; Marshall, Sarah P.; Sugihara, Izumi; Apps, Richard; Lang, Eric J.			Systematic Regional Variations in Purkinje Cell Spiking Patterns	PLOS ONE			English	Article							RAT CEREBELLAR CORTEX; ALDOLASE-C COMPARTMENTS; GLUTAMATE TRANSPORTER EAAT4; CLIMBING FIBER PROJECTION; ELECTROPHYSIOLOGICAL PROPERTIES; FUNCTIONAL-ORGANIZATION; SYNAPTIC-TRANSMISSION; PARAMEDIAN LOBULE; CHLORIDE CHANNEL; COPULA PYRAMIDIS	In contrast to the uniform anatomy of the cerebellar cortex, molecular and physiological studies indicate that significant differences exist between cortical regions, suggesting that the spiking activity of Purkinje cells (PCs) in different regions could also show distinct characteristics. To investigate this possibility we obtained extracellular recordings from PCs in different zebrin bands in crus IIa and vermis lobules VIII and IX in anesthetized rats in order to compare PC firing characteristics between zebrin positive (Z+) and negative (Z-) bands. In addition, we analyzed recordings from PCs in the A2 and C1 zones of several lobules in the posterior lobe, which largely contain Z+ and Z- PCs, respectively. In both datasets significant differences in simple spike (SS) activity were observed between cortical regions. Specifically, Z- and C1 PCs had higher SS firing rates than Z+ and A2 PCs, respectively. The irregularity of SS firing (as assessed by measures of interspike interval distribution) was greater in Z+ bands in both absolute and relative terms. The results regarding systematic variations in complex spike (CS) activity were less consistent, suggesting that while real differences can exist, they may be sensitive to other factors than the cortical location of the PC. However, differences in the interactions between SSs and CSs, including the post-CS pause in SSs and post-pause modulation of SSs, were also consistently observed between bands. Similar, though less strong trends were observed in the zonal recordings. These systematic variations in spontaneous firing characteristics of PCs between zebrin bands in vivo, raises the possibility that fundamental differences in information encoding exist between cerebellar cortical regions.	[Xiao, Jianqiang; Kotsurovskyy, Yuriy; Marshall, Sarah P.; Lang, Eric J.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY USA; [Cerminara, Nadia L.; Burroughs, Amelia; Apps, Richard] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Wise, Andrew K.] Bion Inst, East Melbourne, Vic, Australia; [Aoki, Hanako; Luo, Yuanjun; Sugihara, Izumi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Syst Neurophysiol, Tokyo, Japan; [Sugihara, Izumi] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan	New York University; University of Bristol; Bionics Institute; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Apps, R (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	r.apps@bristol.ac.uk; eric.lang@nyumc.org	; Wise, Andrew/B-5943-2014; Lang, Eric J/A-1136-2017	Kotsurovskyy, Yuriy/0000-0002-1288-518X; Cerminara, Nadia/0000-0001-8207-5871; Wise, Andrew/0000-0001-9715-8784; Lang, Eric J/0000-0002-8524-9854; Apps, Richard/0000-0002-2064-3359	National Science Foundation, United States of America [IOS-1051858]; National Institute of Neurological Disorders and Stroke [NS-37028]; Japan Society for the Promotion of Science (JSPS) [25430032]; Medical Research Council, United Kingdom [G1100626]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037028] Funding Source: NIH RePORTER; Medical Research Council [G1100626] Funding Source: researchfish; MRC [G1100626] Funding Source: UKRI; Direct For Biological Sciences [1051858] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [25430032, 26430035] Funding Source: KAKEN	National Science Foundation, United States of America(National Science Foundation (NSF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants to EJL from the National Science Foundation, United States of America (www.NSF.gov) (Grant: IOS-1051858) and National Institute of Neurological Disorders and Stroke (www.ninds.nih.gov) (Grant: NS-37028), to RA and NLC from the Medical Research Council, United Kingdom (www.mrc.ac.uk/index.htm) (Grant: G1100626), and to IS from the Japan Society for the Promotion of Science (JSPS) (www.jsps.go.jp/english/) (Grants-in- Aid for Scientific Research-KAKENHI, 25430032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Alvina K, 2010, J NEUROSCI, V30, P7258, DOI 10.1523/JNEUROSCI.3582-09.2010; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Atkins MJ, 1997, J COMP NEUROL, V389, P249; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BLOEDEL JR, 1971, J NEUROPHYSIOL, V34, P17, DOI 10.1152/jn.1971.34.1.17; BLOEDEL JR, 1992, BEHAV BRAIN SCI, V15, P666; Braitenberg V, 2002, ANN NY ACAD SCI, V978, P175, DOI 10.1111/j.1749-6632.2002.tb07565.x; Brasnjo G, 2004, P NATL ACAD SCI USA, V101, P6273, DOI 10.1073/pnas.0308149101; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; BURG D, 1972, PFLUG ARCH EUR J PHY, V337, P367, DOI 10.1007/BF00586652; Cerminara NL, 2013, J NEUROSCI, V33, P16427, DOI 10.1523/JNEUROSCI.0861-13.2013; Cerminara NL, 2011, CEREBELLUM, V10, P484, DOI 10.1007/s12311-010-0209-2; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Chaumont J, 2013, P NATL ACAD SCI USA, V110, P16223, DOI 10.1073/pnas.1302310110; Chung SH, 2009, NEUROSCIENCE, V161, P123, DOI 10.1016/j.neuroscience.2009.03.037; Coddington LT, 2013, NEURON, V78, P1050, DOI 10.1016/j.neuron.2013.04.019; COLIN F, 1980, BRAIN RES, V187, P3, DOI 10.1016/0006-8993(80)90491-6; Dehnes Y, 1998, J NEUROSCI, V18, P3606; DEMER JL, 1985, BRAIN RES, V346, P22, DOI 10.1016/0006-8993(85)91090-X; Dino MR, 1999, J NEUROCYTOL, V28, P99, DOI 10.1023/A:1007072105919; EBNER TJ, 1981, J NEUROPHYSIOL, V45, P933, DOI 10.1152/jn.1981.45.5.933; ECCLES JC, 1973, J PHYSIOL-LONDON, V229, P1; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; ECCLES JC, 1966, EXP BRAIN RES, V2, P18; Eccles JC, 1967, CEREBELLUM NEURONAL; Gao WC, 2006, J NEUROSCI, V26, P8377, DOI 10.1523/JNEUROSCI.2434-06.2006; Glasauer S, 2011, ANN NY ACAD SCI, V1233, P162, DOI 10.1111/j.1749-6632.2011.06149.x; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; HAMORI J, 1980, BRAIN RES, V186, P454, DOI 10.1016/0006-8993(80)90990-7; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; Hawkes R, 1997, PROG BRAIN RES, V114, P39; Heck DH, 2013, J NEUROSCI, V33, P17603, DOI 10.1523/JNEUROSCI.2759-13.2013; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; JI Z, 1994, NEUROSCIENCE, V61, P935, DOI 10.1016/0306-4522(94)90414-6; Jorntell H, 2003, J NEUROSCI, V23, P9620; Kim YS, 2009, J NEUROSCI, V29, P8530, DOI 10.1523/JNEUROSCI.0468-09.2009; Lang EJ, 2002, J NEUROPHYSIOL, V87, P1993, DOI 10.1152/jn.00477.2001; Lang EJ, 1999, J NEUROSCI, V19, P2728; LATHAM A, 1971, J PHYSIOL-LONDON, V213, P135, DOI 10.1113/jphysiol.1971.sp009373; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Marshall SP, 2009, J NEUROSCI, V29, P14352, DOI 10.1523/JNEUROSCI.3498-09.2009; Mathews PJ, 2012, J NEUROSCI, V32, P17988, DOI 10.1523/JNEUROSCI.3916-12.2012; MCDEVITT CJ, 1982, BRAIN RES, V237, P484, DOI 10.1016/0006-8993(82)90460-7; MONTAROLO PG, 1982, J PHYSIOL-LONDON, V332, P187, DOI 10.1113/jphysiol.1982.sp014409; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nagao S, 1997, NEUROSCIENCE, V78, P929; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Ozden I, 2009, J NEUROSCI, V29, P10463, DOI 10.1523/JNEUROSCI.0967-09.2009; Pakan JMP, 2010, J COMP NEUROL, V518, P175, DOI 10.1002/cne.22192; PALKOVITS M, 1977, EXP BRAIN RES, V28, P189; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Pham NQ, 2011, J COMP NEUROL, V519, P874, DOI 10.1002/cne.22555; Pijpers A, 2006, J NEUROSCI, V26, P12067, DOI 10.1523/JNEUROSCI.2905-06.2006; Raman IM, 1999, J NEUROSCI, V19, P1663; RAWSON JA, 1981, NEUROSCI LETT, V25, P125, DOI 10.1016/0304-3940(81)90319-0; Ruigrok TJH, 2011, CEREBELLUM, V10, P464, DOI 10.1007/s12311-010-0164-y; SASAKI K, 1989, EUR J NEUROSCI, V1, P572, DOI 10.1111/j.1460-9568.1989.tb00364.x; SAVIO T, 1985, EXP BRAIN RES, V57, P456; Schonewille M, 2006, NAT NEUROSCI, V9, P459, DOI 10.1038/nn0406-459; Shin JH, 2008, P NATL ACAD SCI USA, V105, P746, DOI 10.1073/pnas.0709407105; Shin SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000485; Simpson JI, 2002, ANN NY ACAD SCI, V978, P232, DOI 10.1111/j.1749-6632.2002.tb07570.x; Stahl JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057895; STEIN RB, 1967, BIOPHYS J, V7, P797, DOI 10.1016/S0006-3495(67)86623-2; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Sugihara I, 2007, J COMP NEUROL, V500, P1076, DOI 10.1002/cne.21219; Sugihara I, 2007, J COMP NEUROL, V501, P13, DOI 10.1002/cne.21223; Sugihara I, 2011, CEREBELLUM, V10, P449, DOI 10.1007/s12311-010-0226-1; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; Szapiro G, 2007, NAT NEUROSCI, V10, P735, DOI 10.1038/nn1907; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Takayasu Y, 2004, EUR J NEUROSCI, V19, P1285, DOI 10.1111/j.1460-9568.2004.03224.x; Tanaka J, 1997, NEUROREPORT, V8, P2461, DOI 10.1097/00001756-199707280-00010; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Voogd J, 2012, CEREBELLUM, V11, P422, DOI 10.1007/s12311-012-0367-5; Voogd J, 2003, J NEUROSCI, V23, P4645; Voogd J, 1997, PROG BRAIN RES, V114, P21; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Winkelman BHJ, 2014, J NEUROSCI, V34, P3218, DOI 10.1523/JNEUROSCI.3080-13.2014; Wise AK, 2010, J PHYSIOL-LONDON, V588, P2373, DOI 10.1113/jphysiol.2010.189704; Zhou HB, 2014, ELIFE, V3, DOI 10.7554/eLife.02536	90	46	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105633	10.1371/journal.pone.0105633	http://dx.doi.org/10.1371/journal.pone.0105633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144311	Green Published, gold			2022-12-25	WOS:000341106100103
J	Chen, B; Zhang, YD; Song, XJ; Wang, XY; Zhang, J; Fang, J				Chen, Bin; Zhang, Yudong; Song, Xiaojian; Wang, Xiaoying; Zhang, Jue; Fang, Jing			Quantitative Estimation of Renal Function with Dynamic Contrast-Enhanced MRI Using a Modified Two-Compartment Model	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; NEPHROGENIC SYSTEMIC FIBROSIS; FRACTIONAL VASCULAR VOLUME; PATLAK PLOT TECHNIQUE; COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; COMPARTMENT MODEL; GRADIENT-ECHO; HUMAN KIDNEY; DCE-MRI	Objective: To establish a simple two-compartment model for glomerular filtration rate (GFR) and renal plasma flow (RPF) estimations by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Materials and Methods: A total of eight New Zealand white rabbits were included in DCE-MRI. The two-compartment model was modified with the impulse residue function in this study. First, the reliability of GFR measurement of the proposed model was compared with other published models in Monte Carlo simulation at different noise levels. Then, functional parameters were estimated in six healthy rabbits to test the feasibility of the new model. Moreover, in order to investigate its validity of GFR estimation, two rabbits underwent acute ischemia surgical procedure in unilateral kidney before DCE-MRI, and pixel-wise measurements were implemented to detect the cortical GFR alterations between normal and abnormal kidneys. Results: The lowest variability of GFR and RPF measurements were found in the proposed model in the comparison. Mean GFR was 3.03 +/- 1.1 ml/min and mean RPF was 2.64 +/- 0.5 ml/g/min in normal animals, which were in good agreement with the published values. Moreover, large GFR decline was found in dysfunction kidneys comparing to the contralateral control group. Conclusion: Results in our study demonstrate that measurement of renal kinetic parameters based on the proposed model is feasible and it has the ability to discriminate GFR changes in healthy and diseased kidneys.	[Chen, Bin; Song, Xiaojian; Wang, Xiaoying; Zhang, Jue; Fang, Jing] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Zhang, Yudong; Wang, Xiaoying] Peking Univ, Hosp 1, Dept Radiol, Beijing 100871, Peoples R China; [Song, Xiaojian] Chengdu Univ Informat Technol, Dept Elect Engn, Chengdu, Sichuan, Peoples R China; [Zhang, Jue; Fang, Jing] Peking Univ, Coll Engn, Beijing 100871, Peoples R China	Peking University; Peking University; Chengdu University of Information Technology; Peking University	Wang, XY (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.	cjr.wangxiaoying@vip.163.com; zhangjue@pku.edu.cn						Annet L, 2004, J MAGN RESON IMAGING, V20, P843, DOI 10.1002/jmri.20173; Bokacheva L, 2009, J MAGN RESON IMAGING, V29, P371, DOI 10.1002/jmri.21642; Cheng HLM, 2006, MAGN RESON MED, V55, P566, DOI 10.1002/mrm.20791; Craig AJ, 2011, EUR RADIOL, V21, P2211, DOI 10.1007/s00330-011-2157-8; de Priester JA, 2003, J MAGN RESON IMAGING, V17, P95, DOI 10.1002/jmri.10217; Fluckiger JU, 2012, MAGN RESON IMAGING, V30, P934, DOI 10.1016/j.mri.2012.02.011; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Hackstein N, 2003, J MAGN RESON IMAGING, V18, P714, DOI 10.1002/jmri.10410; Hackstein N, 2003, AM J ROENTGENOL, V181, P147, DOI 10.2214/ajr.181.1.1810147; Hayashi T, 1999, NEPHRON, V82, P90, DOI 10.1159/000045380; Hermoye L, 2004, MAGN RESON MED, V51, P1017, DOI 10.1002/mrm.20026; Joyce M, 2001, J SURG RES, V101, P79, DOI 10.1006/jsre.2001.6256; Khalifa F, 2013, NMR BIOMED, V26, P1460, DOI 10.1002/nbm.2977; Krier JD, 2001, AM J PHYSIOL-RENAL, V281, pF630, DOI 10.1152/ajprenal.2001.281.4.F630; Kuo PH, 2008, AM J ROENTGENOL, V191, P1861, DOI 10.2214/AJR.08.1179; Laurent D, 2002, MAGN RESON MED, V47, P127, DOI 10.1002/mrm.10034; Lawson RS, 1999, PHYS MED BIOL, V44, pR57, DOI 10.1088/0031-9155/44/4/028; Lee VS, 2007, AM J PHYSIOL-RENAL, V292, pF1548, DOI 10.1152/ajprenal.00347.2006; Lv DJ, 2008, IEEE ENG MED BIOL, V27, P36, DOI 10.1109/MEMB.2008.923949; Miles KA, 2003, BRIT J RADIOL, V76, P220, DOI 10.1259/bjr/13564625; Miles KA, 1999, BRIT J RADIOL, V72, P153, DOI 10.1259/bjr.72.854.10365065; OTT CE, 1979, AM J PHYSIOL, V237, pF479, DOI 10.1152/ajprenal.1979.237.6.F479; Pauliah M, 2007, MAGN RESON IMAGING, V25, P1292, DOI 10.1016/j.mri.2007.03.027; Peeters F, 2004, MAGN RESON MED, V51, P710, DOI 10.1002/mrm.20032; Rusinek H, 2007, MAGN RESON MED, V57, P1159, DOI 10.1002/mrm.21240; Sadowski EA, 2007, RADIOLOGY, V243, P148, DOI 10.1148/radiol.2431062144; Shuter B, 1998, JMRI-J MAGN RESON IM, V8, P853, DOI 10.1002/jmri.1880080415; Sourbron SP, 2008, INVEST RADIOL, V43, P40, DOI 10.1097/RLI.0b013e31815597c5; Tsushima Y, 1999, AM J KIDNEY DIS, V33, P754, DOI 10.1016/S0272-6386(99)70230-1; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Winter JD, 2011, J MAGN RESON IMAGING, V34, P608, DOI 10.1002/jmri.22660; Wolf GL, 1999, AM J KIDNEY DIS, V33, P804, DOI 10.1016/S0272-6386(99)70240-4; Zhang JL, 2008, MAGN RESON MED, V59, P278, DOI 10.1002/mrm.21489; Zhang YD, 2012, CONTRAST MEDIA MOL I, V7, P418, DOI 10.1002/cmmi.1468; Zimmer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053849	35	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105087	10.1371/journal.pone.0105087	http://dx.doi.org/10.1371/journal.pone.0105087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141138	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200051
J	Shum, K; Alperin, P; Shalnova, S; Boytsov, S; Kontsevaya, A; Vigdorchik, A; Guetz, A; Eriksson, J; Hughes, D				Shum, Kenny; Alperin, Peter; Shalnova, Svetlana; Boytsov, Sergey; Kontsevaya, Anna; Vigdorchik, Alexey; Guetz, Adam; Eriksson, Jennifer; Hughes, David			Simulating the Impact of Improved Cardiovascular Risk Interventions on Clinical and Economic Outcomes in Russia	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; ARTERIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; YAROSLAVL REGION; HEART-DISEASE; MORTALITY; PROGRAM; TRENDS; MANAGEMENT; STROKE	Objectives: Russia faces a high burden of cardiovascular disease. Prevalence of all cardiovascular risk factors, especially hypertension, is high. Elevated blood pressure is generally poorly controlled and medication usage is suboptimal. With a disease-model simulation, we forecast how various treatment programs aimed at increasing blood pressure control would affect cardiovascular outcomes. In addition, we investigated what additional benefit adding lipid control and smoking cessation to blood pressure control would generate in terms of reduced cardiovascular events. Finally, we estimated the direct health care costs saved by treating fewer cardiovascular events. Methods: The Archimedes Model, a detailed computer model of human physiology, disease progression, and health care delivery was adapted to the Russian setting. Intervention scenarios of achieving systolic blood pressure control rates (defined as systolic blood pressure < 140 mmHg) of 40% and 60% were simulated by modifying adherence rates of an antihypertensive medication combination and compared with current care (23.9% blood pressure control rate). Outcomes of major adverse cardiovascular events; cerebrovascular event (stroke), myocardial infarction, and cardiovascular death over a 10-year time horizon were reported. Direct health care costs of strokes and myocardial infarctions were derived from official Russian statistics and tariff lists. Results: To achieve systolic blood pressure control rates of 40% and 60%, adherence rates to the antihypertensive treatment program were 29.4% and 65.9%. Cardiovascular death relative risk reductions were 13.2%, and 29.6%, respectively. For the current estimated 43,855,000-person Russian hypertensive population, each control-rate scenario resulted in an absolute reduction of 1.0 million and 2.4 million cardiovascular deaths, and a reduction of 1.2 million and 2.7 million stroke/myocardial infarction diagnoses, respectively. Averted direct costs from current care levels ($7.6 billion [in United States dollars]) were $1.1 billion and $ 2.6 billion, respectively.	[Shum, Kenny; Alperin, Peter; Guetz, Adam] Archimedes, San Francisco, CA USA; [Shalnova, Svetlana; Boytsov, Sergey; Kontsevaya, Anna] Natl Res Ctr Prevent Med, Moscow, Russia; [Vigdorchik, Alexey] Novartis Pharma LLC, Moscow, Russia; [Eriksson, Jennifer] OptumInsight Life Sci, Stockholm, Sweden; [Hughes, David] Novartis Int AG, Dept Healthcare Syst, Basel, Switzerland	National Medical Research Center for Therapy & Preventive Medicine; Novartis	Shum, K (corresponding author), Evidera Inc, San Francisco, CA 94105 USA.	kenny.shum@evidera.com	Kontsevaya, Anna/H-6061-2013; Drapkina, Oksana/AAE-5376-2021; Shalnova, Svetlana/D-3824-2016; Boytsov, Sergey/AAK-5354-2021; Boytsov, Sergey A/M-4486-2014	Drapkina, Oksana/0000-0002-4453-8430; Boytsov, Sergey/0000-0001-6998-8406; Boytsov, Sergey A/0000-0001-6998-8406; Kontsevaya, Anna/0000-0003-2062-1536	Novartis Pharma, Basel, Switzerland	Novartis Pharma, Basel, Switzerland	The work was funded by Novartis Pharma, Basel, Switzerland. The company played a role in this study due to the employment of two authors of this study in subsidiary Novartis companies (these authors were involved in the study concept and initial design, literature review, input into modeling parameters, interpretation of data analysis and assistance with manuscript writing). However, final decisions on content and the decision to publish were the responsibility of the non-Novartis authors.	Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; Belousov Y, 2009, PROBLEMS OF STANDARD; Calhoun DA, 2009, HYPERTENSION, V54, P32, DOI 10.1161/HYPERTENSIONAHA.109.131300; Campbell NRC, 2006, HYPERTENSION, V47, P22, DOI 10.1161/01.HYP.0000196269.98463.fd; Cene CW, 2009, J GEN INTERN MED, V24, P1057, DOI 10.1007/s11606-009-1051-4; Chazova IE, 2010, RUSSIAN GUIDELINES 4, V3, P5; Chazova IE, 2011, ADV THER, V28, P134, DOI 10.1007/s12325-010-0099-1; Cifkova R, 2004, J HUM HYPERTENS, V18, P571, DOI 10.1038/sj.jhh.1001686; Cifkova R, 2010, ATHEROSCLEROSIS, V211, P676, DOI 10.1016/j.atherosclerosis.2010.04.007; Davidkovova H, 2013, HEART, V99, P409, DOI 10.1136/heartjnl-2012-303123; Dudl RJ, 2009, AM J MANAG CARE, V15, pE88; Eberstadt N, 2009, RUSSIAS DEMOGRAPHIC; Eddy D, 2013, VALIDATION METHODOLO; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Godet-Mardirossian H, 2012, EUR J PREV CARDIOL, V19, P213, DOI 10.1177/1741826710394303; Greenberg HM, 2005, AM J HYPERTENS, V18, P943, DOI 10.1016/j.amjhyper.2005.01.012; Guallar E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-704; Huxley RR, 2014, LANCET DIABETES ENDO; International Monetary Fund, 2011, WORLD ECONOMIC OUTLO; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Karpov Y, 2012, ADV THER, V29, P134, DOI 10.1007/s12325-011-0095-0; Kobalava ZD, 2009, CURR MED RES OPIN, V25, P2229, DOI 10.1185/03007990903157531; Kobalava ZD, 2008, TERAPEVT ARKH, V80, P76; Kobalava ZD, 2007, KARDIOLOGIYA, V47, P38; Kontsevaya A, 2010, J HYPERTENS, V28, pE239, DOI 10.1097/01.hjh.0000378910.33276.72; Kontsevaya A, 2013, VALUE HEALTH REG ISS, V2, P199; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Marcevich SY, 2012, RATION PHARMACOTHER, V8, P681, DOI 10.20996/1819-6446-2012-8-5-681-684; Marquez Patricio M., 2005, DYING TOO YOUNG ADDR; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Mozheyko M, 2013, J CLIN HYPERTENS, V15, P918, DOI 10.1111/jch.12214; Mozheyko M, 2012, ADV THER, V29, P1016, DOI 10.1007/s12325-012-0064-2; National High Blood Pressure Education Program, 2004, 7 REP JOINT NATL COM; Nichols M., 2012, EUROPEAN CARDIOVASCU; Oganov RG, 2011, CARDIOVASC THER PREV, V10, P9; Oganov RG, 2001, ROSS MED VESTI, V3, P34; Oparil S, 2010, CLIN THER, V32, P1252, DOI 10.1016/j.clinthera.2010.07.008; Pension Fund of the Russian Federation, PENSION SYSTEM PRINC; Petrukhin IS, 2011, PUBLIC HEALTH REV, V33, P436, DOI 10.1007/BF03391645; Posnenkova OM, 2011, RATION PHARMACOTHER, V7, P725, DOI 10.20996/1819-6446-2011-7-6-725-732; Roberts B, 2012, J EPIDEMIOL COMMUN H, V66, P482, DOI 10.1136/jech.2010.111377; Russian Federal Service of State Statistics, 2011, RUSSIAN FEDERAL SERV; Russian Federation Statistical Service, 2010, THE DEMOGRAPHIC YEAR; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; Schuetz CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066454; Shalnova SA, 2011, CARDIOVASC THER PREV, V10, P5, DOI 10.15829/1728-8800-2011-6-5-10; Taylor Addison A, 2003, Congest Heart Fail, V9, P324, DOI 10.1111/j.1527-5299.2003.03269.x; The Health and Social Care Information Centre, 2012, HEALTH SURVEY FOR EN; Tolpygina SN, 2013, RATION PHARMACOTHER, V9, P138, DOI 10.20996/1819-6446-2013-9-2-138-142; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; Wilkins K, 2010, HEALTH REP, V21; Wong MCS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046309; World Health Organization, 2013, UNIVERSAL HEALTH COV; World Health Organization, 2008, WORLD HEALTH REPORT; World Health Organization, 2009, RUSSIAN FEDERATION 2; World Health Organization, 2012, WORLD HEALTH STATIST; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3	62	7	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103280	10.1371/journal.pone.0103280	http://dx.doi.org/10.1371/journal.pone.0103280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141122	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200006
J	Vasconcelos, TS; Prado, VHM; da Silva, FR; Haddad, CFB				Vasconcelos, Tiago S.; Prado, Vitor H. M.; da Silva, Fernando R.; Haddad, Celio F. B.			Biogeographic Distribution Patterns and Their Correlates in the Diverse Frog Fauna of the Atlantic Forest Hotspot	PLOS ONE			English	Article							REPRODUCTIVE MODES; SPECIES-RICHNESS; REGIONALIZATION; REGIONS; BRACHYCEPHALIDAE; BIODIVERSITY; AMPHIBIANS; STRATEGIES; GRADIENTS; FRAMEWORK	Anurans are a highly diverse group in the Atlantic Forest hotspot (AF), yet distribution patterns and species richness gradients are not randomly distributed throughout the biome. Thus, we explore how anuran species are distributed in this complex and biodiverse hotspot, and hypothesize that this group can be distinguished by different cohesive regions. We used range maps of 497 species to obtain a presence/ absence data grid, resolved to 50x50 km grain size, which was submitted to k-means clustering with v-fold cross-validation to determine the biogeographic regions. We also explored the extent to which current environmental variables, topography, and floristic structure of the AF are expected to identify the cluster patterns recognized by the k-means clustering. The biogeographic patterns found for amphibians are broadly congruent with ecoregions identified in the AF, but their edges, and sometimes the whole extent of some clusters, present much less resolved pattern compared to previous classification. We also identified that climate, topography, and vegetation structure of the AF explained a high percentage of variance of the cluster patterns identified, but the magnitude of the regression coefficients shifted regarding their importance in explaining the variance for each cluster. Specifically, we propose that the anuran fauna of the AF can be split into four biogeographic regions: a) less diverse and widely-ranged species that predominantly occur in the inland semideciduous forests; b) northern small-ranged species that presumably evolved within the Pleistocene forest refugia; c) highly diverse and small-ranged species from the southeastern Brazilian mountain chain and its adjacent semideciduous forest; and d) southern species from the Araucaria forest. Finally, the high congruence among the cluster patterns and previous eco-regions identified for the AF suggests that preserving the underlying habitat structure helps to preserve the historical and ecological signals that underlie the geographic distribution of AF anurans.	[Vasconcelos, Tiago S.] Univ Estatual Paulista, Dept Ciencias Biol, Sao Paulo, Brazil; [Prado, Vitor H. M.; Haddad, Celio F. B.] Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil; [da Silva, Fernando R.] Univ Fed Sao Carlos, Dept Ciencias Ambientais, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Federal de Sao Carlos	Vasconcelos, TS (corresponding author), Univ Estatual Paulista, Dept Ciencias Biol, Sao Paulo, Brazil.	zoologia@ig.com.br	Prado, Vitor H. M./D-3294-2012; Haddad, Célio F. B./C-4267-2012; da Silva, Fernando Rodrigues/G-3026-2012	Haddad, Célio F. B./0000-0002-7044-5764; da Silva, Fernando Rodrigues/0000-0002-0983-3207; Vasconcelos, Tiago/0000-0002-5762-0513; Prado, Vitor/0000-0001-8598-3621	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP) [2008/50928-1, 2010/50125-6, 2011/18510-0, 2012/07765-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP, grants: 2008/50928-1; 2010/50125-6; 2011/18510-0; 2012/07765-0). CFBH research is also supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; [Anonymous], 2012, MAN TECN VEG BRAS; Bishop C. M., 1995, NEURAL NETWORKS PATT; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brusquetti F, 2013, HERPETOLOGICA, V69, P175, DOI 10.1655/HERPETOLOGICA-D-12-00050; Canavero A, 2009, AUSTRAL ECOL, V34, P741, DOI 10.1111/j.1442-9993.2009.01980.x; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carstensen DW, 2013, ECOGRAPHY, V36, P1310, DOI 10.1111/j.1600-0587.2013.00329.x; Condez TH, 2014, HERPETOLOGICA, V70, P89, DOI 10.1655/HERPETOLOGICA-D-13-00044; da Silva FR, 2012, J BIOGEOGR, V39, P1720, DOI 10.1111/j.1365-2699.2012.02726.x; dos Santos TG, 2009, J NAT HIST, V43, P973, DOI 10.1080/00222930802702498; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Frost DR, 2013, AMPHIBIAN SPECIES WO; Gotelli N. J., 2004, PRIMER ECOLOGICAL ST; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Haddad CFB, 2013, GUIA ANFIBIOS MATA A; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2008, FOLIA GEOBOT, V43, P345, DOI 10.1007/s12224-008-9007-8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lobo JM, 2002, GLOBAL ECOL BIOGEOGR, V11, P265, DOI 10.1046/j.1466-822X.2002.00291.x; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; MMA & IBAMA - MINISTERIO DO MEIO AMBIENTE & INSTITUTO BRASILEIRO DO MEIO AMBIENTE EDOS RECURSOS NATURAIS RENOVAVEIS, 2010, MON DESM NOS BIOM BR; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Morrone J.J., 2009, EVOLUTIONARY BIOGEOG; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Proches S, 2005, J BIOGEOGR, V32, P607, DOI 10.1111/j.1365-2699.2004.01186.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rueda M, 2013, J BIOGEOGR, V40, P2215, DOI 10.1111/jbi.12214; Rueda M, 2010, J BIOGEOGR, V37, P2067, DOI 10.1111/j.1365-2699.2010.02388.x; Ruggiero A, 2008, ECOGRAPHY, V31, P306, DOI 10.1111/j.0906-7590.2008.05333.x; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; SOUTHWOOD TRE, 1988, OIKOS, V52, P3, DOI 10.2307/3565974; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Vasconcelos TD, 2011, NAT CONSERVACAO, V9, P67, DOI 10.4322/natcon.2011.008; Vasconcelos TD, 2010, J TROP ECOL, V26, P423, DOI 10.1017/S0266467410000167; Villalobos F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056073; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	47	58	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104130	10.1371/journal.pone.0104130	http://dx.doi.org/10.1371/journal.pone.0104130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140882	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200012
J	Nair, V; Sreevalsan, S; Basha, R; Abdelrahim, M; Abudayyeh, A; Hoffman, AR; Safe, S				Nair, Vijayalekshmi; Sreevalsan, Sandeep; Basha, Riyaz; Abdelrahim, Maen; Abudayyeh, Ala; Hoffman, Aline Rodrigues; Safe, Stephen			Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer ROLE OF SPECIFICITY PROTEIN (Sp) TRANSCRIPTION FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); Gene Expression; Insulin-like Growth Factor (IGF); Pancreatic Cancer; Specificity Protein 1 (Sp1); IGFR Down-regulation; Ras Inhibition; Sp Transcription Factors; mTOR Down-regulation; Metformin	GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; TUMOR-GROWTH; DIABETIC-PATIENTS; EGF RECEPTOR; IN-VITRO; CELL; EXPRESSION; PROLIFERATION; ACTIVATION	Background: Metformin inhibits pancreatic cancer cell and tumor growth and down-regulated Sp transcription factors. Results: Inhibition of mTOR and Ras signaling by metformin is due to decreased expression of Sp-regulated insulin-like growth factor-1 receptor (IGF-1R) and epidermal growth factor receptor (EGFR), respectively. Conclusion: Metformin-induced down-regulation of Sp proteins affects multiple pro-oncogenic pathways. Significance: These results identify important metformin-induced anticancer activities. The antidiabetic drug metformin exhibits both chemopreventive and chemotherapeutic activity for multiple cancers including pancreatic cancer; however, the underlying mechanism of action of metformin is unclear. A recent study showed that metformin down-regulated specificity protein (Sp) transcription factors (TFs) Sp1, Sp3, and Sp4 in pancreatic cancer cells and tumors, and this was accompanied by down-regulation of several pro-oncogenic Sp-regulated genes. Treatment with metformin or down-regulation of Sp TFs by RNAi also inhibits two major pro-oncogenic pathways in pancreatic cancer cells, namely mammalian target of rapamycin (mTOR) signaling and epidermal growth factor (EGFR)-dependent activation of Ras. Metformin and Sp knockdown by RNAi decreased expression of the insulin-like growth factor-1 receptor (IGF-1R), resulting in inhibition of mTOR signaling. Ras activity was also decreased by metformin and Sp knockdown of EGFR, another Sp-regulated gene. Thus, the antineoplastic activities of metformin in pancreatic cancer are due, in part, to down-regulation of Sp TFs and Sp-regulated IGF-1R and EGFR, which in turn results in inhibition of mTOR and Ras signaling, respectively.	[Nair, Vijayalekshmi; Sreevalsan, Sandeep; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Hoffman, Aline Rodrigues] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Basha, Riyaz; Abdelrahim, Maen] Univ Texas MD Anderson Canc Ctr, Canc Res Inst, Orlando, FL 32806 USA; [Basha, Riyaz; Abdelrahim, Maen] Baylor Coll Med, Houston, TX 77030 USA; [Abudayyeh, Ala] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA; [Safe, Stephen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	rodrigues hoffmann, aline/L-6859-2017	rodrigues hoffmann, aline/0000-0001-6148-2531; Basha, Riyaz/0000-0002-4071-0993	National Institutes of Health [R01CA136571, P30ES023512]; Texas AgriLife Research; NATIONAL CANCER INSTITUTE [R01CA136571, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AgriLife Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA136571 and P30ES023512 (to S. S.). This work was also supported by Texas AgriLife Research.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; American Cancer Society, 2011, CANC FACTS FIG 2011; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; BEITNERJOHNSON D, 1995, MOL ENDOCRINOL, V9, P1147, DOI 10.1210/me.9.9.1147; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; BERGMANN U, 1995, CANCER RES, V55, P2007; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Dowling RJO, 2012, J MOL ENDOCRINOL, V48, pR31, DOI 10.1530/JME-12-0007; Engelman JA, 2010, CANCER PREV RES, V3, P1049, DOI 10.1158/1940-6207.CAPR-10-0178; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Garrett CR, 2012, BRIT J CANCER, V106, P1374, DOI 10.1038/bjc.2012.71; Gotlieb WH, 2008, GYNECOL ONCOL, V110, P246, DOI 10.1016/j.ygyno.2008.04.008; Gou SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063969; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; JOHNSON AC, 1988, J BIOL CHEM, V263, P5693; Jutooru I, 2014, MOL CELL BIOL, V34, P2382, DOI 10.1128/MCB.01602-13; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Karnevi E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-235; Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lu SY, 2010, INT J CANCER, V126, P416, DOI 10.1002/ijc.24761; Murtola TJ, 2008, AM J EPIDEMIOL, V168, P925, DOI 10.1093/aje/kwn190; Nair V, 2013, CARCINOGENESIS, V34, P2870, DOI 10.1093/carcin/bgt231; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sinnett-Smith J, 2013, BIOCHEM BIOPH RES CO, V430, P352, DOI 10.1016/j.bbrc.2012.11.010; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Spillane S, 2013, CANCER EPIDEM BIOMAR, V22, P1364, DOI 10.1158/1055-9965.EPI-13-0347; Sreevalsan S, 2013, MOL CANCER THER, V12, P2483, DOI 10.1158/1535-7163.MCT-13-0486; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Tan BK, 2011, J CLIN ENDOCR METAB, V96, P808, DOI 10.1210/jc.2010-1803; Wang LW, 2008, WORLD J GASTROENTERO, V14, P7192, DOI 10.3748/wjg.14.7192; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Yasmeen A, 2011, GYNECOL ONCOL, V121, P492, DOI 10.1016/j.ygyno.2011.02.021; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	51	96	96	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27692	27701		10.1074/jbc.M114.592576	http://dx.doi.org/10.1074/jbc.M114.592576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143389	hybrid, Green Published			2022-12-25	WOS:000342852800028
J	Garcia-Rio, F; Soriano, JB; Miravitlles, M; Munoz, L; Duran-Tauleria, E; Sanchez, G; Sobradillo, V; Ancochea, J				Garcia-Rio, Francisco; Soriano, Joan B.; Miravitlles, Marc; Munoz, Luis; Duran-Tauleria, Enric; Sanchez, Guadalupe; Sobradillo, Victor; Ancochea, Julio			Impact of Obesity on the Clinical Profile of a Population-Based Sample with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITIONAL DEPLETION; SYSTEMIC INFLAMMATION; PROGNOSTIC VALUE; LUNG-DISEASE; COPD; MORTALITY; RISK; PREVALENCE; EXERCISE	Aims: To characterize the distribution of BMI in a population-based sample of COPD patients and to evaluate the impact of obesity on their health status, exercise tolerance, systemic inflammation and comorbidity. Methods: A population-based sample of 3,797 subjects aged 40-80 years from the EPI-SCAN study was selected. Subjects were categorized according their body mass index (BMI) as underweight (<18.5 kg/m(2)), normal weight (18.5-24.9 kg/m(2)), overweight (25.0-29.9 kg/m(2)) or obese (BMI >= 30.0 kg/m(2)). Subjects were evaluated with post-bronchodilator spirometry and 6-minute walk tests. Smoking habits, respiratory symptoms, generic and specific quality of life, daily physical activities, comorbidities and systemic inflammatory biomarkers were recorded. Results: The prevalence of obesity or being overweight was higher in the 382 COPD patients than in the subjects without airflow limitation (29.4%, 95% CI 24.8-33.9% vs. 24.3, 95% CI 22.9-25.8; and 44.7%, 95% CI 39.7-49.6% vs. 43.0%, 95% CI 41.3-44.6, respectively; p = 0.020). In the COPD subgroup, obese subjects presented more dyspnea and less chronic cough, chronic bronchitis or chronic phlegm than normal-weight patients, as well as a worse health status. Moreover, reduced exercise tolerance and higher plasmatic C-reactive protein levels were found in the obese patients, who also presented a greater prevalence of cardiovascular disease (adjusted odds ratio 4.796, 95% CI 1.806-12.736, p = 0.002). Conclusions: In a population-based sample, obesity is more prevalent in COPD patients than in subjects without airflow limitation. Furthermore, obesity affects the clinical manifestations, quality of life and exercise tolerance of COPD patients, and it may contribute to a phenotype characterized by increased systemic inflammation and greater frequency of cardiovascular comorbidity.	[Garcia-Rio, Francisco] Hosp Univ La Paz, Serv Neumol, IdiPAZ, Madrid, Spain; [Garcia-Rio, Francisco] CIBER Enfermedades Resp, Madrid, Spain; [Soriano, Joan B.] Fdn Caubet CIMERA Illes Balears, Bunyola, Illes Balears, Spain; [Soriano, Joan B.] CIBER Enfermedades Resp, Illes Balears, Spain; [Miravitlles, Marc] Hosp Univ Vall Hebron, Dept Pneumol, Barcelona, Spain; [Munoz, Luis] Hosp Reina Sofia, Dept Pneumol, Cordoba, Spain; [Duran-Tauleria, Enric] Ctr Invest Epidemiol Ambiental CREAL, Barcelona, Spain; [Sanchez, Guadalupe] GlaxoSmithkline SA, Dept Med, Madrid, Spain; [Sobradillo, Victor] Hosp Cruces, Dept Pneumol, Bilbao, Spain; [Ancochea, Julio] Inst Invest Sanitaria Princesa, Hosp Univ La Princesa, Serv Neumol, Madrid, Spain	Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitari Vall d'Hebron; Hospital Universitario Reina Sofia - Cordoba; Pompeu Fabra University; GlaxoSmithKline; Hospital Universitario Cruces	Garcia-Rio, F (corresponding author), Hosp Univ La Paz, Serv Neumol, IdiPAZ, Madrid, Spain.	fgr01m@gmail.com	Garcia-Rio, Francisco/AAC-9981-2020; Miravitlles, Marc/AAH-5284-2019; Soriano, Joan B/O-1215-2017	Miravitlles, Marc/0000-0002-9850-9520; Soriano, Joan B/0000-0001-9740-2994; Ancochea, julio/0000-0001-7451-4133; Garcia-Rio, Francisco/0000-0002-7227-2238	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding for the EPI-SCAN study was provided by GlaxoSmithKline. The funder provided support in the form of salaries for authors (GS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section.	Ancochea J, 2009, ARCH BRONCONEUMOL, V45, P41, DOI 10.1016/j.arbres.2008.06.001; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Bernard S, 1998, AM J RESP CRIT CARE, V158, P629, DOI 10.1164/ajrccm.158.2.9711023; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Cao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043892; Cecere LM, 2011, COPD, V8, P275, DOI 10.3109/15412555.2011.586660; Cekerevac I, 2011, SRP ARK CELOK LEK, V139, P322, DOI 10.2298/SARH1106322C; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chailleux E, 2003, CHEST, V123, P1460, DOI 10.1378/chest.123.5.1460; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Oca MM, 2008, RESP MED, V102, P642, DOI 10.1016/j.rmed.2007.12.025; Deesomchok A, 2010, AM J RESP CRIT CARE, V181, P125, DOI 10.1164/rccm.200906-0934OC; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Figarska SM, 2012, EUR J EPIDEMIOL, V27, P867, DOI 10.1007/s10654-012-9736-0; Franssen FME, 2008, THORAX, V63, P1110, DOI 10.1136/thx.2007.086827; Rodriguez LAG, 2009, COPD, V6, P369, DOI 10.1080/15412550903156325; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Garcia-Rio F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-63; GesEPOC, 2012, ARCH BRONCONEUMOL S, V48, P2; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; GrayDonald K, 1996, AM J RESP CRIT CARE, V153, P961, DOI 10.1164/ajrccm.153.3.8630580; Guerra S, 2002, CHEST, V122, P1256, DOI 10.1378/chest.122.4.1256; Ischaki E, 2007, CHEST, V132, P164, DOI 10.1378/chest.06-2789; Jordan JG, 2010, SOUTH MED J, V103, P323, DOI 10.1097/SMJ.0b013e3181d394b4; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lavie CJ, 2003, J AM COLL CARDIOL, V42, P677, DOI 10.1016/S0735-1097(03)00784-8; Laviolette L, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-33; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miravitlles M, 2009, THORAX, V64, P863, DOI 10.1136/thx.2009.115725; Miravitlles M, 2013, RESP MED, V107, P1053, DOI 10.1016/j.rmed.2013.03.007; O'Donnell DE, 2011, CHEST, V140, P461, DOI 10.1378/chest.10-2582; Ora J, 2009, AM J RESP CRIT CARE, V180, P964, DOI [10.1164/rccm.200904-0530OC, 10.1164/rccm.200904-0503OC]; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; Rennard SI, 2003, EUR RESPIR J, V21, P916, DOI 10.1183/09031936.03.00111602; Salome CM, 2008, INT J OBESITY, V32, P502, DOI 10.1038/sj.ijo.0803752; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; SCHOLS AMWJ, 1993, AM REV RESPIR DIS, V147, P1151, DOI 10.1164/ajrccm/147.5.1151; Shim YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061022; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; van den Bemt L, 2009, THORAX, V64, P640, DOI 10.1136/thx.2008.111716; Vozoris NT, 2012, CAN RESPIR J, V19, pE18, DOI 10.1155/2012/732618	44	46	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105220	10.1371/journal.pone.0105220	http://dx.doi.org/10.1371/journal.pone.0105220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153331	gold, Green Submitted, Green Published			2022-12-25	WOS:000340952200042
J	Kim, GR; Kang, J; Kwak, JY; Chang, JH; Kim, SI; Youk, JH; Moon, HJ; Kim, MJ; Kim, EK				Kim, Ga Ram; Kang, Jeeun; Kwak, Jin Young; Chang, Jin Ho; Kim, Seung Il; Youk, Ji Hyun; Moon, Hee Jung; Kim, Min Jung; Kim, Eun-Kyung			Photoacoustic Imaging of Breast Microcalcifications: A Preliminary Study with 8-Gauge Core-Biopsied Breast Specimens	PLOS ONE			English	Article							SONOGRAPHICALLY GUIDED BIOPSY; IN-VIVO; RAMAN-SPECTROSCOPY; IDENTIFYING MICROCALCIFICATIONS; HIGH-RESOLUTION; CANCER; LESIONS; US; MAMMOGRAPHY	Background: We presented the photoacoustic imaging (PAI) tool and to evaluate whether microcalcifications in breast tissue can be detected on photoacoustic (PA) images. Methods: We collected 21 cores containing microcalcifications (n = 11, microcalcification group) and none (n = 10, control group) in stereotactic or ultrasound (US) guided 8-gauge vacuum-assisted biopsies. Photoacoustic (PA) images were acquired through ex vivo experiments by transmitting laser pulses with two different wavelengths (700 nm and 800 nm). The presence of microcalcifications in PA images were blindly assessed by two radiologists and compared with specimen mammography. A ratio of the signal amplitude occurring at 700 nm to that occurring at 800 nm was calculated for each PA focus and was called the PAI ratio. Results: Based on the change of PA signal amplitude between 700 nm and 800 nm, 10 out of 11 specimens containing microcalcifications and 8 out of 10 specimens without calcifications were correctly identified on blind review; the sensitivity, specificity, accuracy, positive predictive and negative predictive values of our blind review were 90.91%, 80.0%, 85.71%, 83.33% and 88.89%. The PAI ratio in the microcalcification group was significantly higher than that in the control group (the median PAI ratio, 2.46 versus 1.11, respectively, P = .001). On subgroup analysis in the microcalcification group, neither malignant diagnosis nor the number or size of calcification-foci was proven to contribute to PAI ratios. Conclusion: Breast microcalcifications generated distinguishable PA signals unlike breast tissue without calcifications. So, PAI, a non-ionizing and non-invasive hybrid imaging technique, can be an alternative in overcoming the limitations of conventional US imaging.	[Kim, Ga Ram; Kwak, Jin Young; Moon, Hee Jung; Kim, Min Jung; Kim, Eun-Kyung] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea; [Kim, Ga Ram; Kwak, Jin Young; Moon, Hee Jung; Kim, Min Jung; Kim, Eun-Kyung] Yonsei Univ, Coll Med, Severance Hosp, Res Inst Radiol Sci, Seoul, South Korea; [Kim, Seung Il] Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea; [Kang, Jeeun; Chang, Jin Ho] Sogang Univ, Sogang Inst Adv Technol, Seoul, South Korea; [Kang, Jeeun; Chang, Jin Ho] Interdisciplinary Program Integrated Biotechnol, Seoul, South Korea; [Youk, Ji Hyun] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sogang University; Yonsei University; Yonsei University Health System	Kim, EK (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea.	ekkim@yuhs.ac	Kim, Eun-Kyung/E-5211-2017; Kang, Jeeun/I-1149-2019	Kim, Eun-Kyung/0000-0002-3368-5013; Kang, Jeeun/0000-0001-6678-2744; Moon, Hee Jung/0000-0002-5643-5885; Kim, Ga Ram/0000-0002-4481-5792; Kwak, Jin Young/0000-0002-6212-1495; CHANG, JIN HO/0000-0002-8323-4202	Yonsei University College of Medicine [6-2012-0019]; International Collaborative R&D Program - Ministry of Knowledge Economy, Korea [2010-TD-500409-001]; Ministry of Science, ICT&Future Planning, Korea, under the C-ITRC support program [NIPA-2013-H0401-13-1007]	Yonsei University College of Medicine(General Electric); International Collaborative R&D Program - Ministry of Knowledge Economy, Korea; Ministry of Science, ICT&Future Planning, Korea, under the C-ITRC support program	This research was supported by a faculty research grant from Yonsei University College of Medicine for 2012 (No. 6-2012-0019). This work was also supported by International Collaborative R&D Program (2010-TD-500409-001) funded by the Ministry of Knowledge Economy, Korea, and by the Ministry of Science, ICT&Future Planning, Korea, under the C-ITRC support program (NIPA-2013-H0401-13-1007) supervised by the NIPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 1997, J ACOUST SOC AM, V101, P29, DOI 10.1121/1.417973; Bai XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092463; Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; Baker R, 2010, BRIT J CANCER, V103, P1034, DOI 10.1038/sj.bjc.6605873; DeAngelis GA, 2000, SEMIN ULTRASOUND CT, V21, P337, DOI 10.1016/S0887-2171(00)90028-3; Ermilov SA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3086616; FROUGE C, 1993, RADIOLOGY, V186, P681, DOI 10.1148/radiology.186.3.8430173; GOING JJ, 1990, HISTOPATHOLOGY, V16, P119; Guevara E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083045; Haka AS, 2002, CANCER RES, V62, P5375; Hendrick RE, 2010, RADIOLOGY, V257, P246, DOI 10.1148/radiol.10100570; Huang CS, 1999, ULTRASOUND OBST GYN, V13, P431, DOI 10.1046/j.1469-0705.1999.13060431.x; Kang J, 2013, J BIOPHOTONICS; Kang J, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3651333; Kim HS, 2008, KOREAN J RADIOL, V9, P503, DOI 10.3348/kjr.2008.9.6.503; Kong F, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3073749; Krishna CM, 2008, EXPERT REV MOL DIAGN, V8, P149, DOI 10.1586/14737159.8.2.149; Kruger RA, 2010, MED PHYS, V37, P6096, DOI 10.1118/1.3497677; Ku G, 2005, APPL OPTICS, V44, P770, DOI 10.1364/AO.44.000770; Liberman L, 1998, AM J ROENTGENOL, V171, P35, DOI 10.2214/ajr.171.1.9648759; Liberman L, 2002, RADIOL CLIN N AM, V40, P483, DOI 10.1016/S0033-8389(01)00011-2; Machado P, 2012, J ULTRAS MED, V31, P885, DOI 10.7863/jum.2012.31.6.885; Manohar S, 2007, OPT EXPRESS, V15, P12277, DOI 10.1364/OE.15.012277; MENGES V, 1981, FORTSCHR RONTG NEUEN, V135, P482; MEYER JE, 1990, JAMA-J AM MED ASSOC, V263, P2341, DOI 10.1001/jama.263.17.2341; Moon WK, 2000, RADIOLOGY, V217, P849, DOI 10.1148/radiology.217.3.r00nv27849; Morgan MP, 2005, J MAMMARY GLAND BIOL, V10, P181, DOI 10.1007/s10911-005-5400-6; Park JS, 2010, J ULTRAS MED, V29, P1687, DOI 10.7863/jum.2010.29.12.1687; Parker SH, 1996, RADIOLOGY, V200, P11, DOI 10.1148/radiology.200.1.8657896; Ranieri E, 1997, ANTICANCER RES, V17, P2831; Saha A, 2011, BIOMED OPT EXPRESS, V2, P2792, DOI 10.1364/BOE.2.002792; Song KH, 2008, MED PHYS, V35, P4524, DOI 10.1118/1.2977534; Soo MS, 2003, AM J ROENTGENOL, V180, P941, DOI 10.2214/ajr.180.4.1800941; Soo MS, 2002, AM J ROENTGENOL, V178, P1007, DOI 10.2214/ajr.178.4.1781007; Spinelli L, 2004, J BIOMED OPT, V9, P1137, DOI 10.1117/1.1803546; Stone N, 2007, ANALYST, V132, P899, DOI 10.1039/b705029a; TORNOS C, 1990, AM J SURG PATHOL, V14, P961, DOI 10.1097/00000478-199010000-00010; Yang WT, 1997, BRIT J RADIOL, V70, P685, DOI 10.1259/bjr.70.835.9245879; Yoon C, 2012, OPT EXPRESS, V20, P3082, DOI 10.1364/OE.20.003082; Youk JH, 2007, RADIOGRAPHICS, V27, P79, DOI 10.1148/rg.271065029; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	41	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105878	10.1371/journal.pone.0105878	http://dx.doi.org/10.1371/journal.pone.0105878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153128	Green Submitted, gold, Green Published			2022-12-25	WOS:000340952200088
J	Odhiambo, C; Venter, M; Limbaso, K; Swanepoel, R; Sang, R				Odhiambo, Collins; Venter, Marietjie; Limbaso, Konongoi; Swanepoel, Robert; Sang, Rosemary			Genome Sequence Analysis of In Vitro and In Vivo Phenotypes of Bunyamwera and Ngari Virus Isolates from Northern Kenya	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; PLAQUE PHENOTYPE; BATAI VIRUS; VERO CELLS; REPLICATION; ORTHOBUNYAVIRUSES; DETERMINANTS; REASSORTMENT; ATTENUATION; MUTAGENESIS	Biological phenotypes of tri-segmented arboviruses display characteristics that map to mutation/s in the S, M or L segments of the genome. Plaque variants have been characterized for other viruses displaying varied phenotypes including attenuation in growth and/or pathogenesis. In order to characterize variants of Bunyamwera and Ngari viruses, we isolated individual plaque size variants; small plaque (SP) and large plaque (LP) and determined in vitro growth properties and in vivo pathogenesis in suckling mice. We performed gene sequencing to identify mutations that may be responsible for the observed phenotype. The LP generally replicated faster than the SP and the difference in growth rate was more pronounced in Bunyamwera virus isolates. Ngari virus isolates were more conserved with few point mutations compared to Bunyamwera virus isolates which displayed mutations in all three genome segments but majority were silent mutations. Contrary to expectation, the SP of Bunyamwera virus killed suckling mice significantly earlier than the LP. The LP attenuation may probably be due to a non-synonymous substitution (T858I) that mapped within the active site of the L protein. In this study, we identify natural mutations whose exact role in growth and pathogenesis need to be determined through site directed mutagenesis studies.	[Odhiambo, Collins; Sang, Rosemary] Int Ctr Insect Physiol & Ecol, Human Hlth Div, Nairobi, Kenya; [Odhiambo, Collins; Venter, Marietjie; Swanepoel, Robert] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, ZA-0001 Pretoria, South Africa; [Odhiambo, Collins; Limbaso, Konongoi; Sang, Rosemary] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya; [Sang, Rosemary] US Army Med Res Unit, Div Emerging Infect Dis, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); University of Pretoria; Kenya Medical Research Institute	Odhiambo, C (corresponding author), Int Ctr Insect Physiol & Ecol, Human Hlth Div, POB 30772, Nairobi, Kenya.	coodhiambo@kemricdc.org	Venter, Marietjie/P-9604-2016	Venter, Marietjie/0000-0003-2696-824X; odhiambo, collins/0000-0002-5534-8720	Swedish International Development Agency (SIDA) under Capacity Building of the International Centre of Insect Physiology and Ecology	Swedish International Development Agency (SIDA) under Capacity Building of the International Centre of Insect Physiology and Ecology	This work was supported by funding from the Swedish International Development Agency (SIDA) administered through the African Region Postgraduate Programme in Insect Science (ARPPIS) under Capacity Building of the International Centre of Insect Physiology and Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blaney JE, 2002, VIROLOGY, V300, P125, DOI 10.1006/viro.2002.1528; Blaney JE, 2003, ARCH VIROL, V148, P999, DOI 10.1007/s00705-003-0007-y; Blaney JE, 2001, J VIROL, V75, P9731, DOI 10.1128/JVI.75.20.9731-9740.2001; Bowen MD, 2001, VIROLOGY, V291, P185, DOI 10.1006/viro.2001.1201; Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05; Davis CT, 2004, VIROLOGY, V330, P342, DOI 10.1016/j.virol.2004.09.016; EASTMAN PS, 1985, J VIROL, V55, P611, DOI 10.1128/JVI.55.3.611-616.1985; Elliot R.M., 2000, VIRUS TAXONOMY, P599; ENDRES MJ, 1991, J VIROL, V65, P5465, DOI 10.1128/JVI.65.10.5465-5470.1991; Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004; Gonzalez J. P., 1988, The arboviruses: epidemiology and ecology. Volume II., P87; Jost H, 2011, AM J TROP MED HYG, V84, P241, DOI 10.4269/ajtmh.2011.10-0483; Kanno T, 1998, ARCH VIROL, V143, P1055, DOI 10.1007/s007050050355; Kanno T, 1999, J VIROL, V73, P2710, DOI 10.1128/JVI.73.4.2710-2716.1999; Kohl A, 2006, J GEN VIROL, V87, P177, DOI 10.1099/vir.0.81227-0; Lowen AC, 2005, J VIROL, V79, P12861, DOI 10.1128/JVI.79.20.12861-12870.2005; Mazel-Sanchez B, 2012, J VIROL, V86, P13672, DOI 10.1128/JVI.02253-12; Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140; R Core Team, 2022, R LANG ENV STAT COMP; Ramsingh AI, 1995, ARCH VIROL, V140, P2215, DOI 10.1007/BF01323241; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; Shi XH, 2009, J GEN VIROL, V90, P297, DOI 10.1099/vir.0.007567-0; Sundstrom KB, 2011, J VIROL, V85, P1747, DOI 10.1128/JVI.01428-10; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yanase T, 2006, ARCH VIROL, V151, P2253, DOI 10.1007/s00705-006-0808-x; ZHANG H, 1995, ARCH VIROL, V140, P959, DOI 10.1007/BF01314972	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105446	10.1371/journal.pone.0105446	http://dx.doi.org/10.1371/journal.pone.0105446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153316	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200049
J	Gautam, D; Dobhal, S; Payton, ME; Fletcher, J; Ma, LM				Gautam, Dhiraj; Dobhal, Shefali; Payton, Mark E.; Fletcher, Jacqueline; Ma, Li Maria			Surface Survival and Internalization of Salmonella through Natural Cracks on Developing Cantaloupe Fruits, Alone or in the Presence of the Melon Wilt Pathogen Erwinia tracheiphila	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; ENTERICA SEROVAR TYPHIMURIUM; TOMATO PLANTS; BACTERIAL WILT; LACTUCA-SATIVA; UNITED-STATES; FRESH FRUITS; CUCUMIS-MELO; COLONIZATION; CONTAMINATION	Outbreaks of foodborne illness attributed to the consumption of Salmonella-tainted cantaloupe have occurred repeatedly, but understanding of the ecology of Salmonella on cantaloupe fruit surfaces is limited. We investigated the interactions between Salmonella enterica Poona, the plant pathogenic bacterium Erwinia tracheiphila, and cantaloupe fruit. Fruit surfaces were inoculated at the natural cracking stage by spreading S. enterica and E. tracheiphila, 20 mu l at 10(7) cfu/ml, independently or together, over a 2 x 2 cm rind area containing a crack. Microbial and microscopic analyses were performed at 0, 9 and 24 days post inoculation (DPI). Even at 24 DPI (fruit maturity) S. enterica was detected on 14% and 40% of the fruit inoculated with S. enterica alone and the two-pathogen mixture, respectively. However, the population of S. enterica declined gradually after initial inoculation. E. tracheiphila, inoculated alone or together with Salmonella, caused watersoaked lesions on cantaloupe fruit; but we could not conclude in this study that S. enterica survival on the fruit surface was enhanced by the presence of those lesions. Of fruit inoculated with E. tracheiphila alone and sampled at 24 DPI, 61% had watersoaked lesions on the surface. In nearly half of those symptomatic fruits the watersoaking extended into the sub-rind mesocarp, and E. tracheiphila was recovered from that tissue in 50% of the symptomatic fruit. In this work, E. tracheiphila internalized through natural cracks on developing fruits. S. enterica was never detected in the fruit interior (ca. 2-3 mm below rind surface) under the limited conditions of our experiments, but the possibility that it, or other human pathogens that contaminate fresh produce, might also do so should be investigated under a wider range of conditions and produce types.	[Gautam, Dhiraj; Dobhal, Shefali; Fletcher, Jacqueline; Ma, Li Maria] Oklahoma State Univ, Natl Inst Microbial Forens & Food & Agr Biosecur, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; [Payton, Mark E.] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Fletcher, J (corresponding author), Oklahoma State Univ, Natl Inst Microbial Forens & Food & Agr Biosecur, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA.	jacqueline.fletcher@okstate.edu; li.ma@okstate.edu		ma, li/0000-0002-9778-6032	Oklahoma Center for the Advancement of Science Technology [PSB 09-007]; Oklahoma Agricultural Experiment Station [OKL 02793, OKL 02059]	Oklahoma Center for the Advancement of Science Technology; Oklahoma Agricultural Experiment Station	This work was supported by Oklahoma Center for the Advancement of Science & Technology (JF, grant number PSB 09-007: https://www.ok.gov/ocast) and Oklahoma Agricultural Experiment Station (LMM, project number OKL 02793; JF, project number OKL 02059: http://oaes.okstate.edu/). The funders had no role in study design, data collection and analysis, decision for publication, or preparation of the manuscript.	Akins ED, 2008, J FOOD PROTECT, V71, P46, DOI 10.4315/0362-028X-71.1.46; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3025; Barak JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001657; Barak JD, 2012, ANNU REV PHYTOPATHOL, V50, P241, DOI 10.1146/annurev-phyto-081211-172936; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Bennik MHJ, 1999, LETT APPL MICROBIOL, V28, P226, DOI 10.1046/j.1365-2672.1999.00497.x; Beuchat LR, 2003, J FOOD PROTECT, V66, P1459, DOI 10.4315/0362-028X-66.8.1459; Bezanson G, 2012, J FOOD PROTECT, V75, P480, DOI 10.4315/0362-028X.JFP-11-306; Bowen A, 2006, EPIDEMIOL INFECT, V134, P675, DOI 10.1017/S0950268805005480; Brand MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025553; Brust GE, 1997, ENVIRON ENTOMOL, V26, P580, DOI 10.1093/ee/26.3.580; BURKHOLDER WH, 1960, PHYTOPATHOLOGY, V50, P179; CDC, 2008, MULT OUTBR SALM LITC; CDC, 2012, MULT OUTBR SALM TYPH; Centers for Disease Control and Prevention, 2021, CURR OUTBR SALM OUTB; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1044; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P549; Cevallos-Cevallos JM, 2012, INT J FOOD MICROBIOL, V158, P140, DOI 10.1016/j.ijfoodmicro.2012.07.009; Cevallos-Cevallos JM, 2012, J FOOD PROTECT, V75, P472, DOI 10.4315/0362-028X.JFP-11-399; Chitrakar Reejana, 2010, J Vis Exp, DOI 10.3791/2185; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328; Cutter EG, 1969, PLANT ANATOMY EXPT I; de Mackiewicz D, 1998, PLANT DIS, V82, P521, DOI 10.1094/PDIS.1998.82.5.521; Duffy B, 2008, EUR J HORTIC SCI, V73, P73; Erickson MC, 2014, J FOOD PROTECT, V77, P189, DOI 10.4315/0362-028X.JFP-13-216; FERGUSON W. E., 1964, CANADIAN JOUR BOT, V42, P333, DOI 10.1139/b64-030; Fett WF, 2006, J FOOD PROTECT, V69, P719, DOI 10.4315/0362-028X-69.4.719; Fleischer SJ, 1999, ENVIRON ENTOMOL, V28, P470, DOI 10.1093/ee/28.3.470; Gagliardi JV, 2003, J FOOD PROTECT, V66, P82, DOI 10.4315/0362-028X-66.1.82; Gautam D, 2011, PHYTOPATHOLOGY, V101, pS59; Gould G.E., 1942, BIOL CONTROL STRIPED, P1; Gu Ganyu, 2013, PLoS One, V8, pe53470, DOI 10.1371/journal.pone.0053470; Gu GY, 2013, PHYTOPATHOLOGY, V103, P381, DOI 10.1094/PHYTO-04-12-0072-FI; Gu GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027340; Guo X, 2001, APPL ENVIRON MICROB, V67, P4760, DOI 10.1128/AEM.67.10.4760-4764.2001; Guo XA, 2002, APPL ENVIRON MICROB, V68, P3639, DOI 10.1128/AEM.68.7.3639-3643.2002; Harris HA, 1940, PHYTOPATHOLOGY, V30, P625; Hauben L, 1998, SYST APPL MICROBIOL, V21, P384, DOI 10.1016/S0723-2020(98)80048-9; Holt PS, 2007, APPL ENVIRON MICROB, V73, P6030, DOI 10.1128/AEM.00803-07; Hora R, 2005, J FOOD PROTECT, V68, P2506, DOI 10.4315/0362-028X-68.12.2506; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Islam Mahbub, 2004, Foodborne Pathog Dis, V1, P27, DOI 10.1089/153531404772914437; Janisiewicz WJ, 1999, J FOOD PROTECT, V62, P1372, DOI 10.4315/0362-028X-62.12.1372; Keren-Keiserman A, 2004, J HORTIC SCI BIOTECH, V79, P107, DOI 10.1080/14620316.2004.11511721; Kisluk G, 2012, APPL ENVIRON MICROB, V78, P4030, DOI 10.1128/AEM.00087-12; Klerks MM, 2007, APPL ENVIRON MICROB, V73, P4905, DOI 10.1128/AEM.02522-06; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Salgado PL, 2009, REV FITOTEC MEX, V32, P209; Lopez-Velasco G, 2012, INT J FOOD MICROBIOL, V158, P65, DOI 10.1016/j.ijfoodmicro.2012.07.005; Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018083; Materon LA, 2007, WORLD J MICROB BIOT, V23, P1281, DOI 10.1007/s11274-007-9362-2; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Mitchell RF, 2009, ENVIRON ENTOMOL, V38, P395, DOI 10.1603/022.038.0212; Morales-Hernandez L., 2009, Agricultura Tecnica en Mexico, V35, P135; NUTTALL V. W., 1958, CANADIAN JOUR PLANT SCI, V38, P401; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Pianetti A, 1998, WATER RES, V32, P1515, DOI 10.1016/S0043-1354(97)00340-0; Potnis N, 2014, APPL ENVIRON MICROB, V80, P3173, DOI 10.1128/AEM.00345-14; PREND J, 1961, PHYTOPATHOLOGY, V51, P255; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Rand FV, 1916, J AGRIC RES, V6, P417; REED GL, 1982, PLANT DIS, V66, P778, DOI 10.1094/PD-66-778; Richards GM, 2005, INT J FOOD MICROBIOL, V103, P1, DOI 10.1016/j.ijfoodmicro.2004.05.023; RIES AA, 1990, 30 INT C ANT AG CHEM, P238; Rojas ES, 2012, PLANT DIS, V96, P62, DOI 10.1094/PDIS-04-11-0277; Semenov AV, 2009, APPL ENVIRON MICROB, V75, P3206, DOI 10.1128/AEM.01791-08; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Smith EF, 1911, WILT CUCURBITS, V2; Solomon EB, 2005, J FOOD PROTECT, V68, P906, DOI 10.4315/0362-028X-68.5.906; Suslow T, 2001, FRESH CUT, V9, P12; Suslow T, 2001, FRESH CUT, V9, P32; Suslow T, 2001, FRESH CUT, P20; Ukuku DO, 2004, J FOOD PROTECT, V67, P432, DOI 10.4315/0362-028X-67.3.432; Walcott RR, 2005, PLANT HLTH INSTRUCTO, DOI [10.1094/PHI-I-2005-1025-02, DOI 10.1094/PHI-I-2005-1025-02]; WEBSTER BD, 1976, J AM SOC HORTIC SCI, V101, P412; Wells JM, 1999, PLANT DIS, V83, P722, DOI 10.1094/PDIS.1999.83.8.722; Wells JM, 1997, PLANT DIS, V81, P867, DOI 10.1094/PDIS.1997.81.8.867; WILLIAMS LANSING E., 1956, PLANT DIS REPORTER, V40, P479; WILSON J. D., 1956, PLANT DIS REPORTER, V40, P437; Xiao CL, 2004, PLANT DIS, V88, P114, DOI 10.1094/PDIS.2004.88.2.114; Zhang GD, 2009, J FOOD PROTECT, V72, P2028, DOI 10.4315/0362-028X-72.10.2028	84	11	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105248	10.1371/journal.pone.0105248	http://dx.doi.org/10.1371/journal.pone.0105248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147942	Green Submitted, Green Published, gold			2022-12-25	WOS:000341230600036
J	Kehoe, MA; Coutts, BA; Buirchell, BJ; Jones, RAC				Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.			Split Personality of a Potyvirus: To Specialize or Not to Specialize?	PLOS ONE			English	Article							YELLOW-MOSAIC-VIRUS; COMPLETE NUCLEOTIDE-SEQUENCE; NON-NECROTIC STRAINS; MAIZE STREAK VIRUS; HOST ADAPTATION; VEIN-VIRUS; RECOMBINATION; EMERGENCE; EVOLUTION; RESISTANCE	Bean yellow mosaic virus (BYMV), genus Potyvirus, has an extensive natural host range encompassing both dicots and monocots. Its phylogenetic groups were considered to consist of an ancestral generalist group and six specialist groups derived from this generalist group during plant domestication. Recombination was suggested to be playing a role in BYMV's evolution towards host specialization. However, in subsequent phylogenetic analysis of whole genomes, group names based on the original hosts of isolates within each of them were no longer supported. Also, nine groups were found and designated I-IX. Recombination analysis was conducted on the complete coding regions of 33 BYMV genomes and two genomes of the related Clover yellow vein virus (CYVV). This analysis found evidence for 12 firm recombination events within BYMV phylogenetic groups I-VI, but none within groups VII-IX or CYVV. The greatest numbers of recombination events within a sequence (two or three each) occurred in four groups, three which formerly constituted the single ancestral generalist group (I, II and IV), and group VI. The individual sequences in groups III and V had one event each. These findings with whole genomes are consistent with recombination being associated with expanding host ranges, and call into question the proposed role of recombination in the evolution of BYMV, where it was previously suggested to play a role in host specialization. Instead, they (i) indicate that recombination explains the very broad natural host ranges of the three BYMV groups which infect both monocots and dicots (I, II, IV), and (ii) suggest that the three groups with narrow natural host ranges (III, V, VI) which also showed recombination now have the potential to reduce host specificity and broaden their natural host ranges.	[Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia; [Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Univ Western Australia, Fac Sci, Inst Agr, Crawley, WA, Australia; [Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Bentley Delivery Ctr, Dept Agr & Food Western Australia, Crop Protect & Lupin Breeding Branches, Perth, WA, Australia	University of Western Australia; University of Western Australia	Kehoe, MA (corresponding author), Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia.	monica.kehoe@agric.wa.gov.au	Jones, Roger A.C./B-1200-2011	Jones, Roger A.C./0000-0003-3593-3102; Buirchell, Bevan/0000-0001-8247-3570	Australian Postgraduate Award (APA); Australian Grains Research and Development Corporation (GRDC) Studentship [GRS10039]	Australian Postgraduate Award (APA)(Australian Government); Australian Grains Research and Development Corporation (GRDC) Studentship(Grains R&D Corp)	This research was funded by an Australian Postgraduate Award (APA), and an Australian Grains Research and Development Corporation (GRDC) Studentship, Project number GRS10039. It was undertaken using the facilities at the Department of Agriculture and Food Western Australia. This study forms part of a PhD project by the first author at the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlandier FA, 1997, ANN APPL BIOL, V131, P297, DOI 10.1111/j.1744-7348.1997.tb05158.x; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; BOS L, 1970, Netherlands Journal of Plant Pathology, V76, P8, DOI 10.1007/BF01976763; Bos L, 1970, DESCRIPTIONS PLANT V; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1075, DOI 10.1094/MPMI-20-9-1075; Buichell BJ, 2008, RLUPINS HLTH WEALTHW; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Cheng Y, 2000, ANN APPL BIOL, V136, P215, DOI 10.1111/j.1744-7348.2000.tb00028.x; Cheng Y, 1999, AUST J AGR RES, V50, P589, DOI 10.1071/A98116; Choi SH, 2013, J VIROL, V87, P7326, DOI 10.1128/JVI.00065-13; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Edwardson JR, 1991, CRC HDB VIRUSES INFE; Gibbs AJ, 2008, ARCH VIROL, V153, P1411, DOI 10.1007/s00705-008-0134-6; Gibbs A, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P229, DOI 10.1016/B978-0-12-374153-0.00011-4; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guyatt KJ, 1996, ARCH VIROL, V141, P1231, DOI 10.1007/BF01718827; Hammond J, 2003, ARCH VIROL, V148, P2461, DOI 10.1007/s00705-003-0185-7; HAMPTON RO, 1992, PHYTOPATHOLOGY, V82, P566, DOI 10.1094/Phyto-82-566; JONES RAC, 1993, ANN APPL BIOL, V122, P501, DOI 10.1111/j.1744-7348.1993.tb04053.x; JONES RAC, 1989, ANN APPL BIOL, V114, P609, DOI 10.1111/j.1744-7348.1989.tb03376.x; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Karasev AV, 2013, AM J POTATO RES, V90, P7, DOI 10.1007/s12230-012-9287-7; Kehoe MA, 2014, PLANT DIS, V98, P739, DOI [10.1094/PDIS-11-13-1144-RE, 10.1094/PDIS-11-13-1144-]; Kehoe MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104580; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, PLOS GENET, V1, P475, DOI 10.1371/journal.pgen.0010051; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Monjane AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-350; Nakamura Shigeo, 1994, Annals of the Phytopathological Society of Japan, V60, P295, DOI 10.3186/jjphytopath.60.295; Nakazono-Nagaoka Eiko, 2004, Journal of General Plant Pathology, V70, P359, DOI 10.1007/s10327-004-0138-3; Nakazono-Nagaoka E, 2009, PHYTOPATHOLOGY, V99, P251, DOI 10.1094/PHYTO-99-3-0251; Ohshima K, 2002, J GEN VIROL, V83, P1511, DOI 10.1099/0022-1317-83-6-1511; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Revers F, 1996, J GEN VIROL, V77, P1953, DOI 10.1099/0022-1317-77-8-1953; Roossinck MJ, 2003, CURR OPIN MICROBIOL, V6, P406, DOI 10.1016/S1369-5274(03)00087-0; SMITH JM, 1992, J MOL EVOL, V34, P126; Sztuba-Solinska J, 2011, ANNU REV PHYTOPATHOL, V49, P415, DOI 10.1146/annurev-phyto-072910-095351; Takahashi Y, 1997, VIRUS GENES, V14, P235, DOI 10.1023/A:1007940028058; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tromas N, 2014, J GEN VIROL, V95, P724, DOI 10.1099/vir.0.060822-0; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0; van der Walt E, 2009, J GEN VIROL, V90, P734, DOI 10.1099/vir.0.007724-0; Varsani A, 2008, J GEN VIROL, V89, P2063, DOI 10.1099/vir.0.2008/003590-0; Wen RH, 2010, VIROLOGY, V400, P1, DOI 10.1016/j.virol.2010.01.022; Wylie SJ, 2009, PHYTOPATHOLOGY, V99, P512, DOI 10.1094/PHYTO-99-5-0512; Wylie SJ, 2008, PLANT DIS, V92, P1596, DOI 10.1094/PDIS-92-12-1596; Wylie SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/j.virusres.2012.10.003	50	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105770	10.1371/journal.pone.0105770	http://dx.doi.org/10.1371/journal.pone.0105770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148372	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600082
J	Parillo, F; Maranesi, M; Mignini, F; Marinelli, L; Di Stefano, A; Boiti, C; Zerani, M				Parillo, Francesco; Maranesi, Margherita; Mignini, Fiorenzo; Marinelli, Lisa; Di Stefano, Antonio; Boiti, Cristiano; Zerani, Massimo			Evidence for a Dopamine Intrinsic Direct Role in the Regulation of the Ovary Reproductive Function: In Vitro Study on Rabbit Corpora Lutea	PLOS ONE			English	Article							PROSTAGLANDIN-F2-ALPHA ANALOG; CORPUS-LUTEUM; NITRIC-OXIDE; RECEPTORS; EXPRESSION; SYNTHASES; EVOLUTION; DARPP-32; CELLS	Dopamine (DA) receptor (DR) type 1 (D1R) has been found to be expressed in luteal cells of various species, but the intrinsic role of the DA/DRs system on corpora lutea (CL) function is still unclear. Experiments were devised to characterize the expression of DR types and the presence of DA, as well as the in vitro effects of DA on hormone productions by CL in pseudopregnant rabbits. Immunoreactivity and gene expression for D1R decreased while that for D3R increased in luteal and blood vessel cells from early to late pseudopregnant stages. DA immunopositivity was evidenced only in luteal cells. The DA and D1R agonist increased in vitro release of progesterone and prostaglandin E2 (PGE2) by early CL, whereas the DA and D3R agonist decreased progesterone and increased PGF2 alpha in vitro release by mid- and late CL. These results provide evidence that the DA/DR system exerts a dual modulatory function in the lifespan of CL: the DA/D1R is luteotropic while the DA/D3R is luteolytic. The present data shed new light on the physiological mechanisms regulating luteal activity that might improve our ability to optimize reproductive efficiency in mammal species, including humans.	[Parillo, Francesco; Zerani, Massimo] Univ Camerino, Scuola Biosci & Med Vet, Matelica, Italy; [Maranesi, Margherita; Boiti, Cristiano] Univ Perugia, Dipartimento Sci Biopatol Vet & Igiene Prod Anim, I-06100 Perugia, Italy; [Mignini, Fiorenzo] Univ Camerino, Scuola Farmaco & Prodotti Salute, I-62032 Camerino, Italy; [Marinelli, Lisa; Di Stefano, Antonio] Univ G DAnnunzio, Dipartimento Farm, Chieti, Italy	University of Camerino; University of Perugia; University of Camerino; G d'Annunzio University of Chieti-Pescara	Zerani, M (corresponding author), Univ Camerino, Scuola Biosci & Med Vet, Matelica, Italy.	massimo.zerani@unicam.it	Zerani, Massimo/L-6348-2015; Maranesi, Margherita/AAG-5142-2021; Zerani, Massimo/AAF-4433-2020	Maranesi, Margherita/0000-0002-1727-4118; Zerani, Massimo/0000-0002-2476-5097; MARINELLI, LISA/0000-0001-8611-6538; DI STEFANO, Antonio/0000-0002-3042-2234	BC Red-water (Perugia, Italy) Trust; PFZM Kitchenbrown (Matelica, Italy) Trust	BC Red-water (Perugia, Italy) Trust; PFZM Kitchenbrown (Matelica, Italy) Trust	This study was supported by generous donations of the BC Red-water (Perugia, Italy) and PFZM Kitchenbrown (Matelica, Italy) Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Boiti C, 2005, ENDOCRINOLOGY, V146, P1293, DOI 10.1210/en.2004-1099; Boiti C, 2003, REPRODUCTION, V125, P807, DOI 10.1530/reprod/125.6.807; Boiti C, 2001, J ENDOCRINOL, V168, P141, DOI 10.1677/joe.0.1680141; Boiti C, 1998, PROSTAG OTH LIPID M, V56, P255; D'Albora H, 2002, MICROSC RES TECHNIQ, V59, P484, DOI 10.1002/jemt.10231; DAVIS JS, 2002, FRONT BIOSCI, V7, P1949, DOI DOI 10.2741/DAVIS1; DOUGLAS RH, 1975, J REPROD FERTIL, P257; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Gerendai I, 2005, ENDOCRINE, V28, P309, DOI 10.1385/ENDO:28:3:309; GUTHRIE HD, 1976, J REPROD FERTIL, V48, P423, DOI 10.1530/jrf.0.0480423; Helliwell RJA, 2004, PROSTAG LEUKOTR ESS, V70, P101, DOI 10.1016/j.plefa.2003.04.002; King SS, 2005, DOMEST ANIM ENDOCRIN, V28, P405, DOI 10.1016/j.domaniend.2005.02.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayerhofer A, 1999, J CLIN ENDOCR METAB, V84, P257, DOI 10.1210/jc.84.1.257; Mayerhofer A, 2000, J CLIN ENDOCR METAB, V85, P4750, DOI 10.1210/jc.85.12.4750; MICHAEL AE, 1993, J REPROD FERTIL, V97, P425; Nasuti C, 2013, TOXICOLOGY, V303, P162, DOI 10.1016/j.tox.2012.09.016; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Parillo F, 2012, MICROSC RES TECHNIQ, V75, P1682, DOI 10.1002/jemt.22116; Parillo F, 2013, ACTA SCI VET, V41; Parillo F, 2013, ANIM REPROD SCI, V138, P118, DOI 10.1016/j.anireprosci.2013.02.001; Polisca A, 2010, THERIOGENOLOGY, V74, P672, DOI 10.1016/j.theriogenology.2010.03.021; Rey-Ares V, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-40; Sarkar C, 2013, J NEUROIMMUNE PHARM, V8, P7, DOI 10.1007/s11481-012-9395-7; Stradaioli G., 1997, World Rabbit Science, V5, P143; Tamanini C, 2004, REPROD DOMEST ANIM, V39, P206, DOI 10.1111/j.1439-0531.2004.00505.x; Wiltbank Milo C, 2003, Reprod Biol Endocrinol, V1, P91, DOI 10.1186/1477-7827-1-91; Yamamoto K, 2013, MOL BIOL EVOL, V30, P833, DOI 10.1093/molbev/mss268; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Zerani M, 2007, REPRODUCTION, V133, P1005, DOI 10.1530/REP-06-0107; Zerani M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107383; Zerani M, 2010, J ENDOCRINOL, V207, P289, DOI 10.1677/JOE-10-0109	33	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104797	10.1371/journal.pone.0104797	http://dx.doi.org/10.1371/journal.pone.0104797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148384	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600022
J	Goodin, DS; Corwin, M; Kaufman, D; Golub, H; Reshef, S; Rametta, MJ; Knappertz, V; Cutter, G; Pleimes, D				Goodin, Douglas S.; Corwin, Michael; Kaufman, David; Golub, Howard; Reshef, Shoshana; Rametta, Mark J.; Knappertz, Volker; Cutter, Gary; Pleimes, Dirk			Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States	PLOS ONE			English	Article							SURVIVAL; MORTALITY	Background: Information on causes of death (CODs) for patients with multiple sclerosis (MS) in the United States is sparse and limited by standard categorizations of underlying and immediate CODs on death certificates. Prior research indicated that excess mortality among MS patients was largely due to greater mortality from infectious, cardiovascular, or pulmonary causes. Objective: To analyze disease categories in order to gain insight to pathways, which lead directly to death in MS patients. Methods: Commercially insured MS patients enrolled in the OptumInsight Research database between 1996 and 2009 were matched to non-MS comparators on age/residence at index year and sex. The cause most-directly leading to death from the death certificate, referred to as the "principal'' COD, was determined using an algorithm to minimize the selection of either MS or cardiac/pulmonary arrest as the COD. Principal CODs were categorized into MS, cancer, cardiovascular, infectious, suicide, accidental, pulmonary, other, or unknown. Infectious, cardiovascular, and pulmonary CODs were further subcategorized. Results: 30,402 MS patients were matched to 89,818 controls, with mortality rates of 899 and 446 deaths/100,000 person-years, respectively. Excluding MS, differences in mortality rate between MS patients and non-MS comparators were largely attributable to infections, cardiovascular causes, and pulmonary problems. Of the 95 excessive deaths (per 100,000 person-years) related to infectious causes, 41 (43.2%) were due to pulmonary infections and 45 (47.4%) were attributed to sepsis. Of the 46 excessive deaths (per 100,000 person-years) related to pulmonary causes, 27 (58.7%) were due to aspiration. No single diagnostic entity predominated for the 60 excessive deaths (per 100,000 person-years) attributable to cardiac CODs. Conclusions: The principal COD algorithm improved on other methods of determining COD in MS patients from death certificates. A greater awareness of the common CODs in MS patients will allow physicians to anticipate potential problems and, thereby, improve the care that they provide.	[Goodin, Douglas S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Corwin, Michael; Kaufman, David] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Corwin, Michael; Golub, Howard] Care Safe, Boston, MA USA; [Reshef, Shoshana; Rametta, Mark J.] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Knappertz, Volker] Teva Pharmaceut, Frazer, PA USA; [Knappertz, Volker] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany; [Cutter, Gary] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Pleimes, Dirk] Myelo Therapeut GmbH, Berlin, Germany	University of California System; University of California San Francisco; Boston University; Bayer AG; Bayer Healthcare Pharmaceuticals; Heinrich Heine University Dusseldorf; University of Alabama System; University of Alabama Birmingham	Goodin, DS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	douglas.goodin@ucsf.edu	Cutter, Gary/AAY-5392-2021	Cutter, Gary/0000-0002-8455-980X; Kaufman, David/0000-0002-2150-5070; Corwin, Michael/0000-0002-6591-209X; Pleimes, Dirk/0000-0002-0876-9418	Bayer HealthCare Pharmaceuticals	Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals)	This project was sponsored by Bayer HealthCare Pharmaceuticals. Other than comments that the authors were not obligated to accept, the funder provided support in the form of salaries for authors SR and MJR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; CDC, 2003, US STAND CERT DEATH; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Goodin DS, 2012, NEUROLOGY, V78, P1315, DOI 10.1212/WNL.0b013e3182535cf6; Goodin DS, 2012, BMJ OPEN, V30, P2, DOI DOI 10.1136/BMJ0PEN-2012-001972; Ho AMH, 2013, ANAESTHESIA, V68, P126, DOI 10.1111/anae.12120; Kaufman DW, MULT SCLER RELATED D, V3, P364; Kingwell E, 2012, J NEUROL NEUROSUR PS, V83, P61, DOI 10.1136/jnnp-2011-300616; Lalmohamed A, 2012, EUR J NEUROL, V19, P1007, DOI 10.1111/j.1468-1331.2012.03668.x; Lewis Adele, 2012, Tenn Med, V105, P37; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Poorjavad M, 2010, MULT SCLER J, V16, P362, DOI 10.1177/1352458509358089; Ragonese P, 2010, EUR J NEUROL, V17, P391, DOI 10.1111/j.1468-1331.2009.02814.x; SADOVNICK AD, 1992, NEUROLOGY, V42, P991, DOI 10.1212/WNL.42.5.991; Torkildsen NG, 2008, MULT SCLER J, V14, P1191, DOI 10.1177/1352458508093890	16	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105207	10.1371/journal.pone.0105207	http://dx.doi.org/10.1371/journal.pone.0105207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144226	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100042
J	Ikels, K; Kuschel, S; Fischer, J; Kaisers, W; Eberhard, D; Ruther, U				Ikels, Kathrin; Kuschel, Stefanie; Fischer, Julia; Kaisers, Wolfgang; Eberhard, Daniel; Ruether, Ulrich			FTO Is a Relevant Factor for the Development of the Metabolic Syndrome in Mice	PLOS ONE			English	Article							CONGENITAL LEPTIN DEFICIENCY; ADIPOSE-TISSUE; OBESE GENE; OB/OB MICE; DIABETES-MELLITUS; MORBID-OBESITY; FOOD-INTAKE; PPAR-GAMMA; FAT MASS; HYPERGLYCEMIA	The metabolic syndrome is a worldwide problem mainly caused by obesity. FTO was found to be a obesity-risk gene in humans and FTO deficiency in mice led to reduction in adipose tissue. Thus, FTO is an important factor for the development of obesity. Leptin-deficient mice are a well characterized model for analysing the metabolic syndrome. To determine the relevance of FTO for the development of the metabolic syndrome we analysed different parameters in combined homozygous deficient mice (Lep(ob/ob); Fto(-/-)). Lep(ob/ob); Fto(-/-) mice showed an improvement in analysed hallmarks of the metabolic syndrome in comparison to leptin-deficient mice wild type or heterozygous for Fto. Lep(ob/ob); Fto(-/-) mice did not develop hyperglycaemia and showed an improved glucose tolerance. Furthermore, extension of beta-cell mass was prevented in Lep(ob/ob); Fto(-/-) mice and accumulation of ectopic fat in the liver was reduced. In conclusion this study demonstrates that FTO deficiency has a protective effect not only on the development of obesity but also on the metabolic syndrome. Thus, FTO plays an important role in the development of metabolic disorders and is an interesting target for therapeutic agents.	[Ikels, Kathrin; Kuschel, Stefanie; Fischer, Julia; Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, Dusseldorf, Germany; [Eberhard, Daniel] Univ Dusseldorf, Inst Metab Physiol, Dusseldorf, Germany; [Kaisers, Wolfgang] Univ Dusseldorf, Coordinat Ctr Clin Trials, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Ruther, U (corresponding author), Univ Dusseldorf, Inst Anim Dev & Mol Biol, Dusseldorf, Germany.	ruether@hhu.de			BMBF (NGFN plus); DFG [SFB612]	BMBF (NGFN plus)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This work was supported by a grant from the BMBF (NGFN plus) and the DFG through SFB612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; de Luis DA, 2013, J DIABETES COMPLICAT, V27, P346, DOI 10.1016/j.jdiacomp.2013.02.003; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Chen BE, 2012, J AM CHEM SOC, V134, P17963, DOI 10.1021/ja3064149; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2986, DOI 10.1172/JCI118007; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Doshi M, 2011, NUCLEOS NUCLEOT NUCL, V30, P1290, DOI 10.1080/15257770.2011.603711; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gat-Yablonski G, 2004, ENDOCRINOLOGY, V145, P343, DOI 10.1210/en.2003-0910; Gulati P, 2013, DIABETOLOGIA; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hauner H, 2004, PHYSIOL BEHAV, V83, P653, DOI 10.1016/j.physbeh.2004.09.016; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Lalonde J, 2004, PHYSIOL BEHAV, V80, P415, DOI 10.1016/j.physbeh.2003.08.013; Lee YS, 2010, BIOCHEM PHARMACOL, V79, P1674, DOI 10.1016/j.bcp.2010.01.034; Legry V, 2009, METABOLISM, V58, P971, DOI 10.1016/j.metabol.2009.02.019; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morton GJ, 2013, J CLIN INVEST; Naveilhan P, 2002, PEPTIDES, V23, P1087, DOI 10.1016/S0196-9781(02)00042-6; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pollex RL, 2006, NAT CLIN PRACT CARD, V3, P482, DOI 10.1038/ncpcardio0638; R Core Team, 2014, R LANG ENV STAT COMP; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8; Tabbi-Anneni I, 2008, ENDOCRINOLOGY, V149, P4043, DOI 10.1210/en.2007-1646; Tews D, 2013, ENDOCRINOLOGY, V154, P3141, DOI 10.1210/en.2012-1873; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Wang HN, 2012, MOL BIOL REP, V39, P5691, DOI 10.1007/s11033-011-1377-y; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049	46	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105349	10.1371/journal.pone.0105349	http://dx.doi.org/10.1371/journal.pone.0105349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144618	gold, Green Submitted, Green Published			2022-12-25	WOS:000341106100057
J	Kruse, W; Krause, M; Aarse, J; Mark, MD; Manahan-Vaughan, D; Herlitze, S				Kruse, Wolfgang; Krause, Martin; Aarse, Janna; Mark, Melanie D.; Manahan-Vaughan, Denise; Herlitze, Stefan			Optogenetic Modulation and Multi-Electrode Analysis of Cerebellar Networks In Vivo	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; NEURAL CIRCUITRY; GRANULE CELL; PURKINJE; ACTIVATION; NEURONS; INHIBITION; SPIKE; AXON; CHANNELRHODOPSIN-2	The firing patterns of cerebellar Purkinje cells (PCs), as the sole output of the cerebellar cortex, determine and tune motor behavior. PC firing is modulated by various inputs from different brain regions and by cell-types including granule cells (GCs), climbing fibers and inhibitory interneurons. To understand how signal integration in PCs occurs and how subtle changes in the modulation of PC firing lead to adjustment of motor behaviors, it is important to precisely record PC firing in vivo and to control modulatory pathways in a spatio-temporal manner. Combining optogenetic and multi-electrode approaches, we established a new method to integrate light-guides into a multi-electrode system. With this method we are able to variably position the light-guide in defined regions relative to the recording electrode with micrometer precision. We show that PC firing can be precisely monitored and modulated by light-activation of channelrhodopsin-2 (ChR2) expressed in PCs, GCs and interneurons. Thus, this method is ideally suited to investigate the spatio/temporal modulation of PCs in anesthetized and in behaving mice.	[Kruse, Wolfgang; Krause, Martin; Mark, Melanie D.; Herlitze, Stefan] Ruhr Univ Bochum, Dept Zool & Neurobiol, Fac Biol & Biotechnol, Bochum, Germany; [Aarse, Janna; Manahan-Vaughan, Denise] Ruhr Univ Bochum, Fac Med, Dept Neurophysiol, Bochum, Germany; [Kruse, Wolfgang; Aarse, Janna; Manahan-Vaughan, Denise; Herlitze, Stefan] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Kruse, W (corresponding author), Ruhr Univ Bochum, Dept Zool & Neurobiol, Fac Biol & Biotechnol, Univ Str 150, Bochum, Germany.	Wolfgang.Kruse@rub.de	Mark, Melanie/ABF-9102-2020	Mark, Melanie/0000-0002-2788-6003; Manahan-Vaughan, Denise/0000-0002-9283-9609	Deutsche Forschungsgemeinschaft (DFG) [Ma5806/1-1, He2471/8-1]; DFG [SFB 874]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grants to MDM (Ma5806/1-1) and to SH (He2471/8-1) and by DFG SFB 874 to DMV and SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Bower JM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00027; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chaumont J, 2013, P NATL ACAD SCI USA, V110, P16223, DOI 10.1073/pnas.1302310110; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; D'Angelo E, 2011, BRAIN RES REV, V66, P5, DOI 10.1016/j.brainresrev.2010.10.002; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; de Solages C, 2008, NEURON, V58, P775, DOI 10.1016/j.neuron.2008.05.008; Dizon MJ, 2011, J NEUROSCI, V31, P10463, DOI 10.1523/JNEUROSCI.1350-11.2011; ECCLES JC, 1973, J PHYSIOL-LONDON, V229, P1; Eccles JC, 1967, CEREBELLUM NEURAL MA; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; Funfschilling U, 2002, GENESIS, V33, P160, DOI 10.1002/gene.10104; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Gundappa-Sulur G, 1999, J COMP NEUROL, V408, P580, DOI 10.1002/(SICI)1096-9861(19990614)408:4<580::AID-CNE11>3.0.CO;2-O; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Heiney SA, 2014, J NEUROSCI, V34, P2321, DOI 10.1523/JNEUROSCI.4547-13.2014; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Huang CM, 2006, EUR J NEUROSCI, V23, P1731, DOI 10.1111/j.1460-9568.2006.04690.x; Kravitz AV, 2011, CURR OPIN NEUROBIOL, V21, P433, DOI 10.1016/j.conb.2011.02.010; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Masseck OA, 2014, NEURON, V81, P1263, DOI 10.1016/j.neuron.2014.01.041; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Ozden I, 2013, J NEUROSCI METH, V219, P142, DOI 10.1016/j.jneumeth.2013.06.011; Raman IM, 1999, J NEUROSCI, V19, P1663; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; THACH WT, 1970, J NEUROPHYSIOL, V33, P537, DOI 10.1152/jn.1970.33.4.537; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsubota T, 2013, BEHAV BRAIN RES, V255, P26, DOI 10.1016/j.bbr.2013.04.019; Tsubota T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022400; Witter L, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00133; Womack MD, 2003, J NEUROSCI, V23, P2600; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007	55	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105589	10.1371/journal.pone.0105589	http://dx.doi.org/10.1371/journal.pone.0105589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144735	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100089
J	Rebourcet, D; O'Shaughnessy, PJ; Monteiro, A; Milne, L; Cruickshanks, L; Jeffrey, N; Guillou, F; Freeman, TC; Mitchell, RT; Smith, LB				Rebourcet, Diane; O'Shaughnessy, Peter J.; Monteiro, Ana; Milne, Laura; Cruickshanks, Lyndsey; Jeffrey, Nathan; Guillou, Florian; Freeman, Tom C.; Mitchell, Rod T.; Smith, Lee B.			Sertoli Cells Maintain Leydig Cell Number and Peritubular Myoid Cell Activity in the Adult Mouse Testis	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; NEONATALLY ADMINISTERED DIETHYLSTILBESTROL; CRE RECOMBINASE ACTIVITY; LUTEINIZING-HORMONE; GERM-CELL; METABOLIC SYNDROME; MESSENGER-RNA; POSTNATAL-DEVELOPMENT; INTERSTITIAL-CELLS; SEX REVERSAL	The Sertoli cells are critical regulators of testis differentiation and development. In the adult, however, their known function is restricted largely to maintenance of spermatogenesis. To determine whether the Sertoli cells regulate other aspects of adult testis biology we have used a novel transgenic mouse model in which Amh-Cre induces expression of the receptor for Diphtheria toxin (iDTR) specifically within Sertoli cells. This causes controlled, cell-specific and acute ablation of the Sertoli cell population in the adult animal following Diphtheria toxin injection. Results show that Sertoli cell ablation leads to rapid loss of all germ cell populations. In addition, adult Leydig cell numbers decline by 75% with the remaining cells concentrated around the rete and in the sub-capsular region. In the absence of Sertoli cells, peritubular myoid cell activity is reduced but the cells retain an ability to exclude immune cells from the seminiferous tubules. These data demonstrate that, in addition to support of spermatogenesis, Sertoli cells are required in the adult testis both for retention of the normal adult Leydig cell population and for support of normal peritubular myoid cell function. This has implications for our understanding of male reproductive disorders and wider androgen-related conditions affecting male health.	[Rebourcet, Diane; Milne, Laura; Cruickshanks, Lyndsey; Jeffrey, Nathan; Mitchell, Rod T.; Smith, Lee B.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [O'Shaughnessy, Peter J.; Monteiro, Ana] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Guillou, Florian] Univ Tours, INRA, CNRS, UMR 6073,Stn Physiol Reprod & Comportements PRC, Nouzilly, France; [Freeman, Tom C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Smith, LB (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	Lee.Smith@ed.ac.uk		Monteiro, Ana/0000-0003-2349-9716; Smith, Lee/0000-0002-4103-3074; Mitchell, Rod/0000-0003-4650-3765; Freeman, Thomas/0000-0001-5235-8483	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J015105/1]; Medical Research Council (MRC) [G1100354/1]; Biotechnology and Biological Sciences Research Council [BB/J016209/1, BBS/E/D/20211552, BB/J015105/1] Funding Source: researchfish; Medical Research Council [G1100354, G1002033] Funding Source: researchfish; BBSRC [BB/J016209/1, BB/J015105/1, BBS/E/D/20211552] Funding Source: UKRI; MRC [G1100354, G1002033] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Biotechnology and Biological Sciences Research Council (BBSRC) Project grant (BB/J015105/1) (to LBS, PJO and TFC), and Medical Research Council (MRC) Programme Grant (G1100354/1) (to LBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Baker PJ, 2003, ENDOCRINOLOGY, V144, P138, DOI 10.1210/en.2002-220637; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Baker PJ, 2001, REPRODUCTION, V122, P553, DOI 10.1530/reprod/122.4.553; BERGMANN M, 1983, ANAT EMBRYOL, V168, P269, DOI 10.1007/BF00315821; BERNDTSON WE, 1990, J ANDROL, V11, P429; Bornstein SR, 2004, MOL CELL ENDOCRINOL, V215, P135, DOI 10.1016/j.mce.2003.11.022; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chen M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114702; CHEN YDI, 1976, P SOC EXP BIOL MED, V153, P473; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; CHRISTENSEN AK, 1975, HDB PHYSIOLOGY     7, V5, P57; Cohen PE, 1997, BIOL REPROD, V56, P110, DOI 10.1095/biolreprod56.1.110; Combes AN, 2009, DEV DYNAM, V238, P1033, DOI 10.1002/dvdy.21925; Cool J, 2012, WIRES DEV BIOL, V1, P847, DOI 10.1002/wdev.62; COQUELIN A, 1982, AM J PHYSIOL, V243, pE257, DOI 10.1152/ajpendo.1982.243.3.E257; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; DALTERIO SL, 1983, PHARMACOL BIOCHEM BE, V18, P81, DOI 10.1016/0091-3057(83)90255-1; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; DONCEL GF, 1989, AM J REPROD IMMUNOL, V20, P44, DOI 10.1111/j.1600-0897.1989.tb00638.x; Dym M, 1970, Biology Reprod., V3, P308; Elkin ND, 2010, TOXICOL SCI, V117, P439, DOI 10.1093/toxsci/kfq210; Faria MJS, 2003, MICROSC MICROANAL, V9, P68, DOI 10.1017/S1431927603030101; Farrell JB, 2008, DIABETES EDUCATOR, V34, P799, DOI 10.1177/0145721708323100; Fawcett D W, 1970, J Reprod Fertil Suppl, V10, P105; FILLION C, 1994, MOL CELL ENDOCRINOL, V99, P25, DOI 10.1016/0303-7207(94)90142-2; Gaytan F, 1996, J ENDOCRINOL, V150, P57, DOI 10.1677/joe.0.1500057; HARDY MP, 1989, ENDOCRINOLOGY, V124, P762, DOI 10.1210/endo-124-2-762; Hazra R, 2013, ENDOCRINOLOGY, V154, P3410, DOI 10.1210/en.2012-2273; Herrera J, 1996, ARCH ANDROLOGY, V37, P127, DOI 10.3109/01485019608988513; Hosoi I, 2002, ANDROLOGIA, V34, P255, DOI 10.1046/j.1439-0272.2002.00502.x; JOHNSON L, 1991, BIOL REPROD, V45, P404, DOI 10.1095/biolreprod45.3.404; JOHNSON L, 1984, BIOL REPROD, V31, P785, DOI 10.1095/biolreprod31.4.785; KEENEY DS, 1990, J ANDROL, V11, P367; KEENEY DS, 1988, ENDOCRINOLOGY, V123, P2906, DOI 10.1210/endo-123-6-2906; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700; McGee SR, 2013, ENDOCRINOLOGY, V154, P3900, DOI 10.1210/en.2012-2179; MENDISHANDAGAMA SMLC, 1990, J ANDROL, V11, P548; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; MORRIS ID, 1986, ENDOCRINOLOGY, V118, P709, DOI 10.1210/endo-118-2-709; NEAVES WB, 1985, BIOL REPROD, V33, P259, DOI 10.1095/biolreprod33.1.259; NEAVES WB, 1984, J CLIN ENDOCR METAB, V59, P756, DOI 10.1210/jcem-59-4-756; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P851, DOI 10.1530/REP-07-0529; O'Shaughnessy PJ, 2009, MOL CELL ENDOCRINOL, V306, P2, DOI 10.1016/j.mce.2008.11.005; O'Shaughnessy PJ, 2011, MOL HUM REPROD, V17, P620, DOI 10.1093/molehr/gar032; O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141; OSHAUGHNESSY PJ, 1993, J MOL ENDOCRINOL, V11, P77, DOI 10.1677/jme.0.0110077; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Papaioannou MD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M900587-MCP200; PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424; Quinn A, 2012, SEMIN REPROD MED, V30, P351, DOI 10.1055/s-0032-1324718; Rebourcet D, 2014, DEVELOPMENT IN PRESS; Russell L.D., 1990, HISTOLOGICAL HISTOPA, P119; Russell LD, 2001, BIOL REPROD, V65, P318, DOI 10.1095/biolreprod65.1.318; Saad F, 2009, J STEROID BIOCHEM, V114, P40, DOI 10.1016/j.jsbmb.2008.12.022; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P2805, DOI 10.1210/me.2003-0203; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Sekido R, 2013, SEX DEV, V7, P21, DOI 10.1159/000342221; SHARPE RM, 1990, AM J ANAT, V188, P3, DOI 10.1002/aja.1001880103; SKINNER MK, 1985, J CELL BIOL, V100, P1941, DOI 10.1083/jcb.100.6.1941; Stanley E, 2012, ENDOCRINOLOGY; SYED V, 1989, INT J ANDROL, V12, P464, DOI 10.1111/j.1365-2605.1989.tb01336.x; Tanwar PS, 2011, MOL ENDOCRINOL, V25, P1725, DOI 10.1210/me.2011-0057; TEERDS KJ, 1989, J ENDOCRINOL, V122, P689, DOI 10.1677/joe.0.1220689; Toyama Y, 2001, J ANDROL, V22, P413; Tyndall V, 2012, REPRODUCTION, V143, P21, DOI 10.1530/REP-11-0239; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; VIHKO KK, 1991, ENDOCRINOLOGY, V129, P1926, DOI 10.1210/endo-129-4-1926; VITALE R, 1973, ANAT REC, V176, P333, DOI 10.1002/ar.1091760309; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Warr N, 2012, WIRES DEV BIOL, V1, P559, DOI 10.1002/wdev.42; Welsh M, 2012, INT J ANDROL, V35, P25, DOI 10.1111/j.1365-2605.2011.01150.x; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505; XIONG YT, 1993, ENDOCRINOLOGY, V133, P2568, DOI 10.1210/en.133.6.2568; Yeap BB, 2010, CURR OPIN ENDOCRINOL, V17, P269, DOI 10.1097/MED.0b013e3283383031; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x; Zhang FP, 2004, ENDOCRINOLOGY, V145, P1453, DOI 10.1210/en.2003-1049; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	87	77	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105687	10.1371/journal.pone.0105687	http://dx.doi.org/10.1371/journal.pone.0105687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144714	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000341106100108
J	Wu, HP; Wang, YQ; Dong, N; Yang, F; Lin, ZR; Shang, XM; Li, C				Wu, Huping; Wang, Yuqian; Dong, Nuo; Yang, Fan; Lin, Zhirong; Shang, Xumin; Li, Cheng			Meibomian Gland Dysfunction Determines the Severity of the Dry Eye Conditions in Visual Display Terminal Workers	PLOS ONE			English	Article							COMPUTER VISION SYNDROME; TEAR FILM; INTERNATIONAL WORKSHOP; OCULAR SURFACE; DISEASE; SUBCOMMITTEE; KERATOGRAPH; PREVALENCE; DISCOMFORT; SYMPTOMS	Objective: To explore meibomian gland dysfunction (MGD) may determine the severity of dry eye conditions in visual display terminal (VDT) workers. Methodology: Prospective, case-control study carried out in China. 106 eyes of 53 patients (VDT work time >4 hour per day) were recruited as the Long time VDT group; 80 eyes of 40 control subjects (VDT work time <= 4 hour per day) served as the Short time VDT group. A questionnaire of Ocular Surface Disease Index (OSDI) and multiple tests were performed. Three dry eye tests: tear film breakup time (BUT), corneal fluorescein staining, Schirmer I test; and three MGD parameters: lid margin abnormality score, meibum expression assessment (meibum score), and meibomian gland dropout degree (meiboscore) using Keratograph 5 M. Principal Findings: OSDI and corneal fluorescein score were significantly higher while BUT was dramatically shorter in the long time VDT group than the short time VDT group. However, the average of Schirmer tear volumes was in normal ranges in both groups. Interestingly, the three MGD parameters were significantly higher in the long time VDT group than the short time one (P<0.0001). When 52 eyes with Schirmer <10 mm and 54 eyes with Schirmer >= 10 mm were separated from the long time VDT workers, no significant differences were found between the two subgroups in OSDI, fluorescein staining and BUT, as well as the three MGD parameters. All three MGD parameters were positively correlated with VDT working time (P<0.0001) and fluorescein scores (P<0.0001), inversely correlated with BUT (P<0.05), but not correlated with Schirmer tear volumes in the VDT workers. Conclusions: Our findings suggest that a malfunction of meibomian glands is associated with dry eye patients in long term VDT workers with higher OSDI scores whereas some of those patients presenting a normal tear volume.	[Wu, Huping; Wang, Yuqian; Dong, Nuo; Yang, Fan; Lin, Zhirong; Shang, Xumin; Li, Cheng] Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China	Xiamen University	Wu, HP (corresponding author), Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China.	wuhuping2014@163.com			Xiamen major technological innovation platform project of China [3502Z20131017, 3502Z20134039, 3502Z20124037]; Fujian medical innovation project [2012-CXB-30, 2013-2-112]	Xiamen major technological innovation platform project of China; Fujian medical innovation project	This work was supported by the Project supported by the Xiamen major technological innovation platform project of China (Grant No. 3502Z20131017, 3502Z20134039, 3502Z20124037) http://www.xminfo.net.cn/; Fujian medical innovation project (2012-CXB-30, 2013-2-112) http://www.fjkjt.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AA, 1999, OPHTHALMOLOGY, V106, P803, DOI 10.1016/S0161-6420(99)90170-7; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2012, CORNEA, V31, P1229, DOI 10.1097/ICO.0b013e31823f8e7d; Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012; Ban Y, 2011, MOL VIS, V17, P2533; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Collins Michael J, 2006, Eye Contact Lens, V32, P287, DOI 10.1097/01.icl.0000224551.58399.9a; Dong N, 2009, INVEST OPHTH VIS SCI, V50, P2710, DOI 10.1167/iovs.08-2905; Fenga C, 2008, EYE, V22, P91, DOI 10.1038/sj.eye.6703025; Foulks GN, 2012, OPHTHALMOLOGY, V119, pS1, DOI 10.1016/j.ophtha.2012.06.064; Green-Church KB, 2011, INVEST OPHTH VIS SCI, V52, P1979, DOI 10.1167/iovs.10-6997d; Hong JX, 2013, CORNEA, V32, P716, DOI 10.1097/ICO.0b013e3182714425; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Kojima T, 2011, AM J OPHTHALMOL, V152, P933, DOI 10.1016/j.ajo.2011.05.025; KORB DR, 1994, CORNEA, V13, P354, DOI 10.1097/00003226-199407000-00012; Miller KL, 2010, ARCH OPHTHALMOL-CHIC, V128, P94, DOI 10.1001/archophthalmol.2009.356; Murube J, 2002, ADV EXP MED BIOL, V506, P1205; Nakamura S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011119; Nelson JD, 2011, INVEST OPHTH VIS SCI, V52, P1930, DOI 10.1167/iovs.10-6997b; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; Pult H, 2012, OPTOMETRY VISION SCI, V89, pE310, DOI 10.1097/OPX.0b013e318244e487; Rosenfield M, 2011, OPHTHAL PHYSL OPT, V31, P502, DOI 10.1111/j.1475-1313.2011.00834.x; ROSSIGNOL AM, 1987, J OCCUP ENVIRON MED, V29, P112; Shimazaki J, 1998, OPHTHALMOLOGY, V105, P1485, DOI 10.1016/S0161-6420(98)98033-2; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Srinivasan S, 2012, OPTOMETRY VISION SCI, V89, P788, DOI 10.1097/OPX.0b013e318253de93; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Uchino M, 2014, AM J OPHTHALMOL, V157, P294, DOI 10.1016/j.ajo.2013.10.014; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Ye Zhaojia, 2007, Journal of Physiological Anthropology, V26, P69, DOI 10.2114/jpa2.26.69	31	47	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105575	10.1371/journal.pone.0105575	http://dx.doi.org/10.1371/journal.pone.0105575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144638	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100087
J	Zhang, YH; Pham, NK; Zhang, HX; Lin, JD; Lin, Q				Zhang, Yanhong; Pham, Nancy Kim; Zhang, Huixian; Lin, Junda; Lin, Qiang			Genetic Variations in Two Seahorse Species (Hippocampus mohnikei and Hippocampus trimaculatus): Evidence for Middle Pleistocene Population Expansion	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; PACIFIC MARGINAL SEAS; MARINE FISH; LIFE-HISTORY; GROWTH; FLOW; DIFFERENTIATION; CONSERVATION; DISPERSAL; DIVERSITY	Population genetic of seahorses is confidently influenced by their species-specific ecological requirements and life-history traits. In the present study, partial sequences of mitochondrial cytochrome b (cytb) and control region (CR) were obtained from 50 Hippocampus mohnikei and 92 H. trimaculatus from four zoogeographical zones. A total of 780 base pairs of cytb gene were sequenced to characterize mitochondrial DNA (mtDNA) diversity. The mtDNA marker revealed high haplotype diversity, low nucleotide diversity, and a lack of population structure across both populations of H. mohnikei and H. trimaculatus. A neighbour-joining (NJ) tree of cytb gene sequences showed that H. mohnikei haplotypes formed one cluster. A maximum likelihood (ML) tree of cytb gene sequences showed that H. trimaculatus belonged to one lineage. The star-like pattern median-joining network of cytb and CR markers indicated a previous demographic expansion of H. mohnikei and H. trimaculatus. The cytb and CR data sets exhibited a unimodal mismatch distribution, which may have resulted from population expansion. Mismatch analysis suggested that the expansion was initiated about 276,000 years ago for H. mohnikei and about 230,000 years ago for H. trimaculatus during the middle Pleistocene period. This study indicates a possible signature of genetic variation and population expansion in two seahorses under complex marine environments.	[Zhang, Yanhong; Zhang, Huixian; Lin, Qiang] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Pham, Nancy Kim; Lin, Junda] Florida Inst Technol, Vero Beach Marine Lab, Vero Beach, FL USA	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Florida Institute of Technology	Lin, Q (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.	linqiangzsu@163.com			Outstanding Youth Foundation in Guangdong Province [S2013050014802]; National Natural Science Foundation of China [41176146, 41306148]; US National Science Foundation East Asia and Pacific Summer Institute Fellowship (EAPSI) [OISE-1209841]	Outstanding Youth Foundation in Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation East Asia and Pacific Summer Institute Fellowship (EAPSI)	This study was funded by the Outstanding Youth Foundation in Guangdong Province (S2013050014802), the National Natural Science Foundation of China (41176146, 41306148), and the US National Science Foundation East Asia and Pacific Summer Institute Fellowship (EAPSI, OISE-1209841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY; Crandall ED, 2008, MOL ECOL, V17, P611, DOI 10.1111/j.1365-294X.2007.03600.x; Curtis JMR, 2006, J FISH BIOL, V68, P707, DOI 10.1111/j.0022-1112.2006.00952.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dsouli-Aymes N, 2011, INFECT GENET EVOL, V11, P334, DOI 10.1016/j.meegid.2010.11.001; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagao Z, 1987, CHIN J OCEANOL LIMN, V5, P67; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Friess C, 2011, J FISH BIOL, V78, P466, DOI 10.1111/j.1095-8649.2010.02857.x; Fu YX, 1997, GENETICS, V147, P915; Goswami M, 2009, HYDROBIOLOGIA, V621, P213, DOI 10.1007/s10750-008-9642-3; GREWE PM, 1993, CAN J FISH AQUAT SCI, V50, P2397, DOI 10.1139/f93-264; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hoarau G, 2000, CR ACAD SCI III-VIE, V323, P315, DOI 10.1016/S0764-4469(00)90124-0; Hu J., 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Kim Ik-Soo, 1995, Korean Journal of Zoology, V38, P74; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HJ, 2007, MOL ECOL, V16, P3084, DOI 10.1111/j.1365-294X.2007.03364.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Lourie S. A., 1999, SEAHORSES IDENTIFICA; Lourie S.A., 2004, GUIDE IDENTIFICATION; Lourie SA, 2004, J BIOGEOGR, V31, P1975, DOI 10.1111/j.1365-2699.2004.01153.x; Masuda H., 1984, FISHES JAPANESE ARCH; MCKENZIE K G, 1991, Australian Systematic Botany, V4, P37, DOI 10.1071/SB9910037; Nei M., 1987, MOL EVOLUTIONARY GEN; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Saarman NP, 2010, CONSERV GENET, V11, P1989, DOI 10.1007/s10592-010-0092-x; Scales H, 2010, PROG PHYS GEOG, V34, P443, DOI 10.1177/0309133310364928; Silva SE, 2013, BIOL J LINN SOC, V108, P494, DOI 10.1111/j.1095-8312.2012.02041.x; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Song ZB, 2008, ENVIRON BIOL FISH, V81, P247, DOI 10.1007/s10641-007-9197-6; Swofford D., 2002, PAUP 4 0 B10 PHYLOGE; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teske PR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000614; Teske PR, 2003, MOL ECOL, V12, P1703, DOI 10.1046/j.1365-294X.2003.01852.x; Tinti F, 2002, MAR BIOTECHNOL, V4, P163, DOI 10.1007/s10126-002-0003-3; Varela AI, 2012, MAR BIOL, V159, P1049, DOI 10.1007/s00227-012-1885-x; Wang PX, 1999, MAR GEOL, V156, P5, DOI 10.1016/S0025-3227(98)00172-8; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033883; Woodall LC, 2011, J FISH BIOL, V78, P1738, DOI 10.1111/j.1095-8649.2011.02974.x; Xiao YS, 2010, BIOCHEM GENET, V48, P402, DOI 10.1007/s10528-009-9321-8; Xu X., 1980, SCI S CHINA OCEANOLO, P137	56	19	20	0	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105494	10.1371/journal.pone.0105494	http://dx.doi.org/10.1371/journal.pone.0105494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144384	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100074
J	Zheng, L; Feng, YH; Shi, YP; Zhang, J; Mu, QF; Qin, L; Berggren-Soderlund, M; Nilsson-Ehle, P; Zhang, XY; Luo, GH; Xu, N				Zheng, Lu; Feng, Yuehua; Shi, Yuanping; Zhang, Jun; Mu, Qinfeng; Qin, Li; Berggren-Soederlund, Maria; Nilsson-Ehle, Peter; Zhang, Xiaoying; Luo, Guanghua; Xu, Ning			Intralipid Decreases Apolipoprotein M Levels and Insulin Sensitivity in Rats	PLOS ONE			English	Article							EXPRESSION IN-VIVO; M GENE-EXPRESSION; PROTEIN-KINASE-C; METABOLIC SYNDROME; SKELETAL-MUSCLE; RESISTANCE; ACID; RECEPTOR; ELEVATION; HDL	Background: Apolipoprotein M (ApoM) is a constituent of high-density lipoproteins (HDL). It plays a crucial role in HDL-mediated reverse cholesterol transport. Insulin resistance is associated with decreased ApoM levels. Aims: To assess the effects of increased free fatty acids (FFAs) levels after short-term Intralipid infusion on insulin sensitivity and hepatic ApoM gene expression. Methods: Adult male Sprague-Dawley (SD) rats infused with 20% Intralipid solution for 6 h. Glucose infusion rates (GIR) were determined by hyperinsulinemic-euglycemic clamp during Intralipid infusion and plasma FFA levels were measured by colorimetry. Rats were sacrificed after Intralipid treatment and livers were sampled. Human embryonic kidney 293T cells were transfected with a lentivirus mediated human apoM overexpression system. Goto-Kakizaki (GK) rats were injected with the lentiviral vector and insulin tolerance was assessed. Gene expression was assessed by real-time RT-PCR and PCR array. Results: Intralipid increased FFAs by 17.6 folds and GIR was decreased by 27.1% compared to the control group. ApoM gene expression was decreased by 40.4% after Intralipid infusion. PPAR(beta/delta) expression was not changed by Intralipid. Whereas the mRNA levels of Acaca, Acox1, Akt1, V-raf murine sarcoma 3611 viral oncogene homolog, G6pc, Irs2, Ldlr, Map2k1, pyruvate kinase and RBC were significantly increased in rat liver after Intralipid infusion. The Mitogen-activated protein kinase 8 (MAPK8) was significantly down-regulated in 293T cells overexpressing ApoM. Overexpression of human ApoM in GK rats could enhance the glucose-lowering effect of exogenous insulin. Conclusion: These results suggest that Intralipid could decrease hepatic ApoM levels. ApoM overexpression may have a potential role in improving insulin resistance in vivo and modulating apoM expression might be a future therapeutic strategy against insulin resistance in type 2 diabetes.	[Zheng, Lu; Feng, Yuehua; Shi, Yuanping; Zhang, Jun; Mu, Qinfeng; Qin, Li; Luo, Guanghua] Soochow Univ, Affiliated Hosp 3, Comprehens Lab, Changzhou, Peoples R China; [Zhang, Xiaoying] Soochow Univ, Affiliated Hosp 3, Dept Cardiothorac Surg, Changzhou, Peoples R China; [Berggren-Soederlund, Maria; Nilsson-Ehle, Peter; Xu, Ning] Lund Univ, Dept Lab Med, Div Clin Chem & Pharmacol, Lund, Sweden	Soochow University - China; Soochow University - China; Lund University	Luo, GH (corresponding author), Soochow Univ, Affiliated Hosp 3, Comprehens Lab, Changzhou, Peoples R China.	shineroar@163.com; ning.xu@med.lu.se		Luo, Guanghua/0000-0001-8339-2828; Zheng, Lu/0000-0002-5563-4348	National Natural Science Foundation of China (NSFC) [81071414, 81201352]; Natural Science Foundation of Jiangsu Province [BK2011245, BK2012154]; Changzhou Science & Technology Bureau [CJ20122012]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Changzhou Science & Technology Bureau	This research project was supported by the National Natural Science Foundation of China (NSFC) (81071414, 81201352, http://www.nsfc.gov.cn/), the Natural Science Foundation of Jiangsu Province (BK2011245, BK2012154, http://www.jskjjh.gov.cn/) and a research grant from the Changzhou Science & Technology Bureau (CJ20122012, http://new.czstb.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Brehm A, 2010, AM J PHYSIOL-ENDOC M, V299, pE33, DOI 10.1152/ajpendo.00756.2009; Choi CS, 2001, DIABETES, V50, P418, DOI 10.2337/diabetes.50.2.418; Chow LS, 2012, J CLIN ENDOCR METAB, V97, P2890, DOI 10.1210/jc.2012-1515; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Dissen GA, 2009, METHODS, V49, P70, DOI 10.1016/j.ymeth.2009.06.004; Dullaart RPF, 2009, CLIN CHIM ACTA, V406, P129, DOI 10.1016/j.cca.2009.06.010; Elsoe S, 2012, ATHEROSCLEROSIS, V221, P91, DOI 10.1016/j.atherosclerosis.2011.11.031; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; GARG A, 1990, JAMA-J AM MED ASSOC, V264, P723, DOI 10.1001/jama.264.6.723; Garvey WT, 2003, DIABETES, V52, P453, DOI 10.2337/diabetes.52.2.453; Gosmanov AR, 2012, METABOLISM, V61, P1370, DOI 10.1016/j.metabol.2012.03.006; GOTO Y, 1988, FRONTIERS DIABETES R, V2, P301; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hu YW, 2012, REJUV RES, V15, P423, DOI 10.1089/rej.2011.1295; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kashyap SR, 2009, OBESITY, V17, P2142, DOI 10.1038/oby.2009.179; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim MY, 2012, EXP DIABETES RES, DOI 10.1155/2012/716425; Krogh-Madsen R, 2008, AM J PHYSIOL-ENDOC M, V294, pE371, DOI 10.1152/ajpendo.00507.2007; Liu J, 2011, J CLIN ENDOCR METAB, V96, P438, DOI 10.1210/jc.2010-1174; Luo GH, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-102; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Ogata M, 1997, BIOL PHARM BULL, V20, P1026; Ooi EMM, 2010, ATHEROSCLEROSIS, V210, P326, DOI 10.1016/j.atherosclerosis.2009.11.024; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Sevvana M, 2009, J MOL BIOL, V393, P920, DOI 10.1016/j.jmb.2009.08.071; Skupien Jan, 2007, Rev Diabet Stud, V4, P231, DOI 10.1900/RDS.2007.4.231; Sullivan PW, 2005, DIABETES CARE, V28, P1599, DOI 10.2337/diacare.28.7.1599; Umpierrez GE, 2009, J CLIN ENDOCR METAB, V94, P609, DOI 10.1210/jc.2008-1590; Venteclef N, 2008, J BIOL CHEM, V283, P3694, DOI 10.1074/jbc.M706382200; Waitzberg DL, 2006, JPEN-PARENTER ENTER, V30, P351, DOI 10.1177/0148607106030004351; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xu N, 2006, BBA-MOL CELL BIOL L, V1761, P256, DOI 10.1016/j.bbalip.2006.02.002; Xu N, 2006, BIOCHEM BIOPH RES CO, V342, P1174, DOI 10.1016/j.bbrc.2006.02.022; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Zhang X, 2008, BIOCHEM BIOPH RES CO, V371, P114, DOI 10.1016/j.bbrc.2008.04.017; Zhang XY, 2007, BBA-MOL CELL BIOL L, V1771, P879, DOI 10.1016/j.bbalip.2007.04.020; Zhang YL, 2005, LIFE SCI, V77, P2071, DOI 10.1016/j.lfs.2004.12.047	41	13	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105681	10.1371/journal.pone.0105681	http://dx.doi.org/10.1371/journal.pone.0105681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144649	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100107
J	Husseneder, C; Simms, DM				Husseneder, Claudia; Simms, Dawn M.			Effects of Caste on the Expression of Genes Associated with Septic Injury and Xenobiotic Exposure in the Formosan Subterranean Termite	PLOS ONE			English	Article							CHITIN-BINDING ACTIVITY; JUVENILE-HORMONE; DROSOPHILA-MELANOGASTER; COPTOTERMES-FORMOSANUS; INSECT IMMUNITY; HOUSEKEEPING GENES; DISEASE RESISTANCE; ANOPHELES-GAMBIAE; SOCIAL INSECT; MANDUCA-SEXTA	As social insects, termites live in densely populated colonies with specialized castes under conditions conducive to microbial growth and transmission. Furthermore, termites are exposed to xenobiotics in soil and their lignocellulose diet. Therefore, termites are valuable models for studying gene expression involved in response to septic injury, immunity and detoxification in relation to caste membership. In this study, workers and soldiers of the Formosan subterranean termite, Coptotermes formosanus, were challenged by bacterial injection or by no-choice feeding with a sublethal concentration (0.5%) of phenobarbital. Constitutive and induced expression of six putative immune response genes (two encoding for lectin-like proteins, one for a ficolin-precursor, one for the Down syndrome cell adhesion molecule, one for a chitin binding protein, and one for the gram-negative binding protein 2) and four putative detoxification genes (two encoding for cytochrome P450s, one for glutathione S-transferase, and one for the multi antimicrobial extrusion protein), were measured via quantitative real time polymerase chain reaction and compared within and among 1) colonies, 2) treatment types and 3) castes via ANOVA. Eight genes were inducible by septic injury, feeding with phenobarbital or both. Colony origin had no effect on inducibility or differential gene expression. However, treatment type showed significant effects on the expression of the eight inducible genes. Caste effects on expression levels were significant in five of the eight inducible genes with constitutive and induced expression of most target genes being higher in workers than in soldiers.	[Husseneder, Claudia; Simms, Dawn M.] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Husseneder, C (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	chusseneder@agcenter.lsu.edu		Husseneder, Claudia/0000-0001-5962-9354	USDA-ARS Specific Cooperative Agreements; state of Louisiana	USDA-ARS Specific Cooperative Agreements; state of Louisiana	This study was funded by USDA-ARS Specific Cooperative Agreements and grants by the state of Louisiana to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anspaugh DD, 2005, J INSECT PHYSIOL, V51, P523, DOI 10.1016/j.jinsphys.2004.12.008; Arai T, 1998, INSECT BIOCHEM MOLEC, V28, P987, DOI 10.1016/S0965-1748(98)00087-3; Basta-Kaim Agnieszka, 2008, Przegl Lek, V65, P799; Bechkage NE, 2008, INSECT IMMUNOLOGY, P360; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brown D, 2003, ARCH INSECT BIOCHEM, V53, P119, DOI 10.1002/arch.10089; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calleri DV, 2006, P ROY SOC B-BIOL SCI, V273, P2633, DOI 10.1098/rspb.2006.3622; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chouvenc T, 2011, BIOL CONTROL, V59, P69, DOI 10.1016/j.biocontrol.2011.06.015; Cornette R, 2006, INSECT MOL BIOL, V15, P235, DOI 10.1111/j.1365-2583.2006.00632.x; Destoumieux D, 2000, J CELL SCI, V113, P461; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; DUNN PE, 1986, ANNU REV ENTOMOL, V31, P321, DOI 10.1146/annurev.en.31.010186.001541; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Feyereisen R., 2005, P1; Gao Q, 2012, ARCH INSECT BIOCHEM, V80, P63, DOI 10.1002/arch.21026; Gatti SS, 2002, J ECON ENTOMOL, V95, P813, DOI 10.1603/0022-0493-95.4.813; Gatti SS, 1996, SOCIOBIOLOGY, V28, P23; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Global Invasive Species Database, 2013, 100 WORLDS WORST INV; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Guzov VM, 1998, ARCH BIOCHEM BIOPHYS, V359, P231, DOI 10.1006/abbi.1998.0901; Hamilton C, 2012, DEV COMP IMMUNOL, V36, P372, DOI 10.1016/j.dci.2011.07.008; Hamilton C, 2011, J INSECT PHYSIOL, V57, P1259, DOI 10.1016/j.jinsphys.2011.05.016; HARITOS VS, 1994, INSECT BIOCHEM MOLEC, V24, P929, DOI 10.1016/0965-1748(94)90021-3; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Higashiguchi DT, 2006, INT J SYST EVOL MICR, V56, P15, DOI 10.1099/ijs.0.63543-0; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hussain A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069543; Husseneder C, 2005, J ECON ENTOMOL, V98, P1421, DOI 10.1603/0022-0493-98.5.1421; Husseneder C, 2009, ANN ENTOMOL SOC AM, V102, P498, DOI 10.1603/008.102.0321; Husseneder C, 2012, BIOL INVASIONS, V14, P419, DOI 10.1007/s10530-011-0087-7; Husseneder C, 2012, COMP BIOCHEM PHYS D, V7, P14, DOI 10.1016/j.cbd.2011.10.002; Infante C, 2008, BMC MOL BIOL, V9, DOI [10.1186/1471-2199-9-19, 10.1186/1471-2199-9-28]; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Ishikawa Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-314; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Johansson KC, 2005, EXP CELL RES, V305, P145, DOI 10.1016/j.yexcr.2004.12.018; JOMORI T, 1990, EUR J BIOCHEM, V190, P201, DOI 10.1111/j.1432-1033.1990.tb15565.x; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; Kasai S, 2001, INSECT BIOCHEM MOLEC, V32, P1, DOI 10.1016/S0965-1748(01)00073-X; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kuballa AV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-575; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Matsushita M, 2010, J INNATE IMMUN, V2, P24, DOI 10.1159/000228160; Messenger MT, 2005, FLA ENTOMOL, V88, P99, DOI 10.1653/0015-4040(2005)088[0099:NFDRFC]2.0.CO;2; Middha S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-260; Moriyama Y, 2008, XENOBIOTICA, V38, P1107, DOI [10.1080/00498250701883753, 10.1080/00498250701883753 ]; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Omote H, 2006, TRENDS PHARM SCI, V27, DOI 10.10/j.tips.2006.09.001; Osbrink WLA, 2001, J ECON ENTOMOL, V94, P1217, DOI 10.1603/0022-0493-94.5.1217; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ratra GS, 2001, TOXICOL LETT, V122, P215, DOI 10.1016/S0378-4274(01)00366-6; Rosengaus RB, 2000, J CHEM ECOL, V26, P21, DOI 10.1023/A:1005481209579; Rosengaus RB, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P165, DOI 10.1007/978-90-481-3977-4_7; Rosengaus RB, 2007, NATURWISSENSCHAFTEN, V94, P25, DOI 10.1007/s00114-006-0151-9; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Scott JG, 1996, ARCH INSECT BIOCHEM, V31, P313, DOI 10.1002/(SICI)1520-6327(1996)31:3&lt;313::AID-ARCH6&gt;3.0.CO;2-Y; Simms DM, 2009, SOCIOBIOLOGY, V52, P1; Steller MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-463; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; SU NY, 1988, SOCIOBIOLOGY, V14, P353; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Tarver MR, 2012, ARCH INSECT BIOCHEM, V80, P92, DOI 10.1002/arch.21030; Tarver MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-28; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Thompson GJ, 2003, INSECT MOL BIOL, V12, P1, DOI 10.1046/j.1365-2583.2003.00381.x; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Traniello JFA, 2002, P NATL ACAD SCI USA, V99, P6838, DOI 10.1073/pnas.102176599; Tsakas S, 2010, ISJ-INVERT SURVIV J, V7, P228; Valles SM, 2002, COMP BIOCHEM PHYS C, V131, P469, DOI 10.1016/S1532-0456(02)00031-5; Valles SM, 2001, INSECT BIOCHEM MOLEC, V31, P715, DOI 10.1016/S0965-1748(00)00179-X; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Wang XG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-114; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wijffels G, 2001, J BIOL CHEM, V276, P15527, DOI 10.1074/jbc.M009393200; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Xu P, 2012, GENET MOL RES, V11, P2247, DOI 10.4238/2012.May.10.2; Yang J, 2011, PLOS ONE, V2; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zhou X, 2006, INSECT MOL BIOL, V15, P749, DOI 10.1111/j.1365-2583.2006.00675.x	96	6	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105582	10.1371/journal.pone.0105582	http://dx.doi.org/10.1371/journal.pone.0105582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141339	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200107
J	Kret, ME; Tomonaga, M; Matsuzawa, T				Kret, Mariska E.; Tomonaga, Masaki; Matsuzawa, Tetsuro			Chimpanzees and Humans Mimic Pupil-Size of Conspecifics	PLOS ONE			English	Article							HUMAN AMYGDALA; PHYSIOLOGICAL LINKAGE; EYE CONTACT; PERCEPTION; RECOGNITION; SENSITIVITY; EVOLUTION; RESPONSES; INGROUP; MODELS	Group-living typically provides benefits to individual group members but also confers costs. To avoid incredulity and betrayal and allow trust and cooperation, individuals must understand the intentions and emotions of their group members. Humans attend to other's eyes and from gaze and pupil-size cues, infer information about the state of mind of the observed. In humans, pupil-size tends to mimic that of the observed. Here we tested whether pupil-mimicry exists in our closest relative, the chimpanzee (P. troglodytes). We conjectured that if pupil-mimicry has adaptive value, e.g. to promote swift communication of inner states and facilitate shared understanding and coordination, pupil-mimicry should emerge within but not across species. Pupillometry data was collected from human and chimpanzee subjects while they observed images of the eyes of both species with dilating/constricting pupils. Both species showed enhanced pupil-mimicry with members of their own species, with effects being strongest in humans and chimpanzee mothers. Pupil-mimicry may be deeply-rooted, but probably gained importance from the point in human evolution where the morphology of our eyes became more prominent. Humans' white sclera surrounding the iris, and the fine muscles around their eyes facilitate nonverbal communication via eye signals.	[Kret, Mariska E.; Tomonaga, Masaki; Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Kret, Mariska E.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Kret, Mariska E.] Amsterdam Brain & Cognit ABC Ctr, Amsterdam, Netherlands	Kyoto University; University of Amsterdam	Kret, ME (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	m.e.kret@uva.nl	Matsuzawa, Tetsuro/ABE-9654-2021; Kret, Mariska/B-4798-2010	Matsuzawa, Tetsuro/0000-0002-8147-2725; Kret, Mariska/0000-0002-3197-5084	Japan Society for the Promotion of Science [pE10084, BR120105]; Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen [UPS/BP/5215]; JSPS [23220006, 20002001, 24000001]; Grants-in-Aid for Scientific Research [23220006] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (pE10084 and BR120105) and the Dobberke Foundation for Comparative Psychology Koningklijke Nederlandse Akademie van Wetenschappen (UPS/BP/5215) awarded to MEK and JSPS Grants in Aid for Scientific Research to MT (#23220006) and TM (#20002001, #24000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Anders S, 2011, NEUROIMAGE, V54, P439, DOI 10.1016/j.neuroimage.2010.07.004; Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1017/S0048577200980648; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Campbell MW, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0013; Carruthers P., 1996, THEORIES THEORIES MI, DOI 10.1017/CBO9780511597985; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Davila-Ross M, 2011, EMOTION, V11, P1013, DOI 10.1037/a0022594; de Waal FB, 2013, BONOBO ATHEIST SEARC, P141; Demos KE, 2008, CEREB CORTEX, V18, P2729, DOI 10.1093/cercor/bhn034; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Feldman R, 2011, INFANT BEHAV DEV, V34, P569, DOI 10.1016/j.infbeh.2011.06.008; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Harrison NA, 2009, SOC NEUROSCI-UK, V4, P233, DOI 10.1080/17470910802553508; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Hattori Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01566; Hattori Y, 2010, BIOL LETTERS, V6, P610, DOI 10.1098/rsbl.2010.0120; Haun DBM, 2008, CURR BIOL, V18, pR288, DOI 10.1016/j.cub.2008.02.031; Helm JL, 2012, EMOTION, V12, P748, DOI 10.1037/a0025036; HESS EH, 1975, SCI AM, V233, P110, DOI 10.1038/scientificamerican1175-110; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Iriki A, 1996, NEUROSCI RES, V25, P173; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Lee DH, 2013, PSYCHOL SCI, V24, P957, DOI 10.1177/0956797612464500; LEVENSON RW, 1983, J PERS SOC PSYCHOL, V45, P587, DOI 10.1037/0022-3514.45.3.587; Lipps T., 1905, PSYCHOL UNTERSUCHUNG, V4, P694; Massen JJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040697; MATSUZAWA T, 1990, FOLIA PRIMATOL, V55, P24, DOI 10.1159/000156494; May PJ, 2008, PROG BRAIN RES, V171, P97, DOI 10.1016/S0079-6123(08)00613-4; Mirman D, 2008, J MEM LANG, V59, P475, DOI 10.1016/j.jml.2007.11.006; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Mussweiler T, 2013, P NATL ACAD SCI USA, V110, P19318, DOI 10.1073/pnas.1215443110; Nakano T, 2009, P ROY SOC B-BIOL SCI, V276, P3635, DOI 10.1098/rspb.2009.0828; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; Parr LA, 2006, SOC COGN AFFECT NEUR, V1, P221, DOI 10.1093/scan/nsl031; Reed RG, 2013, INT J PSYCHOPHYSIOL, V88, P309, DOI 10.1016/j.ijpsycho.2012.08.009; Simms MS, 1967, PERCEP PSYCHOPHYS, V2; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tamietto M, 2010, J COGNITIVE NEUROSCI, V22, P888, DOI 10.1162/jocn.2009.21225; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Tomonaga M, 2007, J COMP PSYCHOL, V121, P156, DOI 10.1037/0735-7036.121.2.156; Tomonaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009131; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; van der Schalk J, 2011, EMOTION, V11, P286, DOI 10.1037/a0022582; van Steenbergen H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00215; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wang Y, 2011, J NEUROSCI, V31, P12001, DOI 10.1523/JNEUROSCI.0845-11.2011; West B. T., 2006, LINEAR MIXED MODELS, P180; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617	63	62	63	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104886	10.1371/journal.pone.0104886	http://dx.doi.org/10.1371/journal.pone.0104886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140998	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200040
J	Lakshminarayana, SB; Boshoff, HIM; Cherian, J; Ravindran, S; Goh, A; Jiricek, J; Nanjundappa, M; Nayyar, A; Gurumurthy, M; Singh, R; Dick, T; Blasco, F; Barry, CE; Ho, PC; Manjunatha, UH				Lakshminarayana, Suresh B.; Boshoff, Helena I. M.; Cherian, Joseph; Ravindran, Sindhu; Goh, Anne; Jiricek, Jan; Nanjundappa, Mahesh; Nayyar, Amit; Gurumurthy, Meera; Singh, Ramandeep; Dick, Thomas; Blasco, Francesca; Barry, Clifton E., III; Ho, Paul C.; Manjunatha, Ujjini H.			Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis	PLOS ONE			English	Article							EARLY BACTERICIDAL ACTIVITY; AEROSOL INFECTION MODEL; PLASMA-PROTEIN BINDING; INTRAPULMONARY PHARMACOKINETICS; MYCOBACTERIUM-TUBERCULOSIS; NITROIMIDAZOPYRAN PA-824; TISSUE DISTRIBUTION; IN-VITRO; DRUG; MOXIFLOXACIN	PA-824 is a bicyclic 4-nitroimidazole, currently in phase II clinical trials for the treatment of tuberculosis. Dose fractionation pharmacokinetic-pharmacodynamic studies in mice indicated that the driver of PA-824 in vivo efficacy is the time during which the free drug concentrations in plasma are above the MIC (fT(>MIC)). In this study, a panel of closely related potent bicyclic 4-nitroimidazoles was profiled in both in vivo PK and efficacy studies. In an established murine TB model, the efficacy of diverse nitroimidazole analogs ranged between 0.5 and 2.3 log CFU reduction compared to untreated controls. Further, a retrospective analysis was performed for a set of seven nitroimidazole analogs to identify the PK parameters that correlate with in vivo efficacy. Our findings show that the in vivo efficacy of bicyclic 4-nitroimidazoles correlated better with lung PK than with plasma PK. Further, nitroimidazole analogs with moderate-to-high volume of distribution and Lung to plasma ratios of >2 showed good efficacy. Among all the PK-PD indices, total lung T->MIC correlated the best with in vivo efficacy (r(s) = 0.88) followed by lung C-max/MIC and AUC/ MIC. Thus, lung drug distribution studies could potentially be exploited to guide the selection of compounds for efficacy studies, thereby accelerating the drug discovery efforts in finding new nitroimidazole analogs.	[Lakshminarayana, Suresh B.; Cherian, Joseph; Ravindran, Sindhu; Goh, Anne; Jiricek, Jan; Nanjundappa, Mahesh; Gurumurthy, Meera; Dick, Thomas; Blasco, Francesca; Manjunatha, Ujjini H.] Novartis Inst Trop Dis, Singapore, Singapore; [Boshoff, Helena I. M.; Nayyar, Amit; Singh, Ramandeep; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Ho, Paul C.] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore	Novartis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National University of Singapore	Lakshminarayana, SB (corresponding author), Novartis Inst Trop Dis, Singapore, Singapore.	suresh.b_lakshminarayana@novartis.com; manjunatha.ujjini@novartis.com	Dick, Thomas/AAB-4109-2019; Barry, III, Clifton/H-3839-2012; Ho, Paul C/O-9652-2014; Cherian, Joseph/Q-2522-2016; Barry, Clifton E/ABE-7992-2020; Jiricek, Jan/AAA-4701-2021; Dick, Thomas/AAC-4824-2019	Dick, Thomas/0000-0002-9604-9452; Barry, III, Clifton/0000-0002-2927-270X; Ho, Paul C/0000-0001-9213-7116; Barry, Clifton E/0000-0002-2927-270X; Singh, Ramandeep/0000-0003-2705-3826; Cherian, Joseph/0000-0003-2663-7192	NITD; NIAID; Bill and Melinda Gates Foundation; Wellcome Trust	NITD; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded in part by NITD, the Intramural Research Program of the NIAID to CEB, the Bill and Melinda Gates Foundation and the Wellcome Trust. NITD provided support in the form of salaries for authors SBL, JC, SR, AG, JJ, MN, MG, TD, FB and UHM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad Z, 2011, ANTIMICROB AGENTS CH, V55, P239, DOI 10.1128/AAC.00849-10; Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Avdeef A, 2007, J PHARM SCI-US, V96, P2893, DOI 10.1002/jps.21068; Balganesh TS, 2008, TRENDS PHARMACOL SCI, V29, P576, DOI 10.1016/j.tips.2008.08.001; Barbour A, 2010, INT J ANTIMICROB AG, V35, P431, DOI 10.1016/j.ijantimicag.2010.01.023; Barry CE, 2011, US Patent, Patent No. [WO 2011/087995, 2011087995]; Blaser A, 2012, J MED CHEM, V55, P312, DOI 10.1021/jm2012276; Brunner M, 2005, CURR OPIN PHARMACOL, V5, P495, DOI 10.1016/j.coph.2005.04.010; Burman W, 2011, PROG RESPIR RES, V40, P18; Chaurasia CS, 2007, PHARM RES, V24, P1014, DOI 10.1007/s11095-006-9206-z; Cherian J, 2011, J MED CHEM, V54, P5639, DOI 10.1021/jm1010644; Chierakul N, 2001, INT J TUBERC LUNG D, V5, P278; Conte JE, 1999, ANTIMICROB AGENTS CH, V43, P1329, DOI 10.1128/AAC.43.6.1329; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P2358, DOI 10.1128/AAC.46.8.2358-2364.2002; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P1475, DOI 10.1128/AAC.46.5.1475-1480.2002; Conte JE, 2001, ANTIMICROB AGENTS CH, V45, P2891, DOI 10.1128/AAC.45.10.2891-2896.2001; Conte JE, 2000, ANTIMICROB AGENTS CH, V44, P985, DOI 10.1128/AAC.44.4.985-990.2000; Craig WA, 2001, CLIN INFECT DIS, V33, pS233, DOI 10.1086/321854; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Denny WA, 2010, FUTURE MED CHEM, V2, P1295, DOI 10.4155/FMC.10.207; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3027, DOI 10.1128/AAC.06125-11; Diacon AH, 2010, ANTIMICROB AGENTS CH, V54, P3402, DOI 10.1128/AAC.01354-09; Djukic M, 2012, ANTIMICROB AGENTS CH, V56, P979, DOI 10.1128/AAC.00437-11; Duijkers IJM, 2002, HUM REPROD, V17, P1987, DOI 10.1093/humrep/17.8.1987; Ferl GZ, 2007, J NUCL MED, V48, P2037, DOI 10.2967/jnumed.107.041061; Fung EN, 2003, J CHROMATOGR B, V795, P187, DOI 10.1016/S1570-0232(03)00564-6; Ginsberg AM, 2009, ANTIMICROB AGENTS CH, V53, P3720, DOI 10.1128/AAC.00106-09; Gonzalez D, 2013, CLIN MICROBIOL REV, V26, P274, DOI 10.1128/CMR.00092-12; Jayaram R, 2004, ANTIMICROB AGENTS CH, V48, P2951, DOI 10.1128/AAC.48.8.2951-2957.2004; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Jiricek J, 2007, US Patent, Patent No. [WO2007/075872, 2007075872]; Kaneko T, 2011, FUTURE MED CHEM, V3, P1373, DOI [10.4155/fmc.11.115, 10.4155/FMC.11.115]; Kiem S, 2008, ANTIMICROB AGENTS CH, V52, P24, DOI 10.1128/AAC.00133-06; Kim P, 2009, J MED CHEM, V52, P1329, DOI 10.1021/jm801374t; Kim P, 2009, J MED CHEM, V52, P1317, DOI 10.1021/jm801246z; Kjellsson MC, 2012, ANTIMICROB AGENTS CH, V56, P446, DOI 10.1128/AAC.05208-11; Kmentova I, 2010, J MED CHEM, V53, P8421, DOI 10.1021/jm101288t; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lin JH, 2006, CURR DRUG METAB, V7, P39, DOI 10.2174/138920006774832578; Liu P, 2002, INT J ANTIMICROB AG, V19, P285, DOI 10.1016/S0924-8579(02)00024-9; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Marino AM, 2005, INT J PHARMACEUT, V297, P235, DOI 10.1016/j.ijpharm.2005.03.008; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; Muller M, 2004, ANTIMICROB AGENTS CH, V48, P1441, DOI 10.1128/AAC.48.5.1441-1453.2004; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Nuermberger E, 2006, ANTIMICROB AGENTS CH, V50, P2621, DOI 10.1128/AAC.00451-06; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; Palmer BD, 2010, J MED CHEM, V53, P282, DOI 10.1021/jm901207n; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Prideaux B, 2011, ANAL CHEM, V83, P2112, DOI 10.1021/ac1029049; Rao SPS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007355; Rosenthal IM, 2012, ANTIMICROB AGENTS CH, V56, P4331, DOI 10.1128/AAC.00912-12; Rouan MC, 2012, ANTIMICROB AGENTS CH, V56, P1444, DOI 10.1128/AAC.00720-11; Scaglione Francesco, 2006, Expert Rev Anti Infect Ther, V4, P479, DOI 10.1586/14787210.4.3.479; Shandil RK, 2007, ANTIMICROB AGENTS CH, V51, P576, DOI 10.1128/AAC.00414-06; Siefert HM, 1999, J ANTIMICROB CHEMOTH, V43, P69, DOI 10.1093/jac/43.suppl_2.69; Siefert HM, 1999, J ANTIMICROB CHEMOTH, V43, P61, DOI 10.1093/jac/43.suppl_2.61; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Soman A, 1999, J ANTIMICROB CHEMOTH, V44, P835, DOI 10.1093/jac/44.6.835; Steingart KR, 2011, INT J TUBERC LUNG D, V15, P305; Stella VJ, 1997, PHARMACEUT RES, V14, P556, DOI 10.1023/A:1012136608249; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Theuretzbacher U, 2007, CURR OPIN PHARMACOL, V7, P498, DOI 10.1016/j.coph.2007.05.003; Thompson AM, 2011, J MED CHEM, V54, P6563, DOI 10.1021/jm200377r; Tyagi S, 2005, ANTIMICROB AGENTS CH, V49, P2289, DOI 10.1128/AAC.49.6.2289-2293.2005; van Ingen J, 2011, CLIN INFECT DIS, V52, pE194, DOI 10.1093/cid/cir184; VEBER B, 1993, J ANTIMICROB CHEMOTH, V32, P473, DOI 10.1093/jac/32.3.473; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, WHOHTMTB20103; Wohnsland F, 2001, J MED CHEM, V44, P923, DOI 10.1021/jm001020e; Zhou LP, 2007, J PHARM SCI-US, V96, P3052, DOI 10.1002/jps.20913; Ziglam HM, 2002, J ANTIMICROB CHEMOTH, V50, P1011, DOI 10.1093/jac/dkf214	76	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105222	10.1371/journal.pone.0105222	http://dx.doi.org/10.1371/journal.pone.0105222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141257	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200061
J	Boon, MR; Kooijman, S; van Dam, AD; Pelgrom, LR; Berbee, JFP; Visseren, CAR; van Aggele, RC; van den Hoek, AM; Sips, HCM; Lombes, M; Havekes, LM; Tamsma, JT; Guigas, B; Meijer, OC; Jukema, JW; Rensen, PCN				Boon, Mariette R.; Kooijman, Sander; van Dam, Andrea D.; Pelgrom, Leonard R.; Berbee, Jimmy F. P.; Visseren, Cheryl A. R.; van Aggele, Robin C.; van den Hoek, Anita M.; Sips, Hetty C. M.; Lombes, Marc; Havekes, Louis M.; Tamsma, Jouke T.; Guigas, Bruno; Meijer, Onno C.; Jukema, J. Wouter; Rensen, Patrick C. N.			Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity	FASEB JOURNAL			English	Article						rimonabant; sympathetic nervous system; uncoupling protein 1	INCREASES HDL-CHOLESTEROL; ENDOCANNABINOID SYSTEM; ANTAGONIST RIMONABANT; CARDIOMETABOLIC RISK; ENERGY-EXPENDITURE; INVERSE AGONIST; WEIGHT; LIPOPROTEIN; OVERWEIGHT; EXPRESSION	The endocannabinoid system is an important player in energy metabolism by regulating appetite, lipolysis, and energy expenditure. Chronic blockade of the cannabinoid 1 receptor (CB1R) leads to long-term maintenance of weight loss and reduction of dyslipidemia in experimental and human obesity. The molecular mechanism by which CB1R blockade reverses dyslipidemia in obesity has not yet been clarified. In this study, we showed that CB1R blockade with the systemic CB1R blocker rimonabant enhanced whole-body energy expenditure and activated brown adipose tissue (BAT), indicated by increased expression of genes involved in BAT thermogenesis and decreased lipid droplet size in BAT. This was accompanied by selectively increased triglyceride (TG) uptake by BAT and lower plasma TG levels. Interestingly, the effects on BAT activation were still present at thermoneutrality and could be recapitulated by using the strictly peripheral CB1R antagonist AM6545, indicatingdirect peripheral activation of BAT. Indeed, CB1R blockade directly activated T37i brown adipocytes, resulting in enhanced uncoupled respiration, most likely via enhancing cAMP/PKA signaling via the adrenergic receptor pathway. Our data indicate that selective targeting of the peripheral CB1R in BAT has therapeutic potential in attenuating dyslipidemia and obesity.	[Boon, Mariette R.; Kooijman, Sander; van Dam, Andrea D.; Pelgrom, Leonard R.; Berbee, Jimmy F. P.; Visseren, Cheryl A. R.; van Aggele, Robin C.; Sips, Hetty C. M.; Havekes, Louis M.; Tamsma, Jouke T.; Meijer, Onno C.; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands; [Havekes, Louis M.; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands; [Guigas, Bruno] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Guigas, Bruno] Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands; [Boon, Mariette R.; Kooijman, Sander; van Dam, Andrea D.; van Aggele, Robin C.; Sips, Hetty C. M.; Havekes, Louis M.; Meijer, Onno C.; Rensen, Patrick C. N.] Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Havekes, Louis M.] TNO Biosci, Leiden, Netherlands; [Lombes, Marc] INSERM, Unite 693, Le Kremlin Bicetre, France	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Institut National de la Sante et de la Recherche Medicale (Inserm)	Boon, MR (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Post Zone C7Q,POB 9600, NL-2300 RC Leiden, Netherlands.	m.r.boon@lumc.nl	Pelgrom, Leonard/GVT-0523-2022; Lombes, Marc/L-5933-2018; Kooijman, Sander/S-3857-2016; Guigas, Bruno/M-2515-2015; Boon, Mariëtte/O-3660-2016; Rensen, Patrick C.N./D-7176-2018; meijer, onno c/D-8070-2018; Jukema, J. Wouter/ABD-6503-2021	Lombes, Marc/0000-0003-3189-023X; Kooijman, Sander/0000-0002-0014-5571; Guigas, Bruno/0000-0002-8856-5799; Rensen, Patrick C.N./0000-0002-8455-4988; meijer, onno c/0000-0002-8394-6859; Jukema, J. Wouter/0000-0002-3246-8359; Pelgrom, Leonard/0000-0002-8422-6810	Board of Directors of Leiden University Medical Center (LUMC); Netherlands Heart Foundation [2009T087]; Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organisation for Health Research and Development; Royal Netherlands Academy of Sciences [CVON2011-19]	Board of Directors of Leiden University Medical Center (LUMC); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Federation of University Medical Centers; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences	M.R.B. is supported by a grant from the Board of Directors of Leiden University Medical Center (LUMC). P.C.N.R. is an established investigator of the Netherlands Heart Foundation (grant 2009T087). The authors also acknowledge support from the Netherlands Cardiovascular Research Initiative, the Dutch Heart Foundation, the Dutch Federation of University Medical Centers, the Netherlands Organisation for Health Research and Development, and the Royal Netherlands Academy of Sciences for the GENIUS project Generating the Best Evidence-Based Pharmaceutical Targets for Atherosclerosis (CVON2011-19). The authors also thank Lianne van der Wee and Trea Streefland (Department of Endocrinology, LUMC) for excellent technical assistance. The excellent help and valuable scientific input from Johanna C. van den Beukel, Gardi J. Voortman, Edith C. H. Friesema, and Aldo Grefhorst (Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands) is highly appreciated.	Addy C, 2008, CELL METAB, V7, P68, DOI 10.1016/j.cmet.2007.11.012; Bajzer M, 2011, DIABETOLOGIA, V54, P3121, DOI 10.1007/s00125-011-2302-6; Bakker LEH, 2014, LANCET DIABETES ENDO, V2, P210, DOI 10.1016/S2213-8587(13)70156-6; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Haan W, 2008, ATHEROSCLEROSIS, V197, P57, DOI 10.1016/j.atherosclerosis.2007.08.001; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; FEURER I, 1986, NUTR CLIN PRACT, V1, P43, DOI DOI 10.1177/088453368600100106; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019423; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Jong MC, 2001, J LIPID RES, V42, P1578; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Molhoj S, 2010, EUR J PHARMACOL, V646, P38, DOI 10.1016/j.ejphar.2010.08.006; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; RENSEN PCN, 1995, NAT MED, V1, P221, DOI 10.1038/nm0395-221; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Van Klinken JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036162; Verty ANA, 2009, OBESITY, V17, P254, DOI 10.1038/oby.2008.509; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu HM, 2011, MOL PHARMACOL, V80, P859, DOI 10.1124/mol.111.072769; ZAMBON A, 1993, J LIPID RES, V34, P1021; Zennaro MC, 1998, J CLIN INVEST, V101, P1254, DOI 10.1172/JCI1915	46	72	75	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5361	5375		10.1096/fj.13-247643	http://dx.doi.org/10.1096/fj.13-247643			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	25154875				2022-12-25	WOS:000345894500029
J	Thompson, JW; Nagel, J; Hoving, S; Gerrits, B; Bauer, A; Thomas, JR; Kirschner, MW; Schirle, M; Luchansky, SJ				Thompson, Joel W.; Nagel, Jane; Hoving, Sjouke; Gerrits, Bertran; Bauer, Andreas; Thomas, Jason R.; Kirschner, Marc W.; Schirle, Markus; Luchansky, Sarah J.			Quantitative Lys-epsilon-Gly-Gly (diGly) Proteomics Coupled with Inducible RNAi Reveals Ubiquitin-mediated Proteolysis of DNA Damage-inducible Transcript 4 (DDIT4) by the E3 Ligase HUWE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HECT-DOMAIN; PROTEIN; IDENTIFICATION; HYPOXIA; ACTIVATION; REDD1; DEGRADATION; PROTEASOME; SUPPRESSOR; EXPRESSION	Targeted degradation of proteins through the ubiquitin-proteasome system (UPS) via the activities of E3 ubiquitin ligases regulates diverse cellular processes, and misregulation of these enzymes contributes to the pathogenesis of human diseases. One of the challenges facing the UPS field is to delineate the complete cohort of substrates for a particular E3 ligase. Advances in mass spectrometry and the development of antibodies recognizing the Lys-epsilon-Gly-Gly (diGly) remnant from ubiquitinated proteins following trypsinolysis have provided a tool to address this question. We implemented an inducible loss of function approach in combination with quantitative diGly proteomics to find novel substrates of HUWE1 (HECT, UBA, and WWE domain containing 1, E3 ubiquitin protein ligase), an E3 ligase implicated in cancer and intellectual disabilities. diGly proteomics results led to the identification of DNA damage-inducible transcript 4 (DDIT4) as a putative HUWE1 substrate. Cell-based assays demonstrated that HUWE1 interacts with and regulates ubiquitination and stability of DDIT4. Together these data suggest a model in which HUWE1 mediates DDIT4 proteasomal degradation. Our results demonstrate proof of concept that inducible knockdown of an E3 ligase in combination with diGly proteomics provides a potentially advantageous method for identifying novel E3 substrates that may help to identify candidates for therapeutic modulation in the UPS.	[Thompson, Joel W.; Nagel, Jane; Thomas, Jason R.; Schirle, Markus; Luchansky, Sarah J.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Hoving, Sjouke; Gerrits, Bertran; Bauer, Andreas] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Novartis; Novartis; Harvard University; Harvard Medical School	Luchansky, SJ (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.	sarah.luchansky@novartis.com		Thompson, Joel/0000-0002-5131-3248	Novartis Institutes for BioMedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039023] Funding Source: NIH RePORTER	Novartis Institutes for BioMedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a Novartis Institutes for BioMedical Research presidential postdoctoral fellowship.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Cano F, 2012, EMBO J, V31, P3596, DOI 10.1038/emboj.2012.218; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Confalonieri S, 2009, ONCOGENE, V28, P2959, DOI 10.1038/onc.2009.156; D'Arca D, 2010, P NATL ACAD SCI USA, V107, P5875, DOI 10.1073/pnas.0912874107; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Khoronenkova SV, 2013, NUCLEIC ACIDS RES, V41, P1750, DOI 10.1093/nar/gks1359; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Lee KA, 2011, J BIOL CHEM, V286, P41530, DOI 10.1074/jbc.M111.248856; Love KR, 2009, ACS CHEM BIOL, V4, P275, DOI 10.1021/cb9000348; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mark KG, 2014, MOL CELL, V53, P148, DOI 10.1016/j.molcel.2013.12.003; Merbl Y, 2013, CELL, V152, P1160, DOI 10.1016/j.cell.2013.02.007; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Poulsen EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050548; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Schwarzer R, 2005, ONCOGENE, V24, P1138, DOI 10.1038/sj.onc.1208236; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Tan CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063970; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; TURNER G, 1994, AM J MED GENET, V51, P575, DOI 10.1002/ajmg.1320510456; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Vega-Rubin-de-Celis S, 2010, BIOCHEMISTRY-US, V49, P2491, DOI 10.1021/bi902135e; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang ZQ, 2003, J BIOL CHEM, V278, P27053, DOI 10.1074/jbc.M303723200; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Williamson A, 2013, MOL CELL, V49, P591, DOI 10.1016/j.molcel.2013.01.028; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Yoon SY, 2005, BIOCHEM BIOPH RES CO, V326, P7, DOI 10.1016/j.bbrc.2004.11.004; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zhang J, 2011, GENE DEV, V25, P2610, DOI 10.1101/gad.170605.111; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	75	41	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28942	28955		10.1074/jbc.M114.573352	http://dx.doi.org/10.1074/jbc.M114.573352			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25147182	Green Published, hybrid			2022-12-25	WOS:000344141000016
J	Colabardini, AC; Ries, LNA; Brown, NA; Savoldi, M; Dinamarco, TM; von Zeska, MR; Goldman, MHS; Goldman, GH				Colabardini, Ana Cristina; Annick Ries, Laure Nicolas; Brown, Neil Andrew; Savoldi, Marcela; Dinamarco, Taisa Magnani; von Zeska, Marcia Regina; Goldman, Maria Helena S.; Goldman, Gustavo Henrique			Protein Kinase C Overexpression Suppresses Calcineurin-Associated Defects in Aspergillus nidulans and Is Involved in Mitochondrial Function	PLOS ONE			English	Article							CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; SIGNALING PATHWAY; HYPHAL ELONGATION; CALCIUM; STRESS; GENE; PKCA; FUNGI	In filamentous fungi, intracellular signaling pathways which are mediated by changing calcium levels and/or by activated protein kinase C (Pkc), control fungal adaptation to external stimuli. A rise in intracellular Ca2+ levels activates calcineurin subunit A (CnaA), which regulates cellular calcium homeostasis among other processes. Pkc is primarily involved in maintaining cell wall integrity (CWI) in response to different environmental stresses. Cross-talk between the Ca2+ and Pkc-mediated pathways has mainly been described in Saccharomyces cerevisiae and in a few other filamentous fungi. The presented study describes a genetic interaction between CnaA and PkcA in the filamentous fungus Aspergillus nidulans. Overexpression of pkcA partially rescues the phenotypes caused by a cnaA deletion. Furthermore, CnaA appears to affect the regulation of a mitogen-activated kinase, MpkA, involved in the CWI pathway. Reversely, PkcA is involved in controlling intracellular calcium homeostasis, as was confirmed by microarray analysis. Furthermore, overexpression of pkcA in a cnaA deletion background restores mitochondrial number and function. In conclusion, PkcA and CnaA-mediated signaling appear to share common targets, one of which appears to be MpkA of the CWI pathway. Both pathways also regulate components involved in mitochondrial biogenesis and function. This study describes targets for PkcA and CnaA-signaling pathways in an A. nidulans and identifies a novel interaction of both pathways in the regulation of cellular respiration.	[Goldman, Gustavo Henrique] Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Sao Paulo, Brazil; [Colabardini, Ana Cristina; Annick Ries, Laure Nicolas; Brown, Neil Andrew; Savoldi, Marcela; von Zeska, Marcia Regina] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Dinamarco, Taisa Magnani; Goldman, Maria Helena S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Goldman, GH (corresponding author), Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Sao Paulo, Brazil.	ggoldman@usp.br	Dinamarco, Taisa M/J-8923-2012; Goldman, Gustavo Henrique/F-1848-2013; Dinamarco, Taisa/M-7174-2019; Goldman, Maria Helena S./D-1424-2012; Colabardini, Ana/P-1791-2015; von Zeska Kress, Marcia Regina/F-2651-2012	Dinamarco, Taisa M/0000-0001-6284-387X; Goldman, Gustavo Henrique/0000-0002-2986-350X; Dinamarco, Taisa/0000-0001-6284-387X; Goldman, Maria Helena S./0000-0002-6786-9320; Colabardini, Ana/0000-0002-2131-7969; Brown, Neil/0000-0002-3555-5765; von Zeska Kress, Marcia Regina/0000-0003-1239-7722	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brand A, 2009, CURR OPIN MICROBIOL, V12, P350, DOI 10.1016/j.mib.2009.05.007; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; Chen SC, 2010, FUNGAL GENET BIOL, V47, P268, DOI 10.1016/j.fgb.2009.12.008; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colabardini AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057630; Colabardini AC, 2010, MOL MICROBIOL, V78, P1259, DOI 10.1111/j.1365-2958.2010.07403.x; Cruz MC, 2001, EMBO J, V20, P1020, DOI 10.1093/emboj/20.5.1020; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Ferreira MED, 2007, FUNGAL GENET BIOL, V44, P219, DOI 10.1016/j.fgb.2006.08.004; Denis V, 2005, EUKARYOT CELL, V4, P36, DOI 10.1128/EC.4.1.36-45.2005; Dinamarco TM, 2010, FUNGAL GENET BIOL, V47, P1055, DOI 10.1016/j.fgb.2010.07.006; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; Flipphi M, 2002, BIOCHEM J, V364, P25, DOI 10.1042/bj3640025; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; Geysens S, 2009, FUNGAL GENET BIOL, V46, pS121, DOI 10.1016/j.fgb.2008.07.016; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; Harris SD, 2010, CELLULAR MOL BIOL FI; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Hernandez-Ortiz P, 2013, MOL MICROBIOL, V89, P532, DOI 10.1111/mmi.12294; Herrmann M, 2006, APPL ENVIRON MICROB, V72, P2957, DOI 10.1128/AEM.72.4.2957-2970.2006; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ichinomiya M, 2007, BIOSCI BIOTECH BIOCH, V71, P2787, DOI 10.1271/bbb.70409; JACKSON SL, 1993, MICROBIOL REV, V57, P367, DOI 10.1128/MMBR.57.2.367-382.1993; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; Katayama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050503; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Kume K, 2011, NAT CELL BIOL, V13, P234, DOI 10.1038/ncb2166; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lodder AL, 1999, GENETICS, V152, P1487; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Morawetz R, 1996, MOL GEN GENET, V250, P17, DOI 10.1007/s004380050047; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Ponting CP, 1996, PROTEIN SCI, V5, P162; Ronen R, 2007, CURR GENET, V51, P321, DOI 10.1007/s00294-007-0129-y; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Steinbach WJ, 2007, ANTIMICROB AGENTS CH, V51, P2979, DOI 10.1128/AAC.01394-06; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; Teepe AG, 2007, FUNGAL GENET BIOL, V44, P554, DOI 10.1016/j.fgb.2006.10.001; Thewes S, 2014, EUKARYOT CE IN PRESS; Virag A, 2006, MYCOL RES, V110, P4, DOI 10.1016/j.mycres.2005.09.005; Wang G, 2006, PROTOPLASMA, V228, P159, DOI 10.1007/s00709-006-0181-3; Wang XY, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-51; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Xiang X, 2003, CURR OPIN MICROBIOL, V6, P628, DOI 10.1016/j.mib.2003.10.009	57	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104792	10.1371/journal.pone.0104792	http://dx.doi.org/10.1371/journal.pone.0104792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153325	Green Published, gold, Green Submitted			2022-12-25	WOS:000340952200026
J	Hebrant, A; Floor, S; Saiselet, M; Antoniou, A; Desbuleux, A; Snyers, B; La, C; de St Aubain, N; Leteurtre, E; Andry, G; Maenhaut, C				Hebrant, Aline; Floor, Sebastien; Saiselet, Manuel; Antoniou, Aline; Desbuleux, Alice; Snyers, Berengere; La, Caroline; de St Aubain, Nicolas; Leteurtre, Emmanuelle; Andry, Guy; Maenhaut, Carine			miRNA Expression in Anaplastic Thyroid Carcinomas	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; MICRORNAS; CANCER; PATHOGENESIS; SURVIVAL; DENSITY; TARGETS; CELLS	Anaplastic thyroid carcinoma (ATC) is the most lethal form of thyroid neoplasia and represents an end stage of thyroid tumor progression. No effective treatment exists so far. In this study, we analyzed the miRNA expression profiles of 11 ATC by microarrays and their relationship with the mRNA expression profiles of the same 11 ATC samples. ATC show distinct miRNA expression profiles compared to other less aggressive thyroid tumor types. ATC show 18 commonly deregulated miRNA compared to normal thyroid tissue (17 downregulated and 1 upregulated miRNA). First, the analysis of a combined approach of the mRNA gene expression and of the bioinformatically predicted mRNA targets of the deregulated miRNA suggested a role for these regulations in the epithelial to mesenchymal transition (EMT) process in ATC. Second, the direct interaction between one of the upregulated mRNA target, the LOX gene which is an EMT key player, and a downregulated miRNA, the miR-29a, was experimentally validated by a luciferase assay in HEK cell. Third, we confirmed that the ATC tissue is composed of about 50% of tumor associated macrophages (TAM) and suggested, by taking into account our data and published data, their most likely direct or paracrine intercommunication between them and the thyroid tumor cells, amplifying the tumor aggressiveness. Finally, we demonstrated by in situ hybridization a specific thyrocyte localization of 3 of the deregulated miRNA: let-7g, miR-29a and miR-30e and we pointed out the importance of identifying the cell type localization before drawing any conclusion on the physiopathological role of a given gene.	[Hebrant, Aline; Floor, Sebastien; Saiselet, Manuel; Antoniou, Aline; Desbuleux, Alice; Snyers, Berengere; La, Caroline; Maenhaut, Carine] Univ Libre Bruxelles, Sch Med, Inst Interdisciplinary Res IRIBHM, Brussels, Belgium; [de St Aubain, Nicolas; Andry, Guy] Inst Jules Bordet, B-1000 Brussels, Belgium; [Leteurtre, Emmanuelle] Univ Lille 2, Fac Med, Lille, France; [Leteurtre, Emmanuelle] CHRU Lille, Inst Pathol, F-59037 Lille, France; [Maenhaut, Carine] Univ Libre Bruxelles, Sch Med, WELBIO, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut Jules Bordet; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite Libre de Bruxelles; Vrije Universiteit Brussel; WELBIO	Maenhaut, C (corresponding author), Univ Libre Bruxelles, Sch Med, Inst Interdisciplinary Res IRIBHM, Campus Erasme, Brussels, Belgium.	cmaenhau@ulb.ac.be		andry, guy/0000-0001-7410-6519	Welbio; Televie; European Union (GENRISK-T project) [036495]; Fonds de la Recherche Scientifique Medicale; Fondation Van Buren; Les amis de l'Institut Bordet; Fondation Contre le Cancer; Fonds National de la Recherche Scientifique (FNRS)	Welbio(WELBIO); Televie; European Union (GENRISK-T project); Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fondation Van Buren; Les amis de l'Institut Bordet; Fondation Contre le Cancer; Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Welbio, Televie, European Union (GENRISK-T project 036495), Fonds de la Recherche Scientifique Medicale, Fondation Van Buren, Les amis de l'Institut Bordet, Fondation Contre le Cancer, Fonds National de la Recherche Scientifique (FNRS). ATC tissue samples from Lille were obtained from the tumour cell and tissue bank of Regional Reference Cancer Center of Lille "Tumorotheque du centre regional de Reference en Cancerologie'' (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner A, 2011, J MOL MED; Ain KB, 1999, SEMIN SURG ONCOL, V16, P64, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<64::AID-SSU10>3.3.CO;2-L; Are C, 2006, ANN SURG ONCOL, V13, P453, DOI 10.1245/ASO.2006.05.042; Baay M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/565187; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chen ZG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/695179; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hebrant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037807; Kim S, 2013, ENDOCRINOL METAB, V28, P192, DOI 10.3803/EnM.2013.28.3.192; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nagaiah G, 2011, J ONCOL, V2011, DOI 10.1155/2011/542358; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Pallante P, 2014, NAT REV ENDOCRINOL, V10, P88, DOI 10.1038/nrendo.2013.223; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Qing W, 2012, THYROID, V22, P905, DOI 10.1089/thy.2011.0452; Ryder M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054302; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Smallridge RC, 2009, ENDOCR-RELAT CANCER, V16, P17, DOI 10.1677/ERC-08-0154; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	40	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103871	10.1371/journal.pone.0103871	http://dx.doi.org/10.1371/journal.pone.0103871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153510	Green Submitted, gold, Green Published			2022-12-25	WOS:000340952200011
J	Jones, KH; Jones, PA; Middleton, RM; Ford, DV; Tuite-Dalton, K; Lockhart-Jones, H; Peng, J; Lyons, RA; John, A; Noble, JG				Jones, Kerina H.; Jones, Philip A.; Middleton, Rodden M.; Ford, David V.; Tuite-Dalton, Katie; Lockhart-Jones, Hazel; Peng, Jeffrey; Lyons, Ronan A.; John, Ann; Noble, J. Gareth			Physical Disability, Anxiety and Depression in People with MS: An Internet-Based Survey via the UK MS Register	PLOS ONE			English	Article							IMPACT SCALE MSIS-29; MULTIPLE-SCLEROSIS; HOSPITAL ANXIETY; MAJOR DEPRESSION; OUTCOME MEASURES; SEVERITY; MRI	Introduction: People with Multiple Sclerosis are known to have a relatively high prevalence of both anxiety and depression. Studies of the relationship between physical disability and mental health in people with MS have reported mixed results, showing the need for further work. Methods: Between May 2011 and April 2012, 4516 people completed the MSIS-29 (v.1) and HADS scales via the dedicated internet site of the UK MS Register within a 7 day time window. These responses were linked with basic demographic and descriptive data and analysed in SPSS (v.20). Results: The proportions of people experiencing anxiety or depression increased with physical disability such that 38.0% of respondents with low, and 66.7% with high disability reported at least mild anxiety, and 17.1% of people with low, and 71.7% with high disability experienced at least mild depression. The multiple regression model explained 18.4% of the variance in anxiety with MSIS-29-PHYS score being the strongest predictor of anxiety. The model for depression explained 37.8% of the variance with MSIS-29-PHYS score being the strongest predictor. Some of the other variables included showed negative associations with anxiety and depression, indicating that the influence of physical disability on mental wellbeing could be underestimated. Conclusions: This study indicates that there is a positive relationship between physical disability and anxiety and depression, that physical disability impacts on anxiety and depression to differing extents, and that the effects vary with gender, age, disease course and disease duration. We have shown that physical disability is a predictor of anxiety and depression, and that other factors may mask the extent of this effect. Whether the causes of anxiety and depression are reactive, organic or a combination, it is essential that mental wellbeing is given due attention in caring for people with MS so that all their health needs can be met.	[Jones, Kerina H.; Jones, Philip A.; Middleton, Rodden M.; Ford, David V.; Tuite-Dalton, Katie; Lockhart-Jones, Hazel; Peng, Jeffrey; Lyons, Ronan A.; John, Ann; Noble, J. Gareth] Swansea Univ, Coll Med, Swansea, W Glam, Wales	Swansea University	Jones, KH (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	k.h.jones@swansea.ac.uk		Middleton, Rodden/0000-0002-2130-4420; Noble, Gareth/0000-0002-4588-049X; Jones, Kerina/0000-0001-8164-3718; Lyons, Ronan/0000-0001-5225-000X; John, Ann/0000-0002-5657-6995; Ford, David/0000-0001-6551-721X	UK MS Society [C001-13.3]; Economic and Social Research Council [ES/L007444/1] Funding Source: researchfish; Medical Research Council [MR/K006525/1] Funding Source: researchfish; ESRC [ES/L007444/1] Funding Source: UKRI; MRC [MR/K006525/1] Funding Source: UKRI	UK MS Society; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK MS Register is supported by a grant from the UK MS Society C001-13.3. The sponsor had no role in the design or conduct of the study; the interpretation or analysis of the data; or in the decision to submit for publication (http://www.mssociety.org.uk/).	Arnett PA, 2008, J INT NEUROPSYCH SOC, V14, P691, DOI 10.1017/S1355617708081174; Bakshi R, 2000, NEUROREPORT, V11, P1153, DOI 10.1097/00001756-200004270-00003; Beiske AG, 2008, EUR J NEUROL, V15, P239, DOI 10.1111/j.1468-1331.2007.02041.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boot CRL, 2010, HEALTH INFORM J, V16, P145, DOI 10.1177/1460458210364786; Bruce JM, 2010, J BEHAV MED, V33, P219, DOI 10.1007/s10865-010-9247-y; Cetin K, 2007, MULT SCLER, V13, P1046, DOI 10.1177/1352458507077864; Chwastiak L, 2002, AM J PSYCHIAT, V159, P1862, DOI 10.1176/appi.ajp.159.11.1862; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; da Silva AM, 2011, J NEUROL SCI, V306, P66, DOI 10.1016/j.jns.2011.03.042; Dahl OP, 2009, MULT SCLER J, V15, P1495, DOI 10.1177/1352458509351542; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Ford DV, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-73; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Gallacher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054331; GILCHRIST AC, 1994, J PSYCHOSOM RES, V38, P193, DOI 10.1016/0022-3999(94)90115-5; Good Alice, 2007, J Healthc Inf Manag, V21, P72; Gray OM, 2009, MULT SCLER, V15, P75, DOI 10.1177/1352458508096872; Haase R, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2133; Health Research Authority website, ETH REV RES DAT; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hobart J, 2009, HLTH TECHNOLOGY ASSE, V13; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Janssens ACJW, 2006, MULT SCLER J, V12, P794, DOI 10.1177/1352458506070935; Jones KH, 2014, J BIOMED INFORM, V50, P196, DOI 10.1016/j.jbi.2014.01.003; Jones KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065640; Jones KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055422; Jones KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041910; KRUPP LB, 1988, ARCH NEUROL-CHICAGO, V45, P435, DOI 10.1001/archneur.1988.00520280085020; Lynch SG, 2001, MULT SCLER J, V7, P411, DOI 10.1191/135245801701566998; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Marrie RA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2466; Michalski D, 2010, MENT ILLN, V2, DOI 10.4081/mi.2010.e5; MINDEN SL, 1987, GEN HOSP PSYCHIAT, V9, P426, DOI 10.1016/0163-8343(87)90052-1; Mohr DC, 2006, MULT SCLER J, V12, P204, DOI 10.1191/135248506ms1265oa; Noble JG, 2012, MULT SCLER J, V18, P1718, DOI 10.1177/1352458512457847; Osborne LA, 2014, PHYS THER REV, V19, P24, DOI 10.1179/1743288X13Y.0000000094; Osborne LA, 2013, INT J HEALTHC INF SY, V8, P1, DOI 10.4018/jhisi.2013010101; Osborne LA, 2013, INT J MED INFORM, V82, P1104, DOI 10.1016/j.ijmedinf.2013.07.005; Osborne LA, 2012, INT J HEALTHC INF SY, V7, P27, DOI 10.4018/jhisi.2012070103; Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI 10.1016/j.genhosppsych.2008.05.001; Ramp M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-58; Sa MJ, 2008, CLIN NEUROL NEUROSUR, V110, P868, DOI 10.1016/j.clineuro.2007.10.001; Siegert RJ, 2005, J NEUROL NEUROSUR PS, V76, P469, DOI 10.1136/jnnp.2004.054635; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zorzon M, 2001, J NEUROL, V248, P416, DOI 10.1007/s004150170184	49	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104604	10.1371/journal.pone.0104604	http://dx.doi.org/10.1371/journal.pone.0104604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153835	gold, Green Published, Green Submitted			2022-12-25	WOS:000340952200021
J	Kwon, JT; Jin, S; Choi, H; Kim, J; Jeong, J; Kim, J; Kim, Y; Cho, BN; Cho, C				Kwon, Jun Tae; Jin, Sora; Choi, Heejin; Kim, Jihye; Jeong, Juri; Kim, Jaehwan; Kim, Youil; Cho, Byung-Nam; Cho, Chunghee			Identification and Characterization of Germ Cell Genes Expressed in the F9 Testicular Teratoma Stem Cell Line	PLOS ONE			English	Article							MOUSE TESTIS; TRANSCRIPTION FACTORS; DNA METHYLATION; RETINOIC ACID; SERTOLI-CELLS; MICE; SPERMATOGENESIS; DIFFERENTIATION; PROMOTER; MEIOSIS	The F9 cell line, which was derived from a mouse testicular teratoma that originated from pluripotent germ cells, has been used as a model for differentiation. However, it is largely unknown whether F9 cells possess the characteristics of male germ cells. In the present study, we investigated spermatogenic stage-and cell type-specific gene expression in F9 cells. Analysis of previous microarray data showed that a large number of stage-regulated germ cell genes are expressed in F9 cells. Specifically, genes that are prominently expressed in spermatogonia and have transcriptional regulatory functions appear to be enriched in F9 cells. Our in silico and in vitro analyses identified several germ cell-specific or - predominant genes that are expressed in F9 cells. Among them, strong promoter activities were observed in the regions upstream of the spermatogonial genes, Dmrt1 (doublesex and mab-3 related transcription factor 1), Stra8 (stimulated by retinoic acid gene 8) and Tex13 (testis expressed gene 13), in F9 cells. A detailed analysis of the Tex13 promoter allowed us to identify an enhancer and a region that is implicated in germ cell-specificity. We also found that Tex13 expression is regulated by DNA methylation. Finally, analysis of GFP (green fluorescent protein) TEX13 localization revealed that the protein distributes heterogeneously in the cytoplasm and nucleus, suggesting that TEX13 shuttles between these two compartments. Taken together, our results demonstrate that F9 cells express numerous spermatogonial genes and could be used for transcriptional studies focusing on such genes. As an example of this, we use F9 cells to provide comprehensive expressional information about Tex13, and report that this gene appears to encode a germ cell-specific protein that functions in the nucleus during early spermatogenesis.	[Kwon, Jun Tae; Jin, Sora; Choi, Heejin; Kim, Jihye; Jeong, Juri; Kim, Jaehwan; Kim, Youil; Cho, Chunghee] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Cho, Byung-Nam] Catholic Univ Korea, Dept Biol, Puchon, South Korea	Gwangju Institute of Science & Technology (GIST); Catholic University of Korea	Cho, C (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea.	choch@gist.ac.kr			General Researcher Program of the National Research Foundation of Korea [NRF-2012R1A1A2039947]; Bio & Medical Technology Development Program of the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2013M3A9A7046297]; GIST Systems Biology Infrastructure Establishment grant	General Researcher Program of the National Research Foundation of Korea(National Research Foundation of Korea); Bio & Medical Technology Development Program of the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); GIST Systems Biology Infrastructure Establishment grant	This work was supported by the General Researcher Program of the National Research Foundation of Korea (NRF-2012R1A1A2039947), the Bio & Medical Technology Development Program of the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9A7046297) and GIST Systems Biology Infrastructure Establishment grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Caires K, 2010, J ENDOCRINOL, V205, P133, DOI 10.1677/JOE-09-0275; Chen YC, 2006, BIOINFORMATICS, V22, P2180, DOI 10.1093/bioinformatics/btl358; Eddy EM, 1995, REPROD FERT DEVELOP, V7, P695, DOI 10.1071/RD9950695; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Grasso M, 2012, REPRODUCTION, V143, P325, DOI 10.1530/REP-11-0385; Havilio M, 2006, J COMPUT BIOL, V13, P63, DOI 10.1089/cmb.2006.13.63; Hayashi T, 2001, J ANDROL, V22, P999; Heaney JD, 2012, DEVELOPMENT, V139, P1577, DOI 10.1242/dev.076851; Herrada G, 1997, J CELL SCI, V110, P1543; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kato T, 2012, REPRODUCTION, V143, P663, DOI 10.1530/REP-11-0365; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Ketola I, 2002, EUR J ENDOCRINOL, V147, P397, DOI 10.1530/eje.0.1470397; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Laursen KB, 2012, NUCLEIC ACIDS RES, V40, P102, DOI 10.1093/nar/gkr637; Lee K, 2002, BIOCHEM BIOPH RES CO, V296, P337, DOI 10.1016/S0006-291X(02)00801-X; LEHTONEN E, 1989, International Journal of Developmental Biology, V33, P105; Lei N, 2009, BIOL REPROD, V81, P118, DOI 10.1095/biolreprod.108.072314; Looijenga LHJ, 1997, AM J PATHOL, V151, P581; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Murphy K, 2005, GENE EXPR PATTERNS, V5, P475, DOI 10.1016/j.modgep.2004.12.007; Nakamura BN, 2010, FREE RADICAL BIO MED, V49, P1368, DOI 10.1016/j.freeradbiomed.2010.07.019; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Rath B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-43; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Romero Y, 2012, SEX DEV, V6, P169, DOI 10.1159/000338415; Saitou M, 2010, REPRODUCTION, V139, P931, DOI 10.1530/REP-10-0043; Sarkar PS, 2004, HUM MOL GENET, V13, P1421, DOI 10.1093/hmg/ddh161; Sato S, 2011, J REPROD DEVELOP, V57, P526, DOI 10.1262/jrd.11-031A; Schmidt JA, 2009, BIOL REPROD, V81, P56, DOI 10.1095/biolreprod.108.075358; Scotland KB, 2009, DEV DYNAM, V238, P1863, DOI 10.1002/dvdy.22037; Shakya A, 2011, J BIOL CHEM, V286, P450, DOI 10.1074/jbc.M110.174045; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; STEVENS LC, 1967, J NATL CANCER I, V38, P549; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; Tedesco M, 2009, J BIOL CHEM, V284, P35781, DOI 10.1074/jbc.M109.056481; Thepot D, 2000, DEVELOPMENT, V127, P143; Thomas K, 2007, MOL CELL ENDOCRINOL, V270, P1, DOI 10.1016/j.mce.2007.03.001; Tian LY, 2009, MOL REPROD DEV, V76, P656, DOI 10.1002/mrd.20997; Tominaga A, 2010, GENES CELLS, V15, P595, DOI 10.1111/j.1365-2443.2010.01403.x; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Zheng B, 2014, PROTEOMICS, V14, P274, DOI 10.1002/pmic.201300395; Zindy F, 2000, MOL CELL BIOL, V20, P372, DOI 10.1128/MCB.20.1.372-378.2000	56	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103837	10.1371/journal.pone.0103837	http://dx.doi.org/10.1371/journal.pone.0103837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153150	Green Submitted, Green Published, gold			2022-12-25	WOS:000340952200009
J	Korhan, P; Erdal, E; Kandemis, E; Cokakli, M; Nart, D; Yilmaz, F; Can, A; Atabey, N				Korhan, Peyda; Erdal, Esra; Kandemis, Emine; Cokakli, Murat; Nart, Deniz; Yilmaz, Funda; Can, Alp; Atabey, Nese			Reciprocal Activating Crosstalk between c-Met and Caveolin 1 Promotes Invasive Phenotype in Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; POTENTIAL THERAPEUTIC TARGET; ENDOCYTIC REGULATION; FACTOR RECEPTOR; CELL BIOLOGY; EXPRESSION; IDENTIFICATION; PHOSPHORYLATION; PROTOONCOGENE; AMPLIFICATION	c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hepatocellular Carcinoma (HCC). Caveolin 1 (CAV1), a plasma membrane protein that modulates signal transduction molecules, is also overexpressed in HCC. The aim of this study was to investigate biological and clinical significance of co-expression and activation of c-Met and CAV1 in HCC. We showed that c-Met and CAV1 were co-localized in HCC cells and HGF treatment increased this association. HGF-triggered c-Met activation caused a concurrent rise in both phosphorylation and expression of CAV1. Ectopic expression of CAV1 accelerated c-Met signaling, resulted in enhanced migration, invasion, and branching-morphogenesis. Silencing of CAV1 downregulated c-Met signaling, and decreased migratory/invasive capability of cells and attenuated branching morphogenesis. In addition, activation and co-localization of c-Met and CAV1 were elevated during hepatocarcinogenesis. In conclusion reciprocal activating crosstalk between c-Met and CAV1 promoted oncogenic signaling of c-Met contributed to the initiation and progression of HCC.	[Korhan, Peyda; Erdal, Esra; Kandemis, Emine; Cokakli, Murat; Atabey, Nese] Dokuz Eylul Univ, Sch Med, Dept Med Biol, Izmir, Turkey; [Nart, Deniz; Yilmaz, Funda] Ege Univ, Sch Med, Dept Pathol, Izmir, Turkey; [Can, Alp] Ankara Univ, Sch Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey	Dokuz Eylul University; Ege University; Ankara University	Atabey, N (corresponding author), Dokuz Eylul Univ, Sch Med, Dept Med Biol, Izmir, Turkey.	nese.atabey@deu.edu.tr	Cokakli, Murat/P-5056-2017; Korhan, Peyda/AAI-5995-2021; Erdal, Esra/AAE-1339-2019; Can, Alp/AAO-5734-2020; Erdal, Esra/T-9057-2018; Atabey, Nese/A-1853-2018; Yilmaz, Funda/O-9646-2018; kandemis, emine/K-1646-2015; Barbet, Funda Yılmaz/V-9938-2017	Cokakli, Murat/0000-0002-1370-204X; Korhan, Peyda/0000-0003-1286-022X; Erdal, Esra/0000-0001-7264-0574; Erdal, Esra/0000-0001-7264-0574; Atabey, Nese/0000-0003-4966-2980; Yilmaz, Funda/0000-0003-1837-6498; Barbet, Funda Yılmaz/0000-0003-1837-6498	Turkish Scientific and Technological Research Council (TUBITAK) [SBAG-107S026]; Dokuz Eylul University Research Foundation [05.KB.SAG.71]	Turkish Scientific and Technological Research Council (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Dokuz Eylul University Research Foundation(Dokuz Eylul University)	This project was funded by grants to Prof. Dr. Atabey from Turkish Scientific and Technological Research Council (TUBITAK, SBAG-107S026) and Dokuz Eylul University Research Foundation (05.KB.SAG.71). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabey N, 2001, J BIOL CHEM, V276, P14308, DOI 10.1074/jbc.M010202200; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Bozkaya G, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-64; Chan SPL, 2012, J GASTROEN HEPATOL, V27, P862, DOI 10.1111/j.1440-1746.2012.07096.x; Cho KW, 2013, ONCOGENE, V32, P1018, DOI 10.1038/onc.2012.122; Chu JS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-16; Chua CL, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/348297; Cokakli M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-65; Coleman DT, 2009, MOL CANCER THER, V8, P214, DOI 10.1158/1535-7163.MCT-08-0722; DErrico A, 1996, HEPATOLOGY, V24, P60, DOI 10.1002/hep.510240112; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gao JJ, 2012, BIOSCI TRENDS, V6, P153, DOI 10.5582/bst.2012.v6.4.153; Gao JJ, 2011, DRUG DISCOV THER, V5, P2, DOI 10.5582/ddt.2011.v5.1.2; Huynh H, 2009, J CELL MOL MED, V13, P2673, DOI 10.1111/j.1582-4934.2009.00692.x; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kermorgant S, 2004, EMBO J, V23, P3721, DOI 10.1038/sj.emboj.7600396; Kondo S, 2013, INT J CLIN ONCOL, V18, P207, DOI 10.1007/s10147-011-0361-9; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Marx-Stoelting P, 2009, INT J CANCER, V124, P1767, DOI 10.1002/ijc.24167; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Mitchell KA, 2013, J CLIN GASTROENTEROL, V47, pS20, DOI 10.1097/MCG.0b013e318291f237; Montesano R, 1998, CELL GROWTH DIFFER, V9, P355; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Ng YS, 2004, LAB INVEST, V84, P1209, DOI 10.1038/labinvest.3700150; Osada S, 2008, HEPATO-GASTROENTEROL, V55, P544; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Tse EYT, 2012, J PATHOL, V226, P645, DOI 10.1002/path.3957; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Urra H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033085; van Malenstein H, 2011, EUR J CANCER, V47, P1789, DOI 10.1016/j.ejca.2011.04.027; Venepalli NK, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/341636; Wang SJ, 2009, OLIGONUCLEOTIDES, V19, P81, DOI 10.1089/oli.2008.0166; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yamaguchi H, 2014, ONCOGENE, V33, P1073, DOI 10.1038/onc.2013.74; Yang SF, 2010, PATHOLOGY, V42, P438, DOI 10.3109/00313025.2010.494293; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Zhang ZB, 2009, PATHOL ONCOL RES, V15, P495, DOI 10.1007/s12253-008-9144-7	44	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105278	10.1371/journal.pone.0105278	http://dx.doi.org/10.1371/journal.pone.0105278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148256	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600039
J	Nagata, E; Fujii, N; Hosomichi, K; Mitsunaga, S; Suzuki, Y; Mashimo, Y; Tsukamoto, H; Satoh, T; Osawa, M; Inoue, I; Hata, A; Takizawa, S				Nagata, Eiichiro; Fujii, Natsuko; Hosomichi, Kazuyoshi; Mitsunaga, Shigeki; Suzuki, Yoichi; Mashimo, Yoichi; Tsukamoto, Hideo; Satoh, Tadayuki; Osawa, Motoki; Inoue, Ituro; Hata, Akira; Takizawa, Shunya			Possible Association between Dysfunction of Vitamin D Binding Protein (GC Globulin) and Migraine Attacks	PLOS ONE			English	Article							IMMUNE-SYSTEM; GENE; CCL2; PAIN	To identify the genetic causality of migraine and acute, severe melalgia, we performed a linkage analysis and exome sequencing in a family with four affected individuals. We identified a variant (R21L) in exon 2 of the GC globulin gene, which is involved in the transportation of vitamin D metabolites and acts as a chemotaxic factor; this variant was co-segregated within the family. To investigate the relationship between GC globulin and melalgia, we investigated the cytokine levels in serum samples from the patients and control subjects using a cytokine antibody array. GC globulin can bind to both MCP-1 and RANTES in human serum but has a higher affinity to MCP-1. In cell culture systems, MCP-1 was able to bind to overexpressed wild-type GC globulin but not to the GC globulin variant, and the GC globulin binding affinity to MCP-1 was significantly lower in sera from the patients than in sera from control subjects. A higher concentration of MCP-1 was also observed in sera from the patients. Thus, the dysfunctional GC globulin affected cytokine release, especially the release of MCP-1, and MCP-1 might play important roles in melalgia and migraine.	[Nagata, Eiichiro; Fujii, Natsuko; Takizawa, Shunya] Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa 25911, Japan; [Hosomichi, Kazuyoshi; Inoue, Ituro] Natl Inst Genet, Dept Integrated Genet, Div Human Genet, Mishima, Shizuoka 411, Japan; [Mitsunaga, Shigeki] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Isehara, Kanagawa 25911, Japan; [Suzuki, Yoichi] Tohoku Univ, Sch Med, Div Genet Epidemiol Res Support, Sendai, Miyagi 980, Japan; [Mashimo, Yoichi; Hata, Akira] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Japan; [Tsukamoto, Hideo; Satoh, Tadayuki] Tokai Univ, Sch Med, Educ & Res Ctr, Isehara, Kanagawa 25911, Japan; [Osawa, Motoki] Tokai Univ, Sch Med, Dept Forens Med, Isehara, Kanagawa 25911, Japan	Tokai University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokai University; Tohoku University; Chiba University; Tokai University; Tokai University	Nagata, E (corresponding author), Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa 25911, Japan.	enagata@is.icc.u-tokai.ac.jp	Hosomichi, Kazuyoshi/K-9477-2015	Hosomichi, Kazuyoshi/0000-0003-2712-1825; HATA, AKIRA/0000-0003-0867-3704	Tokai University School of Medicine, Project Research	Tokai University School of Medicine, Project Research	Funding provided by 2010 similar to 2012 Tokai University School of Medicine, Project Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Binder R, 1999, MOL IMMUNOL, V36, P885, DOI 10.1016/S0161-5890(99)00110-8; Bo SH, 2009, CEPHALALGIA, V29, P365, DOI 10.1111/j.1468-2982.2008.01727.x; Bose S, 2013, ARCH PHARM RES, V36, P1039, DOI 10.1007/s12272-013-0161-z; Bruno PP, 2007, EUR REV MED PHARMACO, V11, P245; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dauvergne C, 2013, EUR J PAIN; Edvinsson L, 2005, BRAIN RES REV, V48, P438, DOI 10.1016/j.brainresrev.2004.09.007; Edvinsson L, 2001, Curr Pain Headache Rep, V5, P71, DOI 10.1007/s11916-001-0013-2; Edvinsson L, 2012, PHARMACOL THERAPEUT, V136, P319, DOI 10.1016/j.pharmthera.2012.08.011; Franceschini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052394; Goadsby PJ, 2000, PROG NEUROBIOL, V62, P509, DOI 10.1016/S0301-0082(00)00010-1; Goadsby PJ, 2003, INTERN MED J, V33, P436, DOI 10.1046/j.1445-5994.2003.00453.x; Goasby PJ, 1993, ANN NEUROL, V33, P48; Headache Classification Committee of the International Headache Society (IHS), 2013, CEPHALALGIA, V33, P629, DOI DOI 10.1177/0333102413485658; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kemper RHA, 2001, CEPHALALGIA, V21, P549, DOI 10.1046/j.1468-2982.2001.00196.x; Levy D, 2009, CURR PAIN HEADACHE R, V13, P237, DOI 10.1007/s11916-009-0040-y; Malik S, 2013, CRIT REV CL LAB SCI, V50, P1, DOI 10.3109/10408363.2012.750262; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OHSAWA M, 1989, BIOCHIM BIOPHYS ACTA, V992, P195, DOI 10.1016/0304-4165(89)90010-X; OSAWA M, 1992, BIOCHIM BIOPHYS ACTA, V1117, P271, DOI 10.1016/0304-4165(92)90024-O; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Prakash S, 2009, CEPHALALGIA, V29, P898, DOI 10.1111/j.1468-2982.2008.01809.x; Qin XM, 2005, J NEUROSCI RES, V82, P51, DOI 10.1002/jnr.20612; ROBBINS L, 1994, HEADACHE, V34, P214, DOI 10.1111/j.1526-4610.1994.hed3404214.x; Sakai F, 1997, CEPHALALGIA, V17, P15, DOI 10.1046/j.1468-2982.1997.1701015.x; Sauro KM, 2009, HEADACHE, V49, P1378, DOI [10.1111/j.1526-4610.2009.01486.x, 10.1111/j.1526-4610.2009.01476.x]; Webb EL, 2005, BIOINFORMATICS, V21, P3060, DOI 10.1093/bioinformatics/bti449	31	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105319	10.1371/journal.pone.0105319	http://dx.doi.org/10.1371/journal.pone.0105319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147936	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600042
J	Raevuori, A; Haukka, J; Vaarala, O; Suvisaari, JM; Gissler, M; Grainger, M; Linna, MS; Suokas, JT				Raevuori, Anu; Haukka, Jari; Vaarala, Outi; Suvisaari, Jaana M.; Gissler, Mika; Grainger, Marjut; Linna, Milla S.; Suokas, Jaana T.			The Increased Risk for Autoimmune Diseases in Patients with Eating Disorders	PLOS ONE			English	Article							ANOREXIA-NERVOSA; SEVERE INFECTIONS; CROHNS-DISEASE; HLA ANTIGENS; TYPE-1; AUTOANTIBODIES; ASSOCIATION; PREVALENCE; MICROBIOTA; CELLS	Objective: Research suggests autoimmune processes to be involved in psychiatric disorders. We aimed to address the prevalence and incidence of autoimmune diseases in a large Finnish patient cohort with anorexia nervosa, bulimia nervosa, and binge eating disorder. Methods: Patients (N = 2342) treated at the Eating Disorder Unit of Helsinki University Central Hospital between 1995 and 2010 were compared with general population controls (N = 9368) matched for age, sex, and place of residence. Data of 30 autoimmune diseases from the Hospital Discharge Register from 1969 to 2010 were analyzed using conditional and Poisson regression models. Results: Of patients, 8.9% vs. 5.4% of control individuals had been diagnosed with one or more autoimmune disease (OR 1.7, 95% CI 1.5-2.0, P<0.001). The increase in endocrinological diseases (OR 2.4, 95% CI 1.8-3.2, P<0.001) was explained by type 1 diabetes, whereas Crohn's disease contributed most to the risk of gastroenterological diseases (OR 1.8, 95% CI 1.4-2.5, P<0.001). Higher prevalence of autoimmune diseases among patients with eating disorders was not exclusively due to endocrinological and gastroenterological diseases; when the two categories were excluded, the increase in prevalence was seen in the patients both before the onset of the eating disorder treatment (OR 1.5, 95% CI 1.1-2.1, P = 0.02) and at the end of the follow-up (OR 1.4, 95% CI 1.1-1.8, P = 0.01). Conclusions: We observed an association between eating disorders and several autoimmune diseases with different genetic backgrounds. Our findings support the link between immune-mediated mechanisms and development of eating disorders. Future studies are needed to further explore the risk of autoimmune diseases and immunological mechanisms in individuals with eating disorders and their family members.	[Raevuori, Anu; Haukka, Jari; Linna, Milla S.] Univ Helsinki, Hjelt Inst, Dept Publ Hlth, Helsinki, Finland; [Raevuori, Anu] Univ Helsinki, Cent Hosp, Dept Adolescent Psychiat, Helsinki, Finland; [Raevuori, Anu] Univ Turku, Inst Clin Med Child Psychiat, Turku, Finland; [Raevuori, Anu; Haukka, Jari; Suvisaari, Jaana M.; Grainger, Marjut; Suokas, Jaana T.] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Raevuori, Anu; Haukka, Jari; Suvisaari, Jaana M.; Grainger, Marjut; Suokas, Jaana T.] Natl Inst Hlth & Welf, Substance Abuse Serv, Helsinki, Finland; [Vaarala, Outi] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Suvisaari, Jaana M.] Tampere Sch Publ Hlth, Dept Social Psychiat, Tampere, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Dept Informat, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Suokas, Jaana T.] Univ Helsinki, Cent Hosp, Dept Psychiat, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Tampere University; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Raevuori, A (corresponding author), Univ Helsinki, Hjelt Inst, Dept Publ Hlth, Helsinki, Finland.	anu.raevuori@helsinki.fi	Haukka, Jari/G-1484-2014	Haukka, Jari/0000-0003-1450-6208; Suvisaari, Jaana/0000-0001-7167-0990; Raevuori, Anu/0000-0001-7704-9441; Gissler, Mika/0000-0001-8254-7525	Academy of Finland [259764]; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Academy of Finland(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by Academy of Finland (Dr. Raevuori, grant number 259764). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunay I, 2011, CLIN COSMET INVESTI, V4, P139, DOI 10.2147/CCID.S24165; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Arigo D, 2012, CHRONIC ILLN, V8, P45, DOI 10.1177/1742395311417639; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Benros ME, 2013, JAMA PSYCHIAT, V70, P812, DOI 10.1001/jamapsychiatry.2013.1111; Benros ME, 2011, AM J PSYCHIAT, V168, P1303, DOI 10.1176/appi.ajp.2011.11030516; BIEDERMAN J, 1984, AM J PSYCHIAT, V141, P1109; Blanchet C, 2002, PRESSE MED, V31, P312; Boraska V, MOL PSYCHIA IN PRESS; Bulik CM, 2003, INT J EAT DISORDER, V34, pS39, DOI 10.1002/eat.10204; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Corcos M, 2003, PSYCHONEUROENDOCRINO, V28, P229, DOI 10.1016/S0306-4530(02)00021-5; Dalbeth N, 2002, LANCET, V360, P1300, DOI 10.1016/S0140-6736(02)11320-1; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; Eaton WW, 2010, BIPOLAR DISORD, V12, P638, DOI 10.1111/j.1399-5618.2010.00853.x; Fetissov SO, 2011, CURR OPIN CLIN NUTR, V14, P477, DOI 10.1097/MCO.0b013e32834936e7; Fetissov SO, 2005, P NATL ACAD SCI USA, V102, P14865, DOI 10.1073/pnas.0507204102; Fetissov SO, 2002, P NATL ACAD SCI USA, V99, P17155, DOI 10.1073/pnas.222658699; Goebel-Fabbri A, 2009, CURR DIABETES REP, V9, P133, DOI 10.1007/s11892-009-0023-8; Hall R C, 1995, J Fla Med Assoc, V82, P187; Harboe E, 2009, ANN RHEUM DIS, V68, P1541, DOI 10.1136/ard.2008.098301; Hornig M, 2013, CURR OPIN RHEUMATOL, V25, P488, DOI 10.1097/BOR.0b013e32836208de; Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563; Karwautz A, 2008, PSYCHOSOMATICS, V49, P399, DOI 10.1176/appi.psy.49.5.399; KISS A, 1989, BIOL PSYCHIAT, V25, P803, DOI 10.1016/0006-3223(89)90255-2; KISS A, 1988, AM J PSYCHIAT, V145, P876; Klump KL, 2006, PSYCHOL MED, V36, P539, DOI 10.1017/S0033291705006653; Lammi N, 2008, DIABETOLOGIA, V51, P897, DOI 10.1007/s00125-008-0952-9; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Limone P, 2000, J ENDOCRINOL INVEST, V23, P422, DOI 10.1007/BF03343750; Lo Sauro C, 2008, NEUROPSYCHOBIOLOGY, V57, P95, DOI 10.1159/000138912; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McDermott JR, 2006, GUT, V55, P492, DOI 10.1136/gut.2005.081752; Mitchell JE, 2006, CURR OPIN PSYCHIATR, V19, P438, DOI 10.1097/01.yco.0000228768.79097.3e; Padmos RC, 2004, BIOL PSYCHIAT, V56, P476, DOI 10.1016/j.biopsych.2004.07.003; Pfleiderer A, 2013, EUR J CLIN MICROBIOL, V32, P1471, DOI 10.1007/s10096-013-1900-2; R Core Team, 2021, R LANG ENV STAT COMP; Rayment D, 2012, INT J EAT DISORDER, V45, P460, DOI 10.1002/eat.20964; Solmi M, 2013, INT J EAT DISORDER, V46, P639, DOI 10.1002/eat.22153; Strober M, 2001, INT J EAT DISORDER, V29, P263, DOI 10.1002/eat.1017; Suokas JT, 2013, PSYCHIAT RES, V210, P1101, DOI 10.1016/j.psychres.2013.07.042; Terashi M, 2011, NUTRITION, V27, P407, DOI 10.1016/j.nut.2011.01.002; TILLER J, 1994, J PSYCHOSOM RES, V38, P609, DOI 10.1016/0022-3999(94)90058-2; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; World Health Organization, 1992, INT STAT CLASS DIS; Young V, 2013, DIABETIC MED, V30, P189, DOI 10.1111/j.1464-5491.2012.03771.x	47	76	77	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104845	10.1371/journal.pone.0104845	http://dx.doi.org/10.1371/journal.pone.0104845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147950	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600024
J	Mirza, AH; Kaur, S; Brorsson, CA; Pociot, F				Mirza, Aashiq H.; Kaur, Simranjeet; Brorsson, Caroline A.; Pociot, Flemming			Effects of GWAS-Associated Genetic Variants on lncRNAs within IBD and T1D Candidate Loci	PLOS ONE			English	Article							LONG NONCODING RNAS; GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; NATURAL-SELECTION; EXPRESSION; EVOLUTION; ANNOTATION; TRANSCRIPTION; PLURIPOTENCY; METAANALYSIS	Long non-coding RNAs are a new class of non-coding RNAs that are at the crosshairs in many human diseases such as cancers, cardiovascular disorders, inflammatory and autoimmune disease like Inflammatory Bowel Disease (IBD) and Type 1 Diabetes (T1D). Nearly 90% of the phenotype-associated single-nucleotide polymorphisms (SNPs) identified by genome-wide association studies (GWAS) lie outside of the protein coding regions, and map to the non-coding intervals. However, the relationship between phenotype-associated loci and the non-coding regions including the long non-coding RNAs (lncRNAs) is poorly understood. Here, we systemically identified all annotated IBD and T1D loci-associated lncRNAs, and mapped nominally significant GWAS/ImmunoChip SNPs for IBD and T1D within these lncRNAs. Additionally, we identified tissue-specific cis-eQTLs, and strong linkage disequilibrium (LD) signals associated with these SNPs. We explored sequence and structure based attributes of these lncRNAs, and also predicted the structural effects of mapped SNPs within them. We also identified lncRNAs in IBD and T1D that are under recent positive selection. Our analysis identified putative lncRNA secondary structure-disruptive SNPs within and in close proximity (+/25 kb flanking regions) of IBD and T1D loci-associated candidate genes, suggesting that these RNA conformation-altering polymorphisms might be associated with diseased-phenotype. Disruption of lncRNA secondary structure due to presence of GWAS SNPs provides valuable information that could be potentially useful for future structure-function studies on lncRNAs.	[Mirza, Aashiq H.; Kaur, Simranjeet; Brorsson, Caroline A.; Pociot, Flemming] Herlev Univ Hosp, Dept Pediat E, Copenhagen Diabet Res Ctr CPH DIRECT, DK-2730 Herlev, Denmark; [Mirza, Aashiq H.; Kaur, Simranjeet] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Mirza, Aashiq H.; Pociot, Flemming] Univ Copenhagen, Ctr Noncoding RNA Technol & Hlth, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen	Pociot, F (corresponding author), Herlev Univ Hosp, Dept Pediat E, Copenhagen Diabet Res Ctr CPH DIRECT, DK-2730 Herlev, Denmark.	flemming.pociot.01@regionh.dk	Kaur, Simranjeet/K-2487-2019	Kaur, Simranjeet/0000-0003-0490-1028; Brorsson, Caroline Anna/0000-0003-3473-1744; Pociot, Flemming/0000-0003-3274-5448	National Institute of Diabetes and Digestive and Kidney Diseases [U01-DK-062418]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK-062418); FP, The Danish Strategic Research Council (09-067036/DSF); FP, AHM, and The Sehested Hansen Foundation; AHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Burren OS, 2011, NUCLEIC ACIDS RES, V39, pD997, DOI 10.1093/nar/gkq912; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen G, 2013, HUM MUTAT, V34, P338, DOI 10.1002/humu.22239; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cohen N, 2005, MOL BIOL EVOL, V22, P1260, DOI 10.1093/molbev/msi115; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Costantini M, 2008, P NATL ACAD SCI USA, V105, P3433, DOI 10.1073/pnas.0710587105; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fay JC, 2008, HEREDITY, V100, P191, DOI 10.1038/sj.hdy.6801000; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jendrzejewski J, 2012, P NATL ACAD SCI USA, V109, P8646, DOI 10.1073/pnas.1205654109; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Kumar V, 2012, SEMIN IMMUNOPATHOL, V34, P567, DOI 10.1007/s00281-012-0312-1; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martin JS, 2012, RNA, V18, P77, DOI 10.1261/rna.029900.111; Martin L, 2012, J CLIN INVEST, V122, P1589, DOI 10.1172/JCI60020; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Meola N, 2012, RNA, V18, P111, DOI 10.1261/rna.029454.111; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Merelli I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S5; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Niazi F, 2012, RNA, V18, P825, DOI 10.1261/rna.029520.111; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Pennisi E, 2010, SCIENCE, V330, P574, DOI 10.1126/science.330.6004.574; Petretto E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000737; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sabarinathan R, 2013, HUM MUTAT, V34, P546, DOI 10.1002/humu.22273; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1	76	57	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105723	10.1371/journal.pone.0105723	http://dx.doi.org/10.1371/journal.pone.0105723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144376	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100114
J	Nishimura, T; Higuchi, K; Sai, Y; Sugita, Y; Yoshida, Y; Tomi, M; Wada, M; Wakayama, T; Tamura, A; Tsukita, S; Soga, T; Nakashima, E				Nishimura, Tomohiro; Higuchi, Kei; Sai, Yoshimichi; Sugita, Yuki; Yoshida, Yuko; Tomi, Masatoshi; Wada, Masami; Wakayama, Tomohiko; Tamura, Atsushi; Tsukita, Sachiko; Soga, Tomoyoshi; Nakashima, Emi			Fetal Growth Retardation and Lack of Hypotaurine in Ezrin Knockout Mice	PLOS ONE			English	Article							ERM PROTEINS; TAURINE; CELLS; LIVER; SYNCYTIOTROPHOBLAST; ORGANIZATION; RESTRICTION; EXPRESSION; OXIDATION; BRAIN	Ezrin is a membrane-associated cytoplasmic protein that serves to link cell-membrane proteins with the actin-based cytoskeleton, and also plays a role in regulation of the functional activities of some transmembrane proteins. It is expressed in placental trophoblasts. We hypothesized that placental ezrin is involved in the supply of nutrients from mother to fetus, thereby influencing fetal growth. The aim of this study was firstly to clarify the effect of ezrin on fetal growth and secondly to determine whether knockout of ezrin is associated with decreased concentrations of serum and placental nutrients. Ezrin knockout mice (Ez(-/-)) were confirmed to exhibit fetal growth retardation. Metabolome analysis of fetal serum and placental extract of ezrin knockout mice by means of capillary electrophoresis-time-of-flight mass spectrometry revealed a markedly decreased concentration of hypotaurine, a precursor of taurine. However, placental levels of cysteine and cysteine sulfinic acid (precursors of hypotaurine) and taurine were not affected. Lack of hypotaurine in Ez(-/-) mice was confirmed by liquid chromatography with tandem mass spectrometry. Administration of hypotaurine to heterogenous dams significantly decreased the placenta-to-maternal plasma ratio of hypotaurine in wild-type fetuses but only slightly decreased it in ezrin knockout fetuses, indicating that the uptake of hypotaurine from mother to placenta is saturable and that disruption of ezrin impairs the uptake of hypotaurine by placental trophoblasts. These results indicate that ezrin is required for uptake of hypotaurine from maternal serum by placental trophoblasts, and plays an important role in fetal growth.	[Nishimura, Tomohiro; Higuchi, Kei; Sai, Yoshimichi; Sugita, Yuki; Yoshida, Yuko; Tomi, Masatoshi; Wada, Masami; Nakashima, Emi] Keio Univ, Fac Pharm, Div Pharmaceut, Minato Ku, Tokyo, Japan; [Sai, Yoshimichi] Kanazawa Univ Hosp, Dept Pharm, Kanazawa, Ishikawa, Japan; [Wakayama, Tomohiko] Kanazawa Univ, Grad Sch Med Sci, Dept Histol & Embryol, Kanazawa, Ishikawa, Japan; [Wada, Masami; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Frontier Biosci, Biol Sci Lab, Suita, Osaka, Japan; [Wada, Masami; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Keio University; Kanazawa University; Kanazawa University; Osaka University; Osaka University; Keio University	Nakashima, E (corresponding author), Keio Univ, Fac Pharm, Div Pharmaceut, Minato Ku, Tokyo, Japan.	nakashima-em@pha.keio.ac.jp	SAI, Yoshimichi/L-3828-2015; Soga, Tomoyoshi/B-8105-2014; Tomi, Masatoshi/ABC-7011-2021	SAI, Yoshimichi/0000-0003-2954-1532; Soga, Tomoyoshi/0000-0001-9502-2509; Tomi, Masatoshi/0000-0002-9829-8436	Japan Society for the Promotion of Science (JSPS); Research Foundation for Pharmaceutical Sciences; Japan Science and Technology Agency (JST); Suzuken Memorial Foundation; Uehara Memorial Foundation; Nateglinide Memorial Toyoshima Research and Education Fund; Grants-in-Aid for Scientific Research [25860396] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Foundation for Pharmaceutical Sciences; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Suzuken Memorial Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Nateglinide Memorial Toyoshima Research and Education Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), the Research Foundation for Pharmaceutical Sciences, Research for Promoting Technological Seeds from Japan Science and Technology Agency (JST), Suzuken Memorial Foundation, the Uehara Memorial Foundation and Nateglinide Memorial Toyoshima Research and Education Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chaimbault P, 2004, ANAL BIOCHEM, V332, P215, DOI 10.1016/j.ab.2004.06.014; DAVISON AN, 1956, BIOCHIM BIOPHYS ACTA, V19, P66, DOI 10.1016/0006-3002(56)90386-9; EDWARDS HC, 1987, J CELL BIOL, V105, P303, DOI 10.1083/jcb.105.1.303; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Hayashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055623; Higuchi K, 2010, BIOL PHARM BULL, V33, P1400, DOI 10.1248/bpb.33.1400; Jansson T, 1998, PEDIATR RES, V44, P532, DOI 10.1203/00006450-199810000-00011; Nishimura T, 2010, PLACENTA, V31, P1003, DOI 10.1016/j.placenta.2010.08.003; Nishimura T, 2013, J PHARM SCI-US, V102, P3356, DOI 10.1002/jps.23551; Norberg S, 1998, PEDIATR RES, V44, P233, DOI 10.1203/00006450-199808000-00016; OJA SS, 1981, BIOCHIM BIOPHYS ACTA, V677, P350, DOI 10.1016/0304-4165(81)90246-4; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pecci L, 2000, ADV EXP MED BIOL, V483, P163; Pecci L, 1999, BIOCHEM BIOPH RES CO, V254, P661, DOI 10.1006/bbrc.1998.9886; Riquelme G, 2011, J MEMBRANE BIOL, V241, P127, DOI 10.1007/s00232-011-9369-3; Roos S, 2004, AM J PHYSIOL-REG I, V287, pR886, DOI 10.1152/ajpregu.00232.2004; Sakuragawa T, 2010, J CLIN BIOCHEM NUTR, V46, P126, DOI 10.3164/jcbn.09-91; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Tomi M, 2011, J PHARM SCI; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105423	10.1371/journal.pone.0105423	http://dx.doi.org/10.1371/journal.pone.0105423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144766	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100069
J	Fisher, A; Bassett, K; Wright, JM; Brookhart, MA; Freeman, H; Dormuth, CR				Fisher, Anat; Bassett, Ken; Wright, James M.; Brookhart, M. Alan; Freeman, Hugh; Dormuth, Colin R.			Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis - A Population-Based Cohort Study	PLOS ONE			English	Article							NECROSIS-FACTOR ANTAGONISTS; ANTI-TNF; CLINICAL-PRACTICE; BLOCKING-AGENTS; FACTOR INHIBITORS; ALPHA AGENTS; INFLIXIMAB; EFFICACY; ETANERCEPT; ADHERENCE	Objective: To compare persistence with tumor necrosis factor alpha (TNF) antagonists among rheumatoid arthritis patients in British Columbia. Treatment persistence has been suggested as a proxy for real-world therapeutic benefit and harm of treatments for chronic non-curable diseases, including rheumatoid arthritis. We hypothesized that the different pharmacological characteristics of infliximab, adalimumab and etanercept cause statistically and clinically significant differences in persistence. Methods: We conducted a population-based cohort study using administrative health data from the Canadian province of British Columbia. The study cohort included rheumatoid arthritis patients who initiated the first course of a TNF antagonist between 2001 and 2008. Persistence was measured as the time between first dispensing to discontinuation. Drug discontinuation was defined as a drug-free interval of 180 days or switching to another TNF antagonist, anakinra, rituximab or abatacept. Persistence was estimated and compared using survival analysis. Results: The study cohort included 2,923 patients, 63% treated with etanercept. Median persistence in years (95% confidence interval) with infliximab was 3.7 (2.9-4.9), with adalimumab 3.3 (2.6-4.1) and with etanercept 3.8 (3.3-4.3). Similar risk of discontinuation was observed for the three drugs: the hazard ratio (95% confidence interval) was 0.98 (0.85-1.13) comparing infliximab with etanercept, 0.95 (0.78-1.15) comparing infliximab with adalimumab and 1.04 (0.88-1.22) comparing adalimumab with etanercept. Conclusions: Similar persistence was observed with infliximab, adalimumab and etanercept in rheumatoid arthritis patients during the first 9 years of use. If treatment persistence is a good proxy for the therapeutic benefit and harm of these drugs, then this finding suggests that the three drugs share an overall similar benefit-harm profile in rheumatoid arthritis patients.	[Fisher, Anat; Bassett, Ken; Wright, James M.; Dormuth, Colin R.] Univ British Columbia, Therapeut Initiat, Vancouver, BC V5Z 1M9, Canada; [Fisher, Anat; Bassett, Ken; Wright, James M.; Dormuth, Colin R.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Bassett, Ken] Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada; [Wright, James M.; Freeman, Hugh] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Brookhart, M. Alan] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of North Carolina; University of North Carolina Chapel Hill	Fisher, A (corresponding author), Univ British Columbia, Therapeut Initiat, Vancouver, BC V5Z 1M9, Canada.	anat.fisher@ti.ubc.ca		Fisher, Anat/0000-0001-9730-5107; Dormuth, Colin/0000-0001-8577-8783	University of British Columbia; British Columbia Ministry of Health	University of British Columbia; British Columbia Ministry of Health	The study was supported by the University of British Columbia Graduate Fellowship and a grant to the University of British Columbia from the British Columbia Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa NE, 2010, CLIN REV ALLERG IMMU, V38, P82, DOI 10.1007/s12016-009-8140-3; Amuah JE, 2010, PHARMACOEPIDEM DR S, V19, P670, DOI 10.1002/pds.1946; Anderson PJ, 2005, SEMIN ARTHRITIS RHEU, V34, P19, DOI 10.1016/j.semarthrit.2005.01.005; Bensen B, 2011, J RHEUMATOL, V38, P1155; Berthelot JM, 2010, JOINT BONE SPINE, V77, P564, DOI 10.1016/j.jbspin.2010.05.011; Blum MA, 2011, CLIN THER, V33, P901, DOI 10.1016/j.clinthera.2011.06.001; BRENNAN FM, 1992, BRIT J RHEUMATOL, V31, P293; British Columbia Ministry of Health, 2011, YOUR LEV FAIR PHARMA; British Columbia Ministry of Health, 2011, SPEC AUTH REQ AB AD; Brocq O, 2007, JOINT BONE SPINE, V74, P148, DOI 10.1016/j.jbspin.2006.06.011; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Carmona L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1941; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cruyssen BV, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2001; Devine EB, 2011, PHARMACOTHERAPY, V31, P39, DOI 10.1592/phco.31.1.39; Du Pan SM, 2009, ARTHRIT RHEUM-ARTHR, V61, P560, DOI 10.1002/art.24463; eCPS (online Compendium of Pharmaceuticals and Specialties), 2008, REM INFL; eCPS (online Compendium of Pharmaceuticals and Specialties), 2009, ENB ET; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Fernandez-Nebro A, 2007, J RHEUMATOL, V34, P2334; Filippini M, 2010, CLIN REV ALLERG IMMU, V38, P90, DOI 10.1007/s12016-009-8142-1; Finckh A, 2006, ANN RHEUM DIS, V65, P746, DOI 10.1136/ard.2005.045062; Flendrie M, 2003, ANN RHEUM DIS, V62, P30; Furst DE, 2012, ANN RHEUM DIS, V71, P2, DOI 10.1136/annrheumdis-2011-201036; Furst DE, 2006, SEMIN ARTHRITIS RHEU, V36, P159, DOI 10.1016/j.semarthrit.2006.02.001; Gartlehner G, 2006, J RHEUMATOL, V33, P2398; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Hochberg MC, 2003, ANN RHEUM DIS, V62, P13, DOI 10.1136/ard.62.suppl_2.ii13; Hyrich KL, 2007, ARTHRITIS RHEUM-US, V56, P13, DOI 10.1002/art.22331; Hyrich KL, 2011, RHEUMATOLOGY, V50, P117, DOI 10.1093/rheumatology/keq209; Ingham M, 2010, ARTHRITIS RHEUM, V62, P76; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Kievit W, 2011, RHEUMATOLOGY, V50, P196, DOI 10.1093/rheumatology/keq325; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Koncz T, 2010, EXPERT OPIN BIOL TH, V10, P1367, DOI 10.1517/14712598.2010.510508; Kristensen LE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2084; Kristensen LE, 2006, ARTHRITIS RHEUM, V54, P600, DOI 10.1002/art.21570; Lacaille D, 2005, ARTHRIT RHEUM-ARTHR, V53, P241, DOI 10.1002/art.21077; Marchesoni A, 2009, ANN NY ACAD SCI, V1173, P837, DOI 10.1111/j.1749-6632.2009.04621.x; Nestorov I, 2005, SEMIN ARTHRITIS RHEU, V34, P12, DOI 10.1016/j.semarthrit.2005.01.004; Nixon RM, 2007, STAT MED, V26, P1237, DOI 10.1002/sim.2624; Ogale S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-204; Ostergaard M, 2007, SCAND J RHEUMATOL, V36, DOI 10.1080/03009740601089267; Pincus T, 2004, RHEUM DIS CLIN N AM, V30, P701, DOI 10.1016/j.rdc.2004.08.002; Pocock JM, 2009, RHEUMATOLOGY, V48, pI69; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rigby WFC, 2007, NAT CLIN PRACT RHEUM, V3, P227, DOI 10.1038/ncprheum0438; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Sokka T, 2003, ARTHRITIS RHEUM-US, V48, P313, DOI 10.1002/art.10817; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; WOLFE F, 1995, BAILLIERE CLIN RHEUM, V9, P619, DOI 10.1016/S0950-3579(05)80305-X; Wu E, 2008, CURR MED RES OPIN, V24, P2229, DOI 10.1185/03007990802229548; Yazici Y, 2009, J RHEUMATOL, V36, P907, DOI 10.3899/jrheum.080592; Zhang J, 2011, ARTHRIT CARE RES, V63, P1672, DOI 10.1002/acr.20643; Zink A, 2006, ARTHRITIS RHEUM-US, V54, P3399, DOI 10.1002/art.22193	57	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105193	10.1371/journal.pone.0105193	http://dx.doi.org/10.1371/journal.pone.0105193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141123	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200059
J	Khibnik, LA; Tritsch, NX; Sabatini, BL				Khibnik, Lena A.; Tritsch, Nicolas X.; Sabatini, Bernardo L.			A Direct Projection from Mouse Primary Visual Cortex to Dorsomedial Striatum	PLOS ONE			English	Article							BASAL GANGLIA; CORTICOSTRIATAL NEURONS; FUNCTIONAL-ORGANIZATION; SUPERIOR COLLICULUS; CAUDATE-NUCLEUS; CRE-RECOMBINASE; CORTICAL INPUT; RAT; CAT; PATHWAY	The mammalian striatum receives inputs from many cortical areas, but the existence of a direct axonal projection from the primary visual cortex (V1) is controversial. In this study we use anterograde and retrograde tracing techniques to demonstrate that V1 directly innervates a topographically defined longitudinal strip of dorsomedial striatum in mice. We find that this projection forms functional excitatory synapses with direct and indirect pathway striatal projection neurons (SPNs) and engages feed-forward inhibition onto these cells. Importantly, stimulation of V1 afferents is sufficient to evoke phasic firing in SPNs. These findings therefore identify a striatal region that is functionally innervated by V1 and suggest that early visual processing may play an important role in striatal-based behaviors.	[Khibnik, Lena A.; Tritsch, Nicolas X.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Tritsch, Nicolas/U-5266-2019	Tritsch, Nicolas/0000-0003-3181-7681	NINDS [NS046579, NS007484]; Nancie Lurie Marks Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Nancie Lurie Marks Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS NS046579 and NS007484, and by the Nancie Lurie Marks Foundation (http://www.nlmfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CT, 2010, NAT NEUROSCI, V13, P739, DOI 10.1038/nn.2538; BATTAGLINI PP, 1982, EXP BRAIN RES, V47, P28; CARMAN JB, 1963, BRAIN, V86, P525, DOI 10.1093/brain/86.3.525; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; FAULL RLM, 1986, NEUROSCIENCE, V19, P1119, DOI 10.1016/0306-4522(86)90128-4; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Kress GJ, 2013, NAT NEUROSCI, V16, P665, DOI 10.1038/nn.3397; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; LOPEZFIGUEROA MO, 1995, ACTA NEUROBIOL EXP, V55, P165; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Nagy A, 2003, EUR J NEUROSCI, V18, P449, DOI 10.1046/j.1460-9568.2003.02764.x; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; RHOADES RW, 1982, J COMP NEUROL, V208, P239, DOI 10.1002/cne.902080304; RHOADES RW, 1985, DEV BRAIN RES, V17, P171, DOI 10.1016/0165-3806(85)90141-5; Rosell A, 1999, NEUROSCI RES, V34, P257, DOI 10.1016/S0168-0102(99)00060-7; SAINTCYR JA, 1990, J COMP NEUROL, V298, P129, DOI 10.1002/cne.902980202; Saunders A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00047; Schulz Jan M, 2010, Front Synaptic Neurosci, V2, P23, DOI 10.3389/fnsyn.2010.00023; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; Smith Y, 2009, BRAIN RES BULL, V78, P60, DOI 10.1016/j.brainresbull.2008.08.015; STRECKER RE, 1985, BRAIN RES, V329, P350, DOI 10.1016/0006-8993(85)90548-7; Tepper JM, 2008, BRAIN RES REV, V58, P272, DOI 10.1016/j.brainresrev.2007.10.008; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; UPDYKE BV, 1993, J COMP NEUROL, V327, P159, DOI 10.1002/cne.903270202; VEENING JG, 1980, NEUROSCIENCE, V5, P1253, DOI 10.1016/0306-4522(80)90198-0; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; WEBSTER KE, 1965, J ANAT, V99, P329; WEBSTER KE, 1961, J ANAT, V95, P532; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	42	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104501	10.1371/journal.pone.0104501	http://dx.doi.org/10.1371/journal.pone.0104501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141172	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200024
J	Singh, S; Dabur, R; Gatne, MM; Singh, B; Gupta, S; Pawar, S; Sharma, SK; Sharma, GL				Singh, Seema; Dabur, Rajesh; Gatne, Madhumanjiri M.; Singh, Bharat; Gupta, Shilpi; Pawar, Sharad; Sharma, Sunil K.; Sharma, Gainda L.			In Vivo Efficacy of a Synthetic Coumarin Derivative in a Murine Model of Aspergillosis	PLOS ONE			English	Article							LIPOSOMAL AMPHOTERICIN-B; INVASIVE ASPERGILLOSIS; FUMIGATUS INFECTION; ANTIFUNGAL ACTIVITY; PHARMACOKINETICS; CASPOFUNGIN; COMBINATION; TOXICITY; THERAPY; PATIENT	Despite advances in therapeutic modalities, aspergillosis remains a leading cause of mortality. This has necessitated the identification of effective and safe antifungal molecules. In the present study, in vivo safety and antifungal efficacy of a coumarin derivative, N, N, N-Triethyl-11-(4-methyl-2-oxo-2H-benzopyran-7-yloxy)-11-oxoundecan-1-aminium bromide (SCD-1), was investigated. The maximum tolerable dose of compound was determined according to OECD 423 guidelines. The compound could be assigned to category IV of the Globally Harmonized System and its LD50 cut-off was found to be 2000 mg/kg body weight. The survival increased in Aspergillus fumigatus-infected mice treated with a dose of 200 mg/kg, orally or 100 mg/kg body weight, intraperitoneally, of SCD-1 in comparison to infected-untreated animals. The SCD-1 treatment resulted in significant reduction in colony counts in vital organs of the animals. Its protective effect was also observed on day 14 as there was marked reduction in fungal colonies. The treatment with SCD-1 also reduced the levels of serum biochemical parameters with respect to infected-untreated animals. It could be concluded that SCD-1 is a quite safe antifungal compound, which conferred dose dependent protection against experimental aspergillosis. Therefore, SCD-1 holds potential for developing new formulations for aspergillosis.	[Singh, Seema; Singh, Bharat; Sharma, Gainda L.] CSIR Inst Genom & Integrat Biol, Delhi, India; [Singh, Seema] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India; [Dabur, Rajesh] Maharshi Dayanand Univ, Dept Biochem, Rohtak, Haryana, India; [Gatne, Madhumanjiri M.] Bombay Vet Coll, Dept Pharmacol & Toxicol, Mumbai, Maharashtra, India; [Gupta, Shilpi; Sharma, Sunil K.] Univ Delhi, Dept Chem, New Delhi, India; [Pawar, Sharad] Natl Res Inst Basic Ayurved Sci, Dept Pharmacol, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Savitribai Phule Pune University; Maharshi Dayanand University; Maharashtra Animal & Fishery Sciences University; University of Delhi	Sharma, GL (corresponding author), CSIR Inst Genom & Integrat Biol, Delhi, India.	drglsharma@hotmail.com	Pawar, Sharad/GRR-2010-2022; Singh, Bharat/GOK-1138-2022; Dabur, Rajesh/AAG-2681-2019	Pawar, Sharad/0000-0003-3765-9426; Dabur, Rajesh/0000-0001-7189-5188; Singh, Bharat/0000-0001-9290-1225; Gupta, Dr. Shilpi/0000-0001-5084-4592	Council of Scientific and Industrial Research, Government of India; University Grants Commission, Government of India; Defence Research and Development Organisation (DRDO), Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India); Defence Research and Development Organisation (DRDO), Government of India(Defence Research & Development Organisation (DRDO))	The authors are thankful to Council of Scientific and Industrial Research, Government of India for providing research facilities and financial support. SS is the recipient of fellowship from University Grants Commission, Government of India. The authors also acknowledge the Defence Research and Development Organisation (DRDO), Government of India, for supporting the project at Department of Chemistry, University of Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad A, 2010, REV IBEROAM MICOL, V27, P155, DOI 10.1016/j.riam.2010.10.003; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; Benincasa M, 2011, ACS NANO, V5, P199, DOI 10.1021/nn1023522; Cardoso SH, 2011, CHEM BIOL DRUG DES, V77, P489, DOI 10.1111/j.1747-0285.2011.01120.x; Carvalho A, 2012, CLIN MICROBIOL INFEC, V18, P120, DOI 10.1111/j.1469-0691.2011.03681.x; Cekmen N, 2011, J RES MED SCI, V16, P219; Clark CR, 2013, REGUL TOXICOL PHARM, V67, P409, DOI 10.1016/j.yrtph.2013.08.020; Gershkovich P, 2009, J ANTIMICROB CHEMOTH, V64, P101, DOI 10.1093/jac/dkp140; Graybill JR, 2003, J ANTIMICROB CHEMOTH, V52, P656, DOI 10.1093/jac/dkg425; Groll AH, 2006, ANTIMICROB AGENTS CH, V50, P3418, DOI 10.1128/AAC.00241-06; Gupta S, 2012, J CHEM SCI, V124, P437, DOI 10.1007/s12039-011-0147-7; Hadjipavlou-Litina D, 2007, J ENZYM INHIB MED CH, V22, P287, DOI 10.1080/14756360601073914; Hadrich I, 2012, MYCOPATHOLOGIA, V174, P131, DOI 10.1007/s11046-012-9526-y; Hope WW, 2010, ANTIMICROB AGENTS CH, V54, P4879, DOI 10.1128/AAC.00673-10; Hu WQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030024; Karthaus M, 2013, CURR PHARM DESIGN, V19, P3569, DOI 10.2174/13816128113199990330; Kauffman CA, 2008, SEMIN RESP CRIT CARE, V29, P211, DOI 10.1055/s-2008-1063859; Kleinberg M, 2006, INT J ANTIMICROB AG, V27, pS12, DOI 10.1016/j.ijantimicag.2006.03.013; Kostova Irena, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P29, DOI 10.2174/1568011053352550; Lamoth F, 2013, ANTIMICROB AGENTS CH, V57, P1035, DOI 10.1128/AAC.01857-12; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee S, 2006, BIOORG MED CHEM LETT, V16, P4596, DOI 10.1016/j.bmcl.2006.06.007; Lehievre L, 2013, MED MALADIES INFECT, V43, P139, DOI 10.1016/j.medmal.2013.02.010; Lessing F, 2007, EUKARYOT CELL, V6, P2290, DOI 10.1128/EC.00267-07; Lewis RE, 2002, ANTIMICROB AGENTS CH, V46, P3208, DOI 10.1128/AAC.46.10.3208-3214.2002; Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P4465, DOI 10.1128/AAC.00185-11; Meersseman W, 2004, AM J RESP CRIT CARE, V170, P621, DOI 10.1164/rccm.200401-093OC; Montagner C, 2008, Z NATURFORSCH C, V63, P21; OECD Guideline for testing of Chemicals, 2001, GUID 423 AC OR TOX A; Phuttharak W, 2005, AM J NEURORADIOL, V26, P835; Richie DL, 2011, VIRULENCE, V2, P12, DOI 10.4161/viru.2.1.13345; Schlede E, 2005, REGUL TOXICOL PHARM, V42, P15, DOI 10.1016/j.yrtph.2004.12.006; Schobel F, 2010, EUKARYOT CELL, V9, P878, DOI 10.1128/EC.00020-10; Seidle T, 2010, TOXICOL SCI, V116, P382, DOI 10.1093/toxsci/kfq143; Sheng CQ, 2011, CURR MED CHEM, V18, P733, DOI 10.2174/092986711794480113; Sheppard DC, 2006, ANTIMICROB AGENTS CH, V50, P3501, DOI 10.1128/AAC.00787-06; Singh G, 2005, ANTIMICROB AGENTS CH, V49, P1369, DOI 10.1128/AAC.49.4.1369-1376.2005; Singh S, 2012, J PROTEOME RES, V11, P3259, DOI 10.1021/pr300006j; Sionov E, 2006, J INFECTION, V53, P131, DOI 10.1016/j.jinf.2005.10.015; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Stein AC, 2006, J ETHNOPHARMACOL, V107, P95, DOI 10.1016/j.jep.2006.02.009; SZOKA FC, 1987, ANTIMICROB AGENTS CH, V31, P421, DOI 10.1128/AAC.31.3.421; Wallace TL, 1997, ANTIMICROB AGENTS CH, V41, P2238, DOI 10.1128/AAC.41.10.2238; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wingard JR, 2000, CLIN INFECT DIS, V31, P1155, DOI 10.1086/317451	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103039	10.1371/journal.pone.0103039	http://dx.doi.org/10.1371/journal.pone.0103039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140804	gold, Green Published, Green Submitted			2022-12-25	WOS:000342687200003
J	Ishii, H; Saitoh, M; Sakamoto, K; Kondo, T; Katoh, R; Tanaka, S; Motizuki, M; Masuyama, K; Miyazawa, K				Ishii, Hiroki; Saitoh, Masao; Sakamoto, Kei; Kondo, Tetsuo; Katoh, Ryohei; Tanaka, Shota; Motizuki, Mitsuyoshi; Masuyama, Keisuke; Miyazawa, Keiji			Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) Suppress Cancer Cell Motility via Different Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Invasion; Cell Motility; Epithelial-Mesenchymal Transition (EMT); RNA Splicing; ESRP; Rac1b; SIP1; EF1	MESENCHYMAL TRANSITION; MESSENGER-RNA; E-CADHERIN; RAC1B; EXPRESSION; ISOFORM; SIP1; BETA; EMT; PROGRESSION	Background: The roles of ESRP1 and ESRP2 during carcinogenesis remain unknown. Results: ESRPs are up-regulated during carcinogenesis but down-regulated in invasive fronts. ESRP1 suppresses expression of the Rac1b isoform, whereas ESRP2 represses epithelial-mesenchymal transition-inducing transcription factors. Conclusion: ESRP1 and ESRP2 suppress cell motility through distinct transcriptional and/or post-transcriptional mechanisms. Significance: Our findings reveal a novel molecular network that regulates cancer cell motility. ESRP1 (epithelial splicing regulatory protein 1) and ESRP2 regulate alternative splicing events associated with epithelial phenotypes of cells, and both are down-regulated during the epithelial-mesenchymal transition. However, little is known about their expression and functions during carcinogenesis. In this study, we found that expression of both ESRP1 and ESRP2 is plastic: during oral squamous cell carcinogenesis, these proteins are up-regulated relative to their levels in normal epithelium but down-regulated in invasive fronts. Importantly, ESRP1 and ESRP2 are re-expressed in the lymph nodes, where carcinoma cells metastasize and colonize. In head and neck carcinoma cell lines, ESRP1 and ESRP2 suppress cancer cell motility through distinct mechanisms: knockdown of ESRP1 affects the dynamics of the actin cytoskeleton through induction of Rac1b, whereas knockdown of ESRP2 attenuates cell-cell adhesion through increased expression of epithelial-mesenchymal transition-associated transcription factors. Down-regulation of ESRP1 and ESRP2 is thus closely associated with a motile phenotype of cancer cells.	[Ishii, Hiroki; Saitoh, Masao; Motizuki, Mitsuyoshi; Miyazawa, Keiji] Univ Yamanashi, Dept Biochem, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4093898, Japan; [Ishii, Hiroki; Tanaka, Shota; Masuyama, Keisuke] Univ Yamanashi, Dept Otolaryngol Head & Neck Surg, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4093898, Japan; [Kondo, Tetsuo; Katoh, Ryohei] Univ Yamanashi, Dept Human Pathol, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4093898, Japan; [Sakamoto, Kei] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Oral Pathol, Bunkyo Ku, Tokyo 1130034, Japan	University of Yamanashi; University of Yamanashi; University of Yamanashi; Tokyo Medical & Dental University (TMDU)	Miyazawa, K (corresponding author), Univ Yamanashi, Dept Biochem, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4093898, Japan.	kmiyazawa@yamanashi.ac.jp			Vehicle Racing Commemorative Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI [24791764, 24592592]; Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS; Grants-in-Aid for Scientific Research [24592592, 25293087] Funding Source: KAKEN	Vehicle Racing Commemorative Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Vehicle Racing Commemorative Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 24791764 and 24592592; the research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the JSPS Core-to-Core Program Cooperative International Framework in TGF-beta Family Signaling.	Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Chikamatsu K, 2008, ORAL ONCOL, V44, P870, DOI 10.1016/j.oraloncology.2007.11.001; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Di Modugno F, 2012, P NATL ACAD SCI USA, V109, P19280, DOI 10.1073/pnas.1214394109; Fagoonee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072300; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Goncalves V, 2009, HUM MOL GENET, V18, P3696, DOI 10.1093/hmg/ddp317; Gout S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046539; Hahn S, 2013, EMBO J, V32, P3079, DOI 10.1038/emboj.2013.236; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Ishii H, 2010, ORAL ONCOL, V46, P373, DOI 10.1016/j.oraloncology.2010.02.014; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Leontieva OV, 2009, CELL CYCLE, V8, P490, DOI 10.4161/cc.8.3.7679; Lu HZ, 2013, DEV CELL, V27, P560, DOI 10.1016/j.devcel.2013.10.020; Maeda G, 2005, INT J ONCOL, V27, P1535; Melamed Z, 2013, MOL CELL, V50, P869, DOI 10.1016/j.molcel.2013.05.007; Motizuki M, 2013, J BIOL CHEM, V288, P18911, DOI 10.1074/jbc.M113.480996; Okugawa Y, 2013, CLIN EXP METASTAS, V30, P417, DOI 10.1007/s10585-012-9547-4; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Reinke LM, 2012, J BIOL CHEM, V287, P36435, DOI 10.1074/jbc.M112.397125; Revil T, 2013, DEV DYNAM, V242, P281, DOI 10.1002/dvdy.23918; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Shirakihara T, 2013, CANCER SCI, V104, P1189, DOI 10.1111/cas.12220; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ueda J, 2014, ONCOGENE, V33, P4485, DOI 10.1038/onc.2013.392; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Xiang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050781; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	44	106	110	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27386	27399		10.1074/jbc.M114.589432	http://dx.doi.org/10.1074/jbc.M114.589432			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143390	Green Published, hybrid			2022-12-25	WOS:000342852800003
J	Balsalobre-Fernandez, C; Tejero-Gonzalez, CM; del Campo-Vecino, J				Balsalobre-Fernandez, Carlos; Ma Tejero-Gonzalez, Carlos; del Campo-Vecino, Juan			Relationships between Training Load, Salivary Cortisol Responses and Performance during Season Training in Middle and Long Distance Runners	PLOS ONE			English	Article							ELITE MALE; FATIGUE; SPORT; INTENSITY; ENDOCRINE; SYMPTOMS; SCIENCE; PLAYERS; KENYAN; TOOL	Purpose: Monitoring training from a multifactorial point of view is of great importance in elite endurance athletes. This study aims to analyze the relationships between indicators of training load, hormonal status and neuromuscular performance, and to compare these values with competition performance, in elite middle and long-distance runners. Method: Fifteen elite middle and long-distance runners (12 men, 3 women; age = 26.3 +/- 5.1 yrs) were measured for training volume, training zone and session rate of perceived exertion (RPE) (daily), countermovement jump (CMJ) and salivary free cortisol (weekly) for 39 weeks (i.e., the whole season). Competition performance was also observed throughout the study, registering the season best and worst competitions. Results: Season average salivary free cortisol concentrations correlate significantly with CMJ (r = -0.777) and RPE (r = 0.551). Also, weekly averages of CMJ significantly correlates with RPE (r = -0.426), distance run (r = -0.593, p<0.001) and training zone (r = 0.437, p<0.05). Finally, it was found that the CMJ (+8.5%, g = 0.65) and the RPE (-17.6%, g = 0.94) measured the week before the best competition performance of the season were significantly different compared with the measurement conducted the week before the season's worst competition performance. Conclusions: Monitoring weekly measurements of CMJ and RPE could be recommended to control training process of such athletes in a non-invasive, field-based, systematic way.	[Balsalobre-Fernandez, Carlos; Ma Tejero-Gonzalez, Carlos; del Campo-Vecino, Juan] Autonomous Univ Madrid, Dept Phys Educ Sport & Human Movement, E-28049 Madrid, Spain	Autonomous University of Madrid	Balsalobre-Fernandez, C (corresponding author), Autonomous Univ Madrid, Dept Phys Educ Sport & Human Movement, E-28049 Madrid, Spain.	carlos.balsalobre@uam.es	/J-1248-2019; Tejero-González, Carlos M/A-1932-2013	/0000-0002-8329-1581; Tejero-González, Carlos M/0000-0002-2842-5911				Arrese AL, 2005, J SPORT MED PHYS FIT, V45, P435; Auersperger I, 2012, INT J SPORT NUTR EXE, V22, P55, DOI 10.1123/ijsnem.22.1.55; Billat V, 2003, MED SCI SPORT EXER, V35, P297, DOI 10.1249/01.MSS.0000053556.59992.A9; Borresen J, 2009, SPORTS MED, V39, P779, DOI 10.2165/11317780-000000000-00000; Bosquet L, 2007, MED SCI SPORT EXER, V39, P1358, DOI 10.1249/mss.0b013e31806010e0; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P359, DOI 10.1123/ijspp.3.3.359; Crewther BT, 2009, J STRENGTH COND RES, V23, P2046, DOI 10.1519/JSC.0b013e3181b73c19; Enoksen E, 2011, INT J SPORTS SCI COA, V6, P273, DOI 10.1260/1747-9541.6.2.273; Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86; Garcia-Pallares J, 2010, EUR J APPL PHYSIOL, V110, P99, DOI 10.1007/s00421-010-1484-9; Garcin M, 2002, INT J SPORTS MED, V23, P16, DOI 10.1055/s-2002-19275; Gorostiaga EM, 2006, MED SCI SPORT EXER, V38, P357, DOI 10.1249/01.mss.0000184586.74398.03; Ingham SA, 2012, INT J SPORT PHYSIOL, V7, P193, DOI 10.1123/ijspp.7.2.193; Izquierdo-Gabarren M, 2010, MED SCI SPORT EXER, V42, P1191, DOI 10.1249/MSS.0b013e3181c67eec; Jimenez-Reyes P., 2011, CULTURA CIENCIA DEPO, V6, P105, DOI DOI 10.1136/BJSP0RTS-2013-093073.18; Knicker AJ, 2011, SPORTS MED, V41, P307, DOI 10.2165/11586070-000000000-00000; Kraemer WJ, 2004, J STRENGTH COND RES, V18, P121; McGuigan MR, 2004, J SPORT SCI MED, V3, P8; McLean BD, 2010, INT J SPORT PHYSIOL, V5, P367, DOI 10.1123/ijspp.5.3.367; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; O'Connor PJ, 2007, SPORTS MED, V37, P408, DOI 10.2165/00007256-200737040-00035; Obminski Z., 2008, RES YB, V14, P103; Papacosta E, 2011, J SCI MED SPORT, V14, P424, DOI 10.1016/j.jsams.2011.03.004; Passelergue PA, 2012, J STRENGTH COND RES, V26, P3049, DOI 10.1519/JSC.0b013e3182473e3d; Petersen K, 2007, EUR J APPL PHYSIOL, V101, P385, DOI 10.1007/s00421-007-0504-x; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/14403.1; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Stellingwerff T, 2012, INT J SPORT NUTR EXE, V22, P392, DOI 10.1123/ijsnem.22.5.392; Tjelta Leif Inge, 2013, IJASS(International Journal of Applied Sports Sciences), V25, P11; Tyndall GL, 1996, EUR J APPL PHYSIOL, V73, P61, DOI 10.1007/BF00262810; Wilber RL, 2012, INT J SPORT PHYSIOL, V7, P92, DOI 10.1123/ijspp.7.2.92	31	20	20	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106066	10.1371/journal.pone.0106066	http://dx.doi.org/10.1371/journal.pone.0106066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153137	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200112
J	Mouveaux, T; Oria, G; Werkmeister, E; Slomianny, C; Fox, BA; Bzik, DJ; Tomavo, S				Mouveaux, Thomas; Oria, Gabrielle; Werkmeister, Elisabeth; Slomianny, Christian; Fox, Barbara A.; Bzik, David J.; Tomavo, Stanislas			Nuclear Glycolytic Enzyme Enolase of Toxoplasma gondii Functions as a Transcriptional Regulator	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; STAGE CONVERSION; GENOME SEQUENCE; DNA-BINDING; PARASITE; APICOMPLEXAN; PROTEIN; IDENTIFICATION; ALDOLASE	Apicomplexan parasites including Toxoplasma gondii have complex life cycles within different hosts and their infectivity relies on their capacity to regulate gene expression. However, little is known about the nuclear factors that regulate gene expression in these pathogens. Here, we report that T. gondii enolase TgENO2 is targeted to the nucleus of actively replicating parasites, where it specifically binds to nuclear chromatin in vivo. Using a ChIP-Seq technique, we provide evidence for TgENO2 enrichment at the 5' untranslated gene regions containing the putative promoters of 241 nuclear genes. Ectopic expression of HA-tagged TgENO1 or TgENO2 led to changes in transcript levels of numerous gene targets. Targeted disruption of TgENO1 gene results in a decrease in brain cyst burden of chronically infected mice and in changes in transcript levels of several nuclear genes. Complementation of this knockout mutant with ectopic TgENO1-HA fully restored normal transcript levels. Our findings reveal that enolase functions extend beyond glycolytic activity and include a direct role in coordinating gene regulation in T. gondii.	[Mouveaux, Thomas; Oria, Gabrielle; Werkmeister, Elisabeth; Tomavo, Stanislas] Univ Lille Nord France, Inst Pasteur Lille, CNRS UMR 8204, Ctr Infect & Immun Lille,INSERM U 1019, Lille, France; [Slomianny, Christian] Univ Lille Nord France, Lab Cell Physiol, INSERM U 1003, Villeneuve Dascq, France; [Fox, Barbara A.; Bzik, David J.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Dartmouth College	Tomavo, S (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, CNRS UMR 8204, Ctr Infect & Immun Lille,INSERM U 1019, Lille, France.	Stan.Tomavo@pasteur-lille.fr	WERKMEISTER, Elisabeth/GLQ-7361-2022; Slomianny, Christian/L-8285-2018	Thomas, Mouveaux/0000-0003-1559-350X	Centre National de la Recherche Scientifique (CNRS); Institut Medicale de la Recherche Scientifique (INSERM); Institut Pasteur de Lille (IPL) and Laboratoire d'Excellence (LabEx) ParaFrap from the National Agency for Research [PIA] [ANR-11-LABX-0024]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105563, R21AI084570, R21AI104514, R01AI041930, R21AI097018] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Medicale de la Recherche Scientifique (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur de Lille (IPL) and Laboratoire d'Excellence (LabEx) ParaFrap from the National Agency for Research [PIA]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Centre National de la Recherche Scientifique (CNRS), Institut Medicale de la Recherche Scientifique (INSERM) and the Institut Pasteur de Lille (IPL) and Laboratoire d'Excellence (LabEx) ParaFrap from the National Agency for Research [PIA, ANR-11-LABX-0024] to ST. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Callebaut I, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-100; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Dzierszinski F, 1999, J BIOL CHEM, V274, P24888, DOI 10.1074/jbc.274.35.24888; Dzierszinski F, 2001, J MOL BIOL, V309, P1017, DOI 10.1006/jmbi.2001.4730; Fauquenoy S, 2008, MOL CELL PROTEOMICS, V7, P891, DOI 10.1074/mcp.M700391-MCP200; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Frenal K, 2006, BIOCHEMISTRY-US, V45, P4867, DOI 10.1021/bi051948e; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; Hakimi MA, 2007, CURR OPIN MICROBIOL, V10, P357, DOI 10.1016/j.mib.2007.07.005; Holmes M, 2010, MICROBES INFECT, V12, P19, DOI 10.1016/j.micinf.2009.09.010; Hutson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014057; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kibe MK, 2005, NUCLEIC ACIDS RES, V33, P1722, DOI 10.1093/nar/gki314; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kim K, 2008, MICROBES INFECT, V10, P978, DOI 10.1016/j.micinf.2008.07.015; Knoll LJ, 1998, MOL CELL BIOL, V18, P807, DOI 10.1128/MCB.18.2.807; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Manger ID, 1998, INFECT IMMUN, V66, P1632, DOI 10.1128/IAI.66.4.1632-1637.1998; Meissner M, 2005, MICROBES INFECT, V7, P1376, DOI 10.1016/j.micinf.2005.04.019; Mercier C, 1996, MOL MICROBIOL, V21, P421, DOI 10.1046/j.1365-2958.1996.6501361.x; Olguin-Lamas A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001328; PARMLEY SF, 1994, MOL BIOCHEM PARASIT, V66, P283, DOI 10.1016/0166-6851(94)90155-4; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; SOLDATI D, 1995, MOL CELL BIOL, V15, P87, DOI 10.1128/MCB.15.1.87; Starnes GL, 2009, CELL HOST MICROBE, V5, P353, DOI 10.1016/j.chom.2009.03.005; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Templeton TJ, 2004, GENOME RES, V14, P1686, DOI 10.1101/gr.2615304; Tomavo S, 2001, INT J PARASITOL, V31, P1023, DOI 10.1016/S0020-7519(01)00193-X; TOMAVO S, 1991, INFECT IMMUN, V59, P3750, DOI 10.1128/IAI.59.10.3750-3753.1991; Tovy A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000775; Vanchinathan P, 2005, INFECT IMMUN, V73, P6680, DOI 10.1128/IAI.73.10.6680-6688.2005; Walker R, 2013, J BIOL CHEM, V288, P31127, DOI 10.1074/jbc.M113.486589; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	44	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105820	10.1371/journal.pone.0105820	http://dx.doi.org/10.1371/journal.pone.0105820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153525	Green Published, Green Submitted, gold			2022-12-25	WOS:000340952200083
J	Burkhardt, J; Blume, M; Petit-Teixeira, E; Teixeira, VH; Steiner, A; Quente, E; Wolfram, G; Scholz, M; Pierlot, C; Migliorini, P; Bombardieri, S; Balsa, A; Westhovens, R; Barrera, P; Radstake, TRDJ; Alves, H; Bardin, T; Prum, B; Emmrich, F; Cornelis, F; Ahnert, P; Kirsten, H				Burkhardt, Jana; Blume, Mechthild; Petit-Teixeira, Elisabeth; Teixeira, Vitor Hugo; Steiner, Anke; Quente, Elfi; Wolfram, Grit; Scholz, Markus; Pierlot, Celine; Migliorini, Paola; Bombardieri, Stefano; Balsa, Alejandro; Westhovens, Rene; Barrera, Pilar; Radstake, Timothy R. D. J.; Alves, Helena; Bardin, Thomas; Prum, Bernard; Emmrich, Frank; Cornelis, Francois; Ahnert, Peter; Kirsten, Holger			Cellular Adhesion Gene SELP Is Associated with Rheumatoid Arthritis and Displays Differential Allelic Expression	PLOS ONE			English	Article							SOLUBLE P-SELECTIN; GENOME-WIDE ASSOCIATION; MULTIPLE-SCLEROSIS; LINKAGE DISEQUILIBRIUM; MYOCARDIAL-INFARCTION; PTPN11 MUTATIONS; RISK; MOLECULES; DISEASES; EVENTS	In rheumatoid arthritis (RA), a key event is infiltration of inflammatory immune cells into the synovial lining, possibly aggravated by dysregulation of cellular adhesion molecules. Therefore, single nucleotide polymorphisms of 14 genes involved in cellular adhesion processes (CAST, ITGA4, ITGB1, ITGB2, PECAM1, PTEN, PTPN11, PTPRC, PXN, SELE, SELP, SRC, TYK2, and VCAM1) were analyzed for association with RA. Association analysis was performed consecutively in three European RA family sample groups (N-families = 407). Additionally, we investigated differential allelic expression, a possible functional consequence of genetic variants. SELP (selectin P, CD62P) SNP-allele rs6136-T was associated with risk for RA in two RA family sample groups as well as in global analysis of all three groups (p(total) = 0.003). This allele was also expressed preferentially (p<10(-6)) with a two- fold average increase in regulated samples. Differential expression is supported by data from Genevar MuTHER (p(1) = 0.004; p(2) = 0.0177). Evidence for influence of rs6136 on transcription factor binding was also found in silico and in public datasets reporting in vitro data. In summary, we found SELP rs6136-T to be associated with RA and with increased expression of SELP mRNA. SELP is located on the surface of endothelial cells and crucial for recruitment, adhesion, and migration of inflammatory cells into the joint. Genetically determined increased SELP expression levels might thus be a novel additional risk factor for RA.	[Burkhardt, Jana; Wolfram, Grit; Emmrich, Frank] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Blume, Mechthild; Steiner, Anke; Emmrich, Frank] Univ Leipzig, Inst Clin Immunol & Tranfus Med IKIT, D-04109 Leipzig, Germany; [Petit-Teixeira, Elisabeth; Pierlot, Celine] Univ Evry Val Essonne, Genhotel EA 3886, Evry, France; [Teixeira, Vitor Hugo] UCL, Ctr Resp Res, London, England; [Quente, Elfi; Emmrich, Frank; Kirsten, Holger] Fraunhofer Inst Celltherapy & Immunol IZI, Leipzig, Germany; [Scholz, Markus; Ahnert, Peter; Kirsten, Holger] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Migliorini, Paola; Bombardieri, Stefano] Univ Pisa, Pisa, Italy; [Balsa, Alejandro] La Paz Hosp, Madrid, Spain; [Westhovens, Rene] Rheumatol KU Leuven, Leuven, Belgium; [Barrera, Pilar] Univ Nijmegen, Nijmegen, Netherlands; [Radstake, Timothy R. D. J.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Alves, Helena] Porto San Joao Hosp, Oporto, Portugal; [Bardin, Thomas] Lariboisiere Hosp, Fed Rhumatol, Paris, France; [Prum, Bernard] Univ Evry Val Essonne, Lab Stat & Genome, Evry, France; [Cornelis, Francois] Univ Auvergne, GenHotel Auvergne, Clermont Ferrand, France; [Ahnert, Peter; Kirsten, Holger] Univ Leipzig, IMISE, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Fraunhofer Gesellschaft; Leipzig University; University of Pisa; Hospital Universitario La Paz; KU Leuven; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Sao Joao Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Universite Clermont Auvergne (UCA); Leipzig University	Burkhardt, J (corresponding author), Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany.	jana.burkhardt@trm.uni-leipzig.de	Migliorini, Paola/P-6176-2015; Balsa, Alejandro/ABF-6456-2020; Ahnert, Peter/I-8150-2015; Kirsten, Holger/AAP-7250-2020	Migliorini, Paola/0000-0001-6433-4964; Ahnert, Peter/0000-0002-1771-0856; Kirsten, Holger/0000-0002-3126-7950; Bardin, Thomas/0000-0002-5080-4790; Burkhardt, Jana/0000-0003-0781-2653; Elisabeth, PETIT-TEIXEIRA/0000-0001-9724-3575; Alves, Helena/0000-0001-5435-0047	German Federal Ministry of Education and Research (BMBF, PtJ-Bio) [1315883]; Sachsische Aufbaubank-Forderbank [7692/1187]; European Fund for Regional Development (EFRE) [4212/04-04]; German Federal Ministry for Education and Research (Hochschul- und Wissenschaftsprogramm; "Kompetenznetz Rheuma") [01GI9949]; Rosa-Luxemburg-Stiftung; Foundation for Science and Technology, Portugal [SFRH/BD/23304/2005]; LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony	German Federal Ministry of Education and Research (BMBF, PtJ-Bio)(Federal Ministry of Education & Research (BMBF)); Sachsische Aufbaubank-Forderbank; European Fund for Regional Development (EFRE)(European Commission); German Federal Ministry for Education and Research (Hochschul- und Wissenschaftsprogramm; "Kompetenznetz Rheuma"); Rosa-Luxemburg-Stiftung; Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology); LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony	The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 1315883, www.bmbf.de). This project was also supported by grant no. 7692/1187 from the Sachsische Aufbaubank-Forderbank (www.sab.sachsen.de), by grant no. 4212/04-04 from the European Fund for Regional Development (EFRE, ec.europa.eu), by the German Federal Ministry for Education and Research (Hochschul- und Wissenschaftsprogramm; "Kompetenznetz Rheuma" 01GI9949 to IM), by the Rosa-Luxemburg-Stiftung (www.rosalux.de) and by the Foundation for Science and Technology, Portugal (grant SFRH/BD/23304/2005, www.fct.pt). PA, MS and HK were also supported by LIFE - Leipzig Research Center for Civilization Diseases (life.uni-leipzig.de), Universitat Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel L, 1998, AM J HUM GENET, V63, P664, DOI 10.1086/301975; ANTOUN GR, 1991, LEUKEMIA RES, V15, P1029, DOI 10.1016/0145-2126(91)90108-6; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ay C, 2008, THROMB HAEMOSTASIS, V99, P899, DOI 10.1160/TH07-11-0672; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burkhardt J, 2009, J RHEUMATOL, V36, P2149, DOI 10.3899/jrheum.090059; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cobankara V, 2004, CLIN RHEUMATOL, V23, P430, DOI 10.1007/s10067-004-0915-6; Conde L, 2004, NUCLEIC ACIDS RES, V32, pW242, DOI 10.1093/nar/gkh438; Davis LS, 2003, AM J PATHOL, V162, P1399, DOI 10.1016/S0002-9440(10)64272-1; Diogo D, 2014, CURR OPIN RHEUMATOL, V26, P85, DOI 10.1097/BOR.0000000000000012; Elrayess MA, 2004, ATHEROSCLEROSIS, V177, P127, DOI 10.1016/j.atherosclerosis.2004.06.009; Ertenli I, 1998, J RHEUMATOL, V25, P1054; Fortea JOY, 2004, ARTHRITIS RHEUM-US, V50, P2757, DOI 10.1002/art.20458; Gasparyan AY, 2011, RHEUMATOL INT, V31, P153, DOI 10.1007/s00296-010-1446-x; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; GROBER JS, 1993, J CLIN INVEST, V91, P2609, DOI 10.1172/JCI116500; Herrmann SM, 1998, HUM MOL GENET, V7, P1277, DOI 10.1093/hmg/7.8.1277; Hillis GS, 2002, AM HEART J, V143, P235, DOI 10.1067/mhj.2002.120303; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ilgner S., 2002, Cellular and Molecular Biology Online Papers, V48, pOL243; Ingley E, 2006, GROWTH FACTORS, V24, P89, DOI 10.1080/08977190500368031; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishihara H, 2003, FEBS LETT, V554, P450, DOI 10.1016/S0014-5793(03)01225-0; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Jacq L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2221; Kaila N, 2007, J MED CHEM, V50, P21, DOI 10.1021/jm0602256; Kee F, 2000, HEART, V84, P548, DOI 10.1136/heart.84.5.548; Kirsten H, 2006, BIOTECHNIQUES, V40, P158, DOI 10.2144/000112115; Kozma GT, 2010, EXP HEMATOL, V38, P489, DOI 10.1016/j.exphem.2010.03.006; Lally F, 2005, ARTHRITIS RHEUM-US, V52, P3460, DOI 10.1002/art.21394; Lee DS, 2008, J THROMB HAEMOST, V6, P20; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Littler AJ, 1997, BRIT J RHEUMATOL, V36, P164; Lowin T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3464; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Makarov SS, 2001, ARTHRITIS RES, V3, P200, DOI 10.1186/ar300; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; MIMORI T, 1995, P NATL ACAD SCI USA, V92, P7267, DOI 10.1073/pnas.92.16.7267; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nasonov EL, 1999, TERAPEVT ARKH, V71, P17; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Rachlin J, 2005, NUCLEIC ACIDS RES, V33, pW544, DOI 10.1093/nar/gki377; Ridker PM, 2001, CIRCULATION, V103, P491, DOI 10.1161/01.CIR.103.4.491; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Roos D, 2001, BLOOD CELL MOL DIS, V27, P1000, DOI 10.1006/bcmd.2001.0473; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Schmitt-Sody M, 2007, PLATELETS, V18, P365, DOI 10.1080/09537100701191315; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sfikakis PP, 1999, CLIN RHEUMATOL, V18, P28, DOI 10.1007/s100670050047; Sidiropoulos PI, 2008, ANN RHEUM DIS, V67, P1382, DOI 10.1136/ard.2007.078014; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Teixeira VH, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2654; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; Turesson C, 2004, ANN RHEUM DIS, V63, P952, DOI 10.1136/ard.2003.018101; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; Vogel A, 2003, GENES IMMUN, V4, P79, DOI 10.1038/sj.gene.6363918; Wenzel T, 2003, NUCLEOS NUCLEOT NUCL, V22, P1579, DOI 10.1081/NCN-120023038; Yamada KM, 2001, J CELL SCI, V114, P2375	67	12	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e103872	10.1371/journal.pone.0103872	http://dx.doi.org/10.1371/journal.pone.0103872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147926	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600006
J	Presley, SJ; Scheiner, SM; Willig, MR				Presley, Steven J.; Scheiner, Samuel M.; Willig, Michael R.			Evaluation of an Integrated Framework for Biodiversity with a New Metric for Functional Dispersion	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; BETA DIVERSITY; HILL NUMBERS; TREE; COMMUNITIES; SIMILARITY; ABUNDANCE; PATTERNS	Growing interest in understanding ecological patterns from phylogenetic and functional perspectives has driven the development of metrics that capture variation in evolutionary histories or ecological functions of species. Recently, an integrated framework based on Hill numbers was developed that measures three dimensions of biodiversity based on abundance, phylogeny and function of species. This framework is highly flexible, allowing comparison of those diversity dimensions, including different aspects of a single dimension and their integration into a single measure. The behavior of those metrics with regard to variation in data structure has not been explored in detail, yet is critical for ensuring an appropriate match between the concept and its measurement. We evaluated how each metric responds to particular data structures and developed a new metric for functional biodiversity. The phylogenetic metric is sensitive to variation in the topology of phylogenetic trees, including variation in the relative lengths of basal, internal and terminal branches. In contrast, the functional metric exhibited multiple shortcomings: (1) species that are functionally redundant contribute nothing to functional diversity and (2) a single highly distinct species causes functional diversity to approach the minimum possible value. We introduced an alternative, improved metric based on functional dispersion that solves both of these problems. In addition, the new metric exhibited more desirable behavior when based on multiple traits.	[Presley, Steven J.; Willig, Michael R.] Univ Connecticut, Ctr Environm Sci & Engn, Storrs, CT 06269 USA; [Presley, Steven J.; Willig, Michael R.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Scheiner, Samuel M.] Natl Sci Fdn, Div Environm Biol, Arlington, VA 22230 USA	University of Connecticut; University of Connecticut; National Science Foundation (NSF); NSF - Directorate for Biological Sciences (BIO); NSF - Division of Environmental Biology (DEB)	Presley, SJ (corresponding author), Univ Connecticut, Ctr Environm Sci & Engn, Storrs, CT 06269 USA.	steven.presley@uconn.edu	Scheiner, Samuel M./A-4320-2009; Presley, Steven/AAE-9189-2020	Scheiner, Samuel M./0000-0003-1677-9752; Presley, Steven/0000-0002-5987-0735	National Science Foundation [1050680, DEB-0620910, DEB-1239764]; International Institute of Tropical Forestry, Long-Term Ecological Research Program in the Luquillo Experimental Forest; Center for Environmental Sciences and Engineering at the University of Connecticut; Direct For Biological Sciences [1239764] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); International Institute of Tropical Forestry, Long-Term Ecological Research Program in the Luquillo Experimental Forest; Center for Environmental Sciences and Engineering at the University of Connecticut; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This manuscript was inspired by the participation of SJP and MRW in a distributed graduate seminar funded by a National Science Foundation grant (1050680) to S. Andelman and J. Parrish entitled "The Dimensions of Biodiversity Distributed Graduate Seminar.'' SJP and MRW were supported by grants from the National Science Foundation (DEB-0620910, DEB-1239764) to the Institute of Tropical Ecosystem Studies, University of Puerto Rico and the International Institute of Tropical Forestry as part of the Long-Term Ecological Research Program in the Luquillo Experimental Forest, and by the Center for Environmental Sciences and Engineering at the University of Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chiu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100014; Chiu CH, 2014, ECOL MONOGR, V84, P21, DOI 10.1890/12-0960.1; Cisneros LM, 2014, J ANIM ECOL, V83, P1124, DOI 10.1111/1365-2656.12201; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; CURTIS JT, 1950, ECOLOGY, V31, P434, DOI 10.2307/1931497; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; Faith DP, 1991, BIOL CONSERV, V61, P1; Fonseca CR, 2001, J ECOL, V89, P118, DOI 10.1046/j.1365-2745.2001.00528.x; FURNAS GW, 1984, J CLASSIF, V1, P187, DOI 10.1007/BF01890123; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Pavoine S, 2010, ECOL MONOGR, V80, P485, DOI 10.1890/09-1290.1; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Scheiner SM, 2012, OIKOS, V121, P1191, DOI 10.1111/j.1600-0706.2012.20607.x; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Vellend Mark, 2011, P194; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wilson E.O., 1988, P3	31	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105818	10.1371/journal.pone.0105818	http://dx.doi.org/10.1371/journal.pone.0105818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148103	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230600086
J	Song, DF; Zhu, MY; Gu, Q				Song, Da-Feng; Zhu, Mu-Yuan; Gu, Qing			Purification and Characterization of Plantaricin ZJ5, a New Bacteriocin Produced by Lactobacillus plantarum ZJ5	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CLASS-II BACTERIOCIN; EAT TURKEY BOLOGNA; LISTERIA-MONOCYTOGENES; COMBINING NISIN; PEPTIDES; DNA; AMPLIFICATION; SEQUENCE; STRAIN	The aim of this study is to investigate the antimicrobial potential of Lactobacillus plantarum ZJ5, a strain isolated from fermented mustard with a broad range of inhibitory activity against both Gram-positive and Gram-negative bacteria. Here we present the peptide plantaricin ZJ5 ( PZJ5), which is an extreme pH and heat-stable. However, it can be digested by pepsin and proteinase K. This peptide has strong activity against Staphylococcus aureus. PZJ5 has been purified using a multi-step process, including ammonium sulfate precipitation, cation-exchange chromatography, hydrophobic interactions and reverse-phase chromatography. The molecular mass of the peptide was found to be 2572.9 Da using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The primary structure of this peptide was determined using amino acid sequencing and DNA sequencing, and these analyses revealed that the DNA sequence translated as a 44-residue precursor containing a 22-amino-acid N-terminal extension that was of the double-glycine type. The bacteriocin sequence exhibited no homology with known bacteriocins when compared with those available in the database, indicating that it was a new class IId bacteriocin. PZJ5 from a food-borne strain may be useful as a promising probiotic candidate.	[Song, Da-Feng; Gu, Qing] Zhejiang Gongshang Univ, Dept Biotechnol, Key Lab Food Microbial Technol Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Song, Da-Feng; Zhu, Mu-Yuan] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Gongshang University; Zhejiang University	Zhu, MY (corresponding author), Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	myzhu@zju.edu.cn; guqing2002@hotmail.com			National Natural Science Foundation of China [31071513, 31271821]; Natural Science Foundation of Zhejiang Province [Z3110399, LY13C00002]; National High Technology Research and Development Program of China [2012AA022105B]; International Science and Technology Cooperation Program of China [2013DFA32330]; Scientific Research Project for the Education Department of Zhejiang Province, China [Y201120078]; key science and technology innovation team of Zhejiang Province [010R50032]; National Agricultural System Program of China [CARS-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); International Science and Technology Cooperation Program of China; Scientific Research Project for the Education Department of Zhejiang Province, China; key science and technology innovation team of Zhejiang Province; National Agricultural System Program of China	This project was supported by the National Natural Science Foundation of China (No. 31071513 and 31271821), the Natural Science Foundation of Zhejiang Province (No. Z3110399 and LY13C00002), the National High Technology Research and Development Program "863" Program) of China (2012AA022105B), the International Science and Technology Cooperation Program of China (2013DFA32330), the Scientific Research Project for the Education Department of Zhejiang Province, China (No. Y201120078), the key science and technology innovation team of Zhejiang Province (No. 010R50032), and National Agricultural System Program of China (CARS-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; Aunpad R, 2007, CURR MICROBIOL, V55, P308, DOI 10.1007/s00284-006-0632-2; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Franke CM, 1999, J BIOL CHEM, V274, P8484, DOI 10.1074/jbc.274.13.8484; Franz CMAP, 2007, FEMS MICROBIOL REV, V31, P293, DOI 10.1111/j.1574-6976.2007.00064.x; GONZALEZ B, 1994, APPL ENVIRON MICROB, V60, P2158; Hata T, 2010, INT J FOOD MICROBIOL, V137, P94, DOI 10.1016/j.ijfoodmicro.2009.10.021; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; HENDERSON JT, 1992, ARCH BIOCHEM BIOPHYS, V295, P5, DOI 10.1016/0003-9861(92)90480-K; Izquierdo E, 2009, APPL ENVIRON MICROB, V75, P4273, DOI 10.1128/AEM.02772-08; JIMENEZDIAZ R, 1995, APPL ENVIRON MICROB, V61, P4459; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Kotake Y, 2008, BIOCHEMISTRY-US, V47, P2531, DOI 10.1021/bi702253n; Lee CH, 1997, FOOD CONTROL, V8, P259, DOI 10.1016/S0956-7135(97)00015-7; Miguel MAL, 2008, CURR MICROBIOL, V57, P429, DOI 10.1007/s00284-008-9224-7; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Maldonado A, 2003, APPL ENVIRON MICROB, V69, P383, DOI 10.1128/AEM.69.1.383-389.2003; Mangalassary S, 2007, J FOOD PROTECT, V70, P2503, DOI 10.4315/0362-028X-70.11.2503; Masuda Y, 2011, APPL ENVIRON MICROB, V77, P8164, DOI 10.1128/AEM.06348-11; Morgan SM, 2005, ANTIMICROB AGENTS CH, V49, P2606, DOI 10.1128/AAC.49.7.2606-2611.2005; Morisset D, 2004, APPL ENVIRON MICROB, V70, P4672, DOI 10.1128/AEM.70.8.4672-4680.2004; Naas H, 2013, POULTRY SCI, V92, P1930, DOI 10.3382/ps.2012-02141; Nes IF, 2000, BIOPOLYMERS, V55, P50, DOI 10.1002/1097-0282(2000)55:1<50::AID-BIP50>3.0.CO;2-3; Remiger A, 1999, J APPL MICROBIOL, V86, P1053, DOI 10.1046/j.1365-2672.1999.00792.x; Singer T, 2003, METH MOL B, V236, P241; Soomro A. H., 2002, Pakistan Journal of Nutrition, V1, P20; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; Tanganurat W, 2009, J BASIC MICROB, V49, P377, DOI 10.1002/jobm.200800185; Tosukhowong A, 2012, APPL ENVIRON MICROB, V78, P1619, DOI 10.1128/AEM.06891-11; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yamazaki K, 2005, APPL ENVIRON MICROB, V71, P554, DOI 10.1128/AEM.71.1.554-557.2005	33	64	70	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105549	10.1371/journal.pone.0105549	http://dx.doi.org/10.1371/journal.pone.0105549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147943	gold, Green Published, Green Submitted			2022-12-25	WOS:000341230600054
J	Lentz, MR; Peterson, KL; Ibrahim, WG; Lee, DE; Sarlls, J; Lizak, MJ; Maric, D; Reid, WC; Hammoud, DA				Lentz, Margaret R.; Peterson, Kristin L.; Ibrahim, Wael G.; Lee, Dianne E.; Sarlls, Joelle; Lizak, Martin J.; Maric, Dragan; Reid, William C.; Hammoud, Dima A.			Diffusion Tensor and Volumetric Magnetic Resonance Measures as Biomarkers of Brain Damage in a Small Animal Model of HIV	PLOS ONE			English	Article							VIRUS-POSITIVE PATIENTS; APPEARING WHITE-MATTER; CORPUS-CALLOSUM; ANTIRETROVIRAL THERAPY; COGNITIVE IMPAIRMENT; ANTIOXIDANT ENZYMES; TRANSGENIC RAT; AXONAL DAMAGE; DEMENTIA; INJURY	Background: There are currently no widely accepted neuro-HIV small animal models. We wanted to validate the HIV-1 Transgenic rat (Tg) as an appropriate neuro-HIV model and then establish in vivo imaging biomarkers of neuropathology, within this model, using MR structural and diffusion tensor imaging (DTI). Methods: Young and middle-aged Tg and control rats were imaged using MRI. A subset of middle-aged animals underwent longitudinal repeat imaging six months later. Total brain volume (TBV), ventricular volume (VV) and parenchymal volume (PV = TBV-VV) were measured. Fractional anisotropy (FA) and mean diffusivity (MD) values of the corpus callosum (CC) were calculated from DTI data. Results: TBV and PV were smaller in Tg compared to control rats in young and middle-aged cohorts (p<0.0001). VV increased significantly (p = 0.005) over time in the longitudinal Tg cohort. There were lower FA (p<0.002) and higher MD (p<0.003) values in the CC of middle-aged Tg rats compared to age-matched controls. Longitudinally, MD significantly decreased over time in Tg rats (p<0.03) while it did not change significantly in the control cohort over the same period of time (p>0.05). Conclusions: We detected brain volume loss in the Tg rat, probably due to astrocytic dysfunction/loss, loss of structural/axonal matrix and striatal neuronal loss as suggested by immunofluorescence. Increased MD and decreased FA in the CC probably reflect microstructural differences between the Tg and Control rats which could include increased extracellular space between white matter tracts, demyelination and axonal degeneration, among other pathologies. We believe that the Tg rat is an adequate model of neuropathology in HIV and that volumetric MR and DTI measures can be potentially used as biomarkers of disease progression.	[Lentz, Margaret R.; Peterson, Kristin L.; Ibrahim, Wael G.; Lee, Dianne E.; Reid, William C.; Hammoud, Dima A.] NIH, Ctr Infect Dis Imaging CIDI Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Sarlls, Joelle] Natl Inst Child Hlth & Human Dev NICHD, NIH, Bethesda, MD USA; [Lizak, Martin J.] NINDS, Magnet Resonance Imaging Res Facil NMRF, NIH, Bethesda, MD 20892 USA; [Maric, Dragan] NINDS, DIR, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hammoud, DA (corresponding author), NIH, Ctr Infect Dis Imaging CIDI Radiol & Imaging Sci, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	hammoudd@cc.nih.gov	Hammoud, Dima A/C-2286-2015	Hammoud, Dima/0000-0001-7406-7871	Intramural National Institutes of Health program Center for Infectious Diseases Imaging, Radiology and Imaging Sciences, CC/NIAID; CLINICAL CENTER [ZIACL090037] Funding Source: NIH RePORTER	Intramural National Institutes of Health program Center for Infectious Diseases Imaging, Radiology and Imaging Sciences, CC/NIAID; CLINICAL CENTER	Funding provided by Intramural National Institutes of Health program Center for Infectious Diseases Imaging, Radiology and Imaging Sciences, CC/NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Agrawal L, 2012, NEUROBIOL DIS, V45, P657, DOI 10.1016/j.nbd.2011.10.005; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alfahad TB, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0387-7; AYLWARD EH, 1993, NEUROLOGY, V43, P2099, DOI 10.1212/WNL.43.10.2099; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bemelmans AP, 2006, J NEUROSCI RES, V83, P50, DOI 10.1002/jnr.20704; Bieniasz PD, 2000, J VIROL, V74, P9868, DOI 10.1128/JVI.74.21.9868-9877.2000; Calabrese E, 2013, NEUROIMAGE, V71, P196, DOI 10.1016/j.neuroimage.2013.01.017; Cardenas VA, 2009, J NEUROVIROL, V15, P324, DOI 10.1080/13550280902973960; Carty ML, 2008, INT J DEV NEUROSCI, V26, P477, DOI 10.1016/j.ijdevneu.2008.02.005; Chang LD, 2008, J NEUROIMMUNE PHARM, V3, P265, DOI 10.1007/s11481-008-9120-8; Chen YS, 2009, NEUROIMAGE, V47, P1154, DOI 10.1016/j.neuroimage.2009.04.030; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; Filippi CG, 2001, AM J NEURORADIOL, V22, P277; Filippi M, 1998, J NEUROL SCI, V159, P94, DOI 10.1016/S0022-510X(98)00144-0; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hua X, 2013, NEUROIMAGE-CLIN, V3, P132, DOI 10.1016/j.nicl.2013.07.009; Jernigan TL, 2011, J NEUROVIROL, V17, P248, DOI 10.1007/s13365-011-0032-7; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996; Lerner A, 2013, WORLD NEUROSURG; Li MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059582; Louboutin JP, 2007, GENE THER, V14, P1650, DOI 10.1038/sj.gt.3303030; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Meisner F, 2008, NEUROPSYCHOPHARMACOL, V33, P2228, DOI 10.1038/sj.npp.1301615; Meulendyke KA, 2012, J NEUROIMMUNE PHARM, V7, P454, DOI 10.1007/s11481-011-9332-1; Moran LM, 2013, J NEUROIMMUNE PHARM, V8, P988, DOI 10.1007/s11481-013-9472-6; Moran LM, 2012, CURR HIV RES, V10, P415, DOI 10.2174/157016212802138788; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Naganawa S, 2003, EUR RADIOL, V13, P6, DOI 10.1007/s00330-002-1549-1; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; Pfefferbaum A, 2009, AIDS, V23, P1977, DOI 10.1097/QAD.0b013e32832e77fe; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pierpaoli C., 2010, TORTOISE INTEGRATED; Ragin AB, 2004, AM J NEURORADIOL, V25, P195; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Schifitto G, 2007, NEUROLOGY, V69, P1314, DOI 10.1212/01.wnl.0000268487.78753.0f; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stebbins GT, 2007, JAIDS-J ACQ IMM DEF, V46, P564, DOI 10.1097/QAI.0b013e318159d807; Stout JC, 1998, ARCH NEUROL-CHICAGO, V55, P161, DOI 10.1001/archneur.55.2.161; Sullivan EV, 2010, DEV NEUROPSYCHOL, V35, P233, DOI 10.1080/87565641003689556; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Thurnher MM, 2005, AM J NEURORADIOL, V26, P2275; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Wright PW, 2012, AIDS, V26, P1501, DOI 10.1097/QAD.0b013e3283550bec; Wu Y, 2006, AM J NEURORADIOL, V27, P656; Ye F, 2005, STRATEGY ENHANCE TIS, P830	58	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105752	10.1371/journal.pone.0105752	http://dx.doi.org/10.1371/journal.pone.0105752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144656	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100117
J	Mathis, SE; Alberico, A; Nande, R; Neto, W; Lawrence, L; McCallister, DR; Denvir, J; Kimmey, GA; Mogul, M; Oakley, G; Denning, KL; Dougherty, T; Valluri, JV; Claudio, PP				Mathis, Sarah E.; Alberico, Anthony; Nande, Rounak; Neto, Walter; Lawrence, Logan; McCallister, Danielle R.; Denvir, James; Kimmey, Gerrit A.; Mogul, Mark; Oakley, Gerard, III; Denning, Krista L.; Dougherty, Thomas; Valluri, Jagan V.; Claudio, Pier Paolo			Chemo-Predictive Assay for Targeting Cancer Stem-Like Cells in Patients Affected by Brain Tumors	PLOS ONE			English	Article							INTRADURAL EXTRAMEDULLARY EPENDYMOMA; EX-VIVO CHEMOSENSITIVITY; SPINAL-CORD EPENDYMOMAS; OVARIAN-CANCER; CHEMORESPONSE ASSAY; ISOTHIOCYANATES; CHEMOTHERAPY; MECHANISM; SERIES	Administration of ineffective anticancer therapy is associated with unnecessary toxicity and development of resistant clones. Cancer stem-like cells (CSLCs) resist chemotherapy, thereby causing relapse of the disease. Thus, development of a test that identifies the most effective chemotherapy management offers great promise for individualized anticancer treatments. We have developed an ex vivo chemotherapy sensitivity assay (ChemoID), which measures the sensitivity of CSLCs as well as the bulk of tumor cells to a variety of chemotherapy agents. Two patients, a 21-year old male (patient 1) and a 5-month female (patient 2), affected by anaplastic WHO grade-III ependymoma were screened using the ChemoID assay. Patient 1 was found sensitive to the combination of irinotecan and bevacizumab, which resulted in a prolonged disease progression free period of 18 months. Following recurrence, the combination of various chemotherapy drugs was tested again with the ChemoID assay. We found that benzyl isothiocyanate (BITC) greatly increased the chemosensitivity of the ependymoma cells to the combination of irinotecan and bevacizumab. After patient 1 was treated for two months with irinotecan, bevacizumab and supplements of cruciferous vegetable extracts containing BITC, we observed over 50% tumoral regression in comparison with pre-ChemoID scan as evidenced by MRI. Patient 2 was found resistant to all treatments tested and following 6 cycles of vincristine, carboplatin, cyclophosphamide, etoposide, and cisplatin in various combinations, the tumor of this patient rapidly progressed and proton beam therapy was recommended. As expected animal studies conducted with patient derived xenografts treated with ChemoID screened drugs recapitulated the clinical observation. This assay demonstrates that patients with the same histological stage and grade of cancer may vary considerably in their clinical response, suggesting that ChemoID testing which measures the sensitivity of CSLCs as well as the bulk of tumor cells to a variety of chemotherapy agents could lead to more effective and personalized anticancer treatments in the future.	[Mathis, Sarah E.; Nande, Rounak; Neto, Walter; Lawrence, Logan; McCallister, Danielle R.; Denvir, James; Claudio, Pier Paolo] Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA; [Mathis, Sarah E.; Nande, Rounak; Neto, Walter; Lawrence, Logan; McCallister, Danielle R.; Denvir, James; Claudio, Pier Paolo] Marshall Univ, Translat Genom Res Inst, Huntington, WV USA; [Alberico, Anthony] Marshall Univ, Dept Neurosurg, Joan C Edwards Sch Med, Huntington, WV USA; [Kimmey, Gerrit A.] St Marys Hosp, Dept Med Oncol, Huntington, WV USA; [Mogul, Mark] Marshall Univ, Dept Pediat, Joan C Edwards Sch Med, Huntington, WV USA; [Oakley, Gerard, III; Denning, Krista L.; Dougherty, Thomas] Marshall Univ, Dept Pathol, Joan C Edwards Sch Med, Huntington, WV USA; [Valluri, Jagan V.] Marshall Univ, Dept Biol, Huntington, WV USA; [Claudio, Pier Paolo] Marshall Univ, Dept Surg, Joan C Edwards Sch Med, Huntington, WV USA	Marshall University; Marshall University; Marshall University; Marshall University; Marshall University; Marshall University; Marshall University	Claudio, PP (corresponding author), Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	claudiop@marshall.edu	Claudio, Pier Paolo/AAW-7282-2021	Claudio, Pier Paolo/0000-0001-7790-1622	National Center for Advancing Translational Sciences, National Institutes of Health through the National Center for Research Resources (NCRR) [UL1TR000117]; National Cancer Institute [5P20RR020180]; WV-INBRE [5P20RR016477]; Marshall University; Marshall University Department of Neuroscience; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477, P20RR020180] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health through the National Center for Research Resources (NCRR); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); WV-INBRE; Marshall University; Marshall University Department of Neuroscience; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The present studies were supported in part by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1TR000117 from the National Center for Research Resources (NCRR), and 5P20RR020180 from the National Cancer Institute, WV-INBRE 5P20RR016477, and in part by a Marshall University Translational Award, and an award from the Marshall University Department of Neuroscience (to PPC). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of NCRR and NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimola P, 2010, DRUG NEWS PERSPECT, V23, P175, DOI 10.1358/dnp.2010.23.3.1489979; Ballard KS, 2010, INT J GYNECOL CANCER, V20, P561, DOI 10.1111/IGC.0b013e3181d320dd; Bouffet E, 1999, CHILD NERV SYST, V15, P563, DOI 10.1007/s003810050544; Breidenbach M, 2002, ANTI-CANCER DRUG, V13, P173, DOI 10.1097/00001813-200202000-00010; Brower Stacey L., 2008, V414, P57; Chamberlain MC, 2011, CURR NEUROL NEUROSCI, V11, P320, DOI 10.1007/s11910-011-0190-2; Chou PM, 1996, PEDIATR PATHOL LAB M, V16, P551, DOI 10.1080/107710496175499; COOPER IS, 1951, SURG GYNECOL OBSTET, V92, P183; Di Pasqua AJ, 2010, CHEM RES TOXICOL, V23, P1307, DOI 10.1021/tx100187f; Duffau H, 2000, SPINE, V25, P1993, DOI 10.1097/00007632-200008010-00021; Duncan John A. Iii, 1995, P493; Gallion H, 2006, INT J GYNECOL CANCER, V16, P194, DOI 10.1111/j.1525-1438.2006.00301.x; Hanbali F, 2002, NEUROSURGERY, V51, P1162, DOI 10.1097/00006123-200211000-00010; Herzog TJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.01.059; Huh WK, 2011, INT J GYNECOL CANCER, V21, P494, DOI 10.1097/IGC.0b013e31820c4cb5; Iunes EA, 2011, J NEUROSURG-SPINE, V14, P65, DOI 10.3171/2010.9.SPINE09963; Kelloff GJ, 1999, ANN NY ACAD SCI, V889, P1, DOI 10.1111/j.1749-6632.1999.tb08718.x; Kelly SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010035; Kleinhans R, 2012, MED BIOL ENG COMPUT, V50, P117, DOI 10.1007/s11517-011-0855-7; Kocak Z, 2004, J EXP CLIN CANC RES, V23, P201; Lamy E, 2011, DRUG METAB REV, V43, P387, DOI 10.3109/03602532.2011.569551; Lin YH, 2005, J NEURO-ONCOL, V71, P205, DOI 10.1007/s11060-004-1386-y; Malik Babar, 2012, Front Biosci (Elite Ed), V4, P2142; McCormick P C, 1990, Neurosurg Clin N Am, V1, P591; Merchant TE, 2002, ONCOLOGY-NY, V16, P629; Metellus P, 2008, CANCER, V113, P175, DOI 10.1002/cncr.23530; Mi LX, 2011, CHEM RES TOXICOL, V24, P1735, DOI 10.1021/tx2002806; Michalova E, 2008, Klin Onkol, V21, P93; Modena P, 2012, NEURO-ONCOLOGY, V14, P1346, DOI 10.1093/neuonc/nos245; Myatt N, 1997, ANTI-CANCER DRUG, V8, P756, DOI 10.1097/00001813-199709000-00004; Ness RB, 2002, ANTICANCER RES, V22, P1145; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Ochs RL, 2005, METH MOLEC MED, V110, P155; Pejavar S, 2012, J NEURO-ONCOL, V106, P367, DOI 10.1007/s11060-011-0671-9; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reni M, 2004, CANCER, V100, P1221, DOI 10.1002/cncr.20074; Reni M, 2007, CRIT REV ONCOL HEMAT, V63, P81, DOI 10.1016/j.critrevonc.2007.03.004; Rice SD, 2011, CANCER BIOL THER, V11, P196, DOI 10.4161/cbt.11.2.13701; Rice SD, 2010, ANTICANCER RES, V30, P2805; Song KW, 2009, CLIN ORTHOP SURG, V1, P74, DOI 10.4055/cios.2009.1.2.74; Suchy SL, 2011, CANCER BIOL THER, V11, P1059, DOI 10.4161/cbt.11.12.15710; Tsubouchi H, 2000, Hum Cell, V13, P203; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Vandertop WP, 2003, NEUROSURGERY, V53, P246, DOI 10.1227/01.NEU.0000072306.16102.BD; Wichmann G, 2009, ONKOLOGIE, V32, P264, DOI 10.1159/000209148; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50; Yu Yang, 2012, Front Biosci (Elite Ed), V4, P1528; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425	49	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105710	10.1371/journal.pone.0105710	http://dx.doi.org/10.1371/journal.pone.0105710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144312	Green Published, gold, Green Submitted			2022-12-25	WOS:000341106100113
J	Micucci, C; Orciari, S; Catalano, A				Micucci, Carla; Orciari, Silvia; Catalano, Alfonso			Hyperglycemia Promotes K-Ras-Induced Lung Tumorigenesis through BASCs Amplification	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; GLUCOSE; CANCER; CELL; EXPRESSION; RISK; OVEREXPRESSION; ADENOCARCINOMA; TRANSPORTERS; PATHOGENESIS	Oncogenic K-Ras represents the most common molecular change in human lung adenocarcinomas, the major histologic subtype of non-small cell lung cancer (NSCLC). The presence of K-Ras mutation is associated with a poor prognosis, but no effective treatment strategies are available for K-Ras -mutant NSCLC. Epidemiological studies report higher lung cancer mortality rates in patients with type 2 diabetes. Here, we use a mouse model of K-Ras-mediated lung cancer on a background of chronic hyperglycemia to determine whether elevated circulating glycemic levels could influence oncogenic K-Ras-mediated tumor development. Inducible oncogenic K-Ras mouse model was treated with subtoxic doses of streptozotocin (STZ) to induce chronic hyperglycemia. We observed increased tumor mass and higher grade of malignancy in STZ treated diabetic mice analyzed at 4, 12 and 24 weeks, suggesting that oncogenic K-Ras increased lung tumorigenesis in hyperglycemic condition. This promoting effect is achieved by expansion of tumor-initiating lung bronchio-alveolar stem cells (BASCs) in bronchio-alveolar duct junction, indicating a role of hyperglycemia in the activity of K-Ras-transformed putative lung stem cells. Notably, after oncogene K-Ras activation, BASCs show upregulation of the glucose transporter (Glut1/Slc2a1), considered as an important player of the active control of tumor cell metabolism by oncogenic K-Ras. Our novel findings suggest that anti-hyperglycemic drugs, such as metformin, may act as therapeutic agent to restrict lung neoplasia promotion and progression.	[Micucci, Carla; Orciari, Silvia; Catalano, Alfonso] Polytech Univ Marche, Sch Med, Dept Clin & Mol Sci, Ancona, Italy	Marche Polytechnic University	Micucci, C (corresponding author), Polytech Univ Marche, Sch Med, Dept Clin & Mol Sci, Ancona, Italy.	carlamicucci@libero.it			Italian Ministry of Research (Progetti di ricerca di interesse nazionale, PRIN) [20098FRBAK_002]; Italian Association for Cancer Research (AIRC) [6348]	Italian Ministry of Research (Progetti di ricerca di interesse nazionale, PRIN)(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	AC was supported by Italian Ministry of Research (Progetti di ricerca di interesse nazionale, PRIN, grant number 20098FRBAK_002) and Italian Association for Cancer Research (AIRC, grant number 6348-MFAG Regional Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrimi G, 2011, APPL ENVIRON MICROB, V77, P2239, DOI 10.1128/AEM.01703-10; [Anonymous], 2009, GLO J PHARM, V3, P81; Aviel-Ronen S, 2006, CLIN LUNG CANCER, V8, P30, DOI 10.3816/CLC.2006.n.030; Chia JSJ, 2013, DIABETES, V62, P2026, DOI 10.2337/db12-0625; de Geus-Oei LF, 2007, LUNG CANCER, V55, P79, DOI 10.1016/j.lungcan.2006.08.018; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Harris CC, 2004, WHO CLASSIFICATION T, P9; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hogan B, 1994, MANIPULATING MOUSE E; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim HJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/639469; Liadis N, 2005, MOL CELL BIOL, V25, P3620, DOI 10.1128/MCB.25.9.3620-3629.2005; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Maki Y, 2013, ONCOL REP, V29, P133, DOI 10.3892/or.2012.2087; Mori M, 1996, CANCER, V77, P665, DOI 10.1002/(SICI)1097-0142(19960215)77:4<665::AID-CNCR12>3.0.CO;2-Z; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Piatkiewicz P, 2011, ARCH IMMUNOL THER EX, V59, P215, DOI 10.1007/s00005-011-0119-0; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Reddy MA, 2013, SEMIN NEPHROL, V33, P341, DOI 10.1016/j.semnephrol.2013.05.006; Sasaki H, 2012, MOL MED REP, V5, P599, DOI 10.3892/mmr.2011.736; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shyamasundar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065945; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stopper H, 2003, CANCER LETT, V190, P151, DOI 10.1016/S0304-3835(02)00626-2; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Xu Z. X., 2010, GLOBAL J PHARM, V4, P111; Yamagishi S, 2008, MED HYPOTHESES, V71, P259, DOI 10.1016/j.mehy.2008.03.020; Yamagishi S, 2005, MED HYPOTHESES, V64, P1208, DOI 10.1016/j.mehy.2005.01.015; Yang Y, 2008, PLOS ONE, V21; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	36	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105550	10.1371/journal.pone.0105550	http://dx.doi.org/10.1371/journal.pone.0105550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144301	Green Submitted, Green Published, gold			2022-12-25	WOS:000341106100083
J	Miyagawa, S; Mihashi, T; Kanda, H; Hirohara, Y; Endo, T; Morimoto, T; Miyoshi, T; Fujikado, T				Miyagawa, Suguru; Mihashi, Toshifumi; Kanda, Hiroyuki; Hirohara, Yoko; Endo, Takao; Morimoto, Takeshi; Miyoshi, Tomomitsu; Fujikado, Takashi			Asymmetric Wavefront Aberrations and Pupillary Shapes Induced by Electrical Stimulation of Ciliary Nerve in Cats Measured with Compact Wavefront Aberrometer	PLOS ONE			English	Article							MONOCHROMATIC ABERRATIONS; SUPERIOR COLLICULUS; LENS ACCOMMODATION; IMAGE QUALITY; MICROSTIMULATION; EYE; MOVEMENTS; GANGLION	To investigate the changes in the wavefront aberrations and pupillary shape in response to electrical stimulation of the branches of the ciliary nerves in cats. Seven eyes of seven cats were studied under general anesthesia. Trains of monophasic pulses (current, 0.1 to 1.0 mA; duration, 0.5 ms/phase; frequency, 5 to 40 Hz) were applied to the lateral or medial branch of the short ciliary nerve near the posterior pole of the eye. A pair of electrodes was hooked onto one or both branch of the short ciliary nerve. The electrodes were placed about 5 mm from the scleral surface. The wavefront aberrations were recorded continuously for 2 seconds before, 8 seconds during, and for 20 seconds after the electrical stimulation. The pupillary images were simultaneously recorded during the stimulation period. Both the wavefront aberrations and the pupillary images were obtained 10 times/sec with a custom-built wavefront aberrometer. The maximum accommodative amplitude was 1.19 diopters (D) produced by electrical stimulation of the short ciliary nerves. The latency of the accommodative changes was very short, and the accommodative level gradually increased up to 4 seconds and reached a plateau. When only one branch of the ciliary nerve was stimulated, the pupil dilated asymmetrically, and the oblique astigmatism and one of the asymmetrical wavefront terms was also altered. Our results showed that the wavefront aberrations and pupillary dilations can be measured simultaneously and serially with a compact wavefront aberrometer. The asymmetric pupil dilation and asymmetric changes of the wavefront aberrations suggest that each branch of the ciliary nerve innervates specific segments of the ciliary muscle and dilator muscle of the pupil.	[Miyagawa, Suguru; Kanda, Hiroyuki; Hirohara, Yoko; Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Suita, Osaka, Japan; [Miyagawa, Suguru; Hirohara, Yoko] Topcon Corp, Res Inst, Itabashi Ku, Tokyo, Japan; [Mihashi, Toshifumi] Tokyo Inst Technol, Innovat Res Initiat, Yokohama, Kanagawa 227, Japan; [Endo, Takao; Morimoto, Takeshi] Osaka Univ, Grad Sch Med, Dept Opthalmol, Suita, Osaka, Japan; [Miyoshi, Tomomitsu] Osaka Univ, Grad Sch Med, Dept Integrat Physiol, Suita, Osaka, Japan	Osaka University; Topcon Corporation; Tokyo Institute of Technology; Osaka University; Osaka University	Fujikado, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Suita, Osaka, Japan.	fujikado@ophthal.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25670730]; Health Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan [H24-medical device-004]; Grants-in-Aid for Scientific Research [25670730] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (25670730) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by Health Sciences Research Grants (H24-medical device-004) from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHE JH, 1978, EXP NEUROL, V59, P413, DOI 10.1016/0014-4886(78)90233-9; ATCHISON DA, 1995, VISION RES, V35, P313, DOI 10.1016/0042-6989(94)00139-D; BANDO T, 1992, NEUROSCI RES, V15, P162, DOI 10.1016/0168-0102(92)90002-T; BANDO T, 1981, BRAIN RES, V213, P201, DOI 10.1016/0006-8993(81)91262-2; BELL RA, 1978, ARCH OPHTHALMOL-CHIC, V96, P638; Bharadwaj SR, 2005, VISION RES, V45, P17, DOI 10.1016/j.visres.2004.07.040; Bhatt UK, 2013, J CATARACT REFR SURG, V39, P36, DOI 10.1016/j.jcrs.2012.08.052; BLOOM M, 1977, VISION RES, V17, P723, DOI 10.1016/S0042-6989(77)80010-2; Cheng H, 2004, J VISION, V4, P272, DOI 10.1167/4.4.3; Christensen K, 1936, J ANAT, V70, P225; Dearworth JR, 2009, VISUAL NEUROSCI, V26, P309, DOI 10.1017/S0952523809090099; He JC, 2000, VISION RES, V40, P41, DOI 10.1016/S0042-6989(99)00156-X; HOSOBA M, 1978, BRAIN RES, V153, P495, DOI 10.1016/0006-8993(78)90334-7; Huxlin KR, 2004, VISION RES, V44, P2159, DOI 10.1016/j.visres.2004.03.017; Konno S, 1997, JPN J OPHTHALMOL, V41, P43, DOI 10.1016/S0021-5155(96)00010-X; KUCHIIWA S, 1990, ANAT EMBRYOL, V181, P299; KUCHIIWA S, 1989, ANAT EMBRYOL, V180, P199, DOI 10.1007/BF00309772; Liang JZ, 1997, J OPT SOC AM A, V14, P2873, DOI 10.1364/JOSAA.14.002873; MARG E, 1954, Am J Optom Arch Am Acad Optom, V31, P127; Netser S, 2010, J NEUROPHYSIOL, V104, P108, DOI 10.1152/jn.01142.2009; Ninomiya S, 2002, AM J OPHTHALMOL, V134, P924, DOI 10.1016/S0002-9394(02)01856-1; ONEILL WD, 1970, VISION RES, V10, P375, DOI 10.1016/0042-6989(70)90118-5; Ostrin LA, 2007, EXP EYE RES, V84, P302, DOI 10.1016/j.exer.2006.10.003; Porter J, 2001, J OPT SOC AM A, V18, P1793, DOI 10.1364/JOSAA.18.001793; Ramamirtham R, 2007, VISION RES, V47, P2751, DOI 10.1016/j.visres.2007.07.014; RIPPS H, 1961, Trans Am Ophthalmol Soc, V59, P176; Ripps H, 1965, AM J PHYSIOL, V203, P857; SAWA M, 1994, VISION RES, V34, P975, DOI 10.1016/0042-6989(94)90001-9; TERDIMAN J, 1969, BRAIN RES, V16, P288, DOI 10.1016/0006-8993(69)90105-X; THIBOS LN, 1990, VISION RES, V30, P33, DOI 10.1016/0042-6989(90)90126-6; Thibos LN, 2002, J REFRACT SURG, V18, pS652; Thibos LN, 2002, J OPT SOC AM A, V19, P2329, DOI 10.1364/JOSAA.19.002329; Vilupuru AS, 2002, VISION RES, V42, P125, DOI 10.1016/S0042-6989(01)00260-7; Wang CA, 2012, J NEUROSCI, V32, P3629, DOI 10.1523/JNEUROSCI.5512-11.2012; WATANABE T, 1990, JPN J APPL PHYS 1, V29, P445, DOI 10.1143/JJAP.29.445	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105615	10.1371/journal.pone.0105615	http://dx.doi.org/10.1371/journal.pone.0105615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144536	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100096
J	Pollux, PMJ; Hall, S; Guo, K				Pollux, Petra M. J.; Hall, Sophie; Guo, Kun			Facial Expression Training Optimises Viewing Strategy in Children and Adults	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; CONFIGURAL INFORMATION; DEVELOPMENTAL-CHANGES; EMOTION RECOGNITION; FACE RECOGNITION; PERCEPTION; INVERSION; CHILDHOOD; BEHAVIOR; SKILLS	This study investigated whether training-related improvements in facial expression categorization are facilitated by spontaneous changes in gaze behaviour in adults and nine-year old children. Four sessions of a self-paced, free-viewing training task required participants to categorize happy, sad and fear expressions with varying intensities. No instructions about eye movements were given. Eye-movements were recorded in the first and fourth training session. New faces were introduced in session four to establish transfer-effects of learning. Adults focused most on the eyes in all sessions and increased expression categorization accuracy after training coincided with a strengthening of this eye-bias in gaze allocation. In children, training-related behavioural improvements coincided with an overall shift in gaze-focus towards the eyes (resulting in more adult-like gaze-distributions) and towards the mouth for happy faces in the second fixation. Gaze-distributions were not influenced by the expression intensity or by the introduction of new faces. It was proposed that training enhanced the use of a uniform, predominantly eyes-biased, gaze strategy in children in order to optimise extraction of relevant cues for discrimination between subtle facial expressions.	[Pollux, Petra M. J.; Guo, Kun] Lincoln Univ, Sch Psychol, Lincoln, Lincs, England; [Hall, Sophie] Lincoln Univ, Sch Life Sci, Lincoln, Lincs, England	University of Lincoln; University of Lincoln	Pollux, PMJ (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, Lincs, England.	ppollux@lincoln.ac.uk		Pollux, Petra/0000-0001-7107-0848; Guo, Kun/0000-0001-6765-1957; Hall, Sophie/0000-0002-9847-8269	University of Lincoln	University of Lincoln	This study was supported by internal funds of the University of Lincoln. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Calder AJ, 2005, VIS COGN, V12, P495, DOI 10.1080/13506280444000418; CAREY S, 1977, SCIENCE, V195, P312, DOI 10.1126/science.831281; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; Carton JS, 1999, J NONVERBAL BEHAV, V23, P91, DOI 10.1023/A:1021339410262; Combs DR, 2011, SCHIZOPHR RES, V127, P151, DOI 10.1016/j.schres.2010.05.011; COSTANZO M, 1992, J EDUC PSYCHOL, V84, P308, DOI 10.1037/0022-0663.84.3.308; Dadds MR, 2012, PSYCHIAT RES, V199, P201, DOI 10.1016/j.psychres.2012.04.033; Durand K, 2007, J EXP CHILD PSYCHOL, V97, P14, DOI 10.1016/j.jecp.2006.12.001; Dwyer DM, 2009, VIS COGN, V17, P334, DOI 10.1080/13506280701757577; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; Elfenbein HA, 2006, J NONVERBAL BEHAV, V30, P21, DOI 10.1007/s10919-005-0002-y; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Grinspan D, 2003, J GENET PSYCHOL, V164, P88, DOI 10.1080/00221320309597505; Guo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042585; Heisz JJ, 2008, J VISION, V8, DOI 10.1167/8.1.9; Heron-Delaney M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019858; Izard C, 2001, PSYCHOL SCI, V12, P18, DOI 10.1111/1467-9280.00304; Izard C.E., 1971, FACE EMOTION; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Johnston PJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00026; Kohler CG, 2004, PSYCHIAT RES, V128, P235, DOI 10.1016/j.psychres.2004.07.003; Lundqvist D., 1998, KAROLINSKA DIRECTED; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McGugin RW, 2011, COGNITIVE SCI, V35, P330, DOI 10.1111/j.1551-6709.2010.01148.x; Mondloch CJ, 2003, J EXP CHILD PSYCHOL, V86, P67, DOI 10.1016/S0022-0965(03)00102-4; Naruse S, 2013, J MED INVESTIG, V60, P114, DOI 10.2152/jmi.60.114; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Palermo R, 2011, NEUROPSYCHOLOGIA, V49, P1226, DOI 10.1016/j.neuropsychologia.2011.02.021; Penton-Voak IS, 2013, PSYCHOL SCI, V24, P688, DOI 10.1177/0956797612459657; Pollak SD, 2009, COGNITION, V110, P242, DOI 10.1016/j.cognition.2008.10.010; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; van Belle G, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00020; Van Belle G, 2010, NEUROPSYCHOLOGIA, V48, P2620, DOI 10.1016/j.neuropsychologia.2010.04.034; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11; Widen SC, 2013, EMOT REV, V5, P72, DOI 10.1177/1754073912451492; Xiao WS, 2012, BEH DEV, V37, P100	43	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105418	10.1371/journal.pone.0105418	http://dx.doi.org/10.1371/journal.pone.0105418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WL	25144680	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000341106100067
J	Swati, S; Hayat, K; Shahid, Z				Swati, Salahuddin; Hayat, Khizar; Shahid, Zafar			A Watermarking Scheme for High Efficiency Video Coding (HEVC)	PLOS ONE			English	Article								This paper presents a high payload watermarking scheme for High Efficiency Video Coding (HEVC). HEVC is an emerging video compression standard that provides better compression performance as compared to its predecessor, i.e. H.264/AVC. Considering that HEVC may will be used in a variety of applications in the future, the proposed algorithm has a high potential of utilization in applications involving broadcast and hiding of metadata. The watermark is embedded into the Quantized Transform Coefficients (QTCs) during the encoding process. Later, during the decoding process, the embedded message can be detected and extracted completely. The experimental results show that the proposed algorithm does not significantly affect the video quality, nor does it escalate the bitrate.	[Swati, Salahuddin; Hayat, Khizar; Shahid, Zafar] COMSATS Inst Informat Technol, Abbottabad, Pakistan; [Hayat, Khizar] Univ Nizwa, Coll Arts & Sci, Nizwa, Oman	COMSATS University Islamabad (CUI); University of Nizwa	Hayat, K (corresponding author), COMSATS Inst Informat Technol, Abbottabad, Pakistan.	khizarhayat@ciit.net.pk	Hayat, Khizar/P-8954-2019	Shahid, Zafar/0000-0002-3759-1591; Hayat, Khizar/0000-0001-5216-6019; Din, Salah Ud/0000-0002-4145-7176				Alattar AM, 2003, IEEE T CIRC SYST VID, V13, P787, DOI 10.1109/TCSVT.2003.815958; Ayele EA, 2012, INT J COMPUTER APPL, V59, P1, DOI DOI 10.5120/9621-4265; Barni M, 2005, IEEE T MULTIMEDIA, V7, P23, DOI 10.1109/TMM.2004.840594; Bodo Y, 2004, EURASIP J APPL SIG P, V2004, P2224, DOI 10.1155/S1110865704401061; Boho A, 2013, IEEE SIGNAL PROC MAG, V30, P97, DOI 10.1109/MSP.2012.2230220; Bross B., 2012, HIGH EFFICIENCY VIDE; Cox I., 2001, DIGITAL WATERMARKING; Deshpande N, 2010, ABS10041770 CORR; Hartung F, 1998, SIGNAL PROCESS, V66, P283, DOI 10.1016/S0165-1684(98)00011-5; Kim SM, 2007, LECT NOTES COMPUT SC, V4633, P698; Langelaar GC, 2001, IEEE T IMAGE PROCESS, V10, P148, DOI 10.1109/83.892451; Liu Z, 2004, 2004 7TH INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING PROCEEDINGS, VOLS 1-3, P2358; Mansouri A, 2010, IEEE T INF FOREN SEC, V5, P649, DOI 10.1109/TIFS.2010.2076280; Mohaghegh N, 2008, 2008 INTERNATIONAL CONFERENCE ON AUDIO, LANGUAGE AND IMAGE PROCESSING, VOLS 1 AND 2, PROCEEDINGS, P1384, DOI 10.1109/ICALIP.2008.4590217; Nguyen CV, 2006, 2006 IEEE ASIA PACIFIC CONFERENCE ON CIRCUITS AND SYSTEMS, P81; Noorkami M, 2008, IEEE T INF FOREN SEC, V3, P441, DOI 10.1109/TIFS.2008.923825; Noorkami M, 2007, IEEE T INF FOREN SEC, V2, P14, DOI 10.1109/TIFS.2006.890306; Qiu G, 2004, INT C PATT RECOG, P865; Shahid Z, 2010, IEEE IMAGE PROC, P2105, DOI 10.1109/ICIP.2010.5652607; Shahid Z, 2011, SIGNAL IMAGE VIDEO P, V5; Sullivan GJ, 2012, IEEE T CIRC SYST VID, V22, P1649, DOI 10.1109/TCSVT.2012.2221191; Tardos G, 2003, P 35 ANN ACM S THEOR, P116, DOI DOI 10.1145/780542.780561; Xingguang Song, 2008, 2008 11th IEEE International Conference on Communication Technology (ICCT 2008), P738, DOI 10.1109/ICCT.2008.4716228; Xu DW, 2011, SIGNAL PROCESS-IMAGE, V26, P267, DOI 10.1016/j.image.2011.04.008; Zhang J, 2001, XIV BRAZILIAN SYMPOSIUM ON COMPUTER GRAPHICS AND IMAGE PROCESSING, PROCEEDINGS, P179, DOI 10.1109/SIBGRAPI.2001.963053; Zhang J, 2007, IEEE T CIRCUITS-II, V54, P205, DOI 10.1109/TCSII.2006.886247; Zou D, 2008, IEEE INT C AC SPEECH, V752	27	36	38	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105613	10.1371/journal.pone.0105613	http://dx.doi.org/10.1371/journal.pone.0105613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144455	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100095
J	Biswas, H; Chattopadhyaya, R				Biswas, Himadri; Chattopadhyaya, Rajagopal			Thermal, Chemical and pH Induced Unfolding of Turmeric Root Lectin: Modes of Denaturation	PLOS ONE			English	Article							LINEAR EXTRAPOLATION METHOD; WHEAT-GERM-AGGLUTININ; ESCHERICHIA-COLI; THERMODYNAMIC CHARACTERIZATION; CARBOHYDRATE-RECOGNITION; CONFORMATIONAL STABILITY; BINDING-PROTEINS; LEGUME LECTINS; PLANT LECTIN; FAMILY	Curcuma longa rhizome lectin, of non-seed origin having antifungal, antibacterial and a-glucosidase inhibitory activities, forms a homodimer with high thermal stability as well as acid tolerance. Size exclusion chromatography and dynamic light scattering show it to be a dimer at pH 7, but it converts to a monomer near pH 2. Circular dichroism spectra and fluorescence emission maxima are virtually indistinguishable from pH 7 to 2, indicating secondary and tertiary structures remain the same in dimer and monomer within experimental error. The tryptophan environment as probed by acrylamide quenching data yielded very similar data at pH 2 and pH 7, implying very similar folding for monomer and dimer. Differential scanning calorimetry shows a transition at 350.3 K for dimer and at 327.0 K for monomer. Thermal unfolding and chemical unfolding induced by guanidinium chloride for dimer are both reversible and can be described by two-state models. The temperatures and the denaturant concentrations at which one-half of the protein molecules are unfolded, are protein concentration-dependent for dimer but protein concentration-independent for monomer. The free energy of unfolding at 298 K was found to be 5.23 Kcal mol(-1) and 14.90 Kcal mol(-1) for the monomer and dimer respectively. The value of change in excess heat capacity upon protein denaturation (Delta C-p) is 3.42 Kcal mol(-1) K-1 for dimer. The small Delta C-p for unfolding of CLA reflects a buried hydrophobic core in the folded dimeric protein. These unfolding experiments, temperature dependent circular dichroism and dynamic light scattering for the dimer at pH 7 indicate its higher stability than for the monomer at pH 2. This difference in stability of dimeric and monomeric forms highlights the contribution of inter-subunit interactions in the former.	[Biswas, Himadri; Chattopadhyaya, Rajagopal] Bose Inst, Dept Biochem, Kolkata 700009, W Bengal, India	Department of Science & Technology (India); Bose Institute	Chattopadhyaya, R (corresponding author), Bose Inst, Dept Biochem, Kolkata 700009, W Bengal, India.	raja@jcbose.ac.in			Bose Institute from the Department of Science and Technology, Government of India	Bose Institute from the Department of Science and Technology, Government of India	All funding for this study received from Bose Institute, which in turn receives funding from the Department of Science and Technology, Government of India. The funder provided support in the form of salaries for authors [HB,RC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bajaj K, 2004, BIOCHEM J, V380, P409, DOI 10.1042/BJ20031528; BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; BLACKWELL JM, 1985, J EXP MED, V162, P324, DOI 10.1084/jem.162.1.324; Bohm G, 1998, CDNN PROGRAM; Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4; Chakrabarty SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1743, DOI 10.1016/j.bbapap.2010.06.010; Chatterjee A, 2005, INT J BIOL MACROMOL, V35, P103, DOI 10.1016/j.ijbiomac.2005.01.005; Chen JW, 2001, PROTEIN SCI, V10, P1079, DOI 10.1110/ps.53201; Portillo-Tellez MD, 2011, BIOPHYS J, V101, P1423, DOI 10.1016/j.bpj.2011.07.037; FUKADA H, 1983, J BIOL CHEM, V258, P3193; Gabor F, 2004, ADV DRUG DELIVER REV, V56, P459, DOI 10.1016/j.addr.2003.10.015; Ghosh G, 2014, BIOCHIMIE, V99, P138, DOI 10.1016/j.biochi.2013.11.022; Gold ER, 1975, RECEPTOR SPECIFIC PR, P251; GOLDSTEIN IJ, 1980, NATURE, V285, P66, DOI 10.1038/285066b0; Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628; Gurjar MM, 1998, BBA-GEN SUBJECTS, V1381, P256, DOI 10.1016/S0304-4165(98)00034-8; Harata K, 2001, ACTA CRYSTALLOGR D, V57, P1513, DOI 10.1107/S090744490101232X; HESTER G, 1995, NAT STRUCT BIOL, V2, P472, DOI 10.1038/nsb0695-472; KAN VL, 1988, J INFECT DIS, V158, P407, DOI 10.1093/infdis/158.2.407; Khan MJ, 2013, PLOS ONE, V8; LADBURY JE, 1994, BIOCHEMISTRY-US, V33, P3688, DOI 10.1021/bi00178a027; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Marcos MJ, 2000, EUR J BIOCHEM, V267, P2127, DOI 10.1046/j.1432-1327.2000.01233.x; Mullen CA, 1996, J MOL BIOL, V262, P746, DOI 10.1006/jmbi.1996.0549; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; NG TB, 1989, INT J BIOCHEM, V21, P149, DOI 10.1016/0020-711X(89)90103-1; Nicholson EM, 1996, BIOCHEMISTRY-US, V35, P11369, DOI 10.1021/bi960863y; Pace CN, 2000, PROTEINS, P1; Petnual P, 2010, FOOD SCI BIOTECHNOL, V19, P907, DOI 10.1007/s10068-010-0128-5; PINEDA T, 1995, EUR J BIOCHEM, V228, P683, DOI 10.1111/j.1432-1033.1995.0683m.x; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; RAIKHEL NV, 1993, ANNU REV PLANT PHYS, V44, P591, DOI 10.1146/annurev.pp.44.060193.003111; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Sharma V, 1997, J MOL BIOL, V267, P433, DOI 10.1006/jmbi.1996.0863; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Sinha S, 2005, BIOPHYS J, V88, P4243, DOI 10.1529/biophysj.105.061309; SPEERT DP, 1988, J CLIN INVEST, V82, P872, DOI 10.1172/JCI113692; Transue TR, 1997, NAT STRUCT BIOL, V4, P779, DOI 10.1038/nsb1097-779; VANDAMME EJM, 1995, PLANT PHYSIOL, V107, P1147, DOI 10.1104/pp.107.4.1147; VANDAMME EJM, 1988, PHYSIOL PLANTARUM, V73, P52, DOI 10.1111/j.1399-3054.1988.tb09192.x; WRIGHT HT, 1991, J MOL EVOL, V33, P283, DOI 10.1007/BF02100680	42	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103579	10.1371/journal.pone.0103579	http://dx.doi.org/10.1371/journal.pone.0103579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25140525	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200009
J	Friesenhengst, A; Pribitzer-Winner, T; Schreiber, M				Friesenhengst, Andrea; Pribitzer-Winner, Tamara; Schreiber, Martin			Association of the G473A Polymorphism and Expression of Lysyl Oxidase with Breast Cancer Risk and Survival in European Women: A Hospital-Based Case-Control Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; GENE-EXPRESSION; PROPEPTIDE DOMAIN; OVARIAN-CANCER; METASTASIS; LOX; POPULATION; HYPOXIA; SUSCEPTIBILITY; SPECIFICITY	Background: Lysyl oxidase (LOX) is an extracellular enzyme essential for the covalent crosslinking of extracellular matrix proteins and may also have additional functions. LOX expression can be both up- and downregulated in cancer and is associated both with tumour suppression and metastasis progression. The G473A polymorphism (rs1800449) results in the Arg158Gln amino acid substitution in the LOX propeptide, compromises its tumour suppressive activity, and was associated with an increased breast cancer risk in a Chinese Han population. In the first hospital-based case-control study in European women, we aimed at investigating the association of LOX expression and the G473A polymorphism with breast cancer risk and survival in unselected and estrogen receptor (ER) negative patients. Methodology/Principal Findings: The G473A polymorphism was genotyped in 386 breast cancer patients and 243 female controls. Moreover, LOX mRNA expression was quantified in the tumors of 105 patients by qRT-PCR. We found that the minor A-allele of this polymorphism is associated with a later age at breast cancer onset, a trend towards a decreased disease-free and metastasis-free survival, but not with an increased breast cancer risk. LOX mRNA expression was significantly elevated in tumours of patients older than 55 years, postmenopausal patients, estrogen receptor positive tumours, and p53 negative tumours, but was unaffected by G473A genotype in tumours and breast cancer cell lines. High LOX expression was associated with a poor disease-free and metastasis-free survival in ER negative but not ER positive patients. LOX expression was an independent prognostic parameter in multivariate analysis, whereas G473A genotype was not. A small, distinct subgroup of the ER negative patients was identified which exhibited a considerably elevated LOX expression and a very poor disease-free (p = 0.001) and metastasis-free survival (p = 0.0003). Conclusions/Significance: This newly identified ER negative/LOX high subgroup may be a suitable collective for future individualized breast cancer diagnosis and therapy.	[Friesenhengst, Andrea; Pribitzer-Winner, Tamara; Schreiber, Martin] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Pribitzer-Winner, Tamara] Univ Appl Sci, Vienna, Austria; [Schreiber, Martin] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Schreiber, M (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria.	martin.schreiber@meduniwien.ac.at	Martin, Schreiber/F-2175-2013	Martin, Schreiber/0000-0003-1102-7789	Austrian Ministry of Education, Science and the Arts (Austrian Genome Research Program GEN-AU); Anniversary Fund of the "Oesterreichische Nationalbank" [12994]	Austrian Ministry of Education, Science and the Arts (Austrian Genome Research Program GEN-AU); Anniversary Fund of the "Oesterreichische Nationalbank"	This study was supported by the Austrian Ministry of Education, Science and the Arts (Austrian Genome Research Program GEN-AU) (http://www.genau.at/); Anniversary Fund of the "Oesterreichische Nationalbank" (12994) (http://www.oenb.at/en/About-Us/Research-Promotion/The-OeNB-Anniversary-Fund.html.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031188; Baker AM, 2011, JNCI-J NATL CANCER I, V103, P407, DOI 10.1093/jnci/djq569; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Behmoaras J, 2008, REJUV RES, V11, P883, DOI 10.1089/rej.2008.0760; Bouez C, 2006, CLIN CANCER RES, V12, P1463, DOI 10.1158/1078-0432.CCR-05-1456; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3; Kerjaschki D, 2011, J CLIN INVEST, V121, P2000, DOI 10.1172/JCI44751; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041610; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Pacher M, 2007, CARCINOGENESIS, V28, P49, DOI 10.1093/carcin/bgl091; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Proestling K, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0047325; Ren JH, 2011, DNA CELL BIOL, V30, P111, DOI 10.1089/dna.2010.1098; Rost T, 2003, ANTICANCER RES, V23, P1565; Shi WW, 2012, TUMOR BIOL, V33, P2379, DOI 10.1007/s13277-012-0501-5; Sleeman JP, 2012, SEMIN CANCER BIOL, V22, P174, DOI 10.1016/j.semcancer.2012.02.007; Spano D, 2012, SEMIN CANCER BIOL, V22, P234, DOI 10.1016/j.semcancer.2012.03.006; Stampfer M R, 1988, Cancer Treat Res, V40, P1; Taubenschuss E, 2013, INT J MOL SCI, V14, P15376, DOI 10.3390/ijms140815376; Vinatzer U, 2005, CLIN CANCER RES, V11, P8348, DOI 10.1158/1078-0432.CCR-05-0841; Wang X, 2012, J INT MED RES, V40, P917, DOI 10.1177/147323001204000310; Wu J, 2012, GENET TEST MOL BIOMA, V16, P915, DOI 10.1089/gtmb.2011.0374; Yoon JH, 2011, APMIS, V119, P762, DOI 10.1111/j.1600-0463.2011.02802.x	32	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105579	10.1371/journal.pone.0105579	http://dx.doi.org/10.1371/journal.pone.0105579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141126	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200104
J	Seo, J; Lee, BK; Jin, SU; Park, JW; Kim, YT; Ryeom, HK; Lee, J; Suh, KJ; Kim, SH; Park, SJ; Jeong, KS; Ham, JO; Kim, Y; Chang, Y				Seo, Jeehye; Lee, Byung-Kook; Jin, Seong-Uk; Park, Jang Woo; Kim, Yang-Tae; Ryeom, Hun-Kyu; Lee, Jongmin; Suh, Kyung Jin; Kim, Suk Hwan; Park, Sin-Jae; Jeong, Kyoung Sook; Ham, Jung-O; Kim, Yangho; Chang, Yongmin			Lead-Induced Impairments in the Neural Processes Related to Working Memory Function	PLOS ONE			English	Article							BLOOD LEAD; LONGITUDINAL DECLINE; COGNITIVE FUNCTION; NATIONAL-HEALTH; PARIETAL CORTEX; EXPOSURE; METAANALYSIS; ATTENTION; BRAIN; FMRI	Background: It is well known that lead exposure induces neurotoxic effects, which can result in a variety of neurocognitive dysfunction. Especially, occupational lead exposures in adults are associated with decreases in cognitive performance including working memory. Despite recent advances in human neuroimaging techniques, the neural correlates of lead-exposed cognitive impairment remain unclear. Therefore, this study was aimed to compare the neural activations in relation to working memory function between the lead-exposed subjects and healthy controls. Methodology/Principal Findings: Thirty-one lead-exposed subjects and 34 healthy subjects performed an n-back memory task during MRI scan. We performed fMRI using the 1-back and 2-back memory tasks differing in cognitive demand. Functional MRI data were analyzed using within-and between-group analysis. We found that the lead-exposed subjects showed poorer working memory performance during high memory loading task than the healthy subjects. In addition, between-group analyses revealed that the lead-exposed subjects showed reduced activation in the dorsolateral prefrontal cortex, ventrolateral prefrontal cortex, pre supplementary motor areas, and inferior parietal cortex. Conclusions/Significance: Our findings suggest that functional abnormalities in the frontoparietal working memory network might contribute to impairments in maintenance and manipulation of working memory in the lead-exposed subjects.	[Seo, Jeehye; Jin, Seong-Uk; Park, Jang Woo; Chang, Yongmin] Kyungpook Natl Univ, Dept Med & Biol Engn, Taegu, South Korea; [Lee, Byung-Kook] Korean Ind Hlth Assoc, Seoul, South Korea; [Kim, Yang-Tae] Keimyung Univ, Sch Med, Dept Psychiat, Taegu, South Korea; [Ryeom, Hun-Kyu; Lee, Jongmin; Chang, Yongmin] Kyungpook Natl Univ, Coll Med, Dept Radiol, Taegu, South Korea; [Suh, Kyung Jin] Dongguk Univ, Dept Radiol, Coll Med, Gyeongju, South Korea; [Kim, Suk Hwan; Kim, Yangho] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Occupat & Environm Med, Ulsan 680749, South Korea; [Park, Sin-Jae] Univ Ulsan, Coll Med, Dept Psychiat, Ulsan Univ Hosp, Ulsan 680749, South Korea; [Jeong, Kyoung Sook] Dongguk Univ, Ilsan Hosp, Dept Occupat & Environm Med, Coll Med, Goyang, South Korea; [Ham, Jung-O] Soonchunhyan Univ Hosp, Dept Occupat & Environm Med, Cheonan, South Korea; [Chang, Yongmin] Kyungpook Natl Univ, Coll Med, Dept Mol Med, Taegu, South Korea	Kyungpook National University; Keimyung University; Kyungpook National University; Dongguk University; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; Dongguk University; NHIS Ilsan Hospital; Kyungpook National University	Kim, Y (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Occupat & Environm Med, Ulsan 680749, South Korea.	yanghokm@nuri.net; ychang@knu.ac.kr	Jeong, Kyoung Sook/AAI-6244-2021	Jeong, Kyoung Sook/0000-0002-6897-8289	Mid-career Researcher Program through NRF - MEST [2010-0004920]; Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092106]	Mid-career Researcher Program through NRF - MEST; Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This work was supported by Mid-career Researcher Program through NRF grant funded by the MEST (No. 2010-0004920). This study was also supported by a grant of the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A092106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadin H, 2007, TOXICOLOGICAL PROFIL; Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; BAKER EL, 1984, BRIT J IND MED, V41, P352; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Benignus VA, 2005, ENVIRON HEALTH PERSP, V113, P532, DOI 10.1289/ehp.7518; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BLUMBERG WE, 1977, J LAB CLIN MED, V89, P712; Chein JM, 2003, J NEUROLINGUIST, V16, P315, DOI 10.1016/S0911-6044(03)00021-6; Fiedler N, 2003, AM J IND MED, V44, P413, DOI 10.1002/ajim.10287; Gidlow DA, 2004, OCCUP MED-OXFORD, V54, P76, DOI 10.1093/occmed/kqh019; Grajewski B, 2005, BIRTH DEFECTS RES B, V74, P157, DOI 10.1002/bdrb.20039; HEINEGAR.D, 1973, CLIN CHIM ACTA, V43, P305, DOI 10.1016/0009-8981(73)90466-X; Kennerley SW, 2004, J NEUROPHYSIOL, V91, P978, DOI 10.1152/jn.00651.2003; Khalil N, 2009, NEUROPSYCHOLOGY, V23, P10, DOI 10.1037/a0013757; Kim Y, 2012, ENVIRON RES, V118, P124, DOI 10.1016/j.envres.2012.06.003; Kneip T. J., 1988, METHODS BIOL MONITOR, P199; Kumar S, 2004, J OCCUP HEALTH, V46, P1, DOI 10.1539/joh.46.1; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Meyer-Baron M, 2000, ARCH TOXICOL, V73, P510, DOI 10.1007/s002040050002; Mikkelsen S, 1997, ENVIRON RES, V73, P101, DOI 10.1006/enrs.1997.3706; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DU, 2002, ANN OCCUP HYG, V46, P237, DOI 10.1093/annhyg/mef036; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; Pollmann S, 2000, EXP BRAIN RES, V133, P12, DOI 10.1007/s002210000396; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Sanders Talia, 2009, Reviews on Environmental Health, V24, P15; Schwartz BS, 2005, EPIDEMIOLOGY, V16, P106, DOI 10.1097/01.ede.0000147109.62324.51; Schwartz BS, 2000, NEUROLOGY, V55, P1144, DOI 10.1212/WNL.55.8.1144; Shih RA, 2006, NEUROLOGY, V67, P1556, DOI 10.1212/01.wnl.0000239836.26142.c5; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; THOMAS WJ, 1982, J PEDIATR-US, V101, P32, DOI 10.1016/S0022-3476(82)80175-3; Todd AC, 2001, OCCUP ENVIRON MED, V58, P73, DOI 10.1136/oem.58.2.73; TOMOKUNI K, 1992, IND HEALTH, V30, P119, DOI 10.2486/indhealth.30.119; Trope I, 2001, PEDIATRICS, V107, P1437, DOI 10.1542/peds.107.6.1437; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Weaver VM, 2003, OCCUP ENVIRON MED, V60, P551, DOI 10.1136/oem.60.8.551; Yuan WH, 2006, PEDIATRICS, V118, P971, DOI 10.1542/peds.2006-0467; [No title captured]	40	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105308	10.1371/journal.pone.0105308	http://dx.doi.org/10.1371/journal.pone.0105308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141213	Green Published, gold, Green Submitted			2022-12-25	WOS:000342687200070
J	Fan, WN; Zhang, SH; Du, HQ; Sun, XG; Shi, YH; Wang, CZ				Fan, Wenna; Zhang, Senhao; Du, Hongqi; Sun, Xiaoge; Shi, Yinghua; Wang, Chengzhang			Genome-Wide Identification of Different Dormant Medicago sativa L. MicroRNAs in Response to Fall Dormancy	PLOS ONE			English	Article							SMALL RNAS; ALFALFA VARIETIES; PLANT MICRORNAS; GENE-EXPRESSION; TRUNCATULA; PHYTOCHROME; PATHWAY; ROOTS; CARBOHYDRATE; ANNOTATION	Background: MicroRNAs (miRNAs) are a class of regulatory small RNAs (sRNAs) that regulate gene post-transcriptional expression in plants and animals. Highthroughput sequencing technology is capable of identifying small RNAs in plant species. Alfalfa (Medicago sativa L.) is one of the most widely cultivated perennial forage legumes worldwide, and fall dormancy is an adaptive characteristic related to the biomass production and winter survival in alfalfa. Here, we applied highthroughput sRNA sequencing to identify some miRNAs that were responsive to fall dormancy in standard variety (Maverick and CUF101) of alfalfa. Results: Four sRNA libraries were generated and sequenced from alfalfa leaves in two typical varieties at distinct seasons. Through integrative analysis, we identified 51 novel miRNA candidates of 206 families. Additionally, we identified 28 miRNAs associated with fall dormancy in standard variety (Maverick and CUF101), including 20 known miRNAs and eight novel miRNAs. Both high-throughput sequencing and RT-qPCR confirmed that eight known miRNA members were up-regulated and six known miRNA members were down-regulated in response to fall dormancy in standard variety (Maverick and CUF101). Among the 51 novel miRNA candidates, five miRNAs were up-regulated and three miRNAs were down-regulated in response to fall dormancy in standard variety (Maverick and CUF101), and five of them were confirmed by Northern blot analysis. Conclusion: We identified 20 known miRNAs and eight new miRNA candidates that were responsive to fall dormancy in standard variety (Maverick and CUF101) by high-throughput sequencing of small RNAs from Medicago sativa. Our data provide a useful resource for investigating miRNA-mediated regulatory mechanisms of fall dormancy in alfalfa, and these findings are important for our understanding of the roles played by miRNAs in the response of plants to abiotic stress in general and fall dormancy in alfalfa.	[Fan, Wenna; Zhang, Senhao; Du, Hongqi; Sun, Xiaoge; Shi, Yinghua; Wang, Chengzhang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China	Henan Agricultural University	Wang, CZ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	wangcz@henau.edu.cn		Zhang, Senhao/0000-0002-9231-9750	China Forage and Grass Research System [CARS-35]; National Natural Science Foundation of China [31172261]	China Forage and Grass Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by China Forage and Grass Research System (CARS-35) and the National Natural Science Foundation of China (No. 31172261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ariss JJ, 2007, CROP SCI, V47, P2274, DOI 10.2135/cropsci2006.12.0782; Arocho A, 2006, DIAGN MOL PATHOL, V15, P56, DOI 10.1097/00019606-200603000-00009; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BULA RJ, 1954, AGRON J, V46, P397, DOI 10.2134/agronj1954.00021962004600090001x; CASTONGUAY Y, 1995, CROP SCI, V35, P509, DOI 10.2135/cropsci1995.0011183X003500020038x; Chen L, 2012, PLANT SCI, V184, P14, DOI 10.1016/j.plantsci.2011.11.007; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Cunningham SM, 2001, CROP SCI, V41, P1091, DOI 10.2135/cropsci2001.4141091x; Cunningham SM, 1998, J PLANT PHYSIOL, V153, P220, DOI 10.1016/S0176-1617(98)80069-2; Deng Y, 2013, STEM CELLS DEV, V22, P2278, DOI 10.1089/scd.2012.0686; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Du H, 2013, ACTA AGRESTIA SINICA, V21, P708; Fairey DT, 1996, CAN J PLANT SCI, V76, P429, DOI 10.4141/cjps96-076; Fan WenNa, 2014, Acta Prataculturae Sinica, V23, P177; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; HEINRICHS D. H., 1960, CANADIAN JOUR PLANT SCI, V40, P638; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Lacombe S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-123; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARSEN K. L., 1963, CROP SCI, V3, P234, DOI 10.2135/cropsci1963.0011183X000300030018x; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McKenzie J. S., 1988, Alfalfa and alfalfa improvement, P259; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Rimi F, 2014, AGRON J, V106, P1258, DOI 10.2134/agronj13.0495; Samac DA, 2006, CHEM IND-SER, V112, P79; Schneider M, 1984, UNIFOLIATE INTERNODE, P96; Schwab PM, 1996, CROP SCI, V36, P418, DOI 10.2135/cropsci1996.0011183X003600020034x; Sharma R, 2001, CURR SCI INDIA, V80, P178; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; SMITH D., 1961, Canadian Journal of Plant Science, V41, P244; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; STOUT DG, 1989, CAN J PLANT SCI, V69, P491, DOI 10.4141/cjps89-060; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Teuber L, 1998, FALL DORMANCY, P2; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Trinh TH, 1998, PLANT CELL REP, V17, P345, DOI 10.1007/s002990050405; Verdonk JC, 2013, BOTANY, V91, P117, DOI 10.1139/cjb-2012-0166; VOLENEC JJ, 1991, PLANT PHYSIOL, V96, P786, DOI 10.1104/pp.96.3.786; Wang CZ, 2008, J PLANT NUTR, V31, P1257, DOI 10.1080/01904160802135027; Wang CZ, 2009, AGRON J, V101, P1146, DOI 10.2134/agronj2009.0026; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang TZ, 2014, PLANT CELL, V18, P2051; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yifen C, 1990, PRATACULTURAL SCI, V7, P60; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	70	20	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114612	10.1371/journal.pone.0114612	http://dx.doi.org/10.1371/journal.pone.0114612			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473944	Green Published, gold, Green Submitted			2022-12-25	WOS:000346382500049
J	Lin, Y; Qian, XN; Krischer, J; Vehik, K; Lee, HS; Huang, S				Lin, Ying; Qian, Xiaoning; Krischer, Jeffrey; Vehik, Kendra; Lee, Hye-Seung; Huang, Shuai			A Rule-Based Prognostic Model for Type 1 Diabetes by Identifying and Synthesizing Baseline Profile Patterns	PLOS ONE			English	Article							RISK; PROGRESSION; GLUCOSE; PERIOD; TRIAL; ONSET; AGE	Objective: To identify the risk-predictive baseline profile patterns of demographic, genetic, immunologic, and metabolic markers and synthesize these patterns for risk prediction. Research Design and Methods: RuleFit is used to identify the risk-predictive baseline profile patterns of demographic, immunologic, and metabolic markers, using 356 subjects who were randomized into the control arm of the prospective Diabetes Prevention Trial-Type 1 (DPT-1) study. A novel latent trait model is developed to synthesize these baseline profile patterns for disease risk prediction. The primary outcome was Type 1 Diabetes (T1D) onset. Results: We identified ten baseline profile patterns that were significantly predictive to the disease onset. Using these ten baseline profile patterns, a risk prediction model was built based on the latent trait model, which produced superior prediction performance over existing risk score models for T1D. Conclusion: Our results demonstrated that the underlying disease progression process of T1D can be detected through some risk-predictive patterns of demographic, immunologic, and metabolic markers. A synthesis of these patterns provided accurate prediction of disease onset, leading to more cost-effective design of prevention trials of T1D in the future.	[Lin, Ying; Huang, Shuai] Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL 33606 USA; [Qian, Xiaoning] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA; [Krischer, Jeffrey; Vehik, Kendra; Lee, Hye-Seung] Univ S Florida, Coll Med, Dept Pediat, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; Texas A&M University System; Texas A&M University College Station; State University System of Florida; University of South Florida	Huang, S (corresponding author), Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL 33606 USA.	shuaihuang@usf.edu	Lin, Ying/AAE-1879-2020; Lin, Zhenyue/O-1211-2019; Lin, Zhenyue/H-1569-2017	Lin, Zhenyue/0000-0002-6367-2459; Lin, Zhenyue/0000-0002-6367-2459; zhang, muqing/0000-0003-3138-3422	University of South Florida; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061010, U01DK085476, UC4DK097835, U01DK061058, T32DK007161, UC4DK117009, U01DK085461] Funding Source: NIH RePORTER	University of South Florida; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by the University of South Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker F.B., 2004, ITEM RESPONSE THEORY; Bingley PJ, 1996, DIABETES, V45, P1720, DOI 10.2337/diabetes.45.12.1720; Bougneres P, 2008, J EXP MED, V205, P2953, DOI 10.1084/jem.20082622; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chase HP, 2001, J PEDIATR-US, V138, P244, DOI 10.1067/mpd.2001.111274; Diabetes Prevention Trial-Type 1 Diabetes Study Group, 2005, DIABETES CARE, V28, P1068; Frieman JH, 2008, ANN APPL STAT, V2, P916, DOI 10.1214/07-AOAS148; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gimenez M, 2007, DIABETES CARE, V30, P1593, DOI 10.2337/dc06-2578; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Lunn D., 2012, BUGS BOOK PRACTICAL; Mrena S, 2006, DIABETES CARE, V29, P662, DOI 10.2337/diacare.29.03.06.dc05-0774; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Sosenko JM, 2008, DIABETES CARE, V31, P2188, DOI 10.2337/dc08-0935; Sosenko JM, 2008, DIABETES CARE, V31, P528, DOI 10.2337/dc07-1459; Sosenko JM, 2011, DIABETES CARE, V34, P1785, DOI 10.2337/dc11-0641; Sosenko JM, 2006, DIABETES CARE, V29, P643, DOI 10.2337/diacare.29.03.06.dc05-1006; SRIKANTA S, 1984, DIABETOLOGIA, V27, P146, DOI 10.1007/BF00275674; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vella A, 2011, CLIN DILEMMAS DIABET; Xu P, 2010, DIABETES CARE, V33, P2508, DOI 10.2337/dc10-0802; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	24	56	72	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e91095	10.1371/journal.pone.0091095	http://dx.doi.org/10.1371/journal.pone.0091095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	25141192	Green Published, gold			2022-12-25	WOS:000338278100001
J	Tan, YW; Ge, GH; Pan, TL; Wen, DF; Gan, JH				Tan, Youwen; Ge, Guohong; Pan, Tengli; Wen, Danfeng; Gan, Jianhe			A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							CIRCULATING MICRORNAS; HEPATIC STEATOSIS; EXPRESSION LEVELS; RT-PCR; STEATOHEPATITIS; FIBROSIS; MIR-122; INJURY; INFLAMMATION; CARCINOMA	Background: The invasive nature of liver biopsy makes the histopathological diagnosis of non-alcoholic fatty liver disease (NAFLD) difficult and its diagnostic performance unsatisfactory. The present study aimed to identify a serum microRNA (miRNA) expression profile that could serve as a novel diagnostic biomarker for NAFLD. Methods: Serum miRNA expression was investigated using three cohorts comprising 465 participants (healthy controls and NAFLD patients) recruited between August 2010 and June 2013. miRNA expression was initially screened by Illumina sequencing using serum samples pooled from 20 patients and 20 controls. Quantitative reverse transcriptase polymerase chain reaction assay was then used to evaluate the expression of selected miRNAs. A logistic regression model was constructed using a training cohort (n = 242) and validated using another cohort (n = 183). The area under the receiver operating characteristic curve (AUC) was used to evaluate diagnostic accuracy. Results: We identified an miRNA panel (hsa-miR-122-5p, hsa-miR-1290, hsa-miR-27b-3p, and hsa-miR-192-5p) with a high diagnostic accuracy for NAFLD. The satisfactory diagnostic performance of the miRNA panel remained regardless of the NAFLD activity score (NAS) status. There was significant difference between the AUC values of the miRNA panel and those of ALT (AUC = 0.786, 95% CI = 0.717-0.855; P = 0.142) and FIB-4 (AUC = 0.795, 95% CI = 0.730-0.860; sensitivity = 69.9%, specificity = 83.7%. Conclusion: We identified a serum microRNA panel with considerable clinical value in NAFLD diagnosis. The results indicate that the miRNA panel is a more sensitive and specific biomarker for NAFLD than ALT and FIB-4.	[Tan, Youwen; Gan, Jianhe] Soochow Univ, Affiliated Hosp 1, Dept Infect Dis, Suzhou, Peoples R China; [Tan, Youwen; Ge, Guohong; Pan, Tengli; Wen, Danfeng] Zhenjiang Affiliated Jiangsu Univ, Hosp 3, Dept Hepatosis, Zhenjiang, Peoples R China	Soochow University - China	Gan, JH (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Infect Dis, Suzhou, Peoples R China.	ganjianhe@aliyun.com			Natural Science Foundation of Jiangsu Province, China [BK2011151]; Medical Project of Health Department Jiangsu Province [H201248]; Social Development Project of Zhenjiang City [SH201346]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Medical Project of Health Department Jiangsu Province; Social Development Project of Zhenjiang City	This work was supported by the Natural Science Foundation of Jiangsu Province, China (BK2011151) (http://www.jstd.gov.cn/), Medical Project of Health Department Jiangsu Province (H201248) (http://www.jswst.gov.cn/), and the Social Development Project of Zhenjiang City (SH201346) (http://kjj.zhenjiang.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Blanco-Calvo M, 2012, SENSORS-BASEL, V12, P9349, DOI 10.3390/s120709349; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Castera L, 2010, LANCET, V375, P1419, DOI 10.1016/S0140-6736(09)62195-4; Cazanave SC, 2011, J LIPID RES, V52, P1517, DOI 10.1194/jlr.M014654; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen WJ, 2012, ATHEROSCLEROSIS, V222, P314, DOI 10.1016/j.atherosclerosis.2012.01.020; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; Chen YP, 2013, LIVER INT, V33, P1257, DOI 10.1111/liv.12196; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Chiang YP, 2012, PATHOL ONCOL RES, V18, P585, DOI 10.1007/s12253-011-9480-x; De Minicis S, 2013, CURR PHARM DESIGN, V19, P5239; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fan JG, 2011, J DIGEST DIS, V12, P38, DOI 10.1111/j.1751-2980.2010.00476.x; Fernandez-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144; Ge Yan, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P908, DOI 10.3969/j.issn.1672-7347.2011.09.017; Geng L, 2013, ONCOGENE; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Gougelet A, 2013, M S-MED SCI, V29, P861, DOI 10.1051/medsci/20132910013; Gougelet A, 2013, WORLD J GASTROENTERO, V19, P440, DOI 10.3748/wjg.v19.i4.440; He Y, 2012, CELL SIGNAL, V24, P2268, DOI 10.1016/j.cellsig.2012.07.023; Hsu Shu-Hao, 2013, Curr Pathobiol Rep, V1, P53; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Iino I, 2013, CANCER SCI, V104, P624, DOI 10.1111/cas.12122; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Li A, 2013, CLIN CANCER RES, V19, P5252, DOI 10.1158/1078-0432.CCR-13-1899; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223; Mottin CC, 2004, OBES SURG, V14, P635, DOI 10.1381/096089204323093408; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Poynard Thierry, 2005, Comp Hepatol, V4, P10; Shimamura T, 2008, J IMMUNOL, V181, P4656, DOI 10.4049/jimmunol.181.7.4656; Singaravelu R, 2014, HEPATOLOGY, V59, P98, DOI 10.1002/hep.26634; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Zhang H, 2012, WORLD J GASTROENTERO, V18, P5188, DOI 10.3748/wjg.v18.i37.5188; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zheng L, 2010, J GASTROEN HEPATOL, V25, P156, DOI 10.1111/j.1440-1746.2009.05949.x	42	197	207	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105192	10.1371/journal.pone.0105192	http://dx.doi.org/10.1371/journal.pone.0105192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	24736723	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200058
J	Tan, Y; Liu, TR; Hu, SW; Tian, D; Li, C; Zhong, JK; Sun, HG; Luo, TT; Lai, WY; Guo, ZG				Tan, Ying; Liu, Ting Rong; Hu, Shui Wang; Tian, Di; Li, Chen; Zhong, Jian Kai; Sun, Hai Ge; Luo, Tian Tian; Lai, Wen Yan; Guo, Zhi-Gang			Acute Coronary Syndrome Remodels the Protein Cargo and Functions of High-Density Lipoprotein Subfractions	PLOS ONE			English	Article							CHOLESTEROL EFFLUX; PROTEOMIC ANALYSIS; DYSFUNCTIONAL HDL; APOLIPOPROTEIN-E; MACROPHAGES; DISEASE; ATHEROSCLEROSIS; INFLAMMATION; HEMOGLOBIN; ACTIVATION	Objectives: This study examined alterations in the functions and proteome of high-density lipoprotein (HDL) subfractions (HDL2 and HDL3) isolated from patients with acute coronary syndrome (ACS) compared with control subjects. Methods: We measured HDL subfraction cholesterol efflux capacity, inflammatory index (HII), paraoxonase-1 (PON1) activity, and lipid hydroperoxide (LOOH) levels in both male age-matched controls and the ACS group (n = 40/group). Additionally, proteomic analysis was used to monitor changes in the HDL subfraction proteome between controls and ACS subjects. Results: Both HDL2 and HDL3 from ACS patients had greater HII and LOOH levels compared with controls (P<0.001); PON1 activity and cholesterol efflux capacity in both HDL2 and HDL3 from the ACS group were significantly less than those of controls (P<0.001). Using proteomic analysis, we demonstrated that, compared with the control group, nine proteins were selectively enriched in HDL3 from subjects with ACS, and ras-related protein Rab-7b was decreased in HDL3. Additionally, in the ACS subjects, 12 proteins were decreased in HDL2 and 4 proteins were increased in HDL2. Conclusions: Functional HDL subfractions shifted to dysfunctional HDL subfractions during ACS, and the functional impairment was linked to remodeled protein cargo in HDL subfractions from ACS patients.	[Tan, Ying; Liu, Ting Rong; Tian, Di; Li, Chen; Zhong, Jian Kai; Sun, Hai Ge; Luo, Tian Tian; Lai, Wen Yan; Guo, Zhi-Gang] Southern Med Univ, Nanfang Hosp, Div Cardiol, Guangzhou, Guangdong, Peoples R China; [Hu, Shui Wang] Southern Med Univ, Lab Pathophysiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Guo, ZG (corresponding author), Southern Med Univ, Nanfang Hosp, Div Cardiol, Guangzhou, Guangdong, Peoples R China.	guozhigang126@126.com			Natural Science Foundation of Guangdong Province of China [10151051501000073]; Special Doctor Station Foundation of the University of the Education Department of China [20104433110006]	Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Special Doctor Station Foundation of the University of the Education Department of China	This work was supported by the Natural Science Foundation of Guangdong Province of China (10151051501000073) and the Special Doctor Station Foundation of the University of the Education Department of China (20104433110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaili K, 2012, BBA-MOL CELL BIOL L, V1821, P405, DOI 10.1016/j.bbalip.2011.07.013; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Arab K, 2004, ANAL BIOCHEM, V325, P158, DOI 10.1016/j.ab.2003.10.022; Beltowski J, 2005, PHARMACOL RES, V51, P523, DOI 10.1016/j.phrs.2005.01.007; Berrougui H, 2007, J LIPID RES, V48, P328, DOI 10.1194/jlr.M600167-JLR200; Charles-Schoeman C, 2009, ARTHRITIS RHEUM-US, V60, P2870, DOI 10.1002/art.24802; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Di Filippo C, 2006, CARDIOVASC DRUG REV, V24, P77; Dodani S, 2008, INT J CARDIOL, V129, P125, DOI 10.1016/j.ijcard.2007.12.019; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Guo ZG, 2012, CHEM PHYS LIPIDS, V165, P32, DOI 10.1016/j.chemphyslip.2011.10.005; Julia Z, 2010, J LIPID RES, V51, P3350, DOI 10.1194/jlr.P009746; Karlsson H, 2005, PROTEOMICS, V5, P1431, DOI 10.1002/pmic.200401010; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Li XA, 1998, BIOCHEM BIOPH RES CO, V244, P249, DOI 10.1006/bbrc.1998.8248; Lin CY, 1999, J LIPID RES, V40, P1618; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Nabais S, 2009, PROGNOSTIC IMPACT HE; Nagy E, 2009, ARTERIOSCLER THROMB, V30, P1347; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Navab M, 2009, J LIPID RES, V50, P1538, DOI 10.1194/jlr.M800539-JLR200; Ortiz-Munoz G, 2009, FASEB J, V23, P3129, DOI 10.1096/fj.08-127928; Ostos MA, 2001, ARTERIOSCL THROM VAS, V21, P1023, DOI 10.1161/01.ATV.21.6.1023; Previsdomini M, 2007, AM J CARDIOL, V100, P579, DOI 10.1016/j.amjcard.2007.03.065; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Schultz JR, 1993, PROTEIN COMPOSITION; Shao BH, 2006, CURR OPIN CARDIOL, V21, P322, DOI 10.1097/01.hco.0000231402.87232.aa; Song ZQ, 2010, ATHEROSCLEROSIS, V211, P90, DOI 10.1016/j.atherosclerosis.2010.01.046; Stewart CR, 2005, BIOCHEMISTRY-US, V44, P9108, DOI 10.1021/bi050497v; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Watanabe J, 2009, J BIOL CHEM, V284, P18292, DOI 10.1074/jbc.M109.017202; Watson CE, 2011, J LIPID RES, V52, P361, DOI 10.1194/jlr.M011098; YAMAMOTO N, 1991, J IMMUNOL, V147, P273; Yao M, 2009, J IMMUNOL, V183, P1751, DOI 10.4049/jimmunol.0900249	38	197	207	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94264	10.1371/journal.pone.0094264	http://dx.doi.org/10.1371/journal.pone.0094264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736723	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600055
J	Raizada, N; Sachdeva, KS; Chauhan, DS; Malhotra, B; Reddy, K; Dave, PV; Mundade, Y; Patel, P; Ramachandran, R; Das, R; Solanki, R; Wares, DF; Sahu, S; O'Brien, R; Paramasivan, CN; Dewan, PK				Raizada, Neeraj; Sachdeva, K. S.; Chauhan, D. S.; Malhotra, Bharti; Reddy, Kishore; Dave, P. V.; Mundade, Yamuna; Patel, Pranav; Ramachandran, Ranjani; Das, Ram; Solanki, Rajesh; Wares, Douglas Fraser; Sahu, Suvanand; O'Brien, Rick; Paramasivan, C. N.; Dewan, Puneet K.			A Multi-Site Validation in India of the Line Probe Assay for the Rapid Diagnosis of Multi-Drug Resistant Tuberculosis Directly from Sputum Specimens	PLOS ONE			English	Article							GENOTYPE MTBDR ASSAY; MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; TREATMENT OUTCOMES; SOUTH-AFRICA; METAANALYSIS; RIFAMPIN; STRAINS; PERFORMANCE; MUTATIONS	Rifampicin (R) and isoniazid (H) are key first-line anti-tuberculosis drugs. Failure to detect resistance to these two drugs early results in treatment failure and poor clinical outcomes. The study purpose was to validate the use of the GenoType MTBDRplus line probe assay (LPA) to detect resistance to R and H in Mycobacterium tuberculosis strains directly from smearpositive sputum samples in India. Method: Smear positive sputum specimens from 320 patients were subjected to LPA and results compared against those from conventional Lowenstein Jensen (LJ) culture and drug susceptibility testing (C& DST). All specimens with discordant R DST results were subjected to either sequencing of the rpoB gene and/or repeat DST on liquid culture (MGIT 960) at a National Reference Laboratory. Results: Significantly higher proportion of interpretable results were observed with LPA compared to LJ C& DST (94% vs. 80%, p-value,0.01). A total of 248 patients had both LJ and LPA DST results available; 232 (93.5%) had concordant R DST results. Among the 16 discordant R DST results, 13 (81%) were resolved in agreement with LPA results. Final LPA performance characteristics were sensitivity 96% (CI: 90%-98%), specificity 99% (CI: 95%-99%), positive predictive value 99% (CI: 95%-99%), and negative predictive value 95% (CI: 89%-98%). The median turnaround testing time, including specimen transportation time, on LPA was 11 days as compared with 89 days for LJ C&DST. Conclusions: LPA proved highly accurate in the rapid detection of R resistance. The reduction in time to diagnosis may potentially enable earlier commencement of the appropriate drug therapy, leading to some reduction of transmission of drug-resistant strains.	[Raizada, Neeraj; Reddy, Kishore; Paramasivan, C. N.] Fdn Innovat New Diagnost, New Delhi, India; [Sachdeva, K. S.] Govt India, Cent TB Div, Directorate Gen Hlth Serv, Minist Hlth & Family Welf, New Delhi, India; [Chauhan, D. S.; Das, Ram] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Malhotra, Bharti] Sawai Man Singh Med Coll, Jaipur, Rajasthan, India; [Dave, P. V.; Patel, Pranav; Solanki, Rajesh] Directorate Hlth Serv, Gandhinagar, Gujarat, India; [Mundade, Yamuna] UNITAID, Geneva, Switzerland; [Ramachandran, Ranjani; Dewan, Puneet K.] WHO, New Delhi, India; [Wares, Douglas Fraser] WHO, Global TB Programme, CH-1211 Geneva, Switzerland; [Sahu, Suvanand] Stop TB Partnership, Geneva, Switzerland; [O'Brien, Rick] Fdn Innovat New Diagnost FIND, Geneva, Switzerland	Foundation For Innovative New Diagnostics; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; SMS Medical College & Hospital; World Health Organization; World Health Organization; Foundation For Innovative New Diagnostics	Raizada, N (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	drneerajraizada@gmail.com	Solanki, Dr. Rajesh/ABE-8666-2021	Solanki, Dr. Rajesh/0000-0003-3915-6064; Gray, Christen/0000-0002-9723-3032; Raizada, Neeraj/0000-0003-2116-332X; Nair, Sreenivas/0000-0002-2586-6797; Chauhan, Devendra Singh/0000-0001-6519-3200	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; [Anonymous], GEN MTBDRPLUS VERS 1; [Anonymous], 2012, GUID PROGR MAN DRUG, P19; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Brossier F, 2006, J CLIN MICROBIOL, V44, P3659, DOI 10.1128/JCM.01054-06; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cavusoglu C, 2006, J CLIN MICROBIOL, V44, P2338, DOI 10.1128/JCM.00425-06; Evans J, 2009, J ANTIMICROB CHEMOTH, V63, P11, DOI 10.1093/jac/dkn433; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1161; Hillemann D, 2005, J CLIN MICROBIOL, V43, P3699, DOI 10.1128/JCM.43.8.3699-3703.2005; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kent PT, 1985, GUIDE LEVEL 3 LAB; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Makinen J, 2006, J CLIN MICROBIOL, V44, P350, DOI 10.1128/JCM.44.2.350-352.2006; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Miotto P, 2006, J CLIN MICROBIOL, V44, P2485, DOI 10.1128/JCM.00083-06; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Revised National tuberculosis programme, RNTCP STAT REP 2009; Srisuwanvilai LO, 2008, DIAGN MICR INFEC DIS, V61, P402, DOI 10.1016/j.diagmicrobio.2008.02.015; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; VESTAL AL, 1977, US DHEW PUBLICATION, P15; World Health Organisation, WHOHTMTB2012411	24	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88626	10.1371/journal.pone.0088626	http://dx.doi.org/10.1371/journal.pone.0088626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586360	Green Submitted, gold, Green Published			2022-12-25	WOS:000331711900035
J	Hermann, P; Romero, C; Schmidt, C; Reis, C; Zerr, I				Hermann, Peter; Romero, Carlos; Schmidt, Christian; Reis, Clemens; Zerr, Inga			CSF Biomarkers and Neuropsychological Profiles in Patients with Cerebral Small-Vessel Disease	PLOS ONE			English	Article							WHITE-MATTER CHANGES; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; NINDS-AIREN; DIAGNOSIS; CRITERIA; PROTEIN; TAU; MRI	Despite existing criteria, differential diagnosis of Vascular Dementia (VD) and Alzheimer's disease (AD) remains difficult. The aim of this study is to figure out cognitive and biomarker profiles that may help to distinguish between VD, AD and AD + Cerebral Small Vessel Disease (CSVD). We examined a cohort of patients with CSVD (n = 92). After stratification of cognitive impaired patients (n = 59) using the standard CSF beta-amyloid 42/40 ratio cut-off point of 0.975, we obtained two groups which differed with respect to several features: 32 patients with normal beta-amyloid 42/40 ratio (>0.975) showed markedly impaired blood-brain-barrier function as indicated by an elevated albumin ratio (median 8.35). They also differed in cognitive profiles when compared to 27 patients with AD typical beta-amyloid ratio and normal albumin ratio. We also enrolled an additional group of patients with AD (no significant CSVD on MRI, n = 27) which showed no impairment of the blood-brain-barrier. We showed a negative correlation between the albumin ratio and executive cognitive function (p = 0.016) and a negative correlation between memory function and typical AD markers like Tau (p = 0.004) and p181-Tau (p = 0.023) in our cohort. We suppose that the group of patients with normal beta-amyloid ratio represents VD while patients in the other groups represent AD+CSVD and pure AD. Our results support the idea that a dysfunction of the blood-brain-barrier might be contributing factor in the development of cognitive decline in CSVD as it seems to be of more importance than the severity of white matter lesions.	[Hermann, Peter; Schmidt, Christian; Reis, Clemens; Zerr, Inga] Univ Gottingen, Dementia Res Grp, Dept Neurol, D-37073 Gottingen, Germany; [Zerr, Inga] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Romero, Carlos] FLENI, Dept Neuroradiol, Buenos Aires, DF, Argentina; [Romero, Carlos] FLENI, Dept Neuropathol, Buenos Aires, DF, Argentina	University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Zerr, I (corresponding author), Univ Gottingen, Dementia Res Grp, Dept Neurol, D-37073 Gottingen, Germany.	ingazerr@med.uni-goettingen.de		Romero, Teresa/0000-0002-1245-9906	mobility exchange program BMBF [ARG 07/008]	mobility exchange program BMBF(Federal Ministry of Education & Research (BMBF))	Part of the study was supported by the mobility exchange program BMBF ARG 07/008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibl M, 2008, DEMENT GERIATR COGN, V25, P256, DOI 10.1159/000115975; Broderick DF, 2009, NEUROLOGY, V73, P1934, DOI 10.1212/WNL.0b013e3181bd6a46; Bronge L, 2003, PSYCHIAT RES-NEUROIM, V122, P199, DOI 10.1016/S0925-4927(03)00005-2; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cavalieri M, 2010, NEURODEGENER DIS, V7, P122, DOI 10.1159/000285521; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hu YY, 2002, AM J PATHOL, V160, P1269, DOI 10.1016/S0002-9440(10)62554-0; Jellinger KA, 2008, J ALZHEIMERS DIS, V14, P107; Jonsson M, 2010, EUR J NEUROL, V17, P377, DOI 10.1111/j.1468-1331.2009.02808.x; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Ma KC, 1997, CEREBROVASC DIS, V7, P324, DOI 10.1159/000108216; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; Pohjasvaara T, 2000, STROKE, V31, P2952, DOI 10.1161/01.STR.31.12.2952; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Schmidtke K, 2002, J NEUROL SCI, V203, P17, DOI 10.1016/S0022-510X(02)00254-X; Silbert LC, 2009, NEUROLOGY, V73, P120, DOI 10.1212/WNL.0b013e3181ad53fd; Sjogren M, 2001, J NEUROSCI RES, V66, P510, DOI 10.1002/jnr.1242; Verdelho A, 2010, NEUROLOGY, V75, P160, DOI 10.1212/WNL.0b013e3181e7ca05; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318	23	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105000	10.1371/journal.pone.0105000	http://dx.doi.org/10.1371/journal.pone.0105000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147945	Green Published, gold, Green Submitted			2022-12-25	WOS:000341230600030
J	Yuan, JS; Chen, S; Qiao, SB; Duan, FJ; Zhang, JF; Wang, H				Yuan, Jiansong; Chen, Shi; Qiao, Shubin; Duan, Fujian; Zhang, Jiafen; Wang, Hao			Characteristics of Myocardial Postsystolic Shortening in Patients with Symptomatic Hypertrophic Obstructive Cardiomyopathy before and Half a Year after Alcohol Septal Ablation Assessed by Speckle Tracking Echocardiography	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; VENTRICULAR DIASTOLIC FUNCTION; STRAIN-RATE; MICROVASCULAR FUNCTION; FOLLOW-UP; DYSFUNCTION; DOPPLER; FIBROSIS; FLOW	Objectives: Postsystolic shortening (PSS) has been proposed as a marker of myocardial dysfunction. Percutaneous transluminal septal myocardial ablation (PTSMA) is an alternative therapy for patients with hypertrophic obstructive cardiomyopathy (HOCM) that results in sustained improvements in atrial structure and function. We investigated the effects of PTSMA on PSS in HOCM patients using speckle tracking imaging. Methods: Conventional echocardiographic and PSS parameters were obtained in 18 healthy controls and 30 HOCM patients before and half a year after PTSMA. Results: Compared with the healthy controls, the number of segments having PSS and the average value of PSS were significantly increased in the HOCM patients. At 6 months after PTSMA, both the number of segments having PSS (10.5 +/- 2.8 vs. 13.2 +/- 2.6; P<0.001) and the average value of PSS (-1.24 +/- 0.57 vs. -1.55 +/- 0.56; P=0.009) were significantly reduced. Moreover, the reductions in the average value of PSS correlated well with the reductions in the E-to-Ea ratio (r = 0.705, P<0.001). Conclusions: Both the number of segments having PSS and the average value of PSS were significantly increased in the HOCM patients. PTSMA has a favourable effect on PSS, which may partly account for the persistent improvement in LV diastolic function in HOCM patients after PTSMA.	[Yuan, Jiansong; Qiao, Shubin] Peking Union Med Coll, Dept Cardiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China; [Yuan, Jiansong; Qiao, Shubin; Duan, Fujian; Zhang, Jiafen; Wang, Hao] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Chen, Shi] Sichuan Univ, Dept Cardiol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Duan, Fujian; Zhang, Jiafen; Wang, Hao] Peking Union Med Coll, Dept Echocardiog, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Qiao, SB (corresponding author), Peking Union Med Coll, Dept Cardiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China.	yuanjs100@sina.com			Immunonephrology Working Group ERA-EDTA	Immunonephrology Working Group ERA-EDTA	This study was partly supported by Immunonephrology Working Group ERA-EDTA. We thank Sonya Siragusa and Daniela Campanella (both of Department of Soil, Plant and Food Sciences, University of Bari Aldo Moro, Bari, Italy) for technical assistance.	BERTHA BG, 1986, CIRCULATION, V74, P901, DOI 10.1161/01.CIR.74.4.901; Biagini E, 2009, AM J CARDIOL, V104, P1727, DOI 10.1016/j.amjcard.2009.07.057; Bradham WS, 2002, J AM COLL CARDIOL, V40, P2165, DOI 10.1016/S0735-1097(02)02595-0; Carlhall C, 2003, AM J CARDIOL, V91, P1490, DOI 10.1016/S0002-9149(03)00407-7; Chen S, 2013, ECHOCARDIOGR-J CARD, V30, P564, DOI 10.1111/echo.12087; Dai ZH, 2012, J CARDIOL, V60, P416, DOI 10.1016/j.jjcc.2012.06.009; Ellims AH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-76; Geske JB, 2007, CIRCULATION, V116, P2702, DOI 10.1161/CIRCULATIONAHA.107.698985; Green JJ, 2012, JACC-CARDIOVASC IMAG, V5, P370, DOI 10.1016/j.jcmg.2011.11.021; Huang L, 2013, CLIN RADIOL, V68, P676, DOI 10.1016/j.crad.2013.01.003; Ito T, 2006, J AM SOC ECHOCARDIOG, V19, P987, DOI 10.1016/j.echo.2006.03.019; Jassal DS, 2006, EUR HEART J, V27, P1805, DOI 10.1093/eurheartj/ehl106; Jensen MK, 2011, CIRC-CARDIOVASC INTE, V4, P256, DOI 10.1161/CIRCINTERVENTIONS.110.959718; Kukulski T, 2002, J AM SOC ECHOCARDIOG, V15, P1, DOI 10.1067/mje.2002.114844; Malek LA, 2008, EUR J HEART FAIL, V10, P1123, DOI 10.1016/j.ejheart.2008.09.005; Matsumura Y, 2002, HEART, V87, P247, DOI 10.1136/heart.87.3.247; Nagueh SF, 2001, CIRCULATION, V103, P1844; Nakai H, 2009, EUR J ECHOCARDIOGR, V10, P926, DOI 10.1093/ejechocard/jep097; Olivotto I, 2011, J AM COLL CARDIOL, V58, P839, DOI 10.1016/j.jacc.2011.05.018; Plaksej R, 2009, J HYPERTENS, V27, P2483, DOI 10.1097/HJH.0b013e3283316c4d; Prinz C, 2012, ACTA CARDIOL, V67, P187, DOI 10.1080/AC.67.2.2154209; Soliman OII, 2008, AM J CARDIOL, V101, P1321, DOI 10.1016/j.amjcard.2007.12.032; Stoylen A, 2003, ECHOCARDIOGR-J CARD, V20, P167, DOI 10.1046/j.1540-8175.2003.03013.x; Stroud RE, 2005, J CARD FAIL, V11, P124, DOI 10.1016/j.cardfail.2004.05.002; Timmer SAJ, 2011, AM J PHYSIOL-HEART C, V301, pH129, DOI 10.1152/ajpheart.00077.2011; Tsai WC, 2012, J HYPERTENS, V30, P787, DOI 10.1097/HJH.0b013e32834f6b2b; Voigt JU, 2003, CIRCULATION, V107, P2120, DOI 10.1161/01.CIR.0000065249.69988.AA; Voigt JV, 2003, J AM SOC ECHOCARDIOG, V16, P415, DOI 10.1016/S0894-7317(03)00111-1; Yang L, 2007, CHINESE MED J-PEKING, V120, P1894, DOI 10.1097/00029330-200711010-00008; Yuan JS, 2010, AM J CARDIOL, V106, P1487, DOI 10.1016/j.amjcard.2010.07.017	30	14	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99014	10.1371/journal.pone.0099014	http://dx.doi.org/10.1371/journal.pone.0099014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922531	gold, Green Published, Green Submitted			2022-12-25	WOS:000338701300024
J	Fan, W; Xu, L; Xie, LC; Yang, DC; Liu, XZ; Zhang, JJ; Li, YR; Yi, CJ				Fan, Wen; Xu, Lei; Xie, Liangcai; Yang, Decai; Liu, Xuezheng; Zhang, Jiajun; Li, Yirong; Yi, Cunjian			Negative Interference by Rheumatoid Factor of Plasma B-Type Natriuretic Peptide in Chemiluminescent Microparticle Immunoassays	PLOS ONE			English	Article							HEART-FAILURE; SERUM; ANTIBODIES; DIAGNOSIS; ARTHRITIS; VALUES; BRAIN; NEED	Background: The chemiluminescent microparticle immunoassay (CMIA) is widely used for the quantitative determination of B-type natriuretic peptide (BNP) in human ethylenediaminetetraacetic acid plasma. Rheumatoid factor (RF) is usually thought to result in a positive interference in immunoassays, but it is not clear whether its presence in plasma can lead to interferences in the CMIA of BNP. Methods: The estimation of BNP recovery was carried out by diluting high-concentration BNP samples with RF-positive or RF-negative plasma at a ratio of 1:9. The diluted samples were then tested using the ARCHITECT i2000 System and ARCHITECT BNP Reagent Kits and the recovery was then calculated. Results: When the RF level ranged from 48 to 1420 IU/mL, the average recovery of BNP was 79.29% and 91.61% in the RF-positive and RF-negative plasma samples, respectively, and was thus significantly lower in the group of RF-positive plasma samples than in the group of RF-negative plasma samples. At a dilution of 1:16, the measured BNP level increased by >36% in six of the seven RF-positive plasma samples. The recovery of BNP increased significantly in the RF-positive plasma samples after pretreatment with IgG-sensitive latex particles. In addition, The BNP recovery was not significantly related to the plasma RF at concentrations ranging from 48 to 2720 IU/mL. Conclusions: Measurement of BNP by CMIA is susceptible to interference from RF leading to predominantly (but not exclusively) lower results. Pretreatment of samples with blocking reagents is advisable prior to the initiation of denying patient's necessary treatment.	[Fan, Wen; Xie, Liangcai; Liu, Xuezheng; Zhang, Jiajun] Jingzhou First Peoples Hosp, Dept Lab Med, Jinzhou, Hubei, Peoples R China; [Xu, Lei; Yang, Decai; Li, Yirong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lab Med, Wuhan 430074, Hubei, Peoples R China; [Yi, Cunjian] Jingzhou First Peoples Hosp, Dept Obstet & Gynecol, Jinzhou, Hubei, Peoples R China	Huazhong University of Science & Technology	Li, YR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lab Med, Wuhan 430074, Hubei, Peoples R China.	liyirong838@163.com; cunjiany@163.com		Zhang, Senhao/0000-0002-9231-9750	National Natural Science Foundation of China [30970060]; Scientific Research Foundation of the Education Ministry of China [2008890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of the Education Ministry of China	This study was supported by grants 30970060 from the National Natural Science Foundation of China and 2008890 from the Scientific Research Foundation of the Education Ministry of China for Returned Chinese Scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels EM, 2013, METHODS, V61, P18, DOI 10.1016/j.ymeth.2012.12.015; BOSCATO LM, 1986, CLIN CHEM, V32, P1491; Eriksson S, 2003, CLIN CHEM, V49, P1095, DOI 10.1373/49.7.1095; Ismail AAA, 2009, J CLIN PATHOL, V62, P673, DOI 10.1136/jcp.2008.055848; Ismail AAA, 2011, ANN CLIN BIOCHEM, V48, P65, DOI 10.1258/acb.2010.010197; Ismail Y, 2007, CLIN MED, V7, P357, DOI 10.7861/clinmedicine.7-4-357; Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC; Li YR, 2014, LABMEDICINE, V45, P82, DOI 10.1309/LMO7HLI8EODNAZSG; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Marks V, 2002, CLIN CHEM, V48, P2008; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; MOORE TL, 1993, CLIN BIOCHEM, V26, P75, DOI 10.1016/0009-9120(93)90032-2; Norden AGW, 1997, CLIN CHEM, V43, P957; Onuska KD, 2000, CLIN CHEM, V46, P307; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Tsavaris N, 2007, ANN RHEUM DIS, V66, P980, DOI 10.1136/ard.2007.070052; Wieczorek SJ, 2002, AM HEART J, V144, P834, DOI 10.1067/mhj.2002.125623; Xu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080620; Xu L, 2013, CLIN BIOCHEM, V46, P799, DOI 10.1016/j.clinbiochem.2013.03.013; YANDLE TG, 1994, J INTERN MED, V235, P561, DOI 10.1111/j.1365-2796.1994.tb01263.x	21	20	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105304	10.1371/journal.pone.0105304	http://dx.doi.org/10.1371/journal.pone.0105304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25473944	gold, Green Published, Green Submitted			2022-12-25	WOS:000341106100048
J	Lin, ZY; Xu, SQ; Que, YX; Wang, JH; Comstock, JC; Wei, JJ; McCord, PH; Chen, BS; Chen, RK; Zhang, MQ				Lin, Zhenyue; Xu, Shiqiang; Que, Youxiong; Wang, Jihua; Comstock, Jack C.; Wei, Jinjin; McCord, Per H.; Chen, Baoshan; Chen, Rukai; Zhang, Muqing			Species-Specific Detection and Identification of Fusarium Species Complex, the Causal Agent of Sugarcane Pokkah Boeng in China	PLOS ONE			English	Article							REAL-TIME PCR; QUANTIFICATION; SEQUENCES; DIAGNOSIS; DIVERSITY; FUJIKUROI; STRAINS; BANANA; PLANTS; SPP.	Background: Pokkah boeng disease caused by the Fusarium species complex results in significant yield losses in sugarcane. Thus, the rapid and accurate detection and identification of the pathogen is urgently required to manage and prevent the spreading of sugarcane pokkah boeng. Methods: A total of 101 isolates were recovered from the pokkah boeng samples collected from five major sugarcane production areas in China throughout 2012 and 2013. The causal pathogen was identified by morphological observation, pathogenicity test, and phylogenetic analysis based on the fungus-conserved rDNA-ITS. Species-specific TaqMan real-time PCR and conventional PCR methods were developed for rapid and accurate detection of the causal agent of sugarcane pokkah boeng. The specificity and sensitivity of PCR assay were also evaluated on a total of 84 isolates of Fusarium from China and several isolates from other fungal pathogens of Sporisorium scitamineum and Phoma sp. and sugarcane endophyte of Acremonium sp. Result: Two Fusarium species (F. verticillioides and F. proliferatum) that caused sugarcane pokahh boeng were identified by morphological observation, pathogenicity test, and phylogenetic analysis. Species-specific TaqMan PCR and conventional PCR were designed and optimized to target their rDNA-ITS regions. The sensitivity of the TaqMan PCR was approximately 10 pg of fungal DNA input, which was 1,000-fold over conventional PCR, and successfully detected pokkah boeng in the field-grown sugarcane. Conclusions/Significance: This study was the first to identify two species, F. verticillioides and F. proliferatum, that were causal pathogens of sugarcane pokkah boeng in China. It also described the development of a species-specific PCR assay to detect and confirm these pathogens in sugarcane plants from mainland China. This method will be very useful for a broad range of research endeavors as well as the regulatory response and management of sugarcane pokkah boeng.	[Lin, Zhenyue; Xu, Shiqiang; Wang, Jihua; Chen, Baoshan; Zhang, Muqing] Guangxi Univ, Nanning 530004, Guangxi, Peoples R China; [Lin, Zhenyue; Que, Youxiong; Wei, Jinjin; Chen, Rukai; Zhang, Muqing] Fujian Agr & Forestry Univ, Fuzhou, Peoples R China; [Comstock, Jack C.; McCord, Per H.] ARS, USDA, Sugarcane Field Stn, Canal Point, FL USA	Guangxi University; Fujian Agriculture & Forestry University; United States Department of Agriculture (USDA)	Zhang, MQ (corresponding author), Guangxi Univ, Nanning 530004, Guangxi, Peoples R China.	mqzhang@ufl.edu	Lin, Ying/AAE-1879-2020; Lin, Zhenyue/O-1211-2019; Lin, Zhenyue/H-1569-2017	Lin, Zhenyue/0000-0002-6367-2459; Lin, Zhenyue/0000-0002-6367-2459; zhang, muqing/0000-0003-3138-3422	Guangxi special funding for distinguished experts and Funds from State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; Guangxi Natural Science Foundation [2014GXNSFFA118002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061010, U01DK085476, UC4DK097835, U01DK061058, T32DK007161, UC4DK117009, U01DK085461] Funding Source: NIH RePORTER	Guangxi special funding for distinguished experts and Funds from State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support was provided by Guangxi special funding for distinguished experts and Funds from State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources. This project is also supported by Guangxi Natural Science Foundation (2014GXNSFFA118002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatulli MT, 2012, EUR J PLANT PATHOL, V134, P401, DOI 10.1007/s10658-012-9998-0; BACON CW, 1994, J FOOD PROTECT, V57, P514, DOI 10.4315/0362-028X-57.6.514; Blackburn F, 1984, SUGAR CANE, P414; Bower NI, 2005, PLANT SCI, V168, P761, DOI 10.1016/j.plantsci.2004.10.006; Diamond M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069542; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; Gonzalez-Jaen MT, 2004, EUR J PLANT PATHOL, V110, P525, DOI 10.1023/B:EJPP.0000032392.20106.81; Goswami D, 2013, J BASIC MICROB, V00, P1; Govender P., 2010, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P267; Irawan Whittle P, 2000, GUIDE SUGARCANE DIS, P136; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Khani KT., 2013, P IRNOP 2013 C JUNE, V28, P1; Kvas M, 2009, FUNGAL DIVERS, V34, P1; Leslie JF, 2006, FUSARIUM LAB MANUAL, P385; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; Lian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063380; Lin ZY, 2014, PLANT DIS, V98, P850, DOI 10.1094/PDIS-10-13-1061-PDN; Martin J, 1989, DIS SUGARCANE MAJOR, P157; Martin JP, 1961, SUGARCANE DIS WORLD, V1; McFarlane S. A., 2005, Proceedings of the 79th Annual Congress of South African Sugar Technologists' Association, held at Kwa-Shukela, Mount Edgecombe, South Africa, 19-22 July 2005, P120; Mohammadi A, 2012, PLANT PROTECT SCI, V48, P80, DOI 10.17221/49/2011-PPS; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Donnell Kerry, 2000, Mycoscience, V41, P61, DOI 10.1007/BF02464387; Sampietro DA, 2010, FUNGAL BIOL-UK, V114, P74, DOI 10.1016/j.mycres.2009.10.008; Sayler RJ, 2012, PLANT DIS, V96, P1757, DOI 10.1094/PDIS-12-11-1033-RE; Sheldon JL, 1904, AGR EXP STN NEBRASKA, V17, P23; Siddique S, 2007, THESIS U MALAYSIA MA; Siti Nordahliawate M. S., 2008, Pertanika Journal of Tropical Agricultural Science, V31, P279; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan MK, 2003, MYCOL RES, V107, P811, DOI 10.1017/S0953756203008013; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Vishwakarma S. K., 2013, Journal of Plant Pathology and Microbiology, V4, P170; Wang H, 2011, J CLIN MICROBIOL, V49, P1890, DOI 10.1128/JCM.02415-10; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wulff EG, 2010, ENVIRON MICROBIOL, V12, P649, DOI 10.1111/j.1462-2920.2009.02105.x; Zeng XY, 2007, J CLIN MICROBIOL, V45, P2872, DOI 10.1128/JCM.00687-07; Zhu YJ, 2010, EUR J PLANT PATHOL, V127, P263, DOI 10.1007/s10658-010-9591-3	38	56	72	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104195	10.1371/journal.pone.0104195	http://dx.doi.org/10.1371/journal.pone.0104195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141192	Green Published, Green Submitted, gold			2022-12-25	WOS:000342687200015
J	Jin, J; Li, WY; Peng, LM; Chen, J; Li, R; Wu, PH; Tan, S				Jin, Jun; Li, Wuying; Peng, Lingmei; Chen, Jian; Li, Rong; Wu, Peihua; Tan, Sheng			Relationship between Interleukin-10-1082A/G Polymorphism and Risk of Ischemic Stroke: A Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISMS; ASSOCIATION; HYPERTENSION; PROMOTER; SNPS	Objective: To analyze the association between -1082A/G polymorphism in interleukin-10 (IL-10) gene and ischemic stroke (IS) risk by meta-analysis. Methods: We carried out a systematic electronic search in PubMed, BIOSIS Previews, Science Direct, Chinese National Knowledge Infrastructure, Chinese Biomedical Database, Weipu database and WANGFANG Database. Pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated to assess the strength of the association. Results: 7 studies were included. There was no significant association between IL-10 -1082A/G polymorphism and IS risk under all genetic models in overall estimates (A vs. G: OR = 1.23,95% CI = 0.85-1.79; AA vs. GG: OR = 1.01,95% CI = 0.47-2.19; AG vs. GG: OR = 0.76, 95% CI = 0.38-1.55; AA+AG vs. GG: OR = 0.89,95% CI = 0.46-1.73; AA vs. AG+GG: OR = 1.39, 95% CI = 0.91-2.13). Similarly, no associations were found in subgroup analysis based on ethnicity and source of controls. However, removing the study deviating from Hardy-Weinberg equilibrium (HWE) produced statistically significant associations for overall estimates under recessive model(AA VS. AG+GG OR 1.58, 95% CI 1.04-2.42) and among Asians in all genetic models (A VS. G OR 1.64, 95% CI 1.07-2.53; AA vs. GG OR1.91, 95% CI 1.31-2.80; AG vs. GG OR1.44, 95% CI 1.09-1.91; AA+AG vs. GG OR 1.54, 95% CI 1.18-2.01; AA VS. AG+ GG OR 1.79, 95% CI 1.07-3.00). Even after Bonferroni correction, the associations were observed still significantly in Asians under the two models (AA vs. GG OR1.91, 95% CI 1.31-2.80, P = 0.0008; AA+AG vs. GG OR 1.54, 95% CI 1.18-2.01, P = 0.001). Conclusion: This meta-analysis indicates that IL10 -1082 A/G polymorphism is associated with IS susceptibility in Asians and the 21082 A allele may increase risk of IS in Asians. Considering the sample size is small and between-study heterogeneity is remarkable, more studies with subtle design are warranted in future.	[Jin, Jun; Li, Wuying; Chen, Jian; Li, Rong; Wu, Peihua; Tan, Sheng] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Peng, Lingmei] First Peoples Hosp Foshan, Dept Neurol, Foshan, Peoples R China; [Jin, Jun] Zhumadian Zhongxin Hosp, Dept Neurol, Zhumadian, Peoples R China	Southern Medical University - China	Tan, S (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	tansheng18@126.com	tan, sheng/GSN-2599-2022	/0000-0002-5091-7218; Kamalam, Biju Sam/0000-0003-1944-0244; Medale, Francoise/0000-0002-8083-1298; Panserat, Stephane/0000-0002-4479-9868				Amarenco P, 2009, CEREBROVASC DIS, V27, P493, DOI 10.1159/000210432; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Balding J, 2004, IRISH J MED SCI, V173, P200, DOI 10.1007/BF02914551; Bis JC, 2008, ATHEROSCLEROSIS, V198, P166, DOI 10.1016/j.atherosclerosis.2007.09.031; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eskdale J, 1998, P NATL ACAD SCI USA, V95, P9465, DOI 10.1073/pnas.95.16.9465; Fei GZ, 2004, ATHEROSCLEROSIS, V177, P409, DOI 10.1016/j.atherosclerosis.2004.07.026; Jin L, 2011, LAB MED, V26, P717; Kilpinen S, 2002, EUR CYTOKINE NETW, V13, P66; Li H, 2008, THESIS SO MED U; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lin KX, 2009, THESIS FUJIAN MED U; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marousi S, 2011, EUR J NEUROL, V18, P637, DOI 10.1111/j.1468-1331.2010.03228.x; Marousi S, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/792923; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Munshi A, 2010, CYTOKINE, V52, P221, DOI 10.1016/j.cyto.2010.09.013; Park HK, 2013, MOL BIOL REP, V40, P1785, DOI 10.1007/s11033-012-2232-5; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stoica AL, 2010, J VASC SURG, V52, P103, DOI 10.1016/j.jvs.2010.01.088; Sultana S, 2011, J GENET, V90, P361, DOI 10.1007/s12041-011-0079-5; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Timasheva YR, 2008, BIOCHEM GENET, V46, P64, DOI 10.1007/s10528-007-9130-x; Trompet S, 2007, ANN NY ACAD SCI, V1100, P189, DOI 10.1196/annals.1395.018; Tuttolomondo A, 2012, CYTOKINE, V58, P398, DOI 10.1016/j.cyto.2012.02.012; Xie GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074126; Xie GQ, 2008, MOL CARDIOL CHINA, V8, P305; Yadav S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057305; Zhang GZ, 2007, CHIN J CEREBROVASC D, V4, P294; Zhang GZ, 2006, THESIS 1 MILITARY ME	33	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94631	10.1371/journal.pone.0094631	http://dx.doi.org/10.1371/journal.pone.0094631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	25141351	Green Submitted, Green Published, gold			2022-12-25	WOS:000336970400061
J	He, XL; Huang, X; Shen, YZ; Huang, ZJ				He, Xiaoliang; Huang, Xi; Shen, Yinzhu; Huang, Zhanjing			Wheat V-H+-ATPase Subunit Genes Significantly Affect Salt Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							PROTON TRANSPORT; NACL REGULATION; OSMOTIC-STRESS; EXPRESSION; PLANT; CLONING; MECHANISM; GROWTH; LEAVES	Genes for V-H+-ATPase subunits were identified and cloned from the salt-tolerant wheat mutant RH8706-49. Sequences of these genes are highly conserved in plants. Overexpression of these genes in Arabidopsis thaliana improved its salt tolerance, and increased the activities of V-H+-ATPase and Na+/H+ exchange, with the largest increase in plants carrying the c subunit of V-H+-ATPase. Results from quantitative RT-PCR analysis indicated that the mRNA level of each V-H+-ATPase subunit in the Arabidopsis increased under salt stress. Overall, our results suggest that each V-H+-ATPase subunit plays a key role in enhancing salt tolerance in plants.	[Huang, Xi; Shen, Yinzhu; Huang, Zhanjing] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China; [He, Xiaoliang] Hebei Univ Sci & Technol, Sch Biol Sci & Engn, Shijiazhuang, Hebei, Peoples R China	Hebei Normal University; Hebei University of Science & Technology	Huang, ZJ (corresponding author), Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China.	huangzhanjing@sohu.com	TANG, Rui/GRS-5116-2022	He, Xing/0000-0001-7676-9930	National Natural Science Fund [30971766]; Hebei Provincial Natural Science Fund [C2009000278]; Doctor Fund of Hebei University of Science and Technology [QD201046]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Hebei Provincial Natural Science Fund; Doctor Fund of Hebei University of Science and Technology	This work was supported by National Natural Science Fund (30971766), Hebei Provincial Natural Science Fund (No. C2009000278), and Doctor Fund of Hebei University of Science and Technology (QD201046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baisakh N, 2012, PLANT BIOTECHNOL J, V10, P453, DOI 10.1111/j.1467-7652.2012.00678.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Forgac M, 2000, J EXP BIOL, V203, P71; Gao CQ, 2011, MOL BIOL REP, V38, P957, DOI 10.1007/s11033-010-0189-9; Ge RC, 2007, PLANT SCI, V173, P55, DOI 10.1016/j.plantsci.2007.04.005; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; He XL, 2012, PLANT MOL BIOL REP, V30, P807, DOI 10.1007/s11105-011-0390-6; Hou XN, 2013, PLANT MOL BIOL REP, V31, P791, DOI 10.1007/s11105-012-0549-9; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Kirsch M, 1996, PLANT MOL BIOL, V32, P543, DOI 10.1007/BF00019107; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Lehr A, 1999, PLANT MOL BIOL, V39, P463, DOI 10.1023/A:1006158310891; Li PH, 2004, ACTA BOT SIN, V46, P93; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Muller ML, 1996, J BIOL CHEM, V271, P1916; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NARASIMHAN ML, 1991, PLANT PHYSIOL, V97, P562, DOI 10.1104/pp.97.2.562; NIU XM, 1993, PLANT PHYSIOL, V103, P713, DOI 10.1104/pp.103.3.713; Ratajczak R, 2000, BBA-BIOMEMBRANES, V1465, P17, DOI 10.1016/S0005-2736(00)00129-2; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; Wang BS, 2001, J EXP BOT, V52, P2355, DOI 10.1093/jexbot/52.365.2355; Wang L, 2011, PLANTA, V234, P1, DOI 10.1007/s00425-011-1383-2; WARD JM, 1992, PLANT PHYSIOL, V99, P925, DOI 10.1104/pp.99.3.925; Xu CX, 2011, PLANT MOL BIOL REP, V29, P424, DOI 10.1007/s11105-010-0247-4; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200; Zhao Q, 2009, PLANT MOL BIOL, V69, P33, DOI 10.1007/s11103-008-9403-8; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	30	96	108	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86982	10.1371/journal.pone.0086982	http://dx.doi.org/10.1371/journal.pone.0086982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498005	Green Submitted, Green Published, gold			2022-12-25	WOS:000330617100043
J	Sun, XR; Sun, Z; Zhu, Z; Guan, HX; Zhang, JY; Zhang, YN; Xu, HM; Sun, MJ				Sun, Xuren; Sun, Zhe; Zhu, Zhi; Guan, Haixia; Zhang, Junyan; Zhang, Yining; Xu, Huimian; Sun, Mingjun			Clinicopathological Significance and Prognostic Value of Lactate Dehydrogenase A Expression in Gastric Cancer Patients	PLOS ONE			English	Article							AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; LDH-A; CELLS; GROWTH	Introduction: LDH-A, the enzyme responsible for transforming pyruvate into lactate, has been demonstrated to be up-regulated in many types of cancer and to give rise to more aggressive behavior by regulating proliferation and antiapoptosis. However, its expression in gastric cancer (GC) has not been characterized thoroughly. The purpose of this study was to clarify the expression and potential impact of LDH-A in GC. Methods: We examined LDH-A expression by immunohistochemistry on GC tissue microarray (TMA) and using Western blot on fresh GC tissues and cell lines. Prognostic value and correlation with other clinicopathologic factors were evaluated. We transfected siRNA into GC cells against LDH-A. LDH-A was analyzed by Western blotting and real-time RT-PCR. Cell growth was evaluated in vitro and in vivo. Lactate and ATP production by cells were determined. Results: There was significantly higher LDH-A expression in carcinoma than in non-neoplastic mucosa (NNM). There was a positive correlation of LDH-A expression with age, histological type and Lymph node metastases. Survival analysis demonstrated that high expression of LDH-A in GC was associated with lower overall survival (OS). When stratified by Lauren grade and histological classification, significance appeared in diffuse type and undifferentiated type GC. In multivariate analysis, the LDH-A expression in GC was an independent prognostic risk factor for OS (hazard ratio = 1.829, 95% CI 1.375-2.433, P<0.0001). Specific siRNA against LDH-A in GC cell line retarded cell growth both in vitro and in mouse models. LDH-A knockdown also reduced lactate and ATP production in GC cells. Conclusions: Our study indicated the oncogenic role of LDH-A in GC. LDH-A expression is an independent prognostic risk factor in GC patients and up-regulated expression of LDH-A could be predictive of poor outcomes in diffuse type and undifferentiated type GC. Our results suggested that LDH-A might be a potential therapeutic target in gastric cancer.	[Sun, Xuren; Sun, Mingjun] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China; [Sun, Zhe; Zhu, Zhi; Zhang, Junyan; Xu, Huimian] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Shenyang, Liaoning Provin, Peoples R China; [Guan, Haixia] China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Yining; Sun, Mingjun] China Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Endoscopy, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Sun, MJ (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China.	smjmw@sina.com		Pan, Chen-Wei/0000-0003-3362-4613	Liaoning Province Science and Technology Department [2007225017, 2009225011-2, 2011415052]; Science and Technology projects in Shenyang City [F11-264-1-19]	Liaoning Province Science and Technology Department; Science and Technology projects in Shenyang City	This study was supported by grants from the research projects in Liaoning Province Science and Technology Department (No. 2007225017, No. 2009225011-2 and No. 2011415052) and Science and Technology projects in Shenyang City (No. F11-264-1-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Cai Z, 2010, MOL CELL PROTEOMICS, V9, P2617, DOI 10.1074/mcp.M110.000661; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Rong YF, 2013, TUMOR BIOL, V34, P1523, DOI 10.1007/s13277-013-0679-1; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yao F, 2013, TUMOR BIOL, V34, P25, DOI 10.1007/s13277-012-0506-0; Zhang YJ, 2012, CANCER LETT, V321, P45, DOI 10.1016/j.canlet.2012.03.013	18	66	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91068	10.1371/journal.pone.0091068	http://dx.doi.org/10.1371/journal.pone.0091068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24788769	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800094
J	He, X; Pu, GB; Tang, R; Zhang, DM; Pan, WQ				He, Xing; Pu, Guangbin; Tang, Rui; Zhang, Dongmei; Pan, Weiqing			Activation of Nuclear Factor Kappa B in the Hepatic Stellate Cells of Mice with Schistosomiasis Japonica	PLOS ONE			English	Article							MICRORNAS; LIVER; EXPRESSION; FIBROSIS; DISEASE; FIBROGENESIS	Schistosomiasis japonica is a serious tropical parasitic disease in humans, which causes inflammation and fibrosis of the liver. Hepatic stellate cells (HSCs) are known to play an important role in schistosome-induced fibrosis, but their role in schistosome-induced inflammation is still largely unknown. Here, we use a murine model of schistosomiasis japonica to investigate the role that nuclear factor kappa B (NF-kappa B), a critical mediator of inflammatory responses, plays in schistosome-induced inflammation. We revealed that NF-kappa B was significantly activated in HSCs at the early stage of infection, but not at later stages. We also show that the expression levels of several chemokines regulated by NF-kappa B signaling (Ccl2, Ccl3 and Ccl5) were similarly elevated at early infection. TLR4 signaling, one of the strongest known inducers of NF-kappa B activation, seemed not activated in HSCs post-infection. Importantly, we found that levels of miR-146 (a known negative regulator of NF-kappa B signaling) in HSCs opposed those of NF-kappa B signaling, elevating at later stage of infection. These results indicate that HSCs might play an important role in the progression of hepatic schistosomiasis japonica by linking liver inflammation to fibrosis via NF-kappa B signaling. Moreover, our work suggests that miR-146 appeared to regulate this process. These findings are significant and imply that manipulating the function of HSCs by targeting either NF-kappa B signaling or miR-146 expression may provide a novel method of treating hepatic schistosomiasis japonica.	[He, Xing; Pu, Guangbin; Tang, Rui; Zhang, Dongmei; Pan, Weiqing] Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China	Naval Medical University	Zhang, DM (corresponding author), Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China.	dmzhangcn@gmail.com; wqpan0912@aliyun.com	TANG, Rui/GRS-5116-2022	He, Xing/0000-0001-7676-9930	National Basic Research Program (973 Program) [2007CB513100]; National Science and Technology Program of China [2012ZX10004220]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Science and Technology Program of China	This study was supported by grants from the National Basic Research Program (973 Program) (2007CB513100) and the National Science and Technology Program of China (2012ZX10004220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Cai PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067037; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHEEVER A W, 1968, Bulletin of the World Health Organization, V39, P328; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chuah C, 2014, TRENDS PARA IN PRESS; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Do H, 1999, J BIOL CHEM, V274, P19587, DOI 10.1074/jbc.274.28.19587; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; He X, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-272; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kelada S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003451; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Liang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042490; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Ramm GA, 2009, HEPATOLOGY, V49, P533, DOI 10.1002/hep.22637; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wang ZX, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000596; Winau F, 2008, CURR OPIN IMMUNOL, V20, P68, DOI 10.1016/j.coi.2007.10.006	35	96	108	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104323	10.1371/journal.pone.0104323	http://dx.doi.org/10.1371/journal.pone.0104323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	24498005	Green Published, Green Submitted, gold			2022-12-25	WOS:000341230400042
